PT	AU	BA	BE	GP	AF	BF	CA	TI	SO	SE	BS	LA	DT	CT	CY	CL	SP	HO	DE	ID	AB	C1	RP	EM	RI	OI	FU	FX	CR	NR	TC	Z9	PU	PI	PA	SN	EI	BN	J9	JI	PD	PY	VL	IS	PN	SU	SI	MA	BP	EP	AR	DI	D2	PG	WC	SC	GA	UT	PM
J	Peckova, K; Ohe, C; Kuroda, N; Martinek, P; Bulimbasic, S; Montiel, DP; Lopez, J; Condom-Mundo, E; Daum, O; Rotterova, P; Hora, M; Michal, M; Hes, O				Peckova, Kvetoslava; Ohe, Chisato; Kuroda, Naoto; Martinek, Petr; Bulimbasic, Stela; Montiel, Delia Perez; Lopez, Jose; Condom-Mundo, Enric; Daum, Ondrej; Rotterova, Pavla; Hora, Milan; Michal, Michal; Hes, Ondrej			Chromophobe Renal Cell Carcinoma With Neuroendocrine Differentiation and Neuroendocrine-Like Features. Morphologic, Immunohistochemical, Ultrastructural, and ArrayCGH Analysis of 18 Cases	MODERN PATHOLOGY			English	Meeting Abstract	104th Annual Meeting of the United-States-and-Canadian-Academy-of-Pathology	MAR 21-27, 2015	Boston, MA	US & Canadian Acad Pathol					Charles Univ Prague, Plzen, Czech Republic; Charles Univ Hosp, Plzen, Czech Republic; Kansai Med Univ, Osaka, Japan; Red Cross Hosp, Kochi, Japan; Univ Hosp Dubrava, Zagreb, Croatia; Inst Nacl Cancerol, Mexico City, DF, Mexico; Cruces Univ Hosp, Baracaldo, Spain; Bellvitge Univ Hosp, Barcelona, Spain								0	0	0	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	0893-3952	1530-0285		MODERN PATHOL	Mod. Pathol.	FEB	2015	28			2		995	250A	250A				1	Pathology	Pathology	CB3BF	WOS:000349502201333		
J	Sarungbam, J; Hakimi, AA; Sato, Y; Ogawa, S; Jacobsen, A; Homma, Y; Morikawa, T; Kume, H; Fukayama, M; Chen, YB; Gopalan, A; Al-Ahmadie, H; Fine, S; Sirintrapun, S; Russo, P; Hsieh, J; Reuter, V; Tickoo, S				Sarungbam, Judy; Hakimi, A. Ari; Sato, Yusuke; Ogawa, Seishi; Jacobsen, Anders; Homma, Yukio; Morikawa, Teppei; Kume, Haruki; Fukayama, Masahi; Chen, Yingbei; Gopalan, Anuradha; Al-Ahmadie, Hikmat; Fine, Samson; Sirintrapun, Sahussapont; Russo, Paul; Hsieh, James; Reuter, Victor; Tickoo, Satish			TCEB1-Mutated Renal Cell Carcinoma (RCC): An Entity With Clear Cytoplasm and Prominent Fibromuscular Stroma Is Distinct From Clear Cell Renal Cell Carcinoma (ccRCC)	MODERN PATHOLOGY			English	Meeting Abstract	104th Annual Meeting of the United-States-and-Canadian-Academy-of-Pathology	MAR 21-27, 2015	Boston, MA	US & Canadian Acad Pathol					Mem Sloan Kettering Canc Ctr, New York, NY 10021 USA; Kyoto Univ, Kyoto, Kansai, Japan; Univ Tokyo, Tokyo, Japan								0	0	0	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	0893-3952	1530-0285		MODERN PATHOL	Mod. Pathol.	FEB	2015	28			2		1022	257A	257A				1	Pathology	Pathology	CB3BF	WOS:000349502201360		
J	Sato, S; Suzuki, S; Naiki-Ito, A; Yamashita, Y; Kuno, T; Takahashi, S				Sato, Shinya; Suzuki, Shugo; Naiki-Ito, Aya; Yamashita, Yoriko; Kuno, Toshiya; Takahashi, Satoru			Suppressive Effect of HDAC Inhibitor, OBP-801, on Prostate Cancer Development, Proliferation, and Invasion In Vivo	MODERN PATHOLOGY			English	Meeting Abstract	104th Annual Meeting of the United-States-and-Canadian-Academy-of-Pathology	MAR 21-27, 2015	Boston, MA	US & Canadian Acad Pathol					Nagoya City West Med Ctr, Nagoya, Aichi, Japan; Nagoya City Univ, Grad Sch Med Sci, Nagoya, Aichi, Japan			Yamashita, Yoriko/B-9810-2011					0	0	0	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	0893-3952	1530-0285		MODERN PATHOL	Mod. Pathol.	FEB	2015	28			2		1024	257A	+				2	Pathology	Pathology	CB3BF	WOS:000349502201362		
J	Sato, S; Takahashi, H; Yorozu, T; Kimura, T; Ikegami, M				Sato, Shun; Takahashi, Hiroyuki; Yorozu, Takashi; Kimura, Takahiro; Ikegami, Masahiro			Dissimilar Clinicopathological and Biological Characteristics of Anterior/Transition Zone Prostate Cancer With Emphasis of Lower Incidence of ERG Overexpression	MODERN PATHOLOGY			English	Meeting Abstract	104th Annual Meeting of the United-States-and-Canadian-Academy-of-Pathology	MAR 21-27, 2015	Boston, MA	US & Canadian Acad Pathol					[Sato, Shun; Takahashi, Hiroyuki; Yorozu, Takashi; Kimura, Takahiro; Ikegami, Masahiro] Jikei Univ, Sch Med, Tokyo, Japan								0	0	0	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	0893-3952	1530-0285		MODERN PATHOL	Mod. Pathol.	FEB	2015	28			2		1025	257A	257A				1	Pathology	Pathology	CB3BF	WOS:000349502201363		
J	Tsuzuki, T; Araki, H; Kimura, T; Tanaka, K; Yamada, S; Sassa, N; Yoshino, Y; Hattori, R; Gotoh, M				Tsuzuki, Toyonori; Araki, Hidemori; Kimura, Tohru; Tanaka, Kuniaki; Yamada, Shin; Sassa, Naoto; Yoshino, Yasushi; Hattori, Ryohei; Gotoh, Momokam			Relationship of Pathological Factors To Efficacy of Sorafenib Treatment in Patients With Metastatic Clear Cell Renal Cell Carcinoma	MODERN PATHOLOGY			English	Meeting Abstract	104th Annual Meeting of the United-States-and-Canadian-Academy-of-Pathology	MAR 21-27, 2015	Boston, MA	US & Canadian Acad Pathol					Japanese Red Cross Nagoya Daini Hosp, Nagoya, Aichi, Japan; Toyohashi Municipal Hosp, Toyohashi, Aichi, Japan; Shakaihoken Chukyo Hosp, Nagoya, Aichi, Japan; Kariya Toyota Gen Hosp, Kariya, Aichi, Japan; Okazaki Municipal Hosp, Okazaki, Aichi, Japan; Nagoya Univ, Grad Sch Med, Nagoya, Aichi 4648601, Japan; Japanese Red Cross Nagoya Daiichi Hosp, Nagoya, Aichi, Japan								0	0	0	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	0893-3952	1530-0285		MODERN PATHOL	Mod. Pathol.	FEB	2015	28			2		1050	263A	264A				2	Pathology	Pathology	CB3BF	WOS:000349502201388		
J	Tsuzuki, T; Katoh, M; Kimura, K; Ishida, R; Sassa, N; Yoshino, Y; Hattori, R; Gotoh, M				Tsuzuki, Toyonori; Katoh, Masashi; Kimura, Kyosuke; Ishida, Ryo; Sassa, Naoto; Yoshino, Yasushi; Hattori, Ryohei; Gotoh, Momokazu			The Presence of Intraductal Carcinoma of the Prostate in Needle Biopsy Is a Significant Prognostic Parameter for Prostate Cancer Patients With Distant Metastasis	MODERN PATHOLOGY			English	Meeting Abstract	104th Annual Meeting of the United-States-and-Canadian-Academy-of-Pathology	MAR 21-27, 2015	Boston, MA	US & Canadian Acad Pathol					Japanese Red Cross Nagoya Daini Hosp, Nagoya, Aichi, Japan; Nagoya Univ Hosp, Nagoya, Aichi, Japan; Nagoya Med Ctr, Nagoya, Aichi, Japan; Japanese Red Cross Nagoya Daiichi Hosp, Nagoya, Aichi, Japan								0	0	0	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	0893-3952	1530-0285		MODERN PATHOL	Mod. Pathol.	FEB	2015	28			2		1051	264A	264A				1	Pathology	Pathology	CB3BF	WOS:000349502201389		
J	Yorozu, T; Takahashi, H; Sato, S; Miki, J; Ikegami, M				Yorozu, Takashi; Takahashi, Hiroyuki; Sato, Shun; Miki, Jun; Ikegami, Masahiro			HER2 Overexpression in Metastasizing Urothelial Carcinoma of Urinary Bladder and Upper Urinary Tracts	MODERN PATHOLOGY			English	Meeting Abstract	104th Annual Meeting of the United-States-and-Canadian-Academy-of-Pathology	MAR 21-27, 2015	Boston, MA	US & Canadian Acad Pathol					[Yorozu, Takashi; Takahashi, Hiroyuki; Sato, Shun; Miki, Jun; Ikegami, Masahiro] Jikei Univ, Sch Med, Tokyo, Japan								0	0	0	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	0893-3952	1530-0285		MODERN PATHOL	Mod. Pathol.	FEB	2015	28			2		1074	269A	269A				1	Pathology	Pathology	CB3BF	WOS:000349502201412		
J	Aman, M; Ohishi, Y; Oda, Y				Aman, Murasaki; Ohishi, Yoshihiro; Oda, Yoshinao			Expression of Protease Activated Receptor-2 Is Related To Advanced Clinical Stage and Adverse Prognosis in Ovarian Clear Cell Adenocarcinoma	MODERN PATHOLOGY			English	Meeting Abstract	104th Annual Meeting of the United-States-and-Canadian-Academy-of-Pathology	MAR 21-27, 2015	Boston, MA	US & Canadian Acad Pathol					[Aman, Murasaki; Ohishi, Yoshihiro; Oda, Yoshinao] Kyushu Univ, Fukuoka 812, Japan								0	0	0	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	0893-3952	1530-0285		MODERN PATHOL	Mod. Pathol.	FEB	2015	28			2		1087	272A	273A				2	Pathology	Pathology	CB3BF	WOS:000349502201425		
J	Ayhan, A; Ogawa, H; Bahadirli-Talbott, A; Wu, RC; Sugimura, H; Wang, TL; Shih, IM				Ayhan, Ayse; Ogawa, Hiroshi; Bahadirli-Talbott, Asli; Wu, Ren-Chin; Sugimura, Haruhiko; Wang, Tian-Li; Shih, Ie-Ming			CCNE1 Amplification and Overexpression Characterizes Ovarian Clear Cell Carcinoma But Not Ovarian Endometrioid Carcinoma	MODERN PATHOLOGY			English	Meeting Abstract	104th Annual Meeting of the United-States-and-Canadian-Academy-of-Pathology	MAR 21-27, 2015	Boston, MA	US & Canadian Acad Pathol					Johns Hopkins Med Inst, Baltimore, MD 21205 USA; Seirei Mikatahara Hosp, Hamamatsu, Shizuoka, Japan; Chang Gung Mem Hosp, Taoyuan, Taiwan; Chang Gung Univ, Coll Med, Taoyuan, Taiwan; Hamamatsu Univ Sch Med, Hamamatsu, Shizuoka 4313192, Japan								0	0	0	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	0893-3952	1530-0285		MODERN PATHOL	Mod. Pathol.	FEB	2015	28			2		1092	273A	274A				2	Pathology	Pathology	CB3BF	WOS:000349502201430		
J	Ayhan, A; Mao, TL; Rahmanto, Y; Zeppernick, F; Ogawa, H; Wu, RC; Wang, TL; Shih, IM				Ayhan, Ayse; Mao, Tsui-Lien; Rahmanto, Yohan; Zeppernick, Felix; Ogawa, Hiroshi; Wu, Ren-Chin; Wang, Tian-Li; Shih, Ie-Ming			Increased Proliferation in "Atypical Hyperplasia/Endometrioid Intraepithelial Neoplasia" of Endometrium With Concurrent Inactivation of ARID1A and PTEN Tumor Suppressors	MODERN PATHOLOGY			English	Meeting Abstract	104th Annual Meeting of the United-States-and-Canadian-Academy-of-Pathology	MAR 21-27, 2015	Boston, MA	US & Canadian Acad Pathol					Johns Hopkins Med Inst, Baltimore, MD 21205 USA; Seirei Mikatahara Hosp, Hamamatsu, Shizuoka, Japan; Natl Taiwan Univ, Coll Med, Taipei 10764, Taiwan; Univ Hosp Aachen, Aachen, Germany; Chang Gung Mem Hosp, Taoyuan, Taiwan; Chang Gung Univ, Coll Med, Taoyuan, Taiwan								0	0	0	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	0893-3952	1530-0285		MODERN PATHOL	Mod. Pathol.	FEB	2015	28			2		1093	274A	274A				1	Pathology	Pathology	CB3BF	WOS:000349502201431		
J	Conlon, N; Kiyokawa, T; Park, K				Conlon, Niamh; Kiyokawa, Takako; Park, Kay			Endocervical Gastric-Type Adenocarcinoma: A Detailed Description of the Morphologic Heterogeneity of a Rare Entity Highlighting the Importance of Adequate Tumor Sampling	MODERN PATHOLOGY			English	Meeting Abstract	104th Annual Meeting of the United-States-and-Canadian-Academy-of-Pathology	MAR 21-27, 2015	Boston, MA	US & Canadian Acad Pathol					Mem Sloan Kettering Canc Ctr, New York, NY 10021 USA; Jikei Univ, Sch Med, Tokyo, Japan								0	0	0	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	0893-3952	1530-0285		MODERN PATHOL	Mod. Pathol.	FEB	2015	28			2		1118	280A	280A				1	Pathology	Pathology	CB3BF	WOS:000349502201456		
J	Fukunaga, M				Fukunaga, Masaharu			Atypical Polypoid Adenomyoma (APA) of the Uterus: A Clinicopathologic Study of 71 Cases	MODERN PATHOLOGY			English	Meeting Abstract	104th Annual Meeting of the United-States-and-Canadian-Academy-of-Pathology	MAR 21-27, 2015	Boston, MA	US & Canadian Acad Pathol					[Fukunaga, Masaharu] Jikei Univ, Daisan Hosp, Komae, Tokyo, Japan								0	0	0	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	0893-3952	1530-0285		MODERN PATHOL	Mod. Pathol.	FEB	2015	28			2		1135	284A	285A				2	Pathology	Pathology	CB3BF	WOS:000349502201473		
J	Fukunaga, M				Fukunaga, Masaharu			Twin Placenta With Complete Hydatidiform Mole in the First Trimester: Histologic Diagnosis and Immunohistochemistry for the Imprint Gene Products P57 (Kip2) and TSSC3	MODERN PATHOLOGY			English	Meeting Abstract	104th Annual Meeting of the United-States-and-Canadian-Academy-of-Pathology	MAR 21-27, 2015	Boston, MA	US & Canadian Acad Pathol					[Fukunaga, Masaharu] Jikei Univ, Daisan Hosp, Tokyo, Japan								0	0	0	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	0893-3952	1530-0285		MODERN PATHOL	Mod. Pathol.	FEB	2015	28			2		1136	285A	285A				1	Pathology	Pathology	CB3BF	WOS:000349502201474		
J	Maeda, D				Maeda, Daichi			Utility of Claudin-18 and p16 Immunohistochemistry for distinguishing Gastric-Type Adenocarcinoma From Other Subtypes of Cervical Adenocarcinoma	MODERN PATHOLOGY			English	Meeting Abstract	104th Annual Meeting of the United-States-and-Canadian-Academy-of-Pathology	MAR 21-27, 2015	Boston, MA	US & Canadian Acad Pathol					[Maeda, Daichi] Akita Univ, Akita 010, Japan; [Maeda, Daichi] Univ Tokyo, Tokyo, Japan								0	0	0	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	0893-3952	1530-0285		MODERN PATHOL	Mod. Pathol.	FEB	2015	28			2		1188	296A	297A				2	Pathology	Pathology	CB3BF	WOS:000349502201526		
J	Uehara, K; Kawakami, F; Zen, Y; Itoh, T; Imai, Y				Uehara, Keiichiro; Kawakami, Fumi; Zen, Yoh; Itoh, Tomoo; Imai, Yukihiro			Minute Lymphangioleiomyomatosis in Pelvic and Paraaortic Lymph Nodes: A Study of 8 Cases	MODERN PATHOLOGY			English	Meeting Abstract	104th Annual Meeting of the United-States-and-Canadian-Academy-of-Pathology	MAR 21-27, 2015	Boston, MA	US & Canadian Acad Pathol					Kobe City Med Ctr Gen Hosp, Kobe, Hyogo, Japan; Kobe Univ Hosp, Kobe, Hyogo, Japan								0	0	0	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	0893-3952	1530-0285		MODERN PATHOL	Mod. Pathol.	FEB	2015	28			2		1250	312A	312A				1	Pathology	Pathology	CB3BF	WOS:000349502201588		
J	Aida, J; Yokoyama, A; Shimomura, N; Nakamura, K; Ishikawa, N; Fujiwara, M; Matsuda, Y; Arai, T; Takubo, K				Aida, Junko; Yokoyama, Akira; Shimomura, Naotaka; Nakamura, Ken-ichi; Ishikawa, Naoshi; Fujiwara, Mutsunori; Matsuda, Yoko; Arai, Tomio; Takubo, Kaiyo			Telomere Shortening in Oral Epithelium in Relation To ADH-1B and ALDH-2 Genotypes and Clinicopathologic Findings	MODERN PATHOLOGY			English	Meeting Abstract	104th Annual Meeting of the United-States-and-Canadian-Academy-of-Pathology	MAR 21-27, 2015	Boston, MA	US & Canadian Acad Pathol					Tokyo Metropolitan Inst Gerontol, Tokyo, Japan; Natl Hosp Org, Kurihama Alcoholism Ctr, Yokosuka, Kanagawa, Japan; Japanese Red Cross Med Ctr, Tokyo, Japan; Tokyo Metropolitan Geriatr Hosp, Tokyo 173, Japan								0	0	0	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	0893-3952	1530-0285		MODERN PATHOL	Mod. Pathol.	FEB	2015	28			2		1274	318A	318A				1	Pathology	Pathology	CB3BF	WOS:000349502201612		
J	Yamamoto, H; Nakano, T; Nishijima, T; Oda, Y				Yamamoto, Hidetaka; Nakano, Takafumi; Nishijima, Toshimitsu; Oda, Yoshinao			A Novel Variant of EWSR1-ATF1 Fusion Gene in Hyalinizing Clear Cell Carcinoma	MODERN PATHOLOGY			English	Meeting Abstract	104th Annual Meeting of the United-States-and-Canadian-Academy-of-Pathology	MAR 21-27, 2015	Boston, MA	US & Canadian Acad Pathol					[Yamamoto, Hidetaka; Nakano, Takafumi; Nishijima, Toshimitsu; Oda, Yoshinao] Kyushu Univ, Fukuoka 812, Japan								0	0	0	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	0893-3952	1530-0285		MODERN PATHOL	Mod. Pathol.	FEB	2015	28			2		1338	334A	334A				1	Pathology	Pathology	CB3BF	WOS:000349502202048		
J	Oishi, N; Kondo, T; Nakazawa, T; Mochizuki, K; Tanioka, F; Oyama, T; Yamamoto, T; Iizuka, J; Tanabe, K; Shibata, N; Kirito, K; Katoh, R				Oishi, Naoki; Kondo, Tetsuo; Nakazawa, Tadao; Mochizuki, Kunio; Tanioka, Fumihiko; Oyama, Toshio; Yamamoto, Tomoko; Iizuka, Junpei; Tanabe, Kazunari; Shibata, Noriyuki; Kirito, Keita; Katoh, Ryohei			High Prevalence of MYD88 Mutation in Testicular Diffuse Large B-Cell Lymphoma	MODERN PATHOLOGY			English	Meeting Abstract	104th Annual Meeting of the United-States-and-Canadian-Academy-of-Pathology	MAR 21-27, 2015	Boston, MA	US & Canadian Acad Pathol					Univ Yamanashi, Chuo Ku, Ube, Yamaguchi, Japan; Iwata City Hosp, Iwata, Shizuoka, Japan; Yamanashi Prefectural Cent Hosp, Kofu, Yamanashi, Japan; Tokyo Womens Med Univ, Shinjuku Ku, Tokyo, Japan								0	0	0	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	0893-3952	1530-0285		MODERN PATHOL	Mod. Pathol.	FEB	2015	28			2		1471	369A	369A				1	Pathology	Pathology	CB3BF	WOS:000349502202180		
J	Hayashi, K; Nakajima, N; Sato, Y; Arashiro, T; Suzuki, T; Katano, H; Nagata, N; Tobiume, M; Yoshida, H; Suzuki, Y; Kumasaka, T; Sata, T; Ariyoshi, K; Hasegawa, H				Hayashi, Kentaro; Nakajima, Noriko; Sato, Yuko; Arashiro, Takeshi; Suzuki, Tadaki; Katano, Harutaka; Nagata, Noriyo; Tobiume, Minoru; Yoshida, Hiroshi; Suzuki, Yoshio; Kumasaka, Toshio; Sata, Tetsutaro; Ariyoshi, Koya; Hasegawa, Hideki			Correlations Among Histopathological Characteristics, Viral Distribution, and Cytokine/Chemokine Expression Level Within an Individual With A/H1N1pdm09 Infection Induced ARDS	MODERN PATHOLOGY			English	Meeting Abstract	104th Annual Meeting of the United-States-and-Canadian-Academy-of-Pathology	MAR 21-27, 2015	Boston, MA	US & Canadian Acad Pathol					Natl Inst Infect Dis, Tokyo, Japan; Nagasaki Univ, Inst Trop Med, Nagasaki 852, Japan; Asashi Gen Hosp, Chiba, Japan; Japanese Red Cross Med Ctr, Tokyo, Japan								0	0	0	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	0893-3952	1530-0285		MODERN PATHOL	Mod. Pathol.	FEB	2015	28			2		1565	393A	393A				1	Pathology	Pathology	CB3BF	WOS:000349502202274		
J	Nakajima, N; Sato, Y; Kotani, O; Suzuki, T; Kamei, T; Takahashi, T; Sata, T; Hasegawa, H				Nakajima, Noriko; Sato, Yuko; Kotani, Osamu; Suzuki, Tadaki; Kamei, Toshiaki; Takahashi, Toru; Sata, Tetsutaro; Hasegawa, Hideki			Modified In Situ Hybridization AT-Tailing To Visualize the Gene Expression in Formalin-Fixed and Paraffin-Embedded Tissues	MODERN PATHOLOGY			English	Meeting Abstract	104th Annual Meeting of the United-States-and-Canadian-Academy-of-Pathology	MAR 21-27, 2015	Boston, MA	US & Canadian Acad Pathol					Natl Inst Infect Dis, Tokyo, Japan; Yamaguchi Grand Med Ctr, Hofu, Japan								0	0	0	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	0893-3952	1530-0285		MODERN PATHOL	Mod. Pathol.	FEB	2015	28			2		1570	394A	394A				1	Pathology	Pathology	CB3BF	WOS:000349502202279		
J	Mai, F; Kazunzi, Y; Yonezawa, H; Ueno, M; Minagawa, C; Ikeda, S; Tuneyama, K; Imura, J; Ueda, Y				Mai, Fukuda; Kazunzi, Yitrie; Yonezawa, Hiroki; Ueno, Mizuki; Minagawa, Chikage; Ikeda, Syo; Tuneyama, Koichi; Imura, Johji; Ueda, Yoshihiko			Renewed Pathological Findings in Cadmium Nephropathy of Itai-Itai Disease - Characteristic Impairment of the Superficial Nephrons and Proximal Tubules	MODERN PATHOLOGY			English	Meeting Abstract	104th Annual Meeting of the United-States-and-Canadian-Academy-of-Pathology	MAR 21-27, 2015	Boston, MA	US & Canadian Acad Pathol					Grad Sch Med & Pharmaceut Sci, Toyama, Japan; Dokkyo Med Sch, Koshigaya Hosp, Koshigaya, Saitama, Japan								0	0	0	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	0893-3952	1530-0285		MODERN PATHOL	Mod. Pathol.	FEB	2015	28			2		1632	410A	410A				1	Pathology	Pathology	CB3BF	WOS:000349502202341		
J	Muragaki, Y				Muragaki, Yasuteru			An Increased Level of Serum 1,25(OH)2-Vitamin D3 Alleviates Renal Tubulointerstitial Fibrosis Induced By Unilateral Ureteral Obstruction in Homozygous Klotho Mutant Mice	MODERN PATHOLOGY			English	Meeting Abstract	104th Annual Meeting of the United-States-and-Canadian-Academy-of-Pathology	MAR 21-27, 2015	Boston, MA	US & Canadian Acad Pathol					[Muragaki, Yasuteru] Wakayama Med Univ, Wakayama, Japan								0	0	0	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	0893-3952	1530-0285		MODERN PATHOL	Mod. Pathol.	FEB	2015	28			2		1636	411A	411A				1	Pathology	Pathology	CB3BF	WOS:000349502202345		
J	Hatanaka, K; Hatanaka, Y; Fujii, K; Kobayashi, H; Kanno, H; Mitsuhashi, T; Nishihara, H; Tanaka, S; Matsuno, Y				Hatanaka, Kanako; Hatanaka, Yutaka; Fujii, Kyoko; Kobayashi, Hiroyuki; Kanno, Hiromi; Mitsuhashi, Tomoko; Nishihara, Hiroshi; Tanaka, Shinya; Matsuno, Yoshihiro			Predictive Value of MGMT Gene Promoter and LINE-1 Methylation Status in Primary Central Nervous System Diffuse Large B-Cell Lymphoma Treated With High-Dose MTX and Radiotherapy	MODERN PATHOLOGY			English	Meeting Abstract	104th Annual Meeting of the United-States-and-Canadian-Academy-of-Pathology	MAR 21-27, 2015	Boston, MA	US & Canadian Acad Pathol					Hokkaido Univ Hosp, Sapporo, Hokkaido 060, Japan; Hokkaido Univ, Grad Sch Med, Sapporo, Hokkaido, Japan								0	0	0	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	0893-3952	1530-0285		MODERN PATHOL	Mod. Pathol.	FEB	2015	28			2		1722	431A	431A				1	Pathology	Pathology	CB3BF	WOS:000349502202430		
J	Sukeda, A; Mori, T; Sekine, S; Maeshima, A; Suzuki, S; Ochiai, A				Sukeda, Aoi; Mori, Taisuke; Sekine, Shigeki; Maeshima, Akiko; Suzuki, Shigenobu; Ochiai, Atsushi			SOX10 Expression and Genetic Alterations Distinguish Pigmented Ciliary Adenocarcinomas or Adenomas From Uveal Melanomas	MODERN PATHOLOGY			English	Meeting Abstract	104th Annual Meeting of the United-States-and-Canadian-Academy-of-Pathology	MAR 21-27, 2015	Boston, MA	US & Canadian Acad Pathol					Natl Canc Res Ctr Hosp, Tokyo, Japan; Natl Canc Res Ctr Res Inst, Tokyo, Japan; Tokyo Med Ctr, Natl Hosp Inst, Tokyo, Japan								0	0	0	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	0893-3952	1530-0285		MODERN PATHOL	Mod. Pathol.	FEB	2015	28			2		1748	437A	437A				1	Pathology	Pathology	CB3BF	WOS:000349502202456		
J	Basturk, O; Mino-Kenudson, M; Furukawa, T; Zamboni, G; Marchegiani, G; Bassi, C; Salvia, R; Malleo, G; Paiella, S; Wolfgang, C; Matthaei, H; Offerhaus, G; Adham, M; Bruno, M; Reid, M; Krasinskas, A; Kloppel, G; Ohike, N; Tajiri, T; Jang, KT; Roa, J; Allen, P; Fernandez-del Castillo, C; Jang, JY; Klimstra, D; Hruban, R; Adsay, V				Basturk, Olca; Mino-Kenudson, Mari; Furukawa, T.; Zamboni, G.; Marchegiani, G.; Bassi, C.; Salvia, R.; Malleo, G.; Paiella, S.; Wolfgang, Christopher; Matthaei, H.; Offerhaus, G.; Adham, M.; Bruno, M.; Reid, M.; Krasinskas, A.; Kloppel, G.; Ohike, N.; Tajiri, T.; Jang, K. T.; Roa, Juan; Allen, P.; Fernandez-del Castillo, C.; Jang, J. Y.; Klimstra, D.; Hruban, R.; Adsay, Volkan			Pathologic Evaluation and Reporting of Intraductal Papillary Mucinous Neoplasms of the Pancreas: Recommendations of Verona Consensus Meeting	MODERN PATHOLOGY			English	Meeting Abstract	104th Annual Meeting of the United-States-and-Canadian-Academy-of-Pathology	MAR 21-27, 2015	Boston, MA	US & Canadian Acad Pathol					Mem Sloan Kettering Canc Ctr, New York, NY 10021 USA; MGH, Boston, MA USA; Tokyo Womens Med Univ, Tokyo, Japan; Univ Verona, I-37100 Verona, Italy; Johns Hopkins Univ, Baltimore, MD USA; Univ Bonn, Bonn, Germany; Univ Med Ctr, Utrecht, Netherlands; E Herriot Hosp, Lyon, France; Erasmus Univ, Med Ctr, Rotterdam, Netherlands; EU, Atlanta, GA USA; Tech U, Munich, Germany; Showa, Yokohama, Kanagawa, Japan; SMC, Seoul, South Korea; Pontificia U, Santiago, Chile; SNU, Seoul, South Korea								0	0	0	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	0893-3952	1530-0285		MODERN PATHOL	Mod. Pathol.	FEB	2015	28			2		1759	439A	439A				1	Pathology	Pathology	CB3BF	WOS:000349502202467		
J	Basturk, O; Hong, SM; Wood, L; Adsay, V; Albores-Saavedra, J; Biankin, A; Brosens, L; Fukushima, N; Goggins, M; Hruban, R; Kato, Y; Kern, S; Klimstra, D; Kloppel, G; Krasinskas, A; Longnecker, D; Maitra, A; Matthei, H; Offerhaus, GJ; Shimizu, M; Takaori, K; Terris, B; Yachida, S; Esposito, I; Furukawa, T				Basturk, Olca; Hong, Seung-Mo; Wood, Laura; Adsay, Volkan; Albores-Saavedra, Jorge; Biankin, Andrew; Brosens, Lodewijk; Fukushima, Noriyoshi; Goggins, Michael; Hruban, Ralph; Kato, Yo; Kern, Scott; Klimstra, David; Kloppel, Gunter; Krasinskas, Alyssa; Longnecker, Daniel; Maitra, Anirban; Matthei, Hanno; Offerhaus, G. Johan; Shimizu, Michio; Takaori, Kyoichi; Terris, Benoit; Yachida, Shinichi; Esposito, Irene; Furukawa, Toru			Revised Recommendations for Assessing Precursor Lesions in the Pancreas	MODERN PATHOLOGY			English	Meeting Abstract	104th Annual Meeting of the United-States-and-Canadian-Academy-of-Pathology	MAR 21-27, 2015	Boston, MA	US & Canadian Acad Pathol					Mem Sloan Kettering Canc Ctr, New York, NY 10021 USA; Asan Med Ctr, Seoul, South Korea; Johns Hopkins Univ, Baltimore, MD USA; Emory Univ, Atlanta, GA 30322 USA; Med Sur Clin, Mexico City, DF, Mexico; Univ Glasgow, Glasgow, Lanark, Scotland; Univ Med Ctr, Utrecht, Netherlands; Jichi Med Univ, Shimotsuke, Japan; Japanese Fdn Canc Res, Tokyo, Japan; Tech Univ Munich, Munich, Germany; Dartmouth Hitchcock Med Ctr, Lebanon, NH 03766 USA; Univ Texas MD Anderson Canc Ctr, Houston, TX 77030 USA; Univ Bonn, Bonn, Germany; Saitama Med Univ, Saitama, Japan; Kyoto Univ, Kyoto, Japan; Hop Cochin, F-75674 Paris, France; Natl CC, Tokyo, Japan; Tokyo Womens Med Univ, Tokyo, Japan								0	0	0	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	0893-3952	1530-0285		MODERN PATHOL	Mod. Pathol.	FEB	2015	28			2		1760	440A	440A				1	Pathology	Pathology	CB3BF	WOS:000349502202468		
J	Notohara, K; Zhang, LZ; Kobashi, Y; Smyrk, T				Notohara, Kenji; Zhang, Lizhi; Kobashi, Yoichiro; Smyrk, Thomas			Histological Characteristics and the Specificity of Pancreatic Lobular Inflammation in Type 2 Autoimmune Pancreatitis - Comparison With the Inflammation Around Pancreatic Ductal Adenocarcinoma	MODERN PATHOLOGY			English	Meeting Abstract	104th Annual Meeting of the United-States-and-Canadian-Academy-of-Pathology	MAR 21-27, 2015	Boston, MA	US & Canadian Acad Pathol					Kurashiki Cent Hosp, Kurashiki, Okayama, Japan; Mayo Clin, Rochester, MN USA; Tenri Hosp, Tenri, Nara 632, Japan								0	0	0	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	0893-3952	1530-0285		MODERN PATHOL	Mod. Pathol.	FEB	2015	28			2		1788	446A	447A				2	Pathology	Pathology	CB3BF	WOS:000349502202496		
J	Reid, M; Ohike, N; Basturk, O; Klimov, S; Bagci, P; Akkas, G; Adsay, V				Reid, Michelle; Ohike, Nobu; Basturk, Olca; Klimov, Sergei; Bagci, Pelin; Akkas, Gizem; Adsay, Volkan			Diagnostic Impact of Intratumoral Heterogeneity of Ki67 Labeling Index in Pancreatic Neuroendocrine Tumors (NETs): Analysis of 91 Cases Shows Hot Spot Counting Correlates Better With Signs of Aggressiveness Than Counting Random Areas	MODERN PATHOLOGY			English	Meeting Abstract	104th Annual Meeting of the United-States-and-Canadian-Academy-of-Pathology	MAR 21-27, 2015	Boston, MA	US & Canadian Acad Pathol					Emory Univ, Atlanta, GA 30322 USA; Shows Univ, Showa, Japan; Mem Sloan Kettering Canc Ctr, New York, NY 10021 USA; Georgia State Univ, Atlanta, GA 30303 USA								0	0	0	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	0893-3952	1530-0285		MODERN PATHOL	Mod. Pathol.	FEB	2015	28			2		1789	447A	447A				1	Pathology	Pathology	CB3BF	WOS:000349502202497		
J	Sato, D; Mitsuhashi, T; Tsuchikawa, T; Hatanaka, Y; Nakamura, T; Hirano, S; Matsuno, Y				Sato, Daisuke; Mitsuhashi, Tomoko; Tsuchikawa, Takahiro; Hatanaka, Yutaka; Nakamura, Toru; Hirano, Satoshi; Matsuno, Yoshihiro			Stromal Palladin Expression Is an Independent Prognostic Factor of Pancreatic Ductal Adenocarcinoma (PDAC)	MODERN PATHOLOGY			English	Meeting Abstract	104th Annual Meeting of the United-States-and-Canadian-Academy-of-Pathology	MAR 21-27, 2015	Boston, MA	US & Canadian Acad Pathol					Hokkaido Univ Hosp, Sapporo, Hokkaido 060, Japan; Hokkaido Univ, Grad Sch Med, Sapporo, Hokkaido, Japan								0	0	0	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	0893-3952	1530-0285		MODERN PATHOL	Mod. Pathol.	FEB	2015	28			2		1793	448A	448A				1	Pathology	Pathology	CB3BF	WOS:000349502202501		
J	Asaka, S; Yoshizawa, A; Matsuda, K; Yamaguchi, A; Kobayashi, Y; Nakata, R; Meng, Z; Sugano, M; Honda, T				Asaka, Shiho; Yoshizawa, Akihiko; Matsuda, Kazuyuki; Yamaguchi, Akemi; Kobayashi, Yukihiro; Nakata, Rie; Meng, Zhang; Sugano, Mitsutoshi; Honda, Takayuki			A Novel High-Speed Droplet-Polymerase Chain Reaction Can Detect Epidermal Growth Factor Receptor Gene Mutation in Non-Small Cell Lung Cancer in Less Than 10 Minutes	MODERN PATHOLOGY			English	Meeting Abstract	104th Annual Meeting of the United-States-and-Canadian-Academy-of-Pathology	MAR 21-27, 2015	Boston, MA	US & Canadian Acad Pathol					Shinshu Univ Hosp, Matsumoto, Nagano, Japan; Seiko Epson Corp, Shiojiri, Nagano, Japan								0	0	0	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	0893-3952	1530-0285		MODERN PATHOL	Mod. Pathol.	FEB	2015	28			2		1891	471A	472A				2	Pathology	Pathology	CB3BF	WOS:000349502203088		
J	Bozkurtlar, E; Uruga, H; Hariri, L; Mino-Kenudson, M; Mark, E				Bozkurtlar, Emine; Uruga, Hironori; Hariri, Lida; Mino-Kenudson, Mart; Mark, Eugene			Idiopathic Tracheal Stenosis	MODERN PATHOLOGY			English	Meeting Abstract	104th Annual Meeting of the United-States-and-Canadian-Academy-of-Pathology	MAR 21-27, 2015	Boston, MA	US & Canadian Acad Pathol					Marmara Univ, Istanbul, Turkey; Toranomon Gen Hosp, Tokyo, Japan; Massachusetts Gen Hosp, Boston, MA 02114 USA								0	0	0	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	0893-3952	1530-0285		MODERN PATHOL	Mod. Pathol.	FEB	2015	28			2		1898	474A	474A				1	Pathology	Pathology	CB3BF	WOS:000349502203095		
J	Dairiki, M; Ichikawa, H; Tanaka, T; Taniguchi, H; Johkoh, T; Kataoka, K; Kondoh, Y; Fukuoka, J				Dairiki, Mutsumi; Ichikawa, Hiromi; Tanaka, Tomonori; Taniguchi, Hiroyuki; Johkoh, Takeshi; Kataoka, Kensuke; Kondoh, Yasuhiro; Fukuoka, Junya			Histological Difference Between Idiopathic Interstitial Pneumonias and Connective Tissue Disease-Associated Interstitial Pneumonias	MODERN PATHOLOGY			English	Meeting Abstract	104th Annual Meeting of the United-States-and-Canadian-Academy-of-Pathology	MAR 21-27, 2015	Boston, MA	US & Canadian Acad Pathol					Nagasaki Univ, Sch Med, Nagasaki 852, Japan; Nagasaki Univ, Grad Sch Biomed Sci, Nagasaki 852, Japan; Nagasaki Univ Hosp, Nagasaki, Japan; Tosei Gen Hosp, Seto, Aichi, Japan; Mutual Aid Assoc Publ Sch Teachers, Kinki Cent Hosp, Itami, Hyogo, Japan								0	0	0	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	0893-3952	1530-0285		MODERN PATHOL	Mod. Pathol.	FEB	2015	28			2		1903	475A	475A				1	Pathology	Pathology	CB3BF	WOS:000349502203099		
J	Gallan, A; Ananthanarayanan, V; Hiroshima, K; Marchevsky, A; McGregor, S; Montero, M; Nabeshima, K; Vigneswaran, W; Walts, A; Krausz, T; Husain, A				Gallan, Alexander; Ananthanarayanan, Vyayalakshmi; Hiroshima, Kenzo; Marchevsky, Alberto; McGregor, Stephanie; Montero, MAngeles; Nabeshima, Kazuki; Vigneswaran, Wickii; Walts, Ann; Krausz, Thomas; Husain, Aliya			Necrosis and Solid Growth Pattern Augment Nuclear Grading in Predicting Survival in Epithelioid Malignant Mesothelioma: An International, Multi-Institutional Study	MODERN PATHOLOGY			English	Meeting Abstract	104th Annual Meeting of the United-States-and-Canadian-Academy-of-Pathology	MAR 21-27, 2015	Boston, MA	US & Canadian Acad Pathol					Univ Chicago, Chicago, IL 60637 USA; Loyola Univ, Maywood, IL 60153 USA; Tokyo Womens Med Univ, Tokyo, Japan; Cedars Sinai Med Ctr, Los Angeles, CA 90048 USA; Royal Brompton Hosp, London SW3 6LY, England; Harefield Hosp, London, England; Fukuoka Univ, Fukuoka 81401, Japan								0	0	0	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	0893-3952	1530-0285		MODERN PATHOL	Mod. Pathol.	FEB	2015	28			2		1908	476A	476A				1	Pathology	Pathology	CB3BF	WOS:000349502203104		
J	Hayashi, T; Kumasaka, T; Mitani, K; Saito, T; Hara, K; Ando, K; Seyama, K; Yao, T				Hayashi, Takuo; Kumasaka, Toshio; Mitani, Keiko; Saito, Tsuyoshi; Hara, Kieko; Ando, Katsutoshi; Seyama, Kuniaki; Yao, Takashi			Clinicopathologic and Molecular Analysis of Explanted Lung of Patients With Lymphangioleiomyomatosis: Identification of Destruction of Airway Walls and Lack of Hypoxia Inducible Factor 1 Alpha Expression	MODERN PATHOLOGY			English	Meeting Abstract	104th Annual Meeting of the United-States-and-Canadian-Academy-of-Pathology	MAR 21-27, 2015	Boston, MA	US & Canadian Acad Pathol					Juntendo Univ, Sch Med, Tokyo 113, Japan; Japanese Red Cross Med Ctr, Tokyo, Japan								0	0	0	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	0893-3952	1530-0285		MODERN PATHOL	Mod. Pathol.	FEB	2015	28			2		1911	477A	477A				1	Pathology	Pathology	CB3BF	WOS:000349502203107		
J	Hida, T; Matsumoto, S; Hamasaki, M; Abe, S; Tsirjimura, T; Hiroshima, K; Nabeshima, K				Hida, Tomoyuki; Matsumoto, Shinji; Hamasaki, Makoto; Abe, Sohsei; Tsirjimura, Tohru; Hiroshima, Kenzo; Nabeshima, Kazuki			p16 FISH Deletion Status in Effusion Smear Preparations Correlates With That in Underlying Malignant Pleural Mesothelioma	MODERN PATHOLOGY			English	Meeting Abstract	104th Annual Meeting of the United-States-and-Canadian-Academy-of-Pathology	MAR 21-27, 2015	Boston, MA	US & Canadian Acad Pathol					Fukuoka Univ, Sch Med & Hosp, Fukuoka 81401, Japan; Hyogo Coll Med, Nishinomiya, Hyogo 6638501, Japan; Tokyo Womens Med Univ, Yachiyo Med Ctr, Yachiyo, Chiba, Japan								0	0	0	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	0893-3952	1530-0285		MODERN PATHOL	Mod. Pathol.	FEB	2015	28			2		1913	477A	477A				1	Pathology	Pathology	CB3BF	WOS:000349502203109		
J	Leduc, C; Zhang, L; Fukuoka, J; Travis, W; Antonescu, C				Leduc, Charles; Zhang, Lei; Fukuoka, Junya; Travis, William; Antonescu, Cristina			Pulmonary Myoepithelial Tumors (MT): A Pathologic and Molecular Study	MODERN PATHOLOGY			English	Meeting Abstract	104th Annual Meeting of the United-States-and-Canadian-Academy-of-Pathology	MAR 21-27, 2015	Boston, MA	US & Canadian Acad Pathol					Mem Sloan Kettering Canc Ctr, New York, NY 10021 USA; Nagasaki Univ Hosp, Nagasaki, Japan								0	0	0	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	0893-3952	1530-0285		MODERN PATHOL	Mod. Pathol.	FEB	2015	28			2		1932	482A	482A				1	Pathology	Pathology	CB3BF	WOS:000349502203128		
J	Li, GY; Wang, XQ; Koul, S; Ohki, R; Maurer, M; Borczuk, A; Halmos, B				Li, Guangyuan; Wang, Xiaoqi; Koul, Sanjay; Ohki, Rieko; Maurer, Matthew; Borczuk, Alain; Halmos, Balazs			PHLDA2 Is a Key Oncogene-Induced Negative Feedback Inhibitor of EGFR/ErbB2 Signaling Via Interference With AKT Signaling	MODERN PATHOLOGY			English	Meeting Abstract	104th Annual Meeting of the United-States-and-Canadian-Academy-of-Pathology	MAR 21-27, 2015	Boston, MA	US & Canadian Acad Pathol					Univ Hosp Case Med Ctr, Cleveland, OH USA; Herbert Irving Comprehens Canc Ctr, New York, NY USA; Columbia Univ, Med Ctr, New York, NY USA; Natl Canc Ctr, Res Inst, Tokyo 104, Japan								0	0	0	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	0893-3952	1530-0285		MODERN PATHOL	Mod. Pathol.	FEB	2015	28			2		1936	483A	483A				1	Pathology	Pathology	CB3BF	WOS:000349502203132		
J	Matsubara, O; Ishikawa, Y; Nakatani, Y; Mark, E				Matsubara, Osamu; Ishikawa, Yuichi; Nakatani, Yukio; Mark, Eugene			Pathological Role of Fibroblastic Foci and Bronchiolar Epithelial Proliferation in Idiopathic Pulmonary Fibrosis (IPF)/Usual Interstitial Pneumonia (UIP)	MODERN PATHOLOGY			English	Meeting Abstract	104th Annual Meeting of the United-States-and-Canadian-Academy-of-Pathology	MAR 21-27, 2015	Boston, MA	US & Canadian Acad Pathol					Japanese Fdn Canc Res, Inst Canc, Tokyo 170, Japan; Hiratsuka Kyosai Hosp, Hiratsuka, Kanagawa, Japan; Chiba Univ, Chiba, Japan; Massachusetts Gen Hosp, Boston, MA 02114 USA; Harvard Univ, Sch Med, Boston, MA USA								0	0	0	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	0893-3952	1530-0285		MODERN PATHOL	Mod. Pathol.	FEB	2015	28			2		1941	484A	484A				1	Pathology	Pathology	CB3BF	WOS:000349502203137		
J	Motoi, N; Matsuura, Y; Ninomiya, H; Nagano, H; Kakita, T; Okumura, S; Ishikawa, Y				Motoi, Noriko; Matsuura, Yosuke; Ninomiya, Hironori; Nagano, Hiroko; Kakita, Tomoyo; Okumura, Sakae; Ishikawa, Yuichi			Diagnostic Value of Immunohistochemical ROS1 Expression in ROS1-Lung Cancer	MODERN PATHOLOGY			English	Meeting Abstract	104th Annual Meeting of the United-States-and-Canadian-Academy-of-Pathology	MAR 21-27, 2015	Boston, MA	US & Canadian Acad Pathol					Japanese Fdn Canc Res, Inst Canc, Tokyo 170, Japan; Japanese Fdn Canc Res, Canc Inst Hosp, Tokyo, Japan								0	0	0	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	0893-3952	1530-0285		MODERN PATHOL	Mod. Pathol.	FEB	2015	28			2		1947	485A	485A				1	Pathology	Pathology	CB3BF	WOS:000349502203143		
J	Naka, T; Hatanaka, Y; Kanno, H; Hatanaka, K; Mitsuhashi, T; Matsuno, Y				Naka, Tomoaki; Hatanaka, Yutaka; Kanno, Hiromi; Hatanaka, Kanako; Mitsuhashi, Tomoko; Matsuno, Yoshihiro			PHGDH and TRIM29 as Novel Diagnostic Markers for Malignant Pleural Mesothelioma: An Exploring Approach From FFPE Tissue-Based Gene Expression Profiling of a Synchronous Thoracic Tumor	MODERN PATHOLOGY			English	Meeting Abstract	104th Annual Meeting of the United-States-and-Canadian-Academy-of-Pathology	MAR 21-27, 2015	Boston, MA	US & Canadian Acad Pathol					[Naka, Tomoaki; Hatanaka, Yutaka; Kanno, Hiromi; Hatanaka, Kanako; Mitsuhashi, Tomoko; Matsuno, Yoshihiro] Hokkaido Univ Hosp, Sapporo, Hokkaido 060, Japan								0	0	0	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	0893-3952	1530-0285		MODERN PATHOL	Mod. Pathol.	FEB	2015	28			2		1949	485A	486A				2	Pathology	Pathology	CB3BF	WOS:000349502203145		
J	Smith, S; Bissonnette, A; Cohen, D; Timmers, C; Jen, J; Fukuoka, J; Franks, T; Travis, W; Carbone, D; Shilo, K				Smith, Stephen; Bissonnette, Adam; Cohen, David; Timmers, Cynthia; Jen, Jin; Fukuoka, Junya; Franks, Teri; Travis, William; Carbone, David; Shilo, Konstantin			Expression of PAK1 and PAK2 Is Associated With Grade of Pulmonary Neuroendocrine Tumors	MODERN PATHOLOGY			English	Meeting Abstract	104th Annual Meeting of the United-States-and-Canadian-Academy-of-Pathology	MAR 21-27, 2015	Boston, MA	US & Canadian Acad Pathol					Ohio State Univ, Columbus, OH 43210 USA; Mayo Clin, Rochester, MN USA; Nagasaki Univ, Nagasaki 852, Japan; Joint Pathol Ctr, Silver Spring, MD USA; Mem Sloan Kettering Canc Ctr, New York, NY 10021 USA								0	0	0	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	0893-3952	1530-0285		MODERN PATHOL	Mod. Pathol.	FEB	2015	28			2		1967	490A	490A				1	Pathology	Pathology	CB3BF	WOS:000349502203163		
J	Yoshikawa, A; Tanaka, T; Hashisako, M; Kashima, Y; Karata, H; Tabata, K; Fukuoka, J				Yoshikawa, Akira; Tanaka, Tomonori; Hashisako, Mikiko; Kashima, Yukio; Karata, Hiroki; Tabata, Kazuhiro; Fukuoka, Junya			3D Pathology Construction Reveals Framework Structure of the Lung and Increase of Pores of Kohn as an Initial Event of Emphysema	MODERN PATHOLOGY			English	Meeting Abstract	104th Annual Meeting of the United-States-and-Canadian-Academy-of-Pathology	MAR 21-27, 2015	Boston, MA	US & Canadian Acad Pathol					[Yoshikawa, Akira; Tanaka, Tomonori; Hashisako, Mikiko; Kashima, Yukio; Karata, Hiroki; Tabata, Kazuhiro; Fukuoka, Junya] Nagasaki Univ, Grad Sch Biomed Sci, Nagasaki 852, Japan								0	0	0	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	0893-3952	1530-0285		MODERN PATHOL	Mod. Pathol.	FEB	2015	28			2		1984	493A	494A				2	Pathology	Pathology	CB3BF	WOS:000349502203180		
J	Yoshizawa, A				Yoshizawa, Akihiko			The Clinicopathological Characteristics of Lung Adenocarcinoma With Lgr5 Expression	MODERN PATHOLOGY			English	Meeting Abstract	104th Annual Meeting of the United-States-and-Canadian-Academy-of-Pathology	MAR 21-27, 2015	Boston, MA	US & Canadian Acad Pathol					[Yoshizawa, Akihiko] Kyoto Univ Hosp, Kyoto 606, Japan								0	0	0	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	0893-3952	1530-0285		MODERN PATHOL	Mod. Pathol.	FEB	2015	28			2		1985	494A	494A				1	Pathology	Pathology	CB3BF	WOS:000349502203181		
J	Torlakovic, E; Brynes, R; Hyjek, E; Lee, SH; Kreipe, H; Kremer, M; McKenna, R; Sadahira, Y; Tzankov, A; Reis, M; Porwit, A				Torlakovic, Emina; Brynes, Russell; Hyjek, Elizabeth; Lee, Szu-Hee; Kreipe, Hans; Kremer, Marcus; McKenna, Robert; Sadahira, Yoshito; Tzankov, Alexandar; Reis, Marciano; Porwit, Anna			ICSH Guidelines for the Standardization of Bone Marrow Immunohistochemistry	MODERN PATHOLOGY			English	Meeting Abstract	104th Annual Meeting of the United-States-and-Canadian-Academy-of-Pathology	MAR 21-27, 2015	Boston, MA	US & Canadian Acad Pathol					Univ Toronto, Univ Hlth Network, Toronto, ON, Canada; Univ So Calif, Keck Sch Med, Los Angeles, CA 90033 USA; St George Hosp, Sydney, NSW, Australia; Hannover Med Sch, Hannover, Germany; Staedt Klinikum, Munich, Germany; Univ Minnesota, Minneapolis, MN USA; Kawasaki Med Univ, Kurashiki, Okayama, Japan; Univ Basel Hosp, CH-4031 Basel, Switzerland; Sunnybrook Hlth Sci Ctr, Toronto, ON M4N 3M5, Canada								0	0	0	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	0893-3952	1530-0285		MODERN PATHOL	Mod. Pathol.	FEB	2015	28			2		2043	509A	509A				1	Pathology	Pathology	CB3BF	WOS:000349502203239		
J	Saegusa-Beecroft, E; Mamou, J; Rohrbach, D; Bui, TM; Coron, A; Yamaguchi, T; Oelze, M; Kobayashi, G; Wong, C; Fung, C; Hata, M; Bridal, SL; Yanagihara, E; Machi, J; Feleppa, EJ				Saegusa-Beecroft, Emi; Mamou, Jonathan; Rohrbach, Daniel; Thanh Minh Bui; Coron, Alain; Yamaguchi, Tadashi; Oelze, Michael; Kobayashi, Gregory; Wong, Clifford; Fung, Conway; Hata, Masaki; Bridal, S. Lori; Yanagihara, Eugene; Machi, Junji; Feleppa, Ernest J.			Advances in Three-Dimensional (3D) High-Frequency (HF) Quantitative Ultrasound (QUS) for the Detection of Metastases in Lymph Nodes of Breast, Colorectal and Gastric Cancers	MODERN PATHOLOGY			English	Meeting Abstract	104th Annual Meeting of the United-States-and-Canadian-Academy-of-Pathology	MAR 21-27, 2015	Boston, MA	US & Canadian Acad Pathol					Univ Hawaii, Kuakini Med Ctr, Honolulu, HI 96822 USA; Riverside Res, New York, NY USA; Univ Paris 06, Paris, France; Chiba Univ, Chiba, Japan; [Saegusa-Beecroft, Emi; Mamou, Jonathan; Rohrbach, Daniel; Thanh Minh Bui; Coron, Alain; Yamaguchi, Tadashi; Oelze, Michael; Kobayashi, Gregory; Wong, Clifford; Fung, Conway; Hata, Masaki; Bridal, S. Lori; Yanagihara, Eugene; Machi, Junji; Feleppa, Ernest J.] Univ Illinois, Urbana, IL 61801 USA								0	0	0	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	0893-3952	1530-0285		MODERN PATHOL	Mod. Pathol.	FEB	2015	28			2		2104	524A	524A				1	Pathology	Pathology	CB3BF	WOS:000349502203300		
J	Bourguignon, T; Lo, N; Cameron, SL; Sobotnik, J; Hayashi, Y; Shigenobu, S; Watanabe, D; Roisin, Y; Miura, T; Evans, TA				Bourguignon, Thomas; Lo, Nathan; Cameron, Stephen L.; Sobotnik, Jan; Hayashi, Yoshinobu; Shigenobu, Shuji; Watanabe, Dai; Roisin, Yves; Miura, Toru; Evans, Theodore A.			The Evolutionary History of Termites as Inferred from 66 Mitochondrial Genomes	MOLECULAR BIOLOGY AND EVOLUTION			English	Article						biogeography; Isoptera; molecular clock; molecular phylogeny	GLOSSOTERMES-OCULATUS ISOPTERA; FUNGUS-GROWING TERMITES; GENE-SEQUENCES; PHYLOGENETIC-RELATIONSHIPS; SECONDARY STRUCTURE; DIVERGENCE TIMES; DRYWOOD TERMITES; FOSSIL RECORD; CASTE-SYSTEM; WORKER CASTE	Termites have colonized many habitats and are among the most abundant animals in tropical ecosystems, which they modify considerably through their actions. The timing of their rise in abundance and of the dispersal events that gave rise to modern termite lineages is not well understood. To shed light on termite origins and diversification, we sequenced the mitochondrial genome of 48 termite species and combined them with 18 previously sequenced termite mitochondrial genomes for phylogenetic and molecular clock analyses using multiple fossil calibrations. The 66 genomes represent most major clades of termites. Unlike previous phylogenetic studies based on fewer molecular data, our phylogenetic tree is fully resolved for the lower termites. The phylogenetic positions of Macrotermitinae and Apicotermitinae are also resolved as the basal groups in the higher termites, but in the crown termitid groups, including Termitinae + Syntermitinae + Nasutitermitinae + Cubitermitinae, the position of some nodes remains uncertain. Our molecular clock tree indicates that the lineages leading to termites and Cryptocercus roaches diverged 170 Ma (153-196 Ma 95% confidence interval [CI]), that modern Termitidae arose 54 Ma (46-66 Ma 95% CI), and that the crown termitid group arose 40 Ma (35-49 Ma 95% CI). This indicates that the distribution of basal termite clades was influenced by the final stages of the breakup of Pangaea. Our inference of ancestral geographic ranges shows that the Termitidae, which includes more than 75% of extant termite species, most likely originated in Africa or Asia, and acquired their pantropical distribution after a series of dispersal and subsequent diversification events.	[Bourguignon, Thomas; Evans, Theodore A.] Natl Univ Singapore, Dept Biol Sci, Singapore 117548, Singapore; [Bourguignon, Thomas; Hayashi, Yoshinobu; Watanabe, Dai; Miura, Toru] Hokkaido Univ, Grad Sch Environm Sci, Sapporo, Hokkaido, Japan; [Bourguignon, Thomas; Sobotnik, Jan] Czech Univ Life Sci, Fac Forestry & Wood Sci, Prague, Czech Republic; [Lo, Nathan; Hayashi, Yoshinobu] Univ Sydney, Sch Biol Sci, Sydney, NSW 2006, Australia; [Cameron, Stephen L.] Queensland Univ Technol, Fac Sci & Engn, Brisbane, Qld 4001, Australia; [Shigenobu, Shuji] Natl Inst Nat Sci, Okazaki Inst Integrat Biosci, Okazaki, Aichi 4448787, Japan; [Roisin, Yves] Univ Libre Bruxelles, Brussels, Belgium	Bourguignon, T (reprint author), Natl Univ Singapore, Dept Biol Sci, Singapore 117548, Singapore.	thomas.bourgui@gmail.com	Cameron, Stephen/A-3742-2008	Cameron, Stephen/0000-0002-6694-4130	Japan Society for Promotion of Science [22-00393]; Ministry of Education, Culture, Sports, Science and Technology of Japan [21677001]; LHK fund of the National University of Singapore; Singapore-MIT Alliance for Research and Technology; Internal Grant Agency of Faculty of Forestry and Wood Sciences (Specific research of the Czech University of Life Sciences) [A08/14]; Australian Research Council [FT120100746, DP1097265]; Fonds de la Recherche Scientifique FNRS (Belgium) [FRFC 2.4594.12]	The authors are grateful to the Japan Society for Promotion of Science, for financial support through a postdoctoral fellowship to T.B. (No. 22-00393). This work was also supported by Grants-in-Aid for Young Scientists (No. 21677001) from the Ministry of Education, Culture, Sports, Science and Technology of Japan; by the LHK fund of the National University of Singapore; by the Singapore-MIT Alliance for Research and Technology; and by the Internal Grant Agency of Faculty of Forestry and Wood Sciences (Specific research of the Czech University of Life Sciences) (A08/14). S.L.C. (FT120100746) and N.L. (DP1097265) were supported by the Australian Research Council. Y.R. was supported by the Fonds de la Recherche Scientifique FNRS (Belgium) (FRFC 2.4594.12).	ABE T, 1979, Japanese Journal of Ecology, V29, P121; Lanfear R, 2012, MOL BIOL EVOL, V29, P1695, DOI 10.1093/molbev/mss020; Hay WW, 1999, GEOL S AM S, P1; Trautwein MD, 2012, ANNU REV ENTOMOL, V57, P449, DOI 10.1146/annurev-ento-120710-100538; Leavitt JR, 2013, MOL PHYLOGENET EVOL, V67, P494, DOI 10.1016/j.ympev.2013.02.019; Sullivan J, 2005, ANNU REV ECOL EVOL S, V36, P445, DOI 10.1146/annurev.ecolsys.36.102003.152633; Schrago CG, 2003, MOL BIOL EVOL, V20, P1620, DOI 10.1093/molbev/msg172; Whitfield JB, 2007, TRENDS ECOL EVOL, V22, P258, DOI 10.1016/j.tree.2007.01.012; Cameron SL, 2007, GENOME, V50, P188, DOI 10.1139/G06-148; Darriba D, 2012, NAT METHODS, V9, P772, DOI 10.1038/nmeth.2109; Lo N, 2000, CURR BIOL, V10, P801, DOI 10.1016/S0960-9822(00)00561-3; Gernhard T, 2008, J THEOR BIOL, V253, P769, DOI 10.1016/j.jtbi.2008.04.005; Upchurch P, 2008, TRENDS ECOL EVOL, V23, P229, DOI 10.1016/j.tree.2007.11.006; Fox-Dobbs K, 2010, ECOLOGY, V91, P1296, DOI 10.1890/09-0653.1; Aanen DK, 2005, CURR BIOL, V15, P851, DOI 10.1016/j.cub.2005.03.043; Degnan JH, 2009, TRENDS ECOL EVOL, V24, P332, DOI 10.1016/j.tree.2009.01.009; McLoughlin S, 2001, AUST J BOT, V49, P271, DOI 10.1071/BT00023; Yu Y, 2010, MOL PHYLOGENET EVOL, V56, P848, DOI 10.1016/j.ympev.2010.04.011; QUENNEDEY A, 1975, INSECT SOC, V22, P243, DOI 10.1007/BF02223076; Letsch HO, 2010, MOL BIOL EVOL, V27, P2507, DOI 10.1093/molbev/msq140; Jones DT, 2011, BIOLOGY OF TERMITES: A MODERN SYNTHESIS, P477, DOI 10.1007/978-90-481-3977-4_17; Jouquet P, 2006, APPL SOIL ECOL, V32, P153, DOI 10.1016/j.apsoil.2005.07.004; Bourguignon T, 2011, ECOL ENTOMOL, V36, P261, DOI 10.1111/j.1365-2311.2011.01265.x; Whiting MF, 2002, ZOOL SCR, V31, P93, DOI 10.1046/j.0300-3256.2001.00095.x; Brandl R, 2007, MOL PHYLOGENET EVOL, V45, P239, DOI 10.1016/j.ympev.2007.07.007; Ho SYW, 2009, SYST BIOL, V58, P367, DOI 10.1093/sysbio/syp035; Nobre T, 2010, P R SOC B, V277, P359, DOI 10.1098/rspb.2009.1373; Wei SJ, 2012, MITOCHONDR DNA, V23, P426, DOI 10.3109/19401736.2012.710215; Sobotnik J, 2010, BIOL J LINN SOC, V99, P839, DOI 10.1111/j.1095-8312.2010.01392.x; Boore JL, 2006, TRENDS ECOL EVOL, V21, P439, DOI 10.1016/j.tree.2006.05.009; [Anonymous], 2007, STUTTG BEITR NA 1228; Moreau CS, 2006, SCIENCE, V312, P101, DOI 10.1126/science.1124891; Legendre F, 2008, MOL PHYLOGENET EVOL, V48, P615, DOI 10.1016/j.ympev.2008.04.017; Bourguignon T, 2011, BIOTROPICA, V43, P473, DOI 10.1111/j.1744-7429.2010.00729.x; Flook PK, 1995, J MOL EVOL, V41, P928; Davies RG, 2003, J BIOGEOGR, V30, P847, DOI 10.1046/j.1365-2699.2003.00883.x; SIMON C, 1994, ANN ENTOMOL SOC AM, V87, P651; Yamauchi MM, 2004, INSECT MOL BIOL, V13, P435, DOI 10.1111/j.0962-1075.2004.00505.x; MEYEN SV, 1984, BOT REV, V50, P1, DOI 10.1007/BF02874305; Ronquist F, 2012, SYST BIOL, V61, P539, DOI 10.1093/sysbio/sys029; Lowe TM, 1997, NUCLEIC ACIDS RES, V25, P955, DOI 10.1093/nar/25.5.955; Stamatakis A, 2008, SYST BIOL, V57, P758, DOI 10.1080/10635150802429642; Xiao B, 2012, CURR GENET, V58, P65, DOI 10.1007/s00294-012-0365-7; Eggleton P, 1996, PHILOS T R SOC B, V351, P51, DOI 10.1098/rstb.1996.0004; Cameron SL, 2012, MOL PHYLOGENET EVOL, V65, P163, DOI 10.1016/j.ympev.2012.05.034; LaPolla JS, 2013, ANNU REV ENTOMOL, V58, P609, DOI 10.1146/annurev-ento-120710-100600; Inward DJG, 2007, MOL PHYLOGENET EVOL, V44, P953, DOI 10.1016/j.ympev.2007.05.014; Cameron SL, 2014, ANNU REV ENTOMOL, V59, P95, DOI 10.1146/annurev-ento-011613-162007; Drummond AJ, 2007, BMC EVOL BIOL, V7, DOI 10.1186/1471-2148-7-214; Zhang YY, 2010, MOL BIOL REP, V37, P3509, DOI 10.1007/s11033-009-9944-1; Lo N, 2004, INSECT SOC, V51, P365, DOI 10.1007/s00040-004-0759-8; Ware Jessica L, 2010, Arthropod Struct Dev, V39, P204, DOI 10.1016/j.asd.2009.11.003; Stromberg CAE, 2011, ANNU REV EARTH PL SC, V39, P517, DOI 10.1146/annurev-earth-040809-152402; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; Bourguignon T, 2009, EVOL DEV, V11, P659, DOI 10.1111/j.1525-142X.2009.00373.x; Bourguignon T, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044527; Cameron SL, 2006, MOL PHYLOGENET EVOL, V38, P274, DOI 10.1016/j.ympev.2005.09.020; Davis R, 2009, J EVOLUTION BIOL, V22, P1950; Dohrmann M, 2014, MOL PHYLOGENET EVOL, V71, P214, DOI 10.1016/j.ympev.2013.12.003; Eggleton P, 2000, TERMITES: EVOLUTION, SOCIALITY, SYMBIOSES, ECOLOGY, P25; Emerson A.E., 1975, American Museum Novitates, VNo. 2570, P1; EMERSON ALFRED E., 1955, FIELDIANA ZOOL, V37, P465; Emerson A.E., 1971, B AM MUS NAT HIST, V146, P243; Engel Michael S., 2007, Stuttgarter Beitraege zur Naturkunde Serie B (Geologie und Palaeontologie), P1; Engel M. S., 2007, Beitraege zur Entomologie, V57, P263; Engel MS, 2011, ZOOKEYS, P105, DOI 10.3897/zookeys.148.1797; Engel MS, 2009, AM MUS NOVIT, P1; Evans TA, 2011, NAT COMMUN, V2, DOI 10.1038/ncomms1257; Gray MW, 2012, CSH PERSPECT BIOL, V4, DOI 10.1101/cshperspect.a011403; Grimaldi David, 2005, pi; Grimaldi DA, 2008, AM MUS NOVIT, P1, DOI 10.1206/616.1; Holt JA, 2000, TERMITES: EVOLUTION, SOCIALITY, SYMBIOSES, ECOLOGY, P389; Komoto N, 2011, MOL PHYLOGENET EVOL, V58, P43, DOI 10.1016/j.ympev.2010.10.013; Krishna Kumar, 1996, American Museum Novitates, V3176, P1; Krishna K, 2003, AM MUS NOVIT, P1, DOI 10.1206/0003-0082(2003)390<0001:TFCRIA>2.0.CO;2; Krishna Kumar, 2013, Bulletin of the American Museum of Natural History, V377, P1; Krishna K, 2009, AM MUS NOVIT, P1; Labandeira CC, 1994, CONTRIB BIOL GEOL, V88, P1; Legendre F, 2013, EVOL DEV, V15, P146, DOI 10.1111/ede.12023; Lepage M, 2000, TERMITES: EVOLUTION, SOCIALITY, SYMBIOSES, ECOLOGY, P333; Letsch HO, 2011, BMC EVOL BIOL, V11, DOI 10.1186/1471-2148-11-146; Luamba J.L.N., 1980, Biologie et Ecologie Mediterraneenne, V7, P169; Maddison WP, 2010, MESQUITE MODULAR SYS; Miura T, 1998, ANN ENTOMOL SOC AM, V91, P515; Parmentier D, 2003, J MORPHOL, V255, P69, DOI 10.1002/jmor.10047; Prasad V, 2011, NAT COMMUN, V2, DOI 10.1038/ncomms1482; PRESTWICH GD, 1984, ANNU REV ENTOMOL, V29, P201; Rambaut A, 2007, TRACER V 1 5; RENOUX J, 1976, Insectes Sociaux, V23, P279; ROISIN Y, 1988, SOCIOBIOLOGY, V14, P21; ROISIN Y, 1988, ZOOMORPHOLOGY, V107, P339, DOI 10.1007/BF00312217; Roisin Y, 2000, TERMITES: EVOLUTION, SOCIALITY, SYMBIOSES, ECOLOGY, P95; Rouland-Lefevre C, 2011, BIOLOGY OF TERMITES: A MODERN SYNTHESIS, P499, DOI 10.1007/978-90-481-3977-4_18; Sallam HM, 2009, P NATL ACAD SCI USA, V106, P16722, DOI 10.1073/pnas.0908702106; Scheffrahn RH, 2006, ANN ENTOMOL SOC AM, V99, P463, DOI 10.1603/0013-8746(2006)99[463:TBANOT]2.0.CO;2; Schlemmermeyer Thomas, 2000, Papeis Avulsos de Zoologia (Sao Paulo), V41, P303; Su NY, 2000, TERMITES: EVOLUTION, SOCIALITY, SYMBIOSES, ECOLOGY, P437; Sugimoto A, 2000, TERMITES: EVOLUTION, SOCIALITY, SYMBIOSES, ECOLOGY, P409; Thompson GJ, 2000, MOL PHYLOGENET EVOL, V17, P419, DOI 10.1006/mpev.2000.0852; Thorne BL, 2000, TERMITES: EVOLUTION, SOCIALITY, SYMBIOSES, ECOLOGY, P77; Tokuda G, 2011, INSECT SOC, V59, P17; Udvarty MDF, 1975, 19 IUCN; WATSON JAL, 1973, INSECT SOC, V20, P1, DOI 10.1007/BF02223558; Yu Y., 2013, RASP RECONSTRUCT ANC	104	8	9	OXFORD UNIV PRESS	OXFORD	GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND	0737-4038	1537-1719		MOL BIOL EVOL	Mol. Biol. Evol.	FEB	2015	32	2					406	421		10.1093/molbev/msu308		16	Biochemistry & Molecular Biology; Evolutionary Biology; Genetics & Heredity	Biochemistry & Molecular Biology; Evolutionary Biology; Genetics & Heredity	CC0TW	WOS:000350050700010		
J	Ebinuma, H; Nakahama, K; Nanto, K				Ebinuma, Hiroyasu; Nakahama, Katsuhiko; Nanto, Kazuya			Enrichments of gene replacement events by Agrobacterium-mediated recombinase-mediated cassette exchange	MOLECULAR BREEDING			English	Article						RMCE; Gene replacement; Negative selection	ZINC-FINGER NUCLEASES; FLORAL DIP TRANSFORMATION; SITE-SPECIFIC INTEGRATION; T-DNA; PLANT-CELLS; TUMEFACIENS; MARKER; ARABIDOPSIS; MUTAGENESIS; TRANSGENES	We report recombinase-mediated cassette exchange (RMCE), which can permit integration of transgenes into pre-defined chromosomal loci with no co-expressed marker gene by using Agrobacterium-mediated transformation. Transgenic tobacco plants which have a single copy of negative marker genes (codA) at target loci in heterozygous and homozygous conditions were used for gene exchange by the RMCE method. By negative selection, we were able to obtain five heterozygous and four homozygous transgenic plants in which the genes were exchanged from 64 leaf segments of heterozygous and homozygous target plants, respectively. Except for one transgenic plant with an extra copy, the other eight plants had only a single copy of marker-free transgenes, and no footprint of random integrated copies was detected in half of the eight plants. The RMCE re-transformation frequencies were calculated as 6.25 % per explant and were approximately the same as the average percentage of intact single-copy transformation events for standard tobacco Agrobacterium-mediated transformation.	[Ebinuma, Hiroyasu] Shinshu Univ, Fac Text Sci & Technol, Ueda, Nagano 3868567, Japan; [Nakahama, Katsuhiko; Nanto, Kazuya] Nippon Paper Ind Co Ltd, Agri Biotechnol Res Lab, Kita Ku, Tokyo 1140002, Japan	Ebinuma, H (reprint author), Shinshu Univ, Fac Text Sci & Technol, 3-15-1 Tokida, Ueda, Nagano 3868567, Japan.	ebynuma@shinshu-u.ac.jp; k.nakahama@nipponpapergroup.com; 0950168@nipponpapergroup.com			NEDO (New Energy and Industrial Technology Organization); RITE (Research Institute of Innovative Technology for the Earth)	This work was supported by NEDO (New Energy and Industrial Technology Organization) and RITE (Research Institute of Innovative Technology for the Earth).	de Pater S, 2009, PLANT BIOTECHNOL J, V7, P821, DOI 10.1111/j.1467-7652.2009.00446.x; Singer K, 2012, PLANT PHYSIOL, V160, P511, DOI 10.1104/pp.112.200212; TINLAND B, 1994, P NATL ACAD SCI USA, V91, P8000, DOI 10.1073/pnas.91.17.8000; Cai CQ, 2009, PLANT MOL BIOL, V69, P699, DOI 10.1007/s11103-008-9449-7; Li ZS, 2010, PLANT PHYSIOL, V154, P622, DOI 10.1104/pp.110.160093; de Pater S, 2013, PLANT BIOTECHNOL J, V11, P510, DOI 10.1111/pbi.12040; AKIYOSHI DE, 1984, P NATL ACAD SCI-BIOL, V81, P5994, DOI 10.1073/pnas.81.19.5994; Shukla VK, 2009, NATURE, V459, P437, DOI 10.1038/nature07992; Turan S, 2011, J MOL BIOL, V407, P193, DOI 10.1016/j.jmb.2011.01.004; Nanto K, 2008, TRANSGENIC RES, V17, P337, DOI 10.1007/s11248-007-9106-y; Zhang Y, 2013, PLANT PHYSIOL, V161, P20, DOI 10.1104/pp.112.205179; Wang YJ, 2011, PLANT CELL REP, V30, P267, DOI 10.1007/s00299-010-0938-1; Townsend JA, 2009, NATURE, V459, P442, DOI 10.1038/nature07845; Nanto K, 2009, PLANT CELL REP, V28, P777, DOI 10.1007/s00299-009-0683-5; Louwerse JD, 2007, PLANT PHYSIOL, V145, P1282, DOI 10.1104/pp.107.108092; Wright DA, 2005, PLANT J, V44, P693, DOI 10.1111/j.1365-313X.2005.02551.x; Nanto K, 2005, PLANT BIOTECHNOL J, V3, P203, DOI 10.1111/j.1467-7652.2005.00118.x; Li ZS, 2009, PLANT PHYSIOL, V151, P1087, DOI 10.1104/pp.109.137612; ARAKI H, 1992, J MOL BIOL, V225, P25, DOI 10.1016/0022-2836(92)91023-I; Belhaj K, 2013, PLANT METHODS, V9, DOI 10.1186/1746-4811-9-39; Ebinuma H, 2005, METH MOL B, V286, P237; Ebinuma H, 2012, METHODS MOL BIOL, V847, P379, DOI 10.1007/978-1-61779-558-9_30; Endo M, 2014, BIOCATAL AGR BIOTECH, V3, P2, DOI DOI 10.1016/J.BCAB.2013.10.002; Maniatis T, 1982, MOL CLONING LAB MANU; NAGEL R, 1990, FEMS MICROBIOL LETT, V67, P325, DOI 10.1016/0378-1097(90)90017-K; Qi YP, 2013, GENOME RES, V23, P547, DOI 10.1101/gr.145557.112; Schlaman HRM, 1997, PLANT J, V11, P1377, DOI 10.1046/j.1365-313X.1997.11061377.x; Srivastava V, 2004, TRENDS BIOTECHNOL, V22, P627, DOI 10.1016/j.tibtech.2004.10.002; Tzfira T, 2012, PLANT BIOTECHNOL J, V10, P373, DOI 10.1111/j.1467-7652.2011.00672.x	29	0	0	SPRINGER	DORDRECHT	VAN GODEWIJCKSTRAAT 30, 3311 GZ DORDRECHT, NETHERLANDS	1380-3743	1572-9788		MOL BREEDING	Mol. Breed.	FEB	2015	35	2							82	10.1007/s11032-015-0215-7		10	Agronomy; Plant Sciences; Genetics & Heredity; Horticulture	Agriculture; Plant Sciences; Genetics & Heredity	CB6VR	WOS:000349765300026		
J	Kawasaki, K; Kondoh, E; Chigusa, Y; Ujita, M; Murakami, R; Mogami, H; Brown, JB; Okuno, Y; Konishi, I				Kawasaki, Kaoru; Kondoh, Eiji; Chigusa, Yoshitsugu; Ujita, Mari; Murakami, Ryusuke; Mogami, Haruta; Brown, J. B.; Okuno, Yasushi; Konishi, Ikuo			Reliable pre-eclampsia pathways based on multiple independent microarray data sets	MOLECULAR HUMAN REPRODUCTION			English	Article						microarray; pathway; pre-eclampsia	GENOME-WIDE SCAN; GENE-EXPRESSION; CANCER; CLASSIFICATION; PLACENTAS; REVEALS; ACTIVATION; SELECTION; PROFILES	Pre-eclampsia is a multifactorial disorder characterized by heterogeneous clinical manifestations. Gene expression profiling of preeclamptic placenta have provided different and even opposite results, partly due to data compromised by various experimental artefacts. Here we aimed to identify reliable pre-eclampsia-specific pathways using multiple independent microarray data sets. Gene expression data of control and preeclamptic placentas were obtained from Gene Expression Omnibus. Single-sample gene-set enrichment analysis was performed to generate gene-set activation scores of 9707 pathways obtained from the Molecular Signatures Database. Candidate pathways were identified by t-test-based screening using data sets, GSE10588, GSE14722 and GSE25906. Additionally, recursive feature elimination was applied to arrive at a further reduced set of pathways. To assess the validity of the pre-eclampsia pathways, a statistically-validated protocol was executed using five data sets including two independent other validation data sets, GSE30186, GSE44711. Quantitative real-time PCR was performed for genes in a panel of potential pre-eclampsia pathways using placentas of 20 women with normal or severe preeclamptic singleton pregnancies (n = 10, respectively). A panel of ten pathways were found to discriminate women with pre-eclampsia from controls with high accuracy. Among these were pathways not previously associated with pre-eclampsia, such as the GABA receptor pathway, as well as pathways that have already been linked to pre-eclampsia, such as the glutathione and CDKN1C pathways. mRNA expression of GABRA3 (GABA receptor pathway), GCLC and GCLM (glutathione metabolic pathway), and CDKN1C was significantly reduced in the preeclamptic placentas. In conclusion, ten accurate and reliable pre-eclampsia pathways were identified based on multiple independent microarray data sets. A pathway-based classification maybe a worthwhile approach to elucidate the pathogenesis of pre-eclampsia.	[Kawasaki, Kaoru; Kondoh, Eiji; Chigusa, Yoshitsugu; Ujita, Mari; Murakami, Ryusuke; Mogami, Haruta; Konishi, Ikuo] Kyoto Univ, Dept Gynecol & Obstet, Kyoto 6068507, Japan; [Brown, J. B.; Okuno, Yasushi] Kyoto Univ, Dept Clin Syst Oncoinformat, Kyoto 6068507, Japan	Kondoh, E (reprint author), Kyoto Univ, Dept Obstet & Gynaecol, Sakyo Ku, 54 Shogoin Kawahara Cho, Kyoto 6068507, Japan.	kondo@kuhp.kyoto-u.ac.jp			Ministry of Education, Science, Culture and Sports, Japan [21592096, 22591822, 23791833]; Smoking Research Foundation	This work was supported in part by Grants-in-Aid for Scientific Research from the Ministry of Education, Science, Culture and Sports, Japan (No. 21592096, 22591822 and 23791833) and by a grant from the Smoking Research Foundation.	Young BC, 2010, ANNU REV PATHOL-MECH, V5, P173, DOI 10.1146/annurev-pathol-121808-102149; Gatza ML, 2010, P NATL ACAD SCI USA, V107, P6994, DOI 10.1073/pnas.0912708107; Hamai Y, 1997, AM J REPROD IMMUNOL, V38, P89; Blair JD, 2013, MOL HUM REPROD, V19, P697, DOI 10.1093/molehr/gat044; Lachmeijer AMA, 2001, EUR J HUM GENET, V9, P758, DOI 10.1038/sj.ejhg.5200706; Rhodes DR, 2004, P NATL ACAD SCI USA, V101, P9309, DOI 10.1073/pnas.0401994101; Kanayama N, 2002, MOL HUM REPROD, V8, P1129, DOI 10.1093/molehr/8.12.1129; Sorlie T, 2003, P NATL ACAD SCI USA, V100, P8418, DOI 10.1073/pnas.0932692100; Arngrimsson R, 1999, HUM MOL GENET, V8, P1799, DOI 10.1093/hmg/8.9.1799; Redman CW, 2005, SCIENCE, V308, P1592, DOI 10.1126/science.1111726; Barbie DA, 2009, NATURE, V462, P108, DOI 10.1038/nature08460; Tsai S, 2011, PLACENTA, V32, P175, DOI 10.1016/j.placenta.2010.11.014; Nevins Joseph R, 2011, Proc Am Thorac Soc, V8, P180, DOI 10.1513/pats.201006-040MS; KRUSKAL JB, 1964, PSYCHOMETRIKA, V29, P1, DOI 10.1007/BF02289565; Sitras V, 2009, PLACENTA, V30, P424, DOI 10.1016/j.placenta.2009.01.012; Maynard SE, 2003, J CLIN INVEST, V111, P649, DOI 10.1172/JCI200317189; Mistry HD, 2010, PLACENTA, V31, P401, DOI 10.1016/j.placenta.2010.02.011; Laivuori H, 2003, AM J HUM GENET, V72, P168, DOI 10.1086/345311; Meng T, 2012, OMICS, V16, P301, DOI 10.1089/omi.2011.0066; Berntsen HF, 2013, NEUROTOXICOLOGY, V35, P129, DOI 10.1016/j.neuro.2013.01.004; Chigusa Y, 2012, J CLIN ENDOCR METAB, V97, pE1862, DOI 10.1210/jc.2012-1268; Chigusa Y, 2013, REPROD SCI, V20, P891, DOI 10.1177/1933719112468956; Gardner LB, 2012, HEPATOL RES, V42, P1131, DOI 10.1111/j.1872-034X.2012.01030.x; Guyon I, 2002, MACH LEARN, V46, P389, DOI 10.1023/A:1012487302797; Louwen F, 2012, ONCOTARGET, V3, P759; Moslehi R, 2013, SCI REP-UK, V3, DOI 10.1038/srep02407; Schclkopf B, 2002, LEARNING KERNELS SUP; Shawe-Taylor J., 2004, KERNEL METHODS PATTE; Winn VD, 2009, ENDOCRINOLOGY, V150, P52	29	1	1	OXFORD UNIV PRESS	OXFORD	GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND	1360-9947	1460-2407		MOL HUM REPROD	Mol. Hum. Reprod.	FEB	2015	21	2					217	224		10.1093/molehr/gau096		8	Developmental Biology; Obstetrics & Gynecology; Reproductive Biology	Developmental Biology; Obstetrics & Gynecology; Reproductive Biology	CC0UK	WOS:000350052500010		
J	Chen, MY; Mao, RL; Liang, D; Kuro-o, M; Zeng, XM; Zhang, P				Chen, Meng-Yun; Mao, Rong-Li; Liang, Dan; Kuro-o, Masaki; Zeng, Xiao-Mao; Zhang, Peng			A reinvestigation of phylogeny and divergence times of Hynobiidae (Amphibia, Caudata) based on 29 nuclear genes	MOLECULAR PHYLOGENETICS AND EVOLUTION			English	Article						Molecular dating; Salamander; Pachyhynobius; Salamandrella	BAYESIAN-ESTIMATION; SALAMANDERS; SELECTION; MODEL; DIVERSIFICATION; CLASSIFICATION; SYSTEMATICS; EVOLUTION; PATTERNS; TREES	Although several recent studies have investigated the major phylogenetic relationships within Hynobiidae, their evolutionary history remains partially resolved and the phylogenetic positions of some genera, particularly Pachyhynobius and Salamandrella are still disputed. Notably, previous studies relied primarily on mitochondrial DNA data and concatenated analyses; thus, a new investigation based on multiple nuclear genes and species-tree inference is needed. Here, we provide an in-depth phylogenetic analysis, based on 29 nuclear genes comprising 29,232 bp of data from a comprehensive taxonomic sampling (24 hynobiids and 7 outgroups), using both concatenated and species-tree methods. Our results robustly resolved most genus-level relationships within Hynobiidae, including the placement of Salamandrella as the sister group to a clade containing Batrachuperus, Liva and Pseudohynobius, and the placement of Pachyhynobius as the sister group to a clade containing all hynobiids excluding Onychodactylus, Paradactylodon and Ranodon. Time estimates based on our data suggest that the major group of living hynobiids (excluding Onychodactylus) originated approximately 40 Ma, similar to 50% younger than estimates from mtDNA data (62.5 Ma) but 10% older than estimates from three nuclear genes (36 Ma). Our results highlight the benefits of using a large number of nuclear loci to infer both phylogeny and time for relatively old lineages. (C) 2014 Elsevier Inc. All rights reserved.	[Chen, Meng-Yun; Mao, Rong-Li; Liang, Dan; Zhang, Peng] Sun Yat Sen Univ, Sch Life Sci, State Key Lab Biocontrol, Guangzhou 510006, Guangdong, Peoples R China; [Kuro-o, Masaki] Hirosaki Univ, Fac Agr & Life Sci, Dept Biol, Hirosaki, Aomori, Japan; [Zeng, Xiao-Mao] Chinese Acad Sci, Chengdu Inst Biol, Chengdu 610041, Peoples R China	Zhang, P (reprint author), Sun Yat Sen Univ, Higher Educ Mega Ctr, Sch Life Sci, Guangzhou 510006, Guangdong, Peoples R China.	alarzhang@gmail.com			National Natural Science Foundation of China [31372172]; National Science Fund for Excellent Young Scholars [31322049]	We thank Yingzhou Tian and Jianli Xiong for help in collecting samples XM1081 and XM1987. Xing Xing Shen provided valuable help in both lab works and data analyses. Many thanks to Editor Allan Larson for his thoughtful comments and help in improving the English usage of the early version of our manuscript. This work was supported by the National Natural Science Foundation of China Grants (31372172) and the National Science Fund for Excellent Young Scholars (No. 31322049) to P.Z.	AmphibiaWeb, 2014, INF AMPH BIOL CONS; Lanfear R, 2012, MOL BIOL EVOL, V29, P1695, DOI 10.1093/molbev/mss020; Peng R, 2010, MOL PHYLOGENET EVOL, V56, P252, DOI 10.1016/j.ympev.2009.12.011; Gao KQ, 2003, NATURE, V422, P424, DOI 10.1038/nature01491; Castresana J, 2000, MOL BIOL EVOL, V17, P540; Thorne JL, 2002, SYST BIOL, V51, P689, DOI 10.1080/10635150290102456; Ane C, 2007, MOL BIOL EVOL, V24, P412; Edwards SV, 2009, EVOLUTION, V63, P1, DOI 10.1111/j.1558-5646.2008.00549.x; Pyron RA, 2011, MOL PHYLOGENET EVOL, V61, P543, DOI 10.1016/j.ympev.2011.06.012; Stamatakis A, 2006, BIOINFORMATICS, V22, P2688, DOI 10.1093/bioinformatics/btl446; Guindon S, 2010, SYST BIOL, V59, P307, DOI 10.1093/sysbio/syq010; Roelants K, 2007, P NATL ACAD SCI USA, V104, P887, DOI 10.1073/pnas.0608378104; Near TJ, 2012, P NATL ACAD SCI USA, V109, P13698, DOI 10.1073/pnas.1206625109; Shen XX, 2013, MOL BIOL EVOL, V30, P2235, DOI 10.1093/molbev/mst122; Shimodaira H, 2001, BIOINFORMATICS, V17, P1246, DOI 10.1093/bioinformatics/17.12.1246; Lemmon EM, 2013, ANNU REV ECOL EVOL S, V44, P99, DOI 10.1146/annurev-ecolsys-110512-135822; Ronquist F, 2012, SYST BIOL, V61, P539, DOI 10.1093/sysbio/sys029; Zheng YC, 2011, MOL BIOL EVOL, V28, P2521, DOI 10.1093/molbev/msr072; Drummond AJ, 2007, BMC EVOL BIOL, V7, DOI 10.1186/1471-2148-7-214; Dos Reis M, 2014, SYST BIOL, V63, P555, DOI 10.1093/sysbio/syu020; EDWARDS JL, 1976, J MORPHOL, V148, P305, DOI 10.1002/jmor.1051480304; Li J, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021506; Liu LA, 2010, BMC EVOL BIOL, V10, DOI 10.1186/1471-2148-10-302; Loytynoja A, 2008, PHILOS T R SOC B, V363, P3913, DOI 10.1098/rstb.2008.0170; REGAL PJ, 1966, EVOLUTION, V20, P392, DOI 10.2307/2406638; Weisrock DW, 2013, ZOOTAXA, V3626, P77; Zhang P, 2006, P NATL ACAD SCI USA, V103, P7360, DOI 10.1073/pnas.0602325103	27	0	0	ACADEMIC PRESS INC ELSEVIER SCIENCE	SAN DIEGO	525 B ST, STE 1900, SAN DIEGO, CA 92101-4495 USA	1055-7903	1095-9513		MOL PHYLOGENET EVOL	Mol. Phylogenet. Evol.	FEB	2015	83						1	6		10.1016/j.ympev.2014.10.010		6	Biochemistry & Molecular Biology; Evolutionary Biology; Genetics & Heredity	Biochemistry & Molecular Biology; Evolutionary Biology; Genetics & Heredity	CC0EK	WOS:000350008400001		
J	Echigoya, Y; Aoki, Y; Miskew, B; Panesar, D; Touznik, A; Nagata, T; Tanihata, J; Nakamura, A; Nagaraju, K; Yokota, T				Echigoya, Yusuke; Aoki, Yoshitsugu; Miskew, Bailey; Panesar, Dharminder; Touznik, Aleksander; Nagata, Tetsuya; Tanihata, Jun; Nakamura, Akinori; Nagaraju, Kanneboyina; Yokota, Toshifumi			Long-Term Efficacy of Systemic Multiexon Skipping Targeting Dystrophin Exons 45-55 With a Cocktail of Vivo-Morpholinos in Mdx52 Mice	MOLECULAR THERAPY-NUCLEIC ACIDS			English	Article						antisense therapeutics; Duchenne muscular dystrophy; dystrophin; mdx52 mouse; multiexon skipping; Vivo-Morpholinos	DUCHENNE MUSCULAR-DYSTROPHY; PEPTIDE-CONJUGATED MORPHOLINO; ANTISENSE OLIGONUCLEOTIDES; MUSCLE PATHOLOGY; SKELETAL-MUSCLES; CARDIAC-MUSCLE; EXPRESSION; DELIVERY; RESCUE; MOUSE	Antisense-mediated exon skipping, which can restore the reading frame, is a most promising therapeutic approach for Duchenne muscular dystrophy. Remaining challenges include the limited applicability to patients and unclear function of truncated dystrophin proteins. Multiexon skipping targeting exons 45-55 at the mutation hotspot of the dystrophin gene could overcome both of these challenges. Previously, we described the feasibility of exons 45-55 skipping with a cocktail of Vivo-Morpholinos in vivo; however, the long-term efficacy and safety of Vivo-Morpholinos remains to be determined. In this study, we examined the efficacy and toxicity of exons 45-55 skipping by intravenous injections of 6 mg/kg 10-Vivo-Morpholino cocktail (0.6 mg/kg each vPMO) every 2 weeks for 18 weeks to dystrophic exon-52 knockout (mdx52) mice. Systemic skipping of the entire exons 45-55 region was induced, and the Western blot analysis exhibited the restoration of 5-27% of normal levels of dystrophin protein in skeletal muscles, accompanied by improvements in histopathology and muscle strength. No obvious immune response and renal and hepatic toxicity were detected at the end-point of the treatment. We demonstrate our new regimen with the 10-Vivo-Morpholino cocktail is effective and safe for long-term repeated systemic administration in the dystrophic mouse model.	[Echigoya, Yusuke; Miskew, Bailey; Panesar, Dharminder; Touznik, Aleksander; Yokota, Toshifumi] Univ Alberta, Fac Med & Dent, Dept Med Genet, Sch Human Dev, Edmonton, AB T6G 2H7, Canada; [Aoki, Yoshitsugu; Nagata, Tetsuya; Tanihata, Jun] Natl Ctr Neurol & Psychiat, Natl Inst Neurosci, Dept Mol Therapy, Kodaira, Tokyo 187, Japan; [Aoki, Yoshitsugu] Univ Oxford, Dept Physiol Anat & Genet, Oxford, England; [Nakamura, Akinori] Shinshu Univ, Sch Med, Dept Med Neurol & Rheumatol, Matsumoto, Nagano 390, Japan; [Nagaraju, Kanneboyina] Childrens Natl Med Ctr, Med Genet Res Ctr, Washington, DC 20010 USA; [Yokota, Toshifumi] Muscular Dystrophy Canada, Edmonton, AB, Canada	Yokota, T (reprint author), Univ Alberta, Fac Med & Dent, Dept Med Genet, 829 Med Sci Bldg, Edmonton, AB T6G 2H7, Canada.	toshifum@ualberta.ca			Foundation to Eradicate Duchenne; University of Alberta Faculty of Medicine and Dentistry, Parent Project Muscular Dystrophy (USA); Canadian Institutes of Health Research (CIHR); Friends of Garrett Cumming Research Funds; HM Toupin Neurological Science Research Funds; Muscular Dystrophy Canada; Canada Foundation for Innovation, Alberta Enterprise and Advanced Education; Women and Children's Health Research Institute (WCHRI); MRC Confidence in Concept award; NIH [1K26RR032082, 1P50AR060836-01, 1U54HD071601, 2R24HD050846-06]; DOD [W81XWH-11-1-0330, W81XWH-11-1-0782, W81XWH-10-1-0659, W81XWH-11-1-0809, W81XWH-09-1-0599]; MDA; PPMD	This work was supported by the Foundation to Eradicate Duchenne, the University of Alberta Faculty of Medicine and Dentistry, Parent Project Muscular Dystrophy (USA), the Canadian Institutes of Health Research (CIHR), the Friends of Garrett Cumming Research Funds, HM Toupin Neurological Science Research Funds, Muscular Dystrophy Canada, the Canada Foundation for Innovation, Alberta Enterprise and Advanced Education, and the Women and Children's Health Research Institute (WCHRI). Y.A. is supported by MRC Confidence in Concept award. K.N. is supported by NIH grants (1K26RR032082, 1P50AR060836-01, 1U54HD071601, and 2R24HD050846-06), DOD grants (W81XWH-11-1-0330, W81XWH-11-1-0782, W81XWH-10-1-0659, W81XWH-11-1-0809, and W81XWH-09-1-0599), a translational research grant from the MDA, and a pilot grant from PPMD.	Aartsma-Rus A, 2006, MOL THER, V14, P401, DOI 10.1016/j.ymthe.2006.02.022; Mercuri E, 2013, LANCET, V381, P845, DOI 10.1016/S0140-6736(12)61897-2; Wu B, 2009, MOL THER, V17, P864, DOI 10.1038/mt.2009.38; Mendell JR, 2013, ANN NEUROL, V74, P637, DOI 10.1002/ana.23982; Sazani P, 2011, INT J TOXICOL, V30, P322, DOI 10.1177/1091581811403504; Aartsma-Rus A, 2009, HUM MUTAT, V30, P293, DOI 10.1002/humu.20918; Yokota T, 2009, ANN NEUROL, V65, P667, DOI 10.1002/ana.21627; Yokota T, 2007, EXPERT OPIN BIOL TH, V7, P831, DOI 10.1517/14712598.7.6.831; Hoffman EP, 2011, AM J PATHOL, V179, P12, DOI 10.1016/j.ajpath.2011.03.050; Ferguson DP, 2014, BIOTECHNIQUES, V56, P251, DOI 10.2144/000114167; Yokota T, 2011, METHODS MOL BIOL, V709, P299, DOI 10.1007/978-1-61737-982-6_20; Spitali P, 2013, FASEB J, V27, P4909, DOI 10.1096/fj.13-232025; Mah JK, 2014, NEUROMUSCULAR DISORD, V24, P482, DOI 10.1016/j.nmd.2014.03.008; Morcos PA, 2008, BIOTECHNIQUES, V45, P613, DOI 10.2144/000113005; Aoki Y, 2012, P NATL ACAD SCI USA, V109, P13763, DOI 10.1073/pnas.1204638109; Aoki Y, 2010, MOL THER, V18, P1995, DOI 10.1038/mt.2010.186; Lu QL, 2005, P NATL ACAD SCI USA, V102, P198, DOI 10.1073/pnas.040600102; Magri F, 2011, J NEUROL, V258, P1610, DOI 10.1007/s00415-011-5979-z; Takeshima Y, 2010, J HUM GENET, V55, P379, DOI 10.1038/jhg.2010.49; Straub V, 1997, J CELL BIOL, V139, P375, DOI 10.1083/jcb.139.2.375; Aoki Y, 2013, HUM MOL GENET, V22, P4914, DOI 10.1093/hmg/ddt341; Lehto T, 2014, NUCLEIC ACIDS RES, V42, P3207, DOI 10.1093/nar/gkt1220; Moulton HM, 2010, BBA-BIOMEMBRANES, V1798, P2296, DOI 10.1016/j.bbamem.2010.02.012; Wu B, 2012, AM J PATHOL, V181, P392, DOI 10.1016/j.ajpath.2012.04.006; Wu B, 2011, MOL THER, V19, P576, DOI 10.1038/mt.2010.288; Voit T, 2014, LANCET NEUROL, V13, P987, DOI 10.1016/S1474-4422(14)70195-4; Wu B, 2010, GENE THER, V17, P132, DOI 10.1038/gt.2009.120; Yokota T, 2012, NUCLEIC ACID THER, V22, P306, DOI 10.1089/nat.2012.0368; Widrick JJ, 2011, MUSCLE NERVE, V44, P563, DOI 10.1002/mus.22126; Aoki Y, 2013, BIOMED RES INT, V2013; Beroud C, 2007, HUM MUTAT, V28, P196, DOI 10.1002/humu.20428; CHELLY J, 1990, CELL, V63, P1239, DOI 10.1016/0092-8674(90)90419-F; Denti MA, 2008, HUM GENE THER, V19, P601, DOI 10.1089/hum.2008.012; Echigoya Y, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0069194; Echigoya Y, 2014, NUCLEIC ACID THER, V24, P57, DOI 10.1089/nat.2013.0451; Jearawiriyapaisarn N, 2010, CARDIOVASC RES, V85, P444, DOI 10.1093/cvr/cvp335; Kohli R, 2005, J PEDIATR GASTR NUTR, V41, P121, DOI 10.1097/01.WNO.0000161657.98895.97; KUNKEL LM, 1989, CLIN CHEM, V35, pB21; Lee Joshua J A, 2013, J Pers Med, V3, P144, DOI 10.3390/jpm3030144; Lu QL, 2011, MOL THER, V19, P9, DOI 10.1038/mt.2010.219; Morcos PA, 2008, BIOTECHNIQUES, V45, P618; Morcos PA, 2008, BIOTECHNIQUES, V45, P616; Mullard A, 2013, NAT REV DRUG DISCOV, V12, P813, DOI 10.1038/nrd4151; MUSSINI E, 1984, MUSCLE NERVE, V7, P388, DOI 10.1002/mus.880070508; Nakamura A, 2008, J CLIN NEUROSCI, V15, P757, DOI 10.1016/j.jocn.2006.12.012; Nakamura H, 2013, ORPHANET J RARE DIS, V8, DOI 10.1186/1750-1172-8-60; Tanganyika-de Winter CL, 2012, MOL THER-NUCL ACIDS, V1, DOI 10.1038/mtna.2012.38; van Vliet L, 2008, BMC MED GENET, V9, DOI 10.1186/1471-2350-9-105; van den Bergen JC, 2014, J NEUROL NEUROSUR PS, V85, P747, DOI 10.1136/jnnp-2013-306350; Wu B, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019906; Yokota T, 2009, ARCH NEUROL-CHICAGO, V66, P32, DOI 10.1001/archneurol.2008.540; ZELLWEGER H, 1975, PEDIATRICS, V55, P30	52	2	2	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	2162-2531			MOL THER-NUCL ACIDS	Mol. Ther.-Nucl. Acids	FEB	2015	4								e225	10.1038/mtna.2014.76		10	Medicine, Research & Experimental	Research & Experimental Medicine	CC1XA	WOS:000350137500001		
J	Kushida, H; Matsumoto, T; Igarashi, Y; Nishimura, H; Watanabe, J; Maemura, K; Kase, Y				Kushida, Hirotaka; Matsumoto, Takashi; Igarashi, Yasushi; Nishimura, Hiroaki; Watanabe, Junko; Maemura, Kazuya; Kase, Yoshio			Metabolic Profiling of the Uncaria Hook Alkaloid Geissoschizine Methyl Ether in Rat and Human Liver Microsomes Using High-Performance Liquid Chromatography with Tandem Mass Spectrometry	MOLECULES			English	Article							2 HYDROXYLATED METABOLITES; INDOLE ALKALOIDS; YOKUKANSAN; YOHIMBINE; RECEPTOR	Geissoschizine methyl ether (GM) is an indole alkaloid found in Uncaria hook, which is a galenical constituent of yokukansan, a traditional Japanese medicine. GM has been identified as the active component responsible for anti-aggressive effects. In this study, the metabolic profiling of GM in rat and human liver microsomes was investigated. Thirteen metabolites of GM were elucidated and identified using a high-performance liquid chromatography with tandem mass spectrometry method, and their molecular structures were proposed on the basis of the characteristics of their precursor ions, product ions, and chromatographic retention times. There were no differences in the metabolites between the rat and human liver microsomes. Among the 13 identified metabolites, there were two demethylation metabolites, one dehydrogenation metabolite, three methylation metabolites, three oxidation metabolites, two water-adduct metabolites, one di-demethylation metabolite, and one water-adduct metabolite followed by oxidation. The metabolic pathways of GM were proposed on the basis of this study. This study will be helpful in understanding the metabolic routes of GM and related Uncaria hook alkaloids, and provide useful information on the pharmacokinetics and pharmacodynamics. This is the first report that describes the separation and identification of GM metabolites in rat and human liver microsomes.	[Kushida, Hirotaka; Matsumoto, Takashi; Watanabe, Junko; Maemura, Kazuya; Kase, Yoshio] Tsumura & Co, Tsumura Res Labs, Ami, Ibaraki 3001192, Japan; [Igarashi, Yasushi; Nishimura, Hiroaki] Tsumura & Co, Kampo Formulat Dev Ctr, Ami, Ibaraki 3001192, Japan	Kushida, H (reprint author), Tsumura & Co, Tsumura Res Labs, 3586 Yoshiwara, Ami, Ibaraki 3001192, Japan.	kushida_hirotaka@mail.tsumura.co.jp; matsumoto_takashi@mail.tsumura.co.jp; igarashi_yasushi@mail.tsumura.co.jp; nishimura_hiroaki@mail.tsumura.co.jp; watanabe_junko@mail.tsumura.co.jp; maemura_kazuya@mail.tsumura.co.jp; kase_yoshio@mail.tsumura.co.jp					Nakazawa T, 2006, BIOL PHARM BULL, V29, P1671, DOI 10.1248/bpb.29.1671; Ueki T, 2013, CELL MOL NEUROBIOL, V33, P129, DOI 10.1007/s10571-012-9878-3; Castro-Perez JM, 2007, DRUG DISCOV TODAY, V12, P249, DOI 10.1016/j.drudis.2007.01.007; Kawakami Z, 2011, J ETHNOPHARMACOL, V134, P74, DOI 10.1016/j.jep.2010.11.063; Yuzurihara M, 2002, EUR J PHARMACOL, V444, P183, DOI 10.1016/S0014-2999(02)01623-0; Imamura S, 2011, CELL MOL NEUROBIOL, V31, P787, DOI 10.1007/s10571-011-9676-3; Pengsuparp T, 2001, EUR J PHARMACOL, V425, P211, DOI 10.1016/S0014-2999(01)01195-5; Ueda T, 2011, EUR J PHARMACOL, V671, P79, DOI 10.1016/j.ejphar.2011.09.007; Deiters A, 2003, J AM CHEM SOC, V125, P4541, DOI 10.1021/ja0296024; Kushida H, 2013, BIOMED CHROMATOGR, V27, P1647, DOI 10.1002/bmc.2974; BERLAN M, 1993, BRIT J PHARMACOL, V108, P927; Gai YN, 2014, J CHROMATOGR B, V972, P22, DOI 10.1016/j.jchromb.2014.09.033; LEVERGE R, 1992, J CHROMATOGR-BIOMED, V574, P283, DOI 10.1016/0378-4347(92)80041-N; Nishi A, 2012, NEUROSCIENCE, V207, P124, DOI 10.1016/j.neuroscience.2012.01.037	14	0	0	MDPI AG	BASEL	POSTFACH, CH-4005 BASEL, SWITZERLAND	1420-3049			MOLECULES	Molecules	FEB	2015	20	2					2100	2114		10.3390/molecules20022100		15	Chemistry, Organic	Chemistry	CD0GH	WOS:000350748200019		
J	Yasumori, A; Yanagida, S; Sawada, J				Yasumori, Atsuo; Yanagida, Sayaka; Sawada, Jun			Preparation of a Titania/X-Zeolite/Porous Glass Composite Photocatalyst Using Hydrothermal and Drop Coating Processes	MOLECULES			English	Article							INDOOR AIR PURIFICATION; SOL-GEL SYNTHESIS; ACTIVATED CARBON; GAS-PHASE; ENVIRONMENTAL IMPROVEMENT; PAPERMAKING TECHNIQUE; TIO2 PHOTOCATALYSIS; SILICA-GEL; OXIDATION; DIOXIDE	Combinations of TiO2 photocatalysts and various adsorbents have been widely studied for the adsorption and photocatalytic decomposition of gaseous pollutants such as volatile organic compounds (VOCs). Herein, a TiO2-zeolite-porous glass composite was prepared using melt-quenching and partial sintering, hydrothermal treatment, and drop coating for preparation of the porous glass support and X-zeolite and their combination with TiO2, respectively. The obtained composite comprised anatase phase TiO2, X-zeolite, and the porous glass support, which were combined at the micro to nanometer scales. The composite had a relatively high specific surface area of approximately 25 m(2)/g and exhibited a good adsorption capacity for 2-propanol. These data indicated that utilization of this particular phase-separated glass as the support was appropriate for the formation of the bulk photocatalyst-adsorbent composite. Importantly, the photocatalytic decomposition of adsorbed 2-propanol proceeded under UV light irradiation. The 2-propanol was oxidized to acetone and then trapped by the X-zeolite rather than being released to the atmosphere. Consequently, it was demonstrated that the micrometer-scaled combination of TiO2 and zeolite in the bulk form is very useful for achieving both the removal of gaseous organic pollutants and decreasing the emission of harmful intermediates.	[Yasumori, Atsuo; Yanagida, Sayaka; Sawada, Jun] Tokyo Univ Sci, Dept Mat Sci & Technol, Katsushika Ku, Tokyo 1258585, Japan; [Yasumori, Atsuo; Yanagida, Sayaka] Tokyo Univ Sci, Res Inst Sci & Technol, Photocatalysis Int Res Ctr, Noda, Chiba 2788510, Japan	Yasumori, A (reprint author), Tokyo Univ Sci, Dept Mat Sci & Technol, Katsushika Ku, 6-3-1 Niijuku, Tokyo 1258585, Japan.	yasumori@rs.noda.tus.ac.jp; YANAGIDA.Sayaka@nims.go.jp; bb_is_my_life_tr@yahoo.co.jp					Yu JC, 2004, CHEM MATER, V16, P1523, DOI 10.1021/cm049955x; Ao CH, 2005, CHEM ENG SCI, V60, P103, DOI 10.1016/j.ces.2004.01.073; Tan LK, 2010, ACS APPL MATER INTER, V2, P498, DOI 10.1021/am900726k; Cheung O, 2014, RSC ADV, V4, P14480, DOI 10.1039/c3ra48052f; Ichiura H, 2003, J MATER SCI, V38, P1611, DOI 10.1023/A:1023246803552; Hashimoto K, 2005, JPN J APPL PHYS 1, V44, P8269, DOI 10.1143/JJAP.44.8269; HOFFMANN MR, 1995, CHEM REV, V95, P69, DOI 10.1021/cr00033a004; Yamashita H, 1998, J PHYS CHEM B, V102, P10707, DOI 10.1021/jp982835q; ANPO M, 1985, J PHYS CHEM-US, V89, P5017, DOI 10.1021/j100269a025; Ismail AA, 2004, J PHOTOCH PHOTOBIO A, V163, P445, DOI 10.1016/j.jphotochem.2004.01.017; Torimoto T, 1997, J PHOTOCH PHOTOBIO A, V103, P153, DOI 10.1016/S1010-6030(96)04503-0; Takeuchi M, 2007, J CATAL, V246, P235, DOI 10.1016/j.jcat.2006.12.010; TAKEDA N, 1995, J PHYS CHEM-US, V99, P9986, DOI 10.1021/j100024a047; Chen HH, 2012, CHEM REV, V112, P5919, DOI 10.1021/cr3002092; Xu YM, 1997, J PHYS CHEM B, V101, P3115, DOI 10.1021/jp962494l; Huang B, 2003, J WOOD SCI, V49, P79, DOI 10.1007/s100860300013; [Anonymous], 2000, AIR QUAL GUID EUR, P32; Torimoto T, 1996, ENVIRON SCI TECHNOL, V30, P1275, DOI 10.1021/es950483k; Zhang H, 2010, ACS NANO, V4, P380, DOI 10.1021/nn901221k; Ding Z, 2000, LANGMUIR, V16, P6216, DOI 10.1021/la000119l; Zhang YH, 2010, ACS NANO, V4, P7303, DOI 10.1021/nn1024219; Ohko Y, 1997, J PHYS CHEM A, V101, P8057, DOI 10.1021/jp972002k; ANDERSON C, 1995, J PHYS CHEM-US, V99, P9882, DOI 10.1021/j100024a033; BICKLEY RI, 1973, J CATAL, V31, P398, DOI 10.1016/0021-9517(73)90311-4; OBEE TN, 1995, ENVIRON SCI TECHNOL, V29, P1223, DOI 10.1021/es00005a013; Yasumori A, 2001, J MATER CHEM, V11, P1253, DOI 10.1039/b100216n; Ao CH, 2003, J PHOTOCH PHOTOBIO A, V156, P171, DOI 10.1016/S1010-6030(03)00009-1; Donphai W, 2014, PHYS CHEM CHEM PHYS, V16, P25004, DOI 10.1039/c4cp03897e; Li HX, 2007, J AM CHEM SOC, V129, P4538, DOI 10.1021/ja069113u; PERAL J, 1992, J CATAL, V136, P554, DOI 10.1016/0021-9517(92)90085-V; Kamat PV, 2010, J PHYS CHEM LETT, V1, P520, DOI 10.1021/jz900265j; Chu SZ, 2003, J PHYS CHEM B, V107, P6586, DOI 10.1021/jp0349684; FOX MA, 1993, CHEM REV, V93, P341, DOI 10.1021/cr00017a016; Mo JH, 2009, ATMOS ENVIRON, V43, P2229, DOI 10.1016/j.atmosenv.2009.01.034; YASUMORI A, 1994, NIPPON SERAM KYO GAK, V102, P702; Kuwahara Y, 2011, J MATER CHEM, V21, P2407, DOI 10.1039/c0jm02741c; Ichiura H, 2002, J MATER SCI, V37, P2937, DOI 10.1023/A:1016060729376; SING KSW, 1985, PURE APPL CHEM, V57, P603, DOI 10.1351/pac198557040603; Qian XF, 2013, J PHYS CHEM C, V117, P19544, DOI 10.1021/jp4071373; SAUER ML, 1994, J CATAL, V149, P81, DOI 10.1006/jcat.1994.1274; Ao CH, 2004, J PHOTOCH PHOTOBIO A, V161, P131, DOI 10.1016/S1010-6030(03)00276-4; Corma A, 2004, CHEM COMMUN, P1443, DOI 10.1039/b400147h; DOMEN K, 1988, B CHEM SOC JPN, V61, P359, DOI 10.1246/bcsj.61.359; Doremus R. H., 1973, GLASS SCI, V44, P73; Fujishima A., 2000, J PHOTOCH PHOTOBIO C, V1, P1, DOI DOI 10.1016/S1389-5567(00)00002-2; Ho WK, 2005, LANGMUIR, V21, P3486, DOI 10.1021/la047308e; Jan YH, 2009, J AIR WASTE MANAGE, V59, P1186, DOI 10.3155/1047-3289.59.10.1186; Kamegawa T., 2011, J PHYS CHEM C, V114, P15049, DOI DOI 10.1021/JP105526D; Kamegawa T, 2014, MOLECULES, V19, P16477, DOI 10.3390/molecules191016477; Kato K., 1993, J CERAM SOC JPN, V101, P245, DOI DOI 10.2109/JCERSJ.101.245; Khl G. H., 1987, ZEOLITES, V7, P451, DOI [10.1016/0144-2449(87)90014-5, DOI 10.1016/0144-2449(87)90014-5]; Lobo R.F., 2003, HDB ZEOLITE SCI TECH, P65; Machida F, 2010, J AM CERAM SOC, V93, P461, DOI 10.1111/j.1551-2916.2009.03472.x; Raillard C, 2004, J PHOTOCH PHOTOBIO A, V163, P425, DOI 10.1016/j.jphotochem.2004.01.014; Robert D., 2013, PHOTOCATALYSIS WATER, P145; SAMPATH S, 1994, J CATAL, V149, P189, DOI 10.1006/jcat.1994.1284; Shaham-Waldmann N., 2013, MODIFIED PHOTOCATALY, P107; Sircar S., 2003, HDB ZEOLITE SCI TECH, P1063; Subotic B., 2003, HDB ZEOLITE SCI TECH, P129; Yamaguchi K, 2009, MICROPOR MESOPOR MAT, V117, P350, DOI 10.1016/j.micromeso.2008.07.009; Yang YX, 2014, RSC ADV, V4, P7279, DOI 10.1039/c3ra46987e; Yasumori A, 1998, J MATER CHEM, V8, P2521, DOI 10.1039/a803265c; YAZAWA T, 1994, J MATER SCI, V29, P3433, DOI 10.1007/BF00352046; Yu CWF, 2013, INDOOR BUILT ENVIRON, V22, P39, DOI 10.1177/1420326X12470282; Zhao J, 2003, BUILD ENVIRON, V38, P645, DOI 10.1016/S0360-1323(02)00212-3	65	0	0	MDPI AG	BASEL	POSTFACH, CH-4005 BASEL, SWITZERLAND	1420-3049			MOLECULES	Molecules	FEB	2015	20	2					2349	2363		10.3390/molecules20022349		15	Chemistry, Organic	Chemistry	CD0GH	WOS:000350748200031		
J	Satoh, T; Yamaguchi, T; Kato, K				Satoh, Tadashi; Yamaguchi, Takumi; Kato, Koichi			Emerging Structural Insights into Glycoprotein Quality Control Coupled with N-Glycan Processing in the Endoplasmic Reticulum	MOLECULES			English	Review							ER-ASSOCIATED DEGRADATION; ASPARAGINE-LINKED OLIGOSACCHARIDES; TRANSPORT RECEPTOR COMPLEX; UBIQUITIN-LIGASE COMPLEX; MANNOSIDASE-LIKE PROTEIN; GLUCOSIDASE-II; CRYSTAL-STRUCTURE; CARGO RECEPTOR; FACTOR-VIII; MRH DOMAIN	In the endoplasmic reticulum (ER), the sugar chain is initially introduced onto newly synthesized proteins as a triantennary tetradecasaccharide (Glc(3)Man(9)GlcNAc(2)). The attached oligosaccharide chain is subjected to stepwise trimming by the actions of specific glucosidases and mannosidases. In these processes, the transiently expressed N-glycans, as processing intermediates, function as signals for the determination of glycoprotein fates, i.e., folding, transport, or degradation through interactions of a series of intracellular lectins. The monoglucosylated glycoforms are hallmarks of incompletely folded states of glycoproteins in this system, whereas the outer mannose trimming leads to ER-associated glycoprotein degradation. This review outlines the recently emerging evidence regarding the molecular and structural basis of this glycoprotein quality control system, which is regulated through dynamic interplay among intracellular lectins, glycosidases, and glycosyltransferase. Structural snapshots of carbohydrate-lectin interactions have been provided at the atomic level using X-ray crystallographic analyses. Conformational ensembles of uncomplexed triantennary high-mannose-type oligosaccharides have been characterized in a quantitative manner using molecular dynamics simulation in conjunction with nuclear magnetic resonance spectroscopy. These complementary views provide new insights into glycoprotein recognition in quality control coupled with N-glycan processing.	[Satoh, Tadashi; Yamaguchi, Takumi; Kato, Koichi] Nagoya City Univ, Grad Sch Pharmaceut Sci, Mizuho Ku, Nagoya, Aichi 4678603, Japan; [Satoh, Tadashi] PRESTO, JST, Mizuho Ku, Nagoya, Aichi 4678603, Japan; [Yamaguchi, Takumi; Kato, Koichi] Natl Inst Nat Sci, Okazaki Inst Integrat Biosci, Okazaki, Aichi 4448787, Japan; [Yamaguchi, Takumi; Kato, Koichi] Natl Inst Nat Sci, Inst Mol Sci, Okazaki, Aichi 4448787, Japan	Satoh, T (reprint author), Nagoya City Univ, Grad Sch Pharmaceut Sci, Mizuho Ku, 3-1 Tanabe Dori, Nagoya, Aichi 4678603, Japan.	tadashisatoh@phar.nagoya-cu.ac.jp; takumi@ims.ac.jp; kkatonmr@ims.ac.jp			Okazaki ORION project; Ministry of Education, Culture, Sports, Science and Technology, Japan [24770102, 25121730, 24750170, 25102008]; PRESTO project from the Japan Science and Technology Agency [13417569]	This work was supported in part by the Okazaki ORION project and Grants-in-Aid for Scientific Research (Grant Numbers 24770102, 25121730 to T.S., 24750170 to T.Y., and 25102008, 24249002 to K.K.) from the Ministry of Education, Culture, Sports, Science and Technology, Japan, and by the PRESTO project (Grant Number 13417569 to T.S.) from the Japan Science and Technology Agency.	Totani K, 2008, J AM CHEM SOC, V130, P2101, DOI 10.1021/ja077570k; ASANO N, 1995, J MED CHEM, V38, P2349, DOI 10.1021/jm00013a012; Takeda Y, 2014, GLYCOBIOLOGY, V24, P344, DOI 10.1093/glycob/cwt163; Fujimori T, 2013, FEBS J, V280, P1563, DOI 10.1111/febs.12157; Kamiya Y, 2008, J BIOL CHEM, V283, P1857, DOI 10.1074/jbc.M709384200; Bernasconi R, 2008, J BIOL CHEM, V283, P16446, DOI 10.1074/jbc.M802272200; Petrescu AJ, 1997, EMBO J, V16, P4302, DOI 10.1093/emboj/16.14.4302; Yamaguchi T, 2013, CHEM LETT, V42, P544, DOI 10.1246/cl.130040; D'Alessio C, 2010, SEMIN CELL DEV BIOL, V21, P491, DOI 10.1016/j.semcdb.2009.12.014; Kozlov G, 2010, J BIOL CHEM, V285, P35551, DOI 10.1074/jbc.M110.160101; Durantel D, 2007, CURR OPIN INVESTIG D, V8, P125; Hosokawa N, 2009, J BIOL CHEM, V284, P17061, DOI 10.1074/jbc.M809725200; Mehta A, 1998, FEBS LETT, V430, P17, DOI 10.1016/S0014-5793(98)00525-0; Kozlov G, 2010, J BIOL CHEM, V285, P38612, DOI 10.1074/jbc.M110.168294; Aebi M, 2010, TRENDS BIOCHEM SCI, V35, P74, DOI 10.1016/j.tibs.2009.10.001; Jakob CA, 2001, EMBO REP, V2, P423; Zhang B, 2003, NAT GENET, V34, P220, DOI 10.1038/ng1153; Hosokawa N, 2010, GLYCOBIOLOGY, V20, P567, DOI 10.1093/glycob/cwq001; Lederkremer GZ, 2009, CURR OPIN STRUC BIOL, V19, P515, DOI 10.1016/j.sbi.2009.06.004; GRINNA LS, 1980, J BIOL CHEM, V255, P2255; Kamiya Y, 2012, BBA-GEN SUBJECTS, V1820, P1327, DOI 10.1016/j.bbagen.2011.12.017; Olivari S, 2005, J BIOL CHEM, V280, P2424, DOI 10.1074/jbc.C400534200; Clerc S, 2009, J CELL BIOL, V184, P159, DOI 10.1083/jcb.200809198; Mikami K, 2010, GLYCOBIOLOGY, V20, P310, DOI 10.1093/glycob/cwp175; Ninagawa S, 2014, J CELL BIOL, V206, P347, DOI 10.1083/jcb.201404075; Deprez P, 2005, MOL CELL, V19, P183, DOI 10.1016/j.molcel.2005.05.029; Labunskyy VM, 2005, J BIOL CHEM, V280, P37839, DOI 10.1074/jbc.M508685200; Schrag JD, 2001, MOL CELL, V8, P633, DOI 10.1016/S1097-2765(01)00318-5; Karaveg K, 2005, J BIOL CHEM, V280, P29837, DOI 10.1074/jbc.M505130200; Molinari M, 2007, NAT CHEM BIOL, V3, P313, DOI 10.1038/nchembio880; Kamiya Y, 2005, J BIOL CHEM, V280, P37178, DOI 10.1074/jbc.M505757200; Quan EM, 2008, MOL CELL, V32, P870, DOI 10.1016/j.molcel.2008.11.017; Christianson JC, 2008, NAT CELL BIOL, V10, P272, DOI 10.1038/ncb1689; Zhang B, 2005, J BIOL CHEM, V280, P25881, DOI 10.1074/jbc.M502160200; Trombetta ES, 2001, BIOCHEMISTRY-US, V40, P10717, DOI 10.1021/bi010629u; Olson LJ, 2013, J BIOL CHEM, V288, P16460, DOI 10.1074/jbc.M113.450239; Satoh T, 2010, MOL CELL, V40, P905, DOI 10.1016/j.molcel.2010.11.017; Caramelo JJ, 2003, P NATL ACAD SCI USA, V100, P86, DOI 10.1073/pnas.262661199; Taylor SC, 2004, NAT STRUCT MOL BIOL, V11, P128, DOI 10.1038/nsmb715; Pollock S, 2004, EMBO J, V23, P1020, DOI 10.1038/sj.emboj.7600119; Satoh T, 2007, J BIOL CHEM, V282, P28246, DOI 10.1074/jbc.M703064200; Kato K, 2007, GLYCOBIOLOGY, V17, P1031, DOI 10.1093/glycob/cwm046; Karaveg K, 2005, J BIOL CHEM, V280, P16197, DOI 10.1074/jbc.M500119200; KORNFELD R, 1985, ANNU REV BIOCHEM, V54, P631, DOI 10.1146/annurev.biochem.54.1.631; Totani K, 2006, J BIOL CHEM, V281, P31502, DOI 10.1074/jbc.M605457200; Hirao K, 2006, J BIOL CHEM, V281, P9650, DOI 10.1074/jbc.M512191200; WOOTEN EW, 1990, EUR BIOPHYS J, V18, P139, DOI 10.1007/BF02427373; HELENIUS A, 1994, MOL BIOL CELL, V5, P253; Totani K, 2009, BIOCHEMISTRY-US, V48, P2933, DOI 10.1021/bi8020586; Yamaguchi D, 2010, GLYCOBIOLOGY, V20, P348, DOI 10.1093/glycob/cwp182; Zheng CL, 2013, J BIOL CHEM, V288, P20499, DOI 10.1074/jbc.M113.461434; Gauss R, 2011, MOL CELL, V42, P782, DOI 10.1016/j.molcel.2011.04.027; VLIEGENTHART JFG, 1983, ADV CARBOHYD CHEM BI, V41, P209, DOI 10.1016/S0065-2318(08)60059-1; Caramelo JJ, 2008, J BIOL CHEM, V283, P10221, DOI 10.1074/jbc.R700048200; Hu D, 2009, GLYCOBIOLOGY, V19, P1127, DOI 10.1093/glycob/cwp104; Dersh D, 2014, MOL BIOL CELL, V25, P2220, DOI 10.1091/mbc.E14-03-0805; Hosokawa N, 2001, EMBO REP, V2, P415; Wormald MR, 2002, CHEM REV, V102, P371, DOI 10.1021/cr990368i; Barker MK, 2013, J BIOL CHEM, V288, P13563, DOI 10.1074/jbc.M113.460436; Zhang B, 2009, BRIT J HAEMATOL, V145, P15, DOI 10.1111/j.1365-2141.2008.07559.x; BALAJI PV, 1994, GLYCOBIOLOGY, V4, P497, DOI 10.1093/glycob/4.4.497; Burkhalter N. F., 2000, CARBOHYDRATES CHEM 1, V2, P863; Chen Y, 2013, GLYCOBIOLOGY, V23, P904, DOI 10.1093/glycob/cwt027; Chouquet A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017886; Hanna J, 2012, J BIOL CHEM, V287, P8633, DOI 10.1074/jbc.M111.317644; Kamiya Y, 2009, GLYCOBIOLOGY RES TRE, P27; Kamiya Yukiko, 2013, Biomolecules, V3, P108, DOI 10.3390/biom3010108; Klaus JP, 2013, CELL HOST MICROBE, V14, P522, DOI 10.1016/j.chom.2013.10.010; Moothoo DN, 1999, GLYCOBIOLOGY, V9, P539, DOI 10.1093/glycob/9.6.539; Nishio M, 2010, P NATL ACAD SCI USA, V107, P4034, DOI 10.1073/pnas.0908526107; Nyfeler B, 2006, TRAFFIC, V7, P1473, DOI 10.1111/j.1600-0854.2006.00483.x; Qin SY, 2012, GLYCOBIOLOGY, V22, P1709, DOI 10.1093/glycob/cws114; Roth J, 2003, BIOCHIMIE, V85, P287, DOI 10.1016/S0300-9084(03)00049-X; Sakono M, 2014, BIOCHEM BIOPH RES CO, V452, P27, DOI 10.1016/j.bbrc.2014.08.041; Satoh T, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0087963; SCHWEIZER A, 1988, J CELL BIOL, V107, P1643, DOI 10.1083/jcb.107.5.1643; Seidler PM, 2014, J MOL BIOL, V426, P3590, DOI 10.1016/j.jmb.2014.08.024; Vallee F, 2000, EMBO J, V19, P581, DOI 10.1093/emboj/19.4.581; Vallee F, 2000, J BIOL CHEM, V275, P41287, DOI 10.1074/jbc.M006927200; Wigren E, 2010, FEBS LETT, V584, P878, DOI 10.1016/j.febslet.2010.02.009; Yamaguchi T., 2014, GLYCOSCIENC IN PRESS, DOI [10.1007/978-4-431-54836-2_101-1, DOI 10.1007/978-4-431-54836-2_101-1]; Yamaguchi T, 2014, ANGEW CHEM INT EDIT, V53, P10941, DOI 10.1002/anie.201406145; Zhang Y, 2015, ADV EXP MED BIOL, V842, P217, DOI 10.1007/978-3-319-11280-0_14; Zhu T, 2014, SCI REP-UK, V4, DOI 10.1038/srep07322	84	2	2	MDPI AG	BASEL	POSTFACH, CH-4005 BASEL, SWITZERLAND	1420-3049			MOLECULES	Molecules	FEB	2015	20	2					2475	2491		10.3390/molecules20022475		17	Chemistry, Organic	Chemistry	CD0GH	WOS:000350748200037		
J	Maeno, Z; Mitsudome, T; Mizugaki, T; Jitsukawa, K; Kaneda, K				Maeno, Zen; Mitsudome, Takato; Mizugaki, Tomoo; Jitsukawa, Koichiro; Kaneda, Kiyotomi			Selective C-C Coupling Reaction of Dimethylphenol to Tetramethyldiphenoquinone Using Molecular Oxygen Catalyzed by Cu Complexes Immobilized in Nanospaces of Structurally-Ordered Materials	MOLECULES			English	Article							POLY(PROPYLENE IMINE) DENDRIMERS; LIQUID-PHASE OXIDATION; COPPER(II) COMPLEXES; POLYAMINE DENDRIMER; HINDERED PHENOLS; SUBSTITUTED PHENOLS; CRYSTAL-STRUCTURE; MAGADIITE; 2,6-DI-TERT-BUTYLPHENOL; 2,6-DIMETHYLPHENOL	Two high-performance Cu catalysts were successfully developed by immobilization of Cu ions in the nanospaces of poly(propylene imine) (PPI) dendrimer and magadiite for the selective C-C coupling of 2,6-dimethylphenol (DMP) to 3,3',5,5'-tetramethyldiphenoquinone (DPQ) with O-2 as a green oxidant. The PPI dendrimer encapsulated Cu ions in the internal nanovoids to form adjacent Cu species, which exhibited significantly high catalytic activity for the regioselective coupling reaction of DMP compared to previously reported enzyme and metal complex catalysts. The magadiite-immobilized Cu complex acted as a selective heterogeneous catalyst for the oxidative C-C coupling of DMP to DPQ. This heterogeneous catalyst was recoverable from the reaction mixture by simple filtration, reusable without loss of efficiency, and applicable to a continuous flow reactor system. Detailed characterization using ultraviolet-visible (UV-vis), Fourier transform infrared (FTIR), electronic spin resonance (ESR), and X-ray absorption fine structure (XAFS) spectroscopies and the reaction mechanism investigation revealed that the high catalytic performances of these Cu catalysts were ascribed to the adjacent Cu species generated within the nanospaces of the PPI dendrimer and magadiite.	[Maeno, Zen; Mitsudome, Takato; Mizugaki, Tomoo; Jitsukawa, Koichiro; Kaneda, Kiyotomi] Osaka Univ, Dept Mat Engn Sci, Grad Sch Engn Sci, Toyonaka, Osaka 5608531, Japan; [Kaneda, Kiyotomi] Osaka Univ, Res Ctr Solar Energy Chem, Toyonaka, Osaka 5608531, Japan	Kaneda, K (reprint author), Osaka Univ, Dept Mat Engn Sci, Grad Sch Engn Sci, 1-3 Machikaneyama, Toyonaka, Osaka 5608531, Japan.	maeno@cheng.es.osaka-u.ac.jp; mitsudom@cheng.es.osaka-u.ac.jp; mizugaki@cheng.es.osaka-u.ac.jp; jitkk@cheng.es.osaka-u.ac.jp; kaneda@cheng.es.osaka-u.ac.jp			JSPS KAKENHI [13J03526, 24246129, 26820352, 26105003]	This work was supported by JSPS KAKENHI Grant Nos. 13J03526, 24246129, 26820352, and 26105003. We thank Tomoya Uruga, Tetsuo Honma, Kiyofumi Nitta, and Toshiaki Ina (SPring-8) for XAFS measurements.	Zhang K, 2011, CHEM-EUR J, V17, P14258, DOI 10.1002/chem.201102026; Ogawa M, 2002, J MATER CHEM, V12, P3304, DOI 10.1039/b204031j; Ooe M, 2002, NANO LETT, V2, P999, DOI 10.1021/nl0202105; Koper GJM, 1997, J AM CHEM SOC, V119, P6512, DOI 10.1021/ja970442j; BARTON DHR, 1988, TETRAHEDRON, V44, P4483, DOI 10.1016/S0040-4020(01)86150-0; Mitsudome T, 2014, ANGEW CHEM INT EDIT, V53, P8348, DOI 10.1002/anie.201403425; Lemon BI, 2000, J AM CHEM SOC, V122, P12886, DOI 10.1021/ja0031321; Niu YH, 2003, CHEM MATER, V15, P3463, DOI 10.1021/cm034172h; Pande S, 2011, NEW J CHEM, V35, P2054, DOI 10.1039/c1nj20083f; Matsushita M, 2005, J AM CHEM SOC, V127, P6632, DOI 10.1021/ja050436k; Ooe M, 2004, J AM CHEM SOC, V126, P1604, DOI 10.1021/ja038455m; Boisselier E, 2010, J AM CHEM SOC, V132, P2729, DOI 10.1021/ja909133f; BORSENBERGER PM, 1995, J POLYM SCI POL PHYS, V33, P2143, DOI 10.1002/polb.1995.090331505; Choy JH, 2002, J PHYS CHEM B, V106, P11120, DOI 10.1021/jp020374+; Choy JH, 1997, INORG CHEM, V36, P189, DOI 10.1021/ic960631n; DEBRABANDERVANDENBERG EMM, 1993, ANGEW CHEM INT EDIT, V32, P1308, DOI 10.1002/anie.199313081; FRANSSON G, 1972, ACTA CHEM SCAND, V26, P3969, DOI 10.3891/acta.chem.scand.26-3969; Fujisawa K, 1999, CHEM LETT, P739; Fujiyama H, 1999, J CATAL, V188, P417, DOI 10.1006/jcat.1999.2667; Gupta R, 2000, TETRAHEDRON LETT, V41, P7763, DOI 10.1016/S0040-4039(00)01326-5; HIRANO M, 1991, B CHEM SOC JPN, V64, P1434, DOI 10.1246/bcsj.64.1434; Hong Z., 2005, CHINESE J CHEM, V23, P835, DOI [10.1002/cjoc.200590835, DOI 10.1002/CJOC.200590835]; JANSEN JFGA, 1994, SCIENCE, V266, P1226, DOI 10.1126/science.266.5188.1226; Kala UL, 2007, POLYHEDRON, V26, P1427, DOI 10.1016/j.poly.2006.11.035; Kibata T, 2013, CHEM COMMUN, V49, P167, DOI 10.1039/c2cc37038g; Kohara I, 2000, J MOL CATAL A-CHEM, V153, P93, DOI 10.1016/S1381-1169(99)00306-4; KOSUGE K, 1992, NIPPON SERAM KYO GAK, V100, P326; KRESTA J, 1975, MAKROMOL CHEM, V176, P157; Li XH, 2010, J MOL CATAL A-CHEM, V328, P88, DOI 10.1016/j.molcata.2010.06.003; Liao BS, 2012, DALTON T, V41, P1158, DOI 10.1039/c1dt11065a; LISSEL M, 1992, TETRAHEDRON LETT, V33, P1795, DOI 10.1016/S0040-4039(00)91735-0; Maeno Z, 2013, RSC ADV, V3, P9662, DOI 10.1039/c3ra41817k; Maeno Z, 2014, CHEM COMMUN, V50, P6526, DOI 10.1039/c4cc00976b; Mitamura Y, 2001, CHEM MATER, V13, P3747, DOI 10.1021/cm010029h; Mochizuki D, 2006, NEW J CHEM, V30, P277, DOI 10.1039/b514157e; Moura AO, 2009, J COLLOID INTERF SCI, V330, P392, DOI 10.1016/j.jcis.2008.10.032; Nishihashi S., 2007, Enzymatic Preparation of Biphenol Derivatives and Diphenoquinone Derivatives, Patent No. [JP 2007129952 A, 2007129952]; NISHINO H, 1992, B CHEM SOC JPN, V65, P620, DOI 10.1246/bcsj.65.620; PANDEY G, 1990, TETRAHEDRON LETT, V31, P3771, DOI 10.1016/S0040-4039(00)97467-7; PATE JE, 1989, J AM CHEM SOC, V111, P5198, DOI 10.1021/ja00196a029; PEISACH J, 1974, ARCH BIOCHEM BIOPHYS, V165, P691, DOI 10.1016/0003-9861(74)90298-7; Quali A., 2011, DENDRIMERS CATALYTIC, P183; Schwieger W, 2004, J PHYS CHEM SOLIDS, V65, P413, DOI 10.1016/j.jpcs.2003.08.032; Takahashi Y, 2013, GREEN CHEM, V15, P2695, DOI 10.1039/c3gc41322e; Tromp M, 2010, ORGANOMETALLICS, V29, P3085, DOI 10.1021/om9010643; vanAert HAM, 1997, MACROMOLECULES, V30, P6056, DOI 10.1021/ma970388r; VILLEMIN D, 1994, SYNLETT, P435; Wariishi H., 2008, Preparation of Phenol Dimer with High Selectivity by Dimerization of Phenols with Manganese(III), Patent No. [JP 2008081449 A, 2008081449]; WELLS AF, 1947, J CHEM SOC, P1670, DOI 10.1039/jr9470001670; Yamamoto K, 2008, POLYMER, V49, P4033, DOI 10.1016/j.polymer.2008.07.046; Zhang ZT, 2003, CHEM MATER, V15, P2921, DOI 10.1021/cm034162g	51	0	0	MDPI AG	BASEL	POSTFACH, CH-4005 BASEL, SWITZERLAND	1420-3049			MOLECULES	Molecules	FEB	2015	20	2					3089	3106		10.3390/molecules20023089		18	Chemistry, Organic	Chemistry	CD0GH	WOS:000350748200077		
J	Manzhos, S; Giorgi, G; Yamashita, K				Manzhos, Sergei; Giorgi, Giacomo; Yamashita, Koichi			A Density Functional Tight Binding Study of Acetic Acid Adsorption on Crystalline and Amorphous Surfaces of Titania	MOLECULES			English	Article							SENSITIZED SOLAR-CELLS; INITIO MOLECULAR-DYNAMICS; TOTAL-ENERGY CALCULATIONS; WAVE BASIS-SET; TIO2 NANOPARTICLES; ANATASE TIO2; ION BATTERIES; ORGANIC-DYES; DFT CALCULATIONS; SINGLE-CRYSTALS	We present a comparative density functional tight binding study of an organic molecule attachment to TiO2 via a carboxylic group, with the example of acetic acid. For the first time, binding to low-energy surfaces of crystalline anatase (101), rutile (110) and (B)-TiO2 (001), as well as to the surface of amorphous (a-) TiO2 is compared with the same computational setup. On all surfaces, bidentate configurations are identified as providing the strongest adsorption energy, E-ads = -1.93, -2.49 and -1.09 eV for anatase, rutile and (B)-TiO2, respectively. For monodentate configurations, the strongest E-ads = -1.06, -1.11 and -0.86 eV for anatase, rutile and (B)-TiO2, respectively. Multiple monodentate and bidentate configurations are identified on a-TiO2 with a distribution of adsorption energies and with the lowest energy configuration having stronger bonding than that of the crystalline counterparts, with E-ads up to -4.92 eV for bidentate and -1.83 eV for monodentate adsorption. Amorphous TiO2 can therefore be used to achieve strong anchoring of organic molecules, such as dyes, that bind via a -COOH group. While the presence of the surface leads to a contraction of the band gap vs. the bulk, molecular adsorption caused no appreciable effect on the band structure around the gap in any of the systems.	[Manzhos, Sergei] Natl Univ Singapore, Dept Mech Engn, Singapore 117576, Singapore; [Giorgi, Giacomo; Yamashita, Koichi] Univ Tokyo, Sch Engn, Dept Chem Syst Engn, Bunkyo Ku, Tokyo 1138656, Japan; [Giorgi, Giacomo; Yamashita, Koichi] CREST JST, Chiyoda Ku, Tokyo 1020076, Japan	Manzhos, S (reprint author), Natl Univ Singapore, Dept Mech Engn, Block EA 07-08,9 Engn Dr 1, Singapore 117576, Singapore.	mpemanzh@nus.edu.sg; giacomo@tcl.t.u-tokyo.ac.jp; yamasita@chemsys.t.u-tokyo.ac.jp	Giorgi, Giacomo/G-4390-2015		Ministry of Education of Singapore [WBS R-265-000-494-112]; Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)	This work was supported by an AcRF Tier 1 grant by the Ministry of Education of Singapore (WBS R-265-000-494-112). S.M. thanks Fleur Legrain for technical assistance and Thomas Frauenheim and Balint Aradi, the University of Bremen, for the discussion about the DFTB method. K.Y. acknowledges the funding from the Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT).	De Angelis F, 2011, J PHYS CHEM LETT, V2, P813, DOI 10.1021/jz200191u; Perron H, 2007, THEOR CHEM ACC, V117, P565, DOI 10.1007/s00214-006-0189-y; Kresse G, 1996, PHYS REV B, V54, P11169, DOI 10.1103/PhysRevB.54.11169; Yang ZG, 2009, J POWER SOURCES, V192, P588, DOI 10.1016/j.jpowsour.2009.02.038; CHASE MW, 1985, J PHYS CHEM REF DATA, V14, P1; Hagfeldt A, 2010, CHEM REV, V110, P6595, DOI 10.1021/cr900356p; BLOCHL PE, 1994, PHYS REV B, V50, P17953, DOI 10.1103/PhysRevB.50.17953; Momma K, 2011, J APPL CRYSTALLOGR, V44, P1272, DOI 10.1107/S0021889811038970; Upadhyaya HM, 2013, SOL ENERG MAT SOL C, V119, P291, DOI 10.1016/j.solmat.2013.08.031; Diebold U, 2003, SURF SCI REP, V48, P53, DOI 10.1016/S0167-5729(02)00100-0; Xiong H, 2011, J PHYS CHEM LETT, V2, P2560, DOI 10.1021/jz2012066; Aradi B, 2007, J PHYS CHEM A, V111, P5678, DOI 10.1021/jp070186p; Kojima A, 2009, J AM CHEM SOC, V131, P6050, DOI 10.1021/ja809598r; Soler JM, 2002, J PHYS-CONDENS MAT, V14, P2745, DOI 10.1088/0953-8984/14/11/302; Perdew JP, 1996, PHYS REV LETT, V77, P3865, DOI 10.1103/PhysRevLett.77.3865; Yildirim H, 2014, ACS APPL MATER INTER, V6, P18962, DOI 10.1021/am5048398; PASCUAL J, 1978, PHYS REV B, V18, P5606, DOI 10.1103/PhysRevB.18.5606; Sushko ML, 2010, J PHYS CHEM C, V114, P20277, DOI 10.1021/jp107982c; Prasai B, 2012, J MATER SCI, V47, P7515, DOI 10.1007/s10853-012-6439-6; Li W, 2013, J AM CHEM SOC, V135, P18300, DOI 10.1021/ja4100723; Hamad BA, 2009, EUR PHYS J B, V70, P163, DOI 10.1140/epjb/e2009-00218-0; Liu S, 2012, ENERG ENVIRON SCI, V5, P9743, DOI 10.1039/c2ee22987k; Vittadini A, 2009, J PHYS CHEM C, V113, P18973, DOI 10.1021/jp9073009; Bai Y, 2014, CHEM REV, V114, P10095, DOI 10.1021/cr400606n; Anselmi C, 2012, PHYS CHEM CHEM PHYS, V14, P15963, DOI 10.1039/c2cp43006a; Giorgi G, 2013, PHYS CHEM CHEM PHYS, V15, P9761, DOI 10.1039/c3cp50879j; Lazzeri M, 2001, PHYS REV B, V63, DOI 10.1103/PhysRevB.63.155409; Asahi R, 2000, PHYS REV B, V61, P7459, DOI 10.1103/PhysRevB.61.7459; TEZUKA Y, 1994, J PHYS SOC JPN, V63, P347, DOI 10.1143/JPSJ.63.347; Hutter J, 2014, WIRES COMPUT MOL SCI, V4, P15, DOI 10.1002/wcms.1159; Ning ZJ, 2010, ENERG ENVIRON SCI, V3, P1170, DOI 10.1039/c003841e; Kang J, 2011, J PHYS CHEM C, V115, P4909, DOI 10.1021/jp1090125; Borghols WJH, 2008, CHEM MATER, V20, P2949, DOI 10.1021/cm703376e; Sun X, 2013, J PHYS CHEM C, V117, P22497, DOI 10.1021/jp4066955; Deng D, 2009, ENERG ENVIRON SCI, V2, P818, DOI 10.1039/b823474d; [Anonymous], 1986, CRC HDB CHEM PHYS; BURDETT JK, 1987, J AM CHEM SOC, V109, P3639, DOI 10.1021/ja00246a021; Kresse G, 1996, COMP MATER SCI, V6, P15, DOI 10.1016/0927-0256(96)00008-0; HORN M, 1972, Z KRISTALLOGR, V136, P273, DOI 10.1524/zkri.1972.136.3-4.273; Liu YB, 2011, CHEM COMMUN, V47, P10314, DOI 10.1039/c1cc13388h; Zhu T, 2014, J PHYS CHEM C, V118, P11385, DOI 10.1021/jp412462m; Lippert G, 1997, MOL PHYS, V92, P477, DOI 10.1080/002689797170220; Elstner M, 1998, PHYS REV B, V58, P7260, DOI 10.1103/PhysRevB.58.7260; TROULLIER N, 1991, PHYS REV B, V43, P1993, DOI 10.1103/PhysRevB.43.1993; Kim KT, 2014, NANO LETT, V14, P416, DOI 10.1021/nl402747x; Yang HG, 2008, NATURE, V453, P638, DOI 10.1038/nature06964; Agosta L, 2015, PHYS CHEM CHEM PHYS, V17, P1556, DOI 10.1039/c4cp03056g; Sorescu DC, 2014, J PHYS CHEM C, V118, P1628, DOI 10.1021/jp410420e; Heckel W, 2014, J PHYS CHEM C, V118, P10771, DOI 10.1021/jp500507a; Borghols WJH, 2009, PHYS CHEM CHEM PHYS, V11, P5742, DOI 10.1039/b823142g; Dolgonos G, 2010, J CHEM THEORY COMPUT, V6, P266, DOI 10.1021/ct900422c; Grimme S, 2010, J CHEM PHYS, V132, DOI 10.1063/1.3382344; Myung ST, 2013, ENERG ENVIRON SCI, V6, P2609, DOI 10.1039/c3ee41960f; Armstrong AR, 2010, CHEM MATER, V22, P6426, DOI 10.1021/cm102589x; Drew K, 2005, J PHYS CHEM B, V109, P11851, DOI 10.1021/jp051073d; Legrain F, 2015, J POWER SOURCES, V278, P197, DOI 10.1016/j.jpowsour.2014.12.058; Hartwigsen C, 1998, PHYS REV B, V58, P3641, DOI 10.1103/PhysRevB.58.3641; KRESSE G, 1994, PHYS REV B, V49, P14251, DOI 10.1103/PhysRevB.49.14251; Coropceanu V, 2007, CHEM REV, V107, P926, DOI 10.1021/cr050140x; TANG H, 1993, SOLID STATE COMMUN, V87, P847, DOI 10.1016/0038-1098(93)90427-O; Jung HS, 2013, J PHYS CHEM LETT, V4, P1682, DOI 10.1021/jz400112n; Vittadini A, 2000, J PHYS CHEM B, V104, P1300, DOI 10.1021/jp993583b; Kakuta N, 2012, J CERAM PROCESS RES, V13, P28; Kaur K, 2012, ENRGY PROCED, V29, P291, DOI 10.1016/j.egypro.2012.09.035; Spreafico C, 2014, J PHYS CHEM C, V118, P6251, DOI 10.1021/jp4117563; BETZ G, 1984, J APPL ELECTROCHEM, V14, P315, DOI 10.1007/BF01269931; Borghols WJH, 2010, J ELECTROCHEM SOC, V157, pA582, DOI 10.1149/1.3332806; Chan M, 2013, PHYS CHEM CHEM PHYS, V15, P10028, DOI 10.1039/c3cp00065f; Dolgonos GA, 2014, SURF SCI, V621, P51, DOI 10.1016/j.susc.2013.10.021; Dylla AG, 2013, ACCOUNTS CHEM RES, V46, P1104, DOI 10.1021/ar300176y; Eithiraj RD, 2013, CHEM PHYS LETT, V585, P138, DOI 10.1016/j.cplett.2013.08.103; Gemming S, 2010, INT J MATER RES, V101, P758, DOI 10.3139/146.110337; Hai-Tao Fang, 2009, Nanotechnology, V20, DOI 10.1088/0957-4484/20/22/225701; Hibino M, 2004, J POWER SOURCES, V126, P139, DOI 10.1016/j.jpowsour.2003.08.025; Kim HS, 2012, SCI REP-UK, V2, DOI 10.1038/srep00591; KRESSE G, 1993, PHYS REV B, V47, P558, DOI 10.1103/PhysRevB.47.558; Labat F., 2007, J CHEM PHYS, V126; Legrain F., 2014, P 14 AS C SOL STAT I; Manzhos S, 2012, PHYS CHEM CHEM PHYS, V14, P1749, DOI 10.1039/c2cp23039a; Muller K., 2013, J PHYS CHEM C, V118, P1576; Niu M, 2014, J PHYS CHEM C, V118, P20107, DOI 10.1021/jp504818j; O'Rurke C., 2010, J PHYS CHEM C, V114, P20240; PASCUAL J, 1977, PHYS REV LETT, V39, P1490, DOI 10.1103/PhysRevLett.39.1490; Pastore M, 2010, ACS NANO, V4, P556, DOI 10.1021/nn901518s; Tang X, 2014, CHEM PHYS, V441, P121, DOI 10.1016/j.chemphys.2014.07.011; Tao JG, 2011, J PHYS CHEM C, V115, P3434, DOI 10.1021/jp111270x; Xiang GL, 2013, SCI REP-UK, V3, DOI 10.1038/srep01411; Xu H, 2011, J PHYS CHEM C, V115, P19710, DOI 10.1021/jp2032884; Yahia M.B., 2009, J CHEM PHYS, V130	89	2	2	MDPI AG	BASEL	POSTFACH, CH-4005 BASEL, SWITZERLAND	1420-3049			MOLECULES	Molecules	FEB	2015	20	2					3371	3388		10.3390/molecules20023371		18	Chemistry, Organic	Chemistry	CD0GH	WOS:000350748200092		
J	Shinoda, K; Asahara, H; Uehara, T; Miyoshi, K; Suzuki, SO; Iwaki, T; Kira, J				Shinoda, Koji; Asahara, Hideaki; Uehara, Taira; Miyoshi, Katsue; Suzuki, Satoshi O.; Iwaki, Toru; Kira, Jun-ichi			Multiphasic acute disseminated encephalomyelitis associated with atypical rubella virus infection	MULTIPLE SCLEROSIS JOURNAL			English	Article						Multiphasic acute disseminated encephalomyelitis; rubella; MRI; brain biopsy	MULTIPLE-SCLEROSIS	We report the first case of an occurrence of multiphasic acute disseminated encephalomyelitis (ADEM) associated with atypical rubella virus infection with no rash and long-term increased titers of serum anti-rubella IgM in a 17-year-old male who had no history of rubella vaccination. He suffered from at least six clinical exacerbations with disseminated hyperintense lesions on FLAIR MR images during the course of 18 months. Repeated methylprednisolone pulse therapy and intravenous immunoglobulin therapy resolved the exacerbations. In patients with multiphasic ADEM of unknown etiology, clinicians should also consider the possibility of preceding infection with rubella virus.	[Shinoda, Koji; Uehara, Taira; Suzuki, Satoshi O.; Iwaki, Toru; Kira, Jun-ichi] Kyushu Univ, Fukuoka 812, Japan; [Asahara, Hideaki] Japanese Red Cross Hiroshima Coll Nursing, Hiroshima, Japan; [Miyoshi, Katsue] Kushiro Kita Hosp, Kushiro, Hokkaido, Japan	Kira, J (reprint author), Kyushu Univ, Neurol Inst, Grad Sch Med Sci, Higashi Ku, 3-1-1 Maidashi, Fukuoka 8128582, Japan.	kira@neuro.med.kyushu-u.ac.jp					Krupp LB, 2007, NEUROLOGY, V68, pS7, DOI 10.1212/01.wnl.0000259422.44235.a8; Banatvala JE, 2004, LANCET, V363, P1127, DOI 10.1016/S0140-6736(04)15897-2; Tenembaum S, 2007, NEUROLOGY, V68, pS23, DOI 10.1212/01.wnl.0000259404.51352.7f; Dabbagh AJ, 2013, MMWR-MORBID MORTAL W, V62, P983; Duvanel CB, 2001, J NEUROSCI RES, V65, P446; Guler E, 2009, INFECTION, V37, P65, DOI 10.1007/s15010-007-6322-6; NATH A, 1990, ANN NEUROL, V27, P533, DOI 10.1002/ana.410270513	7	0	0	SAGE PUBLICATIONS LTD	LONDON	1 OLIVERS YARD, 55 CITY ROAD, LONDON EC1Y 1SP, ENGLAND	1352-4585	1477-0970		MULT SCLER J	Mult. Scler. J.	FEB	2015	21	2					252	254		10.1177/1352458514533845		3	Clinical Neurology; Neurosciences	Neurosciences & Neurology	CB6VL	WOS:000349764700020		
J	Harizon; Pujiastuti, B; Kurnia, D; Sumiarsa, D; Shiono, Y; Supratman, U				Harizon; Pujiastuti, Betry; Kurnia, Dikdik; Sumiarsa, Dadan; Shiono, Yoshihito; Supratman, Unang			Antibacterial Triterpenoids from the Bark of Sonneratia alba (Lythraceae)	NATURAL PRODUCT COMMUNICATIONS			English	Article						Lupane-type triterpenoid; 3 beta-Hydroxy-lup-9(11),12-diene, 28-oic acid; Antibacterial activity; Sonnetaria alba; Lythraceae	LUPANE TRITERPENOIDS; MANGROVE PLANTS; BACTERIA	The new lupane-type triterpenoid, 3 beta-hydroxy-lup-9(11),12 diene, 28-oic acid (1), along with two known lupane-type triterpenoids, lupeol (2) and lupan-3 beta-ol (3), were isolated from the bark of Sonnetaria alba. The structure of the new compound was elucidated on the basis of spectroscopic and mass spectrometric data analysis. Using the broth microdilution method, all compounds exhibited antibacterial activity against the Gram-positive bacteria Staphylococcus aureus ATCC 6538 and Streptococcus mutans ATCC 25175, with minimum inhibitory concentrations ranging from 15-33 to 35-55 mu g/mL, respectively.	[Harizon] Jambi Univ, Fac Sci Educ, Chem Educ Study Programme, Jambi 36361, Indonesia; [Pujiastuti, Betry; Kurnia, Dikdik; Sumiarsa, Dadan; Supratman, Unang] Padjadjaran State Univ, Fac Math & Nat Sci, Dept Chem, Jatinangor 45363, Indonesia; [Shiono, Yoshihito] Yamagata Univ, Dept Bioresource Engn, Fac Agr, Tsuruoka, Yamagata 9978555, Japan	Supratman, U (reprint author), Padjadjaran State Univ, Fac Math & Nat Sci, Dept Chem, Jatinangor 45363, Indonesia.	u_supratman@unpad.ac.id			Directorate General of Higher Education, Ministry of National Education, Indonesia	This work was financially supported by the Directorate General of Higher Education, Ministry of National Education, Indonesia (BPPS Grant, 2011-2013 for Harizon). We thank Mr Ahmad Darmawan and Mrs Sofa Fajriah of the Research Center for Chemistry, Indonesian Science Institute, Serpong, Indonesia for NMR measurements. We are grateful to Mrs Rizky Amalia at the Laboratory of Biochemistry, Department of Chemistry, Faculty of Mathematics and Natural Sciences, Padjadjaran University, Bandung, Indonesia for antibacterial assay.	Adegboye MF, 2008, AFR J BIOTECHNOL, V7, P3934; Ma ZZ, 2004, TETRAHEDRON LETT, V45, P3261, DOI 10.1016/j.tetlet.2004.02.113; Kjer J, 2009, J NAT PROD, V72, P2053, DOI 10.1021/np900417g; Chaturvedula VSP, 2003, J NAT PROD, V66, P419, DOI 10.1021/np0204848; Eloff JN, 1998, PLANTA MED, V64, P711, DOI 10.1055/s-2006-957563; FUJIOKA T, 1994, J NAT PROD, V57, P243, DOI 10.1021/np50104a008; Puapairoj P, 2005, PLANTA MED, V71, P208, DOI 10.1055/s-2005-837818; AYER WA, 1984, TETRAHEDRON, V40, P2069; Azuma H, 2002, J PLANT RES, V115, P47, DOI 10.1007/s102650200007; Bandaranayake W., 1998, MANGROVES SALT MARSH, V2, P133, DOI 10.1023/A:1009988607044; Chaiyadej K, 2004, WALAILAK J SCI TECH, V1, P15; Chen IH, 2008, J NAT PROD, V71, P1352, DOI 10.1021/np800093a; Hogarth PJ, 1999, BIOL MANGROVE; Laith AA, 2012, J ANIM VET ADV, V11, P234; Lee SY, 2013, CAN J CHEM, V91, P382, DOI 10.1139/cjc-2012-0411; Minqing T, 2009, CHIN J OCEANOL LIMN, V27, P288; Noor YS, 2006, INTRO GUIDE INDONESI; Nunez MJ, 2005, J NAT PROD, V68, P1018, DOI 10.1021/np058016w; Oku H, 2003, J PLANT RES, V116, P37, DOI 10.1007/s10265-002-0069-z; Popp M., 1993, RATIONAL USE HIGH SA, V1, P217; PRASHANT A, 1993, PHYTOCHEMISTRY, V32, P484, DOI 10.1016/S0031-9422(00)95025-8; Priya PD, 2012, ASIAN J PHARM CLIN R, V5, P171; Srivastava P, 2013, NATURAL PRODUCT RES, V27, P1; Tomlinson PB, 1994, BOT MANGROVES; Zhou J, 2014, J NAT PROD, V77, P276, DOI 10.1021/np400851k	25	0	0	NATURAL PRODUCTS INC	WESTERVILLE	7963 ANDERSON PARK LN, WESTERVILLE, OH 43081 USA	1934-578X	1555-9475		NAT PROD COMMUN	Nat. Prod. Commun.	FEB	2015	10	2					277	280				4	Chemistry, Medicinal; Food Science & Technology	Pharmacology & Pharmacy; Food Science & Technology	CB7MR	WOS:000349812000015		
J	Jenis, J; Nugroho, AE; Hashimoto, A; Deguchi, J; Hirasawa, Y; Wong, CP; Kaneda, T; Shirota, O; Morita, H				Jenis, Janar; Nugroho, Alfarius Eko; Hashimoto, Akiyo; Deguchi, Jun; Hirasawa, Yusuke; Wong, Chin Piow; Kaneda, Toshio; Shirota, Osamu; Morita, Hiroshi			A New Benzylisoquinoline Alkaloid from Leontice altaica	NATURAL PRODUCT COMMUNICATIONS			English	Article						Leontice altaica; Alkaloids	LIMONOIDS; SAPONINS	A new benzylisoquinoline alkaloid, lincangenine-4-beta-D-glucopyranoside (1), has been isolated from the roots of Leontice altaica, together with 5 known alkaloids. Its structure was elucidated on the basis of 1D and 2D NMR data, and chemical means.	[Jenis, Janar; Nugroho, Alfarius Eko; Hashimoto, Akiyo; Deguchi, Jun; Hirasawa, Yusuke; Wong, Chin Piow; Kaneda, Toshio; Morita, Hiroshi] Hoshi Univ, Fac Pharmaceut Sci, Shinagawa Ku, Tokyo 1428501, Japan; [Jenis, Janar] Al Farabi Kazakh Natl Univ, Dept Chem & Technol Organ Matters Nat Cpds & Poly, Alma Ata 050040, Kazakhstan; [Shirota, Osamu] Tokushima Bunri Univ, Fac Pharmaceut Sci, Sanuki City, Kagawa 7692193, Japan	Morita, H (reprint author), Hoshi Univ, Fac Pharmaceut Sci, Shinagawa Ku, Ebara 2-4-41, Tokyo 1428501, Japan.	moritah@hoshi.ac.jp			Tokyo Biochemical Research Foundation; JSPS	This work was supported by a grant from Tokyo Biochemical Research Foundation and Grants in-Aid for Scientific Research from JSPS.	Albonico SM, 1965, LIEBIGS ANN CHEM, V685, P200, DOI 10.1002/jlac.19656850126; Nagakura Y, 2013, J NAT MED-TOKYO, V67, P381, DOI 10.1007/s11418-012-0677-4; Chen M, 1996, J NAT PROD, V59, P722, DOI 10.1021/np960185g; Chen Z, 2012, MED CHEM RES, V21, P1641, DOI 10.1007/s00044-011-9678-1; Kiren Y, 2014, J NAT MED-TOKYO, V68, P199, DOI 10.1007/s11418-013-0771-2; Kolak U, 2011, REC NAT PROD, V5, P309; Min YD, 2006, ARCH PHARM RES, V29, P757, DOI 10.1007/BF02974076; Safieh KAA, 1986, J NAT PRODUCTS, V49, P726, DOI 10.1021/np50046a044; SLAVIK J, 1985, COLLECT CZECH CHEM C, V50, P2299; Tabatadze N, 2010, FITOTERAPIA, V81, P897, DOI 10.1016/j.fitote.2010.05.021; TACKIE AN, 1980, PHYTOCHEMISTRY, V19, P1882, DOI 10.1016/S0031-9422(00)83846-7; Vashistha SK, 1941, J INDIAN CHEM SOC, V18, P641; Wang YX, 2009, BIOORG MED CHEM LETT, V19, P6004, DOI 10.1016/j.bmcl.2009.09.059; Wong CP, 2012, J NAT MED-TOKYO, V66, P566, DOI 10.1007/s11418-011-0616-9	14	0	0	NATURAL PRODUCTS INC	WESTERVILLE	7963 ANDERSON PARK LN, WESTERVILLE, OH 43081 USA	1934-578X	1555-9475		NAT PROD COMMUN	Nat. Prod. Commun.	FEB	2015	10	2					291	292				2	Chemistry, Medicinal; Food Science & Technology	Pharmacology & Pharmacy; Food Science & Technology	CB7MR	WOS:000349812000019		
J	Teshima, N; Yamada, H; Ju-ichi, M; Uji, T; Kinoshita, T; Ito, C				Teshima, Naoko; Yamada, Hiromi; Ju-ichi, Motoharu; Uji, Tahan; Kinoshita, Takeshi; Ito, Chihiro			Coumarins from Murraya paniculata var. zollingeri Endemic to the Timor Islands	NATURAL PRODUCT COMMUNICATIONS			English	Article						Murraya paniculata var. zollingeri; Murrangatin-1 '-senecioate; 5-Methoxypanial; Mexioticin-2 '-senecioate; Murralongic acid; Coumarins; Chemotaxonomy	OMPHALOCARPA RUTACEAE; STRUCTURE ELUCIDATION; CONSTITUENTS; LEAVES; PRENYLCOUMARIN	Four new coumarins, murrangatin-1'-senecioate (1), 5-methoxypanial (2), mexoticin-2'-senecioate (3) and murralongic acid (4), were isolated from the leaves of Murraya paniculata var. zollingeri, together with 23 known coumarins. The structures of the new compounds were elucidated based on spectroscopic data. The taxonomic status of M. paniculata var. zollingeri is briefly discussed, along with its similarity to M. paniculata.	[Teshima, Naoko; Yamada, Hiromi; Ju-ichi, Motoharu] Mukogawa Womens Univ, Fac Pharm & Pharmaceut Sci, Nishinomiya, Hyogo 6638179, Japan; [Uji, Tahan] Herbarium Bogoriense, Bogor 16122, Indonesia; [Kinoshita, Takeshi] Teikyo Univ, Med Plant Garden, Sagamihara, Kanagawa 2525195, Japan; [Ito, Chihiro] Meijo Univ, Fac Pharm, Tempaku Ku, Nagoya, Aichi 4688503, Japan	Ito, C (reprint author), Meijo Univ, Fac Pharm, Tempaku Ku, Nagoya, Aichi 4688503, Japan.	itochi@meijo-u.ac.jp			JSPS KAKENHI [12672064, 23590026]	This work was supported by JSPS KAKENHI Grant Number 12672064 and 23590026. The authors (T. K and T. U) are grateful to Lembaga Ilmu Pengetahuan Indonesia (LIPI), Jakarta, Indonesia, for permitting us to collect the research materials.	IMAI F, 1989, CHEM PHARM BULL, V37, P358; ITO C, 1987, CHEM PHARM BULL, V35, P4277; Huang C.-C., 1986, FLORA CHINA, V43, P139; IMAI F, 1986, CHEM PHARM BULL, V34, P3978; IMAI F, 1989, CHEM PHARM BULL, V37, P119; ITO C, 1990, J CHEM SOC PERK T 1, P2047, DOI 10.1039/p19900002047; ITO C, 1987, HETEROCYCLES, V26, P2959; Kinoshita T, 1996, CHEM PHARM BULL, V44, P1208; Kinoshita T, 2002, CHEM PHARM BULL, V50, P118, DOI 10.1248/cpb.50.118; KINOSHITA T, 1985, CHEM PHARM BULL, V33, P1770; Kinoshita T, 1996, CHEM PHARM BULL, V44, P1261; Murray RDH, 1982, NATURAL COUMARINS, P27; Tanaka T., 1929, J SOC TROP AGR, V1, P23; TANTIVATANA P, 1983, J ORG CHEM, V48, P268, DOI 10.1021/jo00150a028; WU TS, 1989, PHYTOCHEMISTRY, V28, P293, DOI 10.1016/0031-9422(89)85066-6	15	0	0	NATURAL PRODUCTS INC	WESTERVILLE	7963 ANDERSON PARK LN, WESTERVILLE, OH 43081 USA	1934-578X	1555-9475		NAT PROD COMMUN	Nat. Prod. Commun.	FEB	2015	10	2					309	312				4	Chemistry, Medicinal; Food Science & Technology	Pharmacology & Pharmacy; Food Science & Technology	CB7MR	WOS:000349812000024		
J	Tanaka, K; Arita, M; Li, DH; Ono, N; Tezuka, Y; Kanaya, S				Tanaka, Ken; Arita, Masanori; Li, Donghan; Ono, Naoaki; Tezuka, Yasuhiro; Kanaya, Shigehiko			Metabolomic Characterization of a Low Phytic Acid and High Anti-oxidative Cultivar of Turmeric	NATURAL PRODUCT COMMUNICATIONS			English	Article						Turmeric; Curcuma longa cv. Okinawa Ougon; Phytic acid; Dihydrodemethoxycurcumin; Tetrahydrodemethoxycurcumin	CURCUMA-LONGA; SYNTHASE; EXPRESSION; MUTATION; EXTRACT; ENZYME; MICE; IRON	Turmeric, the rhizome of Curcuma longa, has a long history of use as a spice and also as a traditional medicine in many Asian countries. To reveal unique morphological features of a newly registered Curcuma cultivar, C. longa cv. Okinawa Ougon (Ougon), non-targeted LC-MS and GC-MS analyses were conducted. The analysis revealed its distinctive chemical properties: lower amount of phytic acid and inorganic metals such as Fe, Mn, and Al, as well as higher concentrations of reduced derivatives of curcuminoids, such as dihydrobisdemethoxycurcumin, tetrahydrobisdemethoxycurcumin, dihydrodemethoxycurcumin, and tetrahydrodemethoxycurcumin. In addition, germacrane-type sesquiterpenes were almost absent although alpha-humulene and beta-caryophyllene, generated by the same biosynthetic route, were present. Presumably the alternation of the metal ion content, serving as a cofactor of sesquiterpene synthase, modulates the resulting variation of the sesquiterpenes. In summary, the cultivar Ougon is considered a promising candidate for functional food additives.	[Tanaka, Ken] Ritsumeikan Univ, Coll Pharmaceut Sci, Kusatsu, Shiga 5258577, Japan; [Arita, Masanori] Natl Inst Genet, Ctr Informat Biol, Mishima, Shizuoka 4118540, Japan; [Arita, Masanori] RIKEN Ctr Sustainable Resource Sci, Yokohama, Tsurumi 2300045, Japan; [Li, Donghan; Ono, Naoaki; Kanaya, Shigehiko] Nara Inst Sci & Technol, Grad Sch Informat Sci, Ikoma, Nara 6300192, Japan; [Tezuka, Yasuhiro] Hokuriku Univ, Fac Pharmaceut Sci, Kanazawa, Ishikawa 9201181, Japan	Tanaka, K (reprint author), Ritsumeikan Univ, Coll Pharmaceut Sci, 1-1-1 Noji Higash, Kusatsu, Shiga 5258577, Japan.	ktanaka@fc.ritsumei.ac.jp					Pan MH, 1999, DRUG METAB DISPOS, V27, P486; Sugiyama Y, 1996, BIOCHEM PHARMACOL, V52, P519, DOI 10.1016/0006-2952(96)00302-4; Yoshikuni Y, 2006, NATURE, V440, P1078, DOI 10.1038/nature04607; Ali BH, 2006, NAT PROD COMMUN, V1, P509; Gilani AH, 2005, LIFE SCI, V76, P3089, DOI 10.1016/j.lfs.2004.12.021; Starks CM, 1997, SCIENCE, V277, P1815, DOI 10.1126/science.277.5333.1815; Hoehle SI, 2006, J AGR FOOD CHEM, V54, P756, DOI 10.1021/jf058146a; Hassaninasab A, 2011, P NATL ACAD SCI USA, V108, P6615, DOI 10.1073/pnas.1016217108; KUTTAN R, 1985, CANCER LETT, V29, P197, DOI 10.1016/0304-3835(85)90159-4; Steele CL, 1998, J BIOL CHEM, V273, P2078, DOI 10.1074/jbc.273.4.2078; Picaud S, 2005, PHYTOCHEMISTRY, V66, P961, DOI 10.1016/j.phytochem.2005.03.027; Sengupta Mahuya, 2011, Asian Pacific Journal of Tropical Biomedicine, V1, P193, DOI 10.1016/S2221-1691(11)60026-9; Kumaravel M, 2013, NAT PROD COMMUN, V8, P183; Noel JP, 2010, ACS CHEM BIOL, V5, P377, DOI 10.1021/cb900295g; Gertsch J, 2008, P NATL ACAD SCI USA, V105, P9099, DOI 10.1073/pnas.0803601105; Kim HJ, 2009, J ETHNOPHARMACOL, V124, P189, DOI 10.1016/j.jep.2009.04.046; Fernie AR, 2009, TRENDS GENET, V25, P39, DOI 10.1016/j.tig.2008.10.010; Shi JR, 2003, PLANT PHYSIOL, V131, P507, DOI 10.1104/pp.014258; Jayaprakasha GK, 2005, TRENDS FOOD SCI TECH, V16, P533, DOI 10.1016/j.tifs.2005.08.006; EL-Ansary K, 2006, J APPL SCI, V6, P2991; Hanhinevak K, 2009, MOL TECHNIQUES CROP; Iwata K, 2006, J GASTROENTEROL, V41, P919, DOI 10.1007/s00535-006-1860-8; Jacob JN, 2013, NAT PROD COMMUN, V8, P359; Kawano S, 2013, CHINESE CHEM LETT, V24, P685, DOI 10.1016/j.cclet.2013.05.006; Kim Y, 2014, FOOD CHEM, V151, P148, DOI 10.1016/j.foodchem.2013.11.058; Landoni M, 2013, J AGR FOOD CHEM, V61, P4622, DOI 10.1021/jf400259h; Osawa T, 2012, J FOOD DRUG ANAL, V20, P350; Plotto A, 2004, TURMERIC POSTPRODUCT; Pothitirat W, 2006, CURRENT SCI, V91, P1327; RAMASASTRI BV, 1983, QUAL PLANT, V33, P11, DOI 10.1007/BF01093733; Ravindran P. N., 2007, TURMERIC GENUS CURCU; Vinholes J, 2014, FOOD CHEM, V146, P78, DOI 10.1016/j.foodchem.2013.09.039; Wu NC, 2003, J ALTER COMP MED, V9, P161	33	1	1	NATURAL PRODUCTS INC	WESTERVILLE	7963 ANDERSON PARK LN, WESTERVILLE, OH 43081 USA	1934-578X	1555-9475		NAT PROD COMMUN	Nat. Prod. Commun.	FEB	2015	10	2					329	334				6	Chemistry, Medicinal; Food Science & Technology	Pharmacology & Pharmacy; Food Science & Technology	CB7MR	WOS:000349812000031		
J	Hamada, A; Takayabu, YN; Liu, CT; Zipser, EJ				Hamada, Atsushi; Takayabu, Yukari N.; Liu, Chuntao; Zipser, Edward J.			Weak linkage between the heaviest rainfall and tallest storms	NATURE COMMUNICATIONS			English	Article							TRMM PRECIPITATION RADAR; CATASTROPHIC RAINFALL; PROFILING ALGORITHM; CONVECTION; DISTRIBUTIONS; FEATURES	Conventionally, the heaviest rainfall has been linked to the tallest, most intense convective storms. However, the global picture of the linkage between extreme rainfall and convection remains unclear. Here we analyse an 11-year record of spaceborne precipitation radar observations and establish that a relatively small fraction of extreme convective events produces extreme rainfall rates in any region of the tropics and subtropics. Robust differences between extreme rainfall and convective events are found in the rainfall characteristics and environmental conditions, irrespective of region; most extreme rainfall events are characterized by less intense convection with intense radar echoes not extending to extremely high altitudes. Rainfall characteristics and environmental conditions both indicate the importance of warm-rain processes in producing extreme rainfall rates. Our results demonstrate that, even in regions where severe convective storms are representative extreme weather events, the heaviest rainfall events are mostly associated with less intense convection.	[Hamada, Atsushi; Takayabu, Yukari N.] Univ Tokyo, Atmosphere & Ocean Res Inst, Kashiwa, Chiba 2778568, Japan; [Liu, Chuntao] Texas A&M Univ, Dept Phys & Environm Sci, Corpus Christi, TX 78412 USA; [Zipser, Edward J.] Univ Utah, Dept Atmospher Sci, Salt Lake City, UT 84112 USA	Hamada, A (reprint author), Univ Tokyo, Atmosphere & Ocean Res Inst, Kashiwa, Chiba 2778568, Japan.	a-hamada@aori.u-tokyo.ac.jp			seventh GPM/TRMM RA of the Japan Aerospace Exploration Agency (JAXA), Japan	We would like to express our gratitude to Dr Toshio Iguchi and Dr Katsuhiro Nakagawa of the National Institute of Information and Communications Technology for their helpful comments and discussions. This study was supported by the seventh GPM/TRMM RA of the Japan Aerospace Exploration Agency (JAXA), Japan. We thank JAXA, NASA, National Institute of Information and Communications Technology, Japan and the European Centre for Medium-Range Weather Forecasts, for providing observation and reanalysis data sets. Most of the figures were produced using the GFD-DENNOU Library and the Grid Analysis and Display System (GrADS).	Iguchi T, 2000, J APPL METEOROL, V39, P2038, DOI 10.1175/1520-0450(2001)040<2038:RPAFTT>2.0.CO;2; Dee DP, 2011, Q J ROY METEOR SOC, V137, P553, DOI 10.1002/qj.828; McBride JL, 1999, J ATMOS SCI, V56, P24, DOI 10.1175/1520-0469(1999)056<0024:RBSAMC>2.0.CO;2; Shige S, 2013, J APPL METEOROL CLIM, V52, P242, DOI 10.1175/JAMC-D-12-074.1; CARACENA F, 1979, MON WEATHER REV, V107, P1, DOI 10.1175/1520-0493(1979)107<0001:MOTBTS>2.0.CO;2; Liu CT, 2005, J GEOPHYS RES-ATMOS, V110, DOI 10.1029/2005JD006063; Liu CT, 2009, J CLIMATE, V22, P767, DOI 10.1175/2008JCLI2641.1; Iguchi T, 2009, J METEOROL SOC JPN, V87A, P1, DOI 10.2151/jmsj.87A.1; Romatschke U, 2010, J CLIMATE, V23, P419, DOI 10.1175/2009JCLI3140.1; Smith JA, 2000, J HYDROMETEOROL, V1, P5, DOI 10.1175/1525-7541(2000)001<0005:CRAFIT>2.0.CO;2; Romatschke U, 2010, J CLIMATE, V23, P3761, DOI 10.1175/2010JCLI3465.1; Rasmussen KL, 2012, B AM METEOROL SOC, V93, P1713, DOI 10.1175/BAMS-D-11-00236.1; Petersen WA, 1999, B AM METEOROL SOC, V80, P191, DOI 10.1175/1520-0477(1999)080<0191:MAROOT>2.0.CO;2; Heymsfield GM, 2013, J APPL METEOROL CLIM, V52, P1851, DOI 10.1175/JAMC-D-12-0144.1; Short DA, 2010, J ATMOS OCEAN TECH, V27, P1247, DOI 10.1175/2010JTECHA1426.1; Sohn BJ, 2013, MON WEATHER REV, V141, P3873, DOI 10.1175/MWR-D-13-00075.1; Cecil DJ, 2005, MON WEATHER REV, V133, P543, DOI 10.1175/MWR-2876.1; Zipser EJ, 2006, B AM METEOROL SOC, V87, P1057, DOI 10.1175/BAMS-87-8-1057; ARKIN PA, 1987, MON WEATHER REV, V115, P51, DOI 10.1175/1520-0493(1987)115<0051:TRBLSC>2.0.CO;2; Cecil DJ, 2012, J CLIMATE, V25, P687, DOI 10.1175/JCLI-D-11-00130.1; Davis R. S., 2001, METEOROL MONOGR, V28, P481, DOI 10.1175/0065-9401-28.50.481; Ferraro RR, 1997, J GEOPHYS RES-ATMOS, V102, P16715, DOI 10.1029/97JD01210; Hamada A, 2014, J CLIMATE, V27, P8151, DOI 10.1175/JCLI-D-14-00107.1; Hamada A, 2014, J APPL METEOROL CLIM, V53, P1252, DOI 10.1175/JAMC-D-13-099.1; Houze Jr R. A., 2011, B AM METEOROL SOC, V92, P291; Lamb D, 2001, METEOROL MONOGR AM M, V28, P299, DOI 10.1175/0065-9401-28.50.299; McCollum JR, 2000, J APPL METEOROL, V39, P666, DOI 10.1175/1520-0450-39.5.666; Smith JA, 1996, WATER RESOUR RES, V32, P3099, DOI 10.1029/96WR02107; Takayabu YN, 2009, J METEOROL SOC JPN, V87A, P339, DOI 10.2151/jmsj.87A.339; Xu WX, 2012, GEOPHYS RES LETT, V39, DOI 10.1029/2012GL051242	30	0	0	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	2041-1723			NAT COMMUN	Nat. Commun.	FEB	2015	6								6213	10.1038/ncomms7213		6	Multidisciplinary Sciences	Science & Technology - Other Topics	CC2UW	WOS:000350201100022		
J	Inami, E; Hamada, I; Ueda, K; Abe, M; Morita, S; Sugimoto, Y				Inami, Eiichi; Hamada, Ikutaro; Ueda, Keiichi; Abe, Masayuki; Morita, Seizo; Sugimoto, Yoshiaki			Room-temperature-concerted switch made of a binary atom cluster	NATURE COMMUNICATIONS			English	Article							SCANNING TUNNELING MICROSCOPE; FORCE MICROSCOPY; MANIPULATION; NANOSTRUCTURES; SI(111)-(7X7); SURFACES; PB; DESORPTION; SCATTERING; MECHANISM	Single-atom/molecule manipulation for fabricating an atomic-scale switching device is a promising technology for nanoelectronics. So far, scanning probe microscopy studies have demonstrated several atomic-scale switches, mostly in cryogenic environments. Although a high-performance switch at room temperature is essential for practical applications, this remains a challenging obstacle to overcome. Here we report a room-temperature switch composed of a binary atom cluster on the semiconductor surface. Distinctly different types of manipulation techniques enable the construction of an atomically defined binary cluster and the electronic switching of the conformations, either unidirectionally or bidirectionally. The switching process involves a complex rearrangement of multiple atoms in concerted manner. Such a feature is strikingly different from any switches mediated by single-atom/molecule processes that have been previously reported.	[Inami, Eiichi; Ueda, Keiichi; Sugimoto, Yoshiaki] Osaka Univ, Grad Sch Engn, Suita, Osaka 5650871, Japan; [Hamada, Ikutaro] Natl Inst Mat Sci, Int Ctr Mat Nanoarchitecton, Tsukuba, Ibaraki 3050044, Japan; [Abe, Masayuki] Osaka Univ, Grad Sch Engn Sci, Toyonaka, Osaka 5608531, Japan; [Morita, Seizo] Osaka Univ, Inst Sci & Ind Res, Ibaraki, Osaka 5670047, Japan	Inami, E (reprint author), Osaka Univ, Grad Sch Engn, 2-1 Yamada Oka, Suita, Osaka 5650871, Japan.	eiichi@afm.eei.eng.osaka-u.ac.jp	Hamada, Ikutaro/E-8040-2010; Sugimoto, Yoshiaki/K-1691-2013	Hamada, Ikutaro/0000-0001-5112-2452; 	Ministry of Education, Culture, Sports, Science and Technology of Japan (MEXT) [18860046, 22221006, 24360016, 25106002, 26110516, 26600015, 26600099]; Next-Generation World-Leading Researchers; World Premier International Research Center Initiative (WPI); MEXT	We thank S. Yamazaki for valuable discussions. I.H. thanks the Supercomputer Center at the Institute for Solid State Physics of the University of Tokyo for the use of the facilities. This work was supported by a Grant-in-Aid for Scientific Research (18860046, 22221006, 24360016, 25106002, 26110516, 26600015 and 26600099) from the Ministry of Education, Culture, Sports, Science and Technology of Japan (MEXT), Funding Program for Next-Generation World-Leading Researchers and World Premier International Research Center Initiative (WPI), MEXT.	Abe M, 2007, APPL PHYS LETT, V90, DOI 10.1063/1.2739410; Chang CM, 2003, PHYS REV B, V67, DOI 10.1103/PhysRevB.67.033309; Sweetman A, 2011, PHYS REV LETT, V106, DOI 10.1103/PhysRevLett.106.136101; Nacci C, 2009, NANO LETT, V9, P2996, DOI 10.1021/nl901419g; Quaade UJ, 1998, SURF SCI, V415, pL1037, DOI 10.1016/S0039-6028(98)00560-3; Mohn F, 2010, PHYS REV LETT, V105, DOI 10.1103/PhysRevLett.105.266102; Yang JS, 2011, NANO LETT, V11, P2486, DOI 10.1021/nl2009444; Sugimoto Y, 2008, SCIENCE, V322, P413, DOI 10.1126/science.1160601; Perdew JP, 1996, PHYS REV LETT, V77, P3865, DOI 10.1103/PhysRevLett.77.3865; Stipe BC, 1997, PHYS REV LETT, V79, P4397, DOI 10.1103/PhysRevLett.79.4397; Simic-Milosevic V, 2009, ANGEW CHEM INT EDIT, V48, P4061, DOI 10.1002/anie.200805551; Roach PJ, 2009, SCIENCE, V323, P492, DOI 10.1126/science.1165884; Perera UGE, 2013, NAT NANOTECHNOL, V8, P46, DOI [10.1038/nnano.2012.218, 10.1038/NNANO.2012.218]; Sugimoto Y, 2005, NAT MATER, V4, P156, DOI 10.1038/nmat1297; Folsch S, 2014, NAT NANOTECHNOL, V9, P505, DOI [10.1038/nnano.2014.129, 10.1038/NNANO.2014.129]; TERSOFF J, 1983, PHYS REV LETT, V50, P1998, DOI 10.1103/PhysRevLett.50.1998; Manoharan HC, 2000, NATURE, V403, P512, DOI 10.1038/35000508; Fishlock TW, 2000, NATURE, V404, P743, DOI 10.1038/35008030; Sugimoto Y, 2010, PHYS REV B, V81, DOI 10.1103/PhysRevB.81.245322; Moon CR, 2008, SCIENCE, V319, P782, DOI 10.1126/science.1151490; EIGLER DM, 1990, NATURE, V344, P524, DOI 10.1038/344524a0; Guggisberg M, 2000, PHYS REV B, V61, P11151, DOI 10.1103/PhysRevB.61.11151; Valden M, 1998, SCIENCE, V281, P1647, DOI 10.1126/science.281.5383.1647; PANDEY KC, 1986, PHYS REV LETT, V57, P2287, DOI 10.1103/PhysRevLett.57.2287; EIGLER DM, 1991, NATURE, V352, P600, DOI 10.1038/352600a0; Kumagai T, 2012, NAT MATER, V11, P167, DOI [10.1038/nmat3176, 10.1038/NMAT3176]; Liljeroth P, 2007, SCIENCE, V317, P1203, DOI 10.1126/science.1144366; SALAM GP, 1994, PHYS REV B, V49, P10655, DOI 10.1103/PhysRevB.49.10655; CROMMIE MF, 1993, SCIENCE, V262, P218, DOI 10.1126/science.262.5131.218; Brookes IM, 2001, PHYS REV LETT, V87, DOI 10.1103/PhysRevLett.87.266103; Creyghton EJ, 1998, NATURE, V393, P21, DOI 10.1038/29886; Custance O, 2003, PHYS REV B, V67, DOI 10.1103/PhysRevB.67.235410; GADZUK JW, 1991, PHYS REV B, V44, P13466, DOI 10.1103/PhysRevB.44.13466; GANZ E, 1992, PHYS REV LETT, V68, P1567, DOI 10.1103/PhysRevLett.68.1567; GomezRodriguez JM, 1996, J VAC SCI TECHNOL B, V14, P1005; Gomezrodriguez JM, 1996, PHYS REV LETT, V76, P799, DOI 10.1103/PhysRevLett.76.799; Hwang IS, 2000, JPN J APPL PHYS 1, V39, P4100, DOI 10.1143/JJAP.39.4100; Jelinek P, 2003, SURF SCI, V544, P339, DOI 10.1016/j.susc.2003.09.010; Kawai S, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms5403; LI JL, 2002, PHYS REV LETT, V88, DOI DOI 10.1103/PHYSREVLETT.88.066101; Morikawa Y, 2001, PHYS REV B, V63; Moro R, 2003, SCIENCE, V300, P1265, DOI 10.1126/science.1083247; Nacci C, 2008, PHYS REV B, V77, DOI 10.1103/PhysRevB.77.121405; Ohara M, 2008, PHYS REV B, V78, DOI 10.1103/PhysRevB.78.201405; SAITOH M, 1985, SURF SCI, V154, P394, DOI 10.1016/0039-6028(85)90041-X; Stroscio J. A., 1993, METHODS TUNNELING SP, V27; Sugimoto Y, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms5360; Tansel T, 2006, PHYS REV LETT, V96, DOI 10.1103/PhysRevLett.96.026101; WHITMAN LJ, 1991, SCIENCE, V251, P1206, DOI 10.1126/science.251.4998.1206; WILDBERGER K, 1995, PHYS REV LETT, V75, P509, DOI 10.1103/PhysRevLett.75.509	50	0	0	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	2041-1723			NAT COMMUN	Nat. Commun.	FEB	2015	6								6231	10.1038/ncomms7231		7	Multidisciplinary Sciences	Science & Technology - Other Topics	CC2VF	WOS:000350202100003		
J	Jiang, M; Kumamoto, Y; Ishii, A; Yoshida, M; Shimada, T; Kato, YK				Jiang, M.; Kumamoto, Y.; Ishii, A.; Yoshida, M.; Shimada, T.; Kato, Y. K.			Gate-controlled generation of optical pulse trains using individual carbon nanotubes	NATURE COMMUNICATIONS			English	Article							EXCITONS; EMISSION	In single-walled carbon nanotubes, electron-hole pairs form tightly bound excitons because of limited screening. These excitons display a variety of interactions and processes that could be exploited for applications in nanoscale photonics and optoelectronics. Here we report on optical pulse-train generation from individual air-suspended carbon nanotubes under an application of square-wave gate voltages. Electrostatically induced carrier accumulation quenches photoluminescence, while a voltage sign reversal purges those carriers, resetting the nanotubes to become luminescent temporarily. Frequency-domain measurements reveal photoluminescence recovery with characteristic frequencies that increase with excitation laser power, showing that photoexcited carriers provide a self-limiting mechanism for pulsed emission. Time-resolved measurements directly confirm the presence of an optical pulse train synchronized to the gate voltage signal, and flexible control over pulse timing and duration is also demonstrated. These results identify an unconventional route for optical pulse generation and electrical-to-optical signal conversion, opening up new prospects for controlling light at the nanoscale.	[Jiang, M.; Kumamoto, Y.; Ishii, A.; Yoshida, M.; Shimada, T.; Kato, Y. K.] Univ Tokyo, Inst Engn Innovat, Tokyo 1138656, Japan	Kato, YK (reprint author), Univ Tokyo, Inst Engn Innovat, Tokyo 1138656, Japan.	ykato@sogo.t.u-tokyo.ac.jp	Kato, Yuichiro/B-5051-2008; Shimada, Takashi/B-6058-2008	Kato, Yuichiro/0000-0002-9942-1459; Shimada, Takashi/0000-0001-6647-5541	KAKENHI [24340066, 24654084, 26610080, 26870167]; SCOPE; Canon Foundation; Asahi Glass Foundation; KDDI Foundation; Nanotechnology Platform and Photon Frontier Network Program of MEXT, Japan; MERIT; JSPS Research Fellowship; ALPS	We thank T. Kan and I. Shimoyama for the use of the evaporator, while S. Chiashi and S. Maruyama are acknowledged for the use of the electron microscope. This work was supported by KAKENHI (24340066, 24654084, 26610080, 26870167), SCOPE, Canon Foundation, Asahi Glass Foundation, and KDDI Foundation, as well as the Nanotechnology Platform and Photon Frontier Network Program of MEXT, Japan. A. I. is supported by MERIT and JSPS Research Fellowship, and M.Y. is supported by ALPS.	Kim W, 2003, NANO LETT, V3, P193, DOI 10.1021/nl0259232; Watahiki R, 2012, APPL PHYS LETT, V101, DOI 10.1063/1.4757876; Mueller T, 2010, NAT NANOTECHNOL, V5, P27, DOI [10.1038/nnano.2009.319, 10.1038/NNANO.2009.319]; Kumamoto Y, 2014, PHYS REV LETT, V112, DOI 10.1103/PhysRevLett.112.117401; Mann D, 2007, NAT NANOTECHNOL, V2, P33, DOI 10.1038/nnano.2006.169; Weisman RB, 2003, NANO LETT, V3, P1235, DOI 10.1021/nl034428i; Wang H, 2009, IEEE ELECTR DEVICE L, V30, P547, DOI 10.1109/LED.2009.2016443; Ohno Y, 2006, PHYS REV B, V73, DOI 10.1103/PhysRevB.73.235427; Bachilo SM, 2002, SCIENCE, V298, P2361, DOI 10.1126/science.1078727; Perebeinos V, 2008, PHYS REV LETT, V101, DOI 10.1103/PhysRevLett.101.057401; Maruyama S, 2002, CHEM PHYS LETT, V360, P229, DOI 10.1016/S0009-2614(02)00838-2; Steiner M, 2009, NANO LETT, V9, P3477, DOI 10.1021/nl9016804; Imamura S, 2013, APPL PHYS LETT, V102, DOI 10.1063/1.4802930; Jarillo-Herrero P, 2004, NATURE, V429, P389, DOI 10.1038/nature02568; Lefebvre J, 2006, NANO LETT, V6, P1603, DOI 10.1021/nl060530e; Heinze S, 2002, PHYS REV LETT, V89, DOI 10.1103/PhysRevLett.89.106801; OGAWA T, 1991, PHYS REV B, V44, P8138, DOI 10.1103/PhysRevB.44.8138; Ando T, 1997, J PHYS SOC JPN, V66, P1066, DOI 10.1143/JPSJ.66.1066; O'Connell MJ, 2002, SCIENCE, V297, P593, DOI 10.1126/science.1072631; Matsuda K, 2008, PHYS REV B, V77, DOI 10.1103/PhysRevB.77.033406; Maultzsch J, 2005, PHYS REV B, V72, DOI 10.1103/PhysRevB.72.205438; Hofmann MS, 2013, NAT NANOTECHNOL, V8, P502, DOI [10.1038/nnano.2013.119, 10.1038/NNANO.2013.119]; Gabor NM, 2009, SCIENCE, V325, P1367, DOI 10.1126/science.1176112; Moritsubo S, 2010, PHYS REV LETT, V104, DOI 10.1103/PhysRevLett.104.247402; Kim YL, 2014, NAT PHOTONICS, V8, P239, DOI 10.1038/NPHOTON.2014.1; Wang F, 2005, SCIENCE, V308, P838, DOI 10.1126/science.1110265; Barkelid M, 2014, NAT PHOTONICS, V8, P48, DOI [10.1038/nphoton.2013.311, 10.1038/NPHOTON.2013.311]; Kinder JM, 2008, PHYS REV B, V78, DOI 10.1103/PhysRevB.78.155429; Lefebvre J, 2003, PHYS REV LETT, V90, DOI 10.1103/PhysRevLett.90.217401; Matsuda K, 2010, PHYS REV B, V81, DOI 10.1103/PhysRevB.81.033409; Murakami Y, 2009, PHYS REV LETT, V102, DOI 10.1103/PhysRevLett.102.037401; Sarpkaya I, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3152; Wang F, 2004, PHYS REV B, V70, DOI 10.1103/PhysRevB.70.241403; Xiao YF, 2010, PHYS REV LETT, V104, DOI 10.1103/PhysRevLett.104.017401; Yasukochi S, 2011, PHYS REV B, V84, DOI 10.1103/PhysRevB.84.121409	35	2	2	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	2041-1723			NAT COMMUN	Nat. Commun.	FEB	2015	6								6335	10.1038/ncomms7335		5	Multidisciplinary Sciences	Science & Technology - Other Topics	CC4AD	WOS:000350291800001		
J	Kanno, A; Tanimura, N; Ishizaki, M; Ohko, K; Motoi, Y; Onji, M; Fukui, R; Shimozato, T; Yamamoto, K; Shibata, T; Sano, S; Sugahara-Tobinai, A; Takai, T; Ohto, U; Shimizu, T; Saitoh, S; Miyake, K				Kanno, Atsuo; Tanimura, Natsuko; Ishizaki, Masayuki; Ohko, Kentaro; Motoi, Yuji; Onji, Masahiro; Fukui, Ryutaro; Shimozato, Takaichi; Yamamoto, Kazuhide; Shibata, Takuma; Sano, Shigetoshi; Sugahara-Tobinai, Akiko; Takai, Toshiyuki; Ohto, Umeharu; Shimizu, Toshiyuki; Saitoh, Shin-ichiroh; Miyake, Kensuke			Targeting cell surface TLR7 for therapeutic intervention in autoimmune diseases	NATURE COMMUNICATIONS			English	Article							TOLL-LIKE RECEPTORS; PLASMACYTOID DENDRITIC CELLS; ANTIMICROBIAL PEPTIDE; NUCLEIC-ACID; MURINE MODEL; SELF-DNA; UNC93B1; RNA; LUPUS; LOCALIZATION	Toll-like receptor 7 (TLR7) senses microbial-derived RNA but can also potentially respond to self-derived RNA. To prevent autoimmune responses, TLR7 is thought to localize in endolysosomes. Contrary to this view, we show here that TLR7 is present on the cell surface of immune cells and that TLR7 responses can be inhibited by an anti-TLR7 antibody. The anti-TLR7 antibody is internalized with TLR7 and accumulates in endolysosomes as an immune complex. TLR7 responses in dendritic cells, macrophages and B cells are all inhibited by the anti-TLR7 antibody. Furthermore, the anti-TLR7 antibody inhibits in vivo cytokine production induced by a TLR7 ligand. Spontaneous TLR7 activation in Unc93b1(D34A/D34A) mice causes lethal inflammation. Progressive inflammation such as splenomegaly, thrombocytopenia and chronic active hepatitis are ameliorated by anti-TLR7 antibody treatment. These results demonstrate that cell surface TLR7 is a promising target for therapeutic intervention in autoimmune diseases.	[Kanno, Atsuo; Tanimura, Natsuko; Motoi, Yuji; Fukui, Ryutaro; Shibata, Takuma; Saitoh, Shin-ichiroh; Miyake, Kensuke] Univ Tokyo, Inst Med Sci, Dept Microbiol & Immunol, Div Innate Immun,Minato Ku, Tokyo 1088639, Japan; [Kanno, Atsuo; Miyake, Kensuke] Univ Tokyo, Inst Med Sci, Ctr Expt Med & Syst Biol, Lab Innate Immun,Minato Ku, Tokyo 1088639, Japan; [Tanimura, Natsuko] Japan Soc Promot Sci, Chiyoda Ku, Tokyo 1020083, Japan; [Ishizaki, Masayuki; Shimozato, Takaichi] Daiichi Sankyo Co Ltd, Daiichi Sankyo Shinagawa R&D Ctr, Tokyo 1408710, Japan; [Ohko, Kentaro; Sano, Shigetoshi] Kochi Univ, Kochi Med Sch, Dept Dermatol, Nankoku, Kochi 7838505, Japan; [Onji, Masahiro; Yamamoto, Kazuhide] Okayama Univ, Grad Sch Med Dent & Pharmaceut Sci, Dept Gastroenterol & Hepatol, Kita Ku, Okayama 7008558, Japan; [Shibata, Takuma; Shimizu, Toshiyuki] Japan Sci & Technol Agcy, CREST, Kawaguchi, Saitama 3320012, Japan; [Sugahara-Tobinai, Akiko; Takai, Toshiyuki] Tohoku Univ, Inst Dev Aging & Canc, Dept Expt Immunol, Sendai, Miyagi 9808575, Japan; [Ohto, Umeharu; Shimizu, Toshiyuki] Univ Tokyo, Grad Sch Pharmaceut Sci, Bunkyo Ku, Tokyo 1130033, Japan	Miyake, K (reprint author), Univ Tokyo, Inst Med Sci, Dept Microbiol & Immunol, Div Innate Immun,Minato Ku, 4-6-1 Shirokanedai, Tokyo 1088639, Japan.	kmiyake@ims.u-tokyo.ac.jp			Ministry of Education, Culture, Sports, Science and Technology for the Program of Japan Initiative for Global Research Network on Infectious Diseases; CREST; Daiichi-Sankyo Co. Ltd.; Translational Research Network Program	We thank Professors Shizuo Akira (Osaka University) and Bruce Beutler (University of Texas) for providing mouse strains. This work was supported in part by a contract research fund from the Ministry of Education, Culture, Sports, Science and Technology for the Program of Japan Initiative for Global Research Network on Infectious Diseases, a Grant-in-Aid for Scientific Research on Innovative Areas, a Grant-in-Aid for Scientific Research (A), CREST, a collaborative research grant from Daiichi-Sankyo Co. Ltd. and the Translational Research Network Program.	Sasai M, 2010, SCIENCE, V329, P1530, DOI 10.1126/science.1187029; Barton GM, 2006, NAT IMMUNOL, V7, P49, DOI 10.1038/ni1280; Huh JW, 2014, P NATL ACAD SCI USA, V111, P7072, DOI 10.1073/pnas.1322838111; Tanji H, 2013, SCIENCE, V339, P1426, DOI 10.1126/science.1229159; Tabeta K, 2006, NAT IMMUNOL, V7, P156, DOI 10.1038/ni1297; Santiago-Raber ML, 2010, J AUTOIMMUN, V34, P339, DOI 10.1016/j.jaut.2009.11.001; Kaisho T, 2006, J ALLERGY CLIN IMMUN, V117, P979, DOI 10.1016/j.jaci.2006.02.023; Christensen SR, 2006, IMMUNITY, V25, P417, DOI 10.1016/j.immuni.2006.07.013; Zhu FG, 2013, AUTOIMMUNITY, V46, P419, DOI 10.3109/08916934.2013.798651; Fukui R, 2011, IMMUNITY, V35, P69, DOI 10.1016/j.immuni.2011.05.010; Lande R, 2007, NATURE, V449, P564, DOI 10.1038/nature06116; Ehlers M, 2006, J EXP MED, V203, P553, DOI 10.1084/jem.20052438; Blasius AL, 2010, P NATL ACAD SCI USA, V107, P19973, DOI 10.1073/pnas.1014051107; Ewald SE, 2011, J EXP MED, V208, P643, DOI 10.1084/jem.20100682; Ganguly D, 2009, J EXP MED, V206, P1983, DOI 10.1084/jem.20090480; Kraft S, 2005, J EXP MED, V201, P385, DOI 10.1084/jem.20042085; Nickerson KM, 2010, J IMMUNOL, V184, P1840, DOI 10.4049/jimmunol.0902592; Lindau D, 2013, EUR J IMMUNOL, V43, P2101, DOI 10.1002/eji.201142143; Miyake K, 2007, SEMIN IMMUNOL, V19, P3, DOI 10.1016/j.smim.2006.12.002; Fukui R, 2009, J EXP MED, V206, P1339, DOI 10.1084/jem.20082316; Blasius AL, 2010, IMMUNITY, V32, P305, DOI 10.1016/j.immuni.2010.03.012; Jiang WW, 2013, J INVEST DERMATOL, V133, P1777, DOI 10.1038/jid.2013.57; Mouchess ML, 2011, IMMUNITY, V35, P721, DOI 10.1016/j.immuni.2011.10.009; Leadbetter EA, 2002, NATURE, V416, P603, DOI 10.1038/416603a; Hornung V, 2005, NAT MED, V11, P263, DOI 10.1038/nm1191; Kraft S, 2013, J IMMUNOL, V191, P2871, DOI 10.4049/jimmunol.1202323; Kim YM, 2008, NATURE, V452, P234, DOI 10.1038/nature06726; Kanno A, 2013, INT IMMUNOL, V25, P413, DOI 10.1093/intimm/dxt007; Maruoka R, 2013, GASTROENTEROLOGY, V145, P209, DOI 10.1053/j.gastro.2013.03.011; Onji M, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms2949; Marshak-Rothstein A, 2007, ANNU REV IMMUNOL, V25, P419, DOI 10.1146/annurev.immunol.22.0127030.104514	31	4	4	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	2041-1723			NAT COMMUN	Nat. Commun.	FEB	2015	6								6119	10.1038/ncomms7119		12	Multidisciplinary Sciences	Science & Technology - Other Topics	CC2TL	WOS:000350197400001		
J	Kawano, F; Suzuki, H; Furuya, A; Sato, M				Kawano, Fuun; Suzuki, Hideyuki; Furuya, Akihiro; Sato, Moritoshi			Engineered pairs of distinct photoswitches for optogenetic control of cellular proteins	NATURE COMMUNICATIONS			English	Article							SPATIOTEMPORAL CONTROL; MEDIATED INDUCTION; GENE-EXPRESSION; LIVING CELLS; LIGHT; ACTIVATION; SYSTEM; DYNAMICS; MOTILITY; DOMAIN	Optogenetic methods take advantage of photoswitches to control the activity of cellular proteins. Here, we completed a multi-directional engineering of the fungal photoreceptor Vivid to develop pairs of distinct photoswitches named Magnets. These new photoswitches were engineered to recognize each other based on the electrostatic interactions, thus preventing homodimerization and enhancing light-induced heterodimerization. Furthermore, we tuned the switch-off kinetics by four orders of magnitude and developed several variants, including those with substantially faster kinetics than any of the other conventional dimerization-based blue spectrum photoswitches. We demonstrate the utility of Magnets as powerful tools that can optogenetically manipulate molecular processes in biological systems.	[Kawano, Fuun; Suzuki, Hideyuki; Furuya, Akihiro; Sato, Moritoshi] Univ Tokyo, Grad Sch Arts & Sci, Meguro Ku, Tokyo 1538902, Japan	Sato, M (reprint author), Univ Tokyo, Grad Sch Arts & Sci, Meguro Ku, Tokyo 1538902, Japan.	cmsato@mail.ecc.u-tokyo.ac.jp			Platform for Dynamic Approaches to Living System from the Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT); Japan Society for the Promotion of Science (JSPS)	This work was supported by Platform for Dynamic Approaches to Living System from the Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT). This work was also supported by grants to M.S. from Japan Society for the Promotion of Science (JSPS).	Motta-Mena LB, 2014, NAT CHEM BIOL, V10, P196, DOI [10.1038/nchembio.1430, 10.1038/NCHEMBIO.1430]; Sato M, 2006, NAT METHODS, V3, P797, DOI 10.1038/nmeth930; Heo WD, 2006, SCIENCE, V314, P1458, DOI 10.1126/science.1134389; Tyszkiewicz AB, 2008, NAT METHODS, V5, P303, DOI [10.1038/nmeth.1189, 10.1038/NMETH.1189]; Kontos CD, 1998, MOL CELL BIOL, V18, P4131; Lungu OI, 2012, CHEM BIOL, V19, P507, DOI 10.1016/j.chembiol.2012.02.006; Idevall-Hagren O, 2012, P NATL ACAD SCI USA, V109, pE2316, DOI 10.1073/pnas.1211305109; Shimizu-Sato S, 2002, NAT BIOTECHNOL, V20, P1041, DOI 10.1038/nbt734; Muller K, 2013, MOL BIOSYST, V9, P596, DOI 10.1039/c3mb25590e; Kolsch V, 2008, J CELL SCI, V121, P551, DOI 10.1242/jcs.023333; Sato M, 2003, NAT CELL BIOL, V5, P1016, DOI 10.1038/ncb1054; Toettcher JE, 2011, NAT METHODS, V8, P837, DOI [10.1038/nmeth.1700, 10.1038/NMETH.1700]; Zoltowski BD, 2009, NAT CHEM BIOL, V5, P827, DOI 10.1038/nchembio.210; Yazawa M, 2009, NAT BIOTECHNOL, V27, P941, DOI 10.1038/nbt.1569; HO SN, 1989, GENE, V77, P51, DOI 10.1016/0378-1119(89)90358-2; Levskaya A, 2009, NATURE, V461, P997, DOI 10.1038/nature08446; Kennedy MJ, 2010, NAT METHODS, V7, P973, DOI [10.1038/nmeth.1524, 10.1038/NMETH.1524]; Paulmurugan R, 2007, ANAL CHEM, V79, P2346, DOI 10.1021/ac062053q; Wang X, 2012, NAT METHODS, V9, P266, DOI [10.1038/nmeth.1892, 10.1038/NMETH.1892]; Zoltowski BD, 2007, SCIENCE, V316, P1054, DOI 10.1126/science.1137128; Inoue T, 2005, NAT METHODS, V2, P415, DOI 10.1038/NMETH763; Wu YI, 2009, NATURE, V461, P104, DOI 10.1038/nature08241; Zoltowski BD, 2008, BIOCHEMISTRY-US, V47, P7012, DOI 10.1021/bi8007017; Riedl J, 2008, NAT METHODS, V5, P605, DOI 10.1038/nmeth.1220; Crefcoeur RP, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms2800; Habuchi S, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003944; Kawano F, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0082693; Sawano A, 2000, Nucleic Acids Res, V28, pE78, DOI 10.1093/nar/28.16.e78; Strickland D, 2012, NAT METHODS, V9, P379, DOI [10.1038/nmeth.1904, 10.1038/NMETH.1904]; Suh BC, 2006, SCIENCE, V314, P1454, DOI 10.1126/science.1131163; Taslimi A, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms5925; Vaidya AT, 2011, SCI SIGNAL, V4, DOI 10.1126/scisignal.2001945	32	4	4	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	2041-1723			NAT COMMUN	Nat. Commun.	FEB	2015	6								6256	10.1038/ncomms7256		8	Multidisciplinary Sciences	Science & Technology - Other Topics	CC2VM	WOS:000350202800006		
J	Kuwahara, A; Ozone, C; Nakano, T; Saito, K; Eiraku, M; Sasai, Y				Kuwahara, Atsushi; Ozone, Chikafumi; Nakano, Tokushige; Saito, Koichi; Eiraku, Mototsugu; Sasai, Yoshiki			Generation of a ciliary margin-like stem cell niche from self-organizing human retinal tissue	NATURE COMMUNICATIONS			English	Article							INTERKINETIC NUCLEAR MIGRATION; PIGMENT EPITHELIUM; VERTEBRATE RETINA; PROGENITOR CELLS; EYE DEVELOPMENT; OPTIC-CUP; NEURAL RETINA; HOMEOBOX GENE; MOUSE; DIFFERENTIATION	In the developing neural retina (NR), multipotent stem cells within the ciliary margin (CM) contribute to de novo retinal tissue growth. We recently reported the ability of human embryonic stem cells (hESCs) to self-organize stratified NR using a three-dimensional culture technique. Here we report the emergence of CM-like stem cell niches within human retinal tissue. First, we developed a culture method for selective NR differentiation by timed BMP4 treatment. We then found that inhibiting GSK3 and FGFR induced the transition from NR tissue to retinal pigment epithelium (RPE), and that removing this inhibition facilitated the reversion of this RPE-like tissue back to the NR fate. This step-wise induction-reversal method generated tissue aggregates with RPE at the margin of central-peripherally polarized NR. We demonstrate that the NR-RPE boundary tissue further self-organizes a niche for CM stem cells that functions to expand the NR peripherally by de novo progenitor generation.	[Kuwahara, Atsushi; Ozone, Chikafumi; Nakano, Tokushige; Sasai, Yoshiki] RIKEN, Ctr Dev Biol, Neurogenesis & Organogenesis Grp, Chuo Ku, Kobe, Hyogo 6500047, Japan; [Kuwahara, Atsushi; Nakano, Tokushige; Sasai, Yoshiki] RIKEN, Ctr Dev Biol, Human Stem Cell Technol Unit, Chuo Ku, Kobe, Hyogo 6500047, Japan; [Kuwahara, Atsushi; Nakano, Tokushige; Saito, Koichi] Sumitomo Chem Co Ltd, Environm Hlth Sci Lab, Osaka 5548558, Japan; [Ozone, Chikafumi] Nagoya Univ, Grad Sch Med, Dept Endocrinol & Diabet, Showa Ku, Nagoya, Aichi 4668550, Japan; [Eiraku, Mototsugu] RIKEN, Ctr Dev Biol, Four Dimens Tissue Anal Unit, Chuo Ku, Kobe, Hyogo 6500047, Japan	Kuwahara, A (reprint author), Sumitomo Dainippon Pharma Co Ltd, Regenerat & Cellular Med Off, Chuo Ku, 2-2-2 Minatojima Minamimachi, Kobe, Hyogo 6500047, Japan.	kuwaharaa@cdb.riken.jp; eiraku@cdb.riken.jp			MEXT; JST; Research Center Network for Realization of Regenerative Medicine from JST	This paper is dedicated to Dr Yoshiki Sasai, an incredible mentor who suddenly passed away on 5 August 2014. We are grateful to Nick Love, Keiko Muguruma, Momoko Watanabe, Taisuke Kadoshima and Daiki Nukaya for invaluable comments, and Rieko Yakura for technical support. This work was supported by grants-in-aid from MEXT (Y.S., M.E.), the S-Innovation from JST (K.S.) and the Research Center Network for Realization of Regenerative Medicine from JST (Y.S.).	Ali RR, 2011, NATURE, V472, P42, DOI 10.1038/472042a; Mathers PH, 1997, NATURE, V387, P603, DOI 10.1038/42475; Sasai Y, 2013, NATURE, V493, P318, DOI 10.1038/nature11859; Gonzalez-Cordero A, 2013, NAT BIOTECHNOL, V31, P741, DOI 10.1038/nbt.2643; Nakano T, 2012, CELL STEM CELL, V10, P771, DOI 10.1016/j.stem.2012.05.009; Livesey FJ, 2001, NAT REV NEUROSCI, V2, P109, DOI 10.1038/35053522; Yamaguchi Y, 2006, CELL TISSUE RES, V325, P101, DOI 10.1007/s00441-005-0122-z; Dale K, 1999, DEVELOPMENT, V126, P397; Dyer MA, 2000, DEVELOPMENT, V127, P3593; Watanabe K, 2007, NAT BIOTECHNOL, V25, P681, DOI 10.1038/nbt1310; Meyer JS, 2011, STEM CELLS, V29, P1206, DOI 10.1002/stem.674; Yasumoto K, 2002, EMBO J, V21, P2703, DOI 10.1093/emboj/21.11.2703; Diep DB, 2004, DEV BRAIN RES, V153, P261, DOI 10.1016/j.devbrainres.2004.09.008; YOUNG RW, 1985, ANAT REC, V212, P199, DOI 10.1002/ar.1092120215; Baye LM, 2007, J NEUROSCI, V27, P10143, DOI 10.1523/JNEUROSCI.2754-07.2007; Trimarchi JM, 2009, DEV DYNAM, V238, P2327, DOI 10.1002/dvdy.21973; Hanashima C, 2004, SCIENCE, V303, P56, DOI 10.1126/science.1090674; Boucherie C, 2011, REGEN MED, V6, P469, DOI [10.2217/rme.11.37, 10.2217/RME.11.37]; Eiraku M, 2011, NATURE, V472, P51, DOI 10.1038/nature09941; Ohyama K, 2008, DEVELOPMENT, V135, P3325, DOI 10.1242/dev.027078; Centanin L, 2011, CELL STEM CELL, V9, P553, DOI 10.1016/j.stem.2011.11.004; Wataya T, 2008, P NATL ACAD SCI USA, V105, P11796, DOI 10.1073/pnas.0803078105; Larsen KB, 2009, INT J DEV NEUROSCI, V27, P485, DOI 10.1016/j.ijdevneu.2009.04.004; Bhatia B, 2009, EXP EYE RES, V89, P373, DOI 10.1016/j.exer.2009.04.005; Reh TA, 1998, J NEUROBIOL, V36, P206, DOI 10.1002/(SICI)1097-4695(199808)36:2<206::AID-NEU8>3.0.CO;2-5; Liu W, 2010, J CLIN INVEST, V120, P3568, DOI 10.1172/JCI43219; Cayouette M, 2006, TRENDS NEUROSCI, V29, P563, DOI 10.1016/j.tins.2006.08.003; Tropepe V, 2000, SCIENCE, V287, P2032, DOI 10.1126/science.287.5460.2032; Liu H, 2003, DEV DYNAM, V227, P323, DOI 10.1002/dvdy.10315; Agathocleous M, 2009, ANNU REV CELL DEV BI, V25, P45, DOI 10.1146/annurev.cellbio.042308.113259; Kubo F, 2003, DEVELOPMENT, V130, P587, DOI 10.1242/dev.00244; Norden C, 2009, CELL, V138, P1195, DOI 10.1016/j.cell.2009.06.032; Idelson M, 2009, CELL STEM CELL, V5, P396, DOI 10.1016/j.stem.2009.07.002; Jadhav AP, 2006, P NATL ACAD SCI USA, V103, P18998, DOI 10.1073/pnas.0608155103; Chow RL, 2001, ANNU REV CELL DEV BI, V17, P255, DOI 10.1146/annurev.cellbio.17.1.255; Salero E, 2012, CELL STEM CELL, V10, P88, DOI 10.1016/j.stem.2011.11.018; Rowan S, 2004, DEVELOPMENT, V131, P5139, DOI 10.1242/dev.01300; Lamba DA, 2006, P NATL ACAD SCI USA, V103, P12769, DOI 10.1073/pnas.0601990103; Fujimura N, 2009, DEV BIOL, V334, P31, DOI 10.1016/j.ydbio.2009.07.002; Furuta Y, 1997, DEVELOPMENT, V124, P2203; Osakada F, 2008, NAT BIOTECHNOL, V26, P215, DOI 10.1038/nbt1384; Coles BLK, 2004, P NATL ACAD SCI USA, V101, P15772, DOI 10.1073/pnas.0401596101; Rubenstein JLR, 1998, ANNU REV NEUROSCI, V21, P445, DOI 10.1146/annurev.neuro.21.1.445; Lawrence JM, 2007, STEM CELLS, V25, P2033, DOI 10.1634/stemcells.2006-0724; Ikeda H, 2005, P NATL ACAD SCI USA, V102, P11331, DOI 10.1073/pnas.0500010102; Bhatia Bhairavi, 2010, Open Ophthalmol J, V4, P30, DOI 10.2174/1874364101004010030; Chiba C., 2013, EXP EYE RES, V4835; Cicero SA, 2009, P NATL ACAD SCI USA, V106, P6685, DOI 10.1073/pnas.0901596106; Clarke L, 2012, EUR J NEUROSCI, V36, P1951, DOI 10.1111/j.1460-9568.2012.08123.x; Fischer AJ, 2013, EXP EYE RES, V116, P199, DOI 10.1016/j.exer.2013.08.018; Fuhrmann Sabine, 2008, Organogenesis, V4, P60; Graw J., 2010, CURR TOP DEV BIOL, V90, P344; GUILLEMOT F, 1992, DEVELOPMENT, V114, P743; Hendrickson A, 2006, RETINAL DEVELOPMENT, P126, DOI 10.1017/CBO9780511541629.009; Kawasaki H, 2002, P NATL ACAD SCI USA, V99, P1580, DOI 10.1073/pnas.032662199; Koso H, 2008, STEM CELLS, V26, P3162, DOI 10.1634/stemcells.2008-0303; Kubo F, 2009, DEVELOPMENT, V136, P1823, DOI 10.1242/dev.029272; Lamba DA, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008763; Levine EM, 2000, DEV BIOL, V219, P299, DOI 10.1006/dbio.2000.9622; LIU ISC, 1994, NEURON, V13, P377, DOI 10.1016/0896-6273(94)90354-9; Locker M, 2009, CURR STEM CELL RES T, V4, P118; Martinez-Navarrete GC, 2008, J COMP NEUROL, V511, P557, DOI 10.1002/cne.21860; Mitashov VI, 1997, INT J DEV BIOL, V41, P893; Muller F, 2007, DEVELOPMENT, V134, P3483, DOI 10.1242/dev.02884; Nagai T, 1997, DEV BIOL, V182, P299, DOI 10.1006/dbio.1996.8449; O'Brien KMB, 2003, MOL VIS, V9, P401; PARK CM, 1989, DEV BIOL, V134, P201, DOI 10.1016/0012-1606(89)90089-4; Westenskow P, 2009, DEVELOPMENT, V136, P2505, DOI 10.1242/dev.032136; Zhu Y, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054552	69	4	4	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	2041-1723			NAT COMMUN	Nat. Commun.	FEB	2015	6								6286	10.1038/ncomms7286		15	Multidisciplinary Sciences	Science & Technology - Other Topics	CC3ZJ	WOS:000350289700001		
J	Matsuda, M; Koga, M; Woltjen, K; Nishida, E; Ebisuya, M				Matsuda, Mitsuhiro; Koga, Makito; Woltjen, Knut; Nishida, Eisuke; Ebisuya, Miki			Synthetic lateral inhibition governs cell-type bifurcation with robust ratios	NATURE COMMUNICATIONS			English	Article							DELTA-LIKE 1; LUNATIC-FRINGE; SEGMENTATION CLOCK; SYNCHRONIZED OSCILLATION; PATTERN-FORMATION; NOTCH; NOISE; FATE; SOMITOGENESIS; NEUROGENESIS	Cell-type diversity in multicellular organisms is created through a series of binary cell fate decisions. Lateral inhibition controlled by Delta-Notch signalling is the core mechanism for the choice of alternative cell types by homogeneous neighbouring cells. Here, we show that cells engineered with a Delta-Notch-dependent lateral inhibition circuit spontaneously bifurcate into Delta-positive and Notch-active cell populations. The synthetic lateral inhibition circuit comprises transcriptional repression of Delta and intracellular feedback of Lunatic fringe (Lfng). The Lfng-feedback subcircuit, even alone, causes the autonomous cell-type bifurcation. Furthermore, the ratio of two cell populations bifurcated by lateral inhibition is reproducible and robust against perturbation. The cell-type ratio is adjustable by the architecture of the lateral inhibition circuit as well as the degree of cell-cell attachment. Thus, the minimum lateral inhibition mechanism between adjacent cells not only serves as a binary cell-type switch of individual cells but also governs the cell-type ratio at the cell-population level.	[Matsuda, Mitsuhiro; Koga, Makito; Ebisuya, Miki] RIKEN, Ctr Dev Biol, Kobe, Hyogo 6500047, Japan; [Matsuda, Mitsuhiro; Koga, Makito; Ebisuya, Miki] Kyoto Univ, Career Path Promot Unit Young Life Scientists, Kyoto 6068501, Japan; [Matsuda, Mitsuhiro; Koga, Makito; Nishida, Eisuke] Kyoto Univ, Grad Sch Biostudies, Kyoto 6068502, Japan; [Woltjen, Knut] Kyoto Univ, Ctr iPS Cell Res & Applicat, Kyoto 6068507, Japan; [Woltjen, Knut] Kyoto Univ, Hakubi Ctr Adv Res, Kyoto 6068501, Japan; [Ebisuya, Miki] Japan Sci & Technol Agcy JST, Precursory Res Embryon Sci & Technol PRESTO, Kawaguchi, Saitama 3320012, Japan	Ebisuya, M (reprint author), RIKEN, Quantitat Biol Ctr, Lab Reconstitut Dev Biol, 2-2-3 Minatojima Minamimachi, Kobe, Hyogo 6500047, Japan.	miki.ebisuya@riken.jp	Ebisuya, Miki/N-5388-2015		Precursory Research for Embryonic Science and Technology (PRESTO); Funding Program for Next Generation World-Leading Researchers (NEXT Program); Special Coordination Fund for Promoting Science and Technology; Japan Ministry of Education, Culture, Sports, Science and Technology (MEXT)	We thank J. Miyazaki for the PCAG construct. We also thank I. Wada, T. Shibata, Y. Mukumoto and T. Abe for technical advice, Y. Sakaide for technical assistance and S. Hayashi for critical reading of the manuscript. This work was supported by the following grants to M.E.: the funding from Precursory Research for Embryonic Science and Technology (PRESTO), the Funding Program for Next Generation World-Leading Researchers (NEXT Program), the Special Coordination Fund for Promoting Science and Technology and Grant-in-Aid for Scientific Research on Innovative Areas from Japan Ministry of Education, Culture, Sports, Science and Technology (MEXT).	Yang LT, 2005, MOL BIOL CELL, V16, P927; Kawaguchi D, 2008, DEVELOPMENT, V135, P3849, DOI 10.1242/dev.024570; Visan I, 2006, NAT IMMUNOL, V7, P634, DOI 10.1038/ni1345; Eldar A, 2010, NATURE, V467, P167, DOI 10.1038/nature09326; NIWA H, 1991, GENE, V108, P193; Moloney DJ, 2000, NATURE, V406, P369, DOI 10.1038/35019000; Yang Q, 2001, SCIENCE, V294, P2155, DOI 10.1126/science.1065718; Vooijs M, 2011, GASTROENTEROLOGY, V141, P448, DOI 10.1053/j.gastro.2011.06.003; Horikawa K, 2006, NATURE, V441, P719, DOI 10.1038/nature04861; Cohen M, 2010, DEV CELL, V19, P78, DOI 10.1016/j.devcel.2010.06.006; van Es JH, 2005, NATURE, V435, P959, DOI 10.1038/nature03659; Lewis J, 2003, CURR BIOL, V13, P1398, DOI 10.1016/S0960-9822(03)00534-7; Goodyear R, 1997, J NEUROSCI, V17, P6289; Zhong WM, 1996, NEURON, V17, P43, DOI 10.1016/S0896-6273(00)80279-2; Li XQ, 1998, J BIOL CHEM, V273, P34970, DOI 10.1074/jbc.273.52.34970; Ferrell JE, 2012, CURR BIOL, V22, pR458, DOI 10.1016/j.cub.2012.03.045; Bray SJ, 2006, NAT REV MOL CELL BIO, V7, P678, DOI 10.1038/nrm2009; Jensen J, 2000, NAT GENET, V24, P36; Pierfelice T, 2011, NEURON, V69, P840, DOI 10.1016/j.neuron.2011.02.031; Knoblich JA, 2008, CELL, V132, P583, DOI 10.1016/j.cell.2008.02.007; Hicks C, 2000, NAT CELL BIOL, V2, P515; Sprinzak D, 2010, NATURE, V465, P86, DOI 10.1038/nature08959; Kageyama R, 2008, NAT NEUROSCI, V11, P1247, DOI 10.1038/nn.2208; Woltjen K, 2009, NATURE, V458, P766, DOI 10.1038/nature07863; RYAN MD, 1994, EMBO J, V13, P928; Balazsi G, 2011, CELL, V144, P910, DOI 10.1016/j.cell.2011.01.030; Chau AH, 2012, CELL, V151, P320, DOI 10.1016/j.cell.2012.08.040; Gardner TS, 2000, NATURE, V403, P339; Chrysostomou E, 2012, DEVELOPMENT, V139, P3764, DOI 10.1242/dev.074476; Collier JR, 1996, J THEOR BIOL, V183, P429, DOI 10.1006/jtbi.1996.0233; Ferrell JE, 2002, CURR OPIN CELL BIOL, V14, P140, DOI 10.1016/S0955-0674(02)00314-9; van Es JH, 2005, TRENDS MOL MED, V11, P496, DOI 10.1016/j.molmed.2005.09.008; Lewis J, 1998, SEMIN CELL DEV BIOL, V9, P583, DOI 10.1006/scdb.1998.0266; Artavanis-Tsakonas S, 1999, SCIENCE, V284, P770, DOI 10.1126/science.284.5415.770; Barad O, 2010, SCI SIGNAL, V3, DOI 10.1126/scisignal.2000857; Cole SE, 2002, DEV CELL, V3, P75, DOI 10.1016/S1534-5807(02)00212-5; Dale JK, 2003, NATURE, V421, P275, DOI 10.1038/nature01244; HEITZLER P, 1991, CELL, V64, P1083, DOI 10.1016/0092-8674(91)90263-X; Kato TM, 2010, MOL CELL NEUROSCI, V45, P12, DOI 10.1016/j.mcn.2010.05.004; Kurooka H, 1998, NUCLEIC ACIDS RES, V26, P5448, DOI 10.1093/nar/26.23.5448; Matsuda M, 2012, SCI SIGNAL, V5, DOI 10.1126/scisignal.2002764; Nikolaou N, 2009, DEVELOPMENT, V136, P2523, DOI 10.1242/dev.034736; Okubo Y, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms2133; Sprinzak D, 2011, PLOS COMPUT BIOL, V7, DOI 10.1371/journal.pcbi.1002069	44	0	0	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	2041-1723			NAT COMMUN	Nat. Commun.	FEB	2015	6								6195	10.1038/ncomms7195		12	Multidisciplinary Sciences	Science & Technology - Other Topics	CC2UW	WOS:000350201100004		
J	Matsumura, T; Sugawara, Y; Yutani, M; Amatsu, S; Yagita, H; Kohda, T; Fukuoka, S; Nakamura, Y; Fukuda, S; Hase, K; Ohno, H; Fujinaga, Y				Matsumura, Takuhiro; Sugawara, Yo; Yutani, Masahiro; Amatsu, Sho; Yagita, Hideo; Kohda, Tomoko; Fukuoka, Shin-Ichi; Nakamura, Yutaka; Fukuda, Shinji; Hase, Koji; Ohno, Hiroshi; Fujinaga, Yukako			Botulinum toxin A complex exploits intestinal M cells to enter the host and exert neurotoxicity	NATURE COMMUNICATIONS			English	Article							PATCH M-CELLS; CLOSTRIDIUM-BOTULINUM; EPITHELIAL-CELLS; PROGENITOR TOXIN; HA PROTEINS; E-CADHERIN; BINDING; HEMAGGLUTININ; TRANSCYTOSIS; GLYCOPROTEIN	To cause food-borne botulism, botulinum neurotoxin (BoNT) in the gastrointestinal lumen must traverse the intestinal epithelial barrier. However, the mechanism by which BoNT crosses the intestinal epithelial barrier remains unclear. BoNTs are produced along with one or more non-toxic components, with which they form progenitor toxin complexes (PTCs). Here we show that serotype A1 L-PTC, which has high oral toxicity and makes the predominant contribution to causing illness, breaches the intestinal epithelial barrier from microfold (M) cells via an interaction between haemagglutinin (HA), one of the non-toxic components, and glycoprotein 2 (GP2). HA strongly binds to GP2 expressed on M cells, which do not have thick mucus layers. Susceptibility to orally administered L-PTC is dramatically reduced in M-cell-depleted mice and GP2-deficient (Gp2(-/-)) mice. Our finding provides the basis for the development of novel antitoxin therapeutics and delivery systems for oral biologics.	[Matsumura, Takuhiro; Sugawara, Yo; Yutani, Masahiro; Amatsu, Sho; Fujinaga, Yukako] Osaka Univ, Int Res Ctr Infect Dis, Microbial Dis Res Inst, Lab Infect Cell Biol, Suita, Osaka 5650871, Japan; [Yagita, Hideo] Juntendo Univ, Sch Med, Dept Immunol, Tokyo 1138421, Japan; [Kohda, Tomoko] Osaka Prefecture Univ, Sch Life & Environm Sci, Dept Vet Sci, Izumisano, Osaka 5988531, Japan; [Fukuoka, Shin-Ichi] Aoyama Gakuin Univ, Sch Culture & Creat Studies, Tokyo 1508366, Japan; [Nakamura, Yutaka; Hase, Koji] Keio Univ, Fac Pharm, Dept Biochem, Tokyo 1058512, Japan; [Fukuda, Shinji; Ohno, Hiroshi] RIKEN, Ctr Integrat Medial Sci IMS, Lab Intestinal Ecosyst, Yokohama, Kanagawa 2300045, Japan; [Ohno, Hiroshi] Yokohama City Univ, Grad Sch Med Life Sci, Dept Med Life Sci, Yokohama, Kanagawa 2300045, Japan; [Ohno, Hiroshi] Chiba Univ, Grad Sch Med, Dept Immune Regulat, Chiba 2608670, Japan	Ohno, H (reprint author), RIKEN, Ctr Integrat Medial Sci IMS, Lab Intestinal Ecosyst, Yokohama, Kanagawa 2300045, Japan.	hiroshi.ohno@riken.jp; yukafuji@biken.osaka-u.ac.jp	Ohno, Hiroshi/L-7899-2014	Ohno, Hiroshi/0000-0001-8776-9661	Japan Society for the Promotion of Science (JSPS); Ministry of Education, Culture, Sports, Science and Technology of Japan [20790336, 21390128]	We would like to thank A. Sano, T. Yoshimura, K. Sasaki, C. Aoki and Dr K. Hosomi for technical assistance, and Dr S. Kozaki for providing botulinum toxins. This study was supported in part by the Japan Society for the Promotion of Science (JSPS) through the Funding Program for Next Generation World-Leading Researchers (NEXT Program) and by grants from the Ministry of Education, Culture, Sports, Science and Technology of Japan (20790336, 21390128).	Couesnon A, 2008, CELL MICROBIOL, V10, P375, DOI 10.1111/j.1462-5822.2007.01051.x; Eisele KH, 2011, TOXICON, V57, P555, DOI 10.1016/j.toxicon.2010.12.019; Sato S, 2013, MUCOSAL IMMUNOL, V6, P838, DOI 10.1038/mi.2012.122; Gu SY, 2013, CURR TOP MICROBIOL, V364, P21, DOI 10.1007/978-3-642-33570-9_2; Amatsu S, 2013, J BIOL CHEM, V288, P35617, DOI 10.1074/jbc.M113.521179; Fujinaga Y, 1997, MICROBIOL-UK, V143, P3841; Fujinaga Y, 2000, FEBS LETT, V467, P179, DOI 10.1016/S0014-5793(00)01147-9; Serafini-Cessi F, 2003, AM J KIDNEY DIS, V42, P658, DOI 10.1053/S0272-6386(03)00829-1; Maksymowych AB, 1999, INFECT IMMUN, V67, P4708; Neutra MR, 2001, NAT IMMUNOL, V2, P1004, DOI 10.1038/ni1101-1004; Gu SY, 2012, SCIENCE, V335, P977, DOI 10.1126/science.1214270; Lee K, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003690; Terahara K, 2008, J IMMUNOL, V180, P7840; Lee K, 2014, SCIENCE, V344, P1405, DOI 10.1126/science.1253823; McGuckin MA, 2011, NAT REV MICROBIOL, V9, P265, DOI 10.1038/nrmicro2538; Hase K, 2009, NATURE, V462, P226, DOI 10.1038/nature08529; Benefield DA, 2013, P NATL ACAD SCI USA, V110, P5630, DOI [10.1073/pnas.1222139110, 10.1073/pnas.12222139110]; Maksymowych AB, 2004, J PHARMACOL EXP THER, V310, P633, DOI 10.1124/jpet.104.066845; Mabbott NA, 2013, MUCOSAL IMMUNOL, V6, P666, DOI 10.1038/mi.2013.30; Knoop KA, 2009, J IMMUNOL, V183, P5738, DOI 10.4049/jimmunol.0901563; Jin YJ, 2009, MICROBIOL-SGM, V155, P35, DOI 10.1099/mic.0.021246-0; Frey A, 1996, J EXP MED, V184, P1045, DOI 10.1084/jem.184.3.1045; Nakato G, 2012, J IMMUNOL, V189, P1540, DOI 10.4049/jimmunol.1103332; Inoue K, 2003, MICROBIOL-SGM, V149, P3361, DOI 10.1099/mic.0.26586-0; Couesnon A, 2009, CELL MICROBIOL, V11, P289, DOI 10.1111/j.1462-5822.2008.01253.x; Schiavo G, 2000, PHYSIOL REV, V80, P717; Arnon SS, 2001, JAMA-J AM MED ASSOC, V285, P1059, DOI 10.1001/jama.285.8.1059; Inoue K, 1996, INFECT IMMUN, V64, P1589; Sugawara Y, 2010, J CELL BIOL, V189, P691, DOI 10.1083/jcb.200910119; Kobayashi K, 2004, BIOCHEM BIOPH RES CO, V322, P659, DOI 10.1016/j.bbrc.2004.07.197; Maksymowych AB, 1998, J BIOL CHEM, V273, P21950, DOI 10.1074/jbc.273.34.21950; Matsumura T, 2008, CELL MICROBIOL, V10, P355, DOI 10.1111/j.1462-5822.2007.01048.x; Azizi A, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1001147; Couesnon A, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002583; Donaldson DS, 2012, MUCOSAL IMMUNOL, V5, P216, DOI 10.1038/mi.2011.68; SAKAGUCHI G, 1982, PHARMACOL THERAPEUT, V19, P165, DOI 10.1016/0163-7258(82)90061-4; Sugawara Y, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0111170; Yu S, 2004, J BIOL CHEM, V279, P50274, DOI 10.1074/jbc.M410599200	38	4	4	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	2041-1723			NAT COMMUN	Nat. Commun.	FEB	2015	6								6255	10.1038/ncomms7255		10	Multidisciplinary Sciences	Science & Technology - Other Topics	CC2VM	WOS:000350202800005		
J	Ozaki, K; Kawasumi, K; Shibata, M; Ito, H; Itami, K				Ozaki, Kyohei; Kawasumi, Katsuaki; Shibata, Mari; Ito, Hideto; Itami, Kenichiro			One-shot K-region-selective annulative pi-extension for nanographene synthesis and functionalization	NATURE COMMUNICATIONS			English	Article							POLYCYCLIC AROMATIC-HYDROCARBONS; TRANSITION-METAL-COMPLEXES; CHIRALITY CARBON NANOTUBES; GRAPHENE NANORIBBONS; GEODESIC POLYARENES; LATERAL EXTENSION; BAY REGIONS; ARYLATION; DERIVATIVES; ACTIVATION	The optoelectronic nature of two-dimensional sheets of sp(2)-hydridized carbons (for example, graphenes and nanographenes) can be dramatically altered and tuned by altering the degree of pi-extension, shape, width and edge topology. Among various approaches to synthesize nanographenes with atom-by-atom precision, one-shot annulative pi-extension (APEX) reactions of polycyclic aromatic hydrocarbons hold significant potential not only to achieve a 'growth from template' synthesis of nanographenes, but also to fine-tune the properties of nanographenes. Here we describe one-shot APEX reactions that occur at the K-region (convex armchair edge) of polycyclic aromatic hydrocarbons by the Pd(CH3CN)(4)(SbF6)(2)/o-chloranil catalytic system with silicon-bridged aromatics as p-extending agents. Density functional theory calculations suggest that the complete K-region selectivity stems from the olefinic (decreased aromatic) character of the K-region. The protocol is applicable to multiple APEX and sequential APEX reactions, to construct various nanographene structures in a rapid and programmable manner.	[Ozaki, Kyohei; Kawasumi, Katsuaki; Shibata, Mari; Ito, Hideto; Itami, Kenichiro] Nagoya Univ, Inst Transformat Biomol WPI ITbM, Chikusa Ku, Nagoya, Aichi 4648602, Japan; [Ozaki, Kyohei; Kawasumi, Katsuaki; Shibata, Mari; Ito, Hideto; Itami, Kenichiro] Nagoya Univ, Grad Sch Sci, Chikusa Ku, Nagoya, Aichi 4648602, Japan; [Itami, Kenichiro] Nagoya Univ, JST ERATO, Itami Mol Nanocarbon Project, Chikusa Ku, Nagoya, Aichi 4648602, Japan	Itami, K (reprint author), Nagoya Univ, Inst Transformat Biomol WPI ITbM, Chikusa Ku, Nagoya, Aichi 4648602, Japan.	itami@chem.nagoya-u.ac.jp	Itami, Kenichiro/B-5110-2011; Ito, Hideto/F-1257-2013		ERATO programme from JST; JSPS [220GR049]; MEXT [26810057]; Japan Society for the Promotion of Science (JSPS); World Premier International Research Center (WPI) Initiative, Japan	This work was supported by the ERATO programme from JST (K.I.), the Funding Program for Next Generation World-Leading Researchers from JSPS (220GR049 to K.I.) and KAKENHI from MEXT (26810057 to H.I.). K.O. and K.K. thank the Japan Society for the Promotion of Science (JSPS) for fellowships. We thank Dr Yasutomo Segawa (Nagoya University), Professor Cathleen M. Crudden (Queen's University) and Dr Ayako Miyazaki (Nagoya University) for fruitful discussion and critical comments. Dr Keiko Kuwata (Nagoya University) is acknowledged for assistance in mass spectroscopy. Calculations were performed using the resources of the Research Center for Computational Science, Okazaki, Japan. ITbM is supported by the World Premier International Research Center (WPI) Initiative, Japan.	Fort EH, 2011, J MATER CHEM, V21, P1373, DOI 10.1039/c0jm02517h; Kawasumi K, 2013, NAT CHEM, V5, P739, DOI [10.1038/nchem.1704, 10.1038/NCHEM.1704]; Wencel-Delord J, 2013, NAT CHEM, V5, P369, DOI 10.1038/nchem.1607; Schwab MG, 2012, J AM CHEM SOC, V134, P18169, DOI 10.1021/ja307697j; Thamatam R, 2013, CHEM COMMUN, V49, P9122, DOI 10.1039/c3cc46270f; Mochida K, 2011, J AM CHEM SOC, V133, P10716, DOI 10.1021/ja202975w; Grimme S, 2003, J CHEM PHYS, V118, P9095, DOI 10.1063/1.1569242; Konishi A, 2013, CHEM LETT, V42, P592, DOI 10.1246/cl.130153; BECKE AD, 1993, J CHEM PHYS, V98, P5648, DOI 10.1063/1.464913; Fort EH, 2010, ANGEW CHEM INT EDIT, V49, P6626, DOI 10.1002/anie.201002859; Treier M, 2011, NAT CHEM, V3, P61, DOI [10.1038/nchem.891, 10.1038/NCHEM.891]; Feng XL, 2009, PURE APPL CHEM, V81, P2203, DOI 10.1351/PAC-CON-09-07-07; Okamoto K, 2013, MACROMOLECULES, V46, P8059, DOI 10.1021/ma401190r; Novoselov KS, 2004, SCIENCE, V306, P666, DOI 10.1126/science.1102896; Segawa Y, 2015, ANGEW CHEM INT EDIT, V54, P66, DOI 10.1002/anie.201403729; Mullen K, 2014, ACS NANO, V8, P6531, DOI 10.1021/nn503283d; Watson MD, 2001, CHEM REV, V101, P1267, DOI 10.1021/cr990322p; Cai JM, 2010, NATURE, V466, P470, DOI 10.1038/nature09211; Ureshino T, 2010, J AM CHEM SOC, V132, P14324, DOI 10.1021/ja107698p; Geim AK, 2009, SCIENCE, V324, P1530, DOI 10.1126/science.1158877; Fort EH, 2009, J AM CHEM SOC, V131, P16006, DOI 10.1021/ja907802g; Zhang QY, 2012, J AM CHEM SOC, V134, P15664, DOI 10.1021/ja306992k; Chen L, 2012, ANGEW CHEM INT EDIT, V51, P7640, DOI 10.1002/anie.201201084; Schuler B, 2014, ANGEW CHEM INT EDIT, V53, P9004, DOI 10.1002/anie.201403707; Li JL, 2011, CHEM-EUR J, V17, P14672, DOI 10.1002/chem.201102120; Ozaki K, 2013, CHEM SCI, V4, P3416, DOI 10.1039/c3sc51447a; Kawasumi K, 2013, TETRAHEDRON, V69, P4371, DOI 10.1016/j.tet.2013.01.037; Narita A, 2014, NAT CHEM, V6, P126, DOI [10.1038/nchem.1819, 10.1038/NCHEM.1819]; Omachi H, 2013, NAT CHEM, V5, P572, DOI [10.1038/nchem.1655, 10.1038/NCHEM.1655]; Scott LT, 1999, PURE APPL CHEM, V71, P209, DOI 10.1351/pac199971020209; Kawasumi K, 2012, ORG LETT, V14, P418, DOI 10.1021/ol203235w; Allen MJ, 2010, CHEM REV, V110, P132, DOI 10.1021/cr900070d; Funaki K, 2011, CHEM LETT, V40, P1050, DOI 10.1246/cl.2011.1050; Dreyer DR, 2010, ANGEW CHEM INT EDIT, V49, P9336, DOI 10.1002/anie.201003024; Sanchez-Valencia JR, 2014, NATURE, V512, P61, DOI 10.1038/nature13607; Tsefrikas VM, 2006, CHEM REV, V106, P4868, DOI 10.1021/cr050553y; Yamaguchi J, 2012, ANGEW CHEM INT EDIT, V51, P8960, DOI 10.1002/anie.201201666; Wu JS, 2007, CHEM REV, V107, P718, DOI 10.1021/cr068010r; BALCH AL, 1973, J AM CHEM SOC, V95, P2723, DOI 10.1021/ja00789a074; Dunning Jr TH, 1977, METHODS ELECTRONIC S, P1; Fort EH, 2011, TETRAHEDRON LETT, V52, P2051, DOI 10.1016/j.tetlet.2010.10.033; FOX GA, 1992, INORG CHEM, V31, P3718, DOI 10.1021/ic00044a012; Frisch M. J., 2004, GAUSSIAN09 REVISION; Harvey R. G., 1997, POLYCYCLIC AROMATIC; HASEGAWA T, 1991, INORG CHEM, V30, P449, DOI 10.1021/ic00003a018; NEUGEBAUER W, 1982, J ORGANOMET CHEM, V228, P107, DOI 10.1016/S0022-328X(00)87089-8; Perdew J.P., 1991, UNIFIED THEORY EXCHA, V91, P11; Shimizu M, 2008, CHEM-ASIAN J, V3, P1238, DOI 10.1002/asia.200800094; Vo TH, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4189; HAY PJ, 1985, J CHEM PHYS, V82, P270, DOI 10.1063/1.448799; CLAR E, 1957, J CHEM SOC, P4616, DOI 10.1039/jr9570004616	51	13	13	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	2041-1723			NAT COMMUN	Nat. Commun.	FEB	2015	6								6251	10.1038/ncomms7251		8	Multidisciplinary Sciences	Science & Technology - Other Topics	CC2VM	WOS:000350202800001		
J	Saito, H; Oikawa, T; Hamamoto, S; Ishimaru, Y; Kanamori-Sato, M; Sasaki-Sekimoto, Y; Utsumi, T; Chen, J; Kanno, Y; Masuda, S; Kamiya, Y; Seo, M; Uozumi, N; Ueda, M; Ohta, H				Saito, Hikaru; Oikawa, Takaya; Hamamoto, Shin; Ishimaru, Yasuhiro; Kanamori-Sato, Miyu; Sasaki-Sekimoto, Yuko; Utsumi, Tomoya; Chen, Jing; Kanno, Yuri; Masuda, Shinji; Kamiya, Yuji; Seo, Mitsunori; Uozumi, Nobuyuki; Ueda, Minoru; Ohta, Hiroyuki			The jasmonate-responsive GTR1 transporter is required for gibberellin-mediated stamen development in Arabidopsis	NATURE COMMUNICATIONS			English	Article							ABSCISIC-ACID; GENE COEXPRESSION; PLANT DEVELOPMENT; PROTEIN CONTROLS; AUXIN TRANSPORT; HORMONE; DEFENSE; TRANSLOCATION; FLOWER; GROWTH	Plant hormones are transported across cell membranes during various physiological events. Recent identification of abscisic acid and strigolactone transporters suggests that transport of various plant hormones across membranes does not occur by simple diffusion but requires transporter proteins that are strictly regulated during development. Here, we report that a major glucosinolate transporter, GTR1/NPF2.10, is multifunctional and may be involved in hormone transport in Arabidopsis thaliana. When heterologously expressed in oocytes, GTR1 transports jasmonoyl-isoleucine and gibberellin in addition to glucosinolates. gtr1 mutants are severely impaired in filament elongation and anther dehiscence resulting in reduced fertility, but these phenotypes can be rescued by gibberellin treatment. These results suggest that GTR1 may be a multifunctional transporter for the structurally distinct compounds glucosinolates, jasmonoyl-isoleucine and gibberellin, and may positively regulate stamen development by mediating gibberellin supply.	[Saito, Hikaru; Kanamori-Sato, Miyu; Utsumi, Tomoya; Chen, Jing; Ohta, Hiroyuki] Tokyo Inst Technol, Grad Sch Biosci & Biotechnol, Midori Ku, Yokohama, Kanagawa 2268501, Japan; [Oikawa, Takaya; Ishimaru, Yasuhiro; Ueda, Minoru] Tohoku Univ, Grad Sch Sci, Aoba Ku, Sendai, Miyagi 9800845, Japan; [Hamamoto, Shin; Uozumi, Nobuyuki] Tohoku Univ, Grad Sch Engn, Aoba Ku, Sendai, Miyagi 9808579, Japan; [Sasaki-Sekimoto, Yuko; Masuda, Shinji; Ohta, Hiroyuki] Tokyo Inst Technol, Earth Life Sci Inst, Meguro Ku, Tokyo 1528551, Japan; [Kanno, Yuri; Kamiya, Yuji; Seo, Mitsunori] RIKEN, Ctr Sustainable Resource Sci, Tsurumi Ku, Yokohama, Kanagawa 2300045, Japan; [Masuda, Shinji] Tokyo Inst Technol, Ctr Biol Resources & Informat, Midori Ku, Yokohama, Kanagawa 2268501, Japan	Ohta, H (reprint author), Tokyo Inst Technol, Grad Sch Biosci & Biotechnol, Midori Ku, 4259-B65 Nagatsuta Cho, Yokohama, Kanagawa 2268501, Japan.	hohta@bio.titech.ac.jp	Kamiya, Yuji/F-9420-2010; Sasaki-Sekimoto, Yuko/J-4459-2012; Ohta, Hiroyuki/B-1840-2014; Seo, Mitsunori/N-9603-2015	Kamiya, Yuji/0000-0003-4415-520X; Sasaki-Sekimoto, Yuko/0000-0003-1057-1870; 	Global COE Program (From the Earth to 'Earths'); Botanical Research Grant by the New Technology Development Foundation; MEXT, Japan [23102012, 2301]; Japan Advanced Plant Science Network;  [24580135];  [26102711];  [25119725];  [25292055]	We thank E. E. Farmer for critical reading of our manuscript. We also thank M. Shimojima, K. Hori and other Ohta & Masuda lab members for critical comments and/or technical help. Full-length cDNAs were provided by RIKEN Bio Resource Center (BRC). This work was supported in part by the Global COE Program (From the Earth to 'Earths') for H.S. and H.O., a Grant-in-Aid for Scientific Research (No. 24580135 and 26102711 to S.H, 25119725 to M.S. and 25292055 to N.U.), the Botanical Research Grant by the New Technology Development Foundation for Y.I. and a Grant-in-Aid for Scientific Research (No. 23102012) on Innovative Areas Chemical Biology of Natural Products" (No. 2301) for M.U. from MEXT, Japan. Hormonome analysis was supported by the Japan Advanced Plant Science Network.	Abramoff MD, 2004, BIOPHOTONICS INT, V11, P36, DOI DOI 10.1117/1.3589100; Acosta I. F., 2010, ARABIDOPSIS BOOK; Kanno Y, 2012, P NATL ACAD SCI USA, V109, P9653, DOI 10.1073/pnas.1203567109; Plackett ARG, 2011, TRENDS PLANT SCI, V16, P568, DOI 10.1016/j.tplants.2011.06.007; Weaver LM, 1998, PLANT MOL BIOL, V37, P455, DOI 10.1023/A:1005934428906; Kang J, 2010, P NATL ACAD SCI USA, V107, P2355, DOI 10.1073/pnas.0909222107; Krouk G, 2010, DEV CELL, V18, P927, DOI 10.1016/j.devcel.2010.05.008; Kanno Y, 2010, PLANT CELL PHYSIOL, V51, P1988, DOI 10.1093/pcp/pcq158; Browse J, 2009, ANNU REV PLANT BIOL, V60, P183, DOI 10.1146/annurev.arplant.043008.092007; Obayashi T, 2009, DNA RES, V16, P249, DOI 10.1093/dnares/dsp016; Swain SM, 2005, TRENDS PLANT SCI, V10, P123, DOI 10.1016/j.tplants.2005.01.007; Obayashi T, 2011, PLANT CELL PHYSIOL, V52, P213, DOI 10.1093/pcp/pcq203; Kuromori T, 2010, P NATL ACAD SCI USA, V107, P2361, DOI 10.1073/pnas.0912516107; SUN TP, 1992, PLANT CELL, V4, P119; Kretzschmar T, 2012, NATURE, V483, P341, DOI 10.1038/nature10873; Chini A, 2007, NATURE, V448, P666, DOI 10.1038/nature06006; Nour-Eldin HH, 2012, NATURE, V488, P531, DOI 10.1038/nature11285; Thines B, 2007, NATURE, V448, P661, DOI 10.1038/nature05960; Cheng H, 2004, DEVELOPMENT, V131, P1055, DOI 10.1242/dev.00992; Hong GJ, 2012, PLANT CELL, V24, P2635, DOI 10.1105/tpc.112.098749; Schilmiller AL, 2005, CURR OPIN PLANT BIOL, V8, P369, DOI 10.1016/j.pbi.2005.05.008; Sun TP, 2010, PLANT PHYSIOL, V154, P567, DOI 10.1104/pp.110.161554; KRAMELL R, 1988, TETRAHEDRON, V44, P5791, DOI 10.1016/S0040-4020(01)81437-X; Yamaguchi S, 2008, ANNU REV PLANT BIOL, V59, P225, DOI 10.1146/annurev.arplant.59.032607.092804; Uozumi N, 2000, PLANT PHYSIOL, V122, P1249, DOI 10.1104/pp.122.4.1249; Sasaki-Sekimoto Y, 2013, PLANT PHYSIOL, V163, P291, DOI 10.1104/pp.113.220129; Lorenzo O, 2004, PLANT CELL, V16, P1938, DOI 10.1105/tpc.022319; Yamaguchi N, 2014, SCIENCE, V344, P638, DOI 10.1126/science.1250498; Hou XL, 2010, DEV CELL, V19, P884, DOI 10.1016/j.devcel.2010.10.024; Wasternack C, 2013, BIOCHIMIE, V95, P79, DOI 10.1016/j.biochi.2012.06.005; Czechowski T, 2005, PLANT PHYSIOL, V139, P5, DOI 10.1104/pp.105.063743; Yan YX, 2007, PLANT CELL, V19, P2470, DOI 10.1105/tpc.107.050708; Petrasek J, 2009, DEVELOPMENT, V136, P2675, DOI 10.1242/dev.030353; JEFFERSON RA, 1987, EMBO J, V6, P3901; Adachi S, 2009, DEV BIOL, V329, P306, DOI 10.1016/j.ydbio.2009.03.002; Liu KH, 2003, EMBO J, V22, P1005, DOI 10.1093/emboj/cdg118; KOORNNEEF M, 1980, THEOR APPL GENET, V58, P257, DOI 10.1007/BF00265176; Hirano K, 2008, PLANT CELL PHYSIOL, V49, P1429, DOI 10.1093/pcp/pcn123; Fan LM, 2001, J EXP BOT, V52, P1603, DOI 10.1093/jexbot/52.361.1603; Ko D, 2014, P NATL ACAD SCI USA, V111, P7150, DOI 10.1073/pnas.1321519111; Yang DL, 2012, P NATL ACAD SCI USA, V109, pE1192, DOI 10.1073/pnas.1201616109; Asamitsu Y, 2006, CHEM BIODIVERS, V3, P654, DOI 10.1002/cbdv.200690068; Berberich T., 2008, HDB PLANT FUNCTIONAL, P113, DOI 10.1002/9783527622542.ch6; Thines Bryan, 2013, Methods Mol Biol, V1011, P13, DOI 10.1007/978-1-62703-414-2_2; Kiyota H, 2001, TETRAHEDRON-ASYMMETR, V12, P1035, DOI 10.1016/S0957-4166(01)00169-0; Leran S., 2013, TRENDS PLANT SCI, V19, P5; Nakagawa T., 2007, J BIOSCI BIOENG, V104, P31; Nakamura Y, 2008, BIOSCI BIOTECH BIOCH, V72, P2867, DOI 10.1271/bbb.80338; Peng JR, 2009, J INTEGR PLANT BIOL, V51, P1064, DOI 10.1111/j.1744-7909.2009.00881.x; SMYTH DR, 1990, PLANT CELL, V2, P755; Sun T. P., 2008, ARABIDOPSIS BOOK; Zhang HW, 2014, MOL PLANT, V7, P1522, DOI 10.1093/mp/ssu063; Zhang KW, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4274	53	7	7	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	2041-1723			NAT COMMUN	Nat. Commun.	FEB	2015	6								6095	10.1038/ncomms7095		11	Multidisciplinary Sciences	Science & Technology - Other Topics	CC2TG	WOS:000350196900001		
J	Su, L; Lu, G; Kenens, B; Rocha, S; Fron, E; Yuan, HF; Chen, C; Van Dorpe, P; Roeffaers, MBJ; Mizuno, H; Hofkens, J; Hutchison, JA; Uji-i, H				Su, Liang; Lu, Gang; Kenens, Bart; Rocha, Susana; Fron, Eduard; Yuan, Haifeng; Chen, Chang; Van Dorpe, Pol; Roeffaers, Maarten B. J.; Mizuno, Hideaki; Hofkens, Johan; Hutchison, James A.; Uji-i, Hiroshi			Visualization of molecular fluorescence point spread functions via remote excitation switching fluorescence microscopy	NATURE COMMUNICATIONS			English	Article							PHOTOACTIVATION LOCALIZATION MICROSCOPY; OPTICAL RECONSTRUCTION MICROSCOPY; PHOTONIC MODE DENSITY; SILVER NANOWIRES; METAL NANOPARTICLES; PLASMON PROPAGATION; POLYOL SYNTHESIS; FLUOROPHORE; EMISSION; ANTENNAS	The enhancement of molecular absorption, emission and scattering processes by coupling to surface plasmon polaritons on metallic nanoparticles is a key issue in plasmonics for applications in (bio) chemical sensing, light harvesting and photocatalysis. Nevertheless, the point spread functions for single-molecule emission near metallic nanoparticles remain difficult to characterize due to fluorophore photodegradation, background emission and scattering from the plasmonic structure. Here we overcome this problem by exciting fluorophores remotely using plasmons propagating along metallic nanowires. The experiments reveal a complex array of single-molecule fluorescence point spread functions that depend not only on nanowire dimensions but also on the position and orientation of the molecular transition dipole. This work has consequences for both single-molecule regime-sensing and super-resolution imaging involving metallic nanoparticles and opens the possibilities for fast size sorting of metallic nanoparticles, and for predicting molecular orientation and binding position on metallic nanoparticles via far-field optical imaging.	[Su, Liang; Lu, Gang; Kenens, Bart; Rocha, Susana; Fron, Eduard; Yuan, Haifeng; Mizuno, Hideaki; Hofkens, Johan; Uji-i, Hiroshi] Katholieke Univ Leuven, Dept Chem, B-3001 Heverlee, Belgium; [Chen, Chang; Van Dorpe, Pol] IMEC, B-3001 Heverlee, Belgium; [Chen, Chang; Van Dorpe, Pol] Katholieke Univ Leuven, Dept Phys & Astron, B-3001 Heverlee, Belgium; [Roeffaers, Maarten B. J.] Katholieke Univ Leuven, Dept Microbial & Mol Syst, Ctr Surface Chem & Catalysis, B-3001 Heverlee, Belgium; [Hofkens, Johan] Univ Copenhagen, Nanosci Ctr, DK-2100 Copenhagen, Denmark; [Hofkens, Johan] Univ Copenhagen, Dept Chem, DK-2100 Copenhagen, Denmark; [Hutchison, James A.] Univ Strasbourg, ISIS, F-67000 Strasbourg, France; [Hutchison, James A.] Univ Strasbourg, icFRC, F-67000 Strasbourg, France; [Hutchison, James A.] CNRS UMR 7006, F-67000 Strasbourg, France; [Hutchison, James A.] Univ Melbourne, Sch Chem, Melbourne, Vic 3010, Australia; [Hutchison, James A.] Univ Melbourne, Inst Bio21, Melbourne, Vic 3010, Australia; [Uji-i, Hiroshi] Japan Sci & Technol Agcy JST, PRESTO, Saitama 3320012, Japan	Hutchison, JA (reprint author), Univ Strasbourg, ISIS, F-67000 Strasbourg, France.	hutchison@unistra.fr; hiroshi.ujii@chem.kuleuven.be	Hutchison, James/C-5908-2015; Lu, Gang/A-1893-2011; Yuan, Haifeng/B-4529-2011; Roeffaers, Maarten/D-9328-2011; chen, chang/A-4924-2012	Hutchison, James/0000-0002-0595-9961; Lu, Gang/0000-0003-1722-0176; chen, chang/0000-0002-9988-930X	'Fonds voor Wetenschappelijk Onderzoek FWO' [G0607.09, G.0459.10, G0990.11, G.0197.11, G.0259.12, G.0962.13, G0B55.14]; K.U. Leuven Research Fund [GOA 2011/03, CREA2009, OT/12/059]; Flemish government (long term structural funding-Methusalem funding CASAS) [METH/08/04]; Hercules foundation [HER/08/21]; Belgian Federal Science Policy Office [IAP-VI/27]; EU FP7 programme [ITN-SUPERIOR PITN-GA-2009-238177]; European Research Council [280064, 307523, 291593]; Japan Science and Technology Agency PRESTO programme; Research Foundation-Flanders (FWO); Australian Research Council DECRA scheme [DE130101300]	Financial support of the 'Fonds voor Wetenschappelijk Onderzoek FWO' (Grants G0607.09, G.0459.10, G0990.11, G.0197.11, G.0259.12, G.0962.13, G0B55.14), the K.U. Leuven Research Fund (GOA 2011/03, CREA2009, OT/12/059), the Flemish government (long term structural funding-Methusalem funding CASAS METH/08/04), the Hercules foundation (HER/08/21), the Belgian Federal Science Policy Office (IAP-VI/27), the EU FP7 programme (ITN-SUPERIOR PITN-GA-2009-238177), the European Research Council (starting grant PLASMHACAT #280064 to H.U. starting grant LIGHT #307523 to M.B.J.R. and advanced grant FLUOROCODE #291593 to J.H.) and the Japan Science and Technology Agency PRESTO programme to H.U. are gratefully acknowledged. G.L. and H.Y. thank the Research Foundation-Flanders (FWO) for postdoctoral fellowships. J.A.H. acknowledges the support of the Australian Research Council DECRA scheme (DE130101300).	Anger Pascal, 2006, Phys Rev Lett, V96, P113002; Betzig E, 2006, SCIENCE, V313, P1642, DOI 10.1126/science.1127344; van de Linde S, 2011, NAT PROTOC, V6, P991, DOI 10.1038/nprot.2011.336; Zhou XC, 2012, NAT NANOTECHNOL, V7, P237, DOI [10.1038/nnano.2012.18, 10.1038/NNANO.2012.18]; Atwater HA, 2010, NAT MATER, V9, P205, DOI [10.1038/nmat2629, 10.1038/NMAT2629]; Dickson RM, 2000, J PHYS CHEM B, V104, P6095, DOI 10.1021/jp00143b; Seh ZW, 2012, ADV MATER, V24, P2310, DOI 10.1002/adma.201104241; Yokota H, 1998, PHYS REV LETT, V80, P4606, DOI 10.1103/PhysRevLett.80.4606; Hoogenboom JP, 2009, NANO LETT, V9, P1189, DOI 10.1021/nl803865a; Biebricher A, 2004, J BIOTECHNOL, V112, P97, DOI 10.1016/j.jbiotec.2004.03.019; Frey HG, 2004, PHYS REV LETT, V93, DOI 10.1103/PhysRevLett.93.200801; Hess ST, 2006, BIOPHYS J, V91, P4258, DOI 10.1529/biophysj.106.091116; Blythe KL, 2014, CHEMPHYSCHEM, V15, P784, DOI 10.1002/cphc.201300767; Lu G, 2014, ADV MATER, V26, P5124, DOI 10.1002/adma.201401237; Hu XH, 2004, APPL PHYS LETT, V85, P1520, DOI 10.1063/1.1784883; Anker JN, 2008, NAT MATER, V7, P442, DOI 10.1038/nmat2162; Sun YG, 2003, NANO LETT, V3, P955, DOI 10.1021/nl034312m; Taminiau TH, 2008, NAT PHOTONICS, V2, P234, DOI 10.1038/nphoton.2008.32; Heilemann M, 2008, ANGEW CHEM INT EDIT, V47, P6172, DOI 10.1002/anie.200802376; Sanders AW, 2006, NANO LETT, V6, P1822, DOI [10.1021/nl052471v, 10.1021/nl052171v]; Kuhn S, 2006, PHYS REV LETT, V97, DOI 10.1103/PhysRevLett.97.017402; Hutchison JA, 2009, NANO LETT, V9, P995, DOI 10.1021/nl8030696; Rust MJ, 2006, NAT METHODS, V3, P793, DOI 10.1038/nmeth929; Lin HZ, 2012, CHEMPHYSCHEM, V13, P973, DOI 10.1002/cphc.201100743; Stefani FD, 2005, PHYS REV LETT, V94, DOI 10.1103/PhysRevLett.94.023005; Barnes WL, 2003, NATURE, V424, P824, DOI 10.1038/nature01937; Andoy NM, 2013, J AM CHEM SOC, V135, P1845, DOI 10.1021/ja309948y; Blythe KL, 2013, PHYS CHEM CHEM PHYS, V15, P4136, DOI 10.1039/c2cp43152a; Kuhn S, 2008, MOL PHYS, V106, P893, DOI 10.1080/00268970802002510; Barnes WL, 1998, J MOD OPTIC, V45, P661, DOI 10.1080/09500349808230614; Cheng XD, 2014, ANAL CHEM, V86, P2303, DOI 10.1021/ac403512w; Ditlbacher H, 2005, PHYS REV LETT, V95, DOI 10.1103/PhysRevLett.95.257403; Enderlein J, 2000, BIOPHYS J, V78, P2151; Kenens B, 2013, J PHYS CHEM C, V117, P2547, DOI 10.1021/jp308683b; Kramer A, 2002, APPL PHYS LETT, V80, P1652, DOI 10.1063/1.1453479; Lin HZ, 2011, J PHOTOCH PHOTOBIO A, V221, P220, DOI 10.1016/j.jphotochem.2011.04.015; Liv N, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0055707; Padlan EA, 1996, ADV PROTEIN CHEM, V49, P57, DOI 10.1016/S0065-3233(08)60488-X; Repo S, 2006, CHEM BIOL, V13, P1029, DOI 10.1016/j.chembiol.2006.08.006; Tran ML, 2008, J AM CHEM SOC, V130, P17240, DOI 10.1021/ja807218e	40	4	4	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	2041-1723			NAT COMMUN	Nat. Commun.	FEB	2015	6								6287	10.1038/ncomms7287		9	Multidisciplinary Sciences	Science & Technology - Other Topics	CC3ZJ	WOS:000350289700002		
J	Sumida, T; Naito, AT; Nomura, S; Nakagawa, A; Higo, T; Hashimoto, A; Okada, K; Sakai, T; Ito, M; Yamaguchi, T; Oka, T; Akazawa, H; Lee, JK; Minamino, T; Offermanns, S; Noda, T; Botto, M; Kobayashi, Y; Morita, H; Manabe, I; Nagai, T; Shiojima, I; Komuro, I				Sumida, Tomokazu; Naito, Atsuhiko T.; Nomura, Seitaro; Nakagawa, Akito; Higo, Tomoaki; Hashimoto, Akihito; Okada, Katsuki; Sakai, Taku; Ito, Masamichi; Yamaguchi, Toshihiro; Oka, Toru; Akazawa, Hiroshi; Lee, Jong-Kook; Minamino, Tohru; Offermanns, Stefan; Noda, Tetsuo; Botto, Marina; Kobayashi, Yoshio; Morita, Hiroyuki; Manabe, Ichiro; Nagai, Toshio; Shiojima, Ichiro; Komuro, Issei			Complement C1q-induced activation of beta-catenin signalling causes hypertensive arterial remodelling	NATURE COMMUNICATIONS			English	Article							VASCULAR SMOOTH-MUSCLE; DISEASE; CELLS; ATHEROSCLEROSIS; MICE; PATHWAY; PROLIFERATION; MACROPHAGES; DEFICIENT; GROWTH	Hypertension induces structural remodelling of arteries, which leads to arteriosclerosis and end-organ damage. Hyperplasia of vascular smooth muscle cells (VSMCs) and infiltration of immune cells are the hallmark of hypertensive arterial remodelling. However, the precise molecular mechanisms of arterial remodelling remain elusive. We have recently reported that complement C1q activates beta-catenin signalling independent of Wnts. Here, we show a critical role of complement C1-induced activation of beta-catenin signalling in hypertensive arterial remodelling. Activation of b-catenin and proliferation of VSMCs were observed after blood-pressure elevation, which were prevented by genetic and chemical inhibition of beta-catenin signalling. Macrophage depletion and C1qa gene deletion attenuated the hypertension- induced beta-catenin signalling, proliferation of VSMCs and pathological arterial remodelling. Our findings unveil the link between complement C1 and arterial remodelling and suggest that C1-induced activation of beta-catenin signalling becomes a novel therapeutic target to prevent arteriosclerosis in patients with hypertension.	[Sumida, Tomokazu; Naito, Atsuhiko T.; Nomura, Seitaro; Ito, Masamichi; Yamaguchi, Toshihiro; Akazawa, Hiroshi; Morita, Hiroyuki; Manabe, Ichiro; Komuro, Issei] Univ Tokyo, Grad Sch Med, Dept Cardiovasc Med, Tokyo 1138655, Japan; [Sumida, Tomokazu; Naito, Atsuhiko T.; Oka, Toru; Akazawa, Hiroshi; Lee, Jong-Kook; Shiojima, Ichiro; Komuro, Issei] Japan Sci & Technol Agcy, CREST, Tokyo 1020075, Japan; [Naito, Atsuhiko T.; Nakagawa, Akito; Higo, Tomoaki; Hashimoto, Akihito; Okada, Katsuki; Sakai, Taku; Oka, Toru; Lee, Jong-Kook; Komuro, Issei] Osaka Univ, Grad Sch Med, Dept Cardiovasc Med, Suita, Osaka 5650871, Japan; [Minamino, Tohru] Niigata Univ, Grad Sch Med & Dent Sci, Dept Cardiovasc Biol & Med, Niigata 9518510, Japan; [Offermanns, Stefan] Max Planck Inst Heart & Lung Res, Dept Pharmacol, D-61231 Bad Nauheim, Germany; [Noda, Tetsuo] Japanese Fdn Canc Res, Inst Canc, Dept Cell Biol, Tokyo 1358550, Japan; [Botto, Marina] Univ London Imperial Coll Sci Technol & Med, Dept Med, Ctr Complement & Inflammat Res, London SW7 2AZ, England; [Kobayashi, Yoshio; Nagai, Toshio] Chiba Univ, Grad Sch Med, Dept Cardiovasc Med, Chiba 2608670, Japan; [Shiojima, Ichiro] Kansai Med Univ, Dept Med 2, Osaka 5731191, Japan	Komuro, I (reprint author), Univ Tokyo, Grad Sch Med, Dept Cardiovasc Med, Tokyo 1138655, Japan.	komuro-tky@umin.ac.jp		Minamino, Tohru/0000-0003-1627-6151	Ministry of Education, Culture, Sports, Science and Technology (MEXT); JSPS KAKENHI [21229010, 23689038, 26870141]; CREST; Japan Science and Technology Agency; Japan Research Promotion Society for Cardiovascular Diseases; Japan Prize Foundation; Uehara Memorial Foundation; Nakatomi Foundation; Japan Heart Foundation/Novartis; Kanae Foundation for the Promotion of Medical Science; Japan Foundation for Applied Enzymology and Banyu Research Foundation International; Japan Foundation for Applied Enzymology	We gratefully acknowledge the gift of the CreERT2 cassette from Dr Pierre Chambon (IGBMC/GIE-CERBM). We would like to thank the following individuals for their technical support: A. Furuyama, M. Ikeda, Y. Ohtsuki, I. Sakamoto, M. Shimizu, H. Taniwaki, R. Takizawa, C. Ogawa, N. Igarashi, Y. Xiao, H. Tomita, M. Hayashi and N. Yamanaka. This work was supported by grants from the Ministry of Education, Culture, Sports, Science and Technology (MEXT); JSPS KAKENHI Grant Number 21229010, and CREST, Japan Science and Technology Agency (to L.K.); JSPS KAKENHI Grant Number 23689038, Sakakibara Memorial Research Grant from the Japan Research Promotion Society for Cardiovascular Diseases, Research Grants from the Japan Prize Foundation, the Uehara Memorial Foundation, the Nakatomi Foundation, Japan Heart Foundation/Novartis, Kanae Foundation for the Promotion of Medical Science, the Japan Foundation for Applied Enzymology and Banyu Research Foundation International (to A.T.N.); JSPS KAKENHI Grant Number 26870141, Japan Heart Foundation/Novartis and Research Grants from the Japan Foundation for Applied Enzymology (to T.S.).	Letavernier E, 2008, CIRC RES, V102, P720, DOI 10.1161/CIRCRESAHA.107.160077; VANROOIJEN N, 1984, CELL TISSUE RES, V238, P355; Wenzel P, 2011, CIRCULATION, V124, P1370, DOI 10.1161/CIRCULATIONAHA.111.034470; Lawrence MC, 2008, CELL RES, V18, P436, DOI 10.1038/cr.2008.37; Petry F, 2001, J IMMUNOL, V167, P4033; Li CH, 2000, CELL SIGNAL, V12, P435, DOI 10.1016/S0898-6568(00)00096-6; Cohen ED, 2009, J CLIN INVEST, V119, P2538, DOI 10.1172/JCI38079; Angers S, 2009, NAT REV MOL CELL BIO, V10, P468, DOI 10.1038/nrm2717; van Noort M, 2002, J BIOL CHEM, V277, P17901, DOI 10.1074/jbc.M111635200; Tsaousi A, 2011, CIRC RES, V108, P427, DOI 10.1161/CIRCRESAHA.110.233999; WESSELS MR, 1995, P NATL ACAD SCI USA, V92, P11490, DOI 10.1073/pnas.92.25.11490; Wang XH, 2002, CIRC RES, V90, P340, DOI 10.1161/hh0302.104466; Tieu BC, 2009, J CLIN INVEST, V119, P3637, DOI 10.1172/JCI38308; GIBBONS GH, 1994, NEW ENGL J MED, V330, P1431; Intengan HD, 2001, HYPERTENSION, V38, P581, DOI 10.1161/hy09t1.096249; Yoshioka S, 2012, MOL CANCER RES, V10, P469, DOI 10.1158/1541-7786.MCR-11-0177; Naito AT, 2012, CELL, V149, P1298, DOI 10.1016/j.cell.2012.03.047; Dzau VJ, 2002, NAT MED, V8, P1249, DOI 10.1038/nm1102-1249; Lepourcelet M, 2004, CANCER CELL, V5, P91, DOI 10.1016/S1535-6108(03)00334-9; Kearney PM, 2005, LANCET, V365, P217, DOI 10.1016/S0140-6736(05)17741-1; Wirth A, 2008, NAT MED, V14, P64, DOI 10.1038/nm1666; Logan CY, 2004, ANNU REV CELL DEV BI, V20, P781, DOI 10.1146/annurev.cellbio.20.010403.113126; Dejana E, 2010, CIRC RES, V107, P943, DOI 10.1161/CIRCRESAHA.110.223750; Botto M, 1998, NAT GENET, V19, P56, DOI 10.1038/ng0598-56; Bhatia VK, 2007, AM J PATHOL, V170, P416, DOI 10.2353/ajpath.2007.060406; Lustig B, 2002, MOL CELL BIOL, V22, P1184, DOI 10.1128/MCB.22.4.1184-1193.2002; Horton R, 2012, LANCET, V380, P2053, DOI 10.1016/S0140-6736(12)62133-3; ROSS R, 1993, NATURE, V362, P801, DOI 10.1038/362801a0; Fujiu K, 2014, CARDIOVASC RES, V102, P232, DOI 10.1093/cvr/cvu059; Clevers H, 2006, CELL, V127, P469, DOI 10.1016/j.cell.2006.10.018; Mosser DM, 2008, NAT REV IMMUNOL, V8, P958, DOI 10.1038/nri2448; Brault V, 2001, DEVELOPMENT, V128, P1253; Yeo EJ, 2014, CANCER RES, V74, P2962, DOI 10.1158/0008-5472.CAN-13-2421; Biswas SK, 2006, BLOOD, V107, P2112, DOI 10.1182/blood-2005-01-0428; Bonta PI, 2010, CARDIOVASC RES, V87, P561, DOI 10.1093/cvr/cvq064; Shagdarsuren E, 2008, CIRCULATION, V117, P70, DOI 10.1161/CIRCULATIONAHA.107.715649; HADRAVA V, 1991, AM HEART J, V122, P1198, DOI 10.1016/0002-8703(91)90939-F; Itaranta P, 2006, DEV BIOL, V293, P473, DOI 10.1016/j.ydbio.2006.02.019; Willert K, 2012, CSH PERSPECT BIOL, V4, DOI 10.1101/cshperspect.a007864; SCHWARTZ SM, 1986, CIRC RES, V58, P427; SCOTTBURDEN T, 1989, HYPERTENSION, V13, P295	41	3	3	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	2041-1723			NAT COMMUN	Nat. Commun.	FEB	2015	6								6241	10.1038/ncomms7241		12	Multidisciplinary Sciences	Science & Technology - Other Topics	CC2VI	WOS:000350202400005		
J	Tanaka, K; Caaveiro, JMM; Morante, K; Gonzalez-Manas, JM; Tsumoto, K				Tanaka, Koji; Caaveiro, Jose M. M.; Morante, Koldo; Manuel Gonzalez-Manas, Juan; Tsumoto, Kouhei			Structural basis for self-assembly of a cytolytic pore lined by protein and lipid	NATURE COMMUNICATIONS			English	Article							SEA-ANEMONE; CRYSTAL-STRUCTURE; EQUINATOXIN-II; STICHOLYSIN-II; FORMING TOXIN; MEMBRANE-INSERTION; PHASE COEXISTENCE; MODEL MEMBRANES; BETA-BARREL; MECHANISM	Pore-forming toxins (PFT) are water-soluble proteins that possess the remarkable ability to self-assemble on the membrane of target cells, where they form pores causing cell damage. Here, we elucidate the mechanism of action of the haemolytic protein fragaceatoxin C (FraC), a alpha-barrel PFT, by determining the crystal structures of FraC at four different stages of the lytic mechanism, namely the water-soluble state, the monomeric lipid-bound form, an assembly intermediate and the fully assembled transmembrane pore. The structure of the transmembrane pore exhibits a unique architecture composed of both protein and lipids, with some of the lipids lining the pore wall, acting as assembly cofactors. The pore also exhibits lateral fenestrations that expose the hydrophobic core of the membrane to the aqueous environment. The incorporation of lipids from the target membrane within the structure of the pore provides a membrane-specific trigger for the activation of a haemolytic toxin.	[Tanaka, Koji; Tsumoto, Kouhei] Univ Tokyo, Sch Engn, Dept Chem & Biotechnol, Bunkyo Ku, Tokyo 1138656, Japan; [Caaveiro, Jose M. M.; Morante, Koldo; Tsumoto, Kouhei] Univ Tokyo, Sch Engn, Dept Bioengn, Bunkyo Ku, Tokyo 1138656, Japan; [Morante, Koldo; Manuel Gonzalez-Manas, Juan] Univ Basque Country, Dept Biochem & Mol Biol, Lejona 48940, Vizcaya, Spain; [Tsumoto, Kouhei] Univ Tokyo, Inst Med Sci, Lab Med Prote, Tokyo 1088639, Japan	Caaveiro, JMM (reprint author), Univ Tokyo, Sch Engn, Dept Bioengn, Bunkyo Ku, Tokyo 1138656, Japan.	jose@bioeng.t.u-tokyo.ac.jp; tsumoto@bioeng.t.u-tokyo.ac.jp	Caaveiro, Jose M.M./J-2790-2013	Caaveiro, Jose M.M./0000-0001-5568-2369	JSPS, Japan [25249115]; Platform for Drug Discovery, Informatics and Structural Life Science (MEXT), Japan	We thank the staff of the Photon factory for excellent technical support. Access to beamlines BL-5A, AR-NW12 and AR-NE3A was granted by the Photon Factory Advisory Committee (Proposals 2011G574, 2012G191 and 2013G738). We appreciate expert advice from Mr Takeru Chigira (The University of Tokyo) during preparation of Fig. 6. This work was supported by Project 25249115 (JSPS) and by the Platform for Drug Discovery, Informatics and Structural Life Science (MEXT), both from Japan. KT was supported by a grant-in-aid for JSPS fellows.	Alegre-Cebollada J, 2008, J MOL BIOL, V382, P920, DOI 10.1016/j.jmb.2008.07.053; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; Krissinel E, 2007, J MOL BIOL, V372, P774, DOI 10.1016/j.jmb.2007.05.022; Anderluh G, 2003, J BIOL CHEM, V278, P45216, DOI 10.1074/jbc.M305916200; Payandeh J, 2011, NATURE, V475, P353, DOI 10.1038/nature10238; Iacovache I, 2010, CURR OPIN STRUC BIOL, V20, P241, DOI 10.1016/j.sbi.2010.01.013; Hong Q, 2002, J BIOL CHEM, V277, P41916, DOI 10.1074/jbc.M204625200; Kristan K, 2004, J BIOL CHEM, V279, P46509, DOI 10.1074/jbc.M406193200; Olson R, 1999, NAT STRUCT BIOL, V6, P134; Stewart PDS, 2011, CRYST GROWTH DES, V11, P3432, DOI 10.1021/cg2001442; Song LZ, 1996, SCIENCE, V274, P1859, DOI 10.1126/science.274.5294.1859; Sato TK, 2013, NAT CHEM BIOL, V9, P383, DOI 10.1038/nchembio.1228; Schon P, 2008, BIOPHYS J, V95, P691, DOI 10.1529/biophysj.108.129981; Yamashita K, 2011, P NATL ACAD SCI USA, V108, P17314, DOI 10.1073/pnas.1110402108; Tilley SJ, 2005, CELL, V121, P247, DOI 10.1016/j.cell.2005.02.033; Anderluh G, 2008, TRENDS BIOCHEM SCI, V33, P482, DOI 10.1016/j.tibs.2008.07.004; Degiacomi MT, 2013, NAT CHEM BIOL, V9, P623, DOI [10.1038/nchembio.1312, 10.1038/NCHEMBIO.1312]; Frazao B, 2012, MAR DRUGS, V10, P1812, DOI 10.3390/md10081812; Schuttelkopf AW, 2004, ACTA CRYSTALLOGR D, V60, P1355, DOI 10.1107/S0907444904011679; Barlic A, 2004, J BIOL CHEM, V279, P34209, DOI 10.1074/jbc.M313817200; Rosado CJ, 2007, SCIENCE, V317, P1548, DOI 10.1126/science.1144706; Nieva JL, 2012, NAT REV MICROBIOL, V10, P563, DOI 10.1038/nrmicro2820; Thompson JR, 2011, BIOPHYS J, V101, P2679, DOI 10.1016/j.bpj.2011.09.054; Iacovache I, 2008, BBA-BIOMEMBRANES, V1778, P1611, DOI 10.1016/j.bbamem.2008.01.026; Geny B, 2006, BIOL CELL, V98, P667, DOI 10.1042/BC20050082; BARTLETT GR, 1959, J BIOL CHEM, V234, P466; Kawate T, 2009, NATURE, V460, P592, DOI 10.1038/nature08198; Berman HM, 2000, NUCLEIC ACIDS RES, V28, P235, DOI 10.1093/nar/28.1.235; Valcarcel CA, 2001, BIOPHYS J, V80, P2761; Gonzalez MR, 2008, CELL MOL LIFE SCI, V65, P493, DOI 10.1007/s00018-007-7434-y; De S, 2011, P NATL ACAD SCI USA, V108, P7385, DOI 10.1073/pnas.1017442108; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; Dunstone MA, 2012, CURR OPIN STRUC BIOL, V22, P342, DOI 10.1016/j.sbi.2012.04.008; ELLENS H, 1985, BIOCHEMISTRY-US, V24, P3099, DOI 10.1021/bi00334a005; Bakrac B, 2008, J BIOL CHEM, V283, P18665, DOI 10.1074/jbc.M708747200; Kintzer AF, 2009, J MOL BIOL, V392, P614, DOI 10.1016/j.jmb.2009.07.037; Mueller M, 2009, NATURE, V459, P726, DOI 10.1038/nature08026; EISENBERG D, 1984, J MOL BIOL, V179, P125, DOI 10.1016/0022-2836(84)90309-7; Lee AG, 2003, BBA-BIOMEMBRANES, V1612, P1, DOI 10.1016/S0005-2736(03)00056-7; Bellomio A, 2009, TOXICON, V54, P869, DOI 10.1016/j.toxicon.2009.06.022; Caaveiro JMM, 1998, PROTEIN SCI, V7, P2567; Caaveiro JMM, 2001, BIOPHYS J, V80, P1343; D'Arcy A, 2007, ACTA CRYSTALLOGR D, V63, P550, DOI 10.1107/S0907444907007652; Eifler N, 2006, EMBO J, V25, P2652, DOI 10.1038/sj.emboj.7601130; Garcia-Ortega L, 2011, BBA-BIOMEMBRANES, V1808, P2275, DOI 10.1016/j.bbamem.2011.05.012; LASKOWSKI RA, 1993, J APPL CRYSTALLOGR, V26, P283, DOI 10.1107/S0021889892009944; MACEK P, 1988, TOXICON, V26, P441, DOI 10.1016/0041-0101(88)90183-3; Mancheno JM, 2003, STRUCTURE, V11, P1319, DOI 10.1016/j.str.2003.09.019; Maula T, 2013, BBA-BIOMEMBRANES, V1828, P1390, DOI 10.1016/j.bbamem.2013.01.018; Mechaly AE, 2012, J STRUCT BIOL, V180, P312, DOI 10.1016/j.jsb.2012.06.003; Mechaly AE, 2011, STRUCTURE, V19, P181, DOI 10.1016/j.str.2010.11.013; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Veesler D, 2009, ANAL BIOCHEM, V388, P115, DOI 10.1016/j.ab.2009.02.018; Wohri AB, 2008, STRUCTURE, V16, P1003, DOI 10.1016/j.str.2008.06.003	54	7	7	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	2041-1723			NAT COMMUN	Nat. Commun.	FEB	2015	6								6337	10.1038/ncomms7337		11	Multidisciplinary Sciences	Science & Technology - Other Topics	CC4AE	WOS:000350292000001		
J	Taychatanapat, T; Tan, JY; Yeo, Y; Watanabe, K; Taniguchi, T; Ozyilmaz, B				Taychatanapat, Thiti; Tan, Jun You; Yeo, Yuting; Watanabe, Kenji; Taniguchi, Takashi; Oezyilmaz, Barbaros			Conductance oscillations induced by ballistic snake states in a graphene heterojunction	NATURE COMMUNICATIONS			English	Article							SCANNING-TUNNELING-MICROSCOPY; P-N-JUNCTIONS; MAGNETIC-FIELD; BORON-NITRIDE; TRANSPORT	The realization of p-n junctions in graphene, combined with the gapless and chiral nature of its massless Dirac fermions has led to the observation of many intriguing phenomena such as the quantum Hall effect in the bipolar regime, Klein tunnelling and Fabry-Perot interferences, all of which involve electronic transport across p-n junctions. Ballistic snake states propagating along the p-n junctions have been predicted to induce conductance oscillations, manifesting their twisting nature. However, transport studies along p-n junctions have so far only been performed in low mobility devices. Here, we report the observation of conductance oscillations due to ballistic snake states along a p-n interface in high-quality graphene encapsulated by hexagonal boron nitride. These snake states are exceptionally robust as they can propagate over 12 mu m, limited only by the size of our sample, and survive up to at least 120 K. The ability to guide carriers over a long distance provide a crucial building block for graphene-based electron optics.	[Taychatanapat, Thiti; Tan, Jun You; Yeo, Yuting; Oezyilmaz, Barbaros] Natl Univ Singapore, Graphene Res Ctr, Singapore 117542, Singapore; [Taychatanapat, Thiti; Tan, Jun You; Yeo, Yuting; Oezyilmaz, Barbaros] Natl Univ Singapore, Dept Phys, Singapore 117542, Singapore; [Watanabe, Kenji; Taniguchi, Takashi] Natl Inst Mat Sci, Tsukuba, Ibaraki 3050044, Japan; [Oezyilmaz, Barbaros] Natl Univ Singapore, NanoCore, Singapore 117576, Singapore	Ozyilmaz, B (reprint author), Natl Univ Singapore, Graphene Res Ctr, Singapore 117542, Singapore.	phyob@nus.edu.sg	WATANABE, Kenji/H-2825-2011; Oezyilmaz, Barbaros/G-1683-2012	WATANABE, Kenji/0000-0003-3701-8119; Oezyilmaz, Barbaros/0000-0001-7665-4578	National Research Foundation, Prime Minister's Office, Singapore under its Competitive Research Programme (CRP) [NRF-CRP9-2011-3]; SMF-NUS Research Horizons Award	We thank L. Levitov, J. Martin and I.J. Vera Marun for discussions, A. Avsar, E.C.T. O'Farrell and J. Wu for experimental help. B.O. acknowledges the support by the National Research Foundation, Prime Minister's Office, Singapore under its Competitive Research Programme (CRP Award No. NRF-CRP9-2011-3) and the SMF-NUS Research Horizons Award 2009-Phase II.	MULLER JE, 1992, PHYS REV LETT, V68, P385, DOI 10.1103/PhysRevLett.68.385; Abanin DA, 2007, SCIENCE, V317, P641, DOI 10.1126/science.1144672; Milovanovic SP, 2013, APPL PHYS LETT, V103, DOI 10.1063/1.4838557; Katsnelson MI, 2006, NAT PHYS, V2, P620, DOI 10.1038/nphys384; Zhang LM, 2008, PHYS REV LETT, V100, DOI 10.1103/PhysRevLett.100.116804; Ghosh TK, 2008, PHYS REV B, V77, DOI 10.1103/PhysRevB.77.081404; Gu N, 2011, PHYS REV LETT, V106, DOI 10.1103/PhysRevLett.106.066601; Taychatanapat T, 2013, NAT PHYS, V9, P225, DOI [10.1038/nphys2549, 10.1038/NPHYS2549]; Davies N, 2012, PHYS REV B, V85, DOI 10.1103/PhysRevB.85.155433; Mayorov AS, 2011, NANO LETT, V11, P2396, DOI 10.1021/nl200758b; Beenakker CWJ, 2008, REV MOD PHYS, V80, P1337, DOI 10.1103/RevModPhys.80.1337; Shytov AV, 2008, PHYS REV LETT, V101, DOI 10.1103/PhysRevLett.101.156804; Williams JR, 2011, NAT NANOTECHNOL, V6, P222, DOI 10.1038/nnano.2011.3; Xue JM, 2011, NAT MATER, V10, P282, DOI [10.1038/nmat2968, 10.1038/NMAT2968]; Calado VE, 2014, APPL PHYS LETT, V104, DOI 10.1063/1.4861627; Cheianov VV, 2006, PHYS REV B, V74, DOI 10.1103/PhysRevB.74.041403; Amet F, 2014, PHYS REV LETT, V112, DOI 10.1103/PhysRevLett.112.196601; Wang L, 2013, SCIENCE, V342, P614, DOI 10.1126/science.1244358; Ozyilmaz B, 2007, PHYS REV LETT, V99, DOI 10.1103/PhysRevLett.99.166804; Williams JR, 2007, SCIENCE, V317, P638, DOI 10.1126/science.1144657; Zarenia M, 2013, PHYS REV B, V87, DOI 10.1103/PhysRevB.87.035426; Patel AA, 2012, PHYS REV B, V86, DOI 10.1103/PhysRevB.86.081413; Tan JY, 2014, APPL PHYS LETT, V104, DOI 10.1063/1.4872178; Goossens AM, 2012, APPL PHYS LETT, V100, DOI 10.1063/1.3685504; Milovanovic SP, 2014, J APPL PHYS, V115, DOI 10.1063/1.4863403; Cheianov VV, 2007, SCIENCE, V315, P1252, DOI 10.1126/science.1138020; Nogaret A, 2000, PHYS REV LETT, V84, P2231, DOI 10.1103/PhysRevLett.84.2231; Oroszlany L, 2008, PHYS REV B, V77, DOI 10.1103/PhysRevB.77.081403; Dean CR, 2010, NAT NANOTECHNOL, V5, P722, DOI 10.1038/nnano.2010.172; Carmier P, 2010, PHYS REV B, V81, DOI 10.1103/PhysRevB.81.241406; Milovanovic SP, 2014, APPL PHYS LETT, V105, DOI 10.1063/1.4896769; Decker R, 2011, NANO LETT, V11, P2291, DOI 10.1021/nl2005115; Low T, 2009, PHYS REV B, V80, DOI 10.1103/PhysRevB.80.205423; Williams JR, 2011, PHYS REV LETT, V107, DOI 10.1103/PhysRevLett.107.046602; Young AF, 2009, NAT PHYS, V5, P222, DOI 10.1038/NPHYS1198; Chen JC, 2012, PHYS REV B, V86, DOI 10.1103/PhysRevB.86.035429; VILMS PP, 1988, SOV PHYS SEMICOND+, V22, P1209	37	6	6	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	2041-1723			NAT COMMUN	Nat. Commun.	FEB	2015	6								6093	10.1038/ncomms7093		6	Multidisciplinary Sciences	Science & Technology - Other Topics	CC2TF	WOS:000350196800001		
J	Parrondo, JMR; Horowitz, JM; Sagawa, T				Parrondo, Juan M. R.; Horowitz, Jordan M.; Sagawa, Takahiro			Thermodynamics of information	NATURE PHYSICS			English	Review							2ND LAW; MAXWELLS DEMON; JARZYNSKI EQUALITY; MUTUAL INFORMATION; SYMMETRY-BREAKING; EQUILIBRIUM; ENERGETICS; PRINCIPLE; FEEDBACK; ENTROPY	By its very nature, the second law of thermodynamics is probabilistic, in that its formulation requires a probabilistic description of the state of a system. This raises questions about the objectivity of the second law: does it depend, for example, on what we know about the system? For over a century, much effort has been devoted to incorporating information into thermodynamics and assessing the entropic and energetic costs of manipulating information. More recently, this historically theoretical pursuit has become relevant in practical situations where information is manipulated at small scales, such as in molecular and cell biology, artificial nano-devices or quantum computation. Here we give an introduction to a novel theoretical framework for the thermodynamics of information based on stochastic thermodynamics and fluctuation theorems, review some recent experimental results, and present an overview of the state of the art in the field.	[Parrondo, Juan M. R.] Univ Complutense Madrid, Dept Fis Atom Mol & Nucl, E-28040 Madrid, Spain; [Parrondo, Juan M. R.] Univ Complutense Madrid, GISC, E-28040 Madrid, Spain; [Horowitz, Jordan M.] Univ Massachusetts, Dept Phys, Boston, MA 02125 USA; [Sagawa, Takahiro] Univ Tokyo, Dept Basic Sci, Tokyo 1538902, Japan	Parrondo, JMR (reprint author), Univ Complutense Madrid, Dept Fis Atom Mol & Nucl, E-28040 Madrid, Spain.	parrondo@fis.ucm.es	Parrondo, Juan MR/A-4228-2010; Horowitz, Jordan/C-6754-2009	Parrondo, Juan MR/0000-0001-8525-3709; Horowitz, Jordan/0000-0002-9139-0811	COST Action [MP1209]; Spanish MINECO Grant ENFASIS [FIS2011-22644]; ARO MURI [W911NF-11-1-0268]; JSPS KAKENHI [22340114, 25800217]	This work was partially supported by the COST Action MP1209 'Thermodynamics in the quantum regime J.M.R.P. is supported financially by the Spanish MINECO Grant ENFASIS (FIS2011-22644). J.M.H. is supported financially by the ARO MURI grant W911NF-11-1-0268. T.S. is supported financially by JSPS KAKENHI Grants No. 22340114 and No. 25800217.	Abreu D, 2011, EPL-EUROPHYS LETT, V94, DOI 10.1209/0295-5075/94/10001; Allahverdyan AE, 2009, J STAT MECH-THEORY E, DOI 10.1088/1742-5468/2009/09/P09011; Funo K, 2013, PHYS REV A, V88, DOI 10.1103/PhysRevA.88.052319; Roldan E, 2014, NAT PHYS, V10, P457, DOI [10.1038/nphys2940, 10.1038/NPHYS2940]; Maruyama K, 2009, REV MOD PHYS, V81, P1, DOI 10.1103/RevModPhys.81.1; BENNETT CH, 1979, BIOSYSTEMS, V11, P85, DOI 10.1016/0303-2647(79)90003-0; Still S, 2012, PHYS REV LETT, V109, DOI 10.1103/PhysRevLett.109.120604; Sagawa T, 2008, PHYS REV LETT, V100, DOI 10.1103/PhysRevLett.100.080403; BENNETT CH, 1982, INT J THEOR PHYS, V21, P905, DOI 10.1007/BF02084158; Barato AC, 2014, PHYS REV LETT, V112, DOI 10.1103/PhysRevLett.112.090601; Andrieux D, 2008, P NATL ACAD SCI USA, V105, P9516, DOI 10.1073/pnas.0802049105; Sagawa T, 2012, PHYS REV E, V85, DOI 10.1103/PhysRevE.85.021104; Horowitz JM, 2013, PHYS REV LETT, V111, DOI 10.1103/PhysRevLett.111.010602; Takara K, 2010, PHYS LETT A, V375, P88, DOI 10.1016/j.physleta.2010.11.002; Mandal D, 2013, PHYS REV LETT, V111, DOI 10.1103/PhysRevLett.111.030602; Sagawa T, 2009, PHYS REV LETT, V102, DOI 10.1103/PhysRevLett.102.250602; Deffner S, 2013, PHYS REV E, V88, DOI 10.1103/PhysRevE.88.062128; Barato AC, 2013, J STAT PHYS, V153, P460, DOI 10.1007/s10955-013-0834-5; Koski JV, 2014, PHYS REV LETT, V113, DOI 10.1103/PhysRevLett.113.030601; Seifert U, 2012, REP PROG PHYS, V75, DOI 10.1088/0034-4885/75/12/126001; Sartori P, 2013, PHYS REV LETT, V110, DOI 10.1103/PhysRevLett.110.188101; Reimann P, 2002, PHYS REP, V361, P57, DOI 10.1016/S0370-1573(01)00081-3; Deffner S, 2013, PHYS REV X, V3, DOI 10.1103/PhysRevX.3.041003; HOPFIELD JJ, 1974, P NATL ACAD SCI USA, V71, P4135, DOI 10.1073/pnas.71.10.4135; Ito S, 2013, PHYS REV LETT, V111, DOI 10.1103/PhysRevLett.111.180603; Jun Y, 2014, PHYS REV LETT, V113, DOI 10.1103/PhysRevLett.113.190601; Hasegawa HH, 2010, PHYS LETT A, V374, P1001, DOI 10.1016/j.physleta.2009.12.042; LANDAUER R, 1991, PHYS TODAY, V44, P23, DOI 10.1063/1.881299; Dillenschneider R, 2009, PHYS REV LETT, V102, DOI 10.1103/PhysRevLett.102.210601; Zurek WH, 2003, PHYS REV A, V67, DOI 10.1103/PhysRevA.67.012320; Serreli V, 2007, NATURE, V445, P523, DOI 10.1038/nature05452; Toyabe S, 2010, NAT PHYS, V6, P988, DOI [10.1038/nphys1821, 10.1038/NPHYS1821]; Ponmurugan M, 2010, PHYS REV E, V82, DOI 10.1103/PhysRevE.82.031129; Fujitani Y, 2010, J PHYS SOC JPN, V79, DOI 10.1143/JPSJ.79.104003; Albash T, 2013, PHYS REV E, V88, DOI 10.1103/PhysRevE.88.032146; Depken M, 2013, CELL REP, V5, P521, DOI 10.1016/j.celrep.2013.09.007; Mandal D, 2012, P NATL ACAD SCI USA, V109, P11641, DOI 10.1073/pnas.1204263109; Abreu D, 2012, PHYS REV LETT, V108, DOI 10.1103/PhysRevLett.108.030601; Sagawa T, 2010, PHYS REV LETT, V104, DOI 10.1103/PhysRevLett.104.090602; Barato AC, 2014, PHYS REV E, V90, DOI 10.1103/PhysRevE.90.042150; Barato AC, 2014, NEW J PHYS, V16, DOI 10.1088/1367-2630/16/10/103024; Barato AC, 2013, EPL-EUROPHYS LETT, V101, DOI 10.1209/0295-5075/101/60001; Bauer M, 2012, J PHYS A-MATH THEOR, V45, DOI 10.1088/1751-8113/45/16/162001; Berut A, 2013, EPL-EUROPHYS LETT, V103, DOI 10.1209/0295-5075/103/60002; Berut A., 2011, NATURE, V483, P187; Callen H B, 1985, THERMODYNAMICS INTRO; Cao FJ, 2009, PHYS REV E, V79, DOI 10.1103/PhysRevE.79.041118; Cover T. M., 2006, ELEMENTS INFORM THEO; Deffner S., 2012, PREPRINT; Diana G, 2013, PHYS REV E, V87, DOI 10.1103/PhysRevE.87.012111; Esposito M, 2012, EPL-EUROPHYS LETT, V99, DOI 10.1209/0295-5075/99/30003; Esposito M, 2011, EPL-EUROPHYS LETT, V95, DOI 10.1209/0295-5075/95/40004; Feynman R. P., 1966, FEYNMAN LECT PHYS, VI, P46; Funo K, 2013, PHYS REV E, V88, DOI 10.1103/PhysRevE.88.052121; Gaveau B, 1997, PHYS LETT A, V229, P347, DOI 10.1016/S0375-9601(97)00185-0; Granger L, 2011, PHYS REV E, V84, DOI 10.1103/PhysRevE.84.061110; Hartich D, 2014, J STAT MECH-THEORY E, DOI 10.1088/1742-5468/2014/02/P02016; Hoppenau J, 2014, EPL-EUROPHYS LETT, V105, DOI 10.1209/0295-5075/105/50002; Horowitz JM, 2010, PHYS REV E, V82, DOI 10.1103/PhysRevE.82.061120; Horowitz JM, 2014, PHYS REV X, V4, DOI 10.1103/PhysRevX.4.031015; Horowitz JM, 2014, NEW J PHYS, V16, DOI 10.1088/1367-2630/16/12/125007; Horowitz JM, 2013, ACTA PHYS POL B, V44, P803, DOI 10.5506/APhysPolB.44.803; Horowitz JM, 2011, NEW J PHYS, V13, DOI 10.1088/1367-2630/13/12/123019; Ito S., 2014, PREPRINT; Jacobs K, 2009, PHYS REV A, V80, DOI 10.1103/PhysRevA.80.012322; Jarzynski C, 2008, P NATL ACAD SCI USA, V105, P9451, DOI 10.1073/pnas.0805209105; Jarzynski C, 2011, ANNU REV CONDEN MA P, V2, P329, DOI 10.1146/annurev-conmatphys-062910-140506; Kim SW, 2011, PHYS REV LETT, V106, DOI 10.1103/PhysRevLett.106.070401; Landauer R., 1990, MAXWELLS DEMON ENTRO; LLOYD S, 1989, PHYS REV A, V39, P5378, DOI 10.1103/PhysRevA.39.5378; Mlodinow L, 2014, PHYS REV E, V89, DOI 10.1103/PhysRevE.89.052102; Morkuni Y., 2011, J STAT PHYS, V143, P1; Murugan A, 2014, PHYS REV X, V4, DOI 10.1103/PhysRevX.4.021016; Park JJ, 2013, PHYS REV LETT, V111, DOI 10.1103/PhysRevLett.111.230402; Parrondo JMR, 2001, CHAOS, V11, P725, DOI 10.1063/1.1388006; Penrose O., 1970, FDN STAT MECH DEDUCT; Plenio MB, 2001, CONTEMP PHYS, V42, P25, DOI 10.1080/00107510010018916; Rex AF, 1990, MAXWELLS DEMON ENTRO; Sagawa T, 2012, PHYS REV LETT, V109, DOI 10.1103/PhysRevLett.109.180602; Sagawa T, 2014, J STAT MECH-THEORY E, DOI 10.1088/1742-5468/2014/03/P03025; Sagawa T., 2013, INFORM THERMODYNAMIC, P181; Sagawa T, 2013, NEW J PHYS, V15, DOI 10.1088/1367-2630/15/12/125012; Sagawa T., 2012, THERMODYNAMICS INFOR; Sandberg H, 2014, PHYS REV E, V90, DOI 10.1103/PhysRevE.90.042119; Sartori P, 2014, PLOS COMPUT BIOL, V10, DOI 10.1371/journal.pcbi.1003974; Harris RJ, 2007, J STAT MECH-THEORY E, DOI 10.1088/1742-5468/2007/07/P07020; Sekimoto K., 2010, LECT NOTES PHYS; Shiraishi N, 2015, PHYS REV E, V91, DOI 10.1103/PhysRevE.91.012130; Szilard L, 1990, MAXWELLS DEMON ENTRO; Tasaki H., 2013, PREPRINT; von Smoluchowski M, 1912, PHYS Z, V13, P1069; Zulkowski PR, 2014, PHYS REV E, V89, DOI 10.1103/PhysRevE.89.052140; Zurek W., 1990, MAXWELLS DEMON ENTRO	93	22	22	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1745-2473	1745-2481		NAT PHYS	Nat. Phys.	FEB	2015	11	2					131	139		10.1038/NPHYS3230		9	Physics, Multidisciplinary	Physics	CB9EL	WOS:000349934700016		
J	Huntington, CM; Fiuza, F; Ross, JS; Zylstra, AB; Drake, RP; Froula, DH; Gregori, G; Kugland, NL; Kuranz, CC; Levy, MC; Li, CK; Meinecke, J; Morita, T; Petrasso, R; Plechaty, C; Remington, BA; Ryutov, DD; Sakawa, Y; Spitkovsky, A; Takabe, H; Park, HS				Huntington, C. M.; Fiuza, F.; Ross, J. S.; Zylstra, A. B.; Drake, R. P.; Froula, D. H.; Gregori, G.; Kugland, N. L.; Kuranz, C. C.; Levy, M. C.; Li, C. K.; Meinecke, J.; Morita, T.; Petrasso, R.; Plechaty, C.; Remington, B. A.; Ryutov, D. D.; Sakawa, Y.; Spitkovsky, A.; Takabe, H.; Park, H. -S.			Observation of magnetic field generation via the Weibel instability in interpenetrating plasma flows	NATURE PHYSICS			English	Article							RELATIVISTIC COLLISIONLESS SHOCKS; ELECTRON-ION PLASMAS; ACCELERATION; AFTERGLOW; WAVES	Collisionless shocks can be produced as a result of strong magnetic fields in a plasma flow, and therefore are common in many astrophysical systems. The Weibel instability is one candidate mechanism for the generation of sufficiently strong fields to create a collisionless shock. Despite their crucial role in astrophysical systems, observation of the magnetic fields produced by Weibel instabilities in experiments has been challenging. Using a proton probe to directly image electromagnetic fields, we present evidence of Weibel-generated magnetic fields that grow in opposing, initially unmagnetized plasma flows from laser-driven laboratory experiments. Three-dimensional particle-in-cell simulations reveal that the instability efficiently extracts energy from the plasma flows, and that the self-generated magnetic energy reaches a few percent of the total energy in the system. This result demonstrates an experimental platform suitable for the investigation of a wide range of astrophysical phenomena, including collisionless shock formation in supernova remnants, large-scale magnetic field amplification, and the radiation signature from gamma-ray bursts.	[Huntington, C. M.; Fiuza, F.; Ross, J. S.; Levy, M. C.; Plechaty, C.; Remington, B. A.; Ryutov, D. D.; Park, H. -S.] Lawrence Livermore Natl Lab, Livermore, CA 94550 USA; [Zylstra, A. B.; Li, C. K.; Petrasso, R.] MIT, Cambridge, MA 02139 USA; [Drake, R. P.; Kuranz, C. C.] Univ Michigan, Dept Atmospher Ocean & Space Sci, Ann Arbor, MI 48109 USA; [Froula, D. H.] Univ Rochester, Dept Phys, Rochester, NY 14636 USA; [Froula, D. H.] Univ Rochester, Laser Energet Lab, Rochester, NY 14636 USA; [Gregori, G.; Meinecke, J.] Univ Oxford, Dept Phys, Oxford OX1 3PU, England; [Kugland, N. L.] Lam Res Corp, Fremont, CA 94538 USA; [Morita, T.; Sakawa, Y.; Takabe, H.] Osaka Univ, Inst Laser Engn, Suita, Osaka 5650871, Japan; [Spitkovsky, A.] Princeton Univ, Dept Astrophys Sci, Princeton, NJ 08544 USA	Huntington, CM (reprint author), Lawrence Livermore Natl Lab, Livermore, CA 94550 USA.	huntington4@llnl.gov			US Department of Energy by the Lawrence Livermore National Laboratory [DE-AC52-07NA27344]; LLNL LDRD grant [11-ERD-054]; European Research Council under the European Community's Seventh Framework Programme (FP7), ERC grant [256973]; ALCF [DE-AC02-06CH11357]; LLNL Lawrence Fellowship; DOE [DE-NA0002200]	We thank the staff of the Omega Laser Facility for their experimental support. This work was performed under the auspices of the US Department of Energy by the Lawrence Livermore National Laboratory, under Contract No. DE-AC52-07NA27344, with funding support from LLNL LDRD grant No. 11-ERD-054 and from the European Research Council under the European Community's Seventh Framework Programme (FP7/2007-2013), ERC grant agreement no. 256973. Computing support for this work came from ALCC and INCITE awards on Mira (ALCF supported under contract DE-AC02-06CH11357) and from the LLNL Institutional Computing Grand Challenge program on Vulcan. Additionally, the authors would like to acknowledge the OSIRIS Consortium, consisting of UCLA and IST (Lisbon, Portugal) for the use of the OSIRIS 2.0 framework and the visXD framework. F.F. acknowledges the LLNL Lawrence Fellowship for financial support. A.S. is supported by DOE grant DE-NA0002200.	Gruzinov A, 1999, ASTROPHYS J, V511, P852, DOI 10.1086/306720; BOEHLY TR, 1995, REV SCI INSTRUM, V66, P508, DOI 10.1063/1.1146333; Bernet ML, 2008, NATURE, V454, P302, DOI 10.1038/nature07105; Ross JS, 2012, PHYS PLASMAS, V19, DOI 10.1063/1.3694124; Lazar M, 2009, ASTROPHYS J, V693, P1133, DOI 10.1088/0004-637X/693/2/1133; Gregori G, 2012, NATURE, V481, P480, DOI 10.1038/nature10747; Fonseca RA, 2008, PLASMA PHYS CONTR F, V50, DOI 10.1088/0741-3335/50/12/124034; Medvedev MV, 1999, ASTROPHYS J, V526, P697, DOI 10.1086/308038; Ryutov DD, 2012, PLASMA PHYS CONTR F, V54, DOI 10.1088/0741-3335/54/10/105021; WEIBEL ES, 1959, PHYS REV LETT, V2, P83, DOI 10.1103/PhysRevLett.2.83; Ross JS, 2013, PHYS REV LETT, V110, DOI 10.1103/PhysRevLett.110.145005; Kugland NL, 2012, NAT PHYS, V8, P809, DOI [10.1038/nphys2434, 10.1038/NPHYS2434]; Spitkovsky A, 2008, ASTROPHYS J LETT, V673, pL39, DOI 10.1086/527374; Frail DA, 2000, ASTROPHYS J, V537, P191, DOI 10.1086/309024; Kato TN, 2008, ASTROPHYS J LETT, V681, pL93, DOI 10.1086/590387; Spitkovsky A, 2008, ASTROPHYS J LETT, V682, pL5, DOI 10.1086/590248; Fonseca R., 2002, COMP SCI ICCS 202 2, V2331, P342, DOI 10.1007/3-540-47789-6_36; Fox W, 2013, PHYS REV LETT, V111, DOI 10.1103/PhysRevLett.111.225002; Kato TN, 2010, PHYS PLASMAS, V17, DOI 10.1063/1.3372138; Kugland NL, 2013, PHYS PLASMAS, V20, DOI 10.1063/1.4804548; Martins SF, 2009, ASTROPHYS J LETT, V695, pL189, DOI 10.1088/0004-637X/695/2/L189; Medvedev MV, 2006, ASTROPHYS J, V651, pL9, DOI 10.1086/509075; MEDVEDEV MIKHAIL V., 2004, Journal of the Korean Astronomical Society, V37, P533; Moiseev S.S., 1963, Journal of Nuclear Energy. C. Plasma Physics, Accelerators, Thermonuclear Research, V5, DOI 10.1088/0368-3281/5/1/309; Ryutov DD, 2014, PHYS PLASMAS, V21, DOI 10.1063/1.4867062; Ryutov DD, 2013, PHYS PLASMAS, V20, DOI 10.1063/1.4794200; Schoeffler KM, 2014, PHYS REV LETT, V112, DOI 10.1103/PhysRevLett.112.175001; Takabe H, 2008, PLASMA PHYS CONTR F, V50, DOI 10.1088/0741-3335/50/12/124057	28	21	21	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1745-2473	1745-2481		NAT PHYS	Nat. Phys.	FEB	2015	11	2					173	176		10.1038/NPHYS3178		4	Physics, Multidisciplinary	Physics	CB9EL	WOS:000349934700023		
J	Allan, MP; Lee, K; Rost, AW; Fischer, MH; Massee, F; Kihou, K; Lee, CH; Iyo, A; Eisaki, H; Chuang, TM; Davis, JC; Kim, EA				Allan, M. P.; Lee, Kyungmin; Rost, A. W.; Fischer, M. H.; Massee, F.; Kihou, K.; Lee, C-H.; Iyo, A.; Eisaki, H.; Chuang, T-M.; Davis, J. C.; Kim, Eun-Ah			Identifying the 'fingerprint' of antiferromagnetic spin fluctuations in iron pnictide superconductors	NATURE PHYSICS			English	Article								Cooper pairing in the iron-based high-T-c superconductors(1-3) is often conjectured to involve bosonic fluctuations. Among the candidates are antiferromagnetic spin fluctuations(1,4,5) and d-orbital fluctuations amplified by phonons(6,7). Any such electron-boson interaction should alter the electron's 'self-energy', and then become detectable through consequent modifications in the energy dependence of the electron's momentum and lifetime(8-10). Here we introduce a novel theoretical/experimental approach aimed at uniquely identifying the relevant fluctuations of iron-based superconductors by measuring effects of their self-energy. We use innovative quasiparticle interference (QPI) imaging(11) techniques in LiFeAs to reveal strongly momentum-space anisotropic self-energy signatures that are focused along the Fe-Fe (interband scattering) direction, where the spin fluctuations of LiFeAs are concentrated. These effects coincide in energy with perturbations to the density of states N(omega) usually associated with the Cooper pairing interaction. We show that all the measured phenomena comprise the predicted QPI 'fingerprint' of a self-energy due to antiferromagnetic spin fluctuations, thereby distinguishing them as the predominant electron-boson interaction.	[Allan, M. P.; Lee, Kyungmin; Rost, A. W.; Fischer, M. H.; Massee, F.; Davis, J. C.; Kim, Eun-Ah] Cornell Univ, Dept Phys, LASSP, Ithaca, NY 14853 USA; [Allan, M. P.; Massee, F.; Davis, J. C.] Brookhaven Natl Lab, CMPMS Dept, Upton, NY 11973 USA; [Rost, A. W.; Davis, J. C.] Univ St Andrews, Sch Phys & Astron, St Andrews KY16 9SS, Fife, Scotland; [Rost, A. W.] Univ Tokyo, Dept Phys, Bunkyo Ku, Tokyo 1130033, Japan; [Kihou, K.; Lee, C-H.; Iyo, A.; Eisaki, H.] Inst Adv Ind Sci & Technol, Tsukuba, Ibaraki 3058568, Japan; [Kihou, K.; Lee, C-H.; Iyo, A.; Eisaki, H.] JST, Transformat Res Project Iron Pnictides TRIP, Tokyo 1020075, Japan; [Chuang, T-M.] Acad Sinica, Inst Phys, Taipei 11529, Taiwan; [Davis, J. C.] Cornell Univ, Kavli Inst Cornell Nanoscale Sci, Ithaca, NY 14853 USA	Kim, EA (reprint author), Cornell Univ, Dept Phys, LASSP, Ithaca, NY 14853 USA.	eun-ah.kim@cornell.edu	Rost, Andreas/F-3004-2011; Lee, Kyungmin/L-5846-2015; Massee, Freek/N-2617-2015	Lee, Kyungmin/0000-0001-6018-4014; 	US Department of Energy, Office of Basic Energy Sciences, Division of Materials Science and Engineering [DE-SC0010313]; NSF [DMR-1120296]; NSF CAREER grant [DMR-0955822]; Center for Emergent Superconductivity, an Energy Frontier Research Center, headquartered at Brookhaven National Laboratory; US Department of Energy [DE-2009-BNL-PM015]; UK EPSRC; Japan Society for the Promotion of Science [22540380];  [NSC101-2112-M-001-029-MY3]	We are especially grateful to A. P. Mackenzie and D. J. Scalapino for key guidance with this project. We acknowledge and thank D. H. Lee, A. Chubukov, P. J. Hirschfeld, M. Norman and J. Schmalian for helpful discussions and communications. Theoretical studies are supported by the US Department of Energy, Office of Basic Energy Sciences, Division of Materials Science and Engineering under Award DE-SC0010313 (K.L. and E-A.K.); NSF DMR-1120296 to the Cornell Center for Materials Research and NSF CAREER grant DMR-0955822 (M.H.F.). Experimental studies are supported by the Center for Emergent Superconductivity, an Energy Frontier Research Center, headquartered at Brookhaven National Laboratory and funded by the US Department of Energy, under DE-2009-BNL-PM015; by the UK EPSRC; by a Grant-in-Aid for Scientific Research C (No. 22540380) from the Japan Society for the Promotion of Science. T-M.C. acknowledges support by NSC101-2112-M-001-029-MY3.	Shan L, 2012, PHYS REV LETT, V108, DOI 10.1103/PhysRevLett.108.227002; Umezawa K, 2012, PHYS REV LETT, V108, DOI 10.1103/PhysRevLett.108.037002; Wang F, 2011, SCIENCE, V332, P200, DOI 10.1126/science.1200182; Knolle J, 2012, PHYS REV B, V86, DOI 10.1103/PhysRevB.86.174519; Kontani H, 2010, PHYS REV LETT, V104, DOI 10.1103/PhysRevLett.104.157001; Allan MP, 2012, SCIENCE, V336, P563, DOI 10.1126/science.1218726; Eschrig H, 2009, PHYS REV B, V80, DOI 10.1103/PhysRevB.80.104503; Yang J, 2009, PHYS REV LETT, V102, DOI 10.1103/PhysRevLett.102.187003; Mazin II, 2008, PHYS REV LETT, V101, DOI 10.1103/PhysRevLett.101.057003; Shamoto S, 2010, PHYS REV B, V82, DOI 10.1103/PhysRevB.82.172508; Scalapino DJ, 2012, REV MOD PHYS, V84, P1383, DOI 10.1103/RevModPhys.84.1383; Choi KY, 2010, J PHYS-CONDENS MAT, V22, DOI 10.1088/0953-8984/22/11/115802; Hirschfeld PJ, 2011, REP PROG PHYS, V74, DOI 10.1088/0034-4885/74/12/124508; Qureshi N, 2012, PHYS REV LETT, V108, DOI 10.1103/PhysRevLett.108.117001; Chi S, 2012, PHYS REV LETT, V109, DOI 10.1103/PhysRevLett.109.087002; Kuroki K, 2008, PHYS REV LETT, V101, DOI 10.1103/PhysRevLett.101.087004; Borisenko SV, 2012, SYMMETRY-BASEL, V4, P251, DOI 10.3390/sym4010251; Cai P, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms2592; Dahm T, 2014, NEW J PHYS, V16, DOI 10.1088/1367-2630/16/2/023003; Fasano Y, 2010, PHYS REV LETT, V105, DOI 10.1103/PhysRevLett.105.167005; Hajiri T, 2012, PHYS REV B, V85, DOI 10.1103/PhysRevB.85.094509; Heimes A, 2011, PHYS REV LETT, V106, DOI 10.1103/PhysRevLett.106.047003; Heimes A, 2012, PHYS REV B, V86, DOI 10.1103/PhysRevB.86.064528; Koitzsch A, 2009, PHYS REV LETT, V102, DOI 10.1103/PhysRevLett.102.167001; Kordyuk AA, 2011, PHYS REV B, V83, DOI 10.1103/PhysRevB.83.134513; Marsiglio F., 2008, SUPERCONDUCTIVITY, V2; Richard P, 2009, PHYS REV LETT, V102, DOI 10.1103/PhysRevLett.102.047003; Stanescu TD, 2008, PHYS REV B, V78, DOI 10.1103/PhysRevB.78.195114; Taylor AE, 2011, PHYS REV B, V83, DOI 10.1103/PhysRevB.83.220514; Wang M, 2011, PHYS REV B, V83, DOI 10.1103/PhysRevB.83.220515; Wray L, 2008, PHYS REV B, V78, DOI 10.1103/PhysRevB.78.184508; Wu D, 2010, PHYS REV B, V82, DOI 10.1103/PhysRevB.82.144519; Zhang JH, 2010, PHYS REV B, V82, DOI 10.1103/PhysRevB.82.134527	33	3	3	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1745-2473	1745-2481		NAT PHYS	Nat. Phys.	FEB	2015	11	2					177	182		10.1038/NPHYS3187		6	Physics, Multidisciplinary	Physics	CB9EL	WOS:000349934700024		
J	Daikoku, T; Yatomi, Y; Yumoto, M				Daikoku, Tatsuya; Yatomi, Yutaka; Yumoto, Masato			Statistical learning of music- and language-like sequences and tolerance for spectral shifts	NEUROBIOLOGY OF LEARNING AND MEMORY			English	Article						Language and music; Statistical learning; Domain generality; Spectral shifts; Markov process; Magnetoencephalography	LONG-TERM-MEMORY; MISMATCH NEGATIVITY; CONGENITAL AMUSIA; AUDITORY-CORTEX; TONE SEQUENCES; MARKOV LOGIC; INFANTS; SPEECH; PITCH; RESPONSIVENESS	In our previous study (Daikoku, Yatomi, & Yumoto, 2014), we demonstrated that the N1m response could be a marker for the statistical learning process of pitch sequence, in which each tone was ordered by a Markov stochastic model. The aim of the present study was to investigate how the statistical learning of music- and language-like auditory sequences is reflected in the N1m responses based on the assumption that both language and music share domain generality. By using vowel sounds generated by a formant synthesizer, we devised music- and language-like auditory sequences in which higher-ordered transitional rules were embedded according to a Markov stochastic model by controlling fundamental (F0) and/or formant frequencies (F1-F2). In each sequence, F0 and/or F1-F2 were spectrally shifted in the last one-third of the tone sequence. Neuromagnetic responses to the tone sequences were recorded from 14 right-handed normal volunteers. In the music- and language-like sequences with pitch change, the N1m responses to the tones that appeared with higher transitional probability were significantly decreased compared with the responses to the tones that appeared with lower transitional probability within the first two-thirds of each sequence. Moreover, the amplitude difference was even retained within the last one-third of the sequence after the spectral shifts. However, in the language-like sequence without pitch change, no significant difference could be detected. The pitch change may facilitate the statistical learning in language and music. Statistically acquired knowledge may be appropriated to process altered auditory sequences with spectral shifts. The relative processing of spectral sequences may be a domain-general auditory mechanism that is innate to humans. (C) 2014 Elsevier Inc. All rights reserved.	[Daikoku, Tatsuya; Yatomi, Yutaka; Yumoto, Masato] Univ Tokyo, Grad Sch Med, Dept Clin Lab, Tokyo 1138655, Japan	Yumoto, M (reprint author), Univ Tokyo, Grad Sch Med, Dept Clin Lab, Bunkyo Ku, 7-3-1 Hongo, Tokyo 1138655, Japan.	yumoto-tky@umin.ac.jp					DOWLING WJ, 1971, J ACOUST SOC AM, V49, P524, DOI 10.1121/1.1912382; Richardson M, 2006, MACH LEARN, V62, P107, DOI 10.1007/s10994-006-5833-1; Singla P, 2006, IEEE DATA MINING, P572; Knecht S, 2000, BRAIN, V123, P2512, DOI 10.1093/brain/123.12.2512; Plantinga J, 2005, COGNITION, V98, P1, DOI 10.1016/j.cognition.2004.09.008; KEWLEYPORT D, 1994, J ACOUST SOC AM, V95, P485, DOI 10.1121/1.410024; Naatanen R, 2007, CLIN NEUROPHYSIOL, V118, P2544, DOI 10.1016/j.clinph.2007.04.026; Romberg AR, 2010, WIRES COGN SCI, V1, P906, DOI 10.1002/wcs.78; KLATT DH, 1980, J ACOUST SOC AM, V67, P971, DOI 10.1121/1.383940; Peretz I, 2012, ANN NY ACAD SCI, V1252, P361, DOI 10.1111/j.1749-6632.2011.06429.x; Jackendoff R, 2006, COGNITION, V100, P33, DOI 10.1016/j.cognition.2005.11.005; Ross B, 2009, HEARING RES, V248, P48, DOI 10.1016/j.heares.2008.11.012; Haenschel C, 2005, J NEUROSCI, V25, P10494, DOI 10.1523/JNEUROSCI.1227-05.2005; OLDFIELD RC, 1971, NEUROPSYCHOLOGIA, V9, P97, DOI 10.1016/0028-3932(71)90067-4; Schonwiesner M, 2005, EUR J NEUROSCI, V22, P1521, DOI 10.1111/j.1460-9568.2005.04315.x; PETERSON GE, 1952, J ACOUST SOC AM, V24, P175, DOI 10.1121/1.1906875; Archibald LMD, 2013, MEM COGNITION, V41, P268, DOI 10.3758/s13421-012-0259-4; Abla D, 2008, J COGNITIVE NEUROSCI, V20, P952, DOI 10.1162/jocn.2008.20058; Taulu S, 2009, HUM BRAIN MAPP, V30, P1524, DOI 10.1002/hbm.20627; Rao RPN, 2005, NEUROREPORT, V16, P1843, DOI 10.1097/01.wnr.0000183900.92901.fc; Shestakova A, 2002, NEUROREPORT, V13, P1813, DOI 10.1097/00001756-200210070-00025; Trainor LJ, 2004, DEVELOPMENTAL SCI, V7, P289, DOI 10.1111/j.1467-7687.2004.00348.x; Trehub SE, 2001, ANN NY ACAD SCI, V930, P1; Olshausen BA, 2004, CURR OPIN NEUROBIOL, V14, P481, DOI 10.1016/j.conb.2004.07.007; Schon D, 2008, COGNITION, V106, P975, DOI 10.1016/j.cognition.2007.03.005; Ayotte J, 2002, BRAIN, V125, P238, DOI 10.1093/brain/awf028; Houston DM, 2000, J EXP PSYCHOL HUMAN, V26, P1570, DOI 10.1037//0096-1523.26.5.1570; Saffran JR, 1999, COGNITION, V70, P27, DOI 10.1016/S0010-0277(98)00075-4; Asaad P., 1998, THESIS U ROCHESTER N; Crothers J., 1978, UNIVERSALS HUMAN LAN, V2, P93; Daikoku T, 2014, NEUROPSYCHOLOGIA, V63, P194, DOI 10.1016/j.neuropsychologia.2014.08.028; Ellis Rod, 2009, IMPLICIT EXPLICIT KN, P3; Furl N, 2011, NEUROIMAGE, V54, P2267, DOI 10.1016/j.neuroimage.2010.10.038; Hauser MD, 2002, SCIENCE, V298, P1569, DOI 10.1126/science.298.5598.1569; Hunt R. H., 1998, P 20 ANN C COGN SCI; Ito M, 2001, J ACOUST SOC AM, V110, P1141, DOI 10.1121/1.1384908; Jusczyk PW, 1999, TRENDS COGN SCI, V3, P323, DOI 10.1016/S1364-6613(99)01363-7; Kiebel SJ, 2008, PLOS COMPUT BIOL, V4, DOI 10.1371/journal.pcbi.1000209; Kuriki S, 2007, CEREB CORTEX, V17, P2725, DOI 10.1093/cercor/bhl182; Markov A. A., 1971, DYNAMIC PROBABILISTI; Numminen J, 1999, NEUROSCI LETT, V265, P119, DOI 10.1016/S0304-3940(99)00218-9; Paraskevopoulos E, 2012, NEUROPSYCHOLOGIA, V50, P341, DOI 10.1016/j.neuropsychologia.2011.12.007; Poon H., 2007, P 22 AAAI C ART INT, P913; Poon H., 2008, P 2008 C EMP METH NA, P650, DOI 10.3115/1613715.1613796; Saffran JR, 2003, ANN NY ACAD SCI, V999, P397, DOI 10.1196/annals.1284.050; Saffran JR, 2001, ANN NY ACAD SCI, V930, P397; Saffran JR, 2003, DEVELOPMENTAL SCI, V6, P35, DOI 10.1111/1467-7687.00250; Saffran JR, 1996, SCIENCE, V274, P1926, DOI 10.1126/science.274.5294.1926; Stewart L., 2011, FRONTIERS PSYCHOL, V2; Teismann IK, 2004, NEUROREPORT, V15, P1267, DOI 10.1097/01.wnr.0000129856.58404.2d; Trehub SE, 2006, COGNITION, V100, P73, DOI 10.1016/j.cognition.2005.11.006; Ueda Y., 1987, Journal of the Acoustical Society of Japan (E), V8; Wright AA, 2007, J EXP ANAL BEHAV, V88, P405, DOI 10.1901/jeab.2007.88-405; Yumoto M, 2005, NEUROREPORT, V16, P1175, DOI 10.1097/00001756-200508010-00008	54	0	0	ACADEMIC PRESS INC ELSEVIER SCIENCE	SAN DIEGO	525 B ST, STE 1900, SAN DIEGO, CA 92101-4495 USA	1074-7427	1095-9564		NEUROBIOL LEARN MEM	Neurobiol. Learn. Mem.	FEB	2015	118						8	19		10.1016/j.nlm.2014.11.001		12	Behavioral Sciences; Neurosciences; Psychology; Psychology, Multidisciplinary	Behavioral Sciences; Neurosciences & Neurology; Psychology	CC0EH	WOS:000350008100003		
J	Horie, N; Hiu, T; Nagata, I				Horie, Nobutaka; Hiu, Takeshi; Nagata, Izumi			Stem Cell Transplantation Enhances Endogenous Brain Repair after Experimental Stroke	NEUROLOGIA MEDICO-CHIRURGICA			English	Review						stroke; stem cell; transplantation; endogenous repair	FOCAL CEREBRAL-ISCHEMIA; MARROW STROMAL CELLS; FUNCTIONAL RECOVERY; BONE-MARROW; EMERGING PARADIGM; THERAPY; RATS; NEUROGENESIS; ANGIOGENESIS; PLASTICITY	Stem cell transplantation for stroke treatment has been a promising therapy in small and large animal models, and many clinical trials are ongoing to establish this strategy in a clinical setting. However, the mechanism underlying functional recovery after stem cell transplantation has not been fully established and there is still a need to determine the ideal subset of stem cells for such therapy. We herein reviewed the recent evidences showing the underlying mechanism of functional recovery after cell transplantation, focusing on endogenous brain repair. First, angiogenesistneovascularization is promoted by trophic factors including vascular endothelial growth factor secreted from stem cells, and stem cells migrated to the lesion along with the vessels. Second, axonal sprouting, dendritic branching, and synaptogenesis were enhanced altogether in the both ipsilateral and contralateral hemisphere remapping the pyramidal tract across the board. Finally, endogenous neurogenesis was also enhanced although little is known how much these neurogenesis contribute to the functional recovery. Taken together, it is clear that stem cell transplantation provides functional recovery via endogenous repair enhancement from multiple ways. This is important to maximize the effect of stem cell therapy after stroke, although it is still undetermined which repair mechanism is mostly contributed.	[Horie, Nobutaka; Hiu, Takeshi; Nagata, Izumi] Nagasaki Univ, Dept Neurosurg, Sch Med, Nagasaki, Nagasaki 8528501, Japan	Horie, N (reprint author), Nagasaki Univ, Dept Neurosurg, Sch Med, 1-7-1 Sakamoto, Nagasaki, Nagasaki 8528501, Japan.	nobstanford@gmail.com			 [26462165]	This work was supported in part by a Grant-in-Aid for Scientific Research to Nobutaka Hone. (No. 26462165).	Amar AP, 2003, NEUROSURGERY, V52, P402, DOI 10.1227/01.NEU.0000043698.86548.A0; Chen JL, 2001, STROKE, V32, P1005; Carmichael ST, 2008, STROKE, V39, P1380, DOI 10.1161/STROKEAHA.107.499962; Andres RH, 2011, BRAIN, V134, P1777, DOI 10.1093/brain/awr094; Zhang J, 2013, EXPERT OPIN BIOL TH, V13, P1229, DOI 10.1517/14712598.2013.804507; Nakatomi H, 2002, CELL, V110, P429, DOI 10.1016/S0092-8674(02)00862-0; Moisan A, 2012, NMR BIOMED, V25, P1340, DOI 10.1002/nbm.2806; JONES TA, 1992, BRAIN RES, V581, P156, DOI 10.1016/0006-8993(92)90356-E; Carmeliet P, 2005, NATURE, V436, P193, DOI 10.1038/nature03875; Abe K, 2012, J CEREBR BLOOD F MET, V32, P1317, DOI 10.1038/jcbfm.2011.187; Savitz SI, 2014, STROKE, V45, P634, DOI 10.1161/STROKEAHA.113.003379; Horie N, 2011, STEM CELLS, V29, P274, DOI 10.1002/stem.584; Liauw J, 2008, J CEREBR BLOOD F MET, V28, P1722, DOI 10.1038/jcbfm.2008.65; Kokaia Z, 2003, CURR OPIN NEUROBIOL, V13, P127, DOI 10.1016/S0959-4388(03)00017-5; Savitz SI, 2011, STROKE, V42, P825, DOI 10.1161/STROKEAHA.110.601914; Arvidsson A, 2002, NAT MED, V8, P963, DOI 10.1038/nm747; Mine Y, 2013, NEUROBIOL DIS, V52, P191, DOI 10.1016/j.nbd.2012.12.006; Murphy TH, 2009, NAT REV NEUROSCI, V10, P861, DOI 10.1038/nrn2735; Yan YP, 2007, J CEREBR BLOOD F MET, V27, P1213, DOI 10.1038/sj.jcbfm.9600432; Imitola J, 2004, P NATL ACAD SCI USA, V101, P18117, DOI 10.1073/pnas.0408258102; Ishizaka S, 2013, STROKE, V44, P720, DOI 10.1161/STROKEAHA.112.677328; Dijkhuizen RM, 2003, J NEUROSCI, V23, P510; Bliss T, 2007, STROKE, V38, P817, DOI 10.1161/01.STR.0000247888.25985.62; Zhang J, 2009, J CEREBR BLOOD F MET, V29, P1166, DOI 10.1038/jcbfm.2009.41; Bliss TM, 2010, NEUROBIOL DIS, V37, P275, DOI 10.1016/j.nbd.2009.10.003; Tang YH, 2014, J CEREBR BLOOD F MET, V34, P1138, DOI 10.1038/jcbfm.2014.61; Pendharkar AV, 2010, STROKE, V41, P2064, DOI 10.1161/STROKEAHA.109.575993; [Anonymous], 2009, STROKE, V40; Nakagomi T, 2009, EUR J NEUROSCI, V29, P1842, DOI 10.1111/j.1460-9568.2009.06732.x; Takatsuru Y, 2009, J NEUROSCI, V29, P10081, DOI 10.1523/JNEUROSCI.1638-09.2009; Yoshikawa G, 2010, J NEUROSURG, V113, P835, DOI 10.3171/2010.2.JNS09989; Zhang L, 2011, STROKE, V42, P1437, DOI 10.1161/STROKEAHA.110.593129; Hayashi T, 2003, J CEREBR BLOOD F MET, V23, P166, DOI 10.1097/00004647-200302000-00004; Carmichael ST, 2001, NEUROBIOL DIS, V8, P910, DOI 10.1006/nbdi.2001.0425; Byun JS, 2013, J KOREAN NEUROSURG S, V54, P467, DOI 10.3340/jkns.2013.54.6.467; Daadi MM, 2009, CELL TRANSPLANT, V18, P815, DOI 10.3727/096368909X470829; Ding XS, 2013, J CEREBR BLOOD F MET, V33, P1015, DOI 10.1038/jcbfm.2013.50; Gonzalez CLR, 2003, EUR J NEUROSCI, V18, P1950, DOI 10.1046/j.1460-9568.2003.02928.x; Gutierrez-Fernandez M, 2013, STEM CELL RES THER, V4, DOI 10.1186/scrt159; Hsieh JY, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0072604; Jiu K, 2010, P NATL ACAD SCI USA, V107, P7993; KRUPINSKI J, 1993, LANCET, V342, P742, DOI 10.1016/0140-6736(93)91734-4; Li Yi, 2005, Glia, V49, P407, DOI 10.1002/glia.20126; Li Y, 2006, EXP NEUROL, V198, P313, DOI 10.1016/j.expneurol.2005.11.029; Liu Y, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0078514; Rosado-de-Castro PH, 2013, STEM CELLS DEV, V22, P2095, DOI 10.1089/scd.2013.0089; Senior K, 2001, LANCET, V358, P817, DOI 10.1016/S0140-6736(01)06014-7; Zhang PB, 2011, NEUROPATHOLOGY, V31, P384, DOI 10.1111/j.1440-1789.2010.01182.x	48	0	0	JAPAN NEUROSURGICAL SOC	TOKYO	5-25-16 HONGO, BUNKYO-KU, TOKYO, 113-0033, JAPAN	0470-8105	1349-8029		NEUROL MED-CHIR	Neurol. Med.-Chir.	FEB	2015	55	2					107	112		10.2176/nmc.ra.2014-0271		6	Clinical Neurology; Surgery	Neurosciences & Neurology; Surgery	CC1DS	WOS:000350082000001		
J	Yasuhara, T; Kameda, M; Agari, T; Date, I				Yasuhara, Takao; Kameda, Masahiro; Agari, Takashi; Date, Isao			Regenerative Medicine for Parkinson's Disease	NEUROLOGIA MEDICO-CHIRURGICA			English	Review						cell therapy; dopaminergic neuron; gene therapy; induced pluripotent stem cells	PLURIPOTENT STEM-CELLS; RANDOMIZED CONTROLLED-TRIAL; PHASE-I TRIAL; GENE-THERAPY; NEUROTROPHIC FACTOR; RAT MODEL; DOPAMINERGIC-NEURONS; CLINICAL-APPLICATION; SUBSTANTIA-NIGRA; DOUBLE-BLIND	Regenerative medicine for Parkinson's disease (PD) is expected to develop dramatically with the advancement of biotechnology as represented by induced pluripotent stem cells. Existing therapeutic strategy for PD consists of medication using L-DOPA, surgery such as deep brain stimulation and rehabilitation. Current treatment cannot stop the progression of the disease, although there is definite therapeutic effect. True neurorestoration is strongly desired by regenerative medicine. This review article describes the historical development of regenerative medicine for PD, with a focus on fetal nigral cell transplantation and glial cell line-derived neurotrophic factor infusion. Subsequently, the current status of regenerative medicine for PD in terms of cell therapy and gene therapy are reviewed. In the end, the future direction to realize regenerative medicine for PD is discussed.	[Yasuhara, Takao; Kameda, Masahiro; Agari, Takashi; Date, Isao] Okayama Univ, Grad Sch Med, Dept Neurol Surg, Okayama, Okayama 7008558, Japan	Yasuhara, T (reprint author), Okayama Univ, Grad Sch Med, Dept Neurol Surg, Kita Ku, 2-5-1 Shikata Cho, Okayama, Okayama 7008558, Japan.	tyasu37@cc.okayama-u.ac.jp			Ministry of Education, Culture, Sports, Science and Technology, Japan	This work was supported in part by Grants-in-Aid for Scientific Research and the Grant of the project for realization of regenerative medicine from the Ministry of Education, Culture, Sports, Science and Technology, Japan. The authors show their sincere gratitude for the dedicated works to the following doctors:; Professor Cesario V. Borlongan and Dr. Naoki Tajiri in Center of Excellence for Aging & Brain Repair, Department of Neurosurgery and Brain Repair, University of South Florida Morsani College of Medicine.; Professor Mitsunori Matsumae, Dr. Tanefumi Baba and Dr. Kenichiro Sato in Department of Neurosurgery, Tokai University.; Dr. Noriyuki Matsukawa in Department of Neurology, Nagoya City University.; Dr. Koichi Hara in Department of Neurosurgery, Hino Municipal Hospital.; Drs. Tetsuro Shingo, Kazuki Kobayashi, Akira Takeuchi, Akimasa Yano, Kenichiro Muraoka, Kazuya Takahashi, Satoshi Kuramoto, Ji YW, Akihiko Kondo, Meng Jing, Takamasa Morimoto, Feifei Wang, Tomohito Kadota, Judith Thomas Tayra, Aiko Shinko, Takaaki Wakamori, Susumu Sasada, Atsuhiko Toyoshima, Tatsuya Sasaki, Hayato Takeuchi, Jun Morimoto, and Mihoko Okazaki in Department of Neurological Surgery, Okayama University Graduate School of Medicine.	Lee SH, 2000, NAT BIOTECHNOL, V18, P675, DOI 10.1038/76536; Yasuhara T, 2006, J NEUROSCI, V26, P12497, DOI 10.1523/JNEUROSCI.3719-06.2006; Sturkenboom IHWM, 2014, LANCET NEUROL, V13, P557, DOI 10.1016/S1474-4422(14)70055-9; Olanow CW, 2003, ANN NEUROL, V54, P403, DOI 10.1002/ana.10720; Tajiri N, 2010, BRAIN RES, V1310, P200, DOI 10.1016/j.brainres.2009.10.075; Gasser T, 2007, MOVEMENT DISORD, V22, pS343, DOI 10.1002/mds.21676; Kuroda Y, 2013, NAT PROTOC, V8, P1391, DOI 10.1038/nprot.2013.076; Nakagawa M, 2008, NAT BIOTECHNOL, V26, P101, DOI 10.1038/nbt1374; Kim JB, 2008, NATURE, V454, P646, DOI 10.1038/nature07061; Vitek JL, 2003, ANN NEUROL, V53, P558, DOI 10.1002/ana.10517; Chambers SM, 2009, NAT BIOTECHNOL, V27, P275, DOI 10.1038/nbt.1529; Gill SS, 2003, NAT MED, V9, P589, DOI 10.1038/nm850; Kawasaki H, 2000, NEURON, V28, P31, DOI 10.1016/S0896-6273(00)00083-0; Zhou HY, 2009, CELL STEM CELL, V4, P381, DOI 10.1016/j.stem.2009.04.005; Kirkeby A, 2012, CELL REPORTS, V1, P703, DOI 10.1016/j.celrep.2012.04.009; Ma YL, 2002, ANN NEUROL, V52, P628, DOI 10.1002/ana.10359; Bartus RT, 2014, MOL THER, V22, P487, DOI 10.1038/mt.2013.281; Freed CR, 2001, NEW ENGL J MED, V344, P710, DOI 10.1056/NEJM200103083441002; REYNOLDS BA, 1992, SCIENCE, V255, P1707, DOI 10.1126/science.1553558; Stoessl AJ, 2014, LANCET, V383, P1107, DOI 10.1016/S0140-6736(13)62108-X; LeWitt PA, 2011, LANCET NEUROL, V10, P309, DOI 10.1016/S1474-4422(11)70039-4; Bartus RT, 2013, NEUROLOGY, V80, P1698, DOI 10.1212/WNL.0b013e3182904faa; Kiskinis E, 2010, J CLIN INVEST, V120, P51, DOI 10.1172/JCI40553; Kefalopoulou Z, 2014, JAMA NEUROL, V71, P83, DOI 10.1001/jamaneurol.2013.4749; Lang AE, 2006, ANN NEUROL, V59, P459, DOI 10.1002/ana.20737; Takahashi K, 2007, CELL, V131, P861, DOI 10.1016/j.cell.2007.11.019; Kim JB, 2009, CELL, V136, P411, DOI 10.1016/j.cell.2009.01.023; Kaplitt MG, 2007, LANCET, V369, P2097, DOI 10.1016/S0140-6736(07)60982-9; MADRAZO I, 1988, NEW ENGL J MED, V318, P51; Slevin JT, 2005, J NEUROSURG, V102, P216, DOI 10.3171/jns.2005.102.2.0216; Marks WJ, 2008, LANCET NEUROL, V7, P400, DOI 10.1016/S1474-4422(08)70065-6; Yasuhara T, 2004, EUR J NEUROSCI, V19, P1494, DOI 10.1111/j.1460-9568.2004.03254.x; Kriks S, 2011, NATURE, V480, P547, DOI 10.1038/nature10648; Palfi S, 2014, LANCET, V383, P1138, DOI 10.1016/S0140-6736(13)61939-X; Dezawa M, 2004, J CLIN INVEST, V113, P1701, DOI 10.1172/JCI200420935; Olanow CW, 2013, MOVEMENT DISORD, V28, P31, DOI 10.1002/mds.25373; Takagi Y, 2005, J CLIN INVEST, V115, P102, DOI 10.1172/JCI200521137; Doi D, 2012, STEM CELLS, V30, P935, DOI 10.1002/stem.1060; Nutt JG, 2003, NEUROLOGY, V60, P69; Kordower JH, 2013, MOVEMENT DISORD, V28, P96, DOI 10.1002/mds.25344; Vierbuchen T, 2010, NATURE, V463, P1035, DOI 10.1038/nature08797; Maekawa M, 2011, NATURE, V474, P225, DOI 10.1038/nature10106; Eberling JL, 2008, NEUROLOGY, V70, P1980, DOI 10.1212/01.wnl.0000312381.29287.ff; Fan HC, 2013, CELL TRANSPLANT, V22, P639, DOI 10.3727/096368912X655082; Mendez I, 2005, BRAIN, V128, P1498, DOI 10.1093/brain/awh510; Okita K, 2008, SCIENCE, V322, P949, DOI 10.1126/science.1164270; Kaji K, 2009, NATURE, V458, P771, DOI 10.1038/nature07864; Azzouz M, 2002, J NEUROSCI, V22, P10302; Morizane A, 2011, J NEUROSCI RES, V89, P117, DOI 10.1002/jnr.22547; Kuroda Y, 2010, P NATL ACAD SCI USA, V107, P8639, DOI 10.1073/pnas.0911647107; Patel NK, 2005, ANN NEUROL, V57, P298, DOI 10.1002/ana.20374; Takahashi K, 2006, CELL, V126, P663, DOI 10.1016/j.cell.2006.07.024; Toledo-Aral JJ, 2003, J NEUROSCI, V23, P141; Aoi M, 2000, ACTA NEUROCHIR, V142, P805, DOI 10.1007/s007010070096; Belin AC, 2008, FEBS J, V275, P1377, DOI 10.1111/j.1742-4658.2008.06301.x; Benabid AL, 2000, NEUROLOGY, V55, pS40; Borlongan CV, 1999, LANCET S1, V353, pS129; DATE I, 1995, NEUROSURGERY, V37, P515; Date I, 1996, EXP NEUROL, V137, P333, DOI 10.1006/exnr.1996.0034; Date I, 1995, NEUROSURGERY, V37, P518; Denyer R, 2012, PARKINSONS DIS, V2012; Devine MJ, 2011, NAT COMMUN, V2, DOI 10.1038/ncomms1453; During M J, 2001, Hum Gene Ther, V12, P1589; Gibson SAJ, 2012, STEM CELL RES THER, V3, DOI 10.1186/scrt102; Hayakawa Takao, 2012, Brain and Nerve (Tokyo), V64, P47; JAEGER CB, 1990, PROG BRAIN RES, V82, P41; Jarraya B, 2009, SCI TRANSL MED, V1, p2ra4; Kobayashi K, 2006, BRAIN RES, V1102, P1, DOI 10.1016/j.brainres.2006.04.078; LINDVALL O, 1988, LANCET, V2, P1483; Love S, 2005, NAT MED, V11, P703, DOI 10.1038/nm0705-703; Ma YL, 2011, BRIT MED BULL, V100, P173, DOI 10.1093/bmb/ldr040; Minguez-Castellanos A, 2007, J NEUROL NEUROSUR PS, V78, P825, DOI 10.1136/jnnp.2006.106021; Morizane Asuka, 2012, Brain and Nerve (Tokyo), V64, P29; Muraoka K, 2008, J NEUROSURG, V108, P149, DOI 10.3171/JNS/2008/108/01/0149; Okano H, 2014, MOL BRAIN, V7, DOI 10.1186/1756-6606-7-22; Petit GH, 2014, NEUROPATH APPL NEURO, V40, P60, DOI 10.1111/nan.12110; Porras G, 2008, EXP NEUROL, V209, P72, DOI 10.1016/j.expneurol.2007.08.003; Prodoehl J., 2014, NEUROREHABIL NEURAL; Qiu Zhifang, 2013, Stem Cells Cloning, V6, P19, DOI 10.2147/SCCAA.S34798; Ramos-Moreno T, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0052714; Sethi KD, 2010, NEUROLOGIST, V16, P76, DOI 10.1097/NRL.0b013e3181be6d15; Shinko A, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0101468; Tayra JT, 2013, BRAIN RES, V1502, P55, DOI 10.1016/j.brainres.2013.01.042; Ulusoy A, 2008, EXP NEUROL, V209, P89, DOI 10.1016/j.expneurol.2007.09.011; Wang FF, 2010, BMC NEUROSCI, V11, DOI 10.1186/1471-2202-11-52; Wang F, 2011, NEUROSCI RES, V71, P92, DOI 10.1016/j.neures.2011.05.019; Yasuhara T, 2009, J NEURAL TRANSM-SUPP, P301, DOI 10.1007/978-3-211-92660-4_25; Yasuhara T, 2007, CELL TRANSPLANT, V16, P125	88	1	1	JAPAN NEUROSURGICAL SOC	TOKYO	5-25-16 HONGO, BUNKYO-KU, TOKYO, 113-0033, JAPAN	0470-8105	1349-8029		NEUROL MED-CHIR	Neurol. Med.-Chir.	FEB	2015	55	2					113	123		10.2176/nmc.ra.2014-0264		11	Clinical Neurology; Surgery	Neurosciences & Neurology; Surgery	CC1DS	WOS:000350082000002		
J	Sato, K; Suzuki, S; Yamada, M; Oka, H; Kurata, A; Okamoto, H; Fujii, K; Kumabe, T				Sato, Kimitoshi; Suzuki, Sachio; Yamada, Masaru; Oka, Hidehiro; Kurata, Akira; Okamoto, Hirotsugu; Fujii, Kiyotaka; Kumabe, Toshihiro			Selecting an Appropriate Surgical Treatment Instead of Carotid Artery Stenting Alone According to the Patient's Risk Factors Contributes to Reduced Perioperative Complications in Patients with Internal Carotid Stenosis: A Single Institutional Retrospective Analysis	NEUROLOGIA MEDICO-CHIRURGICA			English	Article						carotid artery stenting; carotid endarterectomy; carotid stenosis	CERVICAL RADIATION-THERAPY; CORONARY-HEART-DISEASE; TRANSCRANIAL DOPPLER; ENDARTERECTOMY; JAPAN; ANGIOPLASTY; PROTECTION; CALIFORNIA; OCCLUSION; SURGERY	This retrospective study was aimed to compare the perioperative complications for internal carotid artery stenosis (ICS) in a Japanese single institute between the use of carotid artery stenting (CAS) alone or the use of an appropriate individualized treatment method allowing either carotid endarterectomy (CEA) or CAS based on patient risk factors. Based on the policy at our hospital, only CAS was performed on patients (n = 33) between January 2005 and November 2009. From December 2009 to December 2012, either CEA or CAS (tailored treatment) was selected for patients (n = 61) based on individual patient risk factors. CEA was considered the first-line treatment in all cases. In high-risk CEA cases, CAS was performed instead (n = 11), whereas in low-risk CEA cases, CEA was performed (n = 19). Further, in moderate-risk CEA cases based on own criteria, CAS was considered first, whereas for high-risk CAS cases, CEA was performed (n = 17). For low-risk CAS cases, CAS was performed (n = 9). Perioperative clinical complications (any stroke, myocardial infarction, or death within 30 days) were compared between both periods. Significantly reduced perioperative complications were observed during the tailored period (4/61 sites, 6.6%) as compared with the CAS period (8/33 sites, 24.2%) [Fisher's exact test p = 0.022; odds ratio, 4.56 (CAS/tailored); 95% confidence interval, 1.26-16.5]. Selecting an appropriate individualized treatment method according to patient risk factors, as opposed to adhering to a single treatment approach such as CAS, may contribute to improved overall outcomes in patients with ICS.	[Sato, Kimitoshi; Suzuki, Sachio; Yamada, Masaru; Oka, Hidehiro; Kurata, Akira; Fujii, Kiyotaka; Kumabe, Toshihiro] Kitasato Univ, Sch Med, Dept Neurosurg, Sagamihara, Kanagawa 2520374, Japan; [Okamoto, Hirotsugu] Kitasato Univ, Sch Med, Dept Anesthesiol, Sagamihara, Kanagawa 2520374, Japan	Sato, K (reprint author), Kitasato Univ, Sch Med, Dept Neurosurg, Minami Ku, 1-15-1 Kitasato, Sagamihara, Kanagawa 2520374, Japan.	kimitoshi@k8.dion.ne.jp					Allie DE, 1998, ANN THORAC SURG, V66, P1230, DOI 10.1016/S0003-4975(98)00841-8; Economopoulos KP, 2011, STROKE, V42, P687, DOI 10.1161/STROKEAHA.110.606079; Nallamothu BK, 2011, JAMA-J AM MED ASSOC, V306, P1338, DOI 10.1001/jama.2011.1357; Silver FL, 2011, STROKE, V42, P675, DOI 10.1161/STROKEAHA.110.610212; ROBERTSON TL, 1977, AM J CARDIOL, V39, P239, DOI 10.1016/S0002-9149(77)80197-5; WALKER MD, 1995, JAMA-J AM MED ASSOC, V273, P1421; Yamada K, 2011, ATHEROSCLEROSIS, V215, P399, DOI 10.1016/j.atherosclerosis.2011.01.002; Almekhlafi MA, 2013, STROKE, V44, P1317, DOI 10.1161/STROKEAHA.111.000659; Shin SH, 2009, J VASC SURG, V50, P762, DOI 10.1016/j.jvs.2009.04.066; MARMOT MG, 1975, AM J EPIDEMIOL, V102, P514; Iyer SS, 2008, J AM COLL CARDIOL, V51, P427, DOI 10.1016/j.jacc.2007.09.045; Brott TG, 2010, NEW ENGL J MED, V363, P11, DOI 10.1056/NEJMoa0912321; Fokkema M, 2012, STROKE, V43, P793, DOI 10.1161/STROKEAHA.111.633743; Spence JD, 2010, ARCH NEUROL-CHICAGO, V67, P180, DOI 10.1001/archneurol.2009.289; Goode SD, 2013, J VASC INTERV RADIOL, V24, P528, DOI 10.1016/j.jvir.2012.12.014; Yadav JS, 2004, NEW ENGL J MED, V351, P1493, DOI 10.1056/NEJMoa040127; Naylor AR, 2011, STROKE, V42, P2080, DOI 10.1161/STROKEAHA.110.597708; Dalainas I, 2007, ANN VASC SURG, V21, P16, DOI 10.1016/j.avsg.2006.06.003; Marquardt L, 2010, STROKE, V41, pE11, DOI 10.1161/STROKEAHA.109.561837; Miyachi S, 2012, ACTA NEUROCHIR, V154, P2127, DOI 10.1007/s00701-012-1508-9; Gray WA, 2006, J VASC SURG, V44, P258, DOI 10.1016/j.jvs.2006.03.044; Beretta F, 2006, NEUROSURGERY, V59, P25, DOI 10.1227/01.NEU.0000219877.43072.49; Brewster LP, 2012, J VASC SURG, V56, P1291, DOI 10.1016/j.jvs.2012.04.033; Hassen-Khodja R, 2000, ANN VASC SURG, V14, P608, DOI 10.1007/s100169910110; Ederle J, 2010, LANCET, V375, P985, DOI 10.1016/S0140-6736(10)60239-5; TAYLOR DW, 1991, NEW ENGL J MED, V325, P445; Pieniazek P, 2012, KARDIOL POL, V70, P378; Shinohara Y, 2009, JAPANESE GUIDELINES, P123; Siewiorek GM, 2007, J ENDOVASC THER, V14, P712, DOI 10.1583/1545-1550(2007)14[712:IVPAOD]2.0.CO;2; Steg PG, 2007, JAMA-J AM MED ASSOC, V297, P1197, DOI 10.1001/jama.297.11.1197; Sundt Jr TM, 1987, OCCLUSIVE CEREBROVAS, P226; Tadros RO, 2013, ANN VASC SURG, V27, P96, DOI 10.1016/j.avsg.2012.06.007; Wimmer NJ, 2012, STROKE, V43, P3218, DOI 10.1161/STROKEAHA.112.673194; Yoshida K, 2010, J NEUROSURG, V113, P885, DOI 10.3171/2010.4.JNS091819	34	0	0	JAPAN NEUROSURGICAL SOC	TOKYO	5-25-16 HONGO, BUNKYO-KU, TOKYO, 113-0033, JAPAN	0470-8105	1349-8029		NEUROL MED-CHIR	Neurol. Med.-Chir.	FEB	2015	55	2					124	132		10.2176/nmc.oa.2014-0049		9	Clinical Neurology; Surgery	Neurosciences & Neurology; Surgery	CC1DS	WOS:000350082000003		
J	Okada, H; Terada, T; Tanaka, Y; Tomura, N; Kono, K; Yoshimura, R; Shintani, A				Okada, Hideo; Terada, Tomoaki; Tanaka, Yuko; Tomura, Nagatsuki; Kono, Kenichi; Yoshimura, Ryo; Shintani, Aki			Reappraisal of Primary Balloon Angioplasty without Stenting for Patients with Symptomatic Middle Cerebral Artery Stenosis	NEUROLOGIA MEDICO-CHIRURGICA			English	Article						intracranial stenosis; angioplasty; middle cerebral artery; stent	AGGRESSIVE MEDICAL-MANAGEMENT; PREVENTING RECURRENT STROKE; TERM-FOLLOW-UP; INTRACRANIAL ANGIOPLASTY; ATHEROSCLEROTIC STENOSIS; SAMMPRIS; THERAPY	There is a controversy regarding the safety and efficacy of intracranial stenting. We describe our experience with primary balloon angioplasty without stenting for symptomatic middle cerebral artery (MCA) stenosis. All patients who underwent balloon angioplasty without stenting for MCA stenosis between 1996 and 2010 were retrospectively reviewed. We evaluated technical success rates, degrees of stenosis, and stroke or death within 30 days. Among patients who were followed-up for > 1 year we evaluated latest functional outcomes, stroke recurrence at 1 year, and restenosis. In total 45/47 patients (95.7%) were successfully treated. Average pre- and postprocedure stenosis rates were 79.9% and 39.5%, respectively. Three neurological complications occurred within 30 days: one thromboembolism during the procedure; one lacunar infarction; and one fatal intraparenchymal hemorrhage after the procedure. Stroke or death rate within 30 days was 6.4%. Thirty-three patients were available for follow-up analysis with a mean period of 51.5 months. The combined rate of stroke or death within 30 days and ipsilateral ischemic stroke of the followed-up patients within 1 year beyond 30 days was 9.4%. Restenosis was observed in 26.9% of patients and all remained asymptomatic. In our retrospective series, balloon angioplasty without stenting was a safe, effective modality for symptomatic MCA stenosis. For patients refractory to medical therapy, primary balloon angioplasty may offer a better supplemental treatment option.	[Okada, Hideo; Terada, Tomoaki; Tanaka, Yuko; Tomura, Nagatsuki; Kono, Kenichi; Yoshimura, Ryo; Shintani, Aki] Wakayama Rosai Hosp, Dept Neurosurg, Wakayama, Wakayama 6408505, Japan	Okada, H (reprint author), Wakayama Rosai Hosp, Dept Neurosurg, 93-1 Kinomoto, Wakayama, Wakayama 6408505, Japan.	hdo-okada@wakayamah.rofuku.go.jp					Chiam PTL, 2008, AM J NEURORADIOL, V29, P1956, DOI 10.3174/ajnr.A1221; Chimowitz MI, 2005, NEW ENGL J MED, V352, P1305, DOI 10.1056/NEJMoa043033; Albuquerque FC, 2008, NEUROSURGERY, V63, P23, DOI [10.1227/01.NEU.0000335067.53190.A2, 10.1227/01.NEU.0000316428.68824.23]; Mori T, 1998, AM J NEURORADIOL, V19, P1525; Derdeyn CP, 2013, NEUROSURGERY, V72, P777, DOI 10.1227/NEU.0b013e318286fdc8; Marks MP, 2005, AM J NEURORADIOL, V26, P525; Marks MP, 2012, STROKE, V43, P580, DOI 10.1161/STROKEAHA.111.645507; Chimowitz MI, 2011, NEW ENGL J MED, V365, P993, DOI 10.1056/NEJMoa1105335; Dumont TM, 2012, NEUROSURGERY, V71, P1103, DOI 10.1227/NEU.0b013e318271bcb8; Lee JH, 2003, CEREBROVASC DIS, V15, P90, DOI 10.1159/000067135; Leung TW, 2009, STROKE, V40, P1910, DOI 10.1161/STROKEAHA.108.532416; Masuo O, 2005, AM J NEURORADIOL, V26, P543; Terada T, 2006, NEUROSURGERY, V59, P310, DOI 10.1227/01.NEU.0000225326.81661.68; Tomycz Luke, 2013, Surg Neurol Int, V4, P18, DOI 10.4103/2152-7806.107542; Yoon W, 2005, RADIOLOGY, V237, P620, DOI 10.1148/radiol.2372041620	15	0	0	JAPAN NEUROSURGICAL SOC	TOKYO	5-25-16 HONGO, BUNKYO-KU, TOKYO, 113-0033, JAPAN	0470-8105	1349-8029		NEUROL MED-CHIR	Neurol. Med.-Chir.	FEB	2015	55	2					133	140		10.2176/nmc.oa.2014-0156		8	Clinical Neurology; Surgery	Neurosciences & Neurology; Surgery	CC1DS	WOS:000350082000004		
J	Oshida, S; Ogasawara, K; Saura, H; Yoshida, K; Fujiwara, S; Kojima, D; Kobayashi, M; Yoshida, K; Kubo, Y; Ogawa, A				Oshida, Sotaro; Ogasawara, Kuniaki; Saura, Hiroaki; Yoshida, Koji; Fujiwara, Shunro; Kojima, Daigo; Kobayashi, Masakazu; Yoshida, Kenji; Kubo, Yoshitaka; Ogawa, Akira			Does Preoperative Measurement of Cerebral Blood Flow with Acetazolamide Challenge in Addition to Preoperative Measurement of Cerebral Blood Flow at the Resting State Increase the Predictive Accuracy of Development of Cerebral Hyperperfusion after Carotid Endarterectomy? Results from 500 Cases with Brain Perfusion Single-photon Emission Computed Tomography Study	NEUROLOGIA MEDICO-CHIRURGICA			English	Article						acetazolamide; carotid endarterectomy; cerebral blood flow; cerebrovascular reactivity; hyperperfusion	FREE-RADICAL SCAVENGER; CEREBROVASCULAR-REACTIVITY; HEMODYNAMIC IMPAIRMENT; COGNITIVE IMPAIRMENT; OCCLUSIVE DISEASES; MISERY-PERFUSION; ARTERY; ISCHEMIA; OXYGEN; SPECT	The purpose of the present study was to determine whether preoperative measurement of cerebral blood flow (CBF) with acetazolamide in addition to preoperative measurement of CBF at the resting state increases the predictive accuracy of development of cerebral hyperperfusion after carotid endarterectomy (CEA). CBF at the resting state and cerebrovascular reactivity (CVR) to acetazolamide were quantitatively assessed using N-isopropyl-p-[I-123]-iodoamphetamine (IMP)-autoradiography method with single-photon emission computed tomography (SPECT) before CEA in 500 patients with ipsilateral internal carotid artery stenosis (>= 70%). CBF measurement using I-123-IMP SPECT was also performed immediately and 3 days after CEA. A region of interest (ROI) was automatically placed in the middle cerebral artery territory in the affected cerebral hemisphere using a three-dimensional stereotactic ROI template. Preoperative decreases in CBF at the resting state [95% confidence intervals (CIs), 0.855 to 0.967; P = 0.0023] and preoperative decreases in CVR to acetazolamide (95% CIs, 0.844 to 0.912; P < 0.0001) were significant independent predictors of post-CEA hyperperfusion. The area under the receiver operating characteristic curve for prediction of the development of post-CEA hyperperfusion was significantly greater for CVR to acetazolamide than for CBF at the resting state (difference between areas, 0.173; P < 0.0001). Sensitivity, specificity, and positive- and negative-predictive values for the prediction of the development of post-CEA hyperperfusion were significantly greater for CVR to acetazolamide than for CBF at the resting state (P < 0.05, respectively). The present study demonstrated that preoperative measurement of CBF with acetazolamide in addition to preoperative measurement of CBF at the resting state increases the predictive accuracy of the development of post-CEA hyperperfusion.	[Oshida, Sotaro; Ogasawara, Kuniaki; Saura, Hiroaki; Yoshida, Koji; Fujiwara, Shunro; Kojima, Daigo; Kobayashi, Masakazu; Yoshida, Kenji; Kubo, Yoshitaka; Ogawa, Akira] Iwate Med Univ, Dept Neurosurg, Morioka, Iwate 0208505, Japan	Ogasawara, K (reprint author), Iwate Med Univ, Dept Neurosurg, 19-1 Uchimaru, Morioka, Iwate 0208505, Japan.	kuogasa@iwate-med.ac.jp			Ministry of Education, Culture, Sports, Science, and Technology of Japan [S1491001]; JSPS KAKENHI [2612345]	This work was partly supported by Grant-in-Aid for Strategic Medical Science Research (S1491001, 2014-2018) from the Ministry of Education, Culture, Sports, Science, and Technology of Japan; JSPS KAKENHI Grant Number 2612345.	Komoribayashi N, 2006, J CEREBR BLOOD F MET, V26, P878, DOI 10.1038/sj.jcbf.9600244; PIEPGRAS DG, 1988, J NEUROSURG, V68, P532, DOI 10.3171/jns.1988.68.4.0532; POWERS WJ, 1985, STROKE, V16, P361; Takeuchi R, 2004, EUR J NUCL MED MOL I, V31, P578, DOI 10.1007/s00259-003-1406-8; Ogasawara K, 2007, J NEUROSURG, V107, P1130, DOI 10.3171/JNS-07/12/1130; GIBBS JM, 1984, LANCET, V1, P310; VORSTRUP S, 1984, J CLIN INVEST, V74, P1634, DOI 10.1172/JCI111579; Chida K, 2009, STROKE, V40, P448, DOI 10.1161/STROKEAHA.108.515775; Ogasawara K, 2003, J NEUROSURG, V99, P504, DOI 10.3171/jns.2003.99.3.0504; Ogasawara K, 2003, J NUCL MED, V44, P520; Ogasawara K, 2005, J NEUROSURG, V102, P38, DOI 10.3171/jns.2005.102.1.0038; Nanba T, 2012, CEREBROVASC DIS, V34, P358, DOI 10.1159/000343505; Yoshida K, 2012, NEUROL MED-CHIR, V52, P154; Hosoda K, 2001, STROKE, V32, P1567; SUNDT TM, 1981, MAYO CLIN PROC, V56, P533; Yoshimoto T, 1997, SURG NEUROL, V48, P132; Rutgers DR, 2000, STROKE, V31, P3021; Ogasawara K, 2004, NEUROSURGERY, V54, P1258, DOI 10.1227/1.NEU.0000120064.55339.F9; BARON JC, 1981, STROKE, V12, P454; Pepe MS, 2005, EPIDEMIOLOGY, V16, P598, DOI 10.1097/01.ede.0000173041.03470.8b; BERNSTEIN M, 1984, NEUROSURGERY, V15, P50; Hirooka R, 2008, J NEUROSURG, V108, P1178, DOI 10.3171/JNS/2008/108/6/1178; Hosoda K, 2005, NEUROSURGERY, V57, P32, DOI 10.1227/01.NEU.0000163088.66798.59; Kobayashi M, 2007, NEUROL MED-CHIR, V47, P121, DOI 10.2176/nmc.47.121; Kobayashi M, 2009, NEUROL RES, V31, P728, DOI 10.1179/174313209X382269; Kuroda H, 2012, CLIN NUCL MED, V37, P235, DOI 10.1097/RLU.0b013e31823ea69f; Kuroda S, 2006, STROKE, V37, P393, DOI 10.1161/01.STR.0000198878.66000.4e; TAYLOR DW, 1991, NEW ENGL J MED, V325, P445; Nishimiya M, 2008, ANN NUCL MED, V22, P921, DOI 10.1007/s12149-008-0211-7; Ogasawara K, 2004, NEUROSURGERY, V55, P1060, DOI 10.1227/01.NEU.0000140838.27450.63; Ogasawara K, 2006, NEUROL MED-CHIR, V46, P161, DOI 10.2176/nmc.46.161; REIGEL MM, 1987, J VASC SURG, V5, P628; Saito H, 2011, NEUROL MED-CHIR, V51, P479; Sato Y, 2011, J NUCL MED, V52, P1400, DOI 10.2967/jnumed.111.087940; Spetzler R F, 1978, Clin Neurosurg, V25, P651; Suga Y, 2007, STROKE, V38, P2712, DOI 10.1161/STROKEAHA.107.483495; Yamauchi H, 2011, J CEREBR BLOOD F MET, V31, P953, DOI 10.1038/jcbfm.2010.176; Yoshimoto T, 1997, SURG NEUROL, V48, P138, DOI 10.1016/S0090-3019(97)90106-3	38	0	0	JAPAN NEUROSURGICAL SOC	TOKYO	5-25-16 HONGO, BUNKYO-KU, TOKYO, 113-0033, JAPAN	0470-8105	1349-8029		NEUROL MED-CHIR	Neurol. Med.-Chir.	FEB	2015	55	2					141	148		10.2176/nmc.oa.2014-0269		8	Clinical Neurology; Surgery	Neurosciences & Neurology; Surgery	CC1DS	WOS:000350082000005		
J	Hashimura, N; Mutoh, T; Matsuda, K; Matsumoto, K				Hashimura, Naoki; Mutoh, Tatsushi; Matsuda, Kazuya; Matsumoto, Keigo			Evaluation and Management of Plaque Protrusion or Thrombus following Carotid Artery Stenting	NEUROLOGIA MEDICO-CHIRURGICA			English	Article						carotid artery stenting; plaque rupture; complication	CLOSED-CELL STENTS; CEREBRAL EMBOLISM; HIGH-RISK; ANGIOPLASTY; STENOSIS; ANGIOGRAPHY; DESIGN; STROKE	Carotid artery stenting (CAS) has become a common treatment for carotid artery stenosis. However, complications, such as an ischemic event, can occur with CAS during intra- and post-operative periods. Among these ischemic complications, plaque protrusion into the stent and thrombus on the stent have occurred after CAS. We retrospectively evaluated the temporal profile and treatment options for these complications in 32 consecutive cases who underwent CAS at our hospital between April 2009 and December 2011. The cases were evaluated pre-operatively for risk factors, as well as the plaque morphology and characteristics using computed tomographic angiography (CTA), ultrasound (US), and magnetic resonance imaging (MM). Post-operatively, lesions were examined by CTA and/or US within 1 week of CAS. As a result, among the 32 cases, 8 experienced plaque protrusions or thrombus, which were treated with medication (anti-platelet and/or anti-coagulation reinforcement). In 7 of these 8 cases, the plaque protrusion or thrombus was stabilized with medication alone. However, the remaining case showed growth and migration of the plaque protrusion or thrombus when treated with medication alone, and therefore, required further endovascular treatment. We identified that a history of symptomatic cerebral infarction and plaques with ulceration were risk factors for plaque protrusion or thrombus formation after CAS, and pre dilatation can decrease the risk of these complications. Medication was effective in most cases of plaque protrusion or thrombus; however, further endovascular treatment was required when medication alone was unsuccessful.	[Hashimura, Naoki; Matsuda, Kazuya; Matsumoto, Keigo] JCHO Kobe Cent Hosp, Dept Neurosurg, Kobe, Hyogo 6511145, Japan; [Mutoh, Tatsushi] Tohoku Univ, Inst Dev Aging & Canc, Sendai, Miyagi 980, Japan	Hashimura, N (reprint author), JCHO Kobe Cent Hosp, Dept Neurosurg, Kita Ku, 2-1-1 Souyama Cho, Kobe, Hyogo 6511145, Japan.	hsmrnok1226@gmail.com					Gronholdt MLM, 2001, CIRCULATION, V104, P68, DOI 10.1161/hc2601.091704; Polak JF, 1998, RADIOLOGY, V208, P649; Diethrich EB, 2007, J ENDOVASC THER, V14, P676, DOI 10.1583/1545-1550(2007)14[676:VHIUAO]2.0.CO;2; Takigawa T, 2009, NEUROL MED-CHIR, V49, P413; Silvestrini M, 2013, J CEREBR BLOOD F MET, V33, P619, DOI 10.1038/jcbfm.2013.5; Brott TG, 2010, NEW ENGL J MED, V363, P11, DOI 10.1056/NEJMoa0912321; Yoshimura S, 2011, STROKE, V42, P3132, DOI 10.1161/STROKEAHA.111.615708; Nighoghossian N, 2005, STROKE, V36, P2764, DOI 10.1161/01.STR.0000190895.51934.43; Biasi GM, 2004, CIRCULATION, V110, P756, DOI 10.1161/01.CIR.0000138103.91187.E3; Timaran CH, 2011, J VASC SURG, V54, P1310, DOI 10.1016/j.jvs.2011.05.013; Saam T, 2007, RADIOLOGY, V244, P64, DOI 10.1148/radiol.2441051769; Tadros RO, 2012, J VASC SURG, V56, P89, DOI 10.1016/j.jvs.2011.12.077; Aikawa H, 2008, RADIAT MED, V26, P318, DOI 10.1007/s11604-008-0231-1; Ferrero E, 2010, INTERACT CARDIOV TH, V11, P254, DOI 10.1510/icvts.2010.241976; Hart JP, 2010, J CARDIOVASC SURG, V51, P799; Kobayashi E, 2000, INTERV NEURORADIOL, V6, P165; Kuroiwa T, 2004, SURG CEREBRAL STROKE, V32, P107, DOI 10.2335/scs.32.107; Okahara M, 2008, INTERV NEURORADIOL, V14, P41; Qiao Y, 2007, ARTERIOSCL THROM VAS, V27, P1440, DOI 10.1161/ATVBAHA.107.141028	19	0	0	JAPAN NEUROSURGICAL SOC	TOKYO	5-25-16 HONGO, BUNKYO-KU, TOKYO, 113-0033, JAPAN	0470-8105	1349-8029		NEUROL MED-CHIR	Neurol. Med.-Chir.	FEB	2015	55	2					149	154		10.2176/nmc.oa.2014-0105		6	Clinical Neurology; Surgery	Neurosciences & Neurology; Surgery	CC1DS	WOS:000350082000006		
J	Matsubara, N; Miyachi, S; Izumi, T; Yamanouchi, T; Asai, T; Ota, K; Wakabayashi, T				Matsubara, Noriaki; Miyachi, Shigeru; Izumi, Takashi; Yamanouchi, Takashi; Asai, Takumi; Ota, Keisuke; Wakabayashi, Toshihiko			Results and Current Trends of Multimodality Treatment for Infectious Intracranial Aneurysms	NEUROLOGIA MEDICO-CHIRURGICA			English	Article						infectious aneurysm; intracranial; surgery; endovascular treatment; medical treatment	CEREBRAL MYCOTIC-ANEURYSMS; ENDOVASCULAR TREATMENT; CAROTID-ARTERY; MANAGEMENT; EMBOLIZATION; ENDOCARDITIS; SURGERY	The authors retrospectively reviewed their cases of infectious intracranial aneurysms and discuss results and trends of current treatment modalities including medical, neurosurgical, and endovascular. Twenty patients (10 males and 10 females; mean age 46 years) with 23 infectious aneurysms were treated by various treatment modalities during a 15-year period. Fifteen cases (75.0%) were caused by infective endocarditis. Eleven aneurysms (47.8%) were ruptured. Two aneurysms (8.7%) presented a mass effect and 7 (30.4%) were unruptured and asymptomatic. The average aneurysm size was 6.5 +/- 4.8 mm (range 1-22 mm). The aneurysms were located in proximal cerebral circulation in 7 (30.4%) and distal in 16 (69.6%). Six (26.1%) aneurysms were treated surgically (5: trapping, 1: neck clipping), 10 (43.5%) endovascularly (7: trapping, 2: proximal occlusion, 1: saccular coiling), and the remaining 7 (30.4%) medically. Endovascular treatment was gradually increased with time. Medical and surgical treatments were continuously performed during the study period. Surgery was preferred for the patient with intraparenchymal hematoma or treated by bypass surgery. Three periprocedural minor complications occurred in endovascular treatment. There was one postoperative infarction with permanent deficit developed from surgical treatment. During the follow-up period (mean 28.8 months), none of the aneurysms presented a recurrence or rebleeding. Thirteen patients (65.0%) had favorable clinical outcomes (modified Rankin Scale: 0-2), although four (20.0%) had poor outcomes (modified Rankin Score: 5-6). A multimodal approach for the management of infectious aneurysms achieved satisfactory results. Endovascular intervention is a feasible and efficacious treatment option and surgical intervention is still an indispensable procedure.	[Matsubara, Noriaki; Miyachi, Shigeru; Izumi, Takashi; Yamanouchi, Takashi; Asai, Takumi; Ota, Keisuke; Wakabayashi, Toshihiko] Nagoya Univ, Grad Sch Med, Dept Neurosurg, Nagoya, Aichi 4668550, Japan; [Miyachi, Shigeru] Osaka Med Coll, Dept Neurosurg & Endovasc Neurosurg, Takatsuki, Osaka 569, Japan	Matsubara, N (reprint author), Nagoya Univ, Grad Sch Med, Dept Neurosurg, Showa Ku, 65 Tsurumai Cho, Nagoya, Aichi 4668550, Japan.	mnoriaki0817@yahoo.co.jp			Japanese Society for Neuroendovascular Therapy Chubu District	This study was supported by Japanese Society for Neuroendovascular Therapy Chubu District. The authors wish to thank Akiyo Sadato MD (Department of Neurosurgery, Fujita Health University, Toyoake); Hiroshi Iizuka MD (Department of Neurosurgery, Komaki City Hospital, Komaki); Hisaya Hiramatsu MD (Department of Neurosurgery, Hamamatsu University School of Medicine, Hamamatsu); Mitsuhito Mase MD (Department of Neurosurgery, Nagoya City University, Nagoya); Naoyuki Uchiyama MD (Department of Neurosurgery, Kanazawa University, Kanazawa); Shinichi Yoshimura MD (Department of Neurosurgery, Gifu University, Gifu); and Takao Kojima MD (Department of Neurosurgery, Japanese Red Cross Nagoya Daini Hospital, Nagoya) for their generous support in this study.	AHMADI J, 1993, NEUROSURGERY, V32, P45; Ahmadi J, 1993, NEUROSURGERY, V32, P49; Allen LM, 2013, AM J NEURORADIOL, V34, P823, DOI 10.3174/ajnr.A3302; Peters PJ, 2006, LANCET INFECT DIS, V6, P742, DOI 10.1016/S1473-3099(06)70631-4; Chapot R, 2002, RADIOLOGY, V222, P389, DOI 10.1148/radiol.2222010432; Nakahara I, 2006, SURG NEUROL, V66, P405, DOI 10.1016/j.surneu.2006.01.021; Kannoth S, 2009, NEUROCRIT CARE, V11, P120, DOI 10.1007/s12028-009-9208-x; Hot A, 2007, CLIN INFECT DIS, V45, pE156, DOI 10.1086/523005; Zanaty M, 2013, BIOMED RES INT, DOI 10.1155/2013/151643; Ducruet AF, 2010, NEUROSURG REV, V33, P37, DOI 10.1007/s10143-009-0233-1; Appelboom G, 2010, NEUROSURGERY, V66, pE623, DOI 10.1227/01.NEU.0000365370.82554.08; Asai T, 2002, EUR J CARDIO-THORAC, V21, P948, DOI 10.1016/S1010-7940(02)00092-1; Barrow DL, 1990, NEUROSURGERY, V27, P572; BARROW DL, 1990, NEUROSURGERY, V27, P562; Chun JY, 2001, NEUROSURGERY, V48, P1203, DOI 10.1097/00006123-200106000-00001; DAY AL, 1981, NEUROSURGERY, V9, P583; Dhomne S, 2008, BRIT J NEUROSURG, V22, P46, DOI 10.1080/02688690701593561; Ding D, 2014, J CLIN NEUROSCI, V21, P1163, DOI 10.1016/j.jocn.2013.11.013; EGUCHI T, 1982, J NEUROSURG, V56, P443, DOI 10.3171/jns.1982.56.3.0443; Ghali MGZ, 2013, CLIN NEUROL NEUROSUR, V115, P1927, DOI 10.1016/j.clineuro.2013.07.025; Grandhi R, 2014, J NEUROINTERV SURG, V6, P353, DOI 10.1136/neurintsurg-2013-010755; Gross BA, 2013, NEUROSURG REV, V36, P11, DOI 10.1007/s10143-012-0414-1; Kojima Y, 1989, Neurol Med Chir (Tokyo), V29, P202, DOI 10.2176/nmc.29.202; Ota T, 2012, BRIT J NEUROSURG, V26, P767, DOI 10.3109/02688697.2011.645918; Phuong LK, 2002, NEUROSURGERY, V51, P1145, DOI 10.1227/01.NEU.0000032538.92816.59	25	0	0	JAPAN NEUROSURGICAL SOC	TOKYO	5-25-16 HONGO, BUNKYO-KU, TOKYO, 113-0033, JAPAN	0470-8105	1349-8029		NEUROL MED-CHIR	Neurol. Med.-Chir.	FEB	2015	55	2					155	162		10.2176/nmc.oa.2014-0197		8	Clinical Neurology; Surgery	Neurosciences & Neurology; Surgery	CC1DS	WOS:000350082000007		
J	Miyamoto, N; Naito, I; Shimizu, T; Yoshimoto, Y				Miyamoto, Naoko; Naito, Isao; Shimizu, Tatsuya; Yoshimoto, Yuhei			Efficacy and Limitations of Transarterial Acrylic Glue Embolization for Intracranial Dural Arteriovenous Fistulas	NEUROLOGIA MEDICO-CHIRURGICA			English	Article						acrylic glue; dural arteriovenous fistula; embolization	CAROTID-CAVERNOUS FISTULAS; CORTICAL VENOUS DRAINAGE; N-BUTYL-CYANOACRYLATE; ONYX EMBOLIZATION; ENDOVASCULAR MANAGEMENT; EXPERIENCE; CLASSIFICATION; OUTCOMES	The efficacy and limitations of transarterial acrylic glue embolization for the treatment of intracranial dural arteriovenous fistulas (DAVFs) were investigated. Thirty-four DAVFs treated by transarterial embolization using n-butyl cyanoacrylate were retrospectively reviewed. The locations of DAVFs were the transverse-sigmoid sinus in 11, tentorium in 10, cranial vault in 9, and superior sagittal sinus, jugular bulb, foramen magnum, and middle cranial fossa in 1 each. Borden classification was type I in 7, type II in 3, and type III in 24. Eight patients had undergone prior transvenous coil embolization. Complete obliteration rate was 56% immediately after embolization, 71% at follow-up angiography, and 85% after additional treatments (1 transvenous embolization and 4 direct surgery). Complications occurred in three patients, consisting of asymptomatic vessel perforations during cannulation in two patients and leakage of contrast medium resulting in medullary infarction in one patient. Transarterial glue embolization is highly effective for Borden type III DAVF with direct cortical venous drainage, but has limitations for Borden type I and II DAVFs in which the affected sinus is part of the normal venous circulation. Onyx is a new liquid embolic material and is becoming the treatment of choice for DAVE The benefits of glue embolization compared to Onyx embolization are high thrombogenicity, and relatively low risks of cranial nerve palsies and of excessive migration into the draining veins of high flow fistula. Transarterial glue embolization continues to be useful for selected patients, and complete cure can be expected in most patients with fewer complications if combined with transvenous embolization or direct surgery.	[Miyamoto, Naoko; Naito, Isao] Geriatr Res Inst & Hosp, Dept Neurosurg, Maebashi, Gunma 3710847, Japan; [Shimizu, Tatsuya; Yoshimoto, Yuhei] Gunma Univ, Grad Sch Med, Dept Neurosurg, Maebashi, Gunma 371, Japan	Miyamoto, N (reprint author), Geriatr Res Inst & Hosp, Dept Neurosurg, 3-26-8 Ootomo Cho, Maebashi, Gunma 3710847, Japan.	naochop96201088@yahoo.co.jp					Adamczyk P, 2012, NEUROSURG FOCUS, V32, DOI 10.3171/2012.2.FOCUS1224; Rabinov JD, 2013, J NEUROINTERV SURG, V5, P306, DOI 10.1136/neurintsurg-2011-010237; Abud TG, 2011, AM J NEURORADIOL, V32, P2185, DOI 10.3174/ajnr.A2702; Cognard C, 2008, AM J NEURORADIOL, V29, P235, DOI 10.3174/ajnr.A0817; Li MH, 2008, ACTA NEUROCHIR, V150, P1149, DOI 10.1007/s00701-008-0133-0; Guedin P, 2010, J NEUROSURG, V112, P603, DOI 10.3171/2009.7.JNS08490; Natarajan SK, 2010, WORLD NEUROSURG, V73, P365, DOI 10.1016/j.wneu.2010.01.009; Satomi J, 2002, J NEUROSURG, V97, P767, DOI 10.3171/jns.2002.97.4.0767; Nelson PK, 2003, J NEUROSURG, V98, P498, DOI 10.3171/jns.2003.98.3.0498; Jittapiromsak P, 2013, NEURORADIOLOGY, V55, P345, DOI 10.1007/s00234-012-1107-8; Hu YC, 2011, J NEUROINTERV SURG, V3, P5, DOI 10.1136/jnis.2010.003707; De Keukeleire K, 2011, J NEUROINTERV SURG, V3, P224, DOI 10.1136/jnis.2010.004119; van Rooij WJ, 2006, NEURORADIOLOGY, V48, P737, DOI 10.1007/s00234-006-0118-8; Jiang CH, 2009, NEURORADIOLOGY, V51, P103, DOI 10.1007/s00234-008-0473-8; BORDEN JA, 1995, J NEUROSURG, V82, P166, DOI 10.3171/jns.1995.82.2.0166; Elhammady MS, 2010, J NEUROSURG, V112, P589, DOI 10.3171/2009.6.JNS09132; Huang QH, 2009, NEUROSURGERY, V65, P287, DOI 10.1227/01.NEU.0000348298.75128.D0; COGNARD C, 1995, RADIOLOGY, V194, P671; Jiang CH, 2011, EUR J RADIOL, V80, P767, DOI 10.1016/j.ejrad.2010.09.045; Kim DJ, 2011, RADIOLOGY, V258, P554, DOI 10.1148/radiol.10100755; Lv XL, 2011, EUR J RADIOL, V80, pE385, DOI 10.1016/j.ejrad.2010.08.029; Maimon S, 2011, AM J NEURORADIOL, V32, P2180, DOI 10.3174/ajnr.A2728; Miyamoto N, 2010, SURG CEREBRAL STROKE, V38, P235; Moore C, 2006, NEURORADIOLOGY, V48, P327, DOI 10.1007/s00234-006-0059-2; Nogueira RG, 2008, AM J NEURORADIOL, V29, P91, DOI 10.3174/ajnr.A0768; Puffer RC, 2012, NEUROSURG FOCUS, V32, DOI 10.3171/2011.12.FOCUS11323; Rangel-Castilla L, 2014, J NEUROINTERV SURG, V6, P607, DOI 10.1136/neurintsurg-2013-010894; van Rooij WJ, 2010, AM J NEURORADIOL, V31, P1516, DOI 10.3174/ajnr.A2101; Wang H, 2009, INTERV NEURORADIOL, V15, P301	29	1	1	JAPAN NEUROSURGICAL SOC	TOKYO	5-25-16 HONGO, BUNKYO-KU, TOKYO, 113-0033, JAPAN	0470-8105	1349-8029		NEUROL MED-CHIR	Neurol. Med.-Chir.	FEB	2015	55	2					163	172		10.2176/nmc.oa.2014-0223		10	Clinical Neurology; Surgery	Neurosciences & Neurology; Surgery	CC1DS	WOS:000350082000008		
J	Goto, H; Ishikawa, O; Nomura, M; Tanaka, K; Nomura, S; Maeda, K				Goto, Haruo; Ishikawa, Osamu; Nomura, Masashi; Tanaka, Kentaro; Nomura, Seiji; Maeda, Keiichiro			Magnetic Resonance Imaging Findings Predict the Recurrence of Chronic Subdural Hematoma	NEUROLOGIA MEDICO-CHIRURGICA			English	Article						chronic subdural hematoma; magnetic resonance imaging; recurrence; antiplatelet or anticoagulant drug	INDEPENDENT PREDICTORS	The exact predictive factors for postoperative recurrence of chronic subdural hematoma (CSDH) are still unknown. Based on the preoperative magnetic resonance imaging (MRI), low recurrence rate of T-1-hyperintensity hematoma was previously reported. We investigated the other types of radiological findings which are related to the recurrence rate of CSDH in large number of patients analyzed by multi-variate logistic regression model. Preoperative MM and postoperative computed tomography (CT) were performed and the influence of the preoperative use of antiplatelet or anticoagulant drugs was also studied. The overall recurrence rate was 9.3% (47 of 505 hematomas). The MRI T-1-iso/hypointensity group showed a significantly higher recurrence rate (18.2%, 29 of 159) compared to the other groups (5.2%, 18 of 346; p < 0.001). Multivariate logistic regression analysis showed T-1 classification was the solo significant prognostic predictor among various factors such as bilateral hematoma, antiplatelet or anticoagulant drug usage, residual hematoma on postoperative CT, and MRI classification (p < 0.001): adjusted odds ratio for the recurrence in T-1-iso/hypointensity group relative to the T-1-hyperintensity group was 5.58 [95% confidence interval (CI), 2.09-14.861 (p = 0.001). Postoperative residual hematoma and antiplatelet or anticoagulant drug usage did not increase the recurrence risk. The preoperative MM findings, especially T1WI findings, have predictive value for postoperative recurrence of CSDH and the T-1-iso/hypointensity group can be assumed to be a high recurrence risk group.	[Goto, Haruo; Ishikawa, Osamu; Nomura, Masashi; Tanaka, Kentaro; Nomura, Seiji; Maeda, Keiichiro] Aizu Chuo Hosp, Dept Neurosurg, Aizu Wakamatsu, Fukushima 9658611, Japan	Ishikawa, O (reprint author), Aizu Chuo Hosp, Dept Neurosurg, 1-1 Tsuruga, Aizu Wakamatsu, Fukushima 9658611, Japan.	oishikawa-tky@umin.ac.jp					Forster MT, 2010, J CLIN NEUROSCI, V17, P975, DOI 10.1016/j.jocn.2009.11.023; Yamashima T, 2000, NEUROSURG CLIN N AM, V11, P413; Yamamoto H, 2003, J NEUROSURG, V98, P1217, DOI 10.3171/jns.2003.98.6.1217; Oishi M, 2001, NEUROL MED-CHIR, V41, P382, DOI 10.2176/nmc.41.382; Tsutsumi K, 1997, J NEUROSURG, V87, P870, DOI 10.3171/jns.1997.87.6.0870; Tokmak M, 2007, J NEUROSURG, V107, P290, DOI 10.3171/JNS-07/08/0290; Chon KH, 2012, ACTA NEUROCHIR, V154, P1541, DOI 10.1007/s00701-012-1399-9; Torihashi K, 2008, NEUROSURGERY, V63, P1125, DOI 10.1227/01.NEU.0000335782.60059.17; HOSODA K, 1987, J NEUROSURG, V67, P677, DOI 10.3171/jns.1987.67.5.0677; Hong HJ, 2009, SURG NEUROL, V71, P161, DOI 10.1016/j.surneu.2008.01.023; Fujisawa H, 2006, NEUROL MED-CHIR, V46, P333, DOI 10.2176/nmc.46.333; KAWAKAMI Y, 1989, NEUROSURGERY, V25, P25; Loh Joon-Khim, 1998, Kaohsiung Journal of Medical Sciences, V14, P25; Rust T, 2006, J CLIN NEUROSCI, V13, P823, DOI 10.1016/j.jocn.2004.12.013; Stanisic M, 2005, ACTA NEUROCHIR, V147, P1249, DOI 10.1007/s00701-005-0616-1; Weigel R, 2007, NEUROSURGERY, V61, P788, DOI 10.1227/01.NEU.0000280072.36339.9D	16	0	0	JAPAN NEUROSURGICAL SOC	TOKYO	5-25-16 HONGO, BUNKYO-KU, TOKYO, 113-0033, JAPAN	0470-8105	1349-8029		NEUROL MED-CHIR	Neurol. Med.-Chir.	FEB	2015	55	2					173	178		10.2176/nmc.oa.2013-0390		6	Clinical Neurology; Surgery	Neurosciences & Neurology; Surgery	CC1DS	WOS:000350082000009		
J	Matsumoto, H; Yoshida, Y				Matsumoto, Hiroaki; Yoshida, Yasuhisa			Posttraumatic Cerebellar Infarction after Repeated Sport-related Minor Head Injuries in a Young Adult: A Case Report	NEUROLOGIA MEDICO-CHIRURGICA			English	Article						cerebellar infarction; minor head injury; arterial spasm; traumatic brain injury; sport-related head injury	VERTEBRAL ARTERY DISSECTION; CEREBRAL INFARCTION; INTERNAL CAPSULE; BASAL GANGLIA; FOOTBALL; CONCUSSION; CHILDHOOD; STATEMENT; OCCLUSION; CHILDREN	A healthy 23-year-old man suffered helmet-to-helmet collisions with an opponent during American football game twice within 3 days. He then experienced continuous vomiting and dizziness. Magnetic resonance imaging revealed acute infarction in the right cerebellar hemisphere, and magnetic resonance angiography revealed transient stenosis of the right superior cerebellar artery. Although minor head injury is not usually accompanied by complications, posttraumatic ischemic stroke has been reported on rare occasions. We report a case of cerebellar infarction after repeated sports-related minor head injuries in a young adult and discuss the etiology.	[Matsumoto, Hiroaki; Yoshida, Yasuhisa] Eisyokai Yoshida Hosp, Dept Neurosurg, Kobe, Hyogo, Japan	Matsumoto, H (reprint author), 9-2-6 Daikai Dori,Hyogo Ku, Kobe, Hyogo 6520803, Japan.	hiroaki-matsu@umin.ac.jp					Agrawal Amit, 2010, J Emerg Trauma Shock, V3, P207, DOI 10.4103/0974-2700.62102; Ahn JY, 2006, CHILD NERV SYST, V22, P1493, DOI 10.1007/s00381-006-0157-9; Shahlaie K, 2011, J NEUROSURG, V115, P602, DOI 10.3171/2011.5.JNS101667; Harmon KG, 2013, BRIT J SPORT MED, V47, P15, DOI 10.1136/bjsports-2012-091941; Muratsu H, 2005, J SPINAL DISORD TECH, V18, P293; Bartsch A, 2012, J NEUROSURG, V116, P222, DOI 10.3171/2011.9.JNS111059; McCrory P, 2013, BRIT J SPORT MED, V47, P250, DOI 10.1136/bjsports-2013-092313; Rowson S, 2013, ANN BIOMED ENG, V41, P873, DOI 10.1007/s10439-012-0731-0; Crisco JJ, 2011, J BIOMECH, V44, P2673, DOI 10.1016/j.jbiomech.2011.08.003; Giza CC, 2013, NEUROLOGY, V80, P2250, DOI 10.1212/WNL.0b013e31828d57dd; Bailes JE, 2013, J NEUROSURG, V119, P1235, DOI 10.3171/2013.7.JNS121822; Brosch JR, 2011, J CHILD NEUROL, V26, P1493, DOI 10.1177/0883073811418114; Byrd Lorraine Rose, 1996, Journal of the American Osteopathic Association, V96, P245; Clark D, 2012, NEUROLOGY, V78, pE140, DOI 10.1212/WNL.0b013e31825bc685; DHARKER SR, 1993, NEUROSURGERY, V33, P863; Duval E L, 1998, Eur J Emerg Med, V5, P259; Galtes I, 2012, FORENSIC SCI INT, V214, pE12, DOI 10.1016/j.forsciint.2011.07.005; HAUG RH, 1989, J ORAL MAXIL SURG, V47, P1192, DOI 10.1016/0278-2391(89)90012-8; Kieslich M, 2002, J NEUROL NEUROSUR PS, V73, P13, DOI 10.1136/jnnp.73.1.13; Matsumoto H, 2011, CHILD NERV SYST, V27, P1169, DOI 10.1007/s00381-011-1426-9; Muthukumar N, 1996, BRIT J NEUROSURG, V10, P391, DOI 10.1080/02688699647320; Nabika S, 2007, PEDIATR NEUROSURG, V43, P312, DOI 10.1159/000103313; Nagahiro S, 2013, NEUROTRAUMATOLOGY, V36, P119; Peach G, 2013, ANN R COLL SURG ENGL, V92, pW3; Podberesky DJ, 2009, PEDIATR RADIOL, V39, P1264, DOI 10.1007/s00247-009-1359-6; Sepelyak K, 2010, EUR J PEDIATR, V169, P557, DOI 10.1007/s00431-009-1066-1; Shaffer L, 2003, ARCH DIS CHILD, V88, P267, DOI 10.1136/adc.88.3.267; Slemmer JE, 2002, BRAIN, V125, P2699, DOI 10.1093/brain/awf271; SYMON L, 1967, J NEUROL NEUROSUR PS, V30, P497, DOI 10.1136/jnnp.30.6.497; Taniura S, 2008, J TRAUMA, V64, P1674, DOI 10.1097/01.ta.0000233741.95875.6c; Tekin S, 1997, PEDIATR NEUROL, V16, P67, DOI 10.1016/S0887-8994(96)00252-4; TYAGI AK, 1995, BRIT J NEUROSURG, V9, P683, DOI 10.1080/02688699550040990; Weinstein E, 2013, J NEUROSURG-PEDIATR, V11, P331, DOI 10.3171/2012.11.PEDS12343	33	1	1	JAPAN NEUROSURGICAL SOC	TOKYO	5-25-16 HONGO, BUNKYO-KU, TOKYO, 113-0033, JAPAN	0470-8105	1349-8029		NEUROL MED-CHIR	Neurol. Med.-Chir.	FEB	2015	55	2					179	182		10.2176/nmc.cr.2014-0094		4	Clinical Neurology; Surgery	Neurosciences & Neurology; Surgery	CC1DS	WOS:000350082000010		
J	Belobrajdic, DP; Jobling, SA; Morell, MK; Taketa, S; Bird, AR				Belobrajdic, Damien P.; Jobling, Stephen A.; Morell, Matthew K.; Taketa, Shin; Bird, Anthony R.			Wholegrain barley beta-glucan fermentation does not improve glucose tolerance in rats fed a high-fat diet	NUTRITION RESEARCH			English	Article						beta-Glucan; Barley; Incretin; Satiety; Glycemic index; SCFA; Wholegrain	INSULIN-RESISTANCE; GLYCEMIC INDEX; CEREAL-GRAINS; WOMEN; FIBER; CONSUMPTION; OBESITY; STARCH; BREAD; FOODS	Fermentation of oat and barley beta-glucans is believed to mediate in part their metabolic health benefits, but the exact mechanisms remain unclear. In this study, we sought to test the hypothesis that barley p-glucan fermentation raises circulating incretin hormone levels and improves glucose control, independent of other grain components. Male Sprague-Dawley rats (n = 30) were fed a high-fat diet for 6 weeks and then randomly allocated to 1 of 3 dietary treatments for 2 weeks. The low-(LBG, 0% beta-glucan) and high-(HBG, 3% beta-glucan) p-glucan diets contained 25% wholegrain barley and similar levels of insoluble dietary fiber, available carbohydrate, and energy. A low-fiber diet (basal) was included for comparison. Immediately prior to the dietary intervention, gastric emptying rate (using the C-13-octanoic breath test) and postprandial glycemic response of each diet were determined. At the end of the study, circulating gut hormone levels were determined; and a glucose tolerance test was performed. The rats were then killed, and indices of cecal fermentation were assessed. Diet did not affect live weight; however, the HBG diet, compared to basal and LBG, reduced food intake, tended to slow gastric emptying, increased cecal digesta mass and individual and total short-chain fatty acid pools, and lowered digesta pH. In contrast, circulating levels of glucose, insulin, gastric-inhibitory peptide, and glucagon-like peptide-1, and glucose tolerance were unaffected by diet. In conclusion, wholegrain barley p-glucan suppressed feed intake and increased cecal fermentation but did not improve postprandial glucose control or insulin sensitivity. Crown Copyright (C) 2015 Published by Elsevier Inc. All rights reserved.	[Belobrajdic, Damien P.; Morell, Matthew K.; Bird, Anthony R.] CSIRO, Food & Nutr Flagship, Clayton, Vic, Australia; [Jobling, Stephen A.] CSIRO, Agr Flagship, Canberra, ACT 2601, Australia; [Taketa, Shin] Okayama Univ, Inst Plant Sci & Resources, Kurashiki, Okayama 7100046, Japan	Belobrajdic, DP (reprint author), POB 10041, Adelaide, BC 5000, Australia.	damien.belobrajdic@csiro.au; steve.jobling@csiro.au; matthew.morell@csiro.au; staketa@rib.okayama-u.ac.jp; tony.bird@csiro.au			CSIRO Food Futures Flagship	Financial support was provided by the CSIRO Food Futures Flagship.	American Diabetes Association (ADA), 2011, DIABETES CARE S1, V34, pS11, DOI DOI 10.2337/DC11-S011; Jenkins AL, 2002, EUR J CLIN NUTR, V56, P622, DOI 10.1038/sj.ejcn.1601367; Choi JS, 2010, MOL NUTR FOOD RES, V54, P1004, DOI 10.1002/mnfr.200900127; Sayar S, 2007, J AGR FOOD CHEM, V55, P5306, DOI 10.1021/jf070240z; Schirra J, 2005, REGUL PEPTIDES, V128, P109, DOI 10.1016/j.regpep.2004.06.018; Belobrajdic DP, 2012, NUTR RES, V32, P599, DOI 10.1016/j.nutres.2012.06.009; Harris KA, 2010, CURR ATHEROSCLER REP, V12, P368, DOI 10.1007/s11883-010-0136-1; Venn BJ, 2004, EUR J CLIN NUTR, V58, P1443, DOI 10.1038/sj.ejcn.1601995; Granfeldt Y, 2008, EUR J CLIN NUTR, V62, P600, DOI 10.1038/sj.ejcn.1602747; Cavallero A, 2002, J CEREAL SCI, V36, P59, DOI 10.1006/jcrs.2002.0454; Reyna-Villasmil Nadia, 2007, Am J Ther, V14, P203, DOI 10.1097/01.pap.0000249917.96509.e7; Hooda S, 2010, J NUTR, V140, P1564, DOI 10.3945/jn.110.122721; Schulze MB, 2007, ARCH INTERN MED, V167, P956, DOI 10.1001/archinte.167.9.956; Aldughpassi A, 2012, J NUTR, V142, P1666, DOI 10.3945/jn.112.161372; Lin N, 2013, MOL NUTR FOOD RES, V57, P1291, DOI 10.1002/mnfr.201200695; Vitaglione P, 2008, TRENDS FOOD SCI TECH, V19, P451, DOI 10.1016/j.tifs.2008.02.005; Liatis S, 2009, DIABETES METAB, V35, P115, DOI 10.1016/j.diabet.2008.09.004; Robitaille J, 2005, ANN NUTR METAB, V49, P141, DOI 10.1159/000086149; Bartlomiej S, 2012, FOOD SCI TECHNOL INT, V18, P559, DOI 10.1177/1082013211433079; Cloetens L, 2012, NUTR REV, V70, P444, DOI 10.1111/j.1753-4887.2012.00494.x; Behall KM, 2006, DIABETES CARE, V29, P976, DOI 10.2337/dc05-2012; Lutsey PL, 2007, BRIT J NUTR, V98, P397, DOI 10.1017/S0007114507700715; Finocchiaro F, 2012, INT J FOOD SCI NUTR, V63, P23, DOI 10.3109/09637486.2011.593504; Pereira MA, 2002, AM J CLIN NUTR, V75, P848; GHOOS YF, 1993, GASTROENTEROLOGY, V104, P1640; Vitaglione P, 2009, APPETITE, V53, P338, DOI 10.1016/j.appet.2009.07.013; Widanagamage RD, 2009, INT J FOOD SCI NUTR, V60, P215, DOI 10.1080/09637480902849195; Arora T, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043263; Beck EJ, 2010, BRIT J NUTR, V103, P1212, DOI 10.1017/S0007114509992856; Behall KM, 2004, AM J CLIN NUTR, V80, P1185; Belobrajdic DP, 2013, NUTR J, V12, DOI 10.1186/1475-2891-12-62; Belobrajdic DP, 2012, NUTR METAB, V9, DOI 10.1186/1743-7075-9-93; Bird AR, 2004, J NUTR, V134, P831; Brockman DA, 2012, EUR J NUTR, V52, P1743; de Munter JSL, 2007, PLOS MED, V4, P1385, DOI 10.1371/journal.pmed.0040261; Jang Y, 2001, ARTERIOSCL THROM VAS, V21, P2065, DOI 10.1161/hq1201.100258; Jha R, 2010, ANIMAL, V4, P724, DOI 10.1017/S1751731109991510; Liljeberg HGM, 1996, J NUTR, V126, P458; Maki KC, 2007, EUR J CLIN NUTR, V61, P786, DOI 10.1038/sj.ejcn.1602562; Priebe MG, 2008, COCHRANE DB SYST REV, P1; Rave K, 2007, BRIT J NUTR, V98, P929, DOI 10.1017/S0007114507749267; Smith CE, 2011, NUTR RES REV, V15, P1; Tonooka T, 2009, BREEDING SCI, V59, P47, DOI 10.1270/jsbbs.59.47; Wolever TMS, 2006, GLYCAEMIC INDEX: A PHYSIOLOGICAL CLASSIFICATION OF DIETARY CARBOHYDRATE, P1, DOI 10.1079/9781845930516.0000	44	0	0	PERGAMON-ELSEVIER SCIENCE LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND	0271-5317			NUTR RES	Nutr. Res.	FEB	2015	35	2					162	168		10.1016/j.nutres.2014.12.006		7	Nutrition & Dietetics	Nutrition & Dietetics	CB9EE	WOS:000349934000009		
J	Kumagai, I; Takahashi, Y; Murai, Y				Kumagai, Ichiro; Takahashi, Yoshiaki; Murai, Yuichi			Power-saving device for air bubble generation using a hydrofoil to reduce ship drag: Theory, experiments, and application to ships	OCEAN ENGINEERING			English	Article						Ship; Drag reduction; Hydrofoil; Multiphase flow; Bubble	RESISTANCE; BREAKING; FLOWS	We have developed a new power-saving device to reduce the drag of a ship's hull using small bubbles. The device reduces the energy required for bubble generation. The device, which consists of angled hydrofoils with air introducers, uses the low-pressure region produced above the hydrofoil as the ship moves forward to drive atmospheric air into the water. We describe the device principles obtained from simple fluid dynamic theory, and, through experiments performed in a small towing tank, show the fundamental air entrainment and bubble generation processes for the flow behavior around a hydrofoil beneath a free surface. We also present a semi-empirical scaling process for practical application to full-size ships to estimate the net drag reduction achieved by this device. Finally, the results of a series of full-scale tests are reported and show that, with correct operation, our device can produce a net power saving of 5-15% for ships. (C) 2014 The Authors. Published by Elsevier Ltd.	[Kumagai, Ichiro] Meisei Univ, Sch Sci & Engn, Hino, Tokyo 1918506, Japan; [Takahashi, Yoshiaki] R&D Engn Inc, Setagaya Ku, Tokyo 1540015, Japan; [Murai, Yuichi] Hokkaido Univ, Fac Engn, Lab Flow Control, Sapporo, Hokkaido 0608628, Japan	Kumagai, I (reprint author), Meisei Univ, Sch Sci & Engn, Hino, Tokyo 1918506, Japan.	ichiro.kumagai@meisei-u.ac.jp	Murai, Yuichi/G-4716-2012		New Energy and Industrial Technology Development Organization (NEDO) of Japan [08 B 36002]; JSPS KAKENHI [24236033]	The authors would like to thank Dr. Yuji Tasaka and Dr. Yoshihiko Oishi for their contributions to the WAIP project. This work was supported by the New Energy and Industrial Technology Development Organization (NEDO) of Japan (Grant no. 08 B 36002) and by JSPS KAKENHI (Grant no. 24236033).	Kitagawa A, 2005, EXP FLUIDS, V38, P466, DOI 10.1007/s00348-004-0926-8; PEREGRINE DH, 1983, ANNU REV FLUID MECH, V15, P149, DOI 10.1146/annurev.fl.15.010183.001053; DUNCAN JH, 1983, J FLUID MECH, V126, P507, DOI 10.1017/S0022112083000294; Ceccio SL, 2010, ANNU REV FLUID MECH, V42, P183, DOI 10.1146/annurev-fluid-121108-145504; Belkoned Marine Service b, 2012, 973A08 BELK MAR SERV; Belkoned Marine Service b, 2008, 973A08 BELK MAR SERV; Jang JH, 2014, INT J NAV ARCH OCEAN, V6, P363, DOI 10.2478/IJNAOE-2013-0185; Kitagawa A, 2001, INT J MULTIPHAS FLOW, V27, P2129, DOI 10.1016/S0301-9322(01)00040-4; Kodama, 2008, P JAP SOC NAV ARCH O, P163; Kumagai I., 2011, VISUAL MECH PROCESSE; Kumagai I., 2010, P INT C SHIP DRAG RE, P93; Kumagai Ichiro, 2011, Journal of Fluid Science and Technology, V6, DOI 10.1299/jfst.6.851; Makiharju SA, 2012, INT J NAV ARCH OCEAN, V4, P412, DOI 10.3744/JNAOE.2012.4.4.412; Mizokami S., 2010, MITSUBISHI HEAVY IND, V47, P41; Mural Y., 2008, Patent Number, Patent No. 4070385; Mural Y., 2014, EXP FLUIDS, V55, P28; Mural Y., 2010, T JAPAN SOC MECH E B, V76, P483; OHASHI H, 1990, EXP FLUIDS, V8, P249; Schlichting H., 1979, MCGRAW HILL SERIES M, P817; Takahashi Y., 2004, United States Patent No, Patent No. [US 6,789,491 B2, 6789491]; Toffoli A, 2010, GEOPHYS RES LETT, V37, DOI 10.1029/2009GL041771; Watanabe O, 1998, J SOC NAVAL ARCH JPN, V183, P53	22	3	3	PERGAMON-ELSEVIER SCIENCE LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND	0029-8018			OCEAN ENG	Ocean Eng.	FEB 1	2015	95						183	194		10.1016/j.oceaneng.2014.11.019		12	Engineering, Marine; Engineering, Civil; Engineering, Ocean; Oceanography	Engineering; Oceanography	CB6LO	WOS:000349738700017		
J	Ando, M; Sakaguchi, Y; Shiihara, Y; Izuhara, K				Ando, Michiyo; Sakaguchi, Yukihiro; Shiihara, Yasufumi; Izuhara, Kumi			Changes experienced by and the future values of bereaved family members determined using narratives from bereavement life review therapy	PALLIATIVE & SUPPORTIVE CARE			English	Article						Bereaved family; Changes; Values; Bereavement life review	PERSPECTIVE	Objectives: The goals of this study were to investigate the changes experienced by bereaved family members in Japan and to determine what activities they would value in the future based on narratives from a bereavement life review, which is a type of psychotherapy used to treat depression and promote spiritual well-being. Methods: The participants were 20 bereaved Japanese family members who underwent two sessions of bereavement life review over a period of two weeks. Results: Using qualitative analysis, we identified four areas of changes ("learning from the deceased's death and self-growth," "healing process," "relating with others," "relating with society," and "performing new family roles") and five categories of valued activities ("continuing grief work," "living with a philosophy," "attaining life roles," "keeping good human relationships," and "enjoying life"). Significance of results: "Learning from the deceased's death and self-growth" and "relating with others" are common in Japan and Western countries, whereas "relating with society," "healing process," and "performing new family roles" are more characteristic of Japan. The strength of bonding with the deceased may influence the values of bereaved family members. We concluded that bereavement life review therapy can contribute positively to their grief work.	[Ando, Michiyo] St Marys Coll, Fac Nursing, Kurume, Fukuoka, Japan; [Sakaguchi, Yukihiro] Kwansai Gakuin Univ, Sch Human Welf Studies, Osaka, Japan; [Shiihara, Yasufumi] Gunma Univ, Grad Sch Hlth Sci, Maebashi, Gumma 371, Japan; [Izuhara, Kumi] Koekisha Co Ltd, Customer Serv Dept, Osaka Head Off, Osaka, Japan	Ando, M (reprint author), St Marys Coll, Tsubukuhonmachi 422, Kurume, Fukuoka, Japan.	andou@st-mary.ac.jp					Ando M, 2012, PALLIAT SUPPORT CARE, V83480S, P1; Ando M., 2013, AM J HOSPICE PALLIAT; Ando M, 2010, J PAIN SYMPTOM MANAG, V40, P453, DOI 10.1016/j.jpainsymman.2009.12.028; Kang J, 2013, PSYCHO-ONCOLOGY, V22, P564, DOI 10.1002/pon.3033; Bonanno GA, 1999, PSYCHOL BULL, V125, P760, DOI 10.1037//0033-2909.125.6.760; Currier JM, 2013, PSYCHOL RELIG SPIRIT, V5, P69, DOI 10.1037/a0027708; Stroebe M, 2007, LANCET, V370, P1960, DOI 10.1016/S0140-6736(07)61816-9; Dyregrov KM, 2011, DEATH STUD, V35, P685, DOI 10.1080/07481187.2011.553310; BERELSON B., 1952, CONTENT ANAL COMMUNI; Bowlby J., 1980, ATTACHMENT LOSS, VIII; Burnell G. M., 1989, CLIN MANAGEMENT BERE; Erikson E. H., 1950, CHILDHOOD SOC; Funashima N., 2001, CHALLENGES QUALITATI; Hanson R.O., 2007, BEREAVEMENT LATE LIF; Higashimura N., 2001, SHINO RINSYO, V24, P69; LEHMAN DR, 1993, J SOC CLIN PSYCHOL, V12, P90; Milberg A, 2011, PALLIAT SUPPORT CARE, V9, P251, DOI 10.1017/S1478951511000204; Shear MK, 2009, AM J PSYCHIAT, V166, P746, DOI 10.1176/appi.ajp.2009.09050698; Stroebe M.S., 2005, DEATH STUD, V23, P197; Tedeschi RG, 1996, J TRAUMA STRESS, V9, P455, DOI 10.1007/BF02103658; Tracey A., 2011, BEREAVEMENT CARE, V30, P17	21	0	0	CAMBRIDGE UNIV PRESS	NEW YORK	32 AVENUE OF THE AMERICAS, NEW YORK, NY 10013-2473 USA	1478-9515	1478-9523		PALLIAT SUPPORT CARE	Palliat. Support Care	FEB	2015	13	1					59	65		10.1017/S1478951513000990		7	Health Policy & Services	Health Care Sciences & Services	CB6TA	WOS:000349758400009		
J	Zhou, S; Pi, XD; Ni, ZY; Luan, QB; Jiang, YY; Jin, CH; Nozaki, T; Yang, DR				Zhou, Shu; Pi, Xiaodong; Ni, Zhenyi; Luan, Qingbin; Jiang, Yingying; Jin, Chuanhong; Nozaki, Tomohiro; Yang, Deren			Boron- and Phosphorus-Hyperdoped Silicon Nanocrystals	PARTICLE & PARTICLE SYSTEMS CHARACTERIZATION			English	Article						silicon nanocrystals; hyperdoping; boron; phosphorus; nonthermal plasma	MECHANICAL-STRESS; NANOWIRES; NANOPARTICLES; OXIDATION; ATOMS	Hyperdoping silicon nanocrystals (Si NCs) to a concentration exceeding the solubility limit of a dopant may enable their novel applications. Here, the successful hyperdoping of Si NCs with boron (B) and phosphorus (P) is demonstrated, which are the most important dopants for Si. Despite the hyperdoping, the diamond structure of Si NCs is hardly modified. There are both electrically active B and P in hyperdoped Si NCs. It is proposed that the hyperdoping is made possible mainly by the kinetics in the nonthermal plasma synthesis of Si NCs. Collision between Si NCs and B or P atoms and the binding energy of B or P at the NC surface are critical to the understanding on the differences in the doping efficiency and dopant distribution between B and P. B-hyperdoping-induced tensile stress needs to be taken into account in the investigation on the doping and oxidation of Si NCs.	[Zhou, Shu; Pi, Xiaodong; Ni, Zhenyi; Luan, Qingbin; Jiang, Yingying; Jin, Chuanhong; Yang, Deren] Zhejiang Univ, State Key Lab Silicon Mat, Hangzhou 310027, Zhejiang, Peoples R China; [Zhou, Shu; Pi, Xiaodong; Ni, Zhenyi; Luan, Qingbin; Jiang, Yingying; Jin, Chuanhong; Yang, Deren] Zhejiang Univ, Dept Mat Sci & Engn, Hangzhou 310027, Zhejiang, Peoples R China; [Zhou, Shu; Nozaki, Tomohiro] Tokyo Inst Technol, Dept Mech Sci & Engn, Meguro Ku, Tokyo 1528550, Japan	Zhou, S (reprint author), Zhejiang Univ, State Key Lab Silicon Mat, Hangzhou 310027, Zhejiang, Peoples R China.	xdpi@zju.edu.cn; mseyang@zju.edu.cn	yang, deren/J-3311-2012	yang, deren/0000-0002-1745-2105	National Basic Research Program of China [2013CB632101, 2014CB932500]; NSFC [61222404, 51222202]; Ministry of Education of China [625010040202]	The authors are grateful to Dr. Christophe Delerue in the IEMN of France for stimulating discussion. TEM study was carried out at the Center for Electron Microscopy of Zhejiang University. This work is mainly supported by the National Basic Research Program of China (grant Nos. 2013CB632101 & 2014CB932500) and the NSFC for excellent young researchers (grant Nos. 61222404 & 51222202). Partial support is provided by the R&D Program of Ministry of Education of China (grant No. 625010040202). Shanghai Supercomputer Center is acknowledged for providing computation resources.	ALLEN JE, 1992, PHYS SCRIPTA, V45, P497, DOI 10.1088/0031-8949/45/5/013; Norris DJ, 2008, SCIENCE, V319, P1776, DOI 10.1126/science.1143802; Pi XD, 2008, NANOTECHNOLOGY, V19, DOI 10.1088/0957-4484/19/24/245603; Pi XD, 2008, APPL PHYS LETT, V92, DOI 10.1063/1.2897291; Yen JY, 2000, APPL PHYS LETT, V76, P1834, DOI 10.1063/1.126181; CABRERA N, 1948, REP PROG PHYS, V12, P163; Vegard L, 1921, Z PHYS, V5, P17, DOI 10.1007/BF01349680; Pi XD, 2014, PART PART SYST CHAR, V31, P751, DOI 10.1002/ppsc.201300346; HIMPSEL FJ, 1988, PHYS REV B, V38, P6084, DOI 10.1103/PhysRevB.38.6084; Sato K, 2009, APPL PHYS LETT, V94, DOI 10.1063/1.3120768; Mangolini L, 2009, PHYS REV E, V79, DOI 10.1103/PhysRevE.79.026405; Gresback R, 2014, ACS NANO, V8, P5650, DOI 10.1021/nn500182b; Koenraad PM, 2011, NAT MATER, V10, P91, DOI 10.1038/nmat2940; Pi XD, 2007, PHYS REV B, V75, DOI 10.1103/PhysRevB.75.085423; Pi XD, 2013, PHYS REV LETT, V111, DOI 10.1103/PhysRevLett.111.177402; Cui Y, 2001, SCIENCE, V291, P851, DOI 10.1126/science.291.5505.851; FANO U, 1961, PHYS REV, V124, P1866, DOI 10.1103/PhysRev.124.1866; Rowe DJ, 2013, NANO LETT, V13, P1317, DOI 10.1021/nl4001184; Pi XD, 2011, J PHYS CHEM C, V115, P9838, DOI 10.1021/jp111548b; Xie M, 2013, APPL PHYS LETT, V102, DOI 10.1063/1.4798834; Fukata N, 2009, ADV MATER, V21, P2829, DOI 10.1002/adma.200900376; Bustarret E, 2006, NATURE, V444, P465, DOI 10.1038/nature05340; Stegner AR, 2009, PHYS REV B, V80, DOI 10.1103/PhysRevB.80.165326; Knipping J, 2004, J NANOSCI NANOTECHNO, V4, P1039, DOI 10.1166/jnn.2004.149; Moutanabbir O, 2013, NATURE, V496, P78, DOI 10.1038/nature11999; Li XG, 2003, LANGMUIR, V19, P8490, DOI 10.1021/la034487b; Ertekin E, 2012, PHYS REV LETT, V108, DOI 10.1103/PhysRevLett.108.026401; Chen XB, 2011, J PHYS CHEM C, V115, P661, DOI 10.1021/jp1102934; Christensen JS, 2003, APPL PHYS LETT, V82, P2254, DOI 10.1063/1.1566464; Cui H, 2008, NANO LETT, V8, P2731, DOI 10.1021/nl8011853; Fujii M, 2003, J APPL PHYS, V94, P1990, DOI 10.1063/1.1590409; Fujii M, 2002, PHYS REV LETT, V89, DOI 10.1103/PhysRevLett.89.206805; Imakita K, 2012, APPL PHYS LETT, V101, DOI 10.1063/1.4739237; JACOBS EP, 1978, SURF SCI, V73, P357, DOI 10.1016/0039-6028(78)90514-9; Khelifi R, 2013, APPL PHYS LETT, V102, DOI 10.1063/1.4774266; Kodera H., 1963, Japanese Journal of Applied Physics, V2, DOI 10.1143/JJAP.2.527; Luo Y. R., 2007, COMPREHENSIVE HDB CH; Mangolini L, 2005, NANO LETT, V5, P655, DOI 10.1021/nl050066y; Ni ZY, 2014, PHYS REV B, V89, DOI 10.1103/PhysRevB.89.035312; Ni ZY, 2012, RSC ADV, V2, P11227, DOI 10.1039/c2ra21537c; Perego M, 2010, NANOTECHNOLOGY, V21, DOI 10.1088/0957-4484/21/2/025602; Pereira RN, 2012, PHYS REV LETT, V108, DOI 10.1103/PhysRevLett.108.126806; Seah M. P., 1979, Surface and Interface Analysis, V1, DOI 10.1002/sia.740010103; Yu XG, 2013, MAT SCI ENG R, V74, P1, DOI 10.1016/j.mser.2013.01.002	44	3	3	WILEY-V C H VERLAG GMBH	WEINHEIM	BOSCHSTRASSE 12, D-69469 WEINHEIM, GERMANY	0934-0866	1521-4117		PART PART SYST CHAR	Part. Part. Syst. Charact.	FEB	2015	32	2					213	221		10.1002/ppsc.201400103		9	Chemistry, Physical; Nanoscience & Nanotechnology; Materials Science, Multidisciplinary	Chemistry; Science & Technology - Other Topics; Materials Science	CC0BK	WOS:000349999800011		
J	Watanabe, S; Hiratsuka, T; Asahi, Y; Tanaka, A; Mae, K; Miyahara, MT				Watanabe, Satoshi; Hiratsuka, Tatsumasa; Asahi, Yusuke; Tanaka, Asumi; Mae, Kazuhiro; Miyahara, Minoru T.			Flow Synthesis of Plasmonic Gold Nanoshells via a Microreactor	PARTICLE & PARTICLE SYSTEMS CHARACTERIZATION			English	Article						plasmonic particles; core-shell particles; microfluidics; heterogeneous nucleation; seed-mediated growth	SILICA SPHERES; FACILE SYNTHESIS; RECENT PROGRESS; PARTICLE-SIZE; NANOPARTICLES; SHELL; NANOSTRUCTURES; GROWTH; NANOCRYSTALS; CORE/SHELL	Gold nanoshells with tunable surface plasmon resonances are a promising material for optical and biomedical applications. They are produced through seed-mediated growth, in which gold nanoparticles (AuNPs) are seeded on the core particle surface followed by growth of the gold seeds into a shell. However, synthetic gold nanoshell production is typically a multistep, time-consuming batch-type process, and a simple and scalable process remains a challenge. In the present study, a continuous flow process for the seed-mediated growth of silica-gold nanoshells is established by exploiting the excellent mixing performance of a microreactor. In the AuNP-seeding step, the reduction of gold ions in the presence of core particles in the microreactor enables the one-step flow synthesis of gold-decorated silica particles through heterogeneous nucleation. Flow shell growth is also realized using the microreactor by selecting an appropriate reducing agent. Because self-nucleation in the bulk solution phase is suppressed in the microreactor system, no washing is needed after each step, thus enabling the connection of the microreactors for the seeding and shell growth steps into a sequential flow process to synthesize gold nanoshells. The established system is simple and robust, thus making it a promising technology for producing gold nanoshells in an industrial setting.	[Watanabe, Satoshi; Hiratsuka, Tatsumasa; Asahi, Yusuke; Tanaka, Asumi; Mae, Kazuhiro; Miyahara, Minoru T.] Kyoto Univ, Dept Chem Engn, Nishikyo Ku, Kyoto 6158510, Japan	Watanabe, S (reprint author), Kyoto Univ, Dept Chem Engn, Nishikyo Ku, Kyoto 6158510, Japan.	nabe@cheme.kyoto-u.ac.jp; miyahara@cheme.kyoto-u.ac.jp			Japan Society for the Promotion of Science (JSPS) [23656490]	This work was financially supported in part by a Grant-in-Aid for Challenging Exploratory Research (No. 23656490) of Japan Society for the Promotion of Science (JSPS).	Xia XH, 2013, NANO LETT, V13, P4562, DOI 10.1021/nl402741j; Rouleau L, 2013, CONTRAST MEDIA MOL I, V8, P27, DOI 10.1002/cmmi.1491; DUFF DG, 1993, LANGMUIR, V9, P2301, DOI 10.1021/la00033a010; Aoki N, 2006, CHEM ENG J, V118, P189, DOI 10.1016/j.cej.2006.02.011; Ramasamy K, 2013, CHEM MATER, V25, P3551, DOI 10.1021/cm401366q; Oldenburg SJ, 1999, J CHEM PHYS, V111, P4729, DOI 10.1063/1.479235; Holgado JP, 2013, ACS CATAL, V3, P2169, DOI 10.1021/cs400293b; Marre S, 2010, CHEM SOC REV, V39, P1183, DOI 10.1039/b821324k; Xia XH, 2006, NANOTECHNOLOGY, V17, P5435, DOI 10.1088/0957-4484/17/21/025; Sauerbeck C, 2014, ACS NANO, V8, P3088, DOI 10.1021/nn500729r; Zhang N, 2012, NANOSCALE, V4, P2227, DOI 10.1039/c2nr00009a; Navin CV, 2014, NANOTECHNOL REV, V3, P39, DOI 10.1515/ntrev-2013-0028; Jankiewicz BJ, 2012, ADV COLLOID INTERFAC, V170, P28, DOI 10.1016/j.cis.2011.11.002; Pol VG, 2003, CHEM MATER, V15, P1111, DOI 10.1021/cm021013+; Dong WJ, 2011, ADV MATER, V23, P5392, DOI 10.1002/adma.201103521; Brinson BE, 2008, LANGMUIR, V24, P14166, DOI 10.1021/la802049p; Dia N, 2013, INORG CHEM, V52, P10264, DOI 10.1021/ic400303x; Murphy PJ, 1998, GEOCHIM COSMOCHIM AC, V62, P3515, DOI 10.1016/S0016-7037(98)00246-4; Zhang L, 2014, ADV MATER, V26, P2600, DOI 10.1002/adma.201304897; Hassan N, 2013, ANGEW CHEM INT EDIT, V52, P1994, DOI 10.1002/anie.201208324; Graf C, 2002, LANGMUIR, V18, P524, DOI 10.1021/la011093g; Phonthammachai N, 2007, LANGMUIR, V23, P11421, DOI 10.1021/la702230h; Loo C, 2005, NANO LETT, V5, P709, DOI 10.1021/nl050127s; Oldenburg SJ, 1998, CHEM PHYS LETT, V288, P243, DOI 10.1016/S0009-2614(98)00277-2; Commenge JM, 2011, CHEM ENG PROCESS, V50, P979, DOI 10.1016/j.cep.2011.06.006; Wang H, 2013, ACCOUNTS CHEM RES, V46, P1636, DOI 10.1021/ar400020j; Huschka R, 2012, ACS NANO, V6, P7681, DOI 10.1021/nn301135w; Nagasawa H, 2005, CHEM ENG TECHNOL, V28, P324, DOI 10.1002/ceat.200407118; Pham T, 2002, LANGMUIR, V18, P4915, DOI 10.1021/la015561y; Damato TC, 2013, LANGMUIR, V29, P1642, DOI 10.1021/la3045219; Schileo G, 2013, PROG SOLID STATE CH, V41, P87, DOI 10.1016/j.progsolidstchem.2013.09.001; Zaera F, 2013, CHEM SOC REV, V42, P2746, DOI 10.1039/c2cs35261c; Goia DV, 1999, COLLOID SURFACE A, V146, P139, DOI 10.1016/S0927-7757(98)00790-0; Shaikhutdinov S, 2013, ADV MATER, V25, P49, DOI 10.1002/adma.201203426; Neumann O, 2013, ACS NANO, V7, P42, DOI 10.1021/nn304948h; Bogart LK, 2014, ACS NANO, V8, P3107, DOI 10.1021/nn500962q; Park S, 2007, J IND ENG CHEM, V13, P65; Brito-Silva AM, 2013, LANGMUIR, V29, P4366, DOI 10.1021/la3050626; Duraiswamy S, 2010, NANO LETT, V10, P3757, DOI 10.1021/nl102478q; Gomez L, 2012, J MATER CHEM, V22, P21420, DOI 10.1039/c2jm34206e; Guerrero-Martinez A, 2010, ADV MATER, V22, P1182, DOI 10.1002/adma.200901263; Jin Y., 2013, ACCOUNTS CHEM RES, V47, P138; Kobayashi Y, 2005, J COLLOID INTERF SCI, V283, P601, DOI 10.1016/j.jcis.2004.09.002; Pena-Rodriguez O., 2011, INT J SPECTROSC, V2011; Rasch MR, 2009, LANGMUIR, V25, P11777, DOI 10.1021/la901249j; Watanabe S., 2013, J SOC POWDER TECHNOL, V50, P478	46	0	0	WILEY-V C H VERLAG GMBH	WEINHEIM	BOSCHSTRASSE 12, D-69469 WEINHEIM, GERMANY	0934-0866	1521-4117		PART PART SYST CHAR	Part. Part. Syst. Charact.	FEB	2015	32	2					234	242		10.1002/ppsc.201400126		9	Chemistry, Physical; Nanoscience & Nanotechnology; Materials Science, Multidisciplinary	Chemistry; Science & Technology - Other Topics; Materials Science	CC0BK	WOS:000349999800013		
J	Ishige, T; Yagi, H; Tatsuki, M; Hatori, R; Nishida, Y; Takizawa, T; Arakawa, H				Ishige, Takashi; Yagi, Hisako; Tatsuki, Maiko; Hatori, Reiko; Nishida, Yutaka; Takizawa, Takumi; Arakawa, Hirokazu			Endoscopic findings in the acute phase of food protein-induced enterocolitis syndromae	PEDIATRIC ALLERGY AND IMMUNOLOGY			English	Letter									[Ishige, Takashi; Yagi, Hisako; Tatsuki, Maiko; Hatori, Reiko; Nishida, Yutaka; Takizawa, Takumi; Arakawa, Hirokazu] Gunma Univ, Dept Pediat, Grad Sch Med, Maebashi, Gumma 371, Japan	Ishige, T (reprint author), Gunma Univ, Dept Pediat, Grad Sch Med, Maebashi, Gumma 371, Japan.	ishiget@gunma-u.ac.jp					Shakoory B, 2004, J INTERF CYTOK RES, V24, P271, DOI 10.1089/107999004323065057; Katz Y, 2014, CURR OPIN ALLERGY CL, V14, P229, DOI 10.1097/ACI.0000000000000053; ODZE RD, 1993, HUM PATHOL, V24, P668, DOI 10.1016/0046-8177(93)90248-F; Dupont C, 2000, J PEDIATR GASTR NUTR, V30, pS50, DOI 10.1097/00005176-200001001-00008; Jang HJ, 2012, EUR J PEDIATR, V171, P1845, DOI 10.1007/s00431-012-1825-2; Mane SK, 2014, CURR OPIN ALLERGY CL, V14, P217, DOI 10.1097/ACI.0000000000000052; Mehr S, 2009, PEDIATRICS, V123, P459; Sakamoto Y, 1998, PEDIATR ALLERGY IMMU, V9, P20, DOI 10.1111/j.1399-3038.1998.tb00295.x	8	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0905-6157	1399-3038		PEDIAT ALLERG IMM-UK	Pediatr. Allergy Immunol.	FEB	2015	26	1								10.1111/pai.12327		4	Allergy; Immunology; Pediatrics	Allergy; Immunology; Pediatrics	CB9ZB	WOS:000349992500015		
J	Toyota, H				Toyota, Hiroshi			THE ROLE OF WORD CHOICE AND CRITERION ON INTENTIONAL MEMORY	PERCEPTUAL AND MOTOR SKILLS			English	Article							INCIDENTAL FREE-RECALL; SELF-REFERENCE; INDIVIDUAL-ITEM; INFORMATION; ELABORATION; RETENTION; CONGRUITY	The relationship between the criterion for choosing and the self-choice effects (greater recall in a self-choice compared to a forced-choice condition) on intentional memory was examined. Thirty-three female nursing school volunteers were administered 24 word pairs in a 2 x 2 design to assess the influence of motivation upon free recall. When word pairs were presented to participants, they were asked to choose a word to-be-remembered, either in a self-choice condition or a forced-choice condition. Words chosen by the participants were recalled more often than those chosen by the experimenter (forced choice). Thus, the self-choice effect was greater for words chosen with a self-reference criterion compared to a metamemory criterion, supporting the integration hypothesis as the origin of the self-choice effect.	[Toyota, Hiroshi] Nara Univ Educ, Nara 6308528, Japan	Toyota, H (reprint author), Nara Univ Educ, Dept Psychol, Nara 6308528, Japan.	htoyota@nara-edu.ac.jp					ROGERS TB, 1977, J PERS SOC PSYCHOL, V35, P677, DOI 10.1037//0022-3514.35.9.677; BOWER GH, 1979, J RES PERS, V13, P420, DOI 10.1016/0092-6566(79)90005-9; HUNT RR, 1981, J VERB LEARN VERB BE, V20, P497, DOI 10.1016/S0022-5371(81)90138-9; CRAIK FIM, 1975, J EXP PSYCHOL GEN, V104, P268, DOI 10.1037//0096-3445.104.3.268; Czienskowski U, 2002, EXP PSYCHOL, V49, P73, DOI 10.1027//1618-3169-49.1.73; EINSTEIN GO, 1980, J EXP PSYCHOL-HUM L, V6, P588, DOI 10.1037/0278-7393.6.5.588; GOLDMAN SR, 1977, J VERB LEARN VERB BE, V16, P29, DOI 10.1016/S0022-5371(77)80005-4; HALL DM, 1980, J EXP PSYCHOL-HUM L, V6, P778; Hirano T, 2003, JPN PSYCHOL RES, V45, P38, DOI 10.1111/1468-5884.t01-1-00031; HUNT RR, 1980, J EXP PSYCHOL GEN, V109, P49, DOI 10.1037/0096-3445.109.1.49; HUNT RR, 1984, J EXP PSYCHOL LEARN, V10, P454, DOI 10.1037//0278-7393.10.3.454; HYODO M., 2003, 61 ANN M JAP C PSYCH; KOBAYASHI C., 2009, B NARA U ED, V58, P33; MAKI RH, 1985, B PSYCHONOMIC SOC, V23, P169; MONTY RA, 1979, J EXP PSYCHOL-HUM L, V5, P170, DOI 10.1037//0278-7393.5.2.170; MONTY RA, 1973, J EXP PSYCHOL, V97, P16, DOI 10.1037/h0033784; MONTY RA, 1982, B PSYCHONOMIC SOC, V20, P293; PERLMUTER L. C., 1971, J EXP PSYCHOL, V91, P41; PERLMUTER LC, 1982, B PSYCHONOMIC SOC, V20, P290; Rogers T. B., 1981, PERSONALITY COGNITIO, P193; SORACI SA, 1994, J EXP PSYCHOL LEARN, V20, P67, DOI 10.1037//0278-7393.20.1.67; TAKAHASHI M., 1993, MEMOIRS KYOTO TACHIB, V20, P130; TAKAHASHI M., 1989, KYOTO U RES STUDIES, V35, P211; TAKAHASHI M, 1991, PSYCHOLOGIA, V34, P254; Toyota H, 1997, PERCEPT MOTOR SKILL, V85, P1279; Toyota H, 1996, PERCEPT MOTOR SKILL, V82, P811; Toyota H, 2013, JPN PSYCHOL RES, V55, P45, DOI 10.1111/j.1468-5884.2012.00530.x; TOYOTA H., 2007, B NARA U ED, V56, P31; Watanabe T, 2001, JPN PSYCHOL RES, V43, P98, DOI 10.1111/1468-5884.00165	29	0	0	AMMONS SCIENTIFIC, LTD	MISSOULA	PO BOX 9229, MISSOULA, MT 59807-9229 USA	0031-5125			PERCEPT MOTOR SKILL	Percept. Mot. Skills	FEB	2015	120	1					84	94		10.2466/22.PMS.120v12x2		11	Psychology, Experimental	Psychology	CC4RP	WOS:000350341200008		
J	Zulkifli, Z; Kalita, G; Tanemura, M				Zulkifli, Zurita; Kalita, Golap; Tanemura, Masaki			Fabrication of transparent and flexible carbon-doped ZnO field emission display on plastic substrate	PHYSICA STATUS SOLIDI-RAPID RESEARCH LETTERS			English	Article						ZnO; carbon doping; field emission displays; flexible substrates; transparency; cathodoluminescence	THIN-FILM	Transparent and flexible carbon doped ZnO (C: ZnO) field emission device was successfully fabricated on an arylite substrate. Excellent adhesion of deposited C : ZnO on the flexible substrate was achieved with low sputtering power and Ar flow rate. In the fabricated device, nanostructured C : ZnO and as-deposited thin films were used as field emitter and phosphor screen, respectively. The C : ZnO thin film showed a transparency of about 80% at 550 nm wavelength and average sheet resistance of 1.96 k Omega/square The C: ZnO phosphor screen emitted red light during the field emission measurement, correlating the dominant cathodoluminescence peak at 646 nm. Thus, a promising transparent and flexible field emission display can be realized with C: ZnO based material. (C) 2015 WILEY-VCH Verlag GmbH & Co. KGaA, Weinheim	[Zulkifli, Zurita; Kalita, Golap; Tanemura, Masaki] Nagoya Inst Technol, Grad Sch Engn, Dept Frontier Mat, Showa Ku, Nagoya, Aichi 4668555, Japan; [Zulkifli, Zurita] Univ Teknol Mara, Fac Elect Engn, Shah Alam 40450, Selangor, Malaysia	Zulkifli, Z (reprint author), Nagoya Inst Technol, Grad Sch Engn, Dept Frontier Mat, Showa Ku, Gokiso Cho, Nagoya, Aichi 4668555, Japan.	z_zurita@yahoo.com; tanemura.masaki@nitech.ac.jp					Verma VP, 2010, APPL PHYS LETT, V96, DOI 10.1063/1.3431630; Stehr JE, 2014, ADV FUNCT MATER, V24, P3760, DOI 10.1002/adfm.201400220; Das S, 2014, NANO LETT, V14, P2861, DOI 10.1021/nl5009037; Zulkifli Z, 2014, RSC ADV, V4, P64763, DOI 10.1039/c4ra11837e; Ghosh P, 2010, J AM CHEM SOC, V132, P4034, DOI 10.1021/ja909346e; Ghosh D, 2012, PHYS STATUS SOLIDI-R, V6, P303, DOI 10.1002/pssr.201206251; Park JS, 2009, APPL PHYS LETT, V95, DOI 10.1063/1.3159832; Zhou GM, 2014, ENERG ENVIRON SCI, V7, P1307, DOI 10.1039/c3ee43182g; Kuznetzov AA, 2010, CARBON, V48, P41, DOI 10.1016/j.carbon.2009.08.009; Hosseini P, 2014, NATURE, V511, P206, DOI 10.1038/nature13487; Berchmans S, 2014, J MATER CHEM A, V2, P15788, DOI 10.1039/c4ta03256j; Zhang XH, 2010, ADV MATER, V22, P5292, DOI 10.1002/adma.201002526; Wang XJ, 2014, DALTON T, V43, P6120, DOI 10.1039/c3dt53532k; Sun B, 2014, J MATER CHEM C, V2, P1209, DOI 10.1039/c3tc31680g; Jeong HJ, 2011, ADV FUNCT MATER, V21, P1526, DOI 10.1002/adfm.201001469; Kim SH, 2005, SURF COAT TECH, V200, P2072, DOI 10.1016/j.surfcoat.2005.05.021; Ruffatto D, 2014, J R SOC INTERFACE, V11, DOI 10.1098/rsif.2013.1089; Ghosh D, 2013, PHYS STATUS SOLIDI-R, V7, P489, DOI 10.1002/pssr.201307175; Shin DH, 2014, APPL PHYS LETT, V105, DOI 10.1063/1.4891328; Zulkifli Z, 2013, JPN J APPL PHYS, V52, DOI 10.7567/JJAP.52.11NJ07	20	1	1	WILEY-V C H VERLAG GMBH	WEINHEIM	BOSCHSTRASSE 12, D-69469 WEINHEIM, GERMANY	1862-6254	1862-6270		PHYS STATUS SOLIDI-R	Phys. Status Solidi-Rapid Res. Lett.	FEB	2015	9	2					145	148		10.1002/pssr.201409557		4	Materials Science, Multidisciplinary; Physics, Applied; Physics, Condensed Matter	Materials Science; Physics	CB9TB	WOS:000349974500010		
J	Jia, T; Ito, H; Hu, XY; Tanaka, A				Jia, Ting; Ito, Hisashi; Hu, Xueyun; Tanaka, Ayumi			Accumulation of the NON-YELLOW COLORING 1 protein of the chlorophyll cycle requires chlorophyll b in Arabidopsis thaliana	PLANT JOURNAL			English	Article						Arabidopsis; chlorophyll b; chlorophyll b reductase; chlorophyll cycle; post-transcriptional regulation	LIGHT-HARVESTING-COMPLEX; A-OXYGENASE; 7-HYDROXYMETHYL CHLOROPHYLL; BARLEY SEEDLINGS; LEAF SENESCENCE; STAY-GREEN; BIOSYNTHESIS; DEGRADATION; CONVERSION; RICE	Chlorophyll a and chlorophyll b are interconverted in the chlorophyll cycle. The initial step in the conversion of chlorophyll b to chlorophyll a is catalyzed by the chlorophyll b reductases NON-YELLOW COLORING 1 (NYC1) and NYC1-like (NOL), which convert chlorophyll b to 7-hydroxymethyl chlorophyll a. This step is also the first stage in the degradation of the light-harvesting chlorophyll a/b protein complex (LHC). In this study, we examined the effect of chlorophyll b on the level of NYC1. NYC1 mRNA and NYC1 protein were in low abundance in green leaves, but their levels increased in response to dark-induced senescence. When the level of chlorophyll b was enhanced by the introduction of a truncated chlorophyllide a oxygenase gene and the leaves were incubated in the dark, the amount of NYC1 was greatly increased compared with that of the wild type; however, the amount of NYC1 mRNA was the same as in the wild type. In contrast, NYC1 did not accumulate in the mutant without chlorophyll b, even though the NYC1 mRNA level was high after incubation in the dark. Quantification of the LHC protein showed no strong correlation between the levels of NYC1 and LHC proteins. However, the level of chlorophyll fluorescence of the dark adapted plant (F-o) was closely related to the accumulation of NYC1, suggesting that the NYC1 level is related to the energetically uncoupled LHC. These results and previous reports on the degradation of chlorophyllide a oxygenase suggest that the a feedforward and feedback network is included in chlorophyll cycle.	[Jia, Ting; Ito, Hisashi; Hu, Xueyun; Tanaka, Ayumi] Hokkaido Univ, Inst Low Temp Sci, Kita Ku, Sapporo, Hokkaido 0600819, Japan; [Ito, Hisashi; Tanaka, Ayumi] Japan Sci & Technol Agcy, CREST, Kita Ku, Sapporo, Hokkaido 0600819, Japan	Ito, H (reprint author), Hokkaido Univ, Inst Low Temp Sci, Kita Ku, N19 W8, Sapporo, Hokkaido 0600819, Japan.	ito98@lowtem.hokudai.ac.jp	Ito, Hisashi/A-4211-2012		Core Research for Evolutional Science and Technology; China Scholarship Council	This work was supported by Core Research for Evolutional Science and Technology (AT). TJ and HX are supported by a scholarship from the China Scholarship Council.	Ito H, 1996, J BIOL CHEM, V271, P1475; FLACHMANN R, 1995, PLANT CELL, V7, P149; Stenbaek A, 2010, PHYTOCHEMISTRY, V71, P853, DOI 10.1016/j.phytochem.2010.03.022; Earley KW, 2006, PLANT J, V45, P616, DOI 10.1111/j.1365-313X.2005.02617.x; Sakuraba Y, 2010, PLANT CELL PHYSIOL, V51, P1055, DOI 10.1093/pcp/pcq050; Dekker JP, 2005, BBA-BIOENERGETICS, V1706, P12, DOI 10.1016/j.bbabio.2004.09.009; Tanaka R, 2005, PHOTOSYNTH RES, V85, P327, DOI 10.1007/s11120-005-6807-z; Schottkowski M, 2009, MOL PLANT, V2, P1289, DOI 10.1093/mp/ssp075; Belgio E, 2012, BIOPHYS J, V102, P2761, DOI 10.1016/j.bpj.2012.05.004; Kobayashi K, 2012, PLANT CELL, V24, P1081, DOI 10.1105/tpc.111.092254; Hirashima M, 2006, J BIOL CHEM, V281, P15385, DOI 10.1074/jbc.M602903200; Tanaka R, 2003, PLANT CELL PHYSIOL, V44, P1266, DOI 10.1093/pcp/pcg172; Zelisko A, 2005, P NATL ACAD SCI USA, V102, P13699, DOI 10.1073/pnas.0503472102; HORTENSTEINER S, 1995, NEW PHYTOL, V129, P237, DOI 10.1111/j.1469-8137.1995.tb04293.x; Sakuraba Y, 2012, PLANT CELL, V24, P507, DOI 10.1105/tpc.111.089474; Moon J, 2008, P NATL ACAD SCI USA, V105, P9433, DOI 10.1073/pnas.0803611105; Kunugi M, 2013, J BIOL CHEM, V288, P19330, DOI 10.1074/jbc.M113.462663; Meguro M, 2011, PLANT CELL, V23, P3442, DOI 10.1105/tpc.111.089714; Horie Y, 2009, J BIOL CHEM, V284, P17449, DOI 10.1074/jbc.M109.008912; Shimoda Y, 2012, PLANT J, V72, P501, DOI 10.1111/j.1365-313X.2012.05095.x; Hellens RP, 2000, PLANT MOL BIOL, V42, P819, DOI 10.1023/A:1006496308160; Takabayashi A, 2011, PLANT CELL PHYSIOL, V52, P2103, DOI 10.1093/pcp/pcr138; Espineda CE, 1999, P NATL ACAD SCI USA, V96, P10507, DOI 10.1073/pnas.96.18.10507; Hortensteiner S, 2006, ANNU REV PLANT BIOL, V57, P55, DOI 10.1146/annurev.arplant.57.032905.105212; Hudson D, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026765; Nakajima S, 2012, PLANT PHYSIOL, V160, P261, DOI 10.1104/pp.112.196881; Adhikari ND, 2011, PLANT CELL, V23, P1449, DOI 10.1105/tpc.110.082503; Yamasato A, 2005, PLANT CELL, V17, P1585, DOI 10.1105/tpc.105.031518; Clough SJ, 1998, PLANT J, V16, P735, DOI 10.1046/j.1365-313x.1998.00343.x; Tanaka R, 2007, ANNU REV PLANT BIOL, V58, P321, DOI 10.1146/annurev.arplant.57.032905.105448; Meskauskiene R, 2001, P NATL ACAD SCI USA, V98, P12826, DOI 10.1073/pnas.221252798; Sato Y, 2009, PLANT J, V57, P120, DOI 10.1111/j.1365-313X.2008.03670.x; Kusaba M, 2007, PLANT CELL, V19, P1362, DOI 10.1105/tpc.106.042911; Dalal VK, 2012, PLANT CELL ENVIRON, V35, P1685, DOI 10.1111/j.1365-3040.2012.02520.x; Pribil M, 2014, J EXP BOT, V65, P1955, DOI 10.1093/jxb/eru090; Oster U, 2000, PLANT J, V21, P305, DOI 10.1046/j.1365-313x.2000.00672.x; Zapata M, 2000, MAR ECOL PROG SER, V195, P29, DOI 10.3354/meps195029; op den Camp RGL, 2003, PLANT CELL, V15, P2320, DOI 10.1105/tpc.014662; Hirashima M, 2009, PLANT CELL PHYSIOL, V50, P719, DOI 10.1093/pcp/pcp035; Sakuraba Y, 2012, PLANT CELL PHYSIOL, V53, P505, DOI 10.1093/pcp/pcs006; Gaspar L, 2006, PLANTA, V223, P1047, DOI 10.1007/s00425-005-0149-0; Hu XY, 2013, PLANT METHODS, V9, DOI 10.1186/1746-4811-9-19; Ito H, 1996, PLANT PHYSIOL BIOCH, V34, P35; Lermontova I, 2000, PLANT PHYSIOL, V122, P75, DOI 10.1104/pp.122.1.75; Liu XG, 2012, PHYSIOL PLANTARUM, V145, P384, DOI 10.1111/j.1399-3054.2012.01604.x; Nakagawara E, 2007, PLANT J, V49, P800, DOI 10.1111/j.1365-313X.2006.02996.x; Ohtsuka T, 1997, PLANT PHYSIOL, V113, P137; Pruzinska A, 2003, P NATL ACAD SCI USA, V100, P15259, DOI 10.1073/pnas.2036571100; Ruediger W., 2002, Photosynthesis Research, V74, P187; Sakuraba Y, 2007, PLANT PHYSIOL BIOCH, V45, P740, DOI 10.1016/j.plaphy.2007.07.016; Sakuraba Y, 2009, J BIOL CHEM, V284, P36689, DOI 10.1074/jbc.M109.008144; Scheumann V, 1999, PLANTA, V209, P364, DOI 10.1007/s004250050644; TANAKA A, 1991, PLANT CELL PHYSIOL, V32, P195; TANAKA A, 1987, PLANT CELL PHYSIOL, V28, P1537; TANAKA A, 1985, PLANT CELL PHYSIOL, V26, P893; Tanaka A, 1998, P NATL ACAD SCI USA, V95, P12719, DOI 10.1073/pnas.95.21.12719; TERAO T, 1989, PLANT CELL PHYSIOL, V30, P571; Yang QS, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020015	58	3	3	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0960-7412	1365-313X		PLANT J	Plant J.	FEB	2015	81	4					586	596		10.1111/tpj.12753		11	Plant Sciences	Plant Sciences	CC0OV	WOS:000350036200005		
J	Cabeza, RA; Liese, R; Fischinger, SA; Sulieman, S; Avenhaus, U; Lingner, A; Hein, H; Koester, B; Baumgarten, V; Dittert, K; Schulze, J				Cabeza, Ricardo A.; Liese, Rebecca; Fischinger, Stephanie A.; Sulieman, Saad; Avenhaus, Ulrike; Lingner, Annika; Hein, Hans; Koester, Beke; Baumgarten, Vanessa; Dittert, Klaus; Schulze, Joachim			Long-term non-invasive and continuous measurements of legume nodule activity	PLANT JOURNAL			English	Article						H-2 evolution; nitrogenase; nitrogen fixation; legumes; Medicago truncatula; N-2 fixation; Nodule; CO2 concentration; technical advance	N-FEEDBACK REGULATION; BIOLOGICAL NITROGEN-FIXATION; OXYGEN DIFFUSION RESISTANCE; CICER-ARIETINUM L.; MEDICAGO-TRUNCATULA; DROUGHT STRESS; ROOT-NODULES; N-2 FIXATION; SOYBEAN NODULES; HOST SANCTIONS	Symbiotic nitrogen fixation is a process of considerable economic, ecological and scientific interest. The central enzyme nitrogenase reduces H+ alongside N-2, and the evolving H-2 allows a continuous and non-invasive in vivo measurement of nitrogenase activity. The objective of this study was to show that an elaborated set-up providing such measurements for periods as long as several weeks will produce specific insight into the nodule activity's dependence on environmental conditions and genotype features. A system was developed that allows the air-proof separation of a root/nodule and a shoot compartment. H-2 evolution in the root/nodule compartment can be monitored continuously. Nutrient solution composition, temperature, CO2 concentration and humidity around the shoots can concomitantly be maintained and manipulated. Medicago truncatula plants showed vigorous growth in the system when relying on nitrogen fixation. The set-up was able to provide specific insights into nitrogen fixation. For example, nodule activity depended on the temperature in their surroundings, but not on temperature or light around shoots. Increased temperature around the nodules was able to induce higher nodule activity in darkness versus light around shoots for a period of as long as 8h. Conditions that affected the N demand of the shoots (ammonium application, Mg or P depletion, super numeric nodules) induced consistent and complex daily rhythms in nodule activity. It was shown that long-term continuous measurements of nodule activity could be useful for revealing special features in mutants and could be of importance when synchronizing nodule harvests for complex analysis of their metabolic status.	[Cabeza, Ricardo A.; Liese, Rebecca; Fischinger, Stephanie A.; Avenhaus, Ulrike; Lingner, Annika; Hein, Hans; Koester, Beke; Baumgarten, Vanessa; Dittert, Klaus; Schulze, Joachim] Univ Gottingen, Dept Crop Sci, Fac Agr, Sect Plant Nutr & Crop Physiol, D-37075 Gottingen, Germany; [Cabeza, Ricardo A.] Univ Chile, Fac Ciencias Agron, Dept Ingn & Suelos, Santiago, Chile; [Sulieman, Saad] RIKEN Ctr Sustainable Resource Sci, Signaling Pathway Res Unit, Yokohama, Kanagawa 2300045, Japan	Schulze, J (reprint author), Univ Gottingen, Dept Crop Sci, Fac Agr, Sect Plant Nutr & Crop Physiol, Carl Sprengel Weg 1, D-37075 Gottingen, Germany.	jschulz2@gwdg.de	Cabeza, Ricardo/K-8891-2013	Cabeza, Ricardo/0000-0002-9109-4457	German National Science Foundation (DFG) [SCHU 1602/7-1]; Chilean Government (Becas Chile program)	The authors wish to thank Susanne Koch and Reinhard Hilmer for their outstanding help during the experiments. This work was supported by a grant from the German National Science Foundation (DFG SCHU 1602/7-1). Ricardo A. Cabeza was supported by a postdoctoral fellowship from the Chilean Government (Becas Chile program).	OHARA GW, 1988, PLANT SOIL, V108, P93, DOI 10.1007/BF02370104; Schulze J, 2004, J PLANT NUTR SOIL SC, V167, P125, DOI 10.1002/jpln.200320358; Kato K, 2010, J PLANT PHYSIOL, V167, P238, DOI 10.1016/j.jplph.2009.08.006; PEOPLES MB, 1995, PLANT SOIL, V174, P3, DOI 10.1007/BF00032239; KUZMA MM, 1993, PLANT PHYSIOL, V101, P161; Sulieman S, 2010, J PLANT PHYSIOL, V167, P683, DOI 10.1016/j.jplph.2009.12.016; Kiers ET, 2003, NATURE, V425, P78, DOI 10.1038/nature01931; Salvagiotti F, 2008, FIELD CROP RES, V108, P1, DOI 10.1016/j.fcr.2008.03.001; Fischinger SA, 2006, J PLANT PHYSIOL, V163, P987, DOI 10.1016/j.jplph.2006.03.017; Herridge DF, 2008, PLANT SOIL, V311, P1, DOI 10.1007/s11104-008-9668-3; Esfahani MN, 2014, PLANT J, V79, P964, DOI 10.1111/tpj.12599; DAVID M, 1988, CELL, V54, P671, DOI 10.1016/S0092-8674(88)80012-6; Cabeza R, 2014, PLANT PHYSIOL, V164, P400, DOI 10.1104/pp.113.228312; Sulieman S, 2010, PHYSIOL PLANTARUM, V140, P21, DOI 10.1111/j.1399-3054.2010.01380.x; Fowler D, 2013, PHILOS T R SOC B, V368, DOI 10.1098/rstb.2013.0164; CAKMAK I, 1994, J EXP BOT, V45, P1251, DOI 10.1093/jxb/45.9.1251; MYLONA P, 1995, PLANT CELL, V7, P869; Rogers A, 2009, PLANT PHYSIOL, V151, P1009, DOI 10.1104/pp.109.144113; Voisin AS, 2010, PLANT SOIL, V337, P399, DOI 10.1007/s11104-010-0536-6; Cabeza RA, 2014, J EXP BOT, V65, P6035, DOI 10.1093/jxb/eru341; White J, 2007, PLANT PHYSIOL, V144, P604, DOI 10.1104/pp.107.097741; Criddle RS, 1997, PLANTA, V201, P441, DOI 10.1007/s004250050087; Badgley C, 2007, RENEW AGR FOOD SYST, V22, P86, DOI 10.1017/S1742170507001640; Marino D, 2007, PLANT PHYSIOL, V143, P1968, DOI [10.1104/pp.106.097139, 10.1104/pp.107.097139]; Naya L, 2007, PLANT PHYSIOL, V144, P1104, DOI 10.1104/pp.107.099648; Blumenthal JM, 1997, PLANT PHYSIOL, V114, P1405; BREWIN NJ, 1991, ANNU REV CELL BIOL, V7, P191, DOI 10.1146/annurev.cb.07.110191.001203; Cabeza RA, 2014, INT J MOL SCI, V15, P6031, DOI 10.3390/ijms15046031; Denison RF, 1998, BOT ACTA, V111, P191; Fei H, 2009, PHYSIOL PLANTARUM, V135, P317, DOI 10.1111/j.1399-3054.2008.01192.x; Fischinger SA, 2010, J PLANT PHYSIOL, V167, P1112, DOI 10.1016/j.jplph.2010.03.014; Gordon AJ, 2002, J EXP BOT, V53, P423, DOI 10.1093/jexbot/53.368.423; Guo HJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0081373; Guo HJ, 2014, NEW PHYTOL, V201, P279, DOI 10.1111/nph.12484; HUNT S, 1993, ANNU REV PLANT PHYS, V44, P483, DOI 10.1146/annurev.arplant.44.1.483; KAISER BN, 1994, CAN J PLANT SCI, V74, P853; KESSLER W, 1990, ANN BOT-LONDON, V65, P341; LARUE TA, 1981, ADV AGRON, V34, P15, DOI 10.1016/S0065-2113(08)60883-4; LAYZELL DB, 1990, PHYSIOL PLANTARUM, V80, P322, DOI 10.1034/j.1399-3054.1990.800224.x; Lepinay C, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0045740; MINCHIN FR, 1994, ANN BOT-LONDON, V74, P613, DOI 10.1006/anbo.1994.1162; MINCHIN FR, 1992, ANN BOT-LONDON, V70, P283; Minchin FR, 1997, SOIL BIOL BIOCHEM, V29, P881, DOI 10.1016/S0038-0717(96)00204-0; Esfahani MN, 2014, PLANT BIOTECHNOL J, V12, P387, DOI 10.1111/pbi.12146; Oono R, 2009, NEW PHYTOL, V183, P967, DOI 10.1111/j.1469-8137.2009.02941.x; Oono R, 2011, P ROY SOC B-BIOL SCI, V278, P2698, DOI 10.1098/rspb.2010.2193; Schulze J, 2008, BIOL FERT SOILS, V44, P417, DOI 10.1007/s00374-007-0218-6; Schulze J, 2002, PLANT SOIL, V247, P133, DOI 10.1023/A:1021171417525; SCHWEITZER LE, 1980, PLANT PHYSIOL, V65, P51, DOI 10.1104/pp.65.1.51; STEUCEK GL, 1970, PLANT PHYSIOL, V46, P50, DOI 10.1104/pp.46.1.50; Sulieman S, 2014, J PLANT PHYSIOL, V171, P407, DOI 10.1016/j.jplph.2013.12.006; Thumfort PP, 1999, PLANT CELL ENVIRON, V22, P1351, DOI 10.1046/j.1365-3040.1999.00498.x; VANCE CP, 1991, ANNU REV PLANT PHYS, V42, P373, DOI 10.1146/annurev.arplant.42.1.373; WALSH KB, 1986, PLANT PHYSIOL, V80, P249, DOI 10.1104/pp.80.1.249; Wei H, 2006, PLANT PHYSIOL, V141, P280, DOI 10.1104/pp.106.077552; Witty JF, 1998, J EXP BOT, V49, P1041, DOI 10.1093/jexbot/49.323.1041; Witty JF, 1998, J EXP BOT, V49, P1015, DOI 10.1093/jexbot/49.323.1015; WITTY JF, 1984, ANN BOT-LONDON, V53, P13	58	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0960-7412	1365-313X		PLANT J	Plant J.	FEB	2015	81	4					637	648		10.1111/tpj.12751		12	Plant Sciences	Plant Sciences	CC0OV	WOS:000350036200009		
J	Honda, T; Maeda, Y; Yasuda, T; Tanaka, T; Matsunaga, T; Yoshino, T				Honda, Toru; Maeda, Yoshiaki; Yasuda, Takayuki; Tanaka, Tsuyoshi; Matsunaga, Tadashi; Yoshino, Tomoko			Novel designs of single-chain MHC I/peptide complex for the magnetosome display system	PROTEIN ENGINEERING DESIGN & SELECTION			English	Article						antigen peptide; magnetosome display system; magnetotactic bacterium; MHC I	BACTERIAL MAGNETIC PARTICLES; CLASS-I MOLECULES; GENE DELETION MUTANT; HISTOCOMPATIBILITY COMPLEX; MAGNETOSPIRILLUM-MAGNETICUM; T-CELLS; ANTIBODY-BINDING; ANCHOR MOLECULE; PEPTIDE; PROTEIN	The magnetic nanoparticles displaying the class I major histocompatibility complex (MHC I) were biologically synthesized using the magnetotactic bacterium Magnetospirillum magneticum AMB-1. Expression level and antigen peptide (HER2(63-71))-binding capability of the MHC I were evaluated on bacterial magnetic particles (BacMPs, also known as magnetosomes). Furthermore, the single-chain complexes of MHC I and HER2(63-71) were de novo designed for the magnetosome display system in order to improve the interaction between MHC I and HER2(63-71). Two types of the fusion arrangements were tested, and one of the complexes was estimated to fold into the correct conformation at the level of over 70%. In addition to the high folding ratio, an advantage of this system is that any refolding processes were not required even though the N-terminus of HER2(63-71) peptide is not free, which conventional bacterial expression systems have never demonstrated. The as-prepared single-chain MHC I/HER2(63-71) complex-displaying BacMPs (MHC I/HER2-BacMPs) specifically interacted with, and magnetically separated the HER2(63-71)-induced cells, suggesting that the native T-cell receptor could recognize the engineered MHC I/HER2 complex on the BacMPs. By optimizing the magnetic sorting method, the MHC I/HER2-BacMPs developed in this study would be useful in immunotherapeutic applications.	[Honda, Toru; Maeda, Yoshiaki; Yasuda, Takayuki; Tanaka, Tsuyoshi; Matsunaga, Tadashi; Yoshino, Tomoko] Tokyo Univ Agr & Technol, Inst Engn, Div Biotechnol & Life Sci, Koganei, Tokyo 1848588, Japan	Yoshino, T (reprint author), Tokyo Univ Agr & Technol, Inst Engn, Div Biotechnol & Life Sci, 2-24-16 Naka Cho, Koganei, Tokyo 1848588, Japan.	y-tomoko@cc.tuat.ac.jp	Tanaka, Tsuyoshi/B-9949-2013; Yoshino, Tomoko/E-9066-2013; Matsunaga, Tadashi/A-6293-2015; Maeda, Yoshiaki/H-9910-2013	Tanaka, Tsuyoshi/0000-0003-2601-2256; Yoshino, Tomoko/0000-0002-4505-2774; Matsunaga, Tadashi/0000-0002-6216-3687; Maeda, Yoshiaki/0000-0001-9206-2601			Yoshino T, 2006, APPL ENVIRON MICROB, V72, P465, DOI 10.1128/AEM.72.1.465-471.2006; BEDNAREK MA, 1991, J IMMUNOL, V147, P4047; Kanetsuki Y, 2012, BIOCHEM BIOPH RES CO, V426, P7, DOI 10.1016/j.bbrc.2012.07.116; MATSUMURA M, 1992, SCIENCE, V257, P927, DOI 10.1126/science.1323878; Yu YYL, 2002, J IMMUNOL, V168, P3145; Okamura Y, 2003, APPL ENVIRON MICROB, V69, P4274, DOI 10.1128/AEM.69.7.4274-4277.2003; Garboczi DN, 1996, NATURE, V384, P134, DOI 10.1038/384134a0; MATSUNAGA T, 1991, APPL MICROBIOL BIOT, V35, P651; LJUNGGREN HG, 1990, NATURE, V346, P476, DOI 10.1038/346476a0; Yoshino T, 2008, BIOTECHNOL BIOENG, V101, P470, DOI 10.1002/bit.21912; Nagata Y, 1997, J IMMUNOL, V159, P1336; Takahashi M, 2010, BIOMATERIALS, V31, P4952, DOI 10.1016/j.biomaterials.2010.02.048; Bakker AH, 2005, CURR OPIN IMMUNOL, V17, P428, DOI 10.1016/j.coi.2005.06.008; Takahashi M, 2009, BIOTECHNOL PROGR, V25, P219, DOI [10.1002/btpr.101, 10.1021/bp.101]; Luxembourg AT, 1998, NAT BIOTECHNOL, V16, P281, DOI 10.1038/nbt0398-281; Matsunaga T, 2006, BIOCHEM BIOPH RES CO, V350, P1019, DOI 10.1016/j.bbrc.2006.09.145; Fujie T, 1999, INT J CANCER, V80, P169, DOI 10.1002/(SICI)1097-0215(19990118)80:2<169::AID-IJC1>3.0.CO;2-P; Bodinier M, 2000, NAT MED, V6, P707; BRODSKY FM, 1979, IMMUNOL REV, V47, P3, DOI 10.1111/j.1600-065X.1979.tb00288.x; Brophy SE, 2003, J IMMUNOL METHODS, V272, P235, DOI 10.1016/S0022-1759(02)00439-8; FREMONT DH, 1992, SCIENCE, V257, P919, DOI 10.1126/science.1323877; Hansen TH, 2010, TRENDS IMMUNOL, V31, P363, DOI 10.1016/j.it.2010.07.003; Kanetsuki Y, 2013, J BIOSCI BIOENG, V116, P65, DOI 10.1016/j.jbiosc.2013.01.016; Kessels HWHG, 2002, TRENDS IMMUNOL, V23, P264, DOI 10.1016/S1471-4906(02)02219-6; Kuhara M, 2004, ANAL CHEM, V76, P6207, DOI 10.1021/ac0493727; Le Doussal JM, 2000, J IMMUNOL METHODS, V241, P147, DOI 10.1016/S0022-1759(00)00211-8; Lybarger L, 2003, J BIOL CHEM, V278, P27105, DOI 10.1074/jbc.M303716200; Maeda Y, 2009, J MATER CHEM, V19, P6361, DOI 10.1039/b900693a; Matsunaga T, 1999, J MAGN MAGN MATER, V194, P126, DOI 10.1016/S0304-8853(98)00575-7; MOTTEZ E, 1995, J EXP MED, V181, P493, DOI 10.1084/jem.181.2.493; Primeau T, 2005, IMMUNOL RES, V32, P109, DOI 10.1385/IR:32:1-3:109; SCHUMACHER TNM, 1990, CELL, V62, P563, DOI 10.1016/0092-8674(90)90020-F; Takahashi M, 2009, BIOCONJUGATE CHEM, V20, P304, DOI 10.1021/bc800398d; Tanaka F, 1997, CANCER IMMUNOL IMMUN, V44, P21, DOI 10.1007/s002620050350; Tanaka M, 2011, J BIOL CHEM, V286, P6386, DOI 10.1074/jbc.M110.183434; Yoshino T, 2004, APPL ENVIRON MICROB, V70, P2880, DOI 10.1128/AEM.70.5.2880-2885.2004; Yoshino Tomoko, 2010, Recent Pat Biotechnol, V4, P214, DOI 10.2174/187220810793611455	37	1	1	OXFORD UNIV PRESS	OXFORD	GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND	1741-0126	1741-0134		PROTEIN ENG DES SEL	Protein Eng. Des. Sel.	FEB	2015	28	2					53	58		10.1093/protein/gzu056		6	Biochemistry & Molecular Biology; Biotechnology & Applied Microbiology	Biochemistry & Molecular Biology; Biotechnology & Applied Microbiology	CC1UU	WOS:000350131000004		
J	Pfeiffer, MJ; Taher, L; Drexler, H; Suzuki, Y; Makalowski, W; Schwarzer, C; Wang, BY; Fuellen, G; Boiani, M				Pfeiffer, Martin J.; Taher, Leila; Drexler, Hannes; Suzuki, Yutaka; Makalowski, Wojciech; Schwarzer, Caroline; Wang, Bingyuan; Fuellen, Georg; Boiani, Michele			Differences in embryo quality are associated with differences in oocyte composition: A proteomic study in inbred mice	PROTEOMICS			English	Article						Cell biology; Deep RNA sequencing; Development; Mouse strains; Oocyte; SILAC	PLURIPOTENT STEM-CELLS; MOUSE OOCYTES; MESSENGER-RNA; AMINO-ACIDS; IN-VIVO; EXPRESSION; PROTEINS; VARIANTS; GENES; IDENTIFICATION	Current models of early mouse development assign roles to stochastic processes and epigenetic regulation, which are considered to be as influential as the genetic differences that exist between strains of the species Mus musculus. The aim of this study was to test whether mouse oocytes vary from each other in the abundance of gene products that could influence, prime, or even predetermine developmental trajectories and features of derivative embryos. Using the paradigm of inbred mouse strains, we quantified 2010 protein groups (SILAC LC-MS/MS) and 15205 transcripts (RNA deep sequencing) present simultaneously in oocytes of four strains tested (129/Sv, C57Bl/6J, C3H/HeN, DBA/2J). Oocytes differed according to donor strain in the abundance of catalytic and regulatory proteins, as confirmed for a subset (bromodomain adjacent to zinc finger domain, 1B [BAZ1B], heme oxygenase 1 [HMOX1], estrogen related receptor, beta [ESRRB]) via immunofluorescence in situ. Given a Pearson's r correlation coefficient of 0.18-0.20, the abundance of oocytic proteins could not be predicted from that of cognate mRNAs. Our results document that a prerequisite to generate embryo diversity, namely the different abundances of maternal proteins in oocytes, can be studied in the model of inbred mouse strains. Thus, we highlight the importance of proteomic quantifications in modern embryology. All MS data have been deposited in the ProteomeXchange with identifier PXD001059 (http://proteomecentral.proteomexchange.org/dataset/PXD001059).	[Pfeiffer, Martin J.; Schwarzer, Caroline; Wang, Bingyuan; Boiani, Michele] Max Planck Inst Mol Biomed, D-48149 Munster, Germany; [Pfeiffer, Martin J.; Taher, Leila; Fuellen, Georg] Univ Rostock, Med Ctr, Inst Biostat & Informat Med & Ageing Res, D-18055 Rostock, Germany; [Drexler, Hannes] Max Planck Inst Mol Biomed, Bioanalyt Mass Spectrometry Facil, D-48149 Munster, Germany; [Suzuki, Yutaka] Univ Tokyo, Lab Funct Genom, Dept Med Genome Sci, Tokyo 1138654, Japan; [Makalowski, Wojciech] Univ Munster, Fac Med, Inst Bioinformat, D-48149 Munster, Germany	Boiani, M (reprint author), Max Planck Inst Mol Biomed, Rontgenstr 20, D-48149 Munster, Germany.	mboiani@mpi-muenster.mpg.de	Pfeiffer, Martin/A-9332-2011; Schwarzer, Caroline/I-2435-2013; Boiani, Michele/M-3519-2015	Pfeiffer, Martin/0000-0001-9264-9218; Boiani, Michele/0000-0003-2765-2781	Deutsche Forschungsgemeinschaft (DFG) [1356, BO2540/3-2, FU 583/2-2]; European Framework Program 7 (FP7-People-IRSES Project "EVOLGEN") [247633]; Max Planck Society	The MS proteomics data in this paper have been deposited in the ProteomeXchange Consortium (http://proteomecentral.proteomexchange.org) via the PRIDE partner repository [x]: dataset identifier PXD001059. We thank the Max Planck Institute for Molecular Biomedicine in Munster and its Director, Prof. Hans R. Scholer, for infrastructural support. We also thank Afroditi Nanou for help with the immunoconfocal microscopy analysis of the embryos, Dorota Buczek for help with the RNA extraction from oocytes, Terumi Horiuchi for help with the RNA sequencing and data handling. Support from the mouse housing facility and its animal caretakers is gratefully acknowledged. Amy Pavlak performed a language and grammar check on the final version of the manuscript. This study was supported by the priority program (Schwerpunktprogramm) no. 1356 of the Deutsche Forschungsgemeinschaft (DFG grants BO2540/3-2 and FU 583/2-2), by the European Framework Program 7 (FP7-People-2009-IRSES Project "EVOLGEN" No. 247633), and by the Max Planck Society.	ALONSO A, 1991, International Journal of Developmental Biology, V35, P389; Anders S, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-10-r106; Anders S, 2015, BIOINFORMATICS, V31, P166, DOI 10.1093/bioinformatics/btu638; Schwanhausser B, 2011, NATURE, V473, P337, DOI 10.1038/nature10098; Trapnell C, 2009, BIOINFORMATICS, V25, P1105, DOI 10.1093/bioinformatics/btp120; Deutsch DR, 2014, J PROTEOME RES, V13, P4363, DOI 10.1021/pr500550t; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Kanematsu S, 2014, GENE, V533, P520, DOI 10.1016/j.gene.2013.08.005; Bouniol-Baly C, 1999, BIOL REPROD, V60, P580, DOI 10.1095/biolreprod60.3.580; Grubb SC, 2014, NUCLEIC ACIDS RES, V42, pD825, DOI 10.1093/nar/gkt1159; Keane TM, 2011, NATURE, V477, P289, DOI 10.1038/nature10413; Li H, 2009, BIOINFORMATICS, V25, P2078, DOI 10.1093/bioinformatics/btp352; Wen DC, 2014, P NATL ACAD SCI USA, V111, P7325, DOI 10.1073/pnas.1406389111; Liao ZP, 2012, ANAL CHEM, V84, P4535, DOI 10.1021/ac300510t; Vizcaino JA, 2014, NAT BIOTECHNOL, V32, P223, DOI 10.1038/nbt.2839; Singhal N, 2010, CELL, V141, P943, DOI 10.1016/j.cell.2010.04.037; Schwarzer C, 2012, HUM REPROD, V27, P2627, DOI 10.1093/humrep/des223; Yurttas P, 2010, REPRODUCTION, V139, P809, DOI 10.1530/REP-09-0538; Li L, 2010, DEVELOPMENT, V137, P859, DOI 10.1242/dev.039487; Fan YH, 2003, MOL CELL BIOL, V23, P4559, DOI 10.1128/MCB.23.13.4559-4572.2003; Shinagawa T, 2014, CELL STEM CELL, V14, P217, DOI 10.1016/j.stem.2013.12.015; Feng B, 2009, NAT CELL BIOL, V11, P197, DOI 10.1038/ncb1827; Zenclussen ML, 2012, AM J REPROD IMMUNOL, V67, P376, DOI 10.1111/j.1600-0897.2011.01096.x; Zhang XF, 2008, J BIOL CHEM, V283, P35825, DOI 10.1074/jbc.M803481200; Graumann J, 2008, MOL CELL PROTEOMICS, V7, P672, DOI 10.1074/mcp.M700460-MCP200; Vogel C, 2012, NAT REV GENET, V13, P227, DOI 10.1038/nrg3185; Wang SF, 2010, P NATL ACAD SCI USA, V107, P17639, DOI 10.1073/pnas.1013185107; Wakayama T, 2001, MOL REPROD DEV, V58, P376, DOI 10.1002/1098-2795(20010401)58:4<376::AID-MRD4>3.0.CO;2-L; Cavaleri FM, 2008, MECH DEVELOP, V125, P153, DOI 10.1016/j.mod.2007.09.007; Chadwick BP, 2001, HUM MOL GENET, V10, P1101, DOI 10.1093/hmg/10.10.1101; Costanzi C, 2001, J BIOL CHEM, V276, P21776, DOI 10.1074/jbc.M010919200; Daxinger L, 2013, GENOME BIOL, V14, DOI 10.1186/gb-2013-14-9-r96; ENGLER P, 1991, CELL, V65, P939, DOI 10.1016/0092-8674(91)90546-B; Esteves TC, 2011, AGING CELL, V10, P80, DOI 10.1111/j.1474-9726.2010.00644.x; Gao SR, 2004, BIOL REPROD, V70, P1162, DOI 10.1095/biolreprod.103.024216; Gaspar-Maia A, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms2582; Geiger T., 2012, MOL CELL PROTEOMICS, V11, DOI DOI 10.1074/MCP.M111.014050; LATHAM KE, 1994, DEVELOPMENT, V120, P3419; Latham KE, 1998, DEVELOPMENT, V125, P929; Ma MY, 2008, J PROTEOME RES, V7, P4821, DOI 10.1021/pr800392s; Mamo S, 2007, BMC DEV BIOL, V7, DOI 10.1186/1471-213X-7-14; Mar JC, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002207; Pfeiffer MJ, 2011, J PROTEOME RES, V10, P2140, DOI 10.1021/pr100706k; RICHOUX V, 1991, MOL REPROD DEV, V28, P218, DOI 10.1002/mrd.1080280303; Schwarzer C, 2014, REPRODUCTION, V148, P55, DOI 10.1530/REP-14-0126; Sun LL, 2014, SCI REP-UK, V4, DOI 10.1038/srep04365; Thomas R, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-576; Vizcaino JA, 2013, NUCLEIC ACIDS RES, V41, pD1063, DOI 10.1093/nar/gks1262; Wu GM, 2013, NAT CELL BIOL, V15, P1089, DOI 10.1038/ncb2816; Yamanaka Y, 2011, REPROD BIOMED ONLINE, V22, P525, DOI 10.1016/j.rbmo.2011.03.011; Zhang P, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-348	51	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1615-9853	1615-9861		PROTEOMICS	Proteomics	FEB	2015	15	4			SI		675	687		10.1002/pmic.201400334		13	Biochemical Research Methods; Biochemistry & Molecular Biology	Biochemistry & Molecular Biology	CC0CM	WOS:000350002600007		
J	Suzuki, S				Suzuki, Shuji			NEGATIVE EMOTION OR PROBLEM CONTENT? TESTING EXPLANATIONS OF THE PEANUTS EFFECT	PSYCHOLOGICAL REPORTS			English	Article							CUSTOMER LOYALTY PROGRAMS; DECISION-MAKING; PROSPECT-THEORY; RISK-SEEKING; UNCERTAINTY; CHOICE; DISAPPOINTMENT; MAGNITUDE; COMMON; PROBABILITY	342 participants made decisions between a larger payout but riskier gamble and a smaller payout but less risky gamble on three response modes: a choice, a rejection and an exchange mode. When the probability ratio between the gambles was large, they preferred the larger payout but riskier gamble more, as amounts of the payout decreased. Their preference for the larger payout but riskier gamble on the rejection mode was weaker than that on the choice mode. On the other hand, there was no difference in extent of the preference between the exchange mode and the choice mode. The results support the hypothesis that preference for a risky option depends on negative emotion.	[Suzuki, Shuji] Hokkai Gakuen Univ, Sapporo, Hokkaido 0628605, Japan	Suzuki, S (reprint author), Hokkai Gakuen Univ, Toyohira Ku, Asahi Machi 4-1-40, Sapporo, Hokkaido 0628605, Japan.	ssuzuki@econ.hokkai-s-u.ac.jp					Kivetz R, 2002, J MARKETING RES, V39, P155, DOI 10.1509/jmkr.39.2.155.19084; PRELEC D, 1991, MANAGE SCI, V37, P770, DOI 10.1287/mnsc.37.7.770; KAHNEMAN D, 1984, AM PSYCHOL, V39, P341, DOI 10.1037//0003-066X.39.4.341; Weber BJ, 2005, ORGAN BEHAV HUM DEC, V97, P31, DOI 10.1016/j.obhdp.2005.03.001; RYAN TA, 1960, PSYCHOL BULL, V57, P318, DOI 10.1037/h0044320; TVERSKY A, 1992, J RISK UNCERTAINTY, V5, P297, DOI 10.1007/BF00122574; KAHNEMAN D, 1991, J ECON PERSPECT, V5, P193; Kirby KN, 1997, J EXP PSYCHOL GEN, V126, P54, DOI 10.1037/0096-3445.126.1.54; Meloy MG, 2004, ORGAN BEHAV HUM DEC, V93, P114, DOI 10.1016/j.obhdp.2003.12.002; Weber EU, 2006, CONSTRUCTION OF PREFERENCE, P397, DOI 10.1017/CBO9780511618031.022; RACHLIN H, 1986, PSYCHOL REV, V93, P33, DOI 10.1037/0033-295X.93.1.33; Uncles MD, 2003, J CONSUM MARK, V20, P294, DOI 10.1108/07363760310483676; Mellers BA, 1997, PSYCHOL SCI, V8, P423, DOI 10.1111/j.1467-9280.1997.tb00455.x; GODDEN DR, 1975, BRIT J PSYCHOL, V66, P325; Green L, 1997, MEM COGNITION, V25, P715, DOI 10.3758/BF03211314; Mellers B, 1999, J EXP PSYCHOL GEN, V128, P332, DOI 10.1037//0096-3445.128.3.332; BELL DE, 1985, OPER RES, V33, P1, DOI 10.1287/opre.33.1.1; Chapman GB, 1998, PSYCHON B REV, V5, P119, DOI 10.3758/BF03209466; Chapman GB, 2006, MEM COGNITION, V34, P589, DOI 10.3758/BF03193582; Cheng PY, 2010, PSYCHOL REP, V106, P247, DOI 10.2466/PR0.106.1.247-254; Dowling GR, 1997, SLOAN MANAGE REV, V38, P71; Grace RC, 2005, PSYCHON B REV, V12, P732, DOI 10.3758/BF03196765; Haisley E, 2008, J RISK UNCERTAINTY, V37, P57, DOI 10.1007/s11166-008-9041-1; Jones S, 2011, J EXP PSYCHOL LEARN, V37, P739, DOI 10.1037/a0022219; KAHNEMAN D, 1979, ECONOMETRICA, V47, P263, DOI 10.2307/1914185; Kwong JYY, 2011, J CONSUM PSYCHOL, V21, P146, DOI 10.1016/j.jcps.2010.08.005; LOOMES G, 1986, REV ECON STUD, V53, P271, DOI 10.2307/2297651; McKerchar TL, 2012, PSYCHOL REC, V62, P817; Rachlin H., 2000, SCI SELF CONTROL; Roca M, 2009, ORGAN BEHAV HUM DEC, V109, P56, DOI 10.1016/j.obhdp.2009.01.002; SHAFIR E, 1993, MEM COGNITION, V21, P546, DOI 10.3758/BF03197186; Tulving E., 1983, ELEMENTS EPISODIC ME; vanDijk WW, 1997, ORGAN BEHAV HUM DEC, V69, P277, DOI 10.1006/obhd.1997.2688	33	0	0	AMMONS SCIENTIFIC, LTD	MISSOULA	PO BOX 9229, MISSOULA, MT 59807-9229 USA	0033-2941			PSYCHOL REP	Psychol. Rep.	FEB	2015	116	1					1	12		10.2466/15.04.PRO.116k15w5		12	Psychology, Multidisciplinary	Psychology	CC1XY	WOS:000350139900001		
J	Jin, Z; Shiomura, K; Jiang, LZ				Jin, Zheng; Shiomura, Kimihiro; Jiang, Lizhu			ASSESSING IMPLICIT MATE PREFERENCES AMONG CHINESE AND JAPANESE WOMEN BY PROVIDING LOVE, SEX, OR MONEY CUES	PSYCHOLOGICAL REPORTS			English	Article							ROMANTIC LOVE; AUTOMATIC ACTIVATION; SOCIAL COGNITION; 37 CULTURES; PSYCHOLOGY; ATTITUDES; SELECTION; CHOICE; DESIRE; ATTACHMENT	Love, sex, and money are the most direct cues involved in the fundamental forms of mate preferences. These fundamental forms are not mutually exclusive but are interrelated. As a result, humans base their mate choices on multiple cues. In this study, 62 undergraduate women (M age = 20.4 yr., SD = 1.4) from China and Japan served as the participants. They performed a variation of the semantic priming task, in which they were instructed to decide by means of a key-press whether the target was human or non-human. The primes were images that portrayed potent evolutionary factors for mate preference (i.e., love, sex, and money), and the manipulation was based on whether the prime and target matched regarding gender, independent of the target decision task (human vs non-human). Participants gave faster responses to male targets than to female targets under priming. The results generally supported the evolutionary premises that assume mate preference is determined by fundamental forms of providing emotional (love), material (money), and fertility support (sex). The money priming effect was stronger in the Chinese women than in the Japanese women, suggesting that social context may influence mate preferences.	[Jin, Zheng; Jiang, Lizhu] Zhengzhou Normal Univ, Zhengzhou, Peoples R China; [Shiomura, Kimihiro] Ferris Univ, Yokohama, Kanagawa, Japan; [Jiang, Lizhu] Zhengzhou Womens Coll, Zhengzhou, Peoples R China	Jin, Z (reprint author), Zhengzhou Normal Univ, Adm Bldg,6 Yingcai St, Zhengzhou 450044, Henan, Peoples R China.	zhjin@ucdavis.edu			Scientific Research Fund of Zhengzhou Normal University [2012057]	This study was supported by the Scientific Research Fund of Zhengzhou Normal University (2012057).	Andersson M., 1994, SEXUAL SELECTION; Eastwick PW, 2006, SEX ROLES, V54, P603, DOI 10.1007/s11199-006-9027-x; Fazio RH, 2001, COGNITION EMOTION, V15, P115, DOI 10.1080/0269993004200024; Cain VS, 2003, J SEX RES, V40, P266; Buss DM, 2001, J MARRIAGE FAM, V63, P491, DOI 10.1111/j.1741-3737.2001.00491.x; Lu HJ, 2012, EVOL PSYCHOL-US, V10, P120; Maner JK, 2007, EVOL HUM BEHAV, V28, P28, DOI 10.1016/j.evolhumbehav.2006.05.006; Diamond LM, 2004, CURR DIR PSYCHOL SCI, V13, P116, DOI 10.1111/j.0963-7214.2004.00287.x; Rowe C, 1999, ANIM BEHAV, V58, P921, DOI 10.1006/anbe.1999.1242; Fisher HE, 1998, HUM NATURE-INT BIOS, V9, P23, DOI 10.1007/s12110-998-1010-5; Esch T, 2005, NEUROENDOCRINOL LETT, V26, P175; NG ML, 1990, ARCH SEX BEHAV, V19, P373, DOI 10.1007/BF01541932; Diamond LM, 2003, PSYCHOL REV, V110, P173, DOI 10.1037/0033-295X.110.1.173; Dan-Glauser ES, 2011, BEHAV RES METHODS, V43, P468, DOI 10.3758/s13428-011-0064-1; Woo JST, 2011, ARCH SEX BEHAV, V40, P385, DOI 10.1007/s10508-010-9609-0; Gonzaga GC, 2006, EMOTION, V6, P163, DOI 10.1037/1528-3542.6.2.163; Minear M, 2004, BEHAV RES METH INS C, V36, P630, DOI 10.3758/BF03206543; Dunn EW, 2011, J CONSUM PSYCHOL, V21, P115, DOI 10.1016/j.jcps.2011.02.002; KIRKPATRICK M, 1987, ANNU REV ECOL SYST, V18, P43; GREENWALD AG, 1995, PSYCHOL REV, V102, P4, DOI 10.1037//0033-295X.102.1.4; HAZAN C, 1987, J PERS SOC PSYCHOL, V52, P511, DOI 10.1037//0022-3514.52.3.511; Nosek BA, 2007, CURR DIR PSYCHOL SCI, V16, P65, DOI 10.1111/j.1467-8721.2007.00477.x; Candolin U, 2003, BIOL REV, V78, P575, DOI 10.1017/S1464793103006158; Wagner WE, 1998, ANIM BEHAV, V55, P1029, DOI 10.1006/anbe.1997.0635; BENSON E., 2003, MONITOR PSYCHOL, V34, P50; Buss D. M., 1994, EVOLUTION DESIRE STR; Buss DM, 1998, HANDBOOK OF EVOLUTIONARY PSYCHOLOGY, P405; BUSS DM, 1990, J CROSS CULT PSYCHOL, V21, P5, DOI 10.1177/0022022190211001; BUSS DM, 1989, BEHAV BRAIN SCI, V12, P1; CHANG J., 1997, TAO LOVE SEX ANCIENT; Chang L, 2011, PERS INDIV DIFFER, V50, P678, DOI 10.1016/j.paid.2010.12.016; Darwin C., 1871, DESCENT MAN SELECTIO; Darwin Charles, 1858, J LINNEAN SOC ZOOLOG, V3, P45; Dawkins Richard, 1989, SELFISH GENE; ER J, 2006, HDB IMPLICIT COGNITI; FAZIO RH, 1986, J PERS SOC PSYCHOL, V50, P229, DOI 10.1037//0022-3514.50.2.229; Gao G, 2001, INT J INTERCULT REL, V25, P329, DOI 10.1016/S0147-1767(01)00007-4; Goh JOS, 2004, J NEUROSCI, V24, P10223, DOI 10.1523/JNEUROSCI.3373-04.2004; HATFIELD E., 2003, ANTHOLOGY THEORETICA; Haufe C, 2008, BIOL PHILOS, V23, P115, DOI 10.1007/s10539-007-9071-0; Hazan C., 1999, HDB ATTACHMENT THEOR, p[336, xvii]; HIRANO H., 2005, JAPANS INSURANCE MAR, P2; JIN Z, 2014, EXPLORING IMPLICIT C, P5; Johnstone R. A., 1997, BEHAV ECOLOGY EVOLUT, V4, P155; KENRICK D. T., 1997, HDB PERSONAL RELATIO, P151; KENRICK DT, 1994, ADV EXP SOC PSYCHOL, V26, P75; Klauer KC, 1998, EUROPEAN REV SOCIAL, P67, DOI [10.1080/14792779643000083, http://dx.doi.org/10.1080/14792779643000083]; KNIGHT J, 2013, WORLD BANK RES OBSER, V29, P1; ORGANISATION FOR ECONOMIC CO-OPERATION AND DEVELOPMENT (OECD), 2012, CHIN FOC LESS CHALL, P16; SHOEMAKE E. G., 2007, J SCI PSYCHOL, P35; TRIVERS R., 1972, SEXUAL SELECTION DES; Wentura D, 2010, HDB IMPLICIT SOCIAL, P95	52	0	0	AMMONS SCIENTIFIC, LTD	MISSOULA	PO BOX 9229, MISSOULA, MT 59807-9229 USA	0033-2941			PSYCHOL REP	Psychol. Rep.	FEB	2015	116	1					195	206		10.2466/21.PR0.116k11w6		12	Psychology, Multidisciplinary	Psychology	CC1XY	WOS:000350139900014		
J	Wakebe, T; Hidaka, S; Watamura, E				Wakebe, Toshihiro; Hidaka, Sho; Watamura, Eiichiro			RESOURCE-INDEPENDENT NEGATIVE EFFECTS OF FOREIGN LANGUAGE ON ANALOGICAL PROBLEM SOLVING	PSYCHOLOGICAL REPORTS			English	Article							THINKING ABILITY; WORKING-MEMORY; INNER SPEECH; TASK; BILINGUALS; SIMILARITY; RETRIEVAL; DECLINE; SURFACE; SPAN	It has been shown that analogical problem solving is more difficult when a target problem is written in a foreign language than in one's native language. Possible resource-independence of this negative effect of a foreign language was investigated. After reading an analog or a filler story, participants solved a target problem written in their native or a foreign language. Those who read the problem in their native language performed a concurrent task to reduce their available processing resources. Nevertheless, they were better able to solve it than those who read the problem in a foreign language after reading the analog. This indicates that reading the problem in a foreign language decreases analogical problem-solving ability in a resource-independent manner.	[Wakebe, Toshihiro; Hidaka, Sho; Watamura, Eiichiro] Univ Tokyo, Dept Psychol, Tokyo 1130033, Japan	Wakebe, T (reprint author), Univ Tokyo, Dept Psychol, Bunkyo Ku, 7-3-1 Hongo, Tokyo 1130033, Japan.	wakebe@m.u-tokyo.ac.jp					HOLYOAK KJ, 1987, MEM COGNITION, V15, P332, DOI 10.3758/BF03197035; Gentner D, 2010, ON THINKING, P35, DOI 10.1007/978-3-642-03129-8_3; GICK ML, 1980, COGNITIVE PSYCHOL, V12, P306, DOI 10.1016/0010-0285(80)90013-4; GENTNER D, 1983, COGNITIVE SCI, V7, P155, DOI 10.1207/s15516709cog0702_3; Voga M, 2007, MEM COGNITION, V35, P938, DOI 10.3758/BF03193467; Miyake A, 2004, ACTA PSYCHOL, V115, P123, DOI 10.1016/j.actpsy.2003.12.004; Dijkstra T, 1999, J MEM LANG, V41, P496, DOI 10.1006/jmla.1999.2654; Cho S, 2007, MEM COGNITION, V35, P1445, DOI 10.3758/BF03193614; REEVES LM, 1994, PSYCHOL BULL, V115, P381, DOI 10.1037//0033-2909.115.3.381; GICK ML, 1983, COGNITIVE PSYCHOL, V15, P1, DOI 10.1016/0010-0285(83)90002-6; CATRAMBONE R, 1989, J EXP PSYCHOL LEARN, V15, P1147, DOI 10.1037//0278-7393.15.6.1147; Jaeger TF, 2008, J MEM LANG, V59, P434, DOI 10.1016/j.jml.2007.11.007; GENTNER D, 1993, COGNITIVE PSYCHOL, V25, P524, DOI 10.1006/cogp.1993.1013; Emerson MJ, 2003, J MEM LANG, V48, P148, DOI 10.1016/S0749-596X(02)00511-9; BASSOK M., 2003, PSYCHOL PROBLEM SOLV, P343, DOI DOI 10.1017/CB09780511615771.012; Catrambone R, 2002, J EXP PSYCHOL LEARN, V28, P318, DOI 10.1037//0278-7393.283.2.318; Dunbar K., 1995, NATURE INSIGHT, V18, P365; Francis WS, 1999, J MEM LANG, V40, P301, DOI 10.1006/jmla.1998.2610; GENTNER D., 2003, ENCY COGNITIVE SCI, V1, P106; HOLYOAK KJ, 1989, SIMILARITY AND ANALOGICAL REASONING, P242, DOI 10.1017/CBO9780511529863.012; Holyoak K.J., 1995, MENTAL LEAPS ANALOGY; HUNT E, 1986, PSYCHOL REV, V93, P446; Landrum RE, 2005, PSYCHOL REP, V97, P861, DOI 10.2466/pr0.97.3.861-866; Megalakaki O, 2012, THINK REASONING, V18, P159, DOI 10.1080/13546783.2012.663101; NEELY J. H., 2001, THE NATURE OF REMEMB, P69, DOI [10.1037/10394-005, DOI 10.1037/10394-005]; PINTO AD, 1991, INT J PSYCHOL, V26, P471, DOI 10.1080/00207599108247135; Service E, 2002, EUR J COGN PSYCHOL, V14, P383, DOI 10.1080/09541440143000140; Takano Y, 1995, LANG LEARN, V45, P657, DOI 10.1111/j.1467-1770.1995.tb00457.x; TAKANO Y, 1993, J CROSS CULT PSYCHOL, V24, P445, DOI 10.1177/0022022193244005; THAGARD P, 1990, ARTIF INTELL, V46, P259, DOI 10.1016/0004-3702(90)90018-U; Tyler MD, 2001, LANG LEARN, V51, P257, DOI 10.1111/1467-9922.00155	31	0	0	AMMONS SCIENTIFIC, LTD	MISSOULA	PO BOX 9229, MISSOULA, MT 59807-9229 USA	0033-2941			PSYCHOL REP	Psychol. Rep.	FEB	2015	116	1					207	218		10.2466/28.PR0.116k11w9		12	Psychology, Multidisciplinary	Psychology	CC1XY	WOS:000350139900015		
J	Ishizuka, C; Suda, T; Suzuki, H; Ohnishi, A; Sumiyoshi, K; Toki, H				Ishizuka, Chikako; Suda, Takuma; Suzuki, Hideyuki; Ohnishi, Akira; Sumiyoshi, Kohsuke; Toki, Hiroshi			EOSDB: The database for nuclear equations of state	PUBLICATIONS OF THE ASTRONOMICAL SOCIETY OF JAPAN			English	Article						equation of state; stars: neutron; supernovae: general; X-rays: binaries	METAL-POOR STARS; NEUTRON-STAR; OF-STATE; STELLAR ABUNDANCES; MATTER; SUPERNOVA; SIMULATIONS; MODELS; HOT	The nuclear equation of state (EoS) plays an important role in understanding the formation of compact objects such as neutron stars and black holes. The true nature of the EoS has been a matter of debate at any density range not only in nuclear physics but also in astronomy and astrophysics. We have constructed a database of EoSs by compiling data from the literature. Our database contains the basic properties of the nuclear EoS of symmetric nuclear matter and of pure neutron matter. It also includes detailed information about the theoretical models, for example the adopted methods and assumptions in individual models. The novelty of the database is to consider new experimental probes such as symmetry energy, its slope with respect to the baryon density, and incompressibility, which enables users to check their model dependence. We demonstrate the performance of the EOSDB through examinations of model dependence among different nuclear EoSs. It is revealed that some theoretical EoSs, commonly used in astrophysics, do not satisfactorily agree with the experimental constraints.	[Ishizuka, Chikako] Tokyo Univ Sci, Res Inst Sci & Technol, Noda, Chiba 2788510, Japan; [Suda, Takuma] Univ Tokyo, Res Ctr Early Univ, Bunkyo Ku, Tokyo 1130033, Japan; [Suzuki, Hideyuki] Tokyo Univ Sci, Fac Sci & Technol, Noda, Chiba 2788510, Japan; [Ohnishi, Akira] Kyoto Univ, Yukawa Inst Theoret Phys, Sakyo Ku, Kyoto 6068502, Japan; [Sumiyoshi, Kohsuke] Numazu Coll Technol, Numazu, Shizuoka 4108501, Japan; [Toki, Hiroshi] Osaka Univ, Res Ctr Nucl Phys, Ibaraki, Osaka 5670047, Japan	Ishizuka, C (reprint author), Tokyo Univ Sci, Res Inst Sci & Technol, Yamazaki 2641, Noda, Chiba 2788510, Japan.	chikako@rs.tus.ac.jp; suda@resceu.s.u-tokyo.ac.jp; suzukih@rs.tus.ac.jp; ohnishi@yukawa.kyoto-u.ac.jp; sumi@numazu-ct.ac.jp; toki@rcnp.osaka-u.ac.jp	Ohnishi, Akira/F-7403-2011	Ohnishi, Akira/0000-0003-1513-0468	Japan Society of the Promotion of Science [20105001, 24105001, 22540296, 23224004, 24244036, 26105515, 26104006]	The authors thank Ken'ichiro Nakazato, Matthias Hempel, Shun Furusawa, Nihal Buyukcizmeci, Igor Mishustin, and Tsuyoshi Miyatsu for kindly providing data from their theoretical models. T. S. and C. I. thank Masayuki Y. Fujimoto for fruitful discussions on neutron star mass and radius, and Jirina R. Stone, Thomas Klaehn, and Micaela Oestel for useful discussions on the database. C. I. has been supported by Sasagawa Grants for Scientific Fellows of the Japan Science Society, F12-208. This work has been partially supported by Grant-in-Aid for Scientific Research on Innovative Areas (20105001, 24105001) and by Grant-in-Aid for Scientific Research (22540296, 23224004, 24244036, 26105515, 26104006) from the Japan Society of the Promotion of Science. The authors appreciate the support of Tokyo University of Science and Research Center for Nuclear Physics, Osaka University for the use of the database server.	Tsubakihara K, 2013, NUCL PHYS A, V914, P438, DOI 10.1016/j.nuclphysa.2013.04.006; van Dalen ENE, 2004, NUCL PHYS A, V744, P227, DOI 10.1016/j.nuclphysa.2004.08.019; Drischler C, 2014, PHYS REV C, V89, DOI 10.1103/PhysRevC.89.025806; Buyukcizmeci N, 2013, NUCL PHYS A, V907, P13, DOI 10.1016/j.nuclphysa.2013.03.010; Tsang MB, 2012, PHYS REV C, V86, DOI 10.1103/PhysRevC.86.015803; HILLEBRANDT W, 1984, ASTRON ASTROPHYS, V133, P175; Bauswein A, 2012, PHYS REV D, V86, DOI 10.1103/PhysRevD.86.063001; Sulaksono A, 2012, NUCL PHYS A, V895, P44, DOI 10.1016/j.nuclphysa.2012.09.006; Zuo W, 2002, NUCL PHYS A, V706, P418, DOI 10.1016/S0375-9474(02)00750-9; Shen G, 2011, PHYS REV C, V83, DOI 10.1103/PhysRevC.83.035802; Suda T, 2011, MON NOT R ASTRON SOC, V412, P843, DOI 10.1111/j.1365-2966.2011.17943.x; Typel S, 1999, NUCL PHYS A, V656, P331, DOI 10.1016/S0375-9474(99)00310-3; Bauswein A, 2012, PHYS REV LETT, V108, DOI 10.1103/PhysRevLett.108.011101; Chen LW, 2010, PHYS REV C, V82, DOI 10.1103/PhysRevC.82.024321; LATTIMER JM, 1991, NUCL PHYS A, V535, P331, DOI 10.1016/0375-9474(91)90452-C; Carlson J, 2003, PHYS REV C, V68, DOI 10.1103/PhysRevC.68.025802; Gandolfi S, 2007, PHYS REV LETT, V98, DOI 10.1103/PhysRevLett.98.102503; Weissenborn S, 2012, PHYS REV C, V85, DOI 10.1103/PhysRevC.85.065802; Hotokezaka K, 2013, PHYS REV D, V87, DOI 10.1103/PhysRevD.87.024001; Demorest PB, 2010, NATURE, V467, P1081, DOI 10.1038/nature09466; Schwenk A, 2005, PHYS REV LETT, V95, DOI 10.1103/PhysRevLett.95.160401; Steiner AW, 2012, PHYS REV LETT, V108, DOI 10.1103/PhysRevLett.108.081102; Shen H, 1998, NUCL PHYS A, V637, P435, DOI 10.1016/S0375-9474(98)00236-X; Ishizuka C, 2008, J PHYS G NUCL PARTIC, V35, DOI 10.1088/0954-3899/35/8/085201; Fuchs C, 2006, EUR PHYS J A, V30, P5, DOI 10.1140/epja/i2005-10313-x; Timmes FX, 1999, ASTROPHYS J SUPPL S, V125, P277, DOI 10.1086/313271; Miyatsu T, 2012, PHYS LETT B, V709, P242, DOI 10.1016/j.physletb.2012.02.009; Gandolfi S, 2009, PHYS REV C, V79, DOI 10.1103/PhysRevC.79.054005; FRIEDMAN B, 1981, NUCL PHYS A, V361, P502, DOI 10.1016/0375-9474(81)90649-7; Suda T, 2008, PUBL ASTRON SOC JPN, V60, P1159; Hempel M, 2010, NUCL PHYS A, V837, P210, DOI 10.1016/j.nuclphysa.2010.02.010; Akmal A, 1998, PHYS REV C, V58, P1804, DOI 10.1103/PhysRevC.58.1804; Antoniadis John, 2013, Science, V340, P1233232, DOI 10.1126/science.1233232; Aoki S, 2012, PROG THEOR EXP PHYS, DOI 10.1093/ptep/pts010; Ban SF, 2004, PHYS REV C, V69, DOI 10.1103/PhysRevC.69.045805; Cheoun MK, 2013, J COSMOL ASTROPART P, DOI 10.1088/1475-7516/2013/10/021; Colo G, 2004, NUCL PHYS A, V731, P15, DOI 10.1016/j.nuclphysa.2003.11.014; Danielewicz P., 2002, RICERCA SCI ED PR SN, V119, P66; Furusawa S, 2011, ASTROPHYS J, V738, DOI 10.1088/0004-637X/738/2/178; Gandolfi S, 2012, PHYS REV C, V85, DOI 10.1103/PhysRevC.85.032801; Kanzawa H, 2009, PROG THEOR PHYS, V122, P673, DOI 10.1143/PTP.122.673; Krastev PG, 2006, PHYS REV C, V74, DOI 10.1103/PhysRevC.74.025808; Lattimer J. M., 2011, NUCL STARS FESTSCHRI, P275; Maekawa H, 2007, EUR PHYS J A, V33, P269, DOI 10.1140/epja/i2007-10479-1; Masuda K, 2013, ASTROPHYS J, V764, DOI 10.1088/0004-637X/764/1/12; Newton WG, 2006, J PHYS CONF SER, V46, P408, DOI 10.1088/1742-6596/46/1/056; Niksic T, 2002, PHYS REV C, V66, DOI 10.1103/PhysRevC.66.064302; Ono A, 2002, PROG THEOR PHYS SUPP, P378; Potekhin AY, 2012, PHYS REV C, V85, DOI 10.1103/PhysRevC.85.039801; Schwenk A., 2013, Journal of Physics: Conference Series, V445, DOI 10.1088/1742-6596/445/1/012009; Shen H, 2011, ASTROPHYS J SUPPL S, V197, DOI 10.1088/0067-0049/197/2/20; Steiner AW, 2005, PHYS REV C, V72, DOI 10.1103/PhysRevC.72.041601; Stone JR, 2003, PHYS REV C, V68, DOI 10.1103/PhysRevC.68.034324; Takano M, 2010, PROG THEOR PHYS SUPP, P63; Typel S., 2013, ARXIV13075715; VAUTHERI.D, 1970, PHYS LETT B, VB 33, P381, DOI 10.1016/0370-2693(70)90609-X	56	0	0	OXFORD UNIV PRESS	OXFORD	GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND	0004-6264	2053-051X		PUBL ASTRON SOC JPN	Publ. Astron. Soc. Jpn.	FEB	2015	67	1							13	10.1093/pasj/psu141		17	Astronomy & Astrophysics	Astronomy & Astrophysics	CC1RN	WOS:000350120500014		
J	Isogai, M; Arai, A; Yonehara, A; Kawakita, H; Uemura, M; Nogami, D				Isogai, Mizuki; Arai, Akira; Yonehara, Atsunori; Kawakita, Hideyo; Uemura, Makoto; Nogami, Daisaku			Optical dual-band photometry and spectroscopy of the WZ Sge-type dwarf nova EZ Lyn during the 2010 superoutburst	PUBLICATIONS OF THE ASTRONOMICAL SOCIETY OF JAPAN			English	Article						accretion disks; methods: observational; stars: dwarf novae; techniques: photometric; techniques: spectroscopic	SU URSAE MAJORIS; HUBBLE-SPACE-TELESCOPE; DIGITAL SKY SURVEY; ACCRETION DISKS; SDSS J080434.20+510349.2; CATACLYSMIC VARIABLES; EARLY SUPERHUMPS; ECHO OUTBURSTS; EG CANCRI; DISCOVERY	We performed optical simultaneous dual-band (SDSS g'- and i'-bands) photometry and low-resolution spectroscopy for the WZ Sge-type dwarf nova EZ Lyn during its 2010 super-outburst. Dual-band photometry revealed that the g' - i' color reddened with a decrease in brightness during the main superoutburst and the following rebrightening phase, whereas the color became bluer with a further decrease in brightness during the slow, final decline phase. With a fit to our photometric results by a blackbody function, we estimated the disk radius ratio (ratio of the disk radius to the binary separation) and compared this with that of V455 And, a WZ Sge-type object that did not show any rebrightening in the 2007 superoutburst. The comparison revealed: (1) the disk radius ratio of EZ Lyn decreased more slowly than that of V455 And, and (2) the radius ratio of EZ Lyn at the end of the main superoutburst was larger than that of V455 And. These results favor the mass reservoir model for the mechanism of rebrightening. During both the superoutburst plateau and subsequent rebrightening phase, H alpha and H beta lines were detected. The H alpha line showed a double-peak profile from which we estimated the disk radius ratio. The comparison of this ratio with that derived by photometry indicates that the H alpha disk was larger than the photometric one, which suggests that the optically thin gas was extended to the outer region more than the optically thick gas disk and was possibly responsible for the rebrightening phenomenon. Time-series dual-band photometry during the main superoutburst revealed that color variations during the early superhump show roughly the same behavior as that of V455 And, whereas color variations during the ordinary superhump display clear anticorrelation with brightness, in contrast to that seen in V455 And. Here, we discuss different color behaviors.	[Isogai, Mizuki; Arai, Akira; Yonehara, Atsunori; Kawakita, Hideyo] Kyoto Sangyo Univ, Koyama Astron Observ, Kita Ku, Kyoto 6038555, Japan; [Isogai, Mizuki] Natl Astron Observ Japan, Mitaka, Tokyo 1818588, Japan; [Arai, Akira] Hyogo Univ, Ctr Astron, Nishi Harima Astron Observ, Sayo, Hyogo 6795313, Japan; [Uemura, Makoto] Hiroshima Univ, Hiroshima Astrophys Sci Ctr, Hiroshima 7398526, Japan; [Nogami, Daisaku] Kyoto Univ, Kwasan & Hida Observ, Yamashina Ku, Kyoto, Kyoto 6078471, Japan; [Nogami, Daisaku] Kyoto Univ, Dept Astron, Sakyo Ku, Kyoto, Kyoto 6068502, Japan	Isogai, M (reprint author), Kyoto Sangyo Univ, Koyama Astron Observ, Kita Ku, Kyoto 6038555, Japan.	mizuki.isogai@nao.ac.jp			MEXT-Supported Program for the Strategic Research Foundation at Private Universities; MEXT [22540257]; JSPS KAKENHI [22540252, 25120007]	We acknowledge with thanks the variable star observations from the AAVSO International Database contributed by observers worldwide and used in this research. This work is supported by the MEXT-Supported Program for the Strategic Research Foundation at Private Universities (2008-2012), MEXT under Grant-in-Aid for Scientific Research (C) (22540257), and by JSPS KAKENHI Grant Number 22540252 and 25120007. Part of this work was carried out on the open-use data analysis system at the Astronomy Data Center of the National Astronomical Observatory of Japan.	Kato T, 1996, PUBL ASTRON SOC JPN, V48, pL21; HORNE K, 1986, MON NOT R ASTRON SOC, V218, P761; Hameury JM, 2000, ASTRON ASTROPHYS, V353, P244; Kato T, 2001, PUBL ASTRON SOC JPN, V53, P1191; HOSHI R, 1979, PROG THEOR PHYS, V61, P1307, DOI 10.1143/PTP.61.1307; Osaki Y, 2001, ASTRON ASTROPHYS, V370, P488, DOI 10.1051/0004-6361:20010234; SHAKURA NI, 1973, ASTRON ASTROPHYS, V24, P337; Pavlenko E, 2009, J PHYS CONF SER, V172, DOI 10.1088/1742-6596/172/1/012071; Osaki Y, 2002, ASTRON ASTROPHYS, V383, P574, DOI 10.1051/0004-6361:20011744; Imada A, 2006, PUBL ASTRON SOC JPN, V58, pL23; Eastman J, 2010, PUBL ASTRON SOC PAC, V122, P935; Steeghs D, 2007, ASTROPHYS J, V667, P442, DOI 10.1086/520702; Araujo-Betancor S, 2005, ASTRON ASTROPHYS, V430, P629, DOI 10.1051/0004-6361:20041736; Godon P, 2006, ASTROPHYS J, V642, P1018, DOI 10.1086/501039; Hellier C, 2001, PUBL ASTRON SOC PAC, V113, P469, DOI 10.1086/319540; Howell SB, 2002, PUBL ASTRON SOC PAC, V114, P748, DOI 10.1086/341702; Imada A, 2012, PUBL ASTRON SOC JPN, V64; Imada A, 2013, PUBL ASTRON SOC JPN, V65; Ishioka R, 2002, ASTRON ASTROPHYS, V381, pL41, DOI 10.1051/0004-6361:20011644; Kato T, 2009, PUBL ASTRON SOC JPN, V61, P601; Kato T., 2004, PASJ, V56, P109; Kato T, 2002, PUBL ASTRON SOC JPN, V54, pL11; Kato T., 1998, Astronomical Society of the Pacific Conference Series, V137; Kato T, 2012, PUBL ASTRON SOC JPN, V64; Kato T., 2009, PASJ, V61, P395; Long KS, 2003, ASTROPHYS J, V591, P1172, DOI 10.1086/375365; Matsui R, 2009, PUBL ASTRON SOC JPN, V61, P1081; Nakagawa S, 2013, PUBL ASTRON SOC JPN, V65; Nogami D., 2004, PASJ, V56, P163; OSAKI Y, 1985, ASTRON ASTROPHYS, V144, P369; OSAKI Y, 1989, PUBL ASTRON SOC JPN, V41, P1005; Patterson J, 2002, PUBL ASTRON SOC PAC, V114, P721, DOI 10.1086/341696; Patterson J, 2005, PUBL ASTRON SOC PAC, V117, P1204, DOI 10.1086/447771; Patterson J, 1998, PUBL ASTRON SOC PAC, V110, P1290, DOI 10.1086/316252; Pavlenko E., 2012, MEM SOC ASTRON ITAL, V83, P520; Pavlenko E, 2007, ASTR SOC P, V372, P511; Pavlenko EP, 2009, KINEMAT PHYS CELEST+, V25, P48, DOI 10.3103/S0884591309010073; Schlafly EF, 2011, ASTROPHYS J, V737, DOI 10.1088/0004-637X/737/2/103; Shears J., 2007, J BR ASTRON ASS, V117, P331; Shinnaka Y, 2013, ICARUS, V222, P734, DOI 10.1016/j.icarus.2012.08.001; Szkody P, 2013, ASTRON J, V145, DOI 10.1088/0004-6256/145/5/121; Szkody P, 2006, ASTRON J, V131, P973, DOI 10.1086/499308; Uemura M, 2012, PUBL ASTRON SOC JPN, V64; VOGT N, 1982, ASTROPHYS J, V252, P653, DOI 10.1086/159592; Warner B., 1985, INTERACTING BINARIES, P367; Warner B, 1995, CATACLYSMIC VARIABLE; WHITEHURST R, 1988, MON NOT R ASTRON SOC, V232, P35; WHITEHURST R, 1991, MON NOT R ASTRON SOC, V249, P25; Zharikov S, 2013, ASTRON ASTROPHYS, V549, DOI 10.1051/0004-6361/201220099; Zharikov SV, 2008, ASTRON ASTROPHYS, V486, P505, DOI 10.1051/0004-6361:200809721	50	1	1	OXFORD UNIV PRESS	OXFORD	GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND	0004-6264	2053-051X		PUBL ASTRON SOC JPN	Publ. Astron. Soc. Jpn.	FEB	2015	67	1							7	10.1093/pasj/psu134		17	Astronomy & Astrophysics	Astronomy & Astrophysics	CC1RN	WOS:000350120500008		
J	Kato, T; Hambsch, FJ; Oksanen, A; Starr, P; Henden, A				Kato, Taichi; Hambsch, Franz-Josef; Oksanen, Arto; Starr, Peter; Henden, Arne			CC Sculptoris: Eclipsing SU UMa-type intermediate polar	PUBLICATIONS OF THE ASTRONOMICAL SOCIETY OF JAPAN			English	Article						accretion, accretion disks; novae, cataclysmic variables; stars: dwarf novae; stars: individual (CC Sculptoris)	KEPLER LIGHT-CURVE; CATACLYSMIC VARIABLES; DWARF-NOVA; PERIOD VARIATIONS; RAPID OSCILLATIONS; HT-CAMELOPARDALIS; URSAE MAJORIS; SDSS J080434.20+510349.2; YY-DRACONIS; V1504 CYGNI	We observed the 2014 superoutburst of the SU UMa-type intermediate polar CC Scl. We detected superhumps with a mean period of 0.05998(2) d during the superoutburst plateau and during three nights after the fading. During the post-superoutburst stage after three nights, a stable superhump period of 0.059523(6) d was detected. We found that this object is an eclipsing system with an orbital period of 0.058567233(8) d. By assuming that the disk radius in the post-superoutburst phase is similar to those in other SU UMa-type dwarf novae, we obtained a mass ratio of q = 0.072(3) from the dynamical precession rate of the accretion disk. The eclipse profile during outbursts can be modeled by an inclination of 80 degrees.6 +/- 0 degrees.5. The 2014 superoutburst was preceded by a precursor outburst and the overall appearance of the outburst was similar to superoutbursts in ordinary SU UMa-type dwarf novae. We showed that the standard thermal-tidal instability model can explain the outburst behavior in this system and suggest that inner truncation of the disk by magnetism of the white dwarf does not strongly affect the behavior in the outer part of the disk.	[Kato, Taichi] Kyoto Univ, Dept Astron, Sakyo Ku, Kyoto 6068502, Japan; [Hambsch, Franz-Josef] GEOS, F-28300 Bailleau Leveque, France; [Hambsch, Franz-Josef] Bundesdeutsche Arbeitsgemeinschaft Veranderl Ster, D-12169 Berlin, Germany; [Hambsch, Franz-Josef] VVS, B-2400 Mol, Belgium; [Oksanen, Arto] Nyrola Observ, Jyvaskylan Sirius Ry, FI-40270 Palokka, Finland; [Starr, Peter] Warrumbungle Observ, Coonabarabran, NSW 2357, Australia; [Henden, Arne] Amer Assoc Variable Star Observers, Cambridge, MA 02138 USA	Kato, T (reprint author), Kyoto Univ, Dept Astron, Sakyo Ku, Kyoto 6068502, Japan.	tkato@kusastro.kyoto-u.ac.jp			Ministry of Education, Culture, Sports, Science and Technology (MEXT) of Japan	This work was supported by the Grant-in-Aid "Initiative for High-Dimensional Data-Driven Science through Deepening of Sparse Modeling" from the Ministry of Education, Culture, Sports, Science and Technology (MEXT) of Japan. We are grateful to the Catalina Real-time Transient Survey team for making their photometric database available to the public. We acknowledge with thanks the variable star observations from the AAVSO International Database contributed by observers worldwide and used in this research. We thank an anonymous referee for improving the paper. We thank K. Isogai and T. Ohshima for helping with the compilation of the observation.	Andronov I. L., 1991, IBVS, P3614; PATTERSON J, 1992, ASTROPHYS J, V392, P233, DOI 10.1086/171421; Baba H, 2000, PUBL ASTRON SOC JPN, V52, P429; Osaki Y, 2013, PUBL ASTRON SOC JPN, V65; Tibshirani R, 1996, J ROY STAT SOC B MET, V58, P267; Augusteijn T, 1997, ASTRON ASTROPHYS, V324, pL57; WATSON MG, 1985, MON NOT R ASTRON SOC, V212, P917; de Martino D, 2005, ASTRON ASTROPHYS, V437, P935, DOI 10.1051/0004-6361:20052761; Woudt PA, 2012, MON NOT R ASTRON SOC, V427, P1004, DOI 10.1111/j.1365-2966.2012.22010.x; Skidmore W, 2000, MON NOT R ASTRON SOC, V318, P429; Nogami D, 1998, PUBL ASTRON SOC JPN, V50, P297; HIROSE M, 1990, PUBL ASTRON SOC JPN, V42, P135; Kato T, 2013, PUBL ASTRON SOC JPN, V65; Drake AJ, 2009, ASTROPHYS J, V696, P870, DOI 10.1088/0004-637X/696/1/870; Kemp J, 2002, PUBL ASTRON SOC PAC, V114, P623, DOI 10.1086/341686; Tappert C, 2004, MON NOT R ASTRON SOC, V354, P321, DOI 10.1111/j.1365-2966.2004.08195.x; Warner B, 2008, MON NOT R ASTRON SOC, V383, P1469, DOI 10.1111/j.1365-2966.2007.12645.x; PATTERSON J, 1994, PUBL ASTRON SOC PAC, V106, P209, DOI 10.1086/133375; Chen A, 2001, MON NOT R ASTRON SOC, V325, P89, DOI 10.1046/j.1365-8711.2001.04322.x; Araujo-Betancor S, 2005, ASTRON ASTROPHYS, V430, P629, DOI 10.1051/0004-6361:20041736; BIANCHINI A, 1986, ASTRON ASTROPHYS, V160, P367; CLEVELAND WS, 1979, J AM STAT ASSOC, V74, P829, DOI 10.2307/2286407; Evans PA, 2005, MON NOT R ASTRON SOC, V359, P1531, DOI 10.1111/j.1365-2966.2005.09001.x; FERNIE JD, 1989, PUBL ASTRON SOC PAC, V101, P225, DOI 10.1086/132426; Gessner H., 1989, MITTEIL VERANDERL ST, V11, P186; Hellier C., 2001, CATACLYSMIC VARIABLE; Ishioka R, 2002, PUBL ASTRON SOC JPN, V54, P581; Ishioka R., 2001, INT B VAR STARS, P5023; Kato T, 2009, PUBL ASTRON SOC JPN, V61, P601; Kato T, 2013, PUBL ASTRON SOC JPN, V65; Kato T, 2009, PUBL ASTRON SOC JPN, V61, pS395; Kato T, 2014, PUBL ASTRON SOC JPN, V66, DOI 10.1093/pasj/psu072; Kato T, 2013, PUBL ASTRON SOC JPN, V65; Kato T, 2013, PUBL ASTRON SOC JPN, V65; Kato T, 2012, PUBL ASTRON SOC JPN, V64; Kato T, 2010, PUBL ASTRON SOC JPN, V62, P1525; Osaki Y, 2013, PUBL ASTRON SOC JPN, V65; Kato T, 2014, PUBL ASTRON SOC JPN, V66, DOI 10.1093/pasj/psu014; Mukadam AS, 2010, ASTROPHYS J, V714, P1702, DOI 10.1088/0004-637X/714/2/1702; Neustroev V., 2012, MMSAI, V83, P724; Neustroev VV, 2013, MON NOT R ASTRON SOC, V432, P2596, DOI 10.1093/mnras/stt622; OSAKI Y, 1989, PUBL ASTRON SOC JPN, V41, P1005; Osaki Y, 1996, PUBL ASTRON SOC PAC, V108, P39, DOI 10.1086/133689; Patterson J, 1996, PUBL ASTRON SOC PAC, V108, P748, DOI 10.1086/133798; PATTERSON J, 1993, PUBL ASTRON SOC PAC, V105, P1116, DOI 10.1086/133289; Schwope AD, 2000, ASTRON NACHR, V321, P1, DOI 10.1002/(SICI)1521-3994(200003)321:1<1::AID-ASNA1>3.0.CO;2-C; Silvestri NM, 2012, ASTRON J, V144, DOI 10.1088/0004-6256/144/3/84; STELLINGWERF RF, 1978, ASTROPHYS J, V224, P953, DOI 10.1086/156444; Thorstensen JR, 1996, PUBL ASTRON SOC PAC, V108, P73, DOI 10.1086/133693; Tovmassian GH, 1998, ASTRON ASTROPHYS, V335, P227; VOGT N, 1983, ASTRON ASTROPHYS, V118, P95; Warner B, 1995, CATACLYSMIC VARIABLE; Zharikov S, 2013, ASTRON ASTROPHYS, V549, DOI 10.1051/0004-6361/201220099	53	1	1	OXFORD UNIV PRESS	OXFORD	GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND	0004-6264	2053-051X		PUBL ASTRON SOC JPN	Publ. Astron. Soc. Jpn.	FEB	2015	67	1							3	10.1093/pasj/psu128		11	Astronomy & Astrophysics	Astronomy & Astrophysics	CC1RN	WOS:000350120500004		
J	Konishi, M; Motohara, K; Tateuchi, K; Takahashi, H; Kitagawa, Y; Kato, N; Sako, S; Uchimoto, YK; Toshikawa, K; Ohsawa, R; Yamamuro, T; Asano, K; Ita, Y; Kamizuka, T; Komugi, S; Koshida, S; Manabe, S; Matsunaga, N; Minezaki, T; Morokuma, T; Nakashima, A; Takagi, T; Tanabe, T; Uchiyama, M; Aoki, T; Doi, M; Handa, T; Kato, D; Kawara, K; Kohno, K; Miyata, T; Nakamura, T; Okada, K; Soyano, T; Tamura, Y; Tanaka, M; Tarusawa, K; Yoshii, Y				Konishi, Masahiro; Motohara, Kentaro; Tateuchi, Ken; Takahashi, Hidenori; Kitagawa, Yutaro; Kato, Natsuko; Sako, Shigeyuki; Uchimoto, Yuka K.; Toshikawa, Koji; Ohsawa, Ryou; Yamamuro, Tomoyasu; Asano, Kentaro; Ita, Yoshifusa; Kamizuka, Takafumi; Komugi, Shinya; Koshida, Shintaro; Manabe, Sho; Matsunaga, Noriyuki; Minezaki, Takeo; Morokuma, Tomoki; Nakashima, Asami; Takagi, Toshinobu; Tanabe, Toshihiko; Uchiyama, Mizuho; Aoki, Tsutomu; Doi, Mamoru; Handa, Toshihiro; Kato, Daisuke; Kawara, Kimiaki; Kohno, Kotaro; Miyata, Takashi; Nakamura, Tomohiko; Okada, Kazushi; Soyano, Takao; Tamura, Yoichi; Tanaka, Masuo; Tarusawa, Ken'ichi; Yoshii, Yuzuru			ANIR: Atacama near-infrared camera for the 1.0 m miniTAO telescope	PUBLICATIONS OF THE ASTRONOMICAL SOCIETY OF JAPAN			English	Article						atmospheric effects; infrared: general; instrumentation: detectors; site testing	OPTICAL/INFRARED ASTRONOMICAL QUALITY; INTEGRAL FIELD SPECTROSCOPY; PASCHEN-ALPHA SURVEY; MAUNA-KEA; STAR-FORMATION; FILTER SET; MAGELLANIC-CLOUD; WATER-VAPOR; EXTINCTION; GALAXIES	We have developed a near-infrared camera called ANIR (Atacama Near-InfraRed camera) for the University of Tokyo Atacama Observatory 1.0 m telescope (miniTAO) installed at the summit of Cerro Chajnantor (5640 m above sea level) in the north of Chile. The camera provides a field of view of 5'.1 x 5'.1 with a spatial resolution of 0 ''.298 pixel(-1) in the wavelength range of 0.95 to 2.4 mu m, using Offner relay optics and a PACE HAWAII-2 focal plane array. Taking advantage of the dry site, the camera is capable of narrow-band imaging observations at the hydrogen Paschen-alpha (Pa alpha, lambda = 1.8751 mu m in air) wavelength ground-based observations of which have been quite difficult due to deep atmospheric absorption, mainly from water vapor. We have been successfully obtaining Pa alpha images of Galactic objects and nearby galaxies since the first-light observation in 2009 with ANIR. The throughputs at the narrow-band filters (N1875, N191) including the atmospheric absorption show larger dispersion (similar to 10%) than those at broad-band filters (a few percent), indicating that they are affected by temporal fluctuations in precipitable water vapor (PWV) above the site. We evaluate the PWV content via the atmospheric transmittance at the narrow-band filters, and deduce that the median and the dispersion of the distribution of the PWV are 0.40 +/- 0.30 and 0.37 +/- 0.21mm, for the N1875 and N191 data respectively, which are remarkably smaller (49% +/- 38% for N1875 and 59% +/- 26% for N191) than radiometry measurements at the base of Cerro Chajnantor (an altitude of 5100 m). The decrease in PWV can be explained by the altitude of the site when we assume that the vertical distribution of the water vapor is approximated at an exponential profile with scale heights within 0.3-1.9 km (previously observed values at night). We thus conclude that miniTAO/ANIR at the summit of Cerro Chajnantor indeed provides us an excellent capability for a ground-based Paa observation.	[Konishi, Masahiro; Motohara, Kentaro; Tateuchi, Ken; Takahashi, Hidenori; Kitagawa, Yutaro; Kato, Natsuko; Sako, Shigeyuki; Uchimoto, Yuka K.; Toshikawa, Koji; Asano, Kentaro; Kamizuka, Takafumi; Koshida, Shintaro; Minezaki, Takeo; Morokuma, Tomoki; Tanabe, Toshihiko; Uchiyama, Mizuho; Doi, Mamoru; Handa, Toshihiro; Kawara, Kimiaki; Kohno, Kotaro; Miyata, Takashi; Nakamura, Tomohiko; Okada, Kazushi; Tamura, Yoichi; Tanaka, Masuo; Yoshii, Yuzuru] Univ Tokyo, Inst Astron, Mitaka, Tokyo 1810015, Japan; [Uchimoto, Yuka K.; Ita, Yoshifusa] Tohoku Univ, Astron Inst, Aoba Ku, Sendai, Miyagi 9808578, Japan; [Ohsawa, Ryou; Matsunaga, Noriyuki; Nakashima, Asami; Kato, Daisuke; Nakamura, Tomohiko] Univ Tokyo, Dept Astron, Bunkyo Ku, Tokyo 1130033, Japan; [Yamamuro, Tomoyasu] OptCraft, Midori Ku, Sagamihara, Kanagawa 2520144, Japan; [Ita, Yoshifusa; Komugi, Shinya; Nakashima, Asami] Natl Astron Observ Japan, Mitaka, Tokyo 1818588, Japan; [Komugi, Shinya; Takagi, Toshinobu] Japan Aerosp Explorat Agcy, Inst Space & Astronaut Sci, Chuo Ku, Sagamihara, Kanagawa 2525210, Japan; [Komugi, Shinya] Joint ALMA Observ, Santiago 7630355, Chile; [Koshida, Shintaro] Pontificia Univ Catolica Chile, Dept Elect Engn, Santiago, Chile; [Koshida, Shintaro] Pontificia Univ Catolica Chile, Ctr Astro Engn, Santiago, Chile; [Manabe, Sho] Kobe Univ, Fac Sci, Dept Earth & Planetary Sci, Nada Ku, Kobe, Hyogo 6578501, Japan; [Aoki, Tsutomu; Soyano, Takao; Tarusawa, Ken'ichi] Univ Tokyo, Sch Sci, Inst Astron, Kiso Observ, Kiso, Nagano 3970101, Japan; [Nakashima, Asami] Nagoya City Sci Museum, Naka Ku, Nagoya, Aichi 4600008, Japan; [Handa, Toshihiro] Kagoshima Univ, Fac Sci, Kagoshima, Kagoshima 8908580, Japan; [Nakamura, Tomohiko] Japan Sci & Technol Agcy, Ctr Low Carbon Soc Strategy, Chiyoda Ku, Tokyo 1020076, Japan	Konishi, M (reprint author), Univ Tokyo, Inst Astron, 2-21-1 Osawa, Mitaka, Tokyo 1810015, Japan.	konishi@ioa.s.u-tokyo.ac.jp			Ministry of Education, Culture, Sports, Science and Technology of Japan; Japan Society for the Promotion of Science (JSPS) [17104002, 20040003, 20041003, 21018003, 21018005, 21684006, 22253002, 22540258, 23540261]; Institutional Program for Young Researcher Overseas Visits; Advanced Technology Center, National Astronomical Observatory of Japan (NAOJ); NAOJ Research Grant for Universities; Optical and Near-Infrared Astronomy Inter-University Cooperation Program - MEXT of Japan; Advanced Technology Center, NAOJ; National Aeronautics and Space Administration; National Science Foundation; NASA [NAS5-26555]; NASA Office of Space Science [NNX09AF08G]	We are extremely grateful to the anonymous referee for useful comments and suggestions that helped us to improve the quality of the paper. We would like to acknowledge Maria Teresa Ruiz Gonzalez, Leonardo Bronfman, Mario Hamuy, and Rene Alejandro Mendez Bussard at the University of Chile for their support for the TAO project. Operation of ANIR on the miniTAO telescope is supported by the Ministry of Education, Culture, Sports, Science and Technology of Japan, Grant-in-Aids for Scientific Research (17104002, 20040003, 20041003, 21018003, 21018005, 21684006, 22253002, 22540258, and 23540261) from Japan Society for the Promotion of Science (JSPS). Part of this work has been supported by the the Institutional Program for Young Researcher Overseas Visits operated by JSPS. Part of this work has been supported by the Advanced Technology Center, National Astronomical Observatory of Japan (NAOJ). Part of this work has been supported by a NAOJ Research Grant for Universities, and by the Optical and Near-Infrared Astronomy Inter-University Cooperation Program, supported by the MEXT of Japan. Part of the ANIR development was supported by the Advanced Technology Center, NAOJ. The PACE HAWAII-2 FPA array detector has been generously leased by Subaru Telescope, NAOJ. The Image Reduction and Analysis Facility (IRAF) used in this paper is distributed by the National Optical Astronomy Observatories, which are operated by the Association of Universities for Research in Astronomy, Inc., under cooperative agreement with the National Science Foundation. This publication makes use of data products from the Two Micron All Sky Survey, which is a joint project of the University of Massachusetts and the Infrared Processing and Analysis Center/California Institute of Technology, funded by the National Aeronautics and Space Administration and the National Science Foundation. Some/all of the data presented in this paper were obtained from the Mikulski Archive for Space Telescopes (MAST). STScI is operated by the Association of Universities for Research in Astronomy, Inc., under NASA contract NAS5-26555. Support for MAST for non-HST data is provided by the NASA Office of Space Science via grant NNX09AF08G and by other grants and contracts. We would like to thank APEX for providing their radiometer data on the web. APEX is a collaboration between the Max Planck Institute for Radio Astronomy, the European Southern Observatory, and the Onsala Space Observatory.	Dobashi K, 2009, ASTRON J, V137, P5099, DOI 10.1088/0004-6256/137/6/5099; Tokunaga AT, 2005, PUBL ASTRON SOC PAC, V117, P421, DOI 10.1086/429382; Tokunaga AT, 2002, PUBL ASTRON SOC PAC, V114, P180, DOI 10.1086/338545; Wang QD, 2010, MON NOT R ASTRON SOC, V402, P895, DOI 10.1111/j.1365-2966.2009.15973.x; Skrutskie MF, 2006, ASTRON J, V131, P1163, DOI 10.1086/498708; Giovanelli R, 2001, PUBL ASTRON SOC PAC, V113, P803, DOI 10.1086/322136; Erasmus D, 2002, ASTR SOC P, V266, P310; Lasker BM, 2008, ASTRON J, V136, P735, DOI 10.1088/0004-6256/136/2/735; Rousselot P, 2000, ASTRON ASTROPHYS, V354, P1134; Thompson RI, 1998, ASTROPHYS J, V492, pL95, DOI 10.1086/311095; Alonso-Herrero A, 2006, ASTROPHYS J, V650, P835, DOI 10.1086/506958; Gusten R, 2006, ASTRON ASTROPHYS, V454, pL13, DOI 10.1051/0004-6361:20065420; Motohara K, 2002, PUBL ASTRON SOC JPN, V54, P315; BESSELL MS, 1988, PUBL ASTRON SOC PAC, V100, P1134, DOI 10.1086/132281; Simons DA, 2002, PUBL ASTRON SOC PAC, V114, P169, DOI 10.1086/338544; Dong H, 2011, MON NOT R ASTRON SOC, V417, P114, DOI 10.1111/j.1365-2966.2011.19013.x; Bothwell MS, 2011, MON NOT R ASTRON SOC, V415, P1815, DOI 10.1111/j.1365-2966.2011.18829.x; Finger G, 1998, P SOC PHOTO-OPT INS, V3354, P87, DOI 10.1117/12.317209; Garcia-Marin M, 2006, ASTROPHYS J, V650, P850, DOI 10.1086/507411; Giovanelli R, 2001, PUBL ASTRON SOC PAC, V113, P789, DOI 10.1086/322135; Hodapp K.-W., 1996, New Astronomy, V1, DOI 10.1016/S1384-1076(96)00013-9; Imara N, 2007, ASTROPHYS J, V662, P969, DOI 10.1086/517911; Kennicutt RC, 1998, ANNU REV ASTRON ASTR, V36, P189, DOI 10.1146/annurev.astro.36.1.189; Kerber F, 2010, PROC SPIE, V7733, DOI 10.1117/12.856390; Komugi S, 2012, ASTROPHYS J, V757, DOI 10.1088/0004-637X/757/2/138; Kurucz R, 1993, 13 CDROM SMITHS ASTR, P13; LANDOLT AU, 1992, ASTRON J, V104, P340, DOI 10.1086/116242; Lord S., 1992, NASA TECHNICAL MEMOR; Manduca A., 1979, PUB ASP, V91, P848, DOI 10.1086/130598; Matsushita S, 2003, PUBL ASTRON SOC JPN, V55, P325; McLean IS, 2012, PROC SPIE, V8446, DOI 10.1117/12.926821; Minezaki T, 2010, PROC SPIE, V7733, DOI 10.1117/12.856694; Motohara K, 2008, PROC SPIE, V7012, DOI 10.1117/12.788498; Osterbrock D. E., 1989, ASTROPHYSICS GASEOUS; Otarola A, 2010, PUBL ASTRON SOC PAC, V122, P470; Otarola A. C., 2011, ARXIV11033025; PEI YCC, 1992, ASTROPHYS J, V395, P130, DOI 10.1086/171637; Peterson JB, 2003, PUBL ASTRON SOC PAC, V115, P383, DOI 10.1086/368101; Lopez JP, 2013, ASTRON ASTROPHYS, V553, DOI 10.1051/0004-6361/201220991; Sako S, 2008, PROC SPIE, V7012, DOI 10.1117/12.788563; Sako S, 2008, P SOC PHOTO-OPT INS, V7021, DOI 10.1117/12.788633; Stead JJ, 2011, MON NOT R ASTRON SOC, V418, P2219, DOI 10.1111/j.1365-2966.2011.19522.x; Takeuchi TT, 2010, ASTRON ASTROPHYS, V514, DOI 10.1051/0004-6361/200913476; Tamura Y, 2011, PUBL ASTRON SOC JPN, V63, P347; Tateuchi K., 2012, PUBL KOREAN ASTRON S, V27, P297; Tateuchi K, 2012, PROC SPIE, V8446, DOI 10.1117/12.924263; Tateuchi K., 2014, APJS IN PRESS; Yoshii Y, 2010, PROC SPIE, V7733, DOI 10.1117/12.856680; Yoshikawa T, 2006, P SOC PHOTO-OPT INS, V6274, pY2740, DOI 10.1117/12.670957	49	1	1	OXFORD UNIV PRESS	OXFORD	GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND	0004-6264	2053-051X		PUBL ASTRON SOC JPN	Publ. Astron. Soc. Jpn.	FEB	2015	67	1							4	10.1093/pasj/psu148		15	Astronomy & Astrophysics	Astronomy & Astrophysics	CC1RN	WOS:000350120500005		
J	Konishi, M; Shibai, H; Sumi, T; Fukagawa, M; Matsuo, T; Samland, MS; Yamamoto, K; Sudo, J; Itoh, Y; Arimoto, N; Kajisawa, M; Abe, L; Brandner, W; Brandt, TD; Carson, J; Currie, T; Egner, SE; Feldt, M; Goto, M; Grady, CA; Guyon, O; Hashimoto, J; Hayano, Y; Hayashi, M; Hayashi, SS; Henning, T; Hodapp, KW; Ishii, M; Iye, M; Janson, M; Kandori, R; Knapp, GR; Kudo, T; Kusakabe, N; Kuzuhara, M; Kwon, J; McElwain, MW; Miyama, S; Morino, J; Moro-Martin, A; Nishimura, T; Pyo, TS; Serabyn, E; Suenaga, T; Suto, H; Suzuki, R; Takahashi, YH; Takami, H; Takato, N; Terada, H; Thalmann, C; Tomono, D; Turner, EL; Usuda, T; Watanabe, M; Wisniewski, JP; Yamada, T; Tamura, M				Konishi, Mihoko; Shibai, Hiroshi; Sumi, Takahiro; Fukagawa, Misato; Matsuo, Taro; Samland, Matthias S.; Yamamoto, Kodai; Sudo, Jun; Itoh, Yoichi; Arimoto, Nobuo; Kajisawa, Masaru; Abe, Lyu; Brandner, Wolfgang; Brandt, Timothy D.; Carson, Joseph; Currie, Thayne; Egner, Sebastian E.; Feldt, Markus; Goto, Miwa; Grady, Carol A.; Guyon, Olivier; Hashimoto, Jun; Hayano, Yutaka; Hayashi, Masahiko; Hayashi, Saeko S.; Henning, Thomas; Hodapp, Klaus W.; Ishii, Miki; Iye, Masanori; Janson, Markus; Kandori, Ryo; Knapp, Gillian R.; Kudo, Tomoyuki; Kusakabe, Nobuhiko; Kuzuhara, Masayuki; Kwon, Jungmi; McElwain, Michael W.; Miyama, Shoken; Morino, Jun-Ichi; Moro-Martin, Amaya; Nishimura, Tetsuo; Pyo, Tae-Soo; Serabyn, Eugene; Suenaga, Takuya; Suto, Hiroshi; Suzuki, Ryuji; Takahashi, Yasuhiro H.; Takami, Hideki; Takato, Naruhisa; Terada, Hiroshi; Thalmann, Christian; Tomono, Daigo; Turner, Edwin L.; Usuda, Tomonori; Watanabe, Makoto; Wisniewski, John P.; Yamada, Toru; Tamura, Motohide			Indications of M-dwarf deficits in the halo and thick disk of the Galaxy	PUBLICATIONS OF THE ASTRONOMICAL SOCIETY OF JAPAN			English	Article						Galaxy: disk; Galaxy: halo; stars: imaging; stars: low-mass	MASS BROWN DWARFS; SKY STAR COUNT; MILKY-WAY; ULTRACOOL DWARFS; COOL NEIGHBORS; LUMINOSITY-FUNCTION; MAIN-SEQUENCE; DEEP FIELD; WHOLE SKY; PLANETS	We compared the number of faint stars detected in deep survey fields with the current stellar distribution model of the Galaxy and found that the detected number in the H band is significantly smaller than the predicted number. This indicates that M-dwarfs, the major component, are fewer in the halo and the thick disk. We used archived data of several surveys in both the north and south field of GOODS (Great Observatories Origins Deep Survey), MODS (MOIRCS Deep Survey) in GOODS-N, and ERS (Early Release Science) and CANDELS (Cosmic Assembly Near-infrared Deep Extragalactic Legacy Survey) in GOODS-S. The number density of M-dwarfs in the halo has to be 20%+/- 13% relative to that in the solar vicinity, in order for the detected number of stars fainter than 20.5 mag in the H band to match with the predicted value from the model. In the thick disk, the number density of M-dwarfs must be reduced (52%+/- 13%) or the scale height must be decreased (similar to 600 pc). Alternatively, overall fractions of the halo and thick disks can be significantly reduced to achieve the same effect, because our sample mainly consists of faint M-dwarfs. Our results imply that the M-dwarf population in regions distant from the Galactic plane is significantly smaller than previously thought. We then discussed the implications this has on the suitability of the model predictions for the prediction of non-companion faint stars in direct imaging extrasolar planet surveys by using the best-fitting number densities.	[Konishi, Mihoko; Shibai, Hiroshi; Sumi, Takahiro; Fukagawa, Misato; Sudo, Jun] Osaka Univ, Grad Sch Sci, Dept Earth & Space Sci, Toyonaka, Osaka 5600043, Japan; [Matsuo, Taro; Yamamoto, Kodai] Kyoto Univ, Fac Sci, Dept Astron, Sakyo Ku, Kyoto 6068502, Japan; [Samland, Matthias S.] Heidelberg Univ, Dept Phys & Astron, D-69117 Heidelberg, Germany; [Itoh, Yoichi] Nishi Harima Astron Observ, Sayo, Hyogo 6795313, Japan; [Arimoto, Nobuo; Currie, Thayne; Egner, Sebastian E.; Guyon, Olivier; Hayano, Yutaka; Hayashi, Saeko S.; Ishii, Miki; Kudo, Tomoyuki; Nishimura, Tetsuo; Pyo, Tae-Soo; Takato, Naruhisa; Terada, Hiroshi; Tomono, Daigo] Subaru Telescope, Hilo, HI 96720 USA; [Arimoto, Nobuo; Suenaga, Takuya] Grad Univ Adv Studies SOKENDAI, Mitaka, Tokyo 1818588, Japan; [Kajisawa, Masaru] Ehime Univ, Res Ctr Space & Cosm Evolut, Matsuyama, Ehime 7908577, Japan; [Abe, Lyu] Univ Nice Sophia Antipolis, CNRS, Observ Cote Azur, Lab Lagrange,UMR 7293, F-06108 Nice 2, France; [Brandner, Wolfgang; Feldt, Markus; Henning, Thomas] Max Planck Inst Astron, D-69117 Heidelberg, Germany; [Brandt, Timothy D.; Knapp, Gillian R.; Turner, Edwin L.] Princeton Univ, Dept Astrophys Sci, Princeton, NJ 08544 USA; [Carson, Joseph] Coll Charleston, Dept Phys & Astron, Charleston, SC 29424 USA; [Goto, Miwa] Univ Munich, Univ Sternwarte Munchen, D-81679 Munich, Germany; [Grady, Carol A.] Eureka Sci, Oakland, CA 96002 USA; [Grady, Carol A.; McElwain, Michael W.] ExoPlanets & Stellar Astrophys Lab, Greenbelt, MD 20771 USA; [Hashimoto, Jun; Wisniewski, John P.] Univ Oklahoma, HL Dodge Dept Phys & Astron, Norman, OK 73019 USA; [Hayashi, Masahiko; Iye, Masanori; Kandori, Ryo; Kusakabe, Nobuhiko; Kuzuhara, Masayuki; Kwon, Jungmi; Morino, Jun-Ichi; Suto, Hiroshi; Suzuki, Ryuji; Takahashi, Yasuhiro H.; Takami, Hideki; Usuda, Tomonori; Tamura, Motohide] Natl Astron Observ Japan, Mitaka, Tokyo 1818588, Japan; [Hodapp, Klaus W.] Univ Hawaii, Inst Astron, Hilo, HI 96720 USA; [Janson, Markus] Queens Univ Belfast, Astrophys Res Ctr, Belfast BT7 1NN, Antrim, North Ireland; [Kuzuhara, Masayuki] Tokyo Inst Technol, Dept Earth & Planetary Sci, Meguro Ku, Tokyo 1528551, Japan; [Kuzuhara, Masayuki; Kwon, Jungmi; Takahashi, Yasuhiro H.; Tamura, Motohide] Univ Tokyo, Dept Astron, Bunkyo Ku, Tokyo 1130033, Japan; [Miyama, Shoken] Hiroshima Univ, Higashihiroshima, Hiroshima 7398526, Japan; [Moro-Martin, Amaya] CSIC, CAB, INTA, Dept Astrophys, Madrid 28850, Spain; [Serabyn, Eugene] CALTECH, Jet Prop Lab, Pasadena, CA 91109 USA; [Thalmann, Christian] ETH, Inst Astron, CH-8093 Zurich, Switzerland; [Watanabe, Makoto] Hokkaido Univ, Dept Cosmosciences, Kita Ku, Sapporo, Hokkaido 0600810, Japan; [Yamada, Toru] Tohoku Univ, Astron Inst, Aoba Ku, Sendai, Miyagi 9808578, Japan	Konishi, M (reprint author), Osaka Univ, Grad Sch Sci, Dept Earth & Space Sci, 1-1 Machikaneyama, Toyonaka, Osaka 5600043, Japan.	konishi@iral.ess.sci.osaka-u.ac.jp	MIYAMA, Shoken/A-3598-2015				Kirby EN, 2008, ASTROPHYS J LETT, V685, pL43, DOI 10.1086/592432; Marois C, 2006, ASTROPHYS J, V641, P556, DOI 10.1086/500401; Abadi MG, 2003, ASTROPHYS J, V597, P21, DOI 10.1086/378316; Juric M, 2008, ASTROPHYS J, V673, P864, DOI 10.1086/523619; BAHCALL JN, 1980, ASTROPHYS J SUPPL S, V44, P73, DOI 10.1086/190685; KIRKPATRICK JD, 1994, ASTROPHYS J SUPPL S, V94, P749, DOI 10.1086/192089; Suzuki R, 2010, PROC SPIE, V7735, DOI 10.1117/12.857361; WAINSCOAT RJ, 1992, ASTROPHYS J SUPPL S, V83, P111, DOI 10.1086/191733; Hodapp KW, 2008, P SOC PHOTO-OPT INS, V7014, P1419, DOI 10.1117/12.788088; Robin AC, 2003, ASTRON ASTROPHYS, V409, P523, DOI 10.1051/0004-6361:20031117; Reid IN, 2008, ASTRON J, V136, P1290, DOI 10.1088/0004-6256/136/3/1290; Bertin E, 1996, ASTRON ASTROPHYS SUP, V117, P393, DOI 10.1051/aas:1996164; Cruz KL, 2003, ASTRON J, V126, P2421, DOI 10.1086/378607; Wirth GD, 2004, ASTRON J, V127, P3121, DOI 10.1086/420999; Lafreniere D, 2007, ASTROPHYS J, V660, P770, DOI 10.1086/513180; GILMORE G, 1983, MON NOT R ASTRON SOC, V202, P1025; SEARLE L, 1978, ASTROPHYS J, V225, P357, DOI 10.1086/156499; Pirzkal N, 2009, ASTROPHYS J, V695, P1591, DOI 10.1088/0004-637X/695/2/1591; Bensby T, 2011, ASTROPHYS J LETT, V735, DOI 10.1088/2041-8205/735/2/L46; Bihain G, 2006, ASTRON ASTROPHYS, V458, P805, DOI 10.1051/0004-6361:20065124; Bovy J, 2012, ASTROPHYS J, V751, DOI 10.1088/0004-637X/751/2/131; Bowler BP, 2013, ASTROPHYS J, V774, DOI 10.1088/0004-637X/774/1/55; Brandt TD, 2014, ASTROPHYS J, V794, DOI 10.1088/0004-637X/794/2/159; Burgasser AJ, 2007, ASTROPHYS J, V659, P655, DOI 10.1086/511027; Caballero JA, 2008, ASTRON ASTROPHYS, V488, P181, DOI 10.1051/0004-6361:200809520; Carollo D, 2010, ASTROPHYS J, V712, P692, DOI 10.1088/0004-637X/712/1/692; Chabrier G, 2003, PUBL ASTRON SOC PAC, V115, P763, DOI 10.1086/376392; Chang CK, 2011, ASTROPHYS J, V740, DOI 10.1088/0004-637X/740/1/34; Chang CK, 2012, ASTROPHYS J, V759, DOI 10.1088/0004-637X/759/2/94; Chauvin G., 2014, A A IN PRESS; Czekaj M. A., 2014, ASTRON ASTROPHYS, V564, P102; Guo YC, 2013, ASTROPHYS J SUPPL S, V207, DOI 10.1088/0067-0049/207/2/24; Hayano Y, 2010, P SOC PHOTO-OPT INS, V7736, DOI 10.1117/12.857567; Hayden MR, 2014, ASTRON J, V147, DOI 10.1088/0004-6256/147/5/116; Holwerda BW, 2014, ASTROPHYS J, V788, DOI 10.1088/0004-637X/788/1/77; Ichikawa T, 2006, P SOC PHOTO-OPT INS, V6269, P26916, DOI 10.1117/12.670078; Janson M, 2013, ASTROPHYS J, V773, DOI 10.1088/0004-637X/773/1/73; JONES TJ, 1981, MON NOT R ASTRON SOC, V197, P413; Kajisawa M., 2011, PASJ, V63, P379; Kirkpatrick JD, 2011, ASTROPHYS J SUPPL S, V197, DOI 10.1088/0067-0049/197/2/19; Kirkpatrick JD, 2012, ASTROPHYS J, V753, DOI 10.1088/0004-637X/753/2/156; Konishi M., 2013, J JPN SOC INFRARED S, V23, P108; Nakajima T, 2000, ASTRON J, V120, P2488, DOI 10.1086/316814; Nielsen EL, 2013, ASTROPHYS J, V776, DOI 10.1088/0004-637X/776/1/4; Pecaut MJ, 2013, ASTROPHYS J SUPPL S, V208, DOI 10.1088/0067-0049/208/1/9; Pecaut MJ, 2012, ASTROPHYS J, V746, DOI 10.1088/0004-637X/746/2/154; Pirzkal N, 2005, ASTROPHYS J, V622, P319, DOI 10.1086/427896; Polido P, 2013, ASTROPHYS J, V778, DOI 10.1088/0004-637X/778/1/32; Reid IN, 2004, ASTRON J, V128, P463, DOI 10.1086/421374; Reyle C, 2010, ASTRON ASTROPHYS, V522, DOI 10.1051/0004-6361/200913234; Ryan RE, 2011, ASTROPHYS J, V739, DOI 10.1088/0004-637X/739/2/83; Sumi T, 2011, NATURE, V473, P349, DOI 10.1038/nature10092; Suzuki R, 2008, PUBL ASTRON SOC JPN, V60, P1347; Tamura M, 2009, AIP CONF PROC, V1158, P11, DOI 10.1063/1.3215811; Windhorst RA, 2011, ASTROPHYS J SUPPL S, V193, DOI 10.1088/0067-0049/193/2/27; Yamamoto K, 2013, PUBL ASTRON SOC JPN, V65	56	0	0	OXFORD UNIV PRESS	OXFORD	GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND	0004-6264	2053-051X		PUBL ASTRON SOC JPN	Publ. Astron. Soc. Jpn.	FEB	2015	67	1							1	10.1093/pasj/psu125		13	Astronomy & Astrophysics	Astronomy & Astrophysics	CC1RN	WOS:000350120500002		
J	Miura, RE; Espada, D; Sugai, H; Nakanishi, K; Hirota, A				Miura, Rie E.; Espada, Daniel; Sugai, Hajime; Nakanishi, Kouichiro; Hirota, Akihiko			Witness of gas infall and outflow in the young starburst dwarf galaxy NGC5253	PUBLICATIONS OF THE ASTRONOMICAL SOCIETY OF JAPAN			English	Article						galaxies: individual (NGC 5253); galaxies: starburst; ISM: jets and outflows	SUPER-STAR CLUSTER; X-RAY-EMISSION; NGC 5253; H-I; CHANDRA OBSERVATIONS; CENTRAL REGION; MOLECULAR GAS; IONIZED-GAS; NGC-5253; SPECTROSCOPY	We present (CO)-C-12(2-1) observations towards the dwarf galaxy NGC5253 using the Sub-millimeter Array. The data shows that a large amount of molecular gas is located in the central similar to 200 pc starburst region, physically associated with two young super stellar clusters (SSCs). The molecular gas traced by (CO)-C-12(2-1) is elongated along the minor axis (dust lane) of the galaxy and its kinematics suggest that there is an inflow of molecular gas to the direction of the central SSCs, as is also observed in HI gas at a larger scale. Due to their correlation in spatial and velocity domains, the central SSCs were likely formed from molecular gas in the nucleus. We compare the (CO)-C-12(2-1) with available H-2 1-0 S(1) data, and show that while the relatively cold gas traced by (CO)-C-12(2-1) is distributed around the central starburst region but also along the dust lane, the warm gas traced by H-2 1-0 S(1) is associated with the central H II region and other star-forming regions. Interestingly, a cavity in the H-2 1-0 S(1) emission is found to be spatially correlated with a Ha shell. This H alpha shell may trace a bipolar outflow from the central SSCs and the H-2 1-0 S(1) gas, the gas shocked by the outflow encountering the surrounding quiescent gas. We calculate a molecular gas inflow rate of similar to 2M(circle dot)yr(-1), a star formation rate of 0.3-0.5M(circle dot) yr(-1), and an ionized gas outflow being emitted from the SSCs with a rate of (5-25) x 10(-3) f M-circle dot yr(-1), where f is a volume filling factor.	[Miura, Rie E.; Espada, Daniel; Nakanishi, Kouichiro; Hirota, Akihiko] Natl Inst Nat Sci, Natl Astron Observ Japan, Mitaka, Tokyo 1818588, Japan; [Espada, Daniel; Nakanishi, Kouichiro; Hirota, Akihiko] Joint ALMA Observ, Santiago 7630355, Chile; [Espada, Daniel; Nakanishi, Kouichiro] Grad Univ Adv Studies Sokendai, Dept Astron Sci, Mitaka, Tokyo 1810015, Japan; [Sugai, Hajime] Univ Tokyo, Kavli IPMU, WPI, Kavli Inst Phys & Math Univ,Todai Inst Adv Study, Kashiwa, Chiba 2778583, Japan	Miura, RE (reprint author), Natl Inst Nat Sci, Natl Astron Observ Japan, 2-21-1 Osawa, Mitaka, Tokyo 1818588, Japan.	rie.miura@nao.ac.jp					Martin-Hernandez NL, 2005, ASTRON ASTROPHYS, V429, P449, DOI 10.1051/0004-6361:20041603; Martins F, 2005, ASTRON ASTROPHYS, V436, P1049, DOI 10.1051/0004-6361:20042386; Turner JL, 1997, ASTROPHYS J, V474, pL11, DOI 10.1086/310412; Lopez-Sanchez AR, 2012, MON NOT R ASTRON SOC, V419, P1051, DOI 10.1111/j.1365-2966.2011.19762.x; Calzetti D, 1997, ASTRON J, V114, P1834, DOI 10.1086/118609; Sakai S, 2004, ASTROPHYS J, V608, P42, DOI 10.1086/386540; Turner JL, 2004, ASTROPHYS J, V602, pL85, DOI 10.1086/382699; WILLIAMS JP, 1994, ASTROPHYS J, V428, P693, DOI 10.1086/174279; Vanzi L, 2004, ASTRON ASTROPHYS, V415, P509, DOI 10.1051/0004-6361:20034635; Alonso-Herrero A, 2004, ASTROPHYS J, V612, P222; Bolatto AD, 2013, NATURE, V499, P450, DOI 10.1038/nature12351; Strickland DK, 2002, ASTROPHYS J, V568, P689, DOI 10.1086/338889; Turner JL, 2000, ASTROPHYS J, V532, pL109, DOI 10.1086/312586; Calzetti D, 2004, ASTRON J, V127, P1405, DOI 10.1086/382095; Meier DS, 2002, ASTRON J, V124, P877, DOI 10.1086/341752; CALDWELL N, 1989, ASTROPHYS J, V338, P789, DOI 10.1086/167236; Cresci G, 2005, ASTRON ASTROPHYS, V433, P447, DOI 10.1051/0004-6361:20041028; Kornei KA, 2009, ASTROPHYS J, V697, P1180, DOI 10.1088/0004-637X/697/2/1180; Summers LK, 2004, MON NOT R ASTRON SOC, V351, P1, DOI 10.1111/j.1365-2966.2004.07749.x; Davies RI, 1998, MON NOT R ASTRON SOC, V295, P43, DOI 10.1046/j.1365-8711.1998.29511205.x; Storchi-Bergmann T, 2010, MON NOT R ASTRON SOC, V402, P819, DOI 10.1111/j.1365-2966.2009.15962.x; Boomsma R, 2005, ASTRON ASTROPHYS, V431, P65, DOI 10.1051/0004-6361:20041715; Cresci G, 2010, ASTRON ASTROPHYS, V520, DOI 10.1051/0004-6361/201014864; Espada D., 2010, GALAXIES THEIR MASKS, P97, DOI 10.1007/978-1-4419-7317-7_7; Guseva NG, 2011, ASTRON ASTROPHYS, V529, DOI 10.1051/0004-6361/201016291; Hirashita H, 2013, MON NOT R ASTRON SOC, V429, P3390, DOI 10.1093/mnras/sts602; Kobulnicky HA, 2008, ASTRON J, V135, P527, DOI 10.1088/0004-6256/135/2/527; Kobulnicky HA, 1997, ASTROPHYS J, V477, P679, DOI 10.1086/303742; Lelli F, 2014, ASTRON ASTROPHYS, V566, DOI 10.1051/0004-6361/201322657; Leroy AK, 2011, ASTROPHYS J, V737, DOI 10.1088/0004-637X/737/1/12; Meier DS, 2001, ASTRON J, V121, P740, DOI 10.1086/318782; Miura R, 2010, ASTROPHYS J, V724, P1120, DOI 10.1088/0004-637X/724/2/1120; Monreal-Ibero A, 2010, ASTRON ASTROPHYS, V517, DOI 10.1051/0004-6361/201014154; Sault RJ, 1995, ASTR SOC P, V77, P433; Schwartz CM, 2004, ASTROPHYS J, V610, P201, DOI 10.1086/421546; SCOVILLE NZ, 1991, ASTROPHYS J, V366, pL5, DOI 10.1086/185897; Strickland DK, 2000, ASTRON J, V120, P2965, DOI 10.1086/316846; Westmoquette MS, 2013, ASTRON ASTROPHYS, V550, DOI 10.1051/0004-6361/201220580	38	0	0	OXFORD UNIV PRESS	OXFORD	GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND	0004-6264	2053-051X		PUBL ASTRON SOC JPN	Publ. Astron. Soc. Jpn.	FEB	2015	67	1							L1	10.1093/pasj/psu138		6	Astronomy & Astrophysics	Astronomy & Astrophysics	CC1RN	WOS:000350120500001		
J	Miyamoto, Y; Nakai, N; Seta, M; Salak, D; Hagiwara, K; Nagai, M; Ishii, S; Yamauchi, A				Miyamoto, Yusuke; Nakai, Naomasa; Seta, Masumichi; Salak, Dragan; Hagiwara, Kenzaburo; Nagai, Makoto; Ishii, Shun; Yamauchi, Aya			Hot ammonia in the center of the Seyfert 2 galaxy NGC 3079	PUBLICATIONS OF THE ASTRONOMICAL SOCIETY OF JAPAN			English	Article						galaxies: individual (NGC 3079); galaxies: ISM; radio lines: galaxies; radio lines: ISM	HIGHLY EXCITED OH; DENSE MOLECULAR GAS; NUCLEAR REGION; BRIGHT GALAXIES; SGR B2; NGC-3079; ABSORPTION; DISK; CO; MASER	We present the results of ammonia observations toward the center of NGC 3079. The NH3(J, K) = (1, 1) and (2, 2) inversion lines were detected in absorption with the Tsukuba 32 m telescope, and the NH3(1, 1) through (6, 6) lines with the VLA, although the profile of NH3(3, 3) was in emission in contrast to the other transitions. The background continuum source, whose flux density was similar to 50 mJy, could not be resolved with the VLA beam of less than or similar to 0''.09 x 0''.08. All ammonia absorption lines have two distinct velocity components: one is at the systemic velocity and the other is blueshifted, and both components are aligned along the nuclear jets. For the systemic components, the relatively low temperature gas is extended more than the high temperature gas. The blueshifted NH3(3, 3) emission can be regarded as ammonia masers associated with shocks by strong winds probably from newly formed massive stars or supernova explosions in dense clouds in the nuclear megamaser disk. Using para-NH3(1, 1), (2, 2), (4, 4), and (5, 5) lines with VLA, we derived the rotational temperature T-rot = 120 +/- 12 K and 157 +/- 19 K for the systemic and blueshifted components, respectively. The total column densities of NH3(0, 0)-(6, 6), assuming T-ex approximate to T-rot, were (8.85 +/- 0.70) x 10(16) cm(-2) and (4.47 +/- 0.78) x 10(16) cm(-2) for the systemic and blueshifted components, respectively. The fractional abundance of NH3 relative to molecular hydrogen H-2 for the systemic and blueshifted was [NH3]/[ H-2]= 1.3 x 10(-7) and 6.5 x 10(-8), respectively. We also found the F = 4-4 and F= 5-5 doublet lines of OH (2)Pi(3/2) J = 9/2 in absorption, which could be fitted by two velocity components, systemic and redshifted components. The rotational temperature of OH was estimated to be T-rot,T- OH >= 175 K, tracing hot gas associated with the interaction of the fast nuclear outflow with dense molecular material around the nucleus.	[Miyamoto, Yusuke; Nakai, Naomasa; Seta, Masumichi; Salak, Dragan; Hagiwara, Kenzaburo; Nagai, Makoto; Ishii, Shun] Univ Tsukuba, Fac Pure & Appl Sci, Div Phys, Tsukuba, Ibaraki 3058571, Japan; [Yamauchi, Aya] Natl Astron Observ Japan, Mizusawa VLBI Observ, Mizusawa, Iwate 0230861, Japan	Miyamoto, Y (reprint author), Ibaraki Univ, Ctr Astron, 2-1-1 Bunkyo, Mito, Ibaraki 3108512, Japan.	miya@mx.ibaraki.ac.jp; nakai@physics.px.tsukuba.ac.jp; seta@physics.px.tsukuba.ac.jp; salak.dragan.fm@u.tsukuba.ac.jp; k-hagiwara@wr.jp.nec.com; nagai.makoto.ge@u.tsukuba.ac.jp; sishii@ioa.s.u-tokyo.ac.jp; a.yamauchi@nao.ac.jp			JSPS (Japan Society for the Promotion of Science) KAKENHI [173400052, 17654042, 20244011, 26247019]; Association of Universities for Research in Astronomy, Inc., under NASA [NAS5-26555]; NASA Office of Space Science [NNX13AC07G]	We thank the members of the observational astrophysics group of the University of Tsukuba for participating in the construction of the K-band observing system of the Tsukuba 32 m telescope. We are grateful to the VLBI group of the Geospatial Information Authority of Japan (GSI) for licensing the use of the 32-m radio telescope. The observations with the 32-m telescope have been made under the agreement on joint study between the University of Tsukuba and GSI. This work was supported in part by JSPS (Japan Society for the Promotion of Science) KAKENHI Grant Numbers 173400052, 17654042, 20244011, and 26247019. The National Radio Astronomy Observatory is a facility of the National Science Foundation operated under cooperative agreement by Associated Universities, Inc. This research has made use of the NASA/IPAC Extragalactic Database (NED) which is operated by the Jet Propulsion Laboratory, California Institute of Technology, under contract with the National Aeronautics and Space Administration. Some of the data presented in this paper were obtained from the Mikulski Archive for Space Telescopes (MAST). STScI is operated by the Association of Universities for Research in Astronomy, Inc., under NASA contract NAS5-26555. Support for MAST for non-HST data is provided by the NASA Office of Space Science via grant NNX13AC07G and by other grants and contracts.	Braine J, 1997, ASTRON ASTROPHYS, V326, P963; HECKMAN TM, 1990, ASTROPHYS J SUPPL S, V74, P833, DOI 10.1086/191522; DANBY G, 1988, MON NOT R ASTRON SOC, V235, P229; DRAINE BT, 1993, ANNU REV ASTRON ASTR, V31, P373, DOI 10.1146/annurev.aa.31.090193.002105; WALMSLEY CM, 1983, ASTRON ASTROPHYS, V122, P164; McMullin JP, 2007, ASTR SOC P, V376, P127; Kohno K, 2001, ASTR SOC P, V249, P672; Dame TM, 2001, ASTROPHYS J, V547, P792, DOI 10.1086/318388; Springob CM, 2009, ASTROPHYS J SUPPL S, V182, P474, DOI 10.1088/0067-0049/182/1/474; Yamauchi A, 2004, PUBL ASTRON SOC JPN, V56, P605; VEILLEUX S, 1994, ASTROPHYS J, V433, P48, DOI 10.1086/174624; Koda J, 2002, ASTROPHYS J, V573, P105, DOI 10.1086/340561; Middelberg E, 2007, MON NOT R ASTRON SOC, V377, P731, DOI 10.1111/j.1365-2966.2007.11639.x; Cecil G, 2001, ASTROPHYS J, V555, P338, DOI 10.1086/321481; Ao Y, 2011, ASTRON ASTROPHYS, V529, DOI 10.1051/0004-6361/201116595; BAAN WA, 1995, ASTROPHYS J, V446, P602, DOI 10.1086/175820; BAUDRY A, 1995, ASTRON ASTROPHYS, V298, P905; BAUDRY A, 1981, ASTRON ASTROPHYS, V102, P287; Brunthaler A, 2009, ASTRON ASTROPHYS, V497, P103, DOI 10.1051/0004-6361/200911615; de Vaucouleurs G., 1991, 3 REFERENCE CATALOGU; de Pater I, 2005, ICARUS, V174, P263, DOI 10.1016/j.icarus.2004.10.020; DESTOMBES JL, 1977, ASTRON ASTROPHYS, V60, P55; DURIC N, 1988, ASTROPHYS J, V326, P574, DOI 10.1086/166118; FLOWER DR, 1995, ASTRON ASTROPHYS, V294, P815; FORD HC, 1986, ASTROPHYS J, V311, pL7, DOI 10.1086/184788; GUILLOTEAU S, 1984, ASTRON ASTROPHYS, V131, P45; Hagiwara Y, 2004, MON NOT R ASTRON SOC, V353, P1055, DOI 10.1111/j.1365-2966.2004.08092.x; Hawarden T. G., 1998, MNRAS, V276, P1197; HECKMAN TM, 1980, ASTRON ASTROPHYS, V87, P152; Henkel C., 2000, ASTRON ASTROPHYS, V361, P45; HUTTEMEISTER S, 1993, ASTRON ASTROPHYS, V276, P445; HUTTEMEISTER S, 1995, ASTRON ASTROPHYS, V300, P636; Irwin J. A., 1992, APJ, V396, P75; IRWIN JA, 1991, ASTROPHYS J, V371, P111, DOI 10.1086/169875; Israel FP, 2009, ASTRON ASTROPHYS, V493, P525, DOI 10.1051/0004-6361:200810655; Israel FP, 1998, ASTRON ASTROPHYS, V336, P433; KRAEMER KE, 1995, ASTROPHYS J, V439, pL9, DOI 10.1086/187732; Mangum JG, 2013, ASTROPHYS J, V779, DOI 10.1088/0004-637X/779/1/33; MAUERSBERGER R, 1986, ASTRON ASTROPHYS, V162, P199; Meaburn J., 1998, MNRAS, V295, P45; Mills EAC, 2013, ASTROPHYS J, V772, DOI 10.1088/0004-637X/772/2/105; Moran JM, 1999, J ASTROPHYS ASTRON, V20, P165, DOI 10.1007/BF02702350; Nishiyama K., 2001, PASJ, V63, P755; Oka T., 1971, ASTROPHYS J, V165, P15; Ott J, 2011, ASTROPHYS J, V742, DOI 10.1088/0004-637X/742/2/95; Ott J, 2005, ASTROPHYS J, V629, P767, DOI 10.1086/431661; Petrov L, 2011, ASTRON J, V142, DOI 10.1088/0004-6256/142/3/89; Sawada-Satoh S, 2001, IAU SYMP, P196; SOFUE Y, 1992, PUBL ASTRON SOC JPN, V44, P353; Sofue Y, 2001, ASTROPHYS J, V547, pL115, DOI 10.1086/318907; Takano S, 2013, ASTRON ASTROPHYS, V552, P34; Takano S, 2005, PUBL ASTRON SOC JPN, V57, pL29; Trotter AS, 1998, ASTROPHYS J, V495, P740, DOI 10.1086/305335; ULICH BL, 1976, ASTROPHYS J SUPPL S, V30, P247, DOI 10.1086/190361; WALMSLEY CM, 1986, ASTRON ASTROPHYS, V167, P151; Weiss A, 2001, ASTROPHYS J, V554, pL143, DOI 10.1086/321711; WINNBERG A, 1978, ASTRON ASTROPHYS, V66, P431; Yamagishi M, 2010, PUBL ASTRON SOC JPN, V62, P1085; ZHANG Q, 1995, ASTROPHYS J, V450, pL63, DOI 10.1086/316772	59	0	0	OXFORD UNIV PRESS	OXFORD	GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND	0004-6264	2053-051X		PUBL ASTRON SOC JPN	Publ. Astron. Soc. Jpn.	FEB	2015	67	1							5	10.1093/pasj/psu131		15	Astronomy & Astrophysics	Astronomy & Astrophysics	CC1RN	WOS:000350120500006		
J	Morokuma-Matsui, K; Sorai, K; Watanabe, Y; Kuno, N				Morokuma-Matsui, Kana; Sorai, Kazuo; Watanabe, Yoshimasa; Kuno, Nario			Stacking analysis of (CO)-C-12 and (CO)-C-13 spectra of NGC3627: Existence of non-optically thick (CO)-C-12 emission?	PUBLICATIONS OF THE ASTRONOMICAL SOCIETY OF JAPAN			English	Article						galaxies: ISM; galaxies: structure; ISM: molecules; radio lines: ISM	CO-TO-H-2 CONVERSION FACTOR; GIANT MOLECULAR CLOUDS; NEARBY SPIRAL GALAXIES; INTERSTELLAR-MEDIUM; CARBON-MONOXIDE; STAR-FORMATION; CO; GAS; DIFFUSE; RATIO	We stacked (CO)-C-12 and (CO)-C-13 spectra of NGC3627 after redefining the velocity axis of each spectrum of the mapping data so that the zero corresponds to the local mean velocity of the (CO)-C-12 spectra. The signal-to-noise ratios of the resulting spectra are improved by a factor of up to 3.2 compared to those obtained with normal stacking analysis. We successfully detect a weak (CO)-C-13 emission from the interarm region where the emission was not detected in the individual pointings. We compare the integrated intensity ratios I-12CO/I-13CO among six characteristic regions (center, bar, bar-end, offset, arm, and interarm). We find that I-12CO/I-13CO in the bar and interarm are higher than those in the other regions by a factor of similar to 2 and I-12CO/I-13CO in the center is moderately high. These high I-12CO/I-13CO ratios in the bar and center are attributed to a high intensity ratio (T12CO/T13CO), and that in the interarm is attributed to a high ratio of the full width at half maximum of spectra (FWHM12CO/FWHM13CO). The difference between FWHM12CO and FWHM13CO of the interarm indicates the existence of two components, one with a narrow line width (similar to FWHM13CO) and the other with a broad line width (similar to FWHM12CO). Additionally, the T12CO/T13CO ratio in the broad-line-width component of the interarm is higher than the other regions. The high T12CO/T13CO in the center and bar and of the broad-line-width component in the interarm suggest the existence of non-optically thick (CO)-C-12 components. We find that more than half of the (CO)-C-12 emissions of the interarm are likely to be radiated from the diffuse component. Our result suggests that the use of a universal CO-to-H-2 conversion factor might lead to an overestimation of molecular gas mass and underestimation of star-formation efficiency in the interarm by a factor of a few.	[Morokuma-Matsui, Kana; Kuno, Nario] Nobeyama Radio Observ, Minamimaki, Nagano 3841305, Japan; [Sorai, Kazuo] Hokkaido Univ, Dept Phys, Dept Cosmosci, Sapporo, Hokkaido 0600810, Japan; [Watanabe, Yoshimasa] Univ Tokyo, Dept Phys, Bunkyo Ku, Tokyo 1130033, Japan; [Kuno, Nario] Univ Tsukuba, Fac Pure & Appl Sci, Tsukuba, Ibaraki 3508577, Japan; [Kuno, Nario] Grad Univ Adv Studies SOKENDAI, Mitaka, Tokyo 1818588, Japan	Morokuma-Matsui, K (reprint author), Nobeyama Radio Observ, 462-2 Nobeyama, Minamimaki, Nagano 3841305, Japan.	kana.matsui@nao.ac.jp; sorai@astro1.sci.hokudai.ac.jp; nabe@taurus.phys.s.u-tokyo.ac.jp; kuno.nario.gt@u.tsukuba.ac.jp			National Aeronautics and Space Administration	This research has made use of the NASA/IPAC Infrared Science Archive, which is operated by the Jet Propulsion Laboratory, California Institute of Technology, under contract with the National Aeronautics and Space Administration.	Dobbs CL, 2006, MON NOT R ASTRON SOC, V371, P1663, DOI 10.1111/j.1365-2966.2006.10794.x; Huttemeister S, 2000, ASTRON ASTROPHYS, V363, P93; FRERKING MA, 1982, ASTROPHYS J, V262, P590, DOI 10.1086/160451; Krips M, 2008, ASTROPHYS J, V677, P262, DOI 10.1086/527367; SOLOMON PM, 1987, ASTROPHYS J, V319, P730, DOI 10.1086/165493; Solomon PM, 1997, ASTROPHYS J, V478, P144, DOI 10.1086/303765; LANGER WD, 1990, ASTROPHYS J, V357, P477, DOI 10.1086/168935; Oka T, 1998, ASTROPHYS J SUPPL S, V118, P455, DOI 10.1086/313138; ZHANG XL, 1993, ASTROPHYS J, V418, P100, DOI 10.1086/173374; Koda J, 2009, ASTROPHYS J LETT, V700, pL132, DOI 10.1088/0004-637X/700/2/L132; Galametz M, 2012, MON NOT R ASTRON SOC, V425, P763, DOI 10.1111/j.1365-2966.2012.21667.x; Watanabe Y, 2011, MON NOT R ASTRON SOC, V411, P1409, DOI 10.1111/j.1365-2966.2010.17746.x; BALLY J, 1982, ASTROPHYS J, V255, P143, DOI 10.1086/159812; Dobbs CL, 2013, MON NOT R ASTRON SOC, V432, P653, DOI 10.1093/mnras/stt508; Nakai N, 1995, PUBL ASTRON SOC JPN, V47, P761; WATSON WD, 1976, ASTROPHYS J, V205, pL165, DOI 10.1086/182115; HAYNES MP, 1979, ASTROPHYS J, V229, P83, DOI 10.1086/156932; Sorai K, 2000, P SOC PHOTO-OPT INS, V4015, P86, DOI 10.1117/12.390466; Helfer TT, 2003, ASTROPHYS J SUPPL S, V145, P259, DOI 10.1086/346076; Milam SN, 2005, ASTROPHYS J, V634, P1126, DOI 10.1086/497123; Meier DS, 2004, ASTRON J, V127, P2069, DOI 10.1086/382904; SMITH D, 1980, ASTROPHYS J, V242, P424, DOI 10.1086/158476; Reynaud D, 1998, ASTRON ASTROPHYS, V337, P671; VANDISHOECK EF, 1988, ASTROPHYS J, V334, P771, DOI 10.1086/166877; Paglione TAD, 2001, ASTROPHYS J SUPPL S, V135, P183, DOI 10.1086/321785; Bolatto AD, 2013, ANNU REV ASTRON ASTR, V51, P207, DOI 10.1146/annurev-astro-082812-140944; Leroy AK, 2009, ASTRON J, V137, P4670, DOI 10.1088/0004-6256/137/6/4670; Kennicutt RC, 2003, PUBL ASTRON SOC PAC, V115, P928, DOI 10.1086/376941; SANDERS DB, 1985, ASTROPHYS J, V289, P373, DOI 10.1086/162897; Blanc GA, 2013, ASTROPHYS J, V764, DOI 10.1088/0004-637X/764/2/117; Burgh EB, 2007, ASTROPHYS J, V658, P446, DOI 10.1086/511259; Colombo D, 2014, ASTROPHYS J, V784, DOI 10.1088/0004-637X/784/1/3; Egusa F, 2011, ASTROPHYS J, V726, DOI 10.1088/0004-637X/726/2/85; Fujimoto M., 1968, IAU S, V29, P453; Hirota A., 2010, PASJ, V62, P1261; KNAPP GR, 1988, ASTROPHYS J, V331, P974, DOI 10.1086/166614; Kopp M, 1996, ASTRON ASTROPHYS, V305, P558; Kuno N, 2007, PUBL ASTRON SOC JPN, V59, P117; Liszt HS, 2007, ASTRON ASTROPHYS, V476, P291, DOI 10.1051/0004-6361:20078502; POLK KS, 1988, ASTROPHYS J, V332, P432, DOI 10.1086/166667; ROBERTS WW, 1969, ASTROPHYS J, V158, P123, DOI 10.1086/150177; Saha A, 1999, ASTROPHYS J, V522, P802, DOI 10.1086/307693; Sakamoto K, 1999, ASTROPHYS J SUPPL S, V124, P403, DOI 10.1086/313265; Sandstrom KM, 2013, ASTROPHYS J, V777, DOI 10.1088/0004-637X/777/1/5; Sawada T., 2012, APJ, V759, P26; Sawada T, 2012, ASTROPHYS J, V752, DOI 10.1088/0004-637X/752/2/118; Schruba A, 2011, ASTRON J, V142, DOI 10.1088/0004-6256/142/2/37; Schruba A, 2012, ASTRON J, V143, DOI 10.1088/0004-6256/143/6/138; SCOVILLE NZ, 1987, ASTROPHYS J SUPPL S, V63, P821, DOI 10.1086/191185; Sheffer Y., 2008, APJ, P687; Shetty Y, 2008, APJ, V687, P1075; SOLOMON PM, 1979, ASTROPHYS J, V232, pL89, DOI 10.1086/183042; Sonnentrucker P, 2007, ASTROPHYS J SUPPL S, V168, P58, DOI 10.1086/508687; Sorai K, 2012, PUBL ASTRON SOC JPN, V64; Tosaki T, 2002, PUBL ASTRON SOC JPN, V54, P209; Wada K, 1994, PASJ, V165, P172; YOUNG JS, 1991, ANNU REV ASTRON ASTR, V29, P581, DOI 10.1146/annurev.aa.29.090191.003053	57	0	0	OXFORD UNIV PRESS	OXFORD	GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND	0004-6264	2053-051X		PUBL ASTRON SOC JPN	Publ. Astron. Soc. Jpn.	FEB	2015	67	1							2	10.1093/pasj/psu126		17	Astronomy & Astrophysics	Astronomy & Astrophysics	CC1RN	WOS:000350120500003		
J	Nakajima, T; Takano, S; Kohno, K; Harada, N; Herbst, E; Tamura, Y; Izumi, T; Taniguchi, A; Tosaki, T				Nakajima, Taku; Takano, Shuro; Kohno, Kotaro; Harada, Nanase; Herbst, Eric; Tamura, Yoichi; Izumi, Takuma; Taniguchi, Akio; Tosaki, Tomoka			A multi-transition study of molecules toward NGC 1068 based on high-resolution imaging observations with ALMA	PUBLICATIONS OF THE ASTRONOMICAL SOCIETY OF JAPAN			English	Article						galaxies: individual (NGC 1068); galaxies: nuclei; ISM: abundances; ISM: molecules; radio lines: galaxies	ACTIVE GALACTIC NUCLEUS; NEARBY SEYFERT-GALAXIES; SEPARATING SIS RECEIVER; 45-M RADIO TELESCOPE; SPECTRAL-LINE SURVEY; INTERSTELLAR CLOUDS; DENSE GAS; COMPLEX-MOLECULES; CIRCUMNUCLEAR DISK; APERTURE SYNTHESIS	We present 0.8-mm band molecular images and spectra obtained with the Atacama Large Millimeter/submillimeter Array (ALMA) toward one of the nearest galaxies with an active galactic nucleus (AGN), NGC 1068. Distributions of CO isotopic species ((CO)-C-13 and (CO)-O-18) J = 3-2, CN N = 3-2, and CS J = 7-6 are observed toward the circumnuclear disk (CND) and a part of the starburst ring with an angular resolution of similar to 1''.3 x 1''.2. The physical properties of these molecules and shock-related molecules, such as HNCO, CH3CN, SO, and CH3OH, detected in the 3-mm band were estimated using rotation diagrams under the assumption of local thermodynamic equilibrium. The rotational temperatures of the CO isotopic species and the shock-related molecules in the CND are, respectively, 14-22 K and upper limits of 20-40 K. Although the column densities of the CO isotopic species in the CND are only from one-fifth to one-third of that in the starburst ring, those of the shock-related molecules are enhanced by a factor of 3-10 in the CND. We also discuss the chemistry of each species, and compare the fractional abundances in the CND and starburst ring with those of Galactic sources such as cold cores, hot cores, and shocked molecular clouds in order to study the overall characteristics. We find that the abundances of shock-related molecules are more similar to abundances in hot cores and/or shocked clouds than to cold cores. The CND hosts relatively complex molecules, which are often associated with shocked molecular clouds or hot cores. Because a high X-ray flux can dissociate these molecules, they must also reside in regions shielded from X-rays.	[Nakajima, Taku] Nagoya Univ, Solar Terr Environm Lab, Chikusa Ku, Nagoya, Aichi 4648601, Japan; [Takano, Shuro] Natl Astron Observ Japan, Nobeyama Radio Observ, Minamisa Ku, Minamimaki, Nagano 3841305, Japan; [Takano, Shuro] Grad Univ Adv Studies SOKENDAI, Dept Astron Sci, Minamisa Ku, Minamimaki, Nagano 3841305, Japan; [Kohno, Kotaro; Tamura, Yoichi; Izumi, Takuma; Taniguchi, Akio] Univ Tokyo, Inst Astron, Mitaka, Tokyo 1810015, Japan; [Kohno, Kotaro] Univ Tokyo, Sch Sci, Res Ctr Early Univ, Bunkyo Ku, Tokyo 1130033, Japan; [Harada, Nanase] Max Planck Inst Radioastron, D-53121 Bonn, Germany; [Herbst, Eric] Univ Virginia, Dept Chem, Charlottesville, VA 22904 USA; [Tosaki, Tomoka] Joetsu Univ Educ, Dept Geosci, Joetsu, Niigata 9438512, Japan	Nakajima, T (reprint author), Nagoya Univ, Solar Terr Environm Lab, Chikusa Ku, Furo Cho, Nagoya, Aichi 4648601, Japan.	nakajima@stelab.nagoya-u.ac.jp			National Science Foundation (US); NASA Exobiology and Evolutionary Biology program through a subcontract from Rensselaer Polytechnic Institute	This paper makes use of the following ALMA data: ADS/JAO.ALMA#2011.0.00061.S. ALMA is a partnership of ESO (representing its member states), NSF (USA) and NINS (Japan), together with NRC (Canada) and NSC and ASIAA (Taiwan), in cooperation with the Republic of Chile. The Joint ALMA Observatory is operated by ESO, AUI/NRAO and NAOJ. We thank the ALMA staff, especially Akiko Kawamura, for their support. EH wishes to acknowledge the support of the National Science Foundation (US) for his astrochemistry program. He also acknowledges support from the NASA Exobiology and Evolutionary Biology program through a subcontract from Rensselaer Polytechnic Institute.	Aladro R, 2013, ASTRON ASTROPHYS, V549, DOI 10.1051/0004-6361/201220131; Quan DH, 2010, ASTROPHYS J, V725, P2101, DOI 10.1088/0004-637X/725/2/2101; Bachiller R, 1997, ASTROPHYS J, V487, pL93, DOI 10.1086/310877; BlandHawthorn J, 1997, ASTROPHYS SPACE SCI, V248, P9, DOI 10.1023/A:1000567831370; WILSON TL, 1994, ANNU REV ASTRON ASTR, V32, P191; Krips M, 2008, ASTROPHYS J, V677, P262, DOI 10.1086/527367; Marcelino N, 2009, ASTROPHYS J LETT, V690, pL27, DOI [10.1088/0004-637X/690/1/L27, 10.1088/637X/690/1/L27]; Gallimore JF, 2004, ASTROPHYS J, V613, P794, DOI 10.1086/423167; Meijerink R, 2007, ASTRON ASTROPHYS, V461, P793, DOI 10.1051/0004-6361:20066130; Kohno K, 1996, ASTROPHYS J, V461, pL29, DOI 10.1086/309996; Nakajima T, 2013, PUBL ASTRON SOC PAC, V125, P252, DOI 10.1086/670124; Kohno K, 2003, PUBL ASTRON SOC JPN, V55, pL1; McMullin JP, 2007, ASTR SOC P, V376, P127; Arce HG, 2008, ASTROPHYS J LETT, V681, pL21, DOI 10.1086/590110; Garrod RT, 2008, ASTROPHYS J, V682, P283, DOI 10.1086/588035; Nakajima T, 2008, PUBL ASTRON SOC JPN, V60, P435; Le Petit F, 2006, ASTROPHYS J SUPPL S, V164, P506, DOI 10.1086/503252; Smith IWM, 2004, MON NOT R ASTRON SOC, V350, P323, DOI 10.1111/j.1365-2966.2004.07656.x; LEUNG CM, 1984, ASTROPHYS J SUPPL S, V56, P231, DOI 10.1086/190982; Kohno K, 2001, ASTR SOC P, V249, P672; Muller HSP, 2005, J MOL STRUCT, V742, P215, DOI 10.1016/j.molstruc.2005.01.027; Usero A, 2004, ASTRON ASTROPHYS, V419, P897, DOI 10.1051/0004-6361:20035774; Hollenbach DJ, 1999, REV MOD PHYS, V71, P173, DOI 10.1103/RevModPhys.71.173; Imanishi M, 2007, ASTRON J, V134, P2366, DOI 10.1086/523598; Harada N, 2010, ASTROPHYS J, V721, P1570, DOI 10.1088/0004-637X/721/2/1570; Nummelin A, 2000, ASTROPHYS J SUPPL S, V128, P213, DOI 10.1086/313376; Wakelam V, 2005, ASTRON ASTROPHYS, V437, P149, DOI 10.1051/0004-6361:20042566; Bolatto AD, 2013, ANNU REV ASTRON ASTR, V51, P207, DOI 10.1146/annurev-astro-082812-140944; Watanabe N, 2002, ASTROPHYS J, V571, pL173, DOI 10.1086/341412; Izumi T, 2013, PUBL ASTRON SOC JPN, V65; Lovas FJ, 2004, J PHYS CHEM REF DATA, V33, P177, DOI 10.1063/1.1633275; Bayet E, 2009, ASTROPHYS J, V707, P126, DOI 10.1088/0004-637X/707/1/126; Carter M, 2012, ASTRON ASTROPHYS, V538, DOI 10.1051/0004-6361/201118452; Costagliola F, 2011, ASTRON ASTROPHYS, V528, DOI 10.1051/0004-6361/201015628; de Vicente P, 2000, ASTRON ASTROPHYS, V361, P1058; DICKMAN RL, 1978, ASTROPHYS J SUPPL S, V37, P407, DOI 10.1086/190535; Garcia-Burillo S, 2014, ASTRON ASTROPHYS, V567, DOI 10.1051/0004-6361/201423843; Garcia-Burillo S., 2010, ASTRON ASTROPHYS, V519, P2; GUSTEN R, 1985, ASTRON ASTROPHYS, V149, P195; Harada N, 2013, ASTROPHYS J, V765, DOI 10.1088/0004-637X/765/2/108; HARRISON A, 1995, MON NOT R ASTRON SOC, V277, P413; HELFER TT, 1995, ASTROPHYS J, V450, P90, DOI 10.1086/176122; Henkel C, 2010, ASTRON ASTROPHYS, V516, DOI 10.1051/0004-6361/200912889; Henkel C, 2014, ASTRON ASTROPHYS, V565, DOI 10.1051/0004-6361/201322962; HENKEL C, 1993, ASTRON ASTROPHYS, V268, pL17; HUNTRESS WT, 1979, ASTROPHYS J, V231, P456, DOI 10.1086/157207; IRVINE WM, 1991, ICARUS, V91, P2, DOI 10.1016/0019-1035(91)90120-I; Israel FP, 2009, ASTRON ASTROPHYS, V493, P525, DOI 10.1051/0004-6361:200810655; JACKSON JM, 1993, ASTROPHYS J, V418, pL13, DOI 10.1086/187104; JANSEN DJ, 1995, ASTRON ASTROPHYS, V302, P223; Jimenez-Serra I, 2012, ASTROPHYS J, V753, DOI 10.1088/0004-637X/753/1/34; Kamenetzky J, 2011, ASTROPHYS J, V731, DOI 10.1088/0004-637X/731/2/83; KANEKO N, 1992, PUBL ASTRON SOC JPN, V44, P341; Kohno K, 2005, AIP CONF PROC, V783, P203; Kohno K, 2008, ASTROPHYS SPACE SCI, V313, P279, DOI 10.1007/s10509-007-9695-1; Krips M, 2011, ASTROPHYS J, V736, DOI 10.1088/0004-637X/736/1/37; LEEN TM, 1988, ASTROPHYS J, V325, P411, DOI 10.1086/166013; Martin S, 2010, ASTRON ASTROPHYS, V522, DOI 10.1051/0004-6361/201014972; Martin S, 2006, ASTROPHYS J SUPPL S, V164, P450, DOI 10.1086/503297; Minh YC, 2008, J KOREAN ASTRON SOC, V41, P139; MITCHELL GF, 1983, ASTROPHYS J, V266, P646, DOI 10.1086/160812; Muxlow TWB, 1996, MON NOT R ASTRON SOC, V278, P854; Nakajima T, 2011, ASTROPHYS J LETT, V728, DOI 10.1088/2041-8205/728/2/L38; Nakajima T., 2013, ASP C SER, V476, P299; Papadopoulos PP, 1996, ASTROPHYS J, V465, P173, DOI 10.1086/177410; PLANESAS P, 1991, ASTROPHYS J, V369, P364, DOI 10.1086/169766; Rodriguez-Fernandez NJ, 2010, ASTRON ASTROPHYS, V516, DOI 10.1051/0004-6361/201013997; Schinnerer E., 2000, APJ, V533, P85; Snell RL, 2011, ASTRON J, V141, DOI 10.1088/0004-6256/141/2/38; Spinoglio L, 2012, ASTROPHYS J, V758, DOI 10.1088/0004-637X/758/2/108; TACCONI LJ, 1994, ASTROPHYS J, V426, pL77, DOI 10.1086/187344; Tacconi LJ, 1997, ASTROPHYS SPACE SCI, V248, P59, DOI 10.1023/A:1000532218166; Takano S, 1995, PUBL ASTRON SOC JPN, V47, P801; Takano S, 2014, PUBL ASTRON SOC JPN, V66, DOI 10.1093/pasj/psu052; Tsai MC, 2012, ASTROPHYS J, V746, DOI 10.1088/0004-637X/746/2/129; Tully R. B., 1988, NEARBY GALAXIES CATA; TURNER BE, 1991, ASTROPHYS J SUPPL S, V76, P617, DOI 10.1086/191577; Vasyunin AI, 2013, ASTROPHYS J, V762, DOI 10.1088/0004-637X/762/2/86; Viti S, 2011, ASTROPHYS J LETT, V740, DOI 10.1088/2041-8205/740/1/L3; Viti S, 2014, ASTRON ASTROPHYS, V570, DOI 10.1051/0004-6361/201424116; WILSON TL, 1992, ASTRON ASTROPHYS REV, V4, P1, DOI 10.1007/BF00873568	81	1	1	OXFORD UNIV PRESS	OXFORD	GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND	0004-6264	2053-051X		PUBL ASTRON SOC JPN	Publ. Astron. Soc. Jpn.	FEB	2015	67	1							8	10.1093/pasj/psu136		15	Astronomy & Astrophysics	Astronomy & Astrophysics	CC1RN	WOS:000350120500009		
J	Nakano, T; Murakami, H; Makishima, K; Hiraga, JS; Uchiyama, H; Kaneda, H; Enoto, T				Nakano, Toshio; Murakami, Hiroaki; Makishima, Kazuo; Hiraga, Junoko S.; Uchiyama, Hideki; Kaneda, Hidehiro; Enoto, Teruaki			Suzaku studies of the supernova remnant CTB 109 hosting the magnetar 1E 2259+586	PUBLICATIONS OF THE ASTRONOMICAL SOCIETY OF JAPAN			English	Article						ISM: supernova remnants; stars: magnetars; stars: magnetic fields; stars: neutron; X-rays: individual (CTB 109, 1E 2259+586)	X-RAY PULSAR; SOFT GAMMA-REPEATERS; NEUTRON-STARS; OPTICAL COUNTERPART; PROPER MOTIONS; XMM-NEWTON; SPIN-DOWN; CANDIDATE 1E-2259+586; CTB-109 G109.1-1.0; SWIFT J1822.3-1606	Ages of the magnetar 1E 2259+586 and the associated supernova remnant CTB 109 were studied. Analyzing the Suzaku data of CTB 109, its age was estimated to be similar to 14 kyr, which is much younger than the measured characteristic age of 1E 2259+586, 230 kyr. This reconfirms the previously reported age discrepancy of this magnetar/remnant association, and suggests that the characteristic ages of magnetars are generally over-estimated as compared to their true ages. This discrepancy is thought to arise because the former are calculated without considering decay of the magnetic fields. This novel view is supported independently by much stronger Galactic-plane concentration of magnetars than other pulsars. The process of magnetic field decay in magnetars is mathematically modeled. It is implied that magnetars are much younger objects than previously considered, and can dominate new-born neutron stars.	[Nakano, Toshio; Murakami, Hiroaki; Makishima, Kazuo] Univ Tokyo, Grad Sch Sci, Dept Phys, Bunkyo Ku, Tokyo 1130033, Japan; [Makishima, Kazuo] RIKEN, Inst Phys & Chem Res, MAXI Team, Wako, Saitama 3510198, Japan; [Makishima, Kazuo; Hiraga, Junoko S.] Univ Tokyo, Res Ctr Early Univ, Bunkyo Ku, Tokyo 1130033, Japan; [Uchiyama, Hideki] Shizuoka Univ, Fac Educ, Suruga Ku, Shizuoka 4228529, Japan; [Kaneda, Hidehiro] NASA, Goddard Space Flight Ctr, Greenbelt, MD 20771 USA; [Enoto, Teruaki] Nagoya Univ, Grad Sch Sci, Chikusa Ku, Nagakute, Aichi 4648602, Japan; [Enoto, Teruaki] RIKEN, Nishina Ctr, Wako, Saitama 3510198, Japan	Nakano, T (reprint author), Univ Tokyo, Grad Sch Sci, Dept Phys, Bunkyo Ku, 7-3-1 Hongo, Tokyo 1130033, Japan.	nakano@juno.phys.s.u-tokyo.ac.jp	XRAY, SUZAKU/A-1808-2009		JSPS KAKENHI [12J09081]	This work was supported by JSPS KAKENHI Grant Number 12J09081.	Allen MP, 2004, ASTROPHYS J, V616, P346, DOI 10.1086/424836; HUGHES VA, 1981, ASTROPHYS J, V246, pL127, DOI 10.1086/183568; DUNCAN RC, 1992, ASTROPHYS J, V392, pL9, DOI 10.1086/186413; Vink J, 2006, MON NOT R ASTRON SOC, V370, pL14, DOI 10.1111/j.1745-3933.2006.00178.x; Lyons N, 2010, MON NOT R ASTRON SOC, V402, P705, DOI 10.1111/j.1365-2966.2009.15538.x; Colpi M, 2000, ASTROPHYS J, V529, pL29, DOI 10.1086/312448; USOV VV, 1992, NATURE, V357, P472; GREGORY PC, 1980, NATURE, V287, P805, DOI 10.1038/287805a0; Kothes R, 2002, ASTROPHYS J, V576, P169, DOI 10.1086/341545; THOMPSON C, 1995, MON NOT R ASTRON SOC, V275, P255; Vink J, 2008, ADV SPACE RES, V41, P503, DOI 10.1016/j.asr.2007.06.042; MCKEE CF, 1977, ASTROPHYS J, V218, P148, DOI 10.1086/155667; Rea N, 2010, SCIENCE, V330, P944, DOI 10.1126/science.1196088; Manchester RN, 2005, ASTRON J, V129, P1993, DOI 10.1086/428488; Sasaki M, 2004, ASTROPHYS J, V617, P322, DOI 10.1086/425353; Sasaki M, 2006, ASTROPHYS J, V642, pL149, DOI 10.1086/504844; Hobbs G, 2005, MON NOT R ASTRON SOC, V360, P974, DOI [10.1111/j.1365-2966.2005.09087.x, 10.1111/j.1365-2966.2005.09087/x]; Enoto T, 2010, ASTROPHYS J LETT, V722, pL162, DOI 10.1088/2041-8205/722/2/L162; Dall'Osso S, 2012, MON NOT R ASTRON SOC, V422, P2878, DOI 10.1111/j.1365-2966.2012.20612.x; STAELIN DH, 1968, SCIENCE, V162, P1481, DOI 10.1126/science.162.3861.1481; LYNE AG, 1993, MON NOT R ASTRON SOC, V265, P1003; TATEMATSU K, 1987, ASTRON ASTROPHYS, V184, P279; IWASAWA K, 1992, PUBL ASTRON SOC JPN, V44, P9; Baykal A, 1998, ASTRON ASTROPHYS, V336, P173; Castro D, 2012, ASTROPHYS J, V756, DOI 10.1088/0004-637X/756/1/88; Chevalier RA, 2011, AIP CONF PROC, V1379, DOI 10.1063/1.3629476; Chevalier RA, 2005, ASTROPHYS J, V619, P839, DOI 10.1086/426584; COE MJ, 1994, MON NOT R ASTRON SOC, V270, P178; COE MJ, 1992, MON NOT R ASTRON SOC, V259, P191; DAVIES SR, 1989, MON NOT R ASTRON SOC, V237, P973; Duncan R. C., 1996, AIP C P, V366, P111; Esposito P., 2010, ASTRONOMERS TELEGRAM, P2691; Fahlman G. G., 1983, IAU S, V101, P445; FAHLMAN GG, 1982, ASTROPHYS J, V261, pL1, DOI 10.1086/183878; Ferrand G, 2012, ADV SPACE RES, V49, P1313, DOI 10.1016/j.asr.2012.02.004; Gaensler BM, 2004, ADV SPACE RES, V33, P645, DOI 10.1016/j.asr.2003.04.023; Gavriil FP, 2004, AIP CONF PROC, V714, P302; Gavriil FP, 2002, ASTROPHYS J, V567, P1067, DOI 10.1086/338698; Ghavamian P, 2007, ASTROPHYS J, V654, pL69, DOI 10.1086/510740; Gogus E, 2010, ASTROPHYS J, V722, P899, DOI 10.1088/0004-637X/722/1/899; Graham-Smith F. G., 1998, PULSAR ASTRONOMY; HANSON CG, 1988, ASTRON ASTROPHYS, V195, P114; HEYDARIMALAYERI M, 1981, NATURE, V293, P549, DOI 10.1038/293549a0; Heyl JS, 1999, MON NOT R ASTRON SOC, V304, pL37, DOI 10.1046/j.1365-8711.1999.02516.x; Hulleman F, 2000, ASTRON ASTROPHYS, V358, P605; Igoshev AP, 2012, ASTR SOC P, V466, P207; Ishisaki Y, 2007, PUBL ASTRON SOC JPN, V59, pS113; Kaspi V. M., 2002, ASTRON TELEGR, P99; Kaspi VM, 1999, ASTROPHYS J, V525, pL33, DOI 10.1086/312330; Kothes R, 2012, ASTROPHYS J LETT, V746, DOI 10.1088/2041-8205/746/1/L4; Koyama K, 2007, PUBL ASTRON SOC JPN, V59, pS23; KOYAMA K, 1987, PUBL ASTRON SOC JPN, V39, P801; KOYAMA K, 1989, PUBL ASTRON SOC JPN, V41, P461; Kumar H. S., 2014, IAU S, V296, P235; LEAHY DA, 1991, ASTRON J, V101, P1033, DOI 10.1086/115745; Mereghetti S, 1998, MON NOT R ASTRON SOC, V296, P689, DOI 10.1046/j.1365-8711.1998.01396.x; Nakagawa YE, 2009, PUBL ASTRON SOC JPN, V61, pS387; Nakamura R., 2009, PASJ, V61, P197; Pandey US, 1996, ASTRON ASTROPHYS, V316, P111; Rea N, 2012, ASTROPHYS J, V754, DOI 10.1088/0004-637X/754/1/27; Rea N, 2013, ASTROPHYS J, V770, DOI 10.1088/0004-637X/770/1/65; Safi-Harb S., 2013, IAU S, P480; Sasaki M, 2013, ASTRON ASTROPHYS, V552, DOI 10.1051/0004-6361/201220836; Sato T, 2010, PUBL ASTRON SOC JPN, V62, pL33; Scholz P, 2012, ASTROPHYS J, V761, DOI 10.1088/0004-637X/761/1/66; Sedov L. I., 1959, SIMILARITY DIMENSION; Seward F. D., 1985, Comments on Astrophysics. Comments on Modern Physics: Part C, V11; SOFUE Y, 1983, PUBL ASTRON SOC JPN, V35, P447; TATEMATSU K, 1985, PUBL ASTRON SOC JPN, V37, P345; Taylor G., 1950, RSPSA, V201, P159; Tendulkar SP, 2013, ASTROPHYS J, V772, DOI 10.1088/0004-637X/772/1/31; Tendulkar SP, 2012, ASTROPHYS J, V761, DOI 10.1088/0004-637X/761/1/76; Torii K, 1999, ASTROPHYS J, V523, pL69, DOI 10.1086/312251; USOV VV, 1994, ASTROPHYS J, V427, P984, DOI 10.1086/174205; Woods PM, 2004, AIP CONF PROC, V714, P298; Zhou P, 2014, ASTROPHYS J LETT, V781, DOI 10.1088/2041-8205/781/1/L16	76	2	2	OXFORD UNIV PRESS	OXFORD	GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND	0004-6264	2053-051X		PUBL ASTRON SOC JPN	Publ. Astron. Soc. Jpn.	FEB	2015	67	1							9	10.1093/pasj/psu135		12	Astronomy & Astrophysics	Astronomy & Astrophysics	CC1RN	WOS:000350120500010		
J	Otsuji, K; Sakurai, T; Kuzanyan, K				Otsuji, Kenichi; Sakurai, Takashi; Kuzanyan, Kirill			A statistical analysis of current helicity and twist in solar active regions over the phases of the solar cycle using the spectro-polarimeter data of Hinode	PUBLICATIONS OF THE ASTRONOMICAL SOCIETY OF JAPAN			English	Article						Sun: activity; Sun: magnetic fields; sunspots	MAGNETIC-FIELDS; VECTOR MAGNETOGRAMS; RULE; TELESCOPE; PATTERNS	Current helicity and twist of solar magnetic fields are important in characterizing the dynamo mechanism working in the convection zone of the Sun. We have carried out a statistical study on the current helicity of solar active regions observed with the spectropolarimeter (SP) of the Hinode Solar Optical Telescope (SOT). We used SOT-SP data of 558 vector magnetograms of a total of 80 active regions obtained during the period from 2006 to 2012. We have applied spatial smoothing and division of data points into weak and strong field ranges to compare the contributions from different scales and field strengths. We found that the current helicity follows the "hemispheric sign rule" when weak magnetic fields (absolute field strength < 300 gauss) are considered and no smoothing is applied. On the other hand, the pattern of current helicity fluctuates and violates the hemispheric sign rule when stronger magnetic fields are considered and smoothing of 2''.0 (modeled on ground-based observations) is applied. Furthermore, we found a tendency that weak and inclined fields conform to the hemispheric sign rule and strong and vertical fields violate it. These different properties of helicity through the strong and weak magnetic field components give important clues in understanding the solar dynamo as well as the mechanism of formation and evolution of solar active regions.	[Otsuji, Kenichi; Sakurai, Takashi; Kuzanyan, Kirill] Natl Astron Observ, Solar Observ, Mitaka, Tokyo 1818588, Japan; [Sakurai, Takashi] Grad Univ Adv Studies, Dept Astron Sci, Mitaka, Tokyo 1818588, Japan; [Kuzanyan, Kirill] Russian Acad Sci, IZMIRAN, Troitsk 142190, Moscow, Russia	Otsuji, K (reprint author), Natl Astron Observ, Solar Observ, 2-21-1 Osawa, Mitaka, Tokyo 1818588, Japan.	otsuji@solar.mtk.nao.ac.jp; sakurai@solar.mtk.nao.ac.jp; kuzanyan@izmiran.ru			NAOJ; JSPS; NAOJ Solar Physics Division; Russian Foundation for Basic Research	The authors would like to thank the anonymous referee for constructive criticism that helped us improve the paper. Hinode is a Japanese mission developed and launched by ISAS/JAXA, with NAOJ as domestic partner and with NASA and STFC (UK) as international partners. It is operated by these agencies in cooperation with ESA and NSC (Norway). KK is deeply grateful to the visiting professorship of NAOJ as well as the visiting fellowship of JSPS, and the staff of NAOJ Solar Physics Division for supporting the visit to NAOJ and the fruitful discussions. KK also would like to acknowledge support from Russian Foundation for Basic Research.	Ai Guo-xiang, 1986, Acta Astronomica Sinica, V27; Hagino M, 2005, PUBL ASTRON SOC JPN, V57, P481; Tsuneta S, 2008, SOL PHYS, V249, P167, DOI 10.1007/s11207-008-9174-z; Hao J, 2011, ASTROPHYS J LETT, V733, DOI 10.1088/2041-8205/733/2/L27; PEVTSOV AA, 1994, ASTROPHYS J, V425, pL117, DOI 10.1086/187324; PEVTSOV AA, 1995, ASTROPHYS J, V440, pL109, DOI 10.1086/187773; Tiwari SK, 2009, ASTROPHYS J LETT, V702, pL133, DOI 10.1088/0004-637X/702/2/L133; Bao SD, 1998, ASTROPHYS J, V496, pL43, DOI 10.1086/311232; Bao SD, 2000, J ASTROPHYS ASTRON, V21, P303, DOI 10.1007/BF02702414; Georgoulis MK, 2005, ASTROPHYS J, V629, pL69, DOI 10.1086/444376; Gosain S, 2013, ASTROPHYS J, V772, DOI 10.1088/0004-637X/772/1/52; Hagino M, 2004, PUBL ASTRON SOC JPN, V56, P831; Keller CU, 2003, ASTR SOC P, V307, P13; Lites B., 2007, MEM SOC ASTRON ITAL, V78, P148; Liu Y, 2014, ASTROPHYS J LETT, V783, DOI 10.1088/2041-8205/783/1/L1; MICKEY DL, 1985, SOL PHYS, V97, P223, DOI 10.1007/BF00165987; Pevtsov AA, 2008, ASTROPHYS J, V677, P719, DOI 10.1086/533435; SAKURAI T, 1995, PUBL ASTRON SOC JPN, V47, P81; Sakurai T., 1985, MPA REP, V212, P312; SEEHAFER N, 1990, SOL PHYS, V125, P219, DOI 10.1007/BF00158402; WEST EA, 1983, SOL PHYS, V88, P51; Zhang HQ, 2010, MON NOT R ASTRON SOC, V402, pL30, DOI 10.1111/j.1745-3933.2009.00793.x; Zhang HQ, 2002, ASTRON REP+, V46, P424, DOI 10.1134/1.1479429; Zhang M, 2006, ASTROPHYS J, V646, pL85, DOI 10.1086/506560	24	0	0	OXFORD UNIV PRESS	OXFORD	GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND	0004-6264	2053-051X		PUBL ASTRON SOC JPN	Publ. Astron. Soc. Jpn.	FEB	2015	67	1							6	10.1093/pasj/psu130		9	Astronomy & Astrophysics	Astronomy & Astrophysics	CC1RN	WOS:000350120500007		
J	Takeda, Y; Ohshima, O; Kambe, E; Toda, H; Koyano, H; Sato, B; Nakamura, Y; Narita, N; Sekii, T				Takeda, Yoichi; Ohshima, Osamu; Kambe, Eiji; Toda, Hiroyuki; Koyano, Hisashi; Sato, Bun'ei; Nakamura, Yasuhisa; Narita, Norio; Sekii, Takashi			Solar rotation inferred from radial velocities of the Sun-as-a-star during the 2012 May 21 eclipse	PUBLICATIONS OF THE ASTRONOMICAL SOCIETY OF JAPAN			English	Article						eclipses; line: profiles; Sun: rotation; techniques: radial velocities; techniques: spectroscopic	DIFFERENTIAL ROTATION; MERIDIONAL MOTIONS; SUNSPOT GROUPS; OKAYAMA HIDES; IODINE CELLS; SUBARU HDS; SYSTEM	With the aim of examining how much information of solar rotation can be obtained purely spectroscopically by observing the Sun-as-a-star during the 2012 May 21 eclipse at Okayama Astrophysical Observatory, we studied the variation of radial velocities (V-r), which were derived by using the iodine-cell technique based on a set of 184 high-dispersion spectra consecutively obtained over a time span of similar to 4 hr. The resulting V-r(t) was confirmed to show the characteristic variation (Rossiter-McLaughlin effect) caused by time-varying visibility of the solar disk. By comparing the observed V-r(t) curve with the theoretical ones [which were simulated with the latitude (psi) dependent solar rotation law omega(sidereal)(psi) = A + B sin(2)psi (degree d(-1))] we found that the relation B similar or equal to -5.5A + 77 gives the best fit, though separate determinations of A and B were not possible. Since this relationship is consistent with the real values known for the Sun (A similar or equal to 14.5, B similar or equal to -2.8), we may state that our analysis yielded satisfactory results. This consequence may provide the prospect of getting useful information on stellar rotation of eclipsing binaries from radial-velocity studies during eclipse, if many spectra of sufficiently high time-resolution are available.	[Takeda, Yoichi; Narita, Norio; Sekii, Takashi] Natl Astron Observ Japan, Mitaka, Tokyo 1818588, Japan; [Takeda, Yoichi; Narita, Norio; Sekii, Takashi] Grad Univ Adv Studies, Mitaka, Tokyo 1818588, Japan; [Ohshima, Osamu] Mizushima Tech High Sch, Kurashiki, Okayama 7100807, Japan; [Kambe, Eiji; Toda, Hiroyuki; Koyano, Hisashi] Natl Astron Observ Japan, Okayama Astrophys Observ, Asakuchi, Okayama 7190232, Japan; [Sato, Bun'ei] Tokyo Inst Technol, Meguro Ku, Tokyo 1528550, Japan; [Nakamura, Yasuhisa] Fukushima Univ, Fukushima 9601296, Japan	Takeda, Y (reprint author), Natl Astron Observ Japan, 2-21-1 Osawa, Mitaka, Tokyo 1818588, Japan.	takeda.yoichi@nao.ac.jp			Japan Society for the Promotion of Science (JSPS) [20540240]; NAOJ Fellowship; Inoue Science Research Award; Ministry of Education, Culture, Sports, Science and Technology (MEXT) [25247026]	We express our heartfelt thanks to Dr. Akihiko Fukui for his help in preparing the observation. EK is grateful for financial support by the Grant-in-Aid for Scientific Research (No. 20540240) from the Japan Society for the Promotion of Science (JSPS). NN acknowledges support by NAOJ Fellowship, Inoue Science Research Award, and Grant-in-Aid for Scientific Research (A) (No. 25247026) from the Ministry of Education, Culture, Sports, Science and Technology (MEXT).	Ammler-von Eiff M, 2012, ASTRON ASTROPHYS, V542, DOI 10.1051/0004-6361/201118724; Donati JF, 1997, MON NOT R ASTRON SOC, V291, P1; Sato B, 2002, PUBL ASTRON SOC JPN, V54, P873; Ohta Y, 2005, ASTROPHYS J, V622, P1118, DOI 10.1086/428344; BALTHASAR H, 1986, ASTRON ASTROPHYS, V155, P87; SIVARAMAN KR, 1993, SOL PHYS, V146, P27, DOI 10.1007/BF00662168; BALTHASAR H, 1980, ASTRON ASTROPHYS, V92, P111; Takeda Y, 2005, PUBL ASTRON SOC JPN, V57, P27; Kambe E, 2002, PUBL ASTRON SOC JPN, V54, P865; Molaro P, 2013, MON NOT R ASTRON SOC, V429, pL79, DOI 10.1093/mnrasl/sls027; AREVALO MJ, 1982, ASTRON ASTROPHYS, V111, P266; Collier Cameron A., 2002, MNRAS, V329, P23; GODOLI G, 1979, SOL PHYS, V64, P247, DOI 10.1007/BF00151436; Gray D. F., 2005, OBSERVATION ANAL STE; HOWARD R, 1984, ANNU REV ASTRON ASTR, V22, P131; Kallrath J, 2009, ASTRON ASTROPHYS LIB, P3, DOI 10.1007/978-1-4419-0699-1_1; Kambe E, 2013, PUBL ASTRON SOC JPN, V65; Kurucz R. L., 1993, 13 KUR CDROM HARV SM; Kurucz R. L., 1984, SOLAR FLUX ATLAS 296; Kurucz R. L., 1995, 23 KUR CDROM HARV SM; McLaughlin DB, 1924, ASTROPHYS J, V60, P22, DOI 10.1086/142826; Rossiter RA, 1924, ASTROPHYS J, V60, P15, DOI 10.1086/142825; Sato B, 2008, ASTR SOC P, V398, P67; Takeda Y, 2011, SOL PHYS, V270, P447, DOI 10.1007/s11207-011-9765-y; TAKEDA Y, 1995, PUBL ASTRON SOC JPN, V47, P337; WARD F, 1966, ASTROPHYS J, V145, P416, DOI 10.1086/148783	26	0	0	OXFORD UNIV PRESS	OXFORD	GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND	0004-6264	2053-051X		PUBL ASTRON SOC JPN	Publ. Astron. Soc. Jpn.	FEB	2015	67	1							10	10.1093/pasj/psu139		12	Astronomy & Astrophysics	Astronomy & Astrophysics	CC1RN	WOS:000350120500011		
J	Yoshikawa, A; Yamada, S; Nakahira, S; Matsuoka, M; Negoro, H; Mihara, T; Tamagawa, T				Yoshikawa, Akifumi; Yamada, Shin'ya; Nakahira, Satoshi; Matsuoka, Masaru; Negoro, Hitoshi; Mihara, Tatehiro; Tamagawa, Toru			Repeated short-term spectral softening in the low/hard state of the Galactic black hole candidate Swift J1753.5-0127	PUBLICATIONS OF THE ASTRONOMICAL SOCIETY OF JAPAN			English	Article						accretion, accretion disks; black hole physics; stars: individual (Swift J1753.5-0127); X-rays: binaries	IN-ORBIT PERFORMANCE; SLIT CAMERA GSC; X-RAY; ACCRETION; MAXI; ISS; BINARIES; ONBOARD; PERIOD	We report MAXI and Swift observations of short-term spectral softenings of the Galactic black hole X-ray binary Swift J1753.5-0127 in the low/hard state. These softening events are characterized by a simultaneous increase of soft X-rays (2-4 keV) and a decrease of hard X-rays (15-50 keV) lasting for a few tens of days. The X-ray energy spectra during the softening periods can be reproduced with a model consisting of a multi-color disk blackbody and its Comptonized component. The fraction of the Comptonized component decreased from 0.30 to 0.15 when the spectrum became softer; meanwhile the inner disk temperature (T-in) increased from 0.2 to 0.45 keV. These results imply that the softening events are triggered by a short-term increase of the mass accretion rate. During the observed spectral softening events, the disk flux (F-disk) and T-in did not obey the F-disk proportional to (Tin)(4) relation, suggesting that the inner disk radius does not reach the inner-most stable circular orbit.	[Yoshikawa, Akifumi; Tamagawa, Toru] RIKEN, Nishina Ctr, High Energy Astrophys Lab, Wako, Saitama 3510198, Japan; [Yoshikawa, Akifumi] Tokyo Univ Sci, Dept Phys, Shinjuku Ku, Tokyo 1628602, Japan; [Yamada, Shin'ya] Tokyo Metropolitan Univ, Dept Phys, Hachioji, Tokyo 1920397, Japan; [Nakahira, Satoshi] JAXA, ISAS, ISS Sci Project Off, Tsukuba, Ibaraki 3058505, Japan; [Matsuoka, Masaru; Mihara, Tatehiro] RIKEN, MAXI Team, Wako, Saitama 3510198, Japan; [Negoro, Hitoshi] Nihon Univ, Dept Phys, Chiyoda Ku, Tokyo 1018308, Japan	Yoshikawa, A (reprint author), RIKEN, Nishina Ctr, High Energy Astrophys Lab, 2-1 Hirosawa, Wako, Saitama 3510198, Japan.	akifumi@crab.riken.jp			Japan Society for the Promotion of Science	This research has made use of MAXI data provided by RIKEN, JAXA and the MAXI team, and use of Swift data provided by NASA, ASI, and the University of Leicester. This research was partially supported by the Japan Society for the Promotion of Science.	SHIMURA T, 1995, ASTROPHYS J, V445, P780, DOI 10.1086/175740; Reynolds MT, 2010, ASTROPHYS J, V709, P358, DOI 10.1088/0004-637X/709/1/358; MAKISHIMA K, 1986, ASTROPHYS J, V308, P635, DOI 10.1086/164534; MITSUDA K, 1984, PUBL ASTRON SOC JPN, V36, P741; Cabanac C, 2009, MON NOT R ASTRON SOC, V396, P1415, DOI 10.1111/j.1365-2966.2009.14867.x; Remillard RA, 2006, ANNU REV ASTRON ASTR, V44, P49, DOI 10.1146/annurev.astro.44.051905.092532; Shaw AW, 2013, MON NOT R ASTRON SOC, V433, P740, DOI 10.1093/mnras/stt763; Done C, 2007, ASTRON ASTROPHYS REV, V15, P1, DOI 10.1007/s00159-007-0006-1; Zurita C, 2008, ASTROPHYS J, V681, P1458, DOI 10.1086/588721; Kubota A, 1998, PUBL ASTRON SOC JPN, V50, P667; SHAKURA NI, 1973, ASTRON ASTROPHYS, V24, P337; Matsuoka M, 2009, PUBL ASTRON SOC JPN, V61, P999; Steiner JF, 2009, PUBL ASTRON SOC PAC, V121, P1279; Reis RC, 2009, MON NOT R ASTRON SOC, V395, P1257, DOI 10.1111/j.1365-2966.2009.14622.x; Burrows N. D., 2005, ASTRONOMERS TELEGRAM, P547; Bel MC, 2007, ASTROPHYS J, V659, P549, DOI 10.1086/512004; Cui W, 2002, ASTROPHYS J, V576, P357, DOI 10.1086/341548; Cui W., 1997, APJL, V487, P73; Daikyuji A., 2010, P 1 YEAR MAXI MON VA, P29; EBISAWA K, 1991, ASTROPHYS J, V367, P213, DOI 10.1086/169620; Mihara T, 2011, PUBL ASTRON SOC JPN, V63, pS623; Miller J. M., 2006, APJ, V652, P113; Nakahira S., 2013, J SPACE SCI INFORM J, V2, P29; Negoro H., 2009, ASTRONOMERS TELEGRAM, P2341; Negoro H., 2010, P 1 YEAR MAXI MON VA, P63; Palmer M. D., 2005, ASTRONOMERS TELEGRAM, P546; Ramadevi C. M., 2007, MNRAS, V378, P182; Sarkar R, 2008, AIP CONF PROC, V1053, P215, DOI 10.1063/1.3009485; Soleri P, 2013, MON NOT R ASTRON SOC, V429, P1244, DOI 10.1093/mnras/sts405; Steiner J. F., 2009, APJ, V701, P83; Sugizaki M, 2011, PUBL ASTRON SOC JPN, V63, pS635; Tomida H, 2011, PUBL ASTRON SOC JPN, V63, P397; Tsunemi H, 2010, PUBL ASTRON SOC JPN, V62, P1371	33	0	0	OXFORD UNIV PRESS	OXFORD	GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND	0004-6264	2053-051X		PUBL ASTRON SOC JPN	Publ. Astron. Soc. Jpn.	FEB	2015	67	1							11	10.1093/pasj/psu140		11	Astronomy & Astrophysics	Astronomy & Astrophysics	CC1RN	WOS:000350120500012		
J	Fujita, Y; Myojoyama, A; Saitoh, H				Fujita, Yukio; Myojoyama, Atsushi; Saitoh, Hidetoshi			Bremsstrahlung and photoneutron production in a steel shield for 15-22-MeV clinical electron beams	RADIATION PROTECTION DOSIMETRY			English	Article							NEUTRON CONTAMINATION; ACCELERATOR; SIMULATION; THERAPY	The physical data regarding bremsstrahlung and neutrons produced in a steel shield by high-energy electron beams from a medical linear accelerator were investigated. These data are required to allow the accurate prediction of shielding performance for high-energy electron beams and in the design of radiotherapy facilities. A Monte Carlo code was used to develop Monte Carlo beam models for clinical electron beams and to directly simulate bremsstrahlung and secondary neutron production in a steel shield. The effective dose and dose equivalent of bremsstrahlung X rays and secondary neutrons outside a vault were determined using a realistic radiation source. The accuracy of Monte Carlo simulations was validated experimentally by comparing the measured and calculated physical quantities. In validating the Monte Carlo simulation, the measured and calculated values showed reasonable agreement, indicating that bremsstrahlung and photoneutron production and transport were simulated accurately. The bremsstrahlung X-ray dose was the main component of the total dose outside a vault. The secondary neutron dose was 1-20 % of the bremsstrahlung X-ray dose, but the neutron dose was also at a non-negligible level. The calculated neutron dose outside the vault differed from the McGinley's reported data. These results indicate that McGinley's method overestimates the neutron dose beyond the steel shield. The physical data used here will be useful in the accurate estimation of bremsstrahlung X-ray and neutron doses for high-energy electron beams.	[Fujita, Yukio] Tokai Univ, Sch Med, Dept Radiat Oncol, Isehara, Kanagawa 2591193, Japan; [Myojoyama, Atsushi; Saitoh, Hidetoshi] Tokyo Metropolitan Univ, Grad Sch Human Hlth Sci, Arakawa Ku, Tokyo 1168551, Japan	Fujita, Y (reprint author), Tokai Univ, Sch Med, Dept Radiat Oncol, Isehara, Kanagawa 2591193, Japan.	fujita-yukio@tokai-u.jp					AMELIN NS, 1992, PHYS REV D, V46, P4873, DOI 10.1103/PhysRevD.46.4873; Agostinelli S, 2003, NUCL INSTRUM METH A, V506, P250, DOI 10.1016/S0168-9002(03)01368-8; Allison J, 2006, IEEE T NUCL SCI, V53, P270, DOI 10.1109/TNS.2006.869826; ROGERS DWO, 1995, MED PHYS, V22, P503, DOI 10.1118/1.597552; Muir BR, 2010, MED PHYS, V37, P5939, DOI 10.1118/1.3495537; Mora GM, 1999, MED PHYS, V26, P2494, DOI 10.1118/1.598770; Ongaro C, 2000, PHYS MED BIOL, V45, pL55, DOI 10.1088/0031-9155/45/12/101; SELTZER SM, 1993, RADIAT RES, V136, P147, DOI 10.2307/3578607; Wulff J, 2008, PHYS MED BIOL, V53, P2823, DOI 10.1088/0031-9155/53/11/005; Bourgois L, 1997, RADIAT PROT DOSIM, V74, P239; Garnica-Garza HM, 2005, PHYS MED BIOL, V50, P531, DOI 10.1088/0031-9155/50/3/010; Heikkinen A., 2003, P 2003 C COMP HIGH E, P86; ICRP, 1996, ANN ICRP; ICRP, 1991, ANN ICRP, V21; International Atomic Energy Agency (IAEA), 2001, IAEA TECHN REP SER, V398; KHAN FM, 1978, RADIOLOGY, V126, P249; KLIAUGA P, 1995, INT J RADIAT ONCOL, V31, P629, DOI 10.1016/0360-3016(94)00370-Z; Kwarakow I., 2000, PIRS701 NAT RES COUN; MCGINLEY PH, 1992, HEALTH PHYS, V62, P359, DOI 10.1097/00004032-199204000-00011; MCGINLEY PH, 1989, PHYS MED BIOL, V34, P777, DOI 10.1088/0031-9155/34/6/012; Meyer J. A., 1985, MED PHYS, V12, P473; NATH R, 1980, MED PHYS, V7, P545, DOI 10.1118/1.594716; National Council on Radiation Protection and Measurements, 1984, 79 NCRP; Ohguchi H, 2008, RADIAT MEAS, V43, pS500, DOI 10.1016/j.radmeas.2008.03.015; PALTA JR, 1984, MED PHYS, V11, P498, DOI 10.1118/1.595543; Rose P. F., 1991, BNLNCS1741; RUSTGI SN, 1987, MED PHYS, V14, P884, DOI 10.1118/1.596018; Yukio F., 2009, J RADIAT RES, V50, P363	28	1	1	OXFORD UNIV PRESS	OXFORD	GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND	0144-8420	1742-3406		RADIAT PROT DOSIM	Radiat. Prot. Dosim.	FEB	2015	163	2					148	159		10.1093/rpd/ncu153		12	Environmental Sciences; Public, Environmental & Occupational Health; Nuclear Science & Technology; Radiology, Nuclear Medicine & Medical Imaging	Environmental Sciences & Ecology; Public, Environmental & Occupational Health; Nuclear Science & Technology; Radiology, Nuclear Medicine & Medical Imaging	CC1QL	WOS:000350116400002		
J	Yamauchi-Kawaura, C; Fujii, K; Akahane, K; Yamauchi, M; Narai, K; Aoyama, T; Katsu, T; Obara, S; Imai, K; Ikeda, M				Yamauchi-Kawaura, C.; Fujii, K.; Akahane, K.; Yamauchi, M.; Narai, K.; Aoyama, T.; Katsu, T.; Obara, S.; Imai, K.; Ikeda, M.			Development of age-specific Japanese head phantoms for dose evaluation in paediatric head CT examinations	RADIATION PROTECTION DOSIMETRY			English	Article							COMPUTED-TOMOGRAPHY; ANTHROPOMORPHIC PHANTOM; ORGAN; CHILDREN; SCANS; CHEST	In this study, the authors developed age-specific physical head phantoms simulating the physique of Japanese children for dose evaluation in paediatric head computed tomography (CT) examinations. Anatomical structures at 99 places in 0-, 0.5-, 1- and 3-y-old Japanese patients were measured using DICOM viewer software from CT images, and the head phantom of each age was designed. For trial manufacture, a 3-y-old head phantom consisting of acrylic resin and gypsum was produced by machine processing. Radiation doses for the head phantom were measured with radiophotoluminescence glass dosemeters and Si-pin photodiode dosemeters. To investigate whether the phantom shape was suitable for dose evaluation, organ doses in the same scan protocol were compared between the 3-y-old head and commercially available anthropomorphic phantoms having approximately the same head size. The doses of organs in both phantoms were equivalent. The authors' designed paediatric head phantom will be useful for dose evaluation in paediatric head CT examinations.	[Yamauchi-Kawaura, C.; Fujii, K.; Aoyama, T.; Imai, K.; Ikeda, M.] Nagoya Univ, Grad Sch Med, Dept Radiol Sci, Higashi Ku, Nagoya, Aichi 4618673, Japan; [Akahane, K.; Obara, S.] Natl Inst Radiol Sci, Radiol Protect Sect, Inage Ku, Chiba 2638555, Japan; [Yamauchi, M.] Aichi Med Univ Hosp, Div Radiol, Nagakute, Aichi 4801195, Japan; [Narai, K.] Technorad Inc, Miyama, Kyoto 6130036, Japan; [Katsu, T.] Nagoya Univ Hosp, Div Radiol, Showa Ku, Nagoya, Aichi 4668560, Japan	Yamauchi-Kawaura, C (reprint author), Nagoya Univ, Grad Sch Med, Dept Radiol Sci, Higashi Ku, 1-1-20 Daikominami, Nagoya, Aichi 4618673, Japan.	kawaura@met.nagoya-u.ac.jp	Ikeda, Mitsuru/B-5163-2010	Ikeda, Mitsuru/0000-0002-5695-3527	Japan Society for the Promotion of Science (JSPS) KAKENHI [22611009]	This work was supported by the Japan Society for the Promotion of Science (JSPS) KAKENHI Grant Number 22611009.	Koizumi T, 2010, J CRANIOFAC SURG, V21, P1434, DOI 10.1097/SCS.0b013e3181ecc2f3; Kawaura C, 2006, RADIAT PROT DOSIM, V118, P421, DOI 10.1093/rpd/nci372; Lee C, 2010, PHYS MED BIOL, V55, P339, DOI 10.1088/0031-9155/55/2/002; Pearce MS, 2012, LANCET, V380, P499, DOI 10.1016/S0140-6736(12)60815-0; WAITZMAN AA, 1992, CLEFT PALATE-CRAN J, V29, P112, DOI 10.1597/1545-1569(1992)029<0112:CSMBOC>2.3.CO;2; Yamauchi-Kawaura C, 2010, PEDIATR RADIOL, V40, P1206, DOI 10.1007/s00247-009-1495-z; POSNICK JC, 1993, PLAST RECONSTR SURG, V92, P1015, DOI 10.1097/00006534-199311000-00003; Sugimoto N, 2013, RADIAT PROT DOSIM, V153, P85, DOI 10.1093/rpd/ncs085; WAITZMAN AA, 1992, CLEFT PALATE-CRAN J, V29, P118, DOI 10.1597/1545-1569(1992)029<0118:CSMBOC>2.3.CO;2; Varchena V, 2002, PEDIATR RADIOL, V32, P280, DOI 10.1007/s00247-002-0681-z; BAXTER BS, 1981, INVEST RADIOL, V16, P337, DOI 10.1097/00004424-198107000-00017; Buikstra J. E., 1994, ARKANSAS AERCHEOLOGI, V44; Fujii K, 2011, RADIAT PROT DOSIM, V147, P151, DOI 10.1093/rpd/ncr289; Fujii K, 2007, BRIT J RADIOL, V80, P657, DOI 10.1259/bjr/97260522; Hass L. L., 1952, AM J ROENTGENOL RADI, V67, P197; Hiraoka T., 1999, IYOU HYOUJUN SENRYOU, V4, P23; Hubbell J.H., 1995, 5632 NISTIR; International Commission on Radiation Units and Measurements, 1989, 44 ICRU; International Commission on Radiological Protection, 2007, ICRP PUBL, V103; International Commission on Radiological Protection, 2002, ICRP PUBL, V89; International Commission on Radiological Protection, 1995, ICRP PUBL, V70; Jahanbin A, 2013, J CRANIOFAC SURG, V24, P941, DOI 10.1097/SCS.0b013e31828dcf4f; KOEHLER PR, 1979, RADIOLOGY, V130, P189; MATTESON SR, 1989, J ORAL MAXIL SURG, V47, P1053, DOI 10.1016/0278-2391(89)90180-8; MCCULLOUGH EC, 1977, RADIOLOGY, V124, P99; Ministry of Health Labour and Welfare, 2010, NAT GROWTH SURV PRES; Miyazaki Osamu, 2005, Nihon Igaku Hoshasen Gakkai Zasshi, V65, P216; Nishizawa Kanae, 2004, Nippon Acta Radiologica, V64, P151; Singh GD, 1999, ARCH ORAL BIOL, V44, P429, DOI 10.1016/S0003-9969(99)00012-6; World Health Organization (WHO), 2007, WHO CHILD GROWTH STA	30	0	0	OXFORD UNIV PRESS	OXFORD	GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND	0144-8420	1742-3406		RADIAT PROT DOSIM	Radiat. Prot. Dosim.	FEB	2015	163	2					188	201		10.1093/rpd/ncu155		14	Environmental Sciences; Public, Environmental & Occupational Health; Nuclear Science & Technology; Radiology, Nuclear Medicine & Medical Imaging	Environmental Sciences & Ecology; Public, Environmental & Occupational Health; Nuclear Science & Technology; Radiology, Nuclear Medicine & Medical Imaging	CC1QL	WOS:000350116400007		
J	Naito, W; Uesaka, M; Yamada, C; Ishii, H				Naito, Wataru; Uesaka, Motoki; Yamada, Chie; Ishii, Hideki			Evaluation of dose from external irradiation for individuals living in areas affected by the Fukushima Daiichi Nuclear Plant accident	RADIATION PROTECTION DOSIMETRY			English	Article								In order to effectively and appropriately manage external radiation doses in the affected areas of Fukushima, it is important to identify when, where and how much exposure occurred. It is also necessary to quantitatively measure external exposure and air dose rates for different activity patterns in individuals living and working in Japanese-style buildings. The authors used a new personal dosemeter (D-shuttle) along with a global positioning system and geographical information system to relate personal dose rate with activity patterns and air dose rate. Hourly individual doses obtained by D-shuttle can provide an effective communication tool for those who want to identify when and how much exposure occurs. Personal monitoring of 26 volunteers showed that personal doses obtained from D-shuttle were similar to 30 % of cumulative air dose estimated by data from the airborne monitoring survey. This analysis showed that, for most study volunteers, the exposure from staying at home represented about half of the total cumulative dose. This suggests that even though the peak exposure doses may be observed outside of working hours, to develop appropriate countermeasures for external dose reduction, it is thus important to identify the contributions of individuals' time-activities. This study provides a valuable basis for developing a realistic and pragmatic method to estimate external doses of individuals in Fukushima.	[Naito, Wataru; Uesaka, Motoki; Yamada, Chie] Natl Inst Adv Ind Sci & Technol, Res Inst Sci Safety & Sustainabil RISS, Tsukuba, Ibaraki 3058569, Japan; [Ishii, Hideki] Fukushima Univ, Fukushima Future Ctr Reg Revitalizat, Fukushima 9601296, Japan	Naito, W (reprint author), Natl Inst Adv Ind Sci & Technol, Res Inst Sci Safety & Sustainabil RISS, 16-1 Onogawa, Tsukuba, Ibaraki 3058569, Japan.	w-naito@aist.go.jp			AIST Environment and Energy Unit	This work was supported by AIST Environment and Energy Unit.	Akahane K, 2013, SCI REP-UK, V3, DOI 10.1038/srep01670; Morino Y, 2011, GEOPHYS RES LETT, V38, DOI 10.1029/2011GL048689; Date-City, 2013, MEAS EXT EXP DOS; Hayano R., 2014, FBNEWS, P1; Hirayama H., 2013, J ATOM ENERG SOC JPN, V55, P21; IAEA, 2014, FOLL UP IAEA INT MIS; Koriyama-City, 2014, PERS DOS SURV CHILDR; Ministry of Education Culture Sports Science and Technology, 2011, DISTR MAP RAD DOS ET; Ministry of the Environment, 2011, DEC GUID VER 1; Ministry of the Environment, 2012, PROV CALC STAND DEC; Ministry of the Environment, 2012, POL DEC SPEC DEC AR; Nuclear Regulation Authority, 2014, MON INF ENV RAD LEV; Nuclear Regulation Authority, 2013, AIR DOS RAT RES 7 AI; Yoshida K, 2012, RADIAT PROT DOSIM, V151, P144, DOI 10.1093/rpd/ncr466; Yoshida-Ohuchi H, 2013, RADIAT PROT DOSIM, V154, P385, DOI 10.1093/rpd/ncs245	15	0	0	OXFORD UNIV PRESS	OXFORD	GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND	0144-8420	1742-3406		RADIAT PROT DOSIM	Radiat. Prot. Dosim.	FEB	2015	163	3					353	361		10.1093/rpd/ncu201		9	Environmental Sciences; Public, Environmental & Occupational Health; Nuclear Science & Technology; Radiology, Nuclear Medicine & Medical Imaging	Environmental Sciences & Ecology; Public, Environmental & Occupational Health; Nuclear Science & Technology; Radiology, Nuclear Medicine & Medical Imaging	CC1QN	WOS:000350116700011		
J	Tani, K; Shutt, A; Kurihara, O; Kosako, T				Tani, Kotaro; Shutt, Arron; Kurihara, Osamu; Kosako, Toshiso			Skull counting in late stages after internal contamination by actinides	RADIATION PROTECTION DOSIMETRY			English	Article							IN-VIVO MEASUREMENTS	Monitoring preparation for internal contamination with actinides (e.g. Pu and Am) is required to assess internal doses at nuclear fuel cycle-related facilities. In this paper, the authors focus on skull counting in case of single-incident inhalation of Am-241 and propose an effective procedure for skull counting with an existing system, taking into account the biokinetic behaviour of Am-241 in the human body. The predicted response of the system to skull counting under a certain counting geometry was found to be only similar to 1.0 x 10(-5) cps Bq(-1) 1y after intake. However, this disadvantage could be remedied by repeated measurements of the skull during the late stage of the intake due to the predicted response reaching a plateau at about the 1000th day after exposure and exceeding that in the lung counting. Further studies are needed for the development of a new detection system with higher sensitivity to perform reliable internal dose estimations based on direct measurements.	[Tani, Kotaro] Univ Tokyo, Sch Engn, Dept Nucl Engn & Management, Bunkyo Ku, Tokyo 1130032, Japan; [Shutt, Arron] Publ Hlth England, Dept Toxicol, Internal Dosimetry Grp, Didcot OX11 ORQ, Oxon, England; [Kurihara, Osamu] Natl Inst Radiol Sci, Res Ctr Radiat Emergency Med, Res Program Radiat Emergency Med, Inage Ku, Chiba 2638555, Japan; [Kosako, Toshiso] Univ Tokyo, Sch Engn, Nucl Profess Sch, Tokai, Tokyo 3191188, Japan	Tani, K (reprint author), Univ Tokyo, Sch Engn, Dept Nucl Engn & Management, Bunkyo Ku, 2-11-16 Yayoi, Tokyo 1130032, Japan.	tani@kk.t.u-tokyo.ac.jp			 [248236]	The authors gratefully acknowledge the financial support by Grant-in-Aid for JSPS Fellows Number 248236.	Vrba T, 2007, RADIAT PROT DOSIM, V127, P201, DOI 10.1093/rpd/ncm271; Rodenas J, 2003, NUCL INSTRUM METH A, V496, P390, DOI 10.1016/S0168-9002(02)01748-5; Malatova I, 2000, RADIAT PROT DOSIM, V89, P295; Berger M.J., 2010, XCOM PHOTON CROSS SE; Birchall A, 1998, RADIAT PROT DOSIM, V79, P107; Gomez-Ros JM, 2008, RADIAT MEAS, V43, P510, DOI 10.1016/j.radmeas.2007.12.023; International Commission on Radiological Protection, 1997, ANN ICRP, V27, P3; International Commission on Radiological Protection, 2006, ANN ICRP, V36; International Commission on Radiological Protection, 1994, ANN ICRP, V24; International Commission on Radiological Protection, 1997, ANN ICRP, V27; International Commission on Radiological Protection, 1993, ANN ICRP, V39; International Commission on Radiological Protection, 1993, ANN ICRP, V67; Kramer GH, 2008, RADIAT PROT DOSIM, V128, P449, DOI 10.1093/rpd/ncm437; Kurihara O, 2011, RADIAT PROT DOSIM, V146, P144, DOI 10.1093/rpd/ncr139; LYNCH T P, 1988, Journal of Radiological Protection, V8, P67, DOI 10.1088/0952-4746/8/2/001; Malatova I, 2010, HEALTH PHYS, V99, P495, DOI 10.1097/HP.0b013e3181d18e2e; Navarro JF, 2007, RADIAT PROT DOSIM, V127, P531, DOI 10.1093/rpd/ncm411; PALMER HE, 1983, HEALTH PHYS, V45, P893, DOI 10.1097/00004032-198310000-00007; Pelowitz DB, 2011, LAUR1102295 LOS AL N; Tani K, 2013, RADIAT PROT DOSIM, V157, P323, DOI 10.1093/rpd/nct153; TCHERKEZIAN V, 1995, J ENVIRON RADIOACTIV, V27, P133, DOI 10.1016/0265-931X(95)00014-2	21	0	0	OXFORD UNIV PRESS	OXFORD	GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND	0144-8420	1742-3406		RADIAT PROT DOSIM	Radiat. Prot. Dosim.	FEB	2015	163	3					381	386		10.1093/rpd/ncu189		6	Environmental Sciences; Public, Environmental & Occupational Health; Nuclear Science & Technology; Radiology, Nuclear Medicine & Medical Imaging	Environmental Sciences & Ecology; Public, Environmental & Occupational Health; Nuclear Science & Technology; Radiology, Nuclear Medicine & Medical Imaging	CC1QN	WOS:000350116700014		
J	Ishikawa, N; Kobayashi, Y; Fujii, Y; Kobayashi, M				Ishikawa, Nobustune; Kobayashi, Yoshiyuki; Fujii, Yuji; Kobayashi, Masao			Increased interleukin-6 and high-sensitivity C-reactive protein levels in pediatric epilepsy patients with frequent, refractory generalized motor seizures	SEIZURE-EUROPEAN JOURNAL OF EPILEPSY			English	Article						High-sensitivity CRP; Intractable epilepsy; Generalized motor seizure; IL-6; PTX3; Chronic inflammation	LONG PENTRAXIN PTX3; RECEPTOR ANTAGONIST; CARDIOVASCULAR-DISEASE; CEREBROSPINAL-FLUID; RECURRENT SEIZURES; FOCAL EPILEPSY; INFLAMMATION; PLASMA; BRAIN; ATHEROSCLEROSIS	Purpose: Recently, it was found that chronic inflammation contributes to the pathomechanism of diverse chronic diseases in various organs. There is accumulating evidence that inflammatory processes affect the pathophysiology of epilepsy. We investigated inflammatory markers to determine the chronic inflammatory process underlying the pathophysiology of intractable epilepsy presenting with frequent motor seizures in children. Method: In total, 29 patients with epilepsy and 15 children as control subjects were enrolled. Patients were divided into the DS (daily generalized motor seizures) and the IS (intermittent seizures) groups. Blood levels of serum high-sensitivity C-reactive protein (hs-CRP), plasma pentraxin 3 (PTX3), serum tumor necrosis factor (TNF)-alpha, interleukin (IL)-6, and IL-beta 1 were evaluated in all participants. Results: Hs-CRP levels were significantly higher in the DS group (0.149 +/- 0.161 mg/dL) than in either the IS or control group (0.0156 +/- 0.0136 and 0.0253 +/- 0.0288 mg/dL, p < 0.005 and p < 0.05, respectively), while there was no significant difference between the IS and control groups. The IL-6 level was also significantly higher in the DS group (8.022 +/- 0.161 pg/mL) than in either the IS or the control group (7.783 +/- 0.0563 and 7.864 +/- 0.072 pg/mL; p < 0.005 and p < 0.05, respectively). There were no significant differences in PTX3, TNF-alpha, or IL-1 beta levels. Conclusion: Our results suggest that daily generalized motor seizures result in elevated IL-6 levels, leading to increased CRP. A systemic inflammatory response in intractable patients with frequent generalized motor seizures may affect their prognosis. We may need therapeutic strategies, including methods to control the inflammatory process, to treat intractable epilepsy. (C) 2014 British Epilepsy Association. Published by Elsevier Ltd. All rights reserved.	[Ishikawa, Nobustune; Kobayashi, Yoshiyuki; Fujii, Yuji; Kobayashi, Masao] Hiroshima Univ Hosp, Dept Pediat, Hiroshima, Japan	Ishikawa, N (reprint author), Hiroshima Univ, Grad Sch Biomed Sci, Dept Pediat, Minami Ku, Kasumi 1-2-3, Hiroshima 7348551, Japan.	ishikan@hiroshima-u.ac.jp					Alapirtti T, 2012, EPILEPSIA, V53, P790, DOI 10.1111/j.1528-1167.2012.03449.x; Tan TY, 2009, EPILEPSIA, V50, P1579, DOI 10.1111/j.1528-1167.2009.02024.x; Friedman A, 2011, EPILEPSIA, V52, P33, DOI 10.1111/j.1528-1167.2011.03034.x; Librizzi L, 2012, ANN NEUROL, V72, P82, DOI 10.1002/ana.23567; Vezzani A, 2013, EXP NEUROL, V244, P11, DOI 10.1016/j.expneurol.2011.09.033; Impellizzeri D, 2014, PHARMACOL RES, V81, P91, DOI 10.1016/j.phrs.2014.02.007; Vezzani A, 2005, EPILEPSIA, V46, P1724, DOI 10.1111/j.1528-1167.2005.00298.x; Alapirtti T, 2009, J NEUROL SCI, V280, P94, DOI 10.1016/j.jns.2009.02.355; Ridker PM, 2001, CIRCULATION, V103, P1813; Yasunaga T, 2014, INT HEART J, V55, P160; Mintzer S, 2009, ANN NEUROL, V65, P448, DOI 10.1002/ana.21615; Vezzani A, 2013, NEUROPHARMACOLOGY, V69, P16, DOI 10.1016/j.neuropharm.2012.04.004; Kwon YS, 2013, J NEUROINFLAMM, V10, DOI 10.1186/1742-2094-10-30; Li G, 2011, SEIZURE-EUR J EPILEP, V20, P249, DOI 10.1016/j.seizure.2010.12.005; Padeh S, 2013, IMMUNOL RES, V56, P444, DOI 10.1007/s12026-013-8417-8; Uludag IF, 2013, SEIZURE-EUR J EPILEP, V22, P457, DOI 10.1016/j.seizure.2013.03.004; Bonacina F, 2013, MEDIAT INFLAMM, DOI 10.1155/2013/725102; LIUZZO G, 1994, NEW ENGL J MED, V331, P417, DOI 10.1056/NEJM199408183310701; Chen YH, 2013, NEUROIMMUNOMODULAT, V20, P223, DOI 10.1159/000348440; Ravizza T, 2001, NEUROSCIENCE, V105, P43, DOI 10.1016/S0306-4522(01)00177-4; Almroth G, 2013, SCAND J IMMUNOL, V78, P285, DOI 10.1111/sji.12082; Peltola J, 2000, EPILEPSY RES, V41, P205, DOI 10.1016/S0920-1211(00)00140-6; Song IU, 2011, NEUROL SCI, V32, P31, DOI 10.1007/s10072-010-0335-0; Bevelacqua V, 2006, INT J MOL MED, V18, P415; Deng ZC, 2014, EXP THER MED, V7, P443, DOI 10.3892/etm.2013.1441; Volanakis JE, 2001, MOL IMMUNOL, V38, P189, DOI 10.1016/S0161-5890(01)00042-6; Engelhart MJ, 2004, ARCH NEUROL-CHICAGO, V61, P668, DOI 10.1001/archneur.61.5.668; Lech M, 2013, NEPHROL DIAL TRANSPL, V28, P803, DOI 10.1093/ndt/gfs448; Rojas A, 2014, EPILEPSIA, V55, P17, DOI 10.1111/epi.12461; Assadpour Piranfar M, 2014, INT CARDIOVASC RES J, V8, P6; Firouzjahi A, 2013, INFLAMMATION, V36, P1122, DOI 10.1007/s10753-013-9646-7; Ge W, 2014, EUR J PEDIATR, V173, P213, DOI 10.1007/s00431-013-2150-0; Gomez-Marcos MA, 2012, BMC CARDIOVASC DISOR, V12, DOI 10.1186/1471-2261-12-37; Jenny NS, 2014, J THROMB HAEMOST, V12, P999, DOI 10.1111/jth.12557; Kimura S, 2013, CIRC J, V78, P159; Liu Z, 1999, NEUROSCIENCE, V92, P1443, DOI 10.1016/S0306-4522(99)00064-0; Mantovani A, 2013, ANN NY ACAD SCI, V1285, P1, DOI 10.1111/nyas.12043; Neill JC, 1996, DEV BRAIN RES, V95, P283, DOI 10.1016/S0165-3806(96)00099-5; Peltola J, 1998, EPILEPSY RES, V31, P129, DOI 10.1016/S0920-1211(98)00024-2; Peltola J, 2002, SEIZURE-EUR J EPILEP, V11, P44, DOI 10.1053/seiz.2001.0575; Shiihara T, 2010, BRAIN DEV-JPN, V32, P695, DOI 10.1016/j.braindev.2009.11.001; VanGilder RL, 2014, J CLIN NEUROSCI, V21, P547, DOI 10.1016/j.jocn.2013.06.015; Wasilewska A, 2010, PEDIATR NEPHROL, V25, P1519, DOI 10.1007/s00467-010-1513-2; Yamanaka G, 2010, J NEUROL SCI, V298, P106, DOI 10.1016/j.jns.2010.07.018; Yuen AWC, 2010, EPILEPSY RES, V91, P187, DOI 10.1016/j.eplepsyres.2010.07.011	45	1	1	W B SAUNDERS CO LTD	LONDON	32 JAMESTOWN RD, LONDON NW1 7BY, ENGLAND	1059-1311	1532-2688		SEIZURE-EUR J EPILEP	Seizure	FEB	2015	25						136	140		10.1016/j.seizure.2014.10.007		5	Clinical Neurology; Neurosciences	Neurosciences & Neurology	CB8LM	WOS:000349881100023		
J	Lee, H; Shimizu, Y; Ulenian, JS				Lee, Hajin; Shimizu, Yuki; Ulenian, James S.			CULTURAL DIFFERENCES IN THE AUTOMATICITY OF ELEMENTAL IMPRESSION FORMATION	SOCIAL COGNITION			English	Article							SPONTANEOUS TRAIT INFERENCE; PROCESS DISSOCIATION FRAMEWORK; CORRESPONDENCE BIAS; IMPLICIT THEORIES; SOCIAL INFERENCE; UNITED-STATES; ACTORS FACES; BEHAVIOR; ATTRIBUTION; TRANSFERENCE	Cultural differences in impression formation are well known and multiply determined. Spontaneous impressions (which occur relatively freely from conscious strategies) are basic components of impressions, and spontaneous trait transference (STT) is perhaps the most elemental form. We used process dissociation procedures to estimate the contribution of automatic and controlled processes to STT among Japanese and American participants. STT occurred in both samples, but more frequently among Americans. Controlled processes were equally important in both samples, but automatic processes were weaker among Japanese. Thus, these cultural differences in the most elemental form of impression formation were largely attributable to automatic processes. The results are discussed in terms of both stage theories of trait inference and views of culture as consisting of automatic patterns of thought and action.	[Lee, Hajin; Ulenian, James S.] NYU, Dept Psychol, New York, NY 10003 USA; [Shimizu, Yuki] Saitama Univ, Fac Educ, Saitama, Japan	Lee, H (reprint author), Univ Alberta, Dept Psychol, P-217 Biol Sci Bldg, Edmonton, AB T6G 2E9, Canada.	hajin@ualberta.ca					Kitayama S, 2002, PSYCHOL BULL, V128, P89, DOI 10.1037/0033-2909.128.1.89; Goren A, 2009, SOC COGNITION, V27, P222; RHEE E, 1995, J PERS SOC PSYCHOL, V69, P142, DOI 10.1037/0022-3514.69.1.142; Masuda T, 2001, J PERS SOC PSYCHOL, V81, P922, DOI 10.1037//0022-3514.81.5.922; Knowles ED, 2001, PERS SOC PSYCHOL B, V27, P1344, DOI 10.1177/01461672012710010; TROPE Y, 1986, PSYCHOL REV, V93, P239, DOI 10.1037/0033-295X.93.3.239; Kitayama S, 2003, PSYCHOL SCI, V14, P201, DOI 10.1111/1467-9280.02432; Miyamoto Y, 2006, PSYCHOL SCI, V17, P113, DOI 10.1111/j.1467-9280.2006.01673.x; Crawford MT, 2008, J EXP SOC PSYCHOL, V44, P840, DOI 10.1016/j.jesp.2007.08.001; Ham J, 2003, J EXP SOC PSYCHOL, V39, P434, DOI 10.1016/S0022-1031(03)00033-7; Skowronski JJ, 1998, J PERS SOC PSYCHOL, V74, P837, DOI 10.1037/0022-3514.74.4.837; Wells BM, 2011, J EXP SOC PSYCHOL, V47, P1116, DOI 10.1016/j.jesp.2011.05.013; Uleman JS, 2008, ANNU REV PSYCHOL, V59, P329, DOI 10.1146/annurev.psych.59.103006.093707; CARLSTON DE, 1995, J PERS SOC PSYCHOL, V69, P420, DOI 10.1037/0022-3514.69.3.429; Payne BK, 2006, CURR DIR PSYCHOL SCI, V15, P287, DOI 10.1111/j.1467-8721.2006.00454.x; Crawford MT, 2007, PERS SOC PSYCHOL B, V33, P677, DOI 10.1177/0146167206298567; Norenzayan A, 2002, PERS SOC PSYCHOL B, V28, P109, DOI 10.1177/0146167202281010; Choi I, 1998, PERS SOC PSYCHOL B, V24, P949, DOI 10.1177/0146167298249003; Carlston DE, 2005, J PERS SOC PSYCHOL, V89, P884, DOI 10.1037/0022-3514.89.6.884; BUCHNER A, 1995, J EXP PSYCHOL GEN, V124, P137, DOI 10.1037/0096-3445.124.2.137; Todorov A, 2002, J PERS SOC PSYCHOL, V83, P1051, DOI 10.1037//0022-3514.83.5.1051; Choi I, 1999, PSYCHOL BULL, V125, P47, DOI 10.1037//0033-2909.125.1.47; McCarthy RJ, 2011, J PERS SOC PSYCHOL, V100, P229, DOI 10.1037/a0021991; Todorov A, 2003, J EXP SOC PSYCHOL, V39, P549, DOI 10.1016/S0022-1031(03)00059-3; Na JY, 2011, PSYCHOL SCI, V22, P1025, DOI 10.1177/0956797611414727; Zou X, 2009, J PERS SOC PSYCHOL, V97, P579, DOI 10.1037/a0016399; Todorov A, 2004, J PERS SOC PSYCHOL, V87, P482, DOI 10.1037/0022-3514.87.4.482; JONES EE, 1967, J EXP SOC PSYCHOL, V3, P1, DOI 10.1016/0022-1031(67)90034-0; Varnum MEW, 2012, J EXP PSYCHOL GEN, V141, P518, DOI 10.1037/a0026104; Rim S, 2013, J EXP SOC PSYCHOL, V49, P1204, DOI 10.1016/j.jesp.2013.05.007; Zarate MA, 2001, SOC COGNITION, V19, P295; Bargh J. A., 1994, HDB SOCIAL COGNITION, V2, P1; Brosch T, 2013, SOC COGN AFFECT NEUR, V8, P640, DOI 10.1093/scan/nst019; Chiu C., 2007, SOCIAL PSYCHOL HDB B, P785; Church AT, 2012, J CROSS CULT PSYCHOL, V43, P1268, DOI 10.1177/0022022111428514; COUSINS SD, 1989, J PERS SOC PSYCHOL, V56, P124, DOI 10.1037//0022-3514.56.1.124; Gelfand MJ, 2000, J CROSS CULT PSYCHOL, V31, P498, DOI 10.1177/0022022100031004004; GILBERT DT, 1988, J PERS SOC PSYCHOL, V54, P733, DOI 10.1037/0022-3514.54.5.733; Hintzman DL, 1997, J EXP PSYCHOL LEARN, V23, P511, DOI 10.1037//0278-7393.23.2.511; JACOBY LL, 1991, J MEM LANG, V30, P513, DOI 10.1016/0749-596X(91)90025-F; Jacoby LL, 1997, J EXP PSYCHOL LEARN, V23, P505, DOI 10.1037//0278-7393.23.2.505; KRULL DS, 1993, PERS SOC PSYCHOL B, V19, P340, DOI 10.1177/0146167293193011; Lieberman MD, 2005, PERS SOC PSYCHOL B, V31, P889, DOI 10.1177/01461672042740911; Lillard A. S., 2005, NEW UNCONSCIOUS, P277; Malle B. F., 2004, MIND EXPLAINS BEHAV; Mason MF, 2010, SOC COGN AFFECT NEUR, V5, P292, DOI 10.1093/scan/nsq034; McCrae R. R., 1996, HDB CHINESE PSYCHOL, P189; MILLER FD, 1981, J EXP SOC PSYCHOL, V17, P80, DOI 10.1016/0022-1031(81)90008-1; MILLER JG, 1984, J PERS SOC PSYCHOL, V46, P961, DOI 10.1037/0022-3514.46.5.961; Miyamoto Y, 2002, J PERS SOC PSYCHOL, V83, P1239, DOI 10.1037//0022-3514.83.5.1239; NEWMAN LS, 1993, SOC COGNITION, V11, P243, DOI 10.1521/soco.1993.11.2.243; Shweder R. A., 1984, CULTURE THEORY ESSAY, P158; CARLSTON DE, 1994, J PERS SOC PSYCHOL, V66, P840, DOI 10.1037//0022-3514.66.5.840; Trope Y, 2000, J PERS SOC PSYCHOL, V79, P344, DOI 10.1037/0022-3514.79.3.344; Uleman J. S., 1988, 300 BEHAV SENT UNPUB; Uleman J. S., 2005, NEW UNCONSCIOUS, P362; Uleman JS, 1996, PERS SOC PSYCHOL B, V22, P377, DOI 10.1177/0146167296224005; WINTER L, 1984, J PERS SOC PSYCHOL, V47, P237, DOI 10.1037/0022-3514.47.2.237	58	0	0	GUILFORD PUBLICATIONS INC	NEW YORK	72 SPRING STREET, NEW YORK, NY 10012 USA	0278-016X			SOC COGNITION	Soc. Cogn.	FEB	2015	33	1					1	19				19	Psychology, Social	Psychology	CB9DR	WOS:000349932700001		
J	Vernizzi, G; Nakai, M				Vernizzi, Graziano; Nakai, Miki			A Geometrical Framework for Covariance Matrices of Continuous and Categorical Variables	SOCIOLOGICAL METHODS & RESEARCH			English	Article						categorical data; covariance matrix; social survey data; Gini index	COEFFICIENT	It is well known that a categorical random variable can be represented geometrically by a simplex. Accordingly, several measures of association between categorical variables have been proposed and discussed in the literature. Moreover, the standard definitions of covariance and correlation coefficient for continuous random variables have been extended to categorical variables. In this article, we present a geometrical framework where both continuous and categorical data are represented by simplices and lines in a high-dimensional space, respectively. We introduce a function whose direct minimization leads to a single definition of covariance between categorical-categorical, categorical-continuous, and continuous-continuous data. The novelty of this general approach is that a single space and a single distance function can be used for describing both continuous and categorical data. It thus provides a unified geometrical description of the measure of association, in particular between categorical and continuous data. We discuss virtues and limitations of such a geometrical framework and provide examples with possible applications to sociological surveys.	[Vernizzi, Graziano] Siena Coll, Dept Phys & Astron, Loudonville, NY USA; [Nakai, Miki] Ritsumeikan Univ, Coll Social Sci, Dept Social Sci, Kita Ku, Kyoto, Japan	Nakai, M (reprint author), Ritsumeikan Univ, Coll Social Sci, Dept Social Sci, Kita Ku, 56-1 Tojiinkitamachi, Kyoto, Japan.	mnakai@ss.ritsumei.ac.jp			Japan Society for the Promotion of Science [23530630]	The author(s) disclosed receipt of the following financial support for the research, authorship, and/or publication of this article: This work is supported by Grant-in-Aid for Scientific Research (C; No. 23530630) from the Japan Society for the Promotion of Science.	Agresti A., 1978, SOCIOL METHODOL, V9, P204, DOI 10.2307/270810; Agresti A., 1997, STATISTICAL METHODS; Agresti A, 2007, AN INTRODUCTION TO C; RODGERS JL, 1988, AM STAT, V42, P59, DOI 10.2307/2685263; SOMERS RH, 1962, AM SOCIOL REV, V27, P799, DOI 10.2307/2090408; Allison PD, 2000, SOCIOL METHOD RES, V28, P301, DOI 10.1177/0049124100028003003; SIMPSON EH, 1949, NATURE, V163, P688, DOI 10.1038/163688a0; Ceriani L, 2012, J ECON INEQUAL, V10, P421, DOI 10.1007/s10888-011-9188-x; GOODMAN LA, 1954, J AM STAT ASSOC, V49, P732, DOI 10.2307/2281536; DIXON PM, 1987, ECOLOGY, V68, P1548, DOI 10.2307/1939238; Niitsuma H, 2005, LECT NOTES ARTIF INT, V3518, P523; GOOD IJ, 1953, BIOMETRIKA, V40, P237, DOI 10.2307/2333344; Feller W., 1968, AN INTRODUCTION TO P, VI; Gantmacher F. R., 2000, MATRIX THEORY; Gini C., 1912, VARIABILITY AND MUTA; Goldstein H, 2001, CLASSICAL MECHANICS; Hayes K, 2011, AM STAT, V65, P110, DOI 10.1198/tast.2011.09067; Iversen G. R., 1987, ANALYSIS OF VARIANCE; Knoke D., 2002, STATISTICS FOR SOCIA; KUKLINSKI JH, 1981, AM POLIT SCI REV, V75, P436, DOI 10.2307/1961376; Liebetrau A. M., 1983, SAGE UNIVERSITY PAPE; Lingoes P. H., 1974, PSYCHOMETRIKA, V39, P423; Little RJS, 2002, STATISTICAL ANALYSIS; McCane B, 2008, PATTERN RECOGN LETT, V29, P986, DOI 10.1016/j.patrec.2008.01.021; Nakai M., 2011, NEW PERSPECTIVES IN, P211; Niitsuma H., 2005, COVARIANCE AND PCA F; Okada T., 2000, Intelligent Data Engineering and Automated - IDEAL 2000. Data Mining, Financial Engineering, and Intelligent Agents. Second International Conference. Proceedings (Lecture Notes in Computer Science Vol.1983); Reynolds H. T., 1984, ANALYSIS OF NOMINAL; Sato Y., 2008, WORK STYLE AND CAREE, V4, P143; SCHONEMA.PH, 1970, PSYCHOMETRIKA, V35, P245, DOI 10.1007/BF02291266; Takenoshita H, 2012, COMP SOC RES, V29, P85, DOI 10.1108/S0195-6310(2012)0000029007; The 2005 SSM Research Group Data Management Committee, 2005, SURVEY NO 0764; Van Loan C. F., 1996, MATRIX COMPUTATIONS	33	0	0	SAGE PUBLICATIONS INC	THOUSAND OAKS	2455 TELLER RD, THOUSAND OAKS, CA 91320 USA	0049-1241	1552-8294		SOCIOL METHOD RES	Sociol. Methods. Res.	FEB	2015	44	1					48	79		10.1177/0049124114543243		32	Social Sciences, Mathematical Methods; Sociology	Mathematical Methods In Social Sciences; Sociology	CC2FI	WOS:000350160200002		
J	Xue, R; Han, N; Xia, MY; Ye, C; Hao, ZH; Wang, LH; Wang, Y; Yang, JY; Saiki, I; Yin, J				Xue, Rui; Han, Na; Xia, Mingyu; Ye, Chun; Hao, Zhihui; Wang, Lihui; Wang, Yu; Yang, Jingyu; Saiki, Ikuo; Yin, Jun			TXA9, a cardiac glycoside from Streptocaulon juventas, exerts a potent anti-tumor activity against human non-small cell lung cancer cells in vitro and in vivo	STEROIDS			English	Article						Acovenosigenin A 3-O-beta-D-glucoside; Anti-tumor; NSCLC; Streptocaulon juventas; Cardiac glycosides; Apoptosis	ANTICANCER THERAPY; APOPTOSIS; DIGITOXIN; PATHWAYS; DEATH	Non-small cell lung cancer is the most common type of lung cancer and the most common cause of cancer-related death in humans. TXA9, which is a natural product separated from an anti-tumor-active fraction of the roots of Streptocaulon juventas, may possess potent anti-proliferative activity according to the present study. In this study, the anti-tumor effects and toxicity of TXA9 were tested against human non-small cell lung cancer cell lines (A549, NCI-H1299, Ltep-alpha 2, PC-9, and Lu99) and a normal human lung embryonic fibroblast cell (HE-lung) in vitro, and then toward A549 cells in vivo in a murine xenograft model. The results show that TXA9 exhibits potent cytotoxic activities against non-small lung cancer cells and has no toxic effect on the normal human lung embryonic fibroblast cells. The mechanistic studies demonstrate that TXA9 can induce the apoptosis of A549 cells through the extrinsic pathway. The in vivo study results reveal that the intravenous administration of TXA9 at high-dose (15 mg kg) induces significant tumor growth inhibition of non-small cell lung cancer xenografts with tumor inhibition rate up to 64.2%, compared with mice in the control group. The inhibitory effect was similar to that of taxol (62.5%). In particular, no significantly adverse effects were exerted by TXA9, which suggests that it is well tolerated. This promising natural product may be useful as a potential novel anti-tumor candidate. (C) 2014 Elsevier Inc. All rights reserved.	[Xue, Rui; Han, Na; Ye, Chun; Yin, Jun] Shenyang Pharmaceut Univ, Sch Tradit Chinese Mat Med, Dev & Utilizat Key Lab Northeast Plant Mat, Shenyang 110016, Peoples R China; [Xia, Mingyu; Wang, Lihui; Yang, Jingyu] Shenyang Pharmaceut Univ, Sch Life Sci & Biopharmaceut, Shenyang 110016, Peoples R China; [Hao, Zhihui] Shenyang Pharmaceut Univ, Ctr Expt Anim, Shenyang 110016, Peoples R China; [Wang, Yu] Peoples Liberat Army 463 Hosp, Shenyang 110042, Peoples R China; [Saiki, Ikuo] Toyama Univ, Inst Nat Med, Dept Biosci, Sugitani, Toyama 2630, Japan	Yin, J (reprint author), Shenyang Pharmaceut Univ, Sch Tradit Chinese Mat Med 48, 103 Wenhua Rd, Shenyang 110016, Peoples R China.	yinjun2002@yahoo.com			National Natural Science and Technology Major Project [2010ZX09401-304]; Natural Science Foundation of China [30973958]	This work was financially supported by Grants from the National Natural Science and Technology Major Project "Key New Drug Creation and Manufacturing Program" (No. 2010ZX09401-304) and the Natural Science Foundation of China (No. 30973958).	Fulda S, 2006, ONCOGENE, V25, P4798, DOI 10.1038/sj.onc.1209608; Jemal A, 2011, CA-CANCER J CLIN, V61, P69, DOI 10.3322/caac.20107; Mijatovic T, 2007, BBA-REV CANCER, V1776, P32, DOI 10.1016/j.bbcan.2007.06.002; Xue R, 2013, PHYTOCHEMISTRY, V88, P105, DOI 10.1016/j.phytochem.2012.12.004; KERR JFR, 1972, BRIT J CANCER, V26, P239, DOI 10.1038/bjc.1972.33; Elmore S, 2007, TOXICOL PATHOL, V35, P495, DOI 10.1080/01926230701320337; Therien AG, 2000, AM J PHYSIOL-CELL PH, V279, pC541; Shord SS, 2006, BIOPHARM DRUG DISPOS, V27, P191, DOI 10.1002/bdd.503; Wyllie A H, 1980, Int Rev Cytol, V68, P251; Prassas I, 2008, NAT REV DRUG DISCOV, V7, P926, DOI 10.1038/nrd2682; Lefranc F, 2008, NEOPLASIA, V10, P198, DOI 10.1593/neo.07928; Clardy J, 2004, NATURE, V432, P829, DOI 10.1038/nature03194; Hu W, 2003, LANCET ONCOL, V4, P721, DOI 10.1016/S1470-2045(03)01277-4; Bohmer T, 1998, AGE AGEING, V27, P222, DOI 10.1093/ageing/27.2.222; Dudich E, 1999, EUR J BIOCHEM, V266, P750, DOI 10.1046/j.1432-1327.1999.00868.x; Evans Tracey L, 2004, Oncologist, V9, P232, DOI 10.1634/theoncologist.9-2-232; Favoni RE, 2013, DRUG DISCOV TODAY, V18, P11, DOI 10.1016/j.drudis.2012.07.011; Han N, 2010, PLANTA MED, V76, P561, DOI 10.1055/s-0029-1240600; Lu S, 2011, CHINESE J CANCER RES, V23, P254, DOI 10.1007/s11670-011-0254-5; SHIRATOR.O, 1967, GANN, V58, P521; SMITH TW, 1975, AM J MED, V58, P470, DOI 10.1016/0002-9343(75)90118-7; SMITH TW, 1985, J AM COLL CARDIOL, V5, pA43; Suda K., 2000, Journal of Traditional Medicines, V17, P236; WILLIAMS JF, 1983, AM HEART J, V105, P21, DOI 10.1016/0002-8703(83)90273-9; Wu ZY, 1977, FLORA CHINA, V63, P267; Xue R, 2013, PLANTA MED, V79, P157, DOI 10.1055/s-0032-1328021; Zhang XH, 2007, CHEM BIODIVERS, V4, P998, DOI 10.1002/cbdv.200790091; Zhou FuJun, 2011, Drug Evaluation Research, V34, P81	28	0	0	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0039-128X	1878-5867		STEROIDS	Steroids	FEB	2015	94						51	59		10.1016/j.steroids.2014.12.015		9	Biochemistry & Molecular Biology; Endocrinology & Metabolism	Biochemistry & Molecular Biology; Endocrinology & Metabolism	CC1CT	WOS:000350079500007		
J	Watanabe, M; Suzuki, H; Nomura, S; Hanawa, H; Chihara, N; Mizutani, S; Yoshino, M; Uchida, E				Watanabe, Masanori; Suzuki, Hideyuki; Nomura, Satoshi; Hanawa, Hidetsugu; Chihara, Naoto; Mizutani, Satoshi; Yoshino, Masanori; Uchida, Eiji			Performance Assessment of the Risk Index Category for Surgical Site Infection after Colorectal Surgery	SURGICAL INFECTIONS			English	Article							CARE SAFETY NETWORK; NOSOCOMIAL INFECTIONS; UNITED-STATES; WOUND-INFECTION; SURVEILLANCE; RESECTION; SYSTEM; COLON; TIME	Background: The traditional National Healthcare Safety Network (previously National Nosocomial Infections Surveillance) risk index is used to predict the risk of surgical site infection across many operative procedures. However, this index may be too simple to predict risk in the various procedures performed in colorectal surgery. The aim of this study was to evaluate the usefulness of the risk index by analyzing the impact of the risk index factors on surgical site infection after abdominal colorectal surgery. Methods: Using our surgical site infection surveillance database, we analyzed retrospectively 538 consecutive patients who underwent abdominal colorectal surgery between 2005 and 2010. Correlations between surgical site infection and the following risk index factors were analyzed: length of operation, American Society of Anesthesiologists score, wound classification, and use of laparoscopy. The 75th percentile for length of operation was determined separately for open and laparoscopic surgery in the study model. Results: Univariate analyses showed that surgical site infection was more strongly associated with a >75th percentile length of operation in the study model (odds ratio [OR], 2.07) than in the traditional risk index model (OR, 1.64). Multivariable analysis found that surgical site infection was independently associated with a >75th percentile length of operation in the study model (OR, 2.75; 95% confidence interval [CI], 1.66-4.55), American Society of Anesthesiologists score >= 3 (OR, 2.22; 95% CI, 1.10-4.34), wound classification >= III (OR, 5.29; 95% CI, 2.62-10.69), and open surgery (OR, 2.21; 95% CI, 1.07-5.17). Performance of the risk index category was improved in the study model compared with the traditional model. Conclusions: The risk index category is sufficiently useful for predicting the risk of surgical site infection after abdominal colorectal surgery. However, the 75th percentile length of operation should be set separately for open and laparoscopic surgery.	[Watanabe, Masanori; Suzuki, Hideyuki; Nomura, Satoshi; Hanawa, Hidetsugu; Chihara, Naoto; Mizutani, Satoshi; Yoshino, Masanori] Musashikosugi Hosp, Inst Gastroenterol, Nippon Med Sch, Kawasaki, Kanagawa 2118533, Japan; [Uchida, Eiji] Nippon Med Sch, Dept Surg, Tokyo 113, Japan	Watanabe, M (reprint author), Musashikosugi Hosp, Inst Gastroenterol, Nippon Med Sch, Nakahara Ku, 1-396 Kosugicho, Kawasaki, Kanagawa 2118533, Japan.	margaux82@nifty.com					Acin-Gandara D, 2013, SURG INFECT, V14, P339, DOI 10.1089/sur.2012.043; Mu Y, 2011, INFECT CONT HOSP EP, V32, P970, DOI 10.1086/662016; Kiran RP, 2010, J AM COLL SURGEONS, V211, P232, DOI 10.1016/j.jamcollsurg.2010.03.028; Edwards JR, 2008, AM J INFECT CONTROL, V36, P609, DOI 10.1016/j.ajic.2008.08.001; Tang RP, 2001, ANN SURG, V234, P181, DOI 10.1097/00000658-200108000-00007; Murray BW, 2010, J AM COLL SURGEONS, V211, P812, DOI 10.1016/j.jamcollsurg.2010.07.025; Ho VP, 2011, DIS COLON RECTUM, V54, P818, DOI 10.1007/DCR.0b013e3182138d47; Sehgal R, 2011, J AM COLL SURGEONS, V212, P29, DOI 10.1016/j.jamcollsurg.2010.09.011; Nakamura T, 2008, WORLD J SURG, V32, P1138, DOI 10.1007/s00268-008-9528-6; Kurmann A, 2011, SURG ENDOSC, V25, P3531, DOI 10.1007/s00464-011-1753-7; Gaynes RP, 2001, CLIN INFECT DIS, V33, pS69, DOI 10.1086/321860; HORAN TC, 1993, INFECT CONT HOSP EP, V14, P73; Gervaz P, 2010, ANN SURG, V252, P3, DOI 10.1097/SLA.0b013e3181dbb5a5; Poon JT, 2009, ANN SURG, V249, P77, DOI 10.1097/SLA.0b013e31819279e3; Pastor C, 2010, DIS COLON RECTUM, V53, P721, DOI 10.1007/DCR.0b013e3181cc573b; Gervaz P, 2012, BRIT J SURG, V99, P589, DOI 10.1002/bjs.8656; Konishi T, 2006, ANN SURG, V244, P758, DOI 10.1097/01.sla.0000219017.78611.49; Blumetti J, 2007, SURGERY, V142, P704, DOI 10.1016/j.surg.2007.05.012; Mangram AJ, 1999, INFECT CONT HOSP EP, V20, P250, DOI 10.1086/501620; Watanabe M, 2014, SURG INFECT, V15, P256, DOI 10.1089/sur.2012.154; Culver DH, 1991, AM J MED S3B, V91, P152; Kwaan MR, 2013, SURG INFECT, V14, P363, DOI 10.1089/sur.2012.109; Napolitano LM, 2010, SURG INFECT, V11, P111, DOI 10.1089/sur.2010.9932; Cardo D, 2004, AM J INFECT CONTROL, V32, P470, DOI 10.1016/j.ajic.2004.10.001; Prospero E, 2007, AM J INFECT CONTROL, V35, P582, DOI 10.1016/j.ajic.2007.01.004; Schwenk W, 2005, COCHRANE DB SYST REV, V3; Vandenbroucke-Grauls C, 2002, CURR OPIN INFECT DIS, V15, P415	27	0	0	MARY ANN LIEBERT, INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA	1096-2964	1557-8674		SURG INFECT	Surg. Infect.	FEB 1	2015	16	1					84	89		10.1089/sur.2013.260		6	Infectious Diseases; Surgery	Infectious Diseases; Surgery	CD0GN	WOS:000350748800013		
J	Yamashita, H; Aoyama-Ishikawa, M; Takahara, M; Yamauchi, C; Inoue, T; Miyoshi, M; Maeshige, N; Usami, M; Nakao, A; Kotani, J				Yamashita, Hayato; Aoyama-Ishikawa, Michiko; Takahara, Miki; Yamauchi, Chisato; Inoue, Taketo; Miyoshi, Makoto; Maeshige, Noriaki; Usami, Makoto; Nakao, Atsunori; Kotani, Joji			Endogenous Interleukin 18 Suppresses Hyperglycemia and Hyperinsulinemia during the Acute Phase of Endotoxemia in Mice	SURGICAL INFECTIONS			English	Article							INDUCED INSULIN-RESISTANCE; POLYCYSTIC-OVARY-SYNDROME; STRESS-HYPERGLYCEMIA; OBESITY; IL-18; SEPSIS; HEPATOCYTES; INHIBITION	Background: Hyperglycemia associated with insulin resistance is common among critically ill patients. Interleukin (IL)-18 has been linked with hyperglycemia and insulin resistance in chronic disease, but the relation between IL-18 and insulin resistance during critical illness was unexplored. This study investigated whether IL-18 modulates hyperglycemia and insulin resistance during acute inflammation. Methods: We injected lipopolysaccharide (LPS) 40 mg/kg into wild-type (WT) and IL-18 knockout (KO) mice to induce endotoxemia and examined insulin resistance and insulin-dependent signaling pathways during the acute phase. Results: During the first hour after LPS treatment, IL-18 KO mice showed higher blood glucose and insulin and less insulin receptor substrate-1 and less phosphorylated Akt in the liver compared with WT mice. Interleukin-18 KO mice exhibited better survival after LPS treatment. Conclusions: The findings suggest that endogenous IL-18 may attenuate hyperglycemia and modulate insulin signaling in liver. Accordingly, IL-18 may modulate glucose tolerance during acute inflammation.	[Yamashita, Hayato; Aoyama-Ishikawa, Michiko; Takahara, Miki; Yamauchi, Chisato; Inoue, Taketo; Miyoshi, Makoto; Maeshige, Noriaki; Usami, Makoto] Kobe Univ, Dept Biophys, Grad Sch Hlth Sci, Kobe, Hyogo 6540142, Japan; [Aoyama-Ishikawa, Michiko; Nakao, Atsunori; Kotani, Joji] Hyogo Coll Med, Dept Emergency & Crit Care Med, Nishinomiya, Hyogo, Japan	Aoyama-Ishikawa, M (reprint author), Kobe Univ, Dept Biophys, Grad Sch Hlth Sci, Suma Ku, 7-10-2 Tomogaoka, Kobe, Hyogo 6540142, Japan.	maoyama@people.kobe-u.ac.jp			JSPS KAKENHI [23659852]	This research was supported by JSPS KAKENHI Grant Number 23659852.	Smart MC, 2011, NUTR METAB CARDIOVAS, V21, P476, DOI 10.1016/j.numecd.2009.12.004; Hotamisligil GS, 1996, SCIENCE, V271, P665, DOI 10.1126/science.271.5249.665; Van den Berghe G, 2006, NEW ENGL J MED, V354, P449, DOI 10.1056/NEJMoa052521; Capes SE, 2000, LANCET, V355, P773, DOI 10.1016/S0140-6736(99)08415-9; Senn JJ, 2002, DIABETES, V51, P3391, DOI 10.2337/diabetes.51.12.3391; Raetzsch CF, 2009, HEPATOLOGY, V50, P592, DOI 10.1002/hep.22999; Vriesendorp TM, 2006, CRIT CARE MED, V34, P96, DOI 10.1097/01.CCM.0000194536.89694.06; Marik PE, 2004, INTENS CARE MED, V30, P748, DOI 10.1007/s00134-004-2167-y; Escobar-Morreale HF, 2004, J CLIN ENDOCR METAB, V89, P806, DOI 10.1210/jc.2003-031365; Zilverschoon GRC, 2008, INT J OBESITY, V32, P1407, DOI 10.1038/ijo.2008.109; Netea MG, 2006, NAT MED, V12, P650, DOI 10.1038/nm1415; Thorand B, 2005, DIABETES, V54, P2932, DOI 10.2337/diabetes.54.10.2932; Ikezu T, 1997, J BIOL CHEM, V272, P25289, DOI 10.1074/jbc.272.40.25289; Yang YS, 2007, ENDOCRINE, V32, P297, DOI 10.1007/s12020-008-9048-z; Finfer S, 2009, NEW ENGL J MED, V360, P1283, DOI 10.1056/NEJMoa0810625; Dellinger RP, 2013, INTENS CARE MED, V39, P165, DOI 10.1007/s00134-012-2769-8; Aoyama M, 2009, SHOCK, V32, P401, DOI 10.1097/SHK.0b013e31819c358a; BLUMBERG D, 1995, METABOLISM, V44, P145, DOI 10.1016/0026-0495(95)90255-4; Carter EA, 1998, NUTR REV, V56, pS170; Endo Shigeatsu, 2000, Journal of Medicine (Westbury), V31, P15; Kalina U, 2000, J IMMUNOL, V165, P1307; Kim JW, 2012, EUR J OBSTET GYN R B, V161, P51, DOI 10.1016/j.ejogrb.2011.12.008; Li L, 2009, ENDOCRINOLOGY, V150, P24, DOI 10.1210/en.2008-0742; Ma YC, 2003, AM J PHYSIOL-GASTR L, V284, pG107, DOI 10.1152/ajpgi.00217.2002; Takahara M, 2014, ACUTE MED SURG, V1, P23; Van den Berghe Pieter W, 2001, NEW ENGL J MED, V345, P1359; Zaki ME, 2007, IMMUNOL INVEST, V36, P403, DOI 10.1080/08820130701244275	27	0	0	MARY ANN LIEBERT, INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA	1096-2964	1557-8674		SURG INFECT	Surg. Infect.	FEB 1	2015	16	1					90	96		10.1089/sur.2013.269		7	Infectious Diseases; Surgery	Infectious Diseases; Surgery	CD0GN	WOS:000350748800014		
J	Minakami, M; Kitagawa, N; Iida, H; Anan, H; Inai, T				Minakami, Masahiko; Kitagawa, Norio; Iida, Hiroshi; Anan, Hisashi; Inai, Tetsuichiro			p38 Mitogen-activated protein kinase and c-Jun NH2-terminal protein kinase regulate the accumulation of a tight junction protein, ZO-1, incell-cell contacts in HaCaT cells	TISSUE & CELL			English	Article						Mitogen-activated protein kinase (MAPK); c-jun NH2-terminal protein kinase (JNK); p38 MAPK; Tight junction; ZO-1; HaCaT cell	N-TERMINAL KINASE; EPITHELIAL-CELLS; EPIDERMAL-KERATINOCYTES; DIRECT ASSOCIATION; DIRECT BINDING; ALPHA-CATENIN; OCCLUDIN; EXPRESSION; ADHESION; CADHERIN	To investigate the involvement of stress-activated protein kinases, JNK and p38 MAPK, in the assembly of tight junctions in keratinocytes, we treated HaCaT cells with various combinations of SP600125 (an inhibitor of JNK), SB202190 (an inhibitor of p38 MAPK) and anisomycin (an activator of both JNK and p38 MAPK) and examined the localization of ZO-1, an undercoat constitutive protein of the tight junction. Short-term (8h) incubation with SP600125, SB202190 or anisomycin induced the accumulation of ZO-1 in the cell-cell contacts, with reduced ZO-1 staining in the cytoplasm, while only long-term (24h) incubation with SP600125 induced the accumulation of ZO-1. SP600125, SB202190 or SP600125 plus SB202190 treatment induced thin linear staining for ZO-1 in the cell-cell contacts. Anisomycin treatment induced thick and irregular linear staining for ZO-1, while anisomycin plus SP600125 treatment induced zipper-like staining for ZO-1. Anisomycin plus SB202190 treatment or anisomycin plus both SP600125 and SB202190 treatment for 8h failed to lead to the accumulation of ZO-1 in cell-cell contacts, but induced thin linear staining with several gaps 16h after removal of these agents. These results suggest that the localization of ZO-1 in cell-cell contacts is differently regulated by activation and inhibition of JNK and/or p38 MAPK depending on the incubation period. (C) 2014 Elsevier Ltd. All rights reserved.	[Minakami, Masahiko; Anan, Hisashi] Fukuoka Dent Coll, Dept Odontol, Sawara Ku, Fukuoka 8140193, Japan; [Kitagawa, Norio; Inai, Tetsuichiro] Fukuoka Dent Coll, Dept Morphol Biol, Sawara Ku, Fukuoka 8140193, Japan; [Iida, Hiroshi] Kyushu Univ, Grad Sch Agr, Zool Lab, Higashi Ku, Fukuoka 8128581, Japan	Inai, T (reprint author), Fukuoka Dent Coll, Dept Morphol Biol, Sawara Ku, 2-15-1 Tamura, Fukuoka 8140193, Japan.	tinaitj@college.fdcnet.ac.jp		Kitagawa, Norio/0000-0001-5565-4210	Ministry of Education, Culture, Sports, Science and Technology in Japan [26460285, S1001059]	This work was supported in part by Grants-in-Aid for Scientific Research (C) (No. 26460285) and a MEXT-Supported Program for the Strategic Research Foundation at Private Universities (S1001059), 2010-2015 from the Ministry of Education, Culture, Sports, Science and Technology in Japan.	Kyriakis JM, 2001, PHYSIOL REV, V81, P807; Giepmans BNG, 1998, CURR BIOL, V8, P931, DOI 10.1016/S0960-9822(07)00375-2; FURUSE M, 1994, J CELL BIOL, V127, P1617, DOI 10.1083/jcb.127.6.1617; Itoh M, 1997, J CELL BIOL, V138, P181, DOI 10.1083/jcb.138.1.181; Brandner JM, 2002, EUR J CELL BIOL, V81, P253, DOI 10.1078/0171-9335-00244; Itoh M, 1999, J CELL BIOL, V147, P1351, DOI 10.1083/jcb.147.6.1351; Fanning AS, 1998, J BIOL CHEM, V273, P29745, DOI 10.1074/jbc.273.45.29745; Matter K, 2007, J CELL SCI, V120, P1505, DOI 10.1242/jcs.005975; ITOH M, 1993, J CELL BIOL, V121, P491, DOI 10.1083/jcb.121.3.491; Vaezi A, 2002, DEV CELL, V3, P367, DOI 10.1016/S1534-5807(02)00259-9; Inai T, 2009, HISTOCHEM CELL BIOL, V131, P681, DOI 10.1007/s00418-009-0571-7; Tunggal JA, 2005, EMBO J, V24, P1146, DOI 10.1038/sj.emboj.7600605; Hagemann C, 2001, CELL SIGNAL, V13, P863, DOI 10.1016/S0898-6568(01)00220-0; Pummi K, 2001, J INVEST DERMATOL, V117, P1050, DOI 10.1046/j.0022-202x.2001.01493.x; Ikenouchi J, 2005, J CELL BIOL, V171, P939, DOI 10.1083/jcb.200510043; Schaeffer HJ, 1999, MOL CELL BIOL, V19, P2435; Toyofuku T, 1998, J BIOL CHEM, V273, P12725, DOI 10.1074/jbc.273.21.12725; BOUKAMP P, 1988, J CELL BIOL, V106, P761, DOI 10.1083/jcb.106.3.761; Imamura Y, 1999, J CELL BIOL, V144, P1311, DOI 10.1083/jcb.144.6.1311; Suzuki A, 2002, J CELL SCI, V115, P3565, DOI 10.1242/jcs.00032; Vasioukhin V, 2000, CELL, V100, P209, DOI 10.1016/S0092-8674(00)81559-7; Kojima T, 2010, J CELL PHYSIOL, V225, P720, DOI 10.1002/jcp.22273; Siljamaki E, 2014, ARCH DERMATOL RES, V306, P131, DOI 10.1007/s00403-013-1391-0; Furuse M, 2002, J CELL BIOL, V156, P1099, DOI 10.1083/jcb.200110122; Furuse M, 1998, J CELL BIOL, V143, P391, DOI 10.1083/jcb.143.2.391; Pearson LL, 2001, INT IMMUNOL, V13, P273, DOI 10.1093/intimm/13.3.273; Bogoyevitch MA, 2004, CELL SIGNAL, V16, P1345, DOI 10.1016/j.cellsig.2004.05.004; Aono S, 2008, EXP CELL RES, V314, P3326, DOI 10.1016/j.yexcr.2008.08.012; Gazel A, 2006, J BIOL CHEM, V281, P20530, DOI 10.1074/jbc.M602712200; Inai T, 2010, EUR J CELL BIOL, V89, P547, DOI 10.1016/j.ejcb.2010.01.003; Inai T, 2013, TISSUE CELL, V45, P175, DOI 10.1016/j.tice.2012.11.001; Itoh M, 1999, J BIOL CHEM, V274, P5981, DOI 10.1074/jbc.274.9.5981; Morita K, 1998, J INVEST DERMATOL, V110, P862, DOI 10.1046/j.1523-1747.1998.00209.x; Naydenov NG, 2009, CELL CYCLE, V8, P2110, DOI 10.4161/cc.8.13.8928; Ntagawa N., 2014, CELL BIOL, V142, P389; Schneeberger EE, 2004, AM J PHYSIOL-CELL PH, V286, pC1213, DOI 10.1152/ajpcell.00558.2003	36	0	0	CHURCHILL LIVINGSTONE	EDINBURGH	JOURNAL PRODUCTION DEPT, ROBERT STEVENSON HOUSE, 1-3 BAXTERS PLACE, LEITH WALK, EDINBURGH EH1 3AF, MIDLOTHIAN, SCOTLAND	0040-8166			TISSUE CELL	Tissue Cell	FEB	2015	47	1					1	9		10.1016/j.tice.2014.10.001		9	Anatomy & Morphology; Cell Biology	Anatomy & Morphology; Cell Biology	CB9VQ	WOS:000349982000001		
J	Shiino, M; Hoshi, H; Kawashima, T; Ishikawa, Y; Takayanagi, M; Murakami, K; Kishi, K; Sato, F				Shiino, Mizuho; Hoshi, Hideo; Kawashima, Tomokazu; Ishikawa, Youichi; Takayanagi, Masaaki; Murakami, Kunio; Kishi, Kiyoshi; Sato, Fumi			Quantitative analysis of development and aging of genital corpuscles in glans penis of the rat	TISSUE & CELL			English	Article						Density of genital corpuscle; PGP 9.5-positive-nerve fivers; Glans penis of the rat; Sex hormone; Sexual maturation; Development after puberty	PACINIAN CORPUSCLES; NERVE-ENDINGS; PGP 9.5; BEHAVIOR; PADS	The aim of the present postnatal developmental study was to determine densities of unique genital corpuscles (GCs) in glans penis of developing and aged rats. GCs were identified as corpuscular endings consisting of highly branched and coiled axons with many varicosities, which were immunoreactive for protein gene product 9.5. In addition, GCs were immunoreactive for calcitonin gene-related peptide and substance P, but not for vasoactive intestinal polypeptide and neuropeptide Y. GCs were not found in the glans penis of 1 week old rats. Densities of GCs were low at 3 weeks, significantly increased at 5 and 10 weeks, reached the peak of density at 40 weeks, and tended to decrease at 70 and 100 weeks. Sizes of GCs were small in 3 weeks old rats, increased at 5 and 10 weeks, reached the peak-size at 40 weeks and reduced in size at 70 and 100 weeks. Considering sexual maturation of the rat, the results reveal that GCs of the rat begins to develop postnatal and reaches to the peak of their development after puberty and continues to exist until old age, in contrast to prenatal and early postnatal development of other sensory receptors of glabrous skin. (C) 2014 Elsevier Ltd. All rights reserved.	[Shiino, Mizuho; Hoshi, Hideo; Kawashima, Tomokazu; Ishikawa, Youichi; Takayanagi, Masaaki; Murakami, Kunio; Kishi, Kiyoshi; Sato, Fumi] Toho Univ, Sch Med, Dept Anat, Ota Ku, Tokyo 1438540, Japan	Kawashima, T (reprint author), Toho Univ, Sch Med, Dept Anat, Ota Ku, Omori Nishi 5-21-16, Tokyo 1438540, Japan.	tomokazu.kawashima@med.toho-u.ac.jp					THOMPSON RJ, 1983, BRAIN RES, V278, P224, DOI 10.1016/0006-8993(83)90241-X; JOHNSON RD, 1992, BRAIN RES BULL, V28, P61, DOI 10.1016/0361-9230(92)90231-L; GRAY GD, 1981, ENDOCRINOLOGY, V109, P1597; MUNGER BL, 1988, ARCH HISTOL CYTOL, V51, P1, DOI 10.1679/aohc.51.1; PATRIZI G, 1965, J ULTRA MOL STRUCT R, V13, P500, DOI 10.1016/S0022-5320(65)90011-0; MILLS LR, 1989, DEV BIOL, V136, P61, DOI 10.1016/0012-1606(89)90130-9; ZELENA J, 1978, J NEUROCYTOL, V7, P71, DOI 10.1007/BF01213461; ARONSON LR, 1967, ANAT REC, V157, P71, DOI 10.1002/ar.1091570111; KNORR DW, 1970, ENDOCRINOLOGY, V86, P1298; DORAN JF, 1983, J NEUROCHEM, V40, P1542, DOI 10.1111/j.1471-4159.1983.tb08124.x; JORDAN CL, 1989, J NEUROSCI, V9, P229; HALATA Z, 1986, BRAIN RES, V371, P205, DOI 10.1016/0006-8993(86)90357-4; BEACH FA, 1950, J EXP ZOOL, V114, P159, DOI 10.1002/jez.1401140108; Cauna N, 1965, ADVANCES BIOLOGY SKI, VVI, P63; DAY INM, 1990, BIOCHEM J, V268, P521; Dogiel A.S, 1893, ARCH MIKROSK ANAT, V41, P585, DOI 10.1007/BF02954333; Halata Z., 1988, MECHANORECEPTORS DEV, P319; Hasinzuine K., 1984, JIKKEN DOBUTU, V33, P159; Hebel R., 1986, ANATOMY EMBRYOLOGY L, P70; Holbrook K.A., 1983, BIOCH PHYSL SKIN, V1, P64; JOHNSON RD, 1991, J COMP NEUROL, V312, P299, DOI 10.1002/cne.903120212; Johnson R. D., 1990, Anatomia Histologia Embryologia, V19, P86; Krause W., 1859, Z RATION MED, V5, P28; Krause W., 1881, ARCH MIKROSK ANAT, V19, P53; Lane-Petter W., 1976, UFAW HDB CARE MANAGE, P210; [Anonymous], 1990, PROG BRAIN RES; MALINOVS.L, 1972, ACTA ANAT, V81, P183; Munger B.L., 1971, HDB SENSORY PHYSIOLO, V1, P523; Ohmori D., 1924, Zeitschrift Ges Anat Munchen Abt 1, V70, P347, DOI 10.1007/BF02117201; Prisco C.L., 1980, HORM RES, V12, P149; Retzius G., 1890, INT MONATSSCHR ANAT, V7, P323; WINKELMANN RK, 1957, ARCH DERMATOL, V76, P225; Zelena J., 1988, MECHANORECEPTORS DEV, P9	33	0	0	CHURCHILL LIVINGSTONE	EDINBURGH	JOURNAL PRODUCTION DEPT, ROBERT STEVENSON HOUSE, 1-3 BAXTERS PLACE, LEITH WALK, EDINBURGH EH1 3AF, MIDLOTHIAN, SCOTLAND	0040-8166			TISSUE CELL	Tissue Cell	FEB	2015	47	1					27	32		10.1016/j.tice.2014.10.006		6	Anatomy & Morphology; Cell Biology	Anatomy & Morphology; Cell Biology	CB9VQ	WOS:000349982000004		
J	Kawabata, M; Umemoto, N; Shimada, Y; Nishimura, Y; Zhang, BB; Kuroyanagi, J; Miyabe, M; Tanaka, T				Kawabata, Miko; Umemoto, Noriko; Shimada, Yasuhito; Nishimura, Yuhei; Zhang, Beibei; Kuroyanagi, Junya; Miyabe, Masayuki; Tanaka, Toshio			Downregulation of Stanniocalcin 1 Is Responsible for Sorafenib-Induced Cardiotoxicity	TOXICOLOGICAL SCIENCES			English	Article						sorafenib; stanniocalcin 1; cardiotoxicity; zebrafish; reactive oxygen species	ADVANCED HEPATOCELLULAR-CARCINOMA; KINASE INHIBITORS; OXIDATIVE STRESS; ZEBRAFISH; CANCER; PROTEIN; MECHANISMS; TRIALS; SAFETY; CELLS	Sorafenib is associated with adverse cardiac effects, including left ventricular dysfunction. However, the precise mechanism remains unclear. Here, we aimed to establish the genes responsible for this cardiotoxicity using zebrafish and human cardiomyocytes. Fluorescent cardiac imaging using pigmentless zebrafish with green fluorescent protein hearts revealed that the ventricular dimensions of the longitudinal axis with sorafenib were significantly shorter than those of the control group. Transcriptome analysis of their hearts revealed that stanniocalcin 1 (stc1) was downregulated by sorafenib. stc1 knockdown in zebrafish revealed that reduction of stc1 decreased the longitudinal dimensions of zebrafish ventricles, similar to that which occurs during sorafenib treatment. STC1 downregulation and cytotoxicity were also seen in human cardiomyocytes exposed to sorafenib. To clarify the molecular function of stc1 in sorafenib-induced cardiotoxicity, we focused on oxidative stress in cardiomyocytes treated with sorafenib. Reactive oxygen species (ROS) production significantly increased in both species of human cardiomyocytes and zebrafish exposed to sorafenib and STC1 knockdown compared with the controls. Finally, we found that forced expression of stc1 normalized impairment, decreasing the longitudinal dimensions in zebrafish treated with sorafenib. Our study demonstrated that STC1 plays a protective role against ventricular dysfunction and ROS overproduction, which are induced by sorafenib treatment. We discovered for the first time that STC1 downregulation is responsible for sorafenib-induced cardiotoxicity through activated ROS generation.	[Kawabata, Miko; Umemoto, Noriko; Shimada, Yasuhito; Nishimura, Yuhei; Zhang, Beibei; Kuroyanagi, Junya; Tanaka, Toshio] Mie Univ, Grad Sch Med, Dept Mol & Cellular Pharmacol Pharmacogenom & Pha, Tsu, Mie 5148507, Japan; [Kawabata, Miko; Miyabe, Masayuki] Mie Univ, Grad Sch Med, Dept Clin Anesthesiol, Tsu, Mie 5148507, Japan; [Umemoto, Noriko; Shimada, Yasuhito; Nishimura, Yuhei; Tanaka, Toshio] Mie Univ, Grad Sch Med, Dept Syst Pharmacol, Tsu, Mie 5148507, Japan; [Shimada, Yasuhito; Tanaka, Toshio] Mie Univ, Med Zebrafish Res Ctr, Tsu, Mie 5148507, Japan; [Shimada, Yasuhito; Nishimura, Yuhei; Tanaka, Toshio] Mie Univ, Life Sci Res Ctr, Dept Bioinformat, Tsu, Mie 5148507, Japan; [Shimada, Yasuhito; Nishimura, Yuhei; Tanaka, Toshio] Mie Univ Ind Technol Innovat, Dept Om Med, Tsu, Mie 5148507, Japan	Tanaka, T (reprint author), Mie Univ, Grad Sch Med, Dept Mol & Cellular Pharmacol Pharmacogenom & Pha, Tsu, Mie 5148507, Japan.	tanaka@doc.medic.mie-u.ac.jp			Mie University Graduate School of Medicine; Ministry of Education, Culture, Sports, Science and Technology (MEXT) of Japan; Japan Science and Technology Agency; Long-range Research Initiative of the Japan Chemical Industrial Association [2010NT02, 2011NT02-01]; Johns Hopkins Center for Alternatives to Animal Testing [2011-08, 2012-17]; Sumitomo Foundation [113498]	This work was supported in part by grants from Mie University Graduate School of Medicine; the Ministry of Education, Culture, Sports, Science and Technology (MEXT) of Japan; the Japan Science and Technology Agency; the Long-range Research Initiative of the Japan Chemical Industrial Association (2010NT02, 2011NT02-01); the Johns Hopkins Center for Alternatives to Animal Testing (2011-08, 2012-17); and the Sumitomo Foundation (113498).	Force T, 2007, NAT REV CANCER, V7, P332, DOI 10.1038/nrc2106; Hasinoff BB, 2010, CARDIOVASC TOXICOL, V10, P1, DOI 10.1007/s12012-009-9056-0; Orphanos GS, 2009, ACTA ONCOL, V48, P964, DOI 10.1080/02841860903229124; Ogrunc M, 2014, CELL DEATH DIFFER, V21, P998, DOI 10.1038/cdd.2014.16; Kawakami K, 2004, DEV CELL, V7, P133, DOI 10.1016/j.devcel.2004.06.005; Miyahara K, 2014, WORLD J GASTROENTERO, V20, P4151, DOI 10.3748/wjg.v20.i15.4151; Burns CG, 2006, BIOTECHNIQUES, V40, P274, DOI 10.2141/000112135; Llovet JM, 2008, NEW ENGL J MED, V359, P378, DOI 10.1056/NEJMoa0708857; Roux PP, 2004, MICROBIOL MOL BIOL R, V68, P320, DOI 10.1128/MMBR.68.2.320-344.2004; Seguchi O, 2007, J CLIN INVEST, V117, P2812, DOI 10.1172/JCI30804; Berthiaume JM, 2007, CELL BIOL TOXICOL, V23, P15, DOI 10.1007/s10565-006-0140-y; Cheng AL, 2009, LANCET ONCOL, V10, P25, DOI 10.1016/S1470-2045(08)70285-7; Fumarola C, 2013, BREAST CANCER RES TR, V141, P67, DOI 10.1007/s10549-013-2668-x; Adao R, 2013, REV PORT CARDIOL, V32, P395, DOI 10.1016/j.repc.2012.11.002; Nguyen A, 2009, ONCOGENE, V28, P1982, DOI 10.1038/onc.2009.65; Coriat R, 2012, MOL CANCER THER, V11, P2284, DOI 10.1158/1535-7163.MCT-12-0093; Holmes DIR, 2008, CELL SIGNAL, V20, P569, DOI 10.1016/j.cellsig.2007.11.009; Mellor HR, 2011, TOXICOL SCI, V120, P14, DOI 10.1093/toxsci/kfq378; Schmidinger M, 2008, J CLIN ONCOL, V26, P5204, DOI 10.1200/JCO.2007.15.6331; Tolcher AW, 2011, CANCER CHEMOTH PHARM, V67, P751, DOI 10.1007/s00280-010-1372-3; Yeung BHY, 2012, MOL CELL ENDOCRINOL, V349, P272, DOI 10.1016/j.mce.2011.11.007; Lister JA, 1999, DEVELOPMENT, V126, P3757; Chiou JF, 2009, CANCER BIOL THER, V8, P1904; Bruix J, 2011, HEPATOLOGY, V53, P1020, DOI 10.1002/hep.24199; Llovet JM, 2008, J NATL CANCER I, V100, P698, DOI 10.1093/jnci/djn134; Force T, 2011, NAT REV DRUG DISCOV, V10, P111, DOI 10.1038/nrd3252; Cheng H, 2011, CIRC RES, V109, P1401, DOI 10.1161/CIRCRESAHA.111.255695; Collins TJ, 2007, BIOTECHNIQUES, V43, P25; Di Salvo G, 2011, CLIN CARDIOL, V34, P500, DOI 10.1002/clc.20933; Feng XJ, 2013, SCI REP-UK, V3, DOI 10.1038/srep01814; Guo FJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0053989; Ishibashi K, 2002, AM J PHYSIOL-RENAL, V282, pF367; Jacob E, 2002, AM J PHYSIOL-REG I, V283, pR911, DOI 10.1152/ajpregu.00673.2001; Jiang WQ, 2000, J ENDOCRINOL, V165, P457, DOI 10.1677/joe.0.1650457; Koizumi K, 2007, CIRC J, V71, P796, DOI 10.1253/circj.71.796; Lal H, 2013, J AM COLL CARDIOL, V61, P267, DOI 10.1016/j.jacc.2012.05.066; Liu DJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036994; Strumberg D, 2007, ONCOLOGIST, V12, P426, DOI 10.1634/theoncologist.12-4-426; Umemoto N, 2013, MOL BIOTECHNOL, V55, P131, DOI 10.1007/s12033-013-9664-6; Westerfield M., 2007, ZEBRAFISH BOOK GUIDE	40	0	0	OXFORD UNIV PRESS	OXFORD	GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND	1096-6080	1096-0929		TOXICOL SCI	Toxicol. Sci.	FEB	2015	143	2					374	384		10.1093/toxsci/kfu235		11	Toxicology	Toxicology	CC1LK	WOS:000350102000013		
J	Yamaji, T; Hanada, K				Yamaji, Toshiyuki; Hanada, Kentaro			Sphingolipid Metabolism and Interorganellar Transport: Localization of Sphingolipid Enzymes and Lipid Transfer Proteins	TRAFFIC			English	Review						CERT; glycolipid; lipid transfer protein; membrane contact site; metabolism; sphingolipid	OXYSTEROL-BINDING PROTEIN; PLECKSTRIN HOMOLOGY DOMAIN; HAMSTER OVARY CELLS; GALACTOSE-CERAMIDE GALACTOSYLTRANSFERASE; MAMMALIAN SERINE-PALMITOYLTRANSFERASE; 4-PHOSPHATE ADAPTER PROTEIN-2; GLYCOLIPID TRANSFER PROTEIN; INTEGRAL MEMBRANE-PROTEIN; GOLGI-APPARATUS REQUIRES; ENDOPLASMIC-RETICULUM	In recent decades, many sphingolipid enzymes, sphingolipid-metabolism regulators and sphingolipid transfer proteins have been isolated and characterized. This review will provide an overview of the intracellular localization and topology of sphingolipid enzymes in mammalian cells to highlight the locations where respective sphingolipid species are produced. Interestingly, three sphingolipids that reside or are synthesized in cytosolic leaflets of membranes (ceramide, glucosylceramide and ceramide-1-phosphate) all have cytosolic lipid transfer proteins (LTPs). These LTPs consist of ceramide transfer protein (CERT), four-phosphate adaptor protein 2 (FAPP2) and ceramide-1-phosphate transfer protein (CPTP), respectively. These LTPs execute functions that affect both the location and metabolism of the lipids they bind. Molecular details describing the mechanisms of regulation of LTPs continue to emerge and reveal a number of critical processes, including competing phosphorylation and dephosphorylation reactions and binding interactions with regulatory proteins and lipids that influence the transport, organelle distribution and metabolism of sphingolipids.	[Yamaji, Toshiyuki; Hanada, Kentaro] Natl Inst Infect Dis, Dept Biochem & Cell Biol, Shinjuku Ku, Tokyo 1628640, Japan	Yamaji, T (reprint author), Natl Inst Infect Dis, Dept Biochem & Cell Biol, Shinjuku Ku, 1-23-1 Toyama, Tokyo 1628640, Japan.	tyamaji@nih.go.jp			Japan Society for the Promotion of Science [26440069, 25670045]; Takeda Science Foundation	This work was supported by the Japan Society for the Promotion of Science [Grant-in-Aid for Scientific Research (C), No. 26440069 to T. Y. and Grant-in-Aid for Challenging Exploratory Research, No. 25670045 to K. H.] and also by Takeda Science Foundation (to K. H.).	Adachi-Yamada T, 1999, MOL CELL BIOL, V19, P7276; Amarilio R, 2005, J BIOL CHEM, V280, P5934, DOI 10.1074/jbc.M409566200; Lundmark R, 2008, CURR BIOL, V18, P1802, DOI 10.1016/j.cub.2008.10.044; Riebeling C, 2003, J BIOL CHEM, V278, P43452, DOI 10.1074/jbc.M307104200; Beeler T, 1998, J BIOL CHEM, V273, P30688, DOI 10.1074/jbc.273.46.30688; HACKSTADT T, 1995, P NATL ACAD SCI USA, V92, P4877, DOI 10.1073/pnas.92.11.4877; Pettus BJ, 2003, J BIOL CHEM, V278, P38206, DOI 10.1074/jbc.M304816200; El-Sayed A, 2013, MOL THER, V21, P1118, DOI 10.1038/mt.2013.54; Godi A, 2004, NAT CELL BIOL, V6, P393, DOI 10.1038/ncb1119; Michel C, 1997, FEBS LETT, V416, P153, DOI 10.1016/S0014-5793(97)01187-3; Reiss S, 2011, CELL HOST MICROBE, V9, P32, DOI 10.1016/j.chom.2010.12.002; Peretti D, 2008, MOL BIOL CELL, V19, P3871, DOI 10.1091/mbc.E08-05-0498; Pusapati GV, 2010, MOL BIOL CELL, V21, P1011, DOI 10.1091/mbc.E09-09-0814; HANADA K, 1992, J BIOL CHEM, V267, P23527; Yamaoka S, 2004, J BIOL CHEM, V279, P18688, DOI 10.1074/jbc.M401205200; Levine T, 2004, TRENDS CELL BIOL, V14, P483, DOI 10.1016/j.tcb.2004.07.017; Yamaji T, 2010, J BIOL CHEM, V285, P35505, DOI 10.1074/jbc.M110.154229; van Ooij C, 2000, CELL MICROBIOL, V2, P627, DOI 10.1046/j.1462-5822.2000.00077.x; Vacaru AM, 2009, J CELL BIOL, V185, P1013, DOI 10.1083/jcb.200903152; Weng LY, 2010, J VIROL, V84, P11761, DOI 10.1128/JVI.00638-10; Hanada K, 2003, NATURE, V426, P803, DOI 10.1038/nature02188; Simons K, 1997, NATURE, V387, P569, DOI 10.1038/42408; Cao XW, 2009, P NATL ACAD SCI USA, V106, P21121, DOI 10.1073/pnas.0911789106; Perry RJ, 2006, MOL BIOL CELL, V17, P2604, DOI 10.1091/mbc.E06-01-0060; Kumagai K, 2005, J BIOL CHEM, V280, P6488, DOI 10.1074/jbc.M409290200; Lev S, 2010, NAT REV MOL CELL BIO, V11, P739, DOI 10.1038/nrm2971; Delacour D, 2005, J CELL BIOL, V169, P491, DOI 10.1083/jcb.200407073; Cheong FY, 2010, TRAFFIC, V11, P1180, DOI 10.1111/j.1600-0854.2010.01092.x; Han G, 2009, P NATL ACAD SCI USA, V106, P8186, DOI 10.1073/pnas.0811269106; Loizides-Mangold U, 2012, J LIPID RES, V53, P1522, DOI 10.1194/jlr.M025692; Hausser A, 2005, NAT CELL BIOL, V7, P880, DOI 10.1038/ncb1289; He J, 2011, J BIOL CHEM, V286, P18650, DOI 10.1074/jbc.M111.233015; Fukasawa M, 1999, J CELL BIOL, V144, P673, DOI 10.1083/jcb.144.4.673; Dereeper A, 2008, NUCLEIC ACIDS RES, V36, pW465, DOI 10.1093/nar/gkn180; Holthuis JCM, 2014, NATURE, V510, P48, DOI 10.1038/nature13474; Maeda K, 2013, NATURE, V501, P257, DOI 10.1038/nature12430; Mizutani Y, 2006, BIOCHEM J, V398, P531, DOI 10.1042/BJ20060379; Ladinsky MS, 1999, J CELL BIOL, V144, P1135, DOI 10.1083/jcb.144.6.1135; Maceyka M, 2014, NATURE, V510, P58, DOI 10.1038/nature13475; Michel C, 1997, J BIOL CHEM, V272, P22432, DOI 10.1074/jbc.272.36.22432; De Matteis MA, 2005, BBA-MOL CELL RES, V1744, P396, DOI 10.1016/j.bbamcr.2005.04.013; Alpy F, 2005, J CELL SCI, V118, P2791, DOI 10.1242/jcs.02485; Mishra R, 2010, P NATL ACAD SCI USA, V107, P17633, DOI 10.1073/pnas.1012424107; Levine TP, 2002, CURR BIOL, V12, P695, DOI 10.1016/S0960-9822(02)00779-0; Boath A, 2008, J BIOL CHEM, V283, P8517, DOI 10.1074/jbc.M707107200; Beauchamp E, 2007, BIOCHIMIE, V89, P1553, DOI 10.1016/j.biochi.2007.07.001; Lingwood D, 2010, SCIENCE, V327, P46, DOI 10.1126/science.1174621; Funato K, 2001, J CELL BIOL, V155, P949, DOI 10.1083/jcb.200105033; Pruett ST, 2008, J LIPID RES, V49, P1621, DOI 10.1194/jlr.R800012-JLR200; SCHUCHMAN EH, 1991, J BIOL CHEM, V266, P8531; Carre A, 2004, BIOCHEM BIOPH RES CO, V324, P1215, DOI 10.1016/j.bbrc.2004.09.181; Aizaki H, 2008, J VIROL, V82, P5715, DOI 10.1128/JVI.02530-07; Cadena DL, 1997, BIOCHEMISTRY-US, V36, P6960, DOI 10.1021/bi970091l; Korschen HG, 2013, J BIOL CHEM, V288, P3381, DOI 10.1074/jbc.M112.414714; Weixel KM, 2005, J BIOL CHEM, V280, P10501, DOI 10.1074/jbc.M414304200; Omae F, 2004, BIOCHEM J, V379, P687, DOI 10.1042/BJ20031425; Kojima Y, 2000, J BIOL CHEM, V275, P15152, DOI 10.1074/jbc.M909620199; Tafesse FG, 2007, J BIOL CHEM, V282, P17537, DOI 10.1074/jbc.M702423200; Siow DL, 2012, J BIOL CHEM, V287, P40198, DOI 10.1074/jbc.C112.404012; Levy M, 2010, IUBMB LIFE, V62, P347, DOI 10.1002/iub.319; Liu YZ, 2014, STRUCTURE, V22, P421, DOI 10.1016/j.str.2013.12.011; FUTERMAN AH, 1990, J BIOL CHEM, V265, P8650; Mesmin B, 2013, CELL, V155, P830, DOI 10.1016/j.cell.2013.09.056; Kim TJ, 2006, BIOCHEM BIOPH RES CO, V342, P611, DOI 10.1016/j.bbrc.2006.01.170; SIMONS K, 1988, BIOCHEMISTRY-US, V27, P6197, DOI 10.1021/bi00417a001; vanHelvoort A, 1996, CELL, V87, P507, DOI 10.1016/S0092-8674(00)81370-7; Godi A, 1999, NAT CELL BIOL, V1, P280; Laviad EL, 2008, J BIOL CHEM, V283, P5677, DOI 10.1074/jbc.M707386200; Toth B, 2006, J BIOL CHEM, V281, P36369, DOI 10.1074/jbc.M604935200; Hanada K, 2000, J BIOL CHEM, V275, P8409, DOI 10.1074/jbc.275.12.8409; Kawano M, 2006, J BIOL CHEM, V281, P30279, DOI 10.1074/jbc.M605032200; Kihara A, 2004, J BIOL CHEM, V279, P49243, DOI 10.1074/jbc.M405915200; Chalat M, 2012, J BIOL CHEM, V287, P15523, DOI 10.1074/jbc.M112.343038; Mizutani Y, 2005, BIOCHEM J, V390, P263, DOI 10.1042/BJ20050291; Romer W, 2007, NATURE, V450, P670, DOI 10.1038/nature05996; Venkataraman K, 2002, J BIOL CHEM, V277, P35642, DOI 10.1074/jbc.M205211200; Ishii A, 1998, J BIOL CHEM, V273, P31652, DOI 10.1074/jbc.273.48.31652; MANDON EC, 1992, J BIOL CHEM, V267, P11144; Balla A, 2006, TRENDS CELL BIOL, V16, P351, DOI 10.1016/j.tcb.2006.05.003; Shaner RL, 2009, J LIPID RES, V50, P1692, DOI 10.1194/jlr.D800051-JLR200; SCHULTE S, 1993, P NATL ACAD SCI USA, V90, P10265, DOI 10.1073/pnas.90.21.10265; Wyles JP, 2002, J BIOL CHEM, V277, P29908, DOI 10.1074/jbc.M201191200; Spessott W, 2010, J BIOL CHEM, V285, P41472, DOI 10.1074/jbc.M110.150011; Loewen CJR, 2003, EMBO J, V22, P2025, DOI 10.1093/emboj/cdg201; Giussani P, 2008, BBA-MOL CELL BIOL L, V1781, P40, DOI 10.1016/j.bbalip.2007.11.002; Banerji S, 2010, MOL BIOL CELL, V21, P4141, DOI 10.1091/mbc.E10-05-0424; Taniguchi M, 2014, BBA-MOL CELL BIOL L, V1841, P692, DOI 10.1016/j.bbalip.2013.12.003; Khan I, 2014, J VIROL, V88, P12276, DOI 10.1128/JVI.00970-14; JECKEL D, 1992, J CELL BIOL, V117, P259, DOI 10.1083/jcb.117.2.259; Ewers H, 2010, NAT CELL BIOL, V12, P11, DOI 10.1038/ncb1999; Hayashi Y, 2007, J BIOL CHEM, V282, P30889, DOI 10.1074/jbc.M700832200; Tomishige N, 2009, MOL BIOL CELL, V20, P348, DOI 10.1091/mbc.E08-07-0669; Kim S, 2013, EMBO REP, V14, P891, DOI 10.1038/embor.2013.113; Fugmann T, 2007, J CELL BIOL, V178, P15, DOI 10.1083/jcb.200612017; HIRSCHBERG K, 1993, BIOCHEM J, V290, P751; Ternes P, 2002, J BIOL CHEM, V277, P25512, DOI 10.1074/jbc.M202947200; Sakamoto H, 2005, NAT CHEM BIOL, V1, P333, DOI 10.1038/nchembio742; Tokuda N, 2013, GLYCOBIOLOGY, V23, P1175, DOI 10.1093/glycob/cwt054; Pettus BJ, 2004, J BIOL CHEM, V279, P11320, DOI 10.1074/jbc.M309262200; Park JW, 2014, BBA-MOL CELL BIOL L, V1841, P671, DOI 10.1016/j.bbalip.2013.08.019; Ichikawa S, 1996, P NATL ACAD SCI USA, V93, P4638, DOI 10.1073/pnas.93.10.4638; Nomura T, 1998, J BIOL CHEM, V273, P13570, DOI 10.1074/jbc.273.22.13570; Di Sano F, 2003, CANCER RES, V63, P3860; Kondo Y, 2013, P NATL ACAD SCI USA, V110, P4714, DOI 10.1073/pnas.1218508110; Surma MA, 2012, BBA-MOL CELL BIOL L, V1821, P1059, DOI 10.1016/j.bbalip.2011.12.008; Enomoto A, 2006, BIOCHEM J, V397, P289, DOI 10.1042/BJ20051938; NAGIEC MM, 1994, P NATL ACAD SCI USA, V91, P7899, DOI 10.1073/pnas.91.17.7899; Pewzner-Jung Y, 2006, J BIOL CHEM, V281, P25001, DOI 10.1074/jbc.R600010200; Hansen CG, 2009, J CELL SCI, V122, P1713, DOI 10.1242/jcs.033951; Milhas D, 2010, FEBS LETT, V584, P1887, DOI 10.1016/j.febslet.2009.10.058; Simanshu DK, 2013, NATURE, V500, P463, DOI 10.1038/nature12332; Takematsu H, 2011, J BIOL CHEM, V286, P27214, DOI 10.1074/jbc.M111.234526; Scidmore MA, 1996, J CELL BIOL, V134, P363, DOI 10.1083/jcb.134.2.363; MERRILL AH, 1983, BIOCHIM BIOPHYS ACTA, V754, P284, DOI 10.1016/0005-2760(83)90144-3; Eckford PDW, 2005, BIOCHEM J, V389, P517; BAJJALIEH SM, 1989, J BIOL CHEM, V264, P14354; BECKERS CJM, 1989, J CELL BIOL, V108, P1245, DOI 10.1083/jcb.108.4.1245; BOUDKER O, 1993, J BIOL CHEM, V268, P22150; BRUNING A, 1992, J BIOL CHEM, V267, P5052; Buton X, 2002, BIOCHEMISTRY-US, V41, P13106, DOI 10.1021/bi020385t; D'Angelo G, 2007, NATURE, V449, P62, DOI 10.1038/nature06097; Daniotti JL, 2011, IUBMB LIFE, V63, P513, DOI 10.1002/iub.477; D'Angelo G, 2013, NATURE, V501, DOI 10.1038/nature12423; De Rosa MF, 2004, J BIOL CHEM, V279, P7867, DOI 10.1074/jbc.M305645200; Derre I, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002092; Elwell CA, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002198; ERICKSON AH, 1985, J BIOL CHEM, V260, P4319; Ewers H, 2011, CSH PERSPECT BIOL, V3, DOI 10.1101/cshperspect.a004721; Fujita M, 2011, J CELL BIOL, V194, P61, DOI 10.1083/jcb.201012074; Funakoshi T, 2000, J BIOL CHEM, V275, P29938, DOI 10.1074/jbc.M004470200; Furukawa K, 2004, SEMIN CELL DEV BIOL, V15, P389, DOI 10.1016/j.semedb.2004.03.006; Giraudo CG, 1999, BIOCHEM J, V342, P633, DOI 10.1042/0264-6021:3420633; Halter D, 2007, J CELL BIOL, V179, P101, DOI 10.1083/jcb.200704091; Hanada K, 1998, J BIOL CHEM, V273, P33787, DOI 10.1074/jbc.273.50.33787; Hanada K, 2014, BBA-MOL CELL BIOL L, V1841, P704, DOI 10.1016/j.bbalip.2013.06.006; Hanada K, 1997, J BIOL CHEM, V272, P32108, DOI 10.1074/jbc.272.51.32108; Henion TR, 2001, J BIOL CHEM, V276, P30261, DOI 10.1074/jbc.M102979200; Hidari J K, 1994, Biochem J, V303 ( Pt 3), P957; Hornemann T, 2006, J BIOL CHEM, V281, P37275, DOI 10.1074/jbc.M608066200; Huitema K, 2004, EMBO J, V23, P33, DOI 10.1038/sj.emboj.7600034; Inokuchi J, 2011, P JPN ACAD B-PHYS, V87, P179, DOI 10.2183/pjab.87.179; Jiang XC, 2013, METHODS MOL BIOL, V1027, P253, DOI 10.1007/978-1-60327-369-5_12; KALLEN KJ, 1993, BIOCHEM J, V289, P307; Kamlekar RK, 2013, BBA-MOL CELL BIOL L, V1831, P417, DOI 10.1016/j.bbalip.2012.10.010; Karliner JS, 2013, BBA-MOL CELL BIOL L, V1831, P203, DOI 10.1016/j.bbalip.2012.06.006; Kjellberg MA, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0097263; Kohyama-Koganeya A, 2004, J BIOL CHEM, V279, P35995, DOI 10.1074/jbc.M400444200; Kudo N, 2008, P NATL ACAD SCI USA, V105, P488, DOI 10.1073/pnas.0709191105; Kudo N, 2010, J MOL BIOL, V396, P245, DOI 10.1016/j.jmb.2009.12.029; Kumagai K, 2014, J BIOL CHEM, V289, P10748, DOI 10.1074/jbc.M113.528380; Kumagai K, 2007, J BIOL CHEM, V282, P17758, DOI 10.1074/jbc.M702291200; Kumagai T, 2010, GLYCOCONJUGATE J, V27, P685, DOI 10.1007/s10719-010-9313-2; Lakshminarayan Ramya, 2014, Nat Cell Biol, V16, P595, DOI 10.1038/ncb2970; Lamour NF, 2007, J LIPID RES, V48, P1293, DOI 10.1194/jlr.M700083-JLR200; LANNERT H, 1994, FEBS LETT, V342, P91, DOI 10.1016/0014-5793(94)80591-1; Lemmon MA, 2007, BIOCHEM SOC SYMP, V74, P81; Levine TP, 1998, CURR BIOL, V8, P729, DOI 10.1016/S0960-9822(98)70296-9; Li MG, 2003, J BIOL CHEM, V278, P12013, DOI 10.1074/jbc.M211474200; Lin X, 2000, J BIOL CHEM, V275, P5104, DOI 10.1074/jbc.275.7.5104; Malinina L, 2004, NATURE, V430, P1048, DOI 10.1038/nature02856; MARGGRAF WD, 1981, BIOCHIM BIOPHYS ACTA, V664, P61, DOI 10.1016/0005-2760(81)90028-X; Marks DL, 2001, J BIOL CHEM, V276, P26492, DOI 10.1074/jbc.M102612200; METZ RJ, 1980, J BIOL CHEM, V255, P4463; Mironov AA, 2004, EUR J CELL BIOL, V83, P263, DOI 10.1078/0171-9335-00377; Mitsutake S, 2007, BIOCHEM BIOPH RES CO, V363, P519, DOI 10.1016/j.bbrc.2007.09.010; NAGATA Y, 1992, J BIOL CHEM, V267, P12082; Ngo MH, 2010, BIOCHEM J, V429, P13, DOI 10.1042/BJ20100263; Nishie T, 2010, GLYCOBIOLOGY, V20, P1311, DOI 10.1093/glycob/cwq098; PINTO WJ, 1992, J BACTERIOL, V174, P2575; Rao RP, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0092142; Rojas-Rivera D, 2014, ONCOGENE, DOI [10.1038/onc.2014.6, DOI 10.1038/0NC.2014.6]; Sadeghlar F, 2000, FEBS LETT, V478, P9, DOI 10.1016/S0014-5793(00)01818-4; Saito S, 2008, J BIOL CHEM, V283, P6584, DOI 10.1074/jbc.M707691200; SCHAERENWIEMERS N, 1995, J NEUROCHEM, V65, P2267; SHERWOOD AL, 1992, J BIOL CHEM, V267, P25328; Sprong H, 1998, J BIOL CHEM, V273, P25880, DOI 10.1074/jbc.273.40.25880; Stahelin RV, 2007, J BIOL CHEM, V282, P25737, DOI 10.1074/jbc.M702861200; Sugiki T, 2012, J BIOL CHEM, V287, P33706, DOI 10.1074/jbc.M112.367730; Sugiura M, 2002, J BIOL CHEM, V277, P23294, DOI 10.1074/jbc.M201535200; Tafesse FG, 2014, J CELL SCI, V127, P445, DOI 10.1242/jcs.138933; Tani M, 2007, J BIOL CHEM, V282, P10047, DOI 10.1074/jbc.M611249200; Tettamanti G, 2004, Glycoconj J, V20, P301; Togayachi A, 2001, J BIOL CHEM, V276, P22032, DOI 10.1074/jbc.M011369200; Tomiuk S, 2000, J BIOL CHEM, V275, P5710, DOI 10.1074/jbc.275.8.5710; Uemura S, 2009, MOL BIOL CELL, V20, P3088, DOI 10.1091/mbc.E08-12-1219; van der Bijl P, 1996, BIOCHEM J, V317, P589; Wang X, 2009, J CELL BIOL, V184, P143, DOI 10.1083/jcb.200807176; Weiss B, 1997, EUR J BIOCHEM, V249, P239, DOI 10.1111/j.1432-1033.1997.00239.x; Wijesinghe DS, 2010, J LIPID RES, V51, P641, DOI 10.1194/jlr.D000430; Wirtz KWA, 2006, FEBS LETT, V580, P5436, DOI 10.1016/j.febslet.2006.06.065; Yamaji T, 2008, IUBMB LIFE, V60, P511, DOI 10.1002/iub.83; Yamaji T, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0088124; YAMASHIRO S, 1995, J BIOL CHEM, V270, P6149; Yamashita T, 2005, GENESIS, V43, P175, DOI 10.1002/gene.20167; Yasuda S, 2003, J BIOL CHEM, V278, P4176, DOI 10.1074/jbc.M209602200; Yasuda S, 2001, J BIOL CHEM, V276, P43994, DOI 10.1074/jbc.M104884200	196	5	5	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1398-9219	1600-0854		TRAFFIC	Traffic	FEB	2015	16	2					101	122		10.1111/tra.12239		22	Cell Biology	Cell Biology	CC1XO	WOS:000350138900001		
J	Greger, K				Greger, Konstantin			Spatio-Temporal Building Population Estimation for Highly Urbanized Areas Using GIS	TRANSACTIONS IN GIS			English	Article							SYSTEM; MODELS; RISK	Detailed population information is crucial for the micro-scale modeling and analysis of human behavior in urban areas. Since it is not available on the basis of individual persons, it has become necessary to derive data from aggregated census data. A variety of approaches have been published in the past, yet they are not entirely suitable for use in the micro-scale context of highly urbanized areas, due mainly to their broad spatial scale and missing temporal scale. Here we introduce an enhanced approach for the spatio-temporal estimation of building populations in highly urbanized areas. It builds upon other estimation methodologies, but extends them by introducing multiple usage categories and the temporal dimension. This allows for a more realistic representation of human activities in highly urbanized areas and the fact that populations change over time as a result of these activities. The model makes use of a variety of micro-scale data sets to operationalize the activities and their spatio-temporal representations. The outcome of the model provides estimated population figures for all buildings at each time step and thereby reveals spatio-temporal behavior patterns. It can be used in a variety of applications concerning the implications of human behavior in urban areas.	Univ Tsukuba, Div Spatial Informat Sci, Tsukuba, Ibaraki 3058572, Japan	Greger, K (reprint author), Univ Tsukuba, Div Spatial Informat Sci, 1-1-1 Tennodai, Tsukuba, Ibaraki 3058572, Japan.	greger@geoenv.tsukuba.ac.jp			Sinfonica Statistical & GIS Research Grant of the Statistical Institute for Consulting and Analysis	This research was partially funded by the 2012 Sinfonica Statistical & GIS Research Grant of the Statistical Institute for Consulting and Analysis. Also, we thank the Center for Spatial Information Science at the University of Tokyo for providing several data sets within the scope of joint research No. 405: People Flow data from 2008 for the Tokyo Metropolitan Area provided by the CSIS People Flow Project Office; Zmap-TOWN II 2008/09 Shape files for the Tokyo Metropolitan Area as well as Telepoint Pack DB February 2011 provided by Zenrin Co., Ltd.; 2010 population census data as well as 2009 business census data and the national census map data provided by the Statistical Institute for Consulting and Analysis (Sinfonica). Lastly, this manuscript has benefited from comments from a number of internal and two anonymous external reviewers whose valuable insights and comments we greatly acknowledge.	Lwin K, 2009, T GIS, V13, P401, DOI 10.1111/j.1467-9671.2009.01171.x; Ahola T, 2007, INT J GEOGR INF SCI, V21, P935, DOI 10.1080/13658810701349078; Sutton PC, 2003, PHOTOGRAMM ENG REM S, V69, P545; SCHMITT RC, 1956, J AM I PLANNERS, V22, P83, DOI 10.1080/01944365608979227; Axhausen KW, 2002, TRANSPORTATION, V29, P95, DOI 10.1023/A:1014247822322; Elvidge CD, 1997, PHOTOGRAMM ENG REM S, V63, P727; Bowman JL, 2001, TRANSPORT RES A-POL, V35, P1, DOI 10.1016/S0965-8564(99)00043-9; Jiang S, 2012, DATA MIN KNOWL DISC, V25, P478, DOI 10.1007/s10618-012-0264-z; Bhaduri B., 2007, GEOJOURNAL, V69, P103, DOI DOI 10.1007/S10708-007-9105-9; Dobson JE, 2000, PHOTOGRAMM ENG REM S, V66, P849; Horanont T, 2012, STUDY URBAN MOBILITY; Malczewski J., 1999, GIS MULTICRITERIA DE; Martin D, 2009, P EUR FOR GEOST C HA; Martin D, 1996, INT J GEOGR INF SYST, V10, P973; Mas E, 2013, P 10 INT C URB EARTH; McPherson T N, 2004, ESTIMATING DAYTIME N; Qiu X, 2005, GISCI REMOTE SENS, V42, P80, DOI 10.2747/1548-1603.42.1.80; Sekimoto Y, 2011, IEEE PERVAS COMPUT, V10, P27, DOI 10.1109/MPRV.2011.43; Sutton P, 2001, INT J REMOTE SENS, V22, P3061, DOI 10.1080/01431160010007015; Tobler W, 1997, Int J Popul Geogr, V3, P203, DOI 10.1002/(SICI)1099-1220(199709)3:3<203::AID-IJPG68>3.0.CO;2-C; TOBLER WR, 1979, J AM STAT ASSOC, V74, P519, DOI 10.2307/2286968; Tokyo Metropolitan Area Transportation Planning Council, 2013, PERS STUD; Usui T, 2009, PAPERS P GEOGRAPHIC, V18, P541	23	1	1	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1361-1682	1467-9671		T GIS	Trans. GIS	FEB	2015	19	1					129	150		10.1111/tgis.12086		22	Geography	Geography	CC1XW	WOS:000350139700007		
J	Hagisawa, K; Nishikawa, K; Yanagawa, R; Kinoshita, M; Doi, M; Suzuki, H; Iwaya, K; Saitoh, D; Seki, S; Takeoka, S; Handa, M; Nishida, Y				Hagisawa, Kohsuke; Nishikawa, Kahoko; Yanagawa, Rempei; Kinoshita, Manabu; Doi, Mami; Suzuki, Hidenori; Iwaya, Keiichi; Saitoh, Daizoh; Seki, Shuhji; Takeoka, Shinji; Handa, Makoto; Nishida, Yasuhiro			Treatment with fibrinogen gamma-chain peptide-coated, adenosine 5 '-diphosphate-encapsulated liposomes as an infusible hemostatic agent against active liver bleeding in rabbits with acute thrombocytopenia	TRANSFUSION			English	Article							SYNTHETIC PLATELET SUBSTITUTE; ENCAPSULATED LIPOSOMES; TRAUMA PATIENTS; DODECAPEPTIDE; TRANSFUSION; DIPHOSPHATE; HEMORRHAGE; IMPACT	BackgroundWe evaluated the hemostatic efficacy of H12-(adenosine 5-diphosphate [ADP])-liposomes in the setting of active liver bleeding in rabbits with dilutional thrombocytopenia after massive transfusion. Study Design and MethodsAcute thrombocytopenia (platelet [PLT] count<50x10(9)/L) was induced in rabbits by repeated blood withdrawal and isovolemic transfusion of autologous washed red blood cells. Liver hemorrhage was initiated by a penetrating liver injury. Subsequently, the animals received tamponade treatment for the liver hemorrhage for 5 minutes and were intravenously administered H12-(ADP)-liposomes with PLT-poor plasma (PPP), PLT-rich plasma (PRP), PPP alone, H12-(phosphate-buffered saline [PBS])-liposome/PPP, or H12-(ADP)-liposomes/PPPplusfibrinogen concentrate during the tamponade. ResultsAdministration of H12-(ADP)-liposomes/PPP rescued 60% of the rabbits from the liver hemorrhage; PRP administration rescued 50%. In contrast, rabbits receiving PPP or H12-(PBS)-liposome/PPP achieved only 10 or 17% survival, respectively, for the first 24 hours. H12-(ADP)-liposomes/PPP as well as PRP consistently reduced bleeding volumes and shortened clotting times (CTs) in comparison to PPP administration. Specifically, bleeding volumes in the initial 5 minutes averaged 11mL (H12-(ADP)-liposomes/PPP) and 17mL (PRP) versus 30mL (PPP; p<0.05); CTs averaged 270 and 306 seconds versus 401 seconds (p<0.05). H12-(ADP)-liposomes were observed at the bleeding site with thrombus formation, suggesting an induction of thrombi. Neither macro- nor microthrombi were detected in the lung, kidney, spleen, or liver in rabbits treated with H12-(ADP)-liposomes. Supplementation of fibrinogen to H12-(ADP)-liposomes/PPP did not significantly improve rabbit survival. ConclusionsH12-(ADP)-liposomes might be a safe and effective therapeutic tool during damage control surgery for trauma patients with acute thrombocytopenia and massive bleeding.	[Hagisawa, Kohsuke; Nishida, Yasuhiro] Natl Def Med Coll, Dept Physiol, Tokorozawa, Saitama 3598513, Japan; [Nishikawa, Kahoko] Natl Def Med Coll, Dept Traumatol & Crit Care Med, Tokorozawa, Saitama 3598513, Japan; [Yanagawa, Rempei] Natl Def Med Coll, Dept Def Med, Tokorozawa, Saitama 3598513, Japan; [Kinoshita, Manabu; Seki, Shuhji] Natl Def Med Coll, Dept Immunol & Microbiol, Tokorozawa, Saitama 3598513, Japan; [Iwaya, Keiichi] Natl Def Med Coll, Dept Basic Pathol, Tokorozawa, Saitama 3598513, Japan; [Doi, Mami; Takeoka, Shinji] Waseda Univ, TWIns, Grad Sch Adv Sci & Engn, Dept Life Sci & Med Biosci, Tokyo, Japan; [Suzuki, Hidenori] Nippon Med Sch, Div Morphol & Biomol Res, Grad Sch Med, Tokyo 113, Japan; [Saitoh, Daizoh] Natl Def Med Coll, Res Inst, Div Traumatol, Tokorozawa, Saitama 3598513, Japan; [Handa, Makoto] Keio Univ, Sch Med, Dept Transfus Med & Cell Therapy, Tokyo, Japan	Kinoshita, M (reprint author), Natl Def Med Coll, Dept Immunol & Microbiol, 3-2 Namiki, Tokorozawa, Saitama 3598513, Japan.	manabu@ndmc.ac.jp			Ministry of Health, Labor and Welfare, Japan	This work was supported in part by Health and Labor Sciences Research Grants (Research on Public Essential Drugs and Medical Devices to MK, HS, ST, and MH) from the Ministry of Health, Labor and Welfare, Japan.	American Society of Anesthesiologists Task Force on Perioperative Blood Transfusion and Adjuvant Therapies, 2006, ANESTHESIOLOGY, V105, P198; Nishikawa K, 2012, J THROMB HAEMOST, V10, P2137, DOI 10.1111/j.1538-7836.2012.04889.x; Okamura Y, 2010, J CONTROL RELEASE, V148, P373, DOI 10.1016/j.jconrel.2010.09.013; Holcomb JB, 2010, HEMATOL-AM SOC HEMAT, P465, DOI 10.1182/asheducation-2010.1.465; Lier H, 2011, INTENS CARE MED, V37, P572, DOI 10.1007/s00134-011-2139-y; Jackson SP, 2007, BLOOD, V109, P5087, DOI 10.1182/blood-2007-02-027696; Gonzalez EA, 2007, J TRAUMA, V62, P112, DOI 10.1097/01.ta.0000250497.08101.8b; Okamura Y, 2009, J THROMB HAEMOST, V7, P470, DOI 10.1111/j.1538-7836.2008.03269.x; Perkins JG, 2009, J TRAUMA, V66, pS77, DOI 10.1097/TA.0b013e31819d8936; Miller RD, 2009, ANESTHESIOLOGY, V110, P1412, DOI 10.1097/ALN.0b013e3181a1fd54; Suzuki H, 2011, THROMB RES, V128, P552, DOI 10.1016/j.thromres.2011.07.031; Bolliger D, 2010, ANESTHESIOLOGY, V113, P1205, DOI 10.1097/ALN.0b013e3181f22b5a; Blajchman MA, 1999, NAT MED, V5, P17, DOI 10.1038/4694; Burch JM, 2005, SCHWARTZS PRINCIPLES, P162; Demling RH, 2004, CECIL TXB MED, P642; Macdonald VW, 2010, BLOOD PRODUCTS ADV D; Perkins JG, 2009, J TRAUMA, V66, pS84; Slichter S.J., 2007, ASH ED PROGRAM BOOK, V2007, P172; Takeoka S, 2003, BIOCHEM BIOPH RES CO, V312, P773, DOI 10.1016/j.bbrc.2003.10.184	19	1	1	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0041-1132	1537-2995		TRANSFUSION	Transfusion	FEB	2015	55	2					314	325		10.1111/trf.12829		12	Hematology	Hematology	CB7PX	WOS:000349820900013		
J	Yokomizo, T; Kai, T; Miura, M; Ohto, H				Yokomizo, Tomo; Kai, Takako; Miura, Morikazu; Ohto, Hitoshi			Development of a bifunctional filter for prion protein and leukoreduction of red blood cell components	TRANSFUSION			English	Article							CREUTZFELDT-JAKOB-DISEASE; SPONGIFORM ENCEPHALOPATHY; REDUCTION FILTER; INFECTIVITY; TRANSFUSION; SCRAPIE	BackgroundLeukofiltration of blood components is currently implemented worldwide as a precautionary measure against white blood cell-associated adverse effects and the potential transmission of variant Creutzfeldt-Jakob disease (vCJD). A newly developed bifunctional filter (Sepacell Prima, Asahi Kasei Medical) was assessed for prion removal, leukoreduction (LR), and whether the filter significantly affected red blood cells (RBCs). Study Design and MethodsSepacell Prima's postfiltration effects on RBCs, including hemolysis, complement activation, and RBC chemistry, were compared with those of a conventional LR filter (Sepacell Pure RC). Prion removal was measured by Western blot after spiking RBCs with microsomal fractions derived from scrapie-infected hamster brain homogenate. Serially diluted exogenous prion solutions (0.05mL), with or without filtration, were injected intracerebrally into Golden Syrian hamsters. ResultsLR efficiency of 4.44 log with the Sepacell Prima was comparable to 4.11 log with the conventional LR filter. There were no significant differences between the two filters in hemoglobin loss, hemolysis, complement activation, and RBC biomarkers. In vitro reduction of exogenously spiked prions by the filter exceeded 3 log. The titer, 6.63 (log ID50/mL), of prefiltration infectivity of healthy hamsters was reduced to 2.52 (log ID50/mL) after filtration. The reduction factor was calculated as 4.20 (log ID50). ConclusionWith confirmed removal efficacy for exogenous prion protein, this new bifunctional prion and LR filter should reduce the residual risk of vCJD transmission through blood transfusion without adding complexity to component processing.	[Yokomizo, Tomo; Kai, Takako; Miura, Morikazu] Asahi Kasei Med, Sepacell Dev Planning Dept, Oita, Japan; [Ohto, Hitoshi] Fukushima Med Univ, Sch Med, Dept Blood Transfus & Transplantat Immunol, Fukushima, Japan	Yokomizo, T (reprint author), Asahi Kasei Med Co Ltd, Dev Planning Dept, Sepacell Div, 2111-2 Sato, Oita, Oita 8700396, Japan.	yokomizo.tb@om.asahi-kasei.co.jp			Asahi Kasei Medical Co., Ltd.	TY, TK, and MM are employees of Asahi Kasei Medical Co., Ltd., and HO receives research funds related to the study from Asahi Kasei Medical Co., Ltd.	Akino M, 2001, JPN J TRANSFUS MED, V47, P791; Gregori L, 2004, LANCET, V364, P529, DOI 10.1016/S0140-6736(04)16812-8; Hilton DA, 1998, LANCET, V352, P703, DOI 10.1016/S0140-6736(98)24035-9; Gregori L, 2011, TRANSFUSION, V51, P2596, DOI 10.1111/j.1537-2995.2011.03199.x; Lee DC, 2000, J VIROL METHODS, V84, P77, DOI 10.1016/S0166-0934(99)00135-4; Sowemimo-Coker SO, 2006, VOX SANG, V90, P265, DOI 10.1111/j.1423-0410.2006.00765.x; FRASER H, 1968, J COMP PATHOL, V78, P301, DOI 10.1016/0021-9975(68)90006-6; Murphy CV, 2009, TRANSFUSION MED, V19, P109, DOI 10.1111/j.1365-3148.2009.00918.x; Brown P, 1998, TRANSFUSION, V38, P810, DOI 10.1046/j.1537-2995.1998.38998408999.x; Llewelyn CA, 2004, LANCET, V363, P417, DOI 10.1016/S0140-6736(04)15486-X; Cardone F, 2014, TRANSFUSION, V54, P990, DOI 10.1111/trf.12369; Wiltshire M, 2010, TRANSFUSION, V50, P970, DOI 10.1111/j.1537-2995.2009.02500.x; Peden AH, 2004, LANCET, V364, P527, DOI 10.1016/S0140-6736(04)16811-6; Gill ON, 2013, BMJ-BRIT MED J, V347, DOI 10.1136/bmj.f5675; Lacroux C, 2012, PLOS ONE, V7; Lennette EH, 1964, DIAGNOSTIC PROCEDURE, P48; Yokornizo T, 2008, TRANSFUSION, V48, p86A	17	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0041-1132	1537-2995		TRANSFUSION	Transfusion	FEB	2015	55	2					330	336		10.1111/trf.12839		7	Hematology	Hematology	CB7PX	WOS:000349820900015		
J	Ohkura, T; Minakuchi, M; Sagai, M; Kokuho, T; Konishi, M; Kameyama, K; Takeuchi, K				Ohkura, Takashi; Minakuchi, Moeko; Sagai, Mami; Kokuho, Takehiro; Konishi, Misako; Kameyama, Ken-ichiro; Takeuchi, Kaoru			Infection of the upper respiratory tract of hamsters by the bovine parainfluenza virus type 3 BN-1 strain expressing enhanced green fluorescent protein	VIROLOGY			English	Article						Parainfluenza virus; GFP; Pathogenesis; Reverse genetics; Hamster; Respiratory tract; Ciliated epithelial cell; Bovine respiratory disease complex	PARA-INFLUENZA-3 VIRUS; DISEASE; IMMUNOFLUORESCENT; HEMAGGLUTININ; PATHOGENESIS; TROPISM; CATTLE; CALVES; HPIV3; CELLS	Bovine parainfluenza virus type 3 (BPIV3) is an important pathogen associated with bovine respiratory disease complex (BRDC). We have generated a recombinant BPIV3 expressing enhanced green fluorescent protein (rBPIV3-EGFP) based on the BN-1 strain isolated in Japan. After intranasal infection of hamsters with rBPIV3-EGFP, EGFP fluorescence was detected in the upper respiratory tract including the nasal turbinates, pharynx, larynx, and trachea. In the nasal turbinates, rBPIV3-EGFP attained high titers (> 10(6) TCID50/g of tissue) 2-4 days after infection. Ciliated epithelial cells in the nasal turbinates and trachea were infected with rBPIV3-EGFP. Histopathological analysis indicated that mucosa] epithelial cells in bronchi were shed by 6 days after infection, leaving non-ciliated cells, which may have increased susceptibility to bacterial infection leading to the development of BRDC. These data indicate that rBPIV3-EGFP infection of hamsters is a useful small animal model for studying the development of BPIV3-associated BRDC. (C) 2014 Elsevier Inc. All rights reserved.	[Ohkura, Takashi; Minakuchi, Moeko; Sagai, Mami; Takeuchi, Kaoru] Univ Tsukuba, Fac Med, Lab Environm Microbiol, Tsukuba, Ibaraki, Japan; [Kokuho, Takehiro] Natl Inst Anim Hlth, Ctr Anim Dis Control & Prevent, Tsukuba, Ibaraki 305, Japan; [Konishi, Misako; Kameyama, Ken-ichiro] Natl Inst Anim Hlth, Viral Dis & Epidemiol Res Div, Tsukuba, Ibaraki 305, Japan	Takeuchi, K (reprint author), Univ Tsukuba, Fac Med, Lab Environm Microbiol, Tsukuba, Ibaraki, Japan.	ktakeuch@md.tsukuba.ac.jp			Ministry of Agriculture, Forestry and Fisheries of japan [AGD26073]	This work was supported by a Grant-in-Aid (No. AGD26073) from the Ministry of Agriculture, Forestry and Fisheries of japan.	Amonsen M, 2007, J VIROL, V81, P8341, DOI 10.1128/JVI.00718-07; Griffin D, 2010, VET CLIN N AM-FOOD A, V26, P381, DOI 10.1016/j.cvfa.2010.04.004; Autio T, 2007, VET MICROBIOL, V119, P256, DOI 10.1016/j.vetmic.2006.10.001; Schmidt AC, 2001, J VIROL, V75, P4594, DOI 10.1128/JVI.75.10.4594-4603.2001; Zhang LQ, 2005, J VIROL, V79, P1113, DOI 10.1128/JVI.79.2.1113-1124.2005; von Messling V, 2004, P NATL ACAD SCI USA, V101, P14216, DOI 10.1073/pnas.0403597101; Ackermann MR, 2000, MICROBES INFECT, V2, P1079, DOI 10.1016/S1286-4579(00)01262-4; Snowder GD, 2007, J ANIM SCI, V85, P1885, DOI 10.2527/jas.2007-0008; Bose S, 2002, VIROLOGY, V298, P73, DOI 10.1006/viro.2002.1484; de Swart RL, 2007, PLOS PATHOG, V3, P1771, DOI 10.1371/journal.ppat.0030178; Fukushima K, 2014, VIROLOGY, V464, P424, DOI 10.1016/j.virol.2014.07.033; Haller AA, 2000, J VIROL, V74, P11626, DOI 10.1128/JVI.74.24.11626-11635.2000; INABA Y, 1963, JPN J EXP MED, V33, P313; Karron RA, 2013, FIELDS VIROLOGY, V1, P996; Ohkura T, 2013, GENOME ANNOUNC, V1, DOI 10.1128/genomeA.00247-12; Shi HF, 2014, VIRUS RES, V188, P1, DOI 10.1016/j.virusres.2014.03.017; Suzuki T, 2001, J VIROL, V75, P4604, DOI 10.1128/JVI.75.10.4604-4613.2001; Takeuchi K, 2012, J VIROL, V86, P3027, DOI 10.1128/JVI.06517-11; TSAI KS, 1975, INFECT IMMUN, V11, P783; VANDERMA.MJ, 1969, CAN J COMPARAT MED, V33, P141; VANDERMA.MJ, 1969, CAN J COMPARAT MED, V33, P134; WYATT LS, 1995, VIROLOGY, V210, P202, DOI 10.1006/viro.1995.1332	22	0	0	ACADEMIC PRESS INC ELSEVIER SCIENCE	SAN DIEGO	525 B ST, STE 1900, SAN DIEGO, CA 92101-4495 USA	0042-6822			VIROLOGY	Virology	FEB	2015	476						134	140		10.1016/j.virol.2014.12.015		7	Virology	Virology	CB8MF	WOS:000349883000016		
J	Kumakura, M; Kawaguchi, A; Nagata, K				Kumakura, Michiko; Kawaguchi, Atsushi; Nagata, Kyosuke			Actin-myosin network is required for proper assembly of influenza virus particles	VIROLOGY			English	Article						Blebbistatin; Influenza virus assembly; Non-muscle myosin II	NUCLEAR EXPORT; A VIRUS; PROXIMITY LIGATION; PLASMA-MEMBRANE; MATRIX PROTEIN; M1 PROTEIN; M2 PROTEIN; IN-SITU; CYTOSKELETON; GENOME	Actin filaments are known to play a central role in cellular dynamics. After polymerization of actin, various actin-crosslinking proteins including non-muscle myosin II facilitate the formation of spatially organized actin filament networks. The actin-myosin network is highly expanded beneath plasma membrane. The genome of influenza virus (vRNA) replicates in the cell nucleus. Then, newly synthesized vRNAs are nuclear-exported to the cytoplasm as ribonucleoprotein complexes (vRNPs), followed by transport to the beneath plasma membrane where virus particles assemble. Here, we found that, by inhibiting actin-myosin network formation, the virus titer tends to be reduced and HA viral spike protein is aggregated on the plasma membrane. These results indicate that the actin-myosin network plays an important role in the virus formation. (C) 2014 Elsevier Inc. All rights reserved.	[Kumakura, Michiko; Kawaguchi, Atsushi; Nagata, Kyosuke] Univ Tsukuba, Fac Med, Dept Infect Biol, Tsukuba, Ibaraki 3058575, Japan	Kawaguchi, A (reprint author), Univ Tsukuba, Fac Med, Dept Infect Biol, 1-1-1 Tennodai, Tsukuba, Ibaraki 3058575, Japan.	ats-kawaguchi@md.tsukuba.ac.jp; knagata@md.tsukuba.ac.jp			Ministry of Education, Culture, Sports, Science, and Technology of Japan [26860299, 24115002]	We thank N. Takizawa (Institute of Microbial Chemistry) for helpful discussion, and F. Momose (Kitasato University) for generous gifts of mouse anti-NP monoclonal antibody, and T. Hongu and Y. Kanaho (University of Tsukuba) for generous gifts of mouse anti-beta 1 integrin antibody (T. Hongu and Y. Kanaho). We also thank M. Hirose and I. Hyodo (University of Tsukuba) for their help with CalcuSyn analysis. The research was supported in part by grants-in-aid for Scientific Research (26860299; A.K.) and for Innovative Area "Molecular basis of host cell competency in virus infection" (24115002; K.N.) from the Ministry of Education, Culture, Sports, Science, and Technology of Japan.	Soderberg O, 2006, NAT METHODS, V3, P995, DOI 10.1038/nmeth947; Takizawa N, 2006, MICROBES INFECT, V8, P823, DOI 10.1016/j.micinf.2005.10.005; Eisfeld AJ, 2011, J VIROL, V85, P6117, DOI 10.1128/JVI.00378-11; Bruce EA, 2010, J VIROL, V84, P5848, DOI 10.1128/JVI.00307-10; Berberian K, 2009, J NEUROSCI, V29, P863, DOI 10.1523/JNEUROSCI.2818-08.2009; Vicente-Manzanares M, 2009, NAT REV MOL CELL BIO, V10, P778, DOI 10.1038/nrm2786; Jarvius M, 2007, MOL CELL PROTEOMICS, V6, P1500, DOI 10.1074/mcp.M700166-MCP200; Giannone G, 2007, CELL, V128, P561, DOI 10.1016/j.cell.2006.12.039; Straight AF, 2003, SCIENCE, V299, P1743, DOI 10.1126/science.1081412; Conti MA, 2008, J CELL SCI, V121, P11, DOI 10.1242/jcs.007112; Wu XF, 2002, MOL BIOL CELL, V13, P1735, DOI 10.1091/mbc.01-12-0595; Marjuki H, 2006, J BIOL CHEM, V281, P16707, DOI 10.1074/jbc.M510233200; VERKHOVSKY AB, 1995, J CELL BIOL, V131, P989, DOI 10.1083/jcb.131.4.989; Kenworthy AK, 1998, J CELL BIOL, V142, P69, DOI 10.1083/jcb.142.1.69; Goswami D, 2008, CELL, V135, P1085, DOI 10.1016/j.cell.2008.11.032; Chichili GR, 2009, CELL MOL LIFE SCI, V66, P2319, DOI 10.1007/s00018-009-0022-6; Salles FT, 2009, NAT CELL BIOL, V11, P443, DOI 10.1038/ncb1851; Diz-Munoz A, 2013, TRENDS CELL BIOL, V23, P47, DOI 10.1016/j.tcb.2012.09.006; Jaqaman K, 2011, CELL, V146, P593, DOI 10.1016/j.cell.2011.06.049; Rossman JS, 2010, CELL, V142, P902, DOI 10.1016/j.cell.2010.08.029; AUNIS D, 1988, J EXP BIOL, V139, P253; Gomez-Puertas P, 2000, J VIROL, V74, P11538, DOI 10.1128/JVI.74.24.11538-11547.2000; Kovacs M, 2004, J BIOL CHEM, V279, P35557, DOI 10.1074/jbc.M405319200; Heissler SM, 2013, CELL MOL LIFE SCI, V70, P1, DOI 10.1007/s00018-012-1002-9; Lillemeier BF, 2006, P NATL ACAD SCI USA, V103, P18992, DOI 10.1073/pnas.0609009103; Berg JS, 2001, MOL BIOL CELL, V12, P780; Amorim MJ, 2011, J VIROL, V85, P4143, DOI 10.1128/JVI.02606-10; Elton D, 2001, J VIROL, V75, P408, DOI 10.1128/JVI.75.1.408-419.2001; Mercer J, 2008, SCIENCE, V320, P531, DOI 10.1126/science.1155164; Ali A, 2000, J VIROL, V74, P8709, DOI 10.1128/JVI.74.18.8709-8719.2000; Roberts PC, 1998, P NATL ACAD SCI USA, V95, P5746, DOI 10.1073/pnas.95.10.5746; Elleman CJ, 2004, VIROLOGY, V321, P144, DOI 10.1016/j.virol.2003.12.009; Jolly C, 2007, J VIROL, V81, P5547, DOI 10.1128/JVI.01469-06; Scheiffele P, 1997, EMBO J, V16, P5501, DOI 10.1093/emboj/16.18.5501; Porat-Shliom N, 2013, CELL MOL LIFE SCI, V70, P2099, DOI 10.1007/s00018-012-1156-5; Gudheti MV, 2013, BIOPHYS J, V104, P2182, DOI 10.1016/j.bpj.2013.03.054; O'Neill RE, 1998, EMBO J, V17, P288, DOI 10.1093/emboj/17.1.288; Mishra M, 2013, NAT CELL BIOL, V15, P853, DOI 10.1038/ncb2781; Neumann G, 2000, EMBO J, V19, P6751, DOI 10.1093/emboj/19.24.6751; Lehmann MJ, 2005, J CELL BIOL, V170, P317, DOI 10.1083/jcb.200503059; Takeda M, 2003, P NATL ACAD SCI USA, V100, P14610, DOI 10.1073/pnas.22356210100; Simpson-Holley M, 2002, VIROLOGY, V301, P212, DOI 10.1006/viro.200.1595; Avalos RT, 1997, J VIROL, V71, P2947; Haidari M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021444; Haruki AN, 2011, J INTERF CYTOK RES, V31, P847, DOI 10.1089/jir.2010.0132; Jo S, 2010, MICROBES INFECT, V12, P1079, DOI 10.1016/j.micinf.2010.06.011; Kawaguchi A, 2011, J VIROL, V85, P6197, DOI 10.1128/JVI.00277-11; Kolega J, 2006, MOL BIOL CELL, V17, P4435, DOI 10.1091/mbc.E06-05-0431; Ma K, 2001, VIROLOGY, V282, P215, DOI 10.1006/viro.2001.0833; Momose F, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021123; Momose F, 2007, MICROBES INFECT, V9, P1422, DOI 10.1016/j.micinf.2007.07.007; Papadopulos Andreas, 2013, Front Endocrinol (Lausanne), V4, P153, DOI 10.3389/fendo.2013.00153; Ruigrok R, 2001, INT CONGR SER, V1219, P397, DOI 10.1016/S0531-5131(01)00637-9; Takizawa N, 2010, VIROLOGY, V401, P248, DOI 10.1016/j.virol.2010.02.030; Tang Y, 1999, J VIROL, V73, P10508; Thaa B, 2010, J VIROL, V84, P12445, DOI 10.1128/JVI.01322-10; Veit M, 2011, ADV VIROL, V2011, DOI DOI 10.1155/2011/370606; Vicente-Manzanares M, 2007, J CELL BIOL, V176, P573, DOI 10.1083/jcb.200612043; Watanabe K, 2001, VIRUS RES, V77, P31, DOI 10.1016/S0168-1702(01)00263-5; Xue F., 2010, INT J CELL BIOL, V2010, DOI DOI 10.1155/2010/507821; Zhang J, 2000, VIROLOGY, V269, P325, DOI 10.1006/viro.2000.0228	61	0	0	ACADEMIC PRESS INC ELSEVIER SCIENCE	SAN DIEGO	525 B ST, STE 1900, SAN DIEGO, CA 92101-4495 USA	0042-6822			VIROLOGY	Virology	FEB	2015	476						141	150		10.1016/j.virol.2014.12.016		10	Virology	Virology	CB8MF	WOS:000349883000017		
J	Li, HA; Shirako, Y				Li, Huangai; Shirako, Yukio			Association of VPg and eIF4E in the host tropism at the cellular level of Barley yellow mosaic virus and Wheat yellow mosaic virus in the genus Bymovirus	VIROLOGY			English	Article						Bymovirus; Barley yellow mosaic virus (BaYMV); Wheat yellow mosaic virus (WYMV); Replication; Eukaryotic translation initiation factor 4E (eIF4E); Viral genome-linked protein (VPg); Mesophyll protoplasts	TRANSLATION INITIATION-FACTORS; RECESSIVE RESISTANCE GENE; YEAST 2-HYBRID SYSTEM; POTYVIRUS VPG; FACTORS EIF(ISO)4E; MOLECULAR ANALYSIS; PROTEIN VPG; CI PROTEIN; 4E; REPLICATION	Barley yellow mosaic virus (BaYMV) and Wheat yellow mosaic virus (WYMV) are separate species in the genus Bymovirus with bipartite plus-sense RNA genomes. In fields, BaYMV infects only barley and WYMV infects only wheat. Here, we studied the replicative capability of the two viruses in barley and wheat mesophyll protoplasts. BaYMV replicated in both barley and wheat protoplasts, but WYMV replicated only in wheat protoplasts. The expression of wheat translation initiation factor 4E (eIF4E), a common host factor for potyviruses, from the WYMV genome enabled WYMV replication in barley protoplasts. Replacing the BaYMV VPg gene with that of WYMV abolished BaYMV replication in barley protoplasts, whereas the additional expression of wheat eIF4E from BaYMV genome restored the replication of the BaYMV mutant in barley protoplasts. These results indicate that both VPg and the host eIF4E are involved in the host tropism of BaYMV and WYMV at the replication level. (C) 2014 Elsevier Inc. All rights reserved.	[Li, Huangai; Shirako, Yukio] Univ Tokyo, Grad Sch Agr & Life Sci, Bunkyo Ku, Tokyo 1138657, Japan; [Shirako, Yukio] Univ Tokyo, Asian Nat Environm Sci Ctr, Bunkyo Ku, Tokyo 1138657, Japan	Shirako, Y (reprint author), Univ Tokyo, Asian Nat Environm Sci Ctr, Bunkyo Ku, 1-1-1 Yayoi, Tokyo 1138657, Japan.	yshirako@anesc.u-tokyo.ac.jp			Japanese Government Scholarship Program (MEXT) [111522]; University of Tokyo [3001090101]; Ministry of Agriculture, Forestry and Fisheries, Japan [23039]	H. Li was supported by the Japanese Government Scholarship Program (MEXT) for international graduate students (111522). This work was conducted with a research aid from the University of Tokyo (3001090101) and with a grant from the Ministry of Agriculture, Forestry and Fisheries, Japan (23039).	Adams M., 2012, 9 INT COMM TAX VIR, P1069; Truniger V, 2009, ADV VIRUS RES, V75, P119, DOI 10.1016/S0065-3527(09)07504-6; Robaglia C, 2006, TRENDS PLANT SCI, V11, P40, DOI 10.1016/j.tplants.2005.11.004; Wen RH, 2010, VIROLOGY, V400, P1, DOI 10.1016/j.virol.2010.01.022; Puustinen P, 2004, J BIOL CHEM, V279, P38103, DOI 10.1074/jbc.M402910200; Charron C, 2008, PLANT J, V54, P56, DOI 10.1111/j.1365-313X.2008.03407.x; Li XH, 1997, J VIROL, V71, P1598; Lee JH, 2010, MOL PLANT MICROBE IN, V23, P29, DOI 10.1094/MPMI-23-1-0029; Gao ZH, 2004, PLANT J, V40, P376, DOI 10.1111/j.1365-313X.2004.02215.x; Albar L, 2006, PLANT J, V47, P417, DOI 10.1111/j.1365-313X.2006.02792.x; Kang BC, 2005, ANNU REV PHYTOPATHOL, V43, P581, DOI 10.1146/annurev.phyto.43.011205.141140; Namba S, 1998, ARCH VIROL, V143, P631, DOI 10.1007/s007050050319; Bruun-Rasmussen M, 2007, MOL PLANT MICROBE IN, V20, P1075, DOI 10.1094/MPMI-20-9-1075; Chung BYW, 2008, P NATL ACAD SCI USA, V105, P5897, DOI 10.1073/pnas.0800468105; Abdul-Razzak A, 2009, MOL PLANT PATHOL, V10, P109, DOI 10.1111/j.1364-3703.2008.00513.x; Adams MJ, 2005, MOL PLANT PATHOL, V6, P471, DOI [10.1111/j.1364-3703.2005.00296.x, 10.1111/J.1364-3703.2005.00296.X]; Ruffel S, 2002, PLANT J, V32, P1067, DOI 10.1046/j.1365-313X.2002.01499.x; Carrington JC, 1998, PLANT J, V14, P393, DOI 10.1046/j.1365-313X.1998.00120.x; Monzingo AF, 2007, PLANT PHYSIOL, V143, P1504, DOI 10.1104/pp.106.093146; Roudet-Tavert G, 2007, J GEN VIROL, V88, P1029, DOI 10.1099/vir.0.82501-0; Ala-Poikela M, 2011, J VIROL, V85, P6784, DOI 10.1128/JVI.00485-11; Kanyuka K, 2005, MOL PLANT PATHOL, V6, P449, DOI [10.1111/j.1364-3703.2005.00294.x, 10.1111/J.1364-3703.2005.00294.X]; Chen J, 1999, VIRUS RES, V64, P13, DOI 10.1016/S0168-1702(99)00076-3; Dessens JT, 1996, VIRUS GENES, V12, P95, DOI 10.1007/BF00370006; Dolja V V, 1995, Virology, V206, P1007, DOI 10.1006/viro.1995.1023; Gallois JL, 2010, J GEN VIROL, V91, P288, DOI 10.1099/vir.0.015321-0; Han Chenggui, 2000, Plant Disease, V84, P627, DOI 10.1094/PDIS.2000.84.6.627; Hebrard E, 2008, ARCH VIROL, V153, P1161, DOI 10.1007/s00705-008-0087-9; HUTH W, 1990, INTERVIROLOGY, V31, P38; Ikata S., 1940, STUDIES WHEAT YELLOW, P1; Kanyuka K, 2004, ARCH VIROL, V149, P1469, DOI 10.1007/s00705-004-0318-7; Kusaba T., 1971, SPEC B TOTTORI AGR E, V2, P1; Lee KJ, 2006, VIRUS GENES, V32, P171, DOI 10.1007/s11262-005-6873-5; Leonard S, 2000, J VIROL, V74, P7730, DOI 10.1128/JVI.74.17.7730-7737.2000; Nakahara KS, 2010, MOL PLANT MICROBE IN, V23, P1460, DOI 10.1094/MPMI-11-09-0277; Narayanasamy P., 2008, MOL BIOL PLANT PATHO, P123; Nishigawa H, 2008, ARCH VIROL, V153, P1783, DOI 10.1007/s00705-008-0163-1; Ohki T, 2014, PHYTOPATHOLOGY, V104, P313, DOI 10.1094/PHYTO-06-13-0150-R; Ohsato S, 2003, J GEN VIROL, V84, P995, DOI 10.1099/vir.0.19021-0; Ohto Y., 1999, Proceedings of the Fourth Symposium of the International Working Group on Plant Viruses with Fungal Vectors, Asilomar Conference Centre, Monterey, California, USA, 5-8 October, 1999, P119; RESTREPOHARTWIG MA, 1994, J VIROL, V68, P2388; Sawada E, 1927, J PLANT PROT, V14, P444; Schaad MC, 2000, VIROLOGY, V273, P300, DOI 10.1006/viro.2000.0416; Stein N, 2005, PLANT J, V42, P912, DOI 10.1111/j.1365-313X.2005.02424.x; Sun LY, 2014, MOL PLANT PATHOL, V15, P466, DOI 10.1111/mpp.12109; Vijayapalani P, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002639; Wei TY, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000962; Wittmann S, 1997, VIROLOGY, V234, P84, DOI 10.1006/viro.1997.8634; Yamamiya A, 2000, VIROLOGY, V277, P66, DOI 10.1006/viro.2000.0587; You Y, 2013, PLANT PATHOL, V62, P226, DOI 10.1111/j.1365-3059.2012.02616.x; You Y, 2010, MOL PLANT PATHOL, V11, P383, DOI [10.1111/j.1364-3703.2010.00613.x, 10.1111/J.1364-3703.2010.00613.X]	51	0	0	ACADEMIC PRESS INC ELSEVIER SCIENCE	SAN DIEGO	525 B ST, STE 1900, SAN DIEGO, CA 92101-4495 USA	0042-6822			VIROLOGY	Virology	FEB	2015	476						159	167		10.1016/j.virol.2014.12.010		9	Virology	Virology	CB8MF	WOS:000349883000019		
J	Johannessen, TV; Bratbak, G; Larsen, A; Ogata, H; Egge, ES; Edvardsen, B; Eikrem, W; Sandaa, RA				Johannessen, Torill Vik; Bratbak, Gunnar; Larsen, Aud; Ogata, Hiroyuki; Egge, Elianne S.; Edvardsen, Bente; Eikrem, Wenche; Sandaa, Ruth-Anne			Characterisation of three novel giant viruses reveals huge diversity among viruses infecting Prymnesiales (Haptophyta)	VIROLOGY			English	Article						Marine; Virus; Algae; Phycodnaviridae; Mimiviridae; NCLDV; Prymnesiophyte; Haptophyta; Diversity	18S RDNA SEQUENCES; LARGE DNA VIRUSES; PHYLOGENETIC ANALYSIS; PHAEOCYSTIS-GLOBOSA; POPULATION-DYNAMICS; GEL-ELECTROPHORESIS; MIMIVIRUS RELATIVES; ENGLISH-CHANNEL; VIRAL MORTALITY; FLOW-CYTOMETRY	We have isolated three novel lytic dsDNA-viruses from Raunefjorden (Norway) that are putative members of the Mimiviridae family, namely Haptolina ericina virus RF02 (Hey RF02), Piymnesium kappa virus RF01 (PkV RF01), and Prymnesium kappa virus RF02 (PkV RF02). Each of the novel haptophyte viruses challenges the common conceptions of algal viruses with respect to host range, phylogenetic affiliation and size. PkV RF01 has a capsid of similar to 310 nm and is the largest algal virus particle ever reported while PkV RF01 and HeV RF02 were able to infect different species, even belonging to different genera. Moreover, PkV RF01 and Hey RF02 infected the same hosts, but phylogenetic analysis placed them in different groups. Our results reveal large variation among viruses infecting closely related microalgae, and challenge the common conception that algal viruses have narrow host range, and phylogeny reflecting their host affiliation. (C) 2014 Elsevier Inc. All rights reserved.	[Johannessen, Torill Vik; Bratbak, Gunnar; Sandaa, Ruth-Anne] Univ Bergen, Dept Biol, N-5020 Bergen, Norway; [Larsen, Aud] Uni Res Environm Thormohlensgt, N-5006 Bergen, Norway; [Ogata, Hiroyuki] Kyoto Univ, Inst Chem Res, Uji, Kyoto 6110011, Japan; [Egge, Elianne S.; Edvardsen, Bente; Eikrem, Wenche] Univ Oslo, Dept Biosci, N-0316 Oslo, Norway	Sandaa, RA (reprint author), Univ Bergen, Dept Biol, Postbox 7803, N-5020 Bergen, Norway.	ruth.sandaa@bio.uib.no	Bratbak, Gunnar/N-8786-2015	Bratbak, Gunnar/0000-0001-8388-4945	Research Council of Norway through the Project "HAPTODIV" [190307/S54]; European Research Council through the EU-ERC project "MINOS" [250254]	This work was funded by the Research Council of Norway through the Project 190307/S54 "HAPTODIV" and by the European Research Council through the EU-ERC project no. 250254 "MINOS". We are very grateful to Mikal Heldal, UiB for providing us with TEM pictures of viral particles.	Angly FE, 2006, PLOS BIOL, V4, P2121, DOI 10.1371/journal.pbio.0040368; Anisimova M, 2006, SYST BIOL, V55, P539, DOI 10.1080/10635150600755453; Brussaard CPD, 2004, J EUKARYOT MICROBIOL, V51, P125, DOI 10.1111/j.1550-7408.2004.tb00537.x; ESTEP KW, 1989, MAR ECOL PROG SER, V57, P11, DOI 10.3354/meps057011; Ghedin E, 2005, VIROL J, V2, DOI 10.1186/1743-422X-2-62; Santini S, 2013, P NATL ACAD SCI USA, V110, P10800, DOI 10.1073/pnas.1303251110; Castresana J, 2000, MOL BIOL EVOL, V17, P540; Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404; Moon-van der Staay SY, 2000, LIMNOL OCEANOGR, V45, P98; Hingamp P, 2013, ISME J, V7, P1678, DOI 10.1038/ismej.2013.59; Gjosaeter J, 2000, MAR ECOL PROG SER, V207, P201, DOI 10.3354/meps207201; Brussaard CPD, 2004, APPL ENVIRON MICROB, V70, P1506, DOI 10.1128/AEM.70.3.1506-1513.2004; Edvardsen B, 2011, EUR J PHYCOL, V46, P202, DOI 10.1080/09670262.2011.594095; BRATBAK G, 1993, MAR ECOL PROG SER, V93, P39, DOI 10.3354/meps093039; Larsen A, 2004, LIMNOL OCEANOGR, V49, P180; Claverie JM, 2006, VIRUS RES, V117, P133, DOI 10.1016/j.virusres.2006.01.008; Dereeper A, 2008, NUCLEIC ACIDS RES, V36, pW465, DOI 10.1093/nar/gkn180; MURRAY AG, 1992, MAR ECOL PROG SER, V89, P103, DOI 10.3354/meps089103; Claverie JM, 2010, TRENDS GENET, V26, P431, DOI 10.1016/j.tig.2010.07.003; Iyer LA, 2006, VIRUS RES, V117, P156, DOI 10.1016/j.virusres.2006.01.009; Sandaa RA, 2001, VIROLOGY, V290, P272, DOI 10.1006/viro.2001.1161; Field CB, 1998, SCIENCE, V281, P237, DOI 10.1126/science.281.5374.237; Guindon S, 2010, SYST BIOL, V59, P307, DOI 10.1093/sysbio/syq010; Yoosuf N, 2012, GENOME BIOL EVOL, V4, P1324, DOI 10.1093/gbe/evs109; Baudoux AC, 2005, VIROLOGY, V341, P80, DOI 10.1016/j.virol.2005.07.002; Moon-van der Staay SY, 2001, NATURE, V409, P607, DOI 10.1038/35054541; Moreira D, 2009, NAT REV MICROBIOL, V7, P306, DOI 10.1038/nrmicro2108; Arslan D, 2011, P NATL ACAD SCI USA, V108, P17486, DOI 10.1073/pnas.1110889108; Short SM, 2012, ENVIRON MICROBIOL, V14, P2253, DOI 10.1111/j.1462-2920.2012.02706.x; Jacobsen A, 1996, J PHYCOL, V32, P923, DOI 10.1111/j.0022-3646.1996.00923.x; Claverie JM, 2009, J INVERTEBR PATHOL, V101, P172, DOI 10.1016/j.jip.2009.03.011; Larsen JB, 2008, APPL ENVIRON MICROB, V74, P3048, DOI [10.1128/AEM.02548-07, 10.7128/AEM.02548-07]; Wommack KE, 2000, MICROBIOL MOL BIOL R, V64, P69, DOI 10.1128/MMBR.64.1.69-114.2000; Brussaard CPD, 2005, HARMFUL ALGAE, V4, P859, DOI 10.1016/j.hal.2004.12.015; CHEN F, 1995, APPL ENVIRON MICROB, V61, P1274; Wilson WH, 2009, CURR TOP MICROBIOL, V328, P1; Chevenet F, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-439; Liu H, 2009, P NATL ACAD SCI USA, V106, P12803, DOI 10.1073/pnas.0905841106; Forterre P, 2010, INTERVIROLOGY, V53, P362, DOI 10.1159/000312921; Dahl E, 2005, J SEA RES, V54, P15, DOI 10.1016/j.seares.2005.02.004; Forterre Patrick, 2011, Res Microbiol, V162, P77, DOI 10.1016/j.resmic.2010.10.005; Fischer MG, 2010, P NATL ACAD SCI USA, V107, P19508, DOI 10.1073/pnas.1007615107; Moreau H, 2010, J VIROL, V84, P12555, DOI 10.1128/JVI.01123-10; Marie D, 1999, APPL ENVIRON MICROB, V65, P45; Kristensen DM, 2010, TRENDS MICROBIOL, V18, P11, DOI 10.1016/j.tim.2009.11.003; SUTTLE CA, 1994, APPL ENVIRON MICROB, V60, P3167; SCHWARTZ DC, 1984, CELL, V37, P67, DOI 10.1016/0092-8674(84)90301-5; Colson P, 2012, INTERVIROLOGY, V55, P321, DOI 10.1159/000336562; Raoult D, 2004, SCIENCE, V306, P1344, DOI 10.1126/science.1101485; La Scola B, 2003, SCIENCE, V299, P2033; Clerissi C, 2012, J VIROL, V86, P4611, DOI 10.1128/JVI.07221-11; Boyer M, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015530; Bratbak G., 1993, CURRENT METHODS AQUA, P135; Castberg T, 2002, J PHYCOL, V38, P767, DOI 10.1046/j.1529-8817.2002.02015.x; Chen F, 1996, APPL ENVIRON MICROB, V62, P2869; Colson P, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018935; Dereeper A, 2010, BMC EVOL BIOL, V10, DOI 10.1186/1471-2148-10-8; Edvardsen B., 1998, NATO ASI Series Series G Ecological Sciences, V41, P193; Elias I., 2007, BMC BIOINFORMATICS, V13, P89; Eppley R. W., 1967, J EXP MAR BIOL ECOL, VI, P191, DOI DOI 10.1016/0022-0981(67)90014-7; Felsenstein J., 1989, CLADISTICS, V5, P164, DOI DOI 10.1111/J.1096-0031.1989.TB00562.X; Forterre P, 2009, RES MICROBIOL, V160, P466, DOI 10.1016/j.resmic.2009.07.008; Kapp M, 1998, VIRUS GENES, V16, P111, DOI 10.1023/A:1007962112756; Larsen A, 2001, MAR ECOL PROG SER, V221, P47, DOI 10.3354/meps221047; Leadbeater B.S.C., 1972, Sarsia, VNo. 49, P107; Leblanc K, 2009, BIOGEOSCIENCES, V6, P2155; Monier A, 2008, VIROL J, V5, DOI 10.1186/1743-422X-5-12; Moniruzzaman M., 2014, VIROL; Nagasaki K., 2010, MANUAL AQUATIC VIRAL, P92, DOI 10.4319/mave.2010.978-0-9845591-0-7.92; NAGASAKI K, 1994, J PLANKTON RES, V16, P1595, DOI 10.1093/plankt/16.11.1595; Park Y, 2011, VIRUS RES, V159, P43, DOI 10.1016/j.virusres.2011.04.024; Sandaa RA, 2008, RES MICROBIOL, V159, P374, DOI 10.1016/j.resmic.2008.04.013; Shi XL, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007657; SUTTLE CA, 1995, MAR ECOL PROG SER, V118, P275, DOI 10.3354/meps118275; Thomsen H. A., 1994, HAPTOPHYTE ALGAE, V10, P187; Van Regenmortel MHV, 2010, SYST APPL MICROBIOL, V33, P1, DOI 10.1016/j.syapm.2009.11.001; WIGGINS BA, 1985, APPL ENVIRON MICROB, V49, P19; Williams TA, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021080; Wilson WH, 2006, J MAR BIOL ASSOC UK, V86, P485, DOI 10.1017/S0025315406013385; Wilson WH, 2002, J MAR BIOL ASSOC UK, V82, P369, DOI 10.1017/S002531540200560X; Wommack KE, 1999, APPL ENVIRON MICROB, V65, P231; Yutin N, 2013, VIROL J, V10, DOI 10.1186/1743-422X-10-106	82	3	3	ACADEMIC PRESS INC ELSEVIER SCIENCE	SAN DIEGO	525 B ST, STE 1900, SAN DIEGO, CA 92101-4495 USA	0042-6822			VIROLOGY	Virology	FEB	2015	476						180	188		10.1016/j.virol.2014.12.014		9	Virology	Virology	CB8MF	WOS:000349883000021		
J	Li, CH; Barnes, E; Newton, PN; Fu, YS; Vongsouvath, M; Klenerman, P; Okamoto, H; Abe, K; Pybus, OG; Lu, L				Li, Chunhua; Barnes, Eleanor; Newton, Paul N.; Fu, Yongshui; Vongsouvath, Manivanh; Klenerman, Paul; Okamoto, Hiroaki; Abe, Kenji; Pybus, Oliver G.; Lu, Ling			An expanded taxonomy of hepatitis C virus genotype 6: Characterization of 22 new full-length viral genomes	VIROLOGY			English	Article						HCV; Full-length genome; Genotype 6; Sequence; Laos	VOLUNTEER BLOOD-DONORS; HO-CHI-MINH; HIGH PREVALENCE; RISK-FACTORS; EAST-ASIA; HCV; THAILAND; INFECTION; SEQUENCES; VARIANTS	We characterized the full-length genomes of 22 hepatitis C virus genotype 6 (HCV-6) isolates: 10 from Vietnam (classified into subtypes 6e, 6h, 6p, 6r, 6s, and 6u), one from China (confirmed as a new subtype 6xd), and 11 from the Lao PDR (representing a new subtype 6xe plus eight novel variants). With these 22 new genomes, HCV-6 now has a diverse and extended taxonomic structure, comprised of 28 assigned subtypes (denoted 6a-6xe) and 27 unassigned lineages, all of which have been represented by full-length genomes. Our phylogenetic analyses also included many partially-sequenced novel variants of HCV-6 from Lao PDR. This revealed that Lao HCV isolates are genetically very diverse and are phylogenetically distributed in multiple lineages within genotype 6. Our results suggest that HCV-6 has been maintained in Laos, a landlocked country, since the common ancestor of genotype 6 and indicates historical dispersal of HCV-6 across Southeast Asia. (C) 2014 Elsevier Inc. All rights reserved.	[Li, Chunhua; Lu, Ling] Univ Kansas, Med Ctr, Dept Pathol & Lab Med, Viral Oncol Ctr, Kansas City, KS 66103 USA; [Barnes, Eleanor; Klenerman, Paul] Univ Oxford, Oxford OX1 3SY, England; [Barnes, Eleanor; Klenerman, Paul] Oxford NIHR Biomed Res Ctr, Oxford OX1 3SY, England; [Newton, Paul N.; Vongsouvath, Manivanh] Mahosot Hosp, Microbiol Lab, Lao Oxford Mahosot Hosp Wellcome Trust Res Unit, Viangchan, Laos; [Newton, Paul N.] Univ Oxford, Nuffield Dept Med, Churchill Hosp, Ctr Trop Med & Global Hlth, Oxford OX3 7FZ, England; [Fu, Yongshui] Guangzhou Blood Ctr, Guangzhou 510095, Guangdong, Peoples R China; [Okamoto, Hiroaki] Jichi Med Univ, Sch Med, Dept Infect & Immun, Div Virol, Shimotsuke, Tochigi 3290498, Japan; [Abe, Kenji] Natl Inst Infect Dis, Dept Pathol, Shinjuku Ku, Tokyo 1628640, Japan; [Pybus, Oliver G.] Univ Oxford, Dept Zool, Oxford OX1 3PS, England	Lu, L (reprint author), Univ Kansas, Med Ctr, Dept Pathol & Lab Med, Viral Oncol Ctr, Kansas City, KS 66103 USA.	llu@kumc.edu	Okamoto, Hiroaki/H-4371-2011	Okamoto, Hiroaki/0000-0003-0827-0964	National Institute of Allergy and Infectious Diseases [5 R01 AI080734-03A]; Wellcome Trust of Great Britain; Medical Research Council, UK	The study described was supported by a grant from the National Institute of Allergy and Infectious Diseases (5 R01 AI080734-03A). The funding agencies had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The work of Paul N. Newton and Manivanh Vongsouvath are supported by the Wellcome Trust of Great Britain. EB is funded by the Medical Research Council, UK.	Akkarathamrongsin S, 2011, INTERVIROLOGY, V54, P10, DOI 10.1159/000318884; Noppornpanth S, 2006, J VIROL, V80, P7569, DOI 10.1128/JVI.00312-06; Pybus OG, 2007, INT J PARASITOL, V37, P839, DOI 10.1016/j.ijpara.2007.04.009; Simmonds P, 2005, HEPATOLOGY, V42, P962, DOI 10.1002/hep.20819; Salemi M, 2002, J MOL EVOL, V54, P62, DOI 10.1007/s00239-001-0018-9; Xia GL, 1996, INT HEPATOL COMMUN, V5, P62, DOI 10.1016/S0928-4346(96)82012-3; Pham VH, 2011, JPN J INFECT DIS, V64, P537; Martin DP, 2010, BIOINFORMATICS, V26, P2462, DOI 10.1093/bioinformatics/btq467; Shinji T, 2004, ACTA MED OKAYAMA, V58, P135; Gray RD, 2000, NATURE, V405, P1052, DOI 10.1038/35016575; NAKATA S, 1994, J GASTROEN HEPATOL, V9, P416, DOI 10.1111/j.1440-1746.1994.tb01265.x; Tamura K, 2013, MOL BIOL EVOL, V30, P2725, DOI 10.1093/molbev/mst197; Guindon S, 2003, SYST BIOL, V52, P696, DOI 10.1080/10635150390235520; Lu L, 2014, J VIROL, V88, P7120, DOI 10.1128/JVI.00414-14; An YL, 2014, VIROLOGY, V464, P21, DOI 10.1016/j.virol.2014.06.011; Wang HR, 2013, J GEN VIROL, V94, P76, DOI 10.1099/vir.0.047506-0; TOKITA H, 1994, J GEN VIROL, V75, P931, DOI 10.1099/0022-1317-75-4-931; Apichartpiyakul C, 1999, JPN J INFECT DIS, V52, P121; Baird I. G., 2009, INDIGENOUS WORLD 200, P359; Bernier L, 1996, J CLIN MICROBIOL, V34, P2815; Bodner M, 2011, BMC EVOL BIOL, V11, DOI 10.1186/1471-2148-11-49; Enfield N. J., 2010, J LAO STUDIES, V1, P48; Global surveillance and control of hepatitis C, 1999, J VIRAL HEPATITUS, V6, P35, DOI 10.1046/j.1365-2893.1999.6120139.x; Hall T. A., 1999, NUCL ACIDS S SER, V4, P95, DOI DOI 10.1111/J.1469-8137.2009.02874.X; Hfibschen J. M., 2011, CLIN MICROBIOL INFEC, V17, pE30; Jahan S, 2012, INFECT AGENTS CANCER, V7, DOI 10.1186/1750-9378-7-2; Jutavijittum Prapan, 2007, Southeast Asian Journal of Tropical Medicine and Public Health, V38, P674; Khokhar Nasir, 2004, J Coll Physicians Surg Pak, V14, P534; Kuiken C, 2006, HEPATOLOGY, V44, P1355, DOI 10.1002/hep.21377; KWOK S, 1989, NATURE, V339, P237, DOI 10.1038/339237a0; Li CH, 2014, VIROLOGY, V468, P172, DOI 10.1016/j.virol.2014.08.006; Li DN, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002168; Lu L, 2007, J GEN VIROL, V88, P1519, DOI 10.1099/vir.0.82820-0; Lu L, 2007, J GEN VIROL, V88, P1505, DOI 10.1099/vir.0.82604-0; Lwin AA, 2007, HEPATOL RES, V37, P337, DOI 10.1111/j.1872-034X.2007.00053.x; Mellor J, 1996, J CLIN MICROBIOL, V34, P417; Muhammad Noor, 2005, J Coll Physicians Surg Pak, V15, P11; Nguyen NH, 2010, HEPATOL INT, V4, P523, DOI 10.1007/s12072-010-9181-7; Peng MS, 2011, BMC EVOL BIOL, V11, DOI 10.1186/1471-2148-11-46; Pybus OG, 2009, J VIROL, V83, P1071, DOI 10.1128/JVI.01501-08; SAEED AA, 1991, LANCET, V338, P459, DOI 10.1016/0140-6736(91)91094-B; Smith DB, 2014, HEPATOLOGY, V59, P318, DOI 10.1002/hep.26744; Songsivilai S, 1997, AM J TROP MED HYG, V57, P66; STUYVER L, 1995, VIRUS RES, V38, P137, DOI 10.1016/0168-1702(95)00052-R; Sunanchaikarn S, 2007, ASIAN PAC J ALLERGY, V25, P175; Sy Theodore, 2006, Int J Med Sci, V3, P41; Syhavong B, 2010, T ROY SOC TROP MED H, V104, P475, DOI 10.1016/j.trstmh.2010.03.002; Thaikruea L, 2004, TRANSFUSION, V44, P1433, DOI 10.1111/j.1537-2995.2004.04073.x; Theamboonlers A, 2002, ACTA VIROL, V46, P169; Tokita H, 1998, J GEN VIROL, V79, P1847; Touzet S, 2000, EUR J GASTROEN HEPAT, V12, P667, DOI 10.1097/00042737-200012060-00017; Tran HTT, 2003, HEPATOL RES, V26, P275, DOI 10.1016/S1386-6346(03)00166-9; World Health Organization, 2012, HEP C; Yuan MQ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0064698	54	2	2	ACADEMIC PRESS INC ELSEVIER SCIENCE	SAN DIEGO	525 B ST, STE 1900, SAN DIEGO, CA 92101-4495 USA	0042-6822			VIROLOGY	Virology	FEB	2015	476						355	363		10.1016/j.virol.2014.12.025		9	Virology	Virology	CB8MF	WOS:000349883000041		
J	Hiep, PT; Kohno, R				Pham Thanh Hiep; Kohno, Ryuji			Channel Capacity Delay Tradeoff for Two-Way Multiple-Hop MIMO Relay Systems with MAC-PHY Cross Layer	WIRELESS PERSONAL COMMUNICATIONS			English	Article						Multiple-hop MIMO relay system; Optimizing distance; Optimizing transmit power; MAC-PHY cross-layer; Trade-off between end-to-end channel capacity and delay time	NETWORKS	In multiple-hop MIMO relay systems, an end-to-end channel capacity is restricted by the bottleneck relay. Therefore, in order to obtain the high end-to-end channel capacity, we propose a simple mathematical method to optimize both distances and transmit powers simultaneously. Additionally, the end-to-end channel capacity of optimization based on an one-way and a two-ways transmissions is analyzed. The specific TDMA is proposed to control the transmission of all transmitters on MAC layer and then the distance and the transmit power are optimized based on MAC-PHY cross layer by the proposal particle filter method to obtain the higher end-to-end channel capacity. The calculation result indicates that there is the optimal number of relays that has the maximal end-to-end channel capacity and the trade-off between the end-to-end channel capacity and the delay time.	[Pham Thanh Hiep; Kohno, Ryuji] Yokohama Natl Univ, Grad Sch Engn, Div Phys Elect & Comp Engn, Hodogaya Ku, Yokohama, Kanagawa 2408501, Japan	Hiep, PT (reprint author), Yokohama Natl Univ, Grad Sch Engn, Div Phys Elect & Comp Engn, Hodogaya Ku, 79-5 Tokiwadai, Yokohama, Kanagawa 2408501, Japan.	phamthanhhiep@gmail.com; kohno@ynu.ac.jp					Gesbert D, 2000, GLOB TELECOMM CONF, P1083, DOI 10.1109/GLOCOM.2000.891304; Wang B, 2005, IEEE T INFORM THEORY, V51, P29, DOI 10.1109/TIT.2004.839487; Shiu DS, 2000, IEEE T COMMUN, V48, P502, DOI 10.1109/26.837052; [Anonymous], 2001, P6765 ITUR; Razaghi P, 2009, IEEE T INFORM THEORY, V55, P158, DOI 10.1109/TIT.2008.2008131; [Anonymous], 2003, P14112 ITUR; [Anonymous], 2003, P12383 ITUR; Chizhik D, 2002, IEEE T WIREL COMMUN, V1, P361, DOI 10.1109/7693.994830; [Anonymous], 2001, P10571 ITUR; [Anonymous], 2003, P5268 ITUR; Popovski P, 2007, IEEE ICC, P707, DOI 10.1109/ICC.2007.121; Jin S, 2010, IEEE T INFORM THEORY, V56, P2204, DOI 10.1109/TIT.2010.2043765; [Anonymous], 2003, P8382 ITUR; Gastpar M, 2005, IEEE T INFORM THEORY, V51, P765, DOI [10.1109/TIT.2004.842566, 10.1109/TIT.200.842566]; Doucet A., 2008, TECHNICAL REPORT; Edwards H. M., 1997, GRADUATE TEXTS MATH; Giindiiz D., 2010, IEEE T WIREL COMMUN, V9, P1738; Hiep P. T., 2010, IEICE T COMMUN, VE93-B, P3616, DOI DOI 10.1587/TRANSC0M.E93.B.3616; Hiep PT, 2012, EURASIP J WIREL COMM, DOI 10.1186/1687-1499-2012-153; Katti S., 2006, P 2006 C APPL TECHN, V36, P243; Kita N., 2006, IEICE T COMMUN, VJ89-B, P115; Lee KJ, 2010, IEEE T WIREL COMMUN, V9, P2712, DOI 10.1109/TWC.2010.071410.091701; Levin G., 2010, IEEE T INFORM THEORY, V54, P3232; Liang YB, 2005, IEEE T INFORM THEORY, V51, P3284, DOI 10.1109/TIT.2005.853305; Tsuruta M., 2006, IEICE T COMMUN, VJ89-B, P1746	25	0	0	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0929-6212	1572-834X		WIRELESS PERS COMMUN	Wirel. Pers. Commun.	FEB	2015	80	4					1635	1651		10.1007/s11277-014-2104-5		17	Telecommunications	Telecommunications	CB9NM	WOS:000349958400017		
J	Ichikawa, M; Nakahara, S; Inada, H				Ichikawa, Masao; Nakahara, Shinji; Inada, Haruhiko			Impact of mandating a driving lesson for older drivers at license renewal in Japan	ACCIDENT ANALYSIS AND PREVENTION			English	Article						Older drivers; License renewal; Driving lesson; Collision risk	SAFETY; REQUIREMENTS; CRASHES; LAWS	In Japan, a driving lesson consisting of a lecture, a driver aptitude test, on-road driving assessment and a discussion session was added to the driving license renewal procedure for drivers aged 75 years or older in 1998 and for drivers aged 70 years or older in 2002. We investigated whether these additions contributed to a reduction in at-fault motor vehicle collisions (MVCs) by examining the trend of the at-fault MVC rates per licensed driver and the rate ratios of the older drivers relative to those aged 65-69 years for the years 1986-2011. All data were derived from nationwide traffic statistics. If the introduction of the lesson was effective in reducing at-fault MVCs of older drivers, the rate ratio should have declined, given that the lesson targeted only the older drivers. We found this was not the case, i.e., there was no declining trend in the at-fault MVC rate ratios of both drivers aged 75 years or older and drivers aged 70 years or older, relative to drivers aged 65-69 years, after the driving lesson at license renewal became mandatory for these older drivers. Therefore, the mandatory lesson for the older drivers at license renewal needs to be reconsidered. (C) 2014 Elsevier Ltd. All rights reserved.	[Ichikawa, Masao; Inada, Haruhiko] Univ Tsukuba, Fac Med, Tsukuba, Ibaraki 3058577, Japan; [Nakahara, Shinji] Kanagawa Univ Human Serv, Yokosuka, Kanagawa 2388522, Japan	Ichikawa, M (reprint author), Univ Tsukuba, Fac Med, 1-1-1 Tennodai, Tsukuba, Ibaraki 3058577, Japan.	masao@md.tsukuba.ac.jp					Tay R, 2012, AGEING SOC, V32, P655, DOI 10.1017/S0144686X11000535; Siren A, 2012, ACCIDENT ANAL PREV, V45, P634, DOI 10.1016/j.aap.2011.09.032; Langford J, 2004, ACCIDENT ANAL PREV, V36, P993, DOI 10.1016/j.aap.2003.11.003; Voas RB, 2000, ACCIDENT ANAL PREV, V32, P483, DOI 10.1016/S0001-4575(99)00063-9; Ball K, 2010, J AM GERIATR SOC, V58, P2107, DOI 10.1111/j.1532-5415.2010.03138.x; Cabinet Office, 2012, WHIT PAP TRAFF SAF J; Grabowski DC, 2004, JAMA-J AM MED ASSOC, V291, P2840, DOI 10.1001/jama.291.23.2840; Hingson R, 1998, PUBLIC HEALTH REP, V113, P440; Institute for Traffic Accident Research and Data Analysis, 2006, ITARDA INFORM, V60, P1; Kahvedzic A., 2013, INT RELICENSING MODE; Korner-Bitensky N, 2009, J SAFETY RES, V40, P105, DOI 10.1016/j.jsr.2009.02.002; Kua A, 2007, J SAFETY RES, V38, P81, DOI 10.1016/j.jsr.2007.01.002; Langford J, 2008, ACCIDENT ANAL PREV, V40, P1913, DOI 10.1016/j.aap.2008.08.010; Langford Jim, 2004, Traffic Inj Prev, V5, P326, DOI 10.1080/15389580490509464; Nakahara S, 2011, HEALTH POLICY, V100, P247, DOI 10.1016/j.healthpol.2010.11.003; Nakahara S, 2001, Inj Prev, V7, P242, DOI 10.1136/ip.7.3.242; Nakahara S, 2011, INJURY PREV, V17, P182, DOI 10.1136/ip.2010.027680; National Police Agency, 2013, HEIS 24 NEN CHU KOUT; National Police Agency, 2011, UNT MENK TOUK HEIS 2; National Police Agency, 2012, WHIT PAP POL 2012; National Police Agency, 1987, WHIT PAP POL 1987; National Police Agency, 2014, COGN IMP SCR TEST SE; Organisation for Economic Co-operation and Development, 2001, AG TRANSP MOB NEEDS; Oroku S., 2010, YOBOU JIHOU, V241, P38; Rock SM, 1998, ACCIDENT ANAL PREV, V30, P69, DOI 10.1016/S0001-4575(97)00063-8	25	1	1	PERGAMON-ELSEVIER SCIENCE LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND	0001-4575	1879-2057		ACCIDENT ANAL PREV	Accid. Anal. Prev.	FEB	2015	75						55	60		10.1016/j.aap.2014.11.015		6	Ergonomics; Public, Environmental & Occupational Health; Social Sciences, Interdisciplinary; Transportation	Engineering; Public, Environmental & Occupational Health; Social Sciences - Other Topics; Transportation	CB6GV	WOS:000349726400006		
J	Kumata, K; Yui, JJ; Hatori, A; Maeda, J; Xie, L; Ogawa, M; Yamasaki, T; Nagai, Y; Shimoda, Y; Fujinaga, M; Kawamura, K; Zhang, MR				Kumata, Katsushi; Yui, Joji; Hatori, Akiko; Maeda, Jun; Xie, Lin; Ogawa, Masanao; Yamasaki, Tomoteru; Nagai, Yuji; Shimoda, Yoko; Fujinaga, Masayuki; Kawamura, Kazunori; Zhang, Ming-Rong			Development of [C-11]MFTC for PET Imaging of Fatty Acid Amide Hydrolase in Rat and Monkey Brains	ACS CHEMICAL NEUROSCIENCE			English	Article						FAAH; PET; [C-11]COCl2; [C-11]MFTC; fatty acid amide hydrolase; irreversible specific binding	POSITRON-EMISSION-TOMOGRAPHY; CENTRAL-NERVOUS-SYSTEM; MOUSE-BRAIN; ANANDAMIDE; ENZYME; OLEAMIDE; PROBE	We developed 2-methylpyridin-3-yl-4-(5-(2-fluorophenyl)-4H-1,2,4-triazol-3-yl)piperidine-1-[((11))C]carboxylate ([((11))C]MFTC) as a promising PET tracer for in vivo imaging of fatty acid amide hydrolase (FAAH) in rat and monkey brains. [((11))C]MFTC was synthesized by reacting 3-hydroxy-2-methylpyridine (2) with [((11))C]phosgene ([((11))C]COCl2), followed by reacting with 4-(5-(2-fluorophenyl)-4H-1,2,4-triazol-3-yl)piperidine (3), with a 20 +/- 4.6% radiochemical yield (decay-corrected, n = 30) based on [((11))C]CO2 and 40 min synthesis time from the end of bombardment. A biodistribution study in mice showed high uptake of radioactivity in FAAH-rich organs, including the lung, liver, and kidneys. Positron emission tomography (PET) summation images of rat brains showed high radioactivity in the frontal cortex, cerebellum, and hippocampus, which was consistent with the regional distribution pattern of FAAH in rodent brain. Pretreatment with MFTC or FAAH-selective URB597 significantly reduced the uptake in the brain. PET imaging of monkey brain showed relatively high uptake in the whole brain, particularly in the occipital cortex, which was also inhibited by treatment with MFTC or URB597. More than 96% of the total radioactivity was irreversible in the brain homogenate of rats 5 min after the radiotracer injection. The specific in vivo FAAH binding indicates that [((11))C]MFTC is a promising PET tracer for visualizing FAAH in the brain.	[Kumata, Katsushi; Yui, Joji; Hatori, Akiko; Maeda, Jun; Xie, Lin; Ogawa, Masanao; Yamasaki, Tomoteru; Nagai, Yuji; Shimoda, Yoko; Fujinaga, Masayuki; Kawamura, Kazunori; Zhang, Ming-Rong] Natl Inst Radiol Sci, Mol Imaging Ctr, Chiba 2638555, Japan; [Ogawa, Masanao] SHI Accelerator Serv Co Ltd, Tokyo 1418686, Japan	Zhang, MR (reprint author), Natl Inst Radiol Sci, Mol Imaging Ctr, Chiba 2638555, Japan.	zhang@nirs.go.jp					Cravatt BF, 1996, NATURE, V384, P83, DOI 10.1038/384083a0; Thomas EA, 1997, J NEUROSCI RES, V50, P1047, DOI 10.1002/(SICI)1097-4547(19971215)50:6<1047::AID-JNR16>3.0.CO;2-1; Ahn K, 2008, CHEM REV, V108, P1687, DOI 10.1021/cr0782067; Wilson AA, 2013, J MED CHEM, V56, P201, DOI [10.1021/jm301492y, 10.1021/jm30l492y]; Fowler CJ, 2001, BIOCHEM PHARMACOL, V62, P517, DOI 10.1016/S0006-2952(01)00712-2; Wilson AA, 2010, ORG BIOMOL CHEM, V8, P428, DOI 10.1039/b916419g; Rusjan PM, 2013, J CEREBR BLOOD F MET, V33, P407, DOI 10.1038/jcbfm.2012.180; Ogawa M, 2010, NUCL MED BIOL, V37, P73, DOI 10.1016/j.nucmedbio.2009.08.008; Wilson AA, 2011, NUCL MED BIOL, V38, P247, DOI 10.1016/j.nucmedbio.2010.08.001; Watanabe K, 1998, LIFE SCI, V62, P1223, DOI 10.1016/S0024-3205(98)00052-6; Takada Y, 2010, APPL RADIAT ISOTOPES, V68, P1715, DOI 10.1016/j.apradiso.2010.03.012; Hicks JW, 2013, NUCL MED BIOL, V40, P740, DOI 10.1016/j.nucmedbio.2013.04.008; Rotstein BH, 2014, MOL PHARMACEUT, V11, P3832, DOI 10.1021/mp500316h; Pike VW, 2009, TRENDS PHARMACOL SCI, V30, P431, DOI 10.1016/j.tips.2009.05.005; Piomelli D, 2003, NAT REV NEUROSCI, V4, P873, DOI 10.1038/nrn1247; Pacher P, 2013, FEBS J, V280, P1918, DOI 10.1111/febs.12260; HILLARD CJ, 1995, BBA-LIPID LIPID MET, V1257, P249, DOI 10.1016/0005-2760(95)00087-S; Aoki A., 2010, Azole Compound. Patent, Patent No. [W0 2010/007966 A1, 2010007966]; Kawamura K, 2013, NUCL MED BIOL, V40, P651, DOI 10.1016/j.nucmedbio.2013.03.004; Li WP, 2011, J LABELLED COMPD RAD, V54, pS38; Liu P., 2013, ACS MED CHEM LETT, V4, P509; Pandey MK, 2014, ACS CHEM NEUROSCI, V5, P793, DOI 10.1021/cn400214j; Romero J, 2002, MOL BRAIN RES, V100, P85; Sadovski O, 2013, BIOORGAN MED CHEM, V21, P4351, DOI 10.1016/j.bmc.2013.04.077; Skaddan M. B., 2013, NUCL MED BIOL, V40, P1058	25	1	1	AMER CHEMICAL SOC	WASHINGTON	1155 16TH ST, NW, WASHINGTON, DC 20036 USA	1948-7193			ACS CHEM NEUROSCI	ACS Chem. Neurosci.	FEB	2015	6	2					339	346		10.1021/cn500269g		8	Biochemistry & Molecular Biology; Chemistry, Medicinal; Neurosciences	Biochemistry & Molecular Biology; Pharmacology & Pharmacy; Neurosciences & Neurology	CB7NI	WOS:000349813700015		
J	Nakamura, M; Hayashi, K; Nakano, M; Kanadani, T; Miyamoto, K; Kori, T; Horikawa, K				Nakamura, Michihiro; Hayashi, Koichiro; Nakano, Mutsuki; Kanadani, Takafumi; Miyamoto, Kazue; Kori, Toshinari; Horikawa, Kazuki			Identification of Polyethylene Glycol-Resistant Macrophages on Stealth Imaging in Vitro Using Fluorescent Organosilica Nanoparticles	ACS NANO			English	Article						stealth nanoparticles; single-cell analysis; polyethylene glycol; macrophages; accelerated blood clearance	ACCELERATED BLOOD CLEARANCE; IRON-OXIDE NANOPARTICLES; ONE-POT SYNTHESIS; PEGYLATED LIPOSOMES; PROTEIN ADSORPTION; DRUG-DELIVERY; MARGINAL ZONE; STREPTOCOCCUS-PNEUMONIAE; BIOLOGICAL APPLICATIONS; BIOMEDICAL APPLICATIONS	An in vitro imaging system to evaluate the stealth function of nanoparticles against mouse macrophages was established using fluorescent organosilica nanoparticles. Surface-functionalized organosilica nanoparticles with polyethylene glycol (PEG) were prepared by a one-step process, resulting in a brush-type PEG layer. A simultaneous dual-particle administration approach enabled us to evaluate the stealth function of nanoparticles with respect to single cells using time-lapse fluorescent microscopic imaging and flow cytometry analyses. Single-cell imaging and analysis revealed various patterns and kinetics of bare and PEGylated nanoparticle uptake. The PEGylated nanoparticles revealed a stealth function against most macrophages (PEG-sensitive macrophages); however, a stealth function against certain macrophages (PEG-insensitive macrophages) was not observed. We identified and characterized the PEG-resistant macrophages that could take up PEGylated nanoparticles at the same level as bare nanoparticles.	[Nakamura, Michihiro; Hayashi, Koichiro; Nakano, Mutsuki; Kanadani, Takafumi; Miyamoto, Kazue] Univ Tokushima, Grad Sch Med Sci, Dept Anat & Cell Biol, Tokushima 7708503, Japan; [Nakano, Mutsuki; Kanadani, Takafumi; Miyamoto, Kazue] Univ Tokushima, Student Lab, Fac Med, Tokushima 7708503, Japan; [Kori, Toshinari] Tokushima Prefectural Ind Technol Ctr, Tokushima 7708021, Japan; [Horikawa, Kazuki] Univ Tokushima, Grad Sch, Inst Hlth Biosci, Div Bioimaging, Tokushima 7708503, Japan	Nakamura, M (reprint author), Univ Tokushima, Grad Sch Med Sci, Dept Anat & Cell Biol, 3-18-15 Kuramoto, Tokushima 7708503, Japan.	michy@basic.med.tokushima-u.ac.jp			Ministry of Education, Science, Sports, and Culture of Japan [17790356, 19510117, 21500409, 25350530]; Research for Promoting Technological Seeds and Adaptable and Seamless Technology Transfer Program through target-driven RD from JST [AS2321114D]; New Energy and Industrial Technology Development Organization (NEDO) of Japan	This work was supported in part by a Grant-in-Aid for Younger Scientists (No. 17790356) (to M.N.) and Grants-in-Aid for Scientific Research (C) (Nos. 19510117, 21500409, and 25350530) (to M.N.) from the Ministry of Education, Science, Sports, and Culture of Japan. This work was also supported by the Research for Promoting Technological Seeds and Adaptable and Seamless Technology Transfer Program through target-driven R&D from JST (AS2321114D) (to M.N.) and by a Grant for Practical Application of University R&D Results under the Matching Fund Method (to M.N.) from the New Energy and Industrial Technology Development Organization (NEDO) of Japan. We thank the Support Center for Advanced Medical Sciences, Institute of Health Biosciences, The University of Tokushima Graduate School, for their technical assistance.	Abu Lila AS, 2013, J CONTROL RELEASE, V172, P38, DOI 10.1016/j.jconrel.2013.07.026; Walkey CD, 2012, J AM CHEM SOC, V134, P2139, DOI 10.1021/ja2084338; Namiki Y, 2011, ACCOUNTS CHEM RES, V44, P1080, DOI 10.1021/ar200011r; Szleifer I, 1997, BIOPHYS J, V72, P595; Dreaden EC, 2012, CHEM SOC REV, V41, P2740, DOI 10.1039/c1cs15237h; Ishida T, 2003, J CONTROL RELEASE, V88, P35, DOI 10.1016/S0168-3659(02)00462-5; Albanese A, 2014, ACS NANO, V8, P5515, DOI 10.1021/nn4061012; Lee JE, 2011, ACCOUNTS CHEM RES, V44, P893, DOI 10.1021/ar2000259; Ishida T, 2006, J CONTROL RELEASE, V112, P15, DOI 10.1016/j.jconrel.2006.01.005; Doane TL, 2012, CHEM SOC REV, V41, P2885, DOI 10.1039/c2cs15260f; Rejman J, 2004, BIOCHEM J, V377, P159, DOI 10.1042/BJ20031253; Mebius RE, 2005, NAT REV IMMUNOL, V5, P606, DOI 10.1038/nri1669; Ishida T, 2003, INT J PHARM, V255, P167, DOI 10.1016/S0378-5173(03)00085-1; Kenausis GL, 2000, J PHYS CHEM B, V104, P3298, DOI 10.1021/jp993359m; Bergtold A, 2005, IMMUNITY, V23, P503, DOI 10.1016/j.immuni.2005.09.013; Kang YS, 2003, INT IMMUNOL, V15, P177, DOI 10.1093/intimm/dxg019; Kang YS, 2006, CELL, V125, P47, DOI 10.1016/j.cell.2006.01.046; Ishida T, 2005, J CONTROL RELEASE, V105, P305, DOI 10.1016/j.jconrel.2005.04.003; Ishida T, 2007, J CONTROL RELEASE, V122, P349, DOI 10.1016/j.jconrel.2007.05.015; Chithrani BD, 2006, NANO LETT, V6, P662, DOI 10.1021/nl052396o; Perry JL, 2012, NANO LETT, V12, P5304, DOI 10.1021/nl302638g; Nakamura M, 2008, LANGMUIR, V24, P5099, DOI 10.1021/la703395w; Moffatt S, 2006, INT J PHARMACEUT, V321, P143, DOI 10.1016/j.ijpharm.2006.05.007; Greaves DR, 2009, J LIPID RES, V50, pS282, DOI 10.1194/jlr.R800066-JLR200; Satulovsky J, 2000, P NATL ACAD SCI USA, V97, P9037, DOI 10.1073/pnas.150236197; Moghimi SM, 2005, FASEB J, V19, P311, DOI 10.1096/fj.04-2747rev; Mu QX, 2009, J PHYS CHEM C, V113, P5390, DOI 10.1021/jp809493t; Zandvoort A, 2002, CLIN EXP IMMUNOL, V130, P4, DOI 10.1046/j.1365-2249.2002.01953.x; Tassa C, 2011, ACCOUNTS CHEM RES, V44, P842, DOI 10.1021/ar200084x; Heald CR, 2002, LANGMUIR, V18, P3669, DOI 10.1021/la011393y; STORM G, 1995, ADV DRUG DELIVER REV, V17, P31, DOI 10.1016/0169-409X(95)00039-A; Nakamura M, 2010, ADV SCI LETT, V3, P130, DOI 10.1166/asl.2010.1096; Moghimi SM, 2001, PHARMACOL REV, V53, P283; Li ZX, 2012, CHEM SOC REV, V41, P2590, DOI 10.1039/c1cs15246g; Khandare J, 2012, CHEM SOC REV, V41, P2824, DOI 10.1039/c1cs15242d; Mancini MC, 2008, J AM CHEM SOC, V130, P10836, DOI 10.1021/ja8040477; Yang PP, 2012, CHEM SOC REV, V41, P3679, DOI 10.1039/c2cs15308d; Fang J, 2011, ADV DRUG DELIVER REV, V63, P136, DOI 10.1016/j.addr.2010.04.009; Hanaki K, 2003, BIOCHEM BIOPH RES CO, V302, P496, DOI 10.1016/S0006-291X(03)00211-0; Gref R, 2000, COLLOID SURFACE B, V18, P301, DOI 10.1016/S0927-7765(99)00156-3; Laverman P, 2001, J PHARMACOL EXP THER, V298, P607; Motskin M, 2011, BIOMATERIALS, V32, P9470, DOI 10.1016/j.biomaterials.2011.08.060; Aderem A, 1999, ANNU REV IMMUNOL, V17, P593, DOI 10.1146/annurev.immunol.17.1.593; Wang XY, 2007, J CONTROL RELEASE, V119, P236, DOI 10.1016/j.jconrel.2007.02.010; Liong M, 2008, ACS NANO, V2, P889, DOI 10.1021/nn800072t; Liu YY, 2007, INT J CANCER, V120, P2527, DOI 10.1002/ijc.22709; MOND JJ, 1995, ANNU REV IMMUNOL, V13, P655, DOI 10.1146/annurev.immunol.13.1.655; Chen YY, 2005, J IMMUNOL, V175, P8173; Dams ETM, 2000, J PHARMACOL EXP THER, V292, P1071; MATSUMURA Y, 1986, CANCER RES, V46, P6387; Kang YS, 2004, P NATL ACAD SCI USA, V101, P215, DOI 10.1073/pnas.0307124101; Tirosh O, 1998, BIOPHYS J, V74, P1371; Martin F, 2001, IMMUNITY, V14, P617, DOI 10.1016/S1074-7613(01)00129-7; Medintz IL, 2005, NAT MATER, V4, P435, DOI 10.1038/nmat1390; Rodriguez PL, 2013, SCIENCE, V339, P971, DOI 10.1126/science.1229568; Awaad A, 2012, NANOMED-NANOTECHNOL, V8, P627, DOI 10.1016/j.nano.2011.08.009; Awaad A, 2012, INT J NANOMED, V7, P1423, DOI 10.2147/IJN.S28675; Benedict FG, 1913, J BIOL CHEM, V15, P1; Colino J, 2002, J EXP MED, V195, P1; Do R. K., 2002, J EXP MED, V192, P953; Ishida T, 2002, CELL MOL BIOL LETT, V7, P286; JEON SI, 1991, J COLLOID INTERF SCI, V142, P149, DOI 10.1016/0021-9797(91)90043-8; MAEDA H, 1989, CRIT REV THER DRUG, V6, P193; Mohanraj VJ, 2006, TROP J PHARM RES, V5, P561, DOI DOI 10.4314/TJPR.V5I1.14634; Nakamura M, 2007, J PHYS CHEM C, V111, P18892, DOI 10.1021/jp075798o; Nakamura M, 2012, CHEM MATER, V24, P3772, DOI 10.1021/cm3023677; Nakamura M, 2013, NANOMED-NANOTECHNOL, V9, P274, DOI 10.1016/j.nano.2012.05.018; Nakamura M, 2008, LANGMUIR, V24, P12228, DOI 10.1021/la801950q; Nakamura M, 2010, COLLOID SURFACE B, V79, P19, DOI 10.1016/j.colsurfb.2010.03.008; Nakamura M, 2012, NANOTECHNOL REV, V1, P469, DOI 10.1515/ntrev-2012-0005; Nakamura M., 2009, NANOSTRUCTURED OXIDE, P109; Nakamura M, 2011, J MATER CHEM, V21, P4689, DOI 10.1039/c0jm04259e; Pone EJ, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms1769; Rosen JE, 2012, NANOMED-NANOTECHNOL, V8, P275, DOI 10.1016/j.nano.2011.08.017	74	1	1	AMER CHEMICAL SOC	WASHINGTON	1155 16TH ST, NW, WASHINGTON, DC 20036 USA	1936-0851	1936-086X		ACS NANO	ACS Nano	FEB	2015	9	2					1058	1071		10.1021/nn502319r		14	Chemistry, Multidisciplinary; Chemistry, Physical; Nanoscience & Nanotechnology; Materials Science, Multidisciplinary	Chemistry; Science & Technology - Other Topics; Materials Science	CB9GR	WOS:000349940500004		
J	Ho, D; Zou, JL; Chen, XJ; Munshi, A; Smith, NM; Agarwal, V; Hodgetts, SI; Plant, GW; Bakker, AJ; Harvey, AR; Luzinov, I; Iyer, KS				Ho, Dominic; Zou, Jianli; Chen, Xianjue; Munshi, Alaa; Smith, Nicole M.; Agarwal, Vipul; Hodgetts, Stuart I.; Plant, Giles W.; Bakker, Anthony J.; Harvey, Alan R.; Luzinov, Igor; Iyer, K. Swaminathan			Hierarchical Patterning of Multifunctional Conducting Polymer Nanoparticles as a Bionic Platform for Topographic Contact Guidance	ACS NANO			English	Article						multimodal nanoparticles; conducting polymers; capillary force lithography; neurostimulation	ELECTRICAL-STIMULATION PROMOTES; NERVE GROWTH-FACTOR; NEURITE OUTGROWTH; PC12 CELLS; REGENERATION; EXPRESSION; SURFACES; NEURONS; TISSUE; SPEED	The use of programmed electrical signals to influence biological events has been a widely accepted clinical methodology for neurostimulation. An optimal biocompatible platform for neural activation efficiently transfers electrical signals across the electrode-cell interface and also incorporates large-area neural guidance conduits. Inherently conducting polymers (ICPs) have emerged as frontrunners as soft biocompatible alternatives to traditionally used metal electrodes, which are highly invasive and elicit tissue damage over long-term implantation. However, fabrication techniques for the ICPs suffer a major bottleneck, which limits their usability and medical translation. Herein, we report that these limitations can be overcome using colloidal chemistry to fabricate multimodal conducting polymer nanoparticles. Furthermore, we demonstrate that these polymer nanoparticles can be precisely assembled into large-area linear conduits using surface chemistry. Finally, we validate that this platform can act as guidance conduits for neurostimulation, whereby the presence of electrical current induces remarkable dendritic axonal sprouting of cells.	[Ho, Dominic; Chen, Xianjue; Munshi, Alaa; Smith, Nicole M.; Agarwal, Vipul; Iyer, K. Swaminathan] Univ Western Australia, Sch Chem & Biochem, Crawley, WA 6009, Australia; [Ho, Dominic; Hodgetts, Stuart I.; Bakker, Anthony J.; Harvey, Alan R.] Univ Western Australia, Sch Anat Physiol & Human Biol, Crawley, WA 6009, Australia; [Zou, Jianli] Kyoto Univ, Inst Integrated Cell Mat Sci iCeMS, Sakyo Ku, Kyoto 6068501, Japan; [Smith, Nicole M.] Univ Western Australia, Sch Anim Biol, Crawley, WA 6009, Australia; [Plant, Giles W.] Stanford Univ, Sch Med, Stanford Partnership Spinal Cord Injury & Repair, Dept Neurosurg, Stanford, CA 94305 USA; [Luzinov, Igor] Clemson Univ, Sch Mat Sci & Engn, Clemson, SC 29634 USA	Iyer, KS (reprint author), Univ Western Australia, Sch Chem & Biochem, Crawley, WA 6009, Australia.	swaminatha.iyer@uwa.edu.au	Chen, Xianjue/J-5208-2015; 	Chen, Xianjue/0000-0002-4757-7152; Zou, Jianli/0000-0003-3105-7213; Agarwal, Vipul/0000-0002-6239-5410	Australian Research Council (ARC); National Health & Medical Research Council (NHMRC) of Australia; National Science Foundation [CBET-0756457]	D.H., I.L., and K.S.I. designed the experiments, developed the concept, and analyzed the data. D.H., J.Z., and N.M.S. optimized the capillary force lithography experiments. D.H., X.C., V.A., and A.M. performed image acquisition using confocal microscopy, transmission electron microscopy, scanning electron microscopy, and atomic force microscopy. D.H., A.R.H., G.W.P., S.I.H., and A.B. optimized and designed the electrical stimulation experiments. This work was funded by the Australian Research Council (ARC), the National Health & Medical Research Council (NHMRC) of Australia, and the National Science Foundation (CBET-0756457). The authors acknowledge the Australian Microscopy & Microanalysis Research Facility at the Centre for Microscopy, Characterization & Analysis, and The University of Western Australia, funded by the University, State and Commonwealth Governments. The authors also wish to thank Margaret Pollen and Chrisna LeVaillant for their invaluable contribution in assisting with the PC12 cell cultures and immunohistochemistry, and Ella Marushchenko (wwwscientific-illustrations.com) for assistance with Figure 1.	Geremia NM, 2007, EXP NEUROL, V205, P347, DOI 10.1016/j.expneurol.2007.01.040; Wallace GG, 2009, SCIENCE, V324, P185, DOI 10.1126/science.1168346; Zou JL, 2012, CHEM COMMUN, V48, P1033, DOI 10.1039/c1cc15522a; Kim DH, 2007, ADV FUNCT MATER, V17, P79, DOI 10.1002/adfm.200500594; Eberhardt KA, 2006, EXP NEUROL, V198, P500, DOI 10.1016/j.expneurol.2005.12.018; Moulton SE, 2012, ADV FUNCT MATER, V22, P2003, DOI 10.1002/adfm.201102232; Richardson RT, 2007, BIOMATERIALS, V28, P513, DOI 10.1016/j.biomaterials.2006.09.008; Franz CK, 2008, BRAIN, V131, P1492, DOI 10.1093/brain/awn039; Iyer KS, 2003, MACROMOLECULES, V36, P6519, DOI 10.1021/ma034460z; Lee JI, 2008, NANO LETT, V8, P2315, DOI 10.1021/nl801105s; BOURGUIGNON GJ, 1987, FASEB J, V1, P398; Ciofani G, 2010, ACS NANO, V4, P6267, DOI 10.1021/nn101985a; Wallace GG, 2012, NANOSCALE, V4, P4327, DOI 10.1039/c2nr30758h; Wang JZ, 2004, NAT MATER, V3, P171, DOI 10.1038/nmat1073; Schmidt CE, 1997, P NATL ACAD SCI USA, V94, P8948, DOI 10.1073/pnas.94.17.8948; WONG JY, 1994, P NATL ACAD SCI USA, V91, P3201, DOI 10.1073/pnas.91.8.3201; DRUBIN DG, 1985, J CELL BIOL, V101, P1799, DOI 10.1083/jcb.101.5.1799; Merrill DR, 2005, J NEUROSCI METH, V141, P171, DOI 10.1016/j.jneumeth.2004.10.020; Das KP, 2004, NEUROTOXICOL TERATOL, V26, P397, DOI 10.1016/j.ntt.2004.02.006; Guimard NK, 2007, PROG POLYM SCI, V32, P876, DOI 10.1016/j.progpolymsci.2007.05.012; Al-Majed AA, 2000, J NEUROSCI, V20, P2602; Brushart TM, 2005, EXP NEUROL, V194, P221, DOI 10.1016/j.expneuro.2005.02.007; Khademhosseini A, 2006, P NATL ACAD SCI USA, V103, P2480, DOI 10.1073/pnas.0507681102; Ito Y, 1999, BIOMATERIALS, V20, P2333, DOI 10.1016/S0142-9612(99)00162-3; Chen CS, 1998, BIOTECHNOL PROGR, V14, P356, DOI 10.1021/bp980031m; Brushart TM, 2002, J NEUROSCI, V22, P6631; Choi J, 2010, SYNTHETIC MET, V160, P1415, DOI 10.1016/j.synthmet.2010.04.021; Nakashima H., 2011, LANGMUIR, V28, P804; Weng B, 2012, SYNTHETIC MET, V162, P1375, DOI 10.1016/j.synthmet.2012.05.022; Yan XD, 2014, NEUROCHEM RES, V39, P129, DOI 10.1007/s11064-013-1197-7	30	1	1	AMER CHEMICAL SOC	WASHINGTON	1155 16TH ST, NW, WASHINGTON, DC 20036 USA	1936-0851	1936-086X		ACS NANO	ACS Nano	FEB	2015	9	2					1767	1774		10.1021/nn506607x		8	Chemistry, Multidisciplinary; Chemistry, Physical; Nanoscience & Nanotechnology; Materials Science, Multidisciplinary	Chemistry; Science & Technology - Other Topics; Materials Science	CB9GR	WOS:000349940500072		
J	Sugawa, K; Tahara, H; Yamashita, A; Otsuki, J; Sagara, T; Harumoto, T; Yanagida, S				Sugawa, Kosuke; Tahara, Hironobu; Yamashita, Ayane; Otsuki, Joe; Sagara, Takamasa; Harumoto, Takashi; Yanagida, Sayaka			Refractive Index Susceptibility of the Plasmonic Palladium Nanoparticle: Potential as the Third Plasmonic Sensing Material	ACS NANO			English	Article						localized surface plasmon; palladium nanoparticles; refractive index susceptibility; core-shell nanoparticles; ultraviolet region	SURFACE-ENHANCED RAMAN; SILVER NANOPARTICLES; GOLD NANOPARTICLES; RESONANCE SPECTROSCOPY; OPTICAL-PROPERTIES; HYDROGEN STORAGE; PD NANOPARTICLES; POLYOL SYNTHESIS; SENSITIVITY; SIZE	We demonstrate that Pd nanospheres exhibit much higher susceptibility of the localized surface plasmon resonance (LSPR) peak to medium refractive index changes than commonly used plasmonic sensing materials such as Au and Ag. The susceptibility of spherical Au nanoparticle-core/Pd-shell nanospheres (Au/PdNSs, ca. 73 nm in diameter) was found to be 4.9 and 2.5 times higher, respectively, than those of Au (AuNSs) and Ag nanospheres (AgNSs) having similar diameters. The experimental finding was theoretically substantiated using the Mie exact solution. We also showed from a quasi-static (QS) approximation framework that the high susceptibility of Pd LSPR originates from the smaller dispersion of the real part of its dielectric function than those of Au and Ag LSPR around the resonant wavelength. We conclude that the Pd nanoparticle is a promising candidate of "the third plasmonic sensing material" following Au and Ag to be used in ultrahigh-sensitive LSPR sensors.	[Sugawa, Kosuke; Yamashita, Ayane; Otsuki, Joe] Nihon Univ, Coll Sci & Technol, Chiyoda Ku, Tokyo 1018308, Japan; [Tahara, Hironobu; Sagara, Takamasa] Nagasaki Univ, Grad Sch Engn, Div Chem & Mat Sci, Nagasaki 8528521, Japan; [Harumoto, Takashi; Yanagida, Sayaka] Tokyo Univ Sci, Dept Mat Sci & Technol, Tokyo 1258585, Japan	Sugawa, K (reprint author), Nihon Univ, Coll Sci & Technol, Chiyoda Ku, Tokyo 1018308, Japan.	sugawa.kosuke@nihon-u.ac.jp; h-tahara@nagasaki-u.ac.jp			JSPS KAKENHI [26810102]	This work was supported in part by Grant-in-Aid for Young Scientists B (Grant No. 26810102) from JSPS KAKENHI.	Chiu CY, 2013, ANGEW CHEM INT EDIT, V52, P12709, DOI 10.1002/anie.201306363; Truong PL, 2012, LAB CHIP, V12, P1102, DOI 10.1039/c2lc20588b; Mayer KM, 2011, CHEM REV, V111, P3828, DOI 10.1021/cr100313v; Schneider CA, 2012, NAT METHODS, V9, P671, DOI 10.1038/nmeth.2089; Bigelow NW, 2013, ACS NANO, V7, P4511, DOI 10.1021/nn401161n; Banholzer MJ, 2010, J PHYS CHEM C, V114, P7521, DOI 10.1021/jp911889a; Tian LM, 2012, ANAL CHEM, V84, P9928, DOI 10.1021/ac302332g; Hartings M, 2012, NAT CHEM, V4, P764, DOI 10.1038/nchem.1437; Chen HJ, 2008, LANGMUIR, V24, P5233, DOI 10.1021/la800305j; Dong PP, 2013, ACS APPL MATER INTER, V5, P2392, DOI 10.1021/am4004254; Sonnichsen C, 2005, NAT BIOTECHNOL, V23, P741, DOI 10.1038/nbt1100; Chang YF, 2011, ANAL CHEM, V83, P5324, DOI 10.1021/ac200754x; Chen P, 2014, ANAL CHEM, V86, P7399, DOI 10.1021/ac500883x; Miller MM, 2005, J PHYS CHEM B, V109, P21556, DOI 10.1021/jp054227y; Sun YG, 2002, ANAL CHEM, V74, P5297, DOI 10.1021/ac0258352; Jain PK, 2008, NANO LETT, V8, P4347, DOI 10.1021/nl8021835; Zhang K, 2009, LANGMUIR, V25, P1162, DOI 10.1021/la803060p; Sannomiya T, 2008, NANO LETT, V8, P3450, DOI 10.1021/nl802317d; LEE PC, 1982, J PHYS CHEM-US, V86, P3391, DOI 10.1021/j100214a025; Zhang JW, 2011, CHEM-EUR J, V17, P9915, DOI 10.1002/chem.201100868; Haes AJ, 2004, J PHYS CHEM B, V108, P109, DOI 10.1021/jp0361327; UNDERWOOD S, 1994, LANGMUIR, V10, P3427, DOI 10.1021/la00022a011; Sherry LJ, 2005, NANO LETT, V5, P2034, DOI 10.1021/nl0515753; Jana NR, 2003, ANALYST, V128, P954, DOI 10.1039/b302409a; Liu N, 2011, NAT MATER, V10, P631, DOI [10.1038/nmat3029, 10.1038/NMAT3029]; Li CC, 2009, ANGEW CHEM INT EDIT, V48, P6883, DOI 10.1002/anie.200902786; Omura N, 2009, ANAL SCI, V25, P255; Langhammer C, 2010, NANO LETT, V10, P3529, DOI 10.1021/nl101727b; Larsson EM, 2007, NANO LETT, V7, P1256, DOI 10.1021/nl0701612; Giannini V, 2011, CHEM REV, V111, P3888, DOI 10.1021/cr1002672; Anker JN, 2008, NAT MATER, V7, P442, DOI 10.1038/nmat2162; Lee YH, 2011, J PHYS CHEM C, V115, P7997, DOI 10.1021/jp202574r; Rakic AD, 1998, APPL OPTICS, V37, P5271, DOI 10.1364/AO.37.005271; Hao F, 2007, CHEM PHYS LETT, V446, P115, DOI 10.1016/j.cplett.2007.08.027; Chen HJ, 2012, ACS NANO, V6, P7162, DOI 10.1021/nn302220y; DeSantis CJ, 2012, LANGMUIR, V28, P9055, DOI 10.1021/la3002509; Charles DE, 2010, ACS NANO, V4, P55, DOI 10.1021/nn9016235; Mayer KM, 2008, ACS NANO, V2, P687, DOI 10.1021/nn7003734; Marshall ST, 2010, NAT MATER, V9, P853, DOI [10.1038/nmat2849, 10.1038/NMAT2849]; McPhillips J, 2010, ACS NANO, V4, P2210, DOI 10.1021/nn9015828; Corthey G, 2009, J PHYS CHEM C, V113, P6735, DOI 10.1021/jp9001077; Mahmoud MA, 2010, J AM CHEM SOC, V132, P12704, DOI 10.1021/ja104532z; Larsson EM, 2009, SCIENCE, V326, P1091, DOI 10.1126/science.1176593; Haes AJ, 2002, J AM CHEM SOC, V124, P10596, DOI 10.1021/ja020393x; Arakawa T, 2009, J PHYS CHEM C, V113, P11830, DOI 10.1021/jp9018525; Nath N, 2004, ANAL CHEM, V76, P5370, DOI 10.1021/ac049741z; Lim B, 2007, ANGEW CHEM INT EDIT, V46, P9279, DOI 10.1002/anie.200703755; Berhault G, 2007, J PHYS CHEM C, V111, P5915, DOI 10.1021/jp0702752; Wang F, 2010, SMALL, V6, P2566, DOI 10.1002/smll.201000817; Kreno LE, 2010, ANAL CHEM, V82, P8042, DOI 10.1021/ac102127p; Mahmoud MA, 2014, J PHYS CHEM LETT, V5, P2594, DOI 10.1021/jz501201p; Horinouchi S, 2006, LANGMUIR, V22, P1880, DOI 10.1021/la052657+; Dmitriev A, 2008, NANO LETT, V8, P3893, DOI 10.1021/nl8023142; Pakizeh T, 2009, NANO LETT, V9, P882, DOI 10.1021/nl803794h; Shuai DM, 2013, ACS CATAL, V3, P453, DOI 10.1021/cs300616d; Lee J, 2009, J PHYS CHEM C, V113, P2205, DOI 10.1021/jp8111155; Lee KS, 2006, J PHYS CHEM B, V110, P19220, DOI 10.1021/jp062536y; Langhammer C, 2007, NANO LETT, V7, P3122, DOI 10.1021/nl071664a; Bingham JM, 2010, J AM CHEM SOC, V132, P17358, DOI 10.1021/ja1074272; Xiong YJ, 2005, J AM CHEM SOC, V127, P7332, DOI 10.1021/ja0513741; Khalavka Y, 2009, J AM CHEM SOC, V131, P1871, DOI 10.1021/ja806766w; Tang ML, 2011, J AM CHEM SOC, V133, P13220, DOI 10.1021/ja203215b; Wu CH, 2012, NAT MATER, V11, P69, DOI [10.1038/nmat3161, 10.1038/NMAT3161]; TURKEVICH J, 1951, DISCUSS FARADAY SOC, P55, DOI 10.1039/df9511100055; Nehl CL, 2006, NANO LETT, V6, P683, DOI 10.1021/nl052409y; Bohren C. F., 1983, ABSORPTION SCATTERIN; Hua J.-W., 2005, CHEM PHYS LETT, V408, P354; Jain PK, 2008, ACCOUNTS CHEM RES, V41, P1578, DOI 10.1021/ar7002804; Jiang RB, 2014, ADV FUNCT MATER, V24, P7328, DOI 10.1002/adfm.201402091; Seechurn CCCJ, 2012, ANGEW CHEM INT EDIT, V51, P5062, DOI 10.1002/anie.201107017; Lu LH, 2002, J MATER CHEM, V12, P156, DOI 10.1039/b109797k; MATZLER C., 2002, MATLAB FUNCTIONS MIE; Xiong YJ, 2007, J AM CHEM SOC, V129, P3665, DOI 10.1021/ja0688023; Xiong Y. J., 2007, ANGEW CHEM, V119, P804, DOI DOI 10.1002/ANGE.200604032	74	2	2	AMER CHEMICAL SOC	WASHINGTON	1155 16TH ST, NW, WASHINGTON, DC 20036 USA	1936-0851	1936-086X		ACS NANO	ACS Nano	FEB	2015	9	2					1895	1904		10.1021/nn506800a		10	Chemistry, Multidisciplinary; Chemistry, Physical; Nanoscience & Nanotechnology; Materials Science, Multidisciplinary	Chemistry; Science & Technology - Other Topics; Materials Science	CB9GR	WOS:000349940500086		
J	Ma, W; Ma, RZ; Wang, CX; Liang, JB; Liu, XH; Zhou, KC; Sasaki, T				Ma, Wei; Ma, Renzhi; Wang, Chengxiang; Liang, Jianbo; Liu, Xiaohe; Zhou, Kechao; Sasaki, Takayoshi			A Superlattice of Alternately Stacked Ni-Fe Hydroxide Nanosheets and Graphene for Efficient Splitting of Water	ACS NANO			English	Article						layered double hydroxide; graphene; heteroassembly; water splitting; nonprecious metal catalyst	LAYERED DOUBLE HYDROXIDES; OXYGEN EVOLUTION REACTION; TRANSITION-METALS; NICKEL-OXIDE; CATALYSTS; ELECTROCATALYSTS; REDUCTION; FILM; IRON; OXIDATION	Cost-effective electrocatalysts based on nonprecious metals for efficient water splitting are crucial for various technological applications represented by fuel cell. Here, 3d transition metal layered double hydroxides (LDHs) with varied contents of Ni and Fe were successfully synthesized through a homogeneous precipitation. The exfoliated NiFe LDH nanosheets were heteroassembled with graphene oxide (GO) as well as reduced graphene oxide (rGO) into superlattice-like hybrids, in which two kinds of oppositely charged nanosheets are stacked face-to-face in alternating sequence. Heterostructured composites of Ni2/3Fe1/3 LDH nanosheets and GO (Ni2/3Fe1/3-GO) exhibited an excellent oxygen evolution reaction (OER) efficiency with a small overpotential of about 0.23 V and Tafel slope of 42 mV/decade. The activity was further improved via the combination of Ni2/3Fe1/3 LDH nanosheets with more conductive rGO (Ni2/3Fe1/3-rGO) to achieve an overpotential as low as 0.21 V and Tafel plot of 40 mV/decade. The catalytic activity was enhanced with an increased Fe content in the bimetallic NiFe system. Moreover, the composite catalysts were found to be effective for hydrogen evolution reaction. An electrolyzer cell powered by a single AA battery of 1.5 V was demonstrated by using the bifunctional catalysts.	[Ma, Wei; Ma, Renzhi; Wang, Chengxiang; Liang, Jianbo; Sasaki, Takayoshi] Natl Inst Mat Sci, Int Ctr Mat Nanoarchitecton MANA, Tsukuba, Ibaraki 3050044, Japan; [Ma, Wei; Liu, Xiaohe; Zhou, Kechao] Cent S Univ, Sch Resources Proc & Bioengn, Changsha 410083, Hunan, Peoples R China; [Ma, Wei; Zhou, Kechao] Cent S Univ, State Key Lab Powder Met, Changsha 410083, Hunan, Peoples R China	Ma, RZ (reprint author), Natl Inst Mat Sci, Int Ctr Mat Nanoarchitecton MANA, Namiki 1-1, Tsukuba, Ibaraki 3050044, Japan.	MA.Renzhi@nims.go.jp; liuxh@csu.edu.cn; zhoukechao@csu.edu.cn			World Premier International Center Initiative (WPI) on Materials Nanoarchitectonics, MEXT, Japan; JSPS KAKENNHI [24310095]; National Natural Science Foundation of China [51372279]; Hunan Provincial Natural Science Foundation of China [13JJ1005]; Shenghua Scholar Program of Central South University	The work was supported in part by the World Premier International Center Initiative (WPI) on Materials Nanoarchitectonics, MEXT, Japan. R.M. acknowledges support from JSPS KAKENNHI Grant No. 24310095. X.L. acknowledges support from National Natural Science Foundation of China (51372279), Hunan Provincial Natural Science Foundation of China (13JJ1005), and Shenghua Scholar Program of Central South University.	Adachi-Pagano M, 2000, CHEM COMMUN, P91, DOI 10.1039/a908251d; ALLMANN R, 1968, ACTA CRYSTALL B-STRU, VB 24, P972, DOI 10.1107/S0567740868003511; Li YG, 2010, ADV MATER, V22, P1926, DOI 10.1002/adma.200903896; Subbaraman R, 2012, NAT MATER, V11, P550, DOI [10.1038/nmat3313, 10.1038/NMAT3313]; Zhao JP, 2010, ACS NANO, V4, P5245, DOI 10.1021/nn1015506; Trotochaud L, 2012, J AM CHEM SOC, V134, P17253, DOI 10.1021/ja307507a; CORRIGAN DA, 1987, J PHYS CHEM-US, V91, P5009, DOI 10.1021/j100303a024; Abellan G, 2010, J MATER CHEM, V20, P7451, DOI 10.1039/c0jm01447h; Peng ZM, 2009, J AM CHEM SOC, V131, P7542, DOI 10.1021/ja902256a; Haber JA, 2014, ENERG ENVIRON SCI, V7, P682, DOI 10.1039/c3ee43683g; Strmcnik D, 2013, NAT CHEM, V5, P300, DOI [10.1038/nchem.1574, 10.1038/NCHEM.1574]; Liang YY, 2011, NAT MATER, V10, P780, DOI [10.1038/nmat3087, 10.1038/NMAT3087]; Greeley J, 2009, NAT CHEM, V1, P552, DOI [10.1038/nchem.367, 10.1038/NCHEM.367]; Bashyam R, 2006, NATURE, V443, P63, DOI 10.1038/nature05118; Louie MW, 2013, J AM CHEM SOC, V135, P12329, DOI 10.1021/ja405351s; Gunjakar JL, 2011, J AM CHEM SOC, V133, P14998, DOI 10.1021/ja203388r; Strasser P, 2010, NAT CHEM, V2, P454, DOI [10.1038/nchem.623, 10.1038/NCHEM.623]; Walter MG, 2010, CHEM REV, V110, P6446, DOI 10.1021/cr1002326; CORRIGAN DA, 1989, J ELECTROCHEM SOC, V136, P613, DOI 10.1149/1.2096697; Koper MTM, 2011, J ELECTROANAL CHEM, V660, P254, DOI 10.1016/j.jelechem.2010.10.004; Zhao MQ, 2012, ADV FUNCT MATER, V22, P675, DOI 10.1002/adfm.201102222; Fu Q, 2003, SCIENCE, V301, P935, DOI 10.1126/science.1085721; Esswein AJ, 2007, CHEM REV, V107, P4022, DOI 10.1021/cr050193e; Stankovich S, 2007, CARBON, V45, P1558, DOI 10.1016/j.carbon.2007.02.034; OLIVA P, 1982, J POWER SOURCES, V8, P229, DOI 10.1016/0378-7753(82)80057-8; HUMMERS WS, 1958, J AM CHEM SOC, V80, P1339, DOI 10.1021/ja01539a017; Vrubel H, 2013, CHEM COMMUN, V49, P8985, DOI 10.1039/c3cc45416a; HICKLING A, 1947, DISCUSS FARADAY SOC, V1, P236; Gasteiger HA, 2009, SCIENCE, V324, P48, DOI 10.1126/science.1172083; Park S, 2009, NAT NANOTECHNOL, V4, P217, DOI [10.1038/nnano.2009.58, 10.1038/NNANO.2009.58]; Legrand L, 2001, ELECTROCHIM ACTA, V46, P1815, DOI 10.1016/S0013-4686(00)00728-3; Ma RZ, 2006, J MATER CHEM, V16, P3809, DOI 10.1039/b605422f; Trotochaud L, 2014, J AM CHEM SOC, V136, P6744, DOI 10.1021/ja502379c; CORRIGAN DA, 1987, J ELECTROCHEM SOC, V134, P377, DOI 10.1149/1.2100463; Gong M, 2013, J AM CHEM SOC, V135, P8452, DOI 10.1021/ja4027715; Zou X, 2013, J AM CHEM SOC, V135, P17242, DOI 10.1021/ja407174u; Miller EL, 1997, J ELECTROCHEM SOC, V144, P3072, DOI 10.1149/1.1837961; Cavani F, 1991, CATAL TODAY, V11, P173, DOI 10.1016/0920-5861(91)80068-K; Qu LT, 2010, ACS NANO, V4, P1321, DOI 10.1021/nn901850u; Lu Z, 2014, CHEM COMMUN, V50, P6479, DOI 10.1039/c4cc01625d; McCrory CCL, 2013, J AM CHEM SOC, V135, P16977, DOI 10.1021/ja407115p; Ma RZ, 2014, ADV MATER, V26, P4173, DOI 10.1002/adma.201400054; Armaroli N, 2007, ANGEW CHEM INT EDIT, V46, P52, DOI 10.1002/anie.200602373; CLEARFIELD A, 1988, CHEM REV, V88, P125, DOI 10.1021/cr00083a007; Gong M, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms5695; Greer JR, 2014, SCIENCE, V343, P1319, DOI 10.1126/science.1251865; Lee JH, 2012, B KOREAN CHEM SOC, V33, P725, DOI 10.5012/bkcs.2012.33.2.725; MOGERMAN WD, 1952, IND ENG CHEM, V44, P971, DOI 10.1021/ie50509a021; O'Leary S, 2002, CHEM COMMUN, P1506, DOI 10.1039/b204213d; Song F, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms5477	50	14	14	AMER CHEMICAL SOC	WASHINGTON	1155 16TH ST, NW, WASHINGTON, DC 20036 USA	1936-0851	1936-086X		ACS NANO	ACS Nano	FEB	2015	9	2					1977	1984		10.1021/nn5069836		8	Chemistry, Multidisciplinary; Chemistry, Physical; Nanoscience & Nanotechnology; Materials Science, Multidisciplinary	Chemistry; Science & Technology - Other Topics; Materials Science	CB9GR	WOS:000349940500094		
J	Tsuchiya, T; Tsuruoka, T; Terabe, K; Aono, M				Tsuchiya, Takashi; Tsuruoka, Tohru; Terabe, Kazuya; Aono, Masakazu			In Situ and Nonvolatile Photoluminescence Tuning and Nanodomain Writing Demonstrated by All-Solid-State Devices Based on Graphene Oxide	ACS NANO			English	Article						graphene oxide; solid state ionics; nanoionics; photoluminescence; band gap tuning	ORGANIC SOLAR-CELLS; THIN-FILMS; REDUCTION; FLUORESCENCE; TRANSPARENT; CONDUCTION; LAYER; ELECTRODES; MAGNETISM; ORIGIN	In situ and nonvolatile tuning of photoluminescence (PL) has been achieved based on graphene oxide (GO), the PL of which is receiving much attention because of various potential applications of the oxide (e.g., display, lighting, and nano-biosensor). The technique is based on in situ and nonvolatile tuning of the sp2 domain fraction to the sp(3) domain fraction (sp(2)/sp(3) fraction) in GO through an electrochemical redox reaction achieved by solid electrolyte thin films. The all-solid-state variable PL device was fabricated by GO and proton-conducting mesoporous SiO2 thin films, which showed an extremely low PL background. The device successfully tuned the PL peak wavelength in a very wide range from 393 to 712 nm, covering that for chemically tuned GO, by adjusting the applied DC voltage within several hundred seconds. We also demonstrate the sp2/sp3 fraction tuning using a conductive atomic force microscope. The device achieved not only writing, but also erasing of the sp(2)/sp(3)-fraction-tuned nanodomain (both directions operation). The combination of these techniques is applicable to a wide range of nano-optoelectronic devices including nonvolatile PL memory devices and on-demand rewritable biosensors that can be integrated into nano- and microtips which are transparent, ultrathin, flexible, and inexpensive.	[Tsuchiya, Takashi; Tsuruoka, Tohru; Terabe, Kazuya; Aono, Masakazu] Natl Inst Mat Sci, Int Ctr Mat Nanoarchitechton WPI MANA, Tsukuba, Ibaraki 3050044, Japan	Tsuchiya, T (reprint author), Natl Inst Mat Sci, Int Ctr Mat Nanoarchitechton WPI MANA, 1-1 Namiki, Tsukuba, Ibaraki 3050044, Japan.	TSUCHIYA.Takashi@nims.go.jp; TERABE.Kazuya@nims.go.jp					Kaiser AB, 2009, NANO LETT, V9, P1787, DOI 10.1021/nl803698b; Mattevi C, 2009, ADV FUNCT MATER, V19, P2577, DOI 10.1002/adfm.200900166; Chien CT, 2012, ANGEW CHEM INT EDIT, V51, P6662, DOI 10.1002/anie.201200474; Alberius PCA, 2002, CHEM MATER, V14, P3284, DOI 10.1021/cm011209u; Daiko Y, 2002, CHEM MATER, V14, P4624, DOI 10.1021/cm020323p; Luo ZT, 2009, APPL PHYS LETT, V94, DOI 10.1063/1.3098358; Wang X, 2008, ANGEW CHEM INT EDIT, V47, P2990, DOI 10.1002/anie.200704909; Kochmann S, 2012, J FLUORESC, V22, P849, DOI 10.1007/s10895-011-1019-8; Eng AYS, 2013, ACS NANO, V7, P5930, DOI 10.1021/nn4016289; Sheats JR, 1996, SCIENCE, V273, P884, DOI 10.1126/science.273.5277.884; Jung JH, 2010, ANGEW CHEM INT EDIT, V49, P5708, DOI 10.1002/anie.201001428; Li M, 2012, J MATER CHEM, V22, P23374, DOI 10.1039/c2jm35417a; Tsuchiya T, 2014, ADV MATER, V26, P1087, DOI 10.1002/adma.201304770; Ambrosi A, 2013, CHEM-EUR J, V19, P4748, DOI 10.1002/chem.201204226; Mathkar A, 2012, J PHYS CHEM LETT, V3, P986, DOI 10.1021/jz300096t; Loh KP, 2010, NAT CHEM, V2, P1015, DOI [10.1038/nchem.907, 10.1038/NCHEM.907]; Yang D, 2012, CHEM COMMUN, V48, P8078, DOI 10.1039/c2cc33829g; Gao W, 2009, NAT CHEM, V1, P403, DOI [10.1038/nchem.281, 10.1038/NCHEM.281]; Cushing SK, 2014, ACS NANO, V8, P1002, DOI 10.1021/nn405843d; Khurana G, 2013, NANOSCALE, V5, P3346, DOI [10.1039/c3nr34291c, 10.1039/c3nr34291]; Ju HM, 2010, J KOREAN PHYS SOC, V57, P1649, DOI 10.3938/jkps.57.1649; Weber CM, 2010, SMALL, V6, P184, DOI 10.1002/smll.200901448; Kozawa D, 2014, J PHYS CHEM LETT, V5, P1754, DOI 10.1021/jz500516u; Park S, 2009, NAT NANOTECHNOL, V4, P217, DOI [10.1038/nnano.2009.58, 10.1038/NNANO.2009.58]; Eda G, 2009, J PHYS CHEM C, V113, P15768, DOI 10.1021/jp9051402; Eda G, 2008, NAT NANOTECHNOL, V3, P270, DOI 10.1038/nnano.2008.83; Gokus T, 2009, ACS NANO, V3, P3963, DOI 10.1021/nn9012753; Zhao XH, 2011, ANAL CHEM, V83, P5062, DOI 10.1021/ac200843x; Exarhos AL, 2013, NANO LETT, V13, P344, DOI 10.1021/nl302624p; Li HB, 2002, ADV MATER, V14, P912, DOI 10.1002/1521-4095(20020618)14:12<912::AID-ADMA912>3.0.CO;2-L; Masubuchi S, 2011, NANO LETT, V11, P4542, DOI 10.1021/nl201448q; Funke K, 2013, SCI TECHNOL ADV MAT, V14, DOI 10.1088/1468-6996/14/4/043502; Eda G, 2010, ADV MATER, V22, P505, DOI 10.1002/adma.200901996; Robinson JT, 2008, NANO LETT, V8, P3137, DOI 10.1021/nl8013007; Wang Y, 2009, J PHYS CHEM C, V113, P13103, DOI 10.1021/jp902214f; Chuang CH, 2014, SCI REP-UK, V4, DOI 10.1038/srep04525; Fujimoto H, 2003, CARBON, V41, P1585, DOI 10.1016/S0008-6223(03)00116-7; Galande C, 2011, SCI REP-UK, V1, DOI 10.1038/srep00085; Lu YF, 1997, NATURE, V389, P364; Huh SH, 2011, PHYSICS AND APPLICATIONS OF GRAPHENE - EXPERIMENTS, P73; Jeon SJ, 2014, J AM CHEM SOC, V136, P10842, DOI 10.1021/ja504276z; Matsumoto Y., 2011, J PHYS CHEM C, V115, P19280; Miyoshi S, 2014, CHEM MATER, V26, P5194, DOI 10.1021/cm5012923; Shang JZ, 2012, SCI REP-UK, V2, DOI 10.1038/srep00792; McDonald MP, 2013, NANO LETT, V13, P5777, DOI 10.1021/nl402057j; Tsuchiya T, 2014, APPL PHYS LETT, V105, DOI 10.1063/1.4901103; Tsuchiya T, 2013, APPL PHYS LETT, V103, DOI 10.1063/1.4818736; Tsuchiya T, 2013, SCI TECHNOL ADV MAT, V14, DOI 10.1088/1468-6996/14/4/045001	48	1	1	AMER CHEMICAL SOC	WASHINGTON	1155 16TH ST, NW, WASHINGTON, DC 20036 USA	1936-0851	1936-086X		ACS NANO	ACS Nano	FEB	2015	9	2					2102	2110		10.1021/nn507363g		9	Chemistry, Multidisciplinary; Chemistry, Physical; Nanoscience & Nanotechnology; Materials Science, Multidisciplinary	Chemistry; Science & Technology - Other Topics; Materials Science	CB9GR	WOS:000349940500106		
J	Yin, G; Nishikawa, M; Nosaka, Y; Srinivasan, N; Atarashi, D; Sakai, E; Miyauchi, M				Yin, Ge; Nishikawa, Masami; Nosaka, Yoshio; Srinivasan, Nagarajan; Atarashi, Daiki; Sakai, Etsuo; Miyauchi, Masahiro			Photocatalytic Carbon Dioxide Reduction by Copper Oxide Nanocluster-Grafted Niobate Nanosheets	ACS NANO			English	Article						photocatalysis; electrocatalysis; CO2 reduction; nanocluster; nanosheet; copper oxide; niobate	LIGHT-SENSITIVE PHOTOCATALYST; ELECTROCHEMICAL CO2 REDUCTION; VISIBLE-LIGHT; REACTION-MECHANISM; CHEMILUMINESCENCE PHOTOMETRY; HYBRID PHOTOCATALYSTS; ESR SPECTROSCOPY; METAL-ELECTRODES; CU NANOPARTICLES; LOW-TEMPERATURE	Amorphous copper oxide (Cu(II)) nanoclusters function as efficient electrocatalysts for the reduction of carbon dioxide (CO2) to carbon monoxide (CO). In addition to promoting electrocatalytic activity, Cu(II) nanoclusters act as efficient cocatalyts for CO2 photoreduction when grafted onto the surface of a semiconductor (light harvester), such as niobate (Nb3O8) nanosheets. Here, the photocatalytic activity and reaction pathway of Cu(II)-grafted Nb3O8 nanosheets was investigated using electron spin resonance (ESR) analysis and isotope-labeled molecules (H218O and (CO2)-C-13). The results of the labeling experiments demonstrated that under UV irradiation, electrons are extracted from water to produce oxygen (O-18(2)) and then reduce CO2 to produce (CO)-C-13. ESR analysis confirmed that excited holes in the valence band of Nb3O8 nanosheets react with water, and that excited electrons in the conduction band of Nb3O8 nanosheets are injected into the Cu(II) nanoclusters through the interface and are involved in the reduction of CO2 into CO. The Cu(II) nanocluster-grafted Nb3O8 nanosheets are composed of nontoxic and abundant elements and can be facilely synthesized by a wet chemical method. The nanocluster grafting technique described here can be applied for the surface activation of various semiconductor light harvesters, such as metal oxide and/or metal chalcogenides, and is expected to aid in the development of efficient CO2 photoreduction systems.	[Yin, Ge; Srinivasan, Nagarajan; Atarashi, Daiki; Sakai, Etsuo; Miyauchi, Masahiro] Tokyo Inst Technol, Grad Sch Sci & Engn, Dept Met & Ceram Sci, Meguro Ku, Tokyo 1528552, Japan; [Nishikawa, Masami; Nosaka, Yoshio] Nagaoka Univ Technol, Dept Mat Sci & Technol, Nagaoka, Niigata 9402188, Japan; [Miyauchi, Masahiro] Japan Sci & Technol Agcy JST, Kawaguchi, Saitama 3320012, Japan	Miyauchi, M (reprint author), Tokyo Inst Technol, Grad Sch Sci & Engn, Dept Met & Ceram Sci, Meguro Ku, 2-12-1 Ookayama, Tokyo 1528552, Japan.	mmiyauchi@ceram.titech.ac.jp	Miyauchi, Masahiro/O-3535-2015		Advanced Catalytic Transformation program for Carbon utilization (ACT-C), Japan Science and Technology Agency (JST)	This work has been supported by a grant from Advanced Catalytic Transformation program for Carbon utilization (ACT-C), Japan Science and Technology Agency (JST). We thank Dr. K. Kamiya, Tokyo University, for the XANES and EXAFS measurements performed at SPring-8. We also thank Mr. A. Genseki and Mr. K. Hori at the Center for Advanced Materials Analysis for help with the TEM characterization, and also acknowledge Mr. Greg Newton for the critical reading of the manuscript. G. Yin and M. Miyauchi proposed the concept. G. Yin acquired experimental data. M. Nishikawa and Y. Nosaka performed the ESR analysis. N. Srinivasan, D. Atarashi, and E. Sakai gave important suggestions. G. Yin and M. Miyauchi wrote the manuscript. M. Miyauchi conceived the project.	HALMANN M, 1983, SOL ENERGY, V31, P429, DOI 10.1016/0038-092X(83)90145-7; Neatu S, 2014, J AM CHEM SOC, V136, P15969, DOI 10.1021/ja506433k; Anandan S, 2011, PHYS CHEM CHEM PHYS, V13, P14937, DOI 10.1039/c1cp21514k; Tran PD, 2012, ENERG ENVIRON SCI, V5, P5902, DOI 10.1039/c2ee02849b; In SI, 2012, ANGEW CHEM INT EDIT, V51, P3915, DOI 10.1002/anie.201108936; Nosaka Y, 2012, APPL CATAL B-ENVIRON, V111, P636, DOI 10.1016/j.apcatb.2011.11.017; Habisreutinger SN, 2013, ANGEW CHEM INT EDIT, V52, P7372, DOI 10.1002/anie.201207199; Liu M, 2014, J MATER CHEM A, V2, P13571, DOI 10.1039/c4ta02211d; Li CW, 2012, J AM CHEM SOC, V134, P7231, DOI 10.1021/ja3010978; Liu M, 2014, ACS NANO, V8, P7229, DOI 10.1021/nn502247x; Reske R, 2013, J PHYS CHEM LETT, V4, P2410, DOI 10.1021/jz401087q; HARA K, 1995, J ELECTROANAL CHEM, V391, P141, DOI 10.1016/0022-0728(95)03935-A; SCAIFE DE, 1980, SOL ENERGY, V25, P41, DOI 10.1016/0038-092X(80)90405-3; Durand WJ, 2011, SURF SCI, V605, P1354, DOI 10.1016/j.susc.2011.04.028; INOUE T, 1979, NATURE, V277, P637, DOI 10.1038/277637a0; Magesh G, 2014, J MATER CHEM A, V2, P2044, DOI 10.1039/c3ta14408a; Iizuka K, 2011, J AM CHEM SOC, V133, P20863, DOI 10.1021/ja207586e; Schouten KJP, 2012, J AM CHEM SOC, V134, P9864, DOI 10.1021/ja302668n; Baturina OA, 2014, ACS CATAL, V4, P3682, DOI 10.1021/cs500537y; Ba X, 2014, J PHYS CHEM C, V118, P24467, DOI 10.1021/jp5063397; Qiu XQ, 2010, J AM CHEM SOC, V132, P15259, DOI 10.1021/ja105846n; Kuhl KP, 2014, J AM CHEM SOC, V136, P14107, DOI 10.1021/ja505791r; Barton EE, 2008, J AM CHEM SOC, V130, P6342, DOI 10.1021/ja0776327; ISHIDA H, 1987, ORGANOMETALLICS, V6, P181, DOI 10.1021/om00144a033; Qiu XQ, 2012, ACS NANO, V6, P1609, DOI 10.1021/nn2045888; Manthiram K, 2014, J AM CHEM SOC, V136, P13319, DOI 10.1021/ja5065284; Irie H, 2009, J PHYS CHEM C, V113, P10761, DOI 10.1021/jp903063z; Suzuki TM, 2012, J MATER CHEM, V22, P24584, DOI 10.1039/c2jm33980c; Akatsuka K, 2008, J PHYS CHEM SOLIDS, V69, P1288, DOI 10.1016/j.jpcs.2007.10.018; Reske R, 2014, J AM CHEM SOC, V136, P6978, DOI 10.1021/ja500328k; Sato S, 2010, ANGEW CHEM INT EDIT, V49, P5101, DOI 10.1002/anie.201000613; Liu M, 2011, CHEM MATER, V23, P5282, DOI 10.1021/cm203025b; Hu JL, 2013, APPL CATAL B-ENVIRON, V142, P598, DOI 10.1016/j.apcatb.2013.05.079; Sato S, 2011, J AM CHEM SOC, V133, P15240, DOI 10.1021/ja204881d; HALMANN M, 1978, NATURE, V275, P115, DOI 10.1038/275115a0; Zhang YJ, 2014, ACS CATAL, V4, P3742, DOI 10.1021/cs5012298; Friebel D, 2014, J PHYS CHEM C, V118, P7954, DOI 10.1021/jp412000j; Arai T, 2009, J PHYS CHEM C, V113, P6602, DOI 10.1021/jp8111342; AZUMA M, 1990, J ELECTROCHEM SOC, V137, P1772, DOI 10.1149/1.2086796; Nosaka Y, 2011, J PHYS CHEM C, V115, P21283, DOI 10.1021/jp2070634; Kauffman DR, 2011, J PHYS CHEM LETT, V2, P2038, DOI 10.1021/jz200850y; Anandan S, 2010, APPL CATAL B-ENVIRON, V100, P502, DOI 10.1016/j.apcatb.2010.08.029; NODA H, 1990, CHEM LETT, P1757, DOI 10.1246/cl.1990.1757; Shown I, 2014, NANO LETT, V14, P6097, DOI 10.1021/nl503609v; Hori Y, 2008, MOD ASP ELECTROCHEM, P89; Copperthwaite RG, 1988, CATAL LETT, V1, P11, DOI 10.1007/BF00765348; Dias Filho N. L., 1999, MIKROCHIM ACTA, V<IT>130</IT>, P233; Katsumata K, 2010, ACS APPL MATER INTER, V2, P1236, DOI 10.1021/am100091f; Kim D, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms5948; Peterson A. A., 2001, ENERG ENVIRON SCI, V3, P1311; Satoshi Kaneco K. I. K. O. T. M., 1999, ENERGY SOURCE, V21, P643, DOI 10.1080/00908319950014588; Calle-Vallejo F, 2013, ANGEW CHEM INT EDIT, V52, P7282, DOI 10.1002/anie.201301470	52	9	9	AMER CHEMICAL SOC	WASHINGTON	1155 16TH ST, NW, WASHINGTON, DC 20036 USA	1936-0851	1936-086X		ACS NANO	ACS Nano	FEB	2015	9	2					2111	2119		10.1021/nn507429e		9	Chemistry, Multidisciplinary; Chemistry, Physical; Nanoscience & Nanotechnology; Materials Science, Multidisciplinary	Chemistry; Science & Technology - Other Topics; Materials Science	CB9GR	WOS:000349940500107		
J	Chen, H; Lin, L; Li, HF; Li, JZ; Lin, JM				Chen, Hui; Lin, Ling; Li, Haifang; Li, Jianzhang; Lin, Jin-Ming			Aggregation-Induced Structure Transition of Protein-Stabilized Zinc/Copper Nanoclusters for Amplified Chemiluminescence	ACS NANO			English	Article						nanoclusters; nanoparticles; surface plasmon resonance; fluorescence; chemiluminescence	MN/CDSE QUANTUM DOTS; ACTIVE-SITE; METAL NANOCLUSTERS; HYDROGEN-PEROXIDE; AU NANOCLUSTERS; CU NANOCLUSTERS; LABEL-FREE; FLUORESCENCE; NANOPARTICLES; CLUSTERS	A stable, water-soluble fluorescent Zn/Cu nanocluster (NC) capped with a model protein, bovine serum albumin (BSA), was synthesized and applied to the reaction of hydrogen peroxide and sodium hydrogen carbonate. A significantly amplified chemiluminescence (CL) from the accelerated decomposition of peroxymonocarbonate (HCO4 ) by the nanosluster was observed. The CL reaction led to a structure change of BSA and aggregation of Zn/Cu NCs. In the presence of H2O2, Zn/CuS bonding between BSA scaffolds and the encapsulated Zn/Cu@BSA NC was oxidized to form a disulfide product. Zn/Cu@BSA NCs were prone to aggregate to form larger nanoparticles without the protection of scaffolds. It is revealed that the strong CL emission was initiated from the catalysis of Zn/Cu@BSA NC and the surface plasmon coupling of the formed Zn/Cu nanoparticles in a single chemical reaction. This amplified CL was successfully exploited for selective sensing of hydrogen peroxide in environmental samples.	[Chen, Hui; Li, Jianzhang] Beijing Forestry Univ, MOE Key Lab Wooden Mat Sci & Applicat, Beijing 100083, Peoples R China; [Chen, Hui; Li, Haifang; Lin, Jin-Ming] Tsinghua Univ, Dept Chem, Beijing Key Lab Microanalyt Methods & Instrumenta, Key Lab Bioorgan Phosphorus Chem & Chem Biol, Beijing 100084, Peoples R China; [Lin, Ling] Univ Tokyo, Fac Engn, Tokyo 1138654, Japan	Lin, JM (reprint author), Tsinghua Univ, Dept Chem, Beijing Key Lab Microanalyt Methods & Instrumenta, Key Lab Bioorgan Phosphorus Chem & Chem Biol, Beijing 100084, Peoples R China.	jmlin@mail.tsinghua.edu.cn			National Natural Science Foundation of China [81373373, 91213305]	This work was supported by National Natural Science Foundation of China (Nos. 81373373, 91213305).	Kelly SM, 2000, CURR PROTEIN PEPT SC, V1, P349, DOI 10.2174/1389203003381315; Dainese T, 2014, ACS NANO, V8, P3904, DOI 10.1021/nn500805n; Xu YL, 2014, NANOSCALE, V6, P1515, DOI 10.1039/c3nr06040c; Jia XF, 2014, CHEM COMMUN, V50, P237, DOI 10.1039/c3cc47771a; Jin LH, 2011, BIOSENS BIOELECTRON, V26, P1965, DOI 10.1016/j.bios.2010.08.019; Kelly KL, 2003, J PHYS CHEM B, V107, P668, DOI 10.1021/jp026731y; Liu XQ, 2013, NANO LETT, V13, P309, DOI 10.1021/nl304283c; Choi S, 2012, CHEM SOC REV, V41, P1867, DOI 10.1039/c1cs15226b; Yu JH, 2009, ANGEW CHEM INT EDIT, V48, P318, DOI 10.1002/anie.200804137; Luo ZT, 2014, CHEM COMMUN, V50, P5143, DOI 10.1039/c3cc47512c; Yu Y, 2014, CHEM COMMUN, V50, P13805, DOI 10.1039/c4cc06914e; Yin JJ, 2013, ANAL CHEM, V85, P12011, DOI 10.1021/ac402989u; Wen F, 2011, ANAL CHEM, V83, P1193, DOI 10.1021/ac1031447; Goswami N, 2014, NANOSCALE, V6, P13328, DOI 10.1039/c4nr04561k; Zheng J, 2007, ANNU REV PHYS CHEM, V58, P409, DOI 10.1146/annurev.physchem.58.032806.104546; Yuan ZQ, 2014, CHEM COMMUN, V50, P9800, DOI 10.1039/c4cc02981j; Lin JM, 1998, ANAL CHIM ACTA, V371, P171, DOI 10.1016/S0003-2670(98)00304-3; Lane BS, 2002, J AM CHEM SOC, V124, P11946, DOI 10.1021/ja025956j; Lu C, 2004, CATAL TODAY, V90, P343, DOI 10.1016/j.cattod.2004.04.045; Goswami N, 2011, ANAL CHEM, V83, P9676, DOI 10.1021/ac202610e; Zeng CJ, 2014, J AM CHEM SOC, V136, P11922, DOI 10.1021/ja506802n; Williams WD, 2010, J AM CHEM SOC, V132, P14018, DOI 10.1021/ja1064262; Chen H, 2012, ANAL CHEM, V84, P8871, DOI 10.1021/ac302300z; Wei WT, 2011, J AM CHEM SOC, V133, P2060, DOI 10.1021/ja109303z; Enkin N, 2014, ACS NANO, V8, P11666, DOI 10.1021/nn504983j; Zhou ZH, 2010, SOL ENERG MAT SOL C, V94, P2042, DOI 10.1016/j.solmat.2010.06.010; Richardson DE, 2000, J AM CHEM SOC, V122, P1729, DOI 10.1021/ja9927467; Sun J, 2014, NANOSCALE, V6, P5449, DOI 10.1039/c4nr00445k; Zhou ZX, 2015, NANOSCALE, V7, P1296, DOI 10.1039/c4nr04889j; Wen Q, 2013, ANAL CHEM, V85, P11681, DOI 10.1021/ac403308b; Xie JP, 2009, J AM CHEM SOC, V131, P888, DOI 10.1021/ja806804u; Chen ZY, 2011, INORG CHEM, V50, P4674, DOI 10.1021/ic2004003; Jia XF, 2014, CHEM COMMUN, V50, P9565, DOI 10.1039/c4cc03913k; CHANCE B, 1979, PHYSIOL REV, V59, P527; Asian K., 2009, CHEM SOC REV, V38, P2556; BOLLYKY LJ, 1970, J AM CHEM SOC, V92, P3230, DOI 10.1021/ja00713a077; Chen H, 2010, J PHYS CHEM A, V114, P10049, DOI 10.1021/jp104060x; Choi S, 2012, PHOTOCH PHOTOBIO SCI, V11, P274, DOI 10.1039/c1pp05276d; Cui H, 2005, J PHYS CHEM B, V109, P3099, DOI 10.1021/jo048057c; DECORPO JJ, 1972, J AM CHEM SOC, V94, P2879, DOI 10.1021/ja00763a067; ELBANOWSKI M, 1988, PHOTOCHEM PHOTOBIOL, V47, P463, DOI 10.1111/j.1751-1097.1988.tb02752.x; Gianotti E, 2010, CHEM-EUR J, V16, P8202, DOI 10.1002/chem.201000403; Li QQ, 2011, J PHYS CHEM C, V115, P10964, DOI 10.1021/jp200711a; MOSTAFAVI M, 1990, CHEM PHYS LETT, V167, P193, DOI 10.1016/0009-2614(90)85004-V; Pithawalla YB, 2003, SCRIPTA MATER, V48, P671, DOI 10.1016/S1359-6462(02)00564-X; Qian MC, 2010, ACS NANO, V4, P235, DOI 10.1021/nn9010297; Quintanar L, 2005, J AM CHEM SOC, V127, P13832, DOI 10.1021/ja0421405; Sarkar B, 2014, CHEM COMMUN, V50, P9707, DOI 10.1039/c4cc03842h; Stawinska D., 1998, J BIOLUMIN CHEMILUMI, V13, P13; Villamena FA, 2007, J PHYS CHEM A, V111, P384, DOI 10.1021/jp065692d; Zeng CJ, 2014, CHEM MATER, V26, P2635, DOI 10.1021/cm500139t; Zheng WW, 2011, J PHYS CHEM C, V115, P23305, DOI 10.1021/jp2082215; Zheng WW, 2011, J AM CHEM SOC, V133, P7482, DOI 10.1021/ja200508e; Zheng WW, 2012, NANO LETT, V12, P3132, DOI 10.1021/nl3010447	54	2	2	AMER CHEMICAL SOC	WASHINGTON	1155 16TH ST, NW, WASHINGTON, DC 20036 USA	1936-0851	1936-086X		ACS NANO	ACS Nano	FEB	2015	9	2					2173	2183		10.1021/acsnano.5b00141		11	Chemistry, Multidisciplinary; Chemistry, Physical; Nanoscience & Nanotechnology; Materials Science, Multidisciplinary	Chemistry; Science & Technology - Other Topics; Materials Science	CB9GR	WOS:000349940500114		
J	Watatani, H; Yamasaki, H; Maeshima, Y; Nasu, T; Hinamoto, N; Ujike, H; Sugiyama, H; Sakai, Y; Tanabe, K; Makino, H				Watatani, Hiroyuki; Yamasaki, Hiroko; Maeshima, Yohei; Nasu, Tatsuyo; Hinamoto, Norikazu; Ujike, Haruyo; Sugiyama, Hitoshi; Sakai, Yoshiki; Tanabe, Katsuyuki; Makino, Hirofumi			ONO-1301, a Sustained-Release Prostacyclin Analog, Ameliorates the Renal Alterations in a Mouse Type 2 Diabetes Model Possibly Through Its Protective Effects on Mesangial Cells	ACTA MEDICA OKAYAMA			English	Article						prostacyclin; ONO-1301; diabetic nephropathy; TGF-beta 1; diabetes mellitus	PULMONARY-HYPERTENSION; INHIBITORY-ACTIVITY; GROWTH-FACTOR; MACROPHAGE RECRUITMENT; RECEPTOR ANTAGONIST; SINGLE INJECTION; BERAPROST SODIUM; RATS; MICE; ANGIOGENESIS	Diabetic nephropathy is the most common pathological disorder predisposing patients to end-stage renal disease. Considering the increasing prevalence of type 2 diabetes mellitus worldwide, novel therapeutic approaches are urgently needed. ONO-1301 is a novel sustained-release prostacyclin analog that inhibits thromboxane A(2) synthase. Here we examined the therapeutic effects of the intermittent administration of slow-release ONO-1301 (SR-ONO) on diabetic nephropathy in obese type 2 diabetes mice, as well as its direct effects on mesangial cells. The subcutaneous injection of SR-ONO (3mg/kg) every 3 wks did not affect the obesity or hyperglycemia in the db/db obese mice used as a model of type 2 diabetes, but it significantly ameliorated their albuminuria, glomerular hypertrophy, glomerular accumulation of type IV collagen, and monocyte/macrophage infiltration, and also the increase of TGF-beta 1, a-smooth muscle actin (alpha-SMA) and MCP-1 compared to vehicle treatment. In cultured mouse mesangial cells, ONO-1301 concentration-dependently suppressed the increases in TGF-beta, type IV collagen, alpha-SMA, MCP-1 and fibronectin induced by high ambient glucose, at least partly through prostacyclin (PGI(2)) receptor-mediated signaling. Taken together, these results suggest the potential therapeutic efficacy of the intermittent administration of SR-ONO against type 2 diabetic nephropathy, possibly through protective effects on mesangial cells.	[Watatani, Hiroyuki; Yamasaki, Hiroko; Maeshima, Yohei; Nasu, Tatsuyo; Hinamoto, Norikazu; Ujike, Haruyo; Sugiyama, Hitoshi; Tanabe, Katsuyuki; Makino, Hirofumi] Okayama Univ, Grad Sch Med Dent & Pharmaceut Sci, Dept Med & Clin Sci, Okayama 7008558, Japan; [Maeshima, Yohei] Okayama Univ, Grad Sch Med Dent & Pharmaceut Sci, Dept Chron Kidney Dis & Cardiovasc Dis, Okayama 7008558, Japan; [Sugiyama, Hitoshi] Okayama Univ, Grad Sch Med Dent & Pharmaceut Sci, Ctr Chron Kidney Dis & Peritoneal Dialysis, Okayama 7008558, Japan; [Sakai, Yoshiki] ONO Pharmaceut Co Ltd, Osaka 5418564, Japan	Tanabe, K (reprint author), Okayama Univ, Grad Sch Med Dent & Pharmaceut Sci, Dept Med & Clin Sci, Okayama 7008558, Japan.	tanabek@okayama-u.ac.jp			Ministry of Education, Science and Culture of Japan; Ono Pharmaceutical Co. Ltd.; Ono Pharmaceutical Co.	A portion of this study was supported by research grants from Ono Pharmaceutical Co. Ltd. (2010-2011, YM), and by a Grant-in-Aid for Scientific Research from the Ministry of Education, Science and Culture of Japan (2010-2011, TN). Ono Pharmaceutical Co. financially supported this study in part and provided the ONO-1301 and SR-ONO. Ono Pharmaceutical Co. had no role in this study's design, experimental assays, data collection or statistical analysis of the experimental data, or the interpretation of the experimental results, decision to publish, or preparation of the manuscript. Ono Pharmaceutical Co. did not give any qualitative alterations on the experimental data throughout this study.	Huijun Wang, 2005, Exp Mol Pathol, V78, P17, DOI 10.1016/j.yexmp.2004.07.006; SHARMA K, 1995, DIABETES, V44, P1139, DOI 10.2337/diabetes.44.10.1139; Yamasaki H, 2011, PROSTAG LEUKOTR ESS, V84, P99, DOI 10.1016/j.plefa.2010.11.005; Chow FY, 2007, DIABETOLOGIA, V50, P471, DOI 10.1007/s00125-006-0497-8; Saito D, 2011, AM J PHYSIOL-RENAL, V300, pF873, DOI 10.1152/ajprenal.00503.2010; Tanabe K, 2007, KIDNEY INT, V71, P227, DOI 10.1038/sj.ki.5002040; MONCADA S, 1979, NEW ENGL J MED, V300, P1142, DOI 10.1056/NEJM197905173002006; McLaughlin VV, 1998, NEW ENGL J MED, V338, P273, DOI 10.1056/NEJM199801293380501; Nasu T, 2009, DIABETES, V58, P2365, DOI 10.2337/db08-1790; Sharma K, 1996, DIABETES, V45, P522, DOI 10.2337/diabetes.45.4.522; Watanabe M, 2009, AM J NEPHROL, V30, P1, DOI 10.1159/000195722; Maeshima Y, 2002, SCIENCE, V295, P140, DOI 10.1126/science.1065298; Nasu T, 2012, AM J PHYSIOL-RENAL, V302, pF1616, DOI 10.1152/ajprenal.00538.2011; MONCADA S, 1976, NATURE, V263, P663, DOI 10.1038/263663a0; BROWNLEE M, 1988, NEW ENGL J MED, V318, P1315; Yamashita T, 2002, DIABETES RES CLIN PR, V57, P149, DOI 10.1016/S0168-8227(02)00054-2; Makino H, 1996, DIABETES, V45, P488, DOI 10.2337/diabetes.45.4.488; Murakami S, 2006, AM J PHYSIOL-LUNG C, V290, pL59, DOI 10.1152/ajplung.00042.2005; Awad AS, 2006, AM J PHYSIOL-RENAL, V290, pF1516, DOI 10.1152/ajprenal.00311.2005; BILOUS RW, 1989, DIABETES, V38, P1142, DOI 10.2337/diabetes.38.9.1142; ELLIS EN, 1986, KIDNEY INT, V29, P889, DOI 10.1038/ki.1986.82; Gonzalez Suarez ML, 2013, WORLD J DIABETES, V4, P245; Hayashi K, 1997, JPN J PHARMACOL, V73, P73, DOI 10.1254/jjp.73.73; Hazekawa M, 2012, J PHARM PHARMACOL, V64, P353, DOI 10.1111/j.2042-7158.2011.01416.x; Ichinose K, 2006, DIABETES, V55, P1232, DOI 10.2337/db05-1367; JOHNSON G, 1990, CIRC RES, V66, P1362; Kataoka M, 2005, AM J RESP CRIT CARE, V172, P1575, DOI 10.1164/rccm.200501-1020C; lchinose K, 2005, DIABETES, V54, P2891; lehara N, 1996, KIDNEY INT, V49, P1330; lmawaka H, 1998, J PHARMACOL EXP THER, V284, P949; lwata H, 2009, LIFE SCI, V85, P255; Maeshima Y, 1998, J CLIN INVEST, V101, P2589, DOI 10.1172/JCI429; Maeshima Y, 1996, J AM SOC NEPHROL, V7, P2219; Mizuno S, 2004, AM J PHYSIOL-RENAL, V286, pF134, DOI 10.1152/ajprenal.00199.2003; Nakamura K, 2007, CLIN SCI, V112, P607, DOI 10.1042/CS20060301; Obata H, 2008, AM J RESP CRIT CARE, V177, P195, DOI 10.1164/rccm.200703-349OC; Qi XM, 2006, NEPHRON EXP NEPHROL, V104, pE147, DOI 10.1159/000094966; Sassy-Prigent C, 2000, DIABETES, V49, P466, DOI 10.2337/diabetes.49.3.466; Sebekova K, 2007, DIABETES, V56, P968, DOI 10.2337/db06-1136; Uchida T, 2013, J PHARMACOL SCI, V123, P392, DOI 10.1254/jphs.13073FP; Weibel ER, 1979, STEREOLOGICAL METHOD, V1, P51; Xu SQ, 2006, DIABETES, V55, P110, DOI 10.2337/diabetes.55.01.06.db05-0831; Yamamoto Y, 2004, DIABETES, V53, P1831, DOI 10.2337/diabetes.53.7.1831	43	0	0	OKAYAMA UNIV MED SCHOOL	OKAYAMA	EDITORIAL OFFICE, ACTA MEDICA OKAYAMA OKAYAMA UNIVERSITY MEDICAL SCHOOL 2-5-1 SHIKATA-CHO, KITA-KU, OKAYAMA, 700-8558, JAPAN	0386-300X			ACTA MED OKAYAMA	Acta Med. Okayama	FEB	2015	69	1					1	15				15	Medicine, Research & Experimental	Research & Experimental Medicine	CB6ME	WOS:000349740300001		
J	Suzuki, N; Takata, M; Shirafuji, Y; Otsuka, M; Yamasaki, O; Asagoe, K; Hatta, N; Iwatsuki, K				Suzuki, Norihiro; Takata, Minoru; Shirafuji, Yoshinori; Otsuka, Masaki; Yamasaki, Osamu; Asagoe, Kenji; Hatta, Naohito; Iwatsuki, Keiji			Assessment of Melanoma-Initiating Cell Markers and Conventional Parameters in Sentinel Lymph Nodes of Malignant Melanoma	ACTA MEDICA OKAYAMA			English	Article						melanoma; cancer-initiating cell; sentinel lymph node; ABCB5	METASTATIC MELANOMA; STEM-CELL; BIOPSY; IDENTIFICATION; SUBPOPULATION; GROWTH	Sentinel lymph node (SLN) biopsies have widely been used for the detection of occult LN metastasis of malignant melanoma (MM). In addition to conventional biomarkers, we assessed the diagnostic and prognostic significance of melanoma-initiating cell (MIC) markers in SLNs of MM. We examined the expressions of gp100, MART-1 and tyrosinase mRNA for routine diagnosis and those of ABCB5, CD133, nestin, KDM5B, NGFR and RANK mRNA as MIC markers. The presence of micrometastasis was confirmed immunohistochemically using antibodies to S-100, HMB-45, MART-1, and tyrosinase. Discordance between immunohistochemical and molecular data was observed in 14 of 70 (20.0%) patients, among whom five (7.1%) were positive for only molecular markers; two of these five patients tested positive for micrometastasis by repeated immunohistochemical stainings. The quantitative expression levels of gp100, MART-1, and tyrosinase mRNA were significantly higher in the metastatic LNs; the cut-off values remain to be elucidated. ABCB5 mRNA expression was detected more frequently in the metastatic SLNs (p < 0.05) and in the group of patients with recurrence. To make a definite diagnosis of metastasis, we still need a combination of immunohistochemical and molecular probes. ABCB5 might be a suitable molecular marker for the detection of melanoma-initiating cells in SLNs.	[Suzuki, Norihiro; Takata, Minoru; Shirafuji, Yoshinori; Otsuka, Masaki; Yamasaki, Osamu; Iwatsuki, Keiji] Okayama Univ, Grad Sch Med Dent & Pharmaceut Sci, Dept Dermatol, Okayama 7008558, Japan; [Asagoe, Kenji] Okayama Med Ctr, Dept Dermatol, Okayama 7011192, Japan; [Hatta, Naohito] Toyama Prefectural Cent Hosp, Dept Dermatol, Toyama 9300975, Japan	Iwatsuki, K (reprint author), Okayama Univ, Grad Sch Med Dent & Pharmaceut Sci, Dept Dermatol, Okayama 7008558, Japan.	keijiiwa@cc.okayama-u.ac.jp			Ministry of Education, Culture, Science and Technology (MEXT), Japan [2351619, 23791269]	This work was partly supported by a Grant-in-Aid for Scientific Research (C) from the Ministry of Education, Culture, Science and Technology (MEXT), Japan (M.T: #C, 2351619, and M.O: #C, 23791269)	Singh SK, 2004, NATURE, V432, P396, DOI 10.1038/nature03128; Kondo T, 2004, P NATL ACAD SCI USA, V101, P781, DOI 10.1073/pnas.0307618100; Morton DL, 2003, ANN SURG, V238, P538, DOI 10.1097/01.sla.0000086543.45557.cb; Rappa G, 2008, STEM CELLS, V26, P3008, DOI 10.1634/stemcells.2008-0601; Frank NY, 2005, CANCER RES, V65, P4320, DOI 10.1158/0008-5472.CAN-04-3327; Boiko AD, 2010, NATURE, V466, P133, DOI 10.1038/nature09161; Al-Hajj M, 2003, P NATL ACAD SCI USA, V100, P3983, DOI 10.1073/pnas.0530291100; Kupas V, 2011, J INVEST DERMATOL, V131, P944, DOI 10.1038/jid.2010.377; Schatton T, 2008, NATURE, V451, P345, DOI 10.1038/nature06489; Roesch A, 2010, CELL, V141, P583, DOI 10.1016/j.cell.2010.04.020; Fincher TR, 2004, ARCH OTOLARYNGOL, V130, P844, DOI 10.1001/archotol.130.7.844; Grichnik JM, 2006, J INVEST DERMATOL, V126, P142, DOI 10.1038/sj.jid.5700017; Jarrett P, 1999, BRIT J DERMATOL, V141, P361; Moroi Y, 2009, INT J CLIN ONCOL, V14, P485, DOI 10.1007/s10147-009-0942-z; Morton DL, 2014, NEW ENGL J MED, V370, P599, DOI 10.1056/NEJMoa1310460; Setoguchi T, 2004, CELL CYCLE, V3, P414; Shivers SC, 1998, JAMA-J AM MED ASSOC, V280, P1410, DOI 10.1001/jama.280.16.1410; Starz H, 2004, ANN SURG ONCOL, V11, p162S, DOI 10.1245/ASO.2004.12.920; Yu LL, 1999, CANCER, V86, P617, DOI 10.1002/(SICI)1097-0142(19990815)86:4<617::AID-CNCR10>3.0.CO;2-S	19	0	0	OKAYAMA UNIV MED SCHOOL	OKAYAMA	EDITORIAL OFFICE, ACTA MEDICA OKAYAMA OKAYAMA UNIVERSITY MEDICAL SCHOOL 2-5-1 SHIKATA-CHO, KITA-KU, OKAYAMA, 700-8558, JAPAN	0386-300X			ACTA MED OKAYAMA	Acta Med. Okayama	FEB	2015	69	1					17	27				11	Medicine, Research & Experimental	Research & Experimental Medicine	CB6ME	WOS:000349740300002		
J	Nakahara, R; Nishida, K; Hashizume, K; Harada, R; Machida, T; Horita, M; Ohtsuka, A; Ozaki, T				Nakahara, Ryuichi; Nishida, Keiichiro; Hashizume, Kenzo; Harada, Ryouzou; Machida, Takahiro; Horita, Masahiro; Ohtsuka, Aiji; Ozaki, Toshifumi			MRI of Rheumatoid Arthritis: Comparing the Outcome Measures in Rheumatology Clinical Trials (OMERACT) Scoring and Volume of Synovitis for the Assessment of Biologic Therapy	ACTA MEDICA OKAYAMA			English	Article						magnetic resonance imaging; rheumatoid arthritis; outcome measures in rheumatology clinical trials scoring system; direct volume measuring; medical work station	REFERENCE IMAGE ATLAS; FINGER JOINTS; WRIST; RA; MEMBRANE; QUANTIFICATION; SCINTIGRAPHY; METHOTREXATE; PROGRESSION; INFLIXIMAB	The outcome measures in rheumatology clinical trials (OMERACT) scores are the most mature quantitation system for rheumatoid arthritis (RA) on magnetic resonance imaging (MRI). Direct measuring techniques of synovial volume have been reported with good reproducibility, although few reports have demonstrated the changes of these measures in response to treatment. To assess these clinical responses, we evaluated the correlation of the changes of clinical activity score 28-joints disease activity score (DAS28-CRP) with the changes of OMERACT scores and with synovial volume measurements. Eight RA patients who were treated by biologic agents were examined with MRI of the dominant affected wrist and finger joints before and one year after the treatment. The total OMERACT score was reduced from 48.0 to 41.3, and synovial volume was reduced from 15.4 to 8.8 milliliters. Positive correlations were seen between the changes of DAS28-CRP and the changes of OMERACT synovitis score (r = 0.27), OMERACT total score (r = 0.43) and synovial volume (r = 0.30). Limited to synovium assessment, synovial volume showed a better correlation with DAS28-CRP than the OMERACT synovitis score. On the other hand, the OMERACT total score showed a higher correlation with DAS28-CRP than synovial volume, probably because the OMERACT total score includes scores for bone erosion and bone edema as well.	[Nakahara, Ryuichi; Hashizume, Kenzo; Harada, Ryouzou; Machida, Takahiro; Horita, Masahiro; Ozaki, Toshifumi] Okayama Univ, Grad Sch Med Dent & Pharmaceut Sci, Dept Orthopaed Surg, Okayama 7008558, Japan; [Nishida, Keiichiro; Ohtsuka, Aiji] Okayama Univ, Grad Sch Med Dent & Pharmaceut Sci, Dept Human Morphol, Okayama 7008558, Japan	Nakahara, R (reprint author), Okayama Univ, Grad Sch Med Dent & Pharmaceut Sci, Dept Orthopaed Surg, Okayama 7008558, Japan.	gmd1602@s.okayama-u.ac.jp					Conaghan P, 2005, ANN RHEUM DIS, V64, P11, DOI 10.1136/ard.2004.031815; Lassere M, 2003, J RHEUMATOL, V30, P1366; Ostergaard M, 2001, ANN RHEUM DIS, V60, P1050, DOI 10.1136/ard.60.11.1050; PALMER WE, 1995, RADIOLOGY, V196, P647; Conaghan P, 2003, J RHEUMATOL, V30, P1376; Ostergaard M, 2003, J RHEUMATOL, V30, P1385; Ejbjerg B, 2005, ANN RHEUM DIS, V64, P23, DOI 10.1136/ard.2004.031823; McQueen F, 2003, J RHEUMATOL, V30, P1387; Ostergaard M, 1997, ARTHRITIS RHEUM, V40, P1856, DOI 10.1002/art.1780401020; Argyropoulou MI, 2005, JOINT BONE SPINE, V72, P557, DOI 10.1016/j.jbspin.2004.08.014; Lee SH, 2003, KOREAN J RADIOL, V4, P170; Ostergaard M, 1997, BRIT J RHEUMATOL, V36, P1166; Ostergaard M, 2005, ANN RHEUM DIS, V64, P1503, DOI 10.1136/ard.2005.038018; Palosaari K, 2006, RHEUMATOLOGY, V45, P1542, DOI 10.1093/rheumatology/kel137; Palosaari K, 2004, RHEUMATOLOGY, V43, P1364, DOI 10.1093/rheumatology/keh302; Savnik A, 2002, EUR RADIOL, V12, P1203, DOI 10.1007/s003300101114; Savnik A, 2002, EUR RADIOL, V12, P94, DOI 10.1007/s003300100986; Savnik A, 2001, EUR RADIOL, V11, P1030, DOI 10.1007/s003300000709; Tam LS, 2007, CLIN RHEUMATOL, V26, P941, DOI 10.1007/s10067-006-0372-5	19	0	0	OKAYAMA UNIV MED SCHOOL	OKAYAMA	EDITORIAL OFFICE, ACTA MEDICA OKAYAMA OKAYAMA UNIVERSITY MEDICAL SCHOOL 2-5-1 SHIKATA-CHO, KITA-KU, OKAYAMA, 700-8558, JAPAN	0386-300X			ACTA MED OKAYAMA	Acta Med. Okayama	FEB	2015	69	1					29	35				7	Medicine, Research & Experimental	Research & Experimental Medicine	CB6ME	WOS:000349740300003		
J	Iwamuro, M; Okada, H; Takata, K; Kawai, Y; Kawano, S; Nasu, J; Kawahara, Y; Tanaka, T; Yoshino, T; Yamamoto, K				Iwamuro, Masaya; Okada, Hiroyuki; Takata, Katsuyoshi; Kawai, Yoshinari; Kawano, Seiji; Nasu, Junichiro; Kawahara, Yoshiro; Tanaka, Takehiro; Yoshino, Tadashi; Yamamoto, Kazuhide			Magnified Endoscopic Features of Duodenal Follicular Lymphoma and Other Whitish Lesions	ACTA MEDICA OKAYAMA			English	Article						duodenal neoplasm; follicular lymphoma; gastrointestinal lymphoma; magnifying endoscopy	GASTROINTESTINAL-TRACT; CASE SERIES	The sensitivity and specificity of magnified endoscopic features for differentiating follicular lymphoma from other diseases with duodenal whitish lesions have never been investigated. Here we compared the magnified endoscopic features of duodenal follicular lymphoma with those of other whitish lesions. We retrospectively reviewed the cases of patients with follicular lymphoma (n = 9), lymphangiectasia (n = 7), adenoma (n = 10), duodenitis (n = 4), erosion (n = 1), lymphangioma (n = 1), and hyperplastic polyp (n = 1). The magnified features of the nine follicular lymphomas included enlarged villi (n = 8), dilated microvessels (n = 5), and opaque white spots of various sizes (n = 9). The lymphangiectasias showed enlarged villi, dilated microvessels, and white spots, but the sizes of the white spots were relatively homogeneous and their margin was clear. Observation of the adenoma and duodenitis revealed only whitish villi. Although the lymphangioma was indistinguishable from the follicular lymphomas by magnified features, it was easily diagnosed based on the macroscopic morphology. In conclusion, magnified endoscopic features, in combination with macroscopic features, are useful for differentiating follicular lymphomas from other duodenal diseases presenting whitish lesions.	[Iwamuro, Masaya] Okayama Univ, Grad Sch Med Dent & Pharmaceut Sci, Dept Mol Hepatol, Okayama 7008558, Japan; [Takata, Katsuyoshi; Yoshino, Tadashi] Okayama Univ, Grad Sch Med Dent & Pharmaceut Sci, Dept Pathol, Okayama 7008558, Japan; [Nasu, Junichiro; Yamamoto, Kazuhide] Okayama Univ, Grad Sch Med Dent & Pharmaceut Sci, Dept Gastroenterol & Hepatol, Okayama 7008558, Japan; [Okada, Hiroyuki; Kawano, Seiji; Kawahara, Yoshiro] Okayama Univ Hosp, Dept Endoscopy, Okayama 7008558, Japan; [Tanaka, Takehiro] Okayama Univ Hosp, Dept Pathol, Okayama 7008558, Japan; [Iwamuro, Masaya; Kawai, Yoshinari] Onomichi Municipal Hosp, Dept Gastroenterol, Onamichi, Hiroshima 7228503, Japan	Iwamuro, M (reprint author), Okayama Univ, Grad Sch Med Dent & Pharmaceut Sci, Dept Mol Hepatol, Okayama 7008558, Japan.	iwamuromasaya@yahoo.co.jp					Shia J, 2002, AM J SURG PATHOL, V26, P216, DOI 10.1097/00000478-200202000-00008; Takata K, 2011, CANCER SCI, V102, P1532, DOI 10.1111/j.1349-7006.2011.01980.x; Schmatz AI, 2011, J CLIN ONCOL, V29, P1445, DOI 10.1200/JCO.2010.32.9193; Harris NL, 1999, J CLIN ONCOL, V17, P3835; Damaj G, 2003, ANN ONCOL, V14, P623, DOI 10.1093/annonc/mdg168; Yoshino T, 2000, AM J SURG PATHOL, V24, P688, DOI 10.1097/00000478-200005000-00007; Chowdhury M, 2009, GASTROENT RES PRACT, DOI 10.1155/2009/835258; Harris NL, 2008, WHO CLASSIFICATION T, P220; Higuchi K, 2007, INTERNAL MED, V46, P705, DOI 10.2169/internalmedicine.46.6087; Inoue N, 2009, GASTROINTEST ENDOSC, V69, P158, DOI 10.1016/j.gie.2008.06.055; Kodama M, 2008, ENDOSCOPY, V40, P343, DOI 10.1055/s-2007-995365; lwamuro M, 2013, CASE REP GASTROENTER, V7, P229; lwamuro M, 2013, GUT LIVER, V7, P258; Nakase H, 2007, INTERNAL MED, V46, P141, DOI 10.2169/internalmedicine.46.6229; Norimura D, 2010, ENDOSCOPY, V42, pE320, DOI 10.1055/s-0030-1255825; Norimura D, 2011, GASTROINTEST ENDOSC, V74, P428, DOI 10.1016/j.gie.2011.03.1237; Sato Y, 2008, J CLIN PATHOL, V61, P377, DOI 10.1136/jcp.2007.049825; Takeuchi K, 2012, CASE REP MED, V2012	18	0	0	OKAYAMA UNIV MED SCHOOL	OKAYAMA	EDITORIAL OFFICE, ACTA MEDICA OKAYAMA OKAYAMA UNIVERSITY MEDICAL SCHOOL 2-5-1 SHIKATA-CHO, KITA-KU, OKAYAMA, 700-8558, JAPAN	0386-300X			ACTA MED OKAYAMA	Acta Med. Okayama	FEB	2015	69	1					37	44				8	Medicine, Research & Experimental	Research & Experimental Medicine	CB6ME	WOS:000349740300004		
J	Iida, T; Inoue, K; Ito, Y; Ishikawa, H; Kagiono, M; Teradaira, R; Chikamura, C; Harada, T; Ezoe, S; Yatsuya, H				Iida, Tadayuki; Inoue, Ken; Ito, Yasuhiro; Ishikawa, Hiroaki; Kagiono, Miwa; Teradaira, Ryoji; Chikamura, Chiho; Harada, Toshihide; Ezoe, Satoko; Yatsuya, Hiroshi			Comparison of Urinary Levels of 8-Hydroxy-2 '-deoxyguanosine between Young Females with and without Depressive Symptoms during Different Menstrual Phases	ACTA MEDICA OKAYAMA			English	Article						depression; 8-OHdG; menstrual cycle	OXIDATIVE STRESS; PSYCHOSOCIAL STRESS; MAJOR DEPRESSION; REACTIVITY; RESPONSES; DISORDER; SYSTEM; CELLS; RISK	This study aimed to clarify the association between depressive symptoms and a marker of oxidative stress-induced DNA damage in young females. Since the menstrual cycle may confound or modify this association, depressive symptoms and urinary levels of 8-hydroxy-2' deoxyguanosine (8-OHdG) were evaluated during each menstrual phase. A total of 57 female fourth-year students (aged 21.6 +/- 0.8) from a Japanese health science university were studied. The menstrual cycle was divided into 3 phases: menstrual (days 1 to 3 after the onset of menses); proliferative (days 13 to 15); and secretory (days 24 to 26). Depressive symptoms were assessed by the self-rating depression scale (SDS). Positive depressive symptoms were defined as a score of 53 or more during 2 different menstrual phases. The association between the presence of depressive symptoms and 8-OHdG levels adjusting for the menstrual cycle was examined by two-way analysis of variance with the menstrual cycle (menstrual, proliferative, and secretory phases) as the within-individual factor. The menstrual cycle did not show a significant correlation with urinary 8-OHdG levels. On the other hand, the menstrual cycle-adjusted 8-OHdG level was significantly higher in those with depressive symptoms (7.01ng/mL) than in those without them (3.98 ng/mL). The ROC curve analysis showed that urinary 8-OHdG levels had reasonably high discriminative performance throughout all the menstrual cycles (0.73-0.81; all p < 0.05). These results indicated the presence of oxidative stress in subjects with depressive symptoms independent of the menstrual cycle.	[Iida, Tadayuki; Harada, Toshihide] Prefectural Univ Hiroshima, Fac Hlth & Welf, Dept Phys Therapy, Mihara, Hiroshima 7230053, Japan; [Chikamura, Chiho] Prefectural Univ Hiroshima, Attached Clin, Mihara, Hiroshima 7230053, Japan; [Inoue, Ken] Shimane Univ, Fac Med, Dept Publ Hlth, Izumo, Shimane 6938501, Japan; [Ezoe, Satoko] Shimane Univ, Hlth Serv Ctr Izumo, Izumo, Shimane 6938501, Japan; [Ito, Yasuhiro; Ishikawa, Hiroaki; Teradaira, Ryoji] Fujita Hlth Univ, Toyoake, Aichi 4701192, Japan; [Yatsuya, Hiroshi] Fujita Hlth Univ, Sch Med, Dept Publ Hlth, Toyoake, Aichi 4701192, Japan; [Kagiono, Miwa] Gifu Univ Med Sci, Seki, Gifu 5013892, Japan	Iida, T (reprint author), Prefectural Univ Hiroshima, Fac Hlth & Welf, Dept Phys Therapy, Mihara, Hiroshima 7230053, Japan.	iida@pu-hiroshima.ac.jp			JSPS KAKENHI [23500823]	We express our gratitude to all who so generously cooperated in this questionnaire survey. This work was supported by JSPS KAKENHI Grant-in-Aid for Scientific Research (C) Number 23500823.	American Psychiatric Association, 1994, DIAGN STAT MAN MENT, P866; Morris MC, 2014, DEPRESS ANXIETY, V31, P44, DOI 10.1002/da.22125; ZUNG WWK, 1965, ARCH GEN PSYCHIAT, V12, P63; Zhang Y, 2011, CHEM-BIOL INTERACT, V189, P186, DOI 10.1016/j.cbi.2010.12.011; Taniyama Y, 2003, HYPERTENSION, V42, P1075, DOI 10.1161/01.HYP.0000100443.09293.4F; Habets P, 2012, PSYCHOL MED, V42, P1523, DOI 10.1017/S0033291711002728; Iida T, 2011, J NEUROPSYCH CLIN N, V23, pE10, DOI 10.1176/appi.neuropsych.23.1.E10; Miyaoka T, 2005, EUR NEUROPSYCHOPHARM, V15, P249, DOI 10.1016/j.euroneuro.2004.11.002; Lopresti AL, 2014, PROG NEURO-PSYCHOPH, V48, P102, DOI 10.1016/j.pnpbp.2013.09.017; Forlenza MJ, 2006, PSYCHOSOM MED, V68, P1, DOI 10.1097/01.psy.0000195780.37277.2a; Morris MC, 2012, J AFFECT DISORDERS, V143, P223, DOI 10.1016/j.jad.2012.05.059; Barton DA, 2007, J HYPERTENS, V25, P2117; Rao U, 2008, BIOL PSYCHIAT, V64, P521, DOI 10.1016/j.biopsych.2008.05.012; Mehta PK, 2007, AM J PHYSIOL-CELL PH, V292, pC82, DOI 10.1152/ajpcell.00287.2006; Sanchez-Gonzalez MA, 2013, AM J HYPERTENS, V26, P1389, DOI 10.1093/ajh/hpt131; Atanackovic D, 2002, IMMUNOL INVEST, V31, P73, DOI 10.1081/IMM-120004800; Chikamura Chiho, 2008, Hiroshima Journal of Medical Sciences, V57, P93; Clempus RE, 2006, CARDIOVASC RES, V71, P216, DOI 10.1016/j.cardiores.2006.02.033; Fukuda K, 1973, Seishin Shinkeigaku Zasshi, V75, P673; Hankin BL, 2012, J CLIN CHILD ADOLESC, V41, P611, DOI 10.1080/15374416.2012.710162; Health and Welfare Statistics Association, 2009, J HLTH WELFARE STAT, V56, P454; Hiraoka A, 2003, CURRENT BIOFEEDBACK, V29, P29; Ishihara Itsuko, 2008, Journal of UOEH, V30, P293; JOHNSON SR, 1987, CLIN OBSTET GYNECOL, V30, P367, DOI 10.1097/00003081-198706000-00017; KIECOLTGLASER JK, 1985, J BEHAV MED, V8, P311, DOI 10.1007/BF00848366; Matsumoto Y, 2008, J OCCUP HEALTH, V50, P366, DOI 10.1539/joh.L7144; Michell D, 1992, COMPREHENSIVE GYNECO, P121; Shiga N, 2011, NIHON JYOSEI SHINSHI, V16, P89; TAYLOR JR, 1984, ALCOHOL CLIN EXP RES, V8, P283, DOI 10.1111/j.1530-0277.1984.tb05512.x; VEITH RC, 1994, ARCH GEN PSYCHIAT, V51, P411; Yi SY, 2012, PSYCHIAT RES, V200, P318, DOI 10.1016/j.psychres.2012.05.035	31	0	0	OKAYAMA UNIV MED SCHOOL	OKAYAMA	EDITORIAL OFFICE, ACTA MEDICA OKAYAMA OKAYAMA UNIVERSITY MEDICAL SCHOOL 2-5-1 SHIKATA-CHO, KITA-KU, OKAYAMA, 700-8558, JAPAN	0386-300X			ACTA MED OKAYAMA	Acta Med. Okayama	FEB	2015	69	1					45	50				6	Medicine, Research & Experimental	Research & Experimental Medicine	CB6ME	WOS:000349740300005		
J	Shwe, MM; Nyunt, KK; Okada, S; Harano, T; Thu, HM; Mo, HMM; Win, MM; Oo, KK; Wai, K; Aye, KS; Khin, M				Shwe, Mu Mu; Nyunt, Kyi Kyi; Okada, Shigeru; Harano, Teruo; Thu, Hlaing Myat; Mo, Hla Myat Mo; Win, Mo Mo; Oo, Khin Khin; Wai, KhinThet; Aye, Khin Saw; Khin, Myo			Trend of Human Papillomavirus Genotypes in Cervical Neoplasia Observed in a Newly Developing Township in Yangon, Myanmar	ACTA MEDICA OKAYAMA			English	Article						human papillomavirus; genotyping; Myanmar	INTRAEPITHELIAL NEOPLASIA; YOUNG-WOMEN; CANCER; PREVALENCE; RISK; HPV; METAANALYSIS; POPULATION; INFECTION; SPAIN	Persistent infection with oncogenic types of human papillomavirus (HPV) is the most important risk factor associated with cervical cancer. This study detected the oncogenic HPV genotypes in cervical neoplasia in relation to clinicopathological findings using a cross-sectional descriptive method in 2011 and 2012. Cervical swabs and colposcopy-directed cervical biopsy tissues were collected from 108 women (median age 45 years; range 20-78) showing cervical cytological changes at Sanpya General Hospital, Yangon, Myanmar. HPV DNA testing and genotyping were performed by polymerase chain reaction and restriction fragment length polymorphism. HPV was identified in women with cervical intraepithelial neoplasia (CIN) 1 (44.4%), CIN2 (63.2%), CIN3 (70.6%), and squamous cell carcinoma (SCC) (74.1%). The association between cervical neoplasia and HPV positivity was highly significant = 0.008). Most patients infected with HPV were between 40-49 years of age, and the youngest were in the 20- to 29-year-old age group. The most common genotype was HPV 16 (65.6%) with the following distribution: 70% in CIN1, 41.7% in CIN2, 91.7% in CIN3, and 60% in SCC. HPV-31 was the second-most frequent (21.9%): 30% in CIN1, 33.3% in CIN2, 8.3% in CIN3, and 15% in SCC. The third-most frequent-genotype was HPV-18 (7.8%): 8.3% in CIN1, and 20% in SCC. Another genotype was HPV-58 (4.7%): 16.7% in CIN1 and 5% in SCC. The majority of CIN/SCC cases were associated with HPV genotypes 16, 31, 18, and 58. If oncogenic HPV genotypes are positive, the possibility of cervical neoplasia can be predicted. Knowledge of the HPV genotypes distribution can predict the effectiveness of the currently used HPV vaccine.	[Shwe, Mu Mu; Thu, Hlaing Myat; Win, Mo Mo; Oo, Khin Khin; Wai, KhinThet; Aye, Khin Saw; Khin, Myo] Minist Hlth, Dept Med Res Lower Myanmar, Yangon, Myanmar; [Nyunt, Kyi Kyi; Mo, Hla Myat Mo] Sanpya Gen Hosp, Yangon, Myanmar; [Okada, Shigeru] Okayama Univ, Okayama 7000811, Japan; [Harano, Teruo] Okayama Univ Hosp, Dept Gen Med, Okayama 7008558, Japan	Shwe, MM (reprint author), Minist Hlth, Dept Med Res Lower Myanmar, Yangon, Myanmar.	drmumushwe@gmail.com; shigeru.dragon40@gmail.com					de Sanjose S, 2007, LANCET INFECT DIS, V7, P453, DOI 10.1016/S1473-3099(07)70158-5; Smith JS, 2007, INT J CANCER, V121, P621, DOI 10.1002/ijc.22527; Bao YP, 2008, INT J GYNECOL CANCER, V18, P71, DOI 10.1111/j.1525-1438.2007.00959.x; Jemal A, 2011, CA-CANCER J CLIN, V61, P69, DOI 10.3322/caac.20107; Cuschieri KS, 2004, J CLIN PATHOL, V57, P68, DOI 10.1136/jcp.57.1.68; Schiffman M, 2005, J NATL CANCER I, V97, P147, DOI 10.1093/jnci/dji014; Bulkmans NWJ, 2004, INT J CANCER, V110, P94, DOI 10.1002/ijc.20076; Hildesheim A, 2002, VIRUS RES, V89, P229, DOI 10.1016/S0168-1702(02)00191-0; Castle PE, 2005, J INFECT DIS, V191, P1808, DOI 10.1086/428779; Jariene K, 2012, MED LITH, V48, P22; Woodman CBJ, 2001, LANCET, V357, P1831, DOI 10.1016/S0140-6736(00)04956-4; Castle PE, 2009, OBSTET GYNECOL, V113, P18, DOI 10.1097/AOG.0b013e31818f5008; Li N, 2011, INT J CANCER, V128, P927, DOI 10.1002/ijc.25396; Conesa-Zamora P, 2009, BMC INFECT DIS, V9, DOI 10.1186/1471-2334-9-124; Arbyn Marc, 2006, Vaccine, V24 Suppl 3; Ciapponi A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025493; Cobo Fernando, 2009, Open Virol J, V3, P60, DOI 10.2174/1874357900903010060; FUJINAGA Y, 1991, J GEN VIROL, V72, P1039, DOI 10.1099/0022-1317-72-5-1039; Kitchener HC, 2008, VACCINES PREVENTION, V8, P77; Martin P, 2011, BMC INFECT DIS, V11, DOI 10.1186/1471-2334-11-316; Monsonego J, 2006, INT J GYNECOL CANCER, V16, P591, DOI 10.1111/j.1525-1438.2006.00361.x; Otero-Motta AP, 2011, APMIS, V119, P204, DOI 10.1111/j.1600-0463.2010.02711.x; Ripabelli G, 2010, CANCER EPIDEMIOL, V34, P162, DOI 10.1016/j.canep.2009.12.010; Rozendaal L, 1996, INT J CANCER, V68, P766, DOI 10.1002/(SICI)1097-0215(19961211)68:6<766::AID-IJC13>3.0.CO;2-Z; Safaeian M, 2007, OBSTET GYNECOL, V109, P1325, DOI 10.1097/01.AOG.0000263461.71732.40; Shwe Mu Mu, 2014, ACTA MED OKAYAMA, V68, P79; Trottier Helen, 2006, Vaccine, V24 Suppl 1, pS1; World Health Organization, 2011, GLOBOCAN 2008; World Health Organization, 2010, WHO ICO HPV CERV CAN; Wu DM, 2010, EUR J OBSTET GYN R B, V151, P86, DOI 10.1016/j.ejogrb.2010.02.040	30	1	1	OKAYAMA UNIV MED SCHOOL	OKAYAMA	EDITORIAL OFFICE, ACTA MEDICA OKAYAMA OKAYAMA UNIVERSITY MEDICAL SCHOOL 2-5-1 SHIKATA-CHO, KITA-KU, OKAYAMA, 700-8558, JAPAN	0386-300X			ACTA MED OKAYAMA	Acta Med. Okayama	FEB	2015	69	1					51	58				8	Medicine, Research & Experimental	Research & Experimental Medicine	CB6ME	WOS:000349740300006		
J	Tsuchie, H; Miyakoshi, N; Nishi, T; Abe, H; Segawa, T; Shimada, Y				Tsuchie, Hiroyuki; Miyakoshi, Naohisa; Nishi, Tomio; Abe, Hidekazu; Segawa, Toyohito; Shimada, Yoichi			A Case of Incomplete Atypical Femoral Fracture with Histomorphometrical Evidence of Osteomalacia	ACTA MEDICA OKAYAMA			English	Article						osteomalacia; atypical fracture; femur; osteoporosis; kyphosis	BONE	Roughly half of the femoral fracture patients diagnosed with AFF according to the criteria suggested by a task force of the American Society for Bone and Mineral Research (ASBMR) have not undergone bisphosphonate (BP) therapy. One suspected cause of such fractures is severe bone loss due to osteomalacia, but the pathogenesis remains unknown. We report a case of an 84-year-old woman with AFF not treated by BP therapy, in whom underlying osteomalacia was histologically diagnosed. The involvement of femoral curvature and spino-pelvic malaligment in the fracture in the present case was considered.	[Tsuchie, Hiroyuki] Nakadori Gen Hosp, Div Orthoped Surg, Akita 0108577, Japan; [Miyakoshi, Naohisa; Shimada, Yoichi] Akita Univ, Grad Sch Med, Dept Orthoped Surg, Akita 0108543, Japan; [Nishi, Tomio; Abe, Hidekazu; Segawa, Toyohito] Ugo Municipal Hosp, Ugo, Akita 0121131, Japan	Tsuchie, H (reprint author), Nakadori Gen Hosp, Div Orthoped Surg, Akita 0108577, Japan.	tuchikiti@yahoo.co.jp					Suzuki T, 2008, J BONE MINER RES, V23, P1309, DOI [10.1359/jbmr.080328, 10.1359/JBMR.080328]; Shane E, 2014, J BONE MINER RES, V29, P1, DOI 10.1002/jbmr.1998; Hongo M, 2012, OSTEOPOROSIS INT, V23, P1029, DOI 10.1007/s00198-011-1624-z; Sasaki S, 2012, J BONE MINER METAB, V30, P561, DOI 10.1007/s00774-012-0358-0; REHMAN MTA, 1994, J CLIN PATHOL, V47, P529, DOI 10.1136/jcp.47.6.529; Odvina CV, 2005, J CLIN ENDOCR METAB, V90, P1294, DOI 10.1210/jc.2004-0952; Bamias A, 2010, ONKOLOGIE, V33, P288, DOI 10.1159/000313684; Goto E, 2004, J JOINT SURG, V23, P504; Hagino H, 2013, NIPPON SEIKEIGEKA GA, V87, P733; Hashimoto N, 2000, HIGASHINIHONSEISAIKA, V12, P362; RECKER RR, 1988, J BONE MINER RES, V3, P133; Ohata Yasuhisa, 2013, Clin Calcium, V23, P1421, DOI CliCa131014211428; Ozawa H, 2004, SEIKEIGEKA, V55, P696; Tan SC, 2010, OSTEOPOROS INT  0421, V22, P2211	14	0	0	OKAYAMA UNIV MED SCHOOL	OKAYAMA	EDITORIAL OFFICE, ACTA MEDICA OKAYAMA OKAYAMA UNIVERSITY MEDICAL SCHOOL 2-5-1 SHIKATA-CHO, KITA-KU, OKAYAMA, 700-8558, JAPAN	0386-300X			ACTA MED OKAYAMA	Acta Med. Okayama	FEB	2015	69	1					59	63				5	Medicine, Research & Experimental	Research & Experimental Medicine	CB6ME	WOS:000349740300007		
J	Ueno, T; Yamashita, M; Sawada, S; Suehisa, H; Kawamoto, H; Takahata, H				Ueno, Tsuyoshi; Yamashita, Motohiro; Sawada, Shigeki; Suehisa, Hiroshi; Kawamoto, Hiroaki; Takahata, Hiroyuki			A Rare Case of Inflammatory Myofibroblastic Tumor of the Diaphragmatic Parietal Pleura with Dissemination	ACTA MEDICA OKAYAMA			English	Article						inflammatory myofibroblastic tumor; pleura; dissemination	LUNG; PSEUDOTUMORS	Inflammatory myofibroblastic tumor (IMT) is a rare neoplasm that occurs at different sites in the body. Pleural IMT in particular is especially rare. IMTs infrequently tend to have malignancy. We report a rare case of advanced diaphragmatic parietal pleural IMT with dissemination. A 30-year-old woman complained of right upper abdominal pain. Computed tomography showed a large lobulated mass over the right diaphragm, but no disseminated nodules were noted. Intraoperatively, we found the primary tumor arising from the diaphragmatic parietal pleura and a dozen disseminated nodules, and we removed them completely. The histopathological and immunohistochemical diagnosis was IMT.	[Ueno, Tsuyoshi; Yamashita, Motohiro; Sawada, Shigeki; Suehisa, Hiroshi; Kawamoto, Hiroaki] Shikoku Canc Ctr, Dept Thorac Surg, Matsuyama, Ehime 7910280, Japan; [Takahata, Hiroyuki] Shikoku Canc Ctr, Dept Pathol, Matsuyama, Ehime 7910280, Japan	Ueno, T (reprint author), Shikoku Canc Ctr, Dept Thorac Surg, Matsuyama, Ehime 7910280, Japan.	tsueno@shikoku-cc.go.jp					Li J, 2013, MICRO NANO LETT, V8, P8, DOI 10.1049/mnl.2012.0578; Makhlouf HR, 2002, HUM PATHOL, V33, P307, DOI 10.1053/hupa.2002.32213; Lee HJ, 2007, ANN THORAC SURG, V84, P221, DOI 10.1016/j.athoracsur.2007.03.037; Applebaum H, 2005, J PEDIATR SURG, V40, P999, DOI 10.1016/j.jpedsurg.2005.03.016; PETTINATO G, 1990, AM J CLIN PATHOL, V94, P538; Butrynski JE, 2010, NEW ENGL J MED, V363, P1727, DOI 10.1056/NEJMoa1007056; Cerfolio RJ, 1999, ANN THORAC SURG, V67, P933, DOI 10.1016/S0003-4975(99)00155-1; COFFIN CM, 1995, AM J SURG PATHOL, V19, P859, DOI 10.1097/00000478-199508000-00001; Jo VY, 2014, PATHOLOGY, V46, P95, DOI 10.1097/PAT.0000000000000050; Kubo N, 2012, INTERNAL MED, V51, P2399, DOI 10.2169/internalmedicine.51.7599; Takayama Y, 2008, RADIAT MED, V26, P613, DOI 10.1007/s11604-008-0284-1; Bothale KA, 2013, INDIAN J SURG, V75, pS243, DOI 10.1007/s12262-012-0640-3; Kakitsubata Y, 2007, COMPUT MED IMAG GRAP, V31, P607, DOI 10.1016/j.compinedimag.2007.07.002; Kusunoki-Nakamoto F, 2013, INTERNAL MED, V52, P623, DOI 10.2169/internalmedicine.52.8785; Loeffler-Ragg J, 2012, CASE REP PULMONOL, V2012	15	0	0	OKAYAMA UNIV MED SCHOOL	OKAYAMA	EDITORIAL OFFICE, ACTA MEDICA OKAYAMA OKAYAMA UNIVERSITY MEDICAL SCHOOL 2-5-1 SHIKATA-CHO, KITA-KU, OKAYAMA, 700-8558, JAPAN	0386-300X			ACTA MED OKAYAMA	Acta Med. Okayama	FEB	2015	69	1					65	68				4	Medicine, Research & Experimental	Research & Experimental Medicine	CB6ME	WOS:000349740300008		
J	Shiroma, N; Miyauchi, R; Nagafusa, A; Haga, Y; Matsuno, F				Shiroma, Naoji; Miyauchi, Ryo; Nagafusa, Akira; Haga, Youhei; Matsuno, Fumitoshi			Gaze direction based vehicle teleoperation method with omnidirectional image stabilization and automatic body rotation control	ADVANCED ROBOTICS			English	Article						image stabilization; rotation control; vehicle teleoperation; multiple-camera system; gaze direction		In robot teleoperation, a robot works as a physical agent at a remote site for a robot operator. There are mainly two tasks in robot teleoperation using camera images: environment recognition using visual information and robot control according to the recognition. In this paper, we propose a gaze direction based vehicle teleoperation method with an omnidirectional image stabilization and an automatic body rotation control. In the proposed method, we manage above two tasks in the same manner that are usually treated separately. This method is an intuitive vehicle teleoperation method where an operator do not need to have concern about vehicle body orientations and can absorb differences of vehicle driving mechanisms. That is, this method frees an operator from being bothered from controlling a vehicle and the operator can concentrate on where he/she intends to go. This method mainly consists of two technologies: an omnidirectional image stabilization technology and automatic body rotation control. The conducted experiments show effectiveness of the proposed method.	[Shiroma, Naoji] Ibaraki Univ, Coll Engn, Hitachi, Ibaraki, Japan; [Miyauchi, Ryo] Furukawa Elect Corp Ltd, Prod Technol & Engn Div, Nikko, Tochigi, Japan; [Nagafusa, Akira] ARTNER CO LTD, Hyper Artner Div, Kita Ku, Osaka, Japan; [Haga, Youhei] Ibaraki Univ, Grad Sch Sci & Engn, Hitachi, Ibaraki, Japan; [Matsuno, Fumitoshi] Kyoto Univ, Grad Sch Engn, Nishikyo Ku, Kyoto, Japan	Shiroma, N (reprint author), Ibaraki Univ, Coll Engn, Hitachi, Ibaraki, Japan.	naoji@mx.ibaraki.ac.jp					Casper J, 2002, THESIS U S FLORIDA T; Hayashi K, 2005, JSME J ROBOTICS MECH, V17, P181; Kon K, 2006, P 2006 IEEE INT C RO, P427; Miyauchi R, 2008, J FIELD ROBOT, V25, P268, DOI 10.1002/rob.20237; MIYAUCHI R, 2007, P IEEE INT C ROB BIO, P920; SHIROMA N, 2008, 17 IEEE INT S ROB HU, P477; Shiroma N, 2005, P INT C FIELD SERV R, P309	7	0	0	TAYLOR & FRANCIS LTD	ABINGDON	4 PARK SQUARE, MILTON PARK, ABINGDON OX14 4RN, OXON, ENGLAND	0169-1864	1568-5535		ADV ROBOTICS	Adv. Robot.	FEB 1	2015	29	3			SI		149	163		10.1080/01691864.2014.1000967		15	Robotics	Robotics	CB3IP	WOS:000349521700001		
J	Takahashi, N; Kami, C; Ota, I; Morita, N; Imaichi, R				Takahashi, Naoko; Kami, Chieko; Ota, Isao; Morita, Nana; Imaichi, Ryoko			DEVELOPMENTAL MORPHOLOGY OF THE TYPICAL CORDATE GAMETOPHYTE OF A HOMOSPOROUS LEPTOSPORANGIATE FERN, LYGODIUM JAPONICUM (LYGODIACEAE), FOCUSING ON THE INITIAL CELL BEHAVIOR OF TWO DISTINCT MERISTEMS	AMERICAN JOURNAL OF BOTANY			English	Article						apical cell; cell lineage; development; evolution; fern; gametophyte; habitat; initial cell; Lygodiaceae; Lygodium; meristem	SHOOT APICAL MERISTEM; ARABIDOPSIS; PLANTS; PHYLOGENY; EVOLUTION; GROWTH; APEX; DIFFERENTIATION; MAINTENANCE; HOMEOSTASIS	Premise of the study: Understanding the origin and early evolution of vascular plants requires thorough consideration of the gametophyte generation of ferns and lycophytes. Unfortunately, information about this generation is quite limited. To reveal the origin and evolution of varied gametophyte shapes, we used comparative morphological studies of meristem behavior of gametophytes of Lygodium japonicum, which exhibit the typical cordate shape. Methods: Microscopic images of epi-illuminated growing gametophytes cultured from spores were captured periodically using a metallurgical microscope equipped with a digital camera to analyze the cell lineage in the meristem. Key results: Gametophytes form from two meristems: the apical-cell-based meristem and the multicellular meristem. The triangular apical cell produces six to eight derivatives from two lateral facets, then disappears. Subsequently, the multicellular meristem, with a row of several rectangular cells, forms in the notch. These rectangular cells divide asynchronously in the periclinal and anticlinal walls to produce cells to both lateral sides and downward. Usually two, and sometimes three, cells located at the center of the meristem divide at a slower pace in the periclinal and anticlinal planes than others at the periphery. The cells at the periphery are pushed away and become involved in the wing base. Conclusions: The triangular apical cell behaves as a permanent initial cell. In the multicellular meristem, however, two or three central cells behave as initial cells that are transient and regulated in a position-dependent manner. The organization and behavior of both meristems are shared with the ribbon-shaped gametophytes of Colysis.	[Takahashi, Naoko; Kami, Chieko; Imaichi, Ryoko] Japan Womens Univ, Dept Chem & Biol Sci, Tokyo 1128681, Japan; [Ota, Isao] Tamagawa Univ, Fac Agr, Dept Bioenvironm Syst, Machida, Tokyo 1948681, Japan; [Morita, Nana] Mie Prefectural Museum, Tsu, Mie 5140061, Japan	Imaichi, R (reprint author), Japan Womens Univ, Dept Chem & Biol Sci, Tokyo 1128681, Japan.	ryoko@fc.jwu.ac.jp			 [16370046]	This study was supported by Grants-in-Aid for Scientific Research, Japan (grant number 16370046 to Ryoko Imaichi).	Schoof H, 2000, CELL, V100, P635, DOI 10.1016/S0092-8674(00)80700-X; Yadav RK, 2009, P NATL ACAD SCI USA, V106, P4941, DOI 10.1073/pnas.0900843106; Kenrick P, 1997, NATURE, V389, P33, DOI 10.1038/37918; Takahashi N, 2009, ANN BOT-LONDON, V104, P1353, DOI 10.1093/aob/mcp245; NAYAR BK, 1971, BOT REV, V37, P295, DOI 10.1007/BF02859157; Reddy GV, 2005, SCIENCE, V310, P663, DOI 10.1126/science.1116261; Zhao Z, 2010, NATURE, V465, P1089, DOI 10.1038/nature09126; Dodsworth S, 2009, DEV BIOL, V336, P1, DOI 10.1016/j.ydbio.2009.09.031; Imaichi R, 2008, BIOLOGY AND EVOLUTION OF FERNS AND LYCOPHYTES, P75, DOI 10.1017/CBO9780511541827.004; Laux T, 2003, CELL, V113, P281, DOI 10.1016/S0092-8674(03)00312-X; Sharma VK, 2003, P NATL ACAD SCI USA, V100, P11823, DOI 10.1073/pnas.1834206100; Brand U, 2000, SCIENCE, V289, P617, DOI 10.1126/science.289.5479.617; Grandjean O, 2004, PLANT CELL, V16, P74, DOI 10.1105/tpc.017962; Yadav RK, 2010, DEVELOPMENT, V137, P3581, DOI 10.1242/dev.054973; Schuettpelz E, 2007, TAXON, V56, P1037; Williams L, 2005, CURR OPIN PLANT BIOL, V8, P582, DOI 10.1016/j.pbi.2005.09.010; Reddy GV, 2004, DEVELOPMENT, V131, P4225, DOI 10.1242/dev.01261; JERNSTEDT JA, 1992, ANN BOT-LONDON, V69, P351; Pryer KM, 2004, AM J BOT, V91, P1582, DOI 10.3732/ajb.91.10.1582; Watkins JE, 2007, AM J BOT, V94, P701, DOI 10.3732/ajb.94.4.701; Imaichi R, 2007, AM J BOT, V94, P1911, DOI 10.3732/ajb.94.12.1911; Harrison CJ, 2007, DEVELOPMENT, V134, P881, DOI 10.1242/dev.001008; ATKINSON L. R., 1964, PHYTOMORPHOLOGY, V14, P51; BALL E. A., 1972, DYNAMICS MERISTEM CE, P75; BAUKE H., 1880, BEILAGE BOT Z, V38, P1; Bierhorst D. W., 1971, MORPHOLOGY VASCULAR; Bleckmann A, 2009, MOL CELLS, V27, P615, DOI 10.1007/s10059-009-0094-z; Castellano MM, 2005, CURR OPIN PLANT BIOL, V8, P26, DOI 10.1016/j.pbi.2004.11.010; Dassler CL, 1997, INT J PLANT SCI, V158, P622, DOI 10.1086/297476; DUMAIS J., 2003, J EXPT BOT, V54, P1585; FARRAR D. R., BIOL EVOLUTION FERNS, P222; Gross-Hardt R, 2003, J CELL SCI, V116, P1659, DOI 10.1242/jcs.00406; HAUFLER CH, 1982, AM J BOT, V69, P1560, DOI 10.2307/2442910; Herrero A, 2002, BOT J LINN SOC, V139, P87, DOI 10.1046/j.1095-8339.2002.00042.x; Imaichi R., 2013, Fern Gazette, V19, P141; KATO M., 1997, EVOLUTION DIVERSIFIC, P27; Kenrick P., 1997, ORIGIN EARLY DIVERSI; Klekowski EJ, 1969, BOT J LINN SOC, V62, P361, DOI 10.1111/j.1095-8339.1969.tb01973.x; Momose S., 1967, PROTHALLIA JAPANESE; PHILIPSON WR, 1990, PLANT SYST EVOL, V173, P17, DOI 10.1007/BF00937760; PRYER K. M., 2008, BIOL EVOLUTION FERNS, P395; Raghavan V., 1989, DEV BIOL FERN GAMETO; Rogers LM, 1923, BOT GAZ, V75, P75, DOI 10.1086/333137; RUTH J, 1985, AM J BOT, V72, P1127, DOI 10.2307/2443459; Steeves T. A., 1989, PATTERNS PLANT DEV; STEWART RN, 1970, AM J BOT, V57, P816, DOI 10.2307/2441339; STOKEY ALMA G., 1956, PHYTOMORPHOLOGY [DELHI], V6, P19; Stokey AG, 1942, BOT GAZ, V103, P559, DOI 10.1086/335069; Takahashi N, 2012, J PLANT RES, V125, P371, DOI 10.1007/s10265-011-0453-7	49	1	1	BOTANICAL SOC AMER INC	ST LOUIS	PO BOX 299, ST LOUIS, MO 63166-0299 USA	0002-9122	1537-2197		AM J BOT	Am. J. Bot.	FEB	2015	102	2					197	207		10.3732/ajb.1400333		11	Plant Sciences	Plant Sciences	CB3PF	WOS:000349539800004		
J	Satoh, M; Kikuya, M; Hosaka, M; Asayama, K; Inoue, R; Metoki, H; Tsubota-Utsugi, M; Hara, A; Hirose, T; Obara, T; Mori, T; Totsune, K; Hoshi, H; Mano, N; Imai, Y; Ohkubo, T				Satoh, Michihiro; Kikuya, Masahiro; Hosaka, Miki; Asayama, Kei; Inoue, Ryusuke; Metoki, Hirohito; Tsubota-Utsugi, Megumi; Hara, Azusa; Hirose, Takuo; Obara, Taku; Mori, Takefumi; Totsune, Kazuhito; Hoshi, Haruhisa; Mano, Nariyasu; Imai, Yutaka; Ohkubo, Takayoshi			Association of Aldosterone-to-Renin Ratio With Hypertension Differs by Sodium Intake: The Ohasama Study	AMERICAN JOURNAL OF HYPERTENSION			English	Article						aldosterone; blood pressure; epidemiology; hypertension; relative aldosterone excess; renin; salt intake	SALT-SENSITIVE HYPERTENSION; HOME BLOOD-PRESSURE; JAPANESE SOCIETY; AFRICAN ANCESTRY; EXCESS; GUIDELINES; COMMUNITY; STROKE; RISK	BACKGROUND In cross-sectional studies, the aldosterone-to-renin ratio (ARR) has been reported to be associated with hypertension under conditions of higher sodium intake. The objective of this prospective study was to investigate the association between ARR and the development of hypertension in community residents stratified by dietary sodium intake. METHODS From the general population of Ohasama, we obtained plasma renin activity (PRA) and plasma aldosterone concentrations (PACs) for 608 participants (mean age = 57.6 years; 71.4% women) without hypertension at baseline. Using the Cox model, we computed the adjusted hazard ratio (HR) of natural log-transformed ARR (lnARR) for the development of hypertension, defined as blood pressure >= 140/90 mm Hg or start of treatment with antihypertensive drugs during follow-up. RESULTS During a mean follow-up of 6.8 years, 298 participants developed hypertension. The median PRA, PAC, and ARR were 1.2 ng/ml/hour, 6.6 ng/dl, and 5.5 ng/dl per ng/ml/hour, respectively. Each 1 SD increase in lnARR was associated with an increased risk for the development of hypertension in participants overall (HR = 1.18; P = 0.007). In participants with higher sodium intake (median >= 4,102 mg/day), a significant association of lnARR with hypertension remained (HR = 1.25; P = 0.009), whereas no significant association was observed in participants with lower sodium intake (P = 0.18). Participants who developed hypertension had significantly lower PRA than those who did not (P = 0.003), despite no differences in PAC (P = 0.91). CONCLUSIONS These results raise the hypothesis that relative aldosterone excess may have a deleterious effect on the development of hypertension by contributing to salt/volume-related hypertension.	[Satoh, Michihiro; Obara, Taku; Mano, Nariyasu] Tohoku Univ Hosp, Dept Pharm, Sendai, Miyagi, Japan; [Kikuya, Masahiro; Metoki, Hirohito; Obara, Taku] Tohoku Univ, Tohoku Med Megabank Org, Sendai, Miyagi 980, Japan; [Hosaka, Miki; Asayama, Kei; Totsune, Kazuhito; Imai, Yutaka] Tohoku Univ, Grad Sch Pharmaceut Sci, Dept Planning Drug Dev & Clin Evaluat, Sendai, Miyagi 980, Japan; [Asayama, Kei; Ohkubo, Takayoshi] Teikyo Univ, Sch Med, Dept Hyg & Publ Hlth, Tokyo 173, Japan; [Inoue, Ryusuke] Tohoku Univ Hosp, Dept Med Informat, Ctr Technol, Sendai, Miyagi, Japan; [Tsubota-Utsugi, Megumi] Natl Inst Hlth & Nutr, Tokyo 162, Japan; [Hara, Azusa] Univ Leuven, KU Leuven Dept Cardiovasc Sci, Res Unit Hypertens & Cardiovasc Epidemiol, Studies Coordinating Ctr, Leuven, Belgium; [Hirose, Takuo] Coll France, Ctr Interdisciplinary Res Biol, F-75231 Paris, France; [Mori, Takefumi] Tohoku Univ, Grad Sch Med, Div Nephrol Endocrinol & Vasc Med, Sendai, Miyagi 980, Japan; [Totsune, Kazuhito] Tohoku Fukushi Univ, Dept Social Welf, Sendai, Miyagi, Japan; [Hoshi, Haruhisa] Ohasama Hosp, Ohasama, Iwate, Japan	Satoh, M (reprint author), Tohoku Univ Hosp, Dept Pharm, Sendai, Miyagi, Japan.	satoh.mchr@hosp.tohoku.ac.jp			Ministry of Education, Culture, Sports, Science, and Technology, Japan [23249036, 23390171, 24390084, 24591060, 24790654, 25461205, 25461083, 25860156, 25253059, 26860093, 26282200]; Intramural Research Fund for Cardiovascular Diseases of National Cerebral and Cardiovascular Center [22-4-5]	This work was supported by Grants for Scientific Research (23249036, 23390171, 24390084, 24591060, 24790654, 25461205, 25461083, 25860156, 25253059, 26860093, and 26282200) from the Ministry of Education, Culture, Sports, Science, and Technology, Japan; Grant-in-Aid for Japan Society for the Promotion of Science fellows (25.7756 and 25.9328); and the Intramural Research Fund (22-4-5) for Cardiovascular Diseases of National Cerebral and Cardiovascular Center. M. Satoh wrote the first draft of this manuscript. All authors conducted the Ohasama Study and commented on the manuscript.	Meneton P, 2008, J HUM HYPERTENS, V22, P550, DOI 10.1038/jhh.2008.27; Matsuo S, 2009, AM J KIDNEY DIS, V53, P982, DOI 10.1053/j.ajkd.2008.12.034; Kuzuya T, 2002, DIABETES RES CLIN PR, V55, P65, DOI 10.1016/S0168-8227(01)00365-5; IMAI Y, 1989, J HYPERTENS, V7, P983, DOI 10.1097/00004872-198912000-00009; Anderson CAM, 2010, J AM DIET ASSOC, V110, P736, DOI 10.1016/j.jada.2010.02.007; Kikuya M, 2000, HYPERTENSION, V36, P901; WILLETT W, 1986, AM J EPIDEMIOL, V124, P17; White WB, 2001, BLOOD PRESS MONIT, V6, P107, DOI 10.1097/00126097-200104000-00007; Ohkubo T, 2004, J HYPERTENS, V22, P1099, DOI 10.1097/01.hjh.0000125406.50839.15; Newton-Cheh C, 2007, HYPERTENSION, V49, P846, DOI 10.1161/01.HYP.0000258554.87444.91; Utsugi MT, 2008, HYPERTENS RES, V31, P1435, DOI 10.1291/hypres.31.1435; Ogihara T, 2009, HYPERTENS RES, V32, P3, DOI 10.1038/hr.2008.15; Imai Y, 2003, HYPERTENS RES, V26, P771, DOI 10.1291/hypres.26.771; Association for the Advancement of Medical Instrumentation, 1987, AM NAT STAND EL AUT; Duffy SJ, 2005, HYPERTENSION, V46, P707, DOI 10.1161/01.HYP.0000184231.84465.62; Funder JW, 2005, HYPERTENSION, V46, P643, DOI 10.1161/01.HYP.0000184227.75221.6e; GORDON RD, 1994, LANCET, V344, P240; Jurgens G, 2004, COCHRANE DB SYST REV, DOI DOI 10.1002/14651858.CD004022.PUB2; Lim PO, 2002, J HUM HYPERTENS, V16, P153, DOI 10.1038/sj/jhh/1001320; Mattsson C, 2006, NAT CLIN PRACT NEPHR, V2, P198, DOI 10.1038/ncpneph0151; Satoh M, 2012, AM J HYPERTENS, V25, P777, DOI 10.1038/ajh.2012.33; Satoh M, 2012, HYPERTENSION, V59, pE57, DOI 10.1161/HYPERTENSIONAHA.112.195230; Satoh M, 2011, HYPERTENS RES, V34, P361, DOI 10.1038/hr.2010.236; Satoh M, 2012, AM J HYPERTENS, V25, P398, DOI 10.1038/ajh.2011.235; Satoh M, 2011, J HYPERTENS, V29, P1940, DOI 10.1097/HJH.0b013e32834ab46a; Scott L, 2011, AM J HYPERTENS, V24, P951, DOI 10.1038/ajh.2011.49; Tanabe A, 2003, J CLIN ENDOCR METAB, V88, P2489, DOI 10.1210/jc.2002-021476; Tiu SC, 2005, J CLIN ENDOCR METAB, V90, P72, DOI 10.1210/jc.2004-1149; Tsubono Y, 2001, NUTR CANCER, V39, P78, DOI 10.1207/S15327914nc391_11	29	0	0	OXFORD UNIV PRESS	OXFORD	GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND	0895-7061	1941-7225		AM J HYPERTENS	Am. J. Hypertens.	FEB	2015	28	2					208	215		10.1093/ajh/hpu115		8	Peripheral Vascular Disease	Cardiovascular System & Cardiology	CB3WF	WOS:000349559300008		
J	Tsuda, K				Tsuda, Kazushi			Calcium Metabolism and Its Relation to Blood Pressure During Pregnancy	AMERICAN JOURNAL OF HYPERTENSION			English	Letter							BONE-MINERAL DENSITY; HYPERTENSION		Kansai Univ Hlth Sci, Cardiovasc & Metab Res Ctr, Dept Cardiovasc Med, Osaka, Japan	Tsuda, K (reprint author), Kansai Univ Hlth Sci, Cardiovasc & Metab Res Ctr, Dept Cardiovasc Med, Osaka, Japan.	tsudak@mail.wakayama-med.ac.jp					Tsuda K, 2001, AM J HYPERTENS, V14, P704, DOI 10.1016/S0895-7061(01)01303-6; LALAU JD, 1993, AM J HYPERTENS, V6, P522; Nielsen TF, 2011, ARCH GYNECOL OBSTET, V283, P443, DOI 10.1007/s00404-010-1371-y; Shao HF, 2012, AUST NZ J OBSTET GYN, V52, P571, DOI 10.1111/j.1479-828X.2012.01477.x; Weinert LS, 2014, AM J HYPERTENS, V27, P1316, DOI 10.1093/ajh/hpu043	5	0	0	OXFORD UNIV PRESS	OXFORD	GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND	0895-7061	1941-7225		AM J HYPERTENS	Am. J. Hypertens.	FEB	2015	28	2					283	283		10.1093/ajh/hpu207		1	Peripheral Vascular Disease	Cardiovascular System & Cardiology	CB3WF	WOS:000349559300018		
J	Watanabe, Y; Ohtsuka, T; Kimura, H; Matsunaga, T; Tamura, K; Ideno, N; Aso, T; Miyasaka, Y; Ueda, J; Takahata, S; Tanaka, M				Watanabe, Yusuke; Ohtsuka, Takao; Kimura, Hideyo; Matsunaga, Taketo; Tamura, Koji; Ideno, Noboru; Aso, Teppei; Miyasaka, Yoshihiro; Ueda, Junji; Takahata, Shunichi; Tanaka, Masao			Braun enteroenterostomy reduces delayed gastric emptying after pylorus-preserving pancreatoduodenectomy: a retrospective review	AMERICAN JOURNAL OF SURGERY			English	Article						Braun enteroenterostomy; Pylorus-preserving pancreatoduodenectomy; Delayed gastric emptying	INTERNATIONAL STUDY-GROUP; PANCREATIC SURGERY ISGPS; WHIPPLE PROCEDURE; BILLROTH-II; RECONSTRUCTION; DEFINITION; PERIAMPULLARY; PRESERVATION; RESECTION; TRIAL	BACKGROUND: Several recent studies have suggested that Braun enteroenterostomy (BEE) during conventional pancreatoduodenectomy might decrease delayed gastric emptying (DGE). However, the advantages and disadvantages of performing BEE during pylorus-preserving pancreatoduodenectomy (PPPD) remain controversial. METHODS: The medical records of 185 patients who underwent PPPD either with or without BEE between January 2008 and June 2013 were retrospectively reviewed, and the postoperative course of the 2 groups was compared. RESULTS: Ninety-eight patients underwent PPPD with BEE and 87 without BEE. DGE occurred in 4% of patients with BEE and in 21% of those without BEE (P < .01). The addition of BEE did not affect postoperative complications other than DGE. By multivariate analysis, the omission of BEE was the only independent factor associated with DGE (odds ratio 5.04, 95% confidence interval: 1.59 to 19.66; P < .01). CONCLUSIONS: BEE during PPPD reduced the incidence of DGE. (C) 2015 Elsevier Inc. All rights reserved.	[Watanabe, Yusuke; Ohtsuka, Takao; Kimura, Hideyo; Matsunaga, Taketo; Tamura, Koji; Ideno, Noboru; Aso, Teppei; Miyasaka, Yoshihiro; Ueda, Junji; Takahata, Shunichi; Tanaka, Masao] Kyushu Univ, Dept Surg & Oncol, Grad Sch Med Sci, Higashi Ku, Fukuoka 8128582, Japan	Tanaka, M (reprint author), Kyushu Univ, Dept Surg & Oncol, Grad Sch Med Sci, Higashi Ku, 3-1-1 Maidashi, Fukuoka 8128582, Japan.	masaotan@med.kyushu-u.ac.jp					Kawai M, 2011, ANN SURG, V253, P495, DOI 10.1097/SLA.0b013e31820d98f1; Karanicolas PJ, 2007, ANN SURG ONCOL, V14, P1825, DOI 10.1245/s10434-006-9330-3; Bassi C, 2005, SURGERY, V138, P8, DOI 10.1016/j.surg.2005.05.001; Hochwald SN, 2010, J SURG ONCOL, V101, P351, DOI 10.1002/jso.21490; Wente MN, 2007, SURGERY, V142, P20, DOI 10.1016/j.surg.2007.02.001; Winter JM, 2006, J GASTROINTEST SURG, V10, P1280, DOI 10.1016/j.gassur.2006.07.020; Tani M, 2006, ANN SURG, V243, P316, DOI 10.1097/01.sla.0000201479.84934.ca; Diener MK, 2007, ANN SURG, V245, P187, DOI 10.1097/01.sla.0000242711.74502.a9; Raty S, 2006, J GASTROINTEST SURG, V10, P1131, DOI 10.1016/j.gassur.2006.05.012; Seiler CA, 2005, BRIT J SURG, V92, P547, DOI 10.1002/bjs.4881; Wagner M, 2004, BRIT J SURG, V91, P586, DOI 10.1002/bjs.4484; Horstmann O, 2004, PANCREAS, V28, P69, DOI 10.1097/00006676-200401000-00011; Tran KTC, 2004, ANN SURG, V240, P738, DOI 10.1097/01.sla.0000143248.71964.29; TANAKA M, 1988, GASTROENTEROLOGY, V94, P622; Park YC, 2003, J AM COLL SURGEONS, V196, P859, DOI 10.1016/S1072-7515(03)00127-3; Clavien PA, 2009, ANN SURG, V250, P187, DOI 10.1097/SLA.0b013e3181b13ca2; Pessaux P, 2011, ANN SURG, V253, P879, DOI 10.1097/SLA.0b013e31821219af; TRAVERSO LW, 1978, SURG GYNECOL OBSTET, V146, P959; Welsch T, 2010, BRIT J SURG, V97, P1043, DOI 10.1002/bjs.7071; Park JS, 2009, SURGERY, V146, P882, DOI 10.1016/j.surg.2009.05.012; Hartel M, 2005, ARCH SURG-CHICAGO, V140, P1094, DOI 10.1001/archsurg.140.11.1094; WILLIAMSON RCN, 1993, SURGERY, V114, P82; Shimoda M, 2013, ANN SURG, V257, P938, DOI 10.1097/SLA.0b013e31826c3f90; Wente MN, 2007, SURGERY, V142, P761, DOI 10.1016/j.surg.2007.05.005; Gangavatiker R, 2011, J GASTROINTEST SURG, V15, P843, DOI 10.1007/s11605-011-1480-3; Fujii T, 2012, ANN SURG ONCOL, V19, P176, DOI 10.1245/s10434-011-1901-2; Fischer CP, 2006, J GASTROINTEST SURG, V10, P251; Goei TH, 2001, DIGEST SURG, V18, P376, DOI 10.1159/000050177; Kim DK, 2005, ANN SURG ONCOL, V12, P222, DOI 10.1245/ASO.2005.03.078; Kurosaki I, 2005, HEPATO-GASTROENTEROL, V52, P143; Kurosaki I, 2005, J GASTROINTEST SURG, V9, P846, DOI 10.1016/j.gassur.2005.02.009; Masui T, 2012, SURG TODAY, V42, P441, DOI 10.1007/s00595-011-0097-1; Nikfarjam Mehrdad, 2012, JOP, V13, P488, DOI 10.6092/1590-8577/800; Ogata Yoshiro, 2002, J Hepatobiliary Pancreat Surg, V9, P223, DOI 10.1007/s005340200023; Ohwada S, 2001, ANN SURG, V234, P668, DOI 10.1097/00000658-200111000-00013; Sakaguchi T, 2000, J Hepatobiliary Pancreat Surg, V7, P193, DOI 10.1007/s005340050175; VOGEL SB, 1994, ANN SURG, V219, P458, DOI 10.1097/00000658-199405000-00003; Vogel SB, 1944, ANN SURG, V219, P465; Yamaguchi K, 1999, J Hepatobiliary Pancreat Surg, V6, P303, DOI 10.1007/s005340050122; Yeo CJ, 1997, ANN SURG, V226, P248, DOI 10.1097/00000658-199709000-00004	40	3	3	EXCERPTA MEDICA INC-ELSEVIER SCIENCE INC	BRIDGEWATER	685 ROUTE 202-206 STE 3, BRIDGEWATER, NJ 08807 USA	0002-9610	1879-1883		AM J SURG	Am. J. Surg.	FEB	2015	209	2					369	377		10.1016/j.amjsurg.2014.05.007		9	Surgery	Surgery	CB6EU	WOS:000349720500023		
J	Meller, W; Specker, S; Schultz, P; Kishi, Y; Thurber, S; Kathol, R				Meller, William; Specker, Sheila; Schultz, Pam; Kishi, Yasuhiro; Thurber, Steven; Kathol, Roger			Using the INTERMED complexity instrument for a retrospective analysis of patients presenting with medical illness, substance use disorder, and other psychiatric illnesses	ANNALS OF CLINICAL PSYCHIATRY			English	Article								BACKGROUND: The financial and treatment challenges of complex patients must be addressed with adequate assessment and evaluation. The INTERMED complexity instrument (INTERMED) has been developed for this purpose, but to date has not been used retrospectively. The current study represents a retrospective validity investigation of INTERMED with patients with substance use disorder comorbid with other psychiatric and medical conditions (triple diagnoses). Such patients were expected to generate high complexity scores on the INTERMED instrument. METHODS: Information on 66 patients with triple diagnoses was submitted to the INTERMED complexity grid. These data were subjected to cluster analysis and other analytic procedures. RESULTS: Total INTERMED scores reflected elevated complexity for patients with triple diagnoses. As a group, they represented a single cluster of complex patients. CONCLUSIONS: The validity of the INTERMED complexity assessment was corroborated in relation to retrospective data. In addition to elevations in the biological domain that hospital personnel typically confront, findings related to coping deficiencies and problems in living conditions were noteworthy in requiring comprehensive interventions.	[Meller, William; Specker, Sheila] Univ Minnesota, Dept Psychiat, Minneapolis, MN 55455 USA; [Schultz, Pam] Hazelden Betty Ford Fdn, Minneapolis, MN USA; [Kishi, Yasuhiro] Nippon Med Sch, Musashikosugi Hosp, Dept Psychiat, Tokyo 113, Japan; [Thurber, Steven] Child & Adolescent Behav Hlth Serv, Minnesota Dept Human Serv, Willmar, MN 56201 USA; [Kathol, Roger] Cartesian Solut Inc, Case Management Soc Amer, Minneapolis, MN USA	Thurber, S (reprint author), Child & Adolescent Behav Hlth Serv, 1701 Technol Dr Northeast, Willmar, MN 56201 USA.	steven_thurber@yahoo.com					de Jonge P, 2003, PSYCHOSOM MED, V65, P534, DOI 10.1097/01.PSY.0000077504.01963.1B; Stiefel FC, 1999, GEN HOSP PSYCHIAT, V21, P49, DOI 10.1016/S0163-8343(98)00061-9; de Jonge P, 2001, PSYCHOSOMATICS, V42, P106, DOI 10.1176/appi.psy.42.2.106; Huyse FJ, 2001, PSYCHOSOMATICS, V42, P5, DOI 10.1176/appi.psy.42.1.5; Druss BG, 1999, PSYCHIATR SERV, V50, P214; Kathol RG, 2005, J GEN INTERN MED, V20, P160, DOI 10.1111/j.1525-1497.2005.40099.x; de Jonge P, 2005, AUST NZ J PSYCHIAT, V39, P795; Hoogervorst ELJ, 2003, J NEUROL NEUROSUR PS, V74, P20, DOI 10.1136/jnnp.74.1.20; Huyse FJ, 1999, GEN HOSP PSYCHIAT, V21, P31; Kishi Y, 2010, J PSYCHOSOM RES, V69, P583, DOI 10.1016/j.jpsychores.2010.02.006; Matzer F, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041775; Statistical package for the social sciences, SPSS 2 STEP CLUST CO	12	0	0	QUADRANT HEALTHCOM INC	PARSIPPANY	7 CENTURY DRIVE, STE 302, PARSIPPANY, NJ 07054-4603 USA	1040-1237	1547-3325		ANN CLIN PSYCHIATRY	Ann. Clin. Psychiatry	FEB	2015	27	1					39	43				5	Psychiatry	Psychiatry	CB3FJ	WOS:000349513300007		
J	Sunakawa, Y; Stremitzer, S; Cao, S; Zhang, W; Yang, D; Wakatsuki, T; Ning, Y; Yamauchi, S; Stintzing, S; Sebio, A; El-Khoueiry, R; Matsusaka, S; Parekh, A; Barzi, A; Azuma, M; Watanabe, M; Koizumi, W; Lenz, HJ				Sunakawa, Y.; Stremitzer, S.; Cao, S.; Zhang, W.; Yang, D.; Wakatsuki, T.; Ning, Y.; Yamauchi, S.; Stintzing, S.; Sebio, A.; El-Khoueiry, R.; Matsusaka, S.; Parekh, A.; Barzi, A.; Azuma, M.; Watanabe, M.; Koizumi, W.; Lenz, H. -J.			Association of variants in genes encoding for macrophage-related functions with clinical outcome in patients with locoregional gastric cancer	ANNALS OF ONCOLOGY			English	Article						NF-kappa B; CCL2; single-nucleotide polymorphism; gastric cancer; ethnic difference	NF-KAPPA-B; HELICOBACTER-PYLORI; MONOCYTE; CLASSIFICATION; EPIDEMIOLOGY; METAANALYSIS; EXPRESSION; CARCINOMA; DISEASE; MCP-1	Background: Nuclear factor-kappaB (NF-kappa B) and CCL2/CCR2 chemokine axis play a central role in tumor progression such as stimulation of angiogenesis, acceleration of tumor invasion and migration, and suppression of innate immunosurveillance in the macrophage-related functions. There have been few reports regarding association of the macrophage function-related genes with the clinical outcome in gastric cancer. We hypothesized that variants in genes encoding for NF-kappa B and CCL2/CCR2 axis may predict prognosis in gastric cancer and tested whether the functional single-nucleotide polymorphisms (SNPs) will be associated with clinical outcome in patients with gastric cancer across two independent groups. Patients and methods: This study enrolled two cohorts which consisted of 160 Japanese patients and 104 US patients with locoregional gastric cancer. Genomic DNA was analyzed for association of 11 SNPs in NFKB1, RELA, CCL2, and CCR2 with clinical outcome using PCR-based direct DNA sequencing. Results: The univariable analysis showed four SNPs had significant association with clinical outcome in the Japanese cohort, NFKB1 rs230510 remained significant upon multivariable analysis. The patients with the A allele of the NFKB1 rs230510 had significantly longer overall survival (OS) compared with those with the T/T genotype in both the Japanese and US cohort in the univariable analysis. In contrast, genotypes with the T allele of CCL2 rs4586 were significantly associated with shorter OS compared with the C/C genotype in the US cohort [hazard ratio (HR) 2.43; P = 0.015] but longer OS in the Japanese cohort (HR 0.58; P = 0.021), resulting in the statistically significant opposite impact on OS (P = 0.001). Conclusions: Our study provides the first evidence that the NFKB1 rs230510 and CCL2 rs4586 are significantly associated with the clinical outcome in patients with locoregional gastric cancer. These results also suggest that the genetic predisposition of the host may dictate the immune-related component of the tumor for progression in gastric cancer.	[Sunakawa, Y.; Stremitzer, S.; Zhang, W.; Wakatsuki, T.; Ning, Y.; Yamauchi, S.; Stintzing, S.; Sebio, A.; El-Khoueiry, R.; Matsusaka, S.; Parekh, A.; Barzi, A.; Lenz, H. -J.] Univ So Calif, Keck Sch Med, Norris Comprehens Canc Ctr, Div Med Oncol, Los Angeles, CA 90033 USA; [Cao, S.; Yang, D.] Univ So Calif, Keck Sch Med, Norris Comprehens Canc Ctr, Dept Prevent Med, Los Angeles, CA 90033 USA; [Azuma, M.; Koizumi, W.] Kitasato Univ, Sch Med, Dept Gastroenterol, Sagamihara, Kanagawa 228, Japan; [Watanabe, M.] Kitasato Univ, Sch Med, Dept Surg, Sagamihara, Kanagawa 228, Japan	Lenz, HJ (reprint author), Univ So Calif, Keck Sch Med, Norris Comprehens Canc Ctr, Div Med Oncol, 1441 Eastlake Ave,Suite 3456, Los Angeles, CA 90033 USA.	lenz@usc.edu					Condeelis J, 2006, CELL, V124, P263, DOI 10.1016/j.cell.2006.01.007; Tan IB, 2011, GASTROENTEROLOGY, V141, P476, DOI 10.1053/j.gastro.2011.04.042; Ben-Neriah Y, 2011, NAT IMMUNOL, V12, P715, DOI 10.1038/ni.2060; Lee PH, 2008, NUCLEIC ACIDS RES, V36, pD820, DOI 10.1093/nar/gkm904; Pomerantz JL, 2002, MOL CELL, V10, P693, DOI 10.1016/S1097-2765(02)00697-4; Chong ML, 2014, INT J CANCER, V134, P1232, DOI 10.1002/ijc.28444; Gordon S, 2005, NAT REV IMMUNOL, V5, P953, DOI 10.1038/nri1733; Shah MA, 2010, J NATL COMPR CANC NE, V8, P437; [Anonymous], 2011, GASTRIC CANC, V14, P101; Deshmane SL, 2009, J INTERF CYTOK RES, V29, P313, DOI 10.1089/jir.2008.0027; Crew KD, 2006, WORLD J GASTROENTERO, V12, P354; Sasaki N, 2001, CLIN CANCER RES, V7, P4136; ASAKA M, 1992, GASTROENTEROLOGY, V102, P760; Tao LL, 2014, WORLD J GASTROENTERO, V20, P4421, DOI 10.3748/wjg.v20.i15.4421; LAUREN P, 1965, ACTA PATHOL MIC SC, V64, P31; Roca H, 2008, J BIOL CHEM, V283, P25057, DOI 10.1074/jbc.M801073200; Shah MA, 2011, CLIN CANCER RES, V17, P2693, DOI 10.1158/1078-0432.CCR-10-2203; Bass AJ, 2014, NATURE, V513, P202, DOI 10.1038/nature13480; Coussens AK, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003468; DOOLEY CP, 1989, NEW ENGL J MED, V321, P1562, DOI 10.1056/NEJM198912073212302; Jia LQ, 2013, ASIAN PAC J CANCER P, V14, P3575, DOI 10.7314/APJCP.2013.14.6.3575; Lee BL, 2005, CLIN CANCER RES, V11, P2518, DOI 10.1158/1078-0432.CCR-04-1282; Wakatsuki T, 2012, J CLIN ONCOL S, V30; Xu B, 2010, MED ONCOL, V27, P1031, DOI 10.1007/s12032-009-9329-2	24	2	2	OXFORD UNIV PRESS	OXFORD	GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND	0923-7534	1569-8041		ANN ONCOL	Ann. Oncol.	FEB	2015	26	2					332	339		10.1093/annonc/mdu542		9	Oncology	Oncology	CB4PH	WOS:000349609600012		
J	Hirai, F; Yamanaka, T; Taguchi, K; Daga, H; Ono, A; Tanaka, K; Kogure, Y; Shimizu, J; Kimura, T; Fukuoka, J; Iwamoto, Y; Sasaki, H; Takeda, K; Seto, T; Ichinose, Y; Nakagawa, K; Nakanishi, Y				Hirai, F.; Yamanaka, T.; Taguchi, K.; Daga, H.; Ono, A.; Tanaka, K.; Kogure, Y.; Shimizu, J.; Kimura, T.; Fukuoka, J.; Iwamoto, Y.; Sasaki, H.; Takeda, K.; Seto, T.; Ichinose, Y.; Nakagawa, K.; Nakanishi, Y.		West Japan Oncology Grp	A multicenter phase II study of carboplatin and paclitaxel for advanced thymic carcinoma: WJOG4207L	ANNALS OF ONCOLOGY			English	Article						advanced thymic carcinoma; the standard treatments for non-small-cell lung cancer; carboplatin; paclitaxel	CELL LUNG-CANCER; COMBINATION CHEMOTHERAPY; ADVANCED THYMOMA; EPITHELIAL TUMORS; INTERGROUP TRIAL; CISPLATIN; CYCLOPHOSPHAMIDE; DOXORUBICIN; VINCRISTINE; EXPERIENCE	Background: Thymic carcinoma (TC) is an exceptionally rare tumor, which has a very poor prognosis differing from thymoma. Till date, there has been no report of any results of clinical trials focusing on TC. The role of non-anthracycline-based chemotherapy has not been elucidated since the previous studies included a relatively small number of TC patients. This single-arm study evaluated carboplatin and paclitaxel (CbP) in chemotherapy-naive patients with advanced TC. Patients and methods: The study treatment consisted of carboplatin (area under the curve 6) and paclitaxel (200 mg/m(2)) every 3 weeks for a maximum of six cycles. The primary end point was objective response rate (ORR) by independent review. The secondary end points included overall survival (OS), progression-free survival (PFS), and safety. Based on the SWOG 2-stage design, the planned sample size of 40 patients was determined to reject the ORR of 20% under the expectation of 40% with a power of 0.85 and a type I error of 0.05. Results: Forty patients from 21 centers were enrolled for this study from May 2008 to November 2010. Of the 39 patients evaluable for analysis, 36 were pathologically diagnosed by independent review, and 97% patients were eventually TC. There was 1/13 complete/partial responses with an ORR of 36% (95% confidence interval 21%-53%; P = 0.031). The median PFS was 7.5 (6.2-12.3) months, while OS did not reach the median value. Major adverse event was grade 3-4 neutropenia in 34 patients (87%). There was no treatment-related death. Conclusions: In this largest trial with TC, CbP showed promising efficacy in advanced TC when compared with anthracycline-based chemotherapy, which is the current standard treatment of thymic neoplasm. Our results established that CbP, one of the standard treatments for non-small-cell lung cancer, might be an option as a chemotherapy regimen for TC.	[Hirai, F.; Seto, T.; Ichinose, Y.] Kyushu Natl Canc Ctr, Dept Thorac Oncol, Fukuoka 8111395, Japan; [Yamanaka, T.] Yokohama City Univ, Dept Biostat, Yokohama, Kanagawa 232, Japan; [Taguchi, K.] Kyushu Natl Canc Ctr, Dept Pathol, Fukuoka 8111395, Japan; [Daga, H.; Takeda, K.] Osaka City Gen Hosp, Dept Clin Oncol, Osaka, Japan; [Ono, A.] Shizuoka Canc Ctr, Div Thorac Oncol, Shizuoka, Japan; [Tanaka, K.; Nakagawa, K.] Kinki Univ, Fac Med, Dept Med Oncol, Osaka, Japan; [Kogure, Y.] Nagoya Med Ctr, Natl Hosp Org, Dept Resp Med, Nagoya, Aichi, Japan; [Shimizu, J.] Aichi Canc Ctr Hosp, Dept Thorac Oncol, Nagoya, Aichi 464, Japan; [Kimura, T.] Osaka City Univ, Grad Sch Med, Dept Resp Med, Osaka 558, Japan; [Fukuoka, J.] Nagasaki Univ, Grad Sch Biomed Sci, Dept Pathol, Nagasaki 852, Japan; [Iwamoto, Y.] Hiroshima City Hosp, Dept Med Oncol, Hiroshima, Japan; [Sasaki, H.] Nagoya City Univ, Grad Sch Med Sci, Dept Oncol Immunol & Surg, Nagoya, Aichi, Japan; [Nakanishi, Y.] Kyushu Univ, Grad Sch Med Sci, Res Inst Dis Chest, Fukuoka 812, Japan	Seto, T (reprint author), Kyushu Natl Canc Ctr, Dept Thorac Oncol, Minami Ku, 3-1-1 Notame, Fukuoka 8111395, Japan.	tseto@nk-cc.go.jp					Agatsuma T, 2011, J THORAC ONCOL, V6, P2130, DOI 10.1097/JTO.0b013e31822e71c0; Loehrer PJ, 2001, CANCER, V91, P2010, DOI 10.1002/1097-0142(20010601)91:11<2010::AID-CNCR1226>3.0.CO;2-2; Koizumi T, 2002, AM J CLIN ONCOL-CANC, V25, P266, DOI 10.1097/00000421-200206000-00012; Liu HC, 2002, ANN THORAC SURG, V73, P1076, DOI 10.1016/S0003-4975(01)03607-4; Schiller JH, 2002, NEW ENGL J MED, V346, P92, DOI 10.1056/NEJMoa011954; MASAOKA A, 1981, CANCER, V48, P2485, DOI 10.1002/1097-0142(19811201)48:11<2485::AID-CNCR2820481123>3.0.CO;2-R; de Jong WK, 2008, EUR J CANCER, V44, P123, DOI 10.1016/j.ejca.2007.11.004; Lemma GL, 2011, J CLIN ONCOL, V29, P2060, DOI 10.1200/JCO.2010.32.9607; Engels EA, 2003, INT J CANCER, V105, P546, DOI 10.1002/ijc.11099; Ohe Y, 2007, ANN ONCOL, V18, P317, DOI 10.1093/annonc/mdl377; FORNASIERO A, 1991, CANCER, V68, P30, DOI 10.1002/1097-0142(19910701)68:1<30::AID-CNCR2820680106>3.0.CO;2-4; Grassin F, 2010, J THORAC ONCOL, V5, P893, DOI 10.1097/JTO.0b013e3181db3dee; LOEHRER PJ, 1994, J CLIN ONCOL, V12, P1164; Palmieri G, 2010, ANN ONCOL, V21, P1168, DOI 10.1093/annonc/mdp483; Igawa S, 2010, LUNG CANCER, V67, P194, DOI 10.1016/j.lungcan.2009.03.031; Berruti A, 1999, BRIT J CANCER, V81, P841, DOI 10.1038/sj.bjc.6690773; Furugen M, 2011, JPN J CLIN ONCOL, V41, P1013, DOI 10.1093/jjco/hyr089; Kondo K, 2003, ANN THORAC SURG, V76, P884; Kondo K, 2003, ANN THORAC SURG, V76, P878, DOI 10.1016/S0003-4975(03)00555-1; Maruyama R, 2006, ONCOLOGY-BASEL, V70, P325, DOI 10.1159/000097944; Okuma Y, 2011, LUNG CANCER, V74, P492, DOI 10.1016/j.lungcan.2011.05.013; OSHITA F, 1995, JPN J CLIN ONCOL, V25, P208; Travis W, 2004, TUMOURS LUNG PLEURA; Yoh K, 2003, CANCER, V98, P926, DOI 10.1002/cncr.11606	24	3	3	OXFORD UNIV PRESS	OXFORD	GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND	0923-7534	1569-8041		ANN ONCOL	Ann. Oncol.	FEB	2015	26	2					363	368		10.1093/annonc/mdu541		6	Oncology	Oncology	CB4PH	WOS:000349609600016		
J	Zhang, Y; Hiroshima, Y; Ma, HY; Zhang, N; Zhao, M; Hoffman, RM				Zhang, Yong; Hiroshima, Yukihiko; Ma, Huaiyu; Zhang, Nan; Zhao, Ming; Hoffman, Robert M.			Complementarity of Variable-magnification and Spectral-separation Fluorescence Imaging Systems for Noninvasive Detection of Metastasis and Intravital Detection of Single Cancer Cells in Mouse Models	ANTICANCER RESEARCH			English	Article						GFP; RFP; nude mice; human tumors; metastasis; imaging; noninvasive; variable magnification; subcellular in vivo imaging; spectral separation; tunable filter	PANCREATIC-CANCER; TUMORS; MICE	Imaging of tumor growth, progression and metastasis with fluorescent proteins in mouse models is a powerful technology. A limit to fluorescent-protein imaging has been for non-invasive deep-seated tumors, such as those in the lung. In the present study, the Maestro spectral-separation fluorescence imaging system and the OV100 variable-magnification imaging system were compared for noninvasive detection of metastasis in fluorescent protein-expressing orthotopic lung, liver, pancreas, and colon cancer in nude mouse tumor models, as well as for intravital single-cell imaging. Sensitivity, multispectral capability, contrast, and single cell resolution were investigated. The Maestro system outperformed the OV100 for noninvasive imaging of primary and metastatic tumors. The Maestro system detected brain tumor metastasis five days earlier than did the OV100. The Maestro had greater depth of detection compared with the OV100. By separating skin and food autofluorescence, the Maestro provided high-contrast images. The Maestro system was able to produce composite images with more unmixed components and detected more different color signals simultaneously than did the OV100. However, the OV100 system had higher resolution and was able to detect single cells in vivo unlike the Maestro. The present study demonstrates that the two instruments are complementary for imaging of all stages of cancer in mice, including single-cell trafficking and the superiority of in vivo fluorescent-protein imaging over luciferase imaging.	[Zhang, Yong; Hiroshima, Yukihiko; Ma, Huaiyu; Zhang, Nan; Zhao, Ming; Hoffman, Robert M.] AntiCancer Inc, San Diego, CA 92111 USA; [Hiroshima, Yukihiko; Hoffman, Robert M.] Univ Calif San Diego, Dept Surg, San Diego, CA 92103 USA; [Hiroshima, Yukihiko] Yokohama City Univ, Grad Sch Med, Yokohama, Kanagawa 232, Japan	Hoffman, RM (reprint author), AntiCancer Inc, 7917 Ostrow St, San Diego, CA 92111 USA.	all@anticancer.com			National Cancer Institute [CA CA132971]	This study was supported in part by National Cancer Institute grants CA CA132971.	Hoffman RM, 2006, NAT PROTOC, V1, P775, DOI 10.1038/nprot.2006.109; Gucev ZS, 1997, ENDOCRINOLOGY, V138, P1464, DOI 10.1210/en.138.4.1464; Hoffman RM, 1999, INVEST NEW DRUG, V17, P343, DOI 10.1023/A:1006326203858; Yamauchi K, 2006, CANCER RES, V66, P4208, DOI 10.1158/0008-5472.CAN-05-3927; Hoffman RM, 2006, NAT PROTOC, V1, P1429, DOI 10.1038/nprot.2006.223; Katz MH, 2003, J SURG RES, V113, P151, DOI 10.1016/S0022-4804(03)00234-8; Kocher B, 2013, CANCER DISCOV, V3, P616, DOI 10.1158/2159-8290.CD-12-0503; Rajput A, 2008, J SURG RES, V147, P276, DOI 10.1016/j.jss.2007.04.021; Yang M, 2005, BIOTECHNIQUES, V39, P170, DOI 10.2144/05392BM02; Hoffman RM, 2006, NAT PROTOC, V1, P928, DOI 10.1038/nprot.2006.119; Yang M, 2000, P NATL ACAD SCI USA, V97, P1206, DOI 10.1073/pnas.97.3.1206; Hiroshima Y, 2014, J SURG RES, V187, P510, DOI 10.1016/j.jss.2013.11.1083; Ke CC, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0069658; Levenson Richard, 2004, Proceedings of the American Association for Cancer Research Annual Meeting, V45, P46; Levenson RM, 2006, CYTOM PART A, V69A, P748, DOI 10.1002/cyto.a.20319; Rashidi B, 2013, J CELL BIOCHEM, V114, P1738, DOI 10.1002/jcb.24516; Cao HST, 2010, MOL CANCER THER, V9, P2068, DOI 10.1158/1535-7163.MCT-10-0201; Zhang Y, ONCOTARGET IN PRESS	18	3	3	INT INST ANTICANCER RESEARCH	ATHENS	EDITORIAL OFFICE 1ST KM KAPANDRITIOU-KALAMOU RD KAPANDRITI, PO BOX 22, ATHENS 19014, GREECE	0250-7005	1791-7530		ANTICANCER RES	Anticancer Res.	FEB	2015	35	2					661	667				7	Oncology	Oncology	CB4LG	WOS:000349598600007		
J	Sugano, K; Maeda, K; Ohtani, H; Nagahara, H; Shibutani, M; Hirakawa, K				Sugano, Kenji; Maeda, Kiyoshi; Ohtani, Hiroshi; Nagahara, Hisashi; Shibutani, Masatsune; Hirakawa, Kosei			Expression of xCT as a Predictor of Disease Recurrence in Patients with Colorectal Cancer	ANTICANCER RESEARCH			English	Article						xCT; CD44v6; CRC; immunohistochemistry; colorectal cancer; recurrence	SQUAMOUS-CELL CARCINOMA; COLON-CANCER; STEM-CELLS; CD44; TRANSPORTER; METASTASIS; ANTIPORTER; PROGNOSIS; SURVIVAL; THERAPY	Background: The function of a cysteine-glutamate exchanger (xCT) transporter is to increase the intracellular concentration of glutathione in order to protect cells from oxidative stress. In several types of cancer, xCT is thought to play a role in the onset of resistance to chemotherapy and radiotherapy. xCT is stabilized on the tumor cell surface after combining with cluster of differentiation 44 variant (CD44v). Materials and Methods: We examined the xCT and CD44v6 expression in 304 primary tumor samples obtained from patients with colorectal cancer using immunohistochemical analysis. Results: Immunoreactivity for xCT was observed in 208 (68.4%) tumors. Among 218 patients with stage I-III disease who underwent curative surgery, the postoperative recurrence rate was 32.9% in those with xCT-positive tumors, which was significantly (p = 0.003) higher than in those with xCT-negative tumors (10.7%). Immunoreactivity for CD44v6 was observed in 101 cases (33.2%), although the rate of postoperative recurrence in patients with CD44v6-positive tumors did not exhibit any significant correlation. Multivariate analyses revealed increased xCT expression to be an independent significant predictor of disease recurrence, in addition to depth of tumor invasion, lymph node metastasis and venous invasion.	[Sugano, Kenji; Maeda, Kiyoshi; Ohtani, Hiroshi; Nagahara, Hisashi; Shibutani, Masatsune; Hirakawa, Kosei] Osaka City Univ, Dept Surg Oncol, Grad Sch Med, Osaka 558, Japan	Maeda, K (reprint author), Osaka City Univ, Dept Surg Oncol, Grad Sch Med, Abeno Ku, 1-4-3 Asahimachi, Osaka 558, Japan.	m1378386@med.osaka-cu.ac.jp					Andre T, 2009, J CLIN ONCOL, V27, P3109, DOI 10.1200/JCO.2008.20.6771; Ishimoto T, 2011, CANCER CELL, V19, P387, DOI 10.1016/j.ccr.2011.01.038; Nabeyama A, 2010, P NATL ACAD SCI USA, V107, P6436, DOI 10.1073/pnas.0912827107; Takeuchi S, 2013, NEUROSURGERY, V72, P33, DOI 10.1227/NEU.0b013e318276b2de; Engstrom PF, 2009, J NATL COMPR CANC NE, V7, P778; Backos DS, 2012, BIOCHEM PHARMACOL, V83, P1005, DOI 10.1016/j.bcp.2011.11.016; Nagano O, 2004, CANCER SCI, V95, P930, DOI 10.1111/j.1349-7006.2004.tb03179.x; Timmerman LA, 2013, CANCER CELL, V24, P450, DOI 10.1016/j.ccr.2013.08.020; Saito S, 2013, ONCOL REP, V29, P1570, DOI 10.3892/or.2013.2273; Yoshikawa M, 2013, CANCER RES, V73, P1855, DOI 10.1158/0008-5472.CAN-12-3609-T; Ponta H, 2003, NAT REV MOL CELL BIO, V4, P33, DOI 10.1038/nrm1004; GUNTHERT U, 1991, CELL, V65, P13, DOI 10.1016/0092-8674(91)90403-L; Todaro M, 2014, CELL STEM CELL, V14, P342, DOI 10.1016/j.stem.2014.01.009; Lo M, 2008, J CELL PHYSIOL, V215, P593, DOI 10.1002/jcp.21366; MULDER JWR, 1994, LANCET, V344, P1470, DOI 10.1016/S0140-6736(94)90290-9; Chen RS, 2009, ONCOGENE, V28, P599, DOI 10.1038/onc.2008.414; Boyle P, 2005, ANN ONCOL, V16, P481, DOI 10.1093/annonc/mdi098; Jung T, 2011, J BIOL CHEM, V286, DOI 10.1074/jbc.M110.208421; Kinoshita H, 2013, ONCOL REP, V29, P685, DOI 10.3892/or.2012.2162; Langan RC, 2012, J CANCER, V3, P231, DOI 10.7150/jca.4542; Nagano O, 2012, ONCOGENE, V32, P5191; Nanashima A, 2001, DIGEST DIS SCI, V46, P1623, DOI 10.1023/A:1010680815954; Shiozaki A, 2014, J GASTROENTEROL, V49, P853, DOI 10.1007/s00535-013-0847-5; Sobin LH, 2009, TNM CLASSIFICATION M; Wada T, 2013, CANCER SCI, V104, P1323, DOI 10.1111/cas.12236; World Cancer Research Fund/ American Institute for Cancer Research, 2007, FOOD NUTR PHYS ACT P; Yae T, 2012, NAT COMMUN, V3, P1; Zlobec I, 2009, HISTOPATHOLOGY, V55, P564, DOI 10.1111/j.1365-2559.2009.03421.x	28	1	1	INT INST ANTICANCER RESEARCH	ATHENS	EDITORIAL OFFICE 1ST KM KAPANDRITIOU-KALAMOU RD KAPANDRITI, PO BOX 22, ATHENS 19014, GREECE	0250-7005	1791-7530		ANTICANCER RES	Anticancer Res.	FEB	2015	35	2					677	682				6	Oncology	Oncology	CB4LG	WOS:000349598600009		
J	Hiroshima, Y; Zhang, Y; Zhang, N; Uehara, F; Maawy, A; Murakami, T; Mii, S; Yamamoto, M; Miwa, S; Yano, S; Momiyama, M; Mori, R; Matsuyama, R; Chishima, T; Tanaka, K; Ichikawa, Y; Bouvet, M; Endo, I; Hoffman, RM				Hiroshima, Yukihiko; Zhang, Yong; Zhang, Nan; Uehara, Fuminari; Maawy, Ali; Murakami, Takashi; Mii, Sumiyuki; Yamamoto, Mako; Miwa, Shinji; Yano, Shuya; Momiyama, Masashi; Mori, Ryutaro; Matsuyama, Ryusei; Chishima, Takashi; Tanaka, Kuniya; Ichikawa, Yasushi; Bouvet, Michael; Endo, Itaru; Hoffman, Robert M.			Patient-derived Orthotopic Xenograft (PDOX) Nude Mouse Model of Soft-tissue Sarcoma More Closely Mimics the Patient Behavior in Contrast to the Subcutaneous Ectopic Model	ANTICANCER RESEARCH			English	Article						Soft-tissue sarcoma; patient-derived orthotopic xenograft (PDOX); subcutaneous model; nude mouse; histology; spindle cells	FLUORESCENCE-GUIDED SURGERY; METASTATIC MODELS; IMAGING-SYSTEM; BREAST-CANCER; INTACT TISSUE; COLON-CANCER; MICE; SPECIMENS; CHEMOTHERAPY	Aim: Soft-tissue sarcomas are a group of rare mesenchymal carcinomas that include approximately 50 histological types, and account for 1% of all adult cancer cases. The yearly incidence of soft-tissue sarcomas in the USA is approximately 11,280 cases, with an overall mortality of 3,900 deaths per year. Materials and Methods: In this study, we established a patient-derived orthotopic xenograft (PDOX) from a patient with a soft-tissue sarcoma of the retroperitoneum in nude mice and compared it to a subcutaneous patient-derived model of the same tumor for histology. Results: In the PDOX model, a bulky tumor grew in the left retroperitoneum in the same manner as the patient's tumor. Upon histological examination, the majority of the PDOX tissue section comprised sarcomatous high-grade spindle cells of varying sizes, similar to the original patient tumor. In contrast, the majority of the subcutaneously-implanted tumor comprised round to oval cells. Conclusion: These results indicate that the PDOX recapitulated the histology of the original tumor more than the subcutaneous model.	[Hiroshima, Yukihiko; Zhang, Yong; Zhang, Nan; Uehara, Fuminari; Murakami, Takashi; Mii, Sumiyuki; Yamamoto, Mako; Miwa, Shinji; Yano, Shuya; Hoffman, Robert M.] AntiCancer Inc, San Diego, CA 92111 USA; [Hiroshima, Yukihiko; Uehara, Fuminari; Maawy, Ali; Murakami, Takashi; Mii, Sumiyuki; Yamamoto, Mako; Miwa, Shinji; Yano, Shuya; Bouvet, Michael; Hoffman, Robert M.] Univ Calif San Diego, Dept Surg, San Diego, CA 92103 USA; [Hiroshima, Yukihiko; Momiyama, Masashi; Mori, Ryutaro; Matsuyama, Ryusei; Chishima, Takashi; Tanaka, Kuniya; Ichikawa, Yasushi; Endo, Itaru] Yokohama City Univ, Grad Sch Med, Dept Gastroenterol Surg, Yokohama, Kanagawa 232, Japan	Hoffman, RM (reprint author), AntiCancer Inc, 7917 Ostrow St, San Diego, CA 92111 USA.	all@anticancer.com			National Cancer Institute [CA183280]; JSPS KAKENHI [26830081, 26462070, 24592009]	This study was supported in part by National Cancer Institute grant CA183280 and JSPS KAKENHI Grant Numbers 26830081 to Y.H., 26462070 to I.E and 24592009 to K.T.	DeRose YS, 2011, NAT MED, V17, P1514, DOI 10.1038/nm.2454; Siegel R, 2012, CA-CANCER J CLIN, V62, P10, DOI 10.3322/caac.20138; Suetsugu A, 2012, ANTICANCER RES, V32, P3063; Hiroshima Y, 2014, J LAPAROENDOSC ADV S, V24, P241, DOI 10.1089/lap.2013.0418; Suetsugu A, 2012, ANTICANCER RES, V32, P1175; Dong X, 2010, CLIN CANCER RES, V16, P1442, DOI 10.1158/1078-0432.CCR-09-2878; Bertotti A, 2011, CANCER DISCOV, V1, P508, DOI 10.1158/2159-8290.CD-11-0109; FU XY, 1991, P NATL ACAD SCI USA, V88, P9345, DOI 10.1073/pnas.88.20.9345; Tentler JJ, 2012, NAT REV CLIN ONCOL, V9, P338, DOI 10.1038/nrclinonc.2012.61; Clark MA, 2005, NEW ENGL J MED, V353, P701, DOI 10.1056/NEJMra041866; Couzin-Frankel J, 2014, SCIENCE, V346, P25; FU XY, 1992, P NATL ACAD SCI USA, V89, P5645, DOI 10.1073/pnas.89.12.5645; FU XY, 1993, ANTICANCER RES, V13, P283; FU XY, 1993, ANTICANCER RES, V13, P901; FURUKAWA T, 1993, CANCER RES, V53, P1204; Hiroshima Y, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0114310; Hiroshima Y, 2014, J SURG RES, V187, P510, DOI 10.1016/j.jss.2013.11.1083; RYGAARD J, 1969, Acta Pathologica et Microbiologica Scandinavica, V77, P758; Uehara F, 2014, J CELL BIOCH, V115, P1254; WANG XO, 1992, INT J CANCER, V51, P992	20	0	0	INT INST ANTICANCER RESEARCH	ATHENS	EDITORIAL OFFICE 1ST KM KAPANDRITIOU-KALAMOU RD KAPANDRITI, PO BOX 22, ATHENS 19014, GREECE	0250-7005	1791-7530		ANTICANCER RES	Anticancer Res.	FEB	2015	35	2					697	701				5	Oncology	Oncology	CB4LG	WOS:000349598600012		
J	Okumura, T; Shimada, Y; Omura, T; Hirano, K; Nagata, T; Tsukada, K				Okumura, Tomoyuki; Shimada, Yutaka; Omura, Tetsuya; Hirano, Katsuhisa; Nagata, Takuya; Tsukada, Kazuhiro			MicroRNA Profiles to Predict Postoperative Prognosis in Patients with Small Cell Carcinoma of the Esophagus	ANTICANCER RESEARCH			English	Article						Esophageal cancer; small cell carcinoma; miRNA; prognostic marker; surgery	HEPATOCELLULAR-CARCINOMA; GASTRIC-CANCER; EXPRESSION; BIOMARKER; SURVIVAL; MIRNAS; PATHOGENESIS; TISSUE	Background/Aim: Small cell carcinoma of the esophagus (SCCE) is a rare but very aggressive disease with poor prognosis. The aim of the present study was to identify a molecular signature to predict postoperative outcomes in patients with SCCE. Materials and Methods: Expression of microRNA was detected in surgically-removed SCCE tumors using microarrays. A SCCE cell line (TYUC-1) was established to investigate the biological role of differentially expressed microRNAs. Results: Hierarchical clustering of microRNA expression revealed two discrete clusters that were identical to the cases with rapid tumor relapse (n= 3; median survival, 5.1 months) and the cases with long-term survival (n= 3; median observation, 144.7 months), respectively. Eight microRNAs (miR-4323, miR-625, miR-3619-3p, miR-4419b, miR-1249, miR-4648, miR-4664-3p and miR-1203) showed significant correlation with tumor relapse (p < 0.01). Migration of TYUC-1 was significantly inhibited by down-regulation of miR-625. Conclusion: The expression profiles of microRNAs in tumors may represent a novel predictor for postoperative outcomes in patients with SCCE.	[Okumura, Tomoyuki; Shimada, Yutaka; Omura, Tetsuya; Hirano, Katsuhisa; Nagata, Takuya; Tsukada, Kazuhiro] Toyama Univ, Grad Sch Med & Pharmaceut Sci, Dept Surg & Sci, Toyama 930, Japan; [Shimada, Yutaka] Kyoto Univ, Grad Sch Pharmaceut Sci, Dept Nanobio Drug Discovery, Kyoto, Japan	Okumura, T (reprint author), Sugitani 2630, Toyama 9300194, Japan.	okumura@med.u-toyama.ac.jp			MEXT KAKENHI [23591920]	This work was supported by a Grant-in-Aid for Scientific Research (C) MEXT KAKENHI Grant Number 23591920.	Al Mansoor S, 2013, GER MED SCI, V11; Li T, 2014, ONCOGENE, V33, P783, DOI 10.1038/onc.2012.637; Gu J, 2013, CURR PHARM DESIGN, V19, P1292; Hirata H, 2014, BRIT J CANCER, V110, P1645, DOI 10.1038/bjc.2014.48; Chen SB, 2011, DIS ESOPHAGUS, V24, P114, DOI 10.1111/j.1442-2050.2010.01112.x; Chen ZL, 2011, J BIOL CHEM, V286, P10725, DOI 10.1074/jbc.M110.165654; Mathe EA, 2009, CLIN CANCER RES, V15, P6192, DOI 10.1158/1078-0432.CCR-09-1467; Liu SG, 2013, ONCOL LETT, V5, P1639, DOI 10.3892/ol.2013.1251; Chen JY, 2013, INT J MOL MED, V32, P557, DOI 10.3892/ijmm.2013.1424; Kano M, 2010, INT J CANCER, V127, P2804, DOI 10.1002/ijc.25284; Okumura T, 2014, INT J ONCOL, V44, P1923, DOI 10.3892/ijo.2014.2365; Zhu Y, 2014, DIS ESOPHAGUS, V27, P152, DOI 10.1111/dote.12069; Katayama Y, 2012, ONCOL LETT, V4, P817, DOI 10.3892/ol.2012.810; Hu YX, 2011, INT J CANCER, V128, P132, DOI 10.1002/ijc.25330; Rasmussen MH, 2013, MOL ONCOL, V7, P637, DOI 10.1016/j.molonc.2013.02.016; Eisfeld AK, 2012, BLOOD, V120, P249, DOI 10.1182/blood-2012-02-408492; Guo Y, 2008, CANCER RES, V68, P26, DOI 10.1158/0008-5472.CAN-06-4418; Baek D, 2008, NATURE, V455, P64, DOI 10.1038/nature07242; SHIMADA Y, 1992, CANCER, V69, P277, DOI 10.1002/1097-0142(19920115)69:2<277::AID-CNCR2820690202>3.0.CO;2-C; Ranade AR, 2010, J THORAC ONCOL, V5, P1273, DOI 10.1097/JTO.0b013e3181dea6be; Lin RJ, 2012, J SURG ONCOL, V105, P175, DOI 10.1002/jso.22066; Takeshita N, 2013, BRIT J CANCER, V108, P644, DOI 10.1038/bjc.2013.8; Navarro A, 2011, J SURG ONCOL, V103, P411, DOI 10.1002/jso.21847; Kirschner MB, 2012, J THORAC ONCOL, V7, P1184, DOI 10.1097/JTO.0b013e3182572e83; Zhang B, 2013, CANCER CELL INT, V13, DOI 10.1186/1475-2867-13-118; Gao R, 2013, DIS ESOPHAGUS, DOI [10.1111/dote.12149, DOI 10.1111/DOTE.12149.EPUB]; Huang YH, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037188; Kozinn Spencer I, 2013, Genes Cancer, V4, P61, DOI 10.1177/1947601913484495; Kukar M, 2013, ANN SURG ONCOL, V20, P4239, DOI 10.1245/s10434-013-3167-3; Li X, 2013, PLOS ONE, V8, DOI [10.1371/journal.pone.0073009, DOI 10.1371/JOURNAL.PONE.0073009]; Liu RY, 2013, CANCER LETT, V335, P351, DOI 10.1016/j.canlet.2013.02.045; Nouraee N, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0073009; Omura T, 2014, ONCOL REP, V31, P613, DOI 10.3892/or.2013.2900; Osawa S, 2011, ONCOL LETT, V2, P613, DOI 10.3892/ol.2011.313; Sobin LH, 2010, TNM CLASSIFICATION M; Xu XL, 2013, ANN THORAC SURG, V97, P1037; Zhao WX, 2013, TUMOR BIOL, V34, P3245, DOI 10.1007/s13277-013-0896-7; Zhou CX, 2012, GENE, V507, P95, DOI 10.1016/j.gene.2012.06.073	38	1	1	INT INST ANTICANCER RESEARCH	ATHENS	EDITORIAL OFFICE 1ST KM KAPANDRITIOU-KALAMOU RD KAPANDRITI, PO BOX 22, ATHENS 19014, GREECE	0250-7005	1791-7530		ANTICANCER RES	Anticancer Res.	FEB	2015	35	2					719	727				9	Oncology	Oncology	CB4LG	WOS:000349598600015		
J	Saito, Y; Kishimoto, M; Yoshizawa, Y; Kawaii, S				Saito, Yusuke; Kishimoto, Maho; Yoshizawa, Yuko; Kawaii, Satoru			Synthesis and Structure-Activity Relationship Studies of Furan-ring Fused Chalcones as Antiproliferative Agents	ANTICANCER RESEARCH			English	Article						Furochalcones; antiproliferative activity; HL60 cells; structure and activity relationship	CANCER-CELL-LINES; DERIVATIVES; FLAVONOIDS	As part of our continuing investigation of flavonoid derivatives as potential anticancer substances, the synthesis of 25 cinnamoyl derivatives of benzofuran as furan-fused chalcones was carried-out and these compounds were further evaluated for their antiproliferative activity towards HL60 promyelocytic leukemia cells. In comparison with 2',4'-dihydroxychalcone, attachment of a furan moiety on the A-ring enhanced activity by more than twofold. Benzofurans may be useful in the design of biologically active flavonoids.	[Saito, Yusuke; Kishimoto, Maho; Kawaii, Satoru] Tokyo Denki Univ, Lab Bioorgan Chem, Hatoyama, Saitama 3500394, Japan; [Yoshizawa, Yuko] Akita Prefectural Univ, Lab Bioorgan Chem, Akita, Japan	Kawaii, S (reprint author), Tokyo Denki Univ, Fac Sci & Engn, Hatoyama, Saitama 3500394, Japan.	kawaii@mail.dendai.ac.jp					Kawaii S, 1999, BIOSCI BIOTECH BIOCH, V63, P896, DOI 10.1271/bbb.63.896; Katsori AM, 2009, CURR MED CHEM, V16, P1062; Achanta G, 2006, MOL PHARMACOL, V70, P426, DOI 10.1124/mol.105.021311; Dimmock JR, 1999, CURR MED CHEM, V6, P1125; Avila HP, 2008, BIOORGAN MED CHEM, V16, P9790, DOI 10.1016/j.bmc.2008.09.064; Rao RR, 2012, MED CHEM RES, V21, P760, DOI 10.1007/s00044-011-9583-7; Sortino M, 2007, BIOORGAN MED CHEM, V15, P484, DOI 10.1016/j.bmc.2006.09.038; Cheng JH, 2008, BIOORGAN MED CHEM, V16, P7270, DOI 10.1016/j.bmc.2008.06.031; Decharchoochart P, 2014, J NAT MED-TOKYO, V68, P730, DOI 10.1007/s11418-014-0851-y; Kawaii S, 2001, ANTICANCER RES, V21, P1905; Kawaii S, 2012, ANTICANCER RES, V32, P5239; Kawaii S, 2012, ANTICANCER RES, V32, P2819; Lopez SN, 2001, BIOORGAN MED CHEM, V9, P1999, DOI 10.1016/S0968-0896(01)00116-X; Magalhaes AE, 2004, AN ACAD BRAS CIENC, V76, P651, DOI 10.1590/S0001-37652004000400004; Modzelewska A, 2006, BIOORGAN MED CHEM, V14, P3491, DOI 10.1016/j.bmc.2006.01.003; Nimmanapalli PR, 2010, BIOORGAN MED CHEM, V18, P5807; Tomar V, 2007, BIOORG MED CHEM LETT, V17, P5321, DOI 10.1016/j.bmcl.2007.08.021; Vargas MLY, 2003, BIOORGAN MED CHEM, V11, P1531, DOI DOI 10.1016/S0968-0896(02)00605-3	18	1	1	INT INST ANTICANCER RESEARCH	ATHENS	EDITORIAL OFFICE 1ST KM KAPANDRITIOU-KALAMOU RD KAPANDRITI, PO BOX 22, ATHENS 19014, GREECE	0250-7005	1791-7530		ANTICANCER RES	Anticancer Res.	FEB	2015	35	2					811	817				7	Oncology	Oncology	CB4LG	WOS:000349598600025		
J	Schmeel, LC; Schmeel, FC; Kim, Y; Blaum-Feder, S; Endo, T; Schmidt-Wolf, IGH				Schmeel, Leonard Christopher; Schmeel, Frederic Carsten; Kim, Young; Blaum-Feder, Sabine; Endo, Tomoyuki; Schmidt-Wolf, Ingo G. H.			In Vitro Efficacy of Cinnarizine Against Lymphoma and Multiple Myeloma	ANTICANCER RESEARCH			English	Article						Cinnarizine; multiple myeloma; lymphoma; cancer therapy; WNT	WNT/BETA-CATENIN PATHWAY; STEM-CELL TRANSPLANTATION; ETHACRYNIC-ACID; VIVO EFFICACY; WNT INHIBITORS; BETA-CATENIN; BONE-MARROW; CANCER; LENALIDOMIDE; PROGRESSION	Background/Aim: Multiple myeloma, a well-known but still incurable disease, is a hematological malignancy of B-lymphocytes. While standard chemotherapy regimens have been used for years, novel agents, such as lenalidomide and bortezomib, have become an essential part of today's therapies. Nevertheless, new therapeutical strategies are required in the future. Aberrant activation of wingless-related integration site (WNT)/beta-catenin signaling promotes the development of several types of cancer. Recently, it has been demonstrated that the WNT pathway is also activated in lymphoma and myeloma. Thus, the WNT signaling molecules are attractive candidates for the development of targeted therapies. To this extent, we recently confirmed that the diuretic agent ethacrynic acid (EA) and the antifungal agent ciclopirox olamine (CIC) inhibit WNT signaling. Cinnarizine has similar chemical features to those of CIC. Materials and Methods: Thus, in this study the antitumor effect of cinnarizine on myeloma and lymphoma cells was investigated by DiOC6 and propidium iodide (PI)-staining in flow cytometry. Results: Cinnarizine triggered a significant apoptotic activity in all tested myeloma and lymphoma cell lines in a concentration-dependent manner. Interestingly, healthy cells were mainly unaffected. Conclusion: These results reveal a significant selective induction of apoptosis by cinnarizine that might result from an inhibition of WNT signaling and suggest an in vivo efficacy against lymphoma and myeloma.	[Schmeel, Leonard Christopher; Schmeel, Frederic Carsten; Kim, Young; Blaum-Feder, Sabine; Schmidt-Wolf, Ingo G. H.] Univ Hosp Bonn, CIO, Dept Internal Med 3, D-53105 Bonn, Germany; [Schmeel, Frederic Carsten] Univ Hosp Bonn, Dept Radiol, D-53105 Bonn, Germany; [Endo, Tomoyuki] Hokkaido Univ, Dept Hematol, Grad Sch Med, Sapporo, Hokkaido, Japan	Schmidt-Wolf, IGH (reprint author), Univ Hosp Bonn, CIO, Sigmund Freud Str 25, D-53105 Bonn, Germany.	Ingo.Schmidt-Wolf@ukb.uni-bonn.de					Aberle H, 1997, EMBO J, V16, P3797, DOI 10.1093/emboj/16.13.3797; Ashihara E, 2009, CLIN CANCER RES, V15, P2731, DOI 10.1158/1078-0432.CCR-08-1350; Sukhdeo K, 2007, P NATL ACAD SCI USA, V104, P7516, DOI 10.1073/pnas.0610299104; Moreau P, 2006, BLOOD, V107, P397, DOI 10.1182/blood-2005-06-2573; Kim Y, 2011, IN VIVO, V25, P99; Hideshima T, 2007, NAT REV CANCER, V7, P585, DOI 10.1038/nrc2189; Wall I, 2014, ANTICANCER RES, V34, P5375; Schmidt M, 2011, IN VIVO, V25, P325; Dutta-Simmons J, 2009, BLOOD, V114, P2699, DOI 10.1182/blood-2008-12-194290; Kuehl WM, 2002, NAT REV CANCER, V2, P175, DOI 10.1038/nrc746; Kim Y, 2012, LEUKEMIA RES, V36, P598, DOI 10.1016/j.leukres.2012.01.025; Palumbo A, 2011, NEW ENGL J MED, V364, P1046, DOI 10.1056/NEJMra1011442; Rosinol L, 2008, BLOOD, V112, P3591, DOI 10.1182/blood-2008-02-141598; Kim Y, 2011, IN VIVO, V25, P887; Kim Y, 2011, ANTICANCER RES, V31, P725; Fowler JA, 2012, CANCER RES, V72, P2183, DOI 10.1158/0008-5472.CAN-11-2067; Schmidt M, 2009, BRIT J HAEMATOL, V144, P796, DOI 10.1111/j.1365-2141.2008.07503.x; Qiang YW, 2003, ONCOGENE, V22, P1536, DOI 10.1038/sj.onc.1206239; Willert K, 2006, GENE DEV, V20, P1394, DOI 10.1101/gad.1424006; Bringhen S, 2006, EXPERT OPIN INV DRUG, V15, P1565, DOI 10.1517/13543784.15.12.1565; Harousseau JL, 2009, NEW ENGL J MED, V360, P2645, DOI 10.1056/NEJMct0805626; Tosoni C, 2009, CLIN EXP DERMATOL, V34, P166, DOI 10.1111/j.1365-2230.2008.02891.x; Derksen PWB, 2004, P NATL ACAD SCI USA, V101, P6122, DOI 10.1073/pnas.0305855101; Koller CM, 2013, ANTICANCER RES, V33, P2435; Polakis P, 2000, GENE DEV, V14, P1837; Clevers H, 2006, CELL, V127, P469, DOI 10.1016/j.cell.2006.10.018; Chapman MA, 2011, NATURE, V471, P467, DOI 10.1038/nature09837; Schmeel LC, 2013, ANTICANCER RES, V33, P4719; Haasler T, 2009, N-S ARCH PHARMACOL, V380, P531, DOI 10.1007/s00210-009-0463-3; Howlader N, 2014, SEER CANC STAT REV 1; Kocemba KA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030359; Lu DS, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008294; SALETU B, 1980, PROG NEURO-PSYCHOPHA, V4, P469, DOI 10.1016/0364-7722(80)90017-X; Schmeel FC, 2014, HEMATOL ONCOL, V32, P197, DOI 10.1002/hon.2122; Singh B. N., 1986, BR J CLIN PHARM S, V21, P109; Von Schulz-Hausmann SA, 2014, ANTICANCER RES, V34, P4101; WILDERSMITH CH, 1991, ACTA ONCOL, V30, P731	37	1	1	INT INST ANTICANCER RESEARCH	ATHENS	EDITORIAL OFFICE 1ST KM KAPANDRITIOU-KALAMOU RD KAPANDRITI, PO BOX 22, ATHENS 19014, GREECE	0250-7005	1791-7530		ANTICANCER RES	Anticancer Res.	FEB	2015	35	2					835	841				7	Oncology	Oncology	CB4LG	WOS:000349598600028		
J	Yoneyama, K; Kojima, S; Kodani, Y; Yamaguchi, N; Igarashi, A; Kurose, K; Kawase, R; Takeshita, T; Hattori, S; Nagata, K				Yoneyama, Koichi; Kojima, Shigeyuki; Kodani, Yoshiko; Yamaguchi, Nozomi; Igarashi, Akira; Kurose, Keisuke; Kawase, Rieko; Takeshita, Toshiyuki; Hattori, Seisuke; Nagata, Kinya			Proteomic Identification of Autoantibodies in Sera from Patients with Ovarian Cancer as Possible Diagnostic Biomarkers	ANTICANCER RESEARCH			English	Article						Autoantibody; diagnosis; biomarker; ovarian cancer slot-blot	CLEAR-CELL CARCINOMA; P53 ANTIBODIES; MUTATIONS; CALRETICULIN; IMMUNITY; MONITOR; ANTIGEN; TARGET; ARID1A; TUMORS	Background/Aim: Accumulating evidence shows that various types of cancers induce a specific immune response resulting in the production of antibodies against self-components (autoantibodies). The aim of the present study was to identify antigens for autoantibodies in sera from patients with ovarian cancer, especially clear cell carcinoma (CCC), as novel diagnostic markers for the disease. Materials and Methods: The reactivity of individual sera from patients was examined by two-dimensional (2-D) immunoblotting using lysates of CCC cell lines, ES-2 and RMG-1, as antigens to identify autoantigens. ELISA was established to quantitatively measure autoantibody titer of patients' sera. Results: Autoantibodies against RhoGDI were induced in sera of ovarian cancer patients. Elevated levels of autoantibodies against heterogeneous nuclear ribonucleoprotein L (hnRNPL) and a mitochondrial protein, dihydrolipoamide dehydrogenase (DLD), were detected in patients with CCC. Conclusion: Autoantibodies against RhoGDI and hnRNPL and DLD may serve as novel diagnostic markers for ovarian cancer and CCC, respectively.	[Yoneyama, Koichi; Kurose, Keisuke; Kawase, Rieko; Takeshita, Toshiyuki] Main Hosp, Nippon Med Sch, Dept Obstet & Gynecol, Tokyo, Japan; [Kojima, Shigeyuki; Kodani, Yoshiko; Yamaguchi, Nozomi; Igarashi, Akira; Nagata, Kinya] BML Inc, Dept Adv Med & Dev, Saitama, Japan; [Hattori, Seisuke] Univ Tokyo, Inst Med Sci, Div Cellular Prote, Tokyo, Japan; [Hattori, Seisuke] Kitasato Univ, Sch Pharmaceut Sci, Div Biochem, Tokyo 1088641, Japan	Hattori, S (reprint author), Kitasato Univ, Sch Pharmaceut Sci, Minato Ku, 5-9-1 Shirokane, Tokyo 1088641, Japan.	hattoris@pharm.kitasato-u.ac.jp					Tan EM, 2001, J CLIN INVEST, V108, P1411, DOI 10.1172/JCI14451; Arakawa N, 2013, J PROTEOME RES, V12, P4340, DOI 10.1021/pr400282j; Shih IM, 2011, AM J PATHOL, V178, P1442, DOI 10.1016/j.ajpath.2011.01.009; Soussi T, 2000, CANCER RES, V60, P1777; Chiang WF, 2011, ORAL ONCOL, V47, P452, DOI 10.1016/j.oraloncology.2011.03.025; CANNEY PA, 1984, BRIT J CANCER, V50, P765, DOI 10.1038/bjc.1984.254; Chapman C, 2007, ANN ONCOL, V18, P868, DOI 10.1093/annonc/mdm007; Hanash SM, 2008, NATURE, V452, P571, DOI 10.1038/nature06916; Sugiyama T, 2000, CANCER, V88, P2584, DOI 10.1002/1097-0142(20000601)88:11<2584::AID-CNCR22>3.0.CO;2-5; Kuo KT, 2009, AM J PATHOL, V174, P1597, DOI 10.2353/ajpath.2009.081000; Romero I, 2012, ENDOCRINOLOGY, V153, P1593, DOI 10.1210/en.2011-2123; Tian CQ, 2009, CANCER, V115, P1395, DOI 10.1002/cncr.24152; Chapman CJ, 2012, TUMOR BIOL, V33, P1319, DOI 10.1007/s13277-012-0379-2; Jones S, 2010, SCIENCE, V330, P228, DOI 10.1126/science.1196333; Cheng Y, 2013, CLIN TRANSL ONCOL, V15, P398, DOI 10.1007/s12094-012-0941-9; Hanash SM, 2011, NAT REV CLIN ONCOL, V8, P142, DOI 10.1038/nrclinonc.2010.220; Shimada H, 2003, CANCER, V97, P682, DOI 10.1002/cncr.11092; Wiegand KC, 2010, NEW ENGL J MED, V363, P1532, DOI 10.1056/NEJMoa1008433; MIZUSHIMA S, 1990, NUCLEIC ACIDS RES, V18, P5322, DOI 10.1093/nar/18.17.5322; D'Angelo E, 2010, CLIN TRANSL ONCOL, V12, P783, DOI 10.1007/s12094-010-0599-0; Pekarikova A, 2010, CLIN EXP IMMUNOL, V160, P215, DOI 10.1111/j.1365-2249.2009.04085.x; Babel I, 2011, MOL CELL PROTEOMICS, V10; BAST RC, 1985, EUR J OBSTET GYN R B, V19, P354, DOI 10.1016/0028-2243(85)90130-3; BAST RC, 1983, NEW ENGL J MED, V309, P883, DOI 10.1056/NEJM198310133091503; Dordic M, 2012, BMC COMPLEM ALTERN M, V12, DOI 10.1186/1472-6882-12-109; Eric-Nikolic A, 2012, ONCOLOGY-BASEL, V82, P48, DOI 10.1159/000335267; Finn OJ, 2005, NEW ENGL J MED, V353, P1288, DOI 10.1056/NEJMe058157; IWAMATSU A, 1992, ELECTROPHORESIS, V13, P142, DOI 10.1002/elps.1150130129; Katsumata Y, 2011, MOL CELL PROTEOMICS, V10; Katsumata Y, 2013, MOD RHEUMATOL, V23, P71, DOI 10.1007/s10165-012-0624-y; Lee K, 2003, WHO CLASSIFICATION T, P117; Li J, 2012, SCAND J IMMUNOL, V75, P342, DOI 10.1111/j.1365-3083.2011.02657.x; WHO. International Agency for Research on Cancer, GLOBOCAN 2012; Yoneyama K, 2014, ANTICANCER RES, V34, P5021	34	0	0	INT INST ANTICANCER RESEARCH	ATHENS	EDITORIAL OFFICE 1ST KM KAPANDRITIOU-KALAMOU RD KAPANDRITI, PO BOX 22, ATHENS 19014, GREECE	0250-7005	1791-7530		ANTICANCER RES	Anticancer Res.	FEB	2015	35	2					881	889				9	Oncology	Oncology	CB4LG	WOS:000349598600034		
J	Yamamoto, M; Miyata, H; Yamasaki, M; Maeda, N; Miyazaki, Y; Takahashi, T; Kurokawa, Y; Nakajima, K; Takiguchi, S; Mori, M; Doki, Y				Yamamoto, Masaaki; Miyata, Hiroshi; Yamasaki, Makoto; Maeda, Noboru; Miyazaki, Yasuhiro; Takahashi, Tsuyoshi; Kurokawa, Yukinori; Nakajima, Kiyokazu; Takiguchi, Shuji; Mori, Masaki; Doki, Yuichiro			Chylothorax After Esophagectomy Cured by Intranodal Lymphangiography: A Case Report	ANTICANCER RESEARCH			English	Article						Esophageal cancer; chylothorax; lymphangiography; case report	THORACIC-DUCT; COMPLICATING ESOPHAGECTOMY; CHYLOUS FISTULA; RISK-FACTORS; MANAGEMENT; CANCER; FEASIBILITY; LIGATION	This is a case report of chylothorax after esophagectomy for esophageal cancer cured by intranodal lymphangiography in the groin. A 62-year-old man was admitted to our Hospital with dysphagia. The diagnosis was made of advanced esophageal cancer (T3N1M0, stage IIIA). After neoadjuvant chemotherapy, radical surgery was performed. On postoperative day (POD) 9, left pleural effusion drainage increased sharply and changed to a milky white color, leading to a diagnosis of chylothorax. Although chylothorax was managed with conservative treatment, there was an inadequate response to it. On POD 15, lymphangiography was performed. Inguinal nodes were directly accessed under ultrasound guidance and lipiodol was injected into nodes. After the lymphangiography, the left pleural effusion drainage immediately decreased. On POD 40, the patient was discharged. To the best of our knowledge, this is the first report of a chylothorax after esophagectomy for esophageal cancer to be cured by ultrasound-guided intranodal lymphangiography in the groin.	[Yamamoto, Masaaki; Miyata, Hiroshi; Yamasaki, Makoto; Miyazaki, Yasuhiro; Takahashi, Tsuyoshi; Kurokawa, Yukinori; Nakajima, Kiyokazu; Takiguchi, Shuji; Mori, Masaki; Doki, Yuichiro] Osaka Univ, Dept Surg Gastroenterol, Grad Sch Med, Suita, Osaka 5650871, Japan; [Maeda, Noboru] Osaka Univ, Dept Diagnost & Intervent Radiol, Grad Sch Med, Suita, Osaka 5650871, Japan	Miyata, H (reprint author), Osaka Univ, Dept Surg Gastroenterol, Grad Sch Med, 2-2 Yamadaoka, Suita, Osaka 5650871, Japan.	hmiyata@gesurg.med.osaka-u.ac.jp					SELLE JG, 1973, ANN SURG, V177, P245, DOI 10.1097/00000658-197302000-00022; Dugue L, 1998, BRIT J SURG, V85, P1147; Lagarde SM, 2005, ANN THORAC SURG, V80, P449, DOI 10.1016/j.athoracsur.2005.02.076; Wemyss-Holden SA, 2001, BRIT J SURG, V88, P1442, DOI 10.1046/j.0007-1323.2001.01896.x; PATTERSON GA, 1981, ANN THORAC SURG, V32, P44; Kawasaki R, 2013, AM J ROENTGENOL, V201, P659, DOI 10.2214/AJR.12.10008; Eisenhauer EA, 2009, EUR J CANCER, V45, P228, DOI 10.1016/j.ejca.2008.10.026; Shah RD, 2012, ANN THORAC SURG, V93, P897, DOI 10.1016/j.athoracsur.2011.10.060; Nadolski GJ, 2012, J VASC INTERV RADIOL, V23, P613, DOI 10.1016/j.jvir.2012.01.078; Yoshida N, 2014, SURG TODAY, V44, P526, DOI 10.1007/s00595-013-0577-6; Watanabe M, 2013, SURG TODAY, V43, P237, DOI 10.1007/s00595-012-0300-z; Hayden JD, 2007, DIS ESOPHAGUS, V20, P251, DOI 10.1111/j.1442-2050.2007.00644.x; Japanese Society for Esophageal Diseases, 2007, GUID CLIN PATH STUD; KINMONTH JB, 1954, ANN ROY COLL SURG, V15, P300; Merigliano S, 2000, J THORAC CARDIOV SUR, V119, P453, DOI 10.1016/S0022-5223(00)70123-1; Morimoto Junya, 2013, Kyobu Geka, V66, P133; Nakashima S, 2013, JPN J CANC CHEMOTHER, V40, P2161; Rajebi MR, 2011, J VASC INTERV RADIOL, V22, P1300, DOI 10.1016/j.jvir.2011.05.003; ROBINSON CLN, 1985, ANN THORAC SURG, V39, P90; Sobin LH, 2009, INT UNION CANC UICC; Syed Labib H, 2007, Semin Intervent Radiol, V24, P106, DOI 10.1055/s-2007-971180; Uemura M, 2005, JPN J GASTROENTEROL, V38, P7	22	0	0	INT INST ANTICANCER RESEARCH	ATHENS	EDITORIAL OFFICE 1ST KM KAPANDRITIOU-KALAMOU RD KAPANDRITI, PO BOX 22, ATHENS 19014, GREECE	0250-7005	1791-7530		ANTICANCER RES	Anticancer Res.	FEB	2015	35	2					891	895				5	Oncology	Oncology	CB4LG	WOS:000349598600035		
J	Yamashita, K; Hosoda, K; Katada, N; Moriya, H; Mieno, H; Higuchi, K; Sasaki, T; Katada, C; Sakuramoto, S; Tanabe, S; Koizumi, W; Kikuchi, S; Watanabe, M				Yamashita, Keishi; Hosoda, Kei; Katada, Natsuya; Moriya, Hiromitsu; Mieno, Hiroaki; Higuchi, Katsuhiko; Sasaki, Tohru; Katada, Chikatoshi; Sakuramoto, Shinichi; Tanabe, Satoshi; Koizumi, Wasaburo; Kikuchi, Shiro; Watanabe, Masahiko			Survival Outcome of Borrmann Type IV Gastric Cancer Potentially Improved by Multimodality Treatment	ANTICANCER RESEARCH			English	Article						Type IV gastric cancer; survival; chemotherapy	ADJUVANT CHEMOTHERAPY; PHASE-II; S-1; SURGERY; CARCINOMA; CISPLATIN; FEATURES; TRIAL	Background: Type IV macroscopic gastric cancer has the poorest prognosis of all gastric cancer types. Although progress of multidisciplinary treatments is outstanding, the current survival outcome of such therapies is obscure. Patients and Methods: Among 5,172 patients with gastric cancer between 1971 and 2013, 287 cases of type IV were identified (5%). We divided time period into early (1971-2004) and late periods (2005-2013), and compared their prognosis. Multi-variate Cox proportional hazards model was applied to the univariate prognostic factors, and identified independent prognostic factors and long-term survivors. Results: Five-year overall survival (OS) was 13% and 31% in the early and late periods, respectively (p=0.0010). Univariate prognostic factors were age, pathological tumor depth of invasion (pT), pathological lymph node metastasis (pN), peritoneal dis semination (P), intra-peritoneal cytology test (CY), and margin status. Multivariate analysis determined independent prognostic factors to be treatment period (p=0.0001), pT (p=0.0024) and P (p=0.035). Survival outcomes were stratified by combination of pT and P in both periods, where OS was improved in the late period. Long-term survivors often underwent long-term postoperative chemotherapy with S-1. Conclusion: Long-term postoperative S-1 chemotherapy may improve survival outcome of patients with type IV gastric cancer, and their prognosis is predicted by pT and P status.	[Yamashita, Keishi; Hosoda, Kei; Katada, Natsuya; Moriya, Hiromitsu; Mieno, Hiroaki; Kikuchi, Shiro; Watanabe, Masahiko] Kitasato Univ, Dept Surg, Sch Med, Sagamihara, Kanagawa 2520380, Japan; [Higuchi, Katsuhiko; Sasaki, Tohru; Katada, Chikatoshi; Tanabe, Satoshi; Koizumi, Wasaburo] Kitasato Univ, Dept Gastroenterol, Sch Med, Sagamihara, Kanagawa 2520380, Japan; [Sakuramoto, Shinichi] Saitama Med Univ, Int Med Ctr, Dept Upper Gastrointestinal Surg, Hidaka, Saitama, Japan	Yamashita, K (reprint author), Kitasato Univ, Dept Surg, Sch Med, Minami Ku, Asamizodai 2-1-1, Sagamihara, Kanagawa 2520380, Japan.	keishi23@med.kitasato-u.ac.jp					Yamashita K, 2013, SURG TODAY, V43, P1013, DOI 10.1007/s00595-012-0388-1; Msika S, 2000, EUR J CANCER, V36, P390, DOI 10.1016/S0959-8049(99)00308-1; Kinoshita T, 2009, GASTRIC CANCER, V12, P37, DOI 10.1007/s10120-008-0496-1; Aoyama T, 2013, ANN SURG ONCOL, V20, P2000, DOI 10.1245/s10434-012-2776-6; Cunningham D, 2006, NEW ENGL J MED, V355, P11, DOI 10.1056/NEJMoa055531; Sasako M, 2011, J CLIN ONCOL, V29, P4387, DOI 10.1200/JCO.2011.36.5908; Koizumi W, 2012, CANCER CHEMOTH PHARM, V69, P407, DOI 10.1007/s00280-011-1701-1; Kodera Y, 2001, J SURG ONCOL, V78, P175, DOI 10.1002/jso.1144; Iwasaki Y, 2013, J SURG ONCOL, V107, P741, DOI 10.1002/jso.23301; Yamashita K, 2008, GASTRIC CANCER, V11, P111, DOI 10.1007/s10120-008-0466-7; Macdonald JS, 2001, NEW ENGL J MED, V345, P725, DOI 10.1056/NEJMoa010187; Okuyama T, 2012, SURG TODAY, V42, P734, DOI 10.1007/s00595-012-0129-5; Cancer IUA, 2009, TNM CLASSIFICATION M; International Agency for Research on Cancer WHO, 2012, GLOBOCAN 2012 EST CA; Japanese Gastric Canc Assoc, 2011, GASTRIC CANCER, V14, P101, DOI 10.1007/s10120-011-0041-5; Kim DY, 2002, ANZ J SURG, V72, P739, DOI 10.1046/j.1445-2197.2002.02523.x; Li C, 2009, ONCOLOGY-BASEL, V77, P197, DOI 10.1159/000236018; Nakayama N, 2008, ONCOLOGY-BASEL, V75, P1, DOI 10.1159/000151613; Sakuramoto S, 2007, NEW ENGL J MED, V357, P1810, DOI 10.1056/NEJMoa072252; Yamashita K, 2014, HEPATO-GASTROENTEROL, V61, P512, DOI 10.5754/hge12979; Yook Jeong Hwan, 2005, Cancer Res Treat, V37, P87, DOI 10.4143/crt.2005.37.2.87	21	0	0	INT INST ANTICANCER RESEARCH	ATHENS	EDITORIAL OFFICE 1ST KM KAPANDRITIOU-KALAMOU RD KAPANDRITI, PO BOX 22, ATHENS 19014, GREECE	0250-7005	1791-7530		ANTICANCER RES	Anticancer Res.	FEB	2015	35	2					897	906				10	Oncology	Oncology	CB4LG	WOS:000349598600036		
J	Shimada, K; Ishikawa, T; Kita, K; Narui, K; Sugae, S; Shimizu, D; Tanabe, M; Sasaki, T; Chishima, T; Ichikawa, Y; Endo, I				Shimada, Kazuhiro; Ishikawa, Takashi; Kita, Kumiko; Narui, Kazutaka; Sugae, Sadayoshi; Shimizu, Daisuke; Tanabe, Mikiko; Sasaki, Takeshi; Chishima, Takashi; Ichikawa, Yasushi; Endo, Itaru			Neoadjuvant Docetaxel/Cyclophosphamide in Triple-negative Breast Cancer: Predictive Value of Class III-beta Tubulin and Non-basal Subtype	ANTICANCER RESEARCH			English	Article						Breast cancer; neoadjuvant chemotherapy; docetaxel; cyclophosphamide; predictive factor; triple-negative	DOCETAXEL-BASED CHEMOTHERAPY; PHASE-II; EXPRESSION; SURVIVAL; TRIAL; CYCLOPHOSPHAMIDE; OVEREXPRESSION; SENSITIVITY; DOXORUBICIN; RESISTANCE	Aim: We aimed to clarify which breast cancer subtypes respond best to docetaxel/cyclophosphamide chemo therapy (TC) as neoadjuvant chemotherapy (NAC). Patients and Methods: We analyzed pathological responses, clinico pathological characteristics and biological markers (estrogen receptor (ER), progesterone receptor (PR), human epidermal growth factor receptor-2 (HER-2), Ki-67, p53, topoisomerase IIa, class III beta tubulin, cytokeratin 5/6, epidermal growth factor receptor (EGFR)) in specimens from 79 patients who received NAC-TC. Results: Out of 79 patients, 33 (41.8%) achieved quasipathological complete responses (QpCR). Univariate analysis associated negative ER (p < 0.001), negative PR (p = 0.007), triple-negative subtype (TNBC; p = 0.001), high Ki-67 (p = 0.022) and low class III beta tubulin (p = 0.032) with QpCR. Multivariate analyses associated only negative ER (p = 0.050) and low class III beta tubulin (p = 0.028) and only non-basal subtype in TNBC with QpCR. Conclusion: NAC-TC may be especially effective in ER-breast cancer with low class III beta tubulin or non-basal TNBC.	[Shimada, Kazuhiro; Ishikawa, Takashi; Kita, Kumiko; Narui, Kazutaka; Sugae, Sadayoshi; Shimizu, Daisuke] Yokohama City Univ, Med Ctr, Dept Breast & Thyroid Surg, Yokohama, Kanagawa 2320024, Japan; [Tanabe, Mikiko; Sasaki, Takeshi] Yokohama City Univ, Med Ctr, Dept Surg Pathol, Yokohama, Kanagawa 2320024, Japan; [Chishima, Takashi; Ichikawa, Yasushi; Endo, Itaru] Yokohama City Univ, Grad Sch Med, Dept Clin Oncol, Yokohama, Kanagawa 2320024, Japan	Shimada, K (reprint author), Yokohama City Univ, Med Ctr, Dept Breast & Thyroid Surg, Minami Ku, 4-57 Urafunecho, Yokohama, Kanagawa 2320024, Japan.	kazu90052003@yahoo.co.jp					Allred D Craig, 2009, J Natl Compr Canc Netw, V7 Suppl 6, pS1; Deng CX, 2006, NUCLEIC ACIDS RES, V34, P1416, DOI 10.1093/nar/gkl010; Byrski T, 2010, J CLIN ONCOL, V28, P375, DOI 10.1200/JCO.2008.20.7019; Liedtke C, 2008, J CLIN ONCOL, V26, P1275, DOI 10.1200/JCO.2007.14.4147; Ploussard G, 2010, CANCER RES, V70, P9253, DOI 10.1158/0008-5472.CAN-10-1447; Kojima Y, 2008, HUM PATHOL, V39, P824, DOI 10.1016/j.humpath.2007.11.001; Toi M, 2008, BREAST CANCER RES TR, V110, P531, DOI 10.1007/s10549-007-9744-z; Nielsen TO, 2004, CLIN CANCER RES, V10, P5367, DOI 10.1158/1078-0432.CCR-04-0220; McGrogan BT, 2008, BBA-REV CANCER, V1785, P96, DOI 10.1016/j.bbcan.2007.10.004; Jones SE, 2006, J CLIN ONCOL, V24, P5381, DOI 10.1200/JCO.2006.06.5391; Gan PP, 2007, CANCER RES, V67, P9356, DOI 10.1158/0008-5472.CAN-07-0509; Noguchi S, 2006, CANCER SCI, V97, P813, DOI 10.1111/j.1349-7006.2006.00265.x; Burkhart CA, 2001, BBA-REV CANCER, V1471, pO1, DOI 10.1016/S0304-419X(00)00022-6; Jones S, 2009, J CLIN ONCOL, V27, P1177, DOI 10.1200/JCO.2008.18.4028; Urano N, 2006, INT J ONCOL, V28, P375; Smoter M, 2011, CANCER CHEMOTH PHARM, V68, P553, DOI 10.1007/s00280-011-1696-7; Baur M, 2008, J CANCER RES CLIN, V134, P125, DOI 10.1007/s00432-007-0259-0; Bernard-Marty Chantal, 2002, Clin Breast Cancer, V3, P341, DOI 10.3816/CBC.2002.n.037; Ferrandina G, 2006, CLIN CANCER RES, V12, P2774, DOI 10.1158/1078-0432.CCR-05-2715; Ganguly A, 2011, ONCOTARGET, V2, P368; Hammond ME, 2011, J CLIN ONCOL, V29, pE458, DOI 10.1200/JCO.2011.35.2245; Hasegawa S, 2003, CLIN CANCER RES, V9, P2992; Honrado E, 2006, ONCOGENE, V25, P5837, DOI 10.1038/sj.onc.1209875; Kuroi Katsumasa, 2006, Breast Cancer, V13, P38, DOI 10.2325/jbcs.13.38; Lakhani SR, 2012, WHO CLASSIFICATION T; Liu Fang, 2006, Zhonghua Zhongliu Zazhi, V28, P449; Masuda H, 2011, CANCER CHEMOTH PHARM, V67, P911, DOI 10.1007/s00280-010-1371-4; Takagawa R, 2010, ANN SURG ONCOL, V17, P81, DOI 10.1245/s10434-009-0708-x; Tiezzi DG, 2007, BMC CANCER, V7, DOI 10.1186/1471-2407-7-36; Valero V, 1997, Oncology (Williston Park), V11, P34; Wang YH, 2013, CLIN BREAST CANCER, V13, P103, DOI 10.1016/j.clbc.2012.11.003	31	0	0	INT INST ANTICANCER RESEARCH	ATHENS	EDITORIAL OFFICE 1ST KM KAPANDRITIOU-KALAMOU RD KAPANDRITI, PO BOX 22, ATHENS 19014, GREECE	0250-7005	1791-7530		ANTICANCER RES	Anticancer Res.	FEB	2015	35	2					907	912				6	Oncology	Oncology	CB4LG	WOS:000349598600037		
J	Muroi, H; Nakajima, M; Satomura, H; Takahashi, M; Yamaguchi, S; Sasaki, K; Yokobori, T; Miyazaki, T; Kuwano, H; Kato, H				Muroi, Hiroto; Nakajima, Masanobu; Satomura, Hitoshi; Takahashi, Masakazu; Yamaguchi, Satoru; Sasaki, Kinro; Yokobori, Takehiko; Miyazaki, Tatsuya; Kuwano, Hiroyuki; Kato, Hiroyuki			Low PHLDA3 Expression in Oesophageal Squamous Cell Carcinomas Is Associated with Poor Prognosis	ANTICANCER RESEARCH			English	Article						Oesophageal cancer; PHLDA3; Akt; prognostic factor	CANCER-CELLS; PATHWAY; AKT; ACTIVATION; GENES; PLAYS; PHLPP; MDM2	Background/Aim: Patients with oesophageal squamous cell carcinoma (ESCC) have a poor prognosis. Akt has been associated with malignant potential in several cancers, including ESCC. Pleckstrin homology-like domain, family A, member 3 (PHLDA3) has been identified as a direct target gene of p53 and as a potent inhibitor of Akt activation. The present study investigated the role of PHLDA3 expression and its ability to predict prognosis in patients with ESCC who did not receive induction therapy. Materials and Methods: The intensity of PHLDA3 expression was immunohistochemically analyzed in tumor and adjacent normal tissue samples from 84 patients with ESCC, 22 who underwent endoscopic submucosal dissection and 62 who underwent thoracic oesophagectomy. Results: High expression of PHLDA3 was observed in 60 (71.4%) patients and low expression in 24 (28.6%). Cancerspecific (p=0.029) and disease-free (p<0.001) survival rates were significantly lower in the PHLDA3 low-than in the PHLDA3 high-expression group, and low PHLDA3 expression was an independent predictor of postoperative recurrence (relative risk (RR)=0.38; 95% confidence interval (CI)=0.1660.78; p=0.0074). Conclusion: Low PHLDA3 expression in ESCC may be predictive of tumor recurrence suggesting that Akt activation may be a therapeutic target in ESCCs.	[Muroi, Hiroto; Nakajima, Masanobu; Satomura, Hitoshi; Takahashi, Masakazu; Yamaguchi, Satoru; Sasaki, Kinro; Kato, Hiroyuki] Dokkyo Med Univ, Dept Surg 1, Mibu, Tochigi 3210293, Japan; [Yokobori, Takehiko; Miyazaki, Tatsuya; Kuwano, Hiroyuki] Gunma Univ, Grad Sch Med, Dept Gen Surg Sci, Gunma, Japan	Muroi, H (reprint author), Dokkyo Med Univ, Dept Surg 1, 880 Kitakobayashi, Mibu, Tochigi 3210293, Japan.	muroi-h@dokkyomed.ac.jp					Sakai N, 2010, DIS ESOPHAGUS, V23, P415, DOI 10.1111/j.1442-2050.2009.01026.x; Christgen M, 2012, LAB INVEST, V92, P1635, DOI 10.1038/labinvest.2012.126; Vivanco I, 2002, NAT REV CANCER, V2, P489, DOI 10.1038/mrc839; Qu W, 2012, MED ONCOL, V29, P113, DOI 10.1007/s12032-010-9768-9; Nakajima M, 2013, EXPERT OPIN PHARMACO, V14, P1345, DOI 10.1517/14656566.2013.801454; Wang WF, 2013, ACTA PHARMACOL SIN, V34, P1560, DOI 10.1038/aps.2013.163; Hill MM, 2002, PHARMACOL THERAPEUT, V93, P243, DOI 10.1016/S0163-7258(02)00193-6; Gao TY, 2005, MOL CELL, V18, P13, DOI 10.1016/j.molcel.2005.03.008; Kawase T, 2009, CELL, V136, P535, DOI 10.1016/j.cell.2008.12.002; Li HX, 2011, CANCER BIOL THER, V11, P950, DOI 10.4161/cbt.11.11.15531; Wen YA, 2013, MOL CELL BIOL, V33, P4594, DOI 10.1128/MCB.00695-13; Liao Y, 2010, AM J TRANSL RES, V2, P19; Osaki M, 2004, APOPTOSIS, V9, P667, DOI 10.1023/B:APPT.0000045801.15585.dd; Li B, 2007, CARCINOGENESIS, V28, P2313, DOI 10.1093/carcin/bgm152; Agrawal N, 2012, CANCER DISCOV, V2, P899, DOI 10.1158/2159-8290.CD-12-0189; Chattopadhyay I, 2010, MUTAT RES-GEN TOX EN, V696, P130, DOI 10.1016/j.mrgentox.2010.01.001; Mayo LD, 2002, TRENDS BIOCHEM SCI, V27, P462, DOI 10.1016/S0968-0004(02)02166-7; Huang Y, 2013, ANTI-CANCER DRUG, V24, P889, DOI 10.1097/CAD.0b013e328363c64e; Fokas E, 2013, DIGEST DIS, V31, P30, DOI 10.1159/000347170; Fresno Vara JA, 2004, CANC TREAT REV, V30, P193, DOI [10.1016/j.ctrv.2003.07.007, DOI 10.1016/J.CTRV.2003.07.007]; Hurmuzlu M, 2010, WORLD J SURG ONCOL, V8, DOI 10.1186/1477-7819-8-46; Kato H, 2007, DIGEST SURG, V24, P88, DOI 10.1159/000101894; Pimkhaokham A, 2000, JPN J CANCER RES, V91, P1126; Takahashi K, 2009, EXP MOL PATHOL, V87, P42, DOI 10.1016/j.yexmp.2008.11.013; Testa JR, 2001, P NATL ACAD SCI USA, V98, P10983, DOI 10.1073/pnas.211430998; Yoo NJ, 2011, PATHOLOGY, V43, P510, DOI 10.1097/PAT.0b013e3283489036	26	1	1	INT INST ANTICANCER RESEARCH	ATHENS	EDITORIAL OFFICE 1ST KM KAPANDRITIOU-KALAMOU RD KAPANDRITI, PO BOX 22, ATHENS 19014, GREECE	0250-7005	1791-7530		ANTICANCER RES	Anticancer Res.	FEB	2015	35	2					949	954				6	Oncology	Oncology	CB4LG	WOS:000349598600043		
J	Nishio, J; Iwasaki, H; Aoki, M; Nabeshima, K; Naito, M				Nishio, Jun; Iwasaki, Hiroshi; Aoki, Mikiko; Nabeshima, Kazuki; Naito, Masatoshi			FDG PET/CT and MR Imaging of CD34-Negative Soft-tissue Solitary Fibrous Tumor with NAB2-STAT6 Fusion Gene	ANTICANCER RESEARCH			English	Article						Solitary fibrous tumor; thigh; PET/CT; MRI; CD34; STAT6; NAB2-STAT6	PLEURA; EXPRESSION; DIAGNOSIS; MIMICS	Extrapleural solitary fibrous tumor (SFT) is an uncommon mesenchymal neoplasm of intermediate biological potential. Herein, we describe the radiological, histological, immunohistochemical and molecular genetic features of an SFT arising in the left thigh of a 55-year-old woman. Magnetic resonance imaging exhibited a well-defined mass with intermediate signal intensity on T1-weighted sequences and heterogeneous high signal intensity on T2-weighted sequences. Contrast-enhanced T1-weighted sequences showed strong homogeneous enhancement of the mass. A prominent vascular pedicle was visible. Integrated positron-emission tomography (PET)/computed tomographic (CT) scan demonstrated a moderate F-18-fluorodeoxyglucose (FDG) uptake (maximum standardized uptake value, 4.45) in the mass. Following an open biopsy, wide excision of the tumor was performed. Histologically, the tumor was composed of a proliferation of spindle cells in a fibrous stroma with focal hyalinization. Thin-walled branching hemangiopericytoma-like vessels were observed. Immunohistochemically, the tumor cells were diffusely positive for signal transducer and activator of transcription 6 (STAT6) but negative for CD34. The MIB-1 labeling index was less than 5%. Subsequent reverse transcriptase-polymerase chain reaction analysis identified a nerve growth factor inducible-A binding protein 2-STAT6 gene fusion. Our case supports the utility of STAT6 immunohistochemistry as an adjunct in the diagnosis of soft-tissue SFT with loss of CD34 positivity. To the best of our knowledge, this is the first report showing the FDG PET/CT findings of soft-tissue SFT.	[Nishio, Jun; Naito, Masatoshi] Fukuoka Univ, Fac Med, Dept Orthopaed Surg, Fukuoka 8140180, Japan; [Iwasaki, Hiroshi; Aoki, Mikiko; Nabeshima, Kazuki] Fukuoka Univ, Fac Med, Dept Pathol, Fukuoka 8140180, Japan	Nishio, J (reprint author), Fukuoka Univ, Fac Med, Dept Orthopaed Surg, Jonan Ku, 7-45-1 Nanakuma, Fukuoka 8140180, Japan.	jnishio@cis.fukuoka-u.ac.jp			Foundation for the Promotion of Medical Science; JSPS KAKENHI [25462355]	This study was supported in part by the Foundation for the Promotion of Medical Science and JSPS KAKENHI Grant Number 25462355.	Mosquera JM, 2009, AM J SURG PATHOL, V33, P1314; Robinson DR, 2013, NAT GENET, V45, P180, DOI 10.1038/ng.2509; Cheah AL, 2014, PATHOLOGY, V46, P389, DOI 10.1097/PAT.0000000000000122; Garcia-Bennett J, 2012, SKELETAL RADIOL, V41, P1427, DOI 10.1007/s00256-012-1364-y; Mohajeri A, 2013, GENE CHROMOSOME CANC, V52, P873, DOI 10.1002/gcc.22083; Wignall OJ, 2010, AM J ROENTGENOL, V195, pW55, DOI 10.2214/AJR.09.3379; Doyle LA, 2014, MODERN PATHOL, V27, P390, DOI 10.1038/modpathol.2013.164; Cortes J, 2003, LUNG, V181, P49, DOI 10.1007/s00408-003-1002-5; Fletcher CDM, 2013, WHO CLASSIFICATION T, P80; Gorospe L, 2012, CLIN NUCL MED, V37, P702, DOI 10.1097/RLU.0b013e31824c6054; Koelsche C, 2014, HISTOPATHOLOGY, V65, P613, DOI 10.1111/his.12431; Kurisaki- Arakawa A, VIRCHOWS AR IN PRESS; Lococo F, 2014, REV ESP MED NUCL IMA, V33, P109, DOI 10.1016/j.remn.2013.07.007; Masuda Y, 2014, INT J CLIN EXP PATHO, V7, P386; Papathanassiou Zafaria G, 2013, Clin Sarcoma Res, V3, P1, DOI 10.1186/2045-3329-3-1; Robinson Lary A, 2006, Cancer Control, V13, P264; Santambrogio L, 2008, WORLD J SURG ONCOL, V6, DOI 10.1186/1477-7819-6-86; Yan JC, 2013, CLIN IMAG, V37, P598, DOI 10.1016/j.clinimag.2012.09.020; Yoshida A, 2014, AM J SURG PATHOL, V38, P552, DOI 10.1097/PAS.0000000000000137	19	0	0	INT INST ANTICANCER RESEARCH	ATHENS	EDITORIAL OFFICE 1ST KM KAPANDRITIOU-KALAMOU RD KAPANDRITI, PO BOX 22, ATHENS 19014, GREECE	0250-7005	1791-7530		ANTICANCER RES	Anticancer Res.	FEB	2015	35	2					967	971				5	Oncology	Oncology	CB4LG	WOS:000349598600046		
J	Moro, Y; Kogashiwa, Y; Sato, D; Matsumoto, Y; Nakamura, T; Yamauchi, K; Sakurai, H; Kohno, N				Moro, Yorihisa; Kogashiwa, Yasunao; Sato, Dai; Matsumoto, Yoshifumi; Nakamura, Takehiro; Yamauchi, Koichi; Sakurai, Hiroyuki; Kohno, Naoyuki			Feasibility Study of Alternate-day S-1 as Adjuvant Chemotherapy for Head and Neck Cancer	ANTICANCER RESEARCH			English	Article						Retrospective study; S-1; toxic effects; oral therapy	RANDOMIZED-TRIAL; CARCINOMA; THERAPY; TEGAFUR; URACIL; AGENT; COLON	Aim: This study analyzed the safety and feasibility of alternate-day S-1, a mixture of tegafur, dehydroxypyrimidine and potassium oxonate, as adjuvant chemotherapy for head and neck cancers. Patients and Methods: Patients with head and neck squamous cell carcinoma (HNSCC) who underwent primary treatment received alternate-day S-1 (80 mg/day for 1 year). The primary end-point was treatment completion rate. The secondary end-point was adverse events. Three-year overall survival (OS) and disease-free survival (DFS) were calculated using the Kaplan-Meier method. Results: One-year completion rate was 65.6%. Out of 26 patients, 19.0% had grade III adverse events. All adverse reactions were tolerable and reversible. Three-year OS and DFS were 74.8% and 57.3%, respectively. Conclusion: S-1 therapy is an effective adjuvant treatment for head and neck cancer patients with relatively mild side-effects and does not adversely affect quality of life. A phase I/II study is warranted to investigate the appropriate dose for an alternate-day S-1 regimen.	[Moro, Yorihisa; Sato, Dai; Matsumoto, Yoshifumi; Nakamura, Takehiro; Yamauchi, Koichi; Kohno, Naoyuki] Kyorin Univ, Sch Med, Dept Otolaryngol Head & Neck Surg, Mitaka, Tokyo 1818611, Japan; [Kogashiwa, Yasunao] Saitama Med Univ, Int Med Ctr, Dept Head & Neck Surg & Otolaryngol, Hidaka, Saitama, Japan; [Sakurai, Hiroyuki] Kyorin Univ, Sch Med, Dept Pharmacol & Toxicol, Mitaka, Tokyo 1818611, Japan	Kohno, N (reprint author), Kyorin Univ, Sch Med, Dept Otolaryngol Head & Neck Surg, 6-20-2 Shinkawa, Mitaka, Tokyo 1818611, Japan.	sukohno@ks.kyorin-u.ac.jp					Adjei AA, 1996, GUT, V38, P531, DOI 10.1136/gut.38.4.531; Arai W, 2008, INT J CLIN ONCOL, V13, P515, DOI 10.1007/s10147-008-0780-4; Miura K, 2012, EXPERT OPIN DRUG DEL, V9, P273, DOI 10.1517/17425247.2012.652945; Denis F, 2004, J CLIN ONCOL, V22, P69, DOI 10.1200/JCO.2004.08.021; LARAMORE GE, 1992, INT J RADIAT ONCOL, V23, P705; Shirasaka T, 2009, JPN J CLIN ONCOL, V39, P2, DOI 10.1093/jjco/hyn127; Sakuma K, 2010, INT J CLIN ONCOL, V15, P166, DOI 10.1007/s10147-010-0036-y; Adelstein DJ, 2003, J CLIN ONCOL, V21, P92, DOI 10.1200/JCO.2003.01.008; Kato H, 2004, NEW ENGL J MED, V350, P1713, DOI 10.1056/NEJMoa032792; Shirasaka T, 1996, CANCER RES, V56, P2602; Cancer statistics, 2013, JAMA, V310, P982; ERVIN TJ, 1987, J CLIN ONCOL, V5, P10; JACOBS C, 1990, J CLIN ONCOL, V8, P838; Johnson JT, 1996, CANCER, V77, P181, DOI 10.1002/(SICI)1097-0142(19960101)77:1<181::AID-CNCR29>3.3.CO;2-4; Yamaue H, 2014, CANCER CHEMOTH PHARM, V73, P97, DOI 10.1007/s00280-013-2323-6; Kinoshita Taira, 2004, Gastric Cancer, V7, P104; LIPKIN M, 1963, GASTROENTEROLOGY, V45, P721; Noguchi S, 2005, J CLIN ONCOL, V23, P2172, DOI 10.1200/JCO.2005.02.158; Shirasaka T, 1996, ANTI-CANCER DRUG, V7, P548, DOI 10.1097/00001813-199607000-00010; Shirasaka T, 2000, INVEST NEW DRUG, V18, P315, DOI 10.1023/A:1006476730671; Shirasaka T, 2000, Gan To Kagaku Ryoho, V27 Suppl 2, P193; Taguchi T, 2013, J CLIN ONCOL, V31; Tsukuda M, 1994, Gan To Kagaku Ryoho, V21, P1169; VOKES EE, 1993, NEW ENGL J MED, V328, P184, DOI 10.1056/NEJM199301213280306	24	0	0	INT INST ANTICANCER RESEARCH	ATHENS	EDITORIAL OFFICE 1ST KM KAPANDRITIOU-KALAMOU RD KAPANDRITI, PO BOX 22, ATHENS 19014, GREECE	0250-7005	1791-7530		ANTICANCER RES	Anticancer Res.	FEB	2015	35	2					977	981				5	Oncology	Oncology	CB4LG	WOS:000349598600048		
J	Kanekiyo, S; Iizuka, N; Tsunedomi, R; Tokumitsu, Y; Hashimoto, N; Tokuhisa, Y; Maeda, Y; Iida, M; Sakamoto, K; Tamesa, T; Fujita, Y; Yoshino, S; Hazama, S; Hamamoto, Y; Oka, M				Kanekiyo, Shinsuke; Iizuka, Norio; Tsunedomi, Ryoichi; Tokumitsu, Yukio; Hashimoto, Noriaki; Tokuhisa, Yoshihiro; Maeda, Yoshinari; Iida, Michihisa; Sakamoto, Kazuhiko; Tamesa, Takao; Fujita, Yusuke; Yoshino, Shigefumi; Hazama, Shoichi; Hamamoto, Yoshihiko; Oka, Masaaki			Preoperative Serum Methylation Signature as Prognostic Tool After Curative Hepatectomy in Patients with Hepatocellular Carcinoma	ANTICANCER RESEARCH			English	Article						HCC; cell-free DNA; methylation; epigenetic; quantitative MSP	HEPATITIS-B; OLIGONUCLEOTIDE MICROARRAY; INTRAHEPATIC RECURRENCE; PHENOTYPE ASSOCIATION; ABERRANT METHYLATION; UNITED-STATES; CANCER; RESECTION; PREDICTION; OUTCOMES	Aim: This study aimed to investigate the relationship between prognosis after curative hepatectomy and serum methylation signature (SMS), defined by methylation levels of six specific genes (cyclin D2, Ras association (RalGDS/AF-6) domain family member 1, serine peptidase inhibitor Kunitz type 2, cystic fibrosis transmembrane conductance regulator, brain abundant membrane attached signal protein 1, and steroid-5-alpha-reductase alpha polypeptide 2). Patients and Methods: Serum samples were collected preoperatively from 125 patients with hepatocellular carcinoma associated with hepatitis C virus infection who underwent curative hepatectomy. We measured the methylation levels of the preceding six genes. We defined the methylation of three genes or more in the serum as SMS-positive in this study. We investigated the prognosis of SMS-positive patients. Results: SMS-positive patients exhibited significantly shorter disease-free survival (DFS) and overall survival (OS) than SMS-negative patients (p=0.0002 and p< 0.0001, respectively). Multivariate analysis showed that SMS positivity was an independent risk factor for shorter DFS (hazard ratio (HR)=2.182; p<0.001) and OS (HR=4.198; p<0.001). Conclusion: SMS is useful as a prognostic predictor in patients with hepatocellular carcinoma after curative hepatectomy.	[Kanekiyo, Shinsuke; Iizuka, Norio; Tsunedomi, Ryoichi; Tokumitsu, Yukio; Hashimoto, Noriaki; Tokuhisa, Yoshihiro; Maeda, Yoshinari; Iida, Michihisa; Sakamoto, Kazuhiko; Tamesa, Takao; Yoshino, Shigefumi; Hazama, Shoichi; Oka, Masaaki] Yamaguchi Univ, Grad Sch Med, Dept Digest Surg & Surg Oncol Surg 2, Ube, Yamaguchi 7558505, Japan; [Iizuka, Norio] Yamaguchi Univ, Grad Sch Med, Dept Kampo Med, Ube, Yamaguchi 7558505, Japan; [Fujita, Yusuke; Hamamoto, Yoshihiko] Yamaguchi Univ, Fac Engn, Dept Comp Sci & Syst Engn, Ube, Yamaguchi 7558505, Japan	Kanekiyo, S (reprint author), Yamaguchi Univ, Grad Sch Med, Dept Digest Surg, 1-1-1 Minami Kogushi, Ube, Yamaguchi 7558505, Japan.	sin018@yamaguchi-u.ac.jp			JSPS KAKENHI [24592002]	This work was supported by JSPS KAKENHI Grant Number 24592002.	Kurokawa Y, 2004, J HEPATOL, V41, P284, DOI 10.1016/j.jhep.2004.04.031; Toyota M, 1999, CANCER RES, V59, P5438; Yoshioka S, 2009, EUR J CANCER, V45, P881, DOI 10.1016/j.ejca.2008.12.019; Anker P, 1999, CANCER METAST REV, V18, P65, DOI 10.1023/A:1006260319913; Esnaola NF, 2003, ANN SURG, V238, P711, DOI 10.1097/01.sla.0000094436.34556.ac; Shimada M, 1996, GASTROENTEROLOGY, V111, P720, DOI 10.1053/gast.1996.v111.pm8780578; Toyota M, 1999, P NATL ACAD SCI USA, V96, P8681, DOI 10.1073/pnas.96.15.8681; El-Serag HB, 1999, NEW ENGL J MED, V340, P745, DOI 10.1056/NEJM199903113401001; Jones PA, 2002, NAT REV GENET, V3, P415, DOI 10.1038/nrg816; Iizuka N, 2003, LANCET, V361, P923, DOI 10.1016/S0140-6736(03)12775-4; Li BK, 2010, ANN SURG ONCOL, V17, P1917, DOI 10.1245/s10434-010-0921-7; Moribe T, 2009, INT J CANCER, V125, P388, DOI 10.1002/ijc.24394; Bruix J, 2011, HEPATOLOGY, V53, P1020, DOI 10.1002/hep.24199; Zhou J, 2012, SEMIN ONCOL, V39, P440, DOI 10.1053/j.seminoncol.2012.05.013; Ushijima T, 2005, NAT REV CANCER, V5, P223, DOI 10.1038/nrc1571; Poon RTP, 2000, CANCER, V89, P500, DOI 10.1002/1097-0142(20000801)89:3<500::AID-CNCR4>3.0.CO;2-O; Ziegler A, 2002, CANCER TREAT REV, V28, P255, DOI 10.1016/S0305-7372(02)00077-4; Deuffic S, 1998, LANCET, V351, P214, DOI 10.1016/S0140-6736(05)78179-4; Herman JG, 2003, NEW ENGL J MED, V349, P2042, DOI 10.1056/NEJMra023075; Iizuka N, 2008, CANCER SCI, V99, P659, DOI 10.1111/j.1349-7006.2008.00751.x; Iizuka N, 2004, LANCET, V364, P1837, DOI 10.1016/S0140-6736(04)17455-2; Iizuka N, 2002, CANCER RES, V62, P3939; Moribe T, 2008, INT J ONCOL, V33, P949, DOI 10.3892/ijo_00000082; Roayaie S, 2000, ANN SURG ONCOL, V7, P764, DOI 10.1007/s10434-000-0764-8; Sakon M, 2000, ARCH SURG-CHICAGO, V135, P1456, DOI 10.1001/archsurg.135.12.1456; Tokuhisa Y, 2007, BRIT J CANCER, V97, P1399, DOI 10.1038/sj.bjc.6604034; Tsutsui M, 2010, CLIN CHIM ACTA, V411, P516, DOI 10.1016/j.cca.2010.01.004; Wu LM, 2010, BMC CANCER, V10, DOI 10.1186/1471-2407-10-399; Zhang CS, 2008, INT J CANCER, V123, P998, DOI 10.1002/ijc.23650; Zhang CS, 2007, CLIN CANCER RES, V13, P944, DOI 10.1158/1078-0432.CCR-06-2268	30	0	0	INT INST ANTICANCER RESEARCH	ATHENS	EDITORIAL OFFICE 1ST KM KAPANDRITIOU-KALAMOU RD KAPANDRITI, PO BOX 22, ATHENS 19014, GREECE	0250-7005	1791-7530		ANTICANCER RES	Anticancer Res.	FEB	2015	35	2					997	1007				11	Oncology	Oncology	CB4LG	WOS:000349598600051		
J	Suzuki, H; Nishio, M; Hanai, N; Hirakawa, H; Tamaki, T; Hasegawa, Y				Suzuki, Hidenori; Nishio, Masami; Hanai, Nobuhiro; Hirakawa, Hitoshi; Tamaki, Tsuneo; Hasegawa, Yasuhisa			Correlation Between F-18-FDG-uptake and In Vitro Chemosensitivity of Cisplatin in Head and Neck Cancer	ANTICANCER RESEARCH			English	Article						Head and neck cancer; overall survival; F-18-FDG-PET/CT; SUVmax; inhibition index cisplatin	DRUG RESPONSE ASSAY; SQUAMOUS-CELL-CARCINOMA; STANDARDIZED UPTAKE VALUE; PROGNOSTIC VALUE; FDG-PET; DEFINITIVE CHEMORADIOTHERAPY; ESOPHAGEAL CANCER; LUNG-CANCER; PREDICTION; SURVIVAL	Aim: High [F-18]-2-fluorodeoxyglucose (F-18-FDG) -uptake of primary tumor, assessed by pretreatment positron emission tomography combined computed tomography (PET/CT), has indicated poor overall survival (OS) in head and neck cancer (HNC). We investigated the correlation between F-18-FDG-uptake and in vitro chemosensitivity of cisplatin using histoculture drug response assay in HNC. Patients and Methods: Twenty-eight patients were evaluated. The maximum standardized uptake value (SUVmax) and inhibition index (I. I.) cisplatin were calculated as F-18-FDG-uptake and in vitro chemosensitivity of cisplatin. Results: Each SUVmax >= 10.5 or I. I. cisplatin <50 could significantly differentiate shorter survival group by OS analyses. I. I. cisplatin of patients with SUVmax = 10.5 was significantly greater. In 19 patients with SUVmax = 10.5, those who received treatment with cisplatin-based chemotherapy exhibited a significant correlation with longer OS. Conclusion: Cisplatin hasthe potential to improve OS for HNC patients that were predicted as shorter OS by(18)F-FDG-PET/CT.	[Suzuki, Hidenori; Hanai, Nobuhiro; Hirakawa, Hitoshi; Hasegawa, Yasuhisa] Aichi Canc Ctr Hosp, Dept Head & Neck Surg, Nagoya, Aichi 4648681, Japan; [Nishio, Masami] Nagoya PET Imaging Ctr, Dept Radiol, Nagoya, Aichi, Japan; [Tamaki, Tsuneo] East Nagoya Imaging Diag, Nagoya, Aichi, Japan	Suzuki, H (reprint author), Aichi Canc Ctr Hosp, Dept Head & Neck Surg, Chikusa Ku, 1-1 Kanokoden, Nagoya, Aichi 4648681, Japan.	hi.suzuki@aichi-cc.jp			JSPS KAKENHI [24791821]	This study was supported by JSPS KAKENHI Grant Number 24791821.	Bille A, 2013, CLIN LUNG CANCER, V14, P149, DOI [10.1016/j.cllc.2012.04.007, 10.1016/j.jllc.2012.04.007]; Teran MD, 2014, J THORAC DIS, V6, P230, DOI 10.3978/j.issn.2072-1439.2013.12.18; Nakahara R, 2012, J RADIAT RES, V53, P906, DOI 10.1093/jrr/rrs052; Jung PS, 2013, ANTICANCER RES, V33, P1029; Xie P, 2011, J CANCER RES CLIN, V137, P1085, DOI 10.1007/s00432-010-0972-y; Zhang BT, 2010, ACTA OTO-LARYNGOL, V130, P756, DOI 10.3109/00016480903402981; Suzuki H, 2009, ORAL ONCOL, V45, P891, DOI 10.1016/j.oraloncology.2009.03.009; Imsande HM, 2011, AM J ROENTGENOL, V197, P976, DOI 10.2214/AJR.10.4884; Kawabe J, 2012, JPN J RADIOL, V30, P463, DOI 10.1007/s11604-012-0076-5; Atsumi K, 2013, J RADIAT RES, V54, P890, DOI 10.1093/jrr/rrt021; Fujita Y, 2009, ONCOL REP, V21, P499, DOI 10.3892/or_00000250; Halfpenny W, 2002, BRIT J CANCER, V86, P512, DOI 10.1038/sj/bjc/6600114; Hasegawa Y, 2007, ONCOLOGY-BASEL, V73, P104, DOI 10.1159/000120998; Hasegawa Y, 2007, ORAL ONCOL, V43, P749, DOI 10.1016/j.oraloncology.2006.09.003; Paidpally V, 2012, IMAGING MED, V4, P633; Shigekawa M, 2010, J HEPATO-BIL-PAN SCI, V17, P269, DOI 10.1007/s00534-009-0172-9; Singh B, 2002, HEAD NECK-J SCI SPEC, V24, P437, DOI 10.1002/hed.10066; Suzuki H, 2014, ANN NUCL MED, V28, P356, DOI 10.1007/s12149-014-0817-x; Torizuka T, 2009, AM J ROENTGENOL, V192, pW156, DOI 10.2214/AJR.08.1429	19	0	0	INT INST ANTICANCER RESEARCH	ATHENS	EDITORIAL OFFICE 1ST KM KAPANDRITIOU-KALAMOU RD KAPANDRITI, PO BOX 22, ATHENS 19014, GREECE	0250-7005	1791-7530		ANTICANCER RES	Anticancer Res.	FEB	2015	35	2					1009	1016				8	Oncology	Oncology	CB4LG	WOS:000349598600052		
J	Hata, A; Katakami, N; Yoshioka, H; Takeshita, J; Tanaka, K; Masago, K; Fujita, S; Kaji, R; Imai, Y; Monden, K; Matsumoto, T; Nagata, K; Otsuka, K; Tachikawa, R; Tomii, K; Kunimasa, K; Iwasaku, M; Nishiyama, A; Ishida, T; Nishimura, Y				Hata, Akito; Katakami, Nobuyuki; Yoshioka, Hiroshige; Takeshita, Jumpei; Tanaka, Kosuke; Masago, Katsuhiro; Fujita, Shiro; Kaji, Reiko; Imai, Yukihiro; Monden, Kazuya; Matsumoto, Takeshi; Nagata, Kazuma; Otsuka, Kyoko; Tachikawa, Ryo; Tomii, Keisuke; Kunimasa, Kei; Iwasaku, Masahiro; Nishiyama, Akihiro; Ishida, Tadashi; Nishimura, Yoshihiro			Prognostic Impact of Central Nervous System Metastases After Acquired Resistance to EGFR-TKI: Poorer Prognosis Associated with T790M-negative Status and Leptomeningeal Metastases	ANTICANCER RESEARCH			English	Article						Central nervous system; epidermal growth factor receptor-tyrosine kinase inhibitor; acquired resistance; T790M; leptomeningeal metastases; brain metastases	CELL LUNG-CANCER; GROWTH-FACTOR RECEPTOR; TYROSINE KINASE INHIBITORS; DOSE WEEKLY ERLOTINIB; GEFITINIB RESISTANCE; ACTIVATING MUTATIONS; 1ST-LINE TREATMENT; BRAIN METASTASES; OPEN-LABEL; ADENOCARCINOMA	Aim: The aim of the present study was to investigate the prognostic impact of central nervous system metastases (CNS) after acquired resistance to epidermal growth factor receptor (EGFR)-tyrosine kinase inhibitor (TKI) in EGFR-mutant non-small cell lung cancer (NSCLC). Patients and Methods: We defined CNS-collapse as death due to uncontrolled and progressive CNS metastases. Post-progression survival (PPS) after initial TKI failure and T790M status were retrospectively compared in 92 patients with or without CNS collapse. Results: The median PPS in 32 patients with CNS-collapse (16.7 months) was significantly shorter than that of 60 without (26.8 months) (p=0.0002). T790M was detected in four (12%) out of the 32 CNS-collapse patients and in 26 (43%) out of 60 without (p=0.0026). Median PPS in 39 patients with leptomeningeal metastases (LM) (11.4 months) was significantly shorter versus 53 without (26.8 months) (p=0.0006). The median PPS was 25.1 months in 40 patients with brain metastases and 11.2 months in 52 without (p=0.0387). T790M was detected in 4/5 resected brain tumors (80%) and in 1/26 cerebrospinal fluid (CSF) samples (4%) (p=0.0008). Conclusion: CNS-collapse represented poorer prognosis, which was associated with T790M-negative status and LM. Controlling CNS metastases, especially LM, is important to achieve longer survival.	[Hata, Akito; Katakami, Nobuyuki; Takeshita, Jumpei; Tanaka, Kosuke; Masago, Katsuhiro; Fujita, Shiro; Kaji, Reiko; Imai, Yukihiro] Inst Biomed Res & Innovat, Div Integrated Oncol, Kobe, Hyogo 6500047, Japan; [Yoshioka, Hiroshige; Kunimasa, Kei; Iwasaku, Masahiro; Nishiyama, Akihiro; Ishida, Tadashi] Kurashiki Cent Hosp, Dept Resp Med, Kurashiki, Okayama, Japan; [Monden, Kazuya; Matsumoto, Takeshi; Nagata, Kazuma; Otsuka, Kyoko; Tachikawa, Ryo; Tomii, Keisuke] Kobe City Med Ctr, Gen Hosp, Dept Resp Med, Kobe, Hyogo, Japan; [Nishimura, Yoshihiro] Kobe Univ, Sch Med, Dept Resp Med, Kobe, Hyogo 650, Japan	Hata, A (reprint author), Inst Biomed Res & Innovat, Div Integrated Oncol, Chuo Ku, 2-2 Minatojima Minamimachi, Kobe, Hyogo 6500047, Japan.	a-hata@fbri.org					Engelman JA, 2007, SCIENCE, V316, P1039, DOI 10.1126/science.1141478; Katayama T, 2009, J THORAC ONCOL, V4, P1415, DOI 10.1097/JTO.0b013e3181b62572; Jackman D, 2010, J CLIN ONCOL, V28, P357, DOI 10.1200/JCO.2009.24.7049; Nagai Y, 2005, CANCER RES, V65, P7276, DOI 10.1158/0008-5472.CAN-05-0331; Oxnard GR, 2011, CLIN CANCER RES, V17, P1616, DOI 10.1158/1078-0432.CCR-10-2692; Rosell R, 2012, LANCET ONCOL, V13, P239, DOI 10.1016/S1470-2045(11)70393-X; Weickhardt AJ, 2012, J THORAC ONCOL, V7, P1807, DOI 10.1097/JTO.0b013e3182745948; Clarke JL, 2010, J NEURO-ONCOL, V99, P283, DOI 10.1007/s11060-010-0128-6; Wang W, 2009, CLIN CANCER RES, V15, P6630, DOI 10.1158/1078-0432.CCR-09-1001; Shukuya T, 2011, LUNG CANCER, V74, P457, DOI 10.1016/j.lungcan.2011.04.007; Yano S, 2008, CANCER RES, V68, P9479, DOI 10.1158/0008-5472.CAN-08-1643; Maemondo M, 2010, NEW ENGL J MED, V362, P2380, DOI 10.1056/NEJMoa0909530; Eichler AF, 2010, NEURO-ONCOLOGY, V12, P1193, DOI 10.1093/neuonc/noq076; Hata A, 2011, J THORAC ONCOL, V6, P653, DOI 10.1097/JTO.0b013e3181d899bb; Kobayashi S, 2005, NEW ENGL J MED, V352, P786, DOI 10.1056/NEJMoa044238; Mok TS, 2009, NEW ENGL J MED, V361, P947, DOI 10.1056/NEJMoa0810699; Zhou CC, 2011, LANCET ONCOL, V12, P735, DOI 10.1016/S1470-2045(11)70184-X; Kuiper JL, 2013, LUNG CANCER, V80, P102, DOI 10.1016/j.lungcan.2012.12.024; Langer CJ, 2005, J CLIN ONCOL, V23, P6207, DOI 10.1200/JCO.2005.03.145; Jamal-Hanjani M, 2012, CLIN CANCER RES, V18, P938, DOI 10.1158/1078-0432.CCR-11-2529; Omuro AMP, 2005, CANCER, V103, P2344, DOI 10.1002/cncr.21033; Mitsudomi T, 2010, LANCET ONCOL, V11, P121, DOI 10.1016/S1470-2045(09)70364-X; Heon S, 2010, CLIN CANCER RES, V16, P5873, DOI 10.1158/1078-0432.CCR-10-1588; Sundstrom JT, 1998, ANN MED, V30, P296, DOI 10.3109/07853899809005858; Paez JG, 2004, SCIENCE, V304, P1497, DOI 10.1126/science.1099314; Lynch TJ, 2004, NEW ENGL J MED, V350, P2129, DOI 10.1056/NEJMoa040938; Jackman DM, 2006, J CLIN ONCOL, V24, P4517, DOI 10.1200/JCO.2006.06.6126; Grommes C, 2011, NEURO-ONCOLOGY, V13, P1364, DOI 10.1093/neuonc/nor121; Chmielecki J, 2011, SCI TRANSL MED, V3, DOI 10.1126/scitranslmed.3002356; Dhruva N, 2009, J CLIN ONCOL, V27, P31; Hata A, 2013, CANCER-AM CANCER SOC, V119, P4325, DOI 10.1002/cncr.28364; Pao W, 2005, PLOS MED, V2, P225, DOI 10.1371/journal.pmed.0020073; Sequist LV, 2011, SCI TRANSL MED, V3, DOI 10.1126/scitranslmed.3002003	33	2	2	INT INST ANTICANCER RESEARCH	ATHENS	EDITORIAL OFFICE 1ST KM KAPANDRITIOU-KALAMOU RD KAPANDRITI, PO BOX 22, ATHENS 19014, GREECE	0250-7005	1791-7530		ANTICANCER RES	Anticancer Res.	FEB	2015	35	2					1025	1031				7	Oncology	Oncology	CB4LG	WOS:000349598600054		
J	Kashiwabara, K; Semba, H; Fujii, S; Tsumura, S; Aoki, R				Kashiwabara, Kosuke; Semba, Hiroshi; Fujii, Shinji; Tsumura, Shinsuke; Aoki, Ryota			Difference in Benefit of Chemotherapy Between Small Cell Lung Cancer Patients with Interstitial Pneumonia and Patients with Non-small Cell Lung Cancer	ANTICANCER RESEARCH			English	Article						Small cell lung cancer; non-small cell lung cancer; idiopathic interstitial pneumonia; drug-induced interstitial lung disease; number of regimens	IDIOPATHIC PULMONARY-FIBROSIS; ACUTE EXACERBATION; WEEKLY PACLITAXEL; PLATINUM AGENTS; DISEASE; EFFICACY; SAFETY; COMBINATION; CARBOPLATIN; THERAPY	Background: It is not clear whether there is a difference in benefit of chemotherapy between small cell lung cancer (SCLC) patients with pre-existing idiopathic interstitial pneumonias (IIPs) and non-small cell lung cancer (NSCLC) patients with IIPs. Patients and Methods: We performed a retrospective study of the overall survival (OS) between advanced lung cancer patients with IIPs (n=28) and those without IIPs (n=145). Results: The OS in NSCLC patients with IIPs was shorter than in those without IIPs (median OS, 10.6 vs. 27.9 months, p=0.008) but the OS in SCLC patients with IIPs was not inferior to that of those without IIPs (12.7 vs. 14.8 months, p=0.835). Multivariate analysis showed that the small number of regimens increased the risk of mortality, instead of pre-existing IIPs. Conclusion: The continuation of chemotherapy in SCLC patients with IIPs made it possible to have a similar prognosis to that in those without IIPs.	[Kashiwabara, Kosuke; Semba, Hiroshi; Fujii, Shinji; Tsumura, Shinsuke; Aoki, Ryota] Kumamoto Reg Med Ctr, Dept Resp Med, Kumamoto 8600811, Japan	Kashiwabara, K (reprint author), Kumamoto Reg Med Ctr, Dept Resp Med, 5-16-10 Honjo, Kumamoto 8600811, Japan.	kskkswbr@krmc.or.jp					American Thoracic Society/European Respiratory Society, 2002, AM J RESP CRIT CARE, V165, P277; Okuda K, 2012, ANTICANCER RES, V32, P5475; Kinoshita T, 2012, ONCOL LETT, V4, P477, DOI 10.3892/ol.2012.753; Minegishi Y, 2009, INTERNAL MED, V48, P665, DOI 10.2169/internalmedicine.48.1650; Katzenstein ALA, 1998, AM J RESP CRIT CARE, V157, P1301; Togashi Y, 2012, CLIN LUNG CANCER, V13, P304, DOI 10.1016/j.cllc.2011.11.001; KONDOH Y, 1993, CHEST, V103, P1808, DOI 10.1378/chest.103.6.1808; Collard HR, 2007, AM J RESP CRIT CARE, V176, P636, DOI 10.1164/rccm.200703-463PP; Hyzy R, 2007, CHEST, V132, P1652, DOI 10.1378/chest.07-0299; Matsushita H, 1995, PATHOL INT, V45, P925, DOI 10.1111/j.1440-1827.1995.tb03417.x; Minegishi Y, 2011, LUNG CANCER, V71, P70, DOI 10.1016/j.lungcan.2010.04.014; Miyazaki K, 2010, MED ONCOL, V27, P763, DOI 10.1007/s12032-009-9283-z; Miyazaki K, 2009, ANTICANCER RES, V29, P2671; Raghu G, 2004, BRIT J CANCER, V91, pS3, DOI 10.1038/sj.bjc.6602061; Minegishi Y, 2011, J THORAC ONCOL, V6, P801, DOI 10.1097/JTO.0b013e3182103d3c; Tamiya A, 2012, ANTICANCER RES, V32, P1103; Camus P, 2004, BRIT J CANCER, V91, pS18, DOI 10.1038/sj.bjc.6602063; Choi MK, 2014, CANCER CHEMOTH PHARM, V73, P1217, DOI 10.1007/s00280-014-2458-0; Kato Motoyasu, 2014, BMC Cancer, V14, P508, DOI 10.1186/1471-2407-14-508; Kenmotsu H, 2011, THORAC ONCOL, V6, P1242; Raghu G, 2011, AM J RESP CRIT CARE, V183, P788, DOI 10.1164/rccm.2009-040GL; Shukuya T, 2010, ANTICANCER RES, V30, P4357; Song DH, KOREAN J PATHOL, V48, P10; Yoshida T, 2013, ANTICANCER RES, V33, P1175	24	0	0	INT INST ANTICANCER RESEARCH	ATHENS	EDITORIAL OFFICE 1ST KM KAPANDRITIOU-KALAMOU RD KAPANDRITI, PO BOX 22, ATHENS 19014, GREECE	0250-7005	1791-7530		ANTICANCER RES	Anticancer Res.	FEB	2015	35	2					1065	1071				7	Oncology	Oncology	CB4LG	WOS:000349598600059		
J	Nanashima, A; Kondo, H; Nakashima, M; Abo, T; Arai, J; Ishii, M; Hidaka, S; Kunizaki, M; To, K; Takeshita, H; Yamasaki, N; Tsuchiya, T; Nagayasu, T				Nanashima, Atsushi; Kondo, Hisayoshi; Nakashima, Masahiro; Abo, Takafumi; Arai, Junichi; Ishii, Mitsutoshi; Hidaka, Shigekazu; Kunizaki, Masaki; To, Kazuo; Takeshita, Hiroaki; Yamasaki, Naoya; Tsuchiya, Tomoshi; Nagayasu, Takeshi			Clinicopathological Characteristics of Multiple Primary Cancers in Hepatobiliary and Pancreas Malignancies	ANTICANCER RESEARCH			English	Article						Multiple primary cancers; hepatobiliary and pancreas; risk factors; surgery; prognosis	ATOMIC-BOMB SURVIVORS; COMPARATIVE GENOMIC HYBRIDIZATION; CARCINOGENESIS; CARCINOMA; 1,2-DICHLOROPROPANE; CHOLANGIOCARCINOMA; CLASSIFICATION; EPIDEMIOLOGY; INSTABILITY; RADIATION	Aim: The present study was designed to define the clinicopathological characteristics of multiple cancers (MC) in 597 patients with hepatobiliary and pancreas (HBP) malignancies who underwent curative resection, in order to clarify risk factors and prognostic significance. Patients and Methods: Patients' demographics, clinicopathological parameters and survival rates were compared between solitary (SC) and MC HBP malignancies for 267 patients with hepatocellular carcinoma (HCC), 77 with intrahepatic cholangiocarcinoma (ICC), 84 with extrahepatic bile duct carcinoma (BDC), 72 with gallbladder carcinoma (GBC) and 97 with pancreatic cancer (PC). Results: MC was observed in 66 patients (11%) and more than three cancers were observed in 13 (2.2%). The mean age of patients of the MC group was significantly higher than that of the SC group. The proportion of Nagasaki atomic bomb survivors among the MC group was significantly higher than among the SC group. These findings were significant in HCC and ICC. The histopathological aggressiveness of malignancies was lower with HCC, BDC and PC. In HCC, the disease-free survival of MC patients with more than three tumors was significantly lower than those with SC and double cancers. In GBC, the overall survival of the MC group was significantly better than the SC group. In PC, the disease-free and overall survival were significantly better in MC than SC. Conclusion: Careful follow-up for second or third occurrence of primary malignancies after primary curative treatment for HBP malignancy is necessary.	[Nanashima, Atsushi; Abo, Takafumi; Arai, Junichi; Ishii, Mitsutoshi; Hidaka, Shigekazu; Kunizaki, Masaki; To, Kazuo; Takeshita, Hiroaki; Yamasaki, Naoya; Tsuchiya, Tomoshi; Nagayasu, Takeshi] Nagasaki Univ, Sch Biomed Sci, Dept Surg Oncol, Atom Bomb Dis Inst, Nagasaki 8528501, Japan; [Nakashima, Masahiro] Nagasaki Univ, Sch Biomed Sci, Dept Tumor & Diagnost Pathol, Atom Bomb Dis Inst, Nagasaki 8528501, Japan; [Kondo, Hisayoshi] Nagasaki Univ, Sch Biomed Sci, Atom Bomb Dis Inst, Biostat Sect,Div Sci Data Registry, Nagasaki 8528501, Japan	Nanashima, A (reprint author), Nagasaki Univ, Grad Sch Biomed Sci, Dept Surg Oncol, 1-7-1 Sakamoto, Nagasaki 8528501, Japan.	a-nanasm@nagasaki-u.ac.jp					Wogan GN, 2004, SEMIN CANCER BIOL, V14, P473, DOI 10.1016/j.semcancer.2004.06.010; Naruke Y, 2009, CANCER-AM CANCER SOC, V115, P3782, DOI 10.1002/cncr.24405; [Anonymous], 2013, INT J CLIN ONCOL; Hayat MJ, 2007, ONCOLOGIST, V12, P20, DOI 10.1634/theoncologist.12-1-20; Horgan AM, 2012, J CLIN ONCOL, V30, P1934, DOI 10.1200/JCO.2011.40.5381; Ozasa K, 2012, RADIAT RES, V177, P229, DOI 10.1667/RR2629.1; Luciani A, 2004, SEMIN ONCOL, V31, P264, DOI 10.1053/j.seminocol.2003.12.035; Hursting SD, 2012, CANCER PREV RES, V5, P1260, DOI 10.1158/1940-6207.CAPR-12-0140; Shimada M, 2001, AM J SURG, V182, P177, DOI 10.1016/S0002-9610(01)00682-1; Arends MJ, 2013, APPL IMMUNOHISTO M M, V21, P97, DOI 10.1097/PAI.0b013e31827ea79e; Umeda Y, 2010, INHAL TOXICOL, V22, P1116, DOI 10.3109/08958378.2010.526973; Ma CQ, 2009, CANCER BIOL THER, V8, P907, DOI 10.4161/cbt.8.10.8132; Lodovici M, 2009, INT J ENV RES PUB HE, V6, P874, DOI 10.3390/ijerph6030874; Yu M, 2011, LIFE SCI, V89, P65, DOI 10.1016/j.lfs.2011.05.010; Kumagai S, 2013, OCCUP ENVIRON MED, V70, P508, DOI 10.1136/oemed-2012-101246; Suzuki K, 2012, JPN J CLIN ONCOL, V42, P563, DOI 10.1093/jjco/hys078; Cauchy F, 2012, AMGENBECKS ARCH SURG, V397, P681; Chijiiwa K, 2000, WORLD J SURG, V24, P1271; Crocetti E, 2001, EUR J CANCER, V37, P2449, DOI 10.1016/S0959-8049(01)00314-8; Garcea Giuseppe, 2008, JOP, V9, P99; Goto Hitomi, 2012, Environmental Health and Preventive Medicine, V17, P228, DOI 10.1007/s12199-011-0246-6; Hart C, 2012, FUTURE ONCOL, V8, P535, DOI [10.2217/fon.12.45, 10.2217/FON.12.45]; Kai K, 2012, INT J HEPATOL, DOI [10.1155/2012/495950, DOI 10.1155/2012/495950]; Kawarada Y, 2003, CLASS PANCR CANC, P4; Kuligina E, 2010, EPIDEMIOLOGY, V21, P366, DOI 10.1097/EDE.0b013e3181cc8871; Le Roux E, 2005, REV EPIDEMIOL SANTE, V53, P257, DOI 10.1016/S0398-7620(05)84603-6; Lomax Richard B, 2004, Toxicol Rev, V23, P91, DOI 10.2165/00139709-200423020-00004; Makuuchi M, 2000, GEN RULES CLIN PATHO; Mann CD, 2010, PB OXFORD, V12, P380; Marsh DJ, 2011, ADV OTO-RHINO-LARYNG, V70, P84, DOI 10.1159/000322479; Murakami T, 2012, INTERNAL MED, V51, P2329, DOI 10.2169/internalmedicine.51.8218; Nagakawa T, 2004, CLASS BIL TRACT CARC, P11; Nakao A, 2006, WORLD J GASTROENTERO, V12, P4466; Nakashima M, 2008, CANCER SCI, V99, P87, DOI 10.1111/j.1349-7006.2007.00657.x; Ochiai H, 2012, SURG TODAY, V42, P164, DOI 10.1007/s00595-011-0044-1; Oikawa M, 2011, RADIAT ONCOL, V6, DOI 10.1186/1748-717X-6-168; Park SH, 2012, TRANSL CANC RES, V1, P15; Schull W J, 1983, Adv Space Res, V3, P231, DOI 10.1016/0273-1177(83)90193-X; SHIMIZU Y, 1991, J RADIAT RES, V32, P54, DOI 10.1269/jrr.32.SUPPLEMENT2_54; Tagawa Y, 1998, J GASTROENTEROL, V33, P670, DOI 10.1007/s005350050154; Wa CV, 2005, MODERN PATHOL, V18, P591, DOI 10.1038/modpathol.3800332; Yamamoto Y, 2009, J SURG ONCOL, V99, P161, DOI 10.1002/jso.21214; Zhang Y, 2013, J PROTEOME RES, V12, P81, DOI 10.1021/pr300834r	43	0	0	INT INST ANTICANCER RESEARCH	ATHENS	EDITORIAL OFFICE 1ST KM KAPANDRITIOU-KALAMOU RD KAPANDRITI, PO BOX 22, ATHENS 19014, GREECE	0250-7005	1791-7530		ANTICANCER RES	Anticancer Res.	FEB	2015	35	2					1073	1083				11	Oncology	Oncology	CB4LG	WOS:000349598600060		
J	Terada, T				Terada, Tadashi			Giant Subserosal Lipoleiomyomas of the Uterine Cervix and Corpus: A Report of 2 Cases	APPLIED IMMUNOHISTOCHEMISTRY & MOLECULAR MORPHOLOGY			English	Article						uterus; lipoleiomyoma; Ki-67; ER; PgR	UTERUS; HISTOGENESIS; TUMORS	Giant lipoleiomyoma (LL) of the uterus is a rare condition. The author reports herein 2 giant LL. The age of the patients was 47 and 66 years. One patient had large LL measuring 10 x 9 x 9 cm located in the subserosa in the uterine cervix. Another patient had giant LL measuring 30 x 30 x 30 cm in the subserosa of the uterine body. Grossly, the LL showed yellowish white color. Microscopically, both the tumors were composed of mature smooth muscle cells and mature lipocytes. Immunohistochemically, both cases showed the same immunohistochemical findings. The adipose tissue element was positive for vimentin, S100 protein, estrogen receptor (ER), and progesterone receptor (PgR); and negative for pancytokeratins (AE1/3 and CAM5.2), alpha-smooth muscle actin, desmin, HMB45, p53, MDM2, and CDK4. The smooth muscle element was positive for vimentin, desmin, alpha-smooth muscle actin, ER, and PgR, but negative for pancytokeratins (AE1/3 and CAM5.2), S100 protein, HMB45, p53, MDM2, and CDK4. The Ki-67 labeling was 0.3% in the smooth muscle element and 0.2% in the adipose tissue element in 1 case, and 0.2% and 0.1%, respectively, in another case. In conclusions, 2 cases of subserosal giant LLs of the cervix and body were reported. The main findings were that the adipose tissue element of LL shows cell proliferative activity and that it is positive for ER and PgR. The positive cell proliferation shows that the adipose element of LL was not degenerative tissue but actively proliferative tissue. The presence of ER and PgR in the adipose element suggests that the adipose element of LL was specific fat tissue related to female genital organs.	[Terada, Tadashi] Shimizu Hosp, Dept Pathol, Shizuoka 4248636, Japan	Terada, T (reprint author), Shimizu Hosp, Dept Pathol, Shimizu Ku, Miyakami 1231, Shizuoka 4248636, Japan.	piyo0111jp@yahoo.co.jp					Akbulut M, 2008, ARCH GYNECOL OBSTET, V278, P291, DOI 10.1007/s00404-008-0580-0; Binh MBN, 2005, AM J SURG PATHOL, V29, P1340, DOI 10.1097/01.pas.0000170343.09562.39; SIEINSKI W, 1989, INT J GYNECOL PATHOL, V8, P357, DOI 10.1097/00004347-198912000-00007; Aung T, 2004, PATHOL INT, V54, P751, DOI 10.1111/j.1440-1827.2004.01748.x; Gentile R., 1996, Pathologica (Genoa), V88, P132; Hendrickson MR, 2003, TUMORS BREAST FEMALE, P233; Lin KC, 1999, INT J GYNECOL OBSTET, V67, P47, DOI 10.1016/S0020-7292(99)00094-6; LIN MS, 1991, ACTA PATHOL JAPON, V41, P164; RESTA L, 1994, PATHOL RES PRACT, V190, P378; SCURRY J, 1990, GYNECOL ONCOL, V39, P381, DOI 10.1016/0090-8258(90)90271-L; Shintaku M, 1996, PATHOL INT, V46, P498, DOI 10.1111/j.1440-1827.1996.tb03644.x; Terada T, 2005, TOHOKU J EXP MED, V206, P271, DOI 10.1620/tjem.206.271; Terada T, 2002, PATHOL INT, V52, P740, DOI 10.1046/j.1440-1827.2002.01416.x; Terada T, ARCH GYNECOL OBSTET; Wang XQ, 2006, DRY TECHNOL, V24, P239, DOI 10.1080/07373930600559191	15	0	0	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	1541-2016	1533-4058		APPL IMMUNOHISTO M M	Appl. Immunohistochem.	FEB	2015	23	2					E1	E3				3	Anatomy & Morphology; Medical Laboratory Technology; Pathology	Anatomy & Morphology; Medical Laboratory Technology; Pathology	CB7AS	WOS:000349778900001		
J	Zhao, N; Iramina, K				Zhao, N.; Iramina, K.			Numerical simulation of effect of convection-diffusion on oxygen transport in microcirculation	APPLIED MATHEMATICS AND MECHANICS-ENGLISH EDITION			English	Article						porous medium; microcirculation; oxygen transport; convection-diffusion; solid deformation; fluid seepage	MIXTURE THEORY; MATHEMATICAL-MODEL; SOLUTE TRANSPORT; SKELETAL-MUSCLE; TUMOR-GROWTH; TISSUE; CAPILLARIES; FLUID; MICROVASCULATURE; METABOLISM	The entire process of oxygen transport in microcirculation by developing a 3D porous media model is calculated numerically with coupled solid deformation-fluid seepage-convection and diffusion. The principal novelty of the model is that it takes into account volumetric deformation of both capillary and tissues resulting from capillary fluctuation. How solid deformation, fluid seepage, and convection-diffusion combine to affect oxygen transport is examined quantitatively: (1) Solid deformation is more significant in the middle of capillary, where the maximum value of volumetric deformation reaches about 0.5%. (2) Solid deformation has positive influence on the tissue fluid so that it flows more uniformly and causes oxygen to be transported more uniformly, and eventually impacts oxygen concentration by 0.1%-0.5%. (3) Convection-diffusion coupled deformation and seepage has a maximum (16%) and average (3%) increase in oxygen concentration, compared with pure molecular diffusion. Its more significant role is to allow oxygen to be transported more evenly.	[Zhao, N.] Kyushu Univ, Grad Sch Syst Life Sci, Fukuoka 8190395, Japan; [Iramina, K.] Kyushu Univ, Grad Sch Informat Sci & Elect Engn, Dept Informat, Fukuoka 8190395, Japan	Zhao, N (reprint author), Kyushu Univ, Grad Sch Syst Life Sci, Fukuoka 8190395, Japan.	zhao7ning7@hotmail.com	赵, 凝/P-8899-2014				Chapman SJ, 2008, B MATH BIOL, V70, P2334, DOI 10.1007/s11538-008-9349-7; den Uil CA, 2008, PROG CARDIOVASC DIS, V51, P161, DOI 10.1016/j.pcad.2008.07.002; Cai Y, 2011, J THEOR BIOL, V279, P90, DOI 10.1016/j.jtbi.2011.02.017; Anderson ARA, 2005, MATH MED BIOL, V22, P163, DOI 10.1093/imammb/dqi005; Macklin P, 2007, J THEOR BIOL, V245, P677, DOI 10.1016/j.jtbi.2006.12.004; Yao H, 2007, BIOMECH MODEL MECHAN, V6, P63, DOI 10.1007/s10237-006-0040-3; Pittman RN, 2011, ACTA PHYSIOL, V202, P311, DOI 10.1111/j.1748-1716.2010.02232.x; Pozrikidis C, 2003, ANN BIOMED ENG, V31, P181, DOI 10.1114/1.1540103; Byrne H, 2003, MATH MED BIOL, V20, P341; Abularrage CJ, 2005, J VASC SURG, V42, P574, DOI 10.1016/j.jvs.2005.05.019; Pozrikidis C, 2010, J MATH BIOL, V60, P75, DOI 10.1007/s00285-009-0259-6; CASCIARI JJ, 1992, J CELL PHYSIOL, V151, P386, DOI 10.1002/jcp.1041510220; Krogh A, 1919, J PHYSIOL-LONDON, V52, P457; Pittman RN, 2013, MICROCIRCULATION, V20, P117, DOI 10.1111/micc.12017; Bear J., 1988, DYNAMICS FLUIDS PORO; Caro C. G., 2012, MECH CIRCULATION, P368; Goldman D, 2008, MICROCIRCULATION, V15, P795, DOI 10.1080/10739680801938289; GREENE AS, 1992, AM J PHYSIOL, V262, pH1486; Grinberg O, 2005, ADV EXP MED BIOL, V566, P127; Hall JE, 2010, GUYTON HALL TXB MED, P495; He Y, 2012, J MECH MED BIOL, V12, DOI 10.1142/S0219519412005101; Hellums JD, 1996, ANN BIOMED ENG, V24, P1; Krogh A, 1919, J PHYSIOL-LONDON, V52, P409; Landis E.M., 1963, HDB PHYSIOLOGY     2, VII, P961; Liu G., 2012, PLOS ONE, V7, P44375; McGuire BJ, 2001, J APPL PHYSIOL, V91, P2255; Michel C. C., 1984, HDB PHYSL 2, P375; Middleman S., 1972, TRANSPORT PHENOMENA, P116; Mikelic A, 2006, NODEA-NONLINEAR DIFF, V13, P349, DOI 10.1007/s00030-006-4008-x; Moschandreou TE, 2011, MATH BIOSCI, V232, P1, DOI 10.1016/j.mbs.2011.03.010; Pittman RN, 2011, REGULATION TISSUE OX, P1; POPEL AS, 1989, CRIT REV BIOMED ENG, V17, P257; Popel AS, 2003, ADV EXP MED BIOL, V530, P485; Salathe EP, 2003, J MATH BIOL, V46, P287, DOI 10.1007/s00285-002-0175-5; Schuff MM, 2013, J MATH BIOL, V66, P1179, DOI 10.1007/s00285-012-0528-7; Schuff MM, 2013, J MATH BIOL, V67, P1307, DOI 10.1007/s00285-012-0544-7; Sharma GC, 2004, COMPUT BIOL MED, V34, P633, DOI 10.1016/S0010-4825(03)00043-X; Skalak R, 1971, MECH MICROCIRCULATIO, P457; Titcombe MS, 2000, SIAM J APPL MATH, V60, P1767, DOI 10.1137/S0036139998343356; Wang P, 2010, ANN BIOMED ENG, V38, P2512, DOI 10.1007/s10439-010-0022-6; Yulianti K, 2012, ITB J SCI, V44, P164; Zhu Q, 2012, COMPUT MATH METHOD M, DOI 10.1155/2012/198145; ZWEIFACH BW, 1974, CIRC RES, V34, P858	43	0	0	SHANGHAI UNIV	SHANGHAI	149 YANCHANG RD, SHANGHAI 200072, PEOPLES R CHINA	0253-4827	1573-2754		APPL MATH MECH-ENGL	Appl. Math. Mech.-Engl. Ed.	FEB	2015	36	2					179	200		10.1007/s10483-015-1908-7		22	Mathematics, Applied; Mechanics	Mathematics; Mechanics	CC3CS	WOS:000350222800004		
J	Abe, R; Toyota, K; Miyakawa, H; Watanabe, H; Oka, T; Miyagawa, S; Nishide, H; Uchiyama, I; Tollefsen, KE; Iguchi, T; Tatarazako, N				Abe, Ryoko; Toyota, Kenji; Miyakawa, Hitoshi; Watanabe, Haruna; Oka, Tomohiro; Miyagawa, Shinichi; Nishide, Hiroyo; Uchiyama, Ikuo; Tollefsen, Knut Erik; Iguchi, Taisen; Tatarazako, Norihisa			Diofenolan induces male offspring production through binding to the juvenile hormone receptor in Daphnia magna	AQUATIC TOXICOLOGY			English	Article						IGR; Insecticide; Juvenile hormone receptor; Juvenile hormone-responsive genes; Reproduction; Two-hybrid assay	DROSOPHILA-MELANOGASTER; MOLECULAR ACTIONS; TOBACCO HORNWORM; FAT-BODY; CRUSTACEAN; CLONING; ECDYSONE; ANALOGS; GENES; EXPRESSION	Juvenile hormone (JH) and JH agonists have been reported to induce male offspring production in various daphnid species including Daphnia magna. We recently established a short-term in vivo screening assay to detect chemicals having male offspring induction activity in adult D. magna. Diofenolan has been developed as a JH agonist for insect pest control, but its male offspring induction activity in daphnids has not been investigated yet. In this study, we found that the insect growth regulator (IGR) diofenolan exhibited a potent male offspring induction activity at low ng/L to mu g/L concentrations, as demonstrated by the short-term in vivo screening assay and the recently developed TG211 ANNEX 7 test protocol. A two-hybrid assay performed using the D. magna JH receptor confirmed that diofenolan had a strong JH activity. Global whole body transcriptome analysis of D. magna exposed to 10 ng/L diofenolan showed an up-regulation of JH-responsive genes and modulation of several genes involved in the ecdysone receptor signaling pathway. These results clearly demonstrate that diofenolan has strong JH activity and male offspring induction activity, and that a combination of modified standardized regulatory testing protocols and rapid in vitro and in vivo screening assays are able to identify potential endocrine disruptors in D. magna. The observation that diofenolan modulates multiple endocrine signaling pathways in D. magna suggests that further investigation of potential interference with growth, development and reproduction is warranted. (C) 2014 Elsevier B.V. All rights reserved.	[Abe, Ryoko; Watanabe, Haruna; Tatarazako, Norihisa] Natl Inst Environm Studies, Res Ctr Environm Risk, Environm Qual Measurement Sect, Tsukuba, Ibaraki 3058506, Japan; [Toyota, Kenji; Miyagawa, Shinichi; Iguchi, Taisen] Grad Univ Adv Studies SOKENDAI, Fac Life Sci, Dept Basic Biol, Okazaki, Aichi 4448787, Japan; [Toyota, Kenji; Miyakawa, Hitoshi; Miyagawa, Shinichi; Iguchi, Taisen] Grad Univ Adv Studies SOKENDAI, Okazaki Inst Integrat Biosci, Natl Inst Basic Biol, Natl Inst Nat Sci, Okazaki, Aichi 4448787, Japan; [Toyota, Kenji; Miyakawa, Hitoshi; Miyagawa, Shinichi; Iguchi, Taisen] Grad Univ Adv Studies SOKENDAI, Dept Basic Biol, Sch Life Sci, Okazaki, Aichi 4448787, Japan; [Oka, Tomohiro] Japan Environm Management Assoc Ind, Chiyoda Ku, Tokyo 1010044, Japan; [Nishide, Hiroyo; Uchiyama, Ikuo] Natl Inst Basic Biol, Data Integrat & Anal Facil, Okazaki, Aichi 4448585, Japan; [Tollefsen, Knut Erik] Norwegian Inst Water Res NIVA, N-0349 Oslo, Norway	Tatarazako, N (reprint author), Natl Inst Environm Studies, Res Ctr Environm Risk, Environm Qual Measurement Sect, 16-2 Onogawa, Tsukuba, Ibaraki 3058506, Japan.	tatarazako.norihisa@nies.go.jp			Japan Society for the Promotion of Science (JSPS); Sasakawa Scientific Research Grant from The Japan Science Society; Saito Ho-on Kai Scientific Research Grant from The Saito Gratitude Foundation; Ministry of Education, Culture, Sports, Science, and Technology of Japan; Ministry of the Environment of Japan; National Institute for Basic Biology; Research Council of Norway [221455]	The authors are grateful to Dr. Masumi Yamamuro, Department of Natural Environmental Studies, Graduate School of Frontier Sciences, The University of Tokyo, for her advice on this research. Thanks are also due to Ms. Yoko Shintaku and Mr. Masaaki Koshio for their assistance in the laboratory. This work was partly supported by the Japan Society for the Promotion of Science (JSPS) Research Fellowship for Young Scientists (KT), the Sasakawa Scientific Research Grant from The Japan Science Society (KT), the Saito Ho-on Kai Scientific Research Grant from The Saito Gratitude Foundation (KT), grants from the Ministry of Education, Culture, Sports, Science, and Technology of Japan (TI), Ministry of the Environment of Japan (NT, TI), National Institute for Basic Biology (TI) and the Research Council of Norway (project 221455-Adverse Outcome Pathways for Endocrine Disruption in Daphnia magna, a conceptual approach for mechanistically-based Risk assessment) (KET, TI, NT).	Abe R, 2015, J APPL TOXICOL, V35, P75, DOI 10.1002/jat.2989; Anasco NC, 2010, ARCH ENVIRON CON TOX, V58, P352, DOI 10.1007/s00244-009-9364-1; Wang HY, 2005, AQUAT TOXICOL, V74, P193, DOI 10.1016/j.aquatox.2005.05.010; ELENDT BP, 1990, WATER RES, V24, P1157, DOI 10.1016/0043-1354(90)90180-E; Kato Y, 2010, GENOMICS, V95, P160, DOI 10.1016/j.ygeno.2009.12.005; TOUHARA K, 1993, J BIOL CHEM, V268, P19604; Olmstead AW, 2003, ENVIRON HEALTH PERSP, V111, P919, DOI 10.1289/ehp.5982; Hartfelder K, 2000, BRAZ J MED BIOL RES, V33, P157, DOI 10.1590/S0100-879X2000000200003; Conesa A, 2005, BIOINFORMATICS, V21, P3674, DOI 10.1093/bioinformatics/bti610; Olmstead AW, 2002, J EXP ZOOL, V293, P736, DOI 10.1002/jez.10162; Lee HK, 2005, BMC BIOINFORMATICS, V6, DOI 10.1186/1471-2105-6-269; Singh S, 2011, PHYTOPARASITICA, V39, P205, DOI 10.1007/s12600-011-0154-8; Watanabe H, 2005, GENOME, V48, P606, DOI 10.1139/G05-038; Tatarazako N, 2003, CHEMOSPHERE, V53, P827, DOI 10.1016/S0045-6535(03)00761-6; LAUFER H, 1987, SCIENCE, V235, P202, DOI 10.1126/science.235.4785.202; Bitra K, 2009, ARCH INSECT BIOCHEM, V70, P90, DOI 10.1002/arch.20281; Tian L, 2010, J MOL CELL BIOL, V2, P255, DOI 10.1093/jmcb/mjq020; Minakuchi C, 2006, J PESTIC SCI, V31, P77, DOI 10.1584/jpestics.31.77; Oda S, 2005, CHEMOSPHERE, V61, P1168, DOI 10.1016/j.chemosphere.2005.02.075; Bergman A, 2013, STATE SCI ENDOCRINE; BUTENANDT A, 1954, Z NATURFORSCH B, V9, P389; FLETCHER JC, 1995, GENETICS, V141, P1025; Ghoneim K.S., 2007, 59 INT S CROP PROT G; Gilbert L.I., 2011, INSECT ENDOCRINOLOGY; Grout TG, 1997, EXP APPL ACAROL, V21, P171; Gunaratne HJ, 2006, BIOCHEM BIOPH RES CO, V339, P443, DOI 10.1016/j.bbrc.2005.11.033; Guo EE, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0053256; JUDY KJ, 1973, P NATL ACAD SCI USA, V70, P1509, DOI 10.1073/pnas.70.5.1509; Kato Y, 2007, J ENDOCRINOL, V193, P183, DOI 10.1677/JOE-06-0228; Lange R, 2002, TOXICOL LETT, V131, P97, DOI 10.1016/S0378-4274(02)00071-1; Liu PC, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019776; Mitchell SE, 2001, HYDROBIOLOGIA, V442, P145, DOI 10.1023/A:1017564105942; Miyakawa H, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms2868; Munn S., 2013, EUR25919JRC, pP34; Oda S, 2005, CHEMOSPHERE, V60, P74, DOI 10.1016/j.chemosphere.2004.12.080; Oda S, 2006, CHEMOSPHERE, V63, P1477, DOI 10.1016/j.chemosphere.2005.09.026; OECD, 2012, OECD SER TEST ASS, P86; OECD, 2004, OECD GUID TEST CHEM, P12; RAIKHEL AS, 1990, GEN COMP ENDOCR, V77, P423, DOI 10.1016/0016-6480(90)90233-C; RICHARD DS, 1989, P NATL ACAD SCI USA, V86, P1421, DOI 10.1073/pnas.86.4.1421; RIDDIFORD LM, 1994, ADV INSECT PHYSIOL, V24, P213, DOI 10.1016/S0065-2806(08)60084-3; RIDDIFORD LM, 1976, NATURE, V259, P115, DOI 10.1038/259115a0; Singh Satya, 2011, International Journal of Tropical Insect Science, V31, P192, DOI 10.1017/S1742758411000269; Tatarazako N, 2007, ECOTOXICOLOGY, V16, P197, DOI 10.1007/s10646-006-0120-2; Tatarazako N., 2002, P JAPAN SOC COMP END, V17, P87; Terashima J, 2005, CELL DEATH DIFFER, V12, P429, DOI 10.1038/sj.cdd.4401587; Toyota K, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-239; Toyota K, 2014, J APPL TOXICOL, V34, P537, DOI 10.1002/jat.2922; Wyatt GR, 1996, ADV INSECT PHYSIOL, V26, P1, DOI 10.1016/S0065-2806(08)60030-2; Xu JJ, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003535; Zhang ZP, 2000, J EXP BIOL, V203, P3411	51	2	2	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	0166-445X	1879-1514		AQUAT TOXICOL	Aquat. Toxicol.	FEB	2015	159						44	51		10.1016/j.aquatox.2014.11.015		8	Marine & Freshwater Biology; Toxicology	Marine & Freshwater Biology; Toxicology	CB4IT	WOS:000349592100005		
J	Tanaka, YT; Doi, A; Inoue, Y; Cheung, CC; Stawarz, L; Fukazawa, Y; Gurwell, MA; Tahara, M; Kataoka, J; Itoh, R				Tanaka, Y. T.; Doi, A.; Inoue, Y.; Cheung, C. C.; Stawarz, L.; Fukazawa, Y.; Gurwell, M. A.; Tahara, M.; Kataoka, J.; Itoh, R.			SIX YEARS OF FERMI-LAT AND MULTI-WAVELENGTH MONITORING OF THE BROAD-LINE RADIO GALAXY 3C 120: JET DISSIPATION AT SUB-PARSEC SCALES FROM THE CENTRAL ENGINE	ASTROPHYSICAL JOURNAL LETTERS			English	Article						galaxies: active; galaxies: individual (3C 120); galaxies: jets; radiation mechanisms: non-thermal; radio continuum: galaxies; gamma-rays: galaxies	ACTIVE GALACTIC NUCLEI; GAMMA-RAY EMISSION; RELATIVISTIC JETS; BLACK-HOLE; ACCRETION DISKS; ORIGIN; POWER; VARIABILITY; CONNECTION; LUMINOSITY	We present multi-wavelength monitoring results for the broad-line radio galaxy 3C 120 in the MeV/GeV, sub-millimeter, and 43 GHz bands over 6 yr. Over the past 2 yr, the Fermi-Large Area Telescope sporadically detected 3C 120 with high significance and the 230 GHz data also suggest an enhanced activity of the source. After the MeV/GeV detection from 3C 120 in MJD 56240-56300, 43 GHz Very Long Baseline Array (VLBA) monitoring revealed a brightening of the radio core, followed by the ejection of a superluminal knot. Since we observed the gamma-ray and VLBA phenomena in temporal proximity to each other, it is naturally assumed that they are physically connected. This assumption was further supported by the subsequent observation that the 43 GHz core brightened again after a gamma-ray flare occurred around MJD 56560. We can then infer that the MeV/GeV emission took place inside an unresolved 43 GHz core of 3C 120 and that the jet dissipation occurred at sub-parsec distances from the central black hole (BH), if we take the distance of the 43 GHz core from the central BH as similar to 0.5 pc, as previously estimated from the time lag between X-ray dips and knot ejections. Based on our constraints on the relative locations of the emission regions and energetic arguments, we conclude that the gamma rays are more favorably produced via the synchrotron self-Compton process, rather than inverse Compton scattering of external photons coming from the broad line region or hot dusty torus. We also derived the electron distribution and magnetic field by modeling the simultaneous broadband spectrum.	[Tanaka, Y. T.] Hiroshima Univ, Hiroshima Astrophys Sci Ctr, Higashihiroshima 7398526, Japan; [Doi, A.; Inoue, Y.; Stawarz, L.] JAXA, Inst Space & Astronaut Sci, Sagamihara, Kanagawa 2525210, Japan; [Cheung, C. C.] Naval Res Lab, Div Space Sci, Washington, DC 20375 USA; [Stawarz, L.] Jagiellonian Univ, Astron Observ, PL-30244 Krakow, Poland; [Fukazawa, Y.; Itoh, R.] Hiroshima Univ, Dept Phys Sci, Hiroshima 7398526, Japan; [Gurwell, M. A.] Harvard Smithsonian Ctr Astrophys, Cambridge, MA 02138 USA; [Tahara, M.; Kataoka, J.] Waseda Univ, Res Inst Sci & Engn, Tokyo 1698555, Japan	Tanaka, YT (reprint author), Hiroshima Univ, Hiroshima Astrophys Sci Ctr, 1-3-1 Kagamiyama, Higashihiroshima 7398526, Japan.	ytanaka@hep01.hepl.hiroshima-u.ac.jp			NASA; DOE (United States); CEA/Irfu; IN2P3/CNRS (France); ASI; INFN (Italy); MEXT (Japan); KEK (Japan); JAXA (Japan); K. A. Wallenberg Foundation; Swedish Research Council; National Space Board (Sweden); INAF (Italy); CNES (France); NASA through the Fermi-LAT Guest Investigator Program; Smithsonian Institution; Academia Sinica; NASA DPR [S-15633]; Polish NSC [DEC-2012/04/A/ST9/00083]	The Fermi-LAT Collaboration acknowledges support for LAT development, operation, and data analysis from NASA and DOE (United States), CEA/Irfu, and IN2P3/CNRS (France), ASI and INFN (Italy), MEXT, KEK, and JAXA (Japan), and the K. A. Wallenberg Foundation, the Swedish Research Council and the National Space Board (Sweden). Science analysis support in the operations phase from INAF (Italy) and CNES (France) is also gratefully acknowledged. This study makes use of 43 GHz VLBA data from the VLBA-BU Blazar Monitoring Program (VLBA-BU-BLAZAR; http://www.bu.edu/blazars/VLBAproject.html), funded by NASA through the Fermi-LAT Guest Investigator Program. The VLBA is an instrument of the National Radio Astronomy Observatory, a facility of the National Science Foundation operated by Associated Universities, Inc. The Submillimeter Array is a joint project between the Smithsonian Astrophysical Observatory and the Academia Sinica Institute of Astronomy and Astrophysics and is funded by the Smithsonian Institution and the Academia Sinica. C.C.C. was supported at NRL by NASA DPR S-15633 Y.L.S. was supported by Polish NSC grant DEC-2012/04/A/ST9/00083.	Ghisellini G, 2010, MON NOT R ASTRON SOC, V409, pL79, DOI 10.1111/j.1745-3933.2010.00952.x; CELOTTI A, 1993, MON NOT R ASTRON SOC, V264, P228; Nemmen RS, 2012, SCIENCE, V338, P1445, DOI 10.1126/science.1227416; Marscher AP, 2008, NATURE, V452, P966, DOI 10.1038/nature06895; Marscher AP, 2002, NATURE, V417, P625, DOI 10.1038/nature00772; Kataoka J, 2011, ASTROPHYS J, V740, DOI 10.1088/0004-637X/740/1/29; Koratkar A, 1999, PUBL ASTRON SOC PAC, V111, P1, DOI 10.1086/316294; Tavecchio F, 2011, ASTRON ASTROPHYS, V534, DOI 10.1051/0004-6361/201117204; Sikora M, 2009, ASTROPHYS J, V704, P38, DOI 10.1088/0004-637X/704/1/38; Gurwell MA, 2007, ASTR SOC P, V375, P234; Stawarz L, 2003, ASTROPHYS J, V597, P186, DOI 10.1086/378290; Chatterjee R, 2009, ASTROPHYS J, V704, P1689, DOI 10.1088/0004-637X/704/2/1689; Jorstad SG, 2005, ASTRON J, V130, P1418, DOI 10.1086/444593; Tchekhovskoy A, 2011, MON NOT R ASTRON SOC, V418, pL79, DOI 10.1111/j.1745-3933.2011.01147.x; Abdo AA, 2010, ASTROPHYS J, V720, P912, DOI 10.1088/0004-637X/720/1/912; Tanaka YT, 2011, ASTROPHYS J, V733, DOI 10.1088/0004-637X/733/1/19; Ghisellini G, 2014, NATURE, V515, P376, DOI 10.1038/nature13856; Finke JD, 2008, ASTROPHYS J, V686, P181, DOI 10.1086/590900; McKinney JC, 2012, MON NOT R ASTRON SOC, V423, P3083, DOI 10.1111/j.1365-2966.2012.21074.x; BLANDFORD RD, 1977, MON NOT R ASTRON SOC, V179, P433; Clausen-Brown E, 2013, ASTRON ASTROPHYS, V558, DOI 10.1051/0004-6361/201322203; Grandi P, 2012, ASTROPHYS J LETT, V751, DOI 10.1088/2041-8205/751/1/L3; Inoue Y, 2011, ASTROPHYS J, V733, DOI 10.1088/0004-637X/733/1/66; Kataoka J, 2007, PUBL ASTRON SOC JPN, V59, P279; Lohfink AM, 2013, ASTROPHYS J, V772, DOI 10.1088/0004-637X/772/2/83; Mattox JR, 1996, ASTROPHYS J, V461, P396, DOI 10.1086/177068; Nunez FP, 2014, ASTRON ASTROPHYS, V568, DOI 10.1051/0004-6361/201322736; Saito S, 2013, ASTROPHYS J LETT, V766, DOI 10.1088/2041-8205/766/1/L11; Sikora M, 2013, ASTROPHYS J LETT, V764, DOI 10.1088/2041-8205/764/2/L24; Sikora M, 2000, ASTROPHYS J, V534, P109, DOI 10.1086/308756; van der Wolk G, 2010, ASTRON ASTROPHYS, V511, DOI 10.1051/0004-6361/200912435; WALKER RC, 1987, ASTROPHYS J, V316, P546, DOI 10.1086/165225	32	3	3	IOP PUBLISHING LTD	BRISTOL	TEMPLE CIRCUS, TEMPLE WAY, BRISTOL BS1 6BE, ENGLAND	2041-8205	2041-8213		ASTROPHYS J LETT	Astrophys. J. Lett.	FEB 1	2015	799	2							L18	10.1088/2041-8205/799/2/L18		6	Astronomy & Astrophysics	Astronomy & Astrophysics	CB0KS	WOS:000349315400004		
J	Ichige, H; Fukuchi, S; Hatano, Y				Ichige, Hiroyuki; Fukuchi, Shun; Hatano, Yuko			Stochastic model for the fluctuations of the atmospheric concentration of radionuclides and its application to uncertainty evaluation	ATMOSPHERIC ENVIRONMENT			English	Article						Chernobyl; Risk assessment; Stochastic process; Time-series analysis; Radionuclide	SPECTRAL-ANALYSIS; TIME-SERIES; CHERNOBYL; RESUSPENSION	We propose a new model of the atmospheric concentration of a radionuclide with the inclusion of fluctuations of the concentration. The model is a stochastic differential equation and we derive the analytic solution of the equation. The solution agrees very well with the Chernobyl Cs-137 data. The advantage of the model is that the uncertainty in radiation exposure risk, with regard to the concentration fluctuations, can be quantitatively estimated. We show the range of fluctuations of +/-sigma, +/- 2 sigma, +/- 3 sigma in the 10-year measurement of the atmospheric concentration in Chernobyl and confirmed the validity of the model. (C) 2014 Elsevier Ltd. All rights reserved.	[Ichige, Hiroyuki; Fukuchi, Shun; Hatano, Yuko] Univ Tsukuba, Grad Sch Syst & Informat Engn, Tsukuba, Ibaraki, Japan	Ichige, H (reprint author), Univ Tsukuba, Grad Sch Syst & Informat Engn, Tsukuba, Ibaraki, Japan.	tanuki28213141@gmail.com			NIPPON STEEL CORPORATION	The authors wish to acknowledge NIPPON STEEL CORPORATION, for financial support of this research. The authors would like to thank Dr.Yusuke Uchiyama for comments and discussion on this manuscript and Dr. H.Amano(Toho Univ.) and Dr. T. Ueno(JAEA) for the data.	Schulz M, 1997, COMPUT GEOSCI, V23, P929, DOI 10.1016/S0098-3004(97)00087-3; Ould-Dada Z, 2001, ATMOS ENVIRON, V35, P3799, DOI 10.1016/S1352-2310(01)00161-3; ARKHIPOV NP, 1994, SCI TOTAL ENVIRON, V157, P383; Ashok K.S., 1997, LOGNORMAL DISTRIBUTI; Eugene Y.R., 1997, ATMOS ENVIRON, V31, P991; Hatano Y, 1997, ATMOS ENVIRON, V31, P2297, DOI 10.1016/S1352-2310(97)00017-4; Hatano Y., 1995, WASTE MANAGE, V16, P495; Hatano Y, 1998, ATMOS ENVIRON, V32, P2587, DOI 10.1016/S1352-2310(97)00511-6; IAEA, 2006, CHERN FOR EXP GROUP; ISHIKAWA H, 1995, J APPL METEOROL, V34, P1653, DOI 10.1175/1520-0450-34.7.1653; Junya H., 2002, TOKYO KANKYOKAGAKU K; Klug W., 1992, EVALUATION LONG RANG; Lazjuk GI, 1997, STEM CELLS, V15, P255; NICHOLSON KW, 1988, ATMOS ENVIRON, V22, P2639, DOI 10.1016/0004-6981(88)90433-7; Romanenko A, 2008, RADIAT RES, V170, P691, DOI 10.1667/RR1402.1; SCARGLE JD, 1982, ASTROPHYS J, V263, P835, DOI 10.1086/160554; Susanne D., 2008, PROBALISTIC ENG MECH, V23, P170; Ueno T., 2003, ENV MONITORING DATA	18	0	0	PERGAMON-ELSEVIER SCIENCE LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND	1352-2310	1873-2844		ATMOS ENVIRON	Atmos. Environ.	FEB	2015	103						156	162		10.1016/j.atmosenv.2014.12.030		7	Environmental Sciences; Meteorology & Atmospheric Sciences	Environmental Sciences & Ecology; Meteorology & Atmospheric Sciences	CB4GO	WOS:000349586400018		
J	Sharma, S; Goel, A; Gupta, D; Kumar, A; Mishra, A; Kundu, S; Chatani, S; Klimont, Z				Sharma, Sumit; Goel, Anju; Gupta, Divya; Kumar, Atul; Mishra, Arabinda; Kundu, Seema; Chatani, Satoru; Klimont, Zbigniew			Emission inventory of non-methane volatile organic compounds from anthropogenic sources in India	ATMOSPHERIC ENVIRONMENT			English	Article						NMVOC emissions; Inventory; Speciation; Solvents; India	AIR-POLLUTION; GREENHOUSE GASES; CHINA; ASIA; SPECIATION; OZONE; MODEL; NOX	This paper presents a new inventory of NMVOC emissions from anthropogenic sources in India for the year 2010. The main new element of this inventory, compared to previous work for India, is the use of new and more detailed data on solvent use sectors and oil production and distribution system. The results are presented at the national and state level for major sectors and VOC species. Finally, the annual emissions were spatially distributed at a fine resolution of 36 x 36 km(2) using detailed spatial information. The total anthropogenic NMVOC emissions in India in 2010 were estimated at 9.81 Tg which is in the range of the estimates made in most other studies. The majority of emissions (60%) originated from residential combustion of biomass for cooking. Solvent use sectors and oil production and distribution contributed about 20% followed by transport (12%) and open burning of agricultural residues (7%). Specie-wise distribution shows highest contribution from alkenes and alkynes (38%), followed by alkanes (22%), and aromatics (16%). (C) 2014 Elsevier Ltd. All rights reserved.	[Sharma, Sumit; Goel, Anju; Gupta, Divya; Kumar, Atul; Mishra, Arabinda; Kundu, Seema] Energy & Resource Inst, New Delhi, India; [Chatani, Satoru] Toyota Cent Res & Dev Labs Inc, Nagakute, Aichi 48011, Japan; [Klimont, Zbigniew] Int Inst Appl Syst Anal, A-2361 Laxenburg, Austria	Sharma, S (reprint author), Energy & Resource Inst, Lodi Rd, New Delhi, India.	sumits@teri.res.in	Chatani, Satoru/B-3697-2014; Klimont, Zbigniew/P-7641-2015	Chatani, Satoru/0000-0002-6272-574X; Klimont, Zbigniew/0000-0003-2630-198X	Toyota Motor Corporation, Japan	This work was funded by the Toyota Motor Corporation, Japan during 2011-2013.	Zhang Q, 2009, ATMOS CHEM PHYS, V9, P5131; [Anonymous], 2003, J GEOPHYS RES, DOI [DOI 10.1029/2002JD003093, 10.1029/2002JD003093]; Matsui H, 2009, J GEOPHYS RES-ATMOS, V114, DOI 10.1029/2008JD010164; Agrawal M, 2003, ENVIRON POLLUT, V126, P323, DOI 10.1016/S0269-7491(03)00245-8; Klimont Z, 2009, TELLUS B, V61, P602, DOI 10.1111/j.1600-0889.2009.00428.x; Volkamer R, 2006, GEOPHYS RES LETT, V33, DOI 10.1029/2006GL026899; Amann M, 2011, ENVIRON MODELL SOFTW, V26, P1489, DOI 10.1016/j.envsoft.2011.07.012; Jacob DJ, 2000, ATMOS ENVIRON, V34, P2131, DOI 10.1016/S1352-2310(99)00462-8; Bignal KL, 2007, APPL GEOCHEM, V22, P1265, DOI 10.1016/j.apgeochem.2007.03.017; Hanna SR, 1998, ATMOS ENVIRON, V32, P3619, DOI 10.1016/S1352-2310(97)00419-6; Li M, 2014, ATMOS CHEM PHYS, V14, P5617, DOI 10.5194/acp-14-5617-2014; Ohara T, 2007, ATMOS CHEM PHYS, V7, P4419; Bond TC, 2013, J GEOPHYS RES-ATMOS, V118, P5380, DOI 10.1002/jgrd.50171; de Gouw JA, 2005, J GEOPHYS RES-ATMOS, V110, DOI 10.1029/2004JD005623; Wei W, 2008, ATMOS ENVIRON, V42, P4976, DOI 10.1016/j.atmosenv.2008.02.044; Wei W, 2014, FRONT ENV SCI ENG, V8, P27, DOI 10.1007/s11783-012-0461-4; Kurokawa J, 2013, ATMOS CHEM PHYS, V13, P11019, DOI 10.5194/acp-13-11019-2013; ARAI, 2008, AIR QUAL MO IN PRESS; Bergin MS, 1999, ENVIRON SCI TECHNOL, V33, P1116, DOI 10.1021/es980749y; CEA, 2011, PERF REV THERM POW S; CITEPA, 2003, PUBL GRAV PREP FRAM; CITEPA, 2003, FIN BACKGR DOC SECT; CITEPA, 2005, PROC REF NMVOC EM PR; CITEPA, 2003, HEAT SET OFFS PREP F; CITEPA, 2003, ARCH DOM US PAINTS P; CITEPA, 2004, IND APPL PAINTS PREP; CMIE, 2011, INFR REP; CORINAIR, 1990, DAT 1990; CPCB, 2000, TRANSP FUEL QUAL 200; CSO, 2011, EN STAT 2011; IBEF, 2008, AUT MARKET OPPORTUNI; IEA (International Energy Agency), 2013, WORLD EN OUTL; IPCC, 2007, CLIMATE CHANGE 2007, P104; ITC, 2010, IND PRINT IND PROF 2; Jiang WM, 1997, ATMOS ENVIRON, V31, P627, DOI 10.1016/S1352-2310(96)00172-0; Kim ST, 2004, ATMOS ENVIRON, V38, P37, DOI 10.1016/j.atmosenv.2003.09.045; Klimont Z, 2002, ATMOS ENVIRON, V36, P1309, DOI 10.1016/S1352-2310(01)00529-5; Kondo Y, 2007, J GEOPHYS RES-ATMOS, V112, DOI 10.1029/2006JD007056; Lewis C.A., 1997, FUEL EN PROD EM FACT; MoCF, 2011, ANN REP YEAR 2010 20; MoPNG, 2010, IND PETR NAT GAS STA; MoPNG, 2002, AUT FUEL POL IND; MoRTH, 2011, ROAD TRANSP YB 2009; NSSO, 2011, LEV PATT CONS EXP 20; PC, 2006, INT EN POL; PI, 2010, SNAPSH IND COAT IND; RGCC, 2011, CENS OF IND 2011; SSO, 2012, HOUS CONS EXP IND 20; TERI, 2006, NAT EN MAP IND; TERI, 2002, PRIC INFR COST SUPPL; TERI, 2014, ASS EM TEST DRIV CYC; Umweltministerium Baden-Wurttemberg, 1993, KONZ MIND VOC EM BAD, V21; USEPA, 2000, RES DEV PREP PREP NA; Varshney C.K., 1998, J IND ECOL, V2, P93, DOI 10.1162/jiec.1998.2.4.93	54	0	0	PERGAMON-ELSEVIER SCIENCE LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND	1352-2310	1873-2844		ATMOS ENVIRON	Atmos. Environ.	FEB	2015	102						209	219		10.1016/j.atmosenv.2014.11.070		11	Environmental Sciences; Meteorology & Atmospheric Sciences	Environmental Sciences & Ecology; Meteorology & Atmospheric Sciences	CB4IB	WOS:000349590300024		
J	Akimoto, H; Mori, Y; Sasaki, K; Nakanishi, H; Ohizumi, T; Itano, Y				Akimoto, Hajime; Mori, Yasuaki; Sasaki, Kansuke; Nakanishi, Hiroto; Ohizumi, Tsuyoshi; Itano, Yasuyuki			Analysis of monitoring data of ground-level ozone in Japan for long-term trend during 1990-2010: Causes of temporal and spatial variation	ATMOSPHERIC ENVIRONMENT			English	Article						Ground-level ozone; Photochemical oxidants; NO titration effect; Transboundary transport; Ozone control strategy	SURFACE OZONE; URBAN ATMOSPHERE; NITROGEN-DIOXIDE; DAILY MORTALITY; BOUNDARY-LAYER; AIR-QUALITY; EAST-ASIA; CHINA; EMISSION; TAIWAN	The puzzling increase of annual average mixing ratio of ozone (oxidant) in spite of the decrease of those of the ambient NOx and NMHC was analyzed using the twenty-one years monitoring data during 1990-2010 focusing on four high O-3 areas in Japan, Tokyo Metropolitan Area (TMA), Nagoya Area (NA), Osaka/Kyoto Area (OKA) and Fukuoka Area (FA). During the period, the NOx and NMHC mixing ratios have decreased by 40-50% and 51-54%, respectively, in these areas. Nevertheless, the annual averaged increasing trends of O-3 by linear regressions during the whole period are all positive, 1.23 +/- 0.09, 0.85 +/- 0.17, 1.41 +/- 0.12 and 1.42 +/- 0.17(1 sigma)% yr(-1) for TMA, NA, OKA and FA, respectively. Three causes of long-term trends of O-3 have been discussed: (1) the decrease of NO titration effect, (2) the increase of transboundary transport, and (3) the decrease of in situ photochemical production. The total ozone (TO) was defined by [TO] = [O-3]+[NO2] -0.1 [NOx] as an index to indicate the net O-3 removing the perturbation by in situ NO titration. TO shows statistically significant annual increasing trends, 0.20 +/- 0.04 and 0.56 +/- 0.08% yr(-1) only in OKA and FA, and the increase of TO is not discernible in TMA and NA. In springtime (March-May), TO shows larger increasing rates of 0.44 +/- 0.08, 0.59 +/- 0.09 and 0.96 +/- 0.18% yr(-1) for TMA, OKA, and FA. The statistically significant increase of TO at higher rates in spring and western part of Japan suggests the increase of transboundary transport during the period. The reduction of domestic emissions of precursors was found to result the decreasing trend of the high mixing ratio range of 98-percentile most clearly in TMA, but is not enough yet to result in the decrease of annual mean mixing ratio of O-3, which is compensated by the increase of transboundary transport and the decrease of the NO titration effect. The similar situation has been reported in Taiwan (Chou et al., 2006), and would apply more or less to other outflow region of Pacific rim, Korea and Hoang Kong, where the emission control started to reduce the O-3 precursors. Further reduction of NOx emissions over a certain limit will negate the NO titration effect, and the decrease of net O-3 due to the reduction of in situ photochemical production is expected. (C) 2014 Elsevier Ltd. All rights reserved.	[Akimoto, Hajime; Ohizumi, Tsuyoshi] Asia Ctr Air Pollut Res, Nishi Ku, Niigata 9502144, Japan; [Mori, Yasuaki; Sasaki, Kansuke; Nakanishi, Hiroto] Japan Weather Assoc, Toshima Ku, Tokyo 1706055, Japan; [Itano, Yasuyuki] Osaka City Inst Publ Hlth & Environm Sci, Tennoji Ku, Osaka 5430026, Japan	Akimoto, H (reprint author), Asia Ctr Air Pollut Res, Nishi Ku, 1182 Sowa, Niigata 9502144, Japan.	akimoto@acap.asia; ohizumi@acap.asia					Akimoto H., 2014, REP AN PHOT OX PROP; Fiore A, 2003, J GEOPHYS RES-ATMOS, V108, DOI 10.1029/2003JD003855; Zhang YH, 2006, ENVIRON HEALTH PERSP, V114, P1227, DOI 10.1289/ehp.9014; Dunlea EJ, 2007, ATMOS CHEM PHYS, V7, P2691; Villena G, 2012, ATMOS MEAS TECH, V5, P149, DOI 10.5194/amt-5-149-2012; Yamaji K, 2006, ATMOS ENVIRON, V40, P1856, DOI 10.1016/j.atmosenv.2005.10.067; Sillman S, 1999, ATMOS ENVIRON, V33, P1821, DOI 10.1016/S1352-2310(98)00345-8; Chang SC, 2007, ENVIRON MONIT ASSESS, V127, P87, DOI 10.1007/s10661-006-9262-1; Wilson RC, 2012, ATMOS CHEM PHYS, V12, P437, DOI 10.5194/acp-12-437-2012; Tian LW, 2011, ENVIRON GEOCHEM HLTH, V33, P623, DOI 10.1007/s10653-011-9375-5; Wang T, 2009, ATMOS CHEM PHYS, V9, P6217; Tanimoto H, 2009, GEOPHYS RES LETT, V36, DOI 10.1029/2009GL041382; Hoshika Y, 2011, ANN FOREST SCI, V68, P607, DOI 10.1007/s13595-011-0051-9; Lee S, 1998, GEOPHYS RES LETT, V25, P1637, DOI 10.1029/98GL01224; Itano Y, 2007, SCI TOTAL ENVIRON, V379, P46, DOI 10.1016/j.scitotenv.2007.01.079; Kurokawa J, 2009, ATMOS CHEM PHYS, V9, P6287; Nagashima T, 2010, ATMOS CHEM PHYS, V10, P11305, DOI 10.5194/acp-10-11305-2010; Chou CCK, 2006, ATMOS ENVIRON, V40, P3898, DOI 10.1016/j.atmosenv.2006.02.018; Oltmans SJ, 2013, ATMOS ENVIRON, V67, P331, DOI 10.1016/j.atmosenv.2012.10.057; Carslaw DC, 2004, ATMOS ENVIRON, V38, P3585, DOI 10.1016/j.atmosenv.2004.03.041; Kurokawa J, 2013, ATMOS CHEM PHYS, V13, P11019, DOI 10.5194/acp-13-11019-2013; Steinbacher M, 2007, J GEOPHYS RES-ATMOS, V112, DOI 10.1029/2006JD007971; CARDELINO CA, 1995, J AIR WASTE MANAGE, V45, P161; Chan CY, 2003, OZONE-SCI ENG, V25, P513, DOI 10.1080/01919510390481829; Chen KS, 2004, J AIR WASTE MANAGE, V54, P36; Finlayson-Pitts B. J., 2000, CHEM UPPER LOWER ATM, P882; Itano Y., 2014, STUD ATMOS SCI, V1, P1; Jenkin ME, 2004, ATMOS ENVIRON, V38, P5117, DOI 10.1016/j.atmosenv.2004.05.056; Kim SY, 2004, ENVIRON RES, V94, P113, DOI 10.1016/j.envres.2003.09.006; Kim Yoo-Keun, 2003, [Journal of Korean Society for Atmospheric Environmnet, 한국대기환경학회지], V19, P561; Kurtenbach Ralf, 2012, Environmental Sciences Europe, V24, P21, DOI 10.1186/2190-4715-24-21; Ministry of Environment Japan, 2014, AIR POLL SIT REP 201; Nawahda A, 2013, ATMOS ENVIRON, V81, P538, DOI 10.1016/j.atmosenv.2013.09.049; Ohara T., 2003, J JAPAN SOC ATMOSPHE, V38, P47; Ohara T., 2007, ATMOS CHEM PHYS, V7, P3319; Ohizumi T., 2013, J JPN SOC ATMOS ENV, V48, P181; Shin HJ, 2012, AEROSOL AIR QUAL RES, V12, P93, DOI 10.4209/aaqr.2011.09.0141; Tang HY, 2014, ATMOS ENVIRON, V86, P74, DOI 10.1016/j.atmosenv.2013.11.078; Tanimoto H., 2006, J JPN SOC ATMOS ENV, V41, P123; [万五星 Wan Wuxing], 2013, [生态学报, Acta Ecologica Sinica], V33, P1098; Williams EJ, 1998, J GEOPHYS RES-ATMOS, V103, P22261, DOI 10.1029/98JD00074; Yamaguchi M, 2014, ENVIRON POLLUT, V184, P472, DOI 10.1016/j.envpol.2013.09.024	42	1	2	PERGAMON-ELSEVIER SCIENCE LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND	1352-2310	1873-2844		ATMOS ENVIRON	Atmos. Environ.	FEB	2015	102						302	310		10.1016/j.atmosenv.2014.12.001		9	Environmental Sciences; Meteorology & Atmospheric Sciences	Environmental Sciences & Ecology; Meteorology & Atmospheric Sciences	CB4IB	WOS:000349590300033		
J	Harao, M; Mittendorf, EA; Radvanyi, LG				Harao, Michiko; Mittendorf, Elizabeth A.; Radvanyi, Laszlo G.			Peptide-Based Vaccination and Induction of CD8+T-Cell Responses Against Tumor Antigens in Breast Cancer	BIODRUGS			English	Review							GROUP-STUDY I-01; CYTOTOXIC T-LYMPHOCYTES; ACTIVE SPECIFIC IMMUNOTHERAPY; COLONY-STIMULATING FACTOR; PULSED DENDRITIC CELLS; HER2/NEU E75 VACCINE; MHC CLASS-I; CLINICAL-TRIAL; METASTATIC BREAST; PHASE-I	Tumor-associated antigens (TAAs) have been identified in many malignant tumors. Within these TAAs are peptide sequences that bind major histocompatibility complex (MHC) class I and class II molecules recognized by T cells triggering antigen-specific CD8+ cytotoxic T-cell and CD4+ T-helper cell responses. Efforts to develop vaccines for breast cancer have been underway for more than 20 years, including peptide and whole inactivated tumor cell vaccines as well as antigen-loaded dendritic cell vaccines. The majority of vaccine trials have used peptides, including single-peptide and multiple-peptide formulations using either MHC class I and class II epitopes in oil-based emulsions alone or in combination with an adjuvant, such as granulocyte-macrophage colony-stimulating factor, and Toll-like receptor agonists. Preclinical research in vitro and in animal models has been aimed at improving vaccine efficacy by identifying more immunogenic peptides and combinations of peptides and adjuvants and cytokine adjuvants that induce stronger immune responses and prolong T-cell memory. Clinical studies investigating the therapeutic potential of active immunization using peptide vaccines has found no serious side effects. In this review, we examine TAA peptide-based vaccination regimens showing promise in breast cancer patients that are also being investigated in clinical trials of safety and efficacy. We also discuss the current limitations in the peptide vaccination field and areas for future development.	[Harao, Michiko; Radvanyi, Laszlo G.] Univ Texas MD Anderson Canc Ctr, Dept Melanoma Med Oncol, Houston, TX 77030 USA; [Harao, Michiko] Tochigi Canc Ctr, Dept Breast Surg Oncol, Utsunomiya, Tochigi, Japan; [Mittendorf, Elizabeth A.] Univ Texas MD Anderson Canc Ctr, Dept Surg Oncol, Houston, TX 77030 USA; [Radvanyi, Laszlo G.] H Lee Moffitt Canc Ctr & Res Inst, Dept Immunol, Tampa, FL 33612 USA; [Radvanyi, Laszlo G.] Lion Biotechnol, Woodland Hills, CA 91367 USA; [Radvanyi, Laszlo G.] USF Connect, Lion Biotechnol, Tampa, FL 33612 USA	Radvanyi, LG (reprint author), USF Connect, Lion Biotechnol, 3802 Spectrum Blvd, Tampa, FL 33612 USA.	laszlo.radvanyi@lionbio.com			My Oncology Dream Award - Japanese Cancer Society; University of Texas, MD Anderson Global Academic Program	We thank Dr. Naoto Ueno (Department of Breast Medical Oncology, MD Anderson Cancer Center, Houston, TX, USA) for critical reading of the manuscript and comments. This study was supported by a 2011 My Oncology Dream Award to Michiko Harao supported by the Japanese Cancer Society and the University of Texas, MD Anderson Global Academic Program.	Lu YC, 2013, J IMMUNOL, V190, P6034, DOI 10.4049/jimmunol.1202830; Holmes JP, 2008, CANCER, V113, P1666, DOI 10.1002/cncr.23772; Zeng G, 2002, CANCER RES, V62, P3630; Bjorkman PJ, 1997, CELL, V89, P167, DOI 10.1016/S0092-8674(00)80195-6; Wang HY, 2007, CURR OPIN IMMUNOL, V19, P217, DOI 10.1016/j.coi.2007.02.004; Wang W, 2006, CANCER RES, V66, P6826, DOI 10.1158/008-5472.CAN-05-3529; Reddish MA, 1996, CANCER IMMUNOL IMMUN, V42, P303, DOI 10.1007/s002620050287; Milani A, 2013, ANN ONCOL, V24, P1740, DOI 10.1093/annonc/mdt133; Alegre ML, 2001, NAT REV IMMUNOL, V1, P220, DOI 10.1038/35105024; Morse MA, 1999, CANCER RES, V59, P56; Morita S, 2006, JPN J CLIN ONCOL, V36, P231, DOI 10.1093/jjco/hyl005; LaCelle MG, 2009, CLIN CANCER RES, V15, P6881, DOI 10.1158/1078-0432.CCR-09-1113; Chui D, 2001, P NATL ACAD SCI USA, V98, P1142, DOI 10.1073/pnas.98.3.1142; Filaci G, 2006, BLOOD, V107, P1505, DOI 10.1182/blood-2005-01-0258; Comin-Anduix B, 2010, CLIN CANCER RES, V16, P6040, DOI 10.1158/1078-0432.CCR-10-1911; Sanderson K, 2005, J CLIN ONCOL, V23, P741, DOI 10.1200/JCO.2005.01.128; Banchereau J, 2001, CANCER RES, V61, P6451; Poulikakos PI, 2010, NATURE, V464, P427, DOI 10.1038/nature08902; Lander ES, 2001, NATURE, V409, P860, DOI 10.1038/35057062; Rosenberg SA, 2004, NAT MED, V10, P909, DOI 10.1038/nm1100; PARKER KC, 1994, J IMMUNOL, V152, P163; Shortman K, 2002, NAT REV IMMUNOL, V2, P151, DOI 10.1038/nri746; Slingluff CL, 2011, CANCER J, V17, P343, DOI 10.1097/PPO.0b013e318233e5b2; Pedersen JW, 2011, INT J CANCER, V128, P1860, DOI 10.1002/ijc.25778; TSANG KY, 1995, J NATL CANCER I, V87, P982, DOI 10.1093/jnci/87.13.982; Musselli C, 2002, INT J CANCER, V97, P660, DOI 10.1002/ijc.10081; Bhardwaj N, 2007, J CLIN INVEST, V117, P1130, DOI 10.1172/JCI32136; Holmes JP, 2008, J CLIN ONCOL, V26, P3426, DOI 10.1200/JCO.2007.15.7842; Sercarz EE, 2003, NAT REV IMMUNOL, V3, P621, DOI 10.1038/nri1149; Murray JL, 2002, CLIN CANCER RES, V8, P3407; Disis ML, 2010, J CLIN ONCOL, V28, P4531, DOI 10.1200/JCO.2009.27.2146; Peoples GE, 2005, J CLIN ONCOL, V23, P7536, DOI 10.1200/JCO.2005.03.047; Sears AK, 2011, EXPERT OPIN BIOL TH, V11, P1543, DOI 10.1517/14712598.2011.616889; Mittendorf EA, 2006, CANCER, V106, P2309, DOI 10.1002/cncr.21849; Okuno K, 2014, ANTICANCER RES, V34, P3045; Segal NH, 2008, CANCER RES, V68, P889, DOI 10.1158/0008-5472.CAN-07-3095; Knutson KL, 2001, J CLIN INVEST, V107, P477, DOI 10.1172/JCI11752; Rudd PM, 2001, SCIENCE, V291, P2370, DOI 10.1126/science.291.5512.2370; Castle JC, 2012, CANCER RES, V72, P1081, DOI 10.1158/0008-5472.CAN-11-3722; Riley JL, 2002, P NATL ACAD SCI USA, V99, P11790, DOI 10.1073/pnas.162359999; Rudd CE, 2009, IMMUNOL REV, V229, P12, DOI 10.1111/j.1600-065X.2009.00770.x; Curigliano G, 2006, ANN ONCOL, V17, P750, DOI 10.1093/annonc/mdj083; Perez SA, 2010, CANCER-AM CANCER SOC, V116, P2071, DOI 10.1002/cncr.24988; Zaks TZ, 1998, CANCER RES, V58, P4902; Ibrahim NK, 2013, J CANCER, V4, P577, DOI 10.7150/jca.7028; BELLETT AJD, 1985, MOL CELL BIOL, V5, P1933; Rakha EA, 2009, EUR J CANCER, V45, P1780, DOI 10.1016/j.ejca.2009.02.014; Zitvogel L, 2011, NAT REV CLIN ONCOL, V8, P151, DOI 10.1038/nrclinonc.2010.223; Sharma A, 2012, CANCER-AM CANCER SOC, V118, P4354, DOI 10.1002/cncr.26734; FALK K, 1991, NATURE, V351, P290, DOI 10.1038/351290a0; Brockhausen I, 2006, EMBO REP, V7, P599, DOI 10.1038/sj.embor.7400705; Rammensee HG, 2013, EXPERT REV VACCINES, V12, P1211, DOI 10.1586/14760584.2013.836911; Cresswell P, 1999, IMMUNOL REV, V172, P21, DOI 10.1111/j.1600-065X.1999.tb01353.x; Becker JC, 2012, CANCER IMMUNOL IMMUN, V61, P2091, DOI 10.1007/s00262-012-1266-9; Soussi T, 2000, ANN NY ACAD SCI, V910, P121; Banchereau J, 2005, NAT REV IMMUNOL, V5, P296, DOI 10.1038/nri1592; Robson NC, 2010, CURR OPIN IMMUNOL, V22, P137, DOI 10.1016/j.coi.2010.01.002; Oka Y, 2004, P NATL ACAD SCI USA, V101, P13885, DOI 10.1073/pnas.0405884101; Rammensee HG, 1999, IMMUNOGENETICS, V50, P213, DOI 10.1007/s002510050595; Miles D, 2011, ONCOLOGIST, V16, P1092, DOI 10.1634/theoncologist.2010-0307; Benavides LC, 2011, EXPERT REV VACCINES, V10, P201, DOI [10.1586/erv.10.167, 10.1586/ERV.10.167]; Karbach J, 2010, INT J CANCER, V126, P909, DOI 10.1002/ijc.24850; Radvanyi L, 2005, P NATL ACAD SCI USA, V102, P11005, DOI 10.1073/pnas.0500904102; Dhodapkar MV, 2001, J EXP MED, V193, P233, DOI 10.1084/jem.193.2.233; Chapman PB, 2011, NEW ENGL J MED, V364, P2507, DOI 10.1056/NEJMoa1103782; Liew FY, 2002, NAT REV IMMUNOL, V2, P55, DOI 10.1038/nri705; Pardoll DM, 2012, NAT REV CANCER, V12, P252, DOI 10.1038/nrc3239; Mittendorf EA, 2008, CANCER IMMUNOL IMMUN, V57, P1511, DOI 10.1007/s00262-008-0540-3; Peoples GE, 2008, CLIN CANCER RES, V14, P797, DOI 10.1158/1078-0432.CCR-07-1448; Gates JD, 2010, VACCINE, V28, P7476, DOI 10.1016/j.vaccine.2010.09.029; Melief CJM, 2008, NAT REV CANCER, V8, P351, DOI 10.1038/nrc2373; Beatson RE, 2010, IMMUNOTHERAPY-UK, V2, P305, DOI [10.2217/imt.10.17, 10.2217/IMT.10.17]; Toes REM, 1996, J IMMUNOL, V156, P3911; Tran E, 2014, SCIENCE, V344, P641, DOI 10.1126/science.1251102; Toes REM, 1996, P NATL ACAD SCI USA, V93, P7855, DOI 10.1073/pnas.93.15.7855; Cheever MA, 2009, CLIN CANCER RES, V15, P5323, DOI 10.1158/1078-0432.CCR-09-0737; Brossart P, 2000, BLOOD, V96, P3102; Disis ML, 2002, J CLIN ONCOL, V20, P2624, DOI 10.1200/JCO.2002.06.171; Jager D, 2001, CANCER RES, V61, P2055; Melief CJM, 2008, IMMUNITY, V29, P372, DOI 10.1016/j.immuni.2008.08.004; Wang-Johanning F, 2008, CANCER RES, V68, P5869, DOI 10.1158/0008-5472.CAN-07-6838; Hernandez-Chacon JA, 2011, J IMMUNOTHER, V34, P236, DOI 10.1097/CJI.0b013e318209e7ec; Yamada A, 2013, CANCER SCI, V104, P15, DOI 10.1111/cas.12050; Kantoff PW, 2010, NEW ENGL J MED, V363, P411, DOI 10.1056/NEJMoa1001294; FISK B, 1995, J EXP MED, V181, P2109, DOI 10.1084/jem.181.6.2109; Theurillat JP, 2007, INT J CANCER, V120, P2411, DOI 10.1002/ijc.22376; Ambrosini G, 1997, NAT MED, V3, P917, DOI 10.1038/nm0897-917; Masutomi K, 2003, CELL, V114, P241, DOI 10.1016/S0092-8674(03)00550-6; Larocca C, 2011, CANCER J, V17, P359, DOI 10.1097/PPO.0b013e3182325e63; Denkert C, 2010, J CLIN ONCOL, V28, P105, DOI 10.1200/JCO.2009.23.7370; de Gruijl TD, 2008, CANCER IMMUNOL IMMUN, V57, P1569, DOI 10.1007/s00262-008-0536-z; Bijker MS, 2008, EUR J IMMUNOL, V38, P1033, DOI 10.1002/eji.200737995; Kawashima I, 1998, HUM IMMUNOL, V59, P1, DOI 10.1016/S0198-8859(97)00255-3; Bridle BW, 2010, MOL THER, V18, P1430, DOI 10.1038/mt.2010.98; Czerniecki BJ, 2007, CANCER RES, V67, P1842, DOI 10.1158/0008-5472.CAN-06-4038; Pedersen AE, 2011, J IMMUNOTHER, V34, P629, DOI 10.1097/CJI.0b013e3182281381; Leffers N, 2009, INT J CANCER, V125, P2104, DOI 10.1002/ijc.24597; Andersen MH, 2010, J BIOMED BIOTECHNOL, DOI 10.1155/2010/237623; Gilewski T, 2000, CLIN CANCER RES, V6, P1693; Clive KS, 2012, J SURG ONCOL, V105, P452, DOI 10.1002/jso.21723; Baxevanis CN, 2004, CANCER IMMUNOL IMMUN, V53, P166, DOI 10.1007/s00262-003-0475-7; Wang-Johanning F, 2003, ONCOGENE, V22, P1528, DOI 10.1038/sj.onc.1206241; Mahmoud SMA, 2011, J CLIN ONCOL, V29, P1949, DOI 10.1200/JCO.2010.30.5037; Leisegang M, 2010, J CLIN INVEST, V120, P3869, DOI 10.1172/JCI43437; Gannage M, 2005, J IMMUNOL, V174, P8210; Benavides LC, 2009, CLIN CANCER RES, V15, P2895, DOI 10.1158/1078-0432.CCR-08-1126; Berinstein NL, 2012, J TRANSL MED, V10, DOI 10.1186/1479-5876-10-156; Bhattacharya-Chatterjee M, 2008, CURRENT PROTOCOLS IM; Carmichael MG, 2010, CANCER, V116, P292, DOI 10.1002/cncr.24756; Chacon JA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0060031; CHANG FJ, 1995, J CLIN ONCOL, V13, P1009; Chen G, 2014, CANCER IMMUNOL RES, V2, P949, DOI 10.1158/2326-6066.CIR-14-0058; Chikamatsu K, 1999, CLIN CANCER RES, V5, P1281; Cohn A, 2014, INT J ONCOL, V45, P2221, DOI 10.3892/ijo.2014.2679; Curcio C, 2008, CANCER GENE THER, V15, P108, DOI 10.1038/sj.cgt.7701106; DISIS ML, 1994, CANCER RES, V54, P16; Domchek SM, 2007, CANCER RES, V67, P10546, DOI 10.1158/0008-5472.CAN-07-2765; Eggermont AMM, 2009, CLIN CANCER RES, V15, P6745, DOI 10.1158/1078-0432.CCR-09-2377; Elliott RL, 2013, SURG ONCOL, V22, P172, DOI 10.1016/j.suronc.2013.05.003; Emens LA, 2003, CANCER BIOL THER, V2, pS161; Faries MB, 2009, CLIN CANCER RES, V15, P7029, DOI 10.1158/1078-0432.CCR-09-1540; FIORENTINO DF, 1989, J EXP MED, V170, P2081, DOI 10.1084/jem.170.6.2081; Gholami S, 2012, ANN SURG, V256, P437, DOI 10.1097/SLA.0b013e3182654572; Haas C, 1996, CANCER IMMUNOL IMMUN, V43, P190, DOI 10.1007/s002620050321; Hadden JW, 1999, INT J IMMUNOPHARMACO, V21, P79, DOI 10.1016/S0192-0561(98)00077-0; Iversen TZ, 2014, BASIC CLIN PHARM TOX; Jäger Dirk, 2002, Cancer Immun, V2, P5; Jager D, 2004, CANCER IMMUNOL IMMUN, V53, P144, DOI 10.1007/s00262-003-0470-z; Jäger Dirk, 2005, Cancer Immun, V5, P11; KINUGASA T, 1994, INT J CANCER, V58, P102, DOI 10.1002/ijc.2910580117; Klinman DA, 2004, VACCINE, V22, P2881, DOI 10.1016/j.vaccine.2003.12.020; Knutson KL, 2002, CLIN CANCER RES, V8, P1014; Knutson K. L., 2005, Current Drug Targets - Immune Endocrine and Metabolic Disorders, V5, P365, DOI 10.2174/156800805774913006; Knutson K L, 2001, Clin Breast Cancer, V2, P73, DOI 10.3816/CBC.2001.n.014; Lee AHS, 2006, HISTOPATHOLOGY, V48, P692, DOI 10.1111/j.1365-2559.2006.02410.x; MacLean GD, 1996, J IMMUNOTHER, V19, P309, DOI 10.1097/00002371-199607000-00006; MacLean GD, 1996, J IMMUNOTHER, V19, P59, DOI 10.1097/00002371-199601000-00007; Mamalaki A, 2003, CANCER IMMUNOL IMMUN, V52, P513, DOI 10.1007/s00262-002-0371-6; Miles David, 2003, Clin Breast Cancer, V3 Suppl 4, pS134, DOI 10.3816/CBC.2003.s.002; Mittendorf EA, 2006, SURGERY, V139, P407, DOI 10.1016/j.surg.2005.06.059; Mittendorf EA, 2012, CANCER-AM CANCER SOC, V118, P2594, DOI 10.1002/cncr.26574; Mittendorf EA, 2007, BREAST DIS YB Q, V17, P318, DOI 10.1016/S1043-321X(07)80101-9; Mittendorf EA, 2011, EXPERT REV VACCINES, V10, P755, DOI [10.1586/erv.11.59, 10.1586/ERV.11.59]; Murphy K., 2008, IMMUNOBIOLOGY; Neumann F, 2004, CANCER IMMUNOL IMMUN, V53, P589, DOI 10.1007/s00262-003-0492-6; Petersen TR, 2001, SCAND J IMMUNOL, V53, P357, DOI 10.1046/j.1365-3083.2001.00887.x; Rentzsch C, 2003, CLIN CANCER RES, V9, P4376; Rosenberg SA, 1998, J NATL CANCER I, V90, P1894, DOI 10.1093/jnci/90.24.1894; Schlom J, 1996, BREAST CANCER RES TR, V38, P27, DOI 10.1007/BF01803781; Scholl S, 2003, J BIOMED BIOTECHNOL, P194; Soussi T, 2000, ANN NY ACAD SCI, V910, P37; Sung MH, 2004, METHODS, V34, P460, DOI 10.1016/j.ymeth.2004.06.001; Svane IM, 2004, CANCER IMMUNOL IMMUN, V53, P633, DOI 10.1007/s00262-003-0493-5; Svane IM, 2007, CANCER IMMUNOL IMMUN, V56, P1485, DOI 10.1007/s00262-007-0293-4; Svane IM, 2008, VACCINE, V26, P4716, DOI 10.1016/j.vaccine.2008.06.085; Tai Lee-Hwa, 2014, Front Oncol, V4, P217, DOI 10.3389/fonc.2014.00217; Tsuruma T, 2008, J TRANSL MED, V6, DOI 10.1186/1479-5876-6-24; Ward RL, 1999, HUM IMMUNOL, V60, P510, DOI 10.1016/S0198-8859(99)00003-8; Yu B, 2011, ONCOL REP, V26, P255, DOI 10.3892/or.2011.1285; Zeichner Simon B, 2012, J Am Osteopath Assoc, V112, P482; Zhao Jing, 2011, Genes Cancer, V2, P914, DOI 10.1177/1947601911431841	161	2	2	ADIS INT LTD	NORTHCOTE	5 THE WAREHOUSE WAY, NORTHCOTE 0627, AUCKLAND, NEW ZEALAND	1173-8804	1179-190X		BIODRUGS	Biodrugs	FEB	2015	29	1					15	30		10.1007/s40259-014-0114-1		16	Oncology; Immunology; Pharmacology & Pharmacy	Oncology; Immunology; Pharmacology & Pharmacy	CB4RR	WOS:000349616100002		
J	Rosendo, A; Liu, XX; Shimizu, M; Hosoda, K				Rosendo, Andre; Liu, Xiangxiao; Shimizu, Masahiro; Hosoda, Koh			Stretch reflex improves rolling stability during hopping of a decerebrate biped system	BIOINSPIRATION & BIOMIMETICS			English	Article						stretch reflex; hopping stability; decerebrate; frontal plane	UNRESTRAINED LOCOMOTION; FEEDBACK; CAT; VERTEBRATES; MODULATION; MUSCLES; HUMANS; ROBOT; MODEL; GAIT	When humans hop, attitude recovery can be observed in both the sagittal and frontal planes. While it is agreed that the brain plays an important role in leg placement, the role of low-level feedback (the stretch reflex) on frontal plane stabilization remains unclear. Seeking to better understand the contribution of the soleus stretch reflex to rolling stability, we performed experiments on a biomimetic humanoid hopping robot. Various reflex responses to touching the floor, ranging from no response to long muscle activations, were examined, and the effect of a delay upon touching the floor was also examined. We found that the stretch reflex brought the system closer to stable, straight hopping. The presence of a delay did not affect the results; both the cases with and without a delay outperformed the case without a reflex response. The results of this study highlight the importance of low-level control in locomotion for which body stabilization does not require higher-level signals.	[Rosendo, Andre; Liu, Xiangxiao; Shimizu, Masahiro; Hosoda, Koh] Osaka Univ, Grad Sch Engn Sci, Osaka, Japan	Rosendo, A (reprint author), Osaka Univ, Grad Sch Engn Sci, Osaka, Japan.	andre.rosendo@arl.sys.es.osaka-u.ac.jp					ALEXANDER RM, 1995, PHILOS T ROY SOC B, V347, P235, DOI 10.1098/rstb.1995.0024; GOSLOW GE, 1973, J MORPHOL, V141, P1, DOI 10.1002/jmor.1051410102; Hiebert GW, 1999, J NEUROPHYSIOL, V81, P758; Fallon JB, 2005, J NEUROPHYSIOL, V94, P3795, DOI 10.1152/jn.00359.2005; Klute GK, 2002, INT J ROBOT RES, V21, P295, DOI 10.1177/027836402320556331; JONES GM, 1971, J PHYSIOL-LONDON, V219, P709; GRILLNER S, 1975, PHYSIOL REV, V55, P247; Sinkjaer T, 1996, J NEUROPHYSIOL, V76, P1112; Kalveram KT, 2009, J PHYSIOLOGY-PARIS, V103, P232, DOI 10.1016/j.jphysparis.2009.08.006; DYHREPOULSEN P, 1991, J PHYSIOL-LONDON, V437, P287; Calisti M, 2011, BIOINSPIR BIOMIM, V6, DOI 10.1088/1748-3182/6/3/036002; Geyer H, 2010, IEEE T NEUR SYS REH, V18, P263, DOI 10.1109/TNSRE.2010.2047592; Carpenter MG, 1999, EXP BRAIN RES, V129, P93, DOI 10.1007/s002210050940; ENGBERG I, 1969, ACTA PHYSIOL SCAND, V75, P614, DOI 10.1111/j.1748-1716.1969.tb04415.x; Yakovenko S, 2004, BIOL CYBERN, V90, P146, DOI 10.1007/s00422-003-0449-z; Hosoda K, 2010, AUTON ROBOT, V28, P307, DOI 10.1007/s10514-009-9171-6; Boblan I, 2004, EMBODIED ARTIFICIAL; Chou C-P, 1994, P IEEE INT C ROB AUT; Daley M, 2008, CURR BIOL, V18, P1064; Fibley RA, 1969, PSYCHON SCI, V17, P335; Geyer H, 2003, P ROY SOC B-BIOL SCI, V270, P2173, DOI 10.1098/rspb.2003.2454; Haeufle DFB, 2010, BIOINSPIR BIOMIM, V5, DOI 10.1088/1748-3182/5/1/016004; Haeufle DFB, 2012, J R SOC INTERFACE, V9, P1458, DOI 10.1098/rsif.2011.0694; Kukillaya R, 2009, CHAOS, V19, DOI 10.1063/1.3141306; Marques HG, 2014, PLOS COMPUT BIOL, V10, DOI 10.1371/journal.pcbi.1003653; Muybridge R, 1888, ANIMAL LOCOMOTION MU; Paul C, 2005, BIOL CYBERN, V93, P153, DOI 10.1007/s00422-005-0559-x; Perreault EJ, 2003, J BIOMECH, V36, P211, DOI 10.1016/S0021-9290(02)00332-9; Rosendo A, 2013, P IEEE INT C INT ROB; Rosendo A, 2014, ADV ROBOTICS, V28, P351, DOI 10.1080/01691864.2013.870495; van Soest J, 1993, BIOL CYBERN, V69, P195; Voigt M, 1998, EUR J APPL PHYSIOL O, V78, P522, DOI 10.1007/s004210050455	32	0	0	IOP PUBLISHING LTD	BRISTOL	TEMPLE CIRCUS, TEMPLE WAY, BRISTOL BS1 6BE, ENGLAND	1748-3182	1748-3190		BIOINSPIR BIOMIM	Bioinspir. Biomim.	FEB	2015	10	1							016008	10.1088/1748-3190/10/1/016008		12	Engineering, Multidisciplinary; Materials Science, Biomaterials; Robotics	Engineering; Materials Science; Robotics	CB3VT	WOS:000349558000008		
J	Shimoyama, K; Kagawa, S; Ishida, M; Watanabe, S; Noma, K; Takehara, K; Tazawa, H; Hashimoto, Y; Tanabe, S; Matsuoka, J; Kobayashi, H; Fujiwara, T				Shimoyama, Kyoko; Kagawa, Shunsuke; Ishida, Michihiro; Watanabe, Shinichiro; Noma, Kazuhiro; Takehara, Kiyoto; Tazawa, Hiroshi; Hashimoto, Yuuri; Tanabe, Shunsuke; Matsuoka, Junji; Kobayashi, Hisataka; Fujiwara, Toshiyoshi			Viral transduction of the HER2-extracellular domain expands trastuzumab-based photoimmunotherapy for HER2-negative breast cancer cells	BREAST CANCER RESEARCH AND TREATMENT			English	Article						Photoimmunotherapy; HER2; Breast cancer; Adenovirus	PHOTOCHEMICAL INTERNALIZATION PCI; TUMOR NECROSIS FACTOR; MONOCLONAL-ANTIBODY; GENE; TELOMERASE; RESISTANCE; THERAPY; HER2; AMPLIFICATION; CHEMOTHERAPY	The prognosis of HER2-positive breast cancer has been improved by trastuzumab therapy, which features high specificity and limited side effects. However, trastuzumab-based therapy has shortcomings. Firstly, HER2-targeted therapy is only applicable to HER2-expressing tumors, which comprise only 20-25 % of primary breast cancers. Secondly, many patients who initially respond to trastuzumab ultimately develop disease progression. To overcome these problems, we employed virus-mediated HER2 transduction and photoimmunotherapy (PIT) which involves trastuzumab conjugated with a photosensitizer, trastuzumab-IR700, and irradiation of near-infrared light. We hypothesized that the gene transduction technique together with PIT would expand the range of tumor entities suitable for trastuzumab-based therapy and improve its antitumor activity. The HER2-extracellular domain (ECD) was transduced by the adenoviral vector, Ad-HER2-ECD, and PIT with trastuzumab-IR700 was applied in the HER2-negative cancer cells. Ad-HER2-ECD can efficiently transduce HER2-ECD into HER2-negative human cancer cells. PIT with trastuzumab-IR700 induced direct cell membrane destruction of Ad-HER2-ECD-transduced HER2-negative cancer cells. Novel combination of viral transduction of a target antigen and an antibody-based PIT would expand and potentiate molecular-targeted therapy even for target-negative or attenuated cancer cells.	[Shimoyama, Kyoko; Kagawa, Shunsuke; Ishida, Michihiro; Watanabe, Shinichiro; Noma, Kazuhiro; Takehara, Kiyoto; Tazawa, Hiroshi; Hashimoto, Yuuri; Tanabe, Shunsuke; Fujiwara, Toshiyoshi] Okayama Univ, Grad Sch Med Dent & Pharmacol Sci, Dept Surg Gastroenterol, Kita Ku, Okayama 7008558, Japan; [Tazawa, Hiroshi] Okayama Univ Hosp, Ctr Innovat Clin Med, Okayama, Japan; [Matsuoka, Junji] Okayama Univ Hosp, Dept Palliat Care, Okayama, Japan; [Kobayashi, Hisataka] NCI, Mol Imaging Program, Ctr Canc Res, US Natl Inst Hlth, Bethesda, MD 20892 USA	Kagawa, S (reprint author), Okayama Univ, Grad Sch Med Dent & Pharmacol Sci, Dept Surg Gastroenterol, Kita Ku, 2-5-1 Shikata Cho, Okayama 7008558, Japan.	skagawa@md.okayama-u.ac.jp	TAZAWA, Hiroshi/B-2247-2011	TAZAWA, Hiroshi/0000-0003-4658-1050	Ministry of Education Culture, Sports, Science and Technology, Japan; Ministry of Health, Labor and Welfare, Japan	We thank Tomoko Sueishi for her technical support. This study was supported by grants-in-aid from the Ministry of Education Culture, Sports, Science and Technology, Japan (Toshiyoshi Fujiwara, Hiroshi Tazawa, Shunsuke Tanabe, and Shunsuke Kagawa) and grants from the Ministry of Health, Labor and Welfare, Japan (Toshiyoshi Fujiwara).	Sledge GW, 2014, J CLIN ONCOL, V32, P1979, DOI 10.1200/JCO.2014.55.4139; Nahta R, 2006, NAT CLIN PRACT ONCOL, V3, P269, DOI 10.1038/ncponc0509; Schuler M, 2001, J CLIN ONCOL, V19, P1750; Mitsunaga M, 2011, NAT MED, V17, P1685, DOI 10.1038/nm.2554; Burris HA, 2011, J CLIN ONCOL, V29, P398, DOI 10.1200/JCO.2010.29.5865; Carlsson J, 2004, BRIT J CANCER, V90, P2344, DOI 10.1038/sj.bjc.6601881; Garrett JT, 2011, CANCER BIOL THER, V11, P793, DOI 10.4161/cbt.11.9.15045; Mitsunaga M, 2012, BIOCONJUGATE CHEM, V23, P604, DOI 10.1021/bc200648m; Umeoka T, 2004, CANCER RES, V64, P6259, DOI 10.1158/0008-5472.CAN-04-1335; Shirasu N, 2014, INT J CANCER, V135, P2697, DOI 10.1002/ijc.28907; Yin H, 2014, NAT REV GENET, V15, P541, DOI 10.1038/nrg3763; Yoshida R, 2012, CANCER IMMUNOL IMMUN, V61, P1905, DOI 10.1007/s00262-012-1249-x; Zhang SY, 2011, NAT MED, V17, P461, DOI 10.1038/nm.2309; Sliwkowski MX, 1999, SEMIN ONCOL, V26, P60; Slamon DJ, 2001, NEW ENGL J MED, V344, P783, DOI 10.1056/NEJM200103153441101; Slamon D, 2011, NEW ENGL J MED, V365, P1273, DOI 10.1056/NEJMoa0910383; Junutula JR, 2010, CLIN CANCER RES, V16, P4769, DOI 10.1158/1078-0432.CCR-10-0987; Weissleder R, 2001, NAT BIOTECHNOL, V19, P316, DOI 10.1038/86684; HUDZIAK RM, 1989, MOL CELL BIOL, V9, P1165; Smith E, 2011, HUM GENE THER, V22, P1053, DOI 10.1089/hum.2010.227; Dawood S, 2010, J CLIN ONCOL, V28, P92, DOI 10.1200/JCO.2008.19.9844; Berstad MB, 2012, BBA-GEN SUBJECTS, V1820, P1849, DOI 10.1016/j.bbagen.2012.08.027; Owen SC, 2013, J CONTROL RELEASE, V172, P395, DOI 10.1016/j.jconrel.2013.07.011; Berg K, 2010, METHODS MOL BIOL, V635, P133, DOI 10.1007/978-1-60761-697-9_10; Hudis CA, 2007, NEW ENGL J MED, V357, P39, DOI 10.1056/NEJMra043186; Kagawa S, 2001, CANCER RES, V61, P3330; Kishimoto H, 2006, NAT MED, V12, P1213, DOI 10.1038/nm1404; Phillips GDL, 2008, CANCER RES, V68, P9280, DOI 10.1158/0008-5472.CAN-08-1776; Mitsunaga M, 2012, BMC CANCER, V12, DOI 10.1186/1471-2407-12-345; Nakajima T, 2012, CANCER RES, V72, P4622, DOI 10.1158/0008-5472.CAN-12-1298; Papanikolaou V, 2009, INT J ONCOL, V35, P1141, DOI 10.3892/ijo_00000430; Sano K, 2014, MOL CANCER THER, V13, P426, DOI 10.1158/1535-7163.MCT-13-0633; Sano K, 2012, BREAST CANCER RES, V14, DOI 10.1186/bcr3167; SLAMON DJ, 1989, SCIENCE, V244, P707, DOI 10.1126/science.2470152; SLAMON DJ, 1987, SCIENCE, V235, P177, DOI 10.1126/science.3798106; Subik Kristina, 2010, Breast Cancer (Auckl), V4, P35	36	1	1	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0167-6806	1573-7217		BREAST CANCER RES TR	Breast Cancer Res. Treat.	FEB	2015	149	3					597	605		10.1007/s10549-015-3265-y		9	Oncology	Oncology	CB6UC	WOS:000349761200004		
J	Bechtoula, H; Kono, S; Watanabe, F; Mehani, Y; Kibboua, A; Naili, M				Bechtoula, Hakim; Kono, Susumu; Watanabe, Fumio; Mehani, Youcef; Kibboua, Abderrahmane; Naili, Mounir			Performance of HSC columns under severe cyclic loading	BULLETIN OF EARTHQUAKE ENGINEERING			English	Article						High strength concrete; Column; Performance; Scale effect; Curvature; Damage	HIGH-STRENGTH CONCRETE; REINFORCED-CONCRETE; SEISMIC PERFORMANCE; R-C; BEHAVIOR; ELEMENT; MODEL; SHEAR; DUCTILITY; SECTIONS	Experimental and analytical results of seismic investigation of high strength reinforced concrete columns performance is summarized in this paper. Twelve cantilever columns with different sizes and concrete compressive strengths were tested. The column sizes were 325 mm x 325 mm, 520 mm x 520 mm and 650 mm x 650 mm for the small, medium and large scale specimens, respectively. Concrete compressive strength was 80, 130 and 180 MPa. All specimens were designed in accordance with the Japanese design guidelines. It was noticed that spalling of cover concrete was very brittle for specimens made of 180 MPa followed by a significant decrease in strength independently of the column size. It was also observed that, while concrete compressive strength increases, the drift corresponding to the peak load decreases as well as the ductility of the specimen. Curvature was much important for the small size than for the medium size columns. Specimens with high concrete compressive strength showed a higher equivalent viscous damping at all drift angles. An equation was proposed for predicting the moment-drift envelope curves for the medium and large scale columns knowing that of the small scale columns. Experimental moment-drift and axial strain-drift histories were well predicted using a fiber model developed by the authors.	[Bechtoula, Hakim; Mehani, Youcef; Kibboua, Abderrahmane; Naili, Mounir] Natl Earthquake Engn Res Ctr, Hussein Dey, Alger, Algeria; [Kono, Susumu; Watanabe, Fumio] Kyoto Univ, Dept Architecture, Nishikyo Ku, Kyoto 6158540, Japan	Bechtoula, H (reprint author), Natl Earthquake Engn Res Ctr, CGS 01 Rue Kaddour Rahim,BP252, Hussein Dey, Alger, Algeria.	bechhakim@gmail.com			TAISEI company; KAJIMA company; JSPS	The authors are thankful to: Sakashita M., Shibata S., Matsuda T., Oda M. and Ryu N. former students at Kyoto University. The authors also acknowledge TAISEI and KAJIMA companies for their financial support. The first author is grateful to JSPS for their 2 years financial support as Post Doctor at Kyoto University.	ACI Committee 318, 2011, 318 ACI COMM; ACI Committee 363, 2005, ACI COMM SPEC PUBL, VSP-228-5; AIJ, 1999, DES GUID EARTHQ RES; Aktan AE, 1985, AM CONCRETE I SP, VSP-84, P651; Ozbakkaloglu T, 2006, J COMPOS CONSTR, V10, P538, DOI 10.1061/(ASCE)1090-0268(2006)10:6(538); SHIBATA A, 1976, J STRUCT DIV-ASCE, V102, P1; Petrangeli M, 1999, J ENG MECH-ASCE, V125, P994, DOI 10.1061/(ASCE)0733-9399(1999)125:9(994); Wijesundara KK, 2011, B EARTHQ ENG, V9, P1535, DOI 10.1007/s10518-011-9272-4; Mpampatsikos V, 2008, J EARTHQ ENG, V12, P52, DOI 10.1080/13632460801925020; Alemdar BN, 2005, J STRUCT ENG-ASCE, V131, P1811, DOI 10.1061/(ASCE)0733-9445(2005)1331:12(1811); Scott MH, 2006, J STRUCT ENG-ASCE, V132, P244, DOI 10.1061/(ASCE)0733-9445(2006)132:2(244); [Anonymous], 1981, J FAC ENG U TOKYO, VXXXVI, 11, P407; Antonius, 2013, ASIAN J CIVIL ENG BH, V15, P245; Arede A, 1997, THESIS U PORTO PORTO; Bairrao R, 2005, STRUCT ENG MECH, V19, P581; Bechtoula H, 2009, STRUCT ENG MECH, V31, P697; Bechtoula H, 2005, THESIS KYOTO U JAPAN; Bo Wu, 2009, Structural Engineering and Mechanics, V32; Calabrese A, 2008, U STUDI PAVIA PAVIA; Campione G, 2008, STRUCT ENG MECH, V28, P295; Ching Johnny, 2011, STRUCT ENG MECH, V39, P559; Clough RW, 1965, P 3 WORLD C EARTHQ E, VII-4, P68; Collins M. P., 1993, CONCRETE INT, V15, P27; D'Ambrisi A, 1999, J STRUCT ENG-ASCE, V125, P1143, DOI 10.1061/(ASCE)0733-9445(1999)125:10(1143); Dias-da-Costa D, 2010, COMPUT CONCRETE, V7, P533; Dundar C, 2012, STRUCT ENG MECH, V44, P649; FARDIS MN, 1991, EURO RELIAB, V2, P247; Filippou FC, 2004, EARTHQUAKE ENG ENG S; Galal KE, 2003, ENG STRUCT, V25, P1353, DOI 10.1016/S0141-0296(03)00111-1; Garevski M, 2010, EARTHQUAKE ENG EUROP, DOI [10.1007/978-90-481-9544-2, DOI 10.1007/978-90-481-9544-2]; Hadi MNS, 2011, J MATER CIVIL ENG, V23, P823, DOI 10.1061/(ASCE)MT.1943-5533.0000234; Qiang H, 2013, EARTHQ ENG ENG VIB, V12, P433, DOI 10.1007/s11803-013-0184-y; Hashemi SH, 2008, STRUCT ENG MECH, V30, P403; Huang CK, 2005, ACI SP, VSP-228; JICE, 1988, NEW RC RES DEV REP; Kim SH, 2004, STRUCT ENG MECH, V18, P493; Komuro T, 2004, P ARCH I JAP AIJ STR, VC2, P315; Kumagai H, 2005, CONCR RES TECHNOL JC, V16; KURAMOTO H, 1995, ACI STRUCT J, V92, P610; Liu X, 2009, CEERR200906 MICH STA; Liu X, 2009, CEERR200903 MICH STA; Lu XL, 2008, EARTHQ ENG ENG VIB, V7, P77, DOI 10.1007/s11803-008-0771-5; Martinez S, 1982, 8210 CORN U DEP STRU; Mertol HC, 2008, ACI STRUCT J, V105, P626; Mpampatsikos V, 2008, THESIS U STUDI PAVIA; Muguruma H, 1990, P 2 INT S UT HIGH ST; Muramatsu A, 2004, P ARCH I JAP AIJ STR, VC2, P317; Muramatsu A, 2005, P ARCH I JAP AIJ STR, VC2, P169; Nakamura T, 1977, T ARCHITECTURAL I JA, P71; Namiki S, 1999, CONCRETE J, V37, P35; Nishiyama M, 2009, J ADV CONCR TECHNOL, V7, P157; Nishiyama M, 1993, P HIGH STRENGTH CONC, P322; OTANI S, 1974, J STRUCT DIV-ASCE, V100, P1433; Ou YC, 2012, COMPUT CONCRETE, V10, P663; Parande AK, 2013, ADV CONCRETE CONSTRU, V1, P151; Paultre P, 2009, ACI STRUCT J, V106, P395; Paultre P, 2008, J STRUCT ENG-ASCE, V134, P738, DOI 10.1061/(ASCE)0733-9445(2008)134:5(738); Popovics S, 1973, CEMENT CONCRETE RES, V3, P583, DOI DOI 10.1016/0008-8846(73)90096-3; Ramadoss P, 2012, COMPUT CONCRETE, V9, P153; Saatcioglu M, 1998, J STRUCT ENG-ASCE, V124, P1438, DOI 10.1061/(ASCE)0733-9445(1998)124:12(1438); Sakino K, 1994, J STRUCTURAL CONSTRU, V461, P95; Sezen H, 2000, SEISMIC BEHAV MODELI; SFAKIANAKIS MG, 1991, J ENG MECH-ASCE, V117, P2748, DOI 10.1061/(ASCE)0733-9399(1991)117:12(2748); Shing PB, 2001, P US JAP SEM POSTP B; Spacone E, 1996, EARTHQUAKE ENG STRUC, V25, P711, DOI 10.1002/(SICI)1096-9845(199607)25:7<711::AID-EQE576>3.0.CO;2-9; Spacone E, 1992, UCBEERC9207 COLL ENG; Taucer Fabio F, 1991, UCBEERC9117 COLL ENG; Tomosawa F, 1995, J STRUCT CONSTR ENG, V474, P1	68	0	0	SPRINGER	DORDRECHT	VAN GODEWIJCKSTRAAT 30, 3311 GZ DORDRECHT, NETHERLANDS	1570-761X	1573-1456		B EARTHQ ENG	Bull. Earthq. Eng.	FEB	2015	13	2					503	538		10.1007/s10518-014-9617-x		36	Engineering, Geological; Geosciences, Multidisciplinary	Engineering; Geology	CB3TU	WOS:000349552600004		
J	Mazzocca, A; Dituri, F; De Santis, F; Filannino, A; Lopane, C; Betz, RC; Li, YY; Mukaida, N; Winter, P; Tortorella, C; Giannelli, G; Sabba, C				Mazzocca, Antonio; Dituri, Francesco; De Santis, Flavia; Filannino, Addolorata; Lopane, Chiara; Betz, Regina C.; Li, Ying-Yi; Mukaida, Naofumi; Winter, Peter; Tortorella, Cosimo; Giannelli, Gianluigi; Sabba, Carlo			Lysophosphatidic Acid Receptor LPAR6 Supports the Tumorigenicity of Hepatocellular Carcinoma	CANCER RESEARCH			English	Article							TISSUE GROWTH-FACTOR; PROTEIN-COUPLED RECEPTOR; CANCER PROGRESSION; PIM-3 EXPRESSION; CELLS; ACTIVATION; INTEGRIN; HAIR	The aberrant processes driving hepatocellular carcinoma (HCC) are not fully understood. Lysophosphatidic acid receptors (LPAR) are commonly overexpressed in HCC, but their contributions to malignant development are not well established. In this report, we show that aberrant expression of LPAR6 sustains tumorigenesis and growth of HCC. Overexpression of LPAR6 in HCC specimens associated with poor survival in a cohort of 128 patients with HCC. We took a genetic approach to elucidate how LPAR6 sustains the HCC tumorigenic process, including through an expression profiling analysis to identify genes under the control of LPAR6. RNAi-mediated attenuation of LPAR6 impaired HCC tumorigenicity in tumor xenograft assays. Expression profiling and mechanistic analyses identified Pim-3 as a pathophysiologically relevant LPAR6 target gene. In nonmalignant cells where LPAR6 overexpression was sufficient to drive malignant character, Pim-3 was upregulated at the level of transcription initiation through a STAT3-dependent mechanism. A further analysis of HCC clinical specimens validated the connection between overexpression of LPAR6 and Pim-3, high proliferation rates, and poorer survival outcomes. Together, our findings establish LPAR6 as an important theranostic target in HCC tumorigenesis. (C) 2014 AACR.	[Mazzocca, Antonio; Lopane, Chiara; Tortorella, Cosimo; Sabba, Carlo] Univ Bari, Sch Med, Interdisciplinary Dept Med, I-70124 Bari, Italy; [Mazzocca, Antonio] Natl Inst Digest Dis, IRCCS S de Bellis, Bari, Italy; [Dituri, Francesco; Filannino, Addolorata] Univ Bari, Sch Med, Sect Internal Med Allergol & Clin Immunol, Dept Emergency & Organ Transplantat,Sect Internal, I-70124 Bari, Italy; [De Santis, Flavia] Inst Curie, Ctr Rech, Paris, France; [Betz, Regina C.] Univ Bonn, Inst Human Genet, Bonn, Germany; [Li, Ying-Yi] Fudan Univ, Canc Res Inst, Shanghai Canc Ctr, Shanghai 200433, Peoples R China; [Mukaida, Naofumi] Kanazawa Univ, Canc Res Inst, Div Mol Bioregulat, Kanazawa, Ishikawa 920, Japan; [Winter, Peter] GenXPro GmbH, Frankfurt, Germany; [Giannelli, Gianluigi] Univ Bari, Sch Med, Dept Biomed Sci & Human Oncol, I-70124 Bari, Italy	Mazzocca, A (reprint author), Univ Bari, Sch Med, Piazza G Cesare 11, I-70124 Bari, Italy.	a.mazzocca@intmed.uniba.it	Mukaida, Naofumi/D-7623-2011; 	Sabba', Carlo/0000-0002-9874-8740	German Research Foundation (DFG) [BE 2346/4-1]; University of Bari, Italian Ministry of Health; IRCCS "S. de Bellis," National Institute for Digestive Diseases; Italian Association of Cancer Research [11389]	R. C. Betz is a recipient of a Heisenberg Professorship of the German Research Foundation (DFG; BE 2346/4-1). This work was supported by grants from University of Bari, Italian Ministry of Health "5 per mille" - 2011 grant from IRCCS "S. de Bellis," National Institute for Digestive Diseases (A. Mazzocca), and Italian Association of Cancer Research grant N. 11389 (G. Giannelli).	Song H, 2005, P NATL ACAD SCI USA, V102, P4700, DOI 10.1073/pnas.0409894102; Urtasun R, 2011, HEPATOLOGY, V54, P2149, DOI 10.1002/hep.24587; Parkin DM, 2005, CA-CANCER J CLIN, V55, P74; Li YY, 2009, CANCER SCI, V100, P396, DOI 10.1111/j.1349-7006.2008.01059.x; VANCORVEN EJ, 1989, CELL, V59, P45, DOI 10.1016/0092-8674(89)90868-4; Mills GB, 2003, NAT REV CANCER, V3, P582, DOI 10.1038/nrc1143; Farazi PA, 2006, NAT REV CANCER, V6, P674, DOI 10.1038/nrc1934; Mazzocca A, 2010, HEPATOLOGY, V51, P523, DOI 10.1002/hep.23285; Chu CY, 2008, J BIOMED SCI, V15, P675, DOI 10.1007/s11373-008-9264-9; Zheng HC, 2008, J CANCER RES CLIN, V134, P481, DOI 10.1007/s00432-007-0310-1; Choi JW, 2010, ANNU REV PHARMACOL, V50, P157, DOI 10.1146/annurev.pharmtox.010909.105753; Siegel AB, 2009, CANCER-AM CANCER SOC, V115, P5651, DOI 10.1002/cncr.24687; Pasternack SM, 2008, NAT GENET, V40, P329, DOI 10.1038/ng.84; Shimomura Y, 2008, NAT GENET, V40, P335, DOI 10.1038/ng.100; Mazzocca A, 2008, GASTROENTEROLOGY, V135, P244, DOI 10.1053/j.gastro.2008.03.024; Mazzocca A, 2011, HEPATOLOGY, V54, P920, DOI 10.1002/hep.24485; Yang JD, 2011, SEMIN CANCER BIOL, V21, P35, DOI 10.1016/j.semcancer.2010.10.007; Zhu AX, 2011, NAT REV CLIN ONCOL, V8, P292, DOI 10.1038/nrclinonc.2011.30; Carloni V, 2001, HEPATOLOGY, V34, P42, DOI 10.1053/jhep.2001.25224; Naugler WE, 2007, SCIENCE, V317, P121, DOI 10.1126/science.1140485; Moolenaar WH, 2004, BIOESSAYS, V26, P870, DOI 10.1002/bies.20081; Giannelli G, 2006, J CLIN GASTROENTEROL, V40, P842, DOI 10.1097/01.mcg.0000225543.11503.17; Mitsunobu M, 1996, CLIN EXP METASTAS, V14, P520, DOI 10.1007/BF00115112; Mittal S, 2013, J CLIN GASTROENTEROL, V47, pS2, DOI 10.1097/MCG.0b013e3182872f29; Rabinovitz I, 1996, BIOCHEM CELL BIOL, V74, P811; Sokolov E, 2013, J SURG RES, V180, P104, DOI 10.1016/j.jss.2012.10.054; Sun WJ, 2010, CELL SIGNAL, V22, P1799, DOI 10.1016/j.cellsig.2010.05.007	27	0	0	AMER ASSOC CANCER RESEARCH	PHILADELPHIA	615 CHESTNUT ST, 17TH FLOOR, PHILADELPHIA, PA 19106-4404 USA	0008-5472	1538-7445		CANCER RES	Cancer Res.	FEB 1	2015	75	3					532	543		10.1158/0008-5472.CAN-14-1607		12	Oncology	Oncology	CB7XE	WOS:000349841200007		
J	Ryan, BM; Robles, AI; McClary, AC; Haznadar, M; Bowman, ED; Pine, SR; Brown, D; Khan, M; Shiraishi, K; Kohno, T; Okayama, H; Modali, R; Yokota, J; Harris, CC				Ryan, Brd M.; Robles, Ana I.; McClary, Andrew C.; Haznadar, Majda; Bowman, Elise D.; Pine, Sharon R.; Brown, Derek; Khan, Mohammed; Shiraishi, Kouya; Kohno, Takashi; Okayama, Hirokazu; Modali, Ramakrishna; Yokota, Jun; Harris, Curtis C.			Identification of a Functional SNP in the 3 ' UTR of CXCR2 That Is Associated with Reduced Risk of Lung Cancer	CANCER RESEARCH			English	Article							MICRORNA BINDING-SITES; GENETIC-VARIATION; ALTERS SUSCEPTIBILITY; UNTRANSLATED REGION; TARGET SITES; INTERLEUKIN-8; SENESCENCE; POLYMORPHISMS; MECHANISM; PROMOTER	Global changes in gene expression accompany the development of cancer. Thus, inherited variants in miRNA-binding sites are likely candidates for conferring inherited susceptibility. Using an in silico approach, we compiled a comprehensive list of SNPs predicted to modulate miRNA binding in genes from several key lung cancer pathways. We then investigated whether these SNPs were associated with lung cancer risk in two independent populations. In general, SNPs in miRNA-binding sites are rare. However, some allelic variation was observed. We found that rs1126579 in CXCR2 was associated with a reduced risk of lung cancer in both European American [ORTT (vs). (CC) 0.56 (0.37-0.88); P = 0.008] and Japanese [ORTT (vs.) (CC)0.62 (0.38-1.00); P = 0.049] populations. Furthermore, we found that the SNP disrupted a novel binding site for miR-516a-3p, led to a moderate increase in CXCR2 mRNA and protein expression, and increased MAPK signaling. Moreover, analysis of rs1126579 with serum levels of IL8, its endogenous ligand, supported an interaction whereby rs1126579-T and high serum IL8 conferred synergistic protection from lung cancer. Our findings demonstrate a function for a 3 ' UTR SNP in modulating CXCR2 expression, signaling, and susceptibility to lung cancer. (C) 2014 AACR.	[Ryan, Brd M.; Robles, Ana I.; McClary, Andrew C.; Haznadar, Majda; Bowman, Elise D.; Brown, Derek; Khan, Mohammed; Okayama, Hirokazu; Harris, Curtis C.] NCI, Human Carcinogenesis Lab, Ctr Canc Res, Bethesda, MD 20892 USA; [McClary, Andrew C.] Stanford Univ Hosp & Clin, Dept Pathol, Stanford, CA USA; [Pine, Sharon R.] Rutgers State Univ, Rutgers Canc Inst New Jersey, New Brunswick, NJ 08903 USA; [Shiraishi, Kouya; Kohno, Takashi; Okayama, Hirokazu; Yokota, Jun] Natl Canc Ctr, Res Inst, Div Genome Biol, Chuo Ku, Tokyo 104, Japan; [Modali, Ramakrishna] BioServe Ltd, Beltsville, MD USA	Harris, CC (reprint author), NCI, Human Carcinogenesis Lab, Bldg 37,Room 3068,37 Convent Dr,MSC 4258, Bethesda, MD 20892 USA.	Curtis_Harris@nih.gov			Intramural Program of the Centre for Cancer Research, NCI (Bethesda, MD); Ministry of Health, Labor, and Welfare of Japan; National Cancer Center Research and Development Fund [26-A-8]	This work was supported by the Intramural Program of the Centre for Cancer Research, NCI (Bethesda, MD). This work was also supported in part by Grants-in-Aid from the Ministry of Health, Labor, and Welfare of Japan for the 3rd term Comprehensive 10-year Strategy for Cancer Control, and by the National Cancer Center Research and Development Fund (26-A-8).	Campisi J, 2007, NAT REV MOL CELL BIO, V8, P729, DOI 10.1038/nrm2233; Okayama H, 2012, CANCER RES, V72, P100, DOI 10.1158/0008-5472.CAN-11-1403; Zheng YL, 2003, CARCINOGENESIS, V24, P269, DOI 10.1093/carcin/24.2.269; Chin LJ, 2008, CANCER RES, V68, P8535, DOI 10.1158/0008-5472.CAN-08-2129; Pine SR, 2011, J NATL CANCER I, V103, P1112, DOI 10.1093/jnci/djr216; Knol MJ, 2011, EUR J EPIDEMIOL, V26, P433, DOI 10.1007/s10654-011-9554-9; Bartel DP, 2004, CELL, V116, P281, DOI 10.1016/S0092-8674(04)00045-5; Acosta JC, 2008, CELL, V133, P1006, DOI 10.1016/j.cell.2008.03.038; Taguchi A, 2005, CANCER EPIDEM BIOMAR, V14, P2487, DOI 10.1158/1055-9965.EPI-05-0326; Saintigny P, 2013, CANCER RES, V73, P571, DOI 10.1158/0008-5472.CAN-12-0263; Acosta JC, 2009, CANCER RES, V69, P2167, DOI 10.1158/0008-5472.CAN-08-3772; Ryan BM, 2010, NAT REV CANCER, V10, P389, DOI 10.1038/nrc2867; Zu YK, 2013, BIOCHEM BIOPH RES CO, V430, P529, DOI 10.1016/j.bbrc.2012.12.001; Hiard S, 2010, NUCLEIC ACIDS RES, V38, pD640, DOI 10.1093/nar/gkp926; Benoy IH, 2004, CLIN CANCER RES, V10, P7157, DOI 10.1158/1078-0432.CCR-04-0812; Jamieson T, 2012, J CLIN INVEST, V122, P3127, DOI 10.1172/JCI61067; Chen K, 2006, NAT GENET, V38, P1452, DOI 10.1038/ng1910; Bao L, 2007, NUCLEIC ACIDS RES, V35, pD51, DOI 10.1093/nar/gkl797; Rajewsky N, 2006, NAT GENET, V38, pS8, DOI 10.1038/ng1798; Bamford S, 2004, BRIT J CANCER, V91, P355, DOI 10.1038/sj.bjc.6601894; Sethupathy P, 2007, AM J HUM GENET, V81, P405, DOI 10.1086/519979; Abelson JF, 2005, SCIENCE, V310, P317, DOI 10.1126/science.1116502; Kruger J, 2006, NUCLEIC ACIDS RES, V34, pW451, DOI 10.1093/nar/gkl243; Schetter AJ, 2010, CARCINOGENESIS, V31, P37, DOI 10.1093/carcin/bgp272; Pu X, 2013, CANCER RES, V73, P1867, DOI 10.1158/0008-5472.CAN-12-0873; Clop A, 2006, NAT GENET, V38, P813, DOI 10.1038/ng1810; Pasquinelli AE, 2012, NAT REV GENET, V13, P271, DOI 10.1038/nrg3162; Kohno T, 2010, CARCINOGENESIS, V31, P834, DOI 10.1093/carcin/bgq003; Xu N, 2009, CELL, V137, P647, DOI 10.1016/j.cell.2009.02.038; De Gobbi M, 2006, SCIENCE, V312, P1215, DOI 10.1126/science.1126431; Araki S, 2007, CANCER RES, V67, P6854, DOI 10.1158/0008-5472.CAN-07-1162; Seike M, 2009, P NATL ACAD SCI USA, V106, P12085, DOI 10.1073/pnas.0905234106; VanderWeele TJ, 2009, EPIDEMIOLOGY, V20, P863, DOI 10.1097/EDE.0b013e3181ba333c; Lewis BP, 2003, CELL, V115, P787, DOI 10.1016/S0092-8674(03)01018-3; Landi D, 2008, CARCINOGENESIS, V29, P579, DOI 10.1093/carcin/bgm304; Kulkarni S, 2013, P NATL ACAD SCI USA, V110, P20705, DOI 10.1073/pnas.1312237110; Lv K, 2008, BIOCHEM BIOPH RES CO, V374, P101, DOI 10.1016/j.bbrc.2008.06.102; Collado M, 2005, NATURE, V436, P642, DOI 10.1038/436642a; Xiong F, 2011, CANCER RES, V71, P5175, DOI 10.1158/0008-5472.CAN-10-4407; Collado M, 2010, NAT REV CANCER, V10, P51, DOI 10.1038/nrc2772; Saunders MA, 2007, P NATL ACAD SCI USA, V104, P3300, DOI 10.1073/pnas.0611347104; Bond GL, 2004, CELL, V119, P591, DOI 10.1016/j.cell.2004.11.022; KOCH AE, 1992, SCIENCE, V258, P1798, DOI 10.1126/science.1281554; Skrondal A, 2003, AM J EPIDEMIOL, V158, P251, DOI 10.1093/aje/kwg113; Hanin G, 2014, HUM MOL GENET, V23, P4569, DOI 10.1093/hmg/ddu170; Addison CL, 2000, J IMMUNOL, V165, P5269; Lianoglou S, 2013, GENE DEV, V27, P2380, DOI 10.1101/gad.229328.113; Muzny DM, 2012, NATURE, V487, P330, DOI 10.1038/nature11252; Richardson K, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017944; Thomas LF, 2014, BIOINFORMATICS, V30, P2243, DOI 10.1093/bioinformatics/btu257	50	0	0	AMER ASSOC CANCER RESEARCH	PHILADELPHIA	615 CHESTNUT ST, 17TH FLOOR, PHILADELPHIA, PA 19106-4404 USA	0008-5472	1538-7445		CANCER RES	Cancer Res.	FEB 1	2015	75	3					566	575		10.1158/0008-5472.CAN-14-2101		10	Oncology	Oncology	CB7XE	WOS:000349841200010		
J	Yoshida, H; Igarashi, N; Fujita, S; Panpranot, J; Arai, M				Yoshida, Hiroshi; Igarashi, Naoya; Fujita, Shin-ichiro; Panpranot, Joongjai; Arai, Masahiko			Influence of Crystallite Size of TiO2 Supports on the Activity of Dispersed Pt Catalysts in Liquid-Phase Selective Hydrogenation of 3-Nitrostyrene, Nitrobenzene, and Styrene	CATALYSIS LETTERS			English	Article						Titania; Crystallite size; Nanocrystal; Platinum; Hydrogenation	PHOTOCATALYTIC ACTIVITY; THERMAL-DECOMPOSITION; NANOCRYSTALLINE TIO2; NITRO-COMPOUNDS; GOLD CATALYSTS; CO; PRESSURE; TOLUENE; OXIDE; FTIR	Supported Pt catalysts were prepared using several kinds of TiO2 supports different in the crystallite size in the range of 10-500 nm and their catalytic activity was tested for the liquid-phase hydrogenation of 3-nitrostyrene, nitrobenzene, and styrene. With Pt on smaller TiO2 crystallites (nanocrystals), the selectivity to vinylaniline was improved in the hydrogenation of 3-nitrostyrene (regioselective hydrogenation) and the selectivity to aniline was promoted in the hydrogenation of a mixture of nitrobenzene and styrene (chemoselective hydrogenation). The effects of TiO2 crystallite size were discussed on the basis of the results of turnover frequency and FTIR of CO adsorbed on dispersed Pt particles. Low coordinated and/or electron-rich Pt sites should be formed on the surface of nanocrystal TiO2 supports. Nanocrystal TiO2 support is an important factor for controlling and improving the catalytic performance of dispersed Pt particles. Smaller TiO2 crystallites give rougher Pt crystal planes on the surface of Pt particles, beneficial for the hydrogenation of nitro group than vinyl group.	[Yoshida, Hiroshi; Igarashi, Naoya; Fujita, Shin-ichiro; Arai, Masahiko] Hokkaido Univ, Div Chem Proc Engn, Fac Engn, Sapporo, Hokkaido 0608628, Japan; [Panpranot, Joongjai] Chulalongkorn Univ, Dept Chem Engn, Ctr Excellence Catalysis & Catalyt React Engn, Bangkok 10330, Thailand	Arai, M (reprint author), Hokkaido Univ, Div Chem Proc Engn, Fac Engn, Sapporo, Hokkaido 0608628, Japan.	marai@eng.hokudai.ac.jp			JSPS-NRCT	This work was supported by JSPS-NRCT bilateral program for joint research project.	Wang C, 2002, POWDER TECHNOL, V125, P39, DOI 10.1016/S0032-5910(01)00523-X; GREENLER RG, 1985, SURF SCI, V152, P338, DOI 10.1016/0039-6028(85)90163-3; Yoshida H, 2012, PHYS CHEM CHEM PHYS, V14, P4724, DOI 10.1039/c2cp23590k; Su C, 2004, CATAL TODAY, V96, P119, DOI 10.1016/j.cattod.2004.06.132; Panpranot J, 2006, J PHYS CHEM B, V110, P8019, DOI 10.1021/jp057395z; Corma A, 2007, ANGEW CHEM INT EDIT, V46, P7266, DOI 10.1002/anie.200700823; Boccuzzi F, 1996, SURF SCI, V368, P264, DOI 10.1016/S0039-6028(96)01060-6; Weerachawanasak P, 2008, J MOL CATAL A-CHEM, V279, P133, DOI 10.1016/j.molcata.2007.10.006; Jung KY, 1999, J PHOTOCH PHOTOBIO A, V127, P117, DOI 10.1016/S1010-6030(99)00132-X; Weerachawanasak P, 2009, J CATAL, V262, P199, DOI 10.1016/j.jcat.2008.12.011; Alam MJ, 2002, J SOL-GEL SCI TECHN, V25, P137, DOI 10.1023/A:1019912312654; Corma A, 2006, SCIENCE, V313, P332, DOI 10.1126/science.1128383; Kominami H, 1997, CATAL LETT, V46, P235, DOI 10.1023/A:1019022719479; Bessekhouad Y, 2003, J PHOTOCH PHOTOBIO A, V157, P47, DOI 10.1016/S1010-6030(03)00077-7; Rasko J, 2003, J CATAL, V217, P478, DOI 10.1016/S0021-9517(03)00147-7; Boudart M, 1984, KINETICS HETEROGENEO, P26; BRANDT RK, 1993, SURF SCI, V286, P15, DOI 10.1016/0039-6028(93)90552-U; Ertl G., 1997, HDB HETEROGENEOUS CA; Hadjiivanov KI, 1998, J CHEM SOC FARADAY T, V94, P1901, DOI 10.1039/a801892h; Kang M, 2002, J MOL CATAL A-CHEM, V180, P125, DOI 10.1016/S1381-1169(01)00417-4; Karen A, 2012, GREEN CHEM, V14, P260; Keppers MJ, 1991, CATAL LETT, V10, P365; Kim CS, 2003, J CRYST GROWTH, V254, P405, DOI 10.1016/S0022-0248(03)01185-0; Nam HD, 1998, JPN J APPL PHYS 1, V37, P4603, DOI 10.1143/JJAP.37.4603; Payakgul W, 2005, CERAM INT, V31, P391, DOI 10.1016/j.ceramint.2004.05.025; Yoshida H, 2011, J PHYS CHEM C, V115, P2257, DOI 10.1021/jp1105339	26	0	0	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	1011-372X	1572-879X		CATAL LETT	Catal. Lett.	FEB	2015	145	2					606	611		10.1007/s10562-014-1404-4		6	Chemistry, Physical	Chemistry	CB3TY	WOS:000349553000015		
J	Saouma, VE; Martin, RA; Hariri-Ardebili, MA; Katayama, T				Saouma, Victor E.; Martin, Ruth A.; Hariri-Ardebili, Mohammad A.; Katayama, Tetsuya			A mathematical model for the kinetics of the alkali-silica chemical reaction	CEMENT AND CONCRETE RESEARCH			English	Article						Petrography; Long-Term Performance; Reaction rate	AGGREGATE REACTIONS; CONCRETE	Starting from the chain of three chemical reactions which characterize the alkali-silica reaction (ASR), this paper attempts to develop a mathematical framework through which the reaction kinetics can be better understood. A petrographic support is given to better understand the physical implications of these equations, and to provide a reasonable support for the choice of the reaction rates. First an analytical solution is sought. Though one was not found, three new conservation laws were derived. Then a numerical solution is applied, and important observations are made. First, and foremost, the role of water is confirmed, and then the outcome of the reaction when different concentrations of alkali and silica are used is derived. Finally, the temporal evolution of the expansive gel formation is contrasted with both macro-kinetics model, and diffusion based meta-model for the concrete expansions are compared. (C) 2014 Elsevier Ltd. All rights reserved.	[Saouma, Victor E.; Hariri-Ardebili, Mohammad A.] Univ Colorado, Dept Civil Engn, Boulder, CO 80309 USA; [Martin, Ruth A.] Univ Colorado, Dept Appl Math, Boulder, CO 80309 USA; [Katayama, Tetsuya] Taiheiyo Consultant Co Ltd, Dept Instrumental Anal, Sakura, Chiba, Japan	Saouma, VE (reprint author), Univ Colorado, Dept Civil Engn, Boulder, CO 80309 USA.	saouma@colorado.edu			NSF [DMS-1107354]	The first author would like to thank his colleague Prof. Xi who introduced him to this fascinating field of research. The second author acknowledges the financial support of NSF grant, DMS-1107354.	Comi C, 2012, INT J SOLIDS STRUCT, V49, P3367, DOI 10.1016/j.ijsolstr.2012.07.015; [Anonymous], 2013, MATLAB VERS 8 2 R201; Ichikawa T, 2007, CEMENT CONCRETE RES, V37, P1291, DOI 10.1016/j.cemconres.2007.06.008; Chatterji S, 2005, CEMENT CONCRETE COMP, V27, P788, DOI 10.1016/j.cemconcomp.2005.03.005; Dunant CF, 2010, CEMENT CONCRETE RES, V40, P517, DOI 10.1016/j.cemconres.2009.07.024; Bazant ZP, 2000, CEMENT CONCRETE RES, V30, P419, DOI 10.1016/S0008-8846(99)00270-7; Berube MA, 2002, CEMENT CONCRETE RES, V32, P1215, DOI 10.1016/S0008-8846(02)00766-4; Capra B, 1998, CEMENT CONCRETE RES, V28, P251, DOI 10.1016/S0008-8846(97)00261-5; Charpin L, 2012, CEMENT CONCRETE RES, V42, P613, DOI 10.1016/j.cemconres.2012.01.004; Constantiner D, 2003, CEMENT CONCRETE RES, V33, P549, DOI 10.1016/S0008-8846(02)01001-3; DRON R, 1992, CEMENT CONCRETE RES, V22, P941, DOI 10.1016/0008-8846(92)90118-F; Espenson J. H., 2002, CHEM KINETICS REACTI; Furusawa Y., 1994, P 3 INT C DUR CONCR, P757; Glasser D., 1981, CEMENT CONCRETE RES, V11, P1; Gloria A.B., 2013, THESIS SWISS FEDERAL; Haha M.B., 2006, THESIS ECOLE POLYTEC; Hairer E., 1993, SOLVING ORDINARY DIF; Katayama T., 2012, P 14 INT C ALK AGGR; Katayama T., 2008, P 13 INT C ALK AGGR, P174; Katayama T, 2010, P 6 CONSEC MER YUC M, P19; Larive C., 1998, THESIS LAB CENTRAL P; Lemarchand E., 2001, INT C CREEP SHRINK D; Multon S, 2006, CEMENT CONCRETE RES, V36, P912, DOI [10.1016/j.cemconres.2005.11.012, 10.1016/j.cenconres.2005.11.012]; Powers T.C., 1955, J AM CONCRETE I, V26, P497; Puatatsananon W., 2013, ACI MATER J, V110, P67; Saouma V, 2006, ACI MATER J, V103, P194; Suwito A., 2002, CONCRETE SCI ENG RIL, V4, P23	27	1	1	PERGAMON-ELSEVIER SCIENCE LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND	0008-8846	1873-3948		CEMENT CONCRETE RES	Cem. Concr. Res.	FEB	2015	68						184	195		10.1016/j.cemconres.2014.10.021		12	Construction & Building Technology; Materials Science, Multidisciplinary	Construction & Building Technology; Materials Science	CB4BE	WOS:000349572400018		
J	Hirakawa, K; Umemoto, H; Kikuchi, R; Yamaguchi, H; Nishimura, Y; Arai, T; Okazaki, S; Segawa, H				Hirakawa, Kazutaka; Umemoto, Hironobu; Kikuchi, Ryo; Yamaguchi, Hiroki; Nishimura, Yoshinobu; Arai, Tatsuo; Okazaki, Shigetoshi; Segawa, Hiroshi			Determination of Singlet Oxygen and Electron Transfer Mediated Mechanisms of Photosensitized Protein Damage by Phosphorus(V)porphyrins	CHEMICAL RESEARCH IN TOXICOLOGY			English	Article							PHOTODYNAMIC THERAPY; DNA; DERIVATIVES; GENERATION; OXIDATION; TETRAPHENYLPORPHYRIN; TRYPTOPHAN; EXCITATION; CHEMISTRY; SOLVENT	The mechanism of photosensitized protein damage by phosphorus(V) tetraphenylporphyrin derivatives (P(V)TPPs) was quantitatively clarified. P(V)TPPs bound to human serum albumin (HSA), a water-soluble protein, and damaged its tryptophan residue during photoirradiation. P(V)TPPs photosensitized singlet oxygen (O-1(2)) generation, and the contribution of 1O2 to HSA damage was confirmed by the inhibitory effect of sodium azide, a O-1(2) quencher. However, sodium azide could not completely inhibit HSA damage, suggesting the contribution of an electron transfer mechanism to HSA damage. The decrement in the fluorescence lifetime of P(V)TPPs by HSA supported the electron transfer mechanism. The contribution of these processes could be determined by the kinetic analysis of the effect of sodium azide on the photosensitized protein damage by P(V)TPPs.	[Hirakawa, Kazutaka; Umemoto, Hironobu; Kikuchi, Ryo; Yamaguchi, Hiroki] Shizuoka Univ, Grad Sch Engn, Dept Appl Chem & Biochem Engn, Naka Ku, Hamamatsu, Shizuoka 4328561, Japan; [Nishimura, Yoshinobu; Arai, Tatsuo] Univ Tsukuba, Dept Chem, Tsukuba, Ibaraki 3058571, Japan; [Okazaki, Shigetoshi] Hamamatsu Univ Sch Med, Med Photon Res Ctr, Higashi Ku, Hamamatsu, Shizuoka 4313192, Japan; [Segawa, Hiroshi] Univ Tokyo, Adv Sci & Technol Res Ctr, Meguro Ku, Tokyo 1538904, Japan	Hirakawa, K (reprint author), Shizuoka Univ, Grad Sch Engn, Dept Appl Chem & Biochem Engn, Naka Ku, Johoku 3-5-1, Hamamatsu, Shizuoka 4328561, Japan.	hirakawa.kazutaka@shizuoka.ac.jp			JSPS KAKENHI Grant [23750186]	This research was funded by JSPS KAKENHI Grant Number 23750186.	Li MY, 2001, PHOTOCHEM PHOTOBIOL, V74, P760, DOI 10.1562/0031-8655(2001)074<0760:QOSMOO>2.0.CO;2; Hirakawa K, 2012, J PHYS CHEM B, V116, P3037, DOI 10.1021/jp300142e; Shiragami T, 2005, J PHOTOCH PHOTOBIO C, V6, P227, DOI 10.1016/j.jphotochemrev.2005.12.001; Schweitzer C, 2003, CHEM REV, V103, P1685, DOI 10.1021/cr010371d; Wilson BC, 2008, PHYS MED BIOL, V53, pR61, DOI 10.1088/0031-9155/53/9/R01; HE XM, 1992, NATURE, V358, P209, DOI 10.1038/358209a0; Hirakawa K, 1999, J PHOTOCH PHOTOBIO A, V123, P67, DOI 10.1016/S1010-6030(99)00043-X; Hirakawa K, 2013, J PHYS CHEM B, V117, P13490, DOI 10.1021/jp4072444; Castano AP, 2006, NAT REV CANCER, V6, P535, DOI 10.1038/nrc1894; OGILBY PR, 1983, J AM CHEM SOC, V105, P3423, DOI 10.1021/ja00349a007; Ehrenshaft M, 2009, FREE RADICAL BIO MED, V46, P1260, DOI 10.1016/j.freeradbiomed.2009.01.020; Dolmans DEJGJ, 2003, NAT REV CANCER, V3, P380, DOI 10.1038/nrc1071; USUI Y, 1974, PHOTOCHEM PHOTOBIOL, V19, P245, DOI 10.1111/j.1751-1097.1974.tb06506.x; Collins HA, 2008, NAT PHOTONICS, V2, P420, DOI 10.1038/nphoton.2008.100; Thomas AH, 2013, FREE RADICAL BIO MED, V63, P467, DOI 10.1016/j.freeradbiomed.2013.05.044; Bratasz A, 2007, BIOPHYS J, V92, P2918, DOI 10.1529/biophysj.106.099135; DEMAS JN, 1971, J PHYS CHEM-US, V75, P991; FOOTE CS, 1991, PHOTOCHEM PHOTOBIOL, V54, P659, DOI 10.1111/j.1751-1097.1991.tb02071.x; Hirakawa K, 2006, J PHOTOCH PHOTOBIO B, V82, P37, DOI 10.1016/j.photobiol.2005.08.008; Hirakawa K, 2010, PHOTOCH PHOTOBIO SCI, V9, P704, DOI 10.1039/b9pp00204a; Hirakawa K, 2007, J PHOTOCH PHOTOBIO B, V87, P209, DOI 10.1016/j.jphotobiol.2007.04.001; Hirakawa K., 2008, NEW RES DNA DAMAGE, P197; Hirakawa K, 2013, BIOORG MED CHEM LETT, V23, P2704, DOI 10.1016/j.bmcl.2013.02.081; Matsumoto J, 2011, J PHOTOCH PHOTOBIO A, V218, P178, DOI 10.1016/j.jphotochem.2011.01.002; Nan CG, 2002, ANAL CHIM ACTA, V452, P245, DOI 10.1016/S0003-2670(01)01470-2; SEGAWA H, 1992, J CHEM SOC PERK T 1, P939, DOI 10.1039/p19920000939; SUSUMU K, 1995, J PHYS CHEM-US, V99, P29, DOI 10.1021/j100001a006; SUSUMU K, 1995, CHEM LETT, P929, DOI 10.1246/cl.1995.929; Susumu K, 1995, J PHOTOCH PHOTOBIO A, V92, P39, DOI 10.1016/1010-6030(95)04169-4; Yasuda M, 2009, J PHOTOCH PHOTOBIO A, V205, P210, DOI 10.1016/j.jphotochem.2009.05.007	30	2	2	AMER CHEMICAL SOC	WASHINGTON	1155 16TH ST, NW, WASHINGTON, DC 20036 USA	0893-228X	1520-5010		CHEM RES TOXICOL	Chem. Res. Toxicol.	FEB	2015	28	2					262	267		10.1021/tx500492w		6	Chemistry, Medicinal; Chemistry, Multidisciplinary; Toxicology	Pharmacology & Pharmacy; Chemistry; Toxicology	CB5GS	WOS:000349656100013		
J	Shimada, T; Takenaka, S; Murayama, N; Yamazaki, H; Kim, JH; Kim, D; Yoshimoto, FK; Guengerich, FP; Komori, M				Shimada, Tsutomu; Takenaka, Shigeo; Murayama, Norie; Yamazaki, Hiroshi; Kim, Joo-Hwan; Kim, Donghak; Yoshimoto, Francis K.; Guengerich, F. Peter; Komori, Masayuki			Oxidation of Acenaphthene and Acenaphthylene by Human Cytochrome P450 Enzymes	CHEMICAL RESEARCH IN TOXICOLOGY			English	Article							POLYCYCLIC AROMATIC-HYDROCARBONS; METABOLIC-ACTIVATION; 2A ENZYMES; SUBSTRATE-SPECIFICITY; RESPIRATORY-TRACT; HUMAN-MILK; P450 2A13; INHIBITION; CYP2A13; 4-(METHYLNITROSAMINO)-1-(3-PYRIDYL)-1-BUTANONE	Acenaphthene and acenaphthylene, two known environmental polycyclic aromatic hydrocarbon (PAH) pollutants, were incubated at 50 mu M concentrations in a standard reaction mixture with human P450s 2A6, 2A13, 1B1, 1A2, 2C9, and 3A4, and the oxidation products were determined using HPLC and LC-MS. HPLC analysis showed that P450 2A6 converted acenaphthene and acenaphthylene to several mono- and dioxygenated products. LC-MS analysis of acenaphthene oxidation by P450s indicated the formation of 1-acenaphthenol as a major product, with turnover rates of 6.7, 4.5, and 3.6 nmol product formed/min/nmol P450 for P450 2A6, 2A13, and 1B1, respectively. Acenaphthylene oxidation by P450 2A6 showed the formation of 1,2-epoxyacenaphthene as a major product (4.4 nmol epoxide formed/min/nmol P450) and also several mono- and dioxygenated products. P450 2A13, 1B1, 1A2, 2C9, and 3A4 formed 1,2-epoxyacenaphthene at rates of 0.18, 5.3 2.4, 0.16, and 3.8 nmol/min/nmol P450, respectively. 1-Acenaphthenol, which induced Type I binding spectra with P450 2A13, was further oxidized by P450 2A13 but not P450 2A6. 1,2-Epoxyacenaphthene induced Type I binding spectra with P450 2A6 and 2A13 (Ks 1.8 and 0.16 mu M, respectively) and was also oxidized to several oxidation products by these P450s. Molecular docking analysis suggested different orientations of acenaphthene, acenaphthylene, 1-acenaphthenol, and 1,2-epoxyacenaphthene in their interactions with P450 2A6 and 2A13. Neither of these four PAHs induced umu gene expression in a Salmonella typhimurium NM tester strain. These results suggest, for the first time, that acenaphthene and acenaphthylene are oxidized by human P450s 2A6 and 2A13 and other P450s to form several mono- and dioxygenated products. The results are of use in considering the biological and toxicological significance of these environmental PAHs in humans.	[Shimada, Tsutomu; Takenaka, Shigeo; Komori, Masayuki] Osaka Prefecture Univ, Grad Sch Life & Environm Sci, Cellular & Mol Biol Lab, Izumisano, Osaka 5988531, Japan; [Murayama, Norie; Yamazaki, Hiroshi] Showa Pharmaceut Univ, Lab Drug Metab & Pharmacokinet, Machida, Tokyo 1948543, Japan; [Kim, Joo-Hwan; Kim, Donghak] Konkuk Univ, Dept Biol Sci, Seoul 143701, South Korea; [Yoshimoto, Francis K.; Guengerich, F. Peter] Vanderbilt Univ, Dept Biochem, Sch Med, Nashville, TN 37232 USA; [Yoshimoto, Francis K.; Guengerich, F. Peter] Vanderbilt Univ, Ctr Mol Toxicol, Sch Med, Nashville, TN 37232 USA	Shimada, T (reprint author), Osaka Prefecture Univ, Grad Sch Life & Environm Sci, Cellular & Mol Biol Lab, 1-58 Rinku Orai Kita, Izumisano, Osaka 5988531, Japan.	t.shimada@vet.osakafu-u.ac.jp; takenaka@vet.osakafu-u.ac.jp; hyamazak@ac.shoyaku.ac.jp; fguengerich@vanderbilt.edu	Yamazaki, Hiroshi/A-6081-2011	Yamazaki, Hiroshi/0000-0002-1068-4261	Ministry of Education, Science, and Culture of Japan; Ministry of Health and Welfare of Japan; NIH [R37 CA090426]	This work was supported in part by Grants from the Ministry of Education, Science, and Culture of Japan, the Ministry of Health and Welfare of Japan (to T.S, S.T., N.M., H.Y., and M.K.), and NIH grant R37 CA090426 (to F.P.G.).	Wong HL, 2005, CHEM RES TOXICOL, V18, P61, DOI 10.1021/tx0497696; Li QS, 2001, APPL ENVIRON MICROB, V67, P5735, DOI 10.1128/AEM.67.12.5735-5739.2001; Kim D, 2005, J BIOL CHEM, V280, P40319, DOI 10.1074/jbc.M508171200; Fukami T, 2008, CHEM RES TOXICOL, V21, P720, DOI 10.1021/tx700325f; Shimada T, 2013, CHEM RES TOXICOL, V26, P517, DOI 10.1021/tx300492j; Del Bubba M, 2005, ANN CHIM-ROME, V95, P629, DOI 10.1002/adic.200590074; Yan J, 2004, MUTAT RES-GEN TOX EN, V557, P99, DOI 10.1016/j.mrgentox.2003.10.004; Su T, 2000, CANCER RES, V60, P5074; Martorell I, 2012, FOOD CHEM TOXICOL, V50, P4103, DOI 10.1016/j.fct.2012.08.011; Yu YX, 2011, ENVIRON SCI TECHNOL, V45, P10235, DOI 10.1021/es202827g; Smith BD, 2007, J BIOL CHEM, V282, P17306, DOI 10.1074/jbc.M702361200; Yano JK, 2006, J MED CHEM, V49, P6987, DOI 10.1021/jm060519r; Kaur S, 2013, ARCH ENVIRON CON TOX, V65, P382, DOI 10.1007/s00244-013-9912-6; Yamazaki H, 1997, ARCH BIOCHEM BIOPHYS, V342, P329, DOI 10.1006/abbi.1997.0125; Shimada T, 2010, CHEM RES TOXICOL, V23, P1921, DOI 10.1021/tx100286d; Yamazaki H, 2002, PROTEIN EXPRES PURIF, V24, P329, DOI 10.1006/prep.2001.1578; Wu ZL, 2005, J BIOL CHEM, V280, P41090, DOI 10.1074/jbc.M508182200; GATEHOUSE D, 1980, MUTAT RES, V78, P121, DOI 10.1016/0165-1218(80)90091-9; Shimada T, 2013, CHEM RES TOXICOL, V26, P529, DOI 10.1021/tx3004906; BABICH H, 1988, CELL BIOL TOXICOL, V4, P295, DOI 10.1007/BF00058738; Blake LC, 2013, PHARM RES-DORDR, V30, P2290, DOI 10.1007/s11095-013-1054-z; Chiang HC, 2011, TOXICOL APPL PHARM, V253, P145, DOI 10.1016/j.taap.2011.03.022; Chiang HC, 2012, RESPIRATION, V84, P319, DOI 10.1159/000339591; DeVore NM, 2012, J BIOL CHEM, V287, P26576, DOI 10.1074/jbc.M112.372813; DeVore NM, 2008, DRUG METAB DISPOS, V36, P2582, DOI 10.1124/dmd.108.023770; DeVore NM, 2009, DRUG METAB DISPOS, V37, P1319, DOI 10.1124/dmd.109.026765; Fieser L.F., 1961, ADV ORGANIC CHEM; IMUTA M, 1979, J ORG CHEM, V44, P1351, DOI 10.1021/jo01322a038; International Agency for Research on Cancer, 1973, IARC EV CARC RISK CH, V3; KADEN DA, 1979, CANCER RES, V39, P4152; MATTOX CF, 1980, IN SITU, V4, P129; Neurath G. B., 1972, CHEM TOBACCO TOBACCO, P77; Nguyen T, 2013, J ENVIRON SCI HEAL B, V48, P1097, DOI 10.1080/03601234.2013.824300; POTHULURI JV, 1992, APPL ENVIRON MICROB, V58, P3654; Sansen S, 2007, ARCH BIOCHEM BIOPHYS, V464, P197, DOI 10.1016/j.abb.2007.04.028; SCHOCKEN MJ, 1984, APPL ENVIRON MICROB, V48, P10; Shimada T, 2011, CHEM RES TOXICOL, V24, P1327, DOI 10.1021/tx200218u; Stephens ES, 2012, DRUG METAB DISPOS, V40, P1797, DOI 10.1124/dmd.112.045161; Wong HL, 2005, CHEM RES TOXICOL, V18, P913, DOI 10.1021/tx0500777; YUN CH, 1991, MOL PHARMACOL, V40, P679; Zhu LR, 2006, DRUG METAB DISPOS, V34, P1672, DOI 10.1124/dmd.106.011049	41	1	1	AMER CHEMICAL SOC	WASHINGTON	1155 16TH ST, NW, WASHINGTON, DC 20036 USA	0893-228X	1520-5010		CHEM RES TOXICOL	Chem. Res. Toxicol.	FEB	2015	28	2					268	278		10.1021/tx500505y		11	Chemistry, Medicinal; Chemistry, Multidisciplinary; Toxicology	Pharmacology & Pharmacy; Chemistry; Toxicology	CB5GS	WOS:000349656100014		
J	Nakajima, K				Nakajima, Kei			High serum amylase levels may reflect a wide spectrum of health benefits	CLINICAL CHEMISTRY AND LABORATORY MEDICINE			English	Letter						amylase; fitness; metabolic	METABOLIC SYNDROME; SALIVARY AMYLASE; ADULTS; ASSOCIATIONS		Josai Univ, Fac Pharmaceut Sci, Dept Med Dietet, Div Clin Nutr, Sakado, Saitama 3500295, Japan	Nakajima, K (reprint author), Josai Univ, Fac Pharmaceut Sci, Dept Med Dietet, Div Clin Nutr, 1-1 Keyakidai, Sakado, Saitama 3500295, Japan.	keinaka@josai.ac.jp					Mandel AL, 2012, J NUTR, V142, P853, DOI 10.3945/jn.111.156984; Zhao Y, 2014, SCAND J CLIN LAB INV, V74, P235, DOI 10.3109/00365513.2013.878469; Nater UM, 2006, PSYCHONEUROENDOCRINO, V31, P49, DOI 10.1016/j.psyneuen.2005.05.010; Koibuchi E, 2014, EXP THER MED, V7, P773, DOI 10.3892/etm.2014.1497; Falchi M, 2014, NAT GENET, V46, P492, DOI 10.1038/ng.2939; Lee JG, 2011, CLIN CHIM ACTA, V412, P1848, DOI 10.1016/j.cca.2011.06.023; Lippi G, 2015, CLIN CHEM LAB MED, V53, P469, DOI 10.1515/cclm-2014-0850; Muneyuki T, 2012, CARDIOVASC DIABETOL, V11, DOI 10.1186/1475-2840-11-80; Nakajima K, 2011, CARDIOVASC DIABETOL, V10, DOI 10.1186/1475-2840-10-34; Skrha J, 1987, Acta Univ Carol Med Monogr, V120, P1	10	0	0	WALTER DE GRUYTER GMBH	BERLIN	GENTHINER STRASSE 13, D-10785 BERLIN, GERMANY	1434-6621	1437-4331		CLIN CHEM LAB MED	Clin. Chem. Lab. Med.	FEB	2015	53	3					E67	E68		10.1515/cclm-2014-1120		2	Medical Laboratory Technology	Medical Laboratory Technology	CB3VY	WOS:000349558500004		
J	Nakahigashi, M; Yamamoto, T				Nakahigashi, Maki; Yamamoto, Takayuki			Anti-inflammatory effects of enteral nutrition on mesentery fat in patients with Crohn's disease	CLINICAL NUTRITION			English	Letter									[Nakahigashi, Maki; Yamamoto, Takayuki] Yokkaichi Hazu Med Ctr, Ctr Inflammatory Bowel Dis, Yokaichi, Mie 5100016, Japan; [Nakahigashi, Maki] Suzuka Univ Med Sci, Fac Hlth Sci, Suzuka, Japan	Yamamoto, T (reprint author), Yokkaichi Hazu Med Ctr, Ctr Inflammatory Bowel Dis, 10-8 Hazuyamacho, Yokaichi, Mie 5100016, Japan.	nao-taka@sannet.ne.jp					Yamamoto T, 2009, ALIMENT PHARM THER, V30, P99, DOI 10.1111/j.1365-2036.2009.04035.x; Feng Y, 2014, CLIN NUTR, V33, P850, DOI 10.1016/j.clnu.2013.10.009; Keller C, 1995, J Nurs Meas, V3, P159	3	0	0	CHURCHILL LIVINGSTONE	EDINBURGH	JOURNAL PRODUCTION DEPT, ROBERT STEVENSON HOUSE, 1-3 BAXTERS PLACE, LEITH WALK, EDINBURGH EH1 3AF, MIDLOTHIAN, SCOTLAND	0261-5614	1532-1983		CLIN NUTR	Clin. Nutr.	FEB	2015	34	1					165	165		10.1016/j.clnu.2014.11.015		1	Nutrition & Dietetics	Nutrition & Dietetics	CB4BZ	WOS:000349574500027		
J	Hiyoshi-Taniguchi, K; Kawasaki, M; Yokota, T; Bakardjian, H; Fukuyama, H; Cichocki, A; Vialatte, FB				Hiyoshi-Taniguchi, K.; Kawasaki, M.; Yokota, T.; Bakardjian, H.; Fukuyama, H.; Cichocki, A.; Vialatte, F. B.			EEG Correlates of Voice and Face Emotional Judgments in the Human Brain	COGNITIVE COMPUTATION			English	Article						Emotion; Multimodal; EEG	FACIAL EXPRESSIONS; PREFRONTAL CORTEX; FMRI; MODULATION; EXPERIENCE; COGNITION; CHILDREN; STIMULI; FEAR	The purpose of this study is to clarify the neural correlates of human emotional judgment. This study aimed to induce a controlled perturbation in the emotional system of the brain by multimodal stimuli, and to investigate whether such emotional stimuli could induce reproducible and consistent changes in electroencephalography (EEG) signals. We exposed 12 subjects to auditory, visual, or combined audio-visual stimuli. Audio stimuli consisted of voice recordings of the Japanese word "arigato" (thank you) pronounced with three different intonations (angry-A, happy-H or neutral-N). Visual stimuli consisted of faces of women expressing the same emotional valences (A, H or N). Audio-visual stimuli were composed using either congruent combinations of faces and voices (e.g., H x H) or noncongruent combinations (e.g., A x H). The data were collected using an EEG system, and analysis was performed by computing the topographic distributions of EEG signals in the theta, alpha, and beta frequency ranges. We compared the conditions stimuli (A, H or N), and congruent versus noncongruent. Topographic maps of EEG power differed between those conditions. The obtained results demonstrate that EEG could be used as a tool to investigate emotional valence and discriminate various emotions.	[Hiyoshi-Taniguchi, K.; Yokota, T.; Bakardjian, H.; Cichocki, A.; Vialatte, F. B.] RIKEN Brain Sci Inst, Lab Adv Brain Signal Proc, Wako, Saitama, Japan; [Hiyoshi-Taniguchi, K.; Fukuyama, H.] Kyoto Univ, Grad Sch Med, Human Brain Res Ctr, Kyoto, Japan; [Kawasaki, M.] RIKEN, RIKEN BSI TOYOTA Collaborat Ctr, Wako, Saitama, Japan; [Bakardjian, H.] Grp Hosp Pitie Salpetriere, IM2A, F-75634 Paris, France; [Vialatte, F. B.] ESPCI ParisTech, Lab SIGMA, Paris, France	Vialatte, FB (reprint author), RIKEN Brain Sci Inst, Lab Adv Brain Signal Proc, Wako, Saitama, Japan.	francois.vialatte@espci.fr		Vialatte, Francois/0000-0002-9162-4278			Aftanas LI, 1998, INT J PSYCHOPHYSIOL, V28, P63, DOI 10.1016/S0167-8760(97)00067-6; Chakrabarti B, 2006, SOC NEUROSCI-UK, V1, P364, DOI 10.1080/17470910601041317; Evans JSBT, 2008, ANNU REV PSYCHOL, V59, P255, DOI 10.1146/annurev.psych.59.103006.093629; Van den Stock J, 2008, BRAIN RES, V1242, P185, DOI 10.1016/j.brainres.2008.05.040; Doronbekov TK, 2005, PSYCHIAT CLIN NEUROS, V59, P155, DOI 10.1111/j.1440-1819.2005.01351.x; Ochsner KN, 2002, J COGNITIVE NEUROSCI, V14, P1215, DOI 10.1162/089892902760807212; Biehl M, 1997, J NONVERBAL BEHAV, V21, P3, DOI 10.1023/A:1024902500935; Jack RE, 2012, P NATL ACAD SCI USA, V109, P7241, DOI 10.1073/pnas.1200155109; Nakamura K, 1999, J NEUROPHYSIOL, V82, P1610; Van Damme S, 2009, EXP BRAIN RES, V193, P197, DOI 10.1007/s00221-008-1608-1; Kootstra G, 2011, COGN COMPUT, V3, P223, DOI 10.1007/s12559-010-9089-5; WATSON D, 1988, J PERS SOC PSYCHOL, V54, P1063, DOI 10.1037/0022-3514.54.6.1063; Grimm S, 2006, NEUROIMAGE, V30, P325, DOI 10.1016/j.neuroimage.2005.09.006; Gepperth ART, 2011, COGN COMPUT, V3, P146, DOI 10.1007/s12559-010-9092-x; Keightley ML, 2003, NEUROPSYCHOLOGIA, V41, P585, DOI 10.1016/S0028-3932(02)00199-9; MCGURK H, 1976, NATURE, V264, P746, DOI 10.1038/264746a0; Grimm S, 2008, BIOL PSYCHIAT, V63, P369, DOI 10.1016/j.biopsych.2007.05.033; Duncan S, 2007, COGNITION EMOTION, V21, P1184, DOI 10.1080/02699930701437931; Lange K, 2003, BIOL PSYCHIAT, V53, P226, DOI 10.1016/S0006-3223(02)01455-5; Tsuchiya N, 2007, TRENDS COGN SCI, V11, P158, DOI 10.1016/j.tics.2007.01.005; STRACK F, 1988, J PERS SOC PSYCHOL, V54, P768, DOI 10.1037//0022-3514.54.5.768; Northoff G, 2004, HUM BRAIN MAPP, V21, P202, DOI 10.1002/hbm.20002; Barrett LF, 2007, ANNU REV PSYCHOL, V58, P373, DOI 10.1146/annurev.psych.58.110405.085709; Grandjean D, 2008, EMOTION, V8, P341, DOI 10.1037/1528-3542.8.3.341; SCHACHTER S, 1962, PSYCHOL REV, V69, P379, DOI 10.1037/h0046234; Giuliani NR, 2008, EMOTION, V8, P714, DOI 10.1037/a0013236; LeDoux JE, 2000, ANNU REV NEUROSCI, V23, P155, DOI 10.1146/annurev.neuro.23.1.155; Conrad NJ, 2007, J INTELL DISABIL RES, V51, P988, DOI 10.1111/j.1365-2788.2007.01010.x; de Gelder B, 2005, Proc Natl Acad Sci U S A, V102, P18682, DOI 10.1073/pnas.0509179102; Dolan RJ, 2001, P NATL ACAD SCI USA, V98, P10006, DOI 10.1073/pnas.171288598; Ekman P., 1978, MANUAL FACIAL ACTION; Hoshi Y, 2002, PEDIATR NEUROL, V27, P275, DOI 10.1016/S0887-8994(02)00432-0; Lang PJ, 1998, J CLIN NEUROPHYSIOL, V15, P397, DOI 10.1097/00004691-199809000-00004; Li A, 2009, INT S BIOM PHYS MOD, P37; Onton J, 2009, FRONT HUM NEUROSCI, V23, P61; Rigoulot S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030740; Scherer K. R., 2001, APPRAISAL PROCESSES; Scherer K. R., 1999, HDB COGNITION EMOTIO, P637; Sejnowski T. J., 2006, 23 PROBLEMS SYSTEMS; Tsoi DTY, 2008, PSYCHOL MED, V38, P801, DOI 10.1017/S0033291707002528; van Brakel J, 1993, SOCIAL PERSPECTIVES, VII, P179; WELCH PD, 1967, IEEE T ACOUST SPEECH, VAU15, P70, DOI 10.1109/TAU.1967.1161901; Yanulevskaya V, 2011, COGN COMPUT, V3, P94, DOI 10.1007/s12559-010-9087-7	43	1	1	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	1866-9956	1866-9964		COGN COMPUT	Cogn. Comput.	FEB	2015	7	1			SI		11	19		10.1007/s12559-013-9225-0		9	Computer Science, Artificial Intelligence; Neurosciences	Computer Science; Neurosciences & Neurology	CB3KA	WOS:000349525500003		
J	Cai, ZY; Makino, S; Rutkowski, TM				Cai, Zhenyu; Makino, Shoji; Rutkowski, Tomasz M.			Brain Evoked Potential Latencies Optimization for Spatial Auditory Brain-Computer Interface	COGNITIVE COMPUTATION			English	Article						Auditory BCI; Spatial auditory cognition; EEG; Event-related potential (ERP); Feature extraction; Statistical signal processing		We propose a novel method for the extraction of discriminative features in electroencephalography (EEG) evoked potential latency. Based on our offline results, we present evidence indicating that a full surround sound auditory brain-computer interface (BCI) paradigm has potential for an online application. The auditory spatial BCI concept is based on an eight-directional audio stimuli delivery technique, developed by our group, which employs a loudspeaker array in an octagonal horizontal plane. The stimuli presented to the subjects vary in frequency and timbre. To capture brain responses, we utilize an eight-channel EEG system. We propose a methodology for finding and optimizing evoked response latencies in the P300 range in order later to classify them correctly and to elucidate the subject's chosen targets or ignored non-targets. To accomplish the above, we propose an approach based on an analysis of variance for feature selection. Finally, we identify the subjects' intended commands with a Naive Bayesian classifier for sorting the final responses. The results obtained with ten subjects in offline BCI experiments support our research hypothesis by providing higher classification results and an improved information transfer rate compared with state-of-the-art solutions.	[Cai, Zhenyu] Univ Tsukuba, Grad Sch Syst & Informat Engn, Tsukuba, Ibaraki, Japan; [Makino, Shoji; Rutkowski, Tomasz M.] Univ Tsukuba, TARA Ctr, Tsukuba, Ibaraki, Japan; [Rutkowski, Tomasz M.] RIKEN Brain Sci Inst, Wako, Saitama, Japan	Rutkowski, TM (reprint author), Univ Tsukuba, TARA Ctr, Tsukuba, Ibaraki, Japan.	tomek@tara.tsukuba.ac.jp	Rutkowski, Tomasz/D-2445-2015	Rutkowski, Tomasz/0000-0002-4259-4121	Strategic Information and Communications R&D Promotion Program of The Ministry of Internal Affairs and Communication in Japan [121803027]; KAKENHI; Japan Society for the Promotion of Science [12010738, 24700154]	This research was supported in part by the Strategic Information and Communications R&D Promotion Program No. 121803027 of The Ministry of Internal Affairs and Communication in Japan and by KAKENHI, the Japan Society for the Promotion of Science, Grant Nos. 12010738 and 24700154. We also acknowledge the technical support of YAMAHA Sound & IT Development Division in Hamamatsu, Japan.	Jurcak V, 2007, NEUROIMAGE, V34, P1600, DOI 10.1016/j.neuroimage.2006.09.024; Cai Z, 2011, P 3 APSIPA ANN SUMM; Cai Z, 2012, P 4 APSIPA ANN SUMM; Hoehne J, 2011, FRONT NEUROSCI, V5; Mitchell T. M., 1997, MACHINE LEARNING; Rutkowski TM, 2011, LECT NOTES COMPUTER, V6851, P110, DOI DOI 10.1007/978-3-642-22950-3; Rutkowski T.M., 2009, INT WORKSH PRINC APP, pP5, DOI 10.1142/9789814299312_0025; Schlogl A., 2007, BRAIN COMPUTER INTER, P327; Schnupp J, 2010, AUDITORY NEUROSCIENC; Schomer D. L., 2011, NIEDERMEYERS ELECTRO, V6th; Schreuder M, 2011, FRONT NEUROSCI-SWITZ, V5, DOI 10.3389/fnins.2011.00112; Schreuder M, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009813; Wolpaw J, 2012, BRAIN COMPUTER INTER	13	1	1	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	1866-9956	1866-9964		COGN COMPUT	Cogn. Comput.	FEB	2015	7	1			SI		34	43		10.1007/s12559-013-9228-x		10	Computer Science, Artificial Intelligence; Neurosciences	Computer Science; Neurosciences & Neurology	CB3KA	WOS:000349525500005		
J	Iidaka, T				Iidaka, Tetsuya			Resting state functional magnetic resonance imaging and neural network classified autism and control	CORTEX			English	Article						Developmental disorder; Brain imaging; Diagnosis; Machine learning; Classifier	SPECTRUM DISORDER; CONNECTIVITY MRI; SYMPTOM SEVERITY; SOCIAL DEFICITS; BRAIN NETWORKS; GLOBAL SIGNAL; CHILDREN; MACHINE; PREDICTION; PATTERNS	Although the neurodevelopmental and genetic underpinnings of autism spectrum disorder (ASD) have been investigated, the etiology of the disorder has remained elusive, and clinical diagnosis continues to rely on symptom-based criteria. In this study, to classify both control subjects and a large sample of patients with ASD, we used resting state functional magnetic resonance imaging (rs-fMRI) and a neural network. Imaging data from 312 subjects with ASD and 328 subjects with typical development was downloaded from the multi-center research project. Only subjects under 20 years of age were included in this analysis. Correlation matrices computed from rs-fMRI time-series data were entered into a probabilistic neural network (PNN) for classification. The PNN classified the two groups with approximately 90% accuracy (sensitivity = 92%, specificity = 87%). The accuracy of classification did not differ among the institutes, or with respect to experimental and imaging conditions, sex, handedness, or intellectual level. Medication status and degree of head movement did not affect accuracy values. The present study indicates that an intrinsic connectivity matrix produced from rs-fMRI data could yield a possible biomarker of ASD. These results support the view that altered network connectivity within the brain contributes to the neurobiology of ASD. (C) 2014 Elsevier Ltd. All rights reserved.	[Iidaka, Tetsuya] Nagoya Univ, Grad Sch Med, Dept Psychiat, Nagoya, Aichi 4668550, Japan	Iidaka, T (reprint author), Nagoya Univ, Grad Sch Med, Dept Psychiat, Showa Ku, 65 Tsurumai, Nagoya, Aichi 4668550, Japan.	iidaka@med.nagoya-u.ac.jp			KAKENHI [21220005]	This study was supported by KAKENHI 21220005.	ALTMAN DG, 1994, BRIT MED J, V309, P102; American Psychiatric Association APA, 1994, DIAGN STAT MAN MENT; Anderson Jeffrey S, 2011, Brain, V134, P3742, DOI 10.1093/brain/awr263; Supekar K, 2013, CELL REP, V5, P738, DOI 10.1016/j.celrep.2013.10.001; Di Martino A, 2011, BIOL PSYCHIAT, V69, P847, DOI 10.1016/j.biopsych.2010.10.029; Ebisch SJH, 2011, HUM BRAIN MAPP, V32, P1013, DOI 10.1002/hbm.21085; Orru G, 2012, NEUROSCI BIOBEHAV R, V36, P1140, DOI 10.1016/j.neubiorev.2012.01.004; Murphy K, 2009, NEUROIMAGE, V44, P893, DOI 10.1016/j.neuroimage.2008.09.036; Lynch CJ, 2013, BIOL PSYCHIAT, V74, P212, DOI 10.1016/j.biopsych.2012.12.013; Levy SE, 2009, LANCET, V374, P1627, DOI 10.1016/S0140-6736(09)61376-3; Pan GB, 2011, J MED SYST, V35, P1477, DOI 10.1007/s10916-009-9424-0; Ecker C, 2010, NEUROIMAGE, V49, P44, DOI 10.1016/j.neuroimage.2009.08.024; Cardinale RC, 2013, JAMA PSYCHIAT, V70, P975, DOI 10.1001/jamapsychiatry.2013.382; Ingalhalikar M, 2011, NEUROIMAGE, V57, P918, DOI 10.1016/j.neuroimage.2011.05.023; Tzourio-Mazoyer N, 2002, NEUROIMAGE, V15, P273, DOI 10.1006/nimg.2001.0978; Muniz AMS, 2010, J BIOMECH, V43, P720, DOI 10.1016/j.jbiomech.2009.10.018; Castellanos FX, 2013, NEUROIMAGE, V80, P527, DOI 10.1016/j.neuroimage.2013.04.083; Uddin LQ, 2013, JAMA PSYCHIAT, V70, P869, DOI 10.1001/jamapsychiatry.2013.104; Baron-Cohen S, 2009, ANN NY ACAD SCI, V1156, P68, DOI 10.1111/j.1749-6632.2009.04467.x; LORD C, 1994, J AUTISM DEV DISORD, V24, P659, DOI 10.1007/BF02172145; Frith U, 2001, NEURON, V32, P969, DOI 10.1016/S0896-6273(01)00552-9; Lai MC, 2010, BIOL PSYCHIAT, V68, P1092, DOI 10.1016/j.biopsych.2010.06.027; Van Dijk KRA, 2012, NEUROIMAGE, V59, P431, DOI 10.1016/j.neuroimage.2011.07.044; Calderoni S, 2012, NEUROIMAGE, V59, P1013, DOI 10.1016/j.neuroimage.2011.08.070; Barttfeld P, 2012, NEUROPSYCHOLOGIA, V50, P3653, DOI 10.1016/j.neuropsychologia.2012.09.047; Tyszka JM, 2014, CEREB CORTEX, V24, P1894, DOI 10.1093/cercor/bht040; Di Martino A, 2014, MOL PSYCHIATR, V19, P659, DOI 10.1038/mp.2013.78; Assaf M, 2010, NEUROIMAGE, V53, P247, DOI 10.1016/j.neuroimage.2010.05.067; Hill EL, 2003, PHILOS T R SOC B, V358, P281, DOI 10.1098/rstb.2002.1209; Menon V, 2011, TRENDS COGN SCI, V15, P483, DOI 10.1016/j.tics.2011.08.003; Paakki JJ, 2010, BRAIN RES, V1321, P169, DOI 10.1016/j.brainres.2009.12.081; Uddin LQ, 2011, BIOL PSYCHIAT, V70, P833, DOI 10.1016/j.biopsych.2011.07.014; Fox MD, 2009, J NEUROPHYSIOL, V101, P3270, DOI 10.1152/jn.90777.2008; Weng SJ, 2010, BRAIN RES, V1313, P202, DOI 10.1016/j.brainres.2009.11.057; Jiao Y, 2010, NEUROIMAGE, V50, P589, DOI 10.1016/j.neuroimage.2009.12.047; Muller RA, 2011, CEREB CORTEX, V21, P2233, DOI 10.1093/cercor/bhq296; Ecker C, 2010, J NEUROSCI, V30, P10612, DOI 10.1523/JNEUROSCI.5413-09.2010; Jiao Y, 2011, ADV MED SCI-POLAND, V56, P334, DOI 10.2478/v10039-011-0042-y; Keown CL, 2013, CELL REP, V5, P567, DOI 10.1016/j.celrep.2013.10.003; Wiggins JL, 2011, BRAIN RES, V1380, P187, DOI 10.1016/j.brainres.2010.10.102; Di Martino A, 2013, BIOL PSYCHIAT, V74, P623, DOI 10.1016/j.biopsych.2013.02.011; Sato JR, 2013, J PSYCHIATR RES, V47, P453, DOI 10.1016/j.jpsychires.2012.11.017; Bloy L, 2011, LECT NOTES COMPUT SC, V6892, P234, DOI 10.1007/978-3-642-23629-7_29; C.D.C.P, 2012, MODB MORT WEEKL REP; Chao-Gan Yan, 2010, Front Syst Neurosci, V4, P13, DOI 10.3389/fnsys.2010.00013; Deshpande G, 2013, FRONT HUM NEUROSCI, V7, DOI 10.3389/fnhum.2013.00670; Lord C., 1999, AUTISM DIAGNOSTIC OB; Loukas C, 2013, COMPUT MATH METHOD M, V2013; Morillo DS, 2013, MED BIOL ENG COMPUT, V51, P305, DOI 10.1007/s11517-012-0995-4; Mueller S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0067329; Murdaugh DL, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0050064; Nielsen JA, 2013, FRONT HUM NEUROSCI, V7, DOI 10.3389/fnhum.2013.00599; Palumbo B, 2010, EUR J NUCL MED MOL I, V37, P2146, DOI 10.1007/s00259-010-1481-6; Sankari Z, 2011, J NEUROSCI METH, V197, P165, DOI 10.1016/j.jneumeth.2011.01.027; Sherrod P. H., 2003, DTREG MANUAL; Specht D F, 1990, IEEE Trans Neural Netw, V1, P111, DOI 10.1109/72.80210; Ubeyli ED, 2008, NEURAL NETWORKS, V21, P1410, DOI 10.1016/j.neunet.2008.08.005; Uddin LQ, 2013, FRONT HUM NEUROSCI, V7, DOI 10.3389/fnhum.2013.00458; Uddin Lucina Q, 2010, Front Syst Neurosci, V4, P21, DOI 10.3389/fnsys.2010.00021; Varol E, 2012, 2012 9TH IEEE INTERNATIONAL SYMPOSIUM ON BIOMEDICAL IMAGING (ISBI), P146, DOI 10.1109/ISBI.2012.6235505; Yendiki A, 2010, NEUROIMAGE, V53, P119, DOI 10.1016/j.neuroimage.2010.02.084	61	2	2	ELSEVIER MASSON	MILANO	VIA PALEOCAPA 7, 20121 MILANO, ITALY	0010-9452	1973-8102		CORTEX	Cortex	FEB	2015	63						55	67		10.1016/j.cortex.2014.08.011		13	Behavioral Sciences; Neurosciences	Behavioral Sciences; Neurosciences & Neurology	CB4BN	WOS:000349573300007		
J	Asano, M; Imai, M; Kita, S; Kitajo, K; Okada, H; Thierry, G				Asano, Michiko; Imai, Mutsumi; Kita, Sotaro; Kitajo, Keiichi; Okada, Hiroyuki; Thierry, Guillaume			Sound symbolism scaffolds language development in preverbal infants	CORTEX			English	Article						Sound symbolism; Language development; Audio-visual correspondences; Phase synchronization analysis of EEG; Amplitude change analysis of EEG	GAMMA-BAND ACTIVITY; NEURAL SYNCHRONY; PHONETIC DETAIL; BRAIN; CORRESPONDENCES; PERCEPTION; NETWORKS; MEMORY; OSCILLATIONS; INTEGRATION	A fundamental question in language development is how infants start to assign meaning to words. Here, using three Electroencephalogram (EEG)-based measures of brain activity, we establish that preverbal 11-month-old infants are sensitive to the non-arbitrary correspondences between language sounds and concepts, that is, to sound symbolism. In each trial, infant participants were presented with a visual stimulus (e.g., a round shape) followed by a novel spoken word that either sound-symbolically matched ("moma") or mismatched ("kipi") the shape. Amplitude increase in the gamma band showed perceptual integration of visual and auditory stimuli in the match condition within 300 msec of word onset. Furthermore, phase synchronization between electrodes at around 400 msec revealed intensified large-scale, left-hemispheric communication between brain regions in the mismatch condition as compared to the match condition, indicating heightened processing effort when integration was more demanding. Finally, event-related brain potentials showed an increased adult-like N400 response an index of semantic integration difficulty in the mismatch as compared to the match condition. Together, these findings suggest that 11-month-old infants spontaneously map auditory language onto visual experience by recruiting a cross-modal perceptual processing system and a nascent semantic network within the first year of life. (C) 2014 The Authors. Published by Elsevier Ltd.	[Asano, Michiko] Rikkyo Univ, Coll Contemporary Psychol, Dept Psychol, Niiza, Saitama, Japan; [Asano, Michiko; Imai, Mutsumi] Keio Univ, Fac Environm & Informat Studies, Fujisawa, Kanagawa 2520882, Japan; [Asano, Michiko; Okada, Hiroyuki] Tamagawa Univ, Brain Sci Inst, Machida, Tokyo, Japan; [Kita, Sotaro] Univ Warwick, Dept Psychol, Coventry CV4 7AL, W Midlands, England; [Kitajo, Keiichi] RIKEN, Brain Sci Inst, BSI Toyota Collaborat Ctr, Wako, Saitama, Japan; [Kitajo, Keiichi] RIKEN, Brain Sci Inst, Wako, Saitama, Japan; [Thierry, Guillaume] Bangor Univ, Sch Psychol, Bangor, Gwynedd, Wales	Imai, M (reprint author), Keio Univ, Fac Environm & Informat Studies, 5322 Endo, Fujisawa, Kanagawa 2520882, Japan.	imai@sfc.keio.ac.jp	Thierry, Guillaume/C-2688-2008	Thierry, Guillaume/0000-0003-1325-2656	MEXT KAKENHI [15300088, 22243043, 23120003, 21120005]; JST PRESTO; MEXT GCOE program; BBSRC Research Development Fellowship [BB/G023069/1]; Economic and Social Research Council [ES/E024556/1]; European Research Council [ERC-SG-209704]	This research was supported by MEXT KAKENHI (#15300088, #22243043, Grant-in-Aid for Scientific Research on Innovative Areas #23120003) to M.I. and H.O., MEXT KAKENHI (#21120005) and JST PRESTO to K.K., MEXT GCOE program to Tamagawa University, BBSRC Research Development Fellowship (BB/G023069/1) to S.K., Economic and Social Research Council (ES/E024556/1) and European Research Council (ERC-SG-209704) to G.T, and Grant-in-Aid for JSPS Research Fellows (#23-2872) to M.A. We thank Yumi Nakagawa,Yuji Mizuno, Junko Kanero and Mamiko Arata for help in data collection and analysis, and Marilyn Vihman for comments on an earlier version of the manuscript. M.A. and M.I. are joint first authors. G.T. and S.K. made equal contributions. The authors declare no competing financial interests.	Stager CL, 1997, NATURE, V388, P381, DOI 10.1038/41102; Fennell CT, 2003, LANG SPEECH, V46, P245; Ward LM, 2003, TRENDS COGN SCI, V7, P553, DOI 10.1016/j.tics.2003.10.012; Springer JA, 1999, BRAIN, V122, P2033, DOI 10.1093/brain/122.11.2033; Maurer D, 2006, DEVELOPMENTAL SCI, V9, P316, DOI 10.1111/j.1467-7687.2006.00495.x; Thierry G, 2005, INFANT CHILD DEV, V14, P85, DOI 10.1002/icd.353; Werker JF, 1998, DEV PSYCHOL, V34, P1289, DOI 10.1037//0012-1649.34.6.1289; Uhlhaas PJ, 2009, P NATL ACAD SCI USA, V106, P9866, DOI 10.1073/pnas.0900390106; TallonBaudry C, 1996, J NEUROSCI, V16, P4240; Varela F, 2001, NAT REV NEUROSCI, V2, P229, DOI 10.1038/35067550; Melloni L, 2007, J NEUROSCI, V27, P2858, DOI 10.1523/JNEUROSCI.4623-06.2007; Kisley MA, 2006, CLIN NEUROPHYSIOL, V117, P2549, DOI 10.1016/j.clinph.2006.08.003; Herrmann CS, 2004, TRENDS COGN SCI, V8, P347, DOI 10.1016/j.tics.2004.06.006; Rodriguez E, 1999, NATURE, V397, P430; Engel AK, 2001, TRENDS COGN SCI, V5, P16, DOI 10.1016/S1364-6613(00)01568-0; Bergelson E, 2012, P NATL ACAD SCI USA, V109, P3253, DOI 10.1073/pnas.1113380109; Walker P, 2010, PSYCHOL SCI, V21, P21, DOI 10.1177/0956797609354734; Kawasaki M, 2010, EUR J NEUROSCI, V31, P1683, DOI 10.1111/j.1460-9568.2010.07217.x; Csibra G, 2000, SCIENCE, V290, P1582, DOI 10.1126/science.290.5496.1582; Uhlhaas PJ, 2010, TRENDS COGN SCI, V14, P72, DOI 10.1016/j.tics.2009.12.002; Friedrich M, 2005, NEUROREPORT, V16, P653, DOI 10.1097/00001756-200504250-00028; Parise E, 2012, PSYCHOL SCI, V23, P728, DOI 10.1177/0956797612438734; von Stein A, 1999, CEREB CORTEX, V9, P137, DOI 10.1093/cercor/9.2.137; Senkowski D, 2008, TRENDS NEUROSCI, V31, P401, DOI 10.1016/j.tins.2008.05.002; Imai M, 2014, PHILOS T R SOC B, V369, DOI 10.1098/rstb.2013.0298; Ramachandran V, 2001, J CONSCIOUSNESS STUD, V8, P3; BENJAMINI Y, 1995, J ROY STAT SOC B MET, V57, P289; Schneider TR, 2008, NEUROIMAGE, V42, P1244, DOI 10.1016/j.neuroimage.2008.05.033; Ozturk O, 2013, J EXP CHILD PSYCHOL, V114, P173, DOI 10.1016/j.jecp.2012.05.004; Friedrich M, 2011, J COGNITIVE NEUROSCI, V23, P3228, DOI 10.1162/jocn_a_00002; Kutas M, 2011, ANNU REV PSYCHOL, V62, P621, DOI 10.1146/annurev.psych.093008.131123; Torkildsen JV, 2008, J COGNITIVE NEUROSCI, V20, P1266, DOI 10.1162/jocn.2008.20087; Fries P, 2005, TRENDS COGN SCI, V9, P474, DOI 10.1016/j.tics.2005.08.011; Kantartzis K, 2011, COGNITIVE SCI, V35, P575, DOI 10.1111/j.1551-6709.2010.01169.x; Imai M, 2008, COGNITION, V109, P54, DOI 10.1016/j.cognition.2008.07.015; BURGESS AP, 1999, HANDB EL CL, V6, P139; Gogate LJ, 2010, PSYCHOL REV, V117, P496, DOI 10.1037/a0019049; Imai M., SOUND SYMBOLISM FACI; Kitajo K, 2007, EPL-EUROPHYS LETT, V80, P1, DOI [10.1209/0295-5075/80/40009, DOI 10.1209/0295-5075/80/40009]; Kohler W, 1947, GESTALT PSYCHOL; Lachaux JP, 2000, INT J BIFURCAT CHAOS, V10, P2429, DOI 10.1142/S0218127400001560; MESULAM MM, 1990, ANN NEUROL, V28, P597, DOI 10.1002/ana.410280502; Miyazaki M., 2013, P 35 ANN M COGN SCI; Pena M, 2011, PSYCHOL SCI, V22, P1419, DOI 10.1177/0956797611421791	44	7	7	ELSEVIER MASSON	MILANO	VIA PALEOCAPA 7, 20121 MILANO, ITALY	0010-9452	1973-8102		CORTEX	Cortex	FEB	2015	63						196	205		10.1016/j.cortex.2014.08.025		10	Behavioral Sciences; Neurosciences	Behavioral Sciences; Neurosciences & Neurology	CB4BN	WOS:000349573300019		
J	Kagotani, A; Ishida, M; Yoshida, K; Iwai, M; Okabe, H				Kagotani, A.; Ishida, M.; Yoshida, K.; Iwai, M.; Okabe, H.			High-grade urothelial carcinoma of the bladder with rhabdoid features: cytological and histological report of two cases	CYTOPATHOLOGY			English	Letter							RENAL PELVIS; TUMOR		[Kagotani, A.; Ishida, M.; Yoshida, K.; Iwai, M.; Okabe, H.] Shiga Univ Med Sci, Dept Clin Lab Med, Div Diagnost Pathol, Otsu, Shiga 5202192, Japan	Ishida, M (reprint author), Shiga Univ Med Sci, Dept Clin Lab Med, Div Diagnost Pathol, Tsukinowa Cho, Otsu, Shiga 5202192, Japan.	mitsuaki@belle.shiga-med.ac.jp					Duvdevani M, 2001, J UROLOGY, V166, P2337, DOI 10.1016/S0022-5347(05)65582-6; HARRIS M, 1987, HISTOPATHOLOGY, V11, P1083; Fukumura Y, 2009, PATHOL INT, V59, P322, DOI 10.1111/j.1440-1827.2009.02373.x; Perez-Montiel D, 2006, MODERN PATHOL, V19, P494, DOI 10.1038/modpathol.3800559; Parwani AV, 2006, HUM PATHOL, V37, P168, DOI 10.1016/j.humpath.2005.10.002; Inagaki T, 2000, PATHOL INT, V50, P973, DOI 10.1046/j.1440-1827.2000.01135.x; KUMAR S, 1992, AM J SURG PATHOL, V16, P515, DOI 10.1097/00000478-199205000-00011	7	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0956-5507	1365-2303		CYTOPATHOLOGY	Cytopathology	FEB	2015	26	1					54	56		10.1111/cyt.12139		3	Cell Biology; Pathology	Cell Biology; Pathology	CB6YC	WOS:000349771900012		
J	Okada, T; Fukuoka, K; Arata, Y; Yonezawa, S; Kiyokawa, H; Takashima, M				Okada, Takashi; Fukuoka, Kiyoto; Arata, Yoshiaki; Yonezawa, Susumu; Kiyokawa, Hajime; Takashima, Masayuki			Tungsten carbide coating on diamond particles in molten mixture of Na2CO3 and NaCl	DIAMOND AND RELATED MATERIALS			English	Article						Diamond particles; Tungsten carbide; Coating; Molten salts; Sodium carbonate	DIAGRAM-THERMODYNAMIC ANALYSIS; BINARY-SYSTEMS; SODIUM; NO3; CL; OH; LI	Diamond compacts are prepared by bonding diamond particles with substrates. In the bonding process using a metal binder by electro-deposition, it is better to use diamond particles coated with tungsten carbide (WC) because of higher bonding efficiency between WC and the substrates caused by higher electric conductivity of WC In this study, diamond particles were coated with WC in molten salts containing Na2CO3. Thermodynamically, sodium tungstate and WC were predicted to be generated by the reaction between metallic tungsten and Na2CO3, and the WC generation was confirmed experimentally. When the diamond powder and metallic tungsten powder were heated in a molten mixture of Na2CO3 and NaCl at 630-680 degrees C, the diamond was coated with the WC generated by the reaction as mentioned above. Such treatment temperatures are lower than those in the previously proposed methods (800-1500 degrees C). This reduces use of the heat quantity to raise the temperature of the feedstock by 50% compared with a NaCl bath process at 900 degrees C. The specific resistance of the diamond particles decreased with increasing of the WC coating thickness, because of the WC layer With higher electric conductivity than diamond. The specific resistance of the diamond particles treated in a molten mixture of Na2CO3-NaCl was 220 Omega.cm, whereas that of the diamond treated in a molten mixture of NaCl and KCI exceeded the upper detection limit in the used measurement system (>1948 Omega.cm). Therefore, in a Na2CO3 containing molten mixture, the WC coating on the diamond particles proceeds effectively. (C) 2014 Elsevier B.V. All rights reserved.	[Okada, Takashi; Arata, Yoshiaki; Yonezawa, Susumu; Takashima, Masayuki] Univ Fukui, Headquarters Innovat Soc, Acad Cooperat, Fukui 9108507, Japan; [Fukuoka, Kiyoto; Kiyokawa, Hajime] Kiyokawa Plating Ind Co Ltd, Fukui 9188515, Japan	Okada, T (reprint author), Univ Fukui, Headquarters Innovat Soc, Acad Cooperat, Bunkyo 3-9-1, Fukui 9108507, Japan.	t-okada@u-fukui.ac.jp					Amirhaghi S, 2001, SURF COAT TECH, V135, P126, DOI 10.1016/S0257-8972(00)01083-5; YOSHIKAWA M, 1989, APPL PHYS LETT, V55, P2608, DOI 10.1063/1.101951; Lindberg D, 2007, J CHEM THERMODYN, V39, P942, DOI 10.1016/j.jct.2006.11.002; HOLLECK H, 1986, J VAC SCI TECHNOL A, V4, P2661, DOI 10.1116/1.573700; Breval E, 2000, J AM CERAM SOC, V83, P2106; DESSUREAULT Y, 1990, J CHIM PHYS PCB, V87, P407; Leparoux S, 2007, SCRIPTA MATER, V57, P595, DOI 10.1016/j.scriptamat.2007.06.016; Ye LG, 2014, THERMOCHIM ACTA, V596, P14, DOI 10.1016/j.tca.2014.07.002; Kang QP, 2013, APPL THERM ENG, V60, P423, DOI 10.1016/j.applthermaleng.2013.05.038; Barin I., 1989, THERMOCHEMICAL DATA; Barin I., 1977, THERMOCHEMICAL PROPE; Barner H.E., 1978, HDB THERMOCHEMICAL D; DESSUREAULT Y, 1990, J PHYS CHEM REF DATA, V19, P1149; DESSUREAULT Y, 1990, J ELECTROCHEM SOC, V137, P2941, DOI 10.1149/1.2087103; Lide D., 2006, CRC HDB CHEM PHYS; Moore J., 2009, PRINCIPLES CHEM MOL; National Institute for Materials Science in Japan, 2003, INV ENV LOAD SMELT P; Ras AH, 2010, DIAM RELAT MATER, V19, P1411, DOI 10.1016/j.diamond.2010.08.013; Saxena S. K., 1993, THERMODYNAMIC DATA O; Stull D.R., 1985, JANAF THERMOCHEMICAL; Wang Q, 2006, MATER CHEM PHYS, V95, P113, DOI 10.1016/j.matchemphys.2005.06.008; Yaokawa J, 2007, CALPHAD, V31, P155, DOI 10.1016/j.calphad.2007.01.004	22	0	0	ELSEVIER SCIENCE SA	LAUSANNE	PO BOX 564, 1001 LAUSANNE, SWITZERLAND	0925-9635	1879-0062		DIAM RELAT MATER	Diam. Relat. Mat.	FEB	2015	52						11	17		10.1016/j.diamond.2014.11.008		7	Materials Science, Multidisciplinary	Materials Science	CB6GT	WOS:000349726200002		
J	Ariyama, M; Kato, R; Matsumura, M; Yoshimoto, H; Nakajima, Y; Nakano, S; Kasai, T; Tanno, J; Senbonmatsu, T; Matsumoto, K; Nishimura, S				Ariyama, Miyuki; Kato, Ritsushi; Matsumura, Makoto; Yoshimoto, Harumi; Nakajima, Yoshie; Nakano, Shintaro; Kasai, Takatoshi; Tanno, Jun; Senbonmatsu, Takaaki; Matsumoto, Kazuo; Nishimura, Shigeyuki			Left Atrial Appendage Wall-Motion Velocity Associates with Recurrence of Nonparoxysmal Atrial Fibrillation after Catheter Ablation	ECHOCARDIOGRAPHY-A JOURNAL OF CARDIOVASCULAR ULTRASOUND AND ALLIED TECHNIQUES			English	Article						atrial fibrillation; left atrial appendage function; tissue Doppler imaging	EUROPEAN-SOCIETY; UPSTREAM THERAPIES; CLINICAL-EVIDENCE; MANAGEMENT; CARDIOLOGY; ECHOCARDIOGRAPHY; RECOMMENDATIONS; PREVENTION; RHYTHM; HEART	Catheter ablation (CA) for nonparoxysmal atrial fibrillation (AF) is controversial due to its high recurrence rate. The aim of this study was to assess retrospectively the diagnostic value of preprocedural left atrial appendage (LAA) wall-motion velocity in predicting recurrence of AF within 1year after CA. We hypothesized that tissue Doppler-derived measurement of LAA wall-motion velocity associate with recurrence of AF within 1year after CA. We retrospectively reviewed 47 consecutive patients with nonparoxysmal AF (defined as AF lasting for 1week or longer) who underwent both transthoracic and transesophageal echocardiography before their first treatment by CA in a single center. Forty-one patients aged 58 +/- 10years were included, and variables predicting the recurrence of AF within 1year after CA were evaluated. Seventeen patients (41%) developed recurrence of AF within 1year after CA. Univariate analyses showed that preprocedural LAA upward wall-motion velocity at the apex assessed by transesophageal echocardiography was significantly lower in patients with recurrence of AF than those without recurrence (OR=1.45, 95% CI: 1.13-2.01, P=0.009). Multivariate logistic analyses including other potential predictors (duration of AF, left ventricular ejection fraction, E-wave deceleration time, and left atrial wall-motion velocity) identified LAA upward wall-motion velocity at the apex as an independent predictor of outcome. These data suggest in patients with nonparoxysmal AF, preprocedural LAA upward wall-motion velocity at the apex, as determined by tissue Doppler imaging during transesophageal echocardiography, may be a useful indicator for predicting recurrence of AF within 1year after CA.	[Ariyama, Miyuki; Kato, Ritsushi; Matsumura, Makoto; Yoshimoto, Harumi; Nakajima, Yoshie; Nakano, Shintaro; Tanno, Jun; Senbonmatsu, Takaaki; Matsumoto, Kazuo; Nishimura, Shigeyuki] Saitama Med Univ, Dept Cardiol, Int Med Ctr, Hidaka, Saitama 3501298, Japan; [Kasai, Takatoshi] Juntendo Univ, Sch Med, Dept Cardiol, Tokyo 113, Japan	Nakano, S (reprint author), Saitama Med Univ, Dept Cardiol, Int Med Ctr, 1397-1 Yamane, Hidaka, Saitama 3501298, Japan.	snakano@saitama-med.ac.jp					Savelieva I, 2011, EUROPACE, V13, P308, DOI 10.1093/europace/eur002; Mirza M, 2011, J INTERV CARD ELECTR, V31, P197, DOI 10.1007/s10840-011-9560-6; Piccini JP, 2009, CIRC-ARRHYTHMIA ELEC, V2, P626, DOI 10.1161/CIRCEP.109.856633; HONDO T, 1995, JPN HEART J, V36, P225; Tabata T, 1998, AM J CARDIOL, V81, P327, DOI 10.1016/S0002-9149(97)00903-X; Lang RM, 2005, J AM SOC ECHOCARDIOG, V18, P1440, DOI 10.1016/j.echo.2005.10.005; CHAPEAU C, 1985, J HISTOCHEM CYTOCHEM, V33, P541; Yoshida N, 2010, ECHOCARDIOGR-J CARD, V27, P839, DOI 10.1111/j.1540-8175.2010.01157.x; Tamura H, 2010, J AM SOC ECHOCARDIOG, V23, P545, DOI 10.1016/j.echo.2010.02.006; Calkins H, 2012, EUROPACE, V14, P528, DOI 10.1093/europace/eus027; Kirchhof P, 2012, EUROPACE, V14, P8, DOI 10.1093/europace/eur241; Fujiki A, 2003, AM J CARDIOL, V92, P472, DOI 10.1016/S0002-3149(03)00672-6; Tenekecioglu E, 2010, ECHOCARDIOGR-J CARD, V27, P677, DOI 10.1111/j.1540-8175.2009.01102.x; Perrin MJ, 2012, HEART RHYTHM, V9, P610, DOI 10.1016/j.hrthm.2011.11.019; Saito Y, 2010, J CARDIOL, V56, P262, DOI 10.1016/j.jjcc.2010.08.001; Naruse Y, 2011, HEART RHYTHM, V8, P335, DOI 10.1016/j.hrthm.2010.10.047; Hwang HJ, 2009, J INTERV CARD ELECTR, V26, P127, DOI 10.1007/s10840-009-9410-y; Balk EM, 2010, J CARDIOVASC ELECTR, V21, P1208, DOI 10.1111/j.1540-8167.2010.01798.x; Combes S, 2013, ARCH CARDIOVASC DIS, V106, P36, DOI 10.1016/j.acvd.2012.09.002; DAVIS CA, 1990, AM J PHYSIOL, V259, pH1006; densUijl DW, 2011, EUROPACE, V13, P1533; densUijl DW, 2011, AM HEART J, V161, P197; densUijl DW, 2011, HEART, V97, P1847; Hindricks G, 2012, CIRCULATION, V126, P791, DOI 10.1161/CIRCULATIONAHA.112.124735; Hong J, 2013, ECHOCARDIOGR-J CARD, V30, P1051, DOI 10.1111/echo.12200; Savelieva I, 2011, EUROPACE, V13, P610, DOI 10.1093/europace/eur023; Tabata T, 2000, Eur J Echocardiogr, V1, P130, DOI 10.1053/euje.2000.0019	27	1	1	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0742-2822	1540-8175		ECHOCARDIOGR-J CARD	Echocardiography-J. Cardiovasc. Ultrasound Allied Tech.	FEB	2015	32	2					272	280		10.1111/echo.12647		9	Cardiac & Cardiovascular Systems	Cardiovascular System & Cardiology	CB5OG	WOS:000349676600010		
J	Hayabuchi, Y; Sakata, M; Kagami, S				Hayabuchi, Yasunobu; Sakata, Miho; Kagami, Shoji			Assessment of the Helical Ventricular Myocardial Band Using Standard Echocardiography	ECHOCARDIOGRAPHY-A JOURNAL OF CARDIOVASCULAR ULTRASOUND AND ALLIED TECHNIQUES			English	Article						helical ventricular myocardial band; speckle tracking; strain; echocardiography	CARDIAC FIBER; DEFORMATION; SCIENCE; SEPTUM; STRAIN; HEART; MASS; FORM	BackgroundThe purpose of this study was to assess the feasibility of morphological and functional evaluation of the helical ventricular myocardial band using standard echocardiographic images. MethodsEchocardiographic data were obtained from 132 normal children. We attempted to identify the echogenic bright line serving as the boundary between the ascending and descending segments in the ventricular septum, and between the left and ascending segments in the left ventricular inferior wall in the helical myocardial band model proposed by Torrent-Guasp. Myocardial deformations on both sides of the bright line were compared using speckle tracking echocardiography. ResultsThe bright line separating the ascending from descending segment was visible in the mid-ventricular septum in the four-chamber view in all subjects. This echogenic boundary was observed obliquely in the parasternal short-axis view in 116 subjects (87.9%). There was no significant difference in peak longitudinal or circumferential strain between the ascending and descending segments. However, the time from the QRS onset to peak circumferential strain was significantly lower in the descending than ascending segment (394.537.0 vs. 432.7 +/- 33.1ms, P<0.0001), whereas there was no significant difference in the time to peak longitudinal strain (394.4 +/- 26.4 vs. 393.2 +/- 24.1ms). The bright line between the left and ascending segment was detected in the short-axis view from the subcostal region in 86 subjects (65.2%). The time to peak circumferential strain was significantly lower in the left than ascending segment (380.1 +/- 32.0 vs. 435.7 +/- 37.9ms, P<0.0001). ConclusionThere is a helical ventricular myocardial band that can be observed in standard echocardiographic images.	[Hayabuchi, Yasunobu; Sakata, Miho; Kagami, Shoji] Univ Tokushima, Dept Pediat, Tokushima 7708305, Japan	Hayabuchi, Y (reprint author), Univ Tokushima, Dept Pediat, Tokushima 7708305, Japan.	hayabuchi@tokushima-u.ac.jp					Toyoda T, 2004, J AM SOC ECHOCARDIOG, V17, P1234, DOI 10.1016/j.echo.2004.07.010; Helm P, 2005, ANN NY ACAD SCI, V1047, P296, DOI 10.1196/annals.1341.026; Criscione JC, 2005, EUR J CARDIO-THORAC, V28, P363, DOI 10.1016/j.ejcts.2005.04.015; Buckberg G, 2011, ECHOCARDIOGR-J CARD, V28, P782, DOI 10.1111/j.1540-8175.2011.01448.x; Anderson RH, 2005, EUR J CARDIO-THORAC, V28, P517, DOI 10.1016/j.ejcts.2005.06.043; Hayabuchi Y, 2014, ECHOCARDIOGR-J CARD, V31, P815, DOI 10.1111/echo.12484; Sengupta PP, 2006, J AM COLL CARDIOL, V48, P1988, DOI 10.1016/j.jacc.2006.08.030; Hristov N, 2006, EUR J CARDIO-THORAC, V29, pS115, DOI 10.1016/j.ejcts.2006.02.041; Hayabuchi Y, 2011, J AM SOC ECHOCARDIOG, V24, P1205, DOI 10.1016/j.echo.2011.06.016; Gilbert SH, 2007, EUR J CARDIO-THORAC, V32, P231, DOI 10.1016/j.ejcts.2007.03.032; Sengupta PP, 2007, J AM SOC ECHOCARDIOG, V20, P539, DOI 10.1016/j.echo.2006.10.013; Buckberg G, 2008, J THORAC CARDIOV SUR, V136, P578, DOI 10.1016/j.jtcvs.2007.10.088; Biswas M, 2013, ECHOCARDIOGR-J CARD, V30, P88, DOI 10.1111/echo.12079; Boettler P, 2005, HEART, V91, P1343, DOI 10.1136/hrt.2004.043422; Buckberg GD, 2004, CIRCULATION, V110, pE333, DOI 10.1161/01.CIR.0000143625.56882.5C; Holland MR, 2010, ULTRASOUND MED BIOL, V36, P1653, DOI 10.1016/j.ultrasmedbio.2010.07.007; Lindqvist P, 2006, J AM SOC ECHOCARDIOG, V19, P1345, DOI 10.1016/j.echo.2006.05.002; Lunkenheimer PP, 2006, EUR J CARDIO-THORAC, V29, pS41, DOI 10.1016/j.ejcts.2006.02.062; Nasiraei-Moghaddam A, 2009, AM J PHYSIOL-HEART C, V296, pH127, DOI 10.1152/ajpheart.00581.2008; Sosnovik DE, 2009, J CARDIOVASC MAGN R, V11, DOI 10.1186/1532-429X-11-47; Torrent-Guasp F, 2001, Semin Thorac Cardiovasc Surg, V13, P301; Yang M, 2007, J ACOUST SOC AM, V122, P581, DOI 10.1121/1.2737747	22	3	4	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0742-2822	1540-8175		ECHOCARDIOGR-J CARD	Echocardiography-J. Cardiovasc. Ultrasound Allied Tech.	FEB	2015	32	2					310	318		10.1111/echo.12624		9	Cardiac & Cardiovascular Systems	Cardiovascular System & Cardiology	CB5OG	WOS:000349676600014		
J	Riya, S; Muroi, Y; Kamimura, M; Zhou, S; Terada, A; Kobara, Y; Hosomi, M				Riya, Shohei; Muroi, Yurie; Kamimura, Miu; Zhou, Sheng; Terada, Akihiko; Kobara, Yuso; Hosomi, Masaaki			Mitigation of CH4 and N2O emissions from a forage rice field fertilized with aerated liquid fraction of cattle slurry by optimizing water management and topdressing	ECOLOGICAL ENGINEERING			English	Article						Greenhouse gas emission; Rice paddy field; Cattle slurry; Mitigation; Topdressing; Water management	NITROUS-OXIDE EMISSIONS; ANAEROBICALLY DIGESTED SLURRY; PADDY FIELDS; METHANE EMISSION; METHANOGENIC ARCHAEA; IRRIGATED RICE; FLOODED RICE; SOIL; CHINA; DRAINAGE	Fertilization of aerated liquid fraction of cattle slurry (ALCS) to forage rice fields is a method to utilize surplus amount of cattle slurry and produce feed. However, ALCS application causes high emissions of CH4 and N2O from rice fields. In this study, we tested the abilities of several different field management strategies to mitigate CH4 and N2O emissions. The management strategies consisted of two different drainage patterns (midsummer drainage, C; drainage before topdressing, B) and two topdressing patterns (a stepwise increase in topdressing, I; a stepwise decrease in topdressing, D). We also analyzed changes in the archaeal community in each treatment during the experimental period to examine the relationship between CH4 emissions and methanogenic archaea. In each treatment, chemical fertilizer was applied as a basal dressing (50 kgNha (1)) and ALCS was applied three times as a topdressing (214-244 kgNha (1)). In CI, BI, CD, and BD, the cumulative emissions were 191, 158, 127, and 34.5 kg C ha (1) for CH4, respectively, and 0.52, 2.32, -0.18, and -0.21 kgNha (1) for N2O, respectively. The abundance of Methanocella, a genus of methanogenic archaea, increased over time in CI and CD, but remained constant in BI and BD. This result suggested that drainage before topdressing effectively suppressed the growth of Methanocella. The lowest carbon dioxide equivalents (CO2 eq) value was in BD (75-84% lower than those in other treatments). These results indicate that the combination of drainage before topdressing and a stepwise decrease in topdressing is a simple, low-cost management strategy to mitigate greenhouse gas emissions from rice fields supplemented with ALCS. (C) 2014 Elsevier B.V. All rights reserved.	[Riya, Shohei; Muroi, Yurie; Kamimura, Miu; Terada, Akihiko; Hosomi, Masaaki] Tokyo Univ Agr & Technol, Fac Engn, Koganei, Tokyo 1848588, Japan; [Zhou, Sheng] Shanghai Acad Agr Sci, Ecoenvironm Protect Res Inst, Shanghai 201403, Peoples R China; [Kobara, Yuso] Natl Inst Agroenvironm Sci, Div Organochem, Tsukuba, Ibaraki 3058604, Japan	Riya, S (reprint author), Tokyo Univ Agr & Technol, Fac Engn, 2-24-16 Naka Cho, Koganei, Tokyo 1848588, Japan.	sriya@cc.tuat.ac.jp	Terada, Akihiko/C-5749-2012	Terada, Akihiko/0000-0002-9258-6912	Ministry of the Environment, Japan [RF-1002]; Ministry of Education, Culture, Sports, Science and Technology of Japan [23310050, 522710072]	This work was supported by the Environment Research and Technology Development Fund (RF-1002) of the Ministry of the Environment, Japan, and in part by Grants-in-Aid for Scientific Research (B) (23310050) and a Grant-in-Aid for Young Scientists (B) (522710072) from the Ministry of Education, Culture, Sports, Science and Technology of Japan.	Crump BC, 2012, ISME J, V6, P1629, DOI 10.1038/ismej.2012.9; Yuan YL, 2009, ENV MICROBIOL REP, V1, P347, DOI 10.1111/j.1758-2229.2009.00036.x; Steinberg LM, 2009, APPL ENVIRON MICROB, V75, P4435, DOI 10.1128/AEM.02858-08; Yagi K, 1996, GLOBAL BIOGEOCHEM CY, V10, P255, DOI 10.1029/96GB00517; Keerthisinghe DG, 1996, FERT RES, V45, P31; Tyagi L, 2010, SCI TOTAL ENVIRON, V408, P1085, DOI 10.1016/j.scitotenv.2009.09.010; Hou HJ, 2012, CHEMOSPHERE, V89, P884, DOI 10.1016/j.chemosphere.2012.04.066; Wang JY, 2011, AGR ECOSYST ENVIRON, V141, P437, DOI 10.1016/j.agee.2011.04.009; Lu YH, 2005, SCIENCE, V309, P1088, DOI 10.1126/science.1113435; Cai ZC, 1999, SOIL SCI PLANT NUTR, V45, P1; YAGI K, 1990, SOIL SCI PLANT NUTR, V36, P599; Towprayoon S, 2005, CHEMOSPHERE, V59, P1547, DOI 10.1016/j.chemosphere.2005.02.009; Mosier AR, 1998, CLIMATIC CHANGE, V40, P7, DOI 10.1023/A:1005386614431; Yu KW, 2004, SOIL SCI SOC AM J, V68, P2086; Itoh M, 2011, AGR ECOSYST ENVIRON, V141, P359, DOI 10.1016/j.agee.2011.03.019; Clemens J, 2001, NUTR CYCL AGROECOSYS, V59, P193, DOI 10.1023/A:1017562603343; Minamikawa K, 2006, AGR ECOSYST ENVIRON, V116, P181, DOI 10.1016/j.agee.2006.02.006; Singh A, 2012, FEMS MICROBIOL ECOL, V82, P118, DOI 10.1111/j.1574-6941.2012.01411.x; Ghosh S, 2003, CHEMOSPHERE, V51, P181, DOI 10.1016/S0045-6535(02)00822-6; ASAMI T., 1959, Soil and Plant Food, V5, P141; Bronson KF, 1997, SOIL SCI SOC AM J, V61, P981; Chen DJ, 2013, BIOL FERT SOILS, V49, P647, DOI 10.1007/s00374-012-0752-8; Fujino J, 2005, BIOMASS BIOENERG, V29, P367, DOI 10.1016/j.biombioe.2004.06.017; Hori T, 2010, ISME J, V4, P267, DOI 10.1038/ismej.2009.100; IUSS Working Group WRB, 2006, 103 FAO IUSS WORK GR, V103; Jackel U, 2005, SOIL BIOL BIOCHEM, V37, P2150, DOI 10.1016/j.soilbio.2005.03.003; Kato H, 2008, JARQ-JPN AGR RES Q, V42, P231; Lu J, 2012, AGR ECOSYST ENVIRON, V146, P13, DOI 10.1016/j.agee.2011.10.011; Ma K, 2011, FEMS MICROBIOL ECOL, V75, P446, DOI 10.1111/j.1574-6941.2010.01018.x; Majumdar D, 2013, CRIT REV ENV SCI TEC, V43, P2653, DOI 10.1080/10643389.2012.694332; Ministry of Agriculture Forestry and Fisheries (MAFF), 2002, 3 MAFF AGR FOR FISH; Ministry of Agriculture Forestry and Fisheries (MAFF), 2011, RES SURV TREATM LIV; Nakamura M., 2009, TROUBLE RECORDS ANAL, V210, P11; Riya S, 2012, SCI TOTAL ENVIRON, V419, P178, DOI 10.1016/j.scitotenv.2012.01.014; Sakai S, 2007, APPL ENVIRON MICROB, V73, P4326, DOI 10.1128/AEM.03008-06; Sasada Y, 2011, BIOL FERT SOILS, V47, P949, DOI 10.1007/s00374-011-0601-1; Sass RL, 1997, NUTR CYCL AGROECOSYS, V49, P119, DOI 10.1023/A:1009702223478; Solomon S., 2007, CONTRIBUTION WORKING; Takai Y., 1958, JPN J SOIL SCI PLANT, V29, P30; Xu XK, 2002, NUTR CYCL AGROECOSYS, V64, P203, DOI 10.1023/A:1021188415246; Yu KW, 2004, GLOBAL BIOGEOCHEM CY, V18, DOI 10.1029/2004GB002251; Zheng X., 2000, CHEMOSPHERE GLOBAL C, V2, P207, DOI DOI 10.1016/S1465-9972(99)00056-2; Zhou S, 2009, WATER AIR SOIL POLL, V201, P135, DOI 10.1007/s11270-008-9933-3; Zou JW, 2005, GLOBAL BIOGEOCHEM CY, V19, DOI 10.1029/2004GB002401; Zou JW, 2009, AGR ECOSYST ENVIRON, V129, P516, DOI 10.1016/j.agee.2008.11.006	45	1	2	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	0925-8574	1872-6992		ECOL ENG	Ecol. Eng.	FEB	2015	75						24	32		10.1016/j.ecoleng.2014.11.034		9	Ecology; Engineering, Environmental; Environmental Sciences	Environmental Sciences & Ecology; Engineering	CB4LC	WOS:000349598200004		
J	Zhang, L; Wang, SR; Imai, A				Zhang, Li; Wang, Shengrui; Imai, Akio			Spatial and temporal variations in sediment enzyme activities and their relationship with the trophic status of Erhai Lake	ECOLOGICAL ENGINEERING			English	Article						Erhai Lake sediment; Enzyme activity; Trophic status; Eutrophication	ORGANIC-MATTER; NITROGEN; CHINA	The spatial and temporal variations in the activity of six microbial enzymes (invertase, urease, alkaline phosphatase, protease, peroxidase, and polyphenoloxidase) present in the sediment of Erhai Lake, China were investigated. Enzyme activities peaked in summer. This phenomenon can be attributed to high temperature and sediment organic matter accumulation, which could be traced to the breakdown of algal bloom. In addition, sediment enzyme activities exhibited apparent spatial heterogeneity across the lake, but individual enzymes showed similar spatial patterns of activity. Moreover, sediment enzyme activities were found to be closely related to the water quality of Erhai Lake. Enzyme activities were also significantly correlated with sediment total nitrogen and organic matter, implying that the sediment enzyme can be used as a biological indicator that reflects the sediment status. The investigation of sediment enzyme activities can facilitate a comprehensive understanding of the process of nutrient cycling and the mechanisms underlying lake eutrophication. (C) 2014 Elsevier B.V. All rights reserved.	[Zhang, Li; Wang, Shengrui] Chinese Res Inst Environm Sci, State Key Lab Environm Criteria & Risk Assessment, Beijing 100012, Peoples R China; [Zhang, Li; Wang, Shengrui] Chinese Res Inst Environm Sci, State Environm Protect Key Lab Lake Pollut Contro, Res Ctr Lake Ecoenvironm, Beijing 100012, Peoples R China; [Imai, Akio] Natl Inst Environm Studies, Tsukuba, Ibaraki, Japan	Wang, SR (reprint author), Chinese Res Inst Environm Sci, State Key Lab Environm Criteria & Risk Assessment, Beijing 100012, Peoples R China.	wangshengruia@163.com			National Natural Science Foundation of China [U1202235, 41103070]; Major Science and Technology Program for Water Pollution Control and Treatment [2012ZX07102-004]; Free Exploration Foundation of State Key Laboratory of Environmental Criteria and Risk Assessment, Chinese Research Academy of Environmental Sciences; Scientific Research Foundation for the Returned Overseas Chinese Scholars, State Education Ministry	This research was supported by the National Natural Science Foundation of China (nos. U1202235, 41103070), the Major Science and Technology Program for Water Pollution Control and Treatment (no. 2012ZX07102-004), the Free Exploration Foundation of State Key Laboratory of Environmental Criteria and Risk Assessment, Chinese Research Academy of Environmental Sciences, and the Scientific Research Foundation for the Returned Overseas Chinese Scholars, State Education Ministry.	Chen JJ, 2011, J ENVIRON SCI-CHINA, V23, P206, DOI 10.1016/S1001-0742(10)60394-4; Hill BH, 2010, BIOGEOCHEMISTRY, V97, P195, DOI 10.1007/s10533-009-9366-0; Zhang L, 2014, ESTUAR COAST SHELF S, V149, P178, DOI 10.1016/j.ecss.2014.08.009; Zhang L, 2013, ECOL ENG, V60, P336, DOI 10.1016/j.ecoleng.2013.07.027; Wallenstein MD, 2012, SOIL BIOL BIOCHEM, V47, P18, DOI 10.1016/j.soilbio.2011.12.009; Duarte B, 2008, CHEMOSPHERE, V73, P1056, DOI 10.1016/j.chemosphere.2008.07.072; CARLSON RE, 1977, LIMNOL OCEANOGR, V22, P361; Bolag J.M., 1992, SCI TOTAL ENVIRON, V117-118, P357; Corstanje R, 2007, ECOL INDIC, V7, P277, DOI 10.1016/j.ecolind.2006.02.002; Dong L.H., 2007, EUR J SOIL BIOL, V44, P166; Guan S., 1986, SOIL ENZYME ITS RES; Hu ZX, 2014, ECOL INDIC, V37, P1, DOI 10.1016/j.ecolind.2013.10.007; Lei H., 2012, ECOL ENG, V46, P98; Oyekola O, 2006, SOIL BIOL BIOCHEM, V38, P3511, DOI 10.1016/j.soilbio.2006.05.014; Pang X.Y., 2009, ACTA ECOLOGICA SINIC, V29, P286, DOI DOI 10.1016/J.CHNAES.2009.09.005; Sabine W., 2005, MICROB ECOL, V50, P253; SEPA (State Environmental Protection Administration) of China, 2002, MON AN METH WAT WAST; Standard of the People's Republic of China for Environmental Protection, 2007, 3992007 HJT STAND PE; Wu Q, 2014, ECOL ENG, V73, P311, DOI 10.1016/j.ecoleng.2014.09.088; Yang CX, 2010, ENVIRON EARTH SCI, V59, P1437, DOI 10.1007/s12665-009-0130-5; Zeng XA, 2010, J ENVIRON SCI-CHINA, V22, P1779, DOI 10.1016/S1001-0742(09)60319-3; Zhang L, 2013, ECOL ENG, V58, P91, DOI 10.1016/j.ecoleng.2013.06.006	22	1	1	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	0925-8574	1872-6992		ECOL ENG	Ecol. Eng.	FEB	2015	75						365	369		10.1016/j.ecoleng.2014.11.043		5	Ecology; Engineering, Environmental; Environmental Sciences	Environmental Sciences & Ecology; Engineering	CB4LC	WOS:000349598200044		
J	Jing, ZQ; He, R; Hu, Y; Niu, QG; Cao, SW; Li, YY				Jing, Zhaoqian; He, Rui; Hu, Yong; Niu, Qigui; Cao, Shiwei; Li, Yu-You			Practice of integrated system of biofilter and constructed wetland in highly polluted surface water treatment	ECOLOGICAL ENGINEERING			English	Article						Biofilter; Ceramic granule; Constructed wetland; Denitrification; Phosphorus removal	NITRIFYING TRICKLING FILTERS; DOMESTIC WASTE-WATER; PHOSPHORUS REMOVAL; NUTRIENT REMOVAL; RIVER WATER; FLY-ASH; QUALITY; CHINA; PERFORMANCE; EFFICIENCY	To find an appropriate process for highly polluted surface water, an integrated system with a double-layer biofilter and a constructed wetland was developed. In the biofilter packed with carbon-rich ceramic granules, alternation of nitrification and denitrification was realized resulting in prominent TN (total nitrogen) removal. The constructed wetland was designed in subsurface flow mode with 0.15 m depth filled with calcium-rich ceramic granules, which improved phosphorus removal greatly. COD (chemical oxygen demand), TN, NH4+-N and TP (total phosphorus) in the final effluent were mostly below 30, 15, 5 and 0.5 mg/L, respectively. The overall phosphorus removal rate in the constructed wetland reached 158.9 g/m(2) year, in which granules' interception and plants' uptake respectively contributed 74.7% and 25.3%. After one year's operation, the calcium content on the surface of the granules in the constructed wetland decreased obviously, whereas phosphorus content increased greatly. (C) 2014 Elsevier B.V. All rights reserved.	[Jing, Zhaoqian; He, Rui; Cao, Shiwei] Nanjing Forestry Univ, Coll Civil Engn, Nanjing 210037, Jiangsu, Peoples R China; [Hu, Yong; Niu, Qigui; Li, Yu-You] Tohoku Univ, Dept Civil & Environm Engn, Aoba Ku, Sendai, Miyagi 9808579, Japan; [Li, Yu-You] Xian Univ Architecture & Technol, MOE, Key Lab Northwest Water Resource Environm & Ecol, Xian 710055, Peoples R China	Jing, ZQ (reprint author), Nanjing Forestry Univ, Coll Civil Engn, Nanjing 210037, Jiangsu, Peoples R China.	zqjing@njfu.edu.cn; yyli@epl1.civil.tohoku.ac.jp		, Qigui/0000-0001-9061-3844	Technology Project of China Housing and Urban-Rural Development Ministry; Priority Academic Program Development of Jiangsu Higher Education Institutions (PAPD); China National Undergraduate Innovation Project [201310298031z]	This research was supported by the Technology Project of China Housing and Urban-Rural Development Ministry, the Project of the Priority Academic Program Development of Jiangsu Higher Education Institutions (PAPD) and China National Undergraduate Innovation Project (201310298031z).	Reddy KR, 1997, WATER SCI TECHNOL, V35, P1, DOI 10.1016/S0273-1223(97)00046-2; Murphy PNC, 2010, WATER AIR SOIL POLL, V212, P101, DOI 10.1007/s11270-010-0325-0; Wu HM, 2011, ECOL ENG, V37, P560, DOI 10.1016/j.ecoleng.2010.11.020; Li XN, 2010, ECOL ENG, V36, P382, DOI 10.1016/j.ecoleng.2009.11.004; Toscano A, 2009, ECOL ENG, V35, P281, DOI 10.1016/j.ecoleng.2008.07.011; Jing SR, 2001, BIORESOURCE TECHNOL, V76, P131, DOI 10.1016/S0960-8524(00)00100-0; Akratos CS, 2007, ECOL ENG, V29, P173, DOI 10.1016/j.ecoleng.2006.06.013; Kyambadde J, 2004, WATER RES, V38, P475, DOI 10.1016/j.watres.2003.10.008; Konnerup D, 2009, ECOL ENG, V35, P248, DOI 10.1016/j.ecoleng.2008.04.018; Sakadevan K, 1998, WATER RES, V32, P393, DOI 10.1016/S0043-1354(97)00271-6; Lahav O, 2001, WATER RES, V35, P397, DOI 10.1016/S0043-1354(00)00264-5; Lu SG, 2009, J HAZARD MATER, V161, P95, DOI 10.1016/j.jhazmat.2008.02.123; Korner S, 1998, WATER RES, V32, P3651, DOI 10.1016/S0043-1354(98)00166-3; Abou-Elela SI, 2012, ECOL ENG, V47, P209, DOI 10.1016/j.ecoleng.2012.06.044; Koiv M, 2010, WATER RES, V44, P5232, DOI 10.1016/j.watres.2010.06.044; Coveney MF, 2002, ECOL ENG, V19, P141, DOI 10.1016/S0925-8574(02)00037-X; Eding EH, 2006, AQUACULT ENG, V34, P234, DOI 10.1016/j.aquaeng.2005.09.007; Rai UN, 2013, BIORESOURCE TECHNOL, V148, P535, DOI 10.1016/j.biortech.2013.09.005; Jing ZQ, 2012, BIORESOURCE TECHNOL, V120, P212, DOI 10.1016/j.biortech.2012.06.069; Wendling LA, 2012, WATER RES, V46, P2705, DOI 10.1016/j.watres.2012.02.031; APHA-American Public Health Association AWWA - American Water Works Association WEF - Water Environment Federation, 1995, STANDARD METHODS EXA; Chen DJ, 2006, J ENVIRON SCI-CHINA, V18, P680; Cui LH, 2011, INT J PHYTOREMEDIAT, V13, P692, DOI 10.1080/15226514.2010.525552; Dunne EJ, 2012, ECOL ENG, V42, P90, DOI 10.1016/j.ecoleng.2012.01.019; Jenssen PD, 2005, J ENVIRON SCI HEAL A, V40, P1343, DOI 10.1081/ESE-200055846; Jenssen PD, 2010, ECOL ENG, V36, P1651, DOI 10.1016/j.ecoleng.2010.07.004; Kowalczak P, 2011, HYDROLOG SCI J, V56, P588, DOI 10.1080/02626667.2011.572554; Paredes J, 2010, SCI TOTAL ENVIRON, V408, P2576, DOI 10.1016/j.scitotenv.2010.02.037; Peacock S, 2000, J ENVIRON QUAL, V29, P1969; Prasad RM, 2012, J EUR CERAM SOC, V32, P477, DOI 10.1016/j.jeurceramsoc.2011.08.020; Qiu LP, 2010, BIORESOURCE TECHNOL, V101, P7245, DOI 10.1016/j.biortech.2010.04.034; Rahman S, 2008, WATER RESOUR MANAG, V22, P377, DOI 10.1007/s11269-007-9167-y; Stecher MC, 2003, ENVIRON TECHNOL, V24, P471; van den Akker B, 2008, WATER RES, V42, P4514, DOI 10.1016/j.watres.2008.07.038; Xia Y, 2012, WATER SCI TECHNOL, V66, P695, DOI 10.2166/wst.2012.200; Xu ZX, 2011, FRESEN ENVIRON BULL, V20, P2521	36	0	0	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	0925-8574	1872-6992		ECOL ENG	Ecol. Eng.	FEB	2015	75						462	469		10.1016/j.ecoleng.2014.12.015		8	Ecology; Engineering, Environmental; Environmental Sciences	Environmental Sciences & Ecology; Engineering	CB4LC	WOS:000349598200056		
J	Ming, J; Barpanda, P; Nishimura, S; Okubo, M; Yamada, A				Ming, Jun; Barpanda, Prabeer; Nishimura, Shin-ichi; Okubo, Masashi; Yamada, Atsuo			An alluaudite Na-2+Fe-2x(2-x)(SO4)(3)(x=0.2) derivative phase as insertion host for lithium battery	ELECTROCHEMISTRY COMMUNICATIONS			English	Article						Lithium batteries; Sodium batteries; Cathode; Alluaudite; Oxidation	ION BATTERIES; IRON PYROPHOSPHATE; CATHODE	A new desodiated derivative compound, Na0.89Fe1.8(SO4)(3), was prepared by the chemical oxidation of alluaudite Na2.4Fe1.8(SO4)(3) Phase using NOBF4 as oxidant. The structure and valency of Fe were characterized by X-ray diffraction (XRD) and Fe-57 Mossbauer spectroscopy. Intercalation behavior of lithium ions in the structure of Na0.89Fe1.8(SO4)(3) was gauged by electrochemical analyses and ex-situ X-ray diffraction. A high capacity of 110 mAh g(-1) at 0.1 C was obtained with a good rate kinetics within a range of 0.1-10 C(1 C = 118 mAh g-1) involving a high Fe3+/Fe2+ redox potential of 3.75 V (vs. Li/Li+). These results confirmed that the Na2.4-delta Fe1.8(SO4)(3) framework was stable even after oxidation and forms a new competitive cathode for the reversible intercalation of lithium ions. (C) 2014 Elsevier B.V. All rights reserved.	[Ming, Jun; Barpanda, Prabeer; Nishimura, Shin-ichi; Okubo, Masashi; Yamada, Atsuo] Univ Tokyo, Grad Sch Engn, Dept Chem Syst Engn, Tokyo 1138656, Japan; [Barpanda, Prabeer] Indian Inst Sci, Mat Res Ctr, Faraday Mat Lab, Bangalore 560012, Karnataka, India; [Ming, Jun; Barpanda, Prabeer; Nishimura, Shin-ichi; Okubo, Masashi; Yamada, Atsuo] Kyoto Univ, ESICB, Unit Element Strategy Initiat Catalysts & Batteri, Kyoto 6158510, Japan	Yamada, A (reprint author), Univ Tokyo, Grad Sch Engn, Dept Chem Syst Engn, Bunkyo Ku, 7-3-1 Hongo, Tokyo 1138656, Japan.	yamada@chemsys.t.u-tokyo.ac.jp	Barpanda, Prabeer/D-2781-2014; Okubo, Masashi/C-6360-2011; Yamada, Atsuo/A-4920-2011; Nishimura, Shin-ichi/B-2754-2011	Barpanda, Prabeer/0000-0003-0902-3690; Yamada, Atsuo/0000-0002-7880-5701; Nishimura, Shin-ichi/0000-0001-7464-8692	Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)	We acknowledge the financial support from the Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT) under the 'Elemental Strategy Initiative for Catalysts & Batteries' (ESICB) project.	Barpanda P, 2012, ELECTROCHEM COMMUN, V24, P116, DOI 10.1016/j.elecom.2012.08.028; Goodenough JB, 2010, CHEM MATER, V22, P587, DOI 10.1021/cm901452z; Rousse G, 2014, CHEM MATER, V26, P394, DOI 10.1021/cm4022358; Nishimura S, 2010, J AM CHEM SOC, V132, P13596, DOI 10.1021/ja106297a; MANTHIRAM A, 1989, J POWER SOURCES, V26, P403, DOI 10.1016/0378-7753(89)80153-3; Recham N, 2012, CHEM MATER, V24, P4363, DOI 10.1021/cm302428w; Barpanda P, 2011, NAT MATER, V10, P772, DOI [10.1038/nmat3093, 10.1038/NMAT3093]; Barpanda P, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms5358; Barpanda P., 2011, ADV ENERGY MATER, V2, P841; Oyama G., 2014, OFF STOICHIOME UNPUB; Recham N., 2009, NAT MATER, V9, P68; Ye T, 2013, CHEM MATER, V25, P3623, DOI 10.1021/cm401547z	12	4	4	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	1388-2481	1873-1902		ELECTROCHEM COMMUN	Electrochem. Commun.	FEB	2015	51						19	22		10.1016/j.elecom.2014.11.009		4	Electrochemistry	Electrochemistry	CB6ID	WOS:000349729800005		
J	Senoo, Y; Taniguchi, K; Kakinuma, K; Uchida, M; Uchida, H; Deki, S; Watanabe, M				Senoo, Yuichi; Taniguchi, Koji; Kakinuma, Katsuyoshi; Uchida, Makoto; Uchida, Hiroyuki; Deki, Shigehito; Watanabe, Masahiro			Cathodic performance and high potential durability of Ta-SnO2-delta-supported Pt catalysts for PEFC cathodes	ELECTROCHEMISTRY COMMUNICATIONS			English	Article						Tantalum doped tin oxide; Electrical conductivity; Oxygen reduction reaction; Durability; PEFC; Fused aggregate structure	ELECTROLYTE FUEL-CELLS; CARBON-FREE; SUPPORTS; DEGRADATION; SNO2	We evaluated the cathodic activity and durability of Pt/Ta-SnO2-delta catalysts for the cathodes of polymer electrolyte fuel cells (PEFCs). The Ta-SnO2-delta support had a unique fused aggregated structure, for which the electrical conductivity was ca. 40 times higher than that of another candidate high-durability support, Nb-SnO2-delta with the same support structure. The kinetically controlled current density value at 0.85 V for Pt/Ta-SnO2-delta reached 0.97 mA cm(-2), which was higher than that for a commercial Pt/CB. Chemical stability of Ptfra-SnO2-delta in the high potential range (0.9-1.3 V) was the same as that of the high-durability Pt/Nb-SnO2-delta catalyst and was superior to that of commercial Pt/CB and Pt/GCB. We demonstrated that the more highly electrically conductive Pt/Ta-SnO2-delta is an attractive catalyst for the construction of low-resistance catalyst layers of membrane-electrode assemblies with decreased overpotentials. Thus, we conclude that the Pt/Ta-doped SnO2-delta catalyst is a superior cathode candidate catalyst for PEFCs. (C) 2014 Elsevier B.V. All rights reserved.	[Senoo, Yuichi; Kakinuma, Katsuyoshi; Uchida, Makoto; Uchida, Hiroyuki; Deki, Shigehito; Watanabe, Masahiro] Univ Yamanashi, Fuel Cell Nanomat Ctr, Kofu, Yamanashi 4000021, Japan; [Uchida, Hiroyuki] Univ Yamanashi, Clean Energy Res Ctr, Kofu, Yamanashi 4008511, Japan; [Senoo, Yuichi; Taniguchi, Koji] Mitsui Min & Smelting Co Ltd, Engn Mat Sect R&D Ctr, Ageo, Saitama 3620021, Japan	Kakinuma, K (reprint author), Univ Yamanashi, Fuel Cell Nanomat Ctr, Miyamae 6-43, Kofu, Yamanashi 4000021, Japan.	kkakinuma@yamanashi.ac.jp; uchidam@yamanashi.ac.jp; m-watanabe@yamanashi.ac.jp			"Research on Nanotechnology for High Performance Fuel Cells" (HiPer-FC) project from the New Energy and Industrial Technology Development Organization (NEDO) of Japan; Ministry of Education, Science, Sports, and Culture of Japan [B24350093]	This work was partially supported by funds for the "Research on Nanotechnology for High Performance Fuel Cells" (HiPer-FC) project from the New Energy and Industrial Technology Development Organization (NEDO) of Japan, and a Scientific Research Grant (B24350093) from the Ministry of Education, Science, Sports, and Culture of Japan.	Kakinuma K, 2013, ELECTROCHIM ACTA, V110, P316, DOI 10.1016/j.electacta.2013.06.127; Yano H, 2010, PHYS CHEM CHEM PHYS, V12, P3806, DOI 10.1039/b923460h; Hoshi T, 2012, B CHEM SOC JPN, V85, P389, DOI 10.1246/bcsj.20110305; Park YC, 2014, ELECTROCHIM ACTA, V123, P84, DOI 10.1016/j.electacta.2013.12.120; Ignaszak A, 2012, ELECTROCHIM ACTA, V69, P397, DOI 10.1016/j.electacta.2012.03.039; UCHIDA M, 1995, J ELECTROCHEM SOC, V142, P2572, DOI 10.1149/1.2050055; Yoda T, 2007, ELECTROCHIM ACTA, V52, P5997, DOI 10.1016/j.electacta.2007.03.049; Takasaki F, 2011, J ELECTROCHEM SOC, V158, pB1270, DOI 10.1149/1.3625918; Coutanceau C, 2000, ELECTROCHIM ACTA, V46, P579, DOI 10.1016/S0013-4686(00)00641-1; Senoo Y, 2014, RSC ADV, V4, P32180, DOI 10.1039/c4ra03988b; WATANABE M, 1989, J ELECTROANAL CHEM, V261, P375, DOI 10.1016/0022-0728(89)85006-5; Nakao S, 2010, APPL PHYS EXPRESS, V3, DOI 10.1143/APEX.3.031102; Aoki T, 2010, J POWER SOURCES, V195, P2182, DOI 10.1016/j.jpowsour.2009.10.074; Keerthi S., 2012, ELECTROCHIM ACTA, V59, P538; Liu Y, 2014, ELECTROCHIM ACTA, V115, P116, DOI 10.1016/j.electacta.2013.10.155; liyama A., 2009, HDB FUEL CELLS, V6; Masao A, 2009, ELECTROCHEM SOLID ST, V12, pB119, DOI 10.1149/1.3152325	17	3	3	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	1388-2481	1873-1902		ELECTROCHEM COMMUN	Electrochem. Commun.	FEB	2015	51						37	40		10.1016/j.elecom.2014.12.005		4	Electrochemistry	Electrochemistry	CB6ID	WOS:000349729800009		
J	Nguyen, KB; Dan, T; Asano, I				Kim-Bao Nguyen; Dan, Tomohisa; Asano, Ichiro			Effect of double injection on combustion, performance and emissions of Jatropha water emulsion fueled direct-injection diesel engine	ENERGY			English	Article						Jatropha oil; Jatropha water emulsion; Double fuel injection; Combustion; Emissions	COMPRESSION IGNITION ENGINE; SPLIT INJECTION; OIL; BIODIESEL; BLENDS; STRATEGIES; REDUCTION; EGR	The experimental study was carried out using a four-stroke, high speed, DI (direct-injection) diesel engine with double fuel injections. In this study, Jatropha water emulsion was made by mixing a mass ratio of 10% of water. While fixing the first injection timing, we tested the engine on JWE (Jatropha water emulsion) with various injection timings and quantities of second injections. The acquired data was analyzed for various combustion parameters such as heat release rate, combustion center (timing of 50% of total heat release), ignition delay, and combustion duration; for performance parameters such as in-cylinder temperature, exhaust gas temperature, brake thermal efficiency; and emissions of CO (carbon monoxide), CO2 (carbon dioxide), HC (hydrocarbons), NOx (nitrogen oxides), as well as dust and smoke opacity. When using a large second injection amount, we found a significant reduction in the peaks of the in-cylinder pressure, HRR (heat release rate), and average in-cylinder temperatures. We also found a drastic increase in the ignition delay, combustion duration, and a shift in the combustion center toward the later combustion stage, as well as increased exhaust gas temperatures, and reduced brake thermal efficiency compared with those of the Light oil. A large second injection amount reduced NOx emissions up to 48%, and drastically reduced HC emissions at higher loads of the engine. (C) 2014 Elsevier Ltd. All rights reserved.	[Kim-Bao Nguyen; Dan, Tomohisa; Asano, Ichiro] Kobe Univ, Fac Maritime Sci, Higashinada Ku, Kobe, Hyogo 6580022, Japan	Dan, T (reprint author), Kobe Univ, Fac Maritime Sci, Higashinada Ku, 5-1-1 Fukaeminami, Kobe, Hyogo 6580022, Japan.	dan@maritime.kobe-u-ac.jp					Agarwal AK, JATROPHA CHALLENGES, V1; Agarwal D, 2007, APPL THERM ENG, V27, P2314, DOI 10.1016/j.applthermaleng.2007.01.009; Altin R, 2001, ENERG CONVERS MANAGE, V42, P529, DOI 10.1016/S0196-8904(00)00080-7; Mofijur M, 2013, ENERGY, V55, P879, DOI 10.1016/j.energy.2013.02.059; Pramanik K, 2003, RENEW ENERG, V28, P239, DOI 10.1016/S0960-1481(02)00027-7; Yehliu K, 2010, FUEL, V89, P423, DOI 10.1016/j.fuel.2009.08.025; Chauhan BS, 2010, ENERGY, V35, P2484, DOI 10.1016/j.energy.2010.02.043; Choi CY, 1999, FUEL, V78, P1303, DOI 10.1016/S0016-2361(99)00058-7; Maiboom A, 2011, FUEL, V90, P3179, DOI 10.1016/j.fuel.2011.06.014; Kim MY, 2008, ENERG FUEL, V22, P1260, DOI 10.1021/ef700537w; No SY, 2011, RENEW SUST ENERG REV, V15, P131, DOI 10.1016/j.rser.2010.08.012; Mobasheri R, 2012, INT J HEAT FLUID FL, V33, P59, DOI 10.1016/j.ijheatfluidflow.2011.10.004; Chauhan BS, 2012, ENERGY, V37, P616, DOI 10.1016/j.energy.2011.10.043; Qi DH, 2011, FUEL, V90, P1884, DOI 10.1016/j.fuel.2011.01.016; Park SH, 2011, APPL ENERG, V88, P88, DOI 10.1016/j.apenergy.2010.07.024; Prakash R, 2013, ENERGY, V55, P610, DOI 10.1016/j.energy.2013.03.085; Armas Ballesteros, 2005, FUEL, V84, P1011; Crookes RJ, 1997, ENERG CONVERS MANAGE, V38, P1785, DOI 10.1016/S0196-8904(96)00202-6; Ghojel J, 2006, APPL THERM ENG, V26, P2132, DOI 10.1016/j.applthermaleng.2006.04.014; Hemmerlein N, 1991, 910848 SAE; Huzayyiln AS, 2004, ENERG CONVERS MANAGE, V45, P2093, DOI 10.1016/j.enconman.2003.10.017; Kumar MS, 2003, BIOMASS BIOENERG, V25, P309, DOI 10.1016/S0961-9534(03)00018-7; Miyawaki N, 2011, J JPN I MAR ENG, V46, P752; Nguyen KB, 2014, ENERGY, V74, P301, DOI 10.1016/j.energy.2014.03.120; Nguyen LDK, 2011, INT J AUTO TECH-KOR, V12, P339, DOI 10.1007/s12239-011-0040-x; Ochoterena R, 2010, FUEL, V89, P122, DOI 10.1016/j.fuel.2009.06.039	26	1	1	PERGAMON-ELSEVIER SCIENCE LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND	0360-5442	1873-6785		ENERGY	Energy	FEB 1	2015	80						746	755		10.1016/j.energy.2014.12.033		10	Thermodynamics; Energy & Fuels	Thermodynamics; Energy & Fuels	CB6FS	WOS:000349723500069		
J	Yoshimura, M; Zhang, SW; Ueda, Y; Matsuda, K; Imai, K; Takahashi, Y; Inoue, Y				Yoshimura, Masaki; Zhang, Shouwen; Ueda, Yuki; Matsuda, Kazumi; Imai, Katsumi; Takahashi, Yukitoshi; Inoue, Yushi			An analysis of epileptic negative myoclonus by magnetoencephalography	EPILEPSY RESEARCH			English	Article						Negative myoclonus; Magnetoencephalography; Cortical dysplasia; Epilepsy; Silent-periodlocked-averaging	INVOLVEMENT	Purpose: To clarify the neurophysiologic mechanism of epileptic negative myoclonus (ENM), we analyzed the magnetoencephalography (MEG) of a patient with ENM. Methods: The 52-year-old right-handed male had frequent ENM in the right upper limb during awake and monthly seizures with sudden tonic stiffening of the right forearm during sleep. MRI demonstrated a focal cortical dysplasia in the cortex of the posterior portion of the left superior frontal sulcus. Whole-head type MEG, electroencephalography and electromyography were simultaneously recorded during ENM. Single equivalent currents dipoles (ECDs) were calculated for each spike component followed by silent period (SP) in the right deltoid muscle. These MEG spike components were averaged with respect to their peaks, and single ECD was also calculated for the averaged spike component. Furthermore, we analyzed the MEG with the silent-period-locked-averaging (SPLA) method. Twenty MEG signal data were averaged with respect to the onset of SR Twenty epochs in each of five separate periods of recording were repeatedly averaged. ECDs were calculated for spike components observed in each averaged epoch. Results: ECDs of each spike followed by SP were clustered near the cortex of the left central sulcus. In MEG spike averaging and SPLA method, ECDs at the peak of spike components were located near the right shoulder division of the primary sensorimotor cortex reproducibly. ECDs on the ascending phase before the peak were located lateral to the above ECD location in MEG spike averaging method. Conclusions: ENM was produced by an inhibitory action on the primary sensorimotor cortex corresponding to the body segment in which ENM occurs. (C) 2014 Elsevier B.V. All rights reserved.	[Yoshimura, Masaki; Zhang, Shouwen; Ueda, Yuki; Matsuda, Kazumi; Imai, Katsumi; Takahashi, Yukitoshi; Inoue, Yushi] Shizuoka Inst Epilepsy & Neurol Disorders, Natl Epilepsy Ctr, Aoi Ku, Shizuoka 4208688, Japan	Yoshimura, M (reprint author), Shizuoka Inst Epilepsy & Neurol Disorders, Natl Epilepsy Ctr, Aoi Ku, Urushiyama 886, Shizuoka 4208688, Japan.	yosimura@szec.hosp.go.jp; george12188@126.com; ueda.de.yuki@gmail.com; matsuda-1@hosp.go.jp; imaik-1@hosp.go.jp; takahashi-ped@umin.ac.jp; yinoue-jes@umin.net					HAMALAINEN M, 1993, REV MOD PHYS, V65, P413, DOI 10.1103/RevModPhys.65.413; Ikeda A, 2000, BRAIN, V123, P1710, DOI 10.1093/brain/123.8.1710; Rubboli G, 2006, BRAIN, V129, P65, DOI 10.1093/brain/awh661; Noachtar S, 1997, NEUROLOGY, V49, P1534; UGAWA Y, 1989, J NEUROL NEUROSUR PS, V52, P89, DOI 10.1136/jnnp.52.1.89; Baumgartner C, 1996, NEUROLOGY, V46, P753; Capovilla G, 2000, NEUROPEDIATRICS, V31, P273, DOI 10.1055/s-2000-9237; GUERRINI R, 1993, NEUROLOGY, V43, P1078; Kubota M, 2005, SEIZURE-EUR J EPILEP, V14, P28, DOI 10.1016/j.seizure.2004.02.007; Meletti S, 2000, EPILEPTIC DISORD, V2, P163; Oguni H, 1998, NEUROPEDIATRICS, V29, P29, DOI 10.1055/s-2007-973530; RUBBOLI G, 1995, ELECTROEN CLIN NEURO, V95, P201, DOI 10.1016/0013-4694(95)00144-N; Song In-Uk, 2006, J Clin Neurol, V2, P272, DOI 10.3988/jcn.2006.2.4.272; Tassinari C.A., 1981, P INT PUBL SEM EP TO, P42; TASSINARI CA, 1995, ADV NEUROL, V67, P181; Usui K, 2010, EPILEPSY RES, V89, P220, DOI 10.1016/j.eplepsyres.2010.01.004; Wennberg R, 2014, CLIN NEUROPHYSIOL, V125, P903, DOI 10.1016/j.clinph.2013.08.032; Yu HY, 2009, EPILEPSY BEHAV, V14, P687, DOI 10.1016/j.yebeh.2009.01.025	18	0	0	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	0920-1211	1872-6844		EPILEPSY RES	Epilepsy Res.	FEB	2015	110						139	145		10.1016/j.eplepsyres.2014.12.002		7	Clinical Neurology	Neurosciences & Neurology	CB4JA	WOS:000349592800018		
J	Atif, SM; Lee, SJ; Li, LX; Uematsu, S; Akira, S; Gorjestani, S; Lin, X; Schweighoffer, E; Tybulewicz, VLJ; McSorley, SJ				Atif, Shaikh M.; Lee, Seung-Joo; Li, Lin-Xi; Uematsu, Satoshi; Akira, Shizuo; Gorjestani, Sara; Lin, Xin; Schweighoffer, Edina; Tybulewicz, Victor L. J.; McSorley, Stephen J.			Rapid CD4(+) T-cell responses to bacterial flagellin require dendritic cell expression of Syk and CARD9	EUROPEAN JOURNAL OF IMMUNOLOGY			English	Article						Bacterial infection; CARD9; CD4(+) T cells; Syk; TLRs	CHEMICALLY MODIFIED FLAGELLIN; INNATE IMMUNE-RESPONSE; TOLL-LIKE RECEPTOR-5; C-TYPE LECTINS; NF-KAPPA-B; HOST-DEFENSE; IN-VIVO; SALMONELLA-TYPHIMURIUM; TYROSINE KINASE; ACTIVATION	Toll-like receptors (TLRs) can recognize microbial patterns and utilize adaptor molecules, such as-MyD88 or (TRIF TIR-domain-containing adapter-inducing interferon-beta), to initiate downstream signaling that ultimately affects the initiation of adaptive immunity. In addition to this inflammatory role, TLR5 expression on dendritic cells can favor antigen presentation of flagellin peptides and thus increase the sensitivity of flagellin-specific T-cell responses in vitro and in vivo. Here, we examined the role of alternative signaling pathways that might regulate flagellin antigen presentation in addition to MyD88. These studies suggest a requirement for spleen tyrosine kinase, a noncanonical TLR-signaling adaptor molecule, and its downstream molecule CARD9 in regulating the sensitivity of flagellin-specific CD4(+) T-cell responses in vitro and in vivo. Thus, a previously unappreciated signaling pathway plays an important role in regulating the dominance of flagellin-specific T-cell responses.	[Atif, Shaikh M.; Lee, Seung-Joo; Li, Lin-Xi; McSorley, Stephen J.] Univ Calif Davis, Dept Anat Physiol & Cell Biol, Ctr Comparat Med, Davis, CA 95616 USA; [Akira, Shizuo] Osaka Univ, Host Def Lab, WPI Immunol Frontier Res Ctr, Suita, Osaka, Japan; [Uematsu, Satoshi] Chiba Univ, Sch Med, Dept Mucosal Immunol, Chuou Ku, Chiba, Japan; [Gorjestani, Sara; Lin, Xin] Univ Texas MD Anderson Canc Ctr, Dept Mol & Cellular Oncol, Houston, TX 77030 USA; [Schweighoffer, Edina; Tybulewicz, Victor L. J.] Natl Inst Med Res, MRC, London NW7 1AA, England	Atif, SM (reprint author), Univ Calif Davis, Ctr Comparat Med, Cty Rd 98 & Hutchison Dr, Davis, CA 95616 USA.	atif78sm@gmail.com; sjmcsorley@ucdavis.edu	Akira, Shizuo/C-3134-2009		National Institutes of Health [AI076278, AI055743]; MRC [U117527252]	The authors acknowledge the many helpful discussions with current and past members of the McSorley laboratory and the laboratory of Dr. N. Baumgarth in completion of these experiments. This work was supported by grants to S.J.M. from the National Institutes of Health AI076278 and AI055743. V.L.J.T. and E.S. were funded by the MRC program number U117527252.	Parish CR, 1999, IMMUNOL CELL BIOL, V77, P499, DOI 10.1046/j.1440-1711.1999.00877.x; Franchi L, 2006, NAT IMMUNOL, V7, P576, DOI 10.1038/ni1346; Mizel SB, 2010, J IMMUNOL, V185, P5677, DOI 10.4049/jimmunol.1002156; Rogers NC, 2005, IMMUNITY, V22, P507, DOI 10.1016/j.immuni.2005.03.004; Franchi L, 2012, NAT IMMUNOL, V13, P449, DOI 10.1038/ni.2263; Gringhuis SI, 2007, IMMUNITY, V26, P605, DOI 10.1016/j.immuni.2007.03.012; Barnden MJ, 1998, IMMUNOL CELL BIOL, V76, P34, DOI 10.1046/j.1440-1711.1998.00709.x; Bobat S, 2011, EUR J IMMUNOL, V41, P1606, DOI 10.1002/eji.201041089; Vijay-Kumar M, 2010, EUR J IMMUNOL, V40, P3528, DOI 10.1002/eji.201040421; Hara H, 2013, NAT IMMUNOL, V14, P1247, DOI 10.1038/ni.2749; Akira S, 2004, NAT REV IMMUNOL, V4, P499, DOI 10.1038/nri1391; Lodes MJ, 2004, J CLIN INVEST, V113, P1296, DOI 10.1172/JCI200420295; TURNER M, 1995, NATURE, V378, P298, DOI 10.1038/378298a0; Salazar-Gonzalez RM, 2005, IMMUNOL LETT, V101, P117, DOI 10.1016/j.imlet.2005.05.004; Ramos HC, 2004, TRENDS MICROBIOL, V12, P509, DOI 10.1016/j.tim.2004.09.002; Mocsai A, 2010, NAT REV IMMUNOL, V10, P387, DOI 10.1038/nri2765; Kaden SA, 2009, J IMMUNOL, V183, P5069, DOI 10.4049/jimmunol.0900908; Janeway CA, 2002, ANNU REV IMMUNOL, V20, P197, DOI 10.1146/annurev.immunol.20.083001.084359; Lightfield KL, 2008, NAT IMMUNOL, V9, P1171, DOI 10.1038/ni.1646; Drummond RA, 2011, CURR OPIN MICROBIOL, V14, P392, DOI 10.1016/j.mib.2011.07.001; Uematsu S, 2006, NAT IMMUNOL, V7, P868, DOI 10.1038/ni1362; Mariathasan S, 2004, NATURE, V430, P213, DOI 10.1038/nature02664; O'Neill LAJ, 2007, NAT REV IMMUNOL, V7, P353, DOI 10.1038/nri2079; Drummond RA, 2011, EUR J IMMUNOL, V41, P276, DOI 10.1002/eji.201041252; McSorley SJ, 2000, J IMMUNOL, V164, P986; Saijo S, 2007, NAT IMMUNOL, V8, P39, DOI 10.1038/ni1425; Hayashi F, 2001, NATURE, V410, P1099, DOI 10.1038/35074106; Vijay-Kumar M, 2009, INFLAMM BOWEL DIS, V15, P789, DOI 10.1002/ibd.20734; Kerrigan AM, 2011, TRENDS IMMUNOL, V32, P151, DOI 10.1016/j.it.2011.01.002; Medzhitov R, 2002, SCIENCE, V296, P298, DOI 10.1126/science.1068883; Akira S, 2001, NAT IMMUNOL, V2, P675, DOI 10.1038/90609; Hsu YMS, 2007, NAT IMMUNOL, V8, P198, DOI 10.1038/ni1426; McSorley SJ, 2002, IMMUNITY, V16, P365, DOI 10.1016/S1074-7613(02)00289-3; Gross O, 2009, NATURE, V459, P433, DOI 10.1038/nature07965; Letran SE, 2011, EUR J IMMUNOL, V41, P29, DOI 10.1002/eji.201040717; Flores-Langarica A, 2012, J IMMUNOL, V189, P5745, DOI 10.4049/jimmunol.1202283; Gohda J, 2004, J IMMUNOL, V173, P2913; Akira S, 2006, CELL, V124, P783, DOI 10.1016/j.cell.2006.02.015; Adachi O, 1998, IMMUNITY, V9, P143, DOI 10.1016/S1074-7613(00)80596-8; Atif SM, 2014, MUCOSAL IMMUNOL, V7, P68, DOI 10.1038/mi.2013.25; Bates JT, 2009, J IMMUNOL, V182, P7539, DOI 10.4049/jimmunol.0804225; Carvalho FA, 2012, MUCOSAL IMMUNOL, V5, P288, DOI 10.1038/mi.2012.8; McSorley SJ, 2002, J IMMUNOL, V169, P3914; Ospelt C, 2010, INT J BIOCHEM CELL B, V42, P495, DOI 10.1016/j.biocel.2009.10.010; PARISH CR, 1971, J EXP MED, V134, P21, DOI 10.1084/jem.134.1.21; PARISH CR, 1971, J EXP MED, V134, P1, DOI 10.1084/jem.134.1.1; Ruland J, 2008, ANN NY ACAD SCI, V1143, P35, DOI 10.1196/annals.1443.024; Salazar-Gonzalez RM, 2007, J IMMUNOL, V179, P6169; Savva A, 2013, FRONT IMMUNOL, V4, DOI 10.3389/fimmu.2013.00387; Srinivasan A, 2004, J IMMUNOL, V173, P4091; Tallant T, 2004, BMC MICROBIOL, V4, DOI 10.1186/1471-2180-4-33; Yarovinsky F, 2006, IMMUNITY, V25, P655, DOI 10.1016/j.immuni.2006.07.015	52	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0014-2980	1521-4141		EUR J IMMUNOL	Eur. J. Immunol.	FEB	2015	45	2					513	524		10.1002/eji.201444744		12	Immunology	Immunology	CB4VC	WOS:000349625400020		
J	Samejima, T; Koga, K; Nakae, H; Wada-Hiraike, O; Fujimoto, A; Fujii, T; Osuga, Y				Samejima, Taiki; Koga, Kaori; Nakae, Hanako; Wada-Hiraike, Osamu; Fujimoto, Akihisa; Fujii, Tomoyuki; Osuga, Yutaka			Identifying patients who can improve fertility with myomectomy	EUROPEAN JOURNAL OF OBSTETRICS & GYNECOLOGY AND REPRODUCTIVE BIOLOGY			English	Article						Uterine fibroids; Infertility; Myomectomy	INTRAMURAL UTERINE FIBROIDS; ENDOMETRIAL CAVITY	Objective: To identify the characteristics of cases and fibroids that will indicate which patients should undergo myomectomy to improve fertility. Materials and methods: We recruited patients (n = 101) who had undergone myomectomy to improve fertility and received follow-up care for at least six months by the hospital. Medical records were retrospectively reviewed to analyze the pregnancy rates after myomectomy and to identify clinical factors that correlate with pregnancy rates. Cumulative pregnancy rates were analyzed using the Kaplan-Meier method and the Log rank test. The patients were then divided into three groups according to the timing of the myomectomy. The analysis was performed for all patients, for patients in the postsuperovulation and/or intrauterine insemination (post-SO/IUI) group and the post-assisted reproductive technology (post-ART) group combined, and for patients in the post-ART group. Results: Sixty-three pregnancies were achieved by 58 patients (57.4%) who underwent myomectomy. The mean time period between surgery and conception was 9.8 months. Most pregnancies (91.5%) were achieved within two years after surgery. Pregnancy rates were higher in patients aged less than 36 years, with no male factors, and without severe endometriosis, in comparison with patients 36 years of age or older (p < 0.05), with male factor (p < 0.05), and severe endometriosis (p < 0.05). In the analysis of the post-ART group, pregnancy rates were higher (p < 0.05) in cases where enucleation had penetrated the endometrial cavity in comparison with patients where the cavity was not penetrated; however, fibroid characteristics did not correlate with the post-myomectomy pregnancy rate in the post-SO/IUI plus post-ART group. Conclusion: Post-myomectomy pregnancy rates were higher in women who did not have additional infertility factors. These results suggest that the removal of fibroids benefits especially patients who suffer from infertility of an otherwise unknown cause: surgery should be strongly recommended for these patients. Our study also shows the difficulty in identifying fibroids for removal to improve fertility. Further studies are needed to develop new diagnostic techniques for identifying patients who can improve fertility with myomectomy. (C) 2014 Elsevier Ireland Ltd. All rights reserved.	[Samejima, Taiki; Koga, Kaori; Nakae, Hanako; Wada-Hiraike, Osamu; Fujimoto, Akihisa; Fujii, Tomoyuki; Osuga, Yutaka] Univ Tokyo, Dept Obstet & Gynecol, Bunkyo Ku, Tokyo 1138655, Japan	Koga, K (reprint author), Univ Tokyo, Dept Obstet & Gynecol, Bunkyo Ku, 7-3-1 Hongo, Tokyo 1138655, Japan.	kawotan-tky@umin.ac.jp			Ministry of Health, Labor and Welfare [26462478]; Ministry of Education	The authors thank medical colleagues in the University of Tokyo Hospital, and Dr. Kate Hale for editing the manuscript. This work was supported by grants from the Ministry of Health, Labor and Welfare (26462478) and the Ministry of Education (KK).	Stewart EA, 2001, LANCET, V357, P293, DOI 10.1016/S0140-6736(00)03622-9; Khalaf Y, 2006, HUM REPROD, V21, P2640, DOI 10.1093/humrep/del218; Bulletti C, 1999, J AM ASSOC GYN LAP, V6, P441, DOI 10.1016/S1074-3804(99)80008-5; Yoshino O, 2012, J MINIM INVAS GYN, V19, P63, DOI 10.1016/j.jmig.2011.09.010; Somigliana E, 2007, HUM REPROD UPDATE, V13, P465, DOI 10.1093/humupd/dmm013; Brady PC, 2013, CURR OPIN OBSTET GYN, V25, P255, DOI 10.1097/GCO.0b013e3283612188; Check JH, 2002, HUM REPROD, V17, P1244, DOI 10.1093/humrep/17.5.1244; Metwally M, 2012, COCHRANE COLLAB; Oliveira FG, 2004, FERTIL STERIL, V81, P582, DOI 10.1016/j.fertnstert.2003.08.034; Salim R, 2005, HUM REPROD, V20, P253, DOI 10.1093/humrep/deh557; Somigliana E, 2011, HUM REPROD, V26, P834, DOI 10.1093/humrep/der015; Yoshino O, 2011, FERTIL STERIL, V95, P2781, DOI 10.1016/j.fertnstert.2011.01.032	12	0	0	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	0301-2115	1872-7654		EUR J OBSTET GYN R B	Eur. J. Obstet. Gynecol. Reprod. Biol.	FEB	2015	185						28	32		10.1016/j.ejogrb.2014.11.033		5	Obstetrics & Gynecology; Reproductive Biology	Obstetrics & Gynecology; Reproductive Biology	CB3BT	WOS:000349503900006		
J	Da Silva, F; Suwa, R; Kajimoto, T; Ishizuka, M; Higuchi, N; Kunert, N				Da Silva, Fernando; Suwa, Rempei; Kajimoto, Takuya; Ishizuka, Moriyoshi; Higuchi, Niro; Kunert, Norbert			Allometric Equations for Estimating Biomass of Euterpe precatoria, the Most Abundant Palm Species in the Amazon	FORESTS			English	Article							STILT ROOT STRUCTURE; FOREST BIOMASS; BRAZILIAN AMAZON; SPATIAL-DISTRIBUTION; ARBORESCENT PALMS; CARBON; ARECACEAE; BALANCE; STEM	Allometric models to estimate biomass components such as stem mass M-s, foliage mass M-l, root mass M-r and aboveground mass M-a, were developed for the palm species Euterpe precatoria Mart., which is the most abundant tree species in the Amazon. We harvested twenty palms including above- and below-ground parts in an old growth Amazonian forest in Brazil. The diameter at breast height D ranged from 3.9-12.7 cm, and the stem height H ranged from 2.3-16.4 m. The D, diameter at ground basis D-0, crown diameter CD, H, stem specific gravity rho, and number of fronds N-f were considered as independent variables and incorporated into a power function model. The best predictors were (DH)-H-2 rho for M-s and M-a, (DHNf)-H-2 for M-l, and D for M-r. Slender index (H/D) ranged from 0.56-1.46 m center dot cm(-1), and the D-H relationship suggested that the stem shape becomes more slender with increasing D. On the other hand, rho increased with D implying a stiffening of stem tissue. The average root/shoot ratio was estimated as 0.29 which was higher than that reported for the non-palm tree species in the Amazon. Comparisons of several models to estimate M-a of different palm species, suggested that the variations of the D-H relationship and rho should be considered to develop allometric models for estimating biomass in palm species. In particular the rho largely varied depending on individual size, which should be important to consider, when developing the allometric models for palms.	[Da Silva, Fernando; Higuchi, Niro; Kunert, Norbert] Brazilian Natl Inst Res Amazon, Lab Forest Management, BR-69060000 Manaus, Amazonas, Brazil; [Suwa, Rempei] Kansai Res Ctr, Forestry & Forest Prod Res Inst, Fushimi Ku, Kyoto 6120855, Japan; [Kajimoto, Takuya; Ishizuka, Moriyoshi] Forestry & Forest Prod Res Inst, Tsukuba, Ibaraki 3058687, Japan; [Kunert, Norbert] Max Planck Inst Biogeochem, Dept Biogeochem Proc, D-07745 Jena, Germany	Suwa, R (reprint author), Kansai Res Ctr, Forestry & Forest Prod Res Inst, Fushimi Ku, 68 Nagaikyutaroh, Kyoto 6120855, Japan.	silvaflorestal@gmail.com; swrmp2005@yahoo.co.jp; tkaji@ffpri.affrc.go.jp; moriyoshi@jifpro.or.jp; niro@inpa.gov.br; nkunert@bgc-jena.mpg.de			Science and the Technology Research Partnership for Sustainable Development program of the Japan Science and Technology Agency; Japan International Cooperation Agency	The authors thank all members of the international cooperative research project of Carbon Dynamics of Amazonian Forests, and Susan Trumbore and Masahiro Saitoh for their valuable suggestions. Special thanks to Alida Mercado Cardenas for English editing, and anonymous reviewers for their valuable suggestions on the early version of this manuscript. This study was financially supported by the Science and the Technology Research Partnership for Sustainable Development program of the Japan Science and Technology Agency and the Japan International Cooperation Agency. We also want to thank the Brewery Bohemia for brewing some decent pilsener which gave us the inspiration to initiate the Amazon Palm Experiment (APE) project during some pleasant nights sitting in front of the Amazon Theatre.	Alves L. F., 2004, Acta Botanica Brasilica, V18, P369, DOI 10.1590/S0102-33062004000200016; Laurance WF, 1999, FOREST ECOL MANAG, V118, P127, DOI 10.1016/S0378-1127(98)00494-0; Houghton RA, 2005, GLOBAL CHANGE BIOL, V11, P945, DOI 10.1111/j.1365-2486.2005.00955.x; Houghton RA, 2001, GLOBAL CHANGE BIOL, V7, P731, DOI 10.1046/j.1365-2486.2001.00426.x; Mokany K, 2006, GLOBAL CHANGE BIOL, V12, P84, DOI 10.1111/j.1365-2486.2005.001043.x; Avalos G, 2010, AM J BOT, V97, P388, DOI 10.3732/ajb.0900149; Cole TG, 2006, FOREST ECOL MANAG, V229, P351, DOI 10.1016/j.foreco.2006.04.017; Chave J, 2005, OECOLOGIA, V145, P87, DOI 10.1007/s00442-005-0100-x; BRAVARD S, 1989, GEODERMA, V44, P29, DOI 10.1016/0016-7061(89)90004-9; Ngomanda A, 2014, FOREST ECOL MANAG, V312, P1, DOI 10.1016/j.foreco.2013.10.029; Chambers JQ, 2001, FOREST ECOL MANAG, V152, P73, DOI 10.1016/S0378-1127(00)00591-0; Brown S, 2002, ENVIRON POLLUT, V116, P363, DOI 10.1016/S0269-7491(01)00212-3; Cairns MA, 1997, OECOLOGIA, V111, P1, DOI 10.1007/s004420050201; Nogueira EM, 2008, FOREST ECOL MANAG, V256, P1853, DOI 10.1016/j.foreco.2008.07.022; West GB, 1997, SCIENCE, V276, P122, DOI 10.1126/science.276.5309.122; SALDARRIAGA JG, 1988, J ECOL, V76, P938, DOI 10.2307/2260625; Kunert N, 2013, ACTA HORTIC, V991, P197; Avalos G, 2011, ECOTROPICA, V17, P31; Avalos G, 2010, TREES-STRUCT FUNCT, V24, P969, DOI 10.1007/s00468-010-0469-y; Avalos G, 2005, BIOTROPICA, V37, P44; Botanico M. P., 2014, AN ACAD BRAS CIENC, V85, P1461; Brown S., 134 FAO, P55; Castilho C. V., 2006, FOREST ECOL MANAG, V234, P85, DOI DOI 10.1016/J.FORECO.2006.06.024; Clay J. W., 1993, FOMISC936 FAO; Colgan S. M., 2014, TREES-STRUCT FUNCT, V28, P91; Cummings DL, 2002, FOREST ECOL MANAG, V163, P293, DOI 10.1016/S0378-1127(01)00587-4; Fearnside P. M., 1994, EMISSAO SEQUESTRO CO, P95; Ferraz J., 1998, PESQUISAS FLORESTAIS, P111; Goodman C. R., 2013, FOR ECOL MANAG, V310, P994; Henderson A., 1995, PALMS AMAZON, P380; Hughes R. F., 1997, THESIS OREGON STATE; Khan Md. Nabiul Islam, 2007, Wetlands Ecology and Management, V15, P141, DOI 10.1007/s11273-006-9020-8; Kunert N., 2013, ATMOSPHERE EXP UNPUB; Lima J. N. A., 2012, FOREST ECOL MANAG, V277, P163; Lorenzi H., 2006, FRUTAS BRASILEIRAS E, P81; Malhi Y, 2006, GLOBAL CHANGE BIOL, V12, P1, DOI DOI 10.1111/J.1365-2486.2006.01120.X; MCMAHON TA, 1976, J THEOR BIOL, V59, P443, DOI 10.1016/0022-5193(76)90182-X; R Core Team, 2014, R LANG ENV STAT COMP; Rich PM, 1986, PRINCIPES, V30, P117; RICH PM, 1987, BOT GAZ, V148, P42, DOI 10.1086/337626; RICH PM, 1987, AM J BOT, V74, P792, DOI 10.2307/2443860; Simpson W. T., 1993, FPLGTR76 USDA FOR SE; ter Steege H, 2013, SCIENCE, V342, P325, DOI 10.1126/science.1243092; Todd M. C., 2000, THESIS U W AUSTR PER; Tomlinson PB, 2006, BOT J LINN SOC, V151, P5, DOI 10.1111/j.1095-8339.2006.00520.x; Zianis D, 2004, FOREST ECOL MANAG, V187, P311, DOI 10.1016/j.foreco.2003.07.007	46	2	2	MDPI AG	BASEL	POSTFACH, CH-4005 BASEL, SWITZERLAND	1999-4907			FORESTS	Forests	FEB	2015	6	2					450	463		10.3390/f6020450		14	Forestry	Forestry	CC2YX	WOS:000350212200012		
J	Murotomi, K; Umeno, A; Yasunaga, M; Shichiri, M; Ishida, N; Abe, H; Yoshida, Y; Nakajima, Y				Murotomi, K.; Umeno, A.; Yasunaga, M.; Shichiri, M.; Ishida, N.; Abe, H.; Yoshida, Y.; Nakajima, Y.			Switching from singlet-oxygen-mediated oxidation to free-radical-mediated oxidation in the pathogenesis of type 2 diabetes in model mouse	FREE RADICAL RESEARCH			English	Article						type 2 diabetes; oxidative stress; singlet oxygen; free radical; TSOD mouse	ACTIVATED SIGNALING PATHWAYS; LIPID-PEROXIDATION; INSULIN-RESISTANCE; HYDROXYOCTADECADIENOIC ACID; IN-VIVO; STRESS; FAT	Oxidative stress plays a key role in the development of type 2 diabetes. However, it is still unknown what kind of oxidative stress underlies the development of type 2 diabetes. We investigated hydroxyoctadecadienoic acid (HODE) isomers, which have been proposed as a biomarker for evaluating oxidative stress in vivo, during the development of diabetes in Tsumura Suzuki Obese Diabetes (TSOD) mouse, a type 2 diabetes model. It was revealed that glucose tolerance and insulin resistance index HOMA-IR in TSOD mice at 5 weeks of age were approximately normal, namely, the mice were in the prediabetic state, but these levels were significantly exacerbated from 8 weeks of age compared with those in Tsumura Suzuki Non Obesity (TSNO) mice (control). Concomitantly, the plasma levels of free-radical-mediated oxidation products, 9- and 13-(E, E)-HODE and 7 beta-hydroxycholesterol, in TSOD mice were significantly higher than those in TSNO mice at 8, and 8 and 11 weeks of age, respectively. Interestingly, the plasma levels of 10- and 12-(Z, E)-HODE, which are produced specifically by singlet-oxygen-mediated oxidation, in TSOD mice were higher than those in TSNO mice only at 5 weeks of age, and not at 8, 11, and 13 weeks of age. We demonstrated that singlet-oxygen-mediated oxidation occurred in TSOD mice before development of the diabetic phenotypes, including impaired glucose tolerance and insulin resistance. These results suggest that excessive singlet-oxygen-mediated oxidation plays an important role in the pathogenesis of type 2 diabetes.	[Murotomi, K.; Umeno, A.; Yasunaga, M.; Abe, H.; Yoshida, Y.; Nakajima, Y.] Natl Inst Adv Ind Sci & Technol, Hlth Res Inst, Takamatsu, Kagawa 7610395, Japan; [Shichiri, M.; Ishida, N.] Natl Inst Adv Ind Sci & Technol, Hlth Res Inst, Ikeda, Osaka, Japan	Nakajima, Y (reprint author), Natl Inst Adv Ind Sci & Technol, Takamatsu, Kagawa 7610395, Japan.	y-nakajima@aist.go.jp			Japan Society for the Promotion of Science (JSPS) [25860183]; Foundation, Oil & Fat Industry Kaikan	We thank Y. Fujita of AIST for technical assistance; Y. Senba of JAC Co., Ltd., for supporting animal care; and Dr. W. Suzuki of Tsumuro Co., Ltd., Dr. T. Ito of Yamagata University, and Dr. K. Ohwada of AIST for valuable suggestions and discussion. This work was supported by a Grant-in-Aid for Young Scientist (B) (no. 25860183 to K. M.) from the Japan Society for the Promotion of Science (JSPS), and partially supported by a grant from Foundation, Oil & Fat Industry Kaikan.	Akase T, 2011, EVID-BASED COMPL ALT, V2011; Elgazar-Carmon V, 2008, J LIPID RES, V49, P1894, DOI 10.1194/jlr.M800132-JLR200; Wild S, 2004, DIABETES CARE, V27, P1047, DOI 10.2337/diacare.27.5.1047; Yoshida Y, 2013, J CLIN BIOCHEM NUTR, V52, P9, DOI 10.3164/jcbn.12-112; Bagul PK, 2012, PHARMACOL RES, V66, P260, DOI 10.1016/j.phrs.2012.05.003; Evans JL, 2003, DIABETES, V52, P1, DOI 10.2337/diabetes.52.1.1; Cohen G, 2013, FREE RADICAL BIO MED, V65, P978, DOI 10.1016/j.freeradbiomed.2013.08.163; Niki E, 2009, FREE RADICAL BIO MED, V47, P469, DOI 10.1016/j.freeradbiomed.2009.05.032; Yoshida Y, 2008, ANAL BIOCHEM, V379, P105, DOI 10.1016/j.ab.2008.04.028; Evans JL, 2002, ENDOCR REV, V23, P599, DOI 10.1210/er.2001.0039; Lin Y, 2010, J ENDOCRINOL, V204, P1, DOI 10.1677/JOE-09-0260; Popolo A, 2013, FREE RADICAL RES, V47, P346, DOI 10.3109/10715762.2013.779373; Frayn KN, 2000, BRIT J NUTR, V83, pS71, DOI 10.1017/S0007114500000982; Storz P, 2005, BIOCHEM J, V387, P47, DOI 10.1042/BJ20041443; Talukdar S, 2012, NAT MED, V18, P1407, DOI 10.1038/nm.2885; Hong Lei, 2013, J Sci Food Agric, V93, P1833, DOI 10.1002/jsfa.5974; Kiryu C, 1999, FEBS LETT, V443, P154, DOI 10.1016/S0014-5793(98)01700-1; Knight JA, 1997, ANN CLIN LAB SCI, V27, P11; Murotomi K, 2014, J CLIN BIOCHEM NUTR, V55, P216, DOI 10.3164/jcbn.14-73; Umeno A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0063542; Wang QL, 2014, DIABETES, V63, P4172, DOI 10.2337/db14-0026; Yoshida Y, 2005, BIOFACTORS, V24, P7; Zmijewski JW, 2005, BIOCHEM SOC T, V33, P1385	23	1	1	INFORMA HEALTHCARE	LONDON	TELEPHONE HOUSE, 69-77 PAUL STREET, LONDON EC2A 4LQ, ENGLAND	1071-5762	1029-2470		FREE RADICAL RES	Free Radic. Res.	FEB	2015	49	2					133	138		10.3109/10715762.2014.985218		6	Biochemistry & Molecular Biology	Biochemistry & Molecular Biology	CB4SH	WOS:000349617800003		
J	Cheng, TL; Deng, DH; Xue, XJ; Zhang, L; Suzuki, T; Ohishi, Y				Cheng, Tonglei; Deng, Dinghuan; Xue, Xiaojie; Zhang, Lei; Suzuki, Takenobu; Ohishi, Yasutake			Highly Efficient Tunable Dispersive Wave in a Tellurite Microstructured Optical Fiber	IEEE PHOTONICS JOURNAL			English	Article						Dispersive wave; tellurite microstructured optical fiber (TMOF); soliton	PHOTONIC CRYSTAL FIBER; FEMTOSECOND CHERENKOV RADIATION; SUPERCONTINUUM GENERATION; 3RD-HARMONIC GENERATION; VISIBLE WAVELENGTH; FREQUENCY-SHIFT; SOLITON; MODE; EMISSION	We demonstrate a highly efficient, stable, and tunable dispersive wave (DW) emitted by the soliton in a tellurite microstructured optical fiber. The dependence of the generated DW properties on the average pump power is experimentally investigated. By using the 80-MHz pulse emitted from an optical parametric oscillator as the pump source, the DW from similar to 1626 to 1685 nm is obtained with the average pump power changing from similar to 250 to 440 mW at the pump wavelength of similar to 1760 nm. The conversion efficiency is over similar to 65%. The full width at half maximum (FWHM) of DW pulse at the center wavelength of similar to 1626 nm is similar to 90 fs, which was measured by an intensity autocorrelator. The stable DW pulse can be used as a near-infrared femtosecond source.	[Cheng, Tonglei; Deng, Dinghuan; Xue, Xiaojie; Zhang, Lei; Suzuki, Takenobu; Ohishi, Yasutake] Toyota Technol Inst, Res Ctr Adv Photon Technol, Nagoya, Aichi 4688511, Japan	Cheng, TL (reprint author), Toyota Technol Inst, Res Ctr Adv Photon Technol, Nagoya, Aichi 4688511, Japan.	chengtonglei@gmail.com			MEXT	This work was supported by MEXT: the Support Program for Forming Strategic Research Infrastructure (2011-2015).	Agrawal G. P., 2007, NONLINEAR FIBER OPTI; Zhang XB, 2013, APPL PHYS B-LASERS O, V111, P273, DOI 10.1007/s00340-012-5329-6; Erkintalo M, 2010, OPT LETT, V35, P658, DOI 10.1364/OL.35.000658; Tu HH, 2013, OPT EXPRESS, V21, P23188, DOI 10.1364/OE.21.023188; Liao MS, 2009, OPT EXPRESS, V17, P21608, DOI 10.1364/OE.17.021608; AKHMEDIEV N, 1995, PHYS REV A, V51, P2602, DOI 10.1103/PhysRevA.51.2602; Domachuk P, 2008, OPT EXPRESS, V16, P7161, DOI 10.1364/OE.16.007161; Arteaga-Sierra FR, 2014, OPT EXPRESS, V22, P2451, DOI 10.1364/OE.22.002451; Lin AX, 2009, OPT EXPRESS, V17, P16716, DOI 10.1364/OE.17.016716; Judge AC, 2010, J OPT SOC AM B, V27, P2195, DOI 10.1364/JOSAB.27.002195; WAI PKA, 1986, OPT LETT, V11, P464, DOI 10.1364/OL.11.000464; Roy S, 2009, OPT LETT, V34, P2072, DOI 10.1364/OL.34.002072; Roy S, 2011, CURR SCI INDIA, V100, P321; Chang GQ, 2010, OPT LETT, V35, P2361, DOI 10.1364/OL.35.002361; Cheng TL, 2014, OPT EXPRESS, V22, P3740, DOI 10.1364/OE.22.003740; Chan MC, 2014, OPT EXPRESS, V22, P9498, DOI 10.1364/OE.22.009498; Cheng TL, 2014, OPT LETT, V39, P1005, DOI 10.1364/OL.39.001005; Cheng TL, 2014, APPL PHYS LETT, V104, DOI 10.1063/1.4869756; Cristiani I, 2004, OPT EXPRESS, V12, P124, DOI 10.1364/OPEX.12.000124; Hu ML, 2004, OPT EXPRESS, V12, P1932, DOI 10.1364/OPEX.12.001932; Karasawa N, 2010, OPT EXPRESS, V18, P5338, DOI 10.1364/OE.18.005338; Liao MS, 2011, J LIGHTWAVE TECHNOL, V29, P194, DOI 10.1109/JLT.2010.2093869; Liao MS, 2011, OPT EXPRESS, V19, P15389, DOI 10.1364/OE.19.015389; Liu XM, 2012, OPT LETT, V37, P2769, DOI 10.1364/OL.37.002769; Manili G, 2012, OPT LETT, V37, P4101, DOI 10.1364/OL.37.004101; Qin GS, 2010, OPT LETT, V35, P58, DOI 10.1364/OL.35.000058; Tu HH, 2009, OPT EXPRESS, V17, P9858, DOI 10.1364/OE.17.009858; Wang WB, 2013, OPT EXPRESS, V21, P11215, DOI 10.1364/OE.21.011215; Yuan JH, 2011, IEEE PHOTONIC TECH L, V23, P786, DOI 10.1109/LPT.2011.2136431; Zhang L, 2013, J OPTICS-UK, V15, DOI 10.1088/2040-8978/15/7/075201	30	0	0	IEEE-INST ELECTRICAL ELECTRONICS ENGINEERS INC	PISCATAWAY	445 HOES LANE, PISCATAWAY, NJ 08855-4141 USA	1943-0655	1943-0647		IEEE PHOTONICS J	IEEE Photonics J.	FEB	2015	7	1							2200107	10.1109/JPHOT.2014.2381662		7	Engineering, Electrical & Electronic; Optics; Physics, Applied	Engineering; Optics; Physics	CB5OU	WOS:000349678100014		
J	Eriksson, TA; Puttnam, BJ; Luis, RS; Karlsson, M; Andrekson, PA; Awaji, Y; Wada, N				Eriksson, Tobias A.; Puttnam, Benjamin J.; Luis, Ruben S.; Karlsson, Magnus; Andrekson, Peter A.; Awaji, Yoshinari; Wada, Naoya			Experimental Investigation of Crosstalk Penalties in Multicore Fiber Transmission Systems	IEEE PHOTONICS JOURNAL			English	Article						Multicore fiber; spatial division multiplexing; crosstalk; optical fiber communication	AGGREGATE SPECTRAL-EFFICIENCY; 7-CORE FIBER; DISTANCE PRODUCT; CORE FIBER; NOISE	We experimentally study the impact of crosstalk in multicore fibers, using polarization-multiplexed quadrature phase-shift keying signals. Using a 7-core fiber, we perform single-span transmission experiments, where the level of crosstalk to the core under test can be varied. We find the penalty in the required optical signal-to-noise ratio (OSNR), compared to a system with no crosstalk, for different signal-to-crosstalk ratios and at different pre-forward-error-correction target bit-error rates (BERs). We show that, for a 1-dB penalty, a 15.7-dB signal-to-crosstalk ratio can be tolerated at BER = 1 x 10(-3). We also perform recirculating loop experiments with varying amount of crosstalk per span to find the impact on the achievable transmission distance.	[Eriksson, Tobias A.; Karlsson, Magnus; Andrekson, Peter A.] Chalmers, Photon Lab, Dept Microtechnol & Nanosci, SE-41296 Gothenburg, Sweden; [Puttnam, Benjamin J.; Luis, Ruben S.; Awaji, Yoshinari; Wada, Naoya] Natl Inst Informat & Commun Technol, Photon Network Res Inst, Tokyo 1848795, Japan	Eriksson, TA (reprint author), Chalmers, Photon Lab, Dept Microtechnol & Nanosci, SE-41296 Gothenburg, Sweden.	tobias.eriksson@chalmers.se	Karlsson, Magnus/J-5723-2014	Karlsson, Magnus/0000-0002-2438-2491	Swedish Research Council (VR); Sweden-Japan Foundation; Mitsubishi; Angpanneforeningens Forskningsstiftelse	This work was supported by the Swedish Research Council (VR). The work of T. A. Eriksson was supported by the Sweden-Japan Foundation, by Mitsubishi, and by Angpanneforeningens Forskningsstiftelse.	Abedin KS, 2011, OPT EXPRESS, V19, P16715, DOI 10.1364/OE.19.016715; Hayashi T, 2011, OPT EXPRESS, V19, P16576, DOI 10.1364/OE.19.016576; Tottori Y, 2012, IEEE PHOTONIC TECH L, V24, P1926, DOI 10.1109/LPT.2012.2219305; Igarashi K, 2014, OPT EXPRESS, V22, P1220, DOI 10.1364/OE.22.001220; Takahashi H, 1996, J LIGHTWAVE TECHNOL, V14, P1097, DOI 10.1109/50.511611; Chandrasekhar S, 2012, OPT EXPRESS, V20, P706, DOI 10.1364/OE.20.000706; Chang JS, 2013, PEDIAT NEON IN PRESS, P1; Fini J. M., 2011, P ECOC, P1; Hayashi T, 2014, IEICE T COMMUN, VE97B, P936, DOI 10.1587/transcom.E97.B.936; Puttnam BJ, 2013, OPT EXPRESS, V21, P1561, DOI 10.1364/OE.21.001561; Ryf R, 2011, IEEE PHOTONIC TECH L, V23, DOI 10.1109/LPT.2011.2162826; Sakaguchi J., 2012, P OFC NFOFC LOS ANG, P1; Takara H., 2012, EUR C EXH OPT COMM A; Takenaga K., 2011, P OPT FIB COMM C NAT, P1; Winzer P., 2011, P 37 ECOC GEN SWITZ, P1; Xia C., 2013, P OFC NFOEC AN CA US, P1; Zhu B, 2011, OPT EXPRESS, V19, P16665, DOI 10.1364/OE.19.016665	17	1	1	IEEE-INST ELECTRICAL ELECTRONICS ENGINEERS INC	PISCATAWAY	445 HOES LANE, PISCATAWAY, NJ 08855-4141 USA	1943-0655	1943-0647		IEEE PHOTONICS J	IEEE Photonics J.	FEB	2015	7	1							7200507	10.1109/JPHOT.2015.2397275		7	Engineering, Electrical & Electronic; Optics; Physics, Applied	Engineering; Optics; Physics	CB5OU	WOS:000349678100059		
J	Hayashi, N; Mizuno, Y; Nakamura, K				Hayashi, Neisei; Mizuno, Yosuke; Nakamura, Kentaro			Simplified Brillouin Optical Correlation-Domain Reflectometry Using Polymer Optical Fiber	IEEE PHOTONICS JOURNAL			English	Article						Brillouin scattering; distributed measurement; optical fiber sensors; polymer optical fibers; strain sensing; temperature sensing	DISTRIBUTED STRAIN-MEASUREMENT; TEMPERATURE; SCATTERING; PROPOSAL	To perform distributed strain and temperature measurement, we have recently developed simplified Brillouin optical correlation-domain reflectometry (S-BOCDR), in which the light that is Fresnel reflected at the ends of the fiber under test (FUT) is used as a reference light. Here, we implement S-BOCDR using a polymer optical fiber (POF) as an FUT, which provides the following advantages over S-BOCDR using a standard silica single-mode fiber (SMF): 1) The beat signal of the Stokes light and the Fresnel-reflected light that is obtained at the interface between the POF and the SMF (the pigtail of an optical circulator) can be stabilized, and 2) the effect of the zeroth correlation peak can be easily and effectively suppressed by exploiting a so-called Brillouin frequency shift-hopping phenomenon. We then experimentally demonstrate a distributed measurement and detect a 0.46-m-long heated POF section.	[Hayashi, Neisei; Mizuno, Yosuke; Nakamura, Kentaro] Tokyo Inst Technol, Precis & Intelligence Lab, Yokohama, Kanagawa 2268503, Japan	Hayashi, N (reprint author), Tokyo Inst Technol, Precis & Intelligence Lab, Yokohama, Kanagawa 2268503, Japan.	hayashi@sonic.pi.titech.ac.jp			Japan Society for the Promotion of Science (JSPS) [25709032, 26630180, 25007652]; Iwatani Naoji Foundation; SCAT Foundation	This work was supported in part by Grants-in-Aid for Young Scientists (A) under Grant 25709032 and for Challenging Exploratory Research under Grant 26630180 from the Japan Society for the Promotion of Science (JSPS) and in part by research grants from the Iwatani Naoji Foundation and the SCAT Foundation. The work of N. Hayashi was supported by the Grant-in-Aid for JSPS Fellows under Grant 25007652.	Agrawal G. P., 1995, NONLINEAR FIBER OPTI; KURASHIMA T, 1990, APPL OPTICS, V29, P2219, DOI 10.1364/AO.29.002219; Zou WW, 2014, IEEE SENS J, V14, P244, DOI 10.1109/JSEN.2013.2282639; Bernini R, 2012, IEEE PHOTONICS J, V4, P48, DOI 10.1109/JPHOT.2011.2179024; Mizuno Y, 2010, OPT LETT, V35, P3985, DOI 10.1364/OL.35.003985; Hayashi N, 2012, OPT EXPRESS, V20, P21101, DOI 10.1364/OE.20.021101; Norcia S, 2003, OPT LETT, V28, P1888, DOI 10.1364/OL.28.001888; HORIGUCHI T, 1989, J LIGHTWAVE TECHNOL, V7, P1170, DOI 10.1109/50.32378; Garus D, 1996, OPT LETT, V21, P1402, DOI 10.1364/OL.21.001402; Song KY, 2006, OPT LETT, V31, P2526, DOI 10.1364/OL.31.002526; Zhu ZM, 2007, SCIENCE, V318, P1748, DOI 10.1126/science.1149066; Hotate K, 2000, IEICE T ELECTRON, VE83C, P405; Song KY, 2005, OPT EXPRESS, V13, P82, DOI 10.1364/OPEX.13.000082; Mizuno Y, 2010, J LIGHTWAVE TECHNOL, V28, P3300, DOI 10.1109/JLT.2010.2081348; KURASHIMA T, 1993, IEICE T COMMUN, VE76B, P382; Mizuno Y, 2009, IEEE PHOTONIC TECH L, V21, P474, DOI 10.1109/LPT.2009.2013643; Mizuno Y, 2010, APPL PHYS LETT, V97, DOI 10.1063/1.3463038; Mizuno Y, 2008, OPT EXPRESS, V16, P12148, DOI 10.1364/OE.16.012148; Peled Y, 2012, OPT EXPRESS, V20, P8584, DOI 10.1364/OE.20.008584; Hayashi N, 2014, IEEE PHOTONICS J, V6, DOI 10.1109/JPHOT.2014.2361638; Hayashi N, 2014, J LIGHTWAVE TECHNOL, V32, P3999, DOI 10.1109/JLT.2014.2339361; Hayashi N, 2014, IEEE PHOTONICS J, V6, DOI 10.1109/JPHOT.2014.2366107; Hayashi N, 2014, APPL PHYS LETT, V105, DOI 10.1063/1.4895041; Horiguchi T., 1989, IEEE Photonics Technology Letters, V1, DOI 10.1109/68.34756; Hotate K, 2002, MEAS SCI TECHNOL, V13, P1746, DOI 10.1088/0957-0233/13/11/311; Javier U., 2014, OPT EXP, V22; KUZIN EA, 1985, OPT QUANT ELECTRON, V17, P393, DOI 10.1007/BF00619565; Minakawa K, 2014, JPN J APPL PHYS, V53, DOI 10.7567/JJAP.53.042502; Minardo A, 2014, IEEE PHOTONIC TECH L, V26, P387, DOI 10.1109/LPT.2013.2294878; Song KY, 2010, OPT LETT, V35, P52, DOI 10.1364/OL.35.000052; Wosniok A., 2013, P 5 EWOFS KRAK POL, P8794; Yamashita RK, 2012, IEEE PHOTONIC TECH L, V24, P1006, DOI 10.1109/LPT.2012.2192725	32	1	1	IEEE-INST ELECTRICAL ELECTRONICS ENGINEERS INC	PISCATAWAY	445 HOES LANE, PISCATAWAY, NJ 08855-4141 USA	1943-0655	1943-0647		IEEE PHOTONICS J	IEEE Photonics J.	FEB	2015	7	1							6800407	10.1109/JPHOT.2014.2381650		7	Engineering, Electrical & Electronic; Optics; Physics, Applied	Engineering; Optics; Physics	CB5OU	WOS:000349678100046		
J	Matsuura, M; Sato, J				Matsuura, Motoharu; Sato, Jun			Bidirectional Radio-Over-Fiber Systems Using Double-Clad Fibers for Optically Powered Remote Antenna Units	IEEE PHOTONICS JOURNAL			English	Article						Radio-over-fiber (RoF); power-over-fiber (PWoF); double-clad fibers (DCFs); remote antenna units (RAUs); wireless local area network (WLAN); mobile communications	NETWORK; LASERS	This paper shows and experimentally demonstrates bidirectional radio over fiber (RoF) using a double-clad fiber (DCF) for optically powered remote antenna units (RAUs). The DCF for an RoF link has a single mode (SM) core and a multimode inner cladding; the SM core is used for simultaneous downlink and uplink transmissions of the optical RoF data signals, whereas the inner cladding is used for optical power delivery to the RAU. The aim of this approach is to optically power the RAU in such a way that external electrical power supplies, such as batteries or public power lines, are not required. The feasibility of the technique is demonstrated by bidirectional RoF transmission over a 100-m DCF optically feeding with 4.0 W. We successfully achieved high downlink and uplink transmission performance in terms of error vector magnitude measurements, which are based on the IEEE 802.11g wireless local area network (WLAN) standard at a carrier frequency of 2.45 GHz.	[Matsuura, Motoharu; Sato, Jun] Univ Electrocommun, Grad Sch Informat & Engn, Dept Commun Engn & Informat, Tokyo 1828585, Japan	Matsuura, M (reprint author), Univ Electrocommun, Grad Sch Informat & Engn, Dept Commun Engn & Informat, Tokyo 1828585, Japan.	m.matsuura@uec.ac.jp			Ministry of Internal Affairs and Communications in Japan [135003118]	This work was supported in part by the Strategic Information and Communications R&D Promotion Program (SCOPE) under Grant 135003118 from the Ministry of Internal Affairs and Communications in Japan.	Kosterin A, 2004, APPL OPTICS, V43, P3893, DOI 10.1364/AO.43.003893; MILLER RC, 1979, AT&T TECH J, V58, P1735; Wake D, 2008, J LIGHTWAVE TECHNOL, V26, P2484, DOI 10.1109/JLT.2008.927171; Richardson DJ, 2010, J OPT SOC AM B, V27, pB63, DOI 10.1364/JOSAB.27.000B63; BANWELL TC, 1993, J LIGHTWAVE TECHNOL, V11, P481, DOI 10.1109/50.219583; Claussen H, 2008, BELL LABS TECH J, V13, P221, DOI 10.1002/bltj.20292; Yao JP, 2009, J LIGHTWAVE TECHNOL, V27, P314, DOI 10.1109/JLT.2008.2009551; Campany J., 2007, NATURE PHOTON, V1, P319; Cisco, 2013, CISC VIS NETW IND GL; Cooper J., 1990, ELECTRON LETT, V26, P2054; JDSU, PHOT POW MOD; Kirham H., 1989, IEEE T POWER DELIVER, V4, P1997; Lethien C, 2012, IEEE PHOTONIC TECH L, V24, P649, DOI 10.1109/LPT.2012.2185224; Matsuura M., 2014, EUR C NOC MIL IT, P6; Miki T., 2003, OECC SHANGH CHIN; Miyakawa H, 2004, APPL OPTICS, V43, P1379, DOI 10.1364/AO.43.001379; Nakajima N., 2005, INT TOP M MICR PHOT, P11; Pena R, 1999, APPL OPTICS, V38, P2463, DOI 10.1364/AO.38.002463; Roger M, 2008, OPT EXPRESS, V16, P21821, DOI 10.1364/OE.16.021821; Sato J., 2013, OPTOELECTRON COMM C; Sauer M, 2007, J LIGHTWAVE TECHNOL, V25, P3301, DOI 10.1109/JLT.2007.906822; Wake David, 2010, Journal of Lightwave Technology, V28, DOI 10.1109/JLT.2010.2045103	22	0	0	IEEE-INST ELECTRICAL ELECTRONICS ENGINEERS INC	PISCATAWAY	445 HOES LANE, PISCATAWAY, NJ 08855-4141 USA	1943-0655	1943-0647		IEEE PHOTONICS J	IEEE Photonics J.	FEB	2015	7	1							7900609	10.1109/JPHOT.2014.2381669		9	Engineering, Electrical & Electronic; Optics; Physics, Applied	Engineering; Optics; Physics	CB5OU	WOS:000349678100067		
J	Takashina, S; Mori, Y; Hasegawa, H; Sato, KI; Watanabe, T				Takashina, Shoichi; Mori, Yojiro; Hasegawa, Hiroshi; Sato, Ken-Ichi; Watanabe, Toshio			Wavelength-Tunable Filters Utilizing Arrayed Waveguide Gratings for Colorless/Directionless/Contentionless Optical Signal Drop in ROADMs	IEEE PHOTONICS JOURNAL			English	Article						Reconfigurable optical add-drop multiplexer (ROADM); tunable filter; arrayed waveguide grating (AWG)	NETWORKS	The wavelength-tunable filter is a key device for creating colorless, directionless, and contentionless reconfigurable optical add-drop multiplexers. Although arrayed-waveguide gratings (AWGs) can realize compact and cost-effective tunable filters, crosstalk in wavelength-division-multiplexing systems increases as the frequency grid spacing decreases. To resolve this problem, we propose a tunable-filter architecture that can eliminate the crosstalk by utilizing two specific (commeasurable) cyclic AWGs in conjunction with multiple switches based on symmetric Mach-Zehnder interferometers and an asymmetric Mach-Zehnder interferometer (AMZI) filter. To verify the technical feasibility of the proposed architecture, we fabricate a monolithic prototype using planar-lightwave- circuit technology. We confirm, for the first time, its excellent performance by measuring insertion loss, polarization-dependent loss, and bit error ratios (BERs). Alternative tunable-filter configurations employing multiple AMZI-based filters are newly investigated for future applications.	[Takashina, Shoichi; Mori, Yojiro; Hasegawa, Hiroshi; Sato, Ken-Ichi] Nagoya Univ, Dept Elect Engn & Comp Sci, Nagoya, Aichi 4648603, Japan; [Watanabe, Toshio] NTT Corp, NTT Device Innovat Ctr, Atsugi, Kanagawa 2430198, Japan	Takashina, S (reprint author), Nagoya Univ, Dept Elect Engn & Comp Sci, Nagoya, Aichi 4648603, Japan.	s_takasi@echo.nuee.nagoya-u.ac.jp			NICT; KAKENHI [26220905]	This work was supported in part by NICT and KAKENHI under Project 26220905.	Gringeri S, 2010, IEEE COMMUN MAG, V48, P40, DOI 10.1109/MCOM.2010.5496877; Channegowda M, 2013, J OPT COMMUN NETW, V5, pA274, DOI 10.1364/JOCN.5.00A274; Chu YL, 2002, IEEE J SEL TOP QUANT, V8, P1122, DOI 10.1109/JSTQE.2002.805974; Cisco San Jose CA USA, 2014, CISC VIS NETW IND FO; Collings B., 2011, P MARK FOC ECOC, P1; Cvijetic N, 2014, J LIGHTWAVE TECHNOL, V32, P864, DOI 10.1109/JLT.2013.2274991; El-Bawab T. S., 2006, OPTICAL SWITCHING, P282; Jensen R., 2010, 36 EUR C EXH OPT COM; Jensen R. A., 2011, OPT FIB COMM C LOS A; Niwa T., 2012, P AS COMM PHOT C GUA; Niwa T, 2012, IEICE ELECTRON EXPR, V9, P1297, DOI 10.1587/elex.9.1297; Niwa T., 2013, OPT FIB COMM C AN CA; Takashina S., 2014, OPT FIB COMM C SAN F; Watanabe T., 2011, OPT FIB COMM C LOS A; Way W. I., 2012, OPT FIB COMM C EXP N	15	0	0	IEEE-INST ELECTRICAL ELECTRONICS ENGINEERS INC	PISCATAWAY	445 HOES LANE, PISCATAWAY, NJ 08855-4141 USA	1943-0655	1943-0647		IEEE PHOTONICS J	IEEE Photonics J.	FEB	2015	7	1							7100511	10.1109/JPHOT.2015.2400397		11	Engineering, Electrical & Electronic; Optics; Physics, Applied	Engineering; Optics; Physics	CB5OU	WOS:000349678100054		
J	Avci, E; Ohara, K; Nguyen, CN; Theeravithayangkura, C; Kojima, M; Tanikawa, T; Mae, Y; Arai, T				Avci, Ebubekir; Ohara, Kenichi; Chanh-Nghiem Nguyen; Theeravithayangkura, Chayooth; Kojima, Masaru; Tanikawa, Tamio; Mae, Yasushi; Arai, Tatsuo			High-Speed Automated Manipulation of Microobjects Using a Two-Fingered Microhand	IEEE TRANSACTIONS ON INDUSTRIAL ELECTRONICS			English	Article						Fast micromanipulation; high-speed sensing mechanism; releasing by vibration; vibration control	MICROASSEMBLY SYSTEM; MICROMANIPULATION; VIBRATION; COMPLIANT	In this paper, we present a high-speed pick-and-place method for cell-assembly applications. In addition to the range of motion and accuracy, the agility of a manipulation system is an important parameter, but it has been so far underrated in the literature. To begin highspeed micromanipulation, obtaining 3-D positions of both the target microobject and the end effector rapidly is necessary. Controlling the residual vibration of the end effector, which is greater at high speed, is another arduous task. Successful releasing of objects in microscale is also demanding. We propose a new fast detection algorithm for both the target microobject and the end effector, which will enable us to achieve high-speed control of the system. Moreover, to realize stable grasping for very fast movements, the vibration of the system is compensated, and a controllable vibration is applied to the end effectors while performing the releasing task. High-speed control of the microhand system is demonstrated with extensive experiments consisting of pick-and-place actions of 40-60 mu m microspheres; we aimed at performing the task in 1 s. A comparison with similar studies shows the advantage of the proposed automated high-speed micromanipulation system.	[Avci, Ebubekir] Univ London Imperial Coll Sci Technol & Med, Hamlyn Ctr Robot Surg, London SW7 2AZ, England; [Ohara, Kenichi] Meijo Univ, Dept Mechatron Engn, Nagoya, Aichi 4688502, Japan; [Chanh-Nghiem Nguyen] Can Tho Univ, Dept Automat Technol, Can Tho 10000, Vietnam; [Theeravithayangkura, Chayooth] Map Ta Phut Specialty Chem Co Ltd, Bangkok 10500, Thailand; [Kojima, Masaru; Tanikawa, Tamio; Mae, Yasushi; Arai, Tatsuo] Osaka Univ, Dept Syst Innovat, Osaka 5608531, Japan	Avci, E (reprint author), Univ London Imperial Coll Sci Technol & Med, Hamlyn Ctr Robot Surg, London SW7 2AZ, England.	e.avci@imperial.ac.uk			Ministry of Education, Culture, Sports, Science and Technology of Japan [23106005]	This work was supported by Grant-in-Aid for Scientific Research on Innovative Areas "Bio Assembler" under Grant 23106005 from the Ministry of Education, Culture, Sports, Science and Technology of Japan.	RODGERS JL, 1988, AM STAT, V42, P59, DOI 10.2307/2685263; Zhang Y, 2009, IEEE T IND ELECTRON, V56, P231, DOI 10.1109/TIE.2008.925771; Hoover AM, 2007, IEEE INT CONF ROBOT, P812, DOI 10.1109/ROBOT.2007.363086; Norotte C, 2009, BIOMATERIALS, V30, P5910, DOI 10.1016/j.biomaterials.2009.06.034; Li YM, 2011, IEEE T IND ELECTRON, V58, P3601, DOI 10.1109/TIE.2010.2084972; Ferreira A, 2004, IEEE-ASME T MECH, V9, P321, DOI 10.1109/TMECH.2004.828655; Chen T, 2009, IEEE T IND ELECTRON, V56, P996, DOI 10.1109/TIE.2008.2005147; Zhang Y, 2010, IEEE T ROBOT, V26, P200, DOI 10.1109/TRO.2009.2034831; Lu Z, 2010, IEEE INT CONF ROBOT, P494; Ramadan AA, 2009, IEEE T IND ELECTRON, V56, P1121, DOI 10.1109/TIE.2008.2008753; Mason C, 2008, REGEN MED, V3, P1, DOI 10.2217/17460751.3.1.1; Dechev N, 2004, J MICROELECTROMECH S, V13, P176, DOI 10.1109/JMEMS.2004.825311; Xu QS, 2014, IEEE T IND ELECTRON, V61, P893, DOI 10.1109/TIE.2013.2257139; Tang H, 2014, IEEE T IND ELECTRON, V61, P1475, DOI 10.1109/TIE.2013.2258305; Piazzi A, 2000, IEEE-ASME T MECH, V5, P12, DOI 10.1109/3516.828585; Yang J, 2005, BIOMATERIALS, V26, P6415, DOI 10.1016/j.biomaterials.2005.04.061; Nasri M, 2009, NEUROCOMPUTING, V72, P1012, DOI 10.1016/j.neucom.2008.04.016; Avci E., 2013, P IEEE INT C ROB AUT, P1710; Chen T, 2010, IEEE INT C INT ROBOT, P6137; Haliyo D. S., 2002, Proceedings 2002 IEEE International Conference on Robotics and Automation (Cat. No.02CH37292), DOI 10.1109/ROBOT.2002.1014826; Heriban D, 2008, 2008 IEEE/RSJ INTERNATIONAL CONFERENCE ON ROBOTS AND INTELLIGENT SYSTEMS, VOLS 1-3, CONFERENCE PROCEEDINGS, P4042, DOI 10.1109/IROS.2008.4650932; Nakamoto M., 2011, Proceedings of the 2011 24th International Vacuum Nanoelectronics Conference (IVNC 2011); Nguyen C. - N., 2012, P IEEE INT C AUT SCI, P34; Nguyen C. - N., 2012, J MICRONANOMECHATRON, V7, P21; Nguyen CN, 2011, IEEE INT C INT ROBOT, P427; Onal CD, 2007, IEEE T CONTR SYST T, V15, P842, DOI 10.1109/TCST.2007.902944; Ren L, 2008, IEEE T IND ELECTRON, V55, P3324, DOI 10.1109/TIE.2008.927976; Takeuchi M, 2011, IEEE INT C INT ROBOT, P457, DOI 10.1109/IROS.2011.6048868; Thompson J. A., 2001, Proceedings 2001 IEEE/RSJ International Conference on Intelligent Robots and Systems. Expanding the Societal Role of Robotics in the the Next Millennium (Cat. No.01CH37180), DOI 10.1109/IROS.2001.977166; Xie H., 2009, J MICROMECH MICROENG, V19, P1; Yang GE, 2003, J INTELL ROBOT SYST, V37, P43, DOI 10.1023/A:1023982907874	31	0	0	IEEE-INST ELECTRICAL ELECTRONICS ENGINEERS INC	PISCATAWAY	445 HOES LANE, PISCATAWAY, NJ 08855-4141 USA	0278-0046	1557-9948		IEEE T IND ELECTRON	IEEE Trans. Ind. Electron.	FEB	2015	62	2					1070	1079		10.1109/TIE.2014.2347004		10	Automation & Control Systems; Engineering, Electrical & Electronic; Instruments & Instrumentation	Automation & Control Systems; Engineering; Instruments & Instrumentation	AY8JI	WOS:000347799500040		
J	Sato, M; Toda, M				Sato, Masato; Toda, Masayoshi			Robust Motion Control of an Oscillatory-Base Manipulator in a Global Coordinate System	IEEE TRANSACTIONS ON INDUSTRIAL ELECTRONICS			English	Article						Global coordinates; H-infinity control; oscillatory-base manipulator; robust motion control; robust stability analysis	ACTIVE HEAVE COMPENSATION; NONLINEAR CONTROL; ROBOT CONTROL; CRANE; WAVES	This paper presents a control design method for motion control in a global coordinate system of an oscillatory-base manipulator, which can be regarded as a model system of mechanical systems installed on vessels or oceanic structures. This paper proposes a control design method for such systems exploiting H-infinity control and proportional and derivative (PD) control. In order to evaluate the proposed method, tracking control simulations and experiments were conducted for both attitude control and position control with practical constraints such as sensor error and actuator saturation. Furthermore, the proposed controller was compared with a conventional proportional, integral, and derivative (PID) controller. The results demonstrate that the proposed controller is successfully effective and is superior to the PID controller. Moreover, robust control experiments and robust stability analyses using our proposed machinery show that the proposed controller has strong robustness against physical parametric perturbations. Our developed robust stability analysis machinery is based on the state-dependent coefficient form and applicable to a wider class of systems than the previous one.	[Sato, Masato; Toda, Masayoshi] Tokyo Univ Marine Sci & Technol, Grad Sch Marine Sci & Technol, Tokyo 1080075, Japan	Sato, M (reprint author), East Japan Railway Co, Tokyo 1518578, Japan.	toda@kaiyodai.ac.jp					Alves RM, 1999, INT OFFSHORE POLAR E, P332; Korde UA, 1998, OCEAN ENG, V25, P541, DOI 10.1016/S0029-8018(97)00028-0; Neupert J, 2008, P AMER CONTR CONF, P538, DOI 10.1109/ACC.2008.4586547; Ngo Q. H., 2012, IEEE/ASME Transactions on Mechatronics, V17, DOI 10.1109/TMECH.2010.2093907; Fang YC, 2014, IEEE T IND ELECTRON, V61, P414, DOI 10.1109/TIE.2013.2251731; Do KD, 2008, OCEAN ENG, V35, P558, DOI 10.1016/j.oceaneng.2007.11.005; Fallaha CJ, 2011, IEEE T IND ELECTRON, V58, P600, DOI 10.1109/TIE.2010.2045995; Kuchler S, 2011, IEEE-ASME T MECH, V16, P297, DOI 10.1109/TMECH.2010.2041933; Liang YW, 2008, IEEE T IND ELECTRON, V55, P3964, DOI 10.1109/TIE.2008.2005138; Yang J, 2013, IEEE T IND ELECTRON, V60, P160, DOI 10.1109/TIE.2012.2183841; Battista RC, 1999, P SOC PHOTO-OPT INS, V3671, P184, DOI 10.1117/12.348669; Cloutier J. R., 1996, P 1 INT C NONL PROBL, P117; ElHawary F, 1996, COMPUT ELECTR ENG, V22, P257, DOI 10.1016/0045-7906(96)00003-1; Fossen TI, 1994, GUIDANCE CONTROL OCE; HUANG S, 1995, INT OFFSHORE POLAR E, P203; Isram S., 2011, IEEE T IND ELECTRON, V58, P2444; Iwamura T., 2013, P AM CONTR C WASH DC, P5762; Johansen TA, 2003, IEEE J OCEANIC ENG, V28, P720, DOI 10.1109/JOE.2003.819155; Sato M, 2009, IEEE INT CONF CON AU, P349, DOI 10.1109/ICCA.2009.5410148; Toda M., 1999, P IEEE C SYST MAN CY, V2, P878; Toda M, 2004, IEEE T ROBOTIC AUTOM, V20, P283, DOI 10.1109/TRA.2004.824642	21	0	0	IEEE-INST ELECTRICAL ELECTRONICS ENGINEERS INC	PISCATAWAY	445 HOES LANE, PISCATAWAY, NJ 08855-4141 USA	0278-0046	1557-9948		IEEE T IND ELECTRON	IEEE Trans. Ind. Electron.	FEB	2015	62	2					1163	1174		10.1109/TIE.2014.2349363		12	Automation & Control Systems; Engineering, Electrical & Electronic; Instruments & Instrumentation	Automation & Control Systems; Engineering; Instruments & Instrumentation	AY8JI	WOS:000347799500049		
J	Wang, YB; Zhao, YM; Bortoff, SA; Ueda, K				Wang, Yebin; Zhao, Yiming; Bortoff, Scott A.; Ueda, Koichiro			A Real-Time Energy-Optimal Trajectory Generation Method for a Servomotor System	IEEE TRANSACTIONS ON INDUSTRIAL ELECTRONICS			English	Article						Boundary value problem; constrained optimal control; minimum energy; motion planning; servomotor; trajectory generation	INDUCTION-MOTORS; MOBILE ROBOTS; MANIPULATORS; CONSTRAINTS; DRIVES; PATH	This paper considers real-time energy-optimal trajectory generation for a servomotor system that performs a single-axis point-to-point positioning task for a fixed time interval. The servomotor system is subject to acceleration and speed constraints. The trajectory generation is formulated as a linear-constrained optimal control problem (LCOCP), and the Pontryagin's maximum principle is applied to derive necessary optimality conditions. Instead of solving multipoint boundary value problems directly, this paper proposes a novel real-time algorithm based on two realizations: solving the LCOCP is equivalent to determining an optimal time interval of the speed-constrained arc and solving a specific acceleration-constrained optimal control problem (ACOCP), and solving an ACOCP is equivalent to determining optimal switch times of acceleration-constrained arcs and solving a specific two-point boundary value problem (TBVP). The proposed algorithm constructs sequences of time intervals, ACOCPs, switch times, and TBVPs, such that all sequences converge to their counterparts of an optimal solution of the LCOCP. Numerical simulation verifies that the proposed algorithm is capable of generating energy-optimal trajectories in real time. Experiments validate that the use of energy-optimal trajectories as references in a servomotor system does not compromise tracking performance but leads to considerable less energy consumption.	[Wang, Yebin; Zhao, Yiming; Bortoff, Scott A.] Mitsubishi Elect Res Labs, Cambridge, MA 02139 USA; [Ueda, Koichiro] Mitsubishi Electr Corp, Adv Technol R&D Ctr, Amagasaki, Hyogo 6618661, Japan	Wang, YB (reprint author), Mitsubishi Elect Res Labs, Cambridge, MA 02139 USA.	yebinwang@ieee.org; yiming.zhao@halliburton.com; bortoff@merl.com; Ueda.Koichiro@da.MitsubishiElectric.co.jp					Geyer T, 2009, IEEE T IND ELECTRON, V56, P1894, DOI 10.1109/TIE.2008.2007030; Zhao YM, 2011, J GUID CONTROL DYNAM, V34, P271, DOI 10.2514/1.45852; Huang MS, 2012, IEEE-ASME T MECH, V17, P337, DOI 10.1109/TMECH.2010.2103366; Lambrechts P, 2005, CONTROL ENG PRACT, V13, P145, DOI 10.1016/j.conengprac.2004.02.010; Khalil HK, 2009, IEEE T CONTR SYST T, V17, P327, DOI 10.1109/TCST.2008.2000977; Verscheure D, 2009, IEEE T AUTOMAT CONTR, V54, P2318, DOI 10.1109/TAC.2009.2028959; Vasak M, 2007, IEEE T IND ELECTRON, V54, P1483, DOI 10.1109/TIE.2007.893060; Errouissi R, 2012, IEEE T IND ELECTRON, V59, P2849, DOI 10.1109/TIE.2011.2157276; HARTL RF, 1995, SIAM REV, V37, P181, DOI 10.1137/1037043; BARRAQUAND J, 1992, IEEE T SYST MAN CYB, V22, P224, DOI 10.1109/21.148426; Betts J. T., 2001, PRACTICAL METHODS OP; BOBROW JE, 1985, INT J ROBOT RES, V4, P3, DOI 10.1177/027836498500400301; Dodds SJ, 2008, INT POWER ELECT MOT, P2559, DOI 10.1109/EPEPEMC.2008.4635648; Gregory J, 2012, SYST CONTROL LETT, V61, P279, DOI 10.1016/j.sysconle.2011.11.005; Kim CH, 2007, J INTELL ROBOT SYST, V49, P367, DOI 10.1007/s10846-007-9142-0; Kim H, 2014, IEEE T IND ELECTRON, V61, P4771, DOI 10.1109/TIE.2013.2293706; Korayem MH, 2009, ROBOTICA, V27, P147, DOI 10.1017/S0263574708004578; La-Orpacharapan C, 2004, IEEE T MAGN, V40, P85, DOI 10.1109/TMAG.2003.821126; Liu S, 2011, IEEE ASME INT C ADV, P43; Ortega R, 2001, IEEE T AUTOMAT CONTR, V46, P1209, DOI 10.1109/9.940925; Park M.-H., 1991, IEEE T POWER ELECTR, V6, P514; Poirier E., 2001, P IEEE INT EL MACH D, P475; Sergaki ES, 2002, J INTELL ROBOT SYST, V33, P187, DOI 10.1023/A:1014643401778; TRZYNADLOWSKI AM, 1988, IEEE T IND ELECTRON, V35, P60, DOI 10.1109/41.3063; Wang Y., 2013, P 33 CHIN CONTR C XI, P2262; Wang YB, 2013, AUTOMATICA, V49, P3550, DOI 10.1016/j.automatica.2013.09.019	26	1	1	IEEE-INST ELECTRICAL ELECTRONICS ENGINEERS INC	PISCATAWAY	445 HOES LANE, PISCATAWAY, NJ 08855-4141 USA	0278-0046	1557-9948		IEEE T IND ELECTRON	IEEE Trans. Ind. Electron.	FEB	2015	62	2					1175	1188		10.1109/TIE.2014.2360077		14	Automation & Control Systems; Engineering, Electrical & Electronic; Instruments & Instrumentation	Automation & Control Systems; Engineering; Instruments & Instrumentation	AY8JI	WOS:000347799500050		
J	Zhu, CS; Yang, LT; Shu, L; Leung, VCM; Hara, T; Nishio, S				Zhu, Chunsheng; Yang, Laurence T.; Shu, Lei; Leung, Victor C. M.; Hara, Takahiro; Nishio, Shojiro			Insights of Top-k Query in Duty-Cycled Wireless Sensor Networks	IEEE TRANSACTIONS ON INDUSTRIAL ELECTRONICS			English	Article						Always-on wireless sensor networks (A-WSNs); connected k(c)-neighborhood (CKN); data replication (DR); duty-cycled WSNs (D-WSNs); top-k query; WSNs		Aiming at finding the k nodes with the highest readings among sensor nodes, top-k query is a very important and useful query in wireless sensor networks (WSNs). Current studies about top-k query in WSNs mainly focus on always-on WSNs (A-WSNs) where sensors always stay awake and little research pays attention to top-k query in duty-cycled WSNs (D-WSNs) in which sensors are dynamically awake and asleep to conserve energy. In this paper, we originally analyze the research issues when implementing top-k query in D-WSNs and then propose the DRC-WSNs [D-WSNs with data replication (DR) and connected k(c)-neighborhood (CKN)] scheme for performing top-k query. Extensive theoretical analysis and simulation results provide the following two new insights regarding top-k query in D-WSNs: 1) Implementing top-k query in DRC-WSNs can achieve the best tradeoff with respect to query data accessibility and query cost (total energy consumption and query response time), compared with implementing top-k query in DC-WSNs (D-WSNs with only CKN) and A-WSNs; and 2) the query data accessibility and the query cost of DRC-WSNs, DC-WSNs, and A-WSNs can be tuned by varying the number of neighbor nodes that the data are replicated to during DR, the k(c) in CKN, and the total sensor nodes number.	[Zhu, Chunsheng; Leung, Victor C. M.] Univ British Columbia, Dept Elect & Comp Engn, Vancouver, BC V6T 1Z4, Canada; [Yang, Laurence T.] St Francis Xavier Univ, Dept Comp Sci, Antigonish, NS B2G 2W5, Canada; [Shu, Lei] Guangdong Univ Petrochem Technol, Guangdong Prov Key Lab Petrochem Equipment Fault, Maoming 525000, Peoples R China; [Hara, Takahiro; Nishio, Shojiro] Osaka Univ, Dept Multimedia Engn, Suita, Osaka 5650871, Japan	Shu, L (reprint author), Guangdong Univ Petrochem Technol, Guangdong Prov Key Lab Petrochem Equipment Fault, Maoming 525000, Peoples R China.	cszhu@ece.ubc.ca; ltyang@stfx.ca; lei.shu@lab.gdupt.edu.cn; vleung@ece.ubc.ca; hara@ist.osaka-u.ac.jp; nishio@ist.osaka-u.ac.jp		Leung, Victor/0000-0003-3529-2640	University of British Columbia; Natural Sciences and Engineering Research Council of Canada; TELUS; Guangdong University of Petrochemical Technology's Internal Project [2012RC0106]; Educational Commission of Guangdong Province; China Project [2013KJCX0131]; Special Fund of Guangdong Higher School Talent Recruitment	This work was supported in part by a Four Year Doctoral Fellowship from The University of British Columbia, in part by funding from the Natural Sciences and Engineering Research Council of Canada, TELUS, and other industry partners, in part by Guangdong University of Petrochemical Technology's Internal Project under Grant 2012RC0106, in part by the Educational Commission of Guangdong Province, in part by China Project 2013KJCX0131, and in part by 2013 Special Fund of Guangdong Higher School Talent Recruitment. (Corresponding author: Lei Shu.)	Alicherry M, 2005, P ACM MOBICOM, P58, DOI 10.1145/1080829.1080836; He DJ, 2012, IEEE T IND ELECTRON, V59, P4155, DOI 10.1109/TIE.2011.2178214; Nath S, 2007, PROCEEDINGS OF THE SIXTH INTERNATIONAL SYMPOSIUM ON INFORMATION PROCESSING IN SENSOR NETWORKS, P440, DOI 10.1109/IPSN.2007.4379704; Wu MJ, 2007, IEEE T KNOWL DATA EN, V19, P962, DOI 10.1109/TKDE.2007.1038; [Anonymous], 2003, MPR MOT PROC RAD BOA; Ammari HM, 2013, COMPUT NETW, V57, P1913, DOI 10.1016/j.comnet.2013.03.009; Chen JM, 2010, IEEE T IND ELECTRON, V57, P4219, DOI 10.1109/TIE.2010.2043038; Cheng P, 2013, IEEE T IND ELECTRON, V60, P3836, DOI 10.1109/TIE.2012.2208439; Le H, 2013, IEEE T IND ELECTRON, V60, P1070, DOI 10.1109/TIE.2011.2173889; Zhao G, 2011, IEEE T IND ELECTRON, V58, P2247, DOI 10.1109/TIE.2009.2026372; Raghunathan V, 2002, IEEE SIGNAL PROC MAG, V19, P40, DOI 10.1109/79.985679; Wang WZ, 2006, MOBICOM 2006, P262; Lindsey S, 2002, AEROSP CONF PROC, P1125; Babcock B., 2003, P 2003 ACM SIGMOD IN, P28, DOI DOI 10.1145/872757.872764; Bettstetter C., 2002, P 3 ACM INT S MOB AD, P80; Bettstetter C, 2002, IEEE VTS VEH TECHNOL, P1706; Chen B., 2010, P MDM IEEE, P177; Chen B., 2010, P CIKM ACM, P329, DOI 10.1145/1871437.1871482; Chen BC, 2014, WIREL NETW, V20, P591, DOI 10.1007/s11276-013-0625-6; Cho Y.H., 2008, P 5 WORKSH DAT MAN S, P8, DOI 10.1145/1402050.1402053; Heinzelman W., 2000, P 33 ANN HAW INT C S, P3005, DOI DOI 10.1109/HICSS.2000.926982; Liang WF, 2011, INFORM SCIENCES, V181, P869, DOI 10.1016/j.ins.2010.10.006; Mo S., 2011, EURASIP J WIREL COMM, V73, P1; Pan Q., 2007, P WCNC 07 HONG KONG, P4233; Raghunathan V, 2004, WIRELESS SENSOR NETWORKS, P51; Shen HL, 2009, NSWCTC 2009: INTERNATIONAL CONFERENCE ON NETWORKS SECURITY, WIRELESS COMMUNICATIONS AND TRUSTED COMPUTING, VOL 1, PROCEEDINGS, P391, DOI 10.1109/NSWCTC.2009.314; Shu L., 2010, AD HOC NETW, V9, P799; Silberstein A., 2006, P 22 INT C DAT ENG I, P68; Wang F, 2012, IEEE T MOBILE COMPUT, V11, P767, DOI 10.1109/TMC.2011.94; Wu M., 2006, P MDM NAR JAP, P31; Ye M, 2013, IEEE T KNOWL DATA EN, V25, P76, DOI 10.1109/TKDE.2011.145; Yeo M., 2013, INT J DISTRIB SE OCT, P1; Yi F., 2008, IEEE T KNOWL DATA EN, V20, P1669; Zeinalipour-Yazti D., 2005, P 2 INT WORKSH DAT M, P61, DOI 10.1145/1080885.1080896; Zhang Z., 2006, P 8 INT C ADV COMM T, P140	35	2	2	IEEE-INST ELECTRICAL ELECTRONICS ENGINEERS INC	PISCATAWAY	445 HOES LANE, PISCATAWAY, NJ 08855-4141 USA	0278-0046	1557-9948		IEEE T IND ELECTRON	IEEE Trans. Ind. Electron.	FEB	2015	62	2					1317	1328		10.1109/TIE.2014.2334653		12	Automation & Control Systems; Engineering, Electrical & Electronic; Instruments & Instrumentation	Automation & Control Systems; Engineering; Instruments & Instrumentation	AY8JI	WOS:000347799500064		
J	Yamamoto, S; Watabe, T; Kanai, Y; Watabe, H; Hatazawa, J				Yamamoto, Seiichi; Watabe, Tadashi; Kanai, Yasukazu; Watabe, Hiroshi; Hatazawa, Jun			Development of an Optical Fiber-Based MR Compatible Gamma Camera for SPECT/MRI Systems	IEEE TRANSACTIONS ON NUCLEAR SCIENCE			English	Article						Gamma camera; MRI; optical fiber; SPECT	INTEGRATED PET/MRI SYSTEM; HIGH-RESOLUTION PET; SIMULTANEOUS ACQUISITION; SMALL ANIMALS; SCANNER; DETECTOR; IMAGES; MULTISLICE	Optical fiber is a promising material for integrated positron emission tomography (PET) and magnetic resonance imaging (MRI) PET/ MRI systems. Because its material is plastic, it has no interference betweenMRI. However, it is unclear whether this material can also be used for a single photon emission tomography (SPECT)/MRI system. For this purpose, we developed an optical fiber-based block detector for a SPECT/MRI system and tested its performance by combining mm (YSO) pixels into a block and was coupled it to an optical fiber image guide that used was 0.5-mm in diameter with 80-cm long double clad fibers. The image guide had mm rectangular input and an equal size output. The input of the optical fiber-based image guide was bent at 90 degrees, aotomultiplier tube (HQE-PSPMT). The parallel hole, 7-mm-thick collimator made of tungsten plastic was mounted on a YSO block. The diameter of the collimator holes was 0.8 mm which was positioned one-to-one coupled to the YSO pixels. We evaluated the intrinsic and system performances. We resolved most of the YSO pixels in a two-dimensional histogram for Co-57 gamma photons (122-keV) with an average peak-to-value ratio of 1.5. The energy resolution was 38% full-width at half-maximum (FWHM). The system resolution was 1.7-mm FWHM, 1.5 mm from the collimator surface, and the sensitivity was 0.06%. Images of a Co-57 point source could be successfully obtained inside 0.3 T MRI without serious interference. We concnd the output was optically coupled to a 1-in square high quantum efficiency position sensitive phlude that the developed optical fiber-based YSO block detector is promising for SPECT/MRI systems.	[Yamamoto, Seiichi] Nagoya Univ, Grad Sch Med, Dept Radiol & Med Lab Sci, Nagoya, Aichi 4648601, Japan; [Watabe, Tadashi; Kanai, Yasukazu; Hatazawa, Jun] Osaka Univ, Grad Sch Med, Dept Nucl Med & Tracer Kinet, Suita, Osaka, Japan; [Watabe, Hiroshi] Tohoku Univ, Cyclotron & Radioisotope Ctr CYRIC, Suita, Osaka, Japan	Yamamoto, S (reprint author), Nagoya Univ, Grad Sch Med, Dept Radiol & Med Lab Sci, Nagoya, Aichi 4648601, Japan.	s-yama@met.nagoya-u.ac.jp					Hamamura MJ, 2010, PHYS MED BIOL, V55, P1563, DOI 10.1088/0031-9155/55/6/002; Meier D, 2011, NUCL INSTRUM METH A, V652, P731, DOI 10.1016/j.nima.2010.09.116; Yamamoto S, 2011, PHYS MED BIOL, V56, P4147, DOI 10.1088/0031-9155/56/13/026; Goetz C, 2008, J NUCL MED, V49, P88, DOI 10.2967/jnumed.107.044313; Yamamoto S, 2012, MED PHYS, V39, P6660, DOI 10.1118/1.4757911; Schenck JF, 1996, MED PHYS, V23, P815, DOI 10.1118/1.597854; Yamamoto S, 2010, PHYS MED BIOL, V55, P5817, DOI 10.1088/0031-9155/55/19/013; Woody C, 2007, NUCL INSTRUM METH A, V571, P102, DOI 10.1016/j.nima.2006.10.039; Judenhofer MS, 2007, RADIOLOGY, V244, P807, DOI 10.1148/radiol.2443061756; Shao YP, 1997, PHYS MED BIOL, V42, P1965, DOI 10.1088/0031-9155/42/10/010; Judenhofer MS, 2008, NAT MED, V14, P459, DOI 10.1038/nm1700; Catana C, 2006, J NUCL MED, V47, P1968; Pichler BJ, 2006, J NUCL MED, V47, P639; Yoon HS, 2012, J NUCL MED, V53, P608, DOI 10.2967/jnumed.111.097501; Hamamura MJ, 2010, TECHNOL CANCER RES T, V9, P21; Lucas AJ, 2006, TECHNOL CANCER RES T, V5, P337; Mackewn JE, 2005, IEEE T NUCL SCI, V52, P1376, DOI 10.1109/TNS.2005.858260; Raylman RR, 2007, J MAGN RESON, V186, P305, DOI 10.1016/j.jmr.2007.03.012; Tsui B. M., 2011, J NUCL MED, V52, P379; Yamamoto S, 2012, MED PHYS, V39, P6900, DOI 10.1118/1.4760991; Yamamoto S, 2010, ANN NUCL MED, V24, P89, DOI 10.1007/s12149-009-0333-6; Yamamoto S, 2005, IEEE T NUCL SCI, V52, P33, DOI 10.1109/TNS.2004.843091; Yamamoto S, 2012, PHYS MED BIOL, V57, pN1, DOI 10.1088/0031-9155/57/2/N1; Yamamoto S, 2010, NUCL INSTRUM METH A, V622, P261, DOI 10.1016/j.nima.2010.07.038	24	0	0	IEEE-INST ELECTRICAL ELECTRONICS ENGINEERS INC	PISCATAWAY	445 HOES LANE, PISCATAWAY, NJ 08855-4141 USA	0018-9499	1558-1578		IEEE T NUCL SCI	IEEE Trans. Nucl. Sci.	FEB	2015	62	1	1				76	81		10.1109/TNS.2014.2387432		6	Engineering, Electrical & Electronic; Nuclear Science & Technology	Engineering; Nuclear Science & Technology	CB5MX	WOS:000349672700009		
J	Wada, Y; Yamamoto, S; Watanabe, Y				Wada, Yasuhiro; Yamamoto, Seiichi; Watanabe, Yasuyoshi			Development of a Body Shield for Small Animal PET System to Reduce Random and Scatter Coincidences	IEEE TRANSACTIONS ON NUCLEAR SCIENCE			English	Article						Data acquisition; image quality; molecular imaging; positron emission tomography.	FIELD-OF-VIEW; PERFORMANCE; TOMOGRAPH; SCANNER; BRAIN	For small animal positron emission tomography (PET) research using high radioactivity, such as dynamic studies, the resulting high random coincidence rate of the system degrades image quality. The random coincidence rate is increased not only by the gamma photons from inside the axial-field-of-view (axial-FOV) of the PET system but also by those from outside the axial-FOV. For brain imaging in small animal studies, significant interference is observed from gamma photons emitted from the body. Single gamma photons from the body enter the axial-FOV and increase the random and scatter coincidences. Shielding against the gamma photons from outside the axial-FOV would improve the image quality. For this purpose, we developed a body shield for a small animal PET system, the microPET Primate 4-ring system, and evaluated its performance. The body shield is made of 9-mm-thick lead and it surrounds most of a rat's body. We evaluated the effectiveness of the body shield using a head phantom and a body phantom with a radioactivity concentration ratio of 1: 2 and a maximum total activity of approximately 250 MBq. The random coincidence rate was dramatically decreased to 1/10, and the noise equivalent count rate (NECR) was increased 6 times with an activity of 7 MBq in the head phantom. The true count rate was increased to 35% due to the decrease in system deadtime. The average scatter fraction was decreased to 1/2.5 with the body shield. Count rate measurements of rat were also conducted with an injection activity of approximately 25 MBq of [ C-11] N, N-dimethyl-2-(2-amino-4cyanophenylthio) benzylamine ([C-11] DASB) and approximately 70 and 310 MBq of 2-deoxy-2-(F-18) fluoro-D-glucose ([F-18] FDG). Using the body shield, [F-18] FDG images of rats were improved by increasing the amount of radioactivity injected. The body shield designed for small animal PET systems is a promising tool for improving image quality and quantitation accuracy in small animal molecular imaging research.	[Wada, Yasuhiro; Yamamoto, Seiichi] Nagoya Univ, Grad Sch Med, Dept Radiol & Med Lab Sci, Nagoya, Aichi 4618673, Japan; [Wada, Yasuhiro; Watanabe, Yasuyoshi] RIKEN, RIKEN Ctr Life Sci Technol, Kobe, Hyogo 6500047, Japan	Wada, Y (reprint author), Nagoya Univ, Grad Sch Med, Dept Radiol & Med Lab Sci, Nagoya, Aichi 4618673, Japan.	PXL03331@nifty.com					Matsumura A, 2003, NEUROIMAGE, V20, P2040, DOI 10.1016/j.neuroimage.2003.08.020; Hume SP, 1998, EUR J NUCL MED, V25, P173, DOI 10.1007/s002590050211; Boellaard R, 2003, PHYS MED BIOL, V48, pN335, DOI 10.1088/0031-9155/48/23/N02; DaubeWitherspoon M. E., 1998, IEEE NUCL SCI S C RE, V2, P1237; Hasegawa Tomoyuki, 2002, Igaku Butsuri, V22, P318; Lancelot S, 2010, TRENDS PHARMACOL SCI, V31, P411, DOI 10.1016/j.tips.2010.06.002; National Electrical Manufacturers Association, 1994, NEMA STAND PUBL; National Electrical Manufacturers Association, 2008, NEMA STAND PUBL, V3-2008; Spinks TJ, 1998, PHYS MED BIOL, V43, P895, DOI 10.1088/0031-9155/43/4/017; Tai C, 2001, Phys Med Biol, V46, P1845; Thompson CJ, 2001, IEEE T NUCL SCI, V48, P1512, DOI 10.1109/23.958389; Watabe T, 2013, J NUCL MED, V54, P283, DOI 10.2967/jnumed.112.109751; Yamamoto S, 2006, IEEE T NUCL SCI, V53, P2671, DOI 10.1109/TNS.2006.876001; Yamamoto Seiichi, 1996, Kaku Igaku, V33, P641; Young Y., 2006, IEEE T NUCL SCI, V53, P127	15	0	0	IEEE-INST ELECTRICAL ELECTRONICS ENGINEERS INC	PISCATAWAY	445 HOES LANE, PISCATAWAY, NJ 08855-4141 USA	0018-9499	1558-1578		IEEE T NUCL SCI	IEEE Trans. Nucl. Sci.	FEB	2015	62	1	1				95	100		10.1109/TNS.2014.2387192		6	Engineering, Electrical & Electronic; Nuclear Science & Technology	Engineering; Nuclear Science & Technology	CB5MX	WOS:000349672700011		
J	Clement, GT; Nomura, H; Kamakura, T				Clement, Gregory T.; Nomura, Hideyuki; Kamakura, Tomoo			Ultrasound Field Measurement Using a Binary Lens	IEEE TRANSACTIONS ON ULTRASONICS FERROELECTRICS AND FREQUENCY CONTROL			English	Article							FOCUSED TRANSDUCERS; WAVE PROPAGATION; HIGH-FREQUENCY; AIR; PROJECTION; PLANAR; INTERFEROMETER; TOMOGRAPHY; HYDROPHONE; RESOLUTION	Field characterization methods using a scattering target in the absence of a point-like receiver have been well described, in which scattering is recorded by a relatively large receiver located outside the field of measurement. Unfortunately, such methods are prone to artifacts caused by averaging across the receiver surface. To avoid this problem while simultaneously increasing the gain of a received signal, the present study introduces a binary plate lens designed to focus spherically-spreading waves onto a planar region having a nearly-uniform phase proportional to that of the target location. The lens is similar to a zone plate, but modified to produce a bi-convexlike behavior, such that it focuses both planar and spherically spreading waves. A measurement device suitable for characterizing narrowband ultrasound signals in air is designed around this lens by coupling it to a target and planar receiver. A prototype device is constructed and used to characterize the field of a highly-focused 400-kHz in-air transducer along 2 radial lines. Comparison of the measurements with numeric predictions formed from nonlinear acoustic simulation showed good relative pressure correlation, with mean differences of 10% and 12% over the center 3-dB full-width at half-maximum drop and 12% and 17% over the 6-dB drop.	[Clement, Gregory T.] Cleveland Clin, Dept Biomed Engn, Cleveland, OH 44106 USA; [Nomura, Hideyuki; Kamakura, Tomoo] Univ Electrocommun, Grad Sch Informat & Engn, Chofu, Tokyo 182, Japan	Clement, GT (reprint author), Cleveland Clin, Dept Biomed Engn, Cleveland, OH 44106 USA.	gclement@physics.org	Clement, Gregory/A-2518-2014	Clement, Gregory/0000-0002-9054-9173	Center for Industrial and Governmental Relations, The University of Electro-Communications; National Institute of Biomedical Imaging and Bioengineering of the National Institutes of Health [R01EB014296]	This work was supported by The Center for Industrial and Governmental Relations, The University of Electro-Communications. Scattering and field simulation algorithms utilized in the study were developed under award number R01EB014296 from the National Institute of Biomedical Imaging and Bioengineering of the National Institutes of Health.	Almqvist M, 2000, ULTRASONICS, V37, P565, DOI 10.1016/S0041-624X(99)00168-7; Jing Y, 2011, IEEE T ULTRASON FERR, V58, P1097, DOI 10.1109/TUFFC.2011.1910; Jing Y, 2011, J ACOUST SOC AM, V130, P1115, DOI 10.1121/1.3621485; Kamakura T, 2000, J ACOUST SOC AM, V107, P3035, DOI 10.1121/1.429332; Clement GT, 2000, J ACOUST SOC AM, V108, P441, DOI 10.1121/1.429477; Clement GT, 1998, J ACOUST SOC AM, V104, P1266, DOI 10.1121/1.424335; Canney MS, 2008, J ACOUST SOC AM, V124, P2406, DOI 10.1121/1.2967836; Gottlieb D, 1997, SIAM REV, V39, P644, DOI 10.1137/S0036144596301390; Raum K, 1997, IEEE T ULTRASON FERR, V44, P810, DOI 10.1109/58.655196; Harris GR, 2005, IEEE T ULTRASON FERR, V52, P717, DOI 10.1109/TUFFC.2005.1503960; Jing Y, 2011, J ACOUST SOC AM, V129, P32, DOI 10.1121/1.3504705; Bartakova Z, 2006, ULTRASONICS, V44, pE1567, DOI 10.1016/j.ultras.2006.05.163; Bashford AG, 1997, J ACOUST SOC AM, V101, P315, DOI 10.1121/1.418011; BERNIER CA, 1995, J ULTRAS MED, V14, P367; Boutkedjirt T, 2002, ULTRASONICS, V39, P641, DOI 10.1016/S0041-624X(02)00347-5; Clement G. T., 2000, THESIS U RHODE ISLAN, P183; Clement G. T., 2014, LIMITATIONS OPTICAL; Clement GT, 2013, PHYS MED BIOL, V58, P6263, DOI 10.1088/0031-9155/58/18/6263; Clement GT, 2008, ULTRASON, P1800, DOI 10.1109/ULTSYM.2008.0442; Farnow S. A., 1976, THESIS STANFORD U ST; Farnow S. A., 1975, ACOUSTICAL HOLOGRAPH, P259; Fjield T, 1999, PHYS MED BIOL, V44, P1803, DOI 10.1088/0031-9155/44/7/317; Hecht E., 1987, OPTICS, P445; HERMAN BA, 1982, J ACOUST SOC AM, V72, P1357, DOI 10.1121/1.388438; Huang B, 2005, IEEE T ULTRASON FERR, V52, P1608; Kaczkowski P, 2003, ULTRASON, P982; Krasnooshkin PE, 1944, PHYS REV, V65, P190, DOI 10.1103/PhysRev.65.190; Matar OB, 2000, ULTRASONICS, V38, P787; Morse P.M., 1986, THEORETICAL ACOUSTIC; Satyanarayan L, 2010, IEEE T ULTRASON FERR, V57, P2343, DOI 10.1109/TUFFC.2010.1695; Schindel DW, 1997, ULTRASONICS, V35, P275, DOI 10.1016/S0041-624X(97)00011-5; SMITH RA, 1989, PHYS MED BIOL, V34, P1593, DOI 10.1088/0031-9155/34/11/007; Vladisauskas A., 2004, ULTRAGARSAS, V50, P50; Watson G. N., 1966, THEORY BESSEL FUNCTI; Welter JT, 2011, J ACOUST SOC AM, V130, P2789, DOI 10.1121/1.3640841	35	1	1	IEEE-INST ELECTRICAL ELECTRONICS ENGINEERS INC	PISCATAWAY	445 HOES LANE, PISCATAWAY, NJ 08855-4141 USA	0885-3010	1525-8955		IEEE T ULTRASON FERR	IEEE Trans. Ultrason. Ferroelectr. Freq. Control	FEB	2015	62	2					350	359		10.1109/TUFFC.2014.006800		10	Acoustics; Engineering, Electrical & Electronic	Acoustics; Engineering	CB4VH	WOS:000349625900010		
J	Xu, P; Wang, JZ; Wang, JK; Qi, F				Xu, Peng; Wang, Jiangzhou; Wang, Jinkuan; Qi, Feng			Analysis and Design of Channel Estimation in Multicell Multiuser MIMO OFDM Systems	IEEE TRANSACTIONS ON VEHICULAR TECHNOLOGY			English	Article						Channel estimation; H-inf; multiple-input multiple-output (MIMO); multicell; multiuser; orthogonal frequency-division multiplex (OFDM); pilot contamination (PC)	RESOURCE-ALLOCATION; DISTRIBUTED ANTENNA; WIRELESS; CHUNK	This paper investigates the uplink transmission in multicell multiuser multiple-input multiple-output (MIMO) orthogonal frequency-division multiplexing (OFDM) systems. The system model considers imperfect channel estimation, pilot contamination (PC), and multicarrier and multipath channels. Analytical expressions are first presented on the mean square error (MSE) of two classical channel estimation algorithms [i.e., least squares (LS) and minimum mean square error (MMSE)] in the presence of PC. Then, a simple H-infinity (H-inf) channel estimation approach is proposed to have good suppression to PC. This approach exploits the space-alternating generalized expectation-maximization (SAGE) iterative process to decompose the multicell multiuser MIMO (MU-MIMO) problem into a series of single-cell single-user single-input single-output (SISO) problems, which reduces the complexity significantly. According to the analytic results given herein, increasing the number of pilot subcarriers cannot mitigate PC, and a clue for suppressing PC is obtained. It is shown from the results that the H-inf has better suppression capability to PC than classical estimation algorithms. Its performance is close to that of the optimal MMSE as the length of channel impulse response (CIR) is increased. By using the SAGE process, the performance of the H-inf does not degrade when the number of antennas is large at the base station (BS).	[Xu, Peng; Wang, Jiangzhou] Univ Kent, Sch Engn & Digital Arts, Canterbury CT2 7NT, Kent, England; [Xu, Peng; Wang, Jinkuan] Northeastern Univ, Dept Informat Sci & Engn, Shenyang 110819, Peoples R China; [Qi, Feng] RIKEN, Adv Sci Inst, Sendai, Miyagi 9800845, Japan	Xu, P (reprint author), Univ Kent, Sch Engn & Digital Arts, Canterbury CT2 7NT, Kent, England.	p.xu@kent.ac.uk; j.z.wang@kent.ac.uk; wjk@mail.neuq.edu.cn; qifeng@riken.jp			National Natural Science Foundation of China [61374097, 61104005, 61300195]; Basic Scientific Research Business Expenses of China [N120323003]; China Scholarship Council	This work was supported by the National Natural Science Foundation of China under Grant 61374097, Grant 61104005, and Grant 61300195; by the Basic Scientific Research Business Expenses of China under Grant N120323003; and by the China Scholarship Council. The review of this paper was coordinated by Prof. X. Wang.	Mohammed SK, 2013, IEEE T COMMUN, V61, P1059, DOI 10.1109/TCOMM.2013.012913.110827; Zhu HL, 2011, IEEE J SEL AREA COMM, V29, P1151, DOI 10.1109/JSAC.2011.110604; Truong KT, 2013, J COMMUN NETW-S KOR, V15, P338, DOI 10.1109/JCN.2013.000065; Yin HF, 2013, IEEE J SEL AREA COMM, V31, P264, DOI 10.1109/JSAC.2013.130214; Xie YZ, 2003, IEEE T COMMUN, V51, P106, DOI 10.1109/TCOMM.2002.807617; Rusek F, 2013, IEEE SIGNAL PROC MAG, V30, P40, DOI 10.1109/MSP.2011.2178495; Xu P, 2011, IET COMMUN, V5, P2068, DOI 10.1049/iet-com.2010.0487; Ngo HQ, 2012, 2012 IEEE INTERNATIONAL CONFERENCE ON ACOUSTICS, SPEECH AND SIGNAL PROCESSING (ICASSP), P3249; Jose J, 2011, IEEE T WIREL COMMUN, V10, P2640, DOI 10.1109/TWC.2011.060711.101155; Barhumi I, 2003, IEEE T SIGNAL PROCES, V51, P1615, DOI 10.1109/TSP.2003.811243; Ngo HQ, 2011, INT CONF ACOUST SPEE, P3464; Zhu HL, 2012, IEEE T COMMUN, V60, P499, DOI 10.1109/TCOMM.2011.112811.110036; Zhu HL, 2009, IEEE T COMMUN, V57, P2734, DOI 10.1109/TCOMM.2009.09.080067; Paulraj AJ, 2004, P IEEE, V92, P198, DOI 10.1109/JPROC.2003.821915; Wang JZ, 2012, IEEE J SEL AREA COMM, V30, P675, DOI 10.1109/JSAC.2012.120502; Zhu HL, 2012, IEEE J SEL AREA COMM, V30, P748, DOI 10.1109/JSAC.2012.120509; Gesbert D, 2007, IEEE SIGNAL PROC MAG, V24, P36, DOI 10.1109/MSP.2007.904815; Gao J, 2008, IEEE T WIREL COMMUN, V7, P774, DOI 10.1109/TWC.2008.051072; Gesbert D, 2003, IEEE J SEL AREA COMM, V21, P281, DOI 10.1109/JSAC.2003.809458; Marzetta TL, 2010, IEEE T WIREL COMMUN, V9, P3590, DOI 10.1109/TWC.2010.092810.091092; Ngo HQ, 2013, IEEE T COMMUN, V61, P1436, DOI 10.1109/TCOMM.2013.020413.110848; Pitarokoilis Antonios, 2012, IEEE Wireless Communications Letters, V1, DOI 10.1109/WCL.2012.041612.120046; Xu P, 2012, 2012 IEEE INTERNATIONAL CONFERENCE ON ACOUSTICS, SPEECH AND SIGNAL PROCESSING (ICASSP), P3189	23	0	0	IEEE-INST ELECTRICAL ELECTRONICS ENGINEERS INC	PISCATAWAY	445 HOES LANE, PISCATAWAY, NJ 08855-4141 USA	0018-9545	1939-9359		IEEE T VEH TECHNOL	IEEE Trans. Veh. Technol.	FEB	2015	64	2					610	620				11	Engineering, Electrical & Electronic; Telecommunications; Transportation Science & Technology	Engineering; Telecommunications; Transportation	CB6CR	WOS:000349715000016		
J	Tang, SH; Yomo, H; Takeuchi, Y				Tang, Suhua; Yomo, Hiroyuki; Takeuchi, Yoshio			Optimization of Frame Length Modulation-Based Wake-Up Control for Green WLANs	IEEE TRANSACTIONS ON VEHICULAR TECHNOLOGY			English	Article						Burst transmission; frame length modulation; green wireless local area networks (WLANs); wake-up receiver (WuRx)	WIRELESS SENSOR NETWORKS	In this paper, green wireless local area networks (WLANs), where idle access points (APs) are put into sleep and activated upon the request of mobile nodes, are realized by exploiting WLAN signals to convey wake-up messages. Specifically, wake-up messages, sent by nodes, are modulated onto frame lengths (physical transmission time) of successive WLAN signals and detected by non-WLAN low-cost receivers equipped at APs. This method, however, is susceptible to serious 1) false negative events due to low signal quality or collisions with background WLAN frames and 2) false positive events where background WLAN frames happen to have the same frame lengths as those of wake-up messages. In the proposed scheme, WLAN frames forming a wake-up message are transmitted in a burst and interpreted as an equivalent message. On this basis, false probability is reduced from two aspects: 1) Modulation constellations of frame lengths are optimized to maximize the Hamming distance between equivalent messages, and 2) preamble frame and envelope smoothing are used to mitigate false events. In addition to theoretical analysis and simulation, a prototype test bed is built and experimented on. Extensive evaluations confirm that the proposed scheme helps to greatly improve the reliability of wake-up control compared with state-of-the-art methods.	[Tang, Suhua; Takeuchi, Yoshio] Adv Telecommun Res Inst Int ATR, Adapt Commun Res Labs, Kyoto 6190288, Japan; [Yomo, Hiroyuki] Kansai Univ, Fac Engn Sci, Suita, Osaka 5648680, Japan	Tang, SH (reprint author), Adv Telecommun Res Inst Int ATR, Adapt Commun Res Labs, Kyoto 6190288, Japan.	suhua_tang@ieee.org			Strategic Information and Communications R&D Promotion Programme (SCOPE) - Ministry of Internal Affairs and Communication, Japan	This work was supported by the Strategic Information and Communications R&D Promotion Programme (SCOPE), funded by the Ministry of Internal Affairs and Communication, Japan. The review of this paper was coordinated by Dr. I. Krikidis.	Chebrolu K, 2009, FIFTEENTH ACM INTERNATIONAL CONFERENCE ON MOBILE COMPUTING AND NETWORKING (MOBICOM 2009), P85; Kondo Y, 2012, COMPUT COMMUN, V35, P1725, DOI 10.1016/j.comcom.2012.04.022; Jin T, 2011, IEEE INFOCOM SER, P1593; Anastasi G, 2009, AD HOC NETW, V7, P537, DOI 10.1016/j.adhoc.2008.06.003; Jardosh AP, 2009, MOBILE NETW APPL, V14, P798, DOI 10.1007/s11036-008-0123-8; Zhang XY, 2012, IEEE T MOBILE COMPUT, V11, P1441, DOI 10.1109/TMC.2012.112; Bertsekas D. P., 2002, INTRO PROBABILITY; Bianchi G, 2000, IEEE J SEL AREA COMM, V18, P535, DOI 10.1109/49.840210; Carroll A., 2010, P 2010 USENIX C USEN, P21; Demirkol I, 2009, IEEE WIREL COMMUN, V16, P88, DOI 10.1109/MWC.2009.5281260; Dogar F. R., 2010, P 8 INT C MOB SYST A, P107, DOI 10.1145/1814433.1814446; IEEE 802.11 Working Group of the 802 Committee, 2012, 80211 IEEE; Mishra N., 2006, P INT C WORLD WID WE, P761, DOI 10.1145/1135777.1135893; Phillips Caleb, 2009, CRAWDAD DATA SET PDX; Reed I. S., 1999, ERROR CONTROL CODING; Shih E., 2002, P 8 ANN INT C MOB CO, P160; Tang S., 2012, P IEEE ICC, P4954; Tang SH, 2012, EURASIP J WIREL COMM, P1, DOI 10.1186/1687-1499-2012-42; Yomo H., 2012, P IEEEGLOBECOM, P5206; Yomo H, 2012, UEEE INT SYM PERS IN, P419, DOI 10.1109/PIMRC.2012.6362821; Zhang YF, 2013, IEEE INFOCOM SER, P1366	21	0	0	IEEE-INST ELECTRICAL ELECTRONICS ENGINEERS INC	PISCATAWAY	445 HOES LANE, PISCATAWAY, NJ 08855-4141 USA	0018-9545	1939-9359		IEEE T VEH TECHNOL	IEEE Trans. Veh. Technol.	FEB	2015	64	2					768	780		10.1109/TVT.2014.2325643		13	Engineering, Electrical & Electronic; Telecommunications; Transportation Science & Technology	Engineering; Telecommunications; Transportation	CB6CR	WOS:000349715000028		
J	Yoshizawa, R; Ochiai, H				Yoshizawa, Ryota; Ochiai, Hideki			A Trellis Shaping for Peak and Average Power Reduction of BICM-OFDM Signals	IEEE TRANSACTIONS ON WIRELESS COMMUNICATIONS			English	Article						Trellis shaping (TS); soft-in-soft-out (SISO) decoding; peak-to-average power ratio (PAPR) reduction; bit-interleaved coded modulation (BICM); orthogonal frequency-division multiplexing (OFDM)	CONSTELLATION EXTENSION; PAR REDUCTION; SYSTEMS; CODES; RATIO; PERFORMANCE; MODULATION; CHANNEL	One of the major drawbacks of orthogonal frequency-division multiplexing (OFDM) systems is their high peak-to-average power ratio (PAPR) signals, and trellis shaping (TS) is a promising approach for reducing both peak power and average power of OFDM signals. In practice, OFDM should be employed with coded modulation for improving reliability, and bit-interleaved coded modulation (BICM) has been often combined with OFDM to gain robustness against severe fading channels. In this work, we propose a new BICM-OFDM system concatenated with TS for achieving good error performance. To this end, a novel soft-in-soft-out decoder for TS is developed. Optimization of the shaping convolutional code in terms of transmitter performance is also discussed. The effectiveness of our system is demonstrated through the analysis in terms of average mutual information as well as frame error rate (FER) over an additive white Gaussian noise channel. Furthermore, the FER is evaluated over a frequency-selective Rayleigh fading channel and compared with the theoretical outage probability. The simulation results reveal that our system can achieve good frequency diversity effect over such a fading channel while enjoying much lower PAPR.	[Yoshizawa, Ryota; Ochiai, Hideki] Yokohama Natl Univ, Dept Elect & Comp Engn, Yokohama, Kanagawa 2408501, Japan	Yoshizawa, R (reprint author), Yokohama Natl Univ, Dept Elect & Comp Engn, Yokohama, Kanagawa 2408501, Japan.	ryota.yoshizawa@ieee.org; hideki@ynu.ac.jp			MEXT KAKENHI [23686058]; JSPS KAKENHI [25.195]	This work was supported in part by MEXT KAKENHI under Grant 23686058 and in part by JSPS KAKENHI under Grant 25.195. This paper was presented in part at the IEEE International Symposium on Information Theory (ISIT), Cambridge, MA, USA, July 2012, and at the IEEE 78th Vehicular Technology Conference (VTC-Fall), Las Vegas, NV, USA, September 2013. The associate editor coordinating the review of this paper and approving it for publication was L. K. Rasmussen.	ZEHAVI E, 1992, IEEE T COMMUN, V40, P873, DOI 10.1109/26.141453; BAHL LR, 1974, IEEE T INFORM THEORY, V20, P284, DOI 10.1109/TIT.1974.1055186; Caire G, 1998, IEEE T INFORM THEORY, V44, P927, DOI 10.1109/18.669123; Ochiai H, 2002, IEEE T COMMUN, V50, P89, DOI 10.1109/26.975762; Huang X, 2004, IEEE T WIREL COMMUN, V3, P2030, DOI 10.1109/TWC.2004.837619; ROBERTSON P, 1995, ICC '95 - 1995 IEEE INTERNATIONAL CONFERENCE ON COMMUNICATIONS, CONFERENCE RECORD, VOLS 1-3, P1009; Sezginer S, 2007, IEEE T WIREL COMMUN, V6, P2622, DOI 10.1109/TWC.2007.05955.; Wang XB, 1999, IEEE T BROADCAST, V45, P303; Ochiai H, 2004, IEEE T COMMUN, V52, P1916, DOI 10.1109/TCOMM.2004.836593; Acikel OF, 1999, IEEE T COMMUN, V47, P1315, DOI 10.1109/26.789667; Cann AJ, 2012, IEEE T AERO ELEC SYS, V48, P3637, DOI 10.1109/TAES.2012.6324749; Krongold BS, 2003, IEEE T BROADCAST, V49, P258, DOI 10.1109/TBC.2003.817088; Li XD, 1998, IEEE COMMUN LETT, V2, P131, DOI 10.1109/4234.673657; Bauml RW, 1996, ELECTRON LETT, V32, P2056, DOI 10.1049/el:19961384; Aoki T, 2010, IEICE T FUND ELECTR, VE93A, P2663, DOI 10.1587/transfun.E93.A.2663; DOLINAR S, 1995, TDA PROGR REPORT, V42, P56; FORNEY GD, 1992, IEEE T INFORM THEORY, V38, P281, DOI 10.1109/18.119687; Henkel W, 2000, IEEE T COMMUN, V48, P1471, DOI 10.1109/26.870014; Kou YJ, 2007, IEEE T WIREL COMMUN, V6, P1823, DOI 10.1109/TWC.2007.05654; Ochiai H, 2013, IEEE T COMMUN, V61, P1460, DOI 10.1109/TCOMM.2013.020413.120384; PROAKIS J.G., 2007, DIGITAL COMMUNICATIO; Raab F., 1986, P RF TECHN EXP 86 AN, P474; Rapp C., 1991, P 2 EUR C SAT COMM L, V2, P179; Ruttik K., 2009, P ACM ICWCM LEIPZ GE, P75; Tanahashi M, 2010, IEEE T COMMUN, V58, P9, DOI 10.1109/TCOMM.2010.01.070667; Tellado J., 1999, THESIS STANFORD U ST; VITERBI AJ, 1971, IEEE T COMMUN TECHN, VCO19, P751, DOI 10.1109/TCOM.1971.1090700; Yoshizawa R., 2012, Proceedings of the 2012 IEEE International Symposium on Information Theory - ISIT, DOI 10.1109/ISIT.2012.6283500; Yoshizawa R., 2013, P IEEE 78 VTC FALL L, P1	29	0	0	IEEE-INST ELECTRICAL ELECTRONICS ENGINEERS INC	PISCATAWAY	445 HOES LANE, PISCATAWAY, NJ 08855-4141 USA	1536-1276	1558-2248		IEEE T WIREL COMMUN	IEEE Trans. Wirel. Commun.	FEB	2015	14	2					1143	1154		10.1109/TWC.2014.2365018		12	Engineering, Electrical & Electronic; Telecommunications	Engineering; Telecommunications	CB5NP	WOS:000349674800045		
J	Li, X; Saitoh, S; Shibata, T; Tanimura, N; Fukui, R; Miyake, K				Li, Xiaobing; Saitoh, Shin-ichiroh; Shibata, Takuma; Tanimura, Natsuko; Fukui, Ryutaro; Miyake, Kensuke			Mucolipin 1 positively regulates TLR7 responses in dendritic cells by facilitating RNA transportation to lysosomes	INTERNATIONAL IMMUNOLOGY			English	Article						endolysosome; RNA; TLR7; trafficking	TOLL-LIKE RECEPTORS; TRP CHANNEL; IV; INFLAMMATION; TRAFFICKING; RECOGNITION; EXOCYTOSIS; IMMUNITY; UPDATE; ACID	Toll-like receptor 7 (TLR7) and TLR9 sense microbial single-stranded RNA (ssRNA) and ssDNA in endolysosomes. Nucleic acid (NA)-sensing in endolysosomes is thought to be important for avoiding TLR7/9 responses to self-derived NAs. Aberrant self-derived NA transportation to endolysosomes predisposes to autoimmune diseases. To restrict NA-sensing in endolysosomes, TLR7/9 trafficking is tightly controlled by a multiple transmembrane protein Unc93B1. In contrast to TLR7/9 trafficking, little is known about a mechanism underlying NA transportation. We here show that Mucolipin 1 (Mcoln1), a member of the transient receptor potential (TRP) cation channel gene family, has an important role in ssRNA trafficking into lysosomes. Mcoln1(-/-) dendritic cells (DCs) showed impaired TLR7 responses to ssRNA. A mucolipin agonist specifically enhanced TLR7 responses to ssRNAs. The channel activity of Mcoln1 is activated by a phospholipid phosphatidylinositol (3,5) bisphosphate (PtdIns(3,5)P-2), which is generated by a class III lipid kinase PIKfyve. A PIKfyve inhibitor completely inhibited TLR7 responses to ssRNA in DCs. Confocal analyses showed that ssRNA transportation to lysosomes in DCs was impaired by PIKfyve inhibitor as well as by the lack of Mcoln1. Transportation of TLR9 ligands was also impaired by the PIKfyve inhibitor. These results demonstrate that the PtdIns(3,5)P-2-Mcoln1 axis has an important role in ssRNA transportation into lysosomes in DCs.	[Li, Xiaobing; Saitoh, Shin-ichiroh; Shibata, Takuma; Tanimura, Natsuko; Fukui, Ryutaro; Miyake, Kensuke] Univ Tokyo, Inst Med Sci, Dept Microbiol & Immunol, Div Innate Immun, Tokyo 1088639, Japan; [Miyake, Kensuke] Univ Tokyo, Inst Med Sci, Ctr Expt Med & Syst Biol, Lab Innate Immun, Tokyo 1088639, Japan	Miyake, K (reprint author), Univ Tokyo, Inst Med Sci, Dept Microbiol & Immunol, Div Innate Immun, Tokyo 1088639, Japan.	kmiyake@ims.u-tokyo.ac.jp			Ministry of Education, Culture, Sports, Science and Technology for Program of Japan Initiative for Global Research Network on Infectious Diseases [10005010]; CREST;  [21117002];  [24117706];  [25253032];  [26293083];  [25460585]	Contract research fund from the Ministry of Education, Culture, Sports, Science and Technology for Program of Japan Initiative for Global Research Network on Infectious Diseases (10005010); Grant-in-Aid for Scientific Research on Innovative Areas (21117002, 24117706); Grant-in-Aid for Scientific Research (A) 25253032, (B) 26293083, (C) 25460585; CREST.	Barton GM, 2006, NAT IMMUNOL, V7, P49, DOI 10.1038/ni1280; Tabeta K, 2006, NAT IMMUNOL, V7, P156, DOI 10.1038/ni1297; Kaisho T, 2006, J ALLERGY CLIN IMMUN, V117, P979, DOI 10.1016/j.jaci.2006.02.023; Christensen SR, 2006, IMMUNITY, V25, P417, DOI 10.1016/j.immuni.2006.07.013; Fukui R, 2011, IMMUNITY, V35, P69, DOI 10.1016/j.immuni.2011.05.010; Venkatachalam K, 2013, AUTOPHAGY, V9, P98, DOI 10.4161/auto.22260; Schmitz F, 2008, EUR J IMMUNOL, V38, P2981, DOI 10.1002/eji.200838761; Ehlers M, 2006, J EXP MED, V203, P553, DOI 10.1084/jem.20052438; Kawai T, 2010, NAT IMMUNOL, V11, P373, DOI 10.1038/ni.1863; Samie M, 2013, DEV CELL, V26, P511, DOI 10.1016/j.devcel.2013.08.003; Fukui R, 2009, J EXP MED, V206, P1339, DOI 10.1084/jem.20082316; Blasius AL, 2010, IMMUNITY, V32, P305, DOI 10.1016/j.immuni.2010.03.012; Beutler B, 2006, ANNU REV IMMUNOL, V24, P353, DOI 10.1146/annurev.immunol.24.021605.090552; Mouchess ML, 2011, IMMUNITY, V35, P721, DOI 10.1016/j.immuni.2011.10.009; Leadbetter EA, 2002, NATURE, V416, P603, DOI 10.1038/416603a; Cao WP, 2008, NAT IMMUNOL, V9, P1157, DOI 10.1038/ni.1645; Kim YM, 2008, NATURE, V452, P234, DOI 10.1038/nature06726; Dong XP, 2010, NAT COMMUN, V1, DOI 10.1038/ncomms1037; FOLKERTH RD, 1995, J NEUROPATH EXP NEUR, V54, P154, DOI 10.1097/00005072-199503000-00002; Hazeki K, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0073894; Lande R., 2007, NATURE, V449, P56; LaPlante JM, 2006, MOL GENET METAB, V89, P339, DOI 10.1016/j.ymgme.2006.05.016; Marshak-Rothstein A, 2007, ANNU REV IMMUNOL, V25, P419, DOI 10.1146/annurev.immunol.22.0127030.104514; Shen DB, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms1735; Wakabayashi K, 2011, MOL GENET METAB, V104, P206, DOI 10.1016/j.ymgme.2011.06.006	25	1	1	OXFORD UNIV PRESS	OXFORD	GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND	0953-8178	1460-2377		INT IMMUNOL	Int. Immunol.	FEB	2015	27	2					83	94		10.1093/intimm/dxu086		12	Immunology	Immunology	CC2WU	WOS:000350206500003		
J	Kataoka, TR; Kumanogoh, A; Fukuishi, N; Ueshima, C; Hirata, M; Moriyoshi, K; Tsuruyama, T; Haga, H				Kataoka, Tatsuki R.; Kumanogoh, Atsushi; Fukuishi, Nobuyuki; Ueshima, Chiyuki; Hirata, Masahiro; Moriyoshi, Koki; Tsuruyama, Tatsuaki; Haga, Hironori			CD72 negatively regulates mouse mast cell functions and down-regulates the expression of KIT and Fc epsilon RI alpha	INTERNATIONAL IMMUNOLOGY			English	Article						Cbl; CD72; Fc epsilon RI alpha; KIT; mast cell	MONOCLONAL ANTI-LYB-2 ANTIBODY; C-KIT; TYROSINE KINASE; CBL-B; LYMPHOCYTE SEMAPHORIN; INHIBITORY RECEPTORS; ANTIGEN RECEPTOR; POINT MUTATION; ACTIVATION; RESPONSES	CD72 is a transmembrane protein belonging to the C-type lectin family that is expressed by various hematopoietic cells. When bound to its natural ligand, CD100 (semaphorin 4D), CD72 inhibits the KIT-mediated responses of human mast cells, but not IgE/Fc epsilon RI-mediated mast cell degranulation. We extended these findings to examine the role of CD72 in mouse mast cells. CD72 expression was detected in mouse bone marrow-derived mast cells (mBMMCs). As for human mast cells, an agonistic antibody against CD72 (K10.6) suppressed the KIT-mediated cell growth of, IL-6 production by and chemotaxis of mBMMCs. However, in contrast to human mast cells, the IgE-triggered degranulation of mBMMCs was suppressed by K10.6. K10.6 did not affect the phosphorylation of SHP-1 in mBMMCs, although SHP-1 mediated the inhibitory effects of CD72 in human mast cells. Administration of K10.6 induced phosphorylation of the ubiquitin ligase Cbl-b and decreased the expression of KIT and Fc epsilon RI alpha on the surface of murine mast cells. We also observed expression of CD72 in a mouse neoplastic cell line, P815, harboring gain-of-function mutations in KIT genes. In addition, we found that K10.6 activated Cbl-b, down-regulated KIT expression and suppressed the mutated KIT-driven growth of these cells. Thus, the mechanism by which CD72 mediates inhibitory effects in mast cells is species-dependent.	[Kataoka, Tatsuki R.; Ueshima, Chiyuki; Hirata, Masahiro; Moriyoshi, Koki; Tsuruyama, Tatsuaki; Haga, Hironori] Kyoto Univ Hosp, Dept Diagnost Pathol, Sakyo Ku, Kyoto 606, Japan; [Kumanogoh, Atsushi] Osaka Univ, Grad Sch Med, Dept Resp Med Allergy & Rheumat Dis, Suita, Osaka, Japan; [Kumanogoh, Atsushi] Osaka Univ, WPI Immunol Frontier Res Ctr, Suita, Osaka, Japan; [Fukuishi, Nobuyuki] Tokushima Bunri Univ, Fac Pharmaceut Sci, Tokushima 770, Japan	Kataoka, TR (reprint author), Kyoto Univ Hosp, Dept Diagnost Pathol, Sakyo Ku, Kyoto 606, Japan.	trkataoka@yahoo.co.jp			Ministry of Education, Culture, Sports, Science and Technology, Japan	Ministry of Education, Culture, Sports, Science and Technology, Japan.	Adachi T, 2000, J IMMUNOL, V164, P1223; Kalesnikoff J, 2006, P NATL ACAD SCI USA, V103, P2659, DOI 10.1073/pnas.0511191103; Mekori YA, 1999, J ALLERGY CLIN IMMUN, V104, P517, DOI 10.1016/S0091-6749(99)70316-7; Kumanogoh A, 2002, J IMMUNOL, V169, P1175; Okabe S, 2006, BLOOD CELL MOL DIS, V36, P308, DOI 10.1016/j.bcmd.2005.12.035; Wu HJ, 2009, J CLIN IMMUNOL, V29, P12, DOI 10.1007/s10875-008-9264-6; Sohn HW, 2003, J EXP MED, V197, P1511, DOI 10.1084/jem.20021686; Mirmonsef P, 1999, J IMMUNOL, V163, P2530; Gilfillan AM, 2006, NAT REV IMMUNOL, V6, P218, DOI 10.1038/nri1782; Grewal IS, 1998, ANNU REV IMMUNOL, V16, P111, DOI 10.1146/annurev.immunol.16.1.111; Mestas J, 2004, J IMMUNOL, V172, P2731; Okayama Y, 2006, IMMUNOL RES, V34, P97, DOI 10.1385/IR:34:2:97; Kumanogoh A, 2000, IMMUNITY, V13, P621, DOI 10.1016/S1074-7613(00)00062-5; Kataoka TR, 2010, J IMMUNOL, V184, P2468, DOI 10.4049/jimmunol.0902450; Gustin SE, 2006, J IMMUNOL, V177, P5980; DUBOIS CM, 1994, BLOOD, V83, P3138; Hirota S, 1998, SCIENCE, V279, P577, DOI 10.1126/science.279.5350.577; Welle MM, 2008, VET DERMATOL, V19, P321, DOI 10.1111/j.1365-3164.2008.00694.x; Gilfillan AM, 2009, IMMUNOL RES, V43, P15, DOI 10.1007/s12026-008-8046-9; Ishida I, 2003, INT IMMUNOL, V15, P1027, DOI 10.1093/intimm/dxg098; Metcalfe DD, 2008, BLOOD, V112, P946, DOI 10.1182/blood-2007-11-078097; NAGATA H, 1995, P NATL ACAD SCI USA, V92, P10560, DOI 10.1073/pnas.92.23.10560; Alcon VL, 2009, EUR J IMMUNOL, V39, P826, DOI 10.1002/eji.200838682; YAMASHITA T, 1994, P NATL ACAD SCI USA, V91, P11251, DOI 10.1073/pnas.91.23.11251; Kim MS, 2008, J IMMUNOL, V180, P4586; Lin TY, 2010, BLOOD, V115, P4217, DOI 10.1182/blood-2009-07-231985; Baba T, 2005, EUR J IMMUNOL, V35, P1634, DOI 10.1002/eji.200425775; Li DHH, 2008, ARTHRITIS RHEUM, V58, P3192, DOI 10.1002/art.23812; Li LX, 2004, CELL MOL IMMUNOL, V1, P408; SCHWARTING R, 1992, AM J HEMATOL, V41, P151, DOI 10.1002/ajh.2830410303; SNOW EC, 1986, J IMMUNOL, V137, P1793; SUBBARAO B, 1983, J IMMUNOL, V130, P2033; SUBBARAO B, 1984, J EXP MED, V159, P1796, DOI 10.1084/jem.159.6.1796; Tsujimura T, 1996, BLOOD, V87, P273; TSUJIMURA T, 1994, BLOOD, V83, P2619; Unkeless JC, 1997, CURR OPIN IMMUNOL, V9, P338, DOI 10.1016/S0952-7915(97)80079-9; VALENT P, 1990, INT ARCH ALLER A IMM, V91, P198; Wu YJ, 1998, CURR BIOL, V8, P1009, DOI 10.1016/S0960-9822(07)00421-6; YING H, 1995, J IMMUNOL, V154, P2743; Zeng S, 2005, BLOOD, V105, P226, DOI 10.1182/blood-2004-05-1768	40	0	0	OXFORD UNIV PRESS	OXFORD	GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND	0953-8178	1460-2377		INT IMMUNOL	Int. Immunol.	FEB	2015	27	2					95	103		10.1093/intimm/dxu087		9	Immunology	Immunology	CC2WU	WOS:000350206500004		
J	Iinuma, C; Waki, M; Kawakami, A; Yamaguchi, M; Tomaru, U; Sasaki, N; Masuda, S; Matsui, Y; Iwasaki, S; Baba, T; Kasahara, M; Yoshiki, T; Paletta, D; Herrmann, T; Ishizu, A				Iinuma, Chihiro; Waki, Masashi; Kawakami, Ai; Yamaguchi, Madoka; Tomaru, Utano; Sasaki, Naomi; Masuda, Sakiko; Matsui, Yuki; Iwasaki, Sari; Baba, Tomohisa; Kasahara, Masanori; Yoshiki, Takashi; Paletta, Daniel; Herrmann, Thomas; Ishizu, Akihiro			Establishment of a vascular endothelial cell-reactive type II NKT cell clone from a rat model of autoimmune vasculitis	INTERNATIONAL IMMUNOLOGY			English	Article						small vessel vasculitis; type II NKT cell; vascular endothelial cell	KILLER T-CELLS; ENV-PX GENE; TRANSGENIC RATS; RECOGNITION; INFLAMMATION; ACTIVATION; DISEASES; CD1D; MICE	We previously generated a rat model that spontaneously developed small vessel vasculitis (SVV). In this study, a T cell clone reactive with rat vascular endothelial cells (REC) was established and named VASC-1. Intravenous injection of VASC-1 induced SVV in normal recipients. VASC-1 was a TCR alpha beta/CD3-positive CD4/CD8 double-negative T cell clone with expression of NKG2D. The cytokine mRNA profile under unstimulated condition was positive for IL-4 and IFN-gamma but negative for IL-2 and IL-10. After interaction with REC, the mRNA expression of IL-2, IL-5 and IL-6 was induced in VASC-1, which was inhibited by blocking of CD1d on the REC surface. Although the protein levels of these cytokines seemed to be lower than the detection limit in the culture medium, IFN-gamma was detectable. The production of IFN-gamma from the VASC-1 stimulated with LPS-pre-treated REC was inhibited by the CD1d blockade on the REC. These findings indicated VASC-1 as an NKT cell clone. The NKT cell pool includes two major subsets, namely types I and II. Type I NKT cells are characterized by expression of semi-invariant TCRs and the potential to bind to marine sponge-derived alpha-galactosylceramide (alpha-GalCer) loaded on CD1d; whereas, type II NKT cells do not manifest these characteristics. VASC-1 exhibited a usage of TCR other than the type I invariant TCR alpha chain and did not bind to alpha-GalCer-loaded CD1d; therefore, it was determined as a type II NKT cell clone. The collective evidence suggested that REC-reactive type II NKT cells could be involved in the pathogenesis of SVV in rats.	[Iinuma, Chihiro; Waki, Masashi; Kawakami, Ai; Yamaguchi, Madoka; Masuda, Sakiko; Matsui, Yuki] Hokkaido Univ, Grad Sch Hlth Sci, Div Hlth Sci, Sapporo, Hokkaido 0600812, Japan; [Tomaru, Utano; Sasaki, Naomi; Iwasaki, Sari; Baba, Tomohisa; Kasahara, Masanori; Yoshiki, Takashi] Hokkaido Univ, Grad Sch Med, Dept Pathol, Sapporo, Hokkaido 0608638, Japan; [Paletta, Daniel; Herrmann, Thomas] Univ Wurzburg, Inst Virol & Immunbiol, D-97078 Wurzburg, Germany; [Ishizu, Akihiro] Hokkaido Univ, Fac Hlth Sci, Div Med Lab Sci, Sapporo, Hokkaido 0600812, Japan	Ishizu, A (reprint author), Hokkaido Univ, Fac Hlth Sci, Div Med Lab Sci, Sapporo, Hokkaido 0600812, Japan.	aishizu@med.hokudai.ac.jp	Kasahara, Masanori/G-7651-2011; Herrmann, Thomas/J-4943-2012	Herrmann, Thomas/0000-0002-1093-0194	Ministry of Education, Culture, Sports, Science and Technology of Japan [24659171]; Ministry of Health, Labour and Welfare of Japan (Research on Rare and Intractable Diseases); Japan Rheumatism Foundation; Akiyama Life Science Foundation; Suhara Memorial Foundation; Deutsche Forschungsgemeinschaft (DFG) [HE 2346/6-1]	Ministry of Education, Culture, Sports, Science and Technology of Japan (24659171); Ministry of Health, Labour and Welfare of Japan (Research on Rare and Intractable Diseases); Japan Rheumatism Foundation; the Akiyama Life Science Foundation; the Suhara Memorial Foundation and Deutsche Forschungsgemeinschaft (DFG) HE 2346/6-1.	Oh SJ, 2011, J IMMUNOL, V186, P6815, DOI 10.4049/jimmunol.1003916; Rossjohn J, 2012, NAT REV IMMUNOL, V12, P845, DOI 10.1038/nri3328; Jennette JC, 2013, ARTHRITIS RHEUM-US, V65, P1, DOI 10.1002/art.37715; Godfrey DI, 2010, NAT IMMUNOL, V11, P197, DOI 10.1038/ni.1841; Monzon-Casanova E, 2013, EUR J IMMUNOL, V43, P404, DOI 10.1002/eji.201242565; Cui JQ, 1997, SCIENCE, V278, P1623, DOI 10.1126/science.278.5343.1623; Godfrey DI, 2004, NAT REV IMMUNOL, V4, P231, DOI 10.1038/nri11309; Girardi E, 2012, IMMUNOL REV, V250, P167, DOI 10.1111/j.1600-065X.2012.01166.x; Oh K, 2011, EUR J IMMUNOL, V41, P392, DOI 10.1002/eji.201040569; Pyz E, 2006, J IMMUNOL, V176, P7447; Liao CM, 2012, GASTROENTEROLOGY, V142, P326, DOI 10.1053/j.gastro.2011.10.030; Fugo K, 2002, AM J PATHOL, V161, P755, DOI 10.1016/S0002-9440(10)64234-4; Ishizu A, 1995, INT IMMUNOL, V7, P1939, DOI 10.1093/intimm/7.12.1939; Ishizu A, 2003, EXP MOL PATHOL, V74, P309, DOI 10.1016/S0014-4800(02)00019-9; Korkmaz B, 2013, INT IMMUNOPHARMACOL, V17, P1198, DOI 10.1016/j.intimp.2013.07.003; Liu YW, 2011, J CLIN INVEST, V121, P249, DOI 10.1172/JCI43964; Matsuura A, 2000, J IMMUNOL, V164, P3140; Monzon-Casanova E, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013089; Muindi K, 2010, P NATL ACAD SCI USA, V107, P3052, DOI 10.1073/pnas.0915056107; Wu L, 2009, TISSUE ANTIGENS, V73, P535, DOI 10.1111/j.1399-0039.2009.01256.x; Yamazaki H, 1997, INT IMMUNOL, V9, P339, DOI 10.1093/intimm/9.2.339; Yang SC, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022560	22	0	0	OXFORD UNIV PRESS	OXFORD	GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND	0953-8178	1460-2377		INT IMMUNOL	Int. Immunol.	FEB	2015	27	2					105	114		10.1093/intimm/dxu088		10	Immunology	Immunology	CC2WU	WOS:000350206500005		
J	Furutani, K; Suzuki, K				Furutani, Katsushi; Suzuki, Koji			Experimental investigations of deposition conditions for saw wire fabrication by electrical discharge machining	INTERNATIONAL JOURNAL OF ADVANCED MANUFACTURING TECHNOLOGY			English	Article						Electrical discharge machining; Deposition; Wire tool; Machining conditions; Green compact electrode	SURFACE MODIFICATION; TITANIUM CARBIDE	This paper deals with fabrication conditions of a wire saw by electrical discharge machining (EDM). A deposition method by EDM with a compressed tungsten carbide (WC)-cobalt (Co) powder as an electrode has been proposed. In order to improve deposition performance, electrical conditions such as discharge current and open-circuit voltage for EDM were experimentally investigated together with core wire materials, fabrication pressure of the compressed electrode, and wire feeding speed. Cracked carbon coming from working oil by discharge was diffused into the wire, so that the carbon concentration becomes too rich and the wire embrittles. Consequently, stainless steel was preferable for this method. A thick layer was deposited at moderate current of 5 A without breaking of the core wire. A uniform layer was deposited on the wire over an open-circuit voltage of 260 V due to the discharge dispersion and over a compressing pressure of 490 MPa due to the uniform wear of the electrode. After the cyclic and diagonal sequences were compared for the deposition on a 0.2-mm stainless steel wire from four sides, the diagonal one was better because of no discharge concentration.	[Furutani, Katsushi; Suzuki, Koji] Toyota Technol Inst, Dept Adv Sci & Technol, Tempaku Ku, Nagoya, Aichi 4688511, Japan	Furutani, K (reprint author), Toyota Technol Inst, Dept Adv Sci & Technol, Tempaku Ku, 12-1,Hisakata 2 Chome, Nagoya, Aichi 4688511, Japan.	furutani@toyota-ti.ac.jp			Ministry of Education, Culture, Sports, Science and Technology, Japan	The authors would like to thank Mr. Kenji Muramatsu of Shinkikai Giken for his valuable advice and Mr. Yasuo Murase of TTI, Mr. Toshiyuki Yamauchi, and Mr. Hiroyuki Ohue of Tokusen Kogyo for their helpful cooperation. A part of this study was financially supported by Support Program for Forming Strategic Research Infrastructure for Private Universities, "Smart Machine Technology Research Center": matching fund subsidy by Ministry of Education, Culture, Sports, Science and Technology, Japan.	Okazaki Y, 2004, J MANUF SCI E-T ASME, V126, P837, DOI 10.1115/1.1823491; Munir ZA, 2006, J MATER SCI, V41, P763, DOI 10.1007/s10853-006-6555-2; Furutani K, 2009, INT J ADV MANUF TECH, V40, P1093, DOI 10.1007/s00170-008-1420-x; Yu XG, 2012, SOL ENERG MAT SOL C, V98, P337, DOI 10.1016/j.solmat.2011.11.028; Tsao CC, 2012, INT J ADV MANUF TECH, V59, P617, DOI 10.1007/s00170-011-3532-y; Moro T, 2004, J MATER PROCESS TECH, V149, P65, DOI 10.1016/j.jmatprotec.2003.10.058; Kumar S, 2009, J MATER PROCESS TECH, V209, P3675, DOI 10.1016/j.jmatprotec.2008.09.032; Simao J, 2003, INT J MACH TOOL MANU, V43, P121, DOI 10.1016/S0890-6955(02)00187-6; Chiba Y, 2003, CIRP ANN-MANUF TECHN, V52, P281, DOI 10.1016/S0007-8506(07)60584-8; Clark WI, 2003, INT J MACH TOOL MANU, V43, P523, DOI 10.1016/S0890-6955(02)00215-8; Negarestani R, 2010, INT J ADV MANUF TECH, V49, P553, DOI 10.1007/s00170-009-2431-y; Chandra M, 1998, ASME MED, V8, P807; Enomoto T, 1999, CIRP ANN-MANUF TECHN, V48, P273, DOI 10. 1016/S0007-8506(07)63182-5; Furutani K, 2008, MANUFACTURING SYSTEMS AND TECHNOLOGIES FOR THE NEW FRONTIER, P361, DOI 10.1007/978-1-84800-267-8_73; Furutani K, 2009, PROC 2009 IEEE INT C, P2165; Furutani K, 2004, INT J ELECTR MACH, V9, P15; Furutani K, 2003, P 18 ANN M AM SOC PR, P547; Furutani K, 2010, INT J AUTOM TECHNOL, V4, P394; Furutani K, 2001, PRECIS ENG, V25, P138, DOI 10.1016/S0141-6359(00)00068-4; Goto A, 2004, 24 C INT COUNC AER S; Kim JD, 1996, INT J ADV MANUF TECH, V12, P78, DOI 10.1007/BF01178947; Mohri N, 1993, CIRP ANN-MANUF TECHN, V42, P219, DOI 10.1016/S0007-8506(07)62429-9; MOHRI N, 1998, CIRP ANN 1998 MAN, V47, P173, DOI DOI 10.1016/S0007-8506(07)62811-X; Moro T., 2002, Journal of the Japan Society of Precision Engineering, V68; Puri AB, 2003, J MATER PROCESS TECH, V141, P295, DOI [10.1016/S0924-0136(03)00280-2, DOI 10.1016/S0924-0136(03)00280-2]; Samuel MP, 1997, INT J MACH TOOL MANU, V37, P1625, DOI 10.1016/S0890-6955(97)00006-0; Sugawara J, 2004, SEI TECH REV, V58, P7; Suwabe H, 2007, J JPN SOC ABRAS TECH, V15, P351; Suzuki M, 1992, P 2 INT C DIE MOULD, P403; Tomura S, 2009, INT J ELECT MACH, V14, P17	30	0	0	SPRINGER LONDON LTD	LONDON	236 GRAYS INN RD, 6TH FLOOR, LONDON WC1X 8HL, ENGLAND	0268-3768	1433-3015		INT J ADV MANUF TECH	Int. J. Adv. Manuf. Technol.	FEB	2015	76	9-12					1643	1651		10.1007/s00170-014-6393-3		9	Automation & Control Systems; Engineering, Manufacturing	Automation & Control Systems; Engineering	CB6ZW	WOS:000349776600014		
J	Sencer, B; Ishizaki, K; Shamoto, E				Sencer, Burak; Ishizaki, Kosuke; Shamoto, Eiji			A curvature optimal sharp corner smoothing algorithm for high-speed feed motion generation of NC systems along linear tool paths	INTERNATIONAL JOURNAL OF ADVANCED MANUFACTURING TECHNOLOGY			English	Article						Machine tools; NC system; Trajectory generation; Bezier curve; Curvature	QUINTIC SPLINE INTERPOLATION; TRANSITION ALGORITHM; COORDINATED MOTION; POSITIONING TABLE; MACHINE-TOOLS; CURVE; SEGMENTS; DESIGN; ROBOT; APPROXIMATION	Conventional tool paths for computer numerical-controlled (CNC) machine tools or NC positioning systems are mainly composed of linear motion segments, or the so-called G1 commands. This approach exhibits serious limitations in terms of achieving the desired part of geometry and productivity in high-speed machining. Velocity and acceleration discontinuities occur at the junction points of consecutive segments. In order to generate smooth and continuous feed motion, a geometric corner smoothing algorithm is proposed in this paper, which fits quintic B-splines to blend adjacent straight lines together. The proposed transition scheme ensures G(2) continuity transitions and optimal curvature geometry delivering fast cycle time without violating the axis acceleration limits. The cornering error is controlled analytically allowing the user to set the desired cornering tolerance. The feed profile along the corner-blended tool path is generated based on S-curve-type acceleration profile, and it is scheduled for minimum cycle time. At last, the corner-blended tool path is interpolated in real-time with minimum feed fluctuation for accurate and smooth feed motion. Proposed algorithms are implemented, and their effectiveness is tested on a CNC machine tool.	[Sencer, Burak; Ishizaki, Kosuke; Shamoto, Eiji] Nagoya Univ, Nagoya, Aichi 4648601, Japan	Sencer, B (reprint author), Nagoya Univ, Nagoya, Aichi 4648601, Japan.	burak0307@gmail.com					Altintas Y, 2003, CIRP ANN-MANUF TECHN, V52, P297, DOI 10.1016/S0007-8506(07)60588-5; Erkorkmaz K, 2001, INT J MACH TOOL MANU, V41, P1323, DOI 10.1016/S0890-6955(01)00002-5; Pateloup V, 2010, COMPUT AIDED DESIGN, V42, P817, DOI 10.1016/j.cad.2010.05.003; Beudaert X, 2013, INT J MACH TOOL MANU, V73, P9, DOI 10.1016/j.ijmachtools.2013.05.008; Fleisig RV, 2001, COMPUT AIDED DESIGN, V33, P1, DOI 10.1016/S0010-4485(00)00049-X; Heng M, 2010, INT J MACH TOOL MANU, V50, P281, DOI 10.1016/j.ijmachtools.2009.11.005; Bi QZ, 2011, LECT NOTES ARTIF INT, V7102, P465; JOUANEH MK, 1990, IEEE T ROBOTIC AUTOM, V6, P735, DOI 10.1109/70.63274; Langeron JM, 2004, COMPUT AIDED DESIGN, V36, P1219, DOI 10.1016/j.cad.2003.12.002; Barre PJ, 2005, J INTELL ROBOT SYST, V42, P275, DOI 10.1007/s10846-004-4002-7; Ekorkmaz K, 2006, INT J MACH TOOL MANU, V46, P1124; Erkorkmaz K, 2005, J MANUF SCI E-T ASME, V127, P339, DOI 10.1115/1.1830493; Goldenthal R, 2004, COMPUTING, V72, P53, DOI 10.1007/s00607-003-0046-y; JOUANEH MK, 1990, IEEE T ROBOTIC AUTOM, V6, P746, DOI 10.1109/70.63275; Koren Y, 1995, ANN CIRP, V44, P379; Kreyszig E., 1991, DIFFERENTIAL GEOMETR; Lin RS, 2000, INT J MACH TOOL MANU, V40, P1513, DOI 10.1016/S0890-6955(00)00002-X; Macfarlane S, 2001, IEEE INT CONF ROBOT, P979; Piegl L, 2003, NURBS BOOK; Sencer B, 2008, INT J MACH TOOL MANU, V48, P733, DOI [10.1016/j.ijmachtools.2008.01.002, 10.1016/j.jmachtools.2008.01.002]; Sencer B, 2014, 13 IEEE INT WORKSH A; Siemens, 2009, MILL SINUMERIK 5 AX; Sun YW, 2006, INT J MACH TOOL MANU, V46, P235, DOI 10.1016/j.ijmachtools.2005.05.024; Timar SD, 2005, ROBOT CIM-INT MANUF, V21, P37, DOI 10.1016/j.rcim.2004.05.004; Tsai MS, 2010, INT J ADV MANUF TECH, V47, P621, DOI 10.1007/s00170-009-2220-7; Wang FC, 1999, J MECH DESIGN, V121, P430, DOI 10.1115/1.2829479; Wang JB, 2009, INT J ADV MANUF TECH, V41, P1169, DOI 10.1007/s00170-008-1564-8; Werner H, 2004, COMPUT AIDED GEOM D, V12, P837; Yutkowitz SJ, 2005, US Patent, Patent No. 6922606; Zhang LB, 2011, INT J ADV MANUF TECH, V52, P245, DOI 10.1007/s00170-010-2718-z; Zhang QYG, 1998, ROBOT CIM-INT MANUF, V14, P27, DOI 10.1016/S0736-5845(97)00021-5; Zhao H, 2013, INT J MACH TOOL MANU, V65, P88, DOI 10.1016/j.ijmachtools.2012.10.005	32	1	1	SPRINGER LONDON LTD	LONDON	236 GRAYS INN RD, 6TH FLOOR, LONDON WC1X 8HL, ENGLAND	0268-3768	1433-3015		INT J ADV MANUF TECH	Int. J. Adv. Manuf. Technol.	FEB	2015	76	9-12					1977	1992		10.1007/s00170-014-6386-2		16	Automation & Control Systems; Engineering, Manufacturing	Automation & Control Systems; Engineering	CB6ZW	WOS:000349776600043		
J	Yamaguchi, T; Yamauchi, Y; Yamaguchi, J; Hara, K				Yamaguchi, T.; Yamauchi, Y.; Yamaguchi, J.; Hara, K.			Fractures of the pubic rami and sacrum identified after delivery	INTERNATIONAL JOURNAL OF OBSTETRIC ANESTHESIA			English	Letter							INJURIES		[Yamaguchi, T.] Tsushima Izuhara Hosp, Dept Anesthesia, Nagasaki, Japan; [Yamauchi, Y.; Yamaguchi, J.; Hara, K.] Tsushima Izuhara Hosp, Dept Obstet & Gynecol, Nagasaki, Japan	Yamaguchi, T (reprint author), Tsushima Izuhara Hosp, Dept Anesthesia, Nagasaki, Japan.	tyamaguchi@kamigoto-hospital.jp					Alonso-Burgos A, 2007, J BONE JOINT SURG AM, V89A, P396, DOI 10.2106/JBJS.F.00181; Amorosa LF, 2013, ORTHOP CLIN N AM, V44, P301, DOI 10.1016/j.ocl.2013.03.005; Murray DJ, 2011, INT J GYNECOL OBSTET, V115, P289, DOI 10.1016/j.ijgo.2011.06.023; Barel O, 2013, J ULTRAS MED, V32, P815; Brandon C, 2012, ULTRASOUND OBST GYN, V39, P444, DOI 10.1002/uog.9082; Keijzers GB, 2012, SCAND J TRAUMA RESUS, V20, DOI 10.1186/1757-7241-20-77; Pennick V, 2013, COCHRANE DB SYST REV, V8; Scicluna JK, 2004, INT J OBSTET ANESTH, V13, P50, DOI 10.1016/j.ijoa.2003.08.006	8	0	0	ELSEVIER SCI LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND	0959-289X	1532-3374		INT J OBSTET ANESTH	Int. J. Obstet. Anesth.	FEB	2015	24	1					91	93		10.1016/j.ijoa.2014.08.002		3	Anesthesiology; Obstetrics & Gynecology	Anesthesiology; Obstetrics & Gynecology	CB6GP	WOS:000349725800021		
J	Noda, S; Onoda, N; Asano, Y; Kurata, K; Kashiwagi, S; Kawajiri, H; Takashima, T; Hirakawa, K				Noda, Satoru; Onoda, Naoyoshi; Asano, Yuka; Kurata, Kento; Kashiwagi, Shinichiro; Kawajiri, Hidemi; Takashima, Tsutomu; Hirakawa, Kosei			T-stage and positive sentinel nodes ratio are the useful factors to predict non-sentinel node metastasis in breast cancer patients with macro-metastasis in the sentinel node	INTERNATIONAL JOURNAL OF SURGERY			English	Article						Breast cancer; Non-sentinel metastasis	LYMPH-NODE; AXILLARY DISSECTION; SCORING SYSTEM; BIOPSY; WOMEN; INVOLVEMENT; MULTICENTER; VALIDATION; NOMOGRAM; DISEASE	Introduction: Current guidelines recommend completion axillary lymph node dissection (cALND) in case of a sentinel lymph node (SN) metastasis larger than 2 mm (macrometastasis). However in many patients of those, the non-sentinel lymph nodes (NSN) contain no further metastasis, indicating that axillary lymph node dissection provides no benefit. To identify cases who could have undergone omission of the ALND with confidence, we have retrospectively evaluated the predictive factors of NSN metastasis with positive macrometastasis in the SN. Methods: This study was based on a retrospective database of 420 patients who underwent sentinel lymph node biopsy (SNB) for breast cancer, of whom 61 patients had SN macrometastasis intra-and postoperatively. We examined predictive factors of NSN involvement in 51 cases of these 61 patients who underwent cALND. All clinical and histological variables were analyzed according to NSN status, by using Manne-Whitney U test, univariate and multivariate logistic regression model. Results: T stage and the proportion of involved SNs among all identified SNs (SN ratio) were correlated with NSN metastasis. Univariate and multivariate analysis showed that T stage and SN ratio were the independent predictive factor of NSN metastasis. The area under ROC curve for SN ratio was 0.71. The best cut off value of SN ratio was 0.667. Negative predictive value to NSN metastasis in cases with both T2 and more than 0.667 of SN ratio was 85.7%. Conclusion: In patients with invasive breast cancer and macrometastasis of SN, T stage and SN ratio were useful for prediction of NSN metastasis. (C) 2015 Surgical Associates Ltd. Published by Elsevier Ltd. All rights reserved.	[Noda, Satoru; Onoda, Naoyoshi; Asano, Yuka; Kurata, Kento; Kashiwagi, Shinichiro; Kawajiri, Hidemi; Takashima, Tsutomu; Hirakawa, Kosei] Osaka City Univ, Grad Sch Med, Dept Surg Oncol, Abeno Ku, Osaka 5458585, Japan	Noda, S (reprint author), Osaka City Univ, Grad Sch Med, Dept Surg Oncol, Abeno Ku, 1-4-3 Asahi Machi, Osaka 5458585, Japan.	s-noda@med.osaka-cu.ac.jp					Zhu LL, 2013, BREAST CANCER RES TR, V137, P783, DOI 10.1007/s10549-012-2360-6; Mansel RE, 2006, J NATL CANCER I, V98, P599, DOI 10.1093/jnci/djj158; Langer I, 2005, ANN SURG, V241, P152, DOI 10.1097/01.sla.0000149305.23322.3c; Pal A, 2008, BRIT J SURG, V95, P302, DOI 10.1002/bjs.5943; Van Zee KJ, 2003, ANN SURG ONCOL, V10, P1140, DOI 10.1245/ASO.2003.03.015; Coutant C, 2009, J CLIN ONCOL, V27, P2800, DOI 10.1200/JCO.2008.19.7418; Galimberti V, 2012, BREAST CANCER RES TR, V131, P819, DOI 10.1007/s10549-011-1486-2; Barranger E, 2005, BREAST CANCER RES TR, V91, P113, DOI 10.1007/s10549-004-5781-z; Krag DN, 2010, LANCET ONCOL, V11, P927, DOI 10.1016/S1470-2045(10)70207-2; Lyman GH, 2005, J CLIN ONCOL, V23, P7703, DOI 10.1200/JCO.2005.08.001; Veronesi U, 2003, NEW ENGL J MED, V349, P546, DOI 10.1056/NEJMoa012782; Giuliano AE, 2011, JAMA-J AM MED ASSOC, V305, P569, DOI 10.1001/jama.2011.90; Cho J, 2008, ANN SURG ONCOL, V15, P2278, DOI 10.1245/s10434-008-9993-z; Degnim AC, 2005, AM J SURG, V190, P543, DOI 10.1016/j.amjsurg.2005.06.008; Orr RK, 1999, ANN SURG ONCOL, V6, P109, DOI 10.1007/s10434-999-0109-1; Hwang RF, 2003, ANN SURG ONCOL, V10, P248, DOI 10.1245/ASO.2003.05.020; Chagpar AB, 2006, AM J SURG, V192, P882, DOI 10.1016/j.amjsurg.2006.08.063; Chen K, 2012, CANCER SCI, V103, P274, DOI 10.1111/j.1349-7006.2011.02148.x; Coufal O, 2009, PATHOL ONCOL RES, V15, P733, DOI 10.1007/s12253-009-9177-6; Gur AS, 2009, J AM COLL SURGEONS, V208, P229, DOI 10.1016/j.jamcollsurg.2008.10.029; Hessman CJ, 2011, ARCH SURG-CHICAGO, V146, P1035, DOI 10.1001/archsurg.2011.201; Kapur U, 2007, ANN DIAGN PATHOL, V11, P10, DOI 10.1016/j.anndiagpath.2006.08.010; Kohrt HE, 2008, NEW MODELS ONLINE CA, V8, P66; Saidi RF, 2004, AM SURGEON, V70, P101; Tan EY, 2011, ISRN ONCOL, V2011; Yi M, 2010, ANN SURG ONCOL, V17, pS343, DOI 10.1245/s10434-010-1253-3	26	0	0	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	1743-9191	1743-9159		INT J SURG	Int. J. Surg.	FEB	2015	14						56	60		10.1016/j.ijsu.2015.01.006		5	Surgery	Surgery	CB6SK	WOS:000349756700011		
J	Elschner, J; Hu, GH; Yamamoto, M				Elschner, Johannes; Hu, Guanghui; Yamamoto, Masahiro			UNIQUENESS IN INVERSE ELASTIC SCATTERING FROM UNBOUNDED RIGID SURFACES OF RECTANGULAR TYPE	INVERSE PROBLEMS AND IMAGING			English	Article						m Inverse scattering; uniqueness; Navier equation; linear elasticity; Dirichlet boundary condition; rough surface; diffraction grating	PERIODIC STRUCTURES; WAVE SCATTERING; SINGULARITIES; EQUATIONS	Consider the two-dimensional inverse elastic scattering problem of recovering a piecewise linear rigid rough or periodic surface of rectangular type for which the neighboring line segments are always perpendicular. We prove the global uniqueness with at most two incident elastic plane waves by using near-field data. If the Lame constants satisfy a certain condition, then the data of a single plane wave is sufficient to imply the uniqueness. Our proof is based on a transcendental equation for the Navier equation, which is derived from the expansion of analytic solutions to the Helmholtz equation. The uniqueness results apply also to an inverse scattering problem for non-convex bounded rigid bodies of rectangular type.	[Elschner, Johannes; Hu, Guanghui] Weierstrass Inst, D-10117 Berlin, Germany; [Yamamoto, Masahiro] Univ Tokyo, Dept Math Sci, Tokyo 153, Japan	Elschner, J (reprint author), Weierstrass Inst, Mohrenstr 39, D-10117 Berlin, Germany.	Johannes.Elschner@wias-berlin.de; Guanghui.Hu@wias-berlin.de; myama@ms.u-tokyo.ac.jp			German Research Foundation (DFG) [HU 2111/1-1]	Part of this work was finished when G. Hu visited the Graduate School of Mathematical Sciences at the University of Tokyo in December of 2013. He would like to acknowledge the hospitality of the university and the support from the German Research Foundation (DFG) under Grant No. HU 2111/1-1.	Bao G, 2014, T AM MATH SOC, V366, P1333; Charalambopoulos A, 2001, INVERSE PROBL, V17, P1923, DOI 10.1088/0266-5611/17/6/323; Colton D., 1998, INVERSE ACOUSTIC ELE; Costabel M, 2001, COMPUT METHOD APPL M, V190, P2111, DOI 10.1016/S0045-7825(00)00226-7; Elschner J, 2010, INVERSE PROBL, V26, DOI 10.1088/0266-5611/26/11/115002; Elschner J., 2011, METHODS APPL ANAL, V18, P215; Elschner J, 2010, MATH METHOD APPL SCI, V33, P1924, DOI 10.1002/mma.1305; Elschner J., 2003, Journal of Inverse and ILL-Posed Problems, V11, DOI 10.1163/156939403769237024; Elschner J, 2015, APPL ANAL, V94, P252, DOI 10.1080/00036811.2014.887695; Elschner J, 2012, COMMUN COMPUT PHYS, V12, P1434, DOI 10.4208/cicp.220611.130112a; GRISVARD P, 1989, ARCH RATION MECH AN, V107, P157, DOI 10.1007/BF00286498; Hettlich F, 1997, INVERSE PROBL, V13, P351, DOI 10.1088/0266-5611/13/2/010; Hu G., 2013, INVERSE PROBLEMS, V29; Hu GH, 2012, APPL ANAL, V91, P703, DOI 10.1080/00036811.2011.587811; Kirsch A., 1993, LECT NOTE PHYS, V422, P87; MORREY CB, 1957, COMMUN PUR APPL MATH, V10, P271, DOI 10.1002/cpa.3160100204; Nakagawa S, 2003, J ACOUST SOC AM, V113, P3012, DOI 10.1121/1.1572139; Rossle A, 2000, J ELASTICITY, V60, P57, DOI 10.1023/A:1007639413619	18	0	0	AMER INST MATHEMATICAL SCIENCES	SPRINGFIELD	PO BOX 2604, SPRINGFIELD, MO 65801-2604 USA	1930-8337	1930-8345		INVERSE PROBL IMAG	Inverse Probl. Imaging	FEB	2015	9	1					127	141		10.3934/ipi.2015.9.127		15	Mathematics, Applied; Physics, Mathematical	Mathematics; Physics	CB6XB	WOS:000349769000006		
J	Takeuchi, M; Kuwaki, H; Wu, VCC; Otsuji, Y				Takeuchi, Masaaki; Kuwaki, Hiroshi; Wu, Victor Chien-Chia; Otsuji, Yutaka			REPLY: Is New Grade la of Diastolic Dysfunction Relevant at the Population Level?	JACC-CARDIOVASCULAR IMAGING			English	Letter									[Takeuchi, Masaaki; Kuwaki, Hiroshi; Wu, Victor Chien-Chia; Otsuji, Yutaka] Univ Occupat & Environm Hlth, Sch Med, Dept Internal Med 2, Yahatanishi ku, Kitakyushu, Fukuoka 8078555, Japan	Takeuchi, M (reprint author), Univ Occupat & Environm Hlth, Sch Med, Dept Internal Med 2, Yahatanishi ku, 1-1 Iseigaoka, Kitakyushu, Fukuoka 8078555, Japan.	takeuchi@med.uoeh-u.ac.jp					Kuwaki H, 2014, JACC-CARDIOVASC IMAG, V7, P749, DOI 10.1016/j.jcmg.2014.05.002; Pandit A, 2015, ECHOCARDIOGR-J CARD, V32, P56, DOI 10.1111/echo.12600; Tajik AJ, 2014, JACC-CARDIOVASC IMAG, V7, P759, DOI 10.1016/j.jcmg.2014.05.003	3	0	0	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	1936-878X	1876-7591		JACC-CARDIOVASC IMAG	JACC-Cardiovasc. Imag.	FEB	2015	8	2					230	231		10.1016/j.jcmg.2014.10.012		3	Cardiac & Cardiovascular Systems; Radiology, Nuclear Medicine & Medical Imaging	Cardiovascular System & Cardiology; Radiology, Nuclear Medicine & Medical Imaging	CB5HZ	WOS:000349659400020		
J	Takahashi, K; Kurihara, Y; Suzuki, Y; Goshima, Y; Tanaka, F; Takei, K				Takahashi, Keita; Kurihara, Yuji; Suzuki, Yume; Goshima, Yoshio; Tanaka, Fumiaki; Takei, Kohtaro			Association of Cerebrospinal Fluid Levels of Lateral Olfactory Tract Usher Substance (LOTUS) With Disease Activity in Multiple Sclerosis	JAMA NEUROLOGY			English	Article							NOGO RECEPTOR; DEMYELINATION; MARKERS; BANDS	IMPORTANCE Although multiple sclerosis (MS) is generally considered an autoimmune demyelinating disorder of the central nervous system, axonal degeneration through Nogo receptor-1 signaling was recently recognized as an important pathological feature. Our previous identification of lateral olfactory tract usher substance (LOTUS), an endogenous Nogo receptor-1 antagonist, prompted us to analyze the relationship between LOTUS levels of cerebrospinal fluid and the clinical course of MS to evaluate whether LOTUS could be a useful biomarker for MS. OBJECTIVE To examine variations in LOTUS concentrations in the cerebrospinal fluid of patients with MS in accordance with their clinical course. DESIGN, SETTING, AND PARTICIPANTS Cerebrospinal fluid samples were obtained retrospectively from normal controls (NCs; n = 27) and patients with MS (n = 40), amyotrophic lateral sclerosis (n = 22), and multiple system atrophy (n = 10) between January 1, 2008, and January 1, 2014. Patients with MS were divided into relapsing-remitting MS (RRMS; n = 30) and secondary progressive MS (n = 10). Patients with RRMS were further divided into relapse and remission groups. MAIN OUTCOMES AND MEASURES The LOTUS concentration in cerebropsinal fluid was quantitatively detected by immunoblotting using a specific LOTUS antibody and the concentrations compared in accordance with the patients' clinical course, such as remission and relapse groups in RRMS and secondary progressive MS. RESULTS The mean (SD) cerebrospinal fluid LOTUS concentration in the relapse group of RRMS (9.3 [3.6] mu g/dL) was lower than that of NCs (19.2 [4.7] mu g/dL; P < .001) whereas the level in the remission group of RRMS (19.6 [5.8] mu g/dL) was similar to that of NCs. The LOTUS concentration in SPMS (6.7 [1.4] mu g/dL; P < .001) was lower than that of NCs and the remission group of RRMS. The LOTUS levels in other neurodegenerative diseases, such as amyotrophic lateral sclerosis and multiple system atrophy, were normal. CONCLUSIONS AND RELEVANCE Variations in LOTUS concentrations were correlated with disease activity in MS. Therefore, LOTUS concentration may be useful as a possible biomarker for MS. Low LOTUS concentrations may be possibly involved in Nogo receptor-1 signaling, which may induce axonal degeneration in the relapse phase of RRMS and secondary progressive MS.	[Takahashi, Keita; Kurihara, Yuji; Takei, Kohtaro] Yokohama City Univ, Grad Sch Med Life Sci, Dept Med Life Sci, Mol Med Biosci Lab, Yokohama, Kanagawa 2300045, Japan; [Takahashi, Keita; Suzuki, Yume; Tanaka, Fumiaki] Yokohama City Univ, Grad Sch Med, Dept Neurol & Stroke Med, Yokohama, Kanagawa 2300045, Japan; [Goshima, Yoshio] Yokohama City Univ, Grad Sch Med, Dept Mol Pharmacol & Neurobiol, Yokohama, Kanagawa 2300045, Japan	Takei, K (reprint author), Yokohama City Univ, Grad Sch Med Life Sci, Dept Med Life Sci, Mol Med Biosci Lab,Tsurumi Ku, Suehiro Cho 1-7-29, Yokohama, Kanagawa 2300045, Japan.	kohtaro@med.yokohama-cu.ac.jp			Ministry of Education, Culture, Sport, Science, and Technology of Japan; Yokohama City University, Japan; Japan Multiple Sclerosis Society; Takeda Science Foundation for Visionary Research; Astellas Foundation for Research on Metabolic Disorders	This study was supported by grants in aid from the Ministry of Education, Culture, Sport, Science, and Technology of Japan (Drs Takei, Tanaka, Goshima, and Suzuki); a grant for a Research and Development Project III of Yokohama City University, Japan (Drs Takei and Suzuki); a grant for medical research from the Japan Multiple Sclerosis Society (Dr Takahashi); and grants for medical research from the Takeda Science Foundation for Visionary Research and the Astellas Foundation for Research on Metabolic Disorders (Dr Takei).	Lourenco P, 2013, MULT SCLER J, V19, P577, DOI 10.1177/1352458512459684; Teunissen CE, 2005, LANCET NEUROL, V4, P32, DOI 10.1016/S1474-4422(04)00964-0; Satoh JI, 2005, J NEUROPATH EXP NEUR, V64, P129; Petratos S, 2012, BRAIN, V135, P1794, DOI 10.1093/brain/aws100; Kutzelnigg A, 2005, BRAIN, V128, P2705, DOI 10.1093/brain/awh641; Kira J, 2003, LANCET NEUROL, V2, P117, DOI 10.1016/S1474-4422(03)00308-9; Polman CH, 2011, ANN NEUROL, V69, P292, DOI 10.1002/ana.22366; Fournier AE, 2001, NATURE, V409, P341, DOI 10.1038/35053072; Sato Y, 2011, SCIENCE, V333, P769, DOI 10.1126/science.1204144; Yang YH, 2010, ANN NEUROL, V67, P498, DOI 10.1002/ana.21935; Karnezis T, 2004, NAT NEUROSCI, V7, P736, DOI 10.1038/nn1261; Nakashima I, 1999, J NEUROIMMUNOL, V101, P205, DOI 10.1016/S0165-5728(99)00147-2; King J, 2001, NEUROLOGY, V56, P1496	13	1	1	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	2168-6149	2168-6157		JAMA NEUROL	JAMA Neurol.	FEB	2015	72	2					176	179		10.1001/jamaneurol.2014.3613		4	Clinical Neurology	Neurosciences & Neurology	CB4SU	WOS:000349619200009		
J	Inoue, K; Alam, S				Inoue, Katsutoshi; Alam, Shafiq			Hydrometallurgical Recovery of Indium from Flat-Panel Displays of Spent Liquid Crystal Televisions	JOM			English	Article								A recovery process for indium from waste liquid crystal display panels was developed on the basis of hydrometallurgical technology. The powdered sample was leached with 3 M HCl to extract its various metal constituents (indium, aluminum, tin, etc.). The mutual separation and subsequent recovery of the dissolved metals was achieved using two column adsorption tests: The first column was packed with a porous resin impregnated with Aliquat 336, a commercially available solvent extraction reagent based on a quaternary ammonium compound, and the resin contained in the second column was impregnated with Cyanex 923, also a commercially available solvent extraction reagent based on trialkylphosphine oxide. In the first column, tin, iron, and zinc were removed from the leach liquor. In the second column, only indium was selectively recovered. The metal ions trapped in these columns were eluted with 0.1 M H2SO4, yielding a solution purified indium solution with a concentration 10 times that of the feed solution.	[Inoue, Katsutoshi] Saga Univ, Dept Appl Chem, Saga 8408502, Japan; [Alam, Shafiq] Univ Saskatchewan, Dept Chem & Biol Engn, Saskatoon, SK S7N 5A9, Canada	Inoue, K (reprint author), Saga Univ, Dept Appl Chem, Saga 8408502, Japan.	shafiq.alam@usask.ca					European Commission, 2010, CRIT RAW MAT EU; Inoue K., 2008, P ISEC 2008 INT SOLV, V1, P317; Inoue K, 2008, KAGAKU KOGAKU RONBUN, V34, P282, DOI 10.1252/kakoronbunshu.34.282; Senzaki H., 2007, ANN M MMIJ TOK JAP M	4	1	1	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	1047-4838	1543-1851		JOM-US	JOM	FEB	2015	67	2					400	405		10.1007/s11837-014-1287-2		6	Materials Science, Multidisciplinary; Metallurgy & Metallurgical Engineering; Mineralogy; Mining & Mineral Processing	Materials Science; Metallurgy & Metallurgical Engineering; Mineralogy; Mining & Mineral Processing	CB3UM	WOS:000349554500020		
J	Ishii, Y; Noguchi, H; Sato, J; Yoshioka, K; Toyabe, S				Ishii, Yoshinori; Noguchi, Hideo; Sato, Junko; Yoshioka, Keisuke; Toyabe, Shin-ichi			Bone Quality of the Calcaneus 5 Years After Total Knee Arthroplasty	JOURNAL OF ARTHROPLASTY			English	Article						bone quality of calcaneus; ultrasound; bilateral TKA; BUA; 5 year follow-up	X-RAY ABSORPTIOMETRY; MINERAL DENSITY; ELDERLY-WOMEN; FOLLOW-UP; PROXIMAL TIBIA; DISTAL FEMUR; HIP FRACTURE; ULTRASOUND; REPLACEMENT; COMPONENT	We used non-invasive broadband ultrasound attenuation (BUA) to determine whether the pre-surgical bone quality of the calcaneus was improved 5 years postoperatively, and whether the interval between total knee arthroplasty (TKA) surgeries influenced post-surgical calcaneal bone quality. All patients underwent scheduled, staged, bilateral TKA. Twenty-one patients (42 TKAs) with bilateral knee osteoarthritis were evaluated. One day before and 5 years after TKA, BUA through the os calcis on the surgical side was measured. Fourteen out of 21 patients showed post-surgical improvement in BUA bilaterally. When all 42 cases were considered together there was a significant improvement in BUA 5 years after surgery (P = 0.042). There were no significant correlations between the changes in BUA on each side and the interval between TKA surgeries. (C) 2014 Elsevier Inc. All rights reserved.	[Ishii, Yoshinori; Noguchi, Hideo; Sato, Junko; Yoshioka, Keisuke] Ishii Orthopaed & Rehabil Clin, Gyoda, Saitama 3610037, Japan; [Toyabe, Shin-ichi] Niigata Univ, Grad Sch Med & Dent Sci, Div Informat Sci & Biostat, Niigata, Japan	Ishii, Y (reprint author), Ishii Orthopaed & Rehabil Clin, 1089 Shimo Oshi, Gyoda, Saitama 3610037, Japan.						Berth A, 2002, ARCH PHYS MED REHAB, V83, P1432, DOI 10.1053/apmr.2002.34829; Petersen MM, 1999, J ARTHROPLASTY, V14, P77, DOI 10.1016/S0883-5403(99)90206-1; Soininvaara TA, 2004, J CLIN DENSITOM, V7, P424, DOI 10.1385/JCD:7:4:424; UHTHOFF HK, 1978, J BONE JOINT SURG BR, V60, P420; Swanik CB, 2004, J BONE JOINT SURG AM, V86A, P328; Graafmans WC, 1996, BONE, V19, P97, DOI 10.1016/8756-3282(96)00134-2; Lonner JH, 2001, J ARTHROPLASTY, V16, P107, DOI 10.1054/arth.2001.16486; Minoda Y, 2010, J BONE JOINT SURG BR, V92B, P794, DOI 10.1302/0301-620X.92B6.23159; Saari T, 2006, KNEE, V13, P435, DOI 10.1016/j.knee.2006.08.003; Ishii Y, 2000, J ARTHROPLASTY, V15, P519, DOI 10.1054/arth.2000.4639; Jarvenpaa J, 2014, KNEE, V21, P232, DOI 10.1016/j.knee.2013.03.004; Hans D, 1996, LANCET, V348, P511, DOI 10.1016/S0140-6736(95)11456-4; [Anonymous], 1995, J ARTHROPLASTY; Bohr H H, 1987, J Arthroplasty, V2, P309, DOI 10.1016/S0883-5403(87)80064-5; Boonen S, 1997, AGE AGEING, V26, P139, DOI 10.1093/ageing/26.2.139; Hahn Myung Hoon, 2013, J Bone Metab, V20, P105, DOI 10.11005/jbm.2013.20.2.105; Ishii Y, 2013, J ORTHOP SCI, V18, P727, DOI 10.1007/s00776-013-0430-1; Ishii Y, 2004, KNEE, V11, P293, DOI 10.1016/j.knee.2003.08.004; KAUFMAN JJ, 1993, J BONE MINER RES, V8, P517; Kim Kwang Kyoun, 2014, Clin Orthop Surg, V6, P43, DOI 10.4055/cios.2014.6.1.43; LANGTON CM, 1991, OSTEOPOROSIS INT, V1, P194; LEVITZ CL, 1995, CLIN ORTHOP RELAT R, P68; PORTER RW, 1990, BRIT MED J, V301, P638; ROBERTSON DD, 1994, J BONE JOINT SURG AM, V76A, P66; Saari T, 2007, J ORTHOP RES, V25, P798, DOI 10.1002/jor.20358; SEITZ P, 1987, J BONE JOINT SURG BR, V69, P407; Seki T, 1999, J Orthop Sci, V4, P180, DOI 10.1007/s007760050091; Small SR, 2013, BONE JOINT J, V95B, P911, DOI 10.1302/0301-620X.95B7.30537; STEWART A, 1994, CALCIFIED TISSUE INT, V54, P466, DOI 10.1007/BF00334324; Yanagimoto Y, 2000, SCAND J MED SCI SPOR, V10, P103, DOI 10.1034/j.1600-0838.2000.010002103.x; Yung PS, 2005, BRIT J SPORT MED, V39, P547, DOI 10.1136/bjsm.2004.014621	31	0	0	CHURCHILL LIVINGSTONE INC MEDICAL PUBLISHERS	PHILADELPHIA	CURTIS CENTER, INDEPENDENCE SQUARE WEST, PHILADELPHIA, PA 19106-3399 USA	0883-5403	1532-8406		J ARTHROPLASTY	J. Arthroplast.	FEB	2015	30	2					196	198		10.1016/j.arth.2014.08.016		3	Orthopedics	Orthopedics	CB3TM	WOS:000349551700006		
J	Miyazaki, S; Uchiyama, T; Iesaka, Y				Miyazaki, Shinsuke; Uchiyama, Takashi; Iesaka, Yoshito			An Irregular Supraventricular Tachycardia: What is the Mechanism?	JOURNAL OF CARDIOVASCULAR ELECTROPHYSIOLOGY			English	Editorial Material						atrial tachycardia; AV node reentry; catheter ablation; double tachycardia; junctional tachycardia; noncoronary cusp	ATRIOVENTRICULAR NODE		[Miyazaki, Shinsuke; Uchiyama, Takashi; Iesaka, Yoshito] Tsuchiura Kyodo Gen Hosp, Tsuchiura, Ibaraki 3000053, Japan	Miyazaki, S (reprint author), Tsuchiura Kyodo Gen Hosp, Ctr Cardiovasc, Div Cardiol, 11-7 Manabeshin Machi, Tsuchiura, Ibaraki 3000053, Japan.	mshinsuke@k3.dion.ne.jp					Tada H, 2004, PACE, V27, P1440, DOI 10.1111/j.1540-8159.2004.00651.x; Yamabe H, 2010, CIRC-ARRHYTHMIA ELEC, V3, P54, DOI 10.1161/CIRCEP.109.878678; Iesaka Y, 1997, J CARDIOVASC ELECTR, V8, P854, DOI 10.1111/j.1540-8167.1997.tb00846.x	3	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1045-3873	1540-8167		J CARDIOVASC ELECTR	J. Cardiovasc. Electrophysiol.	FEB	2015	26	2					231	232		10.1111/jce.12541		2	Cardiac & Cardiovascular Systems	Cardiovascular System & Cardiology	CB4VO	WOS:000349626600020		
J	Tanabe, T; Sugahara, T; Kitamura, K; Yamazaki, T; Fujimoto, T; Ohgaki, K				Tanabe, Tomohiro; Sugahara, Takeshi; Kitamura, Kazuma; Yamazaki, Takahiro; Fujimoto, Takashi; Ohgaki, Kazunari			High-Pressure Phase Equilibria of Tertiary-Butylamine Hydrates with and without Hydrogen	JOURNAL OF CHEMICAL AND ENGINEERING DATA			English	Article							CLATHRATE HYDRATE; STRUCTURAL TRANSITION; CLUSTERS; STORAGE; SYSTEM	Thermodynamic stability boundaries of the simple tertiary-butylamine (t-BA) hydrate and t-BA+hydrogen (H-2) mixed hydrate were investigated at a pressure up to approximately 100 MPa. All experimental results from the phase equilibrium measurement, in situ Raman spectroscopy, and powder X-ray diffraction analysis arrive at the single conclusion that the t-BA hydrates, under pressurization with H-2, are transformed from the structure VI simple t-BA hydrate into the structure II t-BA+H-2 mixed hydrate. The phase transition point on the hydrate stability boundary in the mother aqueous solutions with the t-BA mole fractions (x(t)-BA) of 0.056 and 0.093 is located at (2.35 MPa, 267.39 K) and (25.3 MPa, 274.19 K), respectively. On the other hand, in the case of the pressurization by decreasing the sample volume instead of supplying H-2, the simple t-BA hydrate retains the structure VI at pressures up to 112 MPa on the thermodynamic stability boundary.	[Tanabe, Tomohiro; Sugahara, Takeshi; Kitamura, Kazuma; Yamazaki, Takahiro; Fujimoto, Takashi; Ohgaki, Kazunari] Osaka Univ, Grad Sch Engn Sci, Div Chem Engn, Dept Mat Engn Sci, Toyonaka, Osaka 5608531, Japan	Sugahara, T (reprint author), Osaka Univ, Grad Sch Engn Sci, Div Chem Engn, Dept Mat Engn Sci, 1-3 Machikaneyama, Toyonaka, Osaka 5608531, Japan.	sugahara@cheng.es.osaka-u.ac.jp			Advanced Low Carbon Technology Research and Development Program (ALCA) of Japan Science and Technology Agency (JST)	We acknowledge financial support from the funding from Advanced Low Carbon Technology Research and Development Program (ALCA) of Japan Science and Technology Agency (JST).	Nakano S, 1998, J CHEM ENG DATA, V43, P807, DOI 10.1021/je9800555; Strobel TA, 2007, FLUID PHASE EQUILIBR, V261, P382, DOI 10.1016/j.fluid.2007.07.028; Prasad PSR, 2009, J PHYS CHEM A, V113, P6540, DOI 10.1021/jp9029997; Florusse LJ, 2004, SCIENCE, V306, P469, DOI 10.1126/science.1102076; Shimada N, 2003, FLUID PHASE EQUILIBR, V205, P17, DOI 10.1016/S0378-3812(02)00186-3; Sugahara K, 2006, J CHEM ENG DATA, V51, P301, DOI 10.1021/je050447t; Dyadin YA, 1999, J STRUCT CHEM+, V40, P790, DOI 10.1007/BF02903454; Mao WL, 2002, SCIENCE, V297, P2247, DOI 10.1126/science.1075394; Du JW, 2011, J CHEM THERMODYN, V43, P617, DOI 10.1016/j.jct.2010.11.018; Hashimoto S, 2007, J CHEM ENG DATA, V52, P517, DOI 10.1021/je060436f; Kim DY, 2005, ANGEW CHEM INT EDIT, V44, P7749, DOI 10.1002/anie.200502376; Kipkemboi P. K., 2002, CAN J CHEM, V80, P785; Liang DQ, 2010, J CHEM ENG DATA, V55, P1039, DOI 10.1021/je900505x; MCMULLAN RK, 1967, J CHEM PHYS, V47, P1229, DOI 10.1063/1.1712073; Prasad PSR, 2009, J PHYS CHEM A, V113, P11311, DOI 10.1021/jp906492j; Staben D, 1995, J INCLUS PHENOM MOL, V22, P145, DOI 10.1007/BF00707689	16	1	1	AMER CHEMICAL SOC	WASHINGTON	1155 16TH ST, NW, WASHINGTON, DC 20036 USA	0021-9568			J CHEM ENG DATA	J. Chem. Eng. Data	FEB	2015	60	2					222	227		10.1021/je5003016		6	Thermodynamics; Chemistry, Multidisciplinary; Engineering, Chemical	Thermodynamics; Chemistry; Engineering	CB4BX	WOS:000349574300005		
J	Uchida, T; Kishi, D; Shiga, T; Nagayama, M; Gohara, K				Uchida, Tsutomu; Kishi, Daisuke; Shiga, Toshiki; Nagayama, Masafumi; Gohara, Kazutoshi			Sintering Process Observations on Gas Hydrates under Hydrate-Stable and Self-Preservation Conditions	JOURNAL OF CHEMICAL AND ENGINEERING DATA			English	Article							ANOMALOUS PRESERVATION; CLATHRATE HYDRATE; METHANE HYDRATE; ICE SHEETS; PRESSURE	Clathrate hydrates have recently received attention as novel storage and transportation materials of natural gases. For the economical storage or transportation of the produced natural gas hydrates, the effect of sintering should be considered because the hydrate particles would be stored in relatively moderate conditions. In the present study, microscopic observations were carried out on gas hydrate particles to investigate their sintering properties. The spherical gas hydrates were prepared from spherical ice particles with carbon dioxide (CO2) or ethane (C2H6) pressures higher than the dissociation ones. The initial sintering rate of CO2 hydrates at temperatures between 271.4 K and 278.2 K and pressures between 1.9 MPa and 2.9 MPa was similar to that of THF hydrate under saturated conditions reported previously. Conversely, the C2H6 hydrate particles were hard to sinter at temperatures between 273.5 K and 281.7 K and pressures between 0.5 MPa and 2.0 MPa. We discussed the sintering process of gas hydrates and their rate-determining process which depended on guest molecules under their stable conditions. The sintering of methane hydrate particles under stable and self-preservation conditions was also investigated to demonstrate the storage and transportation conditions of natural gas hydrate particles.	[Uchida, Tsutomu; Kishi, Daisuke; Shiga, Toshiki; Nagayama, Masafumi; Gohara, Kazutoshi] Hokkaido Univ, Div Appl Phys, Fac Engn, Kita Ku, Sapporo, Hokkaido 0608628, Japan	Uchida, T (reprint author), Hokkaido Univ, Div Appl Phys, Fac Engn, Kita Ku, N13 W8, Sapporo, Hokkaido 0608628, Japan.	t-uchida@eng.hokudai.ac.jp			Hokkaido Gas Co., Ltd.	This study was partially funded by Hokkaido Gas Co., Ltd.	Takeya S, 2001, J PHYS CHEM A, V105, P9756, DOI 10.1021/jp011435r; Falenty A, 2009, J PHYS CHEM B, V113, P15975, DOI 10.1021/jp906859a; ERSHOV ED, 1992, COLD REG SCI TECHNOL, V20, P147, DOI 10.1016/0165-232X(92)90014-L; Takeya S, 2008, ANGEW CHEM INT EDIT, V47, P1276, DOI 10.1002/anie.200703718; Blackford JR, 2007, J PHYS D APPL PHYS, V40, pR355, DOI 10.1088/0022-3727/40/21/R02; Stern LA, 2001, J PHYS CHEM B, V105, P1756, DOI 10.1021/jp003061s; UCHIDA T, 1994, ANN GLACIOL, V20, P143, DOI 10.3189/172756494794587366; Shimada W, 2005, J PHYS CHEM B, V109, P5802, DOI 10.1021/jp044624t; Sun D, 2011, IND ENG CHEM RES, V50, P13854, DOI 10.1021/ie2017724; Kuhs WF, 2006, J PHYS CHEM B, V110, P13283, DOI 10.1021/jp061060f; Salamatin AN, 1998, J CRYST GROWTH, V193, P197, DOI 10.1016/S0022-0248(98)00488-6; Takeya S, 2012, J PHYS CHEM C, V116, P13842, DOI 10.1021/0302269v; Ohno H, 2011, J PHYS CHEM LETT, V2, P201, DOI 10.1021/jz101595t; Kuhs WF, 2004, PHYS CHEM CHEM PHYS, V6, P4917, DOI 10.1039/b412866d; Fujii T., 2009, J GEOGR, V118, P814, DOI DOI 10.5026/JGE0GRAPHY.118.814; Fujii T., 2009, AAPG MEMOIR, V89, P385; German R M, 1996, SINTERING THEORY PRA; Gudmundson J., 1996, P 2 INT C NAT GAS HY, P415; Kuhs F.W., 2000, PHYS ICE CORE REC, P373; MAENO N, 1983, J PHYS CHEM-US, V87, P4103, DOI 10.1021/j100244a023; Nagao J., 2008, P INT C GAS HYDR VAN; Nakata T., 2008, P INT C GAS HYDR VAN; Takeya S., 2009, CHEMPHYSCHEM, V11, P70; Talyer C.J., 2007, J COLLOID INTERF SCI, V306, P255; Uchida T., 2011, J CHEM CHEM ENG, V5, P691; Uchida T, 2010, ENERGIES, V3, P1960, DOI 10.3390/en3121960; Watanabe S., 2008, P INT C GAS HYDR VAN; Yakushev V. S., 1992, PHYS CHEM ICE, P136; Yasuda K, 2008, J CHEM ENG DATA, V53, P2182, DOI 10.1021/je800396v	29	1	1	AMER CHEMICAL SOC	WASHINGTON	1155 16TH ST, NW, WASHINGTON, DC 20036 USA	0021-9568			J CHEM ENG DATA	J. Chem. Eng. Data	FEB	2015	60	2					284	292		10.1021/je500578d		9	Thermodynamics; Chemistry, Multidisciplinary; Engineering, Chemical	Thermodynamics; Chemistry; Engineering	CB4BX	WOS:000349574300013		
J	Kobori, T; Muromachi, S; Ohmura, R				Kobori, Takayuki; Muromachi, Sanehiro; Ohmura, Ryo			Phase Equilibrium for Ionic Semiclathrate Hydrates Formed in the System of Water plus Tetra-n-butylammonium Bromide Pressurized with Carbon Dioxide	JOURNAL OF CHEMICAL AND ENGINEERING DATA			English	Article							SEMI-CLATHRATE HYDRATE; AMMONIUM BROMIDE; CO2; CAPTURE; GAS; SEPARATION; HYDROGEN; CHLORIDE	This paper reports the vaporliquidhydrate three phase equilibrium conditions of ionic semiclathrate hydrates formed in the system of water + tetra-n-butylammonium bromide pressurized with carbon dioxide. The three phase equilibrium temperatures were measured in the ranges from 278.8 to 287.4 K of temperature and from 0.05 to 0.45 of mass fraction of tetra-n-butylammonium bromide (w(TBAB)). Measurements were performed at the system pressures of 0.3 MPa, 0.6 MPa, and 1 MPa. For the three system pressures, the equilibrium temperatures increased with the increase in w(TBAB) for w(TBAB) < 0.35 and decreased for w(TBAB) > 0.40. The highest equilibrium temperatures were obtained at w(TBAB) = 0.35 and 0.40. The equilibrium temperatures of the tetra-n-butylammonium bromide + carbon dioxide hydrates were higher than those of the simple tetra-n-butylammonium bromide hydrates formed under atmospheric pressure. The improvement of the thermodynamic stability of the tetra-n-butylammonium bromide + carbon dioxide hydrates is ascribed to the incorporation of carbon dioxide molecules into the hydrate cages. The data obtained in the present study may be utilized to specify the thermodynamic conditions to form the tetra-n-butylammonium bromide + carbon dioxide hydrates without forming the simple tetra-n-butylammonium hydrates.	[Kobori, Takayuki; Ohmura, Ryo] Keio Univ, Dept Mech Engn, Kohoku Ku, Yokohama, Kanagawa 2238522, Japan; [Muromachi, Sanehiro] Natl Inst Adv Ind Sci & Technol, Methane Hydrate Res Ctr, Tsukuba, Ibaraki 3058569, Japan	Ohmura, R (reprint author), Keio Univ, Dept Mech Engn, Kohoku Ku, 3-14-1 Hiyoshi, Yokohama, Kanagawa 2238522, Japan.	rohmura@mech.keio.ac.jp			JKA Foundation; JSPS KAKENHI [25289045]	This study was supported by a Keirin-racing-based research-promotion fund from the JKA Foundation and by JSPS KAKENHI Grant No. 25289045.	Adisasmito S., 1991, J CHEM ENG DATA, V56, P69; Mohammadi AH, 2011, J CHEM ENG DATA, V56, P3855, DOI 10.1021/je2005159; Shimada W, 2003, JPN J APPL PHYS 2, V42, pL129, DOI 10.1143/JJAP.42.L129; Muromachi S, 2014, CHEM COMMUN, V50, P11476, DOI 10.1039/c4cc02111h; Ye N, 2012, J CHEM ENG DATA, V57, P1557, DOI 10.1021/je3001443; Linga P, 2007, J HAZARD MATER, V149, P625, DOI 10.1016/j.jhazmat.2007.06.086; Sato K, 2013, FLUID PHASE EQUILIBR, V337, P115, DOI 10.1016/j.fluid.2012.09.016; Gholinezhad J, 2011, CHEM ENG RES DES, V89, P1747, DOI 10.1016/j.cherd.2011.03.008; Li SF, 2010, J CHEM ENG DATA, V55, P3212, DOI 10.1021/je100059h; Duc NH, 2007, ENERG CONVERS MANAGE, V48, P1313, DOI 10.1016/j.enconman.2006.09.024; Lin W, 2008, FLUID PHASE EQUILIBR, V264, P220, DOI 10.1016/j.fluid.2007.11.020; Arjmandi M, 2007, J CHEM ENG DATA, V52, P2153, DOI 10.1021/je700144p; Dyadin Yu. A, 1984, J INCLUSION PHENOM, V2, P61, DOI 10.1007/BF00663240; Franks F., 1973, WATER COMPREHENSIVE, P115; GAPONENKO LA, 1984, J STRUCT CHEM+, V25, P157, DOI 10.1007/BF00808575; Jeffrey G.A., 1984, INCLUSION COMPOUNDS, P135; Mori Y. H., 2003, J CHEM IND ENG S, V54, P1; Muromachi S, 2010, J PHYS CHEM B, V114, P11430, DOI 10.1021/jp105031n; Nakajima T., 2011, ANGEW CHEM INT EDIT, V50, P10340; Nakayama T, 2010, ENERG FUEL, V24, P2576, DOI 10.1021/ef100039a; Shimada W., 2005, ACTA CRYSTALLOGR C, V61, P65	21	0	0	AMER CHEMICAL SOC	WASHINGTON	1155 16TH ST, NW, WASHINGTON, DC 20036 USA	0021-9568			J CHEM ENG DATA	J. Chem. Eng. Data	FEB	2015	60	2					299	303		10.1021/je500589z		5	Thermodynamics; Chemistry, Multidisciplinary; Engineering, Chemical	Thermodynamics; Chemistry; Engineering	CB4BX	WOS:000349574300015		
J	Kakuda, Y; Harada, K; Nakanuma, Y				Kakuda, Yuko; Harada, Kenichi; Nakanuma, Yasuni			Canals of Hering loss relates to the progression of the histological stages of primary biliary cirrhosis	JOURNAL OF CLINICAL PATHOLOGY			English	Article							FATTY LIVER-DISEASE; STEM-CELL NICHE; PROGENITOR CELLS; DUCTULAR REACTION; GRADING SYSTEM; GROWTH-FACTOR; REGENERATION; HEPATITIS; FIBROSIS; ACTIVATION	Aims The canals of Hering (CoH), which are the most peripherally located bile drainage pathway, are considered a niche of hepatic progenitor cells. Recently, CoH loss has been described as an early feature of primary biliary cirrhosis (PBC). We investigated the correlation between CoH loss and the histopathological variables of PBC. Methods Liver biopsy specimens from 62 PBC patients (M:F=8:54, age=5812years) were evaluated prior to ursodeoxycholic acid treatment. Liver biopsies of patients with normal liver (n=11), chronic viral hepatitis (n=36) and non-alcoholic fatty liver disease (n=13) were used as controls. The number of CoH per definite area of hepatic parenchyma (c to p ratio) was calculated in individual cases. We compared the c to p ratios of PBC patients with that of controls and analysed the correlations with histological variables and clinical features. Results The c to p ratios in PBC patients with mild and extensive fibrosis were lower than those in controls with each degree of fibrosis. The c to p ratios were negatively correlated with stage, fibrosis, bile duct loss, orcein-positive granule deposition and hepatitis activities in PBC (p<0.01) and with alkaline phosphatase and total bilirubin levels at liver biopsies (p<0.05). Conclusions The number of CoH was low in early stages and further decreased with stage progression in PBC. CoH loss, reflecting a reduced supply of progenitor cells to the biliary tree, may be involved in the histological progression of PBC.	[Kakuda, Yuko; Nakanuma, Yasuni] Shizuoka Canc Ctr, Dept Pathol, Shizuoka 4118777, Japan; [Kakuda, Yuko; Harada, Kenichi; Nakanuma, Yasuni] Kanazawa Univ, Grad Sch Med, Dept Human Pathol, Kanazawa, Ishikawa, Japan	Nakanuma, Y (reprint author), Shizuoka Canc Ctr, Dept Pathol, Shizuoka 4118777, Japan.	nakanuma@staff.kanazawa-u.ac.jp					Kakuda Y, 2013, HUM PATHOL, V44, P1107, DOI 10.1016/j.humpath.2012.09.017; Saxena R, 2002, HUM PATHOL, V33, P983, DOI 10.1053/hupa.2002.128060; Brunt EM, 1999, AM J GASTROENTEROL, V94, P2467, DOI 10.1111/j.1572-0241.1999.01377.x; Roskams T, 2003, AM J PATHOL, V163, P1301, DOI 10.1016/S0002-9440(10)63489-X; Selmi C, 2011, LANCET, V377, P1600, DOI 10.1016/S0140-6736(10)61965-4; Fotiadu A, 2004, LIVER INT, V24, P268, DOI 10.1111/j.1478-3231.2004.0908.x; Richardson MM, 2007, GASTROENTEROLOGY, V133, P80, DOI 10.1053/j.gastro.2007.05.012; Itoh T, 2014, HEPATOLOGY, V59, P1617, DOI 10.1002/hep.26753; Espanol-Suner R, 2012, GASTROENTEROLOGY, V143, P1564, DOI 10.1053/j.gastro.2012.08.024; Khan FM, 2013, HEPATOLOGY, V57, P700, DOI 10.1002/hep.26020; Kuwahara R, 2008, HEPATOLOGY, V47, P1994, DOI 10.1002/hep.22218; Theise ND, 1999, HEPATOLOGY, V30, P1425, DOI 10.1002/hep.510300614; Nakanuma Y, 2010, PATHOL INT, V60, P167, DOI 10.1111/j.1440-1827.2009.02500.x; Saxena R, 2004, SEMIN LIVER DIS, V24, P43; Falkowski O, 2003, J HEPATOL, V39, P357, DOI 10.1016/S0168-8278(03)00309-X; Clouston AD, 2005, HEPATOLOGY, V41, P809, DOI 10.1002/hep.20650; Harada K, 2000, HISTOPATHOLOGY, V37, P347, DOI 10.1046/j.1365-2559.2000.00982.x; Eleazar JA, 2004, J HEPATOL, V41, P983, DOI 10.1016/j.jhep.2004.08.017; Poupon R, 2010, J HEPATOL, V52, P745, DOI 10.1016/j.jhep.2009.11.027; Zhang LL, 2008, HEPATOLOGY, V48, P1598, DOI 10.1002/hep.22516; NAKANUMA Y, 1979, GASTROENTEROLOGY, V76, P1326; [Anonymous], 1994, HEPATOLOGY 1, V20, P15; Nobili V, 2012, HEPATOLOGY, V56, P2142, DOI 10.1002/hep.25742; Delladetsima J, 2010, VIRCHOWS ARCH, V457, P457, DOI 10.1007/s00428-010-0957-x; Ding ZY, 2013, CELL SIGNAL, V25, P1981, DOI 10.1016/j.cellsig.2013.05.027; Harada K, 1997, HEPATOLOGY, V26, P1399; Kaplan MM, 2005, NEW ENGL J MED, V353, P1261, DOI 10.1056/NEJMra043898; Nakanuma Y, 2012, INT J HEPATOL, V2012; SCHEUER PJ, 1967, P ROY SOC MED, V60, P1257; Skoien R, 2013, LIVER INT, V33, P624, DOI 10.1111/liv.12100; Svegliati-Baroni G, 2005, GASTROENTEROLOGY, V128, P1042, DOI 10.1053/j.gastro.2005.01.007	31	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0021-9746	1472-4146		J CLIN PATHOL	J. Clin. Pathol.	FEB	2015	68	2					141	147		10.1136/jclinpath-2014-202417		7	Pathology	Pathology	CB3MQ	WOS:000349532700008		
J	Suda, S; Muroi, Y				Suda, Shintaro; Muroi, Yoshifumi			Computation of Greeks using binomial trees in a jump-diffusion model	JOURNAL OF ECONOMIC DYNAMICS & CONTROL			English	Article						Options; Greeks; Jump-diffusion model; Binomial tree	MALLIAVIN CALCULUS	We propose a new algorithm for computing the Greeks in jump-diffusion settings using binomial trees. We further demonstrate that the Greeks for European options converge to the Malliavin Greeks in the continuous time model. Our proposed algorithm is efficient, because the price and the Greeks (Delta, Gamma, Vega, and Rho) can be computed simultaneously. Computation of the Greeks for American options is also discussed. (C) 2014 Elsevier B.V. All rights reserved.	[Suda, Shintaro] Mitsubishi UFJ Trust Investment Technol Inst Co L, Minato Ku, Tokyo 1070052, Japan; [Muroi, Yoshifumi] Tohoku Univ, Grad Sch Econ & Management, Aoba Ku, Sendai, Miyagi 9808576, Japan	Suda, S (reprint author), Mitsubishi UFJ Trust Investment Technol Inst Co L, Minato Ku, 4-2-6 Akasaka, Tokyo 1070052, Japan.	suda@mtec-institute.co.jp; ymuroi@econ.tohoku.ac.jp					AMIN KI, 1993, J FINANC, V48, P1833, DOI 10.2307/2329069; Kou SG, 2002, MANAGE SCI, V48, P1086, DOI 10.1287/mnsc.48.8.1086.166; MERTON RC, 1976, J FINANC ECON, V3, P125, DOI 10.1016/0304-405X(76)90022-2; Bally V., 2005, Monte Carlo Methods and Applications, V11, DOI 10.1515/156939605777585944; Bavouzet-Morel MP, 2006, ELECTRON J PROBAB, V11, P276; Montero M, 2003, PHYSICA A, V320, P548, DOI 10.1016/S0378-4371(02)01531-5; Muroi Y, 2013, EUR J OPER RES, V231, P349, DOI 10.1016/j.ejor.2013.05.038; Vorst T., 1994, J DERIV, V1, P45, DOI 10.3905/jod.1994.407888; Walsh JB, 2003, FINANC STOCH, V7, P337, DOI 10.1007/s007800200094; Xu CL, 2003, J COMPUT APPL MATH, V156, P23, DOI 10.1016/S0377-0427(02)00903-2	10	0	0	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	0165-1889	1879-1743		J ECON DYN CONTROL	J. Econ. Dyn. Control	FEB	2015	51						93	110		10.1016/j.jedc.2014.09.032		18	Economics	Business & Economics	CB4CX	WOS:000349576900006		
J	Kobayashi, T; Kumakura, M; Yoshie, S; Sugishima, T; Horie, Y				Kobayashi, Tohru; Kumakura, Masahiko; Yoshie, Sumio; Sugishima, Tomomi; Horie, Yoshifumi			Dynamics of Testis-ova in a Wild Population of Japanese Pond Frogs, Rana nigromaculata	JOURNAL OF EXPERIMENTAL ZOOLOGY PART A-ECOLOGICAL GENETICS AND PHYSIOLOGY			English	Article							ENDOCRINE-DISRUPTING CHEMICALS; SEX-DIFFERENTIATION; GONADAL DEVELOPMENT; ORYZIAS-LATIPES; GENE-EXPRESSION; GERM-CELLS; FISH; 17-ALPHA-ETHINYLESTRADIOL; TESTOSTERONE	Although many studies have reported the occurrence of testis-ova in wild frog populations, the origin and trigger of testis-ova differentiation/development remain unclear. A high frequency of testis-ova has been previously reported for wild populations of the Japanese pond frog, Rana nigromaculata (cf. Iwasawa and Asai, '59). In the present study, we aimed to clarify the dynamics of testis-ova in this frog species, including the origin and artificial induction of testis-ova. Testis-ova were observed in both mature frogs and puberty-stage frogs (i.e., 0- and 1-year-old frogs). However, the early stages of testis-ova (approximate to pachytene stage) were mostly observed in puberty-stage male frogs at the onset of spermatogenesis. The early stages of testis-ova were observed in the cysts of early secondary spermatogonia and the single cysts of the primary spermatogonium. This finding indicates that testis-ova differentiation occurs during spermatogonial proliferation and that it is correlated with the initiation of spermatogenesis. We also examined whether estrogen exposure induced testis-ova differentiation and how it is correlated with the progression of spermatogenesis. When 1-year-old frogs were exposed to estradiol-17 during spring (i.e., when spermatogenesis was initiated), testis-ova differentiation was induced in a dose-dependent manner. However, this phenomenon did not occur in 1-year-old frogs during summer, (i.e., when the transition from spermatogonia to spermatocytes mainly occurs). These results present the first evidence that testis-ova of the Japanese pond frog are derived from primary and early secondary spermatogonia, and that estrogen exposure induces testis-ova differentiation accompanied by the initiation of spermatogenesis. J. Exp. Zool. 323A: 74-79, 2015. (c) 2014 Wiley Periodicals, Inc.	[Kobayashi, Tohru; Sugishima, Tomomi; Horie, Yoshifumi] Univ Shizuoka, Inst Environm Sci, Lab Mol Reprod Biol, Suruga Ku, Shizuoka 4228526, Japan; [Kobayashi, Tohru; Horie, Yoshifumi] Univ Shizuoka, Grad Sch Integrated Pharmaceut & Nutr Sci, Lab Mol Reprod Biol, Suruga Ku, Shizuoka 4228526, Japan; [Kumakura, Masahiko; Yoshie, Sumio] Nippon Dent Univ, Sch Life Dent Niigata, Dept Histol, Chuo Ku, Niigata, Japan	Kobayashi, T (reprint author), Univ Shizuoka, Inst Environm Sci, Lab Mol Reprod Biol, Shizuoka 4228526, Japan.	tohruk@u-shizuoka-ken.ac.jp			UK-Japan Research Collaboration on Endocrine Disruptors from Ministry of the Environment, Japan	A part of this work was supported by grants of UK-Japan Research Collaboration on Endocrine Disruptors from Ministry of the Environment, Japan. We are grateful to the late Dr. Honorary Professor, H. Iwasawa and Dr. M. Kobayashi and the members of Iwasawa's lab. (SRL) in Niigata University for their valuable suggestions.	Yoshizaki G, 2010, DEVELOPMENT, V137, P1227, DOI 10.1242/dev.044982; Reeder AL, 1998, ENVIRON HEALTH PERSP, V106, P261; Hayes T, 2002, NATURE, V419, P895, DOI 10.1038/419895a; Harris CA, 2011, ENVIRON HEALTH PERSP, V119, P306, DOI 10.1289/ehp.1002555; McCoy KA, 2008, ENVIRON HEALTH PERSP, V116, P1526, DOI 10.1289/ehp.11536; Kobayashi Y, 2011, DEV DYNAM, V240, P116, DOI 10.1002/dvdy.22507; Orton F, 2011, ECOTOXICOLOGY, V20, P901, DOI 10.1007/s10646-011-0658-5; TANIMURA A, 1988, DEV GROWTH DIFFER, V30, P681; Tyler CR, 1998, CRIT REV TOXICOL, V28, P319, DOI 10.1080/10408449891344236; Blumberg B, 2011, J STEROID BIOCHEM, V127, P1, DOI 10.1016/j.jsbmb.2011.07.012; Okutsu T, 2006, P NATL ACAD SCI USA, V103, P2725, DOI 10.1073/pnas.0509218103; COLBORN T, 1993, ENVIRON HEALTH PERSP, V101, P378, DOI 10.2307/3431890; Nakamura M, 1998, J EXP ZOOL, V281, P362, DOI 10.1002/(SICI)1097-010X(19980801)281:5<362::AID-JEZ3>3.0.CO;2-M; Atz J. W., 1964, INTERSEXUALITY VERTE, P145; CHANG CY, 1956, P SOC EXP BIOL MED, V93, P140; Damstra T., 2002, GLOBAL ASSESSMENT ST, P180; Egami N, 1957, J FAC SCI HOKKAIDO U, V13, P369; Foote C. L., 1964, INTERSEXUALITY VERTE, P233; Goto G, 1944, ACTA ANAT NIPPON, V22, P30; Hirakawa I, 2012, CHEMOSPHERE, V87, P668, DOI 10.1016/j.chemosphere.2011.12.047; Hirakawa I, 2013, J APPL TOXICOL, V33, P1001, DOI 10.1002/jat.2836; Iguchi Taisen, 2002, Congenital Anomalies, V42, P94, DOI 10.1111/j.1741-4520.2002.tb00858.x; Iwasawa H, 1987, SCI REP NIIGATA U D, V24, P1; IWASAWA H, 1974, GEN COMP ENDOCR, V22, P526, DOI 10.1016/0016-6480(74)90029-X; IWASAWA HISAAKI, 1959, JOUR FAC SCI NIIGATA UNIV SER II BIOL GEOL AND MINERALOGY, V2, P213; Iwasawa H., 1964, Zoological Magazine Tokyo, V73, P281; IWASAWA H, 1976, COPEIA, P461; IWASAWA H, 1974, BIOL REPROD, V11, P398, DOI 10.1095/biolreprod11.4.398; KERA Y, 1981, Zoological Magazine (Tokyo), V90, P6; Kobayashi M, 1975, ZOOL MAG TOKYO, P109; KOBAYASHI T, 1986, ZOOL SCI, V3, P387; KOBAYASHI T, 1988, COPEIA, P1067, DOI 10.2307/1445736; MAKINO SAJIRO, 1931, TRANS SAPPORO NAT HIST SOC, V11, P195; Reinboth R, 1983, MECH GONADAL DIFFERE, P82; SATOH N, 1971, Zoological Magazine (Tokyo), V80, P279; Schieb D, 1983, MECH GONADAL DIFFERE, P87; SHIBATA N, 1988, J EXP ZOOL, V245, P71, DOI 10.1002/jez.1402450111; Tanaka S, 1987, ZOOL SCI, V5, P1007; Tanimura A, 1986, SCI REP NIIGATA U D, V23, P11; VILLALPANDO I, 1990, International Journal of Developmental Biology, V34, P281; WITSCHI E., 1957, Journal of the Faculty of Science, Hokkaido University, Series 6. Zoology, V13, P428; Yoshikura M., 1953, Journal of Science of the Hiroshima University Zoology, V14, P165	42	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1932-5223	1932-5231		J EXP ZOOL PART A	J. Exp. Zool. Part A	FEB	2015	323	2					74	79		10.1002/jez.1898		6	Zoology	Zoology	CB6ZY	WOS:000349776800002		
J	Hitokoto, H; Uchida, Y				Hitokoto, Hidehumi; Uchida, Yukiko			Interdependent Happiness: Theoretical Importance and Measurement Validity	JOURNAL OF HAPPINESS STUDIES			English	Article						Interdependent happiness; Cultural self; Within-culture variation; Relationship; Subjective well-being	HIGH SELF-ESTEEM; LIFE SATISFACTION; EMOTION REGULATION; UNITED-STATES; CULTURE; JAPAN; INDIVIDUALISM; INDEPENDENCE; COLLECTIVISM; CONSTRUALS	We proposed the concept of "interdependent happiness," which is interdependently pursued and attained. A nine-item Interdependent Happiness Scale (IHS) was developed to measure the happiness of individuals who are relationally oriented, quiescent and ordinary. Interdependent happiness correlated with both subjective well-being (SWB) and interdependent self-construal among Japanese students (Study 1); their SWB was more likely to be explained by IHS than the SWB of American students (Study 2); and IHS explained the SWB of working adults in the US, Germany, Japan, and Korea (Study 3) and Japanese adults and elders from collectivist regions of the country (Study 4). Cultural and cross-cultural psychological perspectives were incorporated to shed new light on collective happiness.	[Hitokoto, Hidehumi] Univ Michigan, Dept Psychol, Ann Arbor, MI 48109 USA; [Uchida, Yukiko] Kyoto Univ, Kokoro Res Ctr, Kyoto, Japan	Hitokoto, H (reprint author), Univ Michigan, Dept Psychol, 530 Church St,1012 East Hall, Ann Arbor, MI 48109 USA.	hidehumi@mtc.biglobe.ne.jp					MARKUS HR, 1991, PSYCHOL REV, V98, P224, DOI 10.1037/0033-295X.98.2.224; Kitayama S, 2006, J PERS SOC PSYCHOL, V91, P369, DOI 10.1037/0022-3514.91.3.369; Tsai JL, 2006, J PERS SOC PSYCHOL, V90, P288, DOI 10.1037/0022-3514.90.2.288; Uchida Y, 2009, EMOTION, V9, P441, DOI 10.1037/a0015634; Na J, 2010, P NATL ACAD SCI USA, V107, P6192, DOI 10.1073/pnas.1001911107; Kitayama S, 2006, J PERS SOC PSYCHOL, V91, P890, DOI 10.1037/0022-3514.91.5.890; Suh EM, 2007, J PERS, V75, P1321, DOI 10.1111/j.1467-6494.2007.00477.x; Cheung BY, 2011, PSYCHOL SCI, V22, P147, DOI 10.1177/0956797610394661; Oyserman D, 2002, PSYCHOL BULL, V128, P3, DOI 10.1037//0033-2909.128.1.3; Higgins ET, 1997, AM PSYCHOL, V52, P1280, DOI 10.1037/0003-066X.52.12.1280; RYFF CD, 1989, J PERS SOC PSYCHOL, V57, P1069, DOI 10.1037/0022-3514.57.6.1069; Kitayama S, 2004, PSYCHOL SCI, V15, P527, DOI 10.1111/j.0956-7976.2004.00714.x; Oishi S, 1999, PERS SOC PSYCHOL B, V25, P980, DOI 10.1177/01461672992511006; Ji LJ, 2001, PSYCHOL SCI, V12, P450, DOI 10.1111/1467-9280.00384; Mesquita B, 2001, J PERS SOC PSYCHOL, V80, P68, DOI 10.1037//0022-3514.80.1.68; Kitayama S, 2011, ANNU REV PSYCHOL, V62, P419, DOI 10.1146/annurev-psych-120709-145357; Uchida Y, 2008, PERS SOC PSYCHOL B, V34, P741, DOI 10.1177/0146167208315157; Jordan CH, 2003, J PERS SOC PSYCHOL, V85, P969, DOI 10.1037/0022-3514.85.5.969; Kwan VSY, 1997, J PERS SOC PSYCHOL, V73, P1038, DOI 10.1037/0022-3514.73.5.1038; Oishi S, 2001, PERS SOC PSYCHOL B, V27, P1674, DOI 10.1177/01461672012712010; Lee AY, 2000, J PERS SOC PSYCHOL, V78, P1122, DOI 10.1037//0022-3514.78.6.1122; ZEGERS FE, 1985, PSYCHOMETRIKA, V50, P17, DOI 10.1007/BF02294144; Baumeister RF, 1996, PSYCHOL REV, V103, P5, DOI 10.1037/0033-295X.103.1.5; Matsumoto D, 2008, J PERS SOC PSYCHOL, V94, P925, DOI 10.1037/0022-3514.94.6.925; Kan C, 2009, SELF IDENTITY, V8, P300, DOI 10.1080/15298860802505244; Kim H, 1999, J PERS SOC PSYCHOL, V77, P785, DOI 10.1037/0022-3514.77.4.785; Plaut VC, 2002, J PERS SOC PSYCHOL, V83, P160, DOI 10.1037//0022-3514.83.1.160; Vandello JA, 1999, J PERS SOC PSYCHOL, V77, P279, DOI 10.1037//0022-3514.77.2.279; Lyubomirsky S, 1999, SOC INDIC RES, V46, P137, DOI 10.1023/A:1006824100041; TAFARODI RW, 1995, J PERS ASSESS, V65, P322, DOI 10.1207/s15327752jpa6502_8; Suh E, 1998, J PERS SOC PSYCHOL, V74, P482, DOI 10.1037/0022-3514.74.2.482; Christopher JC, 1999, J COUNS DEV, V77, P141; Miyamoto Y, 2011, EMOTION, V11, P1346, DOI 10.1037/a0025135; Oishi S, 2004, J PERS SOC PSYCHOL, V86, P460, DOI 10.1037/0022-3514.86.3.460; Heine SJ, 1999, PSYCHOL REV, V106, P766, DOI 10.1037//0033-295X.106.4.766; Kitayama S, 2009, J PERS SOC PSYCHOL, V97, P236, DOI 10.1037/a0015999; BRIM OG, 2004, HLTH ARE WE NATL STU, P1; Conner A., 2013, CLASH 8 CULTURAL CON; Denissen JJA, 2008, J PERS SOC PSYCHOL, V95, P181, DOI 10.1037/0022-3514.95.1.181; DIENER E, 1985, J PERS ASSESS, V49, P71, DOI 10.1207/s15327752jpa4901_13; Diener E, 2007, J SOC ISSUES, V63, P421, DOI 10.1111/j.1540-4560.2007.00517.x; Diener Ed, 1999, WELL BEING FDN HEDON, P434; DIENER E, 1995, J PERS SOC PSYCHOL, V68, P653, DOI 10.1037/0022-3514.69.1.120; Fujishima Y., 2003, 44 ANN M JAP SOC SOC; Haven S., 1977, HEYMANS B EX UNPUB, V290 EX; Hitokoto H., 2009, HOKK U 21 CENT COE S; Hitokoto H., 2010, 11 ANN C SOC PERS SO; Hofstede G., 2001, CULTURES CONSEQUENCE; Kato T, 2001, JPN J EDUC PSYCHOL, V49, P295; Kitayama S., 2010, FRONT PSYCHOL, V1, P1, DOI DOI 10.3389/FPSYG.2010.00163; Kitayama Shinobu, 2000, CULTURE SUBJECTIVE W, P113; Koo J., 2007, SCI SUBJECTIVE WELL, P414; Koyasu M., 2012, JAPANESE PSYCHOL REV, V55, P70; Kusumi T., 2012, JAPANESE PSYCHOL REV, V55, P3; Lorenzo-Seva U., 2006, METHODOLOGY, V2, P57, DOI [10.1027/1614-2241.2.2.57, DOI 10.1027/1614-2241.2.2.57]; Markus H. R., 2010, 20 INT ASS CROSS CUL; Minoura Y., 1990, CHILDREN CULTURE; Naoi A., 2003, ANN HUMAN SCI, V24, P125; Nisbett R. E., 2003, CULTURE HONOR PSYCHO; Norasakkunkit V, 2011, J SOC ISSUES, V67, P774, DOI 10.1111/j.1540-4560.2011.01727.x; Oishi S, 2009, UNDERSTANDING CULTURE: THEORY, RESEARCH, AND APPLICATION, P223; Otake K., 2006, J HAPPINESS STUD, V7, P361, DOI DOI 10.1007/S10902-005-3650-Z; Raudenbush S. W., 2002, HIERARCHICAL LINEAR; Rosenberg M., 1965, SOC ADOLESCENT SELF; Ryff C. D., 2008, PSYCHOL WELL BEING W; RYFF CD, 1995, J PERS SOC PSYCHOL, V69, P719, DOI 10.1037/0022-3514.69.4.719; Sano Y., 2009, JPN J INTERPERS SOC, V9, P63; SINGELIS TM, 1994, PERS SOC PSYCHOL B, V20, P580, DOI 10.1177/0146167294205014; Smith Richard H., 2008, ENVY THEORY RES; Takahira E., 2000, JAPANESE J PSYCHOL, V71, P197; Takata T., 2005, 52 ANN M JAP GROUP D; Takata T., 1992, SELF SOCIAL COMP; Takata T., 2000, B RES I NARA U, V8, P145; Uchida Y., 2012, JPN PSYCHOL REV, V55, P26; Uchida Y., 2004, J HAPPINESS STUD, V5, P223, DOI DOI 10.1007/S10902-004-8785-9; Uchida Y., 2008, EXPLICIT IMPLICIT SO; Van de Vijver F. J. R., 2008, MULTILEVEL ANAL INDI	77	1	1	SPRINGER	DORDRECHT	VAN GODEWIJCKSTRAAT 30, 3311 GZ DORDRECHT, NETHERLANDS	1389-4978	1573-7780		J HAPPINESS STUD	J. Happiness Stud.	FEB	2015	16	1					211	239		10.1007/s10902-014-9505-8		29	Psychology, Multidisciplinary; Social Sciences, Interdisciplinary	Psychology; Social Sciences - Other Topics	CB4MT	WOS:000349602600012		
J	Imahashi, N; Nishida, T; Goto, T; Terakura, S; Watanabe, K; Hanajiri, R; Sakemura, R; Imai, M; Kiyoi, H; Naoe, T; Murata, M				Imahashi, Nobuhiko; Nishida, Tetsuya; Goto, Tatsunori; Terakura, Seitaro; Watanabe, Keisuke; Hanajiri, Ryo; Sakemura, Reona; Imai, Misa; Kiyoi, Hitoshi; Naoe, Tomoki; Murata, Makoto			Simple and Efficient Generation of Virus-specific T Cells for Adoptive Therapy Using Anti-4-1BB Antibody	JOURNAL OF IMMUNOTHERAPY			English	Article						virus-specific T-cell therapy; anti-4-1BB antibody; costimulatory signals; antigen-presenting cells	TUMOR-INFILTRATING LYMPHOCYTES; VIRAL-INFECTIONS; EFFECTOR FUNCTION; PERIPHERAL-BLOOD; DENDRITIC CELLS; CORD BLOOD; IN-VIVO; CD8(+); IMMUNOTHERAPY; 4-1BB	Although recent studies of virus-specific T-cell (VST) therapy for viral infections after allogeneic hematopoietic stem cell transplantation have shown promising results, simple and less time-intensive and labor-intensive methods are required to generate VSTs for the wider application of VST therapy. We investigated the efficacy of anti-CD28 and anti-4-1BB antibodies, which can provide T cells with costimulatory signals similar in strength to those of antigen-presenting cells, in generating VSTs. When peripheral blood mononuclear cells were stimulated with viral peptides together with isotype control, anti-CD28, or anti-4-1BB antibodies, anti-4-1BB antibodies yielded the highest numbers of VSTs, which were on an average 7.9 times higher than those generated with isotype control antibody. The combination of anti-CD28 and anti-4-1BB antibodies did not result in increased numbers of VSTs compared with anti-4-1BB antibody alone. Importantly, the positive effect of anti-4-1BB antibody was observed regardless of the epitopes of the VSTs. In contrast, the capacity of dendritic cells (DCs) to generate VSTs differed considerably depending on the epitopes of the VSTs. Furthermore, the numbers of VSTs generated with DCs were at most similar to those generated with the anti-4-1BB antibody. Generation of VSTs with anti-4-1BB antibody did not result in excessive differentiation or deteriorated function of the generated VSTs compared with those generated with control antibody or DCs. In conclusion, VSTs can be generated rapidly and efficiently by simply stimulating peripheral blood mononuclear cells with viral peptide and anti-4-1BB antibody without using antigen-presenting cells. We propose using anti-4-1BB antibody as a novel strategy to generate VSTs for adoptive therapy.	[Imahashi, Nobuhiko; Nishida, Tetsuya; Goto, Tatsunori; Terakura, Seitaro; Watanabe, Keisuke; Hanajiri, Ryo; Sakemura, Reona; Imai, Misa; Kiyoi, Hitoshi; Naoe, Tomoki; Murata, Makoto] Nagoya Univ, Grad Sch Med, Dept Hematol & Oncol, Nagoya, Aichi 4668550, Japan; [Imahashi, Nobuhiko] JSPS, Tokyo, Japan	Nishida, T (reprint author), Nagoya Univ, Grad Sch Med, Dept Hematol & Oncol, Showa Ku, 65 Tsurumai Cho, Nagoya, Aichi 4668550, Japan.	tnishida@med.nagoya-u.ac.jp	Terakura, Seitaro/A-6188-2011	Terakura, Seitaro/0000-0002-1194-8046	Japan Society for the Promotion of Science (JSPS) [25-3298]; Hori Sciences and Arts Foundation; JSPS KAKENHI [25461446]; Bristol-Myers Squibb; Chugai Pharmaceutical Co. Ltd; Kyowa Hakko Kirin Co. Ltd; Dainippon Sumitomo Pharma; Zenyaku Kogyo; FUJIFILM Corporation; Nippon Boehringer-Ingelheim Co. Ltd; Otsuka Pharmaceutical Co. Ltd; Toyama Chemical Co. Ltd.	This work was supported by the Japan Society for the Promotion of Science (JSPS) (25-3298 to N.I.), the Hori Sciences and Arts Foundation (N.I.), and JSPS KAKENHI (Grant-in-Aid for Scientific Research (C) 25461446 to T.N.). H.K.: Research funding from Bristol-Myers Squibb, Chugai Pharmaceutical Co. Ltd, Kyowa Hakko Kirin Co. Ltd, Dainippon Sumitomo Pharma, Zenyaku Kogyo, and FUJIFILM Corporation. T.N.: Research funding was from Bristol-Myers Squibb, Chugai Pharmaceutical Co. Ltd, Kyowa Hakko Kirin Co. Ltd, Dainippon Sumitomo Pharma, Zenyaku Kogyo, FUJIFILM Corporation, Nippon Boehringer-Ingelheim Co. Ltd, Otsuka Pharmaceutical Co. Ltd, and Toyama Chemical Co. Ltd.	Anderson EJ, 2008, CURR PHARM DESIGN, V14, P1997, DOI 10.2174/138161208785061364; Terakura S, 2012, BLOOD, V119, P72, DOI 10.1182/blood-2011-07-366419; Wolfl M, 2007, BLOOD, V110, P201, DOI 10.1182/blood-2006-11-056168; Huang JP, 2006, J IMMUNOL, V176, P7726; Cannons JL, 2001, J IMMUNOL, V167, P1313; Melero I, 2007, NAT REV CANCER, V7, P95, DOI 10.1038/nrc2051; Tormo N, 2010, BONE MARROW TRANSPL, V45, P543, DOI 10.1038/bmt.2009.172; Shuford WW, 1997, J EXP MED, V186, P47, DOI 10.1084/jem.186.1.47; Bukczynski J, 2005, J IMMUNOL, V175, P6378; Micklethwaite KP, 2010, BLOOD, V115, P2695, DOI 10.1182/blood-2009-09-242263; Kinnear G, 2013, TRANSPLANTATION, V95, P527, DOI 10.1097/TP.0b013e31826d4672; Fleischer J, 1996, IMMUNOLOGY, V89, P592, DOI 10.1046/j.1365-2567.1996.d01-785.x; Berger C, 2008, J CLIN INVEST, V118, P294, DOI 10.1172/JCI32103; Gerdemann U, 2012, MOL THER, V20, P1622, DOI 10.1038/mt.2012.130; Barker JN, 2010, BLOOD, V116, P5045, DOI 10.1182/blood-2010-04-281873; Banchereau J, 1998, NATURE, V392, P245, DOI 10.1038/32588; Tran KQ, 2008, J IMMUNOTHER, V31, P742, DOI 10.1097/CJI.0b013e31818403d5; Itzhaki O, 2011, J IMMUNOTHER, V34, P212, DOI 10.1097/CJI.0b013e318209c94c; Leen AM, 2013, BLOOD, V121, P5113, DOI 10.1182/blood-2013-02-486324; Serghides L, 2005, J IMMUNOL, V175, P6368; Leen AM, 2004, BLOOD, V104, P2432, DOI 10.1182/blood-2004-02-0646; Fisher TS, 2012, CANCER IMMUNOL IMMUN, V61, P1721, DOI 10.1007/s00262-012-1237-1; Bohnenkamp HR, 2003, CYTOTECHNOLOGY, V42, P121, DOI 10.1023/B:CYTO.0000015833.34696.03; Gerdemann U, 2009, MOL THER, V17, P1616, DOI 10.1038/mt.2009.140; Zhou JH, 2005, J IMMUNOL, V175, P7046; Bukczynski J, 2004, P NATL ACAD SCI USA, V101, P1291, DOI 10.1073/pnas.0306567101; Chacon JA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0060031; Hasan AN, 2009, J IMMUNOL, V183, P2837, DOI 10.4049/jimmunol.0804178; Imahashi N, 2013, MOL IMMUNOL, V56, P399, DOI 10.1016/j.molimm.2013.05.232; Li Shi-Yan, 2013, Clin Pharmacol, V5, P47, DOI 10.2147/CPAA.S46199; Lim JB, 2006, EXP HEMATOL, V34, P296, DOI 10.1016/j.exphem.2005.12.006; Lugthart G, 2012, J IMMUNOTHER, V35, P42, DOI 10.1097/CJI.0b013e31823569e2; Rubio V, 2003, NAT MED, V9, P1377, DOI 10.1038/nm942; Trivedi D, 2005, BLOOD, V105, P2793, DOI 10.1182/blood-2003-05-1433; WALTER EA, 1995, NEW ENGL J MED, V333, P1038, DOI 10.1056/NEJM199510193331603; Wen T, 2002, J IMMUNOL, V168, P4897; Zhang H, 2007, J IMMUNOL, V179, P4910	37	0	0	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	1524-9557	1537-4513		J IMMUNOTHER	J. Immunother.	FEB-MAR	2015	38	2					62	70				9	Oncology; Immunology; Medicine, Research & Experimental	Oncology; Immunology; Research & Experimental Medicine	CB5ND	WOS:000349673400003		
J	Yoshida, K; Westh, P; Inaba, A; Nakano, M; Koga, Y				Yoshida, Koh; Westh, Peter; Inaba, Akira; Nakano, Motohiro; Koga, Yoshikata			Third derivative thermodynamic quantities of aqueous tetrahydrofuran at 25 degrees C	JOURNAL OF MOLECULAR LIQUIDS			English	Article						Aqueous tetrahydrofuran; Excess chemical potential; Excess partial molar enthalpy and entropy; Enthalpic entropic and volumetric; solute-solute interaction functions; Effect of solute on entropy-volume cross fluctuation density; Effect of tetrahydrofuran on liquid water; Tetrahydrofuran is an amphiphile	ENTHALPY-ENTROPY COMPENSATION; PARTIAL MOLAR ENTHALPIES; THERMAL EXPANSIVITIES; VAPOR-PRESSURES; MIXING SCHEMES; WATER; MIXTURES; GLYCEROL; VOLUMES; H2O	We measured the excess chemical potential, mu(E)(THF), the excess partial molar enthalpy and entropy of solute tetrahydrofuran (THF), H-THF(E) and S-THF(E), in THF-H2O at 25 degrees C. Using these second derivatives of G, we graphically evaluated the third derivative quantities; the enthalpic, entropic THF-THF interaction functions, H-THE-THF(E), and S-THF-THF(E). Using the literature density data, the effect of THF on the excess partial molar volume of THF, V-THF-THF(E), was also evaluated. Furthermore, we directly determined the partial molar entropy-volume cross fluctuation density of THF, (SV)delta(THF), another third derivative quantity. By comparing the mole fraction dependence patterns of these third derivative quantities between the present THF-H2O with what we thought to be the weakest member of a hydrophobic mono-ol series, methanol (ME), we suggest that in spite of its larger non-polar surface area, THF is as amphiphilic as ME. A quantitative characterization and any difference between THF and ME ought to wait for characterization by the 1-propanol probing methodology developed by us [PCCP 15(2013) 14548-14565]. (C) 2014 Elsevier B.V. All rights reserved.	[Yoshida, Koh; Inaba, Akira; Nakano, Motohiro] Osaka Univ, Grad Sch Sci, Res Ctr Struct Thermodynam, Toyonaka, Osaka 5600043, Japan; [Westh, Peter] Roskilde Univ, NSM Res Funct Biomat, DK-4000 Roskilde, Denmark; [Koga, Yoshikata] Univ British Columbia, Dept Chem, Vancouver, BC V6T 1Z1, Canada	Koga, Y (reprint author), Univ British Columbia, Dept Chem, 2036 Main Mall, Vancouver, BC V6T 1Z1, Canada.	koga@chem.ubc.ca	Inaba, Akira/G-8887-2011		Japan Society for Promotion of Science [130J01365]; Carlsberg Foundation	KY thanks the Japan Society for Promotion of Science, Grant no. 130J01365. Support from the Carlsberg Foundation to PW is acknowledged. This is contribution no. 46 from Research Center for Structural Thermodynamics, Graduate School of Science, Osaka University.	To ECH, 1999, J SOLUTION CHEM, V28, P1137, DOI 10.1023/A:1021703725091; LUMRY R, 1970, BIOPOLYMERS, V9, P1125, DOI 10.1002/bip.1970.360091002; Koga Y, 2012, J CHEM PHYS, V137, DOI 10.1063/1.4754540; Starikov EB, 2013, CHEM PHYS LETT, V564, P88, DOI 10.1016/j.cplett.2013.02.016; Koga Y, 2013, PHYS CHEM CHEM PHYS, V15, P14548, DOI 10.1039/c3cp51650d; Makino T, 2005, J CHEM ENG DATA, V50, P2058, DOI 10.1021/je0502694; BENSON GC, 1980, J SOLUTION CHEM, V9, P791, DOI 10.1007/BF00646798; Koga Y, 2004, J PHYS CHEM A, V108, P3873, DOI 10.1021/jp0312722; SIGNER R, 1969, HELV CHIM ACTA, V52, P2347, DOI 10.1002/hlca.19690520816; Parsons MT, 2001, J SOLUTION CHEM, V30, P1007, DOI 10.1023/A:1013303427259; Boissonnas CG, 1939, HELV CHIM ACTA, V22, P541, DOI 10.1002/hlca.19390220165; Freed KF, 2011, J PHYS CHEM B, V115, P1689, DOI 10.1021/jp1105696; KIYOHARA O, 1978, CAN J CHEM, V56, P2803, DOI 10.1139/v78-463; Koga Y, 1996, J PHYS CHEM-US, V100, P5172, DOI 10.1021/jp952372d; KOGA Y, 1991, J PHYS CHEM-US, V95, P4119, DOI 10.1021/j100163a041; Koga Y., 2007, SOLUTION THERMODYNAM; Koga Y, 1999, CAN J CHEM, V77, P2039, DOI 10.1139/cjc-77-12-2039; Lumry R, 2003, BIOPHYS CHEM, V105, P545, DOI 10.1016/S0301-4622(03)00065-6; Starikov EB, 2007, J PHYS CHEM B, V111, P14431, DOI 10.1021/jp075784i; Tanaka SH, 1996, CAN J CHEM, V74, P713, DOI 10.1139/v96-077; Yoshida K, 2011, J SOLUTION CHEM, V40, P1271, DOI 10.1007/s10953-011-9715-1	21	1	1	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	0167-7322	1873-3166		J MOL LIQ	J. Mol. Liq.	FEB	2015	202						40	45		10.1016/j.molliq.2014.11.029		6	Chemistry, Physical; Physics, Atomic, Molecular & Chemical	Chemistry; Physics	CB4FD	WOS:000349582700006		
J	Sekijima, Y				Sekijima, Yoshiki			Transthyretin-type cerebral amyloid angiopathy: a serious complication in post-transplant patients with familial amyloid polyneuropathy	JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY			English	Editorial Material									[Sekijima, Yoshiki] Shinshu Univ, Dept Med Neurol & Rheumatol, Sch Med, Matsumoto, Nagano 3908621, Japan; [Sekijima, Yoshiki] Shinshu Univ, Inst Biomed Sci, Matsumoto, Nagano 3908621, Japan	Sekijima, Y (reprint author), Shinshu Univ, Dept Med Neurol & Rheumatol, Sch Med, 3-1-1 Asahi, Matsumoto, Nagano 3908621, Japan.	sekijima@shinshu-u.ac.jp					HOLMGREN G, 1993, LANCET, V341, P1113; Benson MD, 2010, AMYLOID, V17, P43, DOI 10.3109/13506129.2010.483121; Sekijima Y, 2014, J CLIN PHARM THER, V39, P225, DOI 10.1111/jcpt.12145; Maia LF, 2015, J NEUROL NEUROSUR PS, V86, P159, DOI 10.1136/jnnp-2014-308107; USHIYAMA M, 1991, ACTA NEUROPATHOL, V81, P524	5	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0022-3050	1468-330X		J NEUROL NEUROSUR PS	J. Neurol. Neurosurg. Psychiatry	FEB	2015	86	2					124	124		10.1136/jnnp-2014-308576		1	Clinical Neurology; Psychiatry; Surgery	Neurosciences & Neurology; Psychiatry; Surgery	CB6EW	WOS:000349720700002		
J	Yoshizawa, AC; Fukuyama, Y; Kajihara, S; Kuyama, H; Tanaka, K				Yoshizawa, Akiyasu C.; Fukuyama, Yuko; Kajihara, Shigeki; Kuyama, Hiroki; Tanaka, Koichi			Computational Survey of Sequence Specificity for Protein Terminal Tags Covering Nine Organisms and Its Application to Protein Identification	JOURNAL OF PROTEOME RESEARCH			English	Article						Protein terminal specificity; terminal sequence tag; protein identification; database; bioinformatics	TOP-DOWN PROTEOMICS; ALTERNATIVE TRANSLATION INITIATION; TANDEM MASS-SPECTRA; POSITIONAL PROTEOMICS; SPECTROMETRY; PEPTIDES; METHYLATION; ANTIBODIES; RECOVERY; DATABASE	In 1998, Wilkins et al. (J. Mol. Biol. 1998, 278, 599-608) reported high specificity in terminal regions (terminal tags) of 15 519 proteins from five organisms and proposed a methodology for identifying proteins by terminal tags. However, their examined sequence data were not based on complete genome sequences. Here, we examined current proteome data (217-249 entries from UniProt 2013_6 complete/reference proteome for nine organisms including human) in terms of the specificity of terminal tags and their computational annotation. One example from the results indicated that the specificity of N-terminal tags plateaued at 28% at a length of six residues for human; even when using both N- and C-terminal tags, specificity was merely 66%. In order to determine the cause of these low specificities, the annotation of proteins sharing terminal tags with other proteins was examined. The results suggested that a large majority were phylogenetically or functionally related, whereas nonrelated proteins sharing terminal tags made up less than 1% of human proteome data. On the basis of these findings, we constructed the terminal tag sequence database ProteinCarta (http://ms3d.jp/software/proteincarta/), which includes all terminal tags of proteomes from the nine organisms analyzed here, in order to confirm the specificity of terminal tags and to identify the parent protein.	[Yoshizawa, Akiyasu C.; Fukuyama, Yuko; Kajihara, Shigeki; Kuyama, Hiroki; Tanaka, Koichi] Shimadzu Co Ltd, Koichi Tanaka Lab Adv Sci & Technol, Kyoto 6048511, Japan	Yoshizawa, AC (reprint author), Shimadzu Co Ltd, Koichi Tanaka Lab Adv Sci & Technol, Kyoto 6048511, Japan.	acyshzw@shimadzu.co.jp			Japan Society for the Promotion of Science (JSPS) through the Funding Program for World-Leading Innovative R&D on Science and Technology (FIRST Program); Council for Science and Technology Policy (CSTP)	The authors thank Dr. Maiko Kusano for critical reading and valuable suggestions for construction of the website, Dr. Takayuki Yoshimori for helpful discussion about the antibody drug development, and Masaki Murase for technical assistance and valuable discussion. This research is supported by a grant from the Japan Society for the Promotion of Science (JSPS) through the Funding Program for World-Leading Innovative R&D on Science and Technology (FIRST Program), initiated by the Council for Science and Technology Policy (CSTP).	Lanucara F, 2013, MASS SPECTROM REV, V32, P27, DOI 10.1002/mas.21348; Beck A, 2012, ANAL CHEM, V84, P4637, DOI 10.1021/ac3002885; Gevaert K, 2003, NAT BIOTECHNOL, V21, P566, DOI 10.1038/nbt810; Rice P, 2000, TRENDS GENET, V16, P276, DOI 10.1016/S0168-9525(00)02024-2; Kanehisa M, 2014, NUCLEIC ACIDS RES, V42, pD199, DOI 10.1093/nar/gkt1076; EDMAN P, 1949, ARCH BIOCHEM, V22, P475; Vandermarliere E, 2013, MASS SPECTROM REV, V32, P453, DOI 10.1002/mas.21376; Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Elortza F, 2006, J PROTEOME RES, V5, P935, DOI 10.1021/pr050419u; Craig R, 2004, BIOINFORMATICS, V20, P1466, DOI 10.1093/bioinformatics/bth092; SMITH TF, 1981, J MOL BIOL, V147, P195, DOI 10.1016/0022-2836(81)90087-5; Ahlf DR, 2013, CURR OPIN CHEM BIOL, V17, P787, DOI 10.1016/j.cbpa.2013.07.028; Paulick MG, 2008, BIOCHEMISTRY-US, V47, P6991, DOI 10.1021/bi8006324; ENG JK, 1994, J AM SOC MASS SPECTR, V5, P976, DOI 10.1016/1044-0305(94)80016-2; McDonald L, 2005, NAT METHODS, V2, P955, DOI 10.1038/NMETH811; Perkins DN, 1999, ELECTROPHORESIS, V20, P3551, DOI 10.1002/(SICI)1522-2683(19991201)20:18<3551::AID-ELPS3551>3.0.CO;2-2; Craig R, 2003, RAPID COMMUN MASS SP, V17, P2310, DOI 10.1002/rcm.1198; Cox J, 2008, NAT BIOTECHNOL, V26, P1367, DOI 10.1038/nbt.1511; Staes A, 2008, PROTEOMICS, V8, P1362, DOI 10.1002/pmic.200700950; EDMAN P, 1950, ACTA CHEM SCAND, V4, P283, DOI 10.3891/acta.chem.scand.04-0283; Paetzel M, 2002, CHEM REV, V102, P4549, DOI 10.1021/cr010166y; Dick LW, 2008, BIOTECHNOL BIOENG, V100, P1132, DOI 10.1002/bit.21855; Zhang ZQ, 2009, MASS SPECTROM REV, V28, P147, DOI 10.1002/mas.20190; Catherman AD, 2014, BIOCHEM BIOPH RES CO, V445, P683, DOI 10.1016/j.bbrc.2014.02.041; Capriotti AL, 2011, J CHROMATOGR A, V1218, P8760, DOI 10.1016/j.chroma.2011.05.094; Wilkins MR, 1998, J MOL BIOL, V278, P599, DOI 10.1006/jmbi.1998.1726; Hernandez P, 2006, MASS SPECTROM REV, V25, P235, DOI 10.1002/mas.20068; Kuyama H, 2008, PROTEOMICS, V8, P1539, DOI 10.1002/pmic.200701044; Flicek P, 2014, NUCLEIC ACIDS RES, V42, pD749, DOI 10.1093/nar/gkt1196; Baker P. R., PROTEINPROSPECTOR; Van Damme P, 2014, MOL CELL PROTEOMICS, V13, P1245, DOI 10.1074/mcp.M113.036442; Davidson GR, 2011, METHODS MOL BIOL, V753, P229, DOI 10.1007/978-1-61779-148-2_15; FERGUSON MAJ, 1985, J BIOL CHEM, V260, P4547; Gevaert K., 2004, DDT TARGETS, V3, pS16; Goetze A. M., 2014, MABS, V2, P500; Helsens K, 2011, J PROTEOME RES, V10, P3578, DOI [10.1021/pr2002325, 10.1021/pr2007325]; HRYCYNA CA, 1993, PHARMACOL THERAPEUT, V59, P281, DOI 10.1016/0163-7258(93)90071-K; Kuyama H, 2014, INT J MASS SPECTROM, V373, P81, DOI 10.1016/j.ijms.2014.09.010; Kuyama H, 2008, ANAL BIOCHEM, V380, P291, DOI 10.1016/j.ab.2008.05.053; MANBER U, 1993, SIAM J COMPUT, V22, P935, DOI 10.1137/0222058; Nakajima C, 2011, ANALYST, V136, P113, DOI 10.1039/c0an00384k; Nakaya A, 2013, NUCLEIC ACIDS RES, V41, pD353, DOI 10.1093/nar/gks1239; Nakazawa T, 2008, PROTEOMICS, V8, P673, DOI 10.1002/pmic.200700084; Nika Heinz, 2013, J Biomol Tech, V24, P17, DOI 10.7171/jbt.13-2401-003; PERLMAN D, 1983, J MOL BIOL, V167, P391, DOI 10.1016/S0022-2836(83)80341-6; Selinheimo E, 2006, FEBS J, V273, P4322, DOI 10.1111/j.1742-4658.2006.05429.x; Takabayashi S., SARY SUFFIX ARRAY LI; Tanaka S, 2014, J PROTEOME RES, V13, P3846, DOI 10.1021/pr500155z; Apweiler R, 2014, NUCLEIC ACIDS RES, V42, pD191, DOI 10.1093/nar/gkt1140; Van Damme P, 2009, MOL CELL PROTEOMICS, V8, P258, DOI 10.1074/mcp.M800060-MCP200; VOLKER C, 1995, METHOD ENZYMOL, V255, P65; VONHEIJNE G, 1983, EUR J BIOCHEM, V133, P17; Yao J., 2014, MASS SPECTROM, V3, pA0030	53	1	1	AMER CHEMICAL SOC	WASHINGTON	1155 16TH ST, NW, WASHINGTON, DC 20036 USA	1535-3893	1535-3907		J PROTEOME RES	J. Proteome Res.	FEB	2015	14	2					756	767		10.1021/pr500793h		12	Biochemical Research Methods	Biochemistry & Molecular Biology	CA9WV	WOS:000349276400016		
J	Magdeldin, S; Blaser, RE; Yamamoto, T; Yates, JR				Magdeldin, Sameh; Blaser, Rachel E.; Yamamoto, Tadashi; Yates, John R., III			Behavioral and Proteomic Analysis of Stress Response in Zebrafish (Danio rerio)	JOURNAL OF PROTEOME RESEARCH			English	Article						zebrafish; stress; quantitative proteomics; fear; behavior; conditioning; TMT; MudPIT	PROTEIN IDENTIFICATION TECHNOLOGY; HEAT-SHOCK PROTEINS; MASS-SPECTROMETRY; ESSENTIAL INTERPLAY; CELL INTEGRITY; MODEL; CYTOSKELETON; DATABASE; MUDPIT; MS/MS	The purpose of this study is to determine the behavioral and proteomic consequences of shock-induced stress in zebrafish (Danio rerio) as a vertebrate model. Here we describe the behavioral effects of exposure to predictable and unpredictable electric shock, together with quantitative tandem mass tag isobaric labeling workflow to detect altered protein candidates in response to shock exposure. Behavioral results demonstrate a hyperactivity response to electric shock and a suppression of activity to a stimulus predicting shock. On the basis of the quantitative changes in protein abundance following shock exposure, eight proteins were significantly up-regulated (HADHB, hspa8, hspa5, actb1, mych4, atp2a1, zgc:86709, and zgc:86725). These proteins contribute crucially in catalytic activities, stress response, cation transport, and motor activities. This behavioral proteomic driven study clearly showed that besides the rapid induction of heat shock proteins, other catalytic enzymes and cation transporters were rapidly elevated as a mechanism to counteract oxidative stress conditions resulting from elevated fear/anxiety levels.	[Magdeldin, Sameh; Yamamoto, Tadashi] Niigata Univ, Grad Sch Med & Dent Sci, Inst Nephrol, Dept Struct Pathol, Niigata 9518510, Japan; [Magdeldin, Sameh; Yates, John R., III] Scripps Res Inst, Dept Physiol Chem, La Jolla, CA 92037 USA; [Magdeldin, Sameh] Suez Canal Univ, Fac Vet Med, Dept Physiol, Ismailia 41522, Egypt; [Blaser, Rachel E.] Univ San Diego, Dept Psychol Sci, San Diego, CA 92110 USA	Magdeldin, S (reprint author), Niigata Univ, Grad Sch Med & Dent Sci, Inst Nephrol, Dept Struct Pathol, 1-757 Asahimachi Dori, Niigata 9518510, Japan.	samehmagd@med.niigata-u.ac.jp; jyates@scripps.edu	Blaser, Rachel/A-3341-2012	Blaser, Rachel/0000-0002-4342-532X	JSPS (Japan Society for Promotion of Science) from Ministry of Education, Culture, Sports, Science and Technology of Japan [26.04 105]; Center of Innovation Program from Japan Science and Technology Agency, JST; National Institutes of Health [P41 GM103533, R01 MH067880]; UCLA/NHLBI Proteomics Centers [HHSN268201000035C, V19 AI063603]	This work was supported by JSPS (Japan Society for Promotion of Science) Grant-in-Aid for JSPS fellow to S.M. (26.04 105) from Ministry of Education, Culture, Sports, Science and Technology of Japan and by the Center of Innovation Program from Japan Science and Technology Agency, JST to T.Y. Partial funding has been provided by National Institutes of Health grants P41 GM103533, R01 MH067880, UCLA/NHLBI Proteomics Centers (HHSN268201000035C), and V19 AI063603to J.R.Y. The funders had no role-in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	SMITH PK, 1985, ANAL BIOCHEM, V150, P76, DOI 10.1016/0003-2697(85)90442-7; Delahunty CM, 2007, BIOTECHNIQUES, V43, P563; Park SK, 2008, NAT METHODS, V5, P319, DOI [10.1038/nmeth.1195, 10.1038/NMETH.1195]; Mi HY, 2013, NUCLEIC ACIDS RES, V41, pD377, DOI 10.1093/nar/gks1118; Kislinger T, 2005, J AM SOC MASS SPECTR, V16, P1207, DOI 10.1016/j.jasms.2005.02.015; Champagne DL, 2010, BEHAV BRAIN RES, V214, P332, DOI 10.1016/j.bbr.2010.06.001; Steenbergen PJ, 2011, PROG NEURO-PSYCHOPH, V35, P1432, DOI 10.1016/j.pnpbp.2010.10.010; Wettstein G, 2012, INT J BIOCHEM CELL B, V44, P1680, DOI 10.1016/j.biocel.2012.05.024; Tabb DL, 2002, J PROTEOME RES, V1, P21, DOI 10.1021/pr015504q; Magdeldin S, 2014, J PROTEOME RES, V13, P3826, DOI 10.1021/pr500530e; Cachat J, 2010, NAT PROTOC, V5, P1786, DOI 10.1038/nprot.2010.140; Gerlai R, 2003, BEHAV GENET, V33, P461, DOI 10.1023/A:1025762314250; Shen MC, 2013, DEV DYNAM, V242, P539, DOI 10.1002/dvdy.23955; Stricher F, 2013, AUTOPHAGY, V9, P1937, DOI 10.4161/auto.26448; Ashburner M, 2000, NAT GENET, V25, P25; Rupik W, 2011, COMP BIOCHEM PHYS A, V159, P349, DOI 10.1016/j.cbpa.2011.04.002; Valente A, 2012, LEARN MEMORY, V19, P170, DOI 10.1101/lm.025668.112; Ghisleni G, 2012, PROG NEURO-PSYCHOPH, V36, P176, DOI 10.1016/j.pnpbp.2011.08.016; Aizenberg M, 2011, J NEUROSCI, V31, P8708, DOI 10.1523/JNEUROSCI.6565-10.2011; Piato AL, 2011, PROG NEURO-PSYCHOPH, V35, P561, DOI 10.1016/j.pnpbp.2010.12.018; Bradford Y, 2011, NUCLEIC ACIDS RES, V39, pD822, DOI 10.1093/nar/gkq1077; Enany S, 2012, PEPTIDES, V37, P128, DOI 10.1016/j.peptides.2012.06.011; Thompson A, 2003, ANAL CHEM, V75, P1895, DOI 10.1021/ac0262560; Agetsuma M, 2010, NAT NEUROSCI, V13, P1354, DOI 10.1038/nn.2654; Chakravarty S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0063302; Delahunty C. M., 2007, BIOTECHNIQUES, V43, P567; Enany S, 2013, MICROBIOL RES, V168, P504, DOI 10.1016/j.micres.2013.03.004; Lam PY, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0084436; Li H, 2010, BRAIN DEV-JPN, V32, P362, DOI 10.1016/j.braindev.2009.06.001; Magdeldin S, 2010, J PROTEOMICS, V73, P2031, DOI 10.1016/j.jprot.2010.06.010; Magdeldin S, 2012, BIODATA MIN, V5, DOI 10.1186/1756-0381-5-11; Magdeldin S., 2012, AFFINITY CHROMATOGRA; Magdeldin S., 2012, GEL ELECTROPHORESIS, VI; Magdeldin S, 2014, J PROTEOME RES, V13, P1636, DOI 10.1021/pr401122m; Motorykin I, 2014, J PROTEOME RES, V13, P1647, DOI 10.1021/pr401108d; Rauniyar N, 2013, J PROTEOME RES, V12, P1031, DOI 10.1021/pr3008896; Seit-Nebi AS, 2013, INT J BIOCHEM CELL B, V45, P344, DOI 10.1016/j.biocel.2012.11.011; Xu B, 2011, J PROTEOMICS, V74, P1022, DOI 10.1016/j.jprot.2011.03.001; Xu T, 2009, NAT PROTOC, V4, P325, DOI 10.1038/nprot.2008.248; Xu XJ, 2007, NEUROBIOL LEARN MEM, V87, P72, DOI 10.1016/j.nlm.2006.06.002; Zhang Y, 2011, PROTEOME SCI, V9, DOI 10.1186/1477-5956-9-47; Soloviev M, 2008, PEPTIDOMICS: METHODS AND APPLICATIONS, P1	42	0	0	AMER CHEMICAL SOC	WASHINGTON	1155 16TH ST, NW, WASHINGTON, DC 20036 USA	1535-3893	1535-3907		J PROTEOME RES	J. Proteome Res.	FEB	2015	14	2					943	952		10.1021/pr500998e		10	Biochemical Research Methods	Biochemistry & Molecular Biology	CA9WV	WOS:000349276400033		
J	Goto, T; Kubota, Y; Toyoda, A				Goto, Tatsuhiko; Kubota, Yoshifumi; Toyoda, Atsushi			Plasma and Liver Metabolic Profiles in Mice Subjected to Subchronic and Mild Social Defeat Stress	JOURNAL OF PROTEOME RESEARCH			English	Article						liver; metabolome; mouse; plasma; social defeat stress; urine	IONIZATION MASS-SPECTROMETRY; ANIMAL-MODELS; RESISTANCE; DEPRESSION; TAURINE; BRAIN; RAT; 1-METHYLNICOTINAMIDE; PERSPECTIVES; NICOTINAMIDE	To improve the quality of life of animals, understanding of stress-induced changes is necessary. Previously, we established a subchronic and mild social defeat stress (sCSDS) model in mice, which showed significantly higher body weight gain, food intake, and water intake compared to control mice. In this study, we elucidated metabolic profiles of plasma, liver, and urine in sCSDS mice by using metabolome and biochemical analyses. There was no significant difference between defeated and control mice in the plasma metabolites. In the liver of sCSDS mice, levels of taurocyamine (GES), phosphorylcholine, d-alanyl-d-alanine (d-ala-d-ala), and 1-methylnicotinamide (MNA) were elevated compared to controls. Taurine plays a role in osmotic regulation, and GES is a potential inhibitor of the taurine transporter. The polydipsia and increased body water content in sCSDS mice may disrupt body fluid balance following GES elevation. Furthermore, sCSDS increased heart and spleen weight significantly. Because MNA and d-ala-d-ala have anti-inflammatory and hepatoprotective effects, they may reduce inflammation in the liver of sCSDS mice. Finally, suppressed excretion of urine sodium was observed in sCSDS mice. Therefore, sCSDS induces various changes in metabolite concentrations, especially related to osmoregulation and inflammation, that may be used as biomarkers for stress-induced changes in animals.	[Goto, Tatsuhiko; Kubota, Yoshifumi; Toyoda, Atsushi] Ibaraki Univ, Coll Agr, Ami, Ibaraki 3000393, Japan; [Goto, Tatsuhiko; Toyoda, Atsushi] Ibaraki Univ Cooperat Agr & Med Sci IUCAM, Ami, Ibaraki 3000393, Japan; [Toyoda, Atsushi] Tokyo Univ Agr & Technol, United Grad Sch Agr Sci, Fuchu, Tokyo 1838509, Japan	Toyoda, A (reprint author), Ibaraki Univ, Coll Agr, Ami, Ibaraki 3000393, Japan.	atoyoda@mx.ibaraki.ac.jp			Ibaraki University	We thank Dr. Teruo Miyazaki, Dr. Yasunori Miyamoto, Dr. Akira Honda, Dr. Shigeru Chohnan, Dr. Tsuyoshi Koide, Dr. Takamitsu Tsukahara, and Dr. Masaya Katsumata for fruitful comments regarding the manuscript. We also appreciate Dr. Naoko Moriya, Dr. Ayako Aoki-Yoshida, Dr. Reiji Aoki, Dr. Yoshiharu Takayama, and Dr. Chise Suzuki for their helpful comments and technical supports for tissue sampling. We would like to acknowledge the efforts of staffs of Human Metabolome Technologies for metabolite extraction, CE-TOFMS analysis, and data analysis of metabolomics profiling. This research was supported in part by Ibaraki University Cooperation between Agriculture and Medical Science (IUCAM) (The MEXT, Japan) and the Research Project on Development of Agricultural Products and Foods with Health-promoting benefits (NARO) (The MAFF, Japan).	Allen RG, 2012, INFECT IMMUN, V80, P3429, DOI 10.1128/IAI.00714-12; Ooga T, 2011, MOL BIOSYST, V7, P1217, DOI 10.1039/c0mb00141d; Zhao YY, 2012, CLIN CHIM ACTA, V413, P642, DOI 10.1016/j.cca.2011.12.014; Chlopicki S, 2007, BRIT J PHARMACOL, V152, P230, DOI 10.1038/sj.bjp.0707383; Bryniarski K, 2008, EUR J PHARMACOL, V578, P332, DOI 10.1016/j.ejphar.2007.09.011; WRIGHT GD, 1992, ACCOUNTS CHEM RES, V25, P468, DOI 10.1021/ar00022a006; Goto T, 2014, BEHAV BRAIN RES, V270, P339, DOI 10.1016/j.bbr.2014.05.040; Hollenbeck Clarie B., 2012, Central Nervous System Agents in Medicinal Chemistry, V12, P100; Hirayama A, 2012, ANAL BIOANAL CHEM, V404, P3101, DOI 10.1007/s00216-012-6412-x; Fagundes CP, 2013, BRAIN BEHAV IMMUN, V31, P172, DOI 10.1016/j.bbi.2012.05.006; Miczek KA, 2008, PHARMACOL THERAPEUT, V120, P102, DOI 10.1016/j.pharmthera.2008.07.006; Berton O, 2006, SCIENCE, V311, P864, DOI 10.1126/science.1120972; Santos J, 1999, AM J PHYSIOL-GASTR L, V277, pG391; Murakami T, 2010, AMINO ACIDS, V39, P427, DOI 10.1007/s00726-009-0458-x; Yoshimoto S, 2013, NATURE, V499, P97, DOI 10.1038/nature12347; Soga T, 2003, J PROTEOME RES, V2, P488, DOI 10.1021/pr034020m; Kiliaan AJ, 1998, AM J PHYSIOL-GASTR L, V275, pG1037; Kanehisa M, 2014, NUCLEIC ACIDS RES, V42, pD199, DOI 10.1093/nar/gkt1076; Raison CL, 2006, TRENDS IMMUNOL, V27, P24, DOI 10.1016/j.it.2005.11.006; Nestler EJ, 2010, NAT NEUROSCI, V13, P1161, DOI 10.1038/nn.2647; Zheng SN, 2010, CLIN CHIM ACTA, V411, P204, DOI 10.1016/j.cca.2009.11.003; Soga T, 2002, ANAL CHEM, V74, P2233, DOI 10.1021/ac020064n; YOCUM RR, 1980, J BIOL CHEM, V255, P3977; ZEISEL SH, 1994, ANNU REV NUTR, V14, P269; D'Mello C, 2014, BRAIN BEHAV IMMUN, V35, P9, DOI 10.1016/j.bbi.2013.10.009; Krishnan V, 2011, CURR TOP BEHAV NEURO, V7, P121, DOI 10.1007/7854_2010_108; Savignac HM, 2011, NEUROSCIENCE, V192, P524, DOI 10.1016/j.neuroscience.2011.04.054; Storey JD, 2003, P NATL ACAD SCI USA, V100, P9440, DOI 10.1073/pnas.1530509100; Krishnan V, 2007, CELL, V131, P391, DOI 10.1016/j.cell.2007.09.018; Hussy N, 2000, PROG NEUROBIOL, V62, P113, DOI 10.1016/S0301-0082(99)00071-4; Patterson ZR, 2013, ENDOCRINOLOGY, V154, P1080, DOI 10.1210/en.2012-1834; Golden SA, 2011, NAT PROTOC, V6, P1183, DOI 10.1038/nprot.2011.361; Chuang JC, 2010, J LIPID RES, V51, P1344, DOI 10.1194/jlr.M002196; Soga T, 2000, ANAL CHEM, V72, P1236, DOI 10.1021/ac990976y; Wohleb ES, 2014, BIOL PSYCHIAT, V75, P970, DOI 10.1016/j.biopsych.2013.11.029; Antunes-Rodrigues J, 2004, PHYSIOL REV, V84, P169, DOI 10.1152/physrev.00017.2003; Bartolomucci A, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004331; Benjamini Y, 1995, J ROYAL STAT SOC B, V57, P298; BRAND HS, 1994, CELL BIOL, V72, P8; Celetti G., 2012, AMINO ACIDS, V43, P1525; Chen SW, 2004, LIFE SCI, V75, P1503, DOI 10.1016/j.lfs.2004.03.010; DELEON J, 1994, BIOL PSYCHIAT, V35, P408, DOI 10.1016/0006-3223(94)90008-6; Duman CH, 2010, VITAM HORM, V82, P1, DOI 10.1016/S0083-6729(10)82001-1; Duraiswamy K., 2011, GEN HOSP PSYCHIAT, V33, p84e9; Kleemann R, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008817; Koike S, 2014, TRANSL PSYCHIAT, V4, DOI 10.1038/tp.2014.19; Kolber BJ, 2008, STRESS, V11, P321, DOI 10.1080/10253890701821081; Kumar I, 2007, ACS CHEM BIOL, V2, P620, DOI 10.1021/cb7001347; Li Lei O, 2010, Mol Endocrinol, V24, P657, DOI 10.1210/me.2009-0152; lio W., 2012, AMINO ACIDS, V43, P2037; lio W., 2014, BMC NEUROSCI, V15, P72; MAHON WA, 1968, CAN MED ASSOC J, V99, P1090; Patterson Z. R., 2013, FRONT NEUROSCI, V24, P130; PFALLER W, 1993, J CELL PHYSIOL, V154, P248, DOI 10.1002/jcp.1041540206; Pumpo R, 2001, AM J GASTROENTEROL, V96, P1183; SAUNDERS PR, 1994, AM J PHYSIOL-GASTR L, V267, pG794; Sergeeva OA, 2003, J PHYSIOL-LONDON, V550, P911, DOI 10.1113/jphysiol.2003.045864; Soderholm JD, 2001, AM J PHYSIOL-GASTR L, V280, pG7; Sternak R. T., 2009, CRIT CARE MED, V37, pS258; Sugimoto M., 2009, METABOLOMICS, V6, P78; Sysi-Aho M, 2011, PLOS COMPUT BIOL, V7, DOI 10.1371/journal.pcbi.1002257; Takahashi A, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0094657; Voisin DL, 2002, TRENDS NEUROSCI, V25, P199, DOI 10.1016/S0166-2236(02)02142-2; Wang Z., 2010, NATURE, V472, P57; Warren BL, 2013, BIOL PSYCHIAT, V73, P7, DOI 10.1016/j.biopsych.2012.06.006; Wideman CH, 2013, PHYSIOL BEHAV, V120, P220, DOI 10.1016/j.physbeh.2013.08.017; WOODFORD N, 1995, CLIN MICROBIOL REV, V8, P585	67	0	0	AMER CHEMICAL SOC	WASHINGTON	1155 16TH ST, NW, WASHINGTON, DC 20036 USA	1535-3893	1535-3907		J PROTEOME RES	J. Proteome Res.	FEB	2015	14	2					1025	1032		10.1021/pr501044k		8	Biochemical Research Methods	Biochemistry & Molecular Biology	CA9WV	WOS:000349276400040		
J	Levin, R; Dor-Abarbanel, AE; Edelman, S; Durrant, AR; Hashimoto, K; Javitt, DC; Heresco-Levy, U				Levin, Raz; Dor-Abarbanel, Adi Ein; Edelman, Shany; Durrant, Andrea R.; Hashimoto, Kenji; Javitt, Daniel C.; Heresco-Levy, Uriel			Behavioral and cognitive effects of the N-methyl-D-aspartate receptor co-agonist D-serine in healthy humans: Initial findings	JOURNAL OF PSYCHIATRIC RESEARCH			English	Article						Behavior; Cognition; N-methyl-D-aspartate receptor; D-serine	PLACEBO-CONTROLLED TRIAL; ACID OXIDASE INHIBITOR; TREATMENT-RESISTANT DEPRESSION; TARGETED POINT MUTATIONS; GLYCINE BINDING-SITE; NMDA RECEPTOR; D-CYCLOSERINE; DOUBLE-BLIND; PARKINSONS-DISEASE; MAJOR DEPRESSION	The efficacy of compounds having agonistic activity at the glycine site associated with the N-methyl-D-aspartate receptor (NMDAR) is presently assessed in psychiatric disorders. In contrast to NMDAR antagonists, the neuropsychiatric effects of NMDAR agonists in the healthy human organism are not known. We studied neuropsychiatric and neurochemical effects of the NMDAR-glycine site obligatory co-agonist D-serine (DSR) in healthy subjects using a randomized, controlled crossover challenge design including a baseline assessment day and two DSR/placebo administration days. Thirty-five subjects aged 23-29 years participated in the study and received a 2.1 g orally administered DSR dose. The main outcome measures were the changes in scores of mood-related Visual Analogue Scale (VAS), Continuous Performance Test Identical Pairs (CPT-IP), and Rey Auditory Verbal Learning Test (RAVLT). DSR acute administration: (1) was well tolerated and resulted at 2 h in >= 200 times increase in DSR serum levels; (2) elicited reduced VAS-measured depression and anxiety feelings; (3) improved attention and vigilance as measured by CPT-IP d-prime score; (4) preferentially improved performance in RAVLT list 7 reflecting ability to retain information over interference; (5) had significant but nonspecific effects on Category Fluency and Benton Visual Retention tests; and (6) did not affect glycine and glutamate serum levels. These data indicate that in healthy subjects, DSR reduces subjective feelings of sadness and anxiety and has procognitive effects that are overall opposed to the known effects of NMDAR antagonists. The findings are relevant to translational research of NMDAR function and the development of NMDAR-glycine site treatments for specific psychiatric entities. (C) 2014 Elsevier Ltd. All rights reserved.	[Levin, Raz; Durrant, Andrea R.; Heresco-Levy, Uriel] Ezrath Nashim Herzog Mem Hosp, Res Dept, Jerusalem, Israel; [Levin, Raz; Durrant, Andrea R.; Heresco-Levy, Uriel] Ezrath Nashim Herzog Mem Hosp, Dept Psychiat, Jerusalem, Israel; [Dor-Abarbanel, Adi Ein; Edelman, Shany; Heresco-Levy, Uriel] Hebrew Univ Jerusalem, Hadassah Med Sch, IL-91035 Jerusalem, Israel; [Hashimoto, Kenji] Chiba Univ, Ctr Forens Mental Hlth, Div Clin Neurosci, Chiba, Japan; [Javitt, Daniel C.] Columbia Univ, New York, NY 10027 USA	Heresco-Levy, U (reprint author), Hebrew Univ Jerusalem, Dept Psychiat, Hadassah Med Sch, Ezrath Nashim Herzog Mem Hosp, POB 3900, IL-91035 Jerusalem, Israel.	urielh@ekmd.huji.ac.il					Lara DR, 2013, INT J NEUROPSYCHOPH, V16, P2111, DOI 10.1017/S1461145713000485; KLECKNER NW, 1988, SCIENCE, V241, P835, DOI 10.1126/science.2841759; Kew JNC, 2000, J NEUROSCI, V20, P4037; Gardoni F, 2006, EUR J PHARMACOL, V545, P2, DOI 10.1016/j.ejphar.2006.06.022; Rush AJ, 2013, AM J PSYCHIAT, V170, P1079, DOI 10.1176/appi.ajp.2013.13081034; Balu DT, 2013, P NATL ACAD SCI USA, V110, pE2400, DOI 10.1073/pnas.1304308110; Palmer C, 2008, HUM PSYCHOPHARM CLIN, V23, P151, DOI 10.1002/hup.904; Krystal JH, 2005, ARCH GEN PSYCHIAT, V62, P985, DOI 10.1001/archpsyc.62.9.985; Nilsson M, 1997, J NEURAL TRANSM, V104, P1195, DOI 10.1007/BF01294720; Kantrowitz JT, 2010, SCHIZOPHR RES, V121, P125, DOI 10.1016/j.schres.2010.05.012; LOVINGER DM, 1989, SCIENCE, V243, P1721, DOI 10.1126/science.2467382; SCHELL MJ, 1995, P NATL ACAD SCI USA, V92, P3948, DOI 10.1073/pnas.92.9.3948; Malkesman O, 2012, INT J NEUROPSYCHOPH, V15, P1135, DOI 10.1017/S1461145711001386; Huang YJ, 2012, CURR NEUROPHARMACOL, V10, P272, DOI 10.2174/157015912803217288; Moghaddam B, 2012, SCHIZOPHRENIA BULL, V38, P942, DOI 10.1093/schbul/sbs075; Hashimoto K, 2008, EUR NEUROPSYCHOPHARM, V18, P414, DOI 10.1016/j.euroneuro.2007.07.009; Zarate CA, 2006, AM J PSYCHIAT, V163, P153, DOI 10.1176/appi.ajp.163.1.153; Lane HY, 2013, JAMA PSYCHIAT, V70, P1267, DOI 10.1001/jamapsychiatry.2013.2159; Papouin T, 2012, CELL, V150, P633, DOI 10.1016/j.cell.2012.06.029; Kuriyama K, 2011, NEUROBIOL LEARN MEM, V95, P505, DOI 10.1016/j.nlm.2011.02.017; Greenberg WM, 2009, J PSYCHIATR RES, V43, P664, DOI 10.1016/j.jpsychires.2008.10.007; LAHTI AC, 1995, NEUROPSYCHOPHARMACOL, V13, P9, DOI 10.1016/0893-133X(94)00131-I; Bruno MA, 2009, J NEUROPATH EXP NEUR, V68, P1309, DOI 10.1097/NEN.0b013e3181c22569; Onur OA, 2010, BIOL PSYCHIAT, V67, P1205, DOI 10.1016/j.biopsych.2010.01.022; Huang CC, 2013, BIOL PSYCHIAT, V74, P734, DOI 10.1016/j.biopsych.2013.02.020; KRYSTAL JH, 1994, ARCH GEN PSYCHIAT, V51, P199; Preskorn SH, 2008, J CLIN PSYCHOPHARM, V28, P631, DOI 10.1097/JCP.0b013e31818a6cea; Hashimoto K, 2003, ARCH GEN PSYCHIAT, V60, P572, DOI 10.1001/archpsyc.60.6.572; Hardingham GE, 2010, NAT REV NEUROSCI, V11, P682, DOI 10.1038/nrn2911; Kantrowitz JT, 2010, BRAIN RES BULL, V83, P108, DOI [10.1016/j.brainresbull.2010.04.006, 10.1016/j.brainresbull.2010.06.006]; Feld GB, 2013, NEUROPSYCHOPHARMACOL, V38, P2688, DOI 10.1038/npp.2013.179; Parwani A, 2005, PSYCHOPHARMACOLOGY, V183, P265, DOI 10.1007/s00213-005-0177-2; Krystal JH, 2013, BIOL PSYCHIAT, V73, P1133, DOI 10.1016/j.biopsych.2013.03.026; Heresco-Levy U, 2013, INT J NEUROPSYCHOPH, V16, P501, DOI 10.1017/S1461145712000910; Singh SP, 2011, CNS DRUGS, V25, P859, DOI 10.2165/11586650-000000000-00000; Tsai GE, 2010, CURR PHARM DESIGN, V16, P522; Smith EG, 2013, J CLIN PSYCHIAT, V74, P966, DOI 10.4088/JCP.12m08252; Hashimoto K, 2005, PROG NEURO-PSYCHOPH, V29, P767, DOI 10.1016/j.pnpbp.2005.04.023; MATSUI T, 1995, J NEUROCHEM, V65, P454; Bado P, 2011, PSYCHOPHARMACOLOGY, V218, P461, DOI 10.1007/s00213-011-2330-4; Ballard TM, 2002, J NEUROSCI, V22, P6713; Cho HS, 2008, GLUTAMATE NEUROPSYCH, P99; COLOMBO G, 1992, ANN NY ACAD SCI, V654, P421, DOI 10.1111/j.1749-6632.1992.tb25986.x; D'Souza DC, 2000, BIOL PSYCHIAT, V47, P450, DOI 10.1016/S0006-3223(99)00133-X; File SE, 1999, J CLIN PSYCHOPHARM, V19, P506, DOI 10.1097/00004714-199912000-00004; Gelfin E, 2012, INT J NEUROPSYCHOPH, V15, P543, DOI 10.1017/S1461145711001015; Goff DC, 2014, JAMA PSYCHIAT, V71, P620, DOI 10.1001/jamapsychiatry.2014.257; Heresco-Levy U, 2008, GLUTAMATE NEUROPSYCH; Heresco-Levy U, 2013, MOVEMENT DISORD, V28, P419, DOI 10.1002/mds.25306; Ripke S, 2014, NATURE, V511, P421, DOI 10.1038/nature13595; Lai CH, 2012, BIOL PSYCHIAT, V71, pE9, DOI 10.1016/j.biopsych.2011.10.034; Lin CH, 2014, BIOL PSYCHIAT, V75, P678, DOI 10.1016/j.biopsych.2013.08.010; Lingjaerde O, 1987, Acta Psychiatr Scand Suppl, V334, P1; More L, 2008, BEHAV PHARMACOL, V19, P724, DOI 10.1097/FBP.0b013e3283123cad; Moritz S, 2001, PSYCHIAT RES, V101, P23, DOI 10.1016/S0165-1781(00)00241-9; MUIR JL, 1995, PSYCHOPHARMACOLOGY, V118, P82; Neumeister A, 2006, J CLIN PSYCHOPHARM, V26, P595, DOI 10.1097/01.jcp.0000245558.14284.aa; Roche Hofftnann-La, 2013, STUDY BITOPERTIN RO4; SCHWARTZ BL, 1991, NEUROLOGY, V41, P1341; Spitzer R. L., 1990, STRUCTURED CLIN INTE; Tsai GE, 2008, J CLIN PHARMACOL, V48, P524, DOI 10.1177/0091270008314253; Yoshida T, 2012, OPEN CLIN CHEM J, V5, P7, DOI DOI 10.2174/1874241601205010007; Yoshida T, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042676	63	1	1	PERGAMON-ELSEVIER SCIENCE LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND	0022-3956	1879-1379		J PSYCHIATR RES	J. Psychiatr. Res.	FEB	2015	61						188	195		10.1016/j.jpsychires.2014.12.007		8	Psychiatry	Psychiatry	CB6IP	WOS:000349731000026		
J	Miu, L; Mele, P; Ivan, I; Ionescu, AM; Miu, D				Miu, L.; Mele, P.; Ivan, I.; Ionescu, A. M.; Miu, D.			DC Magnetization Relaxation and the AC Susceptibility of YBCO Films with Strong Pinning	JOURNAL OF SUPERCONDUCTIVITY AND NOVEL MAGNETISM			English	Article						YBCO films with BZO nanorods; AC measurements; DC magnetization relaxation; Flux flow; Flux creep	HIGH-TEMPERATURE SUPERCONDUCTORS	AC susceptibility and DC magnetization relaxation measurements have been performed for YBa2Cu3O7 films containing BaZrO3 nanorods preferentially oriented along the c axis, with the external magnetic field perpendicular to the film surface. It was found that the effective vortex activation energy U (e) supplied by the standard analysis of the frequency dependent AC magnetic response remains very high even in the vicinity of the irreversibility line indicated by the DC relaxation. We show that the large U (e) values appearing in the AC signal are related to the pinning enhanced viscous drag and significant vortex velocities.	[Miu, L.; Ivan, I.; Ionescu, A. M.] Natl Inst Mat Phys, Bucharest 77125, Romania; [Mele, P.] Hiroshima Univ, Inst Sustainable Sci & Dev, Higashihiroshima 7398530, Japan; [Miu, D.] Natl Inst Laser Plasma & Radiat Phys, Bucharest 77125, Romania	Miu, L (reprint author), Natl Inst Mat Phys, Bucharest 77125, Romania.	elmiu@infim.ro			UEFISCDI, Romania [138/2012, 7/2012]	Work is supported by UEFISCDI, Romania, under Grant PCCA Nos. 138/2012 and 7/2012. All the authors contributed equally to this work.	Akerman J. J., 2001, PHYS REV B, V64, P184; GUREVICH A, 1993, PHYS REV B, V48, P6477, DOI 10.1103/PhysRevB.48.6477; GOLOSOVSKY M, 1994, PHYS REV B, V50, P470, DOI 10.1103/PhysRevB.50.470; Yeshurun Y, 1996, REV MOD PHYS, V68, P911, DOI 10.1103/RevModPhys.68.911; Gomory F, 1997, SUPERCOND SCI TECH, V10, P523, DOI 10.1088/0953-2048/10/8/001; Mele P, 2007, SUPERCOND SCI TECH, V20, P244, DOI 10.1088/0953-2048/20/3/023; Bartolome E., 2010, PHYS REV B, V81, P184; Blatter G., 1994, REV MOD PHYS, V66, P11; Brandt E. H., 1994, PHYS REV B, V49, P90; Clem J. R., 1994, PHYS REV B, V50, P93; Fabrega F., 1994, PHYS REV B, V50, P11; Ge J., 2014, APPL PHYS LETT, V104, P112; Mele P., 2008, SUPERCOND SCI TECH, V21, P032; Miu L., 2012, PHYS REV B, V85, P104; Prando G., 2011, PHYS REV B, V83, P174; Ruoco V., 2012, SUPERCOND SCI TECH, V25, P122; Vanevic M., 2013, PHYS REV B, V87, P144	17	1	1	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	1557-1939	1557-1947		J SUPERCOND NOV MAGN	J. Supercond. Nov. Magn	FEB	2015	28	2					361	365		10.1007/s10948-014-2652-7		5	Physics, Applied; Physics, Condensed Matter	Physics	CB0XD	WOS:000349350100017		
J	Miura, S; Yoshida, Y; Ichino, Y; Matsumoto, K; Ichinose, A; Awaji, S				Miura, S.; Yoshida, Y.; Ichino, Y.; Matsumoto, K.; Ichinose, A.; Awaji, S.			Flux Pinning Properties of a SmBa2Cu3O (y) Film Including High Number Density of BaHfO3 Nano-rods on LaAlO3 Substrate	JOURNAL OF SUPERCONDUCTIVITY AND NOVEL MAGNETISM			English	Article						BaHfO3; Flux pinning force; Pulsed laser deposition; SmBa2Cu3Oy; Thin film		Flux pinning properties of a BaHfO3 (BHO)-doped SmBa2Cu3O (y) (SmBCO) film, which was fabricated by pulsed laser deposition method adopting a seed layer technique, have been investigated. Nano-rods of the film were small in a diameter of 5.4 nm and had high number density (high-n) of 4,775/mu m(2). The flux pinning properties of the film were compared with a SmBCO film including BHO nano-rods with a larger diameter and a lower number density (low-n). At 65 K, the flux pinning force density of the high-n sample (105.0 GN/m(3)) showed much higher than that of the low-n sample (70.6 GN/m(3)).	[Miura, S.; Yoshida, Y.; Ichino, Y.] Nagoya Univ, Dept Energy Engn & Sci, Nagoya, Aichi 4648603, Japan; [Matsumoto, K.] Kyushu Inst Technol, Dept Mat Sci & Engn, Kitakyushu, Fukuoka 8048550, Japan; [Ichinose, A.] Cent Res Inst Elect Power Ind, Elect Power Engn Res Lab, Yokosuka, Kanagawa 2400196, Japan; [Awaji, S.] Tohoku Univ, Inst Mat Res, Sendai, Miyagi 9808577, Japan	Miura, S (reprint author), Nagoya Univ, Dept Energy Engn & Sci, Nagoya, Aichi 4648603, Japan.	miura-syun12@ees.nagoya-u.ac.jp	Awaji, Satoshi/A-8130-2011		Japan Society for the Promotion of Science (JSPS) [23226014, 19676005, 25289358]; Research Foundation for the Electrotechnology of Chubu	This work was partly supported by Grants-in-Aid for Scientific Research (Nos. 23226014, 19676005, and 25289358) from the Japan Society for the Promotion of Science (JSPS) and Research Foundation for the Electrotechnology of Chubu.	Itoh M, 2004, PHYSICA C, V412, P833, DOI 10.1016/j.physc.2003.12.096; Ozaki T, 2010, J APPL PHYS, V108, DOI 10.1063/1.3498812; Mele P, 2008, SUPERCOND SCI TECH, V21, DOI 10.1088/0953-2048/21/3/032002; Miu D, 2013, SUPERCOND SCI TECH, V26, DOI 10.1088/0953-2048/26/4/045008; Tsuruta A, 2013, IEEE T APPL SUPERCON, V23, DOI 10.1109/TASC.2012.2237218; Macmanus-Driscoll JL, 2004, NAT MATER, V3, P439, DOI 10.1038/nmat1156	6	0	0	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	1557-1939	1557-1947		J SUPERCOND NOV MAGN	J. Supercond. Nov. Magn	FEB	2015	28	2					367	369		10.1007/s10948-014-2754-2		3	Physics, Applied; Physics, Condensed Matter	Physics	CB0XD	WOS:000349350100018		
J	Tanaka, S; Ohtani, T; Uchida, Y; Hatsukade, Y; Suzuki, S				Tanaka, S.; Ohtani, T.; Uchida, Y.; Hatsukade, Y.; Suzuki, S.			Ultra-Sensitive Contaminant Detection System Using High-Tc SQUID	JOURNAL OF SUPERCONDUCTIVITY AND NOVEL MAGNETISM			English	Article						SQUID; Detection; High Tc; Food contaminant	METALLIC CONTAMINANT; C SQUID; FOOD	We report the fabrication of magnetic metallic contaminant detectors using multiple high-Tc superconducting quantum interference devices (SQUIDs) for food. Finding small metallic contaminants is important for food safety. People may ingest contaminants that are accidentally mixed in with the food. Hence, a detection method of small contaminants in food is required. Given the lower detection limit for practical X-ray usage is in the order of 1 mm, a detection system using a SQUID is a more powerful tool for sensitive inspections. We design and set up a three-channel high-Tc rf-SQUID inspection system for food. We report the successful detection of a small phi 0.3-mm steel particle for the food detection system.	[Tanaka, S.; Ohtani, T.; Uchida, Y.; Hatsukade, Y.] Toyohashi Univ Technol, Toyohashi, Aichi 4418580, Japan; [Suzuki, S.] Adv Food Technol Co Ltd, Toyohashi, Aichi 4418113, Japan	Tanaka, S (reprint author), Toyohashi Univ Technol, Toyohashi, Aichi 4418580, Japan.	tanakas@ens.tut.ac.jp			Knowledge Hub of Aichi, The Priority Research Project from Aichi Science & Technology Foundation	This work was supported in part by The Knowledge Hub of Aichi, The Priority Research Project from Aichi Science & Technology Foundation.	Bick M, 2005, SUPERCOND SCI TECH, V18, P346, DOI 10.1088/0953-2048/18/3/024; Krause HJ, 2005, IEEE T APPL SUPERCON, V15, P729, DOI 10.1109/TASC.2005.850027; Tanaka S, 2004, SUPERCOND SCI TECH, V17, P620, DOI 10.1088/0953-2048/17/4/009; Tanaka S, 2007, IEEE T APPL SUPERCON, V17, P756, DOI 10.1109/TASC.2007.898565; Tanaka S, 2013, IEEE T APPL SUPERCON, V23, DOI 10.1109/TASC.2012.2227439; Tanaka S, 2006, SUPERCOND SCI TECH, V19, pS280, DOI 10.1088/0953-2048/19/5/S24; Tanaka S, 2005, IEICE T ELECTRON, VE88C, P175, DOI 10.1093/ietele/E88-C.2.175; Tanaka S, 2009, IEEE T MAGN, V45, P4510, DOI 10.1109/TMAG.2009.2021857; Welch J. J., 1997, COLLIDING BEAM NOTES, V31, P1	9	0	0	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	1557-1939	1557-1947		J SUPERCOND NOV MAGN	J. Supercond. Nov. Magn	FEB	2015	28	2					667	670		10.1007/s10948-014-2668-z		4	Physics, Applied; Physics, Condensed Matter	Physics	CB0XD	WOS:000349350100071		
J	Kushino, A; Kasai, S				Kushino, Akihiro; Kasai, Soichi			Superconducting Semi-Rigid Cable as Low-Pass Filter for Cryogenic Readout	JOURNAL OF SUPERCONDUCTIVITY AND NOVEL MAGNETISM			English	Article						Semi-rigid cable; Thermal conductance; Attenuation; Low-pass filter; Skin effect	COAXIAL CABLES; DETECTORS	We are developing thin semi-rigid cables with outer diameters less than 1 mm, for accurate readout of cryogenic applications. The center conductor is separated from seamless metal outer conductor by dielectric material, polytetrafluoroethylene (PTFE). In order to suppress heat penetration through the cables into cryogenic stage, we used low thermal conductivity normal conducting alloys or superconductors as the material for both center and outer conductors. And to cut high frequency noise components in readout, we adopted bilayer structure in the center conductor, where superconducting wire with a diameter of 178 mu m made of niobium-titanium (NbTi) was clad in normal conducting alloy, cupronickel (CuNi) of 13 mu m thickness. We also used CuNi pipe with an outside diameter of 0.86 mm as the outer conductor. From the results of thermal conductance and attenuation below the critical temperature of NbTi ( similar to 9 K), we confirmed that this kind of semi-rigid cable can work as a low-pass filter used at cryogenic temperature. The -3 dB cutoff frequency of 1 m length cable was observed at similar to 500 MHz, above which attenuation became significant because of the skin effect and large electrical resistivity of CuNi cladding.	[Kushino, Akihiro] Asahikawa Coll, Natl Inst Technol, Asahikawa, Hokkaido 0718142, Japan; [Kasai, Soichi] Coax Co Ltd, Aoba Ku, Yokohama, Kanagawa 2250016, Japan	Kushino, A (reprint author), Asahikawa Coll, Natl Inst Technol, 2-1-6 Shunkodai 2 Jo, Asahikawa, Hokkaido 0718142, Japan.	kushino@asahikawa-nct.ac.jp					Ohkubo M, 2012, J LOW TEMP PHYS, V167, P943, DOI 10.1007/s10909-012-0542-6; Hattori K, 2013, NUCL INSTRUM METH A, V732, P306, DOI 10.1016/j.nima.2013.08.019; Kushino A, 2005, CRYOGENICS, V45, P637, DOI 10.1016/j.cryogenics.2005.07.002; Kushino A, 2008, J LOW TEMP PHYS, V151, P650, DOI 10.1007/s10909-008-9721-x; Kushino A, 2013, J SUPERCOND NOV MAGN, V26, P2085, DOI 10.1007/s10948-012-2053-8; OLSON JR, 1993, CRYOGENICS, V33, P729, DOI 10.1016/0011-2275(93)90027-L; Smith E, 2012, CRYOGENICS, V52, P461, DOI 10.1016/j.cryogenics.2012.05.001; Tancredi G, 2014, REV SCI INSTRUM, V85, DOI 10.1063/1.4863881; Yamada S, 2014, J LOW TEMP PHYS, V176, P310, DOI 10.1007/s10909-013-1056-6	9	0	0	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	1557-1939	1557-1947		J SUPERCOND NOV MAGN	J. Supercond. Nov. Magn	FEB	2015	28	2					715	718		10.1007/s10948-014-2647-4		4	Physics, Applied; Physics, Condensed Matter	Physics	CB0XD	WOS:000349350100080		
J	Hirata, Y; Yamamoto, E; Tokitsu, T; Kusaka, H; Fujisue, K; Kurokawa, H; Sugamura, K; Maeda, H; Tsujita, K; Kaikita, K; Hokimoto, S; Sugiyama, S; Ogawa, H				Hirata, Yoshihiro; Yamamoto, Eiichiro; Tokitsu, Takanori; Kusaka, Hiroaki; Fujisue, Koichiro; Kurokawa, Hirofumi; Sugamura, Koichi; Maeda, Hirofumi; Tsujita, Kenichi; Kaikita, Koichi; Hokimoto, Seiji; Sugiyama, Seigo; Ogawa, Hisao			Reactive Oxygen Metabolites are Closely Associated With the Diagnosis and Prognosis of Coronary Artery Disease	JOURNAL OF THE AMERICAN HEART ASSOCIATION			English	Article						cardiovascular events; coronary artery disease; coronary circulation; follow-up study; reactive oxygen species	OXIDATIVE STRESS; CARDIOVASCULAR-DISEASE; HYPERTENSIVE-RATS; UNSTABLE ANGINA; VITAMIN-E; INJURY; PROTEIN; ATHEROSCLEROSIS; SUPPLEMENTATION; INFLAMMATION	Background-Reactive oxygen species (ROS) are associated with development of coronary artery disease (CAD). However, there's no useful biomarker of ROS in CAD. Methods and Results-We recruited 395 consecutive CAD patients who were performed coronary angiography (262 male and 133 female, age 70.2 +/- 10), and we measured serum derivatives of reactive oxidative metabolites (DROM) were measured. Two hundred twenty-seven non-CAD patients were also enrolled. We performed follow-up study in these 395 CAD patients and case-control study after risk factor and 1: 1 pair matching (both, n= 163). As subgroup analysis, DROM were also measured at the aortic root and the coronary sinus in 59 CAD patients. DROM were significantly higher in CAD patients (n= 163, median [inter-quartile range, IQR]=338 [302 to 386]) than in risk factor-matched non-CAD patients (n= 163, 311 [282 to 352.5], effect size=0.33, P<0.001). During a mean follow-up period of 20 months of 395 CAD patients, 83 cardiovascular events were recorded. Kaplan-Meier analysis showed a higher probability of cardiovascular events in the high-DROM group (>346 U.CARR) than in the low-DROM group (<= 346 U.CARR) (P=0.001 [log-rank test]). Multivariate Cox hazard analysis identified ln-DROM as an independent predictor for cardiovascular events (hazard ratio: 10.8, 95% confidence interval: 2.76 to 42.4, P=0.001). The transcardiac gradient of DROM was significantly higher in CAD patients than in non-CAD patients (-2.0 [-9.0 to 9.0] versus 8 [-8.0 to 28.3], effect size=0.21, P=0.04), indicating that DROM production in coronary circulation is associated with development of CAD. Conclusion-DROM are increased in CAD patients and associated with future cardiovascular events. DROM might provide clinical benefits for risk stratification of CAD.	[Hirata, Yoshihiro; Yamamoto, Eiichiro; Tokitsu, Takanori; Kusaka, Hiroaki; Fujisue, Koichiro; Kurokawa, Hirofumi; Sugamura, Koichi; Maeda, Hirofumi; Tsujita, Kenichi; Kaikita, Koichi; Hokimoto, Seiji; Sugiyama, Seigo; Ogawa, Hisao] Kumamoto Univ, Dept Cardiovasc Med, Fac Life Sci, Grad Sch Med Sci, Kumamoto 8608556, Japan	Yamamoto, E (reprint author), Kumamoto Univ, Dept Cardiovasc Med, Fac Life Sci, Grad Sch Med Sci,Chuo Ku, 1-1-1 Honjo, Kumamoto 8608556, Japan.	eyamamo@kumamoto-u.ac.jp			Japanese Ministry of Education, Science, and Culture [B24790770]; SEN-SHIN Medical Research Foundation; Japan Cardiovascular Research Foundation	This work was supported in part by Grants-in Aid for Scientific Research (grant number: B24790770 to Yamamoto) from the Japanese Ministry of Education, Science, and Culture, SEN-SHIN Medical Research Foundation (to Yamamoto), and Japan Cardiovascular Research Foundation (to Ogawa).	AMBROSE JA, 1985, J AM COLL CARDIOL, V5, P609; AMBROSE JA, 1991, AM J CARDIOL, V68, pB78, DOI 10.1016/0002-9149(91)90388-2; Brown BG, 2001, NEW ENGL J MED, V345, P1583, DOI 10.1056/NEJMoa011090; Mills BJ, 2000, J LAB CLIN MED, V135, P396, DOI 10.1067/mlc.2000.105976; Kummerow FA, 2000, ATHEROSCLEROSIS, V149, P181, DOI 10.1016/S0021-9150(99)00378-0; Bonow RO, 2002, CIRCULATION, V106, P1602, DOI 10.1161/01.CIR.0000035036.22612.2B; Walter MF, 2008, J AM COLL CARDIOL, V51, P1196, DOI 10.1016/j.jacc.2007.11.051; Gerardi G, 2002, CLIN CHEM LAB MED, V40, P104, DOI 10.1515/CCLM.2002.019; Ashfaq S, 2006, J AM COLL CARDIOL, V47, P1005, DOI 10.1016/j.jacc.2005.09.063; Salonen RM, 2003, CIRCULATION, V107, P947, DOI 10.1161/01.CIR.0000050626.25057.51; Kobayashi S, 2003, ARTERIOSCL THROM VAS, V23, P1398, DOI 10.1161/01.ATV.0000081637.36475.BC; Vichova T, 2013, EXP CLIN CARDIOL, V18, pE88; Yasojima K, 2001, AM J PATHOL, V158, P1039, DOI 10.1016/S0002-9440(10)64051-5; Shimano M, 2009, HEART RHYTHM, V6, P935, DOI 10.1016/j.hrthm.2009.03.012; Griendling KK, 2003, CIRCULATION, V108, P2034, DOI 10.1161/01.CIR.0000093661.90582.c4; Leufkens AM, 2012, AM J EPIDEMIOL, V175, P653, DOI 10.1093/aje/kwr418; Yamamoto E, 2008, STROKE, V39, P3049, DOI 10.1161/STROKEAHA.108.517284; Cesarone MR, 1999, INT ANGIOL, V18, P127; Griendling KK, 2003, CIRCULATION, V108, P1912, DOI 10.1161/01.CIR.0000093660.86242.BB; EMOND M, 1994, CIRCULATION, V90, P2645; Higashi Y, 2009, CIRC J, V73, P411; D'Aiuto F, 2010, J DENT RES, V89, P1241, DOI 10.1177/0022034510375830; Digiesi V, 1997, Clin Ter, V148, P515; Valagussa F, 1999, LANCET, V354, P447; Iamele L, 2002, CLIN CHEM LAB MED, V40, P673, DOI 10.1515/CCLM.2002.115; Kamezaki F, 2008, J ATHEROSCLER THROMB, V15, P206; Yamamoto E, 2007, ARTERIOSCL THROM VAS, V27, P2569, DOI 10.1161/ATVBAHA.107.153692; Yamamoto E, 2007, ARTERIOSCL THROM VAS, V27, P556, DOI 10.1161/01.ATV.0000254855.24394.f9	28	1	1	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	2047-9980			J AM HEART ASSOC	J. Am. Heart Assoc.	FEB	2015	4	2							e001451	10.1161/JAHA.114.001451		13	Cardiac & Cardiovascular Systems	Cardiovascular System & Cardiology	CB5LG	WOS:000349668000011		
J	An, WG; Xiao, HH; Liew, KM; Jiang, L; Yan, WG; Zhou, Y; Huang, XJ; Sun, JH; Gao, LJ				An, Weiguang; Xiao, Huahua; Liew, K. M.; Jiang, Lin; Yan, Weigang; Zhou, Yang; Huang, Xinjie; Sun, Jinhua; Gao, Lijing			Downward flame spread over extruded polystyrene	JOURNAL OF THERMAL ANALYSIS AND CALORIMETRY			English	Article						Extruded polystyrene (XPS); Downward flame spread; Heat transfer; Thickness effects; Sidewall effects; Pressure effects	THIN SOLID FUELS; HEAT-TRANSFER; THICKNESS; PRESSURE; MICROGRAVITY; PROPAGATION; SURFACE; WIDTH	An experimental study on the characteristics of downward flame spread of extruded polystyrene (XPS) is presented. The parameters investigated include average mass loss rate per unit of thickness (), average flame height (H (f)), average flame spread rate (v (f)), and mass growth rate () of molten XPS. The effects of sample thickness (d), sidewalls and atmospheric pressure (p), and the combined effects of these factors on the flame spread are studied. The larger sample thickness corresponds to larger and higher flame upon most occasions. As d rises, v (f) and increase under all conditions; v (f) and d follow the equation: . The dimensionless heat release rate: . , v (f) , and obtained without sidewalls are higher than those with sidewalls. , v (f,) and H (f) obtained on the plain (p = 100.8 kPa) are larger than those obtained on the plateau (p = 65.5 kPa). obtained on the plain is lower than that on the plateau. In most cases without sidewalls, , where 1.9 < n (0) < 2, and . H (f) obtained in the cases without sidewalls is larger than that with sidewalls when the sample thickness is small, while the opposite is true for thicker samples. When sidewalls are absent, on the plain, with a rise in thickness, the increase of v (f) is significant for thin samples while the variation is not considerable for thick samples; on the plateau, this increase is significant for all thicknesses tested. The experimental results agree well with the theoretical analysis.	[An, Weiguang; Xiao, Huahua; Jiang, Lin; Yan, Weigang; Zhou, Yang; Sun, Jinhua] Univ Sci & Technol China, State Key Lab Fire Sci, Hefei 230026, Anhui, Peoples R China; [An, Weiguang; Liew, K. M.] City Univ Hong Kong, Dept Architectural & Civil Engn, Kowloon 999077, Hong Kong, Peoples R China; [Huang, Xinjie] Anhui Univ Technol, Sch Civil Engn & Architecture, Maanshan 243002, Anhui, Peoples R China; [Gao, Lijing] Chiba Inst Sci, Fac Risk & Crisis Management, Choshi, Chiba 2880025, Japan	Sun, JH (reprint author), Univ Sci & Technol China, State Key Lab Fire Sci, Hefei 230026, Anhui, Peoples R China.	weiguang@mail.ustc.edu.cn; sunjh@ustc.edu.cn			National Basic Research Program of China (973 Program) [2012CB719702]; Research Fund for the Doctoral Program of Higher Education [20113402110023]; National Natural Science Foundation of China [51036007, 51206002]; Key Technologies R&D Program of China during the 12th Five-Year Plan Period [2013BAJ01B05]; Anhui University of Technology [QZ201109]; State Key Laboratory of Fire Science [HZ2012-KF04, HZ2012-KF08]	This research is supported by National Basic Research Program of China (973 Program, Grant. No. 2012CB719702), the Research Fund for the Doctoral Program of Higher Education (No. 20113402110023), National Natural Science Foundation of China (No. 51036007 and No. 51206002), and Key Technologies R&D Program of China during the 12th Five-Year Plan Period (No. 2013BAJ01B05). The Young Teacher Fund (No. QZ201109) of Anhui University of Technology and the open fund of State Key Laboratory of Fire Science (No. HZ2012-KF04 and No. HZ2012-KF08) are also appreciated.	Zhang Y, 2011, J HAZARD MATER, V189, P34, DOI 10.1016/j.jhazmat.2011.01.101; An WG, 2015, J THERM ANAL CALORIM, V119, P229, DOI 10.1007/s10973-014-4165-9; Zhang Y, 2013, INT J HEAT MASS TRAN, V61, P28, DOI 10.1016/j.ijheatmasstransfer.2013.01.069; Beaulieu PA, 2008, FIRE SAFETY J, V43, P410, DOI 10.1016/j.firesaf.2007.11.008; Fang J, 2011, FUEL, V90, P2760, DOI 10.1016/j.fuel.2011.03.035; Degroote E, 2005, J THERM ANAL CALORIM, V80, P541, DOI 10.1007/s10973-005-0735-1; De Ris JL, 2000, P COMBUST INST, V28, P2751; Huang XJ, 2012, J THERMOPLAST COMPOS, V25, P427, DOI 10.1177/0892705711411341; Huang XJ, 2011, CHINESE SCI BULL, V56, P1617, DOI 10.1007/s11434-010-4187-z; Gong JH, 2013, INT J HEAT MASS TRAN, V61, P191, DOI 10.1016/j.ijheatmasstransfer.2013.01.066; SIBULKIN M, 1976, COMBUST SCI TECHNOL, V14, P43, DOI 10.1080/00102207608946745; Chu L, 1978, FTASTR1978 CAS W RES, P78; Comas B, 2012, COMBUST SCI TECHNOL, V184, P489, DOI 10.1080/00102202.2011.648033; Degroote E, 2007, J THERM ANAL CALORIM, V87, P149, DOI 10.1007/s10973-006-7838-1; Delichatsios MA, 1998, FIRE SAFETY J, V5, P153; DIBLASI C, 1994, COMBUST FLAME, V97, P225, DOI 10.1016/0010-2180(94)90006-X; Fernandez-Pello A.C., 1975, P COMBUST INST, V15, P217; FERNANDEZPELLO A, 1976, COMBUST SCI TECHNOL, V14, P155, DOI 10.1080/00102207608547525; Hasemi Y, 1986, 1ST FIR SAF SCI INT, P87; Heskestad G, 2002, SFPE HDB FIRE PROTEC, P216; Incropera F.P., 2006, FUNDAMENTALS HEAT MA; Kleinhenz J, 2008, COMBUST FLAME, V154, P637, DOI 10.1016/j.combustflame.2008.05.023; Kumar C, 2010, COMBUST SCI TECHNOL, V182, P1321, DOI 10.1080/00102201003694842; Mell WE, 2000, P COMBUST INST, V28, P2843; Mell WE, 2000, P COMBUST INST, V28, P2785; Quintiere J., 2006, FUNDAMENTALS FIRE PH; Quintiere JQ, 1998, FIRE TECHNOL, V34, P18, DOI 10.1023/A:1015356830962; Spalding DB, 1953, P COMBUST INST, V4, P847; Sun J, 2013, THEOR APPL MECH LETT, V3, P1; Tewarson A, 1980, P COMBUST INST, V18, P563; Tsai KC, 2011, FIRE SAFETY J, V46, P294, DOI 10.1016/j.firesaf.2011.03.006; Tsai KC, 2013, J THERM ANAL CALORIM, V112, P1601, DOI 10.1007/s10973-012-2735-2; Williams F. A., 1985, COMBUSTION THEORY	33	2	2	SPRINGER	DORDRECHT	VAN GODEWIJCKSTRAAT 30, 3311 GZ DORDRECHT, NETHERLANDS	1388-6150	1572-8943		J THERM ANAL CALORIM	J. Therm. Anal. Calorim.	FEB	2015	119	2					1091	1103		10.1007/s10973-014-4186-4		13	Thermodynamics; Chemistry, Analytical; Chemistry, Physical	Thermodynamics; Chemistry	AZ4LL	WOS:000348192400039		
J	Saito, A; Namura, Y; Isokawa, K; Shimizu, N				Saito, Ayano; Namura, Yasuhiro; Isokawa, Keitaro; Shimizu, Noriyoshi			CO2 laser debonding of a ceramic bracket bonded with orthodontic adhesive containing thermal expansion microcapsules	LASERS IN MEDICAL SCIENCE			English	Article						Debonding; CO2 laser; Orthodontic adhesive containing thermal expansion microcapsules; Bond strength	CARBON-DIOXIDE LASER; IN-VITRO; STRENGTH; ENAMEL; HEAT	We have been studying an easy bracket debonding method using heating of an orthodontic adhesive containing thermal expansion microcapsules. However, heating with a high-temperature heater brings obvious risks of burns around the oral cavity. Thus, we examined safer and more effective bracket debonding methods. The purpose of this in vitro study was to examine the reduction in debonding strength and the time taken using a bracket bonded with an orthodontic adhesive containing thermal expansion microcapsules and a CO2 laser as the heating method while maintaining safety. Ceramic brackets were bonded to bovine permanent mandibular incisors using bonding materials containing various microcapsule contents (0, 30, and 40 wt%), and the bond strengths were measured after laser irradiation for 4, 5, and 6 s and compared with nonlaser-treated groups. Subsequently, the temperature in the pulp chamber during laser irradiation was measured. After laser irradiation for 5 or 6 s, the bond strengths of the adhesive containing 40 wt% microcapsules were significantly decreased to similar to 0.40 -aEuro parts per thousand 0.48-fold (4.6-5.5 MPa) compared with the nonlaser groups. The mean temperature rise of the pulp chamber was 4.3 A degrees C with laser irradiation for 6 s, which was less than that required to induce pulp damage. Based on these results, we conclude that the combined use of a CO2 laser and an orthodontic adhesive containing thermal expansion microcapsules can be effective and safe for debonding ceramic brackets with less enamel damage or tooth pain.	[Saito, Ayano] Nihon Univ, Grad Sch Dent, Chiyoda Ku, Tokyo 1018310, Japan; [Namura, Yasuhiro; Shimizu, Noriyoshi] Nihon Univ, Sch Dent, Dept Orthodont, Chiyoda Ku, Tokyo 1018310, Japan; [Namura, Yasuhiro; Shimizu, Noriyoshi] Nihon Univ, Sch Dent, Div Clin Res, Dent Res Ctr,Chiyoda Ku, Tokyo 1018310, Japan; [Isokawa, Keitaro] Nihon Univ, Sch Dent, Dept Anat, Chiyoda Ku, Tokyo 1018310, Japan; [Isokawa, Keitaro] Nihon Univ, Sch Dent, Div Funct Morphol, Dent Res Ctr,Chiyoda Ku, Tokyo 1018310, Japan	Shimizu, N (reprint author), Nihon Univ, Sch Dent, Dept Orthodont, Chiyoda Ku, 1-8-13 Kandasurugadai, Tokyo 1018310, Japan.	shimizu.noriyoshi@nihon-u.ac.jp			Dental Research Center, Nihon University School of Dentistry	The authors would like to thank Hideo Nagai for his technical assistance during the present study. This work was supported in part by a grant from the Dental Research Center, Nihon University School of Dentistry, in 2013.	Tsuruoka T, 2007, DENT MATER J, V26, P78; BOYER DB, 1995, AM J ORTHOD DENTOFAC, V108, P262, DOI 10.1016/S0889-5406(95)70019-6; Iijima M, 2010, ANGLE ORTHOD, V80, P1029, DOI [10.2319/041210-204.1, 10.2319/041210.204.1]; ZACH L, 1965, ORAL SURG ORAL MED O, V19, P515, DOI 10.1016/0030-4220(65)90015-0; Algera TJ, 2005, EUR J ORTHODONT, V27, P472, DOI 10.1093/ejo/cji041; BISHARA SE, 1994, ANGLE ORTHOD, V64, P277; Brouns E M, 1993, Eur J Orthod, V15, P115; Convissar RA, 2011, PRINCIPLES PRACTICE; COREIL MN, 1990, AM J ORTHOD DENTOFAC, V97, P126, DOI 10.1016/0889-5406(90)70085-Q; Crooks M, 1997, AM J ORTHOD DENTOFAC, V111, P163, DOI 10.1016/S0889-5406(97)70212-9; Jost-Brinkmann PG, 1997, EUR J ORTHODONT, V19, P623, DOI 10.1093/ejo/19.6.623; Ma T, 1997, AM J ORTHOD DENTOFAC, V111, P203, DOI 10.1016/S0889-5406(97)70217-8; RETIEF DH, 1974, J ORAL REHABIL, V1, P265, DOI 10.1111/j.1365-2842.1974.tb01438.x; Reynolds I.R., 1975, BRIT J ORTHODONT, V2, P171; Rickabaugh JL, 1996, AM J ORTHOD DENTOFAC, V110, P388, DOI 10.1016/S0889-5406(96)70040-9; Rix D, 2001, AM J ORTHOD DENTOFAC, V119, P36, DOI 10.1067/mod.2001.110519; Ryu C, 2011, DENT MATER J, V30, P642, DOI 10.4012/dmj.2011-013; Samruajbenjakul B, 2009, ANGLE ORTHOD, V79, P571, DOI 10.2319/060308-290.1; SERNETZ F, 1991, Journal of Clinical Dentistry, V2, P87; Sfondrini MF, 2011, EUR J ORTHODONT, V33, P71, DOI 10.1093/ejo/cjq041; STROBL K, 1992, AM J ORTHOD DENTOFAC, V101, P152, DOI 10.1016/0889-5406(92)70007-W; Su JP, 2004, AM J ORTHOD DENTOFAC, V125, P51, DOI 10.1016/j.ajodo.2002.12.001; Tehranchi A, 2011, LASER MED SCI, V26, P563, DOI 10.1007/s10103-010-0820-y; TOCCHIO RM, 1993, AM J ORTHOD DENTOFAC, V103, P155, DOI 10.1016/S0889-5406(05)81765-2; Tozlu M, 2012, LASER MED SCI, V27, P1151, DOI 10.1007/s10103-011-1018-7	25	0	0	SPRINGER LONDON LTD	LONDON	236 GRAYS INN RD, 6TH FLOOR, LONDON WC1X 8HL, ENGLAND	0268-8921	1435-604X		LASER MED SCI	Lasers Med. Sci.	FEB	2015	30	2					869	874		10.1007/s10103-013-1482-3		6	Engineering, Biomedical; Surgery	Engineering; Surgery	CB3ST	WOS:000349549500053		
J	Sawabe, M; Aoki, A; Komaki, M; Iwasaki, K; Ogita, M; Izumi, Y				Sawabe, Masanori; Aoki, Akira; Komaki, Motohiro; Iwasaki, Kengo; Ogita, Mayumi; Izumi, Yuichi			Gingival tissue healing following Er:YAG laser ablation compared to electrosurgery in rats	LASERS IN MEDICAL SCIENCE			English	Article						Er:YAG laser; Electrosurgery; Wound healing; Histology; Heat shock protein; Proliferating cell nuclear antigen	ER-YAG LASER; CELL NUCLEAR ANTIGEN; HEAT-SHOCK RESPONSE; PROTEIN; PERIODONTICS; CYCLIN; FIBROBLASTS; EXPRESSION; DURATION; HSP47	The erbium-doped yttrium aluminum garnet (Er:YAG) laser is currently used for periodontal soft tissue management with favorable outcomes. However, the process of wound healing after Er:YAG laser (ErL) treatment has not been fully elucidated yet. The aim of this study was to investigate the gingival tissue healing after ErL ablation in comparison with that after electrosurgery (ElS). Gingival defects were created in 28 rats by ablation with ErL irradiation or ElS. The chronological changes in wound healing were evaluated using histological, histometrical, and immunohistochemical analyses. The ErL-ablated gingival tissue revealed much less thermal damage, compared to the ElS. In the ElS sites, the postoperative tissue destruction continued due to thermal damage, while in the ErL sites, tissue degradation was limited and the defects were re-epithelialized early. Heat shock protein (Hsp) 72/73 expression was detected abundantly remote from the wound in the ElS, whereas it was slightly observed in close proximity to the wound in the ErL sites. Hsp47 expression was observed in the entire connective tissue early in the wound healing and was found limited in the wound area later. This phenomenon proceeded faster in the ErL sites than in the ElS sites. Expression of proliferating cell nuclear antigen (PCNA) persisted in the epithelial tissue for a longer period in the ElS than that in the ErL. The ErL results in faster and more favorable gingival wound healing compared to the ElS, suggesting that the ErL is a safe and suitable tool for periodontal soft tissue management.	[Sawabe, Masanori; Aoki, Akira; Ogita, Mayumi; Izumi, Yuichi] Tokyo Med & Dent Univ, Grad Sch Med & Dent Sci, Dept Periodontol, Bunkyo Ku, Tokyo 1138549, Japan; [Komaki, Motohiro; Iwasaki, Kengo] Tokyo Med & Dent Univ, Grad Sch Med & Dent Sci, Dept Nanomed DNP, Bunkyo Ku, Tokyo 1138549, Japan	Aoki, A (reprint author), Tokyo Med & Dent Univ, Grad Sch Med & Dent Sci, Dept Periodontol, Bunkyo Ku, 1-5-45 Yushima, Tokyo 1138549, Japan.	aoperi@tmd.ac.jp; komaki.peri@tmd.ac.jp			Global Center of Excellence (GCOE) Program for International Research Center for Molecular Science in Tooth and Bone Diseases at Tokyo Medical and Dental University from the Ministry of Education, Culture, Sports, Science and Technology of Japan; Japan Society for the Promotion of Science [22592308]	This study was supported in part by a grant from the Global Center of Excellence (GCOE) Program for International Research Center for Molecular Science in Tooth and Bone Diseases at Tokyo Medical and Dental University from the Ministry of Education, Culture, Sports, Science and Technology of Japan, and by a Grant-in-Aid for Scientific Research (C) (22592308) to A. A. from the Japan Society for the Promotion of Science.	HALE GM, 1973, APPL OPTICS, V12, P555, DOI 10.1364/AO.12.000555; Rosa DSA, 2007, J PERIODONTOL, V78, P2018, DOI 10.1902/jop.2007.070041; WALSH JT, 1989, LASER SURG MED, V9, P314, DOI 10.1002/lsm.1900090403; Ishikawa I, 2009, PERIODONTOL 2000, V50, P90, DOI 10.1111/j.1600-0757.2008.00283.x; Ishikawa I, 2004, J PERIODONTAL RES, V39, P275, DOI 10.1111/j.1600-0765.2004.00738.x; KURKI P, 1986, EXP CELL RES, V166, P209, DOI 10.1016/0014-4827(86)90520-3; WELCH WJ, 1992, PHYSIOL REV, V72, P1063; Nagai N, 2000, J CELL BIOL, V150, P1499, DOI 10.1083/jcb.150.6.1499; Gaspirc B, 2007, J PERIODONTOL, V78, P1864, DOI 10.1902/jop.2007.070054; Silver JT, 2012, CELL STRESS CHAPERON, V17, P1, DOI 10.1007/s12192-011-0290-6; Aoki A, 2004, PERIODONTOL 2000, V36, P59, DOI 10.1111/j.1600-0757.2004.03679.x; Ruell PA, 2004, MOL CELL BIOCHEM, V267, P187, DOI 10.1023/B:MCBI.0000049382.63841.e4; LINDQUIST S, 1986, ANNU REV BIOCHEM, V55, P1151, DOI 10.1146/annurev.bi.55.070186.005443; Schwarz F, 2001, J PERIODONTOL, V72, P361, DOI 10.1902/jop.2001.72.3.361; CELIS JE, 1985, P NATL ACAD SCI USA, V82, P3262, DOI 10.1073/pnas.82.10.3262; Izumi Y, 2011, PERIODONTOL 2000, V56, P166, DOI 10.1111/j.1600-0757.2010.00366.x; Cobb CM, 2006, J PERIODONTOL, V77, P545, DOI 10.1902/jop.2006.050417; Kregel KC, 2002, J APPL PHYSIOL, V92, P2177, DOI 10.1152/japplphysiol.01267.2001; Satoh M, 1996, J CELL BIOL, V133, P469, DOI 10.1083/jcb.133.2.469; Aoki A, 2003, INT CONGR SER, V1248, P367, DOI 10.1016/S0531-5131(02)01319-5; Aoki A, 2004, P 9 INT C LAS DENT, P21; Bashetty Kusum, 2009, J Conserv Dent, V12, P139, DOI 10.4103/0972-0707.58332; CRAIG EA, 1985, CRC CR REV BIOCH MOL, V18, P239, DOI 10.3109/10409238509085135; GLICKMAN I, 1970, J PERIODONTOL, V41, P142; KURKI P, 1988, J IMMUNOL METHODS, V109, P49, DOI 10.1016/0022-1759(88)90441-3; LEACH J, 1993, LARYNGOSCOPE, V103, P619; LI GC, 1991, P NATL ACAD SCI USA, V88, P1681, DOI 10.1073/pnas.88.5.1681; McGuire MK, 2011, INT J PERIODONT REST, V31, P357; MITTAL KR, 1993, AM J SURG PATHOL, V17, P117, DOI 10.1097/00000478-199302000-00003; NAGATA K, 1986, J BIOL CHEM, V261, P7531; Pang P, 2011, J LASER DENT, V18, P123; Ravishankar PL, 2011, INDIAN J DENT ADV, V3, P492; SIMON BI, 1976, J PERIODONTOL, V47, P342; Takei HH, 2006, J CONSERV DENT, P915; WARNAKULASURIYA KAAS, 1993, CELL PROLIFERAT, V26, P545, DOI 10.1111/j.1365-2184.1993.tb00032.x; Watanabe H, 1996, J Clin Laser Med Surg, V14, P67; WILHELMSEN NR, 1976, J PERIODONTOL, V47, P160; Yamasaki A, 2008, LASER SURG MED, V40, P695, DOI 10.1002/lsm.20712; Zeredo JL, 2005, ORAL SURG ORAL MED O, V100, P31, DOI 10.1016/j.tripleo.2004.11.012	39	2	2	SPRINGER LONDON LTD	LONDON	236 GRAYS INN RD, 6TH FLOOR, LONDON WC1X 8HL, ENGLAND	0268-8921	1435-604X		LASER MED SCI	Lasers Med. Sci.	FEB	2015	30	2					875	883		10.1007/s10103-013-1478-z		9	Engineering, Biomedical; Surgery	Engineering; Surgery	CB3ST	WOS:000349549500054		
J	Muto, T; Sashida, G; Hasegawa, N; Nakaseko, C; Yokote, K; Shimoda, K; Iwama, A				Muto, Tomoya; Sashida, Goro; Hasegawa, Nagisa; Nakaseko, Chiaki; Yokote, Koutaro; Shimoda, Kazuya; Iwama, Atsushi			Myelodysplastic syndrome with extramedullary erythroid hyperplasia induced by loss of Tet2 in mice	LEUKEMIA & LYMPHOMA			English	Letter							MYELOID MALIGNANCIES; MUTATIONS; LEADS		[Muto, Tomoya; Sashida, Goro; Hasegawa, Nagisa; Iwama, Atsushi] Chiba Univ, Grad Sch Med, Dept Cellular & Mol Med, Chiba 2608670, Japan; [Muto, Tomoya; Hasegawa, Nagisa; Nakaseko, Chiaki; Yokote, Koutaro] Chiba Univ, Grad Sch Med, Dept Clin Cell Biol & Med, Chiba 2608670, Japan; [Muto, Tomoya; Hasegawa, Nagisa; Nakaseko, Chiaki] Chiba Univ Hosp, Dept Hematol, Chiba, Japan; [Sashida, Goro; Iwama, Atsushi] JST, CREST, Tokyo, Japan; [Shimoda, Kazuya] Miyazaki Univ, Fac Med, Dept Gastroenterol & Hematol, Miyazaki, Japan	Iwama, A (reprint author), Chiba Univ, Grad Sch Med, Dept Cellular & Mol Med, Chuo Ku, 1-8-1 Inohana, Chiba 2608670, Japan.	aiwama@faculty.chiba-u.jp	Sashida, Goro/N-5259-2014				Moran-Crusio K, 2011, CANCER CELL, V20, P11, DOI 10.1016/j.ccr.2011.06.001; Tefferi A, 2009, LEUKEMIA, V23, P905, DOI 10.1038/leu.2009.47; Busque L, 2012, NAT GENET, V44, P1179, DOI 10.1038/ng.2413; Chung YR, 2012, INT J HEMATOL, V96, P413, DOI 10.1007/s12185-012-1181-z; Muto T, 2013, J EXP MED, V210, P2627, DOI 10.1084/jem.20131144; Shide K, 2012, LEUKEMIA, V26, P2216, DOI 10.1038/leu.2012.94; Quivoron C, 2011, CANCER CELL, V20, P25, DOI 10.1016/j.ccr.2011.06.003; Ko M, 2010, NATURE, V468, P839, DOI 10.1038/nature09586; Shih AH, 2012, NAT REV CANCER, V12, P599, DOI 10.1038/nrc3343; Li Z, 2011, BLOOD, V118, P4509, DOI 10.1182/blood-2010-12-325241; Raza A, 2012, NAT REV CANCER, V12, P849, DOI 10.1038/nrc3321; Sashida G, 2012, INT J HEMATOL, V96, P405, DOI 10.1007/s12185-012-1183-x	12	1	1	INFORMA HEALTHCARE	LONDON	TELEPHONE HOUSE, 69-77 PAUL STREET, LONDON EC2A 4LQ, ENGLAND	1042-8194	1029-2403		LEUKEMIA LYMPHOMA	Leuk. Lymphoma	FEB	2015	56	2					520	523		10.3109/10428194.2014.924120		4	Oncology; Hematology	Oncology; Hematology	CB5IZ	WOS:000349662000042		
J	Matsuzaki, T; Oda, M; Kitasaka, T; Hayashi, Y; Misawa, K; Mori, K				Matsuzaki, Tetsuro; Oda, Masahiro; Kitasaka, Takayuki; Hayashi, Yuichiro; Misawa, Kazunari; Mori, Kensaku			Automated anatomical labeling of abdominal arteries and hepatic portal system extracted from abdominal CT volumes	MEDICAL IMAGE ANALYSIS			English	Article						Blood vessel; CT volume; Recognition of anatomical names; Analysis of blood vessel structures	VIRTUAL BRONCHOSCOPY; NOMENCLATURE; NAVIGATION; SURGERY; IMAGES	This paper proposes a method for automated anatomical labeling of abdominal arteries and a hepatic portal system. In abdominal surgeries, understanding blood vessel structure is critical since it is very complicated. The input of the proposed method is the blood vessel region extracted from the CT volume. The blood vessel region is expressed as a tree structure by applying a thinning process to it and compute the mapping from the branches in the tree structure to the anatomical names. First, several characteristic anatomical names are assigned by rule-based pre-processing. The branches assigned to these names are used as references. The remaining blood vessel names are assigned using a likelihood function trained by a machine-learning technique. Simple rule-based postprocessing can correct several blood vessel names. The output of the proposed method is a tree structure with anatomical names. In an experiment using 50 blood vessel regions manually extracted from abdominal CT volumes, the recall and precision rates of the abdominal arteries were 86.2% and 85.3%, and they were 86.5% and 79.5% for the hepatic portal system. (C) 2014 Elsevier B.V. All rights reserved.	[Matsuzaki, Tetsuro; Oda, Masahiro; Mori, Kensaku] Nagoya Univ, Grad Sch Informat Sci, Nagoya, Aichi 4648601, Japan; [Kitasaka, Takayuki] Aichi Inst Technol, Fac Informat Sci, Toyota, Japan; [Hayashi, Yuichiro; Mori, Kensaku] Nagoya Univ, Nagoya, Aichi 4648601, Japan; [Misawa, Kazunari] Aichi Canc Ctr Hosp, Nagoya, Aichi, Japan	Mori, K (reprint author), Nagoya Univ, Strategy Off, Nagoya, Aichi 4648601, Japan.				Kakenhi by MEXT; JSPS [21103006, 25242047, 26560255, 26108006]; JSPS Bilateral International Collaboration Grants	We thank our colleagues for suggestions and advice. Part of this work was supported by the Kakenhi by MEXT and JSPS (21103006, 25242047, 26560255, and 26108006) and JSPS Bilateral International Collaboration Grants.	Liu A, 2003, PRESENCE-TELEOP VIRT, V12, P599, DOI 10.1162/105474603322955905; Bogunovic H, 2013, IEEE T MED IMAGING, V32, P1587, DOI 10.1109/TMI.2013.2259595; Baumhauer M, 2008, J ENDOUROL, V22, P751, DOI 10.1089/end.2007.9827; SAITO T, 1994, PATTERN RECOGN, V27, P1551, DOI 10.1016/0031-3203(94)90133-3; Tschirren J, 2005, IEEE T MED IMAGING, V24, P1540, DOI 10.1109/TMI.2005.857653; Mezger U, 2013, LANGENBECK ARCH SURG, V398, P501, DOI 10.1007/s00423-013-1059-4; Bilgel M., 2013, P SOC PHOTO-OPT INS, V8669; Drechsler K., 2011, ABDOM IMAGING, P149; Farag A., 2014, P SOC PHOTO-OPT INS; Hoang B. H., 2011, P SOC PHOTO-OPT INS, V7962; Li L., 2006, P 23 INT C MACH LEAR, P569, DOI 10.1145/1143844.1143916; Lu L, 2009, IEEE I CONF COMP VIS, P2021; Mori K, 2009, LECT NOTES COMPUT SC, V5762, P707; Mori K, 2005, LECT NOTES COMPUT SC, V3750, P854; Mori K, 2000, IEEE T MED IMAGING, V19, P103, DOI 10.1109/42.836370; Mori K, 2010, LECT NOTES COMPUT SC, V6326, P353; Nimura Y., 2010, P SOC PHOTO-OPT INS, V7623; Pamulapati V, 2011, I S BIOMED IMAGING, P1982, DOI 10.1109/ISBI.2011.5872799; Robben D, 2013, LECT NOTES COMPUT SC, V8149, P566, DOI 10.1007/978-3-642-40811-3_71; Saito T., 1995, P 9 SCAND C IM AN SC, P507; Shinoda T., 2008, PRMU, V107, P145; Stefanidis D., 2013, COMPREHENSIVE TXB HE, P353; Suzuki Y., 2012, IJCARS, V7, pS47; Tao YM, 2011, IEEE T MED IMAGING, V30, P338, DOI 10.1109/TMI.2010.2077740; Uchiyama Y., 2006, 28 ANN INT C IEEE EN, P4865	25	2	2	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	1361-8415	1361-8423		MED IMAGE ANAL	Med. Image Anal.	FEB	2015	20	1					152	161		10.1016/j.media.2014.11.002		10	Computer Science, Artificial Intelligence; Computer Science, Interdisciplinary Applications; Engineering, Biomedical; Radiology, Nuclear Medicine & Medical Imaging	Computer Science; Engineering; Radiology, Nuclear Medicine & Medical Imaging	CB4IS	WOS:000349592000011		
J	Veta, M; van Diest, PJ; Willems, SM; Wang, H; Madabhushi, A; Cruz-Roa, A; Gonzalez, F; Larsen, ABL; Vestergaard, JS; Dahl, AB; Ciresan, DC; Schmidhuber, J; Giusti, A; Gambardella, LM; Tek, FB; Walter, T; Wang, CW; Kondo, S; Matuszewski, BJ; Precioso, F; Snell, V; Kittler, J; de Campos, TE; Khan, AM; Rajpoot, NM; Arkoumani, E; Lacle, MM; Viergever, MA; Pluim, JPW				Veta, Mitko; van Diest, Paul J.; Willems, Stefan M.; Wang, Haibo; Madabhushi, Anant; Cruz-Roa, Angel; Gonzalez, Fabio; Larsen, Anders B. L.; Vestergaard, Jacob S.; Dahl, Anders B.; Ciresan, Dan C.; Schmidhuber, Juergen; Giusti, Alessandro; Gambardella, Luca M.; Tek, F. Boray; Walter, Thomas; Wang, Ching-Wei; Kondo, Satoshi; Matuszewski, Bogdan J.; Precioso, Frederic; Snell, Violet; Kittler, Josef; de Campos, Teofilo E.; Khan, Adnan M.; Rajpoot, Nasir M.; Arkoumani, Evdokia; Lacle, Miangela M.; Viergever, Max A.; Pluim, Josien P. W.			Assessment of algorithms for mitosis detection in breast cancer histopathology images	MEDICAL IMAGE ANALYSIS			English	Article						Breast cancer; Whole slide imaging; Digital pathology; Mitosis detection; Cancer grading	COUNTING MITOSES; SECTIONS; FEASIBILITY	The proliferative activity of breast tumors, which is routinely estimated by counting of mitotic figures in hematoxylin and eosin stained histology sections, is considered to be one of the most important prognostic markers. However, mitosis counting is laborious, subjective and may suffer from low inter-observer agreement. With the wider acceptance of whole slide images in pathology labs, automatic image analysis has been proposed as a potential solution for these issues. In this paper, the results from the Assessment of Mitosis Detection Algorithms 2013 (AMIDA13) challenge are described. The challenge was based on a data set consisting of 12 training and 11 testing subjects, with more than one thousand annotated mitotic figures by multiple observers. Short descriptions and results from the evaluation of eleven methods are presented. The top performing method has an error rate that is comparable to the inter-observer agreement among pathologists. (C) 2014 Elsevier B.V. All rights reserved.	[Veta, Mitko; Viergever, Max A.; Pluim, Josien P. W.] Univ Med Ctr Utrecht, Image Sci Inst, NL-3584 CX Utrecht, Netherlands; [van Diest, Paul J.; Willems, Stefan M.; Lacle, Miangela M.] Univ Med Ctr Utrecht, Dept Pathol, NL-3584 CX Utrecht, Netherlands; [Wang, Haibo; Madabhushi, Anant] Case Western Reserve Univ, BME Dept, Cleveland, OH 44106 USA; [Cruz-Roa, Angel; Gonzalez, Fabio] Univ Nacl Colombia, MindLab, Bogota, Colombia; [Larsen, Anders B. L.; Vestergaard, Jacob S.; Dahl, Anders B.] Tech Univ Denmark, Dept Appl Math & Comp Sci, DK-2800 Lyngby, Denmark; [Ciresan, Dan C.; Schmidhuber, Juergen; Giusti, Alessandro; Gambardella, Luca M.] USI SUPSI, IDSIA, Lugano, Switzerland; [Tek, F. Boray] Isik Univ, Dept Comp Engn, Istanbul, Turkey; [Walter, Thomas] PSL Res Univ, CBIO Ctr Computat Biol, MINES ParisTech, Paris, France; [Walter, Thomas] Inst Curie, Paris, France; [Walter, Thomas] INSERM, U900, Paris, France; [Wang, Ching-Wei] Natl Taiwan Univ Sci & Technol, Grad Inst Biomed Engn, Taipei, Taiwan; [Kondo, Satoshi] Panason Healthcare Co Ltd, Corporate R&D Ctr, Osaka, Japan; [Matuszewski, Bogdan J.] Univ Cent Lancashire, Sch Comp Engn & Phys Sci, Preston PR1 2HE, Lancs, England; [Precioso, Frederic] Univ Nice Sophia Antipolis, UNS CNRS, I3S, UMR 7271, Sophia Antipolis, France; [Snell, Violet; Kittler, Josef; de Campos, Teofilo E.] Univ Surrey, CVSSP, Guildford GU2 5XH, Surrey, England; [de Campos, Teofilo E.] Univ Sheffield, Dept Comp Sci, Sheffield S10 2TN, S Yorkshire, England; [de Campos, Teofilo E.] Univ Sheffield, Sheffield Inst Translat Med, Sheffield S10 2TN, S Yorkshire, England; [Khan, Adnan M.; Rajpoot, Nasir M.] Univ Warwick, Dept Comp Sci, Coventry CV4 7AL, W Midlands, England; [Rajpoot, Nasir M.] Qatar Univ, Coll Engn, Dept Comp Sci & Engn, Doha, Qatar; [Arkoumani, Evdokia] Princess Alexandra Hosp NHS Trust, Michael Letcher Dept Cellular Pathol, Harlow, Essex, England	Veta, M (reprint author), Univ Med Ctr Utrecht, Image Sci Inst, Heidelberglaan 100, NL-3584 CX Utrecht, Netherlands.	mitko@isi.uu.nl	Gonzalez, Fabio/B-9502-2008	Gonzalez, Fabio/0000-0001-9009-7288	European Community [258068]; BBSRC [BB/I004769/2]; (EPSRC), UK [EP/F02827X/1]	Thomas Walter has received funding from the European Community's Seventh Framework Programme (FP7/2007-2013) under Grant Agreements Number 258068 (Systems Microscopy).; Teofilo E. de Campos would like to thank Neil Lawrence and Andreas Damianou for their helpful suggestions. During this work, he received funds from Grants BB/I004769/2 (BBSRC) and EP/F02827X/1 (EPSRC), UK.	Al-Janabi S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0082576; Al-Janabi S, 2012, HUM PATHOL, V43, P2318, DOI 10.1016/j.humpath.2012.03.027; Huisman A, 2010, HUM PATHOL, V41, P751, DOI 10.1016/j.humpath.2009.08.026; van Diest PJ, 2004, J CLIN PATHOL, V57, P675, DOI 10.1136/jcp.2003.010777; VANDIEST PJ, 1992, HUM PATHOL, V23, P603, DOI 10.1016/0046-8177(92)90313-R; Walter T, 2010, J STRUCT BIOL, V170, P1, DOI 10.1016/j.jsb.2009.10.004; Ruifrok AC, 2001, ANAL QUANT CYTOL, V23, P291; Walter T, 2007, MED IMAGE ANAL, V11, P555, DOI 10.1016/j.media.2007.05.001; Padfield D, 2011, MED IMAGE ANAL, V15, P650, DOI 10.1016/j.media.2010.07.006; Veta M, 2014, IEEE T BIO-MED ENG, V61, P1400, DOI 10.1109/TBME.2014.2303852; Seiffert C, 2010, IEEE T SYST MAN CY A, V40, P185, DOI 10.1109/TSMCA.2009.2029559; Larsen ABL, 2014, IEEE T MED IMAGING, V33, P1573, DOI 10.1109/TMI.2014.2318434; Harder N, 2009, GENOME RES, V19, P2113, DOI 10.1101/gr.092494.109; Ciresan D, 2012, PROC CVPR IEEE, P3642, DOI 10.1109/CVPR.2012.6248110; Belien JAM, 1997, CYTOMETRY, V28, P135, DOI 10.1002/(SICI)1097-0320(19970601)28:2<135::AID-CYTO6>3.0.CO;2-E; Ciresan D., 2012, NIPS, P2852; Ciresan DC, 2013, LECT NOTES COMPUT SC, V8150, P411, DOI 10.1007/978-3-642-40763-5_51; Damianou A., 2012, ICML, P145; ELSTON CW, 1991, HISTOPATHOLOGY, V19, P403, DOI 10.1111/j.1365-2559.1991.tb00229.x; Giusti A., 2013, INT C IM PROC ICIP, P4034; Gurcan Metin N, 2009, IEEE Rev Biomed Eng, V2, P147, DOI 10.1109/RBME.2009.2034865; Irshad Humayun, 2013, J Pathol Inform, V4, P10, DOI 10.4103/2153-3539.112695; KAMAN EJ, 1984, CYTOMETRY, V5, P244, DOI 10.1002/cyto.990050305; Khan Adnan Mujahid, 2013, J Pathol Inform, V4, P11, DOI 10.4103/2153-3539.112696; Khan A.M., IEEE T BIOM IN PRESS; Malon C, 2012, ANAL CELL PATHOL, V35, P97, DOI 10.3233/ACP-2011-0029; Quinlan JR, 1996, PROCEEDINGS OF THE THIRTEENTH NATIONAL CONFERENCE ON ARTIFICIAL INTELLIGENCE AND THE EIGHTH INNOVATIVE APPLICATIONS OF ARTIFICIAL INTELLIGENCE CONFERENCE, VOLS 1 AND 2, P725; Roux Ludovic, 2013, J Pathol Inform, V4, P8, DOI 10.4103/2153-3539.112693; Stathonikos N., 2013, J PATHOL INFORM, V4; Tek F Boray, 2013, J Pathol Inform, V4, P12, DOI 10.4103/2153-3539.112697; TENKATE TK, 1993, CYTOMETRY, V14, P241, DOI 10.1002/cyto.990140302; Titsias M.K., 2010, J MACHINE LEARNING R, V9, P844; Veta M, 2013, PROC SPIE, V8676, DOI 10.1117/12.2006626; Wang CW, 2010, APPL INTELL, V33, P357, DOI 10.1007/s10489-009-0172-0; Wang CW, 2010, INT J COMPUT VISION, V90, P313, DOI 10.1007/s11263-010-0365-3; Wang HB, 2014, PROC SPIE, V9041, DOI 10.1117/12.2043902	36	1	1	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	1361-8415	1361-8423		MED IMAGE ANAL	Med. Image Anal.	FEB	2015	20	1					237	248		10.1016/j.media.2014.11.010		12	Computer Science, Artificial Intelligence; Computer Science, Interdisciplinary Applications; Engineering, Biomedical; Radiology, Nuclear Medicine & Medical Imaging	Computer Science; Engineering; Radiology, Nuclear Medicine & Medical Imaging	CB4IS	WOS:000349592000018		
J	Kano, R; Kohata, E; Tateishi, A; Murayama, SY; Hirose, D; Shibata, Y; Kosuge, Y; Inoue, H; Kamata, H; Hasegawa, A				Kano, Rui; Kohata, Erina; Tateishi, Akira; Murayama, Somay Yamagata; Hirose, Dai; Shibata, Yasuko; Kosuge, Yasuhiro; Inoue, Hiroaki; Kamata, Hiroshi; Hasegawa, Atsuhiko			Does farm fungicide use induce azole resistance in Aspergillus fumigatus?	MEDICAL MYCOLOGY			English	Article						Aspergillus fumigatus; farm fungicide; resistance; tetraconazole	TETRACONAZOLE; KINETICS	Azole resistance of Aspergillus fumigatus isolates has been reported worldwide and it would appear to be mainly due to a point mutation in the 14 alpha-sterol demethylase (CYP51A) gene, which is the target enzyme for azoles. The mutation has been confirmed in isolates from patients who received long-term itraconazole (ITZ) therapy and from agricultural fields where high levels of azole fungicides were employed. However, the relationship between farm environments and azole-resistant A. fumigatus has not been fully studied. In this investigation, 50 isolates of A. fumigatus were obtained from a farm where tetraconazole has been sprayed twice a year for more than 15 years. The mean minimum inhibitory concentration (MIC) of isolates was 0.74 (0.19-1.5) mg/L against ITZ, which was below the medical resistance level of ITZ. The sequence of CYP51A from isolates indicated no gene mutations in isolates from the farm. Antifungal susceptibility of isolates to tetraconazole showed that spraying with tetraconazole did not induce resistance to tetraconazole or ITZ in A. fumigatus.	[Kano, Rui; Kohata, Erina; Tateishi, Akira; Inoue, Hiroaki; Kamata, Hiroshi] Nihon Univ, Coll Bioresource Sci, Fuzisawa, Kanagawa 2528510, Japan; [Murayama, Somay Yamagata; Hirose, Dai; Kosuge, Yasuhiro] Nihon Univ, Sch Pharm, Funabashi, Chiba 52748555, Japan; [Shibata, Yasuko] Nihon Univ, Sch Dent Matsudo, Matsudo, Chiba 2718587, Japan; [Hasegawa, Atsuhiko] Teikyo Univ, Inst Med Mycol, Hachioji, Tokyo 1920395, Japan	Kano, R (reprint author), Nihon Univ, Coll Bioresource Sci, 1866 Kameino, Fuzisawa, Kanagawa 2528510, Japan.	kanou.rui@nihon-u.ac.jp			Ministry of Education, Culture, Sports, Science and Technology (MEXT) Japan; Nihon University Multidisciplinary Research Grant	This study was supported by grants of "International joint research and training of young researchers for zoonosis control in the globalized world" from Ministry of Education, Culture, Sports, Science and Technology (MEXT) Japan and Nihon University Multidisciplinary Research Grant for (2013-2014).	AB BIODISK, 2004, ET TECHN GUID; Alam S, 2013, ENVIRON MONIT ASSESS, V185, P9819, DOI 10.1007/s10661-013-3294-0; Balajee SA, 2009, J CLIN MICROBIOL, V47, P3138, DOI 10.1128/JCM.01070-09; Verweij PE, 2009, LANCET INFECT DIS, V9, P789, DOI 10.1016/S1473-3099(09)70265-8; Banerjee K, 2008, PEST MANAG SCI, V64, P283, DOI 10.1002/ps.1524; Tashiro M, 2012, ANTIMICROB AGENTS CH, V56, P584, DOI 10.1128/AAC.05394-11; Diaz-Guerra TM, 2003, ANTIMICROB AGENTS CH, V47, P1120, DOI 10.1128/AAC.47.3.1120-1124.2003; Vermeulen E, 2013, CURR OPIN INFECT DIS, V26, P493, DOI 10.1097/QCO.0000000000000005; Arnoldi A, 2007, J AGR FOOD CHEM, V55, P8187, DOI 10.1021/jf071631g; Bowyer P, 2014, PEST MANAG SCI, V70, P173, DOI 10.1002/ps.3567; Clinical and Laboratory Standards Institute (CLSI), 2008, M38A2 CLSI; Enserink M, 2009, SCIENCE, V326, P1173, DOI 10.1126/science.326.5957.1173; Kwon-Chung KJ, 1982, MED MYCOL, p[130, 816]; Lelièvre L, 2013, Med Mal Infect, V43, P139, DOI 10.1016/j.medmal.2013.02.010; Samson RA, 2007, STUD MYCOL, P147, DOI 10.3114/sim.2007.59.14; Snelders E, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031801	16	1	1	OXFORD UNIV PRESS	OXFORD	GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND	1369-3786	1460-2709		MED MYCOL	Med. Mycol.	FEB	2015	53	2					174	177		10.1093/mmy/myu076		4	Infectious Diseases; Mycology; Veterinary Sciences	Infectious Diseases; Mycology; Veterinary Sciences	CB6OF	WOS:000349745700011		
J	Friedman, MC; McGillivray, S; Murayama, K; Castel, AD				Friedman, Michael C.; McGillivray, Shannon; Murayama, Kou; Castel, Alan D.			Memory for medication side effects in younger and older adults: The role of subjective and objective importance	MEMORY & COGNITION			English	Article						Memory; Aging; Medications; Side effects; Older adults	AGE-DIFFERENCES; KNOWLEDGE INFLUENCES; RECOGNITION; INFORMATION; PERFORMANCE; PRESCRIPTION; HYPOTHESIS; EXPERTISE; ADHERENCE; FRAMEWORK	Older adults often experience memory impairments, but sometimes they can use selective processing and schematic support to remember important information. In the present experiments, we investigated the degrees to which younger and healthy older adults remembered medication side effects that were subjectively or objectively important to remember. Participants studied a list of common side effects and rated how negative these effects would be if they were to experience them, and they were then given a free recall test. In Experiment 1, the severity of the side effects ranged from mild (e.g., itching) to severe (e.g., stroke), and in Experiment 2, certain side effects were indicated as being critical to remember (i.e., "contact your doctor if you experience this"). We observed no age differences in terms of free recall of the side effects, and older adults remembered more severe side effects than mild effects. However, older adults were less likely to recognize the critical side effects on a later recognition test, relative to younger adults. These findings suggest that older adults can selectively remember medication side effects but have difficulty identifying familiar but potentially critical side effects, and this has implications for monitoring medication use in older age.	[Friedman, Michael C.; Castel, Alan D.] Univ Calif Los Angeles, Dept Psychol, Los Angeles, CA 90095 USA; [McGillivray, Shannon] Weber State Univ, Dept Psychol, Ogden, UT 84408 USA; [Murayama, Kou] Univ Reading, Dept Psychol, Reading RG6 6AL, Berks, England; [Murayama, Kou] Kochi Univ Technol, Kami, Kochi 7820003, Japan	Castel, AD (reprint author), Univ Calif Los Angeles, Dept Psychol, 1285 Franz Hall,Box 951563, Los Angeles, CA 90095 USA.	castel@ucla.edu					Castel AD, 2005, PSYCHOL AGING, V20, P718, DOI 10.1037/0882-7974.20.4.718; Naveh-Benjamin M, 2000, J EXP PSYCHOL LEARN, V26, P1170, DOI 10.1037//0278-7393.26.2.1170; Henry JD, 2004, PSYCHOL AGING, V19, P27, DOI 10.1037/0882-7974.19.1.27; White BP, 2006, J AM COLL HEALTH, V54, P261, DOI 10.3200/JACH.54.5.261-268; Castel AD, 2013, PSYCHOL AGING, V28, P232, DOI 10.1037/a0030678; Koutstaal W, 1997, J MEM LANG, V37, P555, DOI 10.1006/jmla.1997.2529; Liu LL, 2004, PSYCHOL AGING, V19, P318, DOI 10.1037/0882-7974.19.2.318; Murayama K, 2014, J EXP PSYCHOL LEARN, V40, P1287, DOI 10.1037/a0036914; McGillivray S, 2011, PSYCHOL AGING, V26, P137, DOI 10.1037/a0022681; Webb J, 2008, PATIENT EDUC COUNS, V72, P443, DOI 10.1016/j.pec.2008.05.019; Baayen RH, 2008, J MEM LANG, V59, P390, DOI 10.1016/j.jml.2007.12.005; Moore Alison A, 2007, Am J Geriatr Pharmacother, V5, P64, DOI 10.1016/j.amjopharm.2007.03.006; Miller LMS, 2003, J GERONTOL B-PSYCHOL, V58, pP217; EINSTEIN GO, 1990, J EXP PSYCHOL LEARN, V16, P717, DOI 10.1037/0278-7393.16.4.717; Chalfonte BL, 1996, MEM COGNITION, V24, P403, DOI 10.3758/BF03200930; Jacoby LL, 2005, J EXP PSYCHOL GEN, V134, P131, DOI 10.1037/0096-3445.134.2.131; Gutchess AH, 2007, SOC NEUROSCI, V2, P117, DOI 10.1080/17470910701399029; CRAIK FIM, 1987, J EXP PSYCHOL LEARN, V13, P474, DOI 10.1037//0278-7393.13.3.474; Kang SHK, 2008, MEM COGNITION, V36, P1151, DOI 10.3758/MC.36.6.1151; Qato DM, 2008, JAMA-J AM MED ASSOC, V300, P2867, DOI 10.1001/jama.2008.892; Scullin MK, 2012, PSYCHOL AGING, V27, P46, DOI 10.1037/a0026112; Castel AD, 2002, MEM COGNITION, V30, P1078, DOI 10.3758/BF03194325; Madan CR, 2012, ACTA PSYCHOL, V139, P343, DOI 10.1016/j.actpsy.2011.12.010; Mather M, 2003, PSYCHOL SCI, V14, P409, DOI 10.1111/1467-9280.01455; Zogg JB, 2012, J BEHAV MED, V35, P47, DOI 10.1007/s10865-011-9341-9; Hines LE, 2011, AM J GERIATR PHARMAC, V9, P364, DOI 10.1016/j.amjopharm.2011.10.004; Jones TC, 2005, ACTA PSYCHOL, V120, P55, DOI 10.1016/j.actpsy.2005.03.003; Rhodes MG, 2008, PSYCHOL AGING, V23, P239, DOI 10.1037/0882-7974.23.2.239; ARBUCKLE TY, 1994, PSYCHOL AGING, V9, P467, DOI 10.1037/0882-7974.9.3.467; Baltes PB, 1990, SUCCESSFUL AGING PER, V1, P1, DOI DOI 10.1017/CB09780511665684.003; Castel A. D., 2008, PSYCHOL LEARN MOTIV, V48, P225, DOI DOI 10.1016/S0079-7421(07)48006-9; Castel A. D., 2014, OLDER YOUNGER UNPUB; Castel A. D., 2007, J GERONTOL B-PSYCHOL, V62B, P194, DOI DOI 10.1093/GERONB/62.3.P194; Castel A. D., 2012, MEMORY AGING CURRENT, P245; COHEN RL, 1987, PSYCHOL AGING, V2, P280, DOI 10.1037/0882-7974.2.3.280; CRAIK FIM, 1992, ST HEAL T, V3, P79; Craik F. I. M., 2002, PSYCHOL TURN MILLENN, V1, P261; BACKMAN L, 1992, PSYCHOL BULL, V112, P259, DOI 10.1037//0033-2909.112.2.259; Friedman MC, 2013, AGING NEUROPSYCHOL C, V20, P660, DOI 10.1080/13825585.2012.762083; Geraci L, 2013, PSYCHOL AGING, V28, P340, DOI 10.1037/a0030332; Hasher L., 1988, PSYCHOL LEARN MOTIV, P193, DOI DOI 10.1016/S0079-7421(08)60041-9; Hess TM, 2005, PSYCHOL BULL, V131, P383, DOI 10.1037/0033-2909.131.3.383; HESS TM, 1990, DEV PSYCHOL, V26, P855, DOI 10.1037//0012-1649.26.5.855; JACOBY LL, 1991, J MEM LANG, V30, P513, DOI 10.1016/0749-596X(91)90025-F; Jacoby LL, 2010, MEM COGNITION, V38, P820, DOI 10.3758/MC.38.6.820; Lustig C., 2007, INHIBITION COGNITION, P145, DOI DOI 10.1037/11587-008; McDaniel M. A., 2007, MED ADHERENCE AGING, P49, DOI 10.1037/11557-003; McDaniel M. A., 2008, HDB AGING COGNITION, V3rd, P255; MORROW D, 1994, PSYCHOL AGING, V9, P134, DOI 10.1037//0882-7974.9.1.134; Morrow DG, 2001, PSYCHOL AGING, V16, P31, DOI 10.1037//0882-7974.16.1.31; Stine-Morrow EAL, 2007, CURR DIR PSYCHOL SCI, V16, P295, DOI 10.1111/j.1467-8721.2007.00524.x; Umanath S, 2014, PERSPECT PSYCHOL SCI, V9, P408, DOI 10.1177/1745691614535933; WOLINSKY FD, 1991, J GERONTOL, V46, pS345; Zacks R. T., 2006, LIFESPAN COGNITION M, P162, DOI DOI 10.1093/ACPROF:OSO/9780195169539.003.0011	54	1	1	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0090-502X	1532-5946		MEM COGNITION	Mem. Cogn.	FEB	2015	43	2					206	215		10.3758/s13421-014-0476-0		10	Psychology, Experimental	Psychology	CB6TL	WOS:000349759500005		
J	Gow, RN; Young, C; Huang, H; Hope, G; Takasaki, Y				Gow, R. N.; Young, C.; Huang, H.; Hope, G.; Takasaki, Y.			Spectroelectrochemistry of enargite I: Reactivity in alkaline solutions	MINERALS & METALLURGICAL PROCESSING			English	Article						Enargite; Arsenic; Raman spectroscopy; Cyclic voltammetry; STABCAL; Mass-balanced E-H-pH Diagrams	SYSTEM COPPER-SULFUR; HYPOCHLORITE; DISSOLUTION; MEDIA	The presence of enargite (Cu3AsS4) is problematic in gold processing not only because it is environmentally hazardous due to its arsenic content but also because it is refractory, causing both cyanide and oxygen consumption to increase. Selective leaching and treatment of the arsenic would prove advantageous prior to applying conventional gold leaching methods. The reactivity of enargite samples from Butte in Montana and Quiruvilca in Peru were spectroelectrochemically studied under alkaline conditions - pH range of 8-13 - using Raman spectroscopy and cyclic voltammetry. Raman spectra of the surface were collected during and after potentially cycled voltammograms in order to determine and compare surface species against theoretical EH-pH diagrams constructed from mass-balanced thermodynamic calculations using STABCAL software. Under slightly oxidizing conditions, covellite (CuS) peaks were found in a short matter of time, above similar to 100mV vs. SHE for pH 9-13, suggesting arsenic leaching specifically occurred. At longer conditioning times, elemental sulfur was observed and tended to passivate the surface. The presence of elemental sulfur suggests that copper was eventually leached from the surface. By operating above pH 12, under slightly reducing conditions near -300mV vs. SHE, arsenic can be selectively leached as thioarsenate (AsS43-) or thiosulfate (AsO43-) without sulfur formation.	[Young, C.; Huang, H.] MontanaTech Univ Montana, Dept Met & Mat Engn, Butte, MT USA; [Gow, R. N.] FLSmidth Inc, Dawson Met Labs, Midvale, UT 84047 USA; [Hope, G.] Griffith Univ, Sch Nat Sci, Nathan, Qld 4111, Australia; [Takasaki, Y.] Akita Univ, Dept Earth Resource Engn & Environm Sci, Akita 010, Japan	Gow, RN (reprint author), FLSmidth Inc, Dawson Met Labs, Midvale, UT 84047 USA.		Griffith University, QMNC/I-5498-2013				Allison J., 1990, MINTEQA2 PRODEFA2 G; Anderson CG, 2008, CAN METALL QUART, V47, P337; WOODS R, 1987, INT J MINER PROCESS, V20, P109, DOI 10.1016/0301-7516(87)90020-2; Padilla R, 2008, METALL MATER TRANS B, V39, P399, DOI 10.1007/s11663-008-9151-9; CRAIG JR, 1973, ECON GEOL, V68, P493; POTTER RW, 1977, ECON GEOL, V72, P1524; GAJAM S, 1983, INT J MINER PROCESS, V10, P113, DOI 10.1016/0301-7516(83)90037-6; Balaz P, 2006, INT J MINER PROCESS, V81, P44, DOI 10.1016/j.minpro.2006.06.004; Barin I., 1995, THERMODYNAMIC DATA P; BRAGE MC, 1979, ELECTROCHIM ACTA, V24, P25, DOI 10.1016/0013-4686(79)80035-3; Curreli L, 2005, MINER ENG, V18, P849, DOI 10.1016/j.mineng.2005.01.023; Delfini M, 2003, MINER ENG, V16, P45, DOI 10.1016/S0892-6875(02)00262-5; Downs R.T., 2006, 19 GEN M INT MIN ASS; Etienne A., 1972, IMM T C, V81, P176; Gow R., 2014, P HYDR 2014 VICT BC; Gow R., 2014, MINERALS METALLURGIC, V32; Gow R., 2014, MINERALS METAL UNPUB; Haynes W.M., 2011, CRC HDB CHEM PHYS; Helz GR, 2008, GEOCHIM COSMOCHIM AC, V72, P4457, DOI 10.1016/j.gca.2008.06.018; Huang H., 2012, STABCAL; Huang H., 1986, ELECTROCHEMISTRY MIN; Huang H., 2005, P COM 2005 35 ANN HY; KOCH DFA, 1976, J ELECTROANAL CHEM, V71, P285, DOI 10.1016/S0022-0728(76)80015-0; MATHIEU HJ, 1972, Z PHYS CHEM NEUE FOL, V79, P315; Mihajlovic I, 2007, MINER ENG, V20, P26, DOI 10.1016/j.mineng.2006.04.006; Nishimura T., 1993, B RES I MINERAL DRES, V49, P61; Robie RA, 1984, US GEOLOGICAL SURVEY, V1452; Tongamp W, 2010, HYDROMETALLURGY, V105, P42, DOI 10.1016/j.hydromet.2010.07.007; Tongamp W, 2010, HYDROMETALLURGY, V101, P64, DOI 10.1016/j.hydromet.2009.11.020; Vinals J, 2003, HYDROMETALLURGY, V68, P183, DOI 10.1016/S0304-386X(02)00200-1; Young C., 2002, HYDROMETALLURGY, V68, P23; Young C., 1988, P INT S EL MIN MET P, P3	32	0	0	SOC MINING METALLURGY EXPLORATION INC	ENGLEWOOD	12999 E ADAM AIRCRAFT CIRCLE, ENGLEWOOD, CO 80112 USA	0747-9182			MINER METALL PROC	Miner. Metall. Process.	FEB	2015	32	1					6	13				8	Metallurgy & Metallurgical Engineering; Mining & Mineral Processing	Metallurgy & Metallurgical Engineering; Mining & Mineral Processing	CB3GR	WOS:000349516700002		
J	Chen, HY; Shao, KT; Kishino, H				Chen, Hungyen; Shao, Kwang-Tsao; Kishino, Hirohisa			Phylogenetic skew: an index of community diversity	MOLECULAR ECOLOGY			English	Article						community diversity; distribution of divergence times; effective species sampling proportion; phylogenetic tree; species composition	MAXIMUM-LIKELIHOOD; DIVERGENCE TIMES; DNA-SEQUENCES; EVOLUTIONARY; CONSERVATION; PATTERNS; INFERENCE; MAMMALS; CLOCKS; BIRDS	The distribution of divergence times between member species of a community reflects the pattern of species composition. In this study, we contrast the species composition of a community against the meta-community, which we define as the species composition of a set of target communities. We regard the collection of species that comprise a community as a sample from the set of member species of the meta-community, and interpret the pattern of the community species composition in terms of the type of species sampled from the meta-community. A newly defined effective species sampling proportion explains the amount of the difference between the divergence time distributions of the community and that of the meta-community, assuming random sampling. We propose a new index of phylogenetic skew (PS), as the ratio of the maximum-likelihood estimate of the effective species sampling proportion to the observed sampling proportion. A PS value of 1 is interpreted as random sampling. If the value is >1, the sampling is suspected to be phylogenetically skewed. If it is <1, systematic thinning of species is likely. Unlike other indices, the PS does not depend on species richness as long as the community has more than a few members of a species. Because it is possible to compare partially observed communities, the index may be effectively used in exploratory analysis to detect candidate communities with unique species compositions from a large number of communities.	[Chen, Hungyen; Kishino, Hirohisa] Univ Tokyo, Grad Sch Agr & Life Sci, Bunkyo Ku, Tokyo 1138657, Japan; [Shao, Kwang-Tsao] Acad Sinica, Biodivers Res Ctr, Nankang 11529, Taiwan	Kishino, H (reprint author), Univ Tokyo, Grad Sch Agr & Life Sci, Bunkyo Ku, 1-1-1 Yayoi, Tokyo 1138657, Japan.	kishino@lbm.ab.a.u-tokyo.ac.jp			Japan Society for the Promotion of Science [25280006]; Taiwan Power Company	The authors thank the anonymous reviewers for their valuable comments. This work was supported in part by funding from the Japan Society for the Promotion of Science to HK (grant number 25280006) and funding by Taiwan Power Company for a long-term monitoring project to KS.	Srivastava DS, 2012, ECOL LETT, V15, P637, DOI 10.1111/j.1461-0248.2012.01795.x; Morlon H, 2011, ECOL LETT, V14, P141, DOI 10.1111/j.1461-0248.2010.01563.x; KENDALL DG, 1949, J ROY STAT SOC B, V11, P230; Leprieur F, 2011, ECOL LETT, V14, P325, DOI 10.1111/j.1461-0248.2011.01589.x; Douzery EJP, 2003, J MOL EVOL, V57, pS201, DOI 10.1007/s00239-003-0028-x; Faith DP, 2004, CONSERV BIOL, V18, P255, DOI 10.1111/j.1523-1739.2004.00330.x; Drummond AJ, 2012, MOL BIOL EVOL, V29, P1969, DOI 10.1093/molbev/mss075; Thorne JL, 1998, MOL BIOL EVOL, V15, P1647; Brum FT, 2012, OIKOS, V121, P899, DOI 10.1111/j.1600-0706.2011.19978.x; Jetz W, 2012, NATURE, V491, P444, DOI 10.1038/nature11631; Knapp S, 2008, ECOL LETT, V11, P1054, DOI 10.1111/j.1461-0248.2008.01217.x; Crisp MD, 2009, NATURE, V458, P754, DOI 10.1038/nature07764; Webb CO, 2000, AM NAT, V156, P145, DOI 10.1086/303378; YANG ZB, 1994, J MOL EVOL, V39, P105; RAO CR, 1982, THEOR POPUL BIOL, V21, P24, DOI 10.1016/0040-5809(82)90004-1; NEE S, 1994, PHILOS T ROY SOC B, V344, P305, DOI 10.1098/rstb.1994.0068; Sanderson MJ, 1997, MOL BIOL EVOL, V14, P1218; Winter M, 2013, TRENDS ECOL EVOL, V28, P199, DOI 10.1016/j.tree.2012.10.015; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; Varin C, 2005, BIOMETRIKA, V92, P519, DOI 10.1093/biomet/92.3.519; Cadotte MW, 2008, P NATL ACAD SCI USA, V105, P17012, DOI 10.1073/pnas.0805962105; Thuiller W, 2011, NATURE, V470, P531, DOI 10.1038/nature09705; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; Yang ZH, 1997, MOL BIOL EVOL, V14, P717; Bell G, 2013, OIKOS, V122, P1380, DOI 10.1111/j.1600-0706.2013.00405.x; Cadotte MW, 2012, ECOLOGY, V93, P223, DOI [10.1890/11-0426.1, DOI 10.1890/11-0426.1]; Cochran W.G., 1977, SAMPLING TECHNIQUES; Davies TJ, 2011, PHILOS T R SOC B, V366, P2414, DOI 10.1098/rstb.2011.0058; dossReis M, 2011, MOL BIOL EVOL, V28, P2161; Drummond AJ, 2010, BMC BIOL, V8, DOI 10.1186/1741-7007-8-114; ERWIN TL, 1991, SCIENCE, V253, P750, DOI 10.1126/science.253.5021.750; FAITH DP, 1992, BIOL CONSERV, V61, P1, DOI 10.1016/0006-3207(92)91201-3; FELSENSTEIN J, 1985, AM NAT, V125, P1, DOI 10.1086/284325; FELSENSTEIN J, 1981, J MOL EVOL, V17, P368, DOI 10.1007/BF01734359; Greenwood MFD, 2008, ESTUAR COAST SHELF S, V76, P121, DOI 10.1016/j.ecss.2007.06.008; Harvey P. H., 1991, COMP METHOD EVOLUTIO; HASEGAWA M, 1985, J MOL EVOL, V22, P160, DOI 10.1007/BF02101694; Liao YC, 2004, J MARINE SCI TECHNOL, V12, P411; Lindsay BG, 1988, CONT MATH, V80, P221, DOI DOI 10.1090/CONM/080/999014; Magurran A. E., 2003, MEASURING BIOL DIVER; Mouquet M, 2012, BIOL REV, V87, P769; NCBI, 2012, NUCL; Pienkowski M.W., 1998, J APPL ECOL, V35, P532; Shao KT, 2013, FISH DATABASE TAIWAN; VANEWRIGHT RI, 1991, BIOL CONSERV, V55, P235, DOI 10.1016/0006-3207(91)90030-D	45	1	1	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0962-1083	1365-294X		MOL ECOL	Mol. Ecol.	FEB	2015	24	4					759	770		10.1111/mec.13064		12	Biochemistry & Molecular Biology; Ecology; Evolutionary Biology	Biochemistry & Molecular Biology; Environmental Sciences & Ecology; Evolutionary Biology	CB7PH	WOS:000349819300006		
J	Morimoto, Y; Tani, M				Morimoto, Yuji; Tani, Motohiro			Synthesis of mannosylinositol phosphorylceramides is involved in maintenance of cell integrity of yeast Saccharomyces cerevisiae	MOLECULAR MICROBIOLOGY			English	Article							CHAIN FATTY-ACIDS; SPHINGOLIPID BIOSYNTHESIS; MEMBRANE-PROTEINS; COMPLEX SPHINGOLIPIDS; LINKED GLYCOSYLATION; S. CEREVISIAE; GPI ANCHORS; GENE; GROWTH; WALL	Complex sphingolipids play important roles in many physiologically important events in yeast Saccharomyces cerevisiae. In this study, we screened yeast mutant strains showing a synthetic lethal interaction with loss of mannosylinositol phosphorylceramide (MIPC) synthesis and found that a specific group of glycosyltransferases involved in the synthesis of mannan-type N-glycans is essential for the growth of cells lacking MIPC synthases (Sur1 and Csh1). The genetic interaction was also confirmed by repression of MNN2, which encodes alpha-1,2-mannosyltransferase that synthesizes mannan-type N-glycans, by a tetracycline-regulatable system. MNN2-repressed sur1 csh1 cells exhibited high sensitivity to zymolyase treatment, and caffeine and sodium dodecyl sulfate (SDS) strongly inhibited the growth of sur1 csh1 cells, suggesting impairment of cell integrity due to the loss of MIPC synthesis. The phosphorylated form of Slt2, a mitogen-activated protein (MAP) kinase activated by impaired cell integrity, increased in sur1 csh1 cells, and this increase was dramatically enhanced by the repression of Mnn2. Moreover, the growth defect of MNN2-repressed sur1 csh1 cells was enhanced by the deletion of SLT2 or RLM1 encoding a downstream target of Slt2. These results indicated that loss of MIPC synthesis causes impairment of cell integrity, and this effect is enhanced by impaired synthesis of mannan-type N-glycans.	[Morimoto, Yuji; Tani, Motohiro] Kyushu Univ, Fac Sci, Dept Chem, Higashi Ku, Fukuoka 8128581, Japan	Tani, M (reprint author), Kyushu Univ, Fac Sci, Dept Chem, Higashi Ku, 6-10-1 Hakozaki, Fukuoka 8128581, Japan.	tani@chem.kyushu-univ.jp			KAKENHI from Ministry of Education, Culture, Sports, Science, and Technology, Japan [26450127]; Nagase Science and Technology Foundation; Noda Institute for Scientific Research, Japan	We wish to thank Drs. O. Kuge and T. Ogishima (Kyushu University) for the valuable suggestions regarding this study. This study was funded by a KAKENHI (26450127) from the Ministry of Education, Culture, Sports, Science, and Technology, Japan; the Nagase Science and Technology Foundation; and the Noda Institute for Scientific Research, Japan.	Dickson RC, 2006, PROG LIPID RES, V45, P447, DOI 10.1016/j.plipres.2006.03.004; Uemura S, 2014, J LIPID RES, V55, P1343, DOI 10.1194/jlr.M048637; Hohmann S, 2002, MICROBIOL MOL BIOL R, V66, P300, DOI 10.1128/MMBR.66.2.300-372.2002; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Corcoles-Saez I, 2012, BIOCHEM J, V446, P477, DOI 10.1042/BJ20120634; HANSON BA, 1980, J LIPID RES, V21, P309; SIKORSKI RS, 1989, GENETICS, V122, P19; Tani M, 2012, MOL MICROBIOL, V86, P1262, DOI 10.1111/mmi.12057; Obara K, 2013, J LIPID RES, V54, P831, DOI 10.1194/jlr.M034678; Brachmann CB, 1998, YEAST, V14, P115; Levin DE, 2005, MICROBIOL MOL BIOL R, V69, P262, DOI 10.1128/MMBR.69.2.262-291.2005; Fujita M, 2008, BBA-GEN SUBJECTS, V1780, P410, DOI 10.1016/j.bbagen.2007.08.009; Tu L, 2008, SCIENCE, V321, P404, DOI 10.1126/science.1159411; Dickson RC, 1997, J BIOL CHEM, V272, P29620, DOI 10.1074/jbc.272.47.29620; Uemura S, 2003, J BIOL CHEM, V278, P45049, DOI 10.1074/jbc.M305498200; Dean N, 1999, BBA-GEN SUBJECTS, V1426, P309, DOI 10.1016/S0304-4165(98)00132-9; Bure C, 2014, ANAL BIOANAL CHEM, V406, P995, DOI 10.1007/s00216-013-7130-8; Janke C, 2004, YEAST, V21, P947, DOI 10.1002/yea.1142; Beeler TJ, 1997, MOL GEN GENET, V255, P570; Kitagaki H, 2002, MOL MICROBIOL, V46, P1011, DOI 10.1046/j.1365-2958.2002.03244.x; Thevissen K, 2000, P NATL ACAD SCI USA, V97, P9531, DOI 10.1073/pnas.160077797; ZHAO C, 1994, J BIOL CHEM, V269, P21480; Nagiec MM, 1997, J BIOL CHEM, V272, P9809; Acharya U, 2005, CELL MOL LIFE SCI, V62, P128, DOI 10.1007/s00018-004-4254-1; Merrill AH, 2011, CHEM REV, V111, P6387, DOI 10.1021/cr2002917; WACH A, 1994, YEAST, V10, P1793, DOI 10.1002/yea.320101310; Ram AFJ, 2006, NAT PROTOC, V1, P2253, DOI 10.1038/nprot.2006.397; Belli G, 1998, YEAST, V14, P1127, DOI 10.1002/(SICI)1097-0061(19980915)14:12<1127::AID-YEA300>3.0.CO;2-#; desNobel H, 2000, MICROBIOLOGY, V146, P2121; Ghugtyal V, 2007, MOL MICROBIOL, V65, P1493, DOI 10.1111/j.1365-2958.2007.05883.x; Hallstrom TC, 2001, J BIOL CHEM, V276, P23674, DOI 10.1074/jbc.M101568200; HECHTBERGER P, 1994, EUR J BIOCHEM, V225, P641, DOI 10.1111/j.1432-1033.1994.00641.x; Lesage G, 2005, BMC GENET, V6, DOI 10.1186/1471-2156-6-8; Lisman Q, 2004, J BIOL CHEM, V279, P1020, DOI 10.1074/jbc.M306119200; Munro S, 2001, FEBS LETT, V498, P223, DOI 10.1016/S0014-5793(01)02488-7; Nakase M, 2010, J CELL SCI, V123, P1578, DOI 10.1242/jcs.059139; Nakase M, 2012, MICROBIOL-SGM, V158, P1219, DOI 10.1099/mic.0.056184-0; Nakayama K, 1998, BBA-GEN SUBJECTS, V1425, P255, DOI 10.1016/S0304-4165(98)00078-6; Phelan JP, 2006, J CELL SCI, V119, P4225, DOI 10.1242/jcs.03188; Simons K, 2011, CSH PERSPECT BIOL, V3, DOI 10.1101/cshperspect.a004697; Stock SD, 2000, ANTIMICROB AGENTS CH, V44, P1174, DOI 10.1128/AAC.44.5.1174-1180.2000; Tani M, 2010, MOL MICROBIOL, V78, P395, DOI 10.1111/j.1365-2958.2010.07340.x; Tomishige N, 2003, MOL GENET GENOMICS, V269, P562, DOI 10.1007/s00438-003-0864-9; Tong Amy Hin Yan, 2006, Methods Mol Biol, V313, P171; Umemura M, 2007, MOL BIOL CELL, V18, P4304, DOI 10.1091/mbc.E07-05-0482; WOOD CM, 2012, FISH PHYSIOL B, V31, P1; Yamagata M, 2013, GENES CELLS, V18, P650, DOI 10.1111/gtc.12062	47	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0950-382X	1365-2958		MOL MICROBIOL	Mol. Microbiol.	FEB	2015	95	4					706	722		10.1111/mmi.12896		17	Biochemistry & Molecular Biology; Microbiology	Biochemistry & Molecular Biology; Microbiology	CB5SG	WOS:000349687200010		
J	Doi, A; Ishikawa, K; Shibata, N; Ito, E; Fujimoto, J; Yamamoto, M; Shiga, H; Mochizuki, H; Kaulamura, Y; Goshima, N; Semba, K; Watanabe, S				Doi, Ayano; Ishikawa, Kosuke; Shibata, Nao; Ito, Emi; Fujimoto, Jiro; Yamamoto, Mizuki; Shiga, Hatsuki; Mochizuki, Hiromi; Kaulamura, Yoshifumi; Goshima, Naoki; Semba, Kentaro; Watanabe, Shinya			Enhanced expression of retinoic acid receptor alpha (RARA) induces epithelial-to-mesenchymal transition and disruption of mammary acinar structures	MOLECULAR ONCOLOGY			English	Article						3D culture; Gene amplification; Breast cancer; EMT; ERBB2; RARA	BREAST-CANCER; SIGNALING NETWORK; HER2 AMPLICON; TARGET GENES; CELL-LINES; ERBB2; MORPHOGENESIS; ZEB1; COAMPLIFICATION; TUMORIGENICITY	The early steps of mammary tumorigenesis include loss of epithelial cell polarity, escape from anoikis, and acquisition of proliferative capacity. The genes responsible for these processes are predicted to be early diagnostic markers or new therapeutic targets. Here we tested 51 genes coamplified with ERBB2 in the 17q12-21 amplicon for these tumorigenic activities using an MCF10A 3D culture-based screening system. We found that overexpression of retinoic acid receptor alpha (RARA) disrupted normal acinar structure and induced epithelial-to-mesenchymal transition (EMT). The mRNA levels of known EMT-inducing factors, including SLUG, FOXC2, ZEB1, and ZEB2, were significantly increased upon RARA overexpression. Knockdown of ZEB1 suppressed the RARA-mediated EMT phenotype. These results suggest that overexpression of RARA enhances malignant transformation during mammary tumorigenesis. (C) 2014 Federation of European Biochemical Societies. Published by Elsevier B.V. All rights reserved.	[Doi, Ayano; Ishikawa, Kosuke; Shibata, Nao; Fujimoto, Jiro; Yamamoto, Mizuki; Semba, Kentaro] Waseda Univ, Sch Adv Sci & Engn, Dept Life Sci & Med Biosci, Shinjuku Ku, Tokyo 1628480, Japan; [Ishikawa, Kosuke; Fujimoto, Jiro; Shiga, Hatsuki; Mochizuki, Hiromi; Kaulamura, Yoshifumi] Japan Biol Informat Consortium JBiC, Koto Ku, Tokyo 1358073, Japan; [Ito, Emi; Watanabe, Shinya] Fukushima Med Univ, Translat Res Ctr, Div Gene Express Anal, Tokyo Branch,Shibuya Ku, Tokyo 1510051, Japan; [Goshima, Naoki] Natl Inst Adv Ind Sci & Technol, Mol Profiling Res Ctr Drug Discovery Molprof, Quantitat Prote Team, Koto Ku, Tokyo 1350064, Japan; [Semba, Kentaro] Fukushima Med Univ, Translat Res Ctr, Div Gene Funct Anal, Fukushima 9601295, Japan	Semba, K (reprint author), Waseda Univ, Sch Adv Sci & Engn, Dept Life Sci & Med Biosci, Shinjuku Ku, 2-2 Wakamatsu Cho, Tokyo 1628480, Japan.	adoi_ioda@yahoo.co.jp; IshikawaKosuke@gmail.com; ksemba@waseda.jp			Japan Society for the Promotion of Science KAKENHI [23241064]; New Energy and Industrial Technology Development Organization (NEDO)	We would like to acknowledge the secretarial assistance of Kumiko Semba. This research was partially supported by Japan Society for the Promotion of Science KAKENHI 23241064 and a grant for Translational Research Program: Achievement of personalized medicine and acceleration of anti-cancer drug development by using gene expression analysis technology from the New Energy and Industrial Technology Development Organization (NEDO).	Yang J, 2008, DEV CELL, V14, P818, DOI 10.1016/j.devcel.2008.05.009; Thiery JP, 2009, CELL, V139, P871, DOI 10.1016/j.cell.2009.11.007; Ross-Innes CS, 2010, GENE DEV, V24, P171, DOI 10.1101/gad.552910; Vargo-Gogola T, 2007, NAT REV CANCER, V7, P659, DOI 10.1038/nrc2193; Taube JH, 2010, P NATL ACAD SCI USA, V107, P15449, DOI 10.1073/pnas.1004900107; Espina V, 2011, NAT REV CANCER, V11, P618, DOI 10.1038/nrc2950-c2; Muthuswamy SK, 2001, NAT CELL BIOL, V3, P785, DOI 10.1038/ncb0901-785; Stratton MR, 2009, NATURE, V458, P719, DOI 10.1038/nature07943; Chaffer CL, 2013, CELL, V154, P61, DOI 10.1016/j.cell.2013.06.005; Burk U, 2008, EMBO REP, V9, P582, DOI 10.1038/embor.2008.74; Baselga J, 2009, NAT REV CANCER, V9, P463, DOI 10.1038/nrc2656; Toma S, 1998, INT J CANCER, V78, P86, DOI 10.1002/(SICI)1097-0215(19980925)78:1<86::AID-IJC14>3.0.CO;2-3; Witt AE, 2006, J PROTEOME RES, V5, P599, DOI 10.1021/pr050395i; Polyak K, 2009, NAT REV CANCER, V9, P265, DOI 10.1038/nrc2620; Mani SA, 2008, CELL, V133, P704, DOI 10.1016/j.cell.2008.03.027; Jacot W, 2013, BBA-REV CANCER, V1836, P146, DOI 10.1016/j.bbcan.2013.04.004; Schug TT, 2007, CELL, V129, P723, DOI 10.1016/j.cell.2007.02.050; Lu J, 2009, CANCER CELL, V16, P195, DOI 10.1016/j.ccr.2009.08.010; Wellner U, 2009, NAT CELL BIOL, V11, P1487, DOI 10.1038/ncb1998; Yamada KM, 2007, CELL, V130, P601, DOI 10.1016/j.cell.2007.08.006; Kao J, 2006, GENE CHROMOSOME CANC, V45, P761, DOI 10.1002/gcc.20339; Kauraniemi P, 2001, CANCER RES, V61, P8235; Paroni G, 2012, ONCOGENE, V31, P3431, DOI 10.1038/onc.2011.506; Debnath J, 2005, NAT REV CANCER, V5, P675, DOI 10.1038/nrc1695; Seton-Rogers SE, 2004, P NATL ACAD SCI USA, V101, P1257, DOI 10.1073/pnas.0308090100; Yarden Y, 2001, NAT REV MOL CELL BIO, V2, P127, DOI 10.1038/35052073; Bastien J, 2004, GENE, V328, P1, DOI 10.1016/j.gene.2003.12.005; Debnath J, 2003, METHODS, V30, P256, DOI 10.1016/S1046-2023(03)00032-X; Altucci L, 2001, NAT REV CANCER, V1, P181, DOI 10.1038/35106036; Bieche I, 1996, CANCER RES, V56, P3886; Chiba H, 1997, MOL CELL BIOL, V17, P3013; CHOMCZYNSKI P, 1987, ANAL BIOCHEM, V162, P156, DOI 10.1006/abio.1987.9999; Cohn E, 2010, BREAST CANCER RES, V12, DOI 10.1186/bcr2724; Farboud B, 2003, MOL CELL BIOL, V23, P2844, DOI 10.1128/MCB.23.8.2844; Gregory PA, 2011, MOL BIOL CELL, V22, P1686, DOI 10.1091/mbc.E11-02-0103; Katz E, 2010, BRIT J CANCER, V103, P401, DOI 10.1038/sj.bjc.6605763; KEITH WN, 1993, EUR J CANCER, V29A, P1469, DOI 10.1016/0959-8049(93)90022-8; KLEINMAN HK, 1982, BIOCHEMISTRY-US, V21, P6188, DOI 10.1021/bi00267a025; Lamy PJ, 2011, BREAST CANCER RES, V13, DOI 10.1186/bcr2824; Peng XJ, 2004, INT J ONCOL, V25, P961; Saito M, 2012, FEBS LETT, V586, P1708, DOI 10.1016/j.febslet.2012.05.003	41	3	3	ELSEVIER SCI LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND	1574-7891	1878-0261		MOL ONCOL	Mol. Oncol.	FEB	2015	9	2					355	364		10.1016/j.molonc.2014.09.005		10	Oncology	Oncology	CB4FE	WOS:000349582800002		
J	Trabasso, P; Matsuzawa, T; Fagnani, R; Muraosa, Y; Tominaga, K; Resende, MR; Kamei, K; Mikami, Y; Schreiber, AZ; Moretti, ML				Trabasso, Plinio; Matsuzawa, Tetsuhiro; Fagnani, Renata; Muraosa, Yasunori; Tominaga, Kenichiro; Resende, Mariangela Ribeiro; Kamei, Katsuhiko; Mikami, Yuzuru; Schreiber, Angelica Zaninelli; Moretti, Maria Luiza			Isolation and Drug Susceptibility of Candida parapsilosis Sensu Lato and other Species of C-parapsilosis Complex from Patients with Blood Stream Infections and Proposal of a Novel LAMP Identification Method for the Species	MYCOPATHOLOGIA			English	Article						Candida parapsilosis; Candidemia; Mycoses; Antifungal susceptibility; Molecular diagnostic techniques; LAMP	MEDIATED ISOTHERMAL AMPLIFICATION; REAL-TIME PCR; ANTIFUNGAL SUSCEPTIBILITY; CLINICAL BREAKPOINTS; FUNGAL PATHOGENS; EPIDEMIOLOGY; ORTHOPSILOSIS; METAPSILOSIS; DNA; SYSTEM	Candida parapsilosis complex (CPC) is the third Candida species isolated in blood cultures of patients from our Hospital, following C. albicans and C. tropicalis. From 2006 to 2010, the median annual distribution of CPC was 8 cases/year. Records of 36 patients were reviewed. CPC were 31 (86.1 %) C. parapsilosis; 4 (11.1 %) C. orthopsilosis; and 1 (2.8 %) C. metapsilosis. Clinical characteristics were central venous catheter, 34 (94.4 %); parental nutrition, 25 (70 %); surgery, 27 (57.9 %); prior bacteremia, 20 (51.3 %); malignancy, 18 (50 %). General mortality was 47.2 %. Death was higher in immunosuppressed patients (17 vs. 11; p = 0.003). Three out four (75 %) patients with C. orthopsilosis and 14 out 31 (45.2 %) with C. parapsilosis died (p = 0.558). Thirty-nine individual isolates were tested for susceptibility to seven antifungal drugs, with MICs values showing susceptibility to all of them. Two isolates, one C. orthopsilosis and one C. parapsilosis, had fluconazole MIC = 4 mu g/mL. Differentiation among CPC has implication in caring for patients with invasive candidiasis since there are differences in virulence, pathogenicity and drug susceptibility. A method targeting the topoisomerase II gene based on loop-mediated isothermal amplification (LAMP) was developed. LAMP emerges as a promising tool for the identification of fungal species due to the high sensitivity and specificity. LAMP can be performed at the point-of-care, being no necessary the use of expensive equipment. In our study, the method was successful comparing to the DNA sequencing and proved to be a reliable and fast assay to distinguish the three species of CPC.	[Trabasso, Plinio; Fagnani, Renata; Resende, Mariangela Ribeiro; Moretti, Maria Luiza] Univ Estadual Campinas, Sch Med Sci, Div Infect Dis, BR-13083887 Sao Paulo, Brazil; [Matsuzawa, Tetsuhiro] Nagasaki Univ, Nagoya, Nagasaki 8512195, Japan; [Muraosa, Yasunori; Tominaga, Kenichiro; Kamei, Katsuhiko; Mikami, Yuzuru] Chiba Univ, Med Mycol Res Ctr, Chuo Ku, Chiba 2608673, Japan; [Schreiber, Angelica Zaninelli] Univ Estadual Campinas, Sch Med Sci, Dept Clin Pathol, BR-13083887 Sao Paulo, Brazil	Trabasso, P (reprint author), Univ Estadual Campinas, Sch Med Sci, Div Infect Dis, Rua Tessalia Vieira de Carvalho, BR-13083887 Sao Paulo, Brazil.	trabasso@fcm.unicamp.br	Trabasso, Plinio/C-3968-2013	Trabasso, Plinio/0000-0002-0588-4859	Ethical Committee of the School of Medical Sciences of the University of Campinas; JICA (Japan International Cooperation Agency); SATREPS (Science and Technology Research Partnership for Sustainable Development) [02P-29548-09]	This project was approved on February 22, 2011 (No. 039/2011) by the Ethical Committee of the School of Medical Sciences of the University of Campinas. This study was partly supported by JICA (Japan International Cooperation Agency) and SATREPS (Science and Technology Research Partnership for Sustainable Development) Grant No. 02P-29548-09.	Pfaller M, 2012, DIAGN MICR INFEC DIS, V74, P323, DOI 10.1016/j.diagmicrobio.2012.10.003; Kuhn DM, 2004, EMERG INFECT DIS, V10, P1074; Nguyen MH, 2012, CLIN INFECT DIS, V54, P1240, DOI 10.1093/cid/cis200; Colombo AL, 2006, J CLIN MICROBIOL, V44, P2816, DOI 10.1128/JCM.00773-06; Tavanti A, 2005, J CLIN MICROBIOL, V43, P284, DOI 10.1128/JCM.43.1.284-292.2005; Uemura N, 2008, J MED MICROBIOL, V57, P50, DOI 10.1099/jmm.0.47216-0; MARTINO P, 1993, AM J MED SCI, V306, P225, DOI 10.1097/00000441-199310000-00004; Inacio J, 2008, J CLIN MICROBIOL, V46, P713, DOI 10.1128/JCM.00514-07; Pfaller MA, 2011, DIAGN MICR INFEC DIS, V70, P330, DOI 10.1016/j.diagmicrobio.2011.03.002; Souza ACR, 2012, J CLIN MICROBIOL, V50, P2310, DOI 10.1128/JCM.00303-12; Falagas ME, 2010, INT J INFECT DIS, V14, pE954, DOI 10.1016/j.ijid.2010.04.006; Pfaller MA, 2011, DRUG RESIST UPDATE, V14, P164, DOI 10.1016/j.drup.2011.01.004; Asmundsdottir LR, 2013, J CLIN MICROBIOL, V51, P841, DOI 10.1128/JCM.02566-12; Pfaller MA, 2010, DRUG RESIST UPDATE, V13, P180, DOI 10.1016/j.drup.2010.09.002; Hara-Kudo Y, 2005, FEMS MICROBIOL LETT, V253, P155, DOI 10.1016/j.femsle.2005.09.032; Canton E, 2011, ANTIMICROB AGENTS CH, V55, P5590, DOI 10.1128/AAC.00466-11; Levin AS, 1998, DIAGN MICR INFEC DIS, V30, P243, DOI 10.1016/S0732-8893(98)00006-6; Horn DL, 2009, CLIN INFECT DIS, V48, P1695, DOI 10.1086/599039; Garcia-Effron G, 2012, J ANTIMICROB CHEMOTH, V67, P2739, DOI 10.1093/jac/dks271; Moretti ML, 2013, MED MYCOL, V51, P225, DOI 10.3109/13693786.2012.708107; Trofa D, 2008, CLIN MICROBIOL REV, V21, P606, DOI 10.1128/CMR.00013-08; Gago S, 2014, VIRULENCE, V5, P278, DOI 10.4161/viru.26973; Lockhart SR, 2008, J CLIN MICROBIOL, V46, P2659, DOI 10.1128/JCM.00803-08; Mori Y, 2004, J BIOCHEM BIOPH METH, V59, P145, DOI 10.1016/j.jbbm.2003.12.005; Poon LLM, 2005, J CLIN MICROBIOL, V43, P427, DOI 10.1128/JCM.43.1.427-430.2005; Azevedo AC, 2011, MYCOPATHOLOGIA, V171, P411, DOI 10.1007/s11046-010-9387-1; Brito LR, 2006, MED MYCOL, V44, P261, DOI 10.1080/13693780500421476; Buelow DR, 2012, MED MYCOL, V50, P775, DOI 10.3109/13693786.2012.666681; Clinical Laboratory Standards Institute (CLST), 2012, M27S4 CLSI; Das I., 2011, INT J INFECT DIS, V15, P759; Dotes J, 2012, PEDIATR INFECT DIS J, V31, P557; Endo S, 2004, FEMS MICROBIOL LETT, V234, P93, DOI 10.1016/j.femsle.2004.03.015; Ferrari MD, 2013, J CLIN MICROBIOL, V51, P3826, DOI 10.1128/JCM.01050-13; Fricke S, 2010, J APPL MICROBIOL, V109, P1150, DOI 10.1111/j.1365-2672.2010.04736.x; Hall L, 2004, J CLIN MICROBIOL, V42, P622, DOI 10.1128/JCM.42.2.622-626.2004; Hung WT, 2011, BMC INFECT DIS, V11, DOI 10.1186/1471-2334-11-91; Iida S., 2005, Japanese Journal of Medical Mycology, V46, P133; Juyal Deepak, 2013, N Am J Med Sci, V5, P541, DOI 10.4103/1947-2714.118919; Kasahara K, 2014, FEMS MICROBIOL LETT, V357, P208, DOI 10.1111/1574-6968.12512; Katsu M, 2004, FEMS YEAST RES, V4, P377, DOI 10.1016/S1567-1356(03)00176-4; Matsuzawa Tetsuhiro, 2010, Nihon Ishinkin Gakkai Zasshi, V51, P109; Muraosa Y, 2014, INT J MED MICROBIOL, V304, P505, DOI 10.1016/j.ijmm.2014.03.001; Nemeth T, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0068704; Oeser C, 2014, CLIN MICROBIOL INFEC, V20, P936, DOI 10.1111/1469-0691.12578; Pfaller MA, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0101510; Pfaller MA, 2013, DIAGN MICR INFEC DIS, V77, P37, DOI 10.1016/j.diagmicrobio.2013.05.019; Pfaller MA, 2010, J CLIN MICROBIOL, V49, P630; Prandini THR, 2013, J CLIN MICROBIOL, V51, P2830, DOI 10.1128/JCM.00981-13; Sakai K, 2014, MYCOPATHOLOGIA, V178, P11, DOI 10.1007/s11046-014-9756-2; Silva AP, 2009, CLIN MICROBIOL, V47, P2392; Singla N, 2012, MYCOPATHOLOGIA, V174, P149, DOI 10.1007/s11046-011-9514-7; Tamura M, 2001, J CLIN MICROBIOL, V39, P4309, DOI 10.1128/JCM.39.12.4309-4315.2001; Wisplinghoff H, 2014, CLIN MICROBIOL, V43, P78	53	3	3	SPRINGER	DORDRECHT	VAN GODEWIJCKSTRAAT 30, 3311 GZ DORDRECHT, NETHERLANDS	0301-486X	1573-0832		MYCOPATHOLOGIA	Mycopathologia	FEB	2015	179	1-2					53	62		10.1007/s11046-014-9830-9		10	Mycology	Mycology	CB3LG	WOS:000349528700006		
J	Kano, R; Tsui, CKM; Hamelin, RC; Anzawa, K; Mochizuki, T; Nishimoto, K; Hiruma, M; Kamata, H; Hasegawa, A				Kano, Rui; Tsui, Clement K. -M.; Hamelin, Richard C.; Anzawa, Kazushi; Mochizuki, Takashi; Nishimoto, Katsutaro; Hiruma, Masataro; Kamata, Hiroshi; Hasegawa, Atsuhiko			The MAT1-1:MAT1-2 Ratio of Sporothrix globosa Isolates in Japan	MYCOPATHOLOGIA			English	Article						Mating type; MAT1-1-1; Sporothrix globosa; Sporotrichosis; Sexual reproduction	HISTOPLASMA-CAPSULATUM; SCHENCKII COMPLEX; MATING TYPES; OPHIOSTOMA; SPOROTRICHOSIS; PHYLOGENY; FUNGUS; GENES	In order to understand the reproductive biology of pathogenic species in the Sporothrix schenckii complex, we characterized the partial mating type (MAT1-1) loci of Sporothrix schenckii, as well as the S. globosa MAT1-1-1 gene, which encoded 262 amino acid sequences. The data confirmed that the MAT1-1 locus of S. globosa was divergent from the MAT1-2 locus of the opposite mating type, suggesting that the fungus is heterothallic. To determine the mating type ratio of 20 isolates from Japanese patients, we analyzed the MAT loci by specific PCR amplification of MAT1-1-1 and MAT1-2-1 genes. The MAT1-1-1 was detected in 5 isolates but not in the other 15 isolates with the presence of MAT1-2-1. The MAT1-1:1-2 ratio of S. globosa isolates in Japan was estimated to be 1:3. Phylogenetic analysis indicated that the sequences of the MAT1-1-1 were identical among S. globosa isolates but different from S. schenckii and Ophiostoma montium.	[Kano, Rui; Kamata, Hiroshi] Nihon Univ, Sch Vet Med, Dept Pathobiol, Fujisawa, Kanagawa 2528510, Japan; [Tsui, Clement K. -M.; Hamelin, Richard C.] Univ British Columbia, Dept Forest & Conservat Sci, Vancouver, BC V6T 1Z4, Canada; [Anzawa, Kazushi; Mochizuki, Takashi] Kanazawa Med Univ, Dept Dermatol, Uchinada, Ishikawa 9200293, Japan; [Nishimoto, Katsutaro] Ekisaikai Nagasaki Hosp, Div Dermatol, Nagasaki 8500034, Japan; [Hiruma, Masataro] Ochanomizu Inst Med Mycol & Allergol, Bunkyo Ku, Tokyo 1130033, Japan; [Hasegawa, Atsuhiko] Teikyo Univ, Inst Med Mycol, Hachioji, Tokyo 1920395, Japan	Kano, R (reprint author), Nihon Univ, Sch Vet Med, Dept Pathobiol, 1866 Kameino, Fujisawa, Kanagawa 2528510, Japan.	kanou.rui@nihon-u.ac.jp			Academic Frontier Project of the Ministry of Education, Culture, Sports, Science, and Technology (MEXT); Nihon University Multidisciplinary Research Grant	This study was supported by grants from the Academic Frontier Project of the Ministry of Education, Culture, Sports, Science, and Technology (MEXT) and Nihon University Multidisciplinary Research Grant for (2013).	de Meyer EM, 2008, MYCOLOGIA, V100, P647, DOI 10.3852/07-157R; Marimon R, 2007, J CLIN MICROBIOL, V45, P3198, DOI 10.1128/JCM.00808-07; de Beer ZW, 2003, MYCOLOGIA, V95, P434, DOI 10.2307/3761885; Marimon R, 2008, MED MYCOL, V46, P621, DOI 10.1080/13693780801992837; Rodrigues AM, 2014, EMERG MICROBES INFEC, V3, DOI 10.1038/emi.2014.33; KWONCHUNG KJ, 1978, AM J EPIDEMIOL, V108, P337; Zhou X, 2014, FUNGAL DIVERS, V66, P153, DOI 10.1007/s13225-013-0220-2; Hinrikson HP, 2005, J CLIN MICROBIOL, V43, P2092, DOI 10.1128/JCM.43.5.2092-2103.2005; BERBEE ML, 1992, EXP MYCOL, V16, P87, DOI 10.1016/0147-5975(92)90044-R; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; Kano R, 2012, MYCOPATHOLOGIA, V173, P103, DOI 10.1007/s11046-011-9487-6; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; Bubnick M, 2007, EUKARYOT CELL, V6, P616, DOI 10.1128/EC.00020-07; Casselton LA, 2008, BIOESSAYS, V30, P711, DOI 10.1002/bies.20782; Kano R, 2013, J DERMATOL, V40, P726, DOI 10.1111/1346-8138.12226; Kwon-Chung KJ, 1992, DERMATOPHYTOSES MED, p[707, 816]; KWONCHUNG KJ, 1984, SABOURAUDIA, V22, P155; Rodrigues AM, MED MYCOL, V51, P405; Romeo O, 2011, MYCOPATHOLOGIA, V172, P179, DOI 10.1007/s11046-011-9420-z; Tsui CKM, 2013, G3-GENES GENOM GENET, V3, P465, DOI 10.1534/g3.112.004986; Vasquez-del-Mercado E, 2012, CLIN DERMATOL, V30, P437, DOI 10.1016/j.clindermatol.2011.09.017; Zipfel RD, 2006, STUD MYCOL, V55, P77, DOI DOI 10.3114/SIM.55.1.75	22	0	0	SPRINGER	DORDRECHT	VAN GODEWIJCKSTRAAT 30, 3311 GZ DORDRECHT, NETHERLANDS	0301-486X	1573-0832		MYCOPATHOLOGIA	Mycopathologia	FEB	2015	179	1-2					81	86		10.1007/s11046-014-9808-7		6	Mycology	Mycology	CB3LG	WOS:000349528700009		
J	Heath, RM; Tanner, MG; Drysdale, TD; Miki, S; Giannini, V; Maier, SA; Hadfield, RH				Heath, Robert M.; Tanner, Michael G.; Drysdale, Timothy D.; Miki, Shigehito; Giannini, Vincenzo; Maier, Stefan A.; Hadfield, Robert H.			Nanoantenna Enhancement for Telecom-Wavelength Superconducting Single Photon Detectors	NANO LETTERS			English	Article						Infrared detector; SNSPD; nanoantenna; superconducting nanowire; single photon detector		Superconducting nanowire single photon detectors are rapidly emerging as a key infrared photon-counting technology. Two front-side-coupled silver dipole nanoantennas, simulated to have resonances at 1480 and 1525 nm, were fabricated in a two-step process. An enhancement of 50 to 130% in the system detection efficiency was observed when illuminating the antennas. This offers a pathway to increasing absorption into superconducting nanowires, creating larger active areas, and achieving more efficient detection at longer wavelengths.	[Heath, Robert M.; Tanner, Michael G.; Drysdale, Timothy D.; Hadfield, Robert H.] Univ Glasgow, Sch Engn, Glasgow G12 8LT, Lanark, Scotland; [Miki, Shigehito] Natl Inst Informat & Commun Technol, Kobe Adv Res Ctr, Nishi Ku, Kobe, Hyogo 6512492, Japan; [Giannini, Vincenzo; Maier, Stefan A.] Univ London Imperial Coll Sci Technol & Med, Dept Phys, Blackett Lab, London SW7 2BZ, England	Heath, RM (reprint author), Univ Glasgow, Sch Engn, Glasgow G12 8LT, Lanark, Scotland.	robert.heath@glasgow.ac.uk	Hadfield, Robert/L-8081-2013; Tanner, Michael/A-4440-2012	Hadfield, Robert/0000-0002-8084-4187; 	U.K. Engineering and Physical Sciences Research Council (EPSRC); NICT; Leverhulme Trust; EPSRC Active Plasmonics Programme; Royal Society of London University	During final preparation of this manuscript it has come to our attention that preliminary data on near-IR antennas coupled to superconducting nanowires was reported by R. Heeres.<SUP>21</SUP> The authors thank the U.K. Engineering and Physical Sciences Research Council (EPSRC) for support. The authors also thank Saburo Imamura of the Japanese National Institute of Information and Communications Technology (NICT) for technical support. R.M.H. thanks NICT for an Internship Research Fellowship. S.A.M. and V.G. acknowledge support from the Leverhulme Trust and the EPSRC Active Plasmonics Programme. R.H.H. acknowledges a Royal Society of London University Research Fellowship.	AGDUR B, 1963, PHYS REV, V130, P996, DOI 10.1103/PhysRev.130.996; Anant V, 2008, OPT EXPRESS, V16, P10750, DOI 10.1364/OE.16.010750; Aizpurua J, 2005, PHYS REV B, V71, DOI 10.1103/PhysRevB.71.235420; Verma VB, 2012, APPL PHYS LETT, V101, DOI 10.1063/1.4768788; Hadfield RH, 2009, NAT PHOTONICS, V3, P696, DOI 10.1038/nphoton.2009.230; Hu XL, 2011, OPT EXPRESS, V19, P17, DOI 10.1364/OE.19.000017; Marsili F, 2013, NAT PHOTONICS, V7, P210, DOI [10.1038/nphoton.2013.13, 10.1038/NPHOTON.2013.13]; Giannini V, 2011, CHEM REV, V111, P3888, DOI 10.1021/cr1002672; O'Connor JA, 2011, APPL PHYS LETT, V98, DOI 10.1063/1.3581054; Casaburi A, 2014, SUPERCOND SCI TECH, V27, DOI 10.1088/0953-2048/27/4/044029; Baek B, 2011, APPL PHYS LETT, V98, DOI 10.1063/1.3600793; Natarajan CM, 2012, SUPERCOND SCI TECH, V25, DOI 10.1088/0953-2048/25/6/063001; Marsili F, 2012, NANO LETT, V12, P4799, DOI 10.1021/nl302245n; Heath RM, 2014, APPL PHYS LETT, V104, DOI 10.1063/1.4865199; Dorenbos SN, 2008, APPL PHYS LETT, V93, DOI 10.1063/1.3003579; Biagioni P, 2012, REP PROG PHYS, V75, DOI 10.1088/0034-4885/75/2/024402; Csete M, 2013, SCI REP-UK, V3, DOI 10.1038/srep02406; Heeres R, 2012, THESIS TU DELFT NETH; Korneeva Y, 2011, IEEE T APPL SUPERCON, V21, P323, DOI 10.1109/TASC.2010.2087740; Miki S, 2007, IEEE T APPL SUPERCON, V17, P285, DOI 10.1109/TASC.2007.898582; Miki S, 2008, APPL PHYS LETT, V92, DOI 10.1063/1.2870099	21	0	0	AMER CHEMICAL SOC	WASHINGTON	1155 16TH ST, NW, WASHINGTON, DC 20036 USA	1530-6984	1530-6992		NANO LETT	Nano Lett.	FEB	2015	15	2					819	822		10.1021/nl503055a		4	Chemistry, Multidisciplinary; Chemistry, Physical; Nanoscience & Nanotechnology; Materials Science, Multidisciplinary; Physics, Applied; Physics, Condensed Matter	Chemistry; Science & Technology - Other Topics; Materials Science; Physics	CB4DI	WOS:000349578000003		
J	Yoshioka, K; Minami, Y; Shudo, K; Dao, TD; Nagao, T; Kitajima, M; Takeda, J; Katayama, I				Yoshioka, Katsumasa; Minami, Yasuo; Shudo, Ken-ichi; Dao, Thang D.; Nagao, Tadaaki; Kitajima, Masahiro; Takeda, Jun; Katayama, Ikufumi			Terahertz-Field-Induced Nonlinear Electron Delocalization in Au Nanostructures	NANO LETTERS			English	Article						Terahertz; nonlinear spectroscopy; metal nanostructures; electron delocalization; quantum tunneling; percolation	OPTICAL RECTIFICATION; METAL TRANSITION; GOLD-FILMS; GENERATION; GRAPHENE; CONDUCTIVITY; SPECTROSCOPY; MODULATION; NANOTUBES; CONSTANTS	Improved control over the electromagnetic properties of metal nanostructures is indispensable for the development of next-generation integrated nanocircuits and plasmonic devices. The use of terahertz (THz)-field-induced nonlinearity is a promising approach to controlling local electromagnetic properties. Here, we demonstrate how intense THz electric fields can be used to modulate electron delocalization in percolated gold (Au) nanostructures on a picosecond time scale. We prepared both isolated and percolated Au nanostructures deposited on high resistivity Si(100) substrates. With increasing the applied THz electric fields, large opacity in the THz transmission spectra takes place in the percolated nanostructures; the maximum THz-field-induced transmittance difference, 50% more, is reached just above the percolation threshold thickness. Fitting the experimental data to a Drude-Smith model, we found furthermore that the localization parameter and the damping constant strongly depend on the applied THz-field strength. These results show that ultrafast nonlinear electron delocalization proceeds via strong electric field of THz pulses; the intense THz electric field modulates the backscattering rate of localized electrons and induces electron tunneling between Au nanostructures across the narrow insulating bridges without any material breakdown.	[Yoshioka, Katsumasa; Minami, Yasuo; Shudo, Ken-ichi; Kitajima, Masahiro; Takeda, Jun; Katayama, Ikufumi] Yokohama Natl Univ, Grad Sch Engn, Dept Phys, Yokohama, Kanagawa 2408501, Japan; [Dao, Thang D.; Nagao, Tadaaki; Kitajima, Masahiro] Natl Inst Mat Sci, Int Ctr Mat Nanoarchitecton, Tsukuba, Ibaraki 3050044, Japan; [Dao, Thang D.; Nagao, Tadaaki; Kitajima, Masahiro] Japan Sci & Technol Agcy, CREST, Kawaguchi, Saitama 3320012, Japan; [Kitajima, Masahiro] LxRay Co Ltd, Nishinomiya, Hyogo 6638172, Japan; [Kitajima, Masahiro] Natl Def Acad, Dept Appl Phys, Yokosuka, Kanagawa 2398686, Japan	Takeda, J (reprint author), Yokohama Natl Univ, Grad Sch Engn, Dept Phys, Yokohama, Kanagawa 2408501, Japan.	minamiyasuo@ynu.ac.jp; jun@ynu.ac.jp; katayama@ynu.ac.jp	Minami, Yasuo/H-4834-2013; Dao, Thang/E-3519-2015	Minami, Yasuo/0000-0002-3382-9160; 	Japan Society for the Promotion of Science (JSPS) [23211034, 23760045, 26107517, 26610083]; Ministry of Education, Culture, Sports, Science, and Technology (MEXT)	This work was supported in part by Grants-in-Aid for Scientific Research (Nos. 23211034, 23760045, 26107517, and 26610083) from the Japan Society for the Promotion of Science (JSPS) and the Ministry of Education, Culture, Sports, Science, and Technology (MEXT).	Minami Y, 2013, APPL PHYS LETT, V102, DOI 10.1063/1.4789773; JOHNSON PB, 1972, PHYS REV B, V6, P4370, DOI 10.1103/PhysRevB.6.4370; Junginger F, 2012, PHYS REV LETT, V109, DOI 10.1103/PhysRevLett.109.147403; Blanchard F, 2014, OPT LETT, V39, P4333, DOI 10.1364/OL.39.004333; Hwang HY, 2013, J PHYS CHEM B, V117, P15819, DOI 10.1021/jp407548a; Liu MK, 2012, NATURE, V487, P345, DOI 10.1038/nature11231; Somma C, 2014, PHYS REV LETT, V112, DOI 10.1103/PhysRevLett.112.146602; Fulop JA, 2010, OPT EXPRESS, V18, P12311, DOI 10.1364/OE.18.012311; Cooke DG, 2012, PHYS REV LETT, V108, DOI 10.1103/PhysRevLett.108.056603; Katayama I, 2012, PHYS REV LETT, V108, DOI 10.1103/PhysRevLett.108.097401; Richter C, 2010, NAT NANOTECHNOL, V5, P769, DOI [10.1038/nnano.2010.196, 10.1038/NNANO.2010.196]; Tu JJ, 2003, PHYS REV LETT, V90, DOI 10.1103/PhysRevLett.90.017402; Ramakrishnan G, 2011, OPT LETT, V36, P2572, DOI 10.1364/OL.36.002572; Bruggeman DAG, 1935, ANN PHYS-BERLIN, V24, P636; Nemec H, 2009, PHYS REV B, V79, DOI 10.1103/PhysRevB.79.115309; YAGIL Y, 1992, PHYS REV B, V46, P2503, DOI 10.1103/PhysRevB.46.2503; Hirori H, 2011, APPL PHYS LETT, V98, DOI 10.1063/1.3560062; YAGIL Y, 1992, PHYS REV LETT, V69, P1423, DOI 10.1103/PhysRevLett.69.1423; Shafir D, 2012, NATURE, V485, P343, DOI 10.1038/nature11025; Yokota K, 2012, APPL PHYS LETT, V100, DOI 10.1063/1.4729149; Jensen SA, 2013, NANO LETT, V13, P5925, DOI 10.1021/nl402978s; Gompf B, 2007, OPT LETT, V32, P1578, DOI 10.1364/OL.32.001578; Tani S, 2012, PHYS REV LETT, V109, DOI 10.1103/PhysRevLett.109.166603; Hebling J, 2008, IEEE J SEL TOP QUANT, V14, P345, DOI 10.1109/JSTQE.2007.914602; ALBAYATI AH, 1991, SURF SCI, V241, P91, DOI 10.1016/0039-6028(91)90214-D; Gao WL, 2014, NANO LETT, V14, P1242, DOI 10.1021/nl4041274; Wen H, 2008, PHYS REV B, V78, DOI 10.1103/PhysRevB.78.125203; Scholl JA, 2013, NANO LETT, V13, P564, DOI 10.1021/nl304078v; Schubert O, 2014, NAT PHOTONICS, V8, P119, DOI [10.1038/nphoton.2013.349, 10.1038/NPHOTON.2013.349]; BITTAR A, 1984, J PHYS-PARIS, V45, P623, DOI 10.1051/jphys:01984004503062300; Garnett JCM, 1904, PHILOS T R SOC LOND, V203, P385, DOI 10.1098/rsta.1904.0024; GEFEN Y, 1986, PHYS REV LETT, V57, P3097, DOI 10.1103/PhysRevLett.57.3097; Hans J. W., 2014, J OPT SOC AM B, V31, P259; Hoang CV, 2013, SCI REP-UK, V3, DOI 10.1038/srep01175; Jewariya M, 2009, J OPT SOC AM B, V26, pA101, DOI 10.1364/JOSAB.26.00A101; Lovrincic R, 2009, PHYS REV B, V80, DOI 10.1103/PhysRevB.80.205404; Miyamoto T, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3586; Smith NV, 2001, PHYS REV B, V64, DOI 10.1103/PhysRevB.64.155106; Tripathi V, 2006, PHYS REV B, V73, DOI 10.1103/PhysRevB.73.195113; Walther M, 2007, PHYS REV B, V76, DOI 10.1103/PhysRevB.76.125408	40	2	2	AMER CHEMICAL SOC	WASHINGTON	1155 16TH ST, NW, WASHINGTON, DC 20036 USA	1530-6984	1530-6992		NANO LETT	Nano Lett.	FEB	2015	15	2					1036	1040		10.1021/nl503916t		5	Chemistry, Multidisciplinary; Chemistry, Physical; Nanoscience & Nanotechnology; Materials Science, Multidisciplinary; Physics, Applied; Physics, Condensed Matter	Chemistry; Science & Technology - Other Topics; Materials Science; Physics	CB4DI	WOS:000349578000036		
J	Holmes, MJ; Kako, S; Choi, K; Podemski, P; Arita, M; Arakawa, Y				Holmes, Mark J.; Kako, Satoshi; Choi, Kihyun; Podemski, Pawel; Arita, Munetaka; Arakawa, Yasuhiko			Probing the Excitonic States of Site-Controlled GaN Nanowire Quantum Dots	NANO LETTERS			English	Article						nanowire; site-control; quantum dot; excited states	EXCITED-STATES; GROWTH; MOCVD	We report the detection of fully confined excited states and the zero-absorption region of individual site-controlled GaN/AlGaN nanowire quantum dots using photoluminescence excitation spectroscopy, which provides evidence of the true zero-dimensional discrete density of states of such quantum dots. Because of the strong quantum confinement in these dots, the p-shell, d-shell, and even higher energy (including some f-shell) states of a single quantum dot are observed, which provides unprecedented insight into the electronic structure. Several emitters are measured and used to build up an average picture of the electronic structure of a single quantum dot via comparison to theoretical simulations.	[Holmes, Mark J.; Choi, Kihyun; Podemski, Pawel; Arita, Munetaka; Arakawa, Yasuhiko] Univ Tokyo, Inst Nano Quantum Informat Elect, Meguro Ku, Tokyo 1538505, Japan; [Kako, Satoshi; Arakawa, Yasuhiko] Univ Tokyo, Inst Ind Sci, Meguro Ku, Tokyo 1538505, Japan	Holmes, MJ (reprint author), Univ Tokyo, Inst Nano Quantum Informat Elect, Meguro Ku, 4-6-1 Komaba, Tokyo 1538505, Japan.	holmes@iis.u-tokyo.ac.jp; arakawa@iis.u-tokyo.ac.jp			Ministry of Education, Culture, Sports, and Technology (MEXT), Japan	This work was supported by the Project for Developing Innovation Systems of the Ministry of Education, Culture, Sports, and Technology (MEXT), Japan. The authors further acknowledge fruitful discussions with S. Iwamoto, S. Sergent, Y. Ota, and K. Kamide.	Woolf A, 2014, P NATL ACAD SCI USA, V111, P14042, DOI 10.1073/pnas.1415464111; Vurgaftman I, 2003, J APPL PHYS, V94, P3675, DOI 10.1063/1.1600519; Choi K, 2013, J CRYST GROWTH, V370, P328, DOI 10.1016/j.jcrysgro.2012.09.019; Birner S, 2007, IEEE T ELECTRON DEV, V54, P2137, DOI 10.1109/TED.2007.902871; Winkelnkemper M, 2008, J PHYS-CONDENS MAT, V20, DOI 10.1088/0953-8984/20/45/454211; Ramvall P, 1999, APPL PHYS LETT, V75, P1935, DOI 10.1063/1.124876; Heitz R, 2000, PHYS REV B, V62, P11017, DOI 10.1103/PhysRevB.62.11017; Holmes M, 2013, PHYS REV LETT, V111, DOI 10.1103/PhysRevLett.111.057401; Choi K, 2012, J CRYST GROWTH, V357, P58, DOI 10.1016/j.jcrysgro.2012.07.025; Kako S, 2006, NAT MATER, V5, P887, DOI 10.1038/nmat1763; Holmes MJ, 2014, NANO LETT, V14, P982, DOI 10.1021/nl404400d; Bonadeo NH, 1998, SCIENCE, V282, P1473, DOI 10.1126/science.282.5393.1473; Stievater TH, 2001, PHYS REV LETT, V87, DOI 10.1103/PhysRevLett.87.133603; Ware ME, 2005, PHYS REV LETT, V95, DOI 10.1103/PhysRevLett.95.177403; Aharonovich I, 2013, APPL PHYS LETT, V103, DOI 10.1063/1.4813471; Choi K, 2013, APPL PHYS LETT, V103, DOI 10.1063/1.4826931; Podemski P, 2013, APPL PHYS EXPRESS, V6, DOI 10.7567/APEX.6.012102; Besombes L, 2003, PHYS REV LETT, V90, DOI 10.1103/PhysRevLett.90.257402; Besombes L, 2004, EUROPHYS LETT, V65, P144, DOI 10.1209/epl/i2003-10055-9; Ester P, 2007, APPL PHYS LETT, V91, DOI 10.1063/1.2784173; Finley JJ, 2001, PHYS REV B, V63, DOI 10.1103/PhysRevB.63.073307; Hessman D, 1996, APPL PHYS LETT, V69, P749, DOI 10.1063/1.117879; Holmes MJ, 2013, JPN J APPL PHYS, V52, DOI 10.7567/JJAP.52.08JL02; Jarjour AF, 2006, PHYSICA E, V32, P119, DOI 10.1016/j.physe.2005.12.022; Kalliakos S, 2002, APPL PHYS LETT, V80, P428, DOI 10.1063/1.1433165; Reid BPL, 2014, APPL PHYS LETT, V104, DOI 10.1063/1.4886961; Toda Y, 1999, PHYS REV LETT, V82, P4114, DOI 10.1103/PhysRevLett.82.4114; Tomic S, 2009, PHYS REV B, V79, DOI 10.1103/PhysRevB.79.245330; Wang QQ, 2005, PHYS REV B, V72, DOI 10.1103/PhysRevB.72.035306	29	1	1	AMER CHEMICAL SOC	WASHINGTON	1155 16TH ST, NW, WASHINGTON, DC 20036 USA	1530-6984	1530-6992		NANO LETT	Nano Lett.	FEB	2015	15	2					1047	1051		10.1021/nl503949u		5	Chemistry, Multidisciplinary; Chemistry, Physical; Nanoscience & Nanotechnology; Materials Science, Multidisciplinary; Physics, Applied; Physics, Condensed Matter	Chemistry; Science & Technology - Other Topics; Materials Science; Physics	CB4DI	WOS:000349578000038		
J	Zhang, Y; Shibata, K; Nagai, N; Ndebeka-Bandou, C; Bastard, G; Hirakawa, K				Zhang, Ya; Shibata, Kenji; Nagai, Naomi; Ndebeka-Bandou, Camille; Bastard, Gerald; Hirakawa, Kazuhiko			Terahertz Intersublevel Transitions in Single Self-Assembled InAs Quantum Dots with Variable Electron Numbers	NANO LETTERS			English	Article						Terahertz spectroscopy; nanostructures; intersublevel transitions; quantum dots; nanometer-scale spectroscopy	SPECTROSCOPY	We propose a method for performing terahertz spectroscopy on nanometer (nm)-scale systems by using metal nanogap electrodes. Intersublevel transition spectra of single self-assembled InAs quantum dots (QDs) have been measured with high signal/noise ratios by using a single electron transistor geometry that consists of a QD and nanogap metal electrodes as a terahertz detector. Photocurrent distribution with respect to the Coulomb diamonds indicates that there are two mechanisms for the photocurrent generation. When the p shell was fully occupied, we observed rather simple photocurrent spectra induced by the p d transitions. However, when the p shell was half-filled, the photocurrent spectra exhibited a markedly different behavior, which we attribute to the fluctuation in electron configuration when the empty p state is filled back from the electrodes.	[Zhang, Ya; Shibata, Kenji; Nagai, Naomi; Ndebeka-Bandou, Camille; Bastard, Gerald; Hirakawa, Kazuhiko] Univ Tokyo, Inst Ind Sci, Ctr Photon Elect Convergence, Meguro Ku, Tokyo 1538505, Japan; [Shibata, Kenji; Hirakawa, Kazuhiko] Univ Tokyo, Inst Nano Quantum Informat Elect, Meguro Ku, Tokyo 1538505, Japan; [Ndebeka-Bandou, Camille; Bastard, Gerald] Ecole Normale Super, Lab Pierre Aigrain, F-75005 Paris, France	Zhang, Y (reprint author), Univ Tokyo, Inst Ind Sci, Ctr Photon Elect Convergence, Meguro Ku, 4-6-1 Komaba, Tokyo 1538505, Japan.	zhangya@iis.u-tokyo.ac.jp; hirakawa@iis.u-tokyo.ac.jp	Shibata, Kenji/D-6151-2013	Shibata, Kenji/0000-0003-3687-6250	CREST-JST; JSPS [25246004, 25600013, 26706002]; Project for Developing Innovation Systems of MEXT; Canon Foundation; Casio Science Foundation; ITS, University of Tokyo; JSPS/CNRS; Yoshida Scholarship Foundation	We thank T. Ando, S. Komiyama, and Y. Arakawa for fruitful discussions. This work was partly supported by CREST-JST, Grants-in-Aid from JSPS (No. 25246004, No. 25600013, and No. 26706002), Project for Developing Innovation Systems of MEXT, and research grants from the Canon Foundation, and the Casio Science Foundation. G.B. gratefully acknowledges ITS, University of Tokyo for support. C.N.-B. and G.B. thank JSPS/CNRS for support. Y.Z. gratefully acknowledges the support from the Yoshida Scholarship Foundation.	Shibata K, 2012, PHYS REV LETT, V109, DOI 10.1103/PhysRevLett.109.077401; MARZIN JY, 1994, PHYS REV LETT, V73, P716, DOI 10.1103/PhysRevLett.73.716; Kanai Y, 2011, NAT NANOTECHNOL, V6, P511, DOI [10.1038/nnano.2011.103, 10.1038/NNANO.2011.103]; BEENAKKER CWJ, 1991, PHYS REV B, V44, P1646, DOI 10.1103/PhysRevB.44.1646; Petroff PM, 2001, PHYS TODAY, V54, P46, DOI 10.1063/1.1381102; Tarucha S, 1996, PHYS REV LETT, V77, P3613, DOI 10.1103/PhysRevLett.77.3613; Takahashi S, 2010, PHYS REV LETT, V104, DOI 10.1103/PhysRevLett.104.246801; Jacob R, 2012, NANO LETT, V12, P4336, DOI 10.1021/nl302078w; Jung M, 2005, APPL PHYS LETT, V87, DOI 10.1063/1.2131177; DREXLER H, 1994, PHYS REV LETT, V73, P2252, DOI 10.1103/PhysRevLett.73.2252; Hameau S, 1999, PHYS REV LETT, V83, P4152, DOI 10.1103/PhysRevLett.83.4152; Zibik EA, 2009, NAT MATER, V8, P803, DOI [10.1038/nmat2511, 10.1038/NMAT2511]; Dekel E, 1998, PHYS REV LETT, V80, P4991, DOI 10.1103/PhysRevLett.80.4991; GRUNDMANN M, 1995, PHYS REV LETT, V74, P4043, DOI 10.1103/PhysRevLett.74.4043; Houel J, 2007, PHYS REV LETT, V99, DOI 10.1103/PhysRevLett.99.217404; Kanai Y, 2010, PHYS REV B, V82, DOI 10.1103/PhysRevB.82.054512; Sauvage S, 2011, PHYS REV B, V83, DOI 10.1103/PhysRevB.83.035302; Shibata K, 2009, APPL PHYS LETT, V94, DOI 10.1063/1.3123816; Shibata Kenji, 2013, Nat Commun, V4, P2664, DOI 10.1038/ncomms3664; Zibik EA, 2004, PHYS REV B, V70, DOI 10.1103/PhysRevB.70.161305	20	2	2	AMER CHEMICAL SOC	WASHINGTON	1155 16TH ST, NW, WASHINGTON, DC 20036 USA	1530-6984	1530-6992		NANO LETT	Nano Lett.	FEB	2015	15	2					1166	1170		10.1021/nl5042319		5	Chemistry, Multidisciplinary; Chemistry, Physical; Nanoscience & Nanotechnology; Materials Science, Multidisciplinary; Physics, Applied; Physics, Condensed Matter	Chemistry; Science & Technology - Other Topics; Materials Science; Physics	CB4DI	WOS:000349578000057		
J	Tanigaki, T; Takahashi, Y; Shimakura, T; Akashi, T; Tsuneta, R; Sugawara, A; Shindo, D				Tanigaki, Toshiaki; Takahashi, Yoshio; Shimakura, Tomokazu; Akashi, Tetsuya; Tsuneta, Ruriko; Sugawara, Akira; Shindo, Daisuke			Three-Dimensional Observation of Magnetic Vortex Cores in Stacked Ferromagnetic Discs	NANO LETTERS			English	Article						Magnetic vortex; ferromagnetic disc; vector field tomography; electron holography	ELECTRON TOMOGRAPHY; INTERFEROMETRY; RECONSTRUCTION; MICROSCOPY; FIELDS; LOGIC	Electron holographic vector field electron tomography visualized three-dimensional (3D) magnetic vortices in stacked ferromagnetic discs in a nanoscale pillar. A special holder with two sample rotation axes, both without missing wedges, was used to reduce artifacts in the reconstructed 3D magnetic vectors. A 1 MV holography electron microscope was used to precisely measure the magnetic phase shifts. Comparison of the observed 3D magnetic field vector distributions in the magnetic vortex cores with the results of micromagnetic simulations based on the LandauLifshitzGilbert equation showed that the proposed technique is well suited for direct 3D visualization of the spin configurations in magnetic materials and spintronics devices	[Tanigaki, Toshiaki; Takahashi, Yoshio; Shimakura, Tomokazu; Akashi, Tetsuya; Tsuneta, Ruriko; Sugawara, Akira] Hitachi Ltd, Cent Res Lab, Hatoyama, Saitama 3500395, Japan; [Tanigaki, Toshiaki; Shindo, Daisuke] RIKEN, CEMS, Wako, Saitama 3510198, Japan; [Shindo, Daisuke] Tohoku Univ, Inst Multidisciplinary Res Adv Mat, Sendai, Miyagi 9808577, Japan	Tanigaki, T (reprint author), Hitachi Ltd, Cent Res Lab, Hatoyama, Saitama 3500395, Japan.	toshiaki.tanigaki.mv@hitachi.com	Shindo, Daisuke/I-3865-2012		Japan Society for the Promotion of Science (JSPS) through the "Funding Program for World-Leading Innovative R&D on Science and Technology (FIRST Program)"; Council for Science and Technology Policy (CSTP)	The authors thank H. Kashima, Y. Kashiwazaki, K. Terada, A. Sakasai, and T. Matsumoto for their technical support. In particular, the authors are grateful to T. Matsuda, H. S. Park, S. Aizawa, K. Harada, and Y. A. Ono for their valuable discussions. This research was supported by a grant from the Japan Society for the Promotion of Science (JSPS) through the "Funding Program for World-Leading Innovative R&D on Science and Technology (FIRST Program)," initiated by the Council for Science and Technology Policy (CSTP).	Wachowiak A, 2002, SCIENCE, V298, P577, DOI 10.1126/science.1075302; Harada K, 2004, APPL PHYS LETT, V84, P3229, DOI 10.1063/1.1715155; Phatak C, 2010, PHYS REV LETT, V104, DOI 10.1103/PhysRevLett.104.253901; Parkin SSP, 2008, SCIENCE, V320, P190, DOI 10.1126/science.1145799; Shinjo T, 2000, SCIENCE, V289, P930, DOI 10.1126/science.289.5481.930; Nagaosa N, 2013, NAT NANOTECHNOL, V8, P899, DOI [10.1038/nnano.2013.243, 10.1038/NNANO.2013.243]; LAI GM, 1994, J APPL PHYS, V75, P4593, DOI 10.1063/1.355955; Pribiag VS, 2007, NAT PHYS, V3, P498, DOI 10.1038/nphys619; Phatak C, 2008, ULTRAMICROSCOPY, V108, P503, DOI 10.1016/j.ultramic.2007.08.002; Ruotolo A, 2009, NAT NANOTECHNOL, V4, P528, DOI [10.1038/nnano.2009.143, 10.1038/NNANO.2009.143]; UNGURIS J, 1991, PHYS REV LETT, V67, P140, DOI 10.1103/PhysRevLett.67.140; Van Waeyenberge B, 2006, NATURE, V444, P461, DOI 10.1038/nature05240; Wolf SA, 2001, SCIENCE, V294, P1488, DOI 10.1126/science.1065389; Voelkl E, 2010, ULTRAMICROSCOPY, V110, P447, DOI 10.1016/j.ultramic.2009.11.017; Suzuki T, 2012, ULTRAMICROSCOPY, V118, P21, DOI 10.1016/j.ultramic.2012.04.007; TONOMURA A, 1992, ADV PHYS, V41, P59, DOI 10.1080/00018739200101473; Yamada K, 2007, NAT MATER, V6, P269, DOI 10.1038/nmat1867; Jung H, 2012, ACS NANO, V6, P3712, DOI 10.1021/nn3000143; Allwood DA, 2005, SCIENCE, V309, P1688, DOI 10.1126/science.1108813; Bussmann K, 1999, APPL PHYS LETT, V75, P2476, DOI 10.1063/1.125053; Dussaux A, 2010, NAT COMMUN, V1, DOI 10.1038/ncomms1006; Kamino T, 2004, J ELECTRON MICROSC, V53, P583, DOI 10.1093/jmicro/dfh089; Kammerer M., 2010, NAT COMMUN, V2, P279; Kawasaki T, 2000, APPL PHYS LETT, V76, P1342, DOI 10.1063/1.126028; Lade SJ, 2005, OPT COMMUN, V253, P392, DOI 10.1016/j.optcom.2005.04.071; Messaoudil C, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-288; Ohnishi T., 1999, ISTFA '99. Proceedings of the 25th International Symposium for Testing and Failure Analysis; Paganin D, 2001, ADV IMAG ELECT PHYS, V118, P85, DOI 10.1016/S1076-5670(01)80104-X; Stolojan V., 1999, C SERIES I PHYS, V168, P243; Tonomura A, 2001, NATURE, V412, P620, DOI 10.1038/35088021; Tonomura A, 1999, ELECT HOLOGRAPHY; Tsuneta R, 2014, MICROSCOPY-JPN, V63, P469, DOI 10.1093/jmicro/dfu030	32	5	5	AMER CHEMICAL SOC	WASHINGTON	1155 16TH ST, NW, WASHINGTON, DC 20036 USA	1530-6984	1530-6992		NANO LETT	Nano Lett.	FEB	2015	15	2					1309	1314		10.1021/nl504473a		6	Chemistry, Multidisciplinary; Chemistry, Physical; Nanoscience & Nanotechnology; Materials Science, Multidisciplinary; Physics, Applied; Physics, Condensed Matter	Chemistry; Science & Technology - Other Topics; Materials Science; Physics	CB4DI	WOS:000349578000078		
J	Imamura, M; Uchihashi, T; Ando, T; Leifert, A; Simon, U; Malay, AD; Heddle, JG				Imamura, Motonori; Uchihashi, Takayuki; Ando, Toshio; Leifert, Annika; Simon, Ulrich; Malay, Ali D.; Heddle, Jonathan G.			Probing Structural Dynamics of an Artificial Protein Cage Using High-Speed Atomic Force Microscopy	NANO LETTERS			English	Article						Protein cage; protein folding; protein disassembly; gold nanoparticle; disulfide bond; high-speed atomic force microscopy	BIOMOLECULAR PROCESSES; BACILLUS-SUBTILIS; GOLD CATALYSTS; TRP OPERON; OXIDATION; RNA; CLUSTERS; TRAP	A cysteine-substituted mutant of the ring-shaped protein TRAP (trp-RNA binding attenuation protein) can be induced to self-assemble into large, monodisperse hollow spherical cages in the presence of 1.4 nm diameter gold nanoparticles. In this study we use high-speed atomic force microscopy (HS-AFM) to probe the dynamics of the structural changes related to TRAP interactions with the gold nanoparticle as well as the disassembly of the cage structure. The dynamic aggregation of TRAP protein in the presence of gold nanoparticles was observed, including oligomeric rearrangements, consistent with a role for gold in mediating intermolecular disulfide bond formation. We were also able to observe that the TRAP-cage is composed of multiple, closely packed TRAP rings in an apparently regular arrangement. A potential role for inter-ring disulfide bonds in forming the TRAP-cage was shown by the fact that ringring interactions were reversed upon the addition of reducing agent dithiothreitol. A dramatic disassembly of TRAP-cages was observed using HS-AFM after the addition of dithiothreitol. To the best of our knowledge, this is the first report to show direct high-resolution imaging of the disassembly process of a large protein complex in real time.	[Imamura, Motonori; Malay, Ali D.; Heddle, Jonathan G.] RIKEN, Heddle Initiat Res Unit, Wako, Saitama 3510198, Japan; [Imamura, Motonori] Tokyo Inst Technol, Dept Biol Informat, Yokohama, Kanagawa 2268502, Japan; [Uchihashi, Takayuki; Ando, Toshio] Kanazawa Univ, Dept Phys, Kanazawa, Ishikawa 9201192, Japan; [Uchihashi, Takayuki; Ando, Toshio] Kanazawa Univ, BioAFM Frontier Res Ctr, Kanazawa, Ishikawa 9201192, Japan; [Leifert, Annika; Simon, Ulrich] Rhein Westfal TH Aachen, Inst Inorgan Chem, D-52074 Aachen, Germany	Malay, AD (reprint author), RIKEN, Heddle Initiat Res Unit, 2-1 Hirosawa, Wako, Saitama 3510198, Japan.	a.malay@riken.jp; heddle@riken.jp	Simon, Ulrich/K-7737-2013; ANDO, Toshio/E-7054-2015; Uchihashi, Takayuki/D-5209-2011; Heddle, Jonathan/H-4586-2014; Malay, Ali/N-9136-2015	Simon, Ulrich/0000-0002-6118-0573; ANDO, Toshio/0000-0001-8819-154X; Malay, Ali/0000-0003-0885-5524	RIKEN Initiative Research Funding; MEXT [25560231, 24227005, 30326300]; Deutsche Forschungsgemeinschaft [Si609/9, SFB 985]	M.I., A.D.M., and J.G.H. were funded by RIKEN Initiative Research Funding awarded to J.G.H. M.I. was a RIKEN Junior Research Associate. A.D.M. was funded by a MEXT Grant-in-Aid for Challenging Exploratory Research (grant #25560231). T.U. and T.A. were funded by MEXT Grant-in-Aids for Basic Research (grants #24227005 and #30326300 respectively). A.L. and U.S. are grateful for financial support by the Deutsche Forschungsgemeinschaft (Investigator Grants Si609/9 and SFB 985). We thank Soshichiro Nagano, RIKEN, Japan for the gift of TRAP WT.	Cedervall T, 2007, P NATL ACAD SCI USA, V104, P2050, DOI 10.1073/pnas.0608582104; Shichibu Y, 2007, SMALL, V3, P835, DOI 10.1002/smll.200600611; HARUTA M, 1987, CHEM LETT, P405, DOI 10.1246/cl.1987.405; Ando T, 2014, CHEM REV, V114, P3120, DOI 10.1021/cr4003837; Miranda FF, 2009, SMALL, V5, P2077, DOI 10.1002/smll.200900667; Ando T, 2001, P NATL ACAD SCI USA, V98, P12468, DOI 10.1073/pnas.211400898; Yanofsky C, 2007, RNA, V13, P1141, DOI 10.1261/rna.620507; Corma A, 2012, CHEM SCI, V3, P398, DOI 10.1039/c1sc00466b; Ando T, 2008, PFLUG ARCH EUR J PHY, V456, P211, DOI 10.1007/s00424-007-0406-0; Malay AD, 2012, NANO LETT, V12, P2056, DOI 10.1021/nl3002155; Turner M, 2008, NATURE, V454, P981, DOI 10.1038/nature07194; Chen XP, 1999, J MOL BIOL, V289, P1003, DOI 10.1006/jmbi.1999.2834; Gollnick P, 2005, ANNU REV GENET, V39, P47, DOI 10.1146/annurev.genet.39.073003.093745; GOLLNICK P, 1994, MOL MICROBIOL, V11, P991, DOI 10.1111/j.1365-2958.1994.tb00377.x; Heddle JG, 2007, SMALL, V3, P1950, DOI 10.1002/smll.200700400; Heddle JG, 2013, CATALYSTS, V3, P683, DOI 10.3390/catal3030683; Heddle JG, 2006, STRUCTURE, V14, P925, DOI 10.1016/j.str.2006.03.013; Hopcroft NH, 2004, J MOL BIOL, V338, P43, DOI 10.1016/j.jmb.2004.02.038; Schrodinger LLC, 2010, PYMOL MOL GRAPHICS S; Yamazoe S, 2014, ACCOUNTS CHEM RES, V47, P816, DOI 10.1021/ar400209a	20	1	1	AMER CHEMICAL SOC	WASHINGTON	1155 16TH ST, NW, WASHINGTON, DC 20036 USA	1530-6984	1530-6992		NANO LETT	Nano Lett.	FEB	2015	15	2					1331	1335		10.1021/nl5045617		5	Chemistry, Multidisciplinary; Chemistry, Physical; Nanoscience & Nanotechnology; Materials Science, Multidisciplinary; Physics, Applied; Physics, Condensed Matter	Chemistry; Science & Technology - Other Topics; Materials Science; Physics	CB4DI	WOS:000349578000081		
J	Hirao, K; Pontone, GM; Smith, GS				Hirao, Kentaro; Pontone, Gregory M.; Smith, Gwenn S.			Molecular imaging of neuropsychiatric symptoms in Alzheimer's and Parkinson's disease	NEUROSCIENCE AND BIOBEHAVIORAL REVIEWS			English	Review						Positron emission tomography; Molecular imaging; Serotonin; Dopamine; Acetylcholine; Alzheimer's disease; Parkinson's disease; Neuropsychiatric symptoms	MILD COGNITIVE IMPAIRMENT; POSITRON-EMISSION-TOMOGRAPHY; PLACEBO-CONTROLLED TRIAL; STRIATAL DOPAMINE TRANSPORTER; PITTSBURGH COMPOUND-B; ATYPICAL ANTIPSYCHOTIC MEDICATIONS; CEREBRAL-BLOOD-FLOW; SEROTONIN 2A RECEPTORS; IN-VIVO; AMYLOID DEPOSITION	Neuropsychiatric symptoms (NPS) are very common in neurodegenerative diseases and are a major contributor to disability and caregiver burden. There is accumulating evidence that NPS may be a prodrome and/or a "risk factor" of neurodegenerative diseases. The medications used to treat these symptoms in younger patients are not very effective in patients with neurodegenerative disease and may have serious side effects. An understanding of the neurobiology of NPS is critical for the development Of more effective intervention strategies. Targeting these symptoms may also have implications for prevention of cognitive or motor decline. Molecular brain imaging represents a bridge between basic and clinical observations and provides many opportunities for translation from animal models and human post-mortem studies to in vivo human studies. Molecular brain imaging studies in Alzheimer's disease (AD) and Parkinson's disease (PD) are reviewed with a primary focus on positron emission tomography studies of NPS. Future directions for the field of molecular imaging in AD and PD to understand the neurobiology of NPS will be discussed. (C) 2014 Elsevier Ltd. All rights reserved.	[Hirao, Kentaro; Pontone, Gregory M.; Smith, Gwenn S.] Johns Hopkins Univ, Sch Med, Dept Psychiat & Behav Sci, Baltimore, MD 21224 USA; [Hirao, Kentaro] Tokyo Med Univ, Dept Geriatr Med, Tokyo 1608402, Japan	Smith, GS (reprint author), Johns Hopkins Univ, Sch Med, Johns Hopkins Bayview Med Ctr, Div Geriatr Psychiat & Neuropsychiat, 5300 Alpha Commons Dr,Fourth Floor, Baltimore, MD 21224 USA.	gsmith95@jhmi.edu			National Institute of Health/National Institute of Mental Health [RO1 MH 086881]; National Institute of Health/National Institute on Aging [K23AG044441, AG038893, AG041633]	Supported in part by National Institute of Health/National Institute of Mental Health: RO1 MH 086881 (GSS) and National Institute of Health/National Institute on Aging: K23AG044441 (GMP), AG038893 (GSS) and AG041633 (GSS).	Albert MS, 2011, NEUROBIOL AGING, V32, pS58, DOI 10.1016/j.neurobiolaging.2011.09.010; Parnetti L, 2013, NAT REV NEUROL, V9, P131, DOI [10.1038/nrneurol.2013.10, 10.1038/nmeurol.2013.10]; Weintraub D, 2005, J NUCL MED, V46, P227; Menza M, 2009, NEUROLOGY, V72, P886, DOI 10.1212/01.wnl.0000336340.89821.b3; Marner L, 2012, NEUROBIOL AGING, V33, P479, DOI 10.1016/j.neurobiolaging.2010.03.023; Mori T, 2014, J NEUROL NEUROSUR PS, V85, P449, DOI 10.1136/jnnp-2013-306110; Leentjens AFG, 2011, MOVEMENT DISORD, V26, P484, DOI 10.1002/mds.23528; Liu Y, 2008, J NEUROSCI, V28, P13805, DOI 10.1523/JNEUROSCI.4218-08.2008; Jack CR, 2009, BRAIN, V132, P1355, DOI 10.1093/brain/awp062; Borghammer P, 2012, ACTA NEUROL SCAND, V125, P303, DOI 10.1111/j.1600-0404.2011.01556.x; WHITEHOUSE PJ, 1982, SCIENCE, V215, P1237, DOI 10.1126/science.7058341; Doder M, 2003, NEUROLOGY, V60, P601; MAYBERG HS, 1990, ANN NEUROL, V28, P57, DOI 10.1002/ana.410280111; BLESSED G, 1968, BRIT J PSYCHIAT, V114, P797, DOI 10.1192/bjp.114.512.797; WHITEHOUSE PJ, 1986, PROG NEURO-PSYCHOPH, V10, P665, DOI 10.1016/0278-5846(86)90035-7; Walker Z, 2004, NEUROLOGY, V62, P1568; Kuhl DE, 1999, NEUROLOGY, V52, P691; Pike KE, 2007, BRAIN, V130, P2837, DOI 10.1093/brain/awm238; Brodney MA, 2012, J MED CHEM, V55, P9240, DOI 10.1021/jm300953p; Ballanger B, 2012, MOVEMENT DISORD, V27, P84, DOI 10.1002/mds.23895; HUGHES AJ, 1992, J NEUROL NEUROSUR PS, V55, P181, DOI 10.1136/jnnp.55.3.181; Rogers MA, 1998, BRAIN RES BULL, V47, P297, DOI 10.1016/S0361-9230(98)00126-9; NORDBERG A, 1994, NEUROCHEM INT, V25, P93, DOI 10.1016/0197-0186(94)90059-0; BIERER LM, 1995, J NEUROCHEM, V64, P749; Kreisl WC, 2013, BRAIN, V136, P2228, DOI 10.1093/brain/awt145; PERRY EK, 1978, NEUROPATH APPL NEURO, V4, P273, DOI 10.1111/j.1365-2990.1978.tb00545.x; Barone P, 2006, J NEUROL, V253, P601, DOI 10.1007/s00415-006-0067-5; Ziolko SK, 2006, NEUROIMAGE, V33, P94, DOI 10.1016/j.neuroimage.2006.05.063; DAVIES P, 1976, LANCET, V2, P1403; Hasselbalch SG, 2008, NEUROBIOL AGING, V29, P1830, DOI 10.1016/j.neurobiolaging.2007.04.011; Sultzer DL, 2008, AM J PSYCHIAT, V165, P844, DOI 10.1176/appi.ajp.2008.07111779; Kandiah N, 2014, J NEUROL SCI, V337, P162, DOI 10.1016/j.jns.2013.11.042; Sheng JG, 1998, ACTA NEUROPATHOL, V95, P229; Gotti C, 2006, NEUROBIOL DIS, V23, P481, DOI 10.1016/j.nbd.2006.04.005; Joutsa J, 2013, J PARKINSON DIS, V3, P325, DOI 10.3233/JPD-130205; Dauer W, 2003, NEURON, V39, P889, DOI 10.1016/S0896-6273(03)00568-3; Erro R, 2012, PARKINSONISM RELAT D, V18, P1034, DOI 10.1016/j.parkreldis.2012.05.022; Witjas T, 2002, NEUROLOGY, V59, P408; Kuhl DE, 1996, ANN NEUROL, V40, P399, DOI 10.1002/ana.410400309; Gomperts SN, 2013, NEUROLOGY, V80, P85, DOI 10.1212/WNL.0b013e31827b1a07; FRIEDLAND RP, 1983, J COMPUT ASSIST TOMO, V7, P590, DOI 10.1097/00004728-198308000-00003; Sultzer DL, 2003, AM J PSYCHIAT, V160, P341, DOI 10.1176/appi.ajp.160.2.341; Weintraub D, 2011, MOVEMENT DISORD, V26, P1022, DOI 10.1002/mds.23664; Mentis MJ, 2002, AM J PSYCHIAT, V159, P746, DOI 10.1176/appi.ajp.159.5.746; Thomas A, 2010, ANN NEUROL, V68, P400, DOI 10.1002/ana.22029; Simoni-Wastila L, 2009, AM J GERIAT PSYCHIAT, V17, P417, DOI 10.1097/JGP.0b013e31819b8936; Brooks DJ, 2010, BIOMARK MED, V4, P651, DOI [10.2217/bmm.10.86, 10.2217/BMM.10.86]; Steeves TDL, 2009, BRAIN, V132, P1376, DOI 10.1093/brain/awp054; Morgante L, 2004, CLIN NEUROPHARMACOL, V27, P153, DOI 10.1097/01.wnf.0000136891.17006.ec; Martin-Ruiz CM, 1999, J NEUROCHEM, V73, P1635, DOI 10.1046/j.1471-4159.1999.0731635.x; Forsberg A, 2008, NEUROBIOL AGING, V29, P1456, DOI 10.1016/j.neurobiolaging.2007.03.029; Brown DR, 2009, THESCIENTIFICWORLDJO, V9, P1061, DOI 10.1100/tsw.2009.111; Court JA, 2000, J CHEM NEUROANAT, V20, P281, DOI 10.1016/S0891-0618(00)00110-1; Rommelfanger KS, 2007, BIOCHEM PHARMACOL, V74, P177, DOI 10.1016/j.bcp.2007.01.036; Reeves S, 2009, NEUROLOGY, V72, P528, DOI 10.1212/01.wnl.0000341932.21961.f3; Kish SJ, 2008, BRAIN, V131, P120, DOI 10.1093/brain/awm239; Steensland P, 2012, BIOL PSYCHIAT, V72, P823, DOI 10.1016/j.biopsych.2012.06.018; WHITEHOUSE PJ, 1988, NEUROLOGY, V38, P720; DEKOSKY ST, 1992, ANN NEUROL, V32, P625; Barone P, 2010, LANCET NEUROL, V9, P573, DOI 10.1016/S1474-4422(10)70106-X; Frisina PG, 2008, INT J NEUROSCI, V118, P667, DOI 10.1080/00207450701239418; Kemppainen NM, 2007, NEUROLOGY, V68, P1603, DOI 10.1212/01.wnl.0000260969.94695.56; David R, 2008, CLIN NEUROL NEUROSUR, V110, P19, DOI 10.1016/j.clineuro.2007.08.007; Tariot PN, 2011, ARCH GEN PSYCHIAT, V68, P853, DOI 10.1001/archgenpsychiatry.2011.72; Geda YE, 2013, ALZHEIMERS DEMENT, V9, P602, DOI 10.1016/j.jalz.2012.12.001; Schuitemaker A, 2013, NEUROBIOL AGING, V34, P128, DOI 10.1016/j.neurobiolaging.2012.04.021; Wiley CA, 2009, ARCH NEUROL-CHICAGO, V66, P60, DOI 10.1001/archneurol.2008.511; Aarsland D, 2009, MOVEMENT DISORD, V24, P2175, DOI 10.1002/mds.22589; Huang CR, 2007, NEUROIMAGE, V34, P714, DOI 10.1016/j.neuroimage.2006.09.003; Tighe SK, 2012, J NEUROPSYCH CLIN N, V24, P484, DOI 10.1176/appi.neuropsych.11120375; Kendziorra K, 2011, EUR J NUCL MED MOL I, V38, P515, DOI 10.1007/s00259-010-1644-5; MCGEER EG, 1990, J NEUROSCI RES, V27, P612, DOI 10.1002/jnr.490270422; Truchot L, 2007, NEUROLOGY, V69, P1012, DOI 10.1212/01.wnl.0000271377.52421.4a; Banerjee S, 2011, LANCET, V378, P403, DOI 10.1016/S0140-6736(11)60830-1; Politis M, 2010, NEUROBIOL DIS, V40, P216, DOI 10.1016/j.nbd.2010.05.028; Walker Z, 2002, J NEUROL NEUROSUR PS, V73, P134, DOI 10.1136/jnnp.73.2.134; Zubieta JK, 2001, SYNAPSE, V39, P275, DOI 10.1002/1098-2396(20010315)39:4<275::AID-SYN1010>3.0.CO;2-3; Klunk WE, 2004, ANN NEUROL, V55, P306, DOI 10.1002/ana.20009; Seppi K, 2011, MOVEMENT DISORD, V26, pS42, DOI 10.1002/mds.23884; BOWEN DM, 1983, J NEUROCHEM, V41, P266, DOI 10.1111/j.1471-4159.1983.tb11838.x; Rosenberg PB, 2010, AM J GERIAT PSYCHIAT, V18, P136, DOI 10.1097/JGP.0b013e3181c796eb; Pontone GM, 2009, MOVEMENT DISORD, V24, P1333, DOI 10.1002/mds.22611; Delacourte A, 1999, NEUROLOGY, V52, P1158; Schapira AHV, 2013, CURR OPIN NEUROL, V26, P395, DOI 10.1097/WCO.0b013e3283633741; Steinberg M, 2008, INT J GERIATR PSYCH, V23, P170, DOI 10.1002/gps.1858; Boileau I, 2008, MOVEMENT DISORD, V23, P1776, DOI 10.1002/mds.22212; Bohnen NI, 2012, J CEREBR BLOOD F MET, V32, P1609, DOI 10.1038/jcbfm.2012.60; Bruck A, 2005, NEUROBIOL AGING, V26, P891, DOI 10.1016/j.neurobiolaging.2004.07.014; Haroon E, 2012, NEUROPSYCHOPHARMACOL, V37, P137, DOI 10.1038/npp.2011.205; Gauthier S, 2010, INT PSYCHOGERIATR, V22, P346, DOI 10.1017/S1041610209991505; DEKOSKY ST, 1990, ANN NEUROL, V27, P457, DOI 10.1002/ana.410270502; Rabinovici GD, 2009, BEHAV NEUROL, V21, P117, DOI 10.3233/BEN-2009-0232; GOTO S, 1989, ANN NEUROL, V26, P766, DOI 10.1002/ana.410260613; Morris JC, 2009, ARCH NEUROL-CHICAGO, V66, P1469, DOI 10.1001/archneurol.2009.269; Remy P, 2005, BRAIN, V128, P1314, DOI 10.1093/brain/awh445; MARICLE RA, 1995, NEUROLOGY, V45, P1757; Dissanayaka NNW, 2010, MOVEMENT DISORD, V25, P838, DOI 10.1002/mds.22833; Edison P, 2008, NEUROBIOL DIS, V32, P412, DOI 10.1016/j.nbd.2008.08.001; PALMER AM, 1987, J NEUROCHEM, V48, P8, DOI 10.1111/j.1471-4159.1987.tb13120.x; Devos D, 2008, MOVEMENT DISORD, V23, P850, DOI 10.1002/mds.21966; Bohnen NI, 2003, ARCH NEUROL-CHICAGO, V60, P1745, DOI 10.1001/archneur.60.12.1745; Vigen CLP, 2011, AM J PSYCHIAT, V168, P831, DOI 10.1176/appi.ajp.2011.08121844; Cummings JL, 1998, AM J GERIAT PSYCHIAT, V6, pS64; Hammoud DA, 2010, NEUROIMAGE, V49, P2588, DOI 10.1016/j.neuroimage.2009.10.037; Olin JT, 2002, AM J GERIAT PSYCHIAT, V10, P125; Marshall GA, 2007, ARCH NEUROL-CHICAGO, V64, P1015, DOI 10.1001/archneur.64.7.1015; Lopez OL, 2001, J NEUROPSYCH CLIN N, V13, P56, DOI 10.1176/appi.neuropsych.13.1.56; Arnold SE, 1991, CEREB CORTEX, V1, P103, DOI 10.1093/cercor/1.1.103; Chaudhuri KR, 2006, LANCET NEUROL, V5, P235, DOI 10.1016/S1474-4422(06)70373-8; DAMATO RJ, 1987, ANN NEUROL, V22, P229, DOI 10.1002/ana.410220207; Huang C, 2008, NEUROLOGY, V70, P1470, DOI 10.1212/01.wnl.0000304050.05332.9c; Davis KL, 1999, JAMA-J AM MED ASSOC, V281, P1401, DOI 10.1001/jama.281.15.1401; Tanaka Y, 2003, ANN NUCL MED, V17, P567; Fenelon G, 2010, J NEUROL SCI, V289, P12, DOI 10.1016/j.jns.2009.08.014; Campbell MC, 2013, NEUROLOGY, V81, P520, DOI 10.1212/WNL.0b013e31829e6f94; Reijnders JSAM, 2008, MOVEMENT DISORD, V23, P183, DOI 10.1002/mds.21803; Rowe CC, 2007, NEUROLOGY, V68, P1718, DOI 10.1212/01.wnl.0000261919.22630.ea; Wang PS, 2005, NEW ENGL J MED, V353, P2335, DOI 10.1056/NEJMoa052827; Kostic VS, 2011, J NEUROL SCI, V310, P61, DOI [10.1016/j.jns.2011.05.036, 10.1016/j.jns.2011.08.036]; Rosenberg PB, 2012, INT J GERIATR PSYCH, V27, P1248, DOI 10.1002/gps.3769; Marner L, 2011, J ALZHEIMERS DIS, V23, P453, DOI 10.3233/JAD-2010-100903; Lavretsky H, 2009, AM J GERIAT PSYCHIAT, V17, P493, DOI 10.1097/JGP.0b013e3181953b82; Rosenberg PB, 2013, J CLIN PSYCHIAT, V74, P810, DOI 10.4088/JCP.12m08099; O'Brien JT, 2007, J NEUROL NEUROSUR PS, V78, P356, DOI 10.1136/jnnp.2006.108209; Niethammer M, 2013, NEUROIMAGE, V78, P204, DOI 10.1016/j.neuroimage.2013.03.070; Garcia-Alloza M, 2005, NEUROPSYCHOLOGIA, V43, P442, DOI 10.1016/j.neuropsychologia.2004.06.007; Verhoeff NPLG, 2004, AM J GERIAT PSYCHIAT, V12, P584, DOI 10.1176/appi.ajgp.12.6.584; Nelson PT, 2012, J NEUROPATH EXP NEUR, V71, P362, DOI 10.1097/NEN.0b013e31825018f7; Burghaus Lothar, 2000, Molecular Brain Research, V76, P385, DOI 10.1016/S0169-328X(00)00031-0; Aizenstein HJ, 2008, ARCH NEUROL-CHICAGO, V65, P1509, DOI 10.1001/archneur.65.11.1509; Ellis JR, 2009, SYNAPSE, V63, P752, DOI 10.1002/syn.20642; Bohnen NI, 2007, MOL IMAGING BIOL, V9, P243, DOI 10.1007/s11307-007-0083-6; Hely MA, 2005, MOVEMENT DISORD, V20, P190, DOI 10.1002/mds.20324; Ikonomovic MD, 2008, BRAIN, V131, P1630, DOI 10.1093/brain/awn016; Trillo L, 2013, NEUROSCI BIOBEHAV R, V37, P1363, DOI 10.1016/j.neubiorev.2013.05.008; NAZARALI AJ, 1992, CELL MOL NEUROBIOL, V12, P581, DOI 10.1007/BF00711237; VOLKOW ND, 1994, SYNAPSE, V16, P255, DOI 10.1002/syn.890160402; Lai MKP, 2011, PSYCHOPHARMACOLOGY, V213, P431, DOI 10.1007/s00213-010-1936-2; Factor SA, 2001, MOVEMENT DISORD, V16, P135, DOI 10.1002/1531-8257(200101)16:1<135::AID-MDS1006>3.0.CO;2-Q; SIEMERS ER, 1993, MOVEMENT DISORD, V8, P501, DOI 10.1002/mds.870080415; Politis M, 2010, NEUROLOGY, V75, P1920, DOI 10.1212/WNL.0b013e3181feb2ab; Hashimoto H, 2006, J NEUROPSYCH CLIN N, V18, P521, DOI 10.1176/appi.neuropsych.18.4.521; Colloby SJ, 2011, NEUROBIOL AGING, V32, P293, DOI 10.1016/j.neurobiolaging.2009.02.005; Mufson EJ, 2007, CURR ALZHEIMER RES, V4, P340, DOI 10.2174/156720507781788855; Ray NJ, 2012, NEUROBIOL DIS, V48, P519, DOI 10.1016/j.nbd.2012.06.021; Ouchi Y, 2009, J NUCL MED, V50, P1260, DOI 10.2967/jnumed.109.063008; Small GW, 2006, NEW ENGL J MED, V355, P2652, DOI 10.1056/NEJMoa054625; ZWEIG RM, 1988, ANN NEUROL, V24, P233, DOI 10.1002/ana.410240210; Villemagne VL, 2008, MOL NEUROBIOL, V38, P1, DOI 10.1007/s12035-008-8019-y; Mathis CA, 2003, J MED CHEM, V46, P2740, DOI 10.1021/jm030026b; Aalten P, 2005, INT J GERIATR PSYCH, V20, P531, DOI 10.1002/gps.1317; Mormino EC, 2009, BRAIN, V132, P1310, DOI 10.1093/brain/awn320; Resnick SM, 2010, NEUROLOGY, V74, P807, DOI 10.1212/WNL.0b013e3181d3e3e9; Bloem BR, 2001, J NEUROL, V248, P950, DOI 10.1007/s004150170047; Jeste DV, 2000, AM J GERIAT PSYCHIAT, V8, P29; Carod-Artal FJ, 2008, PARKINSONISM RELAT D, V14, P102, DOI 10.1016/j.parkreldis.2007.06.011; Petrou M, 2012, NEUROLOGY, V79, P1161, DOI 10.1212/WNL.0b013e3182698d4a; RING HA, 1994, BRIT J PSYCHIAT, V165, P333, DOI 10.1192/bjp.165.3.333; Shoghi-Jadid K, 2002, AM J GERIAT PSYCHIAT, V10, P24, DOI 10.1176/appi.ajgp.10.1.24; Weintraub D, 2010, ARCH NEUROL-CHICAGO, V67, P589, DOI 10.1001/archneurol.2010.65; BROOKS DJ, 1990, ANN NEUROL, V28, P547, DOI 10.1002/ana.410280412; Li Y, 2008, EUR J NUCL MED MOL I, V35, P2169, DOI 10.1007/s00259-008-0833-y; Piggott MA, 1999, BRAIN, V122, P1449, DOI 10.1093/brain/122.8.1449; Butters MA, 2008, ALZ DIS ASSOC DIS, V22, P261, DOI 10.1097/WAD.0b013e31816c92bf; Ouchi Y, 2005, ANN NEUROL, V57, P168, DOI 10.1002/ana.20338; Kamble P, 2009, DRUG AGING, V26, P483, DOI 10.2165/00002512-200926060-00005; Guan ZZ, 2000, J NEUROCHEM, V74, P237, DOI 10.1046/j.1471-4159.2000.0740237.x; RINNE JO, 1989, ANN NEUROL, V26, P47, DOI 10.1002/ana.410260107; BAKER GB, 1989, NEUROSCI LETT, V100, P335, DOI 10.1016/0304-3940(89)90709-X; Ballanger B, 2010, ARCH NEUROL-CHICAGO, V67, P416, DOI 10.1001/archneurol.2010.35; BLIN J, 1993, BRAIN, V116, P497, DOI 10.1093/brain/116.3.497; Bohnen NI, 2010, BRAIN, V133, P1747, DOI 10.1093/brain/awq079; BOWEN DM, 1979, LANCET, V1, P11; Connolly BS, 2012, EXPERT REV NEUROTHER, V12, P1439, DOI [10.1586/ern.12.142, 10.1586/ERN.12.142]; Counts SE, 2007, ARCH NEUROL-CHICAGO, V64, P1771, DOI 10.1001/archneur.64.12.1771; CROSS AJ, 1983, J NEUROL SCI, V60, P383, DOI 10.1016/0022-510X(83)90149-1; Donovan N.J., 2013, AM J GERIATR PSYCHIA; Drye LT, 2011, INT J GERIATR PSYCH, V26, P573, DOI 10.1002/gps.2565; EIDELBERG D, 1994, J CEREBR BLOOD F MET, V14, P783; Fahn Stanley, 2004, NeuroRx, V1, P139, DOI 10.1007/BF03206574; FEARNLEY JM, 1991, BRAIN, V114, P2283, DOI 10.1093/brain/114.5.2283; Felicio AC, 2010, PSYCHOPHARMACOLOGY, V211, P27, DOI 10.1007/s00213-010-1867-y; Ferris S H, 1983, Adv Neurol, V38, P123; FLYNN DD, 1986, J NEUROCHEM, V47, P1948, DOI 10.1111/j.1471-4159.1986.tb13113.x; Frey KA, 1996, ANN NEUROL, V40, P873, DOI 10.1002/ana.410400609; Fukuda M, 2001, PARKINSONISM RELAT D, V8, P91, DOI 10.1016/S1353-8020(01)00022-0; Gerhard A, 2006, NEUROBIOL DIS, V21, P404, DOI 10.1016/j.nbd.2005.08.002; NYTH AL, 1990, BRIT J PSYCHIAT, V157, P894, DOI 10.1192/bjp.157.6.894; Gruber-Baldini AL, 2007, J AM GERIATR SOC, V55, P1508, DOI 10.1111/j.1532-5415.2007.01387.x; Guttman M, 1997, NEUROLOGY, V48, P1578; Herrmann N, 2007, DEMENT GERIATR COGN, V23, P116, DOI 10.1159/000097757; Hirano S, 2009, MOVEMENT DISORD, V24, pS725, DOI 10.1002/mds.22541; HolthoffDetto VA, 1997, ARCH NEUROL-CHICAGO, V54, P145; Itoh M, 1994, Ann Nucl Med, V8, P245; JAGUST WJ, 1985, J NEUROL NEUROSUR PS, V48, P1091, DOI 10.1136/jnnp.48.11.1091; Jorge RE, 2008, ARCH GEN PSYCHIAT, V65, P268, DOI 10.1001/archgenpsychiatry.2007.45; Kadir A, 2006, PSYCHOPHARMACOLOGY, V188, P509, DOI 10.1007/s00213-006-0447-7; Kepe V, 2006, P NATL ACAD SCI USA, V103, P702, DOI 10.1073/pnas.0510237103; Kotagal V, 2012, ARCH NEUROL-CHICAGO, V69, P1628, DOI 10.1001/archneurol.2012.764; Kotagal V, 2013, J NEURAL TRANSM, V120, P1421, DOI 10.1007/s00702-013-1013-1; Kulisevsky J, 2008, EUR J NEUROL, V15, P953, DOI 10.1111/j.1468-1331.2008.02218.x; KUMAR A, 1991, NEUROPSYCHOPHARMACOL, V4, P35; Lai MK, 2005, PSYCHOPHARMACOLOGY, V179, P673, DOI 10.1007/s00213-004-2077-2; Lanctot KL, 2007, AM J GERIAT PSYCHIAT, V15, P888, DOI 10.1097/JGP.0b013e3180488325; Lanctot KL, 2014, INT PSYCHOGERIATR, V26, P239, DOI 10.1017/S1041610213001762; LONDON ED, 1989, NEUROCHEM RES, V14, P745, DOI 10.1007/BF00964952; Lyketsos CG, 2000, AM J PSYCHIAT, V157, P1686, DOI 10.1176/appi.ajp.157.10.1686; Marras C, 2012, AM J GERIAT PSYCHIAT, V20, P149, DOI 10.1097/JGP.0b013e3182051bd6; MASH DC, 1985, SCIENCE, V228, P1115, DOI 10.1126/science.3992249; Matsuda H, 2001, ANN NUCL MED, V15, P85, DOI 10.1007/BF02988596; Matsui H, 2006, MOVEMENT DISORD, V21, P1169, DOI 10.1002/mds.20923; Mayer LS, 2006, INT J GERIATR PSYCH, V21, P930, DOI 10.1002/gps.1583; MCGEER EG, 1986, CAN J NEUROL SCI, V13, P511; Meguro K, 1997, NEUROLOGY, V49, P941; Mizukami K, 2009, PROG NEURO-PSYCHOPH, V33, P349, DOI 10.1016/j.pnpbp.2008.12.019; NAKANO I, 1984, ANN NEUROL, V15, P415, DOI 10.1002/ana.410150503; Olin Jason T, 2003, Expert Rev Neurother, V3, P99, DOI 10.1586/14737175.3.1.99; Padala P.R., 2010, AM J GERIAT PSYCHIAT, V18; Palmer AM, 1996, NEURODEGENERATION, V5, P381, DOI 10.1006/neur.1996.0051; PALMER AM, 1988, ANN NEUROL, V23, P616, DOI 10.1002/ana.410230616; Politis M, 2012, FRONT PHARMACOL, V3, DOI 10.3389/fphar.2012.00096; Rabins PV, 2006, PRACTICAL DEMENTIA C; Raji MA, 2001, ANN PHARMACOTHER, V35, P1024; Sanabria-Diaz G, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0068860; Santhosh L, 2009, PSYCHIAT RES-NEUROIM, V173, P212, DOI 10.1016/j.pscychresns.2009.03.007; SMITH GS, 1992, ARCH NEUROL-CHICAGO, V49, P1142; Smith GS, 1997, AM J PSYCHIAT, V154, P490; Smith GS, 2011, AM J GERIAT PSYCHIAT, V19, P53, DOI 10.1097/JGP.0b013e3181eafde4; Sojkova J, 2008, J NUCL MED, V49, P1465, DOI 10.2967/jnumed.108.051946; SPARKS DL, 1989, ARCH NEUROL-CHICAGO, V46, P138; Steinberg M, 2014, INT J GERIATR PSYCH, V29, P153, DOI 10.1002/gps.3980; Steinberg M, 2004, INT J GERIATR PSYCH, V19, P19, DOI 10.1002/gps.1025; Sultzer DL, 2014, AM J GERIAT PSYCHIAT, V22, P1346, DOI 10.1016/j.jagp.2013.06.005; SULTZER DL, 1995, J NEUROPSYCH CLIN N, V7, P476; Teaktong T, 2004, J NEUROL SCI, V225, P39, DOI 10.1016/j.jns.2004.06.015; Terriere E, 2008, NEUROCHEM RES, V33, P643, DOI 10.1007/s11064-007-9517-4; Truchot L, 2008, NEUROIMAGE, V40, P1251, DOI 10.1016/j.neuroimage.2008.01.030; VOLICER L, 1985, ARCH NEUROL-CHICAGO, V42, P1158; Weinberger D R, 1992, Clin Neuropharmacol, V15 Suppl 1 Pt A, p194A; Weintraub D, 2010, AM J GERIAT PSYCHIAT, V18, P332, DOI 10.1097/JGP.0b013e3181cc0333; WHITEHOUSE PJ, 1981, ANN NEUROL, V10, P122, DOI 10.1002/ana.410100203; ZWEIG RM, 1989, ANN NEUROL, V26, P41, DOI 10.1002/ana.410260106	242	1	1	PERGAMON-ELSEVIER SCIENCE LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND	0149-7634	1873-7528		NEUROSCI BIOBEHAV R	Neurosci. Biobehav. Rev.	FEB	2015	49						157	170		10.1016/j.neubiorev.2014.11.010		14	Behavioral Sciences; Neurosciences	Behavioral Sciences; Neurosciences & Neurology	CB4IW	WOS:000349592400014		
J	Harada, T; Hirabayashi, Y				Harada, Tom; Hirabayashi, Yoshiharu			Continuum pp Lambda spectrum of the He-3(K-, pi(-)) reaction with continuum discretized coupled channels	NUCLEAR PHYSICS A			English	Article						Hypernuclei; Breakup reactions; Continuum states	SIGMA-HYPERNUCLEI; BOUND-STATE; NUCLEI; SHELL; SPECTROSCOPY; POTENTIALS; RESONANCES; SCATTERING; CAPTURE; MODELS	We theoretically investigate an inclusive pi(-) spectrum of a He-3(K- pi(-)) reaction at 870 MeV/c in a distorted-wave impulse approximation using the continuum discretized coupled channels (CDCC) method, in order to well describe the pp Lambda continuum states above the p + p + Lambda breakup threshold. We calculate the continuum ppA states applying the multichannel Green's function with a microscopic 2N - Lambda folding-model potential constructed by the CDCC wavefunctions. The results show that the calculated spectra reproduce available experimental data, and that the pp continuum states lying in higher energies are needed to fully describe these spectra, depending on the momentum transfer in the (K- pi(-)) reaction. It is shown that this calculation provides the ability of describing three-body ppA breakup systems for the (K- pi(-)) spectra. (C) 2014 Elsevier B.V. All rights reserved.	[Harada, Tom] Osaka Electrocommun Univ, Res Ctr Phys & Math, Neyagawa, Osaka 5728530, Japan; [Harada, Tom] High Energy Accelerator Res Org KEK, KEK Theory Ctr, Inst Particle & Nucl Studies, J PARC Branch, Tokai, Ibaraki 3191106, Japan; [Hirabayashi, Yoshiharu] Hokkaido Univ, Informat Initiat Ctr, Sapporo, Hokkaido 0600811, Japan	Harada, T (reprint author), Osaka Electrocommun Univ, Res Ctr Phys & Math, Neyagawa, Osaka 5728530, Japan.	harada@isc.osakac.ac.jp	Hirabayashi, Yoshiharu/F-7253-2012		Japan Society for the Promotion of Science (JSPS); Scientific Research (KAKENHI) [24105008, 25400278]	The authors would like to thank Professor Y. Akaishi, Professor T. Fukuda and Professor T. Kishimoto for many valuable discussions. This work was supported by Japan Society for the Promotion of Science (JSPS), Grant-in-Aid for Scientific Research (KAKENHI), Grant Numbers 24105008, 25400278.	Akaishi Y., 1986, INT REV NUCL PHYS, V4, P259; Garcilazo H, 2007, PHYS REV C, V75, DOI 10.1103/PhysRevC.75.034002; Gal A, 2014, PHYS LETT B, V736, P93, DOI 10.1016/j.physletb.2014.07.009; KERMAN AK, 1971, ANN PHYS-NEW YORK, V66, P738, DOI 10.1016/0003-4916(71)90078-9; Harada T, 1998, PHYS REV LETT, V81, P5287, DOI 10.1103/PhysRevLett.81.5287; POVH B, 1987, PROG PART NUCL PHYS, V18, P183, DOI 10.1016/0146-6410(87)90010-X; Stoks VGJ, 1999, PHYS REV C, V59, P3009, DOI 10.1103/PhysRevC.59.3009; YAHIRO M, 1982, PROG THEOR PHYS, V67, P1467, DOI 10.1143/PTP.67.1467; DOVER CB, 1983, ANN PHYS-NEW YORK, V146, P309, DOI 10.1016/0003-4916(83)90036-2; Klempt E, 2010, REV MOD PHYS, V82, P1095, DOI 10.1103/RevModPhys.82.1095; Haidenbauer J, 2013, NUCL PHYS A, V915, P24, DOI 10.1016/j.nuclphysa.2013.06.008; AUERBACH EH, 1983, ANN PHYS-NEW YORK, V148, P381, DOI 10.1016/0003-4916(83)90245-2; Belyaev VB, 2008, NUCL PHYS A, V803, P210, DOI 10.1016/j.nuclphysa.2008.02.219; DALITZ RH, 1976, PHYS REV LETT, V36, P362, DOI 10.1103/PhysRevLett.36.362; DALITZ RH, 1972, NUCL PHYS B, V47, P109, DOI 10.1016/0550-3213(72)90105-8; DOVER CB, 1979, PHYS REV C, V19, P1393, DOI 10.1103/PhysRevC.19.1393; DOVER CB, 1982, PHYS REP, V89, P1, DOI 10.1016/0370-1573(82)90043-6; GOPAL GP, 1977, NUCL PHYS B, V119, P362, DOI 10.1016/0550-3213(77)90002-5; Harada T, 2000, NUCL PHYS A, V672, P181, DOI 10.1016/S0375-9474(99)00834-9; Harada T, 2014, PHYS REV C, V89, DOI 10.1103/PhysRevC.89.054603; Hiyama E, 2014, PHYS REV C, V89, DOI 10.1103/PhysRevC.89.061302; HUFNER J, 1974, NUCL PHYS A, VA234, P429, DOI 10.1016/0375-9474(74)90573-9; JOHNSTON K, 1992, PHYS REV C, V46, pR1573; KAMIMURA M, 1986, PROG THEOR PHYS SUPP, P1; Kishimoto T., 1989, E829 BNLAGS COLL; Kishimoto T., 2013, COMMUNICATION; Koike T, 2008, NUCL PHYS A, V804, P231, DOI 10.1016/j.nuclphysa.2008.01.015; Koike YH, 1996, NUCL PHYS A, V611, P461, DOI 10.1016/S0375-9474(96)00293-X; MIYAGAWA K, 1993, PHYS REV C, V48, P2576, DOI 10.1103/PhysRevC.48.2576; MORIMATSU O, 1985, NUCL PHYS A, V435, P727, DOI 10.1016/0375-9474(85)90185-X; MORIMATSU O, 1988, NUCL PHYS A, V483, P493, DOI 10.1016/0375-9474(88)90081-4; Povh B., 1981, Progress in Particle and Nuclear Physics, V5, DOI 10.1016/0146-6410(81)90051-X; Rappold C, 2013, PHYS REV C, V88, DOI 10.1103/PhysRevC.88.041001; Rijken TA, 2010, PROG THEOR PHYS SUPP, P14; ROSENTHAL AS, 1980, PHYS REV C, V22, P711, DOI 10.1103/PhysRevC.22.711; TAMAGAKI R, 1968, PROG THEOR PHYS, V39, P91, DOI 10.1143/PTP.39.91; Tamura H, 2012, PROG THEOR EXP PHYS, DOI 10.1093/ptep/pts056; Zhang H, 2013, PHYS REV C, V88, DOI 10.1103/PhysRevC.88.035204; Zhang H, 2013, PHYS REV C, V88, DOI 10.1103/PhysRevC.88.035205	39	0	0	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	0375-9474	1873-1554		NUCL PHYS A	Nucl. Phys. A	FEB	2015	934						8	17		10.1016/j.nuclphysa.2014.11.007		10	Physics, Nuclear	Physics	CB4JK	WOS:000349593800002		
J	Kawasaki, R; Akune, Y; Hiratsuka, Y; Fukuhara, S; Yamada, M				Kawasaki, Ryo; Akune, Yoko; Hiratsuka, Yoshimune; Fukuhara, Shunichi; Yamada, Masakazu			Cost-utility Analysis of Screening for Diabetic Retinopathy in Japan: A Probabilistic Markov Modeling Study	OPHTHALMIC EPIDEMIOLOGY			English	Article						Cost-utility analysis; diabetic retinopathy; Japan; Markov model; screening	MACULAR EDEMA; HEALTH; TRIAMCINOLONE; COMPLICATIONS; RANIBIZUMAB; PREVALENCE; VITRECTOMY; MELLITUS; TIME	Purpose: To evaluate the cost-effectiveness for a screening interval longer than 1 year detecting diabetic retinopathy (DR) through the estimation of incremental costs per quality-adjusted life year (QALY) based on the best available clinical data in Japan. Methods: A Markov model with a probabilistic cohort analysis was framed to calculate incremental costs per QALY gained by implementing a screening program detecting DR in Japan. A 1-year cycle length and population size of 50,000 with a 50-year time horizon (age 40-90 years) was used. Best available clinical data from publications and national surveillance data was used, and a model was designed including current diagnosis and management of DR with corresponding visual outcomes. One-way and probabilistic sensitivity analyses were performed considering uncertainties in the parameters. Results: In the base-case analysis, the strategy with a screening program resulted in an incremental cost of 5,147 Japanese yen ((sic); US$ 64.6) and incremental effectiveness of 0.0054 QALYs per person screened. The incremental cost-effectiveness ratio was (sic) 944,981 (US$ 11,857) per QALY. The simulation suggested that screening would result in a significant reduction in blindness in people aged 40 years or over (-16%). Sensitivity analyses suggested that in order to achieve both reductions in blindness and cost-effectiveness in Japan, the screening program should screen those aged 53-84 years, at intervals of 3 years or less. Conclusions: An eye screening program in Japan would be cost-effective in detecting DR and preventing blindness from DR, even allowing for the uncertainties in estimates of costs, utility, and current management of DR.	[Kawasaki, Ryo] Yamagata Univ, Dept Publ Hlth, Yamagata 9909585, Japan; [Akune, Yoko; Yamada, Masakazu] Natl Tokyo Med Ctr, Natl Inst Sensory Organs, Tokyo, Japan; [Hiratsuka, Yoshimune] Natl Inst Publ Hlth, Saitama, Japan; [Fukuhara, Shunichi] Kyoto Univ, Grad Sch Med & Publ Hlth, Dept Epidemiol & Healthcare Res, Kyoto, Japan; [Yamada, Masakazu] Kyorin Univ, Sch Med, Kyorin Eye Ctr, Tokyo, Japan	Kawasaki, R (reprint author), Yamagata Univ, Dept Publ Hlth, 2-2-2 Iida Nishi, Yamagata 9909585, Japan.	ryok@med.id.yamagata-u.ac.jp			Ministry of Health, Labour and Welfare of Japan	This study was supported by the Ministry of Health, Labour and Welfare of Japan.	Jones S, 2010, DIABETIC MED, V27, P249, DOI 10.1111/j.1464-5491.2009.02870.x; Nguyen QD, 2012, OPHTHALMOLOGY, V119, P789, DOI 10.1016/j.ophtha.2011.12.039; Sakamoto Taiji, 2007, Nippon Ganka Gakkai Zasshi, V111, P936; Bragge P, 2011, ARCH OPHTHALMOL-CHIC, V129, P435, DOI 10.1001/archophthalmol.2010.319; Mitchell P, 2011, OPHTHALMOLOGY, V118, P615, DOI 10.1016/j.ophtha.2011.01.031; Sharma S, 2002, BRIT J OPHTHALMOL, V86, P493, DOI 10.1136/bjo.86.5.493; Fenwick EK, 2011, BRIT J OPHTHALMOL, V95, P774, DOI 10.1136/bjo.2010.191312; Shiroiwa T, 2010, HEALTH ECON, V19, P422, DOI 10.1002/hec.1481; Holden BA, 2008, ARCH OPHTHALMOL-CHIC, V126, P1731, DOI 10.1001/archopht.126.12.1731; Furlong WJ, 2001, ANN MED, V33, P375, DOI 10.3109/07853890109002092; Yau JWY, 2012, DIABETES CARE, V35, P556, DOI 10.2337/dc11-1909; Pershing S, 2014, ANN INTERN MED, V160, P18, DOI 10.7326/M13-0768; Briggs AH, 1999, BRIT MED J, V319, P635; Vijan S, 2000, JAMA-J AM MED ASSOC, V283, P889, DOI 10.1001/jama.283.7.889; Briggs A H, 1999, Health Technol Assess, V3, P1; Brown G C, 1999, Trans Am Ophthalmol Soc, V97, P473; Brown MM, 2005, EVIDENCE BASED VALUE; Chew EY, 2003, OPHTHALMOLOGY, V110, P1683, DOI 10.1016/S0161-6420(03)00579-7; Fenwick E, 2012, CLIN EXP OPHTHALMOL, V40, P27, DOI 10.1111/j.1442-9071.2011.02599.x; Funatsu H, 1997, FOLIA OPHTHALMOLOGIC, V48, P7; Hiratsuka Yoshimune, 2011, Jpn J Ophthalmol, V55, P333, DOI 10.1007/s10384-011-0041-3; Kinukawa J, 2005, CURR EYE RES, V30, P789, DOI 10.1080/02713680591002808; Ministry of Health Labour and Welfare, 2011, NAT HLTH NUTR SURV J; Ministry of Health Labour and Welfare Japan, 2011, IMPL RAT SPEC HLTH C; Ministry of Health Labour and Welfare Japan, 2010, SURV MED CAR ACT PUB; Ministry of Health Labour and Welfare Japan, 2002, NAT HLTH NUTR SURV 2; Miyazaki M, 2004, DIABETOLOGIA, V47, P1411, DOI 10.1007/s00125-004-1466-8; Mulvaney-Day NE, 2010, QUAL LIFE RES, V19, P1529, DOI 10.1007/s11136-010-9713-6; Nakamura S, 2003, FOLIA OPHTHALMOL JPN, V54, P329; OECD, 2007, HLTH GLANC 2007 OECD; Oizumi Toshihide, 2005, Nihon Rinsho, V63 Suppl 2, P73; Szabo SM, 2010, INVEST OPHTH VIS SCI, V51, P3387, DOI 10.1167/iovs.09-4194; Yamakiri K, 2007, OPHTHALMOLOGY, V114, P289, DOI 10.1016/j.ophtha.2006.07.044; Yamamoto T, 2003, AM J OPHTHALMOL, V135, P14, DOI 10.1016/S0002-9394(02)01819-6; Yoshida S, 2010, JPN J CLIN OPHTHAL, V64, P1911	35	3	3	INFORMA HEALTHCARE	LONDON	TELEPHONE HOUSE, 69-77 PAUL STREET, LONDON EC2A 4LQ, ENGLAND	0928-6586	1744-5086		OPHTHAL EPIDEMIOL	Ophthalmic Epidemiol.	FEB	2015	22	1					4	12		10.3109/09286586.2014.988876		9	Ophthalmology	Ophthalmology	AY6SE	WOS:000347695000002		
J	Usman, MA; Kamei, G; Adachi, N; Deie, M; Nakamae, A; Ochi, M				Usman, M. A.; Kamei, G.; Adachi, N.; Deie, M.; Nakamae, A.; Ochi, M.			Revision single-bundle anterior cruciate ligament reconstruction with over-the-top route procedure	ORTHOPAEDICS & TRAUMATOLOGY-SURGERY & RESEARCH			English	Article						Revision anterior cruciate ligament reconstruction; Over-the-top procedure; Single-bundle; Knee stability	FEMORAL TUNNEL PLACEMENT; KNEE; AUGMENTATION; SURGERY; GRAFT	Purpose: In revision anterior cruciate ligament reconstruction (ACLR), the single-stage technique and the over-the-top route (OTTR) procedure were usually selected for cases where the bone tunnel cannot be created at an anatomical position due to tunnel enlargement and overlap with the mal-positioned tunnel of primary reconstruction. The purpose of this study was to evaluate the clinical results of revision single-bundle ACL reconstruction using OTTR procedure and to compare the clinical results of OTTR procedure with those of anatomical single-bundle revision reconstruction (SBR). Hypothesis: The results of OTTR procedure are equivalent to that of SBR. Methods: Seventy-six revision ACL reconstruction knees from April 2002 to December 2012 were involved in our study. We focused on 21 knees which underwent surgery with SBR and 22 knees with OTTR using hamstring tendon. The clinical results were evaluated by means of the Lysholm score and the knee stability was assessed by the Lachman test, pivot-shift test and side-to-side difference by KT-2000 pre-operatively and after 1 year post-operatively. AP translation and rotational laxity using a navigation system were evaluated before and after revision ACL reconstruction under anesthesia in 8 cases of OTTR and in 6 cases of SBR. Results: There was no statistically significant difference between the OTTR and SBR regarding Lysholm score, Lachman test, pivot-shift test, ATT by KT-2000, and AP translation and rotational laxity with a navigation system. Conclusions: The clinical results of OTTR are almost equivalent to those of SBR. For the cases in which it is impossible to create the femoral tunnel in an anatomical position, OTTR is a valuable revision ACL reconstruction method. (C) 2014 Elsevier Masson SAS. All rights reserved.	[Usman, M. A.; Kamei, G.; Adachi, N.; Nakamae, A.; Ochi, M.] Hiroshima Univ, Grad Sch Biomed Sci, Dept Orthopaed Surg, Minami Ku, Hiroshima 7348551, Japan; [Usman, M. A.] Hasanuddin Univ, Fac Med, Dept Orthopaed Traumatol, Sulawesi Selatan, Indonesia; [Deie, M.] Hiroshima Univ, Grad Sch Hlth Sci, Dept Phys Therapy & Occupat Therapy, Hiroshima 7348551, Japan	Kamei, G (reprint author), Hiroshima Univ, Grad Sch Biomed Sci, Dept Orthopaed Surg, Minami Ku, 1-2-3 Kasumi, Hiroshima 7348551, Japan.	go_k_0127@yahoo.co.jp					Adachi N, 2002, ACTA ORTHOP SCAND, V73, P330, DOI 10.1080/000164702320155356; MOYEN BJL, 1992, J BONE JOINT SURG AM, V74A, P1313; Adachi N, 2000, ARCH ORTHOP TRAUM SU, V120, P128, DOI 10.1007/s004020050028; BERTOIA JT, 1985, J BONE JOINT SURG AM, V67A, P1183; ODENSTEN M, 1985, J BONE JOINT SURG AM, V67A, P257; Yagi M, 2002, AM J SPORT MED, V30, P660; MELHORN JM, 1987, AM J SPORT MED, V15, P539, DOI 10.1177/036354658701500603; Musahl V, 2005, AM J SPORT MED, V33, P712, DOI 10.1177/0363546504271747; RADFORD WJP, 1990, J BONE JOINT SURG BR, V72, P1038; Loh JC, 2003, ARTHROSCOPY, V19, P297, DOI 10.1053/jars.2003.50084; Asai S, 2014, KNEE SURG SPORT TR A, V22, P972, DOI 10.1007/s00167-013-2499-7; Scopp JM, 2004, ARTHROSCOPY, V20, P294, DOI 10.1016/j.arthro.2004.01.001; Kanaya A, 2009, KNEE SURG SPORT TR A, V17, P907, DOI 10.1007/s00167-009-0757-5; JONSSON H, 1994, J BONE JOINT SURG BR, V76B, P82; Kazusa H, 2013, CLIN SPORT MED, V32, P127, DOI 10.1016/j.csm.2012.08.012; Lertwanich P, 2011, ARTHROSCOPY, V27, P672, DOI 10.1016/j.arthro.2010.12.001; Lim Hong-Chul, 2012, Clin Orthop Surg, V4, P249, DOI 10.4055/cios.2012.4.4.249; Lo Ian K. Y., 1997, Arthroscopy, V13, P627, DOI 10.1016/S0749-8063(97)90191-2; Macintosh DL, 1976, J BONE JT SURG     B, V58, P142; MacIntosh DL, 1974, J BONE JOINT SURG AM, V52, P1302; Mifune Y, 2013, AM J SPORT MED, V41, P365, DOI 10.1177/0363546512471614; Ochi M, 2009, ARTHROSCOPY, V25, P117, DOI 10.1016/j.arthro.2008.10.011; Ochi M, 1999, J BONE JOINT SURG BR, V81B, P902, DOI 10.1302/0301-620X.81B5.9202; Ohkawa S, 2012, KNEE SURG SPORT TR A, V20, P778; Safran MR, 1996, CLIN ORTHOP RELAT R, P50; Yamamoto Y, AM J SPORTS MED; Yiannakopoulos CK, 2005, ARTHROSCOPY, V21, P243, DOI 10.1016/j.arthro.2005.09.026	27	0	0	ELSEVIER MASSON	MILANO	VIA PALEOCAPA 7, 20121 MILANO, ITALY	1877-0568			ORTHOP TRAUMATOL-SUR	Orthop. Traumatol.-Surg. Res.	FEB	2015	101	1					71	75		10.1016/j.otsr.2014.09.022		5	Orthopedics; Surgery	Orthopedics; Surgery	CB3UL	WOS:000349554400014		
J	Takenouchi, T; Kosaki, R; Nakabayashi, K; Hata, K; Takahashi, T; Kosaki, K				Takenouchi, Toshiki; Kosaki, Rika; Nakabayashi, Kazuhiko; Hata, Kenichiro; Takahashi, Takao; Kosaki, Kenjiro			Paramagnetic Signals in the Globus Pallidus as Late Radiographic Sign of Juvenile-Onset GM1 Gangliosidosis	PEDIATRIC NEUROLOGY			English	Article						GM1 gangliosidosis; GLB1; neurodegeneration with brain iron accumulation; next-generation sequencing		BACKGROUND: The juvenile form of GM1 gangliosidosis lacks specific physical findings and thus is often a diagnostic challenge for clinicians. T-2 hypodensity in the globus pallidus is a characteristic radiographic sign of neurodegeneration with iron accumulation in the brain that is observed in GM1 gangliosidosis, but the exact timing when this radiographic sign becomes apparent remains to be elucidated. PATIENTS: Two male siblings had normal development until 2 years of age and then developed psychomotor regression with dystonia. Their neuroimaging studies indicated progressive global cerebral atrophy. Exome sequencing identified compound heterozygous missense mutations in GLB1, leading to a diagnosis of GM1 gangliosidosis. RESULTS: A retrospective review of neuroimaging studies revealed that the two patients had strikingly similar clinical courses and radiographic progressions with cortical atrophy that preceded the T-2 hypointensity in the globus pallidus. CONCLUSIONS: Paramagnetic signals in the globus pallidus become apparent relatively late during the disease course, once cerebral atrophy has already become prominent. A comprehensive diagnostic approach involving clinical, radiographic, and genetic testing is necessary for the early identification of affected individuals.	[Takenouchi, Toshiki; Takahashi, Takao] Keio Univ, Sch Med, Dept Pediat, Tokyo, Japan; [Kosaki, Rika] Natl Ctr Child Hlth & Dev, Div Med Genet, Tokyo, Japan; [Nakabayashi, Kazuhiko; Hata, Kenichiro] Natl Ctr Child Hlth & Dev, Dept Maternal Fetal Biol, Tokyo, Japan; [Kosaki, Kenjiro] Keio Univ, Sch Med, Ctr Genet Med, Tokyo 1608582, Japan	Kosaki, K (reprint author), Keio Univ, Sch Med, Ctr Genet Med, Shinjuku ku, 35 Shinanomachi, Tokyo 1608582, Japan.	kkosaki@z3.keio.jp			Research on Applying Health Technology [H23-013]; Ministry of Health, Labour and Welfare, Japan [H23 Jit-suyoka [Nanbyo]-Ippan-003]	We thank Namiko Saito and Yumi Obayashi for their technical assistance in the preparation of this article. This work was supported by Research on Applying Health Technology (H23-013) and Research into Rare and Intractable Diseases (H23 Jit-suyoka [Nanbyo]-Ippan-003) from the Ministry of Health, Labour and Welfare, Japan.	Yang YP, 2013, NEW ENGL J MED, V369, P1502, DOI 10.1056/NEJMoa1306555; De Grandis E, 2009, AM J NEURORADIOL, V30, P1325, DOI 10.3174/ajnr.A1508; Brunetti-Pierri N, 2008, MOL GENET METAB, V94, P391, DOI 10.1016/j.ymgme.2008.04.012; AOKI S, 1989, RADIOLOGY, V172, P381; Kosaki R, 2014, AM J MED GENET A, V164, P993, DOI 10.1002/ajmg.a.36364; NISHIMOTO J, 1991, AM J HUM GENET, V49, P566; Pierson TM, 2012, NEUROLOGY, V79, P123, DOI 10.1212/WNL.0b013e31825f047a; Suzuki Y, 2013, BRAIN DEV-JPN, V35, P515, DOI 10.1016/j.braindev.2012.12.002; Vieira JP, 2013, PEDIATR NEUROL, V49, P195, DOI 10.1016/j.pediatrneurol.2013.02.003	9	0	0	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0887-8994	1873-5150		PEDIATR NEUROL	Pediatr. Neurol.	FEB	2015	52	2					226	229		10.1016/j.pediatrneurol.2014.09.022		4	Clinical Neurology; Pediatrics	Neurosciences & Neurology; Pediatrics	CB4EI	WOS:000349580600016		
J	Tanaka, Y; Koga, Y; Takada, H				Tanaka, Yuko; Koga, Yuhki; Takada, Hidetoshi			Pilocytic Astrocytoma at the Medulla Oblongata Dorsal Surface Presenting as Intractable Hiccups	PEDIATRIC NEUROLOGY			English	Editorial Material									[Tanaka, Yuko; Koga, Yuhki; Takada, Hidetoshi] Kyushu Univ, Grad Sch Med Sci, Dept Pediat, Fukuoka 8128582, Japan	Koga, Y (reprint author), Kyushu Univ, Dept Pediat, Grad Sch Med Sci, Higashi Ku, 3-1-1 Maidashi, Fukuoka 8128582, Japan.	yuuki-k@pediatr.med.kyushu-u.ac.jp					Amirjamshidi A, 2007, SURG NEUROL, V67, P395, DOI 10.1016/j.surneu.2006.10.070; Packer RJ, 1997, J NEUROSURG, V86, P747, DOI 10.3171/jns.1997.86.5.0747; ARITA H, 1994, NEUROSCI LETT, V175, P67, DOI 10.1016/0304-3940(94)91079-0	3	0	0	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0887-8994	1873-5150		PEDIATR NEUROL	Pediatr. Neurol.	FEB	2015	52	2					254	255		10.1016/j.pediatmeurol.2014.10.029		2	Clinical Neurology; Pediatrics	Neurosciences & Neurology; Pediatrics	CB4EI	WOS:000349580600023		
J	Yoshida, J; Erwan, E; Chowdhury, VS; Ogino, Y; Shigemura, A; Denbow, DM; Furuse, M				Yoshida, Junki; Erwan, Edi; Chowdhury, Vishwajit Sur; Ogino, Yumi; Shigemura, Asako; Denbow, D. Michael; Furuse, Mitsuhiro			Comparison of centrally injected tryptophan-related substances inducing sedation in acute isolation stress-induced neonatal chicks	PHARMACOLOGY BIOCHEMISTRY AND BEHAVIOR			English	Article						Acute stress; Neonatal chick; Kynurenine; Serotonin; L- and D-tryptophan	PITUITARY-ADRENAL AXIS; CENTRAL-NERVOUS-SYSTEM; KYNURENIC ACID; INTRACEREBROVENTRICULAR INJECTION; D-ASPARTATE; DIFFERENT MECHANISMS; AMINO-ACIDS; L-PROLINE; D-SERINE; SEROTONIN	In the present study, we first focused on the function of L-tryptophan (TRP) metabolites which are synthesized in different metabolic pathways, namely, the kynurenine (KYN) pathway and serotonin (5-HT) pathway during an acute isolation stress. When L-TRP metabolites were intracerebroventricularly injected on an equimolar basis (100 nmol), 5-HT induced a sedative effect in neonatal chicks. Additionally, plasma corticosterone, dopamine, 5-HT, and its metabolite 5-hydroxyindoleacetic acid concentrations were increased in the diencephalon of the 5-HT treated group compared with other groups. Second, the two doses (400 or 800 nmol) of L- and D-TRP were compared under a corticotrophin-releasing hormone-augmented social isolation stress. When comparing the efficacy between L- and D-TRP against stress behavior, both amino acids had a similar effect and quickly suppressed distress vocalizations. Finally, D-amino acid levels in the diencephalon and telencephalon were measured but D-TRP was not found. These results indicate that L- and D-TRP induce the same effect in attenuating stress but the mode of action of TRP derivatives, namely 5-HT differs during an acute isolation stress in neonatal chick. The absence of D-TRP in the diencephalon further suggests that instead of being an endogenous factor it may play role as a pharmacological factor. (C) 2014 Elsevier Inc. All rights reserved.	[Yoshida, Junki; Erwan, Edi; Ogino, Yumi; Shigemura, Asako; Furuse, Mitsuhiro] Kyushu Univ, Fac Agr, Lab Regulat Metab & Behav, Fukuoka 8128581, Japan; [Chowdhury, Vishwajit Sur] Kyushu Univ, Fac Arts & Sci, Div Arts & Sci, Fukuoka 8190395, Japan; [Denbow, D. Michael] Virginia Tech, Dept Anim & Poultry Sci, Blacksburg, VA 24061 USA	Furuse, M (reprint author), Kyushu Univ, Fac Agr, Lab Regulat Metab & Behav, Fukuoka 8128581, Japan.	furuse@brs.kyushu-u.ac.jp			Japan Society for the Promotion of Science [23248046]	Part of this project has been supported by a Grant-in-Aid for Scientific Research from the Japan Society for the Promotion of Science (No. 23248046).	KLECKNER NW, 1988, SCIENCE, V241, P835, DOI 10.1126/science.2841759; Larauche M, 2012, EXP NEUROL, V233, P49, DOI 10.1016/j.expneurol.2011.04.020; Phillips LJ, 2006, AUST NZ J PSYCHIAT, V40, P725, DOI 10.1080/j.1440-1614.2006.01877.x; FRIEDMAN M, 1988, J AGR FOOD CHEM, V36, P1079, DOI 10.1021/jf00083a042; Locatelli V, 2010, ENDOCRIN DEV, V17, P108, DOI 10.1159/000262533; Koutoku T, 2005, NEUROCHEM INT, V47, P183, DOI 10.1016/j.neuint.2005.03.006; Friedman M, 2012, AMINO ACIDS, V42, P1553, DOI 10.1007/s00726-011-0915-1; Di Giovanni G, 2010, CNS NEUROSCI THER, V16, P179, DOI 10.1111/j.1755-5949.2010.00135.x; Marston OJ, 2011, EUR J PHARMACOL, V660, P70, DOI 10.1016/j.ejphar.2010.12.024; Zhang R, 2004, BEHAV BRAIN RES, V151, P47, DOI 10.1016/j.bbr.2003.08.005; Erwan E, 2014, EUR J PHARMACOL, V736, P138, DOI 10.1016/j.ejphar.2014.04.042; Erwan E, 2012, AMINO ACIDS, V43, P1969, DOI 10.1007/s00726-012-1272-4; Asechi M, 2006, BEHAV BRAIN RES, V170, P71, DOI 10.1016/j.bbr.2006.02.005; Friedman M, 2010, CHEM BIODIVERS, V7, P1491, DOI 10.1002/cbdv.200900225; DAVIS JL, 1979, PHYSIOL BEHAV, V22, P693, DOI 10.1016/0031-9384(79)90233-6; Graeff FG, 1996, PHARMACOL BIOCHEM BE, V54, P129, DOI 10.1016/0091-3057(95)02135-3; Littlejohn TK, 2003, J BIOL CHEM, V278, P29525, DOI 10.1074/jbc.M301700200; Tomonaga S, 2008, PHARMACOL BIOCHEM BE, V89, P627, DOI 10.1016/j.pbb.2008.02.021; Goel N, 2014, PSYCHONEUROENDOCRINO, V40, P232, DOI 10.1016/j.psyneuen.2013.11.020; Saito S, 2005, COMP BIOCHEM PHYS A, V141, P305, DOI 10.1016/j.cbpb.2005.05.054; Vernon JA, 2014, SCHIZOPHR RES, V159, P385, DOI 10.1016/j.schres.2014.08.015; ARENTSON BE, 1985, J ANIM SCI, V60, P474; Bielenica A, 2013, MINI-REV MED CHEM, V13, P1516; Bowers BJ, 2000, J NEUROCHEM, V75, P1625, DOI 10.1046/j.1471-4159.2000.0751625.x; CEASAR PM, 1974, BRIT J PHARMACOL, V51, P187; CULMAN J, 1980, NEUROSCIENCE, V5, P1503, DOI 10.1016/0306-4522(80)90012-3; DEMET EM, 1979, BIOCHEM PHARMACOL, V28, P3043, DOI 10.1016/0006-2952(79)90611-7; Findley JW, 1973, J AGR FOOD CHEM, V21, P33; Fukushima T, 2009, CHIRALITY, V21, P468, DOI 10.1002/chir.20620; Hamasu K, 2010, AMINO ACIDS, V38, P57, DOI 10.1007/s00726-008-0204-9; Hashimoto A, 1997, PROG NEUROBIOL, V52, P325, DOI 10.1016/S0301-0082(97)00019-1; Ikeda H, 2014, METABOLISM AMINO ACI, V3, P277; Kobayashi K, 2013, HDB APPL STAT PHARM, P37; Kuenzel WJ, 1988, STEREOTAXIC ATLAS BR; Kurauchi I, 2007, J APPL ANIM RES, V31, P25; Maehashi K, 2007, CHEM SENSES, V32, P183, DOI 10.1093/chemse/bjl048; Manita S, 2006, CHEM SENSES, V31, P785, DOI 10.1093/chemse/bjl020; Markus CR, 2008, NEUROMOL MED, V10, P247, DOI 10.1007/s12017-008-8039-9; Meek JL, 1972, J PHARMACOL EXP THER, V184, P570; NAGATA Y, 1994, BRAIN RES, V634, P291, DOI 10.1016/0006-8993(94)91932-1; Ogaya T, 2010, NEUROCHEM RES, V35, P559, DOI 10.1007/s11064-009-0099-1; Ohmori T, 2012, J BIOSCI BIOENG, V112, P256; Perez-de la Cruz V, 2012, J NEUROCHEM, V120, P1026, DOI 10.1111/j.1471-4159.2012.07653.x; Richell RA, 2005, BIOL PSYCHIAT, V57, P295, DOI 10.1016/j.biopsych.2004.10.001; Robotka H, 2008, FUTURE NEUROL, V3, P169, DOI 10.2217/14796708.3.2.169; STONE EA, 1973, J NEUROCHEM, V21, P589, DOI 10.1111/j.1471-4159.1973.tb06004.x; Suenaga R, 2008, AMINO ACIDS, V35, P139, DOI 10.1007/s00726-007-0610-4; Takagi S, 2013, J PET ANIM NUTR, V16, P67; VANLUIJTELAAR ELJM, 1987, PHYSIOL BEHAV, V41, P409, DOI 10.1016/0031-9384(87)90074-6; Wang XD, 2012, BRAIN RES, V1455, P1, DOI 10.1016/j.brainres.2012.03.026; Yoshida J, 2012, NEUROSCIENCE, V220, P142, DOI 10.1016/j.neuroscience.2012.06.041; Yoshida J, 2013, NEUROSCIENCE, V248, P194, DOI 10.1016/j.neuroscience.2013.06.005	52	1	1	PERGAMON-ELSEVIER SCIENCE LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND	0091-3057			PHARMACOL BIOCHEM BE	Pharmacol. Biochem. Behav.	FEB	2015	129						1	6		10.1016/j.pbb.2014.11.016		6	Behavioral Sciences; Neurosciences; Pharmacology & Pharmacy	Behavioral Sciences; Neurosciences & Neurology; Pharmacology & Pharmacy	CB4HD	WOS:000349587900001		
J	Wang, YQ; Takata, Y; Li, R; Zhang, Z; Zhang, MQ; Urade, Y; Qu, WM; Huang, ZL				Wang, Yi-Qun; Takata, Yohko; Li, Rui; Zhang, Ze; Zhang, Meng-Qi; Urade, Yoshihiro; Qu, Wei-Min; Huang, Zhi-Li			Doxepin and diphenhydramine increased non-rapid eye movement sleep through blockade of histamine H-1 receptors	PHARMACOLOGY BIOCHEMISTRY AND BEHAVIOR			English	Article						H-1 receptor; Knockout mice; NREM sleep; Wakefulness	LOW-DOSE DOXEPIN; DOUBLE-BLIND; AROUSAL MECHANISMS; PRIMARY INSOMNIA; NERVOUS-SYSTEM; RAT-BRAIN; IN-VIVO; ANTAGONISTS; WAKEFULNESS; MICE	Histaminergic neurons have been reported to play an important role in the regulation of sleep-wake behavior through the histamine H-1 receptor (R, H1R). First generation H1R antagonists, such as doxepin and diphenhydramine, produce drowsiness in humans, and are occasionally used to treat insomnia. However, if H1R antagonists function via physically blocking the H1R remains unclear. In the current study, we used H1R knockout (KO) mice to investigate if the sleep-promoting effects of doxepin and diphenhydramine are dependent on blockade of the H1R. When doxepin was administered, non-rapid eye movement (NREM) sleep in wild type (WT) mice increased for 4 h, with an increase in the numbers of NREM sleep bouts of 256-512 s and 512-1024 s. These effects were not observed in the H1R KO mice. Furthermore, diphenhydramine increased NREM sleep for 6 h in WT, and not in the H1R KO mice after the injection. These results indicate that both doxepin at 15 mg/kg and diphenhydramine at 10 mg/kg induce NREM sleep through blockade of H1R. (C) 2014 Elsevier Inc. All rights reserved.	[Wang, Yi-Qun; Li, Rui; Zhang, Ze; Zhang, Meng-Qi; Qu, Wei-Min; Huang, Zhi-Li] Fudan Univ, Sch Basic Med Sci, Dept Pharmacol, Shanghai 200032, Peoples R China; [Wang, Yi-Qun; Li, Rui; Zhang, Ze; Zhang, Meng-Qi; Qu, Wei-Min; Huang, Zhi-Li] Fudan Univ, Sch Basic Med Sci, Shanghai Key Lab Bioact Small Mol, Shanghai 200032, Peoples R China; [Takata, Yohko; Urade, Yoshihiro] Osaka Biosci Inst, Dept Mol Behav Biol, Osaka, Japan; [Takata, Yohko; Urade, Yoshihiro] Univ Tsukuba, Int Inst Integrat Sleep Med WPI IIIS, Tsukuba, Ibaraki, Japan; [Zhang, Ze; Qu, Wei-Min; Huang, Zhi-Li] Fudan Univ, Shanghai Med Coll, Inst Brain Sci, Shanghai 200032, Peoples R China; [Zhang, Meng-Qi; Huang, Zhi-Li] Fudan Univ, Sch Basic Med Sci, State Key Lab Med Neurobiol, Shanghai 200032, Peoples R China	Qu, WM (reprint author), Fudan Univ, Sch Basic Med Sci, Dept Pharmacol, Shanghai 200032, Peoples R China.	quweimin@fudan.edu.cn; huangzl@fudan.edu.cn			National Natural Science Foundation of China [J1210041, 31171010, 31171049, 31121061, 31271164, 81420108015]; National Basic Research Program of China [2011CB711000, 2015CB856401, 2009ZX09303-006]; Fundamental Research Funds for the Central Universities [10FX041]; key laboratory program of Education Commission of Shanghai Municipality [ZDSYS14005]; Shanghai Committee of Science and Technology [13140903100, 14JC1400900, 13dz2260700]; Shanghai Leading Academic Discipline Project [B119]; Ph.D. and the Programs Foundation of Ministry of Education of China [20110071110033]	This study was supported in part by grants-in-aid for scientific research from the National Natural Science Foundation of China (J1210041, 31171010, 31171049, 31121061, 31271164, 81420108015), the National Basic Research Program of China (2011CB711000, 2015CB856401, 2009ZX09303-006), the Fundamental Research Funds for the Central Universities (10FX041), a key laboratory program of the Education Commission of Shanghai Municipality (ZDSYS14005), the Shanghai Committee of Science and Technology (13140903100, 14JC1400900, 13dz2260700), the Shanghai Leading Academic Discipline Project (B119), Ph.D. and the Programs Foundation of Ministry of Education of China (20110071110033).	Hajak G, 2001, J CLIN PSYCHIAT, V62, P453; Qu WM, 2010, J NEUROSCI, V30, P4382, DOI 10.1523/JNEUROSCI.4936-09.2010; Huang ZL, 2006, P NATL ACAD SCI USA, V103, P4687, DOI 10.1073/pnas.0600451103; Inoue I, 1996, P NATL ACAD SCI USA, V93, P13316, DOI 10.1073/pnas.93.23.13316; KUDO Y, 1990, J CLIN PHARMACOL, V30, P1041; Krystal AD, 2009, SLEEP MED REV, V13, P265, DOI 10.1016/j.smrv.2008.08.001; Stahl SM, 2008, CNS SPECTRUMS, V13, P1027; Qu WM, 2012, BRIT J PHARMACOL, V167, P587, DOI 10.1111/j.1476-5381.2012.02010.x; Chu M, 2004, NEUROSCI RES, V49, P417, DOI 10.1016/j.neures.2004.05.001; Haas H, 2003, NAT REV NEUROSCI, V4, P121, DOI 10.1038/nrn1034; LIN JS, 1990, BRAIN RES, V523, P325, DOI 10.1016/0006-8993(90)91508-E; BOUTHENET ML, 1988, NEUROSCIENCE, V26, P553, DOI 10.1016/0306-4522(88)90167-4; Weber J, 2010, CNS DRUGS, V24, P713, DOI 10.2165/11200810-000000000-00000; Wang YQ, 2012, J NEUROCHEM, V120, P314, DOI 10.1111/j.1471-4159.2011.07558.x; Rodenbeck A, 2003, PSYCHOPHARMACOLOGY, V170, P423, DOI 10.1007/s00213-003-1565-0; Huang ZL, 2001, P NATL ACAD SCI USA, V98, P9965, DOI 10.1073/pnas.181330998; RICKELS K, 1983, J CLIN PHARMACOL, V23, P234; Krystal AD, 2013, SLEEP MED REV, V17, P263, DOI 10.1016/j.smrv.2012.08.001; YANAI K, 1992, NEUROSCI LETT, V137, P145, DOI 10.1016/0304-3940(92)90390-S; Goforth HW, 2009, EXPERT OPIN PHARMACO, V10, P1649, DOI 10.1517/14656560903005587; Huang ZL, 2005, NAT NEUROSCI, V8, P858, DOI 10.1038/nn1491; Yan MM, 2011, SLEEP BIOL RHYTHMS, V9, P46, DOI 10.1111/j.1479-8425.2010.00484.x; INAGAKI N, 1988, J COMP NEUROL, V273, P283, DOI 10.1002/cne.902730302; Monti JM, 2010, DRUG TODAY, V46, P183, DOI 10.1358/dot.2010.46.3.1437247; KUBO N, 1987, JPN J PHARMACOL, V43, P277, DOI 10.1254/jjp.43.277; Burde R, 1996, BIOCHEM PHARMACOL, V51, P125, DOI 10.1016/0006-2952(95)02123-X; Franklin K. B. J., 1997, MOUSE BRAIN STEREOTA; Gyongyosi N, 2008, BRAIN RES, V1231, P34, DOI 10.1016/j.brainres.2008.06.099; Huang ZL, 2003, J NEUROSCI, V23, P5975; Ikeda-Sagara M, 2012, BRIT J PHARMACOL, V165, P167, DOI 10.1111/j.1476-5381.2011.01547.x; LIN JS, 1988, NEUROPHARMACOLOGY, V27, P111, DOI 10.1016/0028-3908(88)90159-1; Liu Z, 2012, CNS NEUROSCI THER, V18, P623, DOI 10.1111/j.1755-5949.2012.00334.x; MARTINEZMIR MI, 1990, BRAIN RES, V526, P322, DOI 10.1016/0006-8993(90)91240-H; MONTI JM, 1986, J NEURAL TRANSM, V66, P1, DOI 10.1007/BF01262953; Orzechowski RF, 2005, EUR J PHARMACOL, V506, P257, DOI 10.1016/j.ejphar.2004.11.006; PALACIOS JM, 1981, NEUROSCIENCE, V6, P15, DOI 10.1016/0306-4522(81)90240-2; PRAST H, 1993, N-S ARCH PHARMACOL, V347, P301, DOI 10.1007/BF00167449; PRAST H, 1994, N-S ARCH PHARMACOL, V350, P599; REUSE JJ, 1948, BRIT J PHARM CHEMOTH, V3, P174; Sato I, 2005, BRAIN RES, V1057, P81, DOI 10.1016/j.brainres.2005.07.040; Schutte-Rodin Sharon, 2008, J Clin Sleep Med, V4, P487; Shigemoto Y, 2004, EUR J PHARMACOL, V494, P161, DOI 10.1016/j.ejphar.2004.05.010; Taglialatela M, 2000, TRENDS PHARMACOL SCI, V21, P52, DOI 10.1016/S0165-6147(99)01437-6; Thakkar MM, 2011, SLEEP MED REV, V15, P65, DOI 10.1016/j.smrv.2010.06.004; Tokunaga S, 2009, BIOL PHARM BULL, V32, P51; Tokunaga S, 2007, J PHARMACOL SCI, V103, P201, DOI 10.1254/jphs.FP0061173; Unno K, 2012, EUR J PHARMACOL, V683, P179, DOI 10.1016/j.ejphar.2012.03.017; Vanni-Mercier G, 2003, BEHAV BRAIN RES, V144, P227, DOI 10.1016/S0166-4328(03)00091-3; Wafford KA, 2008, NAT REV DRUG DISCOV, V7, P530, DOI 10.1038/nrd2464; YAMASHITA M, 1991, BIOCHEM BIOPH RES CO, V177, P1233, DOI 10.1016/0006-291X(91)90673-U	50	3	4	PERGAMON-ELSEVIER SCIENCE LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND	0091-3057			PHARMACOL BIOCHEM BE	Pharmacol. Biochem. Behav.	FEB	2015	129						56	64		10.1016/j.pbb.2014.12.002		9	Behavioral Sciences; Neurosciences; Pharmacology & Pharmacy	Behavioral Sciences; Neurosciences & Neurology; Pharmacology & Pharmacy	CB4HD	WOS:000349587900009		
J	Tachibana, T; Sugimoto, I; Ogino, M; Khan, MSI; Masuda, K; Ukena, K; Wang, YJ				Tachibana, Tetsuya; Sugimoto, Ikue; Ogino, Madoka; Khan, Md. Sakirul Islam; Masuda, Keiko; Ukena, Kazuyoshi; Wang, Yajun			Central administration of chicken growth hormone-releasing hormone decreases food intake in chicks	PHYSIOLOGY & BEHAVIOR			English	Article						Chick; Corticotropin-releasing hormone; Feeding; Growth hormone-releasing hormone; Growth hormone-releasing; hormone-like peptide; Intracerebroventricular injection; Pituitary adenylate cyclase-activating polypeptide	CYCLASE-ACTIVATING POLYPEPTIDE; GALANIN-LIKE PEPTIDE; VASOACTIVE-INTESTINAL-PEPTIDE; FEEDING-BEHAVIOR; NEONATAL CHICKS; PITUITARY-CELLS; GHRH RECEPTOR; GHRELIN; INJECTION; OREXINS	Growth hormone-releasing hormone (GHRH) is well known as a stimulator of growth hormone (GH) secretion. GHRH not only stimulates GH release but also modifies feeding behavior and energy homeostasis in rodents. In chickens (Gallus gallus domesticus), on the other hand, two types of GHRH, namely, chicken GHRH (cGHRH) and cGHRH-like peptide (cGHRH-LP), have been identified. The purpose of the present study was to investigate the effect of central injection of cGHRH and cGHRH-LP on feeding behavior in chicks. Intracerebroventricular (ICV) injection of both cGHRH and cGHRH-LP (0.04 to 1 nmol) significantly decreased food intake without any abnormal behavior in chicks. Furthermore, the feeding-inhibitory effect was not abolished by co-injection of the antagonist for pituitary adenylate cyclase-activating polypeptide (PACAP) or corticotropin-releasing hormone (CRH) receptors, suggesting that the anorexigenic effect of cGHRH and cGHRH-LP might not be related to the PACAP and CRH systems in the brain of chicks. Finally, 24-h food deprivation increased mRNA expression of cGHRH but not cGHRH-LP in the diencephalon. These results suggest that central cGHRH is related to inhibiting feeding behavior and energy homeostasis in chicks. (c) 2014 Elsevier Inc. All rights reserved.	[Tachibana, Tetsuya; Sugimoto, Ikue; Ogino, Madoka; Khan, Md. Sakirul Islam] Ehime Univ, Dept Agrobiol Sci, Fac Agr, Matsuyama, Ehime 7908566, Japan; [Masuda, Keiko; Ukena, Kazuyoshi] Hiroshima Univ, Grad Sch Integrated Arts & Sci, Sect Behav Sci, Higashihiroshima 7398521, Japan; [Wang, Yajun] Sichuan Univ, Coll Life Sci, Chengdu 610065, Peoples R China	Tachibana, T (reprint author), Ehime Univ, Dept Agrobiol Sci, Fac Agr, Lab Anim Prod, Matsuyama, Ehime 7908566, Japan.	tetsu@agr.ehime-u.ac.jp			Japan Society for the Promotion of Science (JSPS) [25450398]	This work was supported by a Grant-in-Aid for Scientific Research (C) (25450398) from the Japan Society for the Promotion of Science (JSPS).	Lawrence CB, 2002, J NEUROENDOCRINOL, V14, P853, DOI 10.1046/j.1365-2826.2002.00846.x; Furuse M, 1999, BRIT POULTRY SCI, V40, P698, DOI 10.1080/00071669987115; Matsumoto Y, 2002, NEUROSCI LETT, V322, P67, DOI 10.1016/S0304-3940(01)02515-0; KYRKOULI SE, 1986, EUR J PHARMACOL, V122, P159, DOI 10.1016/0014-2999(86)90175-5; Saito ES, 2005, REGUL PEPTIDES, V125, P201, DOI 10.1016/j.regpep.2004.09.003; Peeters K, 1998, ANN NY ACAD SCI, V865, P471, DOI 10.1111/j.1749-6632.1998.tb11218.x; Sakurai T, 1998, CELL, V92, P573, DOI 10.1016/S0092-8674(00)80949-6; Nakazato M, 2001, NATURE, V409, P194, DOI 10.1038/35051587; Sherwood NM, 2000, ENDOCR REV, V21, P619, DOI 10.1210/er.21.6.619; Tachibana T, 2004, REGUL PEPTIDES, V120, P99, DOI 10.1016/j.regpep.2004.02.016; Tachibana T, 2007, COMP BIOCHEM PHYS A, V147, P173, DOI 10.1016/j.ebpa.2006.12.044; Masunari K, 2013, REGUL PEPTIDES, V187, P1, DOI 10.1016/j.regpep.2013.10.004; DAVIS JL, 1979, PHYSIOL BEHAV, V22, P693, DOI 10.1016/0031-9384(79)90233-6; Tachibana T, 2008, COMP BIOCHEM PHYS A, V151, P637, DOI 10.1016/j.cbpa.2008.08.001; Tachibana T, 2003, NEUROSCI LETT, V348, P25, DOI 10.1016/S0304-3940(03)00646-3; Meng FY, 2014, MOL CELL ENDOCRINOL, V384, P83, DOI 10.1016/j.mce.2014.01.001; Denbow DM, 2000, PHYSIOL BEHAV, V69, P359, DOI 10.1016/S0031-9384(99)00258-9; Bungo T, 1999, BRAIN RES, V817, P196, DOI 10.1016/S0006-8993(98)01223-2; Wang YJ, 2007, ENDOCRINOLOGY, V148, P2405, DOI 10.1210/en.2006-1013; Wren AM, 2000, ENDOCRINOLOGY, V141, P4325, DOI 10.1210/en.141.11.4325; Harvey S., 1999, NEURAL REGULATION VE, P69; Hohmann JG, 1998, ANN NY ACAD SCI, V863, P221, DOI 10.1111/j.1749-6632.1998.tb10697.x; Huang Gui-An, 2012, Sichuan Daxue Xuebao (Ziran Kexueban), V49, P677, DOI 10.3969/j.issn.0490-6756.2012.03.037; IMAKI T, 1985, BRAIN RES, V340, P186, DOI 10.1016/0006-8993(85)90792-9; Kuramochi M, 2005, REGUL PEPTIDES, V126, P85, DOI 10.1016/j.regpep.2004.08.017; Lopez M, 2010, ACTA PHYSIOL, V198, P325, DOI 10.1111/j.1748-1716.2009.02042.x; McRory JE, 1997, DNA CELL BIOL, V16, P95, DOI 10.1089/dna.1997.16.95; Mujahid A, 2009, NEUROSCIENCE, V158, P1571, DOI 10.1016/j.neuroscience.2008.11.047; National Research Council, 1996, GUIDE CARE USE LAB A; Saito ES, 2002, EUR J PHARMACOL, V453, P75, DOI 10.1016/S0014-2999(02)02393-2; Sirotkin AV, 2013, COMP BIOCHEM PHYS A, V164, P141, DOI 10.1016/j.cbpa.2012.07.010; Tachibana T, 2006, COMP BIOCHEM PHYS A, V143, P112, DOI 10.1016/j.cbpa.2005.11.007; TAKAHASHI T, 1995, ENDOCRINOLOGY, V136, P4721, DOI 10.1210/en.136.10.4721; VACCARINO FJ, 1985, NATURE, V314, P167, DOI 10.1038/314167a0; VACCARINO FJ, 1990, ANN NY ACAD SCI, V579, P227; Wang Y, 2010, DOMEST ANIM ENDOCRIN, V38, P13, DOI 10.1016/j.domaniend.2009.07.008	36	0	0	PERGAMON-ELSEVIER SCIENCE LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND	0031-9384			PHYSIOL BEHAV	Physiol. Behav.	FEB	2015	139						195	201		10.1016/j.physbeh.2014.11.043		7	Psychology, Biological; Behavioral Sciences	Psychology; Behavioral Sciences	CB4BY	WOS:000349574400027		
J	Komiyama, T; Sudo, M; Higaki, Y; Kiyonaga, A; Tanaka, H; Ando, S				Komiyama, Takaaki; Sudo, Mizuki; Higaki, Yasuki; Kiyonaga, Akira; Tanaka, Hiroaki; Ando, Soichi			Does moderate hypoxia alter working memory and executive function during prolonged exercise?	PHYSIOLOGY & BEHAVIOR			English	Article						Cognition; Reaction time; Oxygen availability	HIGH-ALTITUDE EXPOSURE; CEREBRAL PERTURBATIONS; COGNITIVE PERFORMANCE; NERVOUS-SYSTEM; REACTION-TIME; BLOOD-FLOW; BRAIN; ACCURACY; FATIGUE; CORTEX	It has been suggested that acute exercise improves cognitive function. However, little is known about how exercise under hypoxia affects cognitive function. The purpose of this study was to determine if hypoxia alters working memory and executive function during prolonged exercise. Sixteen participants performed cognitive tasks at rest and during exercise under normoxia and hypoxia [fraction of inspired oxygen (FIO2) = 0.15, corresponding to an altitude of approximately 2600 m]. The level of hypoxia was moderate. We used a combination of Spatial Delayed Response (Spatial DR) task and Go/No-Go (GNG) task, where spatial working memory and executive function are required. Working memory was assessed by the accuracy of the Spatial DR task, and executive function was assessed by the accuracy and reaction time in the GNG task. The participants cycled an ergometer for 30 min under normoxia and moderate hypoxia while keeping their heart rate (HR) at 140 beats/min. They performed the cognitive tasks 5 mm. 23 mm after their HR reached 140 beats/min. Moderate hypoxia did not alter the accuracy of the Spatial DR (P = 0.38) and GNG tasks (P = 0.14). In contrast, reaction time in the GNG task significantly decreased during exercise relative to rest under normoxia and moderate hypoxia (P = 0.02). These results suggest that moderate hypoxia and resultant biological processes did not provide sufficient stress to impair working memory and executive function during prolonged exercise. The beneficial effects on speed of response appear to persist during prolonged exercise under moderate hypoxia. (c) 2014 Elsevier Inc All rights reserved.	[Komiyama, Takaaki] Fukuoka Univ, Grad Sch Sports & Hlth Sci, Fukuoka, Japan; [Sudo, Mizuki] Meiji Yasuda Life Fdn Hlth & Welf, Phys Fitness Res Inst, Tokyo, Japan; [Sudo, Mizuki; Higaki, Yasuki; Kiyonaga, Akira; Tanaka, Hiroaki] Fukuoka Univ, Inst Phys Act, Fukuoka, Japan; [Higaki, Yasuki; Kiyonaga, Akira; Tanaka, Hiroaki; Ando, Soichi] Fukuoka Univ, Fac Sports & Hlth Sci, Fukuoka 8140180, Japan; [Ando, Soichi] Univ Electrocommun, Grad Sch Informat & Engn, Chofu, Tokyo 1828585, Japan	Ando, S (reprint author), Univ Electrocommun, Grad Sch Informat & Engn, 1-5-1 Chofugaoka, Chofu, Tokyo 1828585, Japan.	soichi.ando@uec.ac.jp			JSPS KAKENHI [25702039]; MEXT	We are grateful to Naoki Okuda and Takuya Inada for their help in data acquisition. Special thanks are due to Dr. Kisou Kubota for providing software to assess cognitive function. This study was supported by JSPS KAKENHI (Grant Number 25702039) and MEXT-Supported Program for the Strategic Research Foundation at Private Universities (2008-2012). The authors declare that there are no conflicts of interest.	Ando S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0063630; Sorensen H, 2012, ANESTHESIOLOGY, V117, P263, DOI 10.1097/ALN.0b013e3182605afe; Koechlin E, 1999, NATURE, V399, P148; Lambourne K, 2010, BRAIN RES, V1341, P12, DOI 10.1016/j.brainres.2010.03.091; Hillman CH, 2008, NAT REV NEUROSCI, V9, P58, DOI 10.1038/nrn2298; Smith EE, 1998, P NATL ACAD SCI USA, V95, P12061, DOI 10.1073/pnas.95.20.12061; Hornbein TF, 2001, J EXP BIOL, V204, P3129; Savourey G, 2003, EUR J APPL PHYSIOL, V89, P122, DOI 10.1007/s00421-002-0789-8; Ando S, 2010, J APPL PHYSIOL, V108, P1210, DOI 10.1152/japplphysiol.01115.2009; Takahashi T, 2011, NEUROIMAGE, V57, P991, DOI 10.1016/j.neuroimage.2011.05.012; Virues-Ortega J, 2006, DEVELOPMENTAL SCI, V9, P400, DOI 10.1111/j.1467-7687.2006.00505.x; Klingberg T, 2006, NEUROPSYCHOLOGIA, V44, P2171, DOI 10.1016/j.neuropsychologia.2005.11.019; Roach RC, 2001, J EXP BIOL, V204, P3161; Hackett PH, 2001, NEW ENGL J MED, V345, P107, DOI 10.1056/NEJM200107123450206; Brisswalter J, 2002, SPORTS MED, V32, P555, DOI 10.2165/00007256-200232090-00002; Etnier JL, 2009, J SPORT EXERCISE PSY, V31, P469; Lemos VD, 2012, PSYCHOPHYSIOLOGY, V49, P1298, DOI 10.1111/j.1469-8986.2012.01411.x; Ogoh S, 2011, CLIN PHYSIOL FUNCT I, V31, P445, DOI 10.1111/j.1475-097X.2011.01040.x; Koechlin E, 2007, TRENDS COGN SCI, V11, P229, DOI 10.1016/j.tics.2007.04.005; Chaddock L, 2011, MED SCI SPORT EXER, V43, P344, DOI 10.1249/MSS.0b013e3181e9af48; Fulco CS, 2013, EXERC SPORT SCI REV, V41, P55, DOI 10.1097/JES.0b013e31825eaa33; Nybo L, 2007, EXERC SPORT SCI REV, V35, P110, DOI 10.1097/jes.0b013e3180a031ec; Amann M, 2009, HIGH ALT MED BIOL, V10, P149, DOI 10.1089/ham.2008.1105; JONIDES J, 1993, NATURE, V363, P623, DOI 10.1038/363623a0; Nybo L, 2004, PROG NEUROBIOL, V72, P223, DOI 10.1016/j.pnuerobio.2004.03.005; Neubauer JA, 2004, J APPL PHYSIOL, V96, P367, DOI 10.1152/japplphysiol.00831.2003; Dietrich A, 2011, NEUROSCI BIOBEHAV R, V35, P1305, DOI 10.1016/j.neubiorev.2011.02.001; Pontifex MB, 2009, MED SCI SPORT EXER, V41, P927, DOI 10.1249/MSS.0b013e3181907d69; CHMURA J, 1994, INT J SPORTS MED, V15, P172, DOI 10.1055/s-2007-1021042; McMorris T, 2012, BRAIN COGNITION, V80, P338, DOI 10.1016/j.bandc.2012.09.001; Verges S, 2012, AM J PHYSIOL-REG I, V302, pR903, DOI 10.1152/ajpregu.00555.2011; McMorris T, 2011, PHYSIOL BEHAV, V102, P421, DOI 10.1016/j.physbeh.2010.12.007; Chang YK, 2012, BRAIN RES, V1453, P87, DOI 10.1016/j.brainres.2012.02.068; Borg G., 1975, PHYSICAL WORK EFFORT, P39; Harada Taeko, 2004, Neuroscience Research, V49, P325, DOI 10.1016/j.neures.2004.03.011; Hasegawa H, 2008, J PHYSIOL-LONDON, V586, P141, DOI 10.1113/jphysiol.2007.142190; Hirasawa A, 2014, CLIN PHYSL FUNCT IMA; Jerde TA, 2013, J PHYSIOL-PARIS, V107, P510, DOI 10.1016/j.jphysparis.2013.04.002; Moore CM, 2014, MED SCI SPORT EXER, V46, P795, DOI 10.1249/MSS.0000000000000148; Richard NA, 2012, AVIAT SPACE ENVIR MD, V83, P677, DOI 10.3357/ASEM.3182.2012; Ungerleider LG, 1998, P NATL ACAD SCI USA, V95, P883, DOI 10.1073/pnas.95.3.883; Virues-Ortega Javier, 2004, Neuropsychology Review, V14, P197, DOI 10.1007/s11065-004-8159-4	42	2	2	PERGAMON-ELSEVIER SCIENCE LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND	0031-9384			PHYSIOL BEHAV	Physiol. Behav.	FEB	2015	139						290	296		10.1016/j.physbeh.2014.11.057		7	Psychology, Biological; Behavioral Sciences	Psychology; Behavioral Sciences	CB4BY	WOS:000349574400040		
J	Eto, T; Hayashi, R; Okubo, Y; Kashimura, A; Koshimoto, C; Sakamoto, SH; Morita, T				Eto, Takeshi; Hayashi, Rintaroh; Okubo, Yoshinobu; Kashimura, Atsushi; Koshimoto, Chihiro; Sakamoto, Shinsuke H.; Morita, Tetsuo			Magnitude of food overabundance affects expression of daily torpor	PHYSIOLOGY & BEHAVIOR			English	Article						Daily torpor; Food overabundance; Small mammal; Recognition; Body temperature; Apodemus speciosus	DJUNGARIAN HAMSTERS; PHODOPUS-SUNGORUS; BODY-TEMPERATURE; MAMMALIAN HIBERNATION; ENERGY AVAILABILITY; PEROMYSCUS-LEUCOPUS; SHORT PHOTOPERIOD; COLD-EXPOSURE; MOUSE; DEPRIVATION	Many small mammal species use torpor as a strategy for reducing energy expenditure in winter. Some rodent hibernators also hoard food to provide reserves of energy, and individuals with large hoards express less torpor than those with smaller reserves. These facts imply that animals can recognize levels of food availability, but where food is very plentiful, it is unclear whether torpor expression is affected by temporal changes in the extent of food overabundance. Moreover, the relationship between daily torpor and excess food availability has not been clearly established. The large Japanese field mouse Apodemus speciosus caches food for use as a winter energy resource and exhibits daily torpor under artificial winter conditions. The present study examined whether individuals exposed to different magnitudes of overabundant food exhibited differences in expression of daily torpor, and secondly whether torpor expression varied in response to changes in the overall quantity of overabundant food. It was observed that while absolute quantities of overabundant food did not appear to affect daily torpor expression, the mice did respond to changes in food availability, even when food remained overabundant. This suggests that the mice respond to fluctuations in food availability, even where these changes do not place any constraint on energy budgets. Thus recognition of changing food availability cannot be a purely physiological response to shortage or plenty, and may contribute to predictions of future energy availability. The expression of torpor was inhibited in response to increasing food availability, and the mice used shallower torpor when food availability increased to superabundance. These findings suggest that daily torpor may be regulated not only physiologically in response to energy constraints but also psychologically, via recognition of food availability. (C) 2014 Published by Elsevier Inc.	[Eto, Takeshi; Okubo, Yoshinobu] Miyazaki Univ, Interdisciplinary Grad Sch Agr & Engn, Miyazaki 8892192, Japan; [Hayashi, Rintaroh; Kashimura, Atsushi; Morita, Tetsuo] Miyazaki Univ, Fac Agr, Miyazaki 8892192, Japan; [Koshimoto, Chihiro; Sakamoto, Shinsuke H.] Miyazaki Univ, Div Bioresources, Frontier Sci Res Ctr, Miyazaki 8891692, Japan	Sakamoto, SH (reprint author), Miyazaki Univ, Div Bioresources, Frontier Sci Res Ctr, Kiyotake Campus, Miyazaki 8891692, Japan.	aposhin1@med.miyazaki-u.ac.jp					RUF T, 1993, J EXP ZOOL, V267, P104, DOI 10.1002/jez.1402670203; Kobbe S, 2011, J COMP PHYSIOL B, V181, P165, DOI 10.1007/s00360-010-0507-5; Vuarin P, 2014, J COMP PHYSIOL B, V184, P683, DOI 10.1007/s00360-014-0833-0; Geiser F, 2004, ANNU REV PHYSIOL, V66, P239, DOI 10.1146/annurev.physiol.66.032102.115105; Palchykova S, 2006, PHYSIOL BEHAV, V87, P144, DOI 10.1016/j.physbeh.2005.09.005; Humphries MM, 2003, PHYSIOL BIOCHEM ZOOL, V76, P165, DOI 10.1086/367950; Brostrom G, 2011, COMPUT STAT DATA AN, V55, P3123, DOI 10.1016/j.csda.2011.06.011; Dzal YA, 2013, J COMP PHYSIOL B, V183, P279, DOI 10.1007/s00360-012-0705-4; Seguy M, 2005, J COMP PHYSIOL B, V175, P107, DOI 10.1007/s00360-004-0467-8; KIRSCH R, 1991, J COMP PHYSIOL A, V168, P121, DOI 10.1007/BF00217110; Hallam SL, 2011, J COMP PHYSIOL B, V181, P437, DOI 10.1007/s00360-010-0531-5; Bozinovic F, 2007, J COMP PHYSIOL B, V177, P393, DOI 10.1007/s00360-006-0137-0; Nowack J, 2013, INT J PRIMATOL, V34, P49, DOI 10.1007/s10764-012-9646-8; ELLIOTT JA, 1987, J COMP PHYSIOL A, V161, P245, DOI 10.1007/BF00615244; Bieber C, 2014, FUNCT ECOL, V28, P167, DOI 10.1111/1365-2435.12173; HELDMAIER G, 1981, OECOLOGIA, V48, P265, DOI 10.1007/BF00347975; Cooper CE, 2005, J COMP PHYSIOL B, V175, P323, DOI 10.1007/s00360-005-0488-y; Deboer T, 2005, J THERM BIOL, V30, P173, DOI 10.1016/j.jtherbio.2004.08.013; Eto T, 2014, PHYSIOL BEHAV, V133, P22, DOI 10.1016/j.physbeh.2014.04.051; Franco M, 2013, COMP BIOCHEM PHYS A, V166, P338, DOI 10.1016/j.cbpa.2013.07.010; French AR, 2000, J MAMMAL, V81, P979, DOI 10.1644/1545-1542(2000)081<0979:IOSFAC>2.0.CO;2; French A.R., 2008, HYPOMETABOLISM ANIMA, P337; French A.R., 1989, LIVING COLD, VII, P129; Geiser F, 2011, J MAMMAL, V92, P452, DOI 10.1644/10-MAMM-A-097.1; Geiser F, 2000, LIFE IN THE COLD, P95; Geiser F, 2007, J COMP PHYSIOL B, V177, P495, DOI 10.1007/s00360-007-0147-6; GEISER F, 1995, PHYSIOL ZOOL, V68, P935; Giroud S, 2009, AM J PHYSIOL-REG I, V297, pR950, DOI 10.1152/ajpregu.00214.2009; Humphries MM, 2003, PHYSIOL BIOCHEM ZOOL, V76, P180, DOI 10.1086/367949; IMAIZUMI Y, 1979, Zoological Magazine (Tokyo), V88, P43; LYNCH GR, 1978, PHYSIOL ZOOL, V51, P289; LYNCH GR, 1980, OECOLOGIA, V45, P318, DOI 10.1007/BF00540198; Munn AJ, 2010, NATURWISSENSCHAFTEN, V97, P601, DOI 10.1007/s00114-010-0670-2; Nakata K., 2009, WILD MAMMALS JAPAN, P169; Pinheiro J, 2012, NLME LINEAR NONLINEA; R Development Core Team, 2012, R LANG ENV STAT COMP; Sone K., 1999, J FOREST RES, V4, P167, DOI 10.1007/BF02762243; Vander Wall SB, 1990, FOOD HOARDING ANIMAL	38	0	0	PERGAMON-ELSEVIER SCIENCE LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND	0031-9384			PHYSIOL BEHAV	Physiol. Behav.	FEB	2015	139						519	523		10.1016/j.physbeh.2014.12.007		5	Psychology, Biological; Behavioral Sciences	Psychology; Behavioral Sciences	CB4BY	WOS:000349574400071		
J	Mekawy, AMM; Assaha, DVM; Yahagi, H; Tada, Y; Ueda, A; Saneoka, H				Mekawy, Ahmad Mohammad M.; Assaha, Dekoum V. M.; Yahagi, Hiroyuki; Tada, Yuma; Ueda, Akihiro; Saneoka, Hirofumi			Growth, physiological adaptation, and gene expression analysis of two Egyptian rice cultivars under salt stress	PLANT PHYSIOLOGY AND BIOCHEMISTRY			English	Article						Na+ exclusion; OsHKT1;5; OsHKT2;1; OsAKT1; OsLti6b; K+ uptake	VACUOLAR NA+/H+ ANTIPORTER; PLASMA-MEMBRANE; SALINITY TOLERANCE; ORYZA-SATIVA; TRANSPORT; ROOTS; SODIUM; BARLEY; PLANTS; ATNHX1	Abiotic stressors, such as high salinity, greatly affect plant growth. In an attempt to explore the mechanisms underlying salinity tolerance, physiological parameters of two local Egyptian rice (Oryza sativa L) cultivars, Sakha 102 and Egyptian Yasmine, were examined under 50 mM NaCl stress for 14 days. The results indicate that Egyptian Yasmine is relatively salt tolerant compared to Sakha 102, and this was evident in its higher dry mass production, lower leaf Na+ levels, and enhanced water conservation under salt stress conditions. Moreover, Egyptian Yasmine exhibited lower Na+/K+ ratios in all tissues examined under salinity stress. The ability to maintain such traits seemed to differ in the leaves and roots of Egyptian Yasmine, and the root K+ content was much higher in Egyptian Yasmine than in Sakha 102. In order to understand the basis for these differences, we studied transcript levels of genes encoding Na+ and K+ transport proteins in different tissues. In response to salinity stress, Egyptian Yasmine showed induction of expression of some membrane transporter/channel genes that may contribute to Na+ exclusion from the shoots (OsHKT1;5), limiting excess Na+ entry into the roots (OsLti6b), K+ uptake (OsAKT1), and reduced expression of a Na+ transporter gene (OsHKT2;1). Therefore, the active regulation of genes related to Na+ transport at the transcription level may be involved in salt tolerance mechanisms of Egyptian Yasmine, and these mechanisms offer the promise of improved salinity stress tolerance in local Egyptian rice genotypes. (C) 2015 Elsevier Masson SAS. All rights reserved.	[Mekawy, Ahmad Mohammad M.; Assaha, Dekoum V. M.; Yahagi, Hiroyuki; Tada, Yuma; Ueda, Akihiro; Saneoka, Hirofumi] Hiroshima Univ, Grad Sch Biosphere Sci, Higashihiroshima 7398528, Japan	Ueda, A (reprint author), Hiroshima Univ, Grad Sch Biosphere Sci, Higashihiroshima 7398528, Japan.	akiueda@hiroshima-u.ac.jp			Ministry of Higher Education and Scientific Research in Egypt;  [25850041]	This research was supported by the Grant-in-Aid for Young Scientists (B) (No. 25850041) to AU and Ministry of Higher Education and Scientific Research in Egypt to AMMM.	Golldack D, 2003, PLANT MOL BIOL, V51, P71, DOI 10.1023/A:1020763218045; Ding L, 1997, PLANT PHYSIOL, V113, P795, DOI 10.1104/pp.113.3.795; Leidi EO, 2010, PLANT J, V61, P495, DOI 10.1111/j.1365-313X.2009.04073.x; Darwish E, 2009, PLANT CELL PHYSIOL, V50, P986, DOI 10.1093/pcp/pcp051; Navarre C, 2000, EMBO J, V19, P2515, DOI 10.1093/emboj/19.11.2515; Ren ZH, 2005, NAT GENET, V37, P1141, DOI 10.1038/ng1643; Zhang HX, 2001, NAT BIOTECHNOL, V19, P765, DOI 10.1038/90824; Munns R, 2008, ANNU REV PLANT BIOL, V59, P651, DOI 10.1146/annurev.arplant.59.032607.092911; Fukuda A, 2004, PLANT CELL PHYSIOL, V45, P146, DOI 10.1093/pcp/pch014; Inada M, 2005, PLANTA, V220, P395, DOI 10.1007/s00425-004-1358-7; Santa-Maria GE, 1997, PLANT CELL, V9, P2281, DOI 10.1105/tpc.9.12.2281; Shi HZ, 2002, PLANT CELL, V14, P465, DOI 10.1105/tpc.010371; Bassil E, 2011, PLANT CELL, V23, P3482, DOI 10.1105/tpc.111.089581; Martinez-Atienza J, 2007, PLANT PHYSIOL, V143, P1001, DOI 10.1104/pp.106.092635; Yamaguchi T, 2005, P NATL ACAD SCI USA, V102, P16107, DOI 10.1073/pnas.0504437102; SENTENAC H, 1992, SCIENCE, V256, P663, DOI 10.1126/science.1585180; Maathuis FJM, 2001, PLANT PHYSIOL, V127, P1617, DOI 10.1104/pp.127.4.1617; Apse MP, 2003, PLANT J, V36, P229, DOI 10.1046/j.1365-313X.2003.01871.x; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Ueda A, 2004, J EXP BOT, V55, P2213, DOI 10.1093/jxb/erh242; Horie T, 2009, TRENDS PLANT SCI, V14, P660, DOI 10.1016/j.tplants.2009.08.009; Roberts SK, 1997, J EXP BOT, V48, P431, DOI 10.1093/jxb/48.Special_Issue.431; Tester M, 2003, ANN BOT-LONDON, V91, P503, DOI 10.1093/aob/mcg058; Koyama ML, 2001, PLANT PHYSIOL, V125, P406, DOI 10.1104/pp.125.1.406; Walia H, 2007, PLANT MOL BIOL, V63, P609, DOI 10.1007/s11103-006-9112-0; Venema K, 2002, J BIOL CHEM, V277, P2413, DOI 10.1074/jbc.M105043200; Assaha DVM, 2013, SOIL SCI PLANT NUTR, V59, P912, DOI 10.1080/00380768.2013.858300; Jain M, 2006, BIOCHEM BIOPH RES CO, V345, P646, DOI 10.1016/j.bbrc.2006.04.140; Fukuda A, 1999, BBA-GENE STRUCT EXPR, V1446, P149, DOI 10.1016/S0167-4781(99)00065-2; Pardo JM, 2010, CURR OPIN BIOTECH, V21, P185, DOI 10.1016/j.copbio.2010.02.005; Garciadeblas B, 2003, PLANT J, V34, P788, DOI 10.1046/j.1365-313X.2003.01764.x; Ueda A, 2002, J PLANT RES, V115, P119, DOI 10.1007/s102650200017; Cotsaftis O., 2012, PLOS ONE, V7; Flowers TJ, 1999, SCI HORTIC-AMSTERDAM, V78, P1; Horie T, 2007, EMBO J, V26, P3003, DOI 10.1038/sj.emboj.7601732; Kushizaki M., 1968, J SCI SOIL MANURE, V39, P489; Mandhania S, 2006, BIOL PLANTARUM, V50, P227, DOI 10.1007/s10535-006-0011-7; Nylander M., 2001, PLANT MOL BIOL, V45, P341; Senadheera P, 2009, J EXP BOT, V60, P2553, DOI 10.1093/jxb/erp099; Ueda A, 2006, THEOR APPL GENET, V112, P1286, DOI 10.1007/s00122-006-0231-4; Ueda A, 2013, SOIL SCI PLANT NUTR, V59, P896, DOI 10.1080/00380768.2013.842883; WEATHERLEY P. E., 1950, NEW PHYTOL, V49, P81, DOI 10.1111/j.1469-8137.1950.tb05146.x; Yao X, 2010, PLANT PHYSIOL, V152, P341, DOI 10.1104/pp.109.145722	43	1	1	ELSEVIER FRANCE-EDITIONS SCIENTIFIQUES MEDICALES ELSEVIER	PARIS	23 RUE LINOIS, 75724 PARIS, FRANCE	0981-9428			PLANT PHYSIOL BIOCH	Plant Physiol. Biochem.	FEB	2015	87						17	25		10.1016/j.plaphy.2014.12.007		9	Plant Sciences	Plant Sciences	CB6IU	WOS:000349731500003		
J	Chen, XM; Baldermann, S; Cao, SY; Lu, Y; Liu, CX; Hirata, H; Watanabe, N				Chen, Xiaomin; Baldermann, Susanne; Cao, Shuyan; Lu, Yao; Liu, Caixia; Hirata, Hiroshi; Watanabe, Naoharu			Developmental patterns of emission of scent compounds and related gene expression in roses of the cultivar Rosa x hybrida cv. 'Yves Piaget'	PLANT PHYSIOLOGY AND BIOCHEMISTRY			English	Article						2-Phenylethanol; 3,5-Dimethoxytoluene; Floral scent compound; Rosa x hybrida cv. 'Yves Piaget'; GC-MS; Real time qRT-PCR; Relative transcript level	FLORAL SCENT; PHENYLACETALDEHYDE REDUCTASE; FUNCTIONAL-CHARACTERIZATION; L-PHENYLALANINE; 2-PHENYLETHANOL; BIOSYNTHESIS; EVOLUTION; SYNTHASE; FLOWERS; ENZYME	2-Phenylethanol (2PE) and 3,5-dimethoxytoluene (DMT) are characteristic scent compounds in specific roses such as Rosa x hybrida cv. 'Yves Piaget'. We analyzed the endogenous concentrations and emission of 2PE and DMT during the unfurling process in different floral organs, as well as changes in transcript levels of the two key genes, PAR and OOMT2. The emission of both 2PE and DMT increased during floral development to reach peaks at the fully unfurled stage. The relative transcripts of PAR and OOMT2 also increased during floral development. Whereas the maximum for OOMT2 was found at the fully unfurled stage (stage 4), similar expression levels of PAR were detected at stage 4 and the senescence stage (stage 6). The results demonstrate a positive correlation between the expression levels of PAR and OOMT2 and the emission of 2PE and DMT. In addition, endogenous volatiles and relative transcripts showed tissue- and development-specific patterns. (C) 2014 Elsevier Masson SAS. All rights reserved.	[Chen, Xiaomin] Wenzhou Med Univ, Res Acad Reprod Biomed, Wenzhou 325027, Zhejiang, Peoples R China; [Baldermann, Susanne] Grossbeeren Erfurt eV, Leibniz Inst Vegetable & Ornamental Crops, D-14979 Grossbeeren, Germany; [Baldermann, Susanne] Univ Potsdam, Inst Nutr Sci, D-14558 Nuthetal, Germany; [Cao, Shuyan; Liu, Caixia] Wenzhou Med Univ, Affiliated Hosp 2, Wenzhou 325027, Zhejiang, Peoples R China; [Cao, Shuyan; Liu, Caixia] Wenzhou Med Univ, Yuying Childrens Hosp, Wenzhou 325027, Zhejiang, Peoples R China; [Lu, Yao] Chinese Acad Sci, Inst Microbiol, State Key Lab Microbial Resources, Beijing 100864, Peoples R China; [Hirata, Hiroshi; Watanabe, Naoharu] Shizuoka Univ, Grad Sch Sci & Technol, Naka Ku, Hamamatsu, Shizuoka 4328561, Japan	Chen, XM (reprint author), Wenzhou Med Univ, Res Acad Reprod Biomed, Wenzhou 325027, Zhejiang, Peoples R China.	xminch@163.com; baldermann@igzev.de; caoshy815@126.com; 46390184@qq.com; wzcaixia1978@163.com; lxjtpt341@ybb.ne.jp; acnwata@ipc.shizuoka.ac.jp	Baldermann, Susanne/C-4292-2014; Lu, yao/O-9663-2015	Baldermann, Susanne/0000-0002-1501-4320; 	National Natural Science Foundation of China [31100575]; Japan Society for Promotion of Science (JSPS)	This work was supported by the National Natural Science Foundation of China (No. 31100575). A part of the work was also supported by Grants-in-Aid for Scientific Research (B) to NW, by Japan Society for Promotion of Science (JSPS). Mrs Hiromi Kobayashi, Shizuoka University, is thanked for technical support in molecular cloning.	Guterman I, 2002, PLANT CELL, V14, P2325, DOI 10.1105/tpc.005207; Sakai M, 2007, BIOSCI BIOTECH BIOCH, V71, P2408, DOI 10.1271/bbb.70090; Kaminaga Y, 2006, J BIOL CHEM, V281, P23357, DOI 10.1074/jbc.M602708200; HARDY M, 1995, LANCET, V346, P701, DOI 10.1016/S0140-6736(95)92310-1; Dudareva N, 2003, PLANT CELL, V15, P1227, DOI 10.1105/tpc.011015; Bergougnoux V, 2007, PLANTA, V226, P853, DOI 10.1007/s00425-007-0531-1; Rasch B, 2007, SCIENCE, V315, P1426, DOI 10.1126/science.1138581; Oka N, 1999, Z NATURFORSCH C, V54, P889; Chen XM, 2011, J PLANT PHYSIOL, V168, P88, DOI 10.1016/j.jplph.2010.06.011; Channeliere S, 2002, FEBS LETT, V515, P35, DOI 10.1016/S0014-5793(02)02413-4; Debener T, 2009, CRIT REV PLANT SCI, V28, P267, DOI 10.1080/07352680903035481; Dudareva N., 2000, Horticultural Reviews, V24, P31; FLAMENT I, 1993, ACS SYM SER, V525, P269; Gudin S., 2000, Plant Breeding Reviews, V17, P159; Hayashi S, 2004, TETRAHEDRON, V60, P7005, DOI 10.1016/j.tet.2003.10.130; Hirata H, 2012, J PLANT PHYSIOL, V169, P444, DOI 10.1016/j.jplph.2011.12.005; Krussmann G., 1981, COMPLETE BOOK ROSES, P67; Lavid N, 2002, PLANT PHYSIOL, V129, P1899, DOI 10.1104/pp.005330; Nakamura S., 1987, Perfumer & Flavorist, V12, P43; Ohloff G., 1978, Perfumer & Flavorist, V3, P11; OMATA A, 1991, Flavour and Fragrance Journal, V6, P149, DOI 10.1002/ffj.2730060211; Oyama-Okubo N, 2005, BIOSCI BIOTECH BIOCH, V69, P773, DOI 10.1271/bbb.69.773; Scalliet G, 2008, P NATL ACAD SCI USA, V105, P5927, DOI 10.1073/pnas.0711551105; Watanabe S, 2001, BIOSCI BIOTECH BIOCH, V65, P442, DOI 10.1271/bbb.65.442; Winterhalter P, 1997, Adv Biochem Eng Biotechnol, V55, P73	25	0	0	ELSEVIER FRANCE-EDITIONS SCIENTIFIQUES MEDICALES ELSEVIER	PARIS	23 RUE LINOIS, 75724 PARIS, FRANCE	0981-9428			PLANT PHYSIOL BIOCH	Plant Physiol. Biochem.	FEB	2015	87						109	114		10.1016/j.plaphy.2014.12.016		6	Plant Sciences	Plant Sciences	CB6IU	WOS:000349731500013		
J	Hozumi, K; Kumai, J; Yamada, Y; Nomizu, M				Hozumi, Kentaro; Kumai, Jun; Yamada, Yuji; Nomizu, Motoyoshi			Active Peptide-Conjugated Chitosan Matrices as an Artificial Basement Membrane	POLYMERS			English	Review							LAMININ ALPHA-1 CHAIN; CELL-BINDING SEQUENCES; BIOLOGICAL-ACTIVITIES; EXTRACELLULAR-MATRIX; TARGETED DISRUPTION; SYNTHETIC PEPTIDES; SCAFFOLD MATERIAL; GLOBULAR DOMAIN; LG4 MODULE; STEM-CELLS	The basement membrane, a thin extracellular matrix, plays a critical role in tissue development and repair. Laminins are the major component of basement membrane and have diverse biological activities. We have identified various cell-adhesive peptides from laminins and their specific cell surface receptors. Polysaccharides, including chitosan, have been used as scaffolds, which regulate cellular functions for tissue engineering. We have developed laminin-derived active peptide-chitosan matrices as functional scaffolds. The biological activity of the peptides was enhanced when the peptides were conjugated to a chitosan matrix, suggesting that the peptide-chitosan matrix approach has an advantage for an active biomaterial. Further, the laminin peptide-chitosan matrices have the potential to mimic the basement membrane and are useful for tissue engineering as an artificial basement membrane.	[Hozumi, Kentaro; Kumai, Jun; Yamada, Yuji; Nomizu, Motoyoshi] Tokyo Univ Pharm & Life Sci, Dept Clin Biochem, Sch Pharm, Hachioji, Tokyo 1920392, Japan	Hozumi, K (reprint author), Tokyo Univ Pharm & Life Sci, Dept Clin Biochem, Sch Pharm, 1432-1 Horinouchi, Hachioji, Tokyo 1920392, Japan.	hozumi@toyaku.ac.jp; y071096@toyaku.ac.jp; y041219@toyaku.ac.jp; nomizu@toyaku.ac.jp			Ministry of Education, Cultures, Sports, Science and Technology of Japan [24500530, 25560228]	We are grateful to Yamato Kikkawa, Fumihiko Katagiri and Yuichi Kadoya for invaluable comments and suggestions. This work was supported by Grants-in-Aid for Scientific Research from the Ministry of Education, Cultures, Sports, Science and Technology of Japan (24500530 and 25560228).	Jayakumar R, 2011, BIOTECHNOL ADV, V29, P322, DOI 10.1016/j.biotechadv.2011.01.005; Miner JH, 2004, DEVELOPMENT, V131, P2247, DOI 10.1242/dev.01112; Thyboll J, 2002, MOL CELL BIOL, V22, P1194, DOI 10.1128/MCB.22.4.1194-1202.2002; Chen YH, 2012, BIOMATERIALS, V33, P1336, DOI 10.1016/j.biomaterials.2011.10.048; Frantz C, 2010, J CELL SCI, V123, P4195, DOI 10.1242/jcs.023820; Suzuki N, 2005, CONNECT TISSUE RES, V46, P142, DOI 10.1080/03008200591008527; Suzuki N, 2010, MATRIX BIOL, V29, P143, DOI 10.1016/j.matbio.2009.09.006; Miner JH, 1998, J CELL BIOL, V143, P1713, DOI 10.1083/jcb.143.6.1713; Wiradjaja F, 2010, BIRTH DEFECTS RES C, V90, P8, DOI 10.1002/bdrc.20172; Ueno H, 2001, ADV DRUG DELIVER REV, V52, P105, DOI 10.1016/S0169-409X(01)00189-2; Scheele S, 2007, J MOL MED-JMM, V85, P825, DOI 10.1007/s00109-007-0182-5; Shigemasa Y, 1996, BIOTECHNOL GENET ENG, V13, P383; Tuan RS, 2013, NAT REV RHEUMATOL, V9, P74, DOI 10.1038/nrrheum.2012.235; Lutolf MP, 2005, NAT BIOTECHNOL, V23, P47, DOI 10.1038/nbt1055; Croisier F, 2013, EUR POLYM J, V49, P780, DOI 10.1016/j.eurpolymj.2012.12.009; Masuko T, 2005, BIOMATERIALS, V26, P5339, DOI 10.1016/j.biomaterials.2005.01.062; Hood JD, 2002, NAT REV CANCER, V2, P91, DOI 10.1038/nrc727; Woods A, 1998, TRENDS CELL BIOL, V8, P189, DOI 10.1016/S0962-8924(98)01244-6; Yang DY, 2013, BIOMATERIALS, V34, P5747, DOI 10.1016/j.biomaterials.2013.04.028; NOMIZU M, 1995, J BIOL CHEM, V270, P20583; Ryan MC, 1999, J CELL BIOL, V145, P1309, DOI 10.1083/jcb.145.6.1309; Otagiri D, 2013, BIOPOLYMERS, V100, P751, DOI 10.1002/bip.22303; Hozumi K, 2010, BIOMATERIALS, V31, P3237, DOI 10.1016/j.biomaterials.2010.01.043; Kikkawa Y, 2005, CONNECT TISSUE RES, V46, P193, DOI 10.1080/03008200500344074; Hansson A, 2012, CARBOHYD POLYM, V90, P1494, DOI 10.1016/j.carbpol.2012.07.020; Suh JKF, 2000, BIOMATERIALS, V21, P2589; Kruegel J, 2010, CELL MOL LIFE SCI, V67, P2879, DOI 10.1007/s00018-010-0367-x; Streuli CH, 2009, BIOCHEM J, V418, P491, DOI 10.1042/BJ20081948; Hozumi K, 2009, BIOMATERIALS, V30, P1596, DOI 10.1016/j.biomaterials.2008.12.011; Patarroyo M, 2002, SEMIN CANCER BIOL, V12, P197, DOI 10.1016/S1044-579X(02)00023-8; Couchman JR, 2001, INT REV CYTOL, V207, P113; Durbeej M, 1998, CURR OPIN CELL BIOL, V10, P594, DOI 10.1016/S0955-0674(98)80034-3; Brown BN, 2014, TRANSL RES, V163, P268, DOI 10.1016/j.trsl.2013.11.003; Boateng JS, 2008, J PHARM SCI-US, V97, P2892, DOI 10.1002/jps.21210; Kikkawa Y, 2013, CELL ADHES MIGR, V7, P150, DOI 10.4161/cam.22827; Yamada Y, 2010, BIOPOLYMERS, V94, P711, DOI 10.1002/bip.21429; Chen HP, 2014, EXP CELL RES, V323, P346, DOI 10.1016/j.yexcr.2014.02.028; Yamada Y, 2013, BIOMATERIALS, V34, P6539, DOI 10.1016/j.biomaterials.2013.05.044; Miner JH, 2004, ANNU REV CELL DEV BI, V20, P255, DOI 10.1146/annurev.cellbio.20.010403.094555; Liu X, 2011, ADV POLYM SCI, V244, P81, DOI 10.1007/12_2011_118; Matsuda A, 2005, BIOMATERIALS, V26, P2273, DOI 10.1016/j.biomaterials.2004.07.032; Miyagoe Y, 1997, FEBS LETT, V415, P33, DOI 10.1016/S0014-5793(97)01007-7; Araki E, 2009, MOL BIOL CELL, V20, P3012, DOI 10.1091/mbc.E08-09-0977; Charonis A, 2005, CURR MED CHEM, V12, P1495, DOI 10.2174/0929867054039071; Dieckmann C, 2010, EXP DERMATOL, V19, P697, DOI 10.1111/j.1600-0625.2010.01087.x; Fox IJ, 2014, SCIENCE, V345, P889, DOI 10.1126/science.1247391; Hibino S, 2005, CANCER RES, V65, P10494, DOI 10.1158/0008-5472.CAN-05-0314; Hibino S, 2004, CANCER RES, V64, P4810, DOI 10.1158/0008-5472.CAN-04-0129; Hoffman MP, 1998, J BIOL CHEM, V273, P28633, DOI 10.1074/jbc.273.44.28633; Hozumi K, 2012, BIOMATERIALS, V33, P4241, DOI 10.1016/j.biomaterials.2012.02.055; Hozumi K, 2006, J BIOL CHEM, V281, P32929, DOI 10.1074/jbc.M605708200; Hozumi K, 2010, ARCH BIOCHEM BIOPHYS, V503, P213, DOI 10.1016/j.abb.2010.08.012; Ikemoto S, 2006, J BIOMED MATER RES A, V79A, P716, DOI 10.1002/jbm.a.30804; Kasai S, 2007, BIOCHEMISTRY-US, V46, P3966, DOI 10.1021/bi062097t; Kuang W, 1998, EXP CELL RES, V241, P117, DOI 10.1006/excr.1998.4025; Martin-Lopez E, 2012, J BIOMAT SCI-POLYM E, V23, P207, DOI 10.1163/092050610X546426; Masuda R, 2009, WOUND REPAIR REGEN, V17, P127, DOI 10.1111/j.1524-475X.2008.00450.x; Mochizuki M, 2003, FASEB J, V17, P875, DOI 10.1096/fj.02-0564fje; Mochizuki M, 2007, BIOPOLYMERS, V88, P122, DOI 10.1002/bip.20684; Mochizuki M, 2007, ARCH BIOCHEM BIOPHYS, V459, P249, DOI 10.1016/j.abb.2006.12.026; Nomizu M, 1998, J BIOL CHEM, V273, P32491, DOI 10.1074/jbc.273.49.32491; Nomizu M, 1997, J BIOL CHEM, V272, P32198, DOI 10.1074/jbc.272.51.32198; Nomizu M, 2000, ARCH BIOCHEM BIOPHYS, V378, P311, DOI 10.1006/abbi.2000.1828; NOMIZU M, 1995, FEBS LETT, V365, P227, DOI 10.1016/0014-5793(95)00475-O; Renner L, 2004, J MATER SCI-MATER M, V15, P387, DOI 10.1023/B:JMSM.0000021107.12809.8d; Shanmugasundaram N, 2001, BIOMATERIALS, V22, P1943, DOI 10.1016/S0142-9612(00)00220-9; Suzuki N, 2003, J BIOL CHEM, V278, P45697, DOI 10.1074/jbc.M304667200; Urushibata S, 2010, ARCH BIOCHEM BIOPHYS, V497, P43, DOI 10.1016/j.abb.2010.03.006; Wang JM, 2006, J BIOL CHEM, V281, P213, DOI 10.1074/jbc.M505061200; Yamada Y, 2011, CHEM-EUR J, V17, P10500, DOI 10.1002/chem.201101064; Zhu N, 2010, BIOFABRICATION, V2, DOI 10.1088/1758-5082/2/4/045002	71	0	0	MDPI AG	BASEL	POSTFACH, CH-4005 BASEL, SWITZERLAND	2073-4360			POLYMERS-BASEL	Polymers	FEB	2015	7	2					281	297		10.3390/polym7020281		17	Polymer Science	Polymer Science	CC3AP	WOS:000350216800006		
J	Takagi, N; Lin, CL; Kawahara, K; Minamitani, E; Tsukahara, N; Kawai, M; Arafune, R				Takagi, Noriaki; Lin, Chun-Liang; Kawahara, Kazuaki; Minamitani, Emi; Tsukahara, Noriyuki; Kawai, Maki; Arafune, Ryuichi			Silicene on Ag(111): Geometric and electronic structures of a new honeycomb material of Si	PROGRESS IN SURFACE SCIENCE			English	Review						Silicene; Graphene; Two-dimensional material; Honeycomb structure; Dirac fermion; Topological insulator; Ag(111); STM; STS; DFT theory	TOTAL-ENERGY CALCULATIONS; SCANNING-TUNNELING-MICROSCOPY; HEXAGONAL BORON-NITRIDE; WAVE BASIS-SET; DIRAC-FERMIONS; GRAPHENE; SURFACE; GRAPHITE; RECONSTRUCTION; SEMICONDUCTORS	Silicene, a two-dimensional honeycomb sheet consisting of Si atoms, has attracted much attention as a new low-dimensional material because it gains various fascinating characteristics originating from the combination of Dirac fermion features with spin-orbit coupling. The novel properties such as the quantum spin Hall effect and the compatibility with the current Si device technologies have fueled competition to realize the silicene. This review article focuses on the geometric and electronic structures of silicene grown on Ag(111) investigated by scanning tunneling microcopy (STM), low energy electron diffraction (LEED) and density functional theory (DFT) calculations. The silicene on Ag(111) takes locally-buckled structure in which the Si atoms are displaced perpendicularly to the basal plane. As a result, several superstructures such as 4 x 4, root 13 x root 13R13.9 degrees,4/root 3 x 4/root 3, and etc. emerge. The atomic arrangement of the 4 x 4 silicene has been determined by STM, DFT calculations and LEED dynamical analysis, while the other superstructures remain to be fully-resolved. In the 4 x 4 silicene, Si atoms are arranged to form a buckled honeycomb structure where six Si atoms of 18 Si atoms in the unit cell are displaced vertically. The displacements lead to the vertical shift of the substrate Ag atoms, indicating the non-negligible coupling at the interface between the silicene layer and the substrate. The interface coupling significantly modifies the electronic structure of the 4 x 4 silicene. No Landau level sequences were observed by scanning tunneling spectroscopy (STS) with magnetic fields applied perpendicularly to the sample surface. The DFT calculations showed that the pi and pi* bands derived from the Si 3p(z) are hybridized with the Ag electronic states, leading to the drastic modification in the band structure and then the absence of Dirac fermion features together with the two-dimensionality in the electronic states. These findings demonstrate that the strong coupling at the interface causes the symmetry breaking for the 4 x 4 silicene and as a result the disappearance of Dirac fermion features. The geometric and electronic structures of other superstructures are also discussed. (C) 2014 Elsevier Ltd. All rights reserved.	[Takagi, Noriaki; Lin, Chun-Liang; Kawahara, Kazuaki; Tsukahara, Noriyuki; Kawai, Maki] Univ Tokyo, Grad Sch Frontier Sci, Dept Adv Mat Sci, Chiba 2778561, Japan; [Minamitani, Emi] Univ Tokyo, Dept Mat Engn, Bunkyo Ku, Tokyo 1138654, Japan; [Arafune, Ryuichi] Natl Inst Mat Sci, Int Ctr Mat Nanoarchitecton WPI MANA, Ibaraki 3040044, Japan	Takagi, N (reprint author), Univ Tokyo, Grad Sch Frontier Sci, Dept Adv Mat Sci, Kashiwa 5-1-5, Chiba 2778561, Japan.	n-takagi@k.u-tokyo.ac.jp			JSPS KAKENHI [24241040]; MEXT KAKENHI [25110008]	This work was partially supported by JSPS KAKENHI Grant Number 24241040 and by MEXT KAKENHI Grant Number 25110008. We would like to thank Prof. Toshio Takahashi, Dr. Tetsuroh Shirasawa, Dr. Yousoo Kim, Mr. Ryo Nagao, Mr. Mao Kanno and Mr. Naoya Kawakami because this article is based on the collaborative works with them. The calculations were performed by using the computer facilities of the Institute of Solid State Physics (ISSP Super Computer Center, the University of Tokyo) and RIKEN Integrated Cluster of Clusters (RICC) facility.	Aizawa H, 1999, SURF SCI, V429, pL509, DOI 10.1016/S0039-6028(99)00424-0; Lin CL, 2013, PHYS REV LETT, V110, DOI 10.1103/PhysRevLett.110.076801; STICH I, 1992, PHYS REV LETT, V68, P1351, DOI 10.1103/PhysRevLett.68.1351; Feng BJ, 2013, ACS NANO, V7, P9049, DOI 10.1021/nn403661h; Chen L, 2013, APPL PHYS LETT, V102, DOI 10.1063/1.4793998; Berger C, 2006, SCIENCE, V312, P1191, DOI 10.1126/science.1125925; Gori P, 2013, J APPL PHYS, V114, DOI 10.1063/1.4821339; Geim AK, 2007, NAT MATER, V6, P183, DOI 10.1038/nmat1849; Kresse G, 1996, PHYS REV B, V54, P11169, DOI 10.1103/PhysRevB.54.11169; Novoselov KS, 2005, NATURE, V438, P197, DOI 10.1038/nature04233; Kara A, 2012, SURF SCI REP, V67, P1, DOI 10.1016/j.surfrep.2011.10.001; Guo ZX, 2014, PHYS REV B, V89, DOI 10.1103/PhysRevB.89.155418; Houssa M, 2014, APPL SURF SCI, V291, P98, DOI 10.1016/j.apsusc.2013.09.062; Chiappe D, 2014, ADV MATER, V26, P2096, DOI 10.1002/adma.201304783; Miller DL, 2009, SCIENCE, V324, P924, DOI 10.1126/science.1171810; BLOCHL PE, 1994, PHYS REV B, V50, P17953, DOI 10.1103/PhysRevB.50.17953; Guo ZX, 2013, PHYS REV B, V87, DOI 10.1103/PhysRevB.87.235435; Ezawa M, 2012, NEW J PHYS, V14, DOI 10.1088/1367-2630/14/3/033003; Radisavljevic B, 2011, NAT NANOTECHNOL, V6, P147, DOI [10.1038/nnano.2010.279, 10.1038/NNANO.2010.279]; Perdew JP, 1996, PHYS REV LETT, V77, P3865, DOI 10.1103/PhysRevLett.77.3865; Guzman-Verri GG, 2007, PHYS REV B, V76, DOI 10.1103/PhysRevB.76.075131; Kawahara K, 2014, SURF SCI, V623, P25, DOI 10.1016/j.susc.2013.12.013; Aufray B, 2010, APPL PHYS LETT, V96, DOI 10.1063/1.3419932; Tabert CJ, 2013, PHYS REV LETT, V110, DOI 10.1103/PhysRevLett.110.197402; Jamgotchian H, 2012, J PHYS-CONDENS MAT, V24, DOI 10.1088/0953-8984/24/17/172001; Tsoutsou D, 2013, APPL PHYS LETT, V103, DOI 10.1063/1.4841335; Tchalala MR, 2013, APPL PHYS LETT, V102, DOI 10.1063/1.4793536; Li G, 2007, NAT PHYS, V3, P623, DOI 10.1038/nphys653; Ezawa M, 2013, PHYS REV LETT, V110, DOI 10.1103/PhysRevLett.110.026603; Chen L, 2013, PHYS REV LETT, V110, DOI 10.1103/PhysRevLett.110.229702; Houssa M, 2010, APPL PHYS LETT, V97, DOI 10.1063/1.3489937; Moras P, 2014, J PHYS-CONDENS MAT, V26, DOI 10.1088/0953-8984/26/18/185001; Chiappe D, 2012, ADV MATER, V24, P5088, DOI 10.1002/adma.201202100; Geim AK, 2009, SCIENCE, V324, P1530, DOI 10.1126/science.1158877; Kubota Y, 2007, SCIENCE, V317, P932, DOI 10.1126/science.1144216; Sugawara K, 2006, PHYS REV B, V73, DOI 10.1103/PhysRevB.73.045124; Wang YZ, 2008, SCIENCE, V321, P1069, DOI 10.1126/science.1160768; Vogt P, 2012, PHYS REV LETT, V108, DOI 10.1103/PhysRevLett.108.155501; Kresse G, 1996, COMP MATER SCI, V6, P15, DOI 10.1016/0927-0256(96)00008-0; Ando Y, 2013, J PHYS SOC JPN, V82, DOI 10.7566/JPSJ.82.102001; Chen L, 2012, PHYS REV LETT, V109, DOI 10.1103/PhysRevLett.109.056804; Kane CL, 2005, PHYS REV LETT, V95, DOI 10.1103/PhysRevLett.95.146802; De Padova P, 2013, APPL PHYS LETT, V102, DOI 10.1063/1.4802782; VANHOVE MA, 1993, SURF SCI REP, V19, P191, DOI 10.1016/0167-5729(93)90011-D; Chen L, 2013, PHYS REV LETT, V110, DOI 10.1103/PhysRevLett.110.085504; Tajima N, 2009, PHYS REV LETT, V102, DOI 10.1103/PhysRevLett.102.176403; Tchalala MR, 2014, APPL SURF SCI, V303, P61, DOI 10.1016/j.apsusc.2014.02.064; Cahangirov S, 2013, PHYS REV B, V88, DOI 10.1103/PhysRevB.88.035432; Mannix AJ, 2014, ACS NANO, V8, P7538, DOI 10.1021/nn503000w; Kane CL, 2005, PHYS REV LETT, V95, DOI 10.1103/PhysRevLett.95.226801; Ezawa M, 2013, PHYS REV B, V87, DOI 10.1103/PhysRevB.87.155415; Zhou SY, 2006, NAT PHYS, V2, P595, DOI 10.1038/nphys393; An XT, 2013, APPL PHYS LETT, V102, DOI 10.1063/1.4790147; Zhang YB, 2005, NATURE, V438, P201, DOI 10.1038/nature04235; Fleurence A, 2012, PHYS REV LETT, V108, DOI 10.1103/PhysRevLett.108.245501; Feng BJ, 2012, NANO LETT, V12, P3507, DOI 10.1021/nl301047g; Meng L, 2013, NANO LETT, V13, P685, DOI 10.1021/nl304347w; Momma K, 2008, J APPL CRYSTALLOGR, V41, P653, DOI 10.1107/S0021889808012016; Reinert F, 2001, PHYS REV B, V63, DOI 10.1103/PhysRevB.63.115415; Majzik Z, 2013, J PHYS-CONDENS MAT, V25, DOI 10.1088/0953-8984/25/22/225301; Kokott S, 2014, J PHYS-CONDENS MAT, V26, DOI 10.1088/0953-8984/26/18/185002; Arafune R, 2013, PHYS REV LETT, V110, DOI 10.1103/PhysRevLett.110.229701; Ezawa M, 2013, APPL PHYS LETT, V102, DOI 10.1063/1.4803010; Drummond ND, 2012, PHYS REV B, V85, DOI 10.1103/PhysRevB.85.075423; Neek-Amal M, 2013, APPL PHYS LETT, V103, DOI 10.1063/1.4852636; Tahir M, 2013, APPL PHYS LETT, V102, DOI 10.1063/1.4803084; Fukaya Y, 2013, PHYS REV B, V88, DOI 10.1103/PhysRevB.88.205413; Kaltsas D, 2014, APPL SURF SCI, V291, P93, DOI 10.1016/j.apsusc.2013.09.115; Arafune R, 2013, SURF SCI, V608, P297, DOI 10.1016/j.susc.2012.10.022; Ezawa M, 2012, PHYS REV LETT, V109, DOI 10.1103/PhysRevLett.109.055502; Lin CL, 2012, APPL PHYS EXPRESS, V5, DOI 10.1143/APEX.5.045802; Pan H, 2014, PHYS REV LETT, V112, DOI 10.1103/PhysRevLett.112.106802; Cahangirov S, 2009, PHYS REV LETT, V102, DOI 10.1103/PhysRevLett.102.236804; TAKEDA K, 1994, PHYS REV B, V50, P14916, DOI 10.1103/PhysRevB.50.14916; Gao N, 2014, CHEM PHYS LETT, V592, P222, DOI 10.1016/j.cplett.2013.12.036; Avila J, 2013, J PHYS-CONDENS MAT, V25, DOI 10.1088/0953-8984/25/26/262001; Castro Neto AH, 2009, REV MOD PHYS, V81, P109, DOI 10.1103/RevModPhys.81.109; Desjonqueres M. C., 1996, CONCEPTS SURFACE PHY, V2nd; Enriquez H., 2012, J PHYS CONDENS MATT, V24; Ezawa M, 2013, EUR PHYS J B, V86, DOI 10.1140/epjb/e2013-31029-1; FEENSTRA RM, 1990, PHYS REV B, V42, P5391, DOI 10.1103/PhysRevB.42.5391; Hassan M.Z., 2010, REV MOD PHYS, V82, P3045; Kaloni TP, 2013, SCI REP-UK, V3, DOI 10.1038/srep03192; Kanno M, 2014, NEW J PHYS, V16, DOI 10.1088/1367-2630/16/10/105019; Lalmi B, 2010, APPL PHYS LETT, V97, DOI 10.1063/1.3524215; Liu C.-C., 2011, PHYS REV LETT, V107, P7680; Mahatha SK, 2014, PHYS REV B, V89, DOI 10.1103/PhysRevB.89.201416; Nagamatsu J, 2001, NATURE, V410, P63, DOI 10.1038/35065039; PENDRY JB, 1980, J PHYS C SOLID STATE, V13, P937, DOI 10.1088/0022-3719/13/5/024; Quhe RG, 2014, SCI REP-UK, V4, DOI 10.1038/srep05476; Resta A, 2013, SCI REP-UK, V3, DOI 10.1038/srep02399; Ryu S., 2009, PHYS REV LETT, V89; Shirai T, 2014, PHYS REV B, V89, DOI 10.1103/PhysRevB.89.241403; Singh N, 2014, PHYS STATUS SOLIDI-R, V8, P353, DOI 10.1002/pssr.201409025; TAKAHASHI T, 1993, SURF SCI, V282, P17, DOI 10.1016/0039-6028(93)90607-L; Tsai WF, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms2525; Van Hove MA, 2009, SURF SCI, V603, P1301, DOI 10.1016/j.susc.2008.09.055; Vanin M, 2010, PHYS REV B, V81, DOI 10.1103/PhysRevB.81.081408; Wang YP, 2013, PHYS REV B, V87, DOI 10.1103/PhysRevB.87.245430	99	4	4	PERGAMON-ELSEVIER SCIENCE LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND	0079-6816			PROG SURF SCI	Prog. Surf. Sci.	FEB	2015	90	1					1	20		10.1016/j.progsurf.2014.10.001		20	Chemistry, Physical; Physics, Condensed Matter	Chemistry; Physics	CB6JP	WOS:000349733600001		
J	Tanji, F; Kakizaki, M; Sugawara, Y; Watanabe, I; Nakaya, N; Minami, Y; Fukao, A; Tsuji, I				Tanji, F.; Kakizaki, M.; Sugawara, Y.; Watanabe, I.; Nakaya, N.; Minami, Y.; Fukao, A.; Tsuji, I.			Personality and suicide risk: the impact of economic crisis in Japan	PSYCHOLOGICAL MEDICINE			English	Article						Cohort study; economic crisis; Japan; personality; suicide risk	PSYCHOLOGICAL AUTOPSY; SOUTH-KOREA; MORTALITY; AGE; NEUROTICISM; LIFE; UNEMPLOYMENT; IDEATION; EPISODES; EVENTS	Background. The interactive effect of personal factors and social factors upon suicide risk is unclear. We conducted prospective cohort study to investigate whether the impact of the economic crisis in 1997-1998 upon suicide risk differed according to Neuroticism and Psychoticism personality traits. Methods. The Miyagi Cohort Study in Japan with a follow-up for 19 years from 1990 to 2008 has 29432 subjects aged 40-64 years at baseline who completed a questionnaire about various health habits and the Japanese version of the Eysenck Personality Questionnaire - Revised Short Form in 1990. Results. The suicide mortality rate increased from 4.6 per 100000 person-years before 1998 to 27.8 after 1998. Although both Neuroticism and Psychoticism were significantly associated with an increased risk of mortality during the whole period from 1990 to 2008, the impact of the economic crisis upon suicide risk differed between the Neuroticism and Psychoticism personality traits. Compared with the lowest category, the hazard ratios (HRs) for the highest Neuroticism increased from 0.66 before 1998 to 2.45 after 1998. On the other hand, the HRs for the highest Psychoticism decreased from 7.85 before 1998 to 2.05 after 1998. Conclusions. The impact of the 1997-1998 economic crisis upon suicide risk differed according to personality. Suicide risk increased among these with higher Neuroticism after the economic crisis, but this was not the case for other personality subscales.	[Tanji, F.; Kakizaki, M.; Sugawara, Y.; Watanabe, I.; Tsuji, I.] Tohoku Univ, Grad Sch Med, Dept Publ Hlth & Forens Med, Div Epidemiol, Sendai, Miyagi 9808575, Japan; [Tanji, F.; Minami, Y.] Tohoku Univ, Grad Sch Med, Div Community Hlth, Sendai, Miyagi 9808575, Japan; [Watanabe, I.] Tohoku Univ, Grad Sch Med, Dept Hlth Sci, Sendai, Miyagi 9808575, Japan; [Nakaya, N.] Tohoku Univ, Tohoku Med Megabank Org, Dept Prevent Med & Epidemiol, Sendai, Miyagi 9808575, Japan; [Fukao, A.] Yamagata Univ, Grad Sch Med Sci, Dept Publ Hlth, Yamagata 990, Japan	Sugawara, Y (reprint author), Tohoku Univ, Grad Sch Med, Dept Publ Hlth & Forens Med, Div Epidemiol,Aoba Ku, 2-1 Seryo Machi, Sendai, Miyagi 9808575, Japan.	yumi1717@med.tohoku.ac.jp			Ministry of Education, Culture, Sports, Science, and Technology, Japan; Ministry of Health, Labour and Welfare, Japan [H23 -Junkankitou(Seisyu)-Ippan-005];  [22659127]	We thank Yoshiko Nakata, Naoko Sato, and Yumi Tamura for their technical assistance. This work was supported by a grant for Scientific Research from Ministry of Education, Culture, Sports, Science, and Technology, Japan, Grant-in-Aid for Challenging Exploratory Research (22659127) and Health Sciences Research Grant for Health Services (H23 -Junkankitou(Seisyu)-Ippan-005) from the Ministry of Health, Labour and Welfare, Japan. The founders do not bear any responsibility for the analyses or interpretations presented here.	Park SM, 2010, J PSYCHOSOM RES, V69, P389, DOI 10.1016/j.jpsychores.2010.03.002; Cox BJ, 2004, BEHAV RES THER, V42, P105, DOI 10.1016/S0005-7967(03)00105-0; Yoshimasu Kouichi, 2008, Environmental Health and Preventive Medicine, V13, P243, DOI 10.1007/s12199-008-0037-x; Sone T, 2008, PSYCHOSOM MED, V70, P709, DOI 10.1097/PSY.0b013e31817e7e64; Lewis G, 1998, BRIT MED J, V317, P1283; Stuckler D, 2009, LANCET, V374, P315, DOI 10.1016/S0140-6736(09)61124-7; Kendler KS, 2004, AM J PSYCHIAT, V161, P631, DOI 10.1176/appi.ajp.161.4.631; DUBERSTEIN PR, 1994, PSYCHIATRY, V57, P213; Kim SY, 2011, CRISIS, V32, P5, DOI 10.1027/0227-5910/a000046; Velting DM, 1999, PERS INDIV DIFFER, V27, P943, DOI 10.1016/S0191-8869(99)00046-X; Useda JD, 2004, COMPR PSYCHIAT, V45, P353, DOI 10.1016/j.comppsych.2004.06.002; Chang SS, 2009, SOC SCI MED, V68, P1322, DOI 10.1016/j.socscimed.2009.01.010; Tsoh J, 2005, AM J GERIAT PSYCHIAT, V13, P562, DOI 10.1176/appi.ajgp.13.7.562; HOSOKAWA T, 1993, PSYCHOL REP, V72, P823; Ormel J, 2001, AM J PSYCHIAT, V158, P885, DOI 10.1176/appi.ajp.158.6.885; Bertolote JM, 2005, AM J MED GENET C, V133C, P8, DOI 10.1002/ajmg.c.30041; Brezo J, 2006, ACTA PSYCHIAT SCAND, V113, P180, DOI 10.1111/j.1600-0447.2005.00702.x; Dupre ME, 2012, ARCH INTERN MED, V172, P1; Eysenck Jr H, 1991, MANUAL EYSENCK PERSO; Fukao A, 1995, J EPIDEMIOL, V5, P153; Hirokawa S, 2012, J AFFECT DISORDERS, V140, P168, DOI 10.1016/j.jad.2012.02.001; Inoue Ken, 2007, Legal Medicine, V9, P139, DOI 10.1016/j.legalmed.2006.11.004; LOLAS F, 1991, PERS INDIV DIFFER, V12, P899, DOI 10.1016/0191-8869(91)90178-E; Nakaya N, 2005, CLIN EXP HYPERTENS, V27, P297, DOI 10.1081/CEH-200048930; Naragon-Gainey K, 2011, PSYCHOL MED, V41, P1437, DOI 10.1017/S0033291710002096; tatistics and Information Department Minister's Secretariant Ministry of Health Labour and Welfare Japan, 2011, VIT STAT JAP 2009; Tsuji I, 2004, J EPIDEMIOL, V14, pS2, DOI 10.2188/jea.14.S2; Wada K, 2012, BRIT MED J, V344, DOI 10.1136/bmj.e1191; World Health Organization, 1977, MAN INT STAT CLASS D; World Health Organization, 1992, INT STAT CLASS DIS R	30	0	0	CAMBRIDGE UNIV PRESS	NEW YORK	32 AVENUE OF THE AMERICAS, NEW YORK, NY 10013-2473 USA	0033-2917	1469-8978		PSYCHOL MED	Psychol. Med.	FEB	2015	45	3					559	573		10.1017/S0033291714001688		15	Psychology, Clinical; Psychiatry; Psychology	Psychology; Psychiatry	CB4SI	WOS:000349617900010		
J	Nakamura, H; Shirakawa, Y; Sato, N; Kitamura, H; Takahashi, S				Nakamura, Hidehito; Shirakawa, Yoshiyuki; Sato, Nobuhiro; Kitamura, Hisashi; Takahashi, Sentaro			Undoped poly (phenyl sulfone) for radiation detection	RADIATION MEASUREMENTS			English	Article						Poly (phenyl sulfone); Aromatic ring polymer; Excitation and emission; Refractive index; Light yield	POLYETHYLENE TEREPHTHALATE; SCINTILLATION MATERIAL; ETHER SULFONE; NAPHTHALATE; FILMS	Undoped aromatic ring polymers are potential scintillation materials. Here, we characterise poly (phenyl sulfone) (PPSU) for radiation detection. The amber-coloured transparent resin emits bluish-white fluorescence with 390-nm maximum. It has an excitation maximum of 340 nm, and has a density of 1.29 g/cm(3). The effective refractive index based on its emission spectrum is 1.75. The light yield is almost equal to that of poly (ethylene terephthalate), which is a transparent resin. These results demonstrate that PPSU can be used as a component substrate in polymer blends for altering optical characteristics. (C) 2014 Elsevier Ltd. All rights reserved.	[Nakamura, Hidehito; Sato, Nobuhiro; Takahashi, Sentaro] Kyoto Univ, Kumatori, Osaka 5900494, Japan; [Nakamura, Hidehito; Shirakawa, Yoshiyuki; Kitamura, Hisashi] Natl Inst Radiol Sci, Inage Ku, Chiba 2638555, Japan	Nakamura, H (reprint author), Kyoto Univ, 2 Asashiro Nishi, Kumatori, Osaka 5900494, Japan.	hidehito@rri.kyoto-u.ac.jp			Kyoto University; National Institute of Radiological Sciences; KUR Research Program for the Scientific Basis of Nuclear Safety	This research was supported by the Kyoto University and the National Institute of Radiological Sciences. The authors thank the KUR Research Program for the Scientific Basis of Nuclear Safety for partial support at this work. The authors are grateful to Dr. T. Murata, Dr. T. Fukunaga, Dr. H. Yamana, Ms. Y. Akahoshi and Ms. M. Yasaku for their cooperation.	Kumar V, 2012, NUCL INSTRUM METH B, V287, P10, DOI 10.1016/j.nimb.2012.07.007; Beringer J, 2012, PHYS REV D, V86, DOI 10.1103/PhysRevD.86.010001; Knoll G. F., 2010, RAD DETECTION MEASUR; Leo W. R., 1992, TECHNIQUES NUCL PART; Nagata S, 2013, J NUCL MATER, V442, pS501, DOI 10.1016/j.jnucmat.2013.05.039; Nagata S, 2013, NUCL INSTRUM METH B, V315, P157, DOI 10.1016/j.nimb.2013.03.027; Nakamura H., 2014, JPN J HLTH PHYS, V49, P98; Nakamura H, 2010, P ROY SOC A-MATH PHY, V466, P2847, DOI 10.1098/rspa.2010.0118; Nakamura H., 2013, PHYS EDUC, V48, P556, DOI DOI 10.1088/0031-9120/48/5/F02; Nakamura H, 2013, RADIAT MEAS, V59, P172, DOI 10.1016/j.radmeas.2013.06.006; Nakamura H, 2011, EPL-EUROPHYS LETT, V95, DOI 10.1209/0295-5075/95/22001; Nakamura H, 2014, APPL RADIAT ISOTOPES, V86, P36, DOI 10.1016/j.apradiso.2013.12.028; Nakamura Hidehito, 2014, Physics Education, V49, DOI 10.1088/0031-9120/49/2/135; Nakamura H, 2012, APPL PHYS LETT, V101, DOI 10.1063/1.4773298; Nakamura H, 2014, APPL RADIAT ISOTOPES, V91, P131, DOI 10.1016/j.apradiso.2014.05.013; Nakamura H, 2013, APPL RADIAT ISOTOPES, V80, P84, DOI 10.1016/j.apradiso.2013.06.011; Nakamura H, 2014, NUCL INSTRUM METH A, V739, P6, DOI [10.1016/j.nima.2013.12.021, 10.1016/J.nima.2013.12.021]; Nakamura H, 2013, APPL PHYS LETT, V103, DOI 10.1063/1.4824467; Nakamura H, 2013, SCI REP-UK, V3, DOI 10.1038/srep02502; Nakamura H, 2014, NUCL INSTRUM METH A, V759, P1, DOI 10.1016/j.nima.2014.05.053; Sellmeier W, 1871, ANN PHYS CHEM, V219, P272; Sen I, 2012, IEEE T NUCL SCI, V59, P1781, DOI 10.1109/TNS.2012.2201503; Shirakawa Yoshiyuki, 2013, Radioisotopes, V62, P879; Shirakawa Y, 2013, RADIAT MEAS, V49, P115, DOI 10.1016/j.radmeas.2012.12.001; Shirakawa Yoshiyuki, 2005, Radioisotopes, V54, P199; Uppal R., 2013, ADV ENG MATER, V16, P196	26	2	2	PERGAMON-ELSEVIER SCIENCE LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND	1350-4487			RADIAT MEAS	Radiat. Meas.	FEB	2015	73						14	17		10.1016/j.radmeas.2014.12.002		4	Nuclear Science & Technology	Nuclear Science & Technology	CB6GM	WOS:000349725500003		
J	Pauluhn, J; Ozaki, K				Pauluhn, Juergen; Ozaki, Keisuke			Transfluthrin: Comparative efficacy and toxicity of reference and generic versions	REGULATORY TOXICOLOGY AND PHARMACOLOGY			English	Article						Relevant impurities; Transfluthrin; Bayothrin; Sensitization; Risk characterization; Permethric acid derivatives	BROWN-NORWAY RATS; RESPIRATORY HYPERSENSITIVITY; GUINEA-PIGS; TRIMELLITIC ANHYDRIDE; TOLUENE DIISOCYANATE; INHALATION TOXICITY; ANIMAL ASSAY; IDENTIFICATION; EXPOSURE	Stringent requirements are in place for the evaluation and registration of new compounds with biocidal or pesticidal activities. However, the registration requirements for established compounds from new suppliers or for established compounds produced by a different manufacturing process have been less clear and ambiguity exists as to how 'equivalence of health hazards' can unequivocally be demonstrated analytically and by toxicological assays. The case presented in this analysis focuses on the chiral pyrethroid transfluthrin (TFL) synthesized by esterification of an acid chloride and alcoholic moiety. According to any modifications of the process of synthesis and purification, new potentially highly toxic and yet chemically reactive impurities in low concentrations (<0.1%) may be formed. Amongst these, that with the structural alert 'organic acid anhydride' was given heightened concern as the most potent putative toxicologically significant impurity. The course taken in this analysis focused on the comparison of reference TFL with commercialized generic TFL from two alternative manufacturing sources in India and China. Despite their apparent high racemic purity, TFLs from generic sources were biologically less effective, genotoxic in the Ames' assay, demonstrated sensory lung irritation and lung/skin sensitization in specialized bioassays. While the off-patent reference TFL was unequivocally negative in all assays (anhydride content not detectable, LOQ<0.01%), positive results with high batch-to-batch variability were a frequent outcome in generic TFLs. Tier I analytical assays failed to detect this relevant impurity in the absence of impurity-specific optimized analytical procedures. This finding suggests that a well-balanced combined approach of analytical and toxicological assays provides the best means to assure that all critical impurities are identified and accounted for. Similarly, putative 'structural alert'-based toxicity tests proved to be more predictive than any indiscriminant battery of standard bioassays commonly applied to demonstrate equivalence, such as acute oral/dermal toxicity and/or eye/skin irritation assays. (C) 2014 The Authors. Published by Elsevier Inc.	[Pauluhn, Juergen] Bayer Pharma AG, Bayer HealthCare, Global Drug Discovery, D-42096 Wuppertal, Germany; [Pauluhn, Juergen] Hannover Med Sch, Hannover, Germany; [Ozaki, Keisuke] Sumitomo Chem Co Ltd, Div Environm Hlth, Tokyo, Japan	Pauluhn, J (reprint author), Bayer Pharma AG, D-42096 Wuppertal, Germany.	juergen.pauluhn@iCLOUD.com					Snodin DJ, 2012, REGUL TOXICOL PHARM, V63, P298, DOI 10.1016/j.yrtph.2012.03.016; Pauluhn J, 2014, TOXICOLOGY, V319, P10, DOI 10.1016/j.tox.2014.02.006; Kroes R, 2005, TOXICOL SCI, V86, P226, DOI 10.1093/toxsci/kfi169; Pauluhn J, 2007, J APPL TOXICOL, V27, P160, DOI 10.1002/jat.1188; Draize JH, 1944, J PHARMACOL EXP THER, V82, P377; ECHA, 2012, GUID INF REQ CHEM SA; FAO and WHO, 2010, FAO WHO JOINT M PEST; GHS, 2013, UNECE UN NAT EC CO 3; Herbold B, 1998, MUTAT RES-GEN TOX EN, V412, P167, DOI 10.1016/S1383-5718(97)00189-7; Hill N, 2014, CHINA MALAR J, V13, P208; Li WL, 2010, TOXICOLOGY, V276, P135, DOI 10.1016/j.tox.2010.07.020; MAGNUSSON B, 1980, CONTACT DERMATITIS, V6, P46, DOI 10.1111/j.1600-0536.1980.tb03894.x; MAGNUSSO.B, 1969, J INVEST DERMATOL, V52, P268; Naumann K., 1990, SYNTHETIC PYRETHROID, V5, P129; OECD, 1992, GUILD TEST CHEM 406; OECD, 2009, OECD SER TEST ASS, V39; OECD, 2002, GUID TEST CHEM, V404; OECD, 1997, GUID TEST CHEM; OECD (Organisation for Economic Co-operation and Development), 1992, GUID TEST CHEM; PAULUHN J, 1994, TOXICOLOGY, V92, P53, DOI 10.1016/0300-483X(94)90167-8; Pauluhn J, 1999, INHAL TOXICOL, V11, P187, DOI 10.1080/089583799197140; Pauluhn J, 1997, FUND APPL TOXICOL, V40, P211, DOI 10.1006/faat.1997.2393; Pauluhn J, 2005, REGUL TOXICOL PHARM, V42, P236, DOI 10.1016/j.yrtph.2005.04.007; Pauluhn Juergen, 2005, Experimental and Toxicologic Pathology, V56, P203, DOI 10.1016/j.etp.2004.10.002; Pauluhn J, 2003, TOXICOLOGY, V194, P1, DOI 10.1016/S0300-483X(03)00285-3; Pauluhn J, 1998, INHAL TOXICOL, V10, P131; Pauluhn J, 2002, J APPL TOXICOL, V22, P89, DOI 10.1002/jat.831; Pauluhn J, 2003, TOXICOL LETT, V140, P229, DOI 10.1016/S0378-4274(03)00077-8; SCCP, 2012, SCCS SCHER SCENIHR A; Snodin, 2010, ORG PROCESS RES DEV, V14, P960; Tarlo S., 2011, OCCUPATIONAL ENV LUN; US Environmental Protection Agency. Office of Prevention Pesticides and Toxic Substances, 1998, OFF PREV PEST TOX SU; US-EPA, 2003, OFF PREV PEST TOX SU; Vesin A, 2013, ENVIRON INT, V60, P1, DOI 10.1016/j.envint.2013.07.011; Wu Y., 2011, PESTICIDES MODERN WO	35	0	0	ACADEMIC PRESS INC ELSEVIER SCIENCE	SAN DIEGO	525 B ST, STE 1900, SAN DIEGO, CA 92101-4495 USA	0273-2300	1096-0295		REGUL TOXICOL PHARM	Regul. Toxicol. Pharmacol.	FEB	2015	71	1					78	92		10.1016/j.yrtph.2014.11.003		15	Medicine, Legal; Pharmacology & Pharmacy; Toxicology	Legal Medicine; Pharmacology & Pharmacy; Toxicology	CB4CT	WOS:000349576500008		
J	Miyata, T; Honma, R; Sato, A; Matsumoto, H; Koyama, H; Tagawa, M				Miyata, Takuma; Honma, Rie; Sato, Asaka; Matsumoto, Hirotaka; Koyama, Hidekazu; Tagawa, Masahiro			Effect of rCaIFN-gamma pretreatment on propofol-isoflurane suppression of NK cytotoxic activity in the peripheral blood of dogs	RESEARCH IN VETERINARY SCIENCE			English	Article						Dog; Isoflurane; IFN-gamma; NK cytotoxic activity	NATURAL-KILLER-CELLS; ATOPIC-DERMATITIS; DENDRITIC CELLS; IFN-GAMMA; INTERFERON; THERAPY; SURGERY; MICE; LYMPHOCYTES; RECRUITMENT	In dogs, natural killer (NK) cell cytotoxic activity, which is an index of antitumor immunity, decreases after general anesthesia. In this study, we examined whether the decrease in NK cytotoxic activity can be controlled with interferon-gamma (IFN-gamma) treatment. Beagles were divided into 2 groups: a treated group (n = 6) that received recombinant canine IFN-gamma (rCaIFN-gamma) and an untreated control group (n = 6). Blood samples were taken before and at 24, 120, and 192 hours after anesthesia. NK cytotoxic activity toward canine thyroid cancer cells was measured in isolated lymphocytes with the Rose Bengal assay. The decrease in NK cytotoxic activity after anesthesia was significantly inhibited by administration of rCaIFN-gamma before propofol-isoflurane anesthesia. Further studies are necessary to evaluate the clinical implications of rCaIFN-gamma treatment in tumor recurrence and morbidity. (C) 2014 Elsevier Ltd. All rights reserved.	[Miyata, Takuma; Matsumoto, Hirotaka; Koyama, Hidekazu] Nippon Vet & Life Sci Univ, Fac Vet Med, Dept Vet Clin Med, Div Therapeut Sci 1, Tokyo, Japan; [Honma, Rie; Sato, Asaka; Tagawa, Masahiro] Nippon Vet & Life Sci Univ, Fac Vet Med, Dept Vet Clin Med, Div Therapeut Sci 2, Tokyo, Japan	Miyata, T (reprint author), Nippon Vet & Life Sci Univ, Fac Vet Med, Dept Vet Clin Med, Div Therapeut Sci 1, 1-7-1 Kyonan Cho, Musashino, Tokyo 1808602, Japan.	sur.miyata@gmail.com					SEDER RA, 1993, P NATL ACAD SCI USA, V90, P10188, DOI 10.1073/pnas.90.21.10188; Gupta K, 2002, CANCER RES, V62, P4491; MARKOVIC SN, 1993, ANESTHESIOLOGY, V78, P700, DOI 10.1097/00000542-199304000-00013; Kertai MD, 2004, AM J MED, V116, P96, DOI 10.1016/j.amjmed.2003.08.029; Mocikat R, 2003, IMMUNITY, V19, P561, DOI 10.1016/S1074-7613(03)00264-4; Wallace AW, 2004, ANESTHESIOLOGY, V101, P284, DOI 10.1097/00000542-200408000-00007; Matsuoka H, 2001, ANESTHESIOLOGY, V95, P1467, DOI 10.1097/00000542-200112000-00028; Martin-Fontecha A, 2004, NAT IMMUNOL, V5, P1260, DOI 10.1038/ni1138; HANIFIN JM, 1993, J AM ACAD DERMATOL, V28, P189, DOI 10.1016/0190-9622(93)70026-P; Inada T, 2004, ANAESTHESIA, V59, P954, DOI 10.1111/j.1365-2044.2004.03837.x; BERENBAU.MC, 1973, BRIT J EXP PATHOL, V54, P597; BUTTNER M, 1993, NAT IMMUN, V12, P92; CULLEN BF, 1975, ANESTHESIOLOGY, V43, P563, DOI 10.1097/00000542-197511000-00014; DJEU JY, 1982, J EXP MED, V156, P1222, DOI 10.1084/jem.156.4.1222; EINHORN S, 1978, INT J CANCER, V22, P405, DOI 10.1002/ijc.2910220407; Frasca L, 2008, J IMMUNOL, V180, P1471; FRIEDMAN RM, 1977, BACTERIOL REV, V41, P543; Funk J, 2005, CANCER IMMUNOL IMMUN, V54, P87, DOI 10.1007/s00262-004-0555-3; Gresser I, 1980, Ann N Y Acad Sci, V350, P12, DOI 10.1111/j.1749-6632.1980.tb20602.x; Katz Y, 2002, J MED VIROL, V66, P576, DOI 10.1002/jmv.2184; MINATO N, 1985, J EXP MED, V162, P1161, DOI 10.1084/jem.162.4.1161; Miyata T, 2013, RES VET SCI, V95, P965, DOI 10.1016/j.rvsc.2013.09.007; Murayama N., 2008, VET DERMATOLOGY S1, V19, P53; SAKSELA E, 1979, SCAND J IMMUNOL, V10, P257, DOI 10.1111/j.1365-3083.1979.tb01348.x; Schneemilch CE, 2004, CLIN ANAESTHESIOL, V18, P493; Schneider LC, 1998, ANN ALLERG ASTHMA IM, V80, P263; Stevens SR, 1998, ARCH DERMATOL, V134, P799, DOI 10.1001/archderm.134.7.799; William E. S., 2001, CLIN IMMUNOLOGY PRIN, P181; Yamada Rieko, 2002, J Anesth, V16, P131, DOI 10.1007/s005400200008	29	0	0	ELSEVIER SCI LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND	0034-5288	1532-2661		RES VET SCI	Res. Vet. Sci.	FEB	2015	98						25	29		10.1016/j.rvsc.2014.12.002		5	Veterinary Sciences	Veterinary Sciences	CB4EZ	WOS:000349582300006		
J	Ishida, T; Quet, VN; Mochizuki, S; Kagawa, Y; Takayama, T; Omata, T				Ishida, Tadashi; Van Nguyen Quet; Mochizuki, Shota; Kagawa, Yusuke; Takayama, Toshio; Omata, Toru			MEMS whistle-type temperature-compensated displacement sensor using resonant frequency shift	SENSORS AND ACTUATORS A-PHYSICAL			English	Article						Displacement sensor; Acoustics; Whistle; MEMS; Resonant frequency; Temperature compensation	INSTRUMENTS	Sound from a whistle can be modulated by adjusting the length of the whistle's resonant tube. Using this principle, a whistle-type displacement sensor has been previously proposed but has not been achieved because of technological constraints. Owing to the precise flow control techniques presently available as well as the high processing accuracy, advanced miniaturization, and high-density integration capabilities offered by MEMS technology, we have developed microelectromechanical systems (MEMS) whistle-type displacement sensors that use only acoustic signals to measure displacement. The MEMS whistle-type displacement sensor was 5.0 mm in length, 2.1 mm in width, and 1.4 mm in thickness. The sensor achieves precise displacement measurement with a possible error of a few mu m. Furthermore, the range of the deviation caused by a temperature change of 10 degrees C was reduced by approximately 90% when an additional whistle-type sensor was used as a temperature compensator, for an input displacement of 200 mu m. (C) 2014 Elsevier B.V. All rights reserved.	[Ishida, Tadashi; Van Nguyen Quet; Mochizuki, Shota; Kagawa, Yusuke; Takayama, Toshio; Omata, Toru] Tokyo Inst Technol, Midori Ku, Yokohama, Kanagawa 2268502, Japan	Ishida, T (reprint author), Tokyo Inst Technol, Midori Ku, 4259 Nagatsuta Cho, Yokohama, Kanagawa 2268502, Japan.	ishida.t.ai@m.titech.ac.jp			JSPS KAKENHI Grant [21300186]	This work was supported by JSPS KAKENHI Grant No. 21300186.	Kato T, 2010, PRECIS ENG, V34, P43, DOI 10.1016/j.precisioneng.2009.01.008; Matern U, 1999, SURG ENDOSC-ULTRAS, V13, P174, DOI 10.1007/s004649900934; Lim JJB, 2003, MECH MACH THEORY, V38, P1133, DOI 10.1016/S0094-114X(03)00063-6; CHANAUD RC, 1970, SCI AM, V222, P40; FRAZIER AB, 1995, IEEE T IND ELECTRON, V42, P423, DOI 10.1109/41.464603; Greef A. D., 2009, PRECIS ENG, V33, P311; Miyashita K., 1989, T JSME C, V88, P2807; Rossing T.D., 1990, SCI SOUND, P213; Takahashi K., 2010, P 20 INT C AC SYDN A, P601; Voider M.D., 2010, J MICROMECH MICROENG, V20; Yoshikawa S., 1980, Journal of the Acoustical Society of Japan (E), V1	11	0	0	ELSEVIER SCIENCE SA	LAUSANNE	PO BOX 564, 1001 LAUSANNE, SWITZERLAND	0924-4247			SENSOR ACTUAT A-PHYS	Sens. Actuator A-Phys.	FEB 1	2015	222						24	30		10.1016/j.sna.2014.11.007		7	Engineering, Electrical & Electronic; Instruments & Instrumentation	Engineering; Instruments & Instrumentation	CB4BO	WOS:000349573400004		
J	Tiwaria, A; Satoh, H; Aoki, M; Takeda, M; Hiromoto, N; Inokawa, H				Tiwaria, Ajay; Satoh, Hiroaki; Aoki, Makoto; Takeda, Masanori; Hiromoto, Norihisa; Inokawa, Hiroshi			Fabrication and analytical modeling of integrated heater and thermistor for antenna-coupled bolometers	SENSORS AND ACTUATORS A-PHYSICAL			English	Article						Microbolometer; Analytical model; Responsivity; Titanium	MICROBOLOMETER ARRAYS	Assuming the use in antenna-coupled bolometers to detect terahertz wave, integrated heater and thermistor were fabricated with titanium (Ti) on a silicon (Si) substrate, and its electrical responsivity was investigated at room temperature. To establish the dependence of microbolometer's responsivity on sizes and material characteristics of the thermistor and heater, an analytical model was made to describe the temperature rise with current in thermally isolated heater and resultant increase in electrical resistance. Although the behavior of the heater resistance could be reproduced by the model successfully, the responsivity coincides only for a bolometer of short heater length, suggesting the effect of slow response speed of the long heaters. (C) 2014 Elsevier B.V. All rights reserved.	[Tiwaria, Ajay; Satoh, Hiroaki; Inokawa, Hiroshi] Shizuoka Univ, Elect Res Inst, Naka Ku, Hamamatsu, Shizuoka 4328011, Japan; [Aoki, Makoto; Takeda, Masanori; Hiromoto, Norihisa] Shizuoka Univ, Grad Sch Engn, Naka Ku, Hamamatsu, Shizuoka 4328561, Japan	Inokawa, H (reprint author), Shizuoka Univ, Elect Res Inst, Naka Ku, 3-5-1 Johoku, Hamamatsu, Shizuoka 4328011, Japan.	inokawa06@rie.shizuoka.ac.jp	Inokawa, Hiroshi/E-6924-2011		Industry-Academia Collaborative R&D Program from Japan Science and Technology Agency (JST) [11100375]	This study is partially supported by Industry-Academia Collaborative R&D Program (subject ID 11100375) from Japan Science and Technology Agency (JST).	KOMINAMI M, 1985, IEEE T ANTENN PROPAG, V33, P600, DOI 10.1109/TAP.1985.1143638; Kato R, 2008, INT J THERMOPHYS, V29, P2062, DOI 10.1007/s10765-008-0536-4; Chen SH, 2007, SMART MATER STRUCT, V16, P696, DOI 10.1088/0964-1726/16/3/016; Aoki M., 2013, MAKARA J TECHNOL, V17, P1; Bhan RK, 2009, DEFENCE SCI J, V59, P580; Cheng YL, 2013, ECS J SOLID STATE SC, V2, pQ12, DOI 10.1149/2.022301jss; Hiromoto N., 2007, 9 TAK KENJ MEML S 4; Hiromoto N., 2014, 39 INT C INFR MILL T; Kimata M., 2006, P SPIE, V6127; KRUSE PW, 1995, P SOC PHOTO-OPT INS, V2552, P556, DOI 10.1117/12.218253; Song WB, 2006, J MICROMECH MICROENG, V16, P1073, DOI 10.1088/0960-1317/16/5/028; Tanaka A, 1996, IEEE T ELECTRON DEV, V43, P1844, DOI 10.1109/16.543017; Tiwari A, 2013, ASIAN J CHEM, V25, pS358; Zhang S., 2003, P ASME SUMM HEAT TRA	14	0	0	ELSEVIER SCIENCE SA	LAUSANNE	PO BOX 564, 1001 LAUSANNE, SWITZERLAND	0924-4247			SENSOR ACTUAT A-PHYS	Sens. Actuator A-Phys.	FEB 1	2015	222						160	166		10.1016/j.sna.2014.10.003		7	Engineering, Electrical & Electronic; Instruments & Instrumentation	Engineering; Instruments & Instrumentation	CB4BO	WOS:000349573400019		
J	Miyoshi, T; Yoshida, K; Eom, SI; Yokota, S				Miyoshi, Tomoya; Yoshida, Kazuhiro; Eom, Sang In; Yokota, Shinichi			Proposal of a multiple ER microactuator system using an alternating pressure source	SENSORS AND ACTUATORS A-PHYSICAL			English	Article						Microactuator; Alternating pressure source; Multiple actuator system; Electro-rheological fluid (ERF); Micromachine; Microrobot	ELECTRORHEOLOGICAL FLUID; INSPECTION; ROBOT	This paper proposes and develops a multiple ER microactuator system using an alternating pressure source for in-pipe working micromachines, medical microrobots, and so on. A hydraulic microactuator is known to have high power density but also has the drawback of requiring large piping space for the supply and return of the working fluid. In this study, an alternating pressure system with synchronized control valves and a single pipe was proposed. As the control valves, simple ER microvalves were employed. The ER microvalves control an electro-theological fluid (ERF) flow through its apparent viscosity change due to the applied electric field. In addition, a pressure transmitter is inserted between the pressure source and the ER valves, and low viscosity fluid such as water is used to transmit the alternating pressure. The use of the low viscosity fluid can reduce the diameter of the connecting pipe due to the low pressure loss. The proposed set-up is composed of multiple ER microactuators and an alternating pressure source; each ER microactuator consists of a pressure transmitter, two ER microvalves and a hydraulic microactuator. As the proposed system has half the number of pipes, of smaller diameter, compared with conventional hydraulic microactuator systems, it is suitable for a multiple actuator system. In this study, for verification of the working principle of the proposed system, we fabricated a large model of the system which consists of an ER finger 13 mm x 10 mm x 33 mm in size as a kind of ER microactuator and an alternating pressure source using a voice coil motor. Through experiments, we confirmed the tip displacement of 17 mm for the 16 mm-long movable part of the finger. Then, we fabricated a gripper using two ER fingers and confirmed its independent motion. (C) 2014 Elsevier B.V. All rights reserved.	[Miyoshi, Tomoya] Tokyo Inst Technol, Grad Sch, Midori Ku, Yokohama, Kanagawa 2268503, Japan; [Yoshida, Kazuhiro; Eom, Sang In; Yokota, Shinichi] Tokyo Inst Technol, Precis & Intelligence Lab, Midori Ku, Yokohama, Kanagawa 2268503, Japan	Yoshida, K (reprint author), Tokyo Inst Technol, Precis & Intelligence Lab, Midori Ku, R2 42,4259 Nagatsuta Cho, Yokohama, Kanagawa 2268503, Japan.	yoshida@pi.titech.ac.jp			JSPS KAKENHI grant [22656042, 26289025]	Part of this research was supported by JSPS KAKENHI grant number 22656042 and 26289025.	Takeda M, 2001, PROC IEEE MICR ELECT, P182; Yoshida K, 2002, SENSOR ACTUAT A-PHYS, V95, P227, DOI 10.1016/S0924-4247(01)00730-0; Kim JW, 2009, SENSOR ACTUAT A-PHYS, V156, P366, DOI 10.1016/j.sna.2009.10.013; De Volder M, 2006, J MICROMECH MICROENG, V16, P612, DOI 10.1088/0960-1317/16/3/017; Kitagawa A., 2008, P 7 JFPS INT S FLUID, V2008, P433; Kuwada A, 2008, IEEE ASME INT C ADV, P558, DOI 10.1109/AIM.2008.4601721; Lim J, 2008, MECHATRONICS, V18, P315, DOI 10.1016/j.mechatronics.2008.05.007; Nishioka Y, 2010, SENSOR ACTUAT A-PHYS, V164, P88, DOI 10.1016/j.sna.2010.09.004; Xu LN, 2012, ADV ENG FORUM, V4, P95, DOI 10.4028/www.scientific.net/AEF.4.95; Yoshida K, 2000, JSME INT J B-FLUID T, V43, P29; Yoshida K, 2012, SENSOR ACTUAT A-PHYS, V175, P101, DOI 10.1016/j.sna.2011.12.049; Yoshida K., 1993, 6 INT C FLOW MEAS FL, V1, P122; Yu-Xia Z., 2009, P 2009 IEEE INT C RO, P360	13	1	1	ELSEVIER SCIENCE SA	LAUSANNE	PO BOX 564, 1001 LAUSANNE, SWITZERLAND	0924-4247			SENSOR ACTUAT A-PHYS	Sens. Actuator A-Phys.	FEB 1	2015	222						167	175		10.1016/j.sna.2014.12.002		9	Engineering, Electrical & Electronic; Instruments & Instrumentation	Engineering; Instruments & Instrumentation	CB4BO	WOS:000349573400020		
J	Ishida, A				Ishida, Akira			Ti-Ni-Cu/polyimide composite-film actuator and simulation tool	SENSORS AND ACTUATORS A-PHYSICAL			English	Article						Shape memory alloy; Thin film; Actuator; MEMS; Composite; Simulation	THIN-FILMS; MICROACTUATORS; SMA	Polyimide/Ti49Ni33Cu18 composite films were fabricated by the sputtering of an alloy target. The composite films could be used as a simple actuator by cutting an appropriately shaped piece out of an as-sputtered films with scissors and then connecting it to a battery. In order to investigate the design parameters for the composite-film actuators, Ti-Ni-Cu films with various thicknesses (0.8-13 mu m) were deposited on two kinds of polyimide films (Kapton EN and H) with various thicknesses (25-175 mu m). The force and stroke of the composite-film actuators were found to vary largely with changes in various parameters such as the thickness ratio of Ti-Ni-Cu and polyimide films and the coefficient of thermal expansion of the polyimide films. A simulation tool based on a simple deformation model for a shape memory alloy was developed, and the effects of dimensional parameters (thickness, length, and width) and material parameters (Young's modulus, elastic strain limit, and transformation strain) on the actuation properties (force and stroke) of the composite-film actuators were systematically investigated on the basis of the simulation results. The simulation results revealed that composite-film actuators allow for various combination of force and stroke. Optimized actuators exhibited a long actuation stroke, a high response speed of 3 Hz, and a large force of 0.4 N. (C) 2015 Elsevier B.V. All rights reserved.	Natl Inst Mat Sci, Tsukuba, Ibaraki 3050047, Japan	Ishida, A (reprint author), Natl Inst Mat Sci, 1-2-1 Sengen, Tsukuba, Ibaraki 3050047, Japan.	ISHIDA.Akira@nims.go.jp					Krulevitch P, 1996, J MICROELECTROMECH S, V5, P270, DOI 10.1109/84.546407; Kohl M, 1999, MAT SCI ENG A-STRUCT, V273, P784, DOI 10.1016/S0921-5093(99)00416-5; Ishida A, 2007, SMART MATER STRUCT, V16, P1672, DOI 10.1088/0964-1726/16/5/020; Fu YQ, 2004, SENSOR ACTUAT A-PHYS, V112, P395, DOI 10.1016/j.sna.2004.02.019; Fu Y, 2005, J MICROMECH MICROENG, V15, P1872, DOI 10.1088/0960-1317/15/10/012; Ishida A, 2013, J ALLOY COMPD, V577, pS184, DOI 10.1016/j.jallcom.2011.12.155; Ishida A, 2008, THIN SOLID FILMS, V516, P7836, DOI 10.1016/j.tsf.2008.04.091; Ishida A., UNPUB; Ishida A, 2010, MATER SCI FORUM, V654-656, P2075, DOI 10.4028/www.scientific.net/MSF.654-656.2075; Ishida A., 2013, P TRANSD 2013 BARC S, P1573; Ishida A, 2014, ACTA MATER, V69, P292, DOI 10.1016/j.actamat.2014.02.006; Ishida A, 2002, MRS BULL, V27, P111, DOI 10.1557/mrs2002.46; Kohl M., 2004, SHAPE MEMORY MICROAC; Martynov V, 2003, MATER SCI FORUM, V426-4, P3475; Meng XL, 2011, ACTA MATER, V59, P2535, DOI 10.1016/j.actamat.2011.01.003; Miyazaki S., 2009, THIN FILM SHAPE MEMO; Shin DD, 2005, SENSOR ACTUAT A-PHYS, V119, P151, DOI [10.1016/j.sna.2004.01.025, 10.1016/j.sna.2004.10.025]; Timoshenko S, 1925, J OPT SOC AM REV SCI, V11, P233, DOI 10.1364/JOSA.11.000233; Timoshenko S., 1968, ELEMENTS STRENGTH MA, V5th	19	0	0	ELSEVIER SCIENCE SA	LAUSANNE	PO BOX 564, 1001 LAUSANNE, SWITZERLAND	0924-4247			SENSOR ACTUAT A-PHYS	Sens. Actuator A-Phys.	FEB 1	2015	222						228	236		10.1016/j.sna.2014.12.012		9	Engineering, Electrical & Electronic; Instruments & Instrumentation	Engineering; Instruments & Instrumentation	CB4BO	WOS:000349573400027		
J	Guo, J; Chee, SK				Guo, Jiang; Chee, Sze Keat			An experimental study on characteristics of a magnetostrictive vibrator	SENSORS AND ACTUATORS A-PHYSICAL			English	Article						Magnetostriction; Vibrator; Vibration mode; Stress; Heat generation	TRANSDUCERS	The paper presents an experimental study on the key characteristics of a magnetostrictive vibrator being developed for polishing application. Firstly, the actuation principle is systematically illustrated by a general model and experimentally verified by measuring magnetic fluxes flowing in the legs of the vibrator. Then the vibration mode is analyzed by finite element method and proved by node position test. It is found that the experiment result shows good consistent with that of simulation. After that, the effect of external stress on vibration amplitude is tested and the result indicates that under the stress of 0-1 N, the vibration amplitude shows in a rough proportion relationship to the stress. However, when the stress is less than 100 mN, vibration amplitude is almost not changed. Finally, the heat generation of the vibrator is evaluated, and a cooling device is developed for effectively decreasing the operating temperature. (C) 2014 Elsevier B.V. All rights reserved.	[Guo, Jiang] RIKEN, RIKEN Ctr Adv Photon RAP, Ultrahigh Precis Opt Technol Team, Wako, Saitama 3510198, Japan; [Chee, Sze Keat] Mech Transformer Corp, Tokyo 1010044, Japan	Guo, J (reprint author), RIKEN, RIKEN Ctr Adv Photon RAP, Ultrahigh Precis Opt Technol Team, 2-1 Hirosawa, Wako, Saitama 3510198, Japan.	guojiang3302@gmail.com			Mazak Foundation	The authors would like to express their grateful thanks to anonymous reviewers for their invaluable advice and suggestions on the paper. The gratitude is extended to VACUUMSCHMELZE GMBH & CO.KG for the supply of Permendur samples. This work was supported by a research grant from Mazak Foundation.	Atulasimha J, 2011, SMART MATER STRUCT, V20, DOI 10.1088/0964-1726/20/4/043001; Suzuki H, 2010, CIRP ANN-MANUF TECHN, V59, P347, DOI 10.1016/j.cirp.2010.03.117; Ueno T, 2008, SENSOR ACTUAT A-PHYS, V148, P280, DOI 10.1016/j.sna.2008.08.017; Claeyssen F, 1997, J ALLOY COMPD, V258, P61, DOI 10.1016/S0925-8388(97)00070-4; Ueno T, 2009, SENSOR ACTUAT A-PHYS, V154, P92, DOI 10.1016/j.sna.2009.01.029; Ekreem NB, 2007, J MATER PROCESS TECH, V191, P96, DOI 10.1016/j.jmatprotec.2007.03.064; Dapino MJ, 2000, J INTEL MAT SYST STR, V11, P135, DOI 10.1106/MJ6A-FBP9-9M61-0E1F; Guo J, 2013, SENSOR ACTUAT A-PHYS, V200, P101, DOI 10.1016/j.sna.2012.11.005; Shamoto E, 2005, CIRP ANN-MANUF TECHN, V54, P321, DOI 10.1016/S0007-8506(07)60113-9; Brehl DE, 2008, PRECIS ENG, V32, P153, DOI 10.1016/j.precisioneng.2007.08.003; Engdahl G., 2000, HDB GIANT MAGNETOSTR; Guo J., 2012, ANN CIRP, V61, P371; Guo J, 2013, PRECIS ENG, V37, P81, DOI 10.1016/j.precisioneng.2012.07.003; Higuchi T, 2010, NEXT-GENERATION ACTUATORS LEADING BREAKTHROUGHS, P1, DOI 10.1007/978-1-84882-991-6; Kim WJ, 2010, IEEE-ASME T MECH, V15, P299, DOI 10.1109/TMECH.2009.2024937; Onikura H., 2000, ANN CIRP, V49, P257; Quandt E, 2000, SENSOR ACTUAT A-PHYS, V81, P275, DOI 10.1016/S0924-4247(99)00173-9; Sarawate NN, 2008, SMART MATER STRUCT, V17, DOI 10.1088/0964-1726/17/6/065013	18	1	1	ELSEVIER SCIENCE SA	LAUSANNE	PO BOX 564, 1001 LAUSANNE, SWITZERLAND	0924-4247			SENSOR ACTUAT A-PHYS	Sens. Actuator A-Phys.	FEB 1	2015	222						237	244		10.1016/j.sna.2014.12.020		8	Engineering, Electrical & Electronic; Instruments & Instrumentation	Engineering; Instruments & Instrumentation	CB4BO	WOS:000349573400028		
J	Liu, Y; Saitoh, SI; Nakada, S; Zhang, X; Hirawake, T				Liu, Yang; Saitoh, Sei-Ichi; Nakada, Satoshi; Zhang, Xun; Hirawake, Toru			Impact of Oceanographic Environmental Shifts and Atmospheric Events on the Sustainable Development of Coastal Aquaculture: A Case Study of Kelp and Scallops in Southern Hokkaido, Japan	SUSTAINABILITY			English	Article							FUNKA BAY; KJELLMANIELLA-CRASSIFOLIA; MIZUHOPECTEN-YESSOENSIS; NORTHEAST; PACIFIC; MODELS; CAPE	We provide an overview of selected recent operational applications of satellite remote sensing and marine Geographic Information Systems (GIS) procedures to the practice of sustainable aquaculture in southern Hokkaido, Japan, focusing mainly on kelp and scallop aquaculture. We also developed a suitable aquaculture site-selection model (SASSM) for suspension culture of Gagome (a kelp species) in the same region. Models for Japanese kelp and Gagome showed that the distributions of the most suitable areas for both species overlapped. Competition between kelps was especially marked along the coastline between Hakodate and Esan. In addition, we examined the impact of oceanographic environmental changes and atmospheric events on scallop and kelp aquaculture sites, demonstrating that variations in the coastal Oyashio Current and the Tsugaru Warm Current significantly influenced the growth and harvesting seasons of scallops and kelps in Funka Bay and other sections of southern Hokkaido. Because a strong El Nino event occurred in 2010, January of that year was extremely cold. The proportion of suitable areas for both scallops and kelps during their respective growing seasons contracted in 2010. Thus, shifts in oceanographic and atmospheric conditions should be incorporated into sustainability management planning for coastal scallop and kelp aquaculture in southern Hokkaido.	[Liu, Yang; Saitoh, Sei-Ichi; Zhang, Xun; Hirawake, Toru] Hokkaido Univ, Fac Fisheries Sci, Lab Marine Environm & Resource Sensing, Hakodate, Hokkaido 0418611, Japan; [Nakada, Satoshi] Kobe Univ, Grad Sch Maritime Sci, Res Lab Tsunami & Marine Hazards, Higashi Nada Ku, Kobe, Hyogo 6580022, Japan	Liu, Y (reprint author), Hokkaido Univ, Fac Fisheries Sci, Lab Marine Environm & Resource Sensing, 3-1-1 Minato, Hakodate, Hokkaido 0418611, Japan.	yangliu315@hotmail.co.jp; ssaitoh@salmon.fish.hokudai.ac.jp; snakada@maritime.kobe-u.ac.jp; awesomexun@gmail.com; hirawake@salmon.fish.hokudai.ac.jp			"Hakodate Marine Bio Cluster Project" in the Regional Innovation Cluster Program (Global Type); Ministry of Education, Culture, Sports, Science and Technology (MEXT), Japan; Project of the Bio-Oriented Technology Research Advancement Institution (NARO)	This work was supported by the "Hakodate Marine Bio Cluster Project" in the Regional Innovation Cluster Program (Global Type) from 2009 onward and a Grant-in-Aid for University and Society Collaboration from the Ministry of Education, Culture, Sports, Science and Technology (MEXT), Japan. Support was also provided by grants from the Project of the Bio-Oriented Technology Research Advancement Institution (NARO).	Ahn Y. H., 2001, KOREAN J REMOTE SENS, V17, P285; Saitoh SI, 2011, ICES J MAR SCI, V68, P687, DOI 10.1093/icesjms/fsq190; Radiarta IN, 2008, AQUACULTURE, V284, P127, DOI 10.1016/j.aquaculture.2008.07.048; Ishikawa Y, 2009, J MARINE SYST, V78, P237, DOI 10.1016/j.jmarsys.2009.02.016; Liu Y, 2013, ICES J MAR SCI, V70, P1460, DOI 10.1093/icesjms/fst108; Zheng J, 2013, CLIM DYNAM, V40, P2023, DOI 10.1007/s00382-012-1478-x; Qiu B, 2002, J PHYS OCEANOGR, V32, P353, DOI 10.1175/1520-0485(2002)032<0353:LSVITM>2.0.CO;2; Radiarta I, 2009, AQUACULT INT, V17, P403, DOI 10.1007/s10499-008-9212-8; Bai XZ, 2011, J APPL METEOROL CLIM, V50, P1922, DOI 10.1175/2011JAMC2675.1; De Silva S.S., 2009, CLIMATE CHANGE IMPLI, P151; Direct Factory Outlets (DFO), ASS SCALL FISH PLAC; FAO, 2014, STAT WORLD FISH AQ 2; Hirose N, 2009, GEOPHYS RES LETT, V36, DOI 10.1029/2009GL037448; Hirose N, 2006, SOLA, V2, P61, DOI 10.2151/sola.2006-016; Kapetsky J. M., 2007, FAO FISHERIES TECHNI, P125; Kirihara S, 2006, J APPL PHYCOL, V18, P521, DOI 10.1007/s10811-006-9057-3; Kleinman S, 1996, AQUACULTURE, V142, P75, DOI 10.1016/0044-8486(95)01165-X; Liu Y, 2014, INT J REMOTE SENS, V35, P4422, DOI 10.1080/01431161.2014.916435; Liu Y, 2014, AQUACULTURE, V422, P172, DOI 10.1016/j.aquaculture.2013.11.033; Marine Net Hokkaido, SEARCH AGGREGATE STA; Mizuta H., 2003, B COAST OCEANOGR, V41, P33; Nakada S., 2012, HYDROL RES LETT, V6, P47, DOI DOI 10.3178/HRL.6.47; Nishida Y., 2003, OCEANOGR JPN, V12, P487; Ohtani K, 1971, B FAC FISH HOKKAIDO, V22, P58; Ozaki A, 2001, FISHERIES SCI, V67, P415, DOI 10.1046/j.1444-2906.2001.00277.x; Seager B. R., 2005, Q J ROY METEOR SOC, V131, P1501, DOI [DOI 10.1256/QJ.04.96, 10.1256/qj.04.96]; TANNO T, 2005, BULL FISH SCI HOKKAI, V56, P33; YAMAMOTO H, 1986, Bulletin of the Faculty of Fisheries Hokkaido University, V37, P165; Yan HM, 2011, BIOSCI BIOTECH BIOCH, V75, P2178, DOI 10.1271/bbb.110473	29	0	0	MDPI AG	BASEL	POSTFACH, CH-4005 BASEL, SWITZERLAND	2071-1050			SUSTAINABILITY-BASEL	Sustainability	FEB	2015	7	2					1263	1279		10.3390/su7021263		17	Environmental Sciences; Environmental Studies	Environmental Sciences & Ecology	CC3AY	WOS:000350217700010		
J	Yang, W; Song, JN; Higano, Y; Tang, J				Yang, Wei; Song, Junnian; Higano, Yoshiro; Tang, Jie			An Integrated Simulation Model for Dynamically Exploring the Optimal Solution to Mitigating Water Scarcity and Pollution	SUSTAINABILITY			English	Article							INPUT-OUTPUT APPROACH; SUSTAINABLE WATER; VIRTUAL WATER; WASTE-WATER; CHINA; SYSTEM; ECONOMY; ENERGY; SENSITIVITY; CONSUMPTION	An integrated optimization simulation model has been developed based on an input-output approach to mitigate water pollution and water scarcity through embedding environmental economic policies and applicable technologies into a complex environ-economic system to obtain an optimal set of policies and technologies that promotes the maximization of the regional economy under the constraints of water pollutant discharge and water availability. An empirical study is undertaken with the Source Region of Liao River as the target area to verify the performance of the model. The relationships between the water environment and socio-economic systems are presented by clarifying the trends in economic development, water pollutant discharge and water supply and demand during a time horizon from 2011 to 2020. The endogenously-formed optimal set of policies and industrial restructuring simultaneously facilitate the reduction of water pollutant discharge and water consumption and increase the water supply. The extent of the mitigation of water pollution and water scarcity via applied policies and technologies promoted by the subsidies provided by the government are specified, and the mechanism of the policy application and subsidization distribution is explained. This model has applicability for other regions in terms of giving an optimal solution via comprehensive assessment of all of the proposed sustainability-related policies with sufficient data accessibility to achieve regional sustainable development.	[Yang, Wei; Song, Junnian; Higano, Yoshiro] Univ Tsukuba, Grad Sch Life & Environm Sci, Tsukuba, Ibaraki 3058577, Japan; [Tang, Jie] Jilin Univ, Coll Environm & Resources, Changchun 130012, Peoples R China	Yang, W (reprint author), Univ Tsukuba, Grad Sch Life & Environm Sci, Tsukuba, Ibaraki 3058577, Japan.	s1235025@u.tsukuba.ac.jp; duliry@163.com; higano@jsrsai.envr.tsukuba.ac.jp; tangjie0724@163.com			"Construction of High Standard University" program of the China Scholarship Council; National Water Pollution Control and Management Project "Technological Integration and Project Demonstration of Comprehensive Water Pollution Control of Liao River Basin" [2012ZX07208-011]	This study is funded by the "Construction of High Standard University" program of the China Scholarship Council and is supported by National Water Pollution Control and Management Project "Technological Integration and Project Demonstration of Comprehensive Water Pollution Control of Liao River Basin (2012ZX07208-011)". We gratefully thank the anonymous reviewers for their comments and suggestions, which have substantially improved the quality of the paper, as well as the editors for their help with the paper.	Yang H, 2013, CURR OPIN ENV SUST, V5, P599, DOI 10.1016/j.cosust.2013.10.003; Hubacek K, 2005, J IND ECOL, V9, P187, DOI 10.1162/1088198054084572; Sanchez-Choliz J, 2005, ECOL ECON, V53, P325, DOI 10.1016/j.ecolecon.2004.09.013; Wang ZY, 2013, J CLEAN PROD, V42, P172, DOI 10.1016/j.jclepro.2012.11.007; Calzadilla A, 2010, J HYDROL, V384, P292, DOI 10.1016/j.jhydrol.2009.12.012; LEONTIEF W, 1970, REV ECON STAT, V52, P262, DOI 10.2307/1926294; Deng XZ, 2014, SUSTAINABILITY-BASEL, V6, P3301, DOI 10.3390/su6063301; Velazquez E, 2006, ECOL ECON, V56, P226, DOI 10.1016/j.ecolecon.2004.09.026; Okadera T, 2006, ECOL ECON, V58, P221, DOI 10.1016/j.ecolecon.2005.07.005; Oliveira C, 2011, ENERGY, V36, P2856, DOI 10.1016/j.energy.2011.02.028; Guan D, 2008, J ENVIRON MANAGE, V88, P1300, DOI 10.1016/j.jenvman.2007.07.010; Cazcarro I, 2013, ENVIRON SCI TECHNOL, V47, P12275, DOI 10.1021/es4019964; Cellura M, 2011, RENEW SUST ENERG REV, V15, P3897, DOI 10.1016/j.rser.2011.07.025; Llop M, 2007, ENERG POLICY, V35, P3410, DOI 10.1016/j.enpol.2006.12.015; Xu ZX, 2002, WATER RESOUR MANAG, V16, P239, DOI 10.1023/A:1020206826669; Tan RR, 2012, APPL ENERG, V90, P154, DOI 10.1016/j.apenergy.2011.01.032; Beall A, 2011, SUSTAINABILITY-BASEL, V3, P720, DOI 10.3390/su3050720; Dias AC, 2014, J CLEAN PROD, V75, P118, DOI 10.1016/j.jclepro.2014.04.012; Eggleston H. S., 2006, 2006 IPCC GUIDELINES, V4; Feng KS, 2011, WATER-SUI, V3, P47, DOI 10.3390/w3010047; HAWDON D, 1995, ENERG ECON, V17, P73, DOI 10.1016/0140-9883(95)98908-M; Higano Y., 1995, REG SCI, V26, P75, DOI [10.2457/srs.26.75, DOI 10.2457/SRS.26.75]; [贾国宁 Jia Guoning], 2013, [自然资源学报, Journal of Natural Resources], V28, P1788; Leistritz L., 2002, J ENVIRON MANAGE, V66, P465, DOI [10.1006/jema.2002.0600, DOI 10.1006/JEMA.2002.0600]; Levine AD, 2004, ENVIRON SCI TECHNOL, V38, p201A, DOI 10.1021/es040504n; Lin C, 2011, J IND ECOL, V15, P367, DOI 10.1111/j.1530-9290.2011.00339.x; Moffatt I, 2001, ENVIRON MODELL SOFTW, V16, P545, DOI 10.1016/S1364-8152(01)00024-X; Ni JR, 2001, J ENVIRON MANAGE, V61, P37, DOI 10.1006/jema.2000.0398; Oliveira C., 2014, ANN OPER RES, DOI [10.1007/s10479-014-1773-5, DOI 10.1007/S10479-014-1773-5]; Pac R. D., 1998, APPL SCI ENV, DOI [10.2495/ASE980291, DOI 10.2495/ASE980291]; Park S, 2014, CIV ENG ENVIRON SYST, V31, P189, DOI 10.1080/10286608.2013.820281; Qin CB, 2011, ENVIRON RES LETT, V6, DOI 10.1088/1748-9326/6/4/044026; Resosudarmo B. P., 2003, International Journal of Environment and Sustainable Development, V2, P62, DOI 10.1504/IJESD.2003.002363; Shevah Y, 2014, PURE APPL CHEM, V86, P1205, DOI 10.1515/pac-2014-0202; Voeroesmarty C.J., 2010, NATURE, V467, P555, DOI DOI 10.1038/NATURE0944020882010; Wang X. Y., 2014, EC MANAG, V28, P74; Wang YC, 2012, WATER AIR SOIL POLL, V223, P2719, DOI 10.1007/s11270-011-1062-8; Xu F, 2011, FRONT ENVIRON SCI EN, V5, P227, DOI 10.1007/s11783-010-0219-9; Xu XM, 2011, MITIG ADAPT STRAT GL, V16, P721, DOI 10.1007/s11027-011-9290-1	39	0	0	MDPI AG	BASEL	POSTFACH, CH-4005 BASEL, SWITZERLAND	2071-1050			SUSTAINABILITY-BASEL	Sustainability	FEB	2015	7	2					1774	1797		10.3390/su7021774		24	Environmental Sciences; Environmental Studies	Environmental Sciences & Ecology	CC3AY	WOS:000350217700038		
J	Ito, H; Langerman, S; Yoshida, Y				Ito, Hiro; Langerman, Stefan; Yoshida, Yuichi			Generalized River Crossing Problems	THEORY OF COMPUTING SYSTEMS			English	Article						River crossing problems; Polynomial-time algorithms; NP-hard; Graphs; Edgeexpansion; Reachability; hypercube	ALCUIN NUMBER; GRAPH	Three men, each with a sister, must cross a river using a boat that can carry only two people in such a way that a sister is never left in the company of another man if her brother is not present. This very famous problem appeared in the Latin book "Problems to Sharpen the Young," one of the earliest collections of recreational mathematics. This paper considers a generalization of such "river crossing problems" and provides a new formulation that can treat wide variations. The main result is that, if there is no upper bound on the number of transportations (river crossings), a large class of subproblems can be solved in polynomial time even when the passenger capacity of the boat is arbitrarily large. The authors speculated this fact at FUN 2012. On the other hand, this paper also demonstrates that, if an upper bound on the number of transportations is given, the problem is NP-hard even when the boat capacity is three, although a large class of subproblems can be solved in polynomial time if the boat capacity is two.	[Ito, Hiro] Univ Electrocommun, Sch Informat & Engn, Tokyo 1828585, Japan; [Langerman, Stefan] Univ Libre Bruxelles, Dept Informat, Brussels, Belgium; [Yoshida, Yuichi] Natl Inst Informat, Tokyo 1018430, Japan; [Yoshida, Yuichi] Preferred Infrastruct Inc, Tokyo 1130033, Japan	Ito, H (reprint author), Univ Electrocommun, Sch Informat & Engn, Tokyo 1828585, Japan.	itohiro@uec.ac.jp; stefan.langerman@ulb.ac.be; yyoshida@nii.ac.jp			JSPS KAKENHI [24650006]; ELC project (MEXT KAKENHI) [24106003]	We would like to express our gratitude to the anonymous referees for their truly careful reviews and very detailed comments. They significantly improved this article. We also thank JSPS KAKENHI Grant Number 24650006 and the ELC project (MEXT KAKENHI Grant Number 24106003), through which this work was partially supported.	Alon N., 1993, PROBAB COMPUT, V11, P1; Hoory S, 2006, B AM MATH SOC, V43, P439, DOI 10.1090/S0273-0979-06-01126-8; Bahls P., WOLF GOAT CABBAGE MO; Bellman R., 1962, MATH MAG, V35, P27; Borndorfer R., 1995, SC9527 KONR ZUS ZENT; Csorba P, 2010, SIAM J DISCRETE MATH, V24, P757, DOI 10.1137/080736661; Csorba P, 2008, LECT NOTES COMPUT SC, V5193, P320, DOI 10.1007/978-3-540-87744-8_27; Garey M.R., 1979, COMPUTERS INTRACTABI; Heeffer A., ALCUIN; Ito Hiro, 2012, LNCS, V7288, P235; Lampis M, 2007, LECT NOTES COMPUT SC, V4475, P227; Peterson I., SCI NEWS ONLINE, V164; Schwartz B. R., 1961, MATH MAG, V34, P187; Trevisan L., 2011, STANFORD U LECT, V6	14	0	0	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	1432-4350	1433-0490		THEOR COMPUT SYST	Theor. Comput. Syst.	FEB	2015	56	2					418	435		10.1007/s00224-014-9562-8		18	Computer Science, Theory & Methods; Mathematics	Computer Science; Mathematics	CB6WY	WOS:000349768700008		
J	Morimoto, T; Banno, K				Morimoto, Takuya; Banno, Kiyoshi			Genetic and physical mapping of Co, a gene controlling the columnar trait of apple	TREE GENETICS & GENOMES			English	Article						Apple; Columnar trait; Malus x domestica; Marker-assisted selection	X-DOMESTICA BORKH.; PEAR PYRUS-PYRIFOLIA; GROWTH HABIT; MICROSATELLITE MARKERS; LINKAGE MAPS; MALUS; LOCUS; QTL; REPEATS; RAPD	The columnar trait in apple (Malus x domestica Borkh.) is characterized by short internodes, reduced branching, and increased spurs, which are labor-saving features useful for high-density planting. In this study, we used six segregating populations of a descendant of the columnar-type cultivar 'Maypole' and constructed a genetic linkage map for the columnar gene (Co). Based on the linkage map of the Co gene, contig sequences of the Co region between simple sequence repeat (SSR) markers CH03d11 and Hi01a03 of the apple genome were screened for SSR motifs. Amplification of 14 out of 26 newly designed SSR markers yielded fragments specifically linked to the Co gene. Genotyping of recombinants with the 14-marker set and five additional Co-linked markers delimited the Co region to a 530-kb region of the apple genome that overlap those found in previous studies in spite of the different genetic materials and backgrounds. Eight markers showed co-segregation with the Co locus. Genotypes of columnar cultivars/selections and normal-type cultivars were determined for four closely linked markers. For three markers, Co-linked fragments were generated not only from columnar-type cultivars but also from the 'McIntosh' and its normal-type offspring. In contrast, the Co-specific marker 29f1-JWl1r corresponded completely with the columnar trait in all cultivars and recombinants, indicating that this marker would be valuable for marker-assisted selection during columnar apple breeding.	[Morimoto, Takuya] Kyoto Univ, Grad Sch Agr, Kyoto 6068502, Japan; [Banno, Kiyoshi] Shinshu Univ, Fac Agr, Nagano 3994598, Japan	Morimoto, T (reprint author), Kyoto Univ, Grad Sch Agr, Kyoto 6068502, Japan.	morimoto30261915@gmail.com					Baldi P, 2013, MOL BREEDING, V31, P429, DOI 10.1007/s11032-012-9800-1; Untergasser A, 2007, NUCLEIC ACIDS RES, V35, pW71, DOI 10.1093/nar/gkm306; Benson G, 1999, NUCLEIC ACIDS RES, V27, P573, DOI 10.1093/nar/27.2.573; Kenis K, 2008, TREE GENET GENOMES, V4, P647, DOI 10.1007/s11295-008-0140-6; Moriya S, 2012, PLANT BREEDING, V131, P641, DOI 10.1111/j.1439-0523.2012.01985.x; Galli P, 2010, MOL BREEDING, V26, P561, DOI 10.1007/s11032-010-9391-7; Yamamoto T, 2002, MOL ECOL NOTES, V2, P14, DOI 10.1046/j.1471-8286.2002.00128.x; Liebhard R, 2002, MOL BREEDING, V10, P217, DOI 10.1023/A:1020525906332; Espley RV, 2009, PLANT CELL, V21, P168, DOI 10.1105/tpc.108.059329; Hokanson SC, 1998, THEOR APPL GENET, V97, P671, DOI 10.1007/s001220050943; Bai TH, 2012, MOL GENET GENOMICS, V287, P437, DOI 10.1007/s00438-012-0689-5; Fernandez-Fernandez F, 2008, TREE GENET GENOMES, V4, P469, DOI 10.1007/s11295-007-0124-y; Fisher DV, 1970, CAN FRUIT VAR HORTIC, V24, P27; GRATTAPAGLIA D, 1994, GENETICS, V137, P1121; Hemmat M, 1997, J AM SOC HORTIC SCI, V122, P347; Inomata Y., 2002, Horticultural Research (Japan), V1, P117, DOI 10.2503/hrj.1.117; Inomata Y, 2001, TOHOKU AGR RES JPN, V54, P131; Kenis K, 2007, MOL BREEDING, V19, P193, DOI 10.1007/s11032-006-9022-5; Kesley DF, 1992, FRUIT VARIETIES J, V46, P83; Kim MY, 2003, J HORTIC SCI BIOTECH, V78, P512; Kosambi D. D., 1944, ANN EUGENICS, V12, P172; LAPINS KO, 1976, J AM SOC HORTIC SCI, V101, P133; Majer C, 2011, TRENDS PLANT SCI, V16, P47, DOI 10.1016/j.tplants.2010.09.009; Morimoto T, 2013, J JPN SOC HORTIC SCI, V82, P97, DOI 10.2503/jjshs1.82.97; Morimoto T, 2013, HORT RES JPN S2, V12, P71; Moriya S, 2009, J JPN SOC HORTIC SCI, V78, P279, DOI 10.2503/jjshs1.78.279; Nishitani C, 2009, BREEDING SCI, V59, P391, DOI 10.1270/jsbbs.59.391; Otto D, 2014, MOL BREEDING, V33, P863, DOI 10.1007/s11032-013-0001-3; Silfverberg-Dilworth E, 2006, TREE GENET GENOMES, V2, P202, DOI 10.1007/s11295-006-0045-1; Tian YK, 2005, EUPHYTICA, V145, P181, DOI 10.1007/s10681-005-1163-9; Tobutt K. R., 1985, ACTA HORTIC, V159, P63; TOBUTT KR, 1984, SCI HORTIC-ENGLAND, V35, P72; UKAI Y, 1995, BREEDING SCI, V45, P139; Wolters PJ, 2013, NEW PHYTOL, V200, P993, DOI 10.1111/nph.12580; Xu K., 2011, MOL BREEDING, V30, P899	35	0	0	SPRINGER HEIDELBERG	HEIDELBERG	TIERGARTENSTRASSE 17, D-69121 HEIDELBERG, GERMANY	1614-2942	1614-2950		TREE GENET GENOMES	Tree Genet. Genomes	FEB	2015	11	1							807	10.1007/s11295-014-0807-0		11	Forestry; Genetics & Heredity; Horticulture	Forestry; Genetics & Heredity; Agriculture	CB3UD	WOS:000349553500027		
J	Nagamitsu, T; Shimada, K; Kanazashi, A				Nagamitsu, Teruyoshi; Shimada, Ken-ichi; Kanazashi, Ayako			A reciprocal transplant trial suggests a disadvantage of northward seed transfer in survival and growth of Japanese red pine (Pinus densiflora) trees	TREE GENETICS & GENOMES			English	Article						Local adaptation; Provenance; Seed transfer; Stem productivity; Stem diameter; Survival rate	LOCAL ADAPTATION; CLIMATE-CHANGE; FOREST TREES; GENE FLOW; NATURAL-POPULATIONS; CONCEPTUAL ISSUES; RESPONSES; GENOTYPE	Seed transfer regulation in forest trees is to prevent the plantation of maladapted trees in non-local sites. Seed transfer from southern to northern Japan is prohibited in Japanese red pine (Pinus densiflora). To evaluate the current regulation of seed transfer, a reciprocal transplant trial was conducted in P. densiflora trees originating from two provenances in southern (S) and northern (N) Japan and planted in sites S and N near these provenances. We observed survival rate at 0-15 years old before a thinning and at 15-30 and 1540 years old after the thinning and measured diameter, per-planted-area cross-sectional area, and shape of stems of 30-year-old trees. The survival rate before the thinning was lower in provenance S than in provenance N and in site S than in site N. The survival rates after the thinning were lower in non-home sites, in particular, provenance S in site N. The stem diameter was largest in provenance S in site S, smallest in the both provenances in site N, and intermediate in provenance N in site S. Thus, trees were fewer and larger in provenance S than in provenance N in their home sites. As a result, the per-planted-area stem cross-sectional area of 30-year-old trees was smallest in provenance S in site N, suggesting a disadvantage of north-ward transplantation. Proportions of trees with broken and/or crooked stems were higher in site N than in site S, suggesting that a northern environment is more stressful. These findings support the current regulation of seed transfer directions in Japanese P. densiflora.	[Nagamitsu, Teruyoshi; Shimada, Ken-ichi] Forestry & Forest Prod Res Inst, Dept Forest Genet, Tsukuba, Ibaraki 3058687, Japan; [Kanazashi, Ayako] Forestry & Forest Prod Res Inst, Hokkaido Res Stn, Toyohira Ku, Sapporo, Hokkaido 0628516, Japan	Nagamitsu, T (reprint author), Forestry & Forest Prod Res Inst, Dept Forest Genet, 1 Matsunosato, Tsukuba, Ibaraki 3058687, Japan.	nagamit@ffpri.affrc.go.jp; shimadak@ffpri.affrc.go.jp; ayakoka@ffpri.affrc.go.jp					Wu HX, 2004, FOREST ECOL MANAG, V194, P177, DOI 10.1016/j.foreco.2004.02.017; Petit RJ, 2006, ANNU REV ECOL EVOL S, V37, P187, DOI 10.1146/annurev.ecolsys.37.091305.110215; Kremer A, 2012, ECOL LETT, V15, P378, DOI 10.1111/j.1461-0248.2012.01746.x; Savolainen O, 2007, ANNU REV ECOL EVOL S, V38, P595, DOI 10.1146/annurev.ecolsys.38.091206.095646; Aitken SN, 2008, EVOL APPL, V1, P95, DOI 10.1111/j.1752-4571.2007.00013.x; Rehfeldt GE, 1999, ECOL MONOGR, V69, P375, DOI 10.1890/0012-9615(1999)069[0375:GRTCIP]2.0.CO;2; O'Brien EK, 2010, RESTOR ECOL, V18, P359, DOI 10.1111/j.1526-100X.2008.00453.x; Wright SJ, 2010, ECOLOGY, V91, P3664, DOI 10.1890/09-2335.1; Bennington CC, 2012, J ECOL, V100, P841, DOI 10.1111/j.1365-2745.2012.01984.x; Kawecki TJ, 2004, ECOL LETT, V7, P1225, DOI 10.1111/j.1461-0248.2004.00684.x; Howe GT, 2003, CAN J BOT, V81, P1247, DOI [10.1139/B03-141, 10.1139/b03-141]; McKay JK, 2005, RESTOR ECOL, V13, P432, DOI 10.1111/j.1526-100X.2005.00058.x; Ishizuka W, 2012, EVOL APPL, V5, P229, DOI 10.1111/j.1752-4571.2011.00216.x; Kreyling J, 2012, ENVIRON EXP BOT, V78, P99, DOI 10.1016/j.envexpbot.2011.12.026; Rehfeldt GE, 2002, GLOBAL CHANGE BIOL, V8, P912, DOI 10.1046/j.1365-2486.2002.00516.x; Verhoeven KJF, 2011, P ROY SOC B-BIOL SCI, V278, P2, DOI 10.1098/rspb.2010.1272; Willi Y, 2007, J EVOLUTION BIOL, V20, P534, DOI 10.1111/j.1420-9101.2006.01263.x; Reich PB, 2008, ECOL LETT, V11, P588, DOI 10.1111/j.1461-0248.2008.01172.x; Ying CC, 2006, FOREST ECOL MANAG, V227, P1, DOI 10.1016/j.foreco.2006.02.028; Breed MF, 2012, CONSERV GENET, V14, P1; Gapare WJ, 2010, TREE GENET GENOMICS, V7, P409; Iwaizumi MG, 2013, FOREST ECOL MANAG, V304, P407, DOI 10.1016/j.foreco.2013.05.026; Iwaizumi MG, 2013, AM J BOT, V100, P1896, DOI 10.3732/ajb.1200563; Leimu R, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0004010; Lin YZ, 2013, FOREST ECOL MANAG, V304, P204, DOI 10.1016/j.foreco.2013.05.015; Liziniewicz M, 2012, SCAND J FOREST RES, V26, P361; MAMIYA Y, 1988, J NEMATOL, V20, P219; Nagamitsu T, 2013, TREE GENET GENOMICS, V10, P87; R Core Team, 2013, R LANG ENV STAT COMP; Salmela MJ, 2010, FORESTRY, V83, P535, DOI 10.1093/forestry/cpq036; Tateishi M, 2010, TREE PHYSIOL, V30, P748, DOI 10.1093/treephys/tpq023; Toda T, 1993, B FOR TREE I, V11, P37; Uemura S, 1989, PLANT ECOL, V82, P127; White TL, 2007, FOREST GENETICS; Working Group on Breeding for Wood Properties, 1972, B GOV FOREST EXP STA, V244, P17; Working Group on Breeding for Wood Properties, 1969, B GOV FOR EXP STATIO, V222, P1; Working Group on Breeding for Wood Properties, 1989, B GOV FOREST EXP STA, V355, P1	37	0	0	SPRINGER HEIDELBERG	HEIDELBERG	TIERGARTENSTRASSE 17, D-69121 HEIDELBERG, GERMANY	1614-2942	1614-2950		TREE GENET GENOMES	Tree Genet. Genomes	FEB	2015	11	1							813	10.1007/s11295-014-0813-2		10	Forestry; Genetics & Heredity; Horticulture	Forestry; Genetics & Heredity; Agriculture	CB3UD	WOS:000349553500033		
J	Ohta, S; Endo, T; Shimada, T; Fujii, H; Shimizu, T; Kita, M; Kuniga, T; Yoshioka, T; Nesumi, H; Yoshida, T; Omura, M				Ohta, S.; Endo, T.; Shimada, T.; Fujii, H.; Shimizu, T.; Kita, M.; Kuniga, T.; Yoshioka, T.; Nesumi, H.; Yoshida, T.; Omura, M.			Construction of genetic linkage map and graphical genotyping of pseudo-backcrossed F-2 (BC2') progeny to introduce a CTV resistance from Poncirus trifoliata (L.) Raf. into Citrus by introgression breeding	TREE GENETICS & GENOMES			English	Article						Citrus; CTV resistance; Genetic linkage map; Graphical genotype; Introgression breeding; Poncirus trifoliata	TRISTEZA VIRUS-RESISTANCE; MOLECULAR MARKERS; REGION; AURANTIOIDEAE; GRANDIS; ORANGE	Most citrus tristeza virus (CTV) strains infect almost all Citrus species and have caused serious damage on citrus production in many countries. Poncirus trifoliata (trifoliate orange) has a single dominant resistance gene effective against a broad range of CTV strains. P. trifoliata is sexually compatible with Citrus species, and introgression breeding programs have been initiated to introduce the CTV resistance into Citrus. "Kankitsu Chukanbohon Nou 8 Gou" (Nou-8) was developed by crossing Citrus sp. "Kiyomi" with an F1 hybrid derived from Citrus hassaku x P. trifoliata, but it still had undesirable eating traits. In aim to progress markerassisted introgression breeding for CTV resistance efficiently, we selected 189 DNA markers which could be applied to genotyping for Citrus and P. trifoliata and constructed a genetic linkage map of Nou-8. The map included 189 DNA markers on 10 linkage groups and extended about 722.8 cM in total length. CTV resistance locus was located at 2.4 cM position in linkage group 02_(1), with the same location found when progeny were scored for resistance using an ELISA assay and for DNA marker for CTV resistant (CTV103). Graphical genotypes of Nou-8 and its progeny suggested that (1) 36 % of the chromosome in the BC2' population were inherited from Nou-8 without any recombination sites, (2) Nou-8 had been already completely substituted by Citrus genotype in two linkage groups, and (3) four of 93 progeny of Nou-8 had recombination sites in the flanking region of the CTV resistance gene locus.	[Ohta, S.; Endo, T.; Shimada, T.; Fujii, H.; Shimizu, T.; Kita, M.; Kuniga, T.; Yoshioka, T.; Nesumi, H.; Yoshida, T.] NARO Inst Fruit Tree Sci, Okitsu Citrus Res Stn, Shizuoka 4240292, Japan; [Omura, M.] Shizuoka Univ, Fac Agr, Shizuoka 4228529, Japan; [Kita, M.] Minist Agr Forestry & Fisheries, Agr Forestry & Fisheries Res Council Secretariat, Tokyo 1008950, Japan; [Kuniga, T.; Nesumi, H.; Yoshida, T.] NARO Western Reg Agr Res Ctr, Shikoku Res Ctr, Zentsuji 7650053, Japan	Ohta, S (reprint author), NARO Inst Fruit Tree Sci, Okitsu Citrus Res Stn, Shizuoka 4240292, Japan.	sohta@affrc.go.jp			Ministry of Agriculture, Forestry, and Fisheries of Japan [GMO-1003]	This work was supported by a grant from the Ministry of Agriculture, Forestry, and Fisheries of Japan (Genomics-based Technology for Agricultural Improvement, GMO-1003).	Moreno P, 2008, MOL PLANT PATHOL, V9, P251, DOI [10.1111/j.1364-3703.2007.00455.x, 10.1111/J.1364-3703.2007.00455.X]; Harper SJ, 2008, AUSTRALAS PLANT PATH, V37, P379, DOI 10.1071/AP08013; YOUNG ND, 1989, THEOR APPL GENET, V77, P95, DOI 10.1007/BF00292322; Fang DQ, 1998, GENETICS, V150, P883; Yang ZN, 2003, PLANT PHYSIOL, V131, P482, DOI 10.1104/pp.011262; Frisch M, 1999, CROP SCI, V39, P1295; Asins MJ, 2012, MOL BREEDING, V29, P575, DOI 10.1007/s11032-011-9574-x; Bernet GP, 2004, THEOR APPL GENET, V108, P592, DOI 10.1007/s00122-003-1479-6; Bordignon R, 2007, B CIENTIFICO, V14; Cristofani M, 1999, EUPHYTICA, V109, P25, DOI 10.1023/A:1003637116745; Dawson T. E., 2000, P 14 C INT ORG CITR, P69; Dawson WO, 2013, FRONT MICROBIOL, V4, DOI 10.3389/fmicb.2013.00088; Dellaporta SL, 1983, PLANT MOL BIOL REP, V1, P19, DOI DOI 10.1007/BF02712670; Fang DQ, 1999, HORTSCIENCE, V34, P334; GARNSEY S M, 1987, Phytophylactica, V19, P187; Garnsey SM, 1997, P 13 C INT ORG CITR, P139; Gmitter FG, 1996, THEOR APPL GENET, V92, P688, DOI 10.1007/BF00226090; Hearn CJ, 1993, HORTSCIENCE, V28, P483; Joshi S, 2009, TRANSGENIC PLANT J, V3, P40; Lee RF, 2013, FRONT MICROBIOL, V4, DOI 10.3389/fmicb.2013.00259; Mestre PF, 1997, THEOR APPL GENET, V94, P458, DOI 10.1007/s001220050437; Mestre PF, 1997, THEOR APPL GENET, V95, P691, DOI 10.1007/s001220050613; Mestre PF, 1997, THEOR APPL GENET, V95, P1282, DOI 10.1007/s001220050694; Ohta S, 2011, J JPN SOC HORTIC SCI, V80, P295; Omura M, 2003, P INT SOC CITRICULT, V2000, P71; Roy A, 2013, PLANT DIS, V97, P1227, DOI 10.1094/PDIS-01-12-0012-RE; Shimada T, 2014, TREE GENET GENOMES, V10, P1001, DOI 10.1007/s11295-014-0738-9; Weber CA, 2003, J AM SOC HORTIC SCI, V128, P508; Yoshida T, 1996, PLANT DIS, V80, P414; Yoshida T, 1993, B FRUIT TREE RES STN, V25, P33; Yoshida T, 1983, B FRUIT TREE RES S B, V10, P51	31	0	0	SPRINGER HEIDELBERG	HEIDELBERG	TIERGARTENSTRASSE 17, D-69121 HEIDELBERG, GERMANY	1614-2942	1614-2950		TREE GENET GENOMES	Tree Genet. Genomes	FEB	2015	11	1							797	10.1007/s11295-014-0797-y		8	Forestry; Genetics & Heredity; Horticulture	Forestry; Genetics & Heredity; Agriculture	CB3UD	WOS:000349553500017		
J	Zhang, CM; Huang, J; Yin, X; Lian, CL; Li, XG				Zhang, Chunmei; Huang, Jian; Yin, Xiao; Lian, Chunlan; Li, Xingang			Genetic diversity and population structure of sour jujube, Ziziphus acidojujuba	TREE GENETICS & GENOMES			English	Article						Sour jujube (Ziziphus acidojujuba); Genetic diversity; Population structure; Microsatellite marker; Gene flow	MULTILOCUS GENOTYPE DATA; ALLELE FREQUENCY DATA; COMPUTER-PROGRAM; MICROSATELLITE MARKERS; PHYLOGENETIC TREES; CELATA RHAMNACEAE; DIFFERENTIATION; SOFTWARE; INFERENCE; DISTANCE	Sour jujube or wild jujube (Ziziphus acidojujuba), considered as the ancestor of cultivated jujube, is an economically and ecologically important species. However, little is known about the population genetics of this species across China. In this study, we detected genetic variation among 874 individuals from 31 natural populations covering the most representative distribution sites of sour jujube in China using nine simple sequence repeat markers. By Bayesian, phylogenetic, and principal component analyses, two genetic groups of sour jujube in China were identified. One group was almost from east of the Taihang Mountains in the North China Plain, and the other was from west of the Taihang Mountains in the Loess Plateau. The high levels of genetic diversity (H-E=0.659 and H-S=0.674) was detected in these populations, and the moderate differentiation was found among populations (F-ST=0.091, R-ST=0.068, G(ST)'=0.271). Populations from the North China Plain harbored higher genetic diversity (H-E=0.686 and H-S=0.706) than those from the Loess Plateau (H-E=0.646 and H-S=0.659) (P<0.05). Analysis of molecular variance revealed that within-population genetic variation (88 %) was higher than that among populations (12 %). High gene flow (Nm=6.572) and weak correlation between genetic and geographical distances (r(2)=0.026, P>0.05) suggested that gene flow occurred frequently among the populations. Understanding the genetic diversity and population structure could benefit germplasm conservation, genetic improvement, and systematic utilization of Ziziphus.	[Zhang, Chunmei; Huang, Jian; Yin, Xiao; Li, Xingang] Northwest A&F Univ, Coll Forestry, State Res Ctr Jujube Engn & Technol, Yangling 712100, Shaanxi, Peoples R China; [Lian, Chunlan] Univ Tokyo, Asian Nat Environm Sci Ctr, Tokyo 1880002, Japan	Li, XG (reprint author), Northwest A&F Univ, Coll Forestry, State Res Ctr Jujube Engn & Technol, Yangling 712100, Shaanxi, Peoples R China.	lian@anesc.u-tokyo.ac.jp; xingangle@nwsuaf.edu.cn			Public Welfare Project from the State Forestry Administration of People's Republic of China [201304110]; Ministry of Science and Technology of People's Republic of China [2013BAD14B03]	We are grateful to Professor CZ Wang, WH Gao, and Driver J Zhang of Northwest A&F University, China, for the assistance in sample collection. We also thank Dr. Yuichi Nakajima and Dr. Yu Matsuki of the Asian Natural Environmental Science Center, The University of Tokyo, Japan, for their technical assistance. This work was supported by the Public Welfare Project from the State Forestry Administration of People's Republic of China (grant no. 201304110) and the Ministry of Science and Technology of People's Republic of China (grant no. 2013BAD14B03).	Akimoto M, 1998, MOL ECOL, V7, P1371, DOI 10.1046/j.1365-294x.1998.00485.x; Islam MB, 2006, SYST BOT, V31, P826, DOI 10.1600/036364406779695997; [Anonymous], 2006, MOL ECOL NOTES, DOI DOI 10.1111/J.1471-8286.2005.01155.X; Kalinowski ST, 2007, MOL ECOL, V16, P1099, DOI 10.1111/j.1365-294X.2007.03089.x; SLATKIN M, 1985, ANNU REV ECOL SYST, V16, P393, DOI 10.1146/annurev.ecolsys.16.1.393; Hardy OJ, 2002, MOL ECOL NOTES, V2, P618, DOI 10.1046/j.1471-8286.2002.00305.x; Luikart G, 1998, CONSERV BIOL, V12, P228, DOI 10.1046/j.1523-1739.1998.96388.x; Zhao SC, 2013, NAT GENET, V45, P67, DOI 10.1038/ng.2494; Ohsawa T, 2011, J PLANT RES, V124, P645, DOI 10.1007/s10265-010-0402-x; Pritchard JK, 2000, GENETICS, V155, P945; Hedrick PW, 2005, EVOLUTION, V59, P1633, DOI 10.1111/j.0014-3820.2005.tb01814.x; Evanno G, 2005, MOL ECOL, V14, P2611, DOI 10.1111/j.1365-294X.2005.02553.x; Asatryan A, 2013, FLORA, V208, P390, DOI 10.1016/j.flora.2013.04.010; Lian CL, 2006, J PLANT RES, V119, P415, DOI 10.1007/s10265-006-0274-2; Goudet J, 1996, GENETICS, V144, P1933; Goodman SJ, 1997, MOL ECOL, V6, P881, DOI 10.1046/j.1365-294X.1997.00260.x; Crawford NG, 2010, MOL ECOL RESOUR, V10, P556, DOI 10.1111/j.1755-0998.2009.02801.x; Dieringer D, 2003, MOL ECOL NOTES, V3, P167, DOI 10.1046/j.1471-8286.2003.00351.x; BARTON NH, 1986, HEREDITY, V56, P409, DOI 10.1038/hdy.1986.63; Wang R, 2011, MOL ECOL, V20, P4421, DOI 10.1111/j.1365-294X.2011.05293.x; Piry S, 1999, J HERED, V90, P502, DOI 10.1093/jhered/90.4.502; Manni F, 2004, HUM BIOL, V76, P173, DOI 10.1353/hub.2004.0034; Rousset F, 2008, MOL ECOL RESOUR, V8, P103, DOI 10.1111/j.1471-8286.2007.01931.x; Liu W, 2013, TREE GENET GENOMES, V9, P975, DOI 10.1007/s11295-013-0610-3; Falush D, 2003, GENETICS, V164, P1567; Summers K, 1997, BEHAV ECOL, V8, P260, DOI 10.1093/beheco/8.3.260; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; Bohonak AJ, 2002, J HERED, V93, P153, DOI 10.1093/jhered/93.2.153; Edwards CE, 2012, DNA RES, V19, P1, DOI 10.1093/dnares/dsr037; EXCOFFIER L, 1992, GENETICS, V131, P479; Gitzendanner MA, 2012, CONSERV GENET, V13, P223, DOI 10.1007/s10592-011-0287-9; Goudet J., 2001, FSTAT PROGRAM ESTIMA; HAMRICK J. L., 1983, GENETICS CONSERVATIO, P335; Hamrick J. L., 1996, P281; Hartl DL, 1997, PRINCIPLES POPULATIO; Hu H, 1940, MIOCENE FLORA SHAN 1, P1; MONMONIE.MS, 1973, GEOGR ANAL, V5, P245; NEI M, 1983, J MOL EVOL, V19, P153, DOI 10.1007/BF02300753; Qu Z, 1993, FRUIT TREE RECORDS C; Saied AS, 2008, GENET RESOUR CROP EV, V55, P929, DOI 10.1007/s10722-007-9299-1; SAITOU N, 1987, MOL BIOL EVOL, V4, P406; Singh AK, 2007, J PLANT BIOCHEM BIOT, V16, P35; Sun J, 2012, TREE GENET GENOMES, V9, P423; Wang SQ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0099842; WEIR BS, 1984, EVOLUTION, V38, P1358, DOI 10.2307/2408641; Wright S., 1978, EVOLUTION GENETICS P, V4; Zhang ChunMei, 2013, Journal of Northwest A & F University - Natural Science Edition, V41, P107; Zhang CM, 2013, INDIAN J GENET PL BR, V73, P338, DOI 10.5958/j.0975-6906.73.3.052	48	1	1	SPRINGER HEIDELBERG	HEIDELBERG	TIERGARTENSTRASSE 17, D-69121 HEIDELBERG, GERMANY	1614-2942	1614-2950		TREE GENET GENOMES	Tree Genet. Genomes	FEB	2015	11	1							809	10.1007/s11295-014-0809-y		12	Forestry; Genetics & Heredity; Horticulture	Forestry; Genetics & Heredity; Agriculture	CB3UD	WOS:000349553500029		
J	Watanabe, M; Kondo, S				Watanabe, Masakatsu; Kondo, Shigeru			Is pigment patterning in fish skin determined by the Turing mechanism?	TRENDS IN GENETICS			English	Review						pigmentation pattern; Turing mechanism; zebrafish; reaction-diffusion	NEURAL CREST DEVELOPMENT; STRIPE FORMATION; DANIO-RERIO; CELL-INTERACTIONS; ADULT ZEBRAFISH; IN-VIVO; GENE; MUTATIONS; MORPHOGENESIS; ENCODES	More than half a century ago, Alan Turing postulated that pigment patterns may arise from a mechanism that could be mathematically modeled based on the diffusion of two substances that interact with each other. Over the past 15 years, the molecular and genetic took to verify this prediction have become available. Here, we review experimental studies aimed at identifying the mechanism underlying pigment pattern formation in zebrafish. Extensive molecular genetic studies in this model organism have revealed the interactions between the pigment cells that are responsible for the patterns. The mechanism discovered is substantially different from that predicted by the mathematical model, but it retains the property of 'local activation and long-range inhibition', a necessary condition for Turing pattern formation. Although some of the molecular details of pattern formation remain to be elucidated, current evidence confirms that the underlying mechanism is mathematically equivalent to the Turing mechanism.	[Watanabe, Masakatsu; Kondo, Shigeru] Osaka Univ, Grad Sch Frontier Biosci, Osaka 5650871, Japan	Kondo, S (reprint author), Osaka Univ, Grad Sch Frontier Biosci, Osaka 5650871, Japan.	skondo@fbs.osaka-u.ac.jp					Kelsh RN, 2009, SEMIN CELL DEV BIOL, V20, P90, DOI 10.1016/j.semcdb.2008.10.001; Parichy DM, 2000, DEVELOPMENT, V127, P3031; Takahashi G, 2008, PIGM CELL MELANOMA R, V21, P677, DOI 10.1111/j.1755-148X.2008.00504.x; Yamanaka H, 2014, P NATL ACAD SCI USA, V111, P1867, DOI 10.1073/pnas.1315416111; Inaba M, 2012, SCIENCE, V335, P677, DOI 10.1126/science.1212821; Dutton KA, 2001, DEVELOPMENT, V128, P4113; Raspopovic J, 2014, SCIENCE, V345, P566, DOI 10.1126/science.1252960; Nakamasu A, 2009, P NATL ACAD SCI USA, V106, P8429, DOI 10.1073/pnas.0808622106; Kondo S, 2010, SCIENCE, V329, P1616, DOI 10.1126/science.1179047; Parichy DM, 2000, DEV BIOL, V227, P294, DOI 10.1006/dbio.2000.9899; Hirata M, 2005, DEV DYNAM, V234, P293, DOI 10.1002/dvdy.20513; Bedell VM, 2012, NATURE, V491, P114, DOI 10.1038/nature11537; Watanabe M, 2006, EMBO REP, V7, P893, DOI 10.1038/sj.embor.7400757; Frohnhofer HG, 2013, DEVELOPMENT, V140, P2997, DOI 10.1242/dev.096719; Meinhardt H, 2000, BIOESSAYS, V22, P753, DOI 10.1002/1521-1878(200008)22:8<753::AID-BIES9>3.0.CO;2-Z; Kelsh RN, 1996, DEVELOPMENT, V123, P369; Parichy DM, 1999, DEVELOPMENT, V126, P3425; Lamason RL, 2005, SCIENCE, V310, P1782, DOI 10.1126/science.1116238; Gibson MC, 2006, NATURE, V442, P1038, DOI 10.1038/nature05014; Yamaguchi M, 2007, P NATL ACAD SCI USA, V104, P4790, DOI 10.1073/pnas.0607790104; Haffter P, 1996, DEV GENES EVOL, V206, P260, DOI 10.1007/s004270050051; Odenthal J, 1996, DEVELOPMENT, V123, P391; Kelsh RN, 2004, PIGM CELL RES, V17, P326, DOI 10.1111/j.1600-0749.2004.00174.x; Maderspacher F, 2003, DEVELOPMENT, V130, P3447, DOI 10.1242/dev.00519; Lister JA, 1999, DEVELOPMENT, V126, P3757; Watanabe M, 2012, PIGM CELL MELANOMA R, V25, P326, DOI 10.1111/j.1755-148X.2012.00984.x; Economou AD, 2012, NAT GENET, V44, P348, DOI 10.1038/ng.1090; Hirata M, 2003, DEV DYNAM, V227, P497, DOI 10.1002/dvdy.10334; Parichy DM, 2003, DEVELOPMENT, V130, P817, DOI 10.1242/dev.00307; Milinkovitch MC, 2013, SCIENCE, V339, P78, DOI 10.1126/science.1226265; Budi EH, 2008, DEVELOPMENT, V135, P2603, DOI 10.1242/dev.019299; Mahalwar P, 2014, SCIENCE, V345, P1362, DOI 10.1126/science.1254837; McMenamin SK, 2014, SCIENCE, V345, P1358, DOI 10.1126/science.1256251; KONDO S, 1995, NATURE, V376, P765, DOI 10.1038/376765a0; Gronskov K, 2013, AM J HUM GENET, V92, P415, DOI 10.1016/j.ajhg.2013.01.006; Liu RT, 2006, PHYS REV E, V74, DOI 10.1103/PhysRevE.74.011914; Asai R, 1999, MECH DEVELOP, V89, P87, DOI 10.1016/S0925-4773(99)00211-7; Beirl AJ, 2014, PIGM CELL MELANOMA R, V27, DOI 10.1111/pcmr.12205; Carroll S. B, 2005, ENDLESS FORMS MOST B; Clancey LF, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0065096; Dooley CM, 2013, PIGM CELL MELANOMA R, V26, DOI 10.1111/pcmr.12053; Elworthy S, 2003, DEVELOPMENT, V130, P2809, DOI 10.1242/dev.00461; Eom DS, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002899; Hamada H, 2014, DEVELOPMENT, V141, P318, DOI 10.1242/dev.099804; Hultman KA, 2007, PLOS GENET, V3, DOI 10.1371/journal.pgen.0030017; Inoue S, 2014, PIGM CELL MELANOMA R, V27, DOI 10.1111/pcmr.12192; Iwashita M, 2006, PLOS GENET, V2, P1861, DOI 10.1371/journal.pgen.0020197; Kawakami K, 2004, METHOD CELL BIOL, V77, P201; Kawakami K, 2000, CURR BIOL, V10, P463, DOI 10.1016/S0960-9822(00)00444-9; Krauss J, 2014, PIGM CELL MELANOMA R, V27, P827, DOI 10.1111/pcmr.12272; Krauss J, 2013, BIOL OPEN, V2, P703, DOI 10.1242/bio.20135132; Lang MR, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000744; Larson TA, 2010, DEV BIOL, V346, P296, DOI 10.1016/j.ydbio.2010.07.035; Lin CM, 2009, DEV BIOL, V334, P369, DOI 10.1016/j.ydbio.2009.07.036; Lister JA, 2006, DEV BIOL, V290, P92, DOI 10.1016/j.ydbio.2005.11.014; Lopes SS, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000026; Meinhardt H., 1995, ALGORITHMIC BEAUTY S; Meinhardt H., 1982, MODELS BIOL PATTERN; Meinhardt H, 2012, INTERFACE FOCUS, V2, P407, DOI 10.1098/rsfs.2011.0097; Murray J.D., 2003, MATH BIOL; MURRAY JD, 1988, SCI AM, V258, P80; Patterson LB, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003561; Shoji H, 2003, DEV DYNAM, V226, P627, DOI 10.1002/dvdy.10277; Shoji H, 2002, J THEOR BIOL, V214, P549, DOI 10.1006/jtbi.2001.2480; Singh AP, 2014, NAT CELL BIOL, V16, P604, DOI 10.1038/ncb2955; Svetic V, 2007, DEVELOPMENT, V134, P1011, DOI 10.1242/dev.02789; TURING AM, 1952, PHILOS T ROY SOC B, V237, P37, DOI 10.1098/rstb.1952.0012	67	4	4	ELSEVIER SCIENCE LONDON	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0168-9525			TRENDS GENET	Trends Genet.	FEB	2015	31	2					88	96		10.1016/j.tig.2014.11.005		9	Genetics & Heredity	Genetics & Heredity	CB6GJ	WOS:000349725200006		
J	Rosenqvist, A; Rebelo, LM; Costa, M				Rosenqvist, Ake; Rebelo, Lisa-Maria; Costa, Maycira			The ALOS Kyoto & Carbon Initiative: enabling the mapping, monitoring and assessment of globally important wetlands	WETLANDS ECOLOGY AND MANAGEMENT			English	Editorial Material									[Rosenqvist, Ake] Solo Earth Observat soloEO, Tokyo, Japan; [Rebelo, Lisa-Maria] Int Water Management Inst, Viangchan, Laos; [Costa, Maycira] Univ Victoria, Victoria, BC, Canada	Rosenqvist, A (reprint author), Solo Earth Observat soloEO, Tokyo, Japan.	ake.rosenqvist@soloEO.com; l.rebelo@cgiar.org; maycira@uvic.ca						0	0	0	SPRINGER	DORDRECHT	VAN GODEWIJCKSTRAAT 30, 3311 GZ DORDRECHT, NETHERLANDS	0923-4861	1572-9834		WETL ECOL MANAG	Wetl. Ecol. Manag.	FEB	2015	23	1			SI		1	1		10.1007/s11273-014-9400-4		1	Environmental Sciences; Water Resources	Environmental Sciences & Ecology; Water Resources	CB4OL	WOS:000349607200001		
J	Thomas, N; Lucas, R; Itoh, T; Simard, M; Fatoyinbo, L; Bunting, P; Rosenqvist, A				Thomas, Nathan; Lucas, Richard; Itoh, Takuya; Simard, Marc; Fatoyinbo, Lola; Bunting, Peter; Rosenqvist, Ake			An approach to monitoring mangrove extents through time-series comparison of JERS-1 SAR and ALOS PALSAR data	WETLANDS ECOLOGY AND MANAGEMENT			English	Article						Remote sensing; Radar; Mangroves; Change	REMOTE-SENSING TECHNIQUES; COASTAL VEGETATION; ELEVATION DATA; FRENCH-GUIANA; RADAR DATA; FORESTS; AQUACULTURE; ECOSYSTEMS; BIOMASS; ICESAT/GLAS	Between 2007 and 2010, Japan's Advanced Land Observing Satellite (ALOS) Phased Arrayed L-band Synthetic Aperture Radar (PALSAR) captured dual polarization HH and HV data across the tropics and sub-tropics. A pan tropical dataset of Japanese Earth Resources Satellite (JERS-1) SAR (HH) data was also acquired between 1995 and 1998. The provision of these comparable cloud-free datasets provided an opportunity for observing changes in the extent of coastal mangroves over more than a decade. Focusing on nine sites distributed through the tropics, this paper demonstrates how these data can be used to backdate and update existing baseline maps of mangrove extent. The benefits of integrating dense time-series of Landsat sensor data for both validating assessments of change and determining the causes of change are outlined. The approach is evaluated for wider application across the geographical range of mangroves in order to advance the development of JAXA's Global Mangrove Watch (GMW) program.	[Thomas, Nathan; Bunting, Peter] Aberystwyth Univ, Dept Geog & Earth Sci, Aberystwyth SY23 3DB, Ceredigion, Wales; [Lucas, Richard] Univ New S Wales, Sch Biol Earth & Environm Sci, Kensington, NSW 2052, Australia; [Itoh, Takuya] Remote Sensing Technol Ctr Japan RESTEC, Minato Ku, Tokyo 1060032, Japan; [Simard, Marc] CALTECH, Jet Prop Lab, Pasadena, CA 90039 USA; [Fatoyinbo, Lola] NASA, Goddard Space Flight Ctr, Biospher Sci Lab, Greenbelt, MD 20771 USA; [Rosenqvist, Ake] Solo Earth Observat soloEO, Chuo Ku, Tokyo 1040054, Japan	Lucas, R (reprint author), Univ New S Wales, Sch Biol Earth & Environm Sci, High St, Kensington, NSW 2052, Australia.	richard.lucas@unsw.edu.au	Fatoyinbo, Lola/G-6104-2012; Bunting, Pete/B-8678-2013	Bunting, Pete/0000-0002-7435-0148	Japanese Space Exploration Agency	Japanese Space Exploration Agency.	Lucas RM, 2007, AQUAT CONSERV, V17, P245, DOI 10.1002/aqc.833; Fatoyinbo TE, 2013, INT J REMOTE SENS, V34, P668, DOI 10.1080/01431161.2012.712224; Simard M, 2008, REMOTE SENS ENVIRON, V112, P2131, DOI 10.1016/j.rse.2007.10.012; Gaveau DLA, 2009, J BIOGEOGR, V36, P2165, DOI 10.1111/j.1365-2699.2009.02147.x; Thu PM, 2007, ESTUAR COAST SHELF S, V71, P98, DOI 10.1016/j.ecss.2006.08.007; Donato DC, 2011, NAT GEOSCI, V4, P293, DOI [10.1038/ngeo1123, 10.1038/NGEO1123]; Rosenqvist A, 2000, INT J REMOTE SENS, V21, P1375, DOI 10.1080/014311600210227; Ewel KC, 1998, GLOBAL ECOL BIOGEOGR, V7, P83, DOI 10.2307/2997700; Pattanaik C, 2011, OCEAN COAST MANAGE, V54, P789, DOI 10.1016/j.ocecoaman.2011.07.013; Shimada M, 2010, IEEE J-STARS, V3, P637, DOI 10.1109/JSTARS.2010.2077619; Allison MA, 2004, MAR GEOL, V208, P169, DOI 10.1016/j.margeo.2004.04.026; Simard M, 2002, INT J REMOTE SENS, V23, P1461, DOI 10.1080/01434460110092984; Kovacs JM, 2005, ESTUAR COAST SHELF S, V62, P377, DOI 10.1016/j.ecss.2004.09.027; Fromard F, 2004, MAR GEOL, V208, P265, DOI 10.1016/j.margeo.2004.04.018; Proisy C, 2000, REMOTE SENS ENVIRON, V71, P56, DOI 10.1016/S0034-4257(99)00064-4; Gopal B, 2006, AQUAT SCI, V68, P338, DOI 10.1007/s00027-006-0868-8; Danielsen F, 2005, SCIENCE, V310, P643, DOI 10.1126/science.1118387; Chauvaud S, 1998, INT J REMOTE SENS, V19, P3625, DOI 10.1080/014311698213858; Simard M, 2006, PHOTOGRAMM ENG REM S, V72, P299; Green EP, 1998, INT J REMOTE SENS, V19, P935, DOI 10.1080/014311698215801; Rahman AF, 2013, REMOTE SENS ENVIRON, V130, P96, DOI 10.1016/j.rse.2012.11.014; Baltzer F, 2004, MAR GEOL, V208, P115, DOI 10.1016/j.margeo.2004.04.024; Bandaranayake W., 1998, MANGROVES SALT MARSH, V2, P133, DOI 10.1023/A:1009988607044; Chong VC, 2001, MAR BIOL, V138, P77, DOI 10.1007/s002270000434; Dahdouh-Guebas F, 2004, MAR ECOL PROG SER, V272, P77, DOI 10.3354/meps272077; Diop ES, 2002, ENVIRONM SCI, P63; Gan B.K., 1995, WORKING PLAN MATANG; Ghandi Y, 2008, BIODIVERSITAS, V9, P156; Giri G, 2011, GLOBAL ECOL BIOGEOGR, V20, P154, DOI DOI 10.1111/J.1466-8238.2010.00584.X; GONG WK, 1990, ESTUAR COAST SHELF S, V31, P519, DOI 10.1016/0272-7714(90)90010-O; Held A, 2003, INT J REMOTE SENS, V24, P2739, DOI 10.1080/0143116031000066323; JAXA EORC, 2014, ALOS 2 BAS OBS SCEN; Kairo J. G., 2002, Environment Development and Sustainability, V4, P153, DOI 10.1023/A:1020890711588; Lucas RM, 2014, MAR FRESHWATER RES, V65, P1; Mitchell AL, 2006, WETL ECOL MANAG, V17, P446; Mougin E, 1999, IEEE T GEOSCI REMOTE, V37, P94, DOI 10.1109/36.739128; Pasqualini V, 1999, HYDROBIOLOGIA, V413, P127, DOI 10.1023/A:1003807330375; Rosenqvist A, 2007, IEEE T GEOSCI REMOTE, V45, P3307, DOI 10.1109/TGRS.2007.901027; ABRAMS EM, 1988, HUM ECOL, V16, P377, DOI 10.1007/BF00891649; Saleh MA, 2007, J ARID ENVIRON, V68, P331, DOI 10.1016/j.jaridenv.2006.05.016; SCHAEFFERNOVELLI Y, 1990, ESTUARIES, V13, P204, DOI 10.2307/1351590; Seto KC, 2007, GLOBAL ENVIRON CHANG, V17, P486, DOI 10.1016/j.gloenvcha.2007.03.001; Spalding M., 2010, WORLD ATLAS MANGROVE, P336; Spalding M.D., 1997, WORLD MANGROVE ATLAS; Wang L, 2004, INT J REMOTE SENS, V25, P5655, DOI 10.1080/014311602331291215; WANG Y, 1993, INT J REMOTE SENS, V14, P2819; Whitten T, 1997, ECOLOGY SUMATRA	47	0	0	SPRINGER	DORDRECHT	VAN GODEWIJCKSTRAAT 30, 3311 GZ DORDRECHT, NETHERLANDS	0923-4861	1572-9834		WETL ECOL MANAG	Wetl. Ecol. Manag.	FEB	2015	23	1			SI		3	17		10.1007/s11273-014-9370-6		15	Environmental Sciences; Water Resources	Environmental Sciences & Ecology; Water Resources	CB4OL	WOS:000349607200002		
J	Jarrige, I; Ishii, K; Matsumura, D; Nishihata, Y; Yoshida, M; Kishi, H; Taniguchi, M; Uenishi, M; Tanaka, H; Kasai, H; Mizuki, J				Jarrige, Ignace; Ishii, Kenji; Matsumura, Daiju; Nishihata, Yasuo; Yoshida, Masahiro; Kishi, Hirofumi; Taniguchi, Masashi; Uenishi, Mari; Tanaka, Hirohisa; Kasai, Hideaki; Mizuki, Jun'ichiro			Toward Optimizing the Performance of Self-Regenerating Pt-Based Perovskite Catalysts	ACS CATALYSIS			English	Article						platinum; perovskite; heterogeneous catalysis; nanoparticle; RIXS; XAS	AUTOMOTIVE-EMISSIONS CONTROL; INITIO MOLECULAR-DYNAMICS; TOTAL-ENERGY CALCULATIONS; AUGMENTED-WAVE METHOD; BASIS-SET; METALS; CAZRO3; RH; PD	Self-regenerating automotive catalysts owe their remarkable performance to the repeated motion of the precious metal atoms in and out of the perovskite lattice under fluctuating oxidizing and reducing conditions, preventing coalescence of the metal nanoparticles. Here we use resonant inelastic X-ray scattering to characterize the occupied and unoccupied Pt 5d states in two self-regenerating Pt-perovskite catalysts, CaTi0.95Pt0.05O3 and CaZr0.95Pt0.05O3. Upon reduction, the element and symmetry-specific charge excitation spectra reveal a sizable hybridization between the Pt 5d and the Ti 3d or Zr 4d states at the interface between the nanoparticles and the perovskite, which involves the occupied states and is thus invisible in X-ray absorption spectra. A correlation is found between the strength of this d-band hybridization and the proportion of Pt nanoparticles that remain buried below the surface during reduction, indicating that the motion of the Pt atoms toward the surface is hindered by this hybridization specifically, rather than by the Pt-O bonding. These results provide direct evidence that the strength of the metal-metal d-band hybridization plays a pivotal role in determining the efficiency of self-regeneration in perovskite catalysts.	[Jarrige, Ignace; Ishii, Kenji; Matsumura, Daiju; Nishihata, Yasuo; Yoshida, Masahiro; Mizuki, Jun'ichiro] Japan Atom Energy Agcy, SPring 8, Sayo, Hyogo 6795148, Japan; [Kishi, Hirofumi; Kasai, Hideaki] Osaka Univ, Dept Precis Sci & Technol & Appl Phys, Suita, Osaka 5650871, Japan; [Taniguchi, Masashi; Uenishi, Mari; Tanaka, Hirohisa] Daihatsu Motor Co Ltd, Div Res & Dev, Gamo, Shiga 5202593, Japan	Jarrige, I (reprint author), Brookhaven Natl Lab, Photon Sci Directorate, Upton, NY 11973 USA.	jarrige@bnl.gov			Elements Science and Technology Project	This work was supported by the Elements Science and Technology Project. The synchrotron radiation experiments were performed at the BL11XU of SPring-8 with the approval of the Japan Synchrotron Radiation Research Institute (JASRI) (Proposal Nos. 2011B3502, 2010B3502, 2010A3502, and 2009B3502).	Kresse G, 1996, PHYS REV B, V54, P11169, DOI 10.1103/PhysRevB.54.11169; BLOCHL PE, 1994, PHYS REV B, V50, P17953, DOI 10.1103/PhysRevB.50.17953; STICH I, 1989, PHYS REV B, V39, P4997, DOI 10.1103/PhysRevB.39.4997; Perdew JP, 1996, PHYS REV LETT, V77, P3865, DOI 10.1103/PhysRevLett.77.3865; Katz MB, 2012, J CATAL, V293, P145, DOI 10.1016/j.jcat.2012.06.017; Hamada I, 2011, J AM CHEM SOC, V133, P18506, DOI 10.1021/ja110302t; Vaarkamp M, 1996, J CATAL, V163, P294, DOI 10.1006/jcat.1996.0330; MONKHORST HJ, 1976, PHYS REV B, V13, P5188, DOI 10.1103/PhysRevB.13.5188; KOOPMANS HJA, 1983, ACTA CRYSTALLOGR C, V39, P1323, DOI 10.1107/S0108270183008392; Nishihata Y, 2002, NATURE, V418, P164, DOI 10.1038/nature00893; Tanaka H, 2006, ANGEW CHEM INT EDIT, V45, P5998, DOI 10.1002/anie.200503938; Kresse G, 1996, COMP MATER SCI, V6, P15, DOI 10.1016/0927-0256(96)00008-0; Glatzel P, 2010, J AM CHEM SOC, V132, P2555, DOI 10.1021/ja907760p; Perdew JP, 1997, PHYS REV LETT, V78, P1396, DOI 10.1103/PhysRevLett.78.1396; Katz MB, 2011, J AM CHEM SOC, V133, P18090, DOI 10.1021/ja2082284; KRESSE G, 1994, PHYS REV B, V49, P14251, DOI 10.1103/PhysRevB.49.14251; Arevalo R. L., 2013, J PHYS CONDENS MATT, V25; Ishii K, 2013, J ELECTRON SPECTROSC, V188, P127, DOI 10.1016/j.elspec.2012.12.003; Kresse G, 1999, PHYS REV B, V59, P1758, DOI 10.1103/PhysRevB.59.1758; KRESSE G, 1993, PHYS REV B, V47, P558, DOI 10.1103/PhysRevB.47.558; Matar SF, 2008, CHEM PHYS, V352, P92, DOI 10.1016/j.chemphys.2008.06.005; Stoch P, 2012, J EUR CERAM SOC, V32, P665, DOI 10.1016/j.jeurceramsoc.2011.10.011; Yang Y., 2012, AIP ADV, V2	23	0	0	AMER CHEMICAL SOC	WASHINGTON	1155 16TH ST, NW, WASHINGTON, DC 20036 USA	2155-5435			ACS CATAL	ACS Catal.	FEB	2015	5	2					1112	1118		10.1021/cs501608k		7	Chemistry, Physical	Chemistry	CA9WK	WOS:000349275300069		
J	Furukawa, S; Suga, A; Komatsu, T				Furukawa, Shinya; Suga, Akifusa; Komatsu, Takayuki			Mechanistic Study on Aerobic Oxidation of Amine over Intermetallic Pd3Pb: Concerted Promotion Effects by Pb and Support Basicity	ACS CATALYSIS			English	Article						Pd3Pb; amine oxidation; intermetallic compound; concerted catalysis; mechanistic study	LIQUID-PHASE OXIDATION; SELECTIVE OXIDATION; MOLECULAR-OXYGEN; METAL-CATALYSTS; COMPOUND ZNPD; LOWER ALKANES; LEAD-OXIDES; PLATINUM; PD; METHANOL	A mechanistic study on aerobic oxidation of amine to imine over Pd3Pb/MOx (MOx = SiO2, TiO2, Al2O3, and MgO) intermetallic catalysts was performed to clarify the role of Pb and the support in enhancing catalytic activity. Results from X-ray absorption and photoelectron spectroscopies revealed that formation of the Pd3Pb phase made Pd electron-rich compared to pure Pd, whereas the electronic states of Pd in Pd3Pb/MOx were identical and independent of the nature of the support. Kinetic studies indicated that desorption of imine was promoted by Pb and that adsorption of amine was accelerated by basic sites on the support. Infrared temperature programmed desorption (IR-TPD) experiments demonstrated that desorption of imine was indeed promoted on Pd3Pb compared to Pd. The support effect only appears on Pd3Pb catalysts and not on pure Pd due to change in the rate-determining step from imine desorption to amine adsorption. The combination of Pb and the support basicity provides a unique and highly efficient bifunctional catalysis.	[Furukawa, Shinya] Tokyo Inst Technol, Dept Chem, Meguro Ku, Tokyo 1528551, Japan; [Suga, Akifusa; Komatsu, Takayuki] Tokyo Inst Technol, Dept Chem & Mat Sci, Meguro Ku, Tokyo 1528551, Japan	Furukawa, S (reprint author), Tokyo Inst Technol, Dept Chem, Meguro Ku, 2-12-1-E1-10 Ookayama, Tokyo 1528551, Japan.	furukawa.s.af@m.titech.ac.jp; komatsu.t.ad@m.titech.ac.jp			JSPS KAKENHI [26820350]	This work was supported by JSPS KAKENHI Grant No. 26820350. The author appreciates Dr. Hiroyuki Asakura of Nagoya University and Prof. Dr. Tsunehiro Tanaka of Kyoto University for the aid of XAFS measurement. The author thanks Dr. Kosuke Ono of the Tokyo Institute of Technology for the help of NMR measurement.	Abdel-Samad H, 1998, APPL SURF SCI, V136, P46, DOI 10.1016/S0169-4332(98)00337-7; TAUSTER SJ, 1981, SCIENCE, V211, P1121, DOI 10.1126/science.211.4487.1121; Kovnir K, 2009, SURF SCI, V603, P1784, DOI 10.1016/j.susc.2008.09.058; SMITS PCC, 1987, APPL CATAL, V33, P83, DOI 10.1016/S0166-9834(00)80585-0; Claus P, 2000, J CATAL, V192, P88, DOI 10.1006/jcat.2000.2834; TAUSTER SJ, 1978, J AM CHEM SOC, V100, P170, DOI 10.1021/ja00469a029; Furukawa S, 2014, ACS CATAL, V4, P1441, DOI 10.1021/cs500082g; MALLAT T, 1993, J CATAL, V142, P237, DOI 10.1006/jcat.1993.1204; Kakiuchi N, 2001, J ORG CHEM, V66, P6620, DOI 10.1021/jo010338r; MALLAT T, 1994, CATAL TODAY, V19, P247, DOI 10.1016/0920-5861(94)80187-8; HERRERO E, 1993, J ELECTROANAL CHEM, V350, P73, DOI 10.1016/0022-0728(93)80197-P; Lin MR, 1997, J AM CHEM SOC, V119, P6048, DOI 10.1021/ja964371k; YU YH, 1990, J PHYS CHEM SOLIDS, V51, P445, DOI 10.1016/0022-3697(90)90182-F; Ravel B, 2005, J SYNCHROTRON RADIAT, V12, P537, DOI 10.1107/S0909049505012719; Iwasa N, 2003, TOP CATAL, V22, P215, DOI 10.1023/A:1023571819211; TSUJINO T, 1992, J MOL CATAL, V71, P25, DOI 10.1016/0304-5102(92)80005-2; Mallat T, 2004, CHEM REV, V104, P3037, DOI 10.1021/cr0200116; Mondelli C, 2007, J CATAL, V252, P77, DOI 10.1016/j.jcat.2007.09.013; Armbruster M, 2013, CATAL REV, V55, P289, DOI 10.1080/01614940.2013.796192; Mondelli C, 2010, PHYS CHEM CHEM PHYS, V12, P5307, DOI 10.1039/b926833b; PARSONS R, 1988, J ELECTROANAL CHEM, V257, P9, DOI 10.1016/0022-0728(88)87028-1; Furukawa S, 2013, J PHYS CHEM C, V117, P442, DOI 10.1021/jp310501h; Wang JR, 2006, TETRAHEDRON LETT, V47, P8293, DOI 10.1016/j.tetlet.2006.09.088; Friedrich M, 2012, J CATAL, V285, P41, DOI 10.1016/j.jcat.2011.09.013; Kovnir K, 2007, SCI TECHNOL ADV MAT, V8, P420, DOI 10.1016/j.stam.2007.05.004; Huang L, 2006, CATAL LETT, V112, P219, DOI 10.1007/s10562-006-0206-8; Furukawa S, 2014, CHEM COMMUN, V50, P3277, DOI 10.1039/c4cc00024b; PAULING L, 1947, J AM CHEM SOC, V69, P542, DOI 10.1021/ja01195a024; Choudhary TV, 2002, APPL CATAL A-GEN, V234, P1, DOI 10.1016/S0926-860X(02)00231-4; Brown P. J., 2006, INT TABLES CRYSTALLO, VC, P544; EVARESTOV RA, 1991, PHYS STATUS SOLIDI B, V165, P411, DOI 10.1002/pssb.2221650211; FIEGE H, 1981, ANGEW CHEM INT EDIT, V20, P783, DOI 10.1002/anie.198107831; FURUYA N, 1979, J ELECTROANAL CHEM, V98, P189, DOI 10.1016/S0022-0728(79)80258-2; Hirano T, 2007, APPL CATAL A-GEN, V320, P91, DOI 10.1016/j.apcata.2006.12.015; Hirano T, 2007, CATAL LETT, V117, P73, DOI 10.1007/s10562-007-9109-6; Kochubey DI, 1996, J CATAL, V161, P500, DOI 10.1006/jcat.1996.0211; MALLAT T, 1991, APPL CATAL, V79, P59, DOI 10.1016/0926-860X(91)85006-J; OCON P, 1987, ELECTROCHIM ACTA, V32, P1095, DOI 10.1016/0013-4686(87)90038-7; SMITH JK, 1985, J ORG CHEM, V50, P4549, DOI 10.1021/jo00223a024	39	1	1	AMER CHEMICAL SOC	WASHINGTON	1155 16TH ST, NW, WASHINGTON, DC 20036 USA	2155-5435			ACS CATAL	ACS Catal.	FEB	2015	5	2					1214	1222		10.1021/cs501695m		9	Chemistry, Physical	Chemistry	CA9WK	WOS:000349275300080		
J	Sharma, S; Bharathi, A; Vinod, K; Sundar, CS; Srihari, V; Sen, S; Ghosh, H; Sinha, AK; Deb, SK				Sharma, Shilpam; Bharathi, A.; Vinod, K.; Sundar, C. S.; Srihari, V.; Sen, Smritijit; Ghosh, Haranath; Sinha, Anil K.; Deb, S. K.			Structural investigations in BaFe2-xRuxAs2 as a function of Ru and temperature	ACTA CRYSTALLOGRAPHICA SECTION B-STRUCTURAL SCIENCE CRYSTAL ENGINEERING AND MATERIALS			English	Article						structural phase transition; orthorhombic distortion; structural parameters; superconductivity; iron arsenide	IRON-PNICTIDES; SUPERCONDUCTIVITY; BAFE2AS2; CHALCOGENIDES; PHASE	We present the results of synchrotron X-ray diffraction (XRD) measurements on powdered single-crystal samples of BaFe2-xRuxAs2, as a function of Ru content, and as a function of temperature, across the spin-density wave transition in BaFe1.9Ru0.1As2. The Rietveld refinements reveal that with Ru substitution, while the a-axis increases, the c-axis decreases. In addition, the variation of positional coordinates of As (z(As)), the FeAs bond length and the AsFeAs bond angles have also been determined. In the sample with x = 0.1, temperature-dependent XRD measurements indicate that the orthorhombicity shows the characteristic increase with a decrease in temperature, below the magnetic transition. It is seen that the c-axis, the AsFeAs bond angles, FeAs bond length and positional coordinates of the As show definite anomalies close to the structural transition. The observed anomalies in structural parameters are analysed in conjunction with restricted geometric optimization of the structure using ab initio electronic structure calculations.	[Sharma, Shilpam; Bharathi, A.; Vinod, K.; Sundar, C. S.] Indira Gandhi Ctr Atom Res, Mat Sci Grp, Kalpakam, India; [Srihari, V.] Natl Lab High Energy Phys, KEK, Photon Factory, Tsukuba, Ibaraki 305, Japan; [Sen, Smritijit; Ghosh, Haranath; Sinha, Anil K.; Deb, S. K.] Raja Ramanna Ctr Adv Technol, Indore, Madhya Pradesh, India	Bharathi, A (reprint author), Indira Gandhi Ctr Atom Res, Mat Sci Grp, Kalpakam, India.	bharathi@igcar.gov.in					Hammersley AP, 1996, HIGH PRESSURE RES, V14, P235, DOI 10.1080/08957959608201408; Johnston DC, 2010, ADV PHYS, V59, P803, DOI 10.1080/00018732.2010.513480; Perdew JP, 1996, PHYS REV LETT, V77, P3865, DOI 10.1103/PhysRevLett.77.3865; Akturk E, 2009, PHYS REV B, V79, DOI 10.1103/PhysRevB.79.184523; Kim MG, 2011, PHYS REV B, V83, DOI 10.1103/PhysRevB.83.054514; Mazin II, 2008, PHYS REV B, V78, DOI 10.1103/PhysRevB.78.085104; Vinod K, 2012, AIP CONF PROC, V1447, P889, DOI 10.1063/1.4710288; Thaler A, 2010, PHYS REV B, V82, DOI 10.1103/PhysRevB.82.014534; Sinha AK, 2011, AIP CONF PROC, V1349, P503, DOI 10.1063/1.3605954; Mazin II, 2008, PHYS REV LETT, V101, DOI 10.1103/PhysRevLett.101.057003; Yin ZP, 2011, NAT MATER, V10, P932, DOI [10.1038/nmat3120, 10.1038/NMAT3120]; Toby BH, 2001, J APPL CRYSTALLOGR, V34, P210, DOI 10.1107/S0021889801002242; Canfield PC, 2010, ANNU REV CONDEN MA P, V1, P27, DOI 10.1146/annurev-conmatphys-070909-104041; Clark SJ, 2005, Z KRISTALLOGR, V220, P567, DOI 10.1524/zkri.220.5.567.65075; Singh DJ, 2008, PHYS REV B, V78, DOI 10.1103/PhysRevB.78.094511; Rahlenbeck M, 2009, PHYS REV B, V80, DOI 10.1103/PhysRevB.80.064509; Canfield PC, 2009, PHYS REV B, V80, DOI 10.1103/PhysRevB.80.060501; Kim MG, 2013, PHYS REV B, V88, DOI 10.1103/PhysRevB.88.014424; Bharathi A., 2012, ANN REPORT PHOTON SC; Brouet V, 2010, PHYS REV LETT, V105, DOI 10.1103/PhysRevLett.105.087001; Devidas TR, 2014, SOLID STATE COMMUN, V185, P62, DOI 10.1016/j.ssc.2014.02.002; Dhaka RS, 2013, PHYS REV LETT, V110, DOI 10.1103/PhysRevLett.110.067002; Eom MJ, 2012, PHYS REV B, V85, DOI 10.1103/PhysRevB.85.024536; Larson A. C., 2004, LAUR86748 GSAS; Marcus T., 2008, J PHYS CONDENS MATT, V20; Reddy R. K., 2015, UNPUB; Rotter M, 2008, PHYS REV B, V78, DOI 10.1103/PhysRevB.78.020503; Rullier-Albenque F, 2010, PHYS REV B, V81, DOI 10.1103/PhysRevB.81.224503; Sen S., 2014, ARXIV14083239; Sharma S, 2010, PHYS REV B, V81, DOI 10.1103/PhysRevB.81.174512; Shilpam S., 2013, SUPERCOND SCI TECH, V26; Teng J, 2013, P NATL ACAD SCI USA, V110, P898, DOI 10.1073/pnas.1220170110; Xu N, 2012, PHYS REV B, V86, DOI 10.1103/PhysRevB.86.064505; Yildirim T, 2009, PHYSICA C, V469, P425, DOI 10.1016/j.physc.2009.03.038; Zhang LJ, 2009, PHYS REV B, V79, DOI 10.1103/PhysRevB.79.174530; Zhang Q. M., 2012, MOD PHYS LETT B, V26	36	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0108-7681	1600-5740		ACTA CRYSTALLOGR B	Acta Crystallogr. Sect. B-Struct. Sci.Cryst. Eng. Mat.	FEB	2015	71		1				61	67		10.1107/S2052520614023634		7	Chemistry, Multidisciplinary; Crystallography	Chemistry; Crystallography	CB0JU	WOS:000349312800008		
J	Komatsu, K; Shinozaki, A; Machida, S; Matsubayashi, T; Watanabe, M; Kagi, H; Sano-Furukawa, A; Hattori, T				Komatsu, Kazuki; Shinozaki, Ayako; Machida, Shinichi; Matsubayashi, Takuto; Watanabe, Mao; Kagi, Hiroyuki; Sano-Furukawa, Asami; Hattori, Takanori			Crystal structure of magnesium dichloride decahydrate determined by X-ray and neutron diffraction under high pressure	ACTA CRYSTALLOGRAPHICA SECTION B-STRUCTURAL SCIENCE CRYSTAL ENGINEERING AND MATERIALS			English	Article						magnesium dichloride hydrate; X-ray powder diffraction; spallation neutron diffraction; high pressure; charge-flipping method	POWDER DIFFRACTION; ICE VII; CHLORIDE; SYSTEM; CELLS; WATER; GPA	Magnesium dichloride decahydrate (MgCl(2)10H(2)O) and its deuterated counterpart (MgCl(2)10D(2)O) are identified for the first time by in-situ powder synchrotron X-ray and spallation neutron diffraction. These substances are crystallized from a previously unidentified nanocrystalline compound, which originates from an amorphous state at low temperature. A combination of a recently developed autoindexing procedure and the charge-flipping method reveals that the crystal structure of MgCl(2)10H(2)O consists of an ABCABC... sequence of Mg(H2O)(6) octahedra. The Cl- anions and remaining water molecules unconnected to the Mg2+ cations bind the octahedra, similar to other water-rich magnesium dichloride hydrates. The D positions in MgCl(2)10D(2)O, determined by the difference Fourier methods using the neutron powder diffraction patterns at 2.5GPa, show the features such as bifurcated hydrogen bonds and tetrahedrally coordinated O atoms, which were not found in other forms of magnesium chloride hydrates.	[Komatsu, Kazuki; Shinozaki, Ayako; Matsubayashi, Takuto; Watanabe, Mao; Kagi, Hiroyuki] Univ Tokyo, Grad Sch Sci, Geochem Res Ctr, Bunkyo Ku, Tokyo 1130033, Japan; [Machida, Shinichi] Comprehens Res Org Sci & Soc, Naka, Ibaraki 3191106, Japan; [Sano-Furukawa, Asami; Hattori, Takanori] Japan Atom Energy Agcy, Quantum Beam Sci Directorate, Tokai, Ibaraki 3191195, Japan; [Sano-Furukawa, Asami; Hattori, Takanori] Japan Atom Energy Agcy, J PARC Ctr, Tokai, Ibaraki 3191195, Japan	Komatsu, K (reprint author), Univ Tokyo, Grad Sch Sci, Geochem Res Ctr, Bunkyo Ku, Hongo 7-3-1, Tokyo 1130033, Japan.	kom@eqchem.s.u-tokyo.ac.jp	Sano-Furukawa, Asami/D-6895-2015; shinozaki, ayako/I-2318-2013		JSPS KAKENHI [19GS0205, 20103001-4, 25870182, 26246039]; PF program [2012 G754]; J-PARC user program [2013B0105]	Drs K. Funakoshi and J. Abe have continuously assisted our experiments at J-PARC. We are particularly grateful to an anonymous referee for their pertinent and constructive comments, which greatly improved the manuscript. This study was supported by JSPS KAKENHI Grant Numbers 19GS0205, 20103001-4, 25870182, 26246039. X-ray and neutron diffraction experiments were performed through the PF (No. 2012 G754) and the J-PARC user programs (No. 2013B0105), respectively.	Andress KR, 1934, Z KRISTALLOGR, V87, P345; Sugimoto K, 2007, ACTA CRYSTALLOGR B, V63, P235, DOI 10.1107/S0108768107002558; Momma K, 2011, J APPL CRYSTALLOGR, V44, P1272, DOI 10.1107/S0021889811038970; Palatinus L, 2007, J APPL CRYSTALLOGR, V40, P786, DOI 10.1107/S0021889807029238; PIERMARINI GJ, 1975, J APPL PHYS, V46, P2774, DOI 10.1063/1.321957; AGRON PA, 1985, ACTA CRYSTALLOGR C, V41, P8, DOI 10.1107/S0108270185002591; LEBAIL A, 1988, MATER RES BULL, V23, P447, DOI 10.1016/0025-5408(88)90019-0; Klotz S, 2009, NAT MATER, V8, P405, DOI [10.1038/nmat2422, 10.1038/NMAT2422]; Fortes AD, 2008, PHYS CHEM MINER, V35, P207, DOI 10.1007/s00269-008-0214-x; Toby BH, 2001, J APPL CRYSTALLOGR, V34, P210, DOI 10.1107/S0021889801002242; PAALMAN HH, 1962, J APPL PHYS, V33, P2635, DOI 10.1063/1.1729034; BESSON JM, 1994, PHYS REV B, V49, P12540, DOI 10.1103/PhysRevB.49.12540; SASVARI K, 1966, ACTA CRYSTALLOGR, V20, P875, DOI 10.1107/S0365110X66001981; VONDREELE RB, 1982, J APPL CRYSTALLOGR, V15, P581, DOI 10.1107/S0021889882012722; Boehler R, 2004, HIGH PRESSURE RES, V24, P391, DOI 10.1080/08957950412331323924; Hennings E, 2013, ACTA CRYSTALLOGR C, V69, P1292, DOI 10.1107/S0108270113028138; Arima H, 2010, J PHYS CONF SER, V215, DOI 10.1088/1742-6596/215/1/012025; Fortes AD, 2012, J APPL CRYSTALLOGR, V45, P523, DOI 10.1107/S0021889812014847; FRIEDMAN HL, 1976, J SOLUTION CHEM, V5, P445, DOI 10.1007/BF00650462; Getman FH, 1935, RECL TRAV CHIM PAY-B, V54, P866; Hattori T., 2015, NUCL INSTRU IN PRESS; Iizuka R, 2012, HIGH PRESSURE RES, V32, P430, DOI 10.1080/08957959.2012.722213; Komatsu K, 2013, HIGH PRESSURE RES, V33, P208, DOI 10.1080/08957959.2012.762914; Larson A. C., 2004, LAUR86748; MAYERS J, 1984, NUCL INSTRUM METH A, V221, P609, DOI 10.1016/0167-5087(84)90073-5; Oishi-Tomiyasu R, 2014, J APPL CRYSTALLOGR, V47, P593, DOI 10.1107/S1600576714000922; Panfilowa I., 1894, ZH RUSS FIZ KHIM, V26, P234; Sano-Furukawa A, 2014, REV SCI INSTRUM, V85, DOI 10.1063/1.4901095; Schmidt H., 2012, ACTA CRYSTALLOGR C, VC68, pi4; Seto Yusuke, 2010, Review of High Pressure Science and Technology, V20, DOI 10.4131/jshpreview.20.269; Tamura I., 2003, JAERIRESEARCH2003008	31	1	1	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0108-7681	1600-5740		ACTA CRYSTALLOGR B	Acta Crystallogr. Sect. B-Struct. Sci.Cryst. Eng. Mat.	FEB	2015	71		1				74	80		10.1107/S205252061500027X		7	Chemistry, Multidisciplinary; Crystallography	Chemistry; Crystallography	CB0JU	WOS:000349312800010		
J	Fujiyama, S; Yoza, K; Kamiya, N; Nishi, K; Yokomori, Y				Fujiyama, Shinjiro; Yoza, Kenji; Kamiya, Natsumi; Nishi, Koji; Yokomori, Yoshinobu			Entrance and diffusion pathway of CO2 and dimethyl ether in silicalite-1 zeolite channels as determined by single-crystal XRD structural analysis	ACTA CRYSTALLOGRAPHICA SECTION B-STRUCTURAL SCIENCE CRYSTAL ENGINEERING AND MATERIALS			English	Article						MFI-type zeolite; silicalite-1; adsorption anisotropy; single-crystal X-ray diffraction	X-RAY-METHOD; MOLECULAR-DYNAMICS; ADSORPTION; ANISOTROPY; KINETICS; METHANE; ZSM-5; NMR	The entrance and diffusion pathway of CO2 and dimethyl ether (DME) in MFI-type zeolite channels were investigated by a selective sealing method using large silicalite-1 crystals. The MFI-type zeolite has two kinds of orthogonal channels: straight channels and sinusoidal channels. The mouths of the straight channels are on (010) crystal faces, while those of the sinusoidal channels are on (100) faces. The channel mouths are directly sealed by silicone resin on the (100) and (010) faces so as to restrict the entrance and diffusion pathways to straight and sinusoidal channel pathways, respectively. The locations and loadings of the guest CO2 and DME molecules are determined by single-crystal X-ray diffraction structural analysis. The loadings show the difference of the adsorption rates between the pathways. The straight channel pathway is 4.2 times faster than the sinusoidal channel pathway for the CO2, and the sinusoidal channel pathway is 5.1 times faster than the straight channel pathway for the DME. It reveals their dominant pathways and the anisotropy of adsorption. The dominant pathway correlates to the stability of the channel as adsorption sites.	[Fujiyama, Shinjiro; Kamiya, Natsumi; Nishi, Koji; Yokomori, Yoshinobu] Natl Def Acad, Yokosuka, Kanagawa 239, Japan; [Yoza, Kenji] Bruker AXS, Yokohama, Kanagawa, Japan	Fujiyama, S (reprint author), Natl Def Acad, Yokosuka, Kanagawa 239, Japan.	shinjiro@2006.jukuin.keio.ac.jp					Momma K, 2011, J APPL CRYSTALLOGR, V44, P1272, DOI 10.1107/S0021889811038970; Zimmermann NER, 2012, J PHYS CHEM C, V116, P3677, DOI 10.1021/jp2112389; Fujiyama S, 2014, PHYS CHEM CHEM PHYS, V16, P15839, DOI 10.1039/c4cp01860e; Kolvenbach R, 2013, CATAL LETT, V143, P1116, DOI 10.1007/s10562-013-1118-z; OKoye IP, 1997, LANGMUIR, V13, P4054, DOI 10.1021/la961040c; Ruthven DM, 2012, MICROPOR MESOPOR MAT, V162, P69, DOI 10.1016/j.micromeso.2011.12.025; Gueudre L, 2012, MATERIALS, V5, P721, DOI 10.3390/ma5040721; Karger J, 2014, MICROPOR MESOPOR MAT, V189, P126, DOI 10.1016/j.micromeso.2013.11.023; CARO J, 1993, J PHYS CHEM-US, V97, P13685, DOI 10.1021/j100153a043; Crank J., 1975, MATH DIFFUSION; DEMONTIS P, 1990, J PHYS CHEM-US, V94, P4329, DOI 10.1021/j100373a083; Fujiyama S, 2014, ACTA CRYSTALLOGR B, V70, P856, DOI 10.1107/S2052520614015911; Fujiyama S., 2014, KRISTALLOGRAFIYA, V229, P303; Fujiyama S, 2014, LANGMUIR, V30, P3749, DOI 10.1021/la404962e; HONG U, 1991, Z PHYS CHEM, V173, P225; HONG U, 1991, ZEOLITES, V11, P816, DOI 10.1016/S0144-2449(05)80061-2; JUNE RL, 1990, J PHYS CHEM-US, V94, P8232, DOI 10.1021/j100384a047; Kamiya N, 2007, Z KRISTALLOGR, V222, P551, DOI 10.1524/zkri.2007.222.10.551; Kamiya N, 2011, ACTA CRYSTALLOGR B, V67, P508, DOI 10.1107/S0108768111038560; KORESH J, 1981, J CHEM SOC FARAD T 1, V77, P3005, DOI 10.1039/f19817703005; Schuring A, 2004, PHYS CHEM CHEM PHYS, V6, P3676, DOI [10.1039/b316174a, 10.1039/n316174s]; Sheldrick GM, 2008, ACTA CRYSTALLOGR A, V64, P112, DOI 10.1107/S0108767307043930	22	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0108-7681	1600-5740		ACTA CRYSTALLOGR B	Acta Crystallogr. Sect. B-Struct. Sci.Cryst. Eng. Mat.	FEB	2015	71		1				112	118		10.1107/S2052520615000256		7	Chemistry, Multidisciplinary; Crystallography	Chemistry; Crystallography	CB0JU	WOS:000349312800014		
J	Maruyama, N; Goshi, T; Sugiyama, S; Niiyama, M; Adachi, H; Takano, K; Murakami, S; Inoue, T; Mori, Y; Matsumura, H; Mikami, B				Maruyama, Nobuyuki; Goshi, Tomohiro; Sugiyama, Shigeru; Niiyama, Mayumi; Adachi, Hiroaki; Takano, Kazufumi; Murakami, Satoshi; Inoue, Tsuyoshi; Mori, Yusuke; Matsumura, Hiroyoshi; Mikami, Bunzo			Preliminary X-ray analysis of the binding domain of the soybean vacuolar sorting receptor complexed with a sorting determinant of a seed storage protein	ACTA CRYSTALLOGRAPHICA SECTION F-STRUCTURAL BIOLOGY COMMUNICATIONS			English	Article						soybean; seed storage protein; beta-conglycinin; vacuolar sorting receptor	C-TERMINAL SEQUENCE; BETA-CONGLYCININ; LIGAND-BINDING; FEATURES; CELLS	beta-Conglycinin is a major seed storage protein in soybeans, which are an important source of protein. The major subunits (alpha, alpha' and beta) of beta-conglycinin are sorted to protein-storage vacuoles in seed cells. Vacuolar sorting receptor (VSR) is an integral membrane protein that recognizes the sorting determinant of vacuolar proteins, including beta-conglycinin, and regulates their sorting process. Vacuolar sorting determinants of the alpha' and beta subunits of beta-conglycinin exist in their C-terminal peptides. Here, the preliminary X-ray diffraction analysis of the binding domain of soybean VSR crystallized with the peptide responsible for the sorting determinant in beta-conglycinin is reported. X-ray diffraction data were collected to a resolution of 3.5 angstrom. The crystals belonged to space group P3(1)21, with unit-cell parameters a = b = 116.4, c = 86.1 angstrom.	[Maruyama, Nobuyuki; Goshi, Tomohiro] Kyoto Univ, Grad Sch Agr, Lab Food Qual Design & Dev, Kyoto 6110011, Japan; [Sugiyama, Shigeru] Osaka Univ, Grad Sch Sci, Toyonaka, Osaka 5608531, Japan; [Niiyama, Mayumi; Inoue, Tsuyoshi; Mori, Yusuke; Matsumura, Hiroyoshi] Osaka Univ, Grad Sch Engn, Suita, Osaka 5650871, Japan; [Adachi, Hiroaki; Takano, Kazufumi; Murakami, Satoshi; Inoue, Tsuyoshi; Mori, Yusuke; Matsumura, Hiroyoshi] SOSHO Inc, Suita, Osaka 5650871, Japan; [Takano, Kazufumi] Kyoto Prefectural Univ, Grad Sch Life & Environm Sci, Sakyo Ku, Kyoto 6068522, Japan; [Murakami, Satoshi] Tokyo Inst Technol, Grad Sch Biosci & Biotechnol, Midori Ku, Yokohama, Kanagawa 2268501, Japan; [Mikami, Bunzo] Kyoto Univ, Grad Sch Agr, Div Appl Life Sci, Lab Appl Struct Biol, Kyoto 6110011, Japan	Maruyama, N (reprint author), Kyoto Univ, Grad Sch Agr, Lab Food Qual Design & Dev, Kyoto 6110011, Japan.	marunobu@kais.kyoto-u.ac.jp	Mori, Yusuke/C-3302-2014		Ministry of Education, Culture, Sports, Science and Technology [21780093, 24658286]	The synchrotron-radiation experiments were performed on BL38B1, BL41XU and BL44XU at SPring-8 with the approval of the Japan Synchrotron Radiation Research Institute (Proposal Nos. 2009B6826, 2010B6538, 2011A1085, 2011B1076 and 2011B1419). This work was supported in part by grants to NM from the Ministry of Education, Culture, Sports, Science and Technology (Nos. 21780093 and 24658286). We thank E. Okuda (Kyoto University) for technical assistance. The study is related to the subject of the Development and Assessment of Sustainable Humanosphere (DASH) system of Kyoto University (NM).	Ahmed SU, 1997, PLANT PHYSIOL, V114, P325, DOI 10.1104/pp.114.1.325; Mori T, 2004, PLANT J, V40, P238, DOI 10.1111/j.1365-313X.2004.02204.x; Winn MD, 2011, ACTA CRYSTALLOGR D, V67, P235, DOI 10.1107/S0907444910045749; Xiang L, 2013, FEBS J, V280, P979, DOI 10.1111/febs.12092; Shimada T, 2003, P NATL ACAD SCI USA, V100, P16095, DOI 10.1073/pnas.2530568100; Watanabe E, 2002, J BIOL CHEM, V277, P8708, DOI 10.1074/jbc.M109346200; Cao XF, 2000, PLANT CELL, V12, P493, DOI 10.1105/tpc.12.4.493; KIRSCH T, 1994, P NATL ACAD SCI USA, V91, P3403, DOI 10.1073/pnas.91.8.3403; Maruyama N, 1998, EUR J BIOCHEM, V258, P854, DOI 10.1046/j.1432-1327.1998.2580854.x; Morimoto S, 2013, CHEM COMMUN, V49, P1811, DOI 10.1039/c3cc38594a; Nishizawa K, 2004, PLANT SCI, V167, P937, DOI 10.1016/j.plantsci.2004.06.004; Nishizawa K, 2003, PLANT J, V34, P647, DOI 10.1046/j.1365-313X.2003.01754.x; Otwinowski Z., 1997, ENZYMOLOGY, V276, P307; Picariello G, 2013, J CHROMATOGR A, V1313, P96, DOI 10.1016/j.chroma.2013.09.014; YAMAUCHI F, 1979, AGR BIOL CHEM TOKYO, V43, P505	15	1	1	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1744-3091			ACTA CRYSTALLOGR F	Acta Crystallogr. F-Struct. Biol. Commun.	FEB	2015	71		2				132	135		10.1107/S2053230X14027484		4	Biochemical Research Methods; Biochemistry & Molecular Biology; Biophysics; Crystallography	Biochemistry & Molecular Biology; Biophysics; Crystallography	CB0YN	WOS:000349353700002		
J	Eda, M; Ishimaru, M; Tada, T				Eda, Masahiro; Ishimaru, Megumi; Tada, Toshiji			Expression, purification, crystallization and preliminary X-ray crystallographic analysis of tomato beta-galactosidase 4	ACTA CRYSTALLOGRAPHICA SECTION F-STRUCTURAL BIOLOGY COMMUNICATIONS			English	Article						beta-galactosidase; Solanum lycopersicum; plant cell wall; TBG4	CELL-WALL POLYSACCHARIDES; CRYSTAL-STRUCTURE; FRUIT; GENES; SUBSTRATE; CLONING; FAMILY; SP.; L.	Plant beta-galactosidases play important roles in carbohydrate-reserve mobilization, cell-wall expansion and degradation, and turnover of signalling molecules during ripening. Tomato beta-galactosidase 4 (TBG4) not only has beta-galactosidase activity but also has exo-beta-(1,4)-galactanase activity, and prefers beta-(1,4)-galactans longer than pentamers as its substrates; most other beta-galactosidases only have the former activity. Recombinant TBG4 protein expressed in the yeast Pichia pastoris was crystallized by the sitting-drop vapour-diffusion method using PEG 10 000 as a precipitant. The crystals belonged to the orthorhombic space group P2(1)2(1)2(1), with unit-parameters a = 92.82, b = 96.30, c = 159.26 angstrom, and diffracted to 1.65 angstrom resolution. Calculation of the Matthews coefficient suggested the presence of two monomers per asymmetric unit (V-M = 2.2 angstrom(3) Da(-1)), with a solvent content of 45%.	[Eda, Masahiro; Tada, Toshiji] Osaka Prefecture Univ, Grad Sch Sci, Sakai, Osaka 5998531, Japan; [Ishimaru, Megumi] Kinki Univ, Fac Biol Oriented Sci & Technol, Wakayama 6318505, Japan	Tada, T (reprint author), Osaka Prefecture Univ, Grad Sch Sci, Sakai, Osaka 5998531, Japan.	tada@b.s.osakafu-u.ac.jp					Maksimainen MM, 2013, INT J BIOL MACROMOL, V60, P109, DOI 10.1016/j.ijbiomac.2013.05.003; Weiss MS, 1997, J APPL CRYSTALLOGR, V30, P203, DOI 10.1107/S0021889897003907; KALNINS A, 1983, EMBO J, V2, P593; Smith DL, 2002, PLANT PHYSIOL, V129, P1755, DOI 10.1104/pp.011025; MATTHEWS BW, 1968, J MOL BIOL, V33, P491, DOI 10.1016/0022-2836(68)90205-2; CAREY AT, 1995, PLANT PHYSIOL, V108, P1099, DOI 10.1104/pp.108.3.1099; Cheng W, 2012, J BIOL CHEM, V287, P22910, DOI 10.1074/jbc.M112.367128; CUBELLIS MV, 1990, GENE, V94, P89, DOI 10.1016/0378-1119(90)90472-4; de Alcantara PHN, 2006, PLANT PHYSIOL BIOCH, V44, P619, DOI 10.1016/j.plaphy.2006.10.007; Esteban R, 2003, PLANT CELL PHYSIOL, V44, P718, DOI 10.1093/pcp/pcg087; Gantulga D, 2008, PHYTOCHEMISTRY, V69, P1661, DOI 10.1016/j.phytochem.2008.01.023; GROSS KC, 1979, PLANT PHYSIOL, V63, P117, DOI 10.1104/pp.63.1.117; Ishimaru M, 2009, PLANTA, V229, P447, DOI 10.1007/s00425-008-0842-x; Kim J., 1991, Postharvest Biology and Technology, V1, P67, DOI 10.1016/0925-5214(91)90020-C; Maksimainen M, 2011, J STRUCT BIOL, V174, P156, DOI 10.1016/j.jsb.2010.11.024; Ohto U, 2012, J BIOL CHEM, V287, P1801, DOI 10.1074/jbc.M111.293795; Ohtsu N, 1998, BIOSCI BIOTECH BIOCH, V62, P1539, DOI 10.1271/bbb.62.1539; Otwinowski Z., 1997, ENZYMOLOGY, V276, P307; PRESSEY R, 1983, PLANT PHYSIOL, V71, P132, DOI 10.1104/pp.71.1.132; Rojas AL, 2004, J MOL BIOL, V343, P1281, DOI 10.1016/j.jmb.2004.09.012; Smith DL, 2000, PLANT PHYSIOL, V123, P1173, DOI 10.1104/pp.123.3.1173; Tanthanuch W, 2008, BMC PLANT BIOL, V8, DOI 10.1186/1471-2229-8-84; Zinin AI, 2002, CARBOHYD RES, V337, P635, DOI 10.1016/S0008-6215(02)00027-7	23	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1744-3091			ACTA CRYSTALLOGR F	Acta Crystallogr. F-Struct. Biol. Commun.	FEB	2015	71		2				153	156		10.1107/S2053230X14027800		4	Biochemical Research Methods; Biochemistry & Molecular Biology; Biophysics; Crystallography	Biochemistry & Molecular Biology; Biophysics; Crystallography	CB0YN	WOS:000349353700007		
J	Takayanagi, H; Yuzawa, S; Sumimoto, H				Takayanagi, Hiroki; Yuzawa, Satoru; Sumimoto, Hideki			Structural basis for the recognition of the scaffold protein Frmpd4/Preso1 by the TPR domain of the adaptor protein LGN	ACTA CRYSTALLOGRAPHICA SECTION F-STRUCTURAL BIOLOGY COMMUNICATIONS			English	Article						LGN; Frmpd4	ASYMMETRIC CELL DIVISIONS; CRYSTALLIZATION; FRMPD1; MOTIF; PINS; NUMA; PDZ	The adaptor protein LGN interacts via the N-terminal domain comprising eight tetratricopeptide-repeat (TPR) motifs with its partner proteins mInsc, NuMA, Frmpd1 and Frmpd4 in a mutually exclusive manner. Here, the crystal structure of the LGN TPR domain in complex with human Frmpd4 is described at 1.5 angstrom resolution. In the complex, the LGN-binding region of Frmpd4 (amino-acid residues 990-1011) adopts an extended structure that runs antiparallel to LGN along the concave surface of the superhelix formed by the TPR motifs. Comparison with the previously determined structures of the LGN-Frmpd1, LGN-mInsc and LGN-NuMA complexes reveals that these partner proteins interact with LGN TPR1-6 via a common core binding region with consensus sequence (E/Q)XEX4-5(E/D/Q)X1-2(K/R)X0-1(V/I). In contrast to Frmpd1, Frmpd4 makes additional contacts with LGN via regions N-and C-terminal to the core sequence. The N-terminal extension is replaced by a specific alpha-helix in mInsc, which drastically increases the direct contacts with LGN TPR7/8, consistent with the higher affinity of mInsc for LGN. A crystal structure of Frmpd4-bound LGN in an oxidized form is also reported, although oxidation does not appear to strongly affect the interaction with Frmpd4.	[Takayanagi, Hiroki; Yuzawa, Satoru; Sumimoto, Hideki] Kyushu Univ, Grad Sch Med Sci, Dept Biochem, Higashi Ku, Fukuoka 8128582, Japan	Sumimoto, H (reprint author), Kyushu Univ, Grad Sch Med Sci, Dept Biochem, Higashi Ku, 3-1-1 Maidashi, Fukuoka 8128582, Japan.	hsumi@med.kyushu-u.ac.jp			MEXT (The Ministry of Education, Culture, Sports, Science and Technology, Japan) [26111009, 26440033]; Uehara Memorial Foundation	This work was supported in part by a Grant-in-Aid for Scientific Research on Innovative Areas 'Oxygen Biology: a new criterion for integrated understanding of life' (No. 26111009), and a KAKENHI Grant (No. 26440033) from MEXT (The Ministry of Education, Culture, Sports, Science and Technology, Japan) and by The Uehara Memorial Foundation. We thank Drs Atsushi Shimada (Kyushu University) and Daisuke Kohda (Kyushu University) for helpful advice, Yohko Kage (Kyushu University) and Namiko Kubo (Kyushu University) for technical assistance, Shoko Miura (Kyushu University) for secretarial assistance, the beamline staff for technical support during data collection on the BL1A beamline at the Photon Factory and on the BL44XU beamline at SPring-8, and the technical staff of The Research Support Center, Research Center for Human Disease Modeling, Kyushu University Graduate School of Medical Sciences, Fukuoka, Japan.	An NF, 2008, J BIOL CHEM, V283, P24718, DOI 10.1074/jbc.M803497200; Krissinel E, 2007, J MOL BIOL, V372, P774, DOI 10.1016/j.jmb.2007.05.022; Barillari C, 2007, J AM CHEM SOC, V129, P2577, DOI 10.1021/ja066980q; Yuzawa S, 2011, P NATL ACAD SCI USA, V108, P19210, DOI 10.1073/pnas.1110951108; Williams SE, 2014, NAT CELL BIOL, V16, P758, DOI 10.1038/ncb3001; Vagin A, 2010, ACTA CRYSTALLOGR D, V66, P22, DOI 10.1107/S0907444909042589; Zhu JW, 2011, MOL CELL, V43, P418, DOI 10.1016/j.molcel.2011.07.011; Culurgioni S, 2011, P NATL ACAD SCI USA, V108, P20998, DOI 10.1073/pnas.1113077108; Murshudov GN, 2011, ACTA CRYSTALLOGR D, V67, P355, DOI 10.1107/S0907444911001314; Lechler T, 2005, NATURE, V437, P275, DOI 10.1038/nature03922; Hu JH, 2012, NAT NEUROSCI, V15, P836, DOI 10.1038/nn.3103; Zigman M, 2005, NEURON, V48, P539, DOI 10.1016/j.neuron.2005.09.030; Du QS, 2004, CELL, V119, P503, DOI 10.1016/j.cell.2004.10.028; Lee HW, 2008, J NEUROSCI, V28, P14546, DOI 10.1523/JNEUROSCI.3112-08.2008; Konno D, 2008, NAT CELL BIOL, V10, P93, DOI 10.1038/ncb1673; CHAYEN NE, 1990, J APPL CRYSTALLOGR, V23, P297, DOI 10.1107/S0021889890003260; Willard FS, 2004, ANNU REV BIOCHEM, V73, P925, DOI 10.1146/annurev.biochem.73.011303.073756; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; Meenan NAG, 2010, P NATL ACAD SCI USA, V107, P10080, DOI 10.1073/pnas.0910756107; Kamakura S, 2013, DEV CELL, V26, P292, DOI 10.1016/j.devcel.2013.06.008; Islam MR, 2012, J AM CHEM SOC, V134, P3687, DOI 10.1021/ja300007h; Izaki T, 2006, BIOCHEM BIOPH RES CO, V341, P1001, DOI 10.1016/j.bbrc.2006.01.050; Luft JR, 1999, ACTA CRYSTALLOGR D, V55, P988, DOI 10.1107/S0907444999002085; Otwinowski Z., 1997, ENZYMOLOGY, V276, P307; Pan Z, 2013, J MOL BIOL, V425, P1039, DOI 10.1016/j.jmb.2013.01.003	25	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1744-3091			ACTA CRYSTALLOGR F	Acta Crystallogr. F-Struct. Biol. Commun.	FEB	2015	71		2				175	183		10.1107/S2053230X14028143		9	Biochemical Research Methods; Biochemistry & Molecular Biology; Biophysics; Crystallography	Biochemistry & Molecular Biology; Biophysics; Crystallography	CB0YN	WOS:000349353700011		
J	Sakamoto, Y; Suzuki, Y; Iizuka, I; Tateoka, C; Roppongi, S; Fujimoto, M; Gouda, H; Nonaka, T; Ogasawara, W; Tanaka, N				Sakamoto, Yasumitsu; Suzuki, Yoshiyuki; Iizuka, Ippei; Tateoka, Chika; Roppongi, Saori; Fujimoto, Mayu; Gouda, Hiroaki; Nonaka, Takamasa; Ogasawara, Wataru; Tanaka, Nobutada			Crystallization and preliminary X-ray crystallographic studies of dipeptidyl peptidase 11 from Porphyromonas gingivalis	ACTA CRYSTALLOGRAPHICA SECTION F-STRUCTURAL BIOLOGY COMMUNICATIONS			English	Article						dipeptidyl peptidase; DPP11; Porphyromonas gingivalis	CRYSTAL-STRUCTURE; CLAN PA; EXOPEPTIDASES; INHIBITORS; PROTEINS; DISEASE; WO24; IV	Dipeptidyl peptidase 11 from Porphyromonas gingivalis (PgDPP11) preferentially cleaves substrate peptides with Asp and Glu at the P1 position [NH2-P2-P1(Asp/Glu)-P1'-P2' ... ]. For crystallographic studies, PgDPP11 was overproduced in Escherichia coli, purified and crystallized using the hanging-drop vapour-diffusion method. X-ray diffraction data to 1.82 angstrom resolution were collected from an orthorhombic crystal form belonging to space group C222(1), with unit-cell parameters a = 99.33, b = 103.60, c = 177.33 angstrom. Structural analysis by the multi-wavelength anomalous diffraction method is in progress.	[Sakamoto, Yasumitsu; Iizuka, Ippei; Tateoka, Chika; Roppongi, Saori; Fujimoto, Mayu; Nonaka, Takamasa] Iwate Med Univ, Sch Pharm, Yahaba, Iwate 0283694, Japan; [Suzuki, Yoshiyuki; Ogasawara, Wataru] Nagaoka Univ Technol, Dept Bioengn, Nagaoka, Niigata 9402188, Japan; [Gouda, Hiroaki; Tanaka, Nobutada] Showa Univ, Sch Pharm, Shinagawa Ku, Tokyo 1428555, Japan	Tanaka, N (reprint author), Showa Univ, Sch Pharm, Shinagawa Ku, 1-5-8 Hatanodai, Tokyo 1428555, Japan.	ntanaka@pharm.showa-u.ac.jp			Program for the Strategic Research Foundation at Private Universities; Platform for Drug Discovery, Informatics and Structural Life Science; MEXT of Japan [25462872]	We thank Drs Y. Yamada and N. Matsugaki of the Photon Factory for their help with data collection at the synchrotron facilities. This work was supported in part by the Program for the Strategic Research Foundation at Private Universities (to NT and YSa), the Platform for Drug Discovery, Informatics and Structural Life Science (to NT and YSa) and a Grant-in-Aid for Scientific Research (C) 25462872 (to YSa) from the MEXT of Japan.	Kabsch W, 2010, ACTA CRYSTALLOGR D, V66, P125, DOI 10.1107/S0907444909047337; Engel M, 2003, P NATL ACAD SCI USA, V100, P5063, DOI 10.1073/pnas.0230620100; Takahashi N, 2000, J BACTERIOL, V182, P4704, DOI 10.1128/JB.182.17.4704-4710.2000; Kadowaki T, 2004, MOL PHARMACOL, V66, P1599, DOI 10.1124/mol.104.004366; Rawlings ND, 2012, NUCLEIC ACIDS RES, V40, pD343, DOI 10.1093/nar/gkr987; JANCARIK J, 1991, J APPL CRYSTALLOGR, V24, P409, DOI 10.1107/S0021889891004430; Ohara-Nemoto Y, 2011, J BIOL CHEM, V286, P38115, DOI 10.1074/jbc.M111.278572; Petersen PE, 2005, J PERIODONTOL, V76, P2187, DOI 10.1902/jop.2005.76.12.2187; MATTHEWS BW, 1968, J MOL BIOL, V33, P491, DOI 10.1016/0022-2836(68)90205-2; HENDRICKSON WA, 1990, EMBO J, V9, P1665; Takahashi N, 2001, J DENT RES, V80, P1425; Vos T, 2012, LANCET, V380, P2163, DOI 10.1016/S0140-6736(12)61729-2; Banbula A, 2001, J BIOL CHEM, V276, P6299, DOI 10.1074/jbc.M008789200; Bezerra GA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043019; Hiramatsu H, 2003, BIOCHEM BIOPH RES CO, V302, P849, DOI 10.1016/S006-291X(03)00258-4; Kononen E., 2011, MANUAL CLIN MICROBIO, P858, DOI 10.1128/9781555816728.ch51; Ogasawara W, 1996, J BACTERIOL, V178, P6288; Rasmussen HB, 2003, NAT STRUCT BIOL, V10, P19, DOI 10.1038/nsb882; Sakamoto Y, 2014, SCI REP-UK, V4, DOI 10.1038/srep04977; Sakamoto Y, 2014, ACTA CRYSTALLOGR F, V70, P221, DOI 10.1107/S2053230X13034584; Sheets SM, 2008, FRONT BIOSCI, V13, P3215; Suzuki Y, 2014, SCI REP-UK, V4, DOI 10.1038/srep04292; Thoma R, 2003, STRUCTURE, V11, P947, DOI 10.1016/S0969-2126(03)00160-6; VANWINKELHOFF AJ, 1987, J DENT RES, V66, P1663, DOI 10.1177/00220345870660111201; Winn M. D., 1994, ACTA CRYSTALLOGR D, V67, P235	25	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1744-3091			ACTA CRYSTALLOGR F	Acta Crystallogr. F-Struct. Biol. Commun.	FEB	2015	71		2				206	210		10.1107/S2053230X15000424		5	Biochemical Research Methods; Biochemistry & Molecular Biology; Biophysics; Crystallography	Biochemistry & Molecular Biology; Biophysics; Crystallography	CB0YN	WOS:000349353700016		
J	Hasebe, N; Sato, M				Hasebe, Norio; Sato, Masahiro			Mixed boundary value problem for quasi-orthotropic elastic plane	ACTA MECHANICA			English	Article							SEMI-INFINITE PLATE; STRESS-ANALYSIS; ELEMENT METHOD; CRACK; STRIP; FORMULATION; HOLES	The quasi-orthotropic elastic plane in which the characteristic roots of the fundamental differential equation for the orthotropic elastic plane are doubled is investigated for a mixed boundary value problem. One of the main purposes of the present paper is to derive a general solution of a mixed boundary value problem. For the associated stress analysis, a rational mapping function is used and a closed-form stress function is obtained. The stress analysis is hence rigorous for the rational mapping function, which gives a comparative arbitrary configuration. The quasi-orthotropic elastic plane problem includes that of an isotropic elastic plane. As a demonstration of the stress analysis, a half plane with an oblique edge rigid line inclusion in which the rim of the half plane and the principal axis for the orthotropic elasticity coincides is analyzed. A uniform tension is applied over the half plane, and the rigid line inclusion is expressed as a fixed boundary. The homogenous solution of the stress function can be obtained without any integration. Stress distributions and stress intensity factors at the tip of the rigid line inclusion are investigated for Poisson's ratio. The relationship between the quasi-orthotropic elastic plane and the isotropic elastic plane with respect to stress intensity factors is derived. Stress functions in which the rim of the half plane and the principal axis of the orthotropic elasticity do not coincide are also described.	[Hasebe, Norio] Nagoya Inst Technol, Dept Civil Engn, Nagoya, Aichi 4668555, Japan; [Sato, Masahiro] Simizu Construct Co, Naka Ku, Nagoya, Aichi 4600033, Japan	Hasebe, N (reprint author), Nagoya Inst Technol, Dept Civil Engn, Nagoya, Aichi 4668555, Japan.	hasebe@tea.ocn.ne.jp					Ahmed SR, 2005, COMPUT STRUCT, V83, P35, DOI [10.1016/j.compstruc.2004.08.007, 10.1016/j.compastruc.2004.08.007]; Aleksandrov V. M., 2006, Journal of Applied Mathematics and Mechanics, DOI 10.1016/j.jappmathmech.2006.03.003; Hasebe N, 2005, J THERM STRESSES, V28, P595, DOI 10.1080/01495730590932706; Nobile L, 2005, COMPOS STRUCT, V68, P285, DOI 10.1016/j.compstruct.2004.03.020; Fotuhi AR, 2007, INT J SOLIDS STRUCT, V44, P1608, DOI 10.1016/j.ijsolstr.2006.06.041; Azhdari A, 2000, INT J SOLIDS STRUCT, V37, P6433, DOI 10.1016/S0020-7683(99)00137-7; Berbinau P, 2001, INT J SOLIDS STRUCT, V38, P143, DOI 10.1016/S0020-7683(00)00011-1; Bigelow C.A., 1994, NASA TECHNICAL REPOR; Carloni C, 2003, ENG FRACT MECH, V70, P2033, DOI 10.1016/S0013-7944(02)00258-8; Gilbert R.D., 1986, MATH METHODS APPLIED, V8, P102, DOI 10.1002/mma.1670080108; HASEBE N, 1980, ING ARCH, V49, P51, DOI 10.1007/BF00536598; Hasebe N, 2013, INT J SOLIDS STRUCT, V50, P209, DOI 10.1016/j.ijsolstr.2012.09.013; HASEBE N, 1985, INT J ENG SCI, V23, P531; HASEBE N, 1978, ING ARCH, V47, P169, DOI 10.1007/BF01047408; Hasebe N., 1975, T CIVIL ENG JPN SOC, V233, P1; Itoh S., 2000, INT J FRACTURE, V103, P279; Lekhnitskii G. C., 1963, THEORY ANISOTROPIC E; Lekhnitskii G.C., 1968, ANISOTROPIC PLATES; Liu CD, 1996, ENG FRACT MECH, V54, P791, DOI 10.1016/0013-7944(95)00229-4; Muskhelishvili N. I., 1963, SOME BASIC PROBLEMS; Riggo F.J., 1970, J COMPOS MATER, V4, P36; Shiah YC, 1997, ENG ANAL BOUND ELEM, V20, P347, DOI 10.1016/S0955-7997(97)00103-3; SOLLERO P, 1994, ENG FRACT MECH, V49, P213, DOI 10.1016/0013-7944(94)90004-3; SUO ZG, 1990, P ROY SOC LOND A MAT, V427, P331, DOI 10.1098/rspa.1990.0016; VABLE M, 1988, INT J SOLIDS STRUCT, V24, P1, DOI 10.1016/0020-7683(88)90094-7; Wei L, 1995, J ELASTICITY, V41, P161, DOI 10.1007/BF00041873; Yusufoglu E, 2012, J FRANKLIN I, V349, P2750, DOI 10.1016/j.jfranklin.2012.09.001	27	0	0	SPRINGER WIEN	WIEN	SACHSENPLATZ 4-6, PO BOX 89, A-1201 WIEN, AUSTRIA	0001-5970	1619-6937		ACTA MECH	Acta Mech.	FEB	2015	226	2					527	545		10.1007/s00707-014-1182-5		19	Mechanics	Mechanics	CB2CO	WOS:000349434500018		
J	Yamaguchi, S; Hirata, K; Kaneko, S; Kobayashi, H; Shiga, T; Kobayashi, K; Onimaru, R; Shirato, H; Tamaki, N; Terasaka, S; Houkin, K				Yamaguchi, Shigeru; Hirata, Kenji; Kaneko, Sadahiro; Kobayashi, Hiroyuki; Shiga, Tohru; Kobayashi, Kentaro; Onimaru, Rikiya; Shirato, Hiroki; Tamaki, Nagara; Terasaka, Shunsuke; Houkin, Kiyohiro			Combined use of 18 F-FDG PET and corticosteroid for diagnosis of deep-seated primary central nervous system lymphoma without histopathological confirmation	ACTA NEUROCHIRURGICA			English	Article						Braintumor; Corticosteroid; 18F-FDG; Position emission tomography; Primary central nervous system lymphoma	POSITRON-EMISSION-TOMOGRAPHY; STEREOTACTIC BIOPSY; NEUROSARCOIDOSIS	Although histological diagnosis is indispensable in treating primary central nervous system lymphoma (PCNSL), we sometimes face an intractable situation in which tissue can be obtained only from a deep-seated brain lesion. In place of a histological diagnosis, the diagnostic adequacy of the combined use of 18 F-FDG PET and corticosteroid administration for PCNSL located in a deep-seated brain structure is reported. Patients with a deep-seated tumor were treated as having PCNSL without histological confirmation, based on the following criteria: (1) there was no evidence of systemic malignancy; (2) the tumor showed an extremely high FDG uptake relative to normal gray matter on pretreatment 18 F-FDG PET; (3) the tumor decreased in size 1 week after diagnostic therapy by corticosteroid administration on contrast-enhanced T1-weighted magnetic resonance imaging (MRI). FDG uptake of the lesion was evaluated by the maximum of standardized uptake values (SUVmax) and tumor-to-normal ratio of the SUV (T/N ratio). The extent of the tumor reduction was calculated by volumetric analysis for the treatment response to corticosteroid administration. Ten patients (4 males and 6 females) matched these criteria. On pretreatment 18 F-FDG PET, mean SUVmax in the tumor was 24.8 (8.75-60.75), and mean T/N ratio was 3.24 (2.17-5.12). The extent of tumor volume reduction was shown to be 21 to 68 % 1 week after diagnostic therapy by corticosteroids. Mean total dose and duration of corticosteroids were 719 mg as prednisolone and 6.5 days, respectively. Nine patients achieved complete response and one patient achieved partial response on MRI after standard treatment for PCNSL with high-dose methotrexate and/or whole-brain irradiation. Although the value of biopsy is universal, combining 18 F-FDG PET and corticosteroid administration is an important alternative method that may lead to the diagnosis of deep-seated PCNSLs in cases with intractable histopathological confirmations.	[Yamaguchi, Shigeru; Kaneko, Sadahiro; Kobayashi, Hiroyuki; Terasaka, Shunsuke; Houkin, Kiyohiro] Hokkaido Univ, Dept Neurosurg, Grad Sch Med, Kita Ku, Sapporo, Hokkaido 0608638, Japan; [Hirata, Kenji; Shiga, Tohru; Kobayashi, Kentaro; Onimaru, Rikiya; Shirato, Hiroki; Tamaki, Nagara] Hokkaido Univ, Dept Neurosurg, Grad Sch Med, Sapporo, Hokkaido 0608638, Japan	Terasaka, S (reprint author), Hokkaido Univ, Dept Neurosurg, Grad Sch Med, Kita Ku, 5 West 7, Sapporo, Hokkaido 0608638, Japan.	terasas@med.hokudai.ac.jp	Yamaguchi, Shigeru/G-5419-2012; Onimaru, Rikiya/C-9805-2012	Yamaguchi, Shigeru/0000-0003-3710-5888; Onimaru, Rikiya/0000-0002-4768-2358			ANDERSEN C, 1993, ACTA NEUROCHIR, V122, P218, DOI 10.1007/BF01405532; Reni M, 1997, ANN ONCOL, V8, P227, DOI 10.1023/A:1008201717089; Zacharia TT, 2008, J NEUROIMAGING, V18, P411, DOI 10.1111/j.1552-6569.2007.00231.x; Hall WA, 1998, CANCER, V82, P1749, DOI 10.1002/(SICI)1097-0142(19980501)82:9<1756::AID-CNCR23>3.0.CO;2-2; Roelcke U, 1999, J NEURO-ONCOL, V43, P231, DOI 10.1023/A:1006202402010; Bromberg JEC, 2002, NEUROLOGY, V59, P762; Yamaguchi S, 2014, ANN NUCL MED, V28, P603, DOI 10.1007/s12149-014-0851-8; ROSENFELD SS, 1992, J NUCL MED, V33, P532; Makino K, 2011, ANN NUCL MED, V25, P432, DOI 10.1007/s12149-011-0483-1; Kongkham PN, 2008, CAN J NEUROL SCI, V35, P79; Kuker W, 2005, J NEURO-ONCOL, V72, P169, DOI 10.1007/s11060-004-3390-7; Omuro AMP, 2006, LANCET NEUROL, V5, P937, DOI 10.1016/S1474-4422(06)70597-X; Baraniskin A, 2011, BRIT J HAEMATOL, V156, P421; Bolat S, 2009, J NEUROL SCI, V287, P257, DOI 10.1016/j.jns.2009.08.060; Karantanis D, 2007, NUCL MED COMMUN, V28, P834; Mathew BS, 2006, CANCER, V106, P383, DOI 10.1002/cncr.21583; Mohile Nimish A, 2008, Clin Adv Hematol Oncol, V6, P818; Ng D, 2006, CLIN NUCL MED, V31, P373, DOI 10.1097/01.rlu.0000222735.19513.bb; Spaepen K, 2003, EUR J NUCL MED MOL I, V30, pS97, DOI 10.1007/s00259-003-1166-5; Zaki HS, 2004, ACTA NEUROCHIR, V146, P841, DOI 10.1007/s00701-004-0282-8	20	0	0	SPRINGER WIEN	WIEN	SACHSENPLATZ 4-6, PO BOX 89, A-1201 WIEN, AUSTRIA	0001-6268	0942-0940		ACTA NEUROCHIR	Acta Neurochir.	FEB	2015	157	2					187	194		10.1007/s00701-014-2290-7		8	Clinical Neurology; Surgery	Neurosciences & Neurology; Surgery	CA5VQ	WOS:000348976300005		
J	Shuto, T; Yagishita, S; Matsunaga, S				Shuto, Takashi; Yagishita, Saburo; Matsunaga, Shigeo			Pathological characteristics of cyst formation following gamma knife surgery for arteriovenous malformation	ACTA NEUROCHIRURGICA			English	Article						Arteriovenous malformation; Gamma knife; Radiosurgery; Complication; Cyst	CENTRAL-NERVOUS-SYSTEM; CAVERNOUS MALFORMATIONS; RADIOSURGERY; RADIATION; IRRADIATION; COMPLICATIONS; BRAIN	The pathological characteristics of cyst development after gamma knife surgery (GKS) for arteriovenous malformation (AVM) were analysed. Sixteen male and 12 female patients aged 17-67 years (mean 31.3 years) were retrospectively identified among 868 patients who underwent GKS for AVM at our hospital. The pathological characteristics of the reddish nodular lesion and chronic encapsulated expanding haematoma associated with cyst following GKS for AVM were examined. Cyst was associated with chronic encapsulated expanding haematoma in 13, and with nodular lesion in 12 patients. The nidus volume at GKS was 0.1-36 ml (median 6.0 ml), and the prescription dose at the nidus margin was 18-25 Gy (median 20 Gy). Cyst formation was detected from 1.1 to 16 years (mean 7.3 years) after GKS. Seven of the 12 patients with nodular lesion underwent surgery. Ten of the 13 patients with expanding haematoma underwent surgical removal of expanding haematoma. Histological examination was possible in 17 cases. Dilated capillary vessels with wall damage such as hyalinisation and fibrinoid necrosis, marked protein exudation and haemorrhage were the most common findings. Brain parenchyma was observed among the dilated vessels in some cases. Structureless necrotic tissue was not evident. The present study suggests that enhanced nodular lesion on magnetic resonance imaging and chronic encapsulated expanding haematoma associated with cyst may have common aetiopathology caused by late radiation effects, mainly consisting of dilated capillary vessels with wall damage. Massive protein exudation from such damaged capillary vessels is important in cyst development.	[Shuto, Takashi; Matsunaga, Shigeo] Yokohama Rosai Hosp, Dept Neurosurg, Kouhoku Ku, Yokohama, Kanagawa 2220036, Japan; [Yagishita, Saburo] Kanagawa Rehabil Hosp, Dept Pathol, Atsugi, Kanagawa, Japan	Shuto, T (reprint author), Yokohama Rosai Hosp, Dept Neurosurg, Kouhoku Ku, 3211 Kozukue Cho, Yokohama, Kanagawa 2220036, Japan.	shuto@yokohamah.rofuku.go.jp					Wang X, 2012, CLIN NEUROL NEUROSUR, V114, P1287, DOI 10.1016/j.clineuro.2012.03.005; Yamamoto M, 1996, NEUROSURGERY, V38, P906, DOI 10.1097/00006123-199605000-00010; Motegi H, 2008, NEUROL MED-CHIR, V48, P397, DOI 10.2176/nmc.48.397; Ohba S, 2010, NEUROSURG REV, V33, P395, DOI 10.1007/s10143-010-0245-x; Izawa M, 2005, J NEUROSURG, V102, P34; Duhem R, 2005, CHILD NERV SYST, V21, P922, DOI 10.1007/s00381-004-1120-2; Rahmathulla G, 2013, J CLIN NEUROSCI, V20, P485, DOI 10.1016/j.jocn.2012.09.011; Shuto T, 2012, J NEUROSURG, V117, P135, DOI 10.3171/2012.6.GKS12318; Larson JJ, 1998, J NEUROSURG, V88, P51, DOI 10.3171/jns.1998.88.1.0051; BLATT DR, 1994, J NEUROSURG, V80, P1046, DOI 10.3171/jns.1994.80.6.1046; Nakamizo A, 2011, ACTA NEUROCHIR, V153, P883, DOI 10.1007/s00701-010-0829-9; Shuto T, 2011, STEREOT FUNCT NEUROS, V89, P96, DOI 10.1159/000323543; Kurita H, 1996, J NEUROSURG, V84, P874, DOI 10.3171/jns.1996.84.5.0874; HOPEWELL JW, 1979, NEUROPATH APPL NEURO, V5, P329, DOI 10.1111/j.1365-2990.1979.tb00633.x; Iwai Y, 2007, NEUROL MED-CHIR, V47, P171, DOI 10.2176/nmc.47.171; LO EH, 1992, INT J RADIAT ONCOL, V22, P47; Munter MW, 1999, RADIOLOGY, V212, P475; Nimjee Shahid M, 2006, Neurosurg Focus, V21, pe4; Pan HC, 2005, J NEUROSURG, V102, P124; REMLER MP, 1986, INT J RADIAT ONCOL, V12, P1965	20	2	2	SPRINGER WIEN	WIEN	SACHSENPLATZ 4-6, PO BOX 89, A-1201 WIEN, AUSTRIA	0001-6268	0942-0940		ACTA NEUROCHIR	Acta Neurochir.	FEB	2015	157	2					293	298		10.1007/s00701-014-2298-z		6	Clinical Neurology; Surgery	Neurosciences & Neurology; Surgery	CA5VQ	WOS:000348976300019		
J	Ishikawa, M; Tanaka, Y; Watanabe, E				Ishikawa, Mami; Tanaka, Yuichi; Watanabe, Eiju			Microvascular decompression under neuroendoscopic view in hemifacial spasm: rostral-type compression and perforator-type compression	ACTA NEUROCHIRURGICA			English	Article						Hemifacial spasm; Electrophysiology; Endoscope; Microvascular decompression	POSTERIOR-FOSSA; SURGERY	We report microvascular decompression (MVD) under neuroendoscopic view in hemifacial spasm (HFS) patients with rostral- and perforator-type compression of the root exit zone (REZ) of the facial nerve. Using either a wireless iPad Mini as a monitor on the microscope or a high-resolution monitor, microscopic and endoscopic views enabled MVD for complete cure of HFS with rostral-type compression (the offender compressing the REZ on the opposite rostral side to the operative approach) or perforator-type compression (the offender tethered to the REZ by the perforator). MVD under neuroendoscopic view may offer more accurate MVD and complete resolution of HFS.	[Ishikawa, Mami; Tanaka, Yuichi] Jichi Med Univ, Dept Neurosurg, Saitama Med Ctr, Saitama 3308503, Japan; [Watanabe, Eiju] Jichi Med Univ, Dept Neurosurg, Shimotsukeshi, Tochigi 3290498, Japan	Ishikawa, M (reprint author), Jichi Med Univ, Dept Neurosurg, Saitama Med Ctr, 1-847 Amanumacho, Saitama 3308503, Japan.	m.ishikawa@jichi.ac.jp					Miyazaki H, 2005, LARYNGOSCOPE, V115, P1612, DOI 10.1097/01.mlg.0000172038.22929.63; Rak R, 2004, NEUROSURGERY, V54, P876, DOI 10.1227/01.NEU.0000115151.52925.37; Park JS, 2008, ACTA NEUROCHIR, V150, P235, DOI 10.1007/s00701-007-1457-x; Badr-El-Dine M, 2002, OTOL NEUROTOL, V23, P122, DOI 10.1097/00129492-200203000-00002; Charalampaki P, 2008, SKULL BASE-INTERD AP, V18, P117, DOI 10.1055/s-2007-1003927; Ishikawa M, 1996, J NEUROL SCI, V137, P109, DOI 10.1016/0022-510X(95)00308-O; King WA, 2001, NEUROSURGERY, V49, P108, DOI 10.1097/00006123-200107000-00017; Li JP, 2012, J CLIN NEUROSCI, V19, P44, DOI 10.1016/j.jocn.2011.04.023; Mooij JJA, 2001, NEUROSURGERY, V49, P1365, DOI 10.1097/00006123-200112000-00012	9	0	0	SPRINGER WIEN	WIEN	SACHSENPLATZ 4-6, PO BOX 89, A-1201 WIEN, AUSTRIA	0001-6268	0942-0940		ACTA NEUROCHIR	Acta Neurochir.	FEB	2015	157	2					329	332		10.1007/s00701-014-2294-3		4	Clinical Neurology; Surgery	Neurosciences & Neurology; Surgery	CA5VQ	WOS:000348976300025		
J	Ohno, K; Tadokoro, S; Michael, N; Kruijff, GJM				Ohno, Kazunori; Tadokoro, Satoshi; Michael, Nathan; Kruijff, Geert-Jan M.			Special issue on disaster response robotics (2) PREFACE	ADVANCED ROBOTICS			English	Editorial Material									[Ohno, Kazunori; Tadokoro, Satoshi] Tohoku Univ, Sendai, Miyagi 980, Japan; [Michael, Nathan] Carnegie Mellon Univ, Pittsburgh, PA 15213 USA; [Kruijff, Geert-Jan M.] Nuance, Ulm, Germany	Ohno, K (reprint author), Tohoku Univ, Sendai, Miyagi 980, Japan.							0	0	0	TAYLOR & FRANCIS LTD	ABINGDON	4 PARK SQUARE, MILTON PARK, ABINGDON OX14 4RN, OXON, ENGLAND	0169-1864	1568-5535		ADV ROBOTICS	Adv. Robot.	FEB 1	2015	29	3			SI		147	147		10.1080/01691864.2015.1007901		1	Robotics	Robotics	CB3IM	WOS:000349521400001		
J	Handa, T; Miyachi, H; Kakuno, H; Ozaki, T; Maruyama, S				Handa, Taro; Miyachi, Hiroaki; Kakuno, Hatsuki; Ozaki, Takaya; Maruyama, Shinji			Modeling of a Feedback Mechanism in Supersonic Deep-Cavity Flows	AIAA JOURNAL			English	Article							PRESSURE OSCILLATIONS; RECTANGULAR CAVITIES	In this study, a feedback mechanism for supersonic deep-cavity flows is modeled. The model is developed on the basis of previous flow visualization results. In this model, two pressure waves play an important role in the feedback mechanism; one wave is generated at the trailing edge of the cavity owing to the motion of the shear layer, and the other wave is generated as a result of the third reflection of the former wave at the cavity bottom. The constants in the model are determined using the flow visualization results. The frequencies calculated in the model agree well with the dominant frequencies observed in experiments; in particular, the feedback mechanism responsible for deep-cavity-induced pressure oscillation is successfully clarified.	[Handa, Taro; Maruyama, Shinji] Kyushu Univ, Dept Energy & Environm Engn, Kasuga, Fukuoka 8168580, Japan; [Miyachi, Hiroaki] Mitsubishi Heavy Ind Co Ltd, Power Syst Plant Engn Dept, Takasago, Hyogo 6768686, Japan; [Kakuno, Hatsuki; Ozaki, Takaya] Nippon Steel & Sumikin Engn, Plant & Machinery Div, Kitakyushu, Fukuoka 8048505, Japan	Handa, T (reprint author), Kyushu Univ, Dept Energy & Environm Engn, 6-1 Kasuga Koen, Kasuga, Fukuoka 8168580, Japan.	t.handa@kyudai.jp					Handa T, 2012, EXP FLUIDS, V53, P1855, DOI 10.1007/s00348-012-1400-7; HELLER HH, 1971, J SOUND VIB, V18, P545, DOI 10.1016/0022-460X(71)90105-2; Chandra BU, 2005, J FLUID ENG-T ASME, V127, P761, DOI 10.1115/1.1949642; YU KH, 1994, COMBUST FLAME, V99, P295, DOI 10.1016/0010-2180(94)90134-1; Unalmis OH, 2004, AIAA J, V42, P2035; TAM CKW, 1978, J FLUID MECH, V89, P373, DOI 10.1017/S0022112078002657; Asai T., 2003, J JPN SOC FLUID MECH, V22, P131; Asai T., 2003, J JAPAN SOC FLUID ME, V22, P147; BILANIN AJ, 1973, AIAA J, V11, P347, DOI 10.2514/3.6747; Delprat N, 2006, PHYS FLUIDS, V18, DOI 10.1063/1.2219767; Handa T, 2009, PHYS FLUIDS, V21, DOI 10.1063/1.3081560; ROCKWELL D, 1978, J FLUID ENG-T ASME, V100, P152; Rossiter J. E., 1964, AERONAUTICAL RES COU	13	1	1	AMER INST AERONAUTICS  ASTRONAUTICS	RESTON	1801 ALEXANDER BELL DRIVE, STE 500, RESTON, VA 22091-4344 USA	0001-1452	1533-385X		AIAA J	AIAA J.	FEB	2015	53	2					420	425		10.2514/1.J053184		6	Engineering, Aerospace	Engineering	CB1DA	WOS:000349365700013		
J	Kako, S; Izutsu, K; Kato, K; Kim, SW; Mori, T; Fukuda, T; Kobayashi, N; Taji, H; Hashimoto, H; Kondo, T; Sakamaki, H; Morishima, Y; Kato, K; Suzuki, R; Suzumiya, J				Kako, Shinichi; Izutsu, Koji; Kato, Koji; Kim, Sung-Won; Mori, Takehiko; Fukuda, Takahiro; Kobayashi, Naoki; Taji, Hirofumi; Hashimoto, Hisako; Kondo, Tadakazu; Sakamaki, Hisashi; Morishima, Yasuo; Kato, Koji; Suzuki, Ritsuro; Suzumiya, Junji		Japanese Soc Hematopoietic Cell	The role of hematopoietic stem cell transplantation for relapsed and refractory Hodgkin lymphoma	AMERICAN JOURNAL OF HEMATOLOGY			English	Article							HIGH-DOSE THERAPY; MARROW-TRANSPLANTATION; BRENTUXIMAB VEDOTIN; PROGNOSTIC-FACTORS; ALLOGENEIC TRANSPLANTATION; EUROPEAN GROUP; DISEASE; CHEMOTHERAPY; BLOOD	The optimal treatment strategy with the use of hematopoietic stem cell transplantation (HSCT) for relapsed and refractory Hodgkin lymphoma (HL) remains unclear. We performed a retrospective analysis using registry data from the Japanese Society for Hematopoietic Cell Transplantation. Adult patients with HL who underwent a first autologous or a first allogeneic HSCT between 2002 and 2009 were included. Patients who underwent HSCT in first complete remission (CR) were excluded. Autologous and allogeneic HSCT were performed in 298 and 122 patients, respectively. For autologous HSCT, overall survival at 3 years (3yOS) was 70%, and sex, age, disease status, and performance status (PS) at HSCT were prognostic factors. OS was favorable even in patients who underwent autologous HSCT in disease status other than CR. For allogeneic HSCT, 3yOS was 43%, and sex and PS at HSCT were prognostic factors. Disease status at HSCT, previous autologous HSCT, and conditioning intensity did not affect OS. Moreover, graft-versus-host disease did not affect progression-free survival or relapse/progression rate. A first allogeneic HSCT without a previous autologous HSCT was performed in 40 patients. 3yOS was 45%, and was significantly inferior to that in patients who underwent their first autologous HSCT. This result was retained after the correction by the different patient characteristics according to the type of HSCT. In conclusion, autologous HSCT is effective in prolonging survival in patients with relapsed and refractory HL. Allogeneic HSCT might be beneficial even to relapsed HL after autologous HSCT, although establishing the role of allogeneic HSCT remains a challenge. Am. J. Hematol. 90:132-138, 2015. (c) 2014 Wiley Periodicals, Inc.	[Kako, Shinichi] Jichi Med Univ, Saitama Med Ctr, Div Hematol, Saitama 3308503, Japan; [Izutsu, Koji] Toranomon Gen Hosp, Dept Hematol, Tokyo, Japan; [Kato, Koji] Kyushu Univ, Grad Sch Med Sci, Dept Med & Biosyst Sci, Fukuoka 812, Japan; [Kim, Sung-Won; Fukuda, Takahiro] Natl Canc Ctr, Hematopoiet Stem Cell Transplantat Div, Tokyo, Japan; [Mori, Takehiko] Keio Univ, Sch Med, Div Hematol, Tokyo, Japan; [Kobayashi, Naoki] Sapporo Hokuyu Hosp, Dept Hematol, Sapporo, Hokkaido, Japan; [Taji, Hirofumi] Aichi Canc Ctr Hosp, Nagoya, Aichi 464, Japan; [Hashimoto, Hisako] Kobe City Med Ctr Gen Hosp, Inst Biomed Res & Innovat, Dept Cell Therapy, Dept Hematol, Kobe, Hyogo, Japan; [Kondo, Tadakazu] Kyoto Univ, Grad Sch Med, Dept Hematol & Oncol, Kyoto, Japan; [Sakamaki, Hisashi] Komagome Hosp, Tokyo Metropolitan Canc & Infect Dis Ctr, Div Hematol, Tokyo, Japan; [Morishima, Yasuo] Aichi Canc Ctr, Res Inst, Div Epidemiol & Prevent, Nagoya, Aichi 464, Japan; [Kato, Koji] Japanese Red Cross Nagoya First Hosp, Dept Hematol & Oncol, Childrens Med Ctr, Nagoya, Aichi, Japan; [Suzuki, Ritsuro] Nagoya Univ, Sch Med, Dept Hematopoiet Stem Cell Transplantat Data Mana, Nagoya, Aichi 466, Japan; [Suzumiya, Junji] Shimane Univ Hosp, Ctr Canc, Izumo, Shimane, Japan	Kako, S (reprint author), Jichi Med Univ, Saitama Med Ctr, Dept Internal Med, Div Hematol,Omiya Ku, 1-847 Amanuma, Saitama 3308503, Japan.	shinichikako@asahi-net.email.ne.jp					Akpek G, 2001, J CLIN ONCOL, V19, P4314; Younes A, 2012, J CLIN ONCOL, V30, P2183, DOI 10.1200/JCO.2011.38.0410; Gopal AK, 2012, BLOOD, V120, P560, DOI 10.1182/blood-2011-12-397893; Atsuta Y, 2007, INT J HEMATOL, V86, P269, DOI 10.1532/IJH97.06239; Sarina B, 2010, BLOOD, V115, P3671, DOI 10.1182/blood-2009-12-253856; Robinson SP, 2009, HAEMATOL-HEMATOL J, V94, P230, DOI 10.3324/haematol.13441; Hasenclever D, 1998, NEW ENGL J MED, V339, P1506, DOI 10.1056/NEJM199811193392104; Sureda A, 2008, J CLIN ONCOL, V26, P455, DOI 10.1200/JCO.2007.13.2415; Thomson KJ, 2008, BONE MARROW TRANSPL, V41, P765, DOI 10.1038/sj.bmt.1705977; Schmitz N, 2002, LANCET, V359, P2065, DOI 10.1016/S0140-6736(02)08938-9; Chen R, 2012, BLOOD, V119, P6379, DOI 10.1182/blood-2012-03-418673; Gooley TA, 1999, STAT MED, V18, P695, DOI 10.1002/(SICI)1097-0258(19990330)18:6<695::AID-SIM60>3.3.CO;2-F; Chakraverty R, 2011, J CLIN ONCOL, V29, P1855, DOI 10.1200/JCO.2010.32.8419; Czyz J, 2004, ANN ONCOL, V15, P1222, DOI 10.1093/annonc/mdh304; Devetten MP, 2009, BIOL BLOOD MARROW TR, V15, P109, DOI 10.1016/j.bbmt.2008.11.011; Federico M, 2003, J CLIN ONCOL, V21, P2320, DOI 10.1200/JCO.2003.11.103; Kanda Y, 2013, BONE MARROW TRANSPL, V48, P452, DOI 10.1038/bmt.2012.244; Kuruvilla J., 2009, HEMATOL-AM SOC HEMAT, V2009, P497; Marcais A, 2013, HAEMATOLOGICA, V98, P1467, DOI 10.3324/haematol.2012.080895; Meyer RM, 2012, HEMATOL-AM SOC HEMAT, P313, DOI 10.1182/asheducation-2012.1.313; Proctor SJ, 2002, EUR J CANCER, V38, P795, DOI 10.1016/S0959-8049(02)00006-0; Sureda A, 2001, J CLIN ONCOL, V19, P1395; Sweetenham JW, 1999, J CLIN ONCOL, V17, P3101; Yuen AR, 1997, BLOOD, V89, P814	24	3	3	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0361-8609	1096-8652		AM J HEMATOL	Am. J. Hematol.	FEB	2015	90	2					132	138		10.1002/ajh.23897		7	Hematology	Hematology	CA4AL	WOS:000348846600014		
J	Kawamura, I; Ohmagari, N; Tsukahara, M; Kudo, T; Kurai, H				Kawamura, Ichiro; Ohmagari, Norio; Tsukahara, Mika; Kudo, Tomoko; Kurai, Hanako			Surveillance of extended-spectrum beta-lactamase-producing Escherichia coli and Klebsiella pneumoniae at a comprehensive cancer center in Japan, 2009-2013	AMERICAN JOURNAL OF INFECTION CONTROL			English	Article						Surveillance; Extended-spectrum beta-lactamase; Escherichia coli; Klebsiella pneumoniae	TRANSMISSION; SPREAD	We examined the results of surveillance of extended-spectrum beta-lactamase (ESBL)-producing Escherichia coli and Klebsiella pneumoniae, which are pathogens known to cause nosocomial outbreaks, at a comprehensive cancer center in Japan over a 5-year period. We found that the admission prevalence and the incidence of ESBL-producing E coli increased during the study period, in contrast with ESBL-producing K pneumoniae, in which the parameters remained low throughout the study period. Copyright (C) 2015 by the Association for Professionals in Infection Control and Epidemiology, Inc. Published by Elsevier Inc. All rights reserved.	[Kawamura, Ichiro; Tsukahara, Mika; Kudo, Tomoko; Kurai, Hanako] Shizuoka Canc Ctr, Div Infect Dis, Sunto, Shizuoka, Japan; [Ohmagari, Norio] Natl Ctr Global Hlth & Med, Ctr Dis Control & Prevent, Shinjuku Ku, Tokyo, Japan	Kawamura, I (reprint author), 1007 Shimonagakubo, Sunto, Shizuoka 4118777, Japan.	i.kawamura@scchr.jp					Adler A, 2012, CLIN MICROBIOL INFEC, V18, pE497, DOI 10.1111/j.1469-0691.2012.03999.x; Matsumura Y, 2012, J ANTIMICROB CHEMOTH, V67, P2612, DOI 10.1093/jac/dks278; Cohen AL, 2008, INFECT CONT HOSP EP, V29, P901, DOI 10.1086/591741; Paterson DL, 2005, CLIN MICROBIOL REV, V18, P657, DOI 10.1128/CMR.18.4.657-686.2005; Tschudin-Sutter S, 2012, CLIN INFECT DIS, V55, P1505, DOI 10.1093/cid/cis770; Clinical Laboratory Standards Institute, 2009, M100S19 CLIN LAB STA; Ohmagari N, 2014, AM J INFECT CONTROL, V42, P739, DOI 10.1016/j.ajic.2014.04.003; Oteo J, 2010, CURR OPIN INFECT DIS, V23, P320	8	1	1	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0196-6553	1527-3296		AM J INFECT CONTROL	Am. J. Infect. Control	FEB 1	2015	43	2					185	187		10.1016/j.ajic.2014.11.005		3	Public, Environmental & Occupational Health; Infectious Diseases	Public, Environmental & Occupational Health; Infectious Diseases	CA2KK	WOS:000348737200022		
J	Kuroda, Y; Saito, T; Nagai, J; Ida, K; Naruto, T; Masuno, M; Kurosawa, K				Kuroda, Yukiko; Saito, Toshiyuki; Nagai, Jun-ichi; Ida, Kazumi; Naruto, Takuya; Masuno, Mitsuo; Kurosawa, Kenji			Microdeletion of 19p13.3 in a Girl With Peutz-Jeghers Syndrome, Intellectual Disability, Hypotonia, and Distinctive Features	AMERICAN JOURNAL OF MEDICAL GENETICS PART A			English	Article						Peutz-Jeghers syndrome; serine; threonine kinase 11 (STK11); array comparative genomic hybridization; intellectual disability; cancer predisposition in childhood	CONTIGUOUS GENE SYNDROME; PHENOTYPE; DELETION; COMPLEX; STK11; FAMILY	Peutz-Jeghers syndrome (PJS) is a rare autosomal dominant disease characterized by gastrointestinal polyposis and mucocutaneous pigmentation. Germline point mutations in the serine/threonine kinase 11 (STK11) have been identified in about 70% of patients with PJS. Only a few large genomic deletions have been identified. We report on a girl with PJS and multiple congenital anomalies. She had intellectual disability, umbilical hernia, bilateral inguinal hernias, scoliosis, and distinct facial appearance including prominent mandible, smooth philtrum, and malformed ears. She developed lip pigmentation at the age of 12 years but had no gastrointestinal polyps. Array comparative genomic hybridization revealed an approximately 610kb deletion at 19p13.3, encompassing STK11. Together with previous reports, the identification of common clinical features suggests that microdeletion at 19p13.3 encompassing STK11 constitutes a distinctive phenotype. (c) 2014 Wiley Periodicals, Inc.	[Kuroda, Yukiko; Ida, Kazumi; Naruto, Takuya; Kurosawa, Kenji] Kanagawa Childrens Med Ctr, Div Med Genet, Yokohama, Kanagawa 2328555, Japan; [Saito, Toshiyuki; Nagai, Jun-ichi] Kanagawa Childrens Med Ctr, Dept Clin Lab, Yokohama, Kanagawa 2328555, Japan; [Masuno, Mitsuo] Kawasaki Univ Med Welf, Genet Counseling Program, Kurashiki, Okayama, Japan	Kurosawa, K (reprint author), Kanagawa Childrens Med Ctr, Div Med Genet, Minami Ku, 2-138-4 Mutsukawa, Yokohama, Kanagawa 2328555, Japan.	kkurosawa@kcmc.jp			Ministry of Health, Labour and Welfare of Japan	Grant sponsor: The Ministry of Health, Labour and Welfare of Japan.	Makeyev EV, 2007, MOL CELL, V27, P435, DOI 10.1016/j.molcel.2007.07.015; Archer HL, 2005, AM J MED GENET A, V136A, P38, DOI 10.1002/ajmg.a.30774; Souza J, 2011, GENET MOL BIOL, V34, P557, DOI 10.1590/S1415-47572011005000044; Nie ZQ, 2000, MOL CELL BIOL, V20, P8879, DOI 10.1128/MCB.20.23.8879-8888.2000; Le Meur N, 2004, EUR J HUM GENET, V12, P415, DOI 10.1038/sj.ejhg.5201155; Tsurusaki Y, 2012, NAT GENET, V44, P376, DOI 10.1038/ng.2219; Aretz S, 2005, HUM MUTAT, V26, P513, DOI 10.1002/humu.20253; Sharma S, 2005, MOL CELL, V19, P485, DOI 10.1016/j.molcel.2005.07.014; Kurosawa K, 2012, CONGENIT ANOM, V52, P106, DOI 10.1111/j.1741-4520.2011.00326.x; Peddibhotla S, 2013, AM J MED GENET A, V161, P2953, DOI 10.1002/ajmg.a.35886; Resta N, 2010, HUM GENET, V128, P323; Scollon S, 2012, AM J MED GENET A, V158A, P2959, DOI 10.1002/ajmg.a.35629	12	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1552-4825	1552-4833		AM J MED GENET A	Am. J. Med. Genet. A	FEB	2015	167	2					389	393		10.1002/ajmg.a.36813		5	Genetics & Heredity	Genetics & Heredity	CA3ZJ	WOS:000348843600017		
J	Nishi, E; Mizuno, S; Nanjo, Y; Niihori, T; Fukushima, Y; Matsubara, Y; Aoki, Y; Kosho, T				Nishi, Eriko; Mizuno, Seiji; Nanjo, Yuka; Niihori, Tetsuya; Fukushima, Yoshimitsu; Matsubara, Yoichi; Aoki, Yoko; Kosho, Tomoki			A Novel Heterozygous MAP2K1 Mutation in a Patient with Noonan Syndrome with Multiple Lentigines	AMERICAN JOURNAL OF MEDICAL GENETICS PART A			English	Article						Noonan syndrome with multiple lentigines (NSML); MAP2K1; cardio-facio-cutaneous syndrome (CFCS)	LEOPARD-SYNDROME; HYPERTROPHIC CARDIOMYOPATHY; SPECTRUM	Noonan syndrome with multiple lentigines (NSML), formerly referred to as LEOPARD syndrome, is a rare autosomal-dominant condition, characterized by multiple lentigines, electrocardiographic conduction abnormalities, ocular hypertelorism, pulmonary stenosis, abnormal genitalia, growth retardation, and sensorineural deafness. To date, PTPN11, RAF1, and BRAF have been reported to be causal for NSML. We report on a 13-year-old Japanese boy, who was diagnosed with NSML. He was found to have a novel heterozygous missense variant (c.305A>G; p.E102G) in MAP2K1, a gene mostly causal for cardio-facio-cutaneous syndrome (CFCS). He manifested fetal macrosomia, and showed hypotonia and poor sucking in the neonatal period. He had mild developmental delay, and multiple lentigines appearing at approximately age 3 years, as well as flexion deformity of knees bilaterally, subtle facial characteristics including ocular hypertelorism, sensorineural hearing loss, and precocious puberty. He lacked congenital heart defects or hypertrophic cardiomyopathy, frequently observed in patients with NSML, mostly caused by PTPN11 mutations. He also lacked congenital heart defects, characteristic facial features, or intellectual disability, frequently observed in those with CFCS caused by MAP2K1 or MAP2K2 mutations. This may be the first patient clinically diagnosed with NSML, caused by a mutation in MAP2K1. (c) 2014 Wiley Periodicals, Inc.	[Nishi, Eriko; Kosho, Tomoki] Nagano Childrens Hosp, Div Med Genet, Azumino, Japan; [Nishi, Eriko; Fukushima, Yoshimitsu; Kosho, Tomoki] Shinshu Univ, Sch Med, Dept Med Genet, Matsumoto, Nagano 390, Japan; [Mizuno, Seiji] Aichi Human Serv Ctr, Cent Hosp, Dept Pediat, Kasugai, Aichi, Japan; [Nanjo, Yuka; Niihori, Tetsuya; Matsubara, Yoichi; Aoki, Yoko] Tohoku Univ, Sch Med, Dept Med Genet, Sendai, Miyagi 980, Japan; [Matsubara, Yoichi] Natl Res Inst Child Hlth & Dev, Tokyo, Japan	Kosho, T (reprint author), Shinshu Univ, Sch Med, Dept Med Genet, 3-1-1 Asahi, Matsumoto, Nagano 3908621, Japan.	ktomoki@shinshu-u.ac.jp			Ministry of Health, Labour and Welfare, Japan; Nagano Children's Hospital Research Foundation	Grant sponsor: Ministry of Health, Labour and Welfare, Japan; Grant sponsor: Nagano Children's Hospital Research Foundation.	Allanson JE, 2011, GENEREVIEWS; VORON DA, 1976, AM J MED, V60, P447, DOI 10.1016/0002-9343(76)90764-6; Sarkozy A, 2009, HUM MUTAT, V30, P695, DOI 10.1002/humu.20955; Koudova M, 2009, EUR J MED GENET, V52, P337, DOI 10.1016/j.ejmg.2009.04.006; Pandit B, 2007, NAT GENET, V39, P1007, DOI 10.1038/ng2073; Aoki Y, 2013, INT J HEMATOL, V97, P30, DOI 10.1007/s12185-012-1239-y; Dentici ML, 2009, EUR J HUM GENET, V17, P733, DOI 10.1038/ejhg.2008.256; Gelb BD, 2010, GENEREVIEWS; Rauen KA., 2012, GENEREVIEWS; Martínez-Quintana E, 2012, Mol Syndromol, V3, P145, DOI 10.1159/000342251; Sarkozy A, 2008, ORPHANET J RARE DIS, V3, DOI 10.1186/1750-1172-3-13; Wakabayashi Y, 2011, AM J MED GENET A, V155A, P2529, DOI 10.1002/ajmg.a.34194	12	1	1	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1552-4825	1552-4833		AM J MED GENET A	Am. J. Med. Genet. A	FEB	2015	167	2					407	411		10.1002/ajmg.a.36842		5	Genetics & Heredity	Genetics & Heredity	CA3ZJ	WOS:000348843600021		
J	Brett-Major, DM; Jacob, ST; Jacquerioz, FA; Risi, GF; Fischer, WA; Kato, Y; Houlihan, CF; Crozier, I; Bosa, HK; Lawler, JV; Adachi, T; Hurley, SK; Berry, LE; Carlson, JC; Button, TC; McLellan, SL; Shea, BJ; Kuniyoshi, GG; Ferri, M; Murthy, SG; Petrosillo, N; Lamontagne, F; Porembka, DT; Schieffelin, JS; Rubinson, L; O'Dempsey, T; Donovan, SM; Bausch, DG; Fowler, RA; Fletcher, TE				Brett-Major, David M.; Jacob, Shevin T.; Jacquerioz, Frederique A.; Risi, George F.; Fischer, William A., II; Kato, Yasuyuki; Houlihan, Catherine F.; Crozier, Ian; Bosa, Henry Kyobe; Lawler, James V.; Adachi, Takuya; Hurley, Sara K.; Berry, Louise E.; Carlson, John C.; Button, Thomas. C.; McLellan, Susan L.; Shea, Barbara J.; Kuniyoshi, Gary G.; Ferri, Mauricio; Murthy, Srinivas G.; Petrosillo, Nicola; Lamontagne, Francois; Porembka, David T.; Schieffelin, John S.; Rubinson, Lewis; O'Dempsey, Tim; Donovan, Suzanne M.; Bausch, Daniel G.; Fowler, Robert A.; Fletcher, Thomas E.			Being Ready to Treat Ebola Virus Disease Patients	AMERICAN JOURNAL OF TROPICAL MEDICINE AND HYGIENE			English	Article							WEST-AFRICA; MANAGEMENT	As the outbreak of Ebola virus disease (EVD) in West Africa continues, clinical preparedness is needed in countries at risk for EVD (e.g., United States) and more fully equipped and supported clinical teams in those countries with epidemic spread of EVD in Africa. Clinical staff must approach the patient with a very deliberate focus on providing effective care while assuring personal safety. To do this, both individual health care providers and health systems must improve EVD care. Although formal guidance toward these goals exists from the World Health Organization, Medecin Sans Frontieres, the Centers for Disease Control and Prevention, and other groups, some of the most critical lessons come from personal experience. In this narrative, clinicians deployed by the World Health Organization into a wide range of clinical settings in West Africa distill key, practical considerations for working safely and effectively with patients with EVD.	[Brett-Major, David M.] Naval Med Res Ctr, Silver Spring, MD 20910 USA; Uniformed Serv Univ Hlth Sci, Bethesda, MD USA; Univ Washington, Seattle, WA 98195 USA; Tulane Univ, Hlth Sci Ctr, New Orleans, LA 70118 USA; Infect Dis Specialists PC, Missoula, MT USA; Univ N Carolina, Div Pulm & Crit Care Med, Chapel Hill, NC USA; Natl Ctr Global Hlth & Med, Ctr Dis Control & Prevent, Div Preparedness & Emerging Infect, Tokyo, Japan; London Sch Hyg & Trop Med, Dept Clin Res, London WC1, England; Makerere Univ, Coll Hlth Sci, Infect Dis Inst, Kampala, Uganda; Uganda Peoples Def Forces, Kampala, Uganda; Naval Med Res Center Frederick, Ft Detrick, MD USA; Austere Environm Consortium Enhanced Sepsis Outco, Ft Detrick, MD USA; Toshima Hosp, Tokyo, Japan; Providence St Patrick Hosp, Missoula, MT USA; Univ Nottingham Hosp, Natl Hlth Serv Trust, Dept Infect Dis, Nottingham NG7 2UH, England; Truman Med Ctr, Kansas City, MO USA; Truman Med Ctr, Toronto, ON, Canada; Queens Med Ctr, Honolulu, HI USA; Univ Calgary, Dept Community Hlth Sci, Calgary, AB, Canada; Univ British Columbia, Vancouver, BC V5Z 1M9, Canada; Natl Inst Infect Dis Lazzaro Spallanzani, Rome, Italy; Univ Sherbrooke, Clin Ctr Hosp, Ctr Rech, Sherbrooke, PQ J1K 2R1, Canada; Univ S Dakota, Sanford Sch Med, Dept Med, Sioux Falls, SD USA; Avera McKenna Med Ctr, Sioux Falls, SD USA; Univ Maryland, Sch Med, R Adams Cowley Shock Trauma Ctr, Crit Care Resuscitat Unit, Baltimore, MD 21201 USA; Univ Liverpool, Liverpool Sch Trop Med, Liverpool L3 5QA, Merseyside, England; Univ Calif Los Angeles, David Geffen Sch Med, Div Infect Dis, Olive View UCLA Med Ctr, Los Angeles, CA 90095 USA; US Naval Med Res Unit 6, Lima, Peru; Univ Toronto, Toronto, ON, Canada	Brett-Major, DM (reprint author), Naval Med Res Ctr, 503 Robert Grant Ave, Silver Spring, MD 20910 USA.	David.Brett-Major@usuhs.edu			American Society of Tropical Medicine and Hygiene (ASTMH)	We acknowledge the sacrifice of patients, families, and the citizens of West Africa in combating EVD. More must be done for them. We are especially grateful to dedicated colleagues from the affected countries who continue to bear sustained burdens of care in their communities, and to the governmental and non-governmental organizations that remain committed to this outbreak response. Clinical care of the patients only occurs safely and effectively when surrounded by infection prevention and control, logistics, water and sanitation, staff health, laboratory and epidemiology colleagues. They are essential in controlling this outbreak. The clinical deployments that led to this manuscript were possible through the efforts of the World Health Organization (WHO), in particular the clinical management team, Global Outbreak Alert and Response Network (GOARN), and event management, staff health, and administrative teams. The American Society of Tropical Medicine and Hygiene (ASTMH) assisted with publication expenses.	Jacob ST, 2012, CRIT CARE MED, V40, P2050, DOI 10.1097/CCM.0b013e31824e65d7; Centers for Disease Control and Prevention (CDC), 2014, EB VIR DIS EVD; Fitzpatrick G, 2014, EUROSURVEILLANCE, V19, P5, DOI 10.2807/1560-7917.ES2014.19.40.20924; Fowler RA, 2014, AM J RESP CRIT CARE, V190, P733, DOI 10.1164/rccm.201408-1514CP; Medicins Sans Frontieres (MSF), 2014, MSF REF BOOKS; Aylward B, 2014, NEW ENGL J MED, V371, P1481, DOI 10.1056/NEJMoa1411100; World Health Organization, 2014, EB VIR DIS EVD	7	1	2	AMER SOC TROP MED & HYGIENE	MCLEAN	8000 WESTPARK DR, STE 130, MCLEAN, VA 22101 USA	0002-9637	1476-1645		AM J TROP MED HYG	Am. J. Trop. Med. Hyg.	FEB	2015	92	2					233	237		10.4269/ajtmh.14-0746		5	Public, Environmental & Occupational Health; Tropical Medicine	Public, Environmental & Occupational Health; Tropical Medicine	CA6ZC	WOS:000349065400009		
J	Moi, ML; Ami, Y; Shirai, K; Lim, CK; Suzaki, Y; Saito, Y; Kitaura, K; Saijo, M; Suzuki, R; Kurane, I; Takasaki, T				Moi, Meng Ling; Ami, Yasushi; Shirai, Kenji; Lim, Chang-Kweng; Suzaki, Yuriko; Saito, Yuka; Kitaura, Kazutaka; Saijo, Masayuki; Suzuki, Ryuji; Kurane, Ichiro; Takasaki, Tomohiko			Formation of Infectious Dengue Virus Antibody Immune Complex In Vivo in Marmosets (Callithrix jacchus) After Passive Transfer of Anti-Dengue Virus Monoclonal Antibodies and Infection with Dengue Virus	AMERICAN JOURNAL OF TROPICAL MEDICINE AND HYGIENE			English	Article							DEPENDENT ENHANCEMENT ASSAY; HEMORRHAGIC-FEVER; SECONDARY INFECTION; ENHANCING ACTIVITY; SHOCK SYNDROME; PRIMATE MODEL; RISK-FACTOR; CELLS; RESPONSES; MONKEYS	Infection with a dengue virus (DENY) serotype induces cross-reactive, weakly neutralizing antibodies to different dengue serotypes. It has been postulated that cross-reactive antibodies form a virus-antibody immune complex and enhance DENV infection of Fc gamma receptor (Fc gamma R)-bearing cells. We determined whether infectious DENV-antibody immune complex is formed in vivo in marmosets after passive transfer of DENV-specific monoclonal antibody (mAb) and DENV inoculation and whether infectious DENY-antibody immune complex is detectable using Fc gamma R-expressing cells. Marmosets showed that DENV-antibody immune complex was exclusively infectious to Fc gamma R-expressing cells on days 2, 4, and 7 after passive transfer of each of the mAbs (mAb 4G2 and mAb 6B6C) and DENV inoculation. Although DENV-antibody immune complex was detected, contribution of the passively transferred antibody to overall viremia levels was limited in this study. The results indicate that DENV cross-reactive antibodies form DEN V-antibody immune complex in vivo, which is infectious to Fc gamma R-bearing cells but not Fc gamma R-negative cells.	[Moi, Meng Ling; Lim, Chang-Kweng; Saito, Yuka; Saijo, Masayuki; Takasaki, Tomohiko] Natl Inst Infect Dis, Dept Virol 1, Tokyo, Japan; [Ami, Yasushi; Suzaki, Yuriko] Natl Inst Infect Dis, Div Expt Anim Res, Tokyo, Japan; [Shirai, Kenji; Kitaura, Kazutaka; Suzuki, Ryuji] Natl Hosp Org, Dept Rheumatol & Clin Immunol, Clin Res Ctr Allergy & Rheumatol, Sagamihara Natl Hosp, Kanagawa, Japan; [Saito, Yuka] Nihon Univ, Coll Bioresource Sci, Fujisawa, Kanagawa, Japan; [Kurane, Ichiro] Natl Inst Infect Dis, Tokyo, Japan	Kurane, I (reprint author), Natl Inst Infect Dis, Tokyo, Japan.	sherry@nih.go.jp; yami@nih.go.jp; k.shirai0727@gmail.com; ck@nih.go.jp; ysuzaki@nih.go.jp; saito-y@nih.go.jp; kitaura@nih.go.jp; msaijo@nih.go.jp; r-suzuki@sagamihara-hosp.gr.jp; kurane@nih.go.jp; takasaki@nih.go.jp			Ministry of Health, Labour and Welfare, Japan [H23-shinkou-ippan-010, H26-shinkou-jitsuyouka-007]; Ministry of Education, Culture, Sports, Science and Technology of Japan [25293112, 26870872]	This work was supported by Research on Emerging and Re-Emerging Infectious Diseases Grants H23-shinkou-ippan-010 and H26-shinkou-jitsuyouka-007 from the Ministry of Health, Labour and Welfare, Japan and Kiban B Grant-in-Aid for Scientific Research 25293112 and Young Scientists B Grant-in-Aid for Scientific Research 26870872 from the Ministry of Education, Culture, Sports, Science and Technology of Japan.	Guzman MG, 2013, ARCH VIROL, V158, P1445, DOI 10.1007/s00705-013-1645-3; Ito M, 2004, J CLIN MICROBIOL, V42, P5935, DOI 10.1128/JCM.42.12.5935-5937.2004; HALSTEAD SB, 1977, J EXP MED, V146, P201, DOI 10.1084/jem.146.1.201; HALSTEAD SB, 1973, J INFECT DIS, V128, P15; Moi ML, 2011, J INFECT DIS, V203, P1405, DOI 10.1093/infdis/jir053; HENCHAL EA, 1982, AM J TROP MED HYG, V31, P830; Chan KR, 2014, P NATL ACAD SCI USA, V111, P2722, DOI 10.1073/pnas.1317454111; HALSTEAD SB, 1979, J INFECT DIS, V140, P527; Wang WK, 2006, CLIN INFECT DIS, V43, P1023, DOI 10.1086/507635; SANGKAWIBHA N, 1984, AM J EPIDEMIOL, V120, P653; Bhatt S, 2013, NATURE, V496, P504, DOI 10.1038/nature12060; Halstead SB, 2010, LANCET INFECT DIS, V10, P712, DOI 10.1016/S1473-3099(10)70166-3; Boonnak K, 2013, J IMMUNOL, V190, P5659, DOI [10.4049/jimmunol.1203052, 10.4049/j.immunol.1203052]; Ubol S, 2010, J INFECT DIS, V201, P923, DOI 10.1086/651018; KLIKS SC, 1988, AM J TROP MED HYG, V38, P411; KLIKS SC, 1989, AM J TROP MED HYG, V40, P444; Goncalvez AP, 2007, P NATL ACAD SCI USA, V104, P9422, DOI 10.1073/pnas.0703498104; Omatsu T, 2011, J GEN VIROL, V92, P2272, DOI 10.1099/vir.0.031229-0; Balsitis SJ, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000790; GUZMAN MG, 1984, T ROY SOC TROP MED H, V78, P235, DOI 10.1016/0035-9203(84)90285-2; Hoffman SL, 2009, DENGUE TROPICAL MED, P219; Ito M, 2011, ARCH VIROL, V156, P1073, DOI 10.1007/s00705-011-0959-2; Ito M, 2010, ARCH VIROL, V155, P1617, DOI 10.1007/s00705-010-0741-x; KONTNY U, 1988, J VIROL, V62, P3928; Moi ML, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001536; Moi ML, 2010, J VIROL METHODS, V163, P205, DOI 10.1016/j.jviromet.2009.09.018; Moi ML, 2014, ARCH VIROL, V159, P103, DOI 10.1007/s00705-013-1787-3; Moi ML, 2013, T ROY SOC TROP MED H, V107, P51, DOI 10.1093/trstmh/trs007; Moi ML, 2014, J GEN VIROL, V95, P591, DOI 10.1099/vir.0.060384-0; Ng JKW, 2014, PLOS PATHOG, V10, DOI 10.1371/journal.ppat.1004031; Nimmerjahn F, 2014, P NATL ACAD SCI USA, V111, P2404, DOI 10.1073/pnas.1324286111; RUANGJIRACHUPORN W, 1979, CLIN EXP IMMUNOL, V36, P46; Worley KC, 2014, NAT GENET, V46, P850, DOI 10.1038/ng.3042; Ubol S, 2010, CLIN VACCINE IMMUNOL, V17, P1829, DOI 10.1128/CVI.00316-10; WHO, 2009, DENG GUID DIAGN TREA	35	0	0	AMER SOC TROP MED & HYGIENE	MCLEAN	8000 WESTPARK DR, STE 130, MCLEAN, VA 22101 USA	0002-9637	1476-1645		AM J TROP MED HYG	Am. J. Trop. Med. Hyg.	FEB	2015	92	2					370	376		10.4269/ajtmh.14-0455		7	Public, Environmental & Occupational Health; Tropical Medicine	Public, Environmental & Occupational Health; Tropical Medicine	CA6ZC	WOS:000349065400034		
J	Naito, M; Harumi, T; Kuwana, T				Naito, Mitsuru; Harumi, Takashi; Kuwana, Takashi			Long-term culture of chicken primordial germ cells isolated from embryonic blood and production of germline chimaeric chickens	ANIMAL REPRODUCTION SCIENCE			English	Article						Chicken; Culture; Embryo; Germline chimaera; Primordial germ cell	IN-VITRO; RECIPIENT EMBRYOS; GALLUS-DOMESTICUS; GFP GENE; GONADS; TRANSMISSION; EXPRESSION; MIGRATION; DIFFERENTIATION; PROLIFERATION	Production of germline chimaeric chickens by the transfer of cultured primordial germ cells (PGC) is a useful system for germline manipulation. A novel culture system was developed for chicken PGC isolated from embryonic blood. The isolated PGC were cultured on feeder cells derived from chicken embryonic fibroblast. The cultured PGC formed colonies and they proliferated about 300-times during the first 30 days. The cultured PGC retained the ability to migrate to recipient gonads and were also chicken VASA homologue (CVH)-positive. Female PGC were present in the mixed-sex PGC populations cultured for more than 90 days and gave rise to viable offspring efficiently via germline chimaeric chickens. Male cultured FCC were transferred to recipient embryos and produced putative chimaeric chickens. The DNA derived from the cultured PGC was detected in the sperm samples of male putative chimaeric chickens, but no donor derived offspring were obtained. Donor-derived offspring were also obtained from germline chimaeric chickens by the transfer of frozen-thawed cultured PGC. The culture method for PGC developed in the present study is useful for manipulation of the germline in chickens, such as preservation of genetic resources and gene transfer. (C) 2014 Elsevier B.V. All rights reserved.	[Naito, Mitsuru; Harumi, Takashi] Natl Inst Agrobiol Sci, Tsukuba, Ibaraki 3058602, Japan; [Kuwana, Takashi] Int Inst Avian Conservat Sci, Abu Dhabi, U Arab Emirates	Naito, M (reprint author), Natl Inst Agrobiol Sci, Tsukuba, Ibaraki 3058602, Japan.	mnaito@affrc.go.jp			Japan Society for the Promotion of Science, Kieikai Research Foundation [20380156]; II-ACS Research Fund	The authors would like to thank the staff of the Poultry Management Section of the National Institute of Livestock and Grassland Science for taking care of the birds and providing the fertilised eggs. This study was supported by a Grant-in-Aid (No. 20380156) from the Japan Society for the Promotion of Science, Kieikai Research Foundation, and II-ACS Research Fund to M.N.	AIGEGIL V, 1991, BRIT POULTRY SCI, V32, P427, DOI 10.1080/00071669108417368; HAMBURGER V, 1951, J MORPHOL, V88, P49, DOI 10.1002/jmor.1050880104; Glover JD, 2012, J POULT SCI, V49, P155, DOI 10.2141/jpsa.011161; EYALGILADI H, 1976, DEV BIOL, V49, P321, DOI 10.1016/0012-1606(76)90178-0; Park TS, 2012, P NATL ACAD SCI USA, V109, P9337, DOI 10.1073/pnas.1203823109; Macdonald J, 2012, P NATL ACAD SCI USA, V109, pE1466, DOI 10.1073/pnas.1118715109; TAJIMA A, 1993, THERIOGENOLOGY, V40, P509, DOI 10.1016/0093-691X(93)90404-S; NAITO M, 1994, MOL REPROD DEV, V39, P153, DOI 10.1002/mrd.1080390206; CARSIENCE RS, 1993, DEVELOPMENT, V117, P669; Tsunekawa N, 2000, DEVELOPMENT, V127, P2741; Nakamura Y, 2010, BIOL REPROD, V83, P130, DOI 10.1095/biolreprod.110.083923; Kerje S, 2004, GENETICS, V168, P1507, DOI 10.1534/genetics.104.027995; Naito Mitsuru, 2007, Journal of Poultry Science, V44, P416, DOI 10.2141/jpsa.44.416; BRESLER M, 1994, BRIT POULTRY SCI, V35, P241, DOI 10.1080/00071669408417688; Choi JW, 2007, J EXP ZOOL PART A, V307A, P241, DOI 10.1002/jez.a.373; Choi JW, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012968; Clinton M, 2001, BRIT POULTRY SCI, V42, P134, DOI 10.1080/713655025; FRESHNEY R. I., 1987, CULTURE ANIMAL CELLS, P245; Kang SJ, 2008, BIOL REPROD, V79, P931, DOI 10.1095/biolreprod.108.069989; Kuwana T, 1996, INT J DEV BIOL, V40, P1061; KUWANA T, 1993, DEV GROWTH DIFFER, V35, P237; Li HC, 2001, COMP BIOCHEM PHYS A, V130, P133, DOI 10.1016/S1095-6433(01)00375-0; Liu CH, 2012, BIOL REPROD, V86, DOI 10.1095/biolreprod.111.094409; Macdonald J, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015518; Matsui Y, 2009, DEV GROWTH DIFFER, V51, P657, DOI 10.1111/j.1440-169X.2009.01125.x; Miyahara D, 2014, J POULT SCI, V51, P87; Naito M., 2003, WORLDS POULTRY SCI J, V59, P375; Naito M, 2010, J POULT SCI, V47, P57, DOI 10.2141/jpsa.009058; Naito M, 1999, J REPROD FERTIL, V117, P291, DOI 10.1530/jrf.0.1170291; NAITO M, 1991, BRIT POULTRY SCI, V32, P79, DOI 10.1080/00071669108417329; Naito M, 2004, BRIT POULTRY SCI, V45, P762, DOI 10.1080/00071660400014325; Naito M, 2012, J POULT SCI, V49, P116, DOI 10.2141/jpsa.011094; Naito M, 1998, BRIT POULTRY SCI, V39, P20; Naito M, 2015, J POULT SCI, V52, P7, DOI 10.2141/jpsa.0140107; NAITO M, 1994, J REPROD FERTIL, V102, P321; Naito M, 1998, J REPROD FERTIL, V113, P137; NAITO M, 1990, J EXP ZOOL, V254, P322, DOI 10.1002/jez.1402540311; Naito M, 2011, J POULT SCI, V48, P112, DOI 10.2141/jpsa.010095; Nakamichi Hiroyuki, 2006, Journal of Poultry Science, V43, P394, DOI 10.2141/jpsa.43.394; Nakamura Y, 2009, J POULT SCI, V46, P127, DOI 10.2141/jpsa.46.127; Park TS, 2013, J REPROD DEVELOP, V59, P252, DOI 10.1262/jrd.2012-183; PERRY MM, 1988, NATURE, V331, P70, DOI 10.1038/331070a0; Raynaud G., 1976, ROUX ARCH DEVEL BIOL, V179, P85; Song YH, 2005, MOL REPROD DEV, V70, P438, DOI 10.1002/mrd.20218; Tajima A, 1998, J EXP ZOOL, V280, P265, DOI 10.1002/(SICI)1097-010X(19980215)280:3<265::AID-JEZ8>3.3.CO;2-T; Tajima A, 1999, J EXP ZOOL, V284, P759, DOI 10.1002/(SICI)1097-010X(19991201)284:7<759::AID-JEZ5>3.0.CO;2-6; van de Lavoir MC, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035664; van de Lavoir MC, 2006, NATURE, V441, P766, DOI 10.1038/nature04831; Wernery U, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015824; Zhao DF, 2003, BRIT POULTRY SCI, V44, P30, DOI 10.1080/0007166031000085382	50	1	1	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	0378-4320	1873-2232		ANIM REPROD SCI	Anim. Reprod. Sci.	FEB	2015	153						50	61		10.1016/j.anireprosci.2014.12.003		12	Agriculture, Dairy & Animal Science; Reproductive Biology	Agriculture; Reproductive Biology	CB1ZL	WOS:000349426400008		
J	Shibuya, K; Sugiyama, A; Ito, S; Misawa, S; Sekiguchi, Y; Mitsuma, S; Watanabe, K; Shimada, H; Kawaguchi, H; Suhara, T; Yokota, H; Matsumoto, H; Kuwabara, S				Shibuya, Kazumoto; Sugiyama, Atsuhiko; Ito, Sho-ichi; Misawa, Sonoko; Sekiguchi, Yukari; Mitsuma, Satsuki; Watanabe, Keisuke; Shimada, Hitoshi; Kawaguchi, Hiroshi; Suhara, Tetsuya; Yokota, Hajime; Matsumoto, Hiroshi; Kuwabara, Satoshi			Reconstruction Magnetic Resonance Neurography in Chronic Inflammatory Demyelinating Polyneuropathy	ANNALS OF NEUROLOGY			English	Article							CLINICAL PROFILES; POLYRADICULONEUROPATHY; DIFFUSE	To study distribution and patterns of nerve hypertrophy in chronic inflammatory demyelinating polyneuropathy (CIDP), magnetic resonance neurography with 3-dimensional reconstruction of short tau inversion recovery images was performed in 33 patients. This technique clearly showed longitudinal morphological changes from the cervical roots to the nerve trunks in the proximal arm. Nerve enlargement was detected in 88% of the patients. According to the clinical subtype of CIDP, typical CIDP patients showed symmetric and root-dominant hypertrophy, whereas Lewis-Sumner syndrome patients had multifocal fusiform hypertrophy in the nerve trunks. The patterns of nerve hypertrophy presumably reflect the different pathophysiology of each CIDP subtype. Ann Neurol 2014.	[Shibuya, Kazumoto; Sugiyama, Atsuhiko; Ito, Sho-ichi; Misawa, Sonoko; Sekiguchi, Yukari; Mitsuma, Satsuki; Watanabe, Keisuke; Shimada, Hitoshi; Kuwabara, Satoshi] Chiba Univ, Grad Sch Med, Dept Neurol, Chiba 2608670, Japan; [Shimada, Hitoshi; Kawaguchi, Hiroshi; Suhara, Tetsuya] Chiba Univ Hosp, Mol Imaging Ctr, Natl Inst Radiol Sci, Chiba, Japan; [Yokota, Hajime; Matsumoto, Hiroshi] Chiba Univ Hosp, Dept Radiol, Chiba, Japan	Kuwabara, S (reprint author), Chiba Univ, Grad Sch Med, Dept Neurol, Chuo Ku, 1-8-1 Inohana, Chiba 2608670, Japan.	kuwabara-s@faculty.chiba-u.jp			Ministry of Education, Culture, Sports, Science, and Technology of Japan [90507360, 30375753, 70282481]; Nakabayashi Trust for ALS research	Funding support was received from the Ministry of Education, Culture, Sports, Science, and Technology of Japan (90507360, K.S.; 30375753, S.Mis.; 70282481, S.K.) and Nakabayashi Trust for ALS research (K.S.).	Kuwabara S, 2006, J NEUROL NEUROSUR PS, V77, P66, DOI 10.1136/jnnp.2005.065441; Sung JY, 2004, MUSCLE NERVE, V29, P28, DOI 10.1002/mus.10516; Vallat JM, 2010, LANCET NEUROL, V9, P402, DOI 10.1016/S1474-4422(10)70041-7; Kuwabara S, 2002, J NEUROL NEUROSUR PS, V72, P37, DOI 10.1136/jnnp.72.1.37; Chhabra A, 2013, AM J NEURORADIOL, V34, P486, DOI 10.3174/ajnr.A3287; Kuwabara S, 1997, NEUROLOGY, V48, P874; Lai WWL, 2007, J NEUROL SCI, V260, P267, DOI 10.1016/j.jns.2007.04.024; Mizuno K, 1998, MUSCLE NERVE, V21, P805; Oguz B, 2003, EUR RADIOL, V13, pL230, DOI 10.1007/s00330-003-1996-3; Rajabally YA, 2014, J NEUROL SCI, V342, P182, DOI 10.1016/j.jns.2014.04.033; Shimizu F, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0104205; Sinclair CDJ, 2011, J NEUROL NEUROSUR PS, V82, P1283, DOI 10.1136/jnnp.2010.211334; vansden Bergh PY, 2010, EUR J NEUROL, V17, P356; Vansden Bergh PY, 2000, MUSCLE NERVE, V23, P283; Yamashita T, 2009, NEW ENGL J MED, V361, P538, DOI 10.1056/NEJMc0902318	15	4	4	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0364-5134	1531-8249		ANN NEUROL	Ann. Neurol.	FEB	2015	77	2					333	337		10.1002/ana.24314		5	Clinical Neurology; Neurosciences	Neurosciences & Neurology	CB1KF	WOS:000349385400017		
J	Gotoh, T				Gotoh, Tetsuo			Untitled	APPLIED ENTOMOLOGY AND ZOOLOGY			English	Editorial Material									Ibaraki Univ, Ami, Ibaraki 3000393, Japan	Gotoh, T (reprint author), Ibaraki Univ, Ami, Ibaraki 3000393, Japan.	gotoh@odokon.org						0	0	0	SPRINGER JAPAN KK	TOKYO	CHIYODA FIRST BLDG EAST, 3-8-1 NISHI-KANDA, CHIYODA-KU, TOKYO, 101-0065, JAPAN	0003-6862	1347-605X		APPL ENTOMOL ZOOL	Appl. Entomol. Zoolog.	FEB	2015	50	1					1	1		10.1007/s13355-015-0324-0		1	Entomology	Entomology	CB0HE	WOS:000349305700001		
J	Imai, T				Imai, Toshihiro			The additive effect of carbon dioxide on mortality of the cigarette beetle Lasioderma serricorne (Coleoptera: Anobiidae) in low-oxygen atmospheres	APPLIED ENTOMOLOGY AND ZOOLOGY			English	Article						Cigarette beetle; Lasioderma serricorne; Controlled atmosphere; Hypoxia; Carbon dioxide	DISCONTINUOUS GAS-EXCHANGE; INSECTS; TOXICITY; HYPOXIA	Low-oxygen (O-2)-controlled atmospheres (CAs) for tobacco pest control require long operation times at moderate temperatures (a parts per thousand currency sign25 A degrees C), causing low throughput and high costs except during summer. The additive effect of CO2 on the mortality of the cigarette beetle Lasioderma serricorne (F.) in 0.5 % O-2 was evaluated to improve the effectiveness of low-O-2 CAs. The lethal times for eggs, larvae, and adults in 0.5 % O-2 were mostly reduced when 3 % CO2 was added. However, the differences were small-only a few percent-and not sufficient to shorten the practical operation times of low-O-2 CAs.	Japan Tobacco Inc, Leaf Tobacco Res Ctr, Oyama, Tochigi 3230808, Japan	Imai, T (reprint author), Japan Tobacco Inc, Leaf Tobacco Res Ctr, Oyama, Tochigi 3230808, Japan.	toshihiro.imai@jt.com					Sakuma M, 1998, APPL ENTOMOL ZOOL, V33, P339; Lighton JRB, 1996, ANNU REV ENTOMOL, V41, P309; Chown SL, 2011, FUNCT ECOL, V25, P1163, DOI 10.1111/j.1365-2435.2011.01879.x; Forster TD, 2010, J INSECT PHYSIOL, V56, P492, DOI 10.1016/j.jinsphys.2009.06.003; Harrison J, 2006, RESP PHYSIOL NEUROBI, V154, P4, DOI 10.1016/j.resp.2006.02.008; Marais E, 2005, J EXP BIOL, V208, P4495, DOI 10.1242/jeb.01928; Lighton JRB, 2008, J EXP BIOL, V211, P563, DOI 10.1242/jeb.010041; Quinlan MC, 2006, RESP PHYSIOL NEUROBI, V154, P18, DOI 10.1016/j.resp.2006.04.004; Mitcham E, 2006, B ENTOMOL RES, V96, P213, DOI 10.1079/BER2006424; Abbott WS, 1925, J ECON ENTOMOL, V18, P265; Hetz SK, 2005, NATURE, V433, P516, DOI 10.1038/nature03106; CALDERON M, 1979, ENTOMOL EXP APPL, V25, P39; Bailey SW, 1975, P 1 INT WORK C STOR, P362; CORESTA, 2013, MOTH; Gay G, 2011, TOBACCO REPORTER, V2011, P52; Imai T, 2012, APPL ENTOMOL ZOOL, V47, P429, DOI 10.1007/s13355-012-0136-4; Imai T, 2006, APPL ENTOMOL ZOOL, V41, P87, DOI 10.1303/aez.2006.87; KRISHNAMURTHY TS, 1986, J STORED PROD RES, V22, P145, DOI 10.1016/0022-474X(86)90008-1; Navarro S, 2013, J PEST SCI, V85, P301	19	0	0	SPRINGER JAPAN KK	TOKYO	CHIYODA FIRST BLDG EAST, 3-8-1 NISHI-KANDA, CHIYODA-KU, TOKYO, 101-0065, JAPAN	0003-6862	1347-605X		APPL ENTOMOL ZOOL	Appl. Entomol. Zoolog.	FEB	2015	50	1					11	15		10.1007/s13355-014-0296-5		5	Entomology	Entomology	CB0HE	WOS:000349305700003		
J	Minakuchi, C; Ohde, T; Miura, K; Tanaka, T; Niimi, T				Minakuchi, Chieka; Ohde, Takahiro; Miura, Ken; Tanaka, Toshiharu; Niimi, Teruyuki			Role of scalloped in the post-embryonic development of the red flour beetle Tribolium castaneum (Coleoptera: Tenebrionidae)	APPLIED ENTOMOLOGY AND ZOOLOGY			English	Article						scalloped; Tribolium castaneum; Ecdysis; Wing formation	TEAD/TEF FAMILY; DROSOPHILA; PATHWAY; YORKIE; METAMORPHOSIS; EFFECTOR; GROWTH; RNAI	scalloped (sd) plays a key role in concert with vestigial (vg) in wing development in Drosophila melanogaster Meigen. We previously showed that as well as its conserved role in wing formation in the 28-spotted ladybird beetle Henosepilachna vigintioctopunctata (Fabricius), sd has a novel function in pupal ecdysis. However, the molecular mechanism responsible remains unknown. To determine whether the function of sd in pupal ecdysis was conserved among Coleoptera, we performed expression and functional analyses of sd in the red flour beetle, Tribolium castaneum (Herbst). T. castaneum sd (Tc-sd) mRNA was present continuously from the embryonic stage to the adult. The RNAi-mediated knockdown of Tc-sd in the larval stage resulted in arrest either in the intermolt phase or during larva-to-larva molting. Prepupae injected with Tc-sd dsRNA were arrested as pupae with shorter wings, while its injection in the early pupal stage resulted in arrest as pharate adults. These results suggested that Tc-sd may be involved in growth, molting, and wing formation. The transcript levels of the genes involved in ecdysone biosynthesis, the ecdysone cascade, and chitin biosynthesis were not markedly affected by the knockdown of Tc-sd, which indicated that Tc-sd knockdown did not affect ecdysone biosynthesis or its cascade directly.	[Minakuchi, Chieka; Ohde, Takahiro; Miura, Ken; Tanaka, Toshiharu; Niimi, Teruyuki] Nagoya Univ, Grad Sch Bioagr Sci, Nagoya, Aichi 4648601, Japan	Minakuchi, C (reprint author), Nagoya Univ, Grad Sch Bioagr Sci, Nagoya, Aichi 4648601, Japan.	c_mina@agr.nagoya-u.ac.jp			JSPS KAKENHI Grant [23780050, 25292199]	We thank Dr. A. Miyanoshita (National Food Research Institute, Japan) for providing T. castaneum. This work was supported by JSPS KAKENHI Grant Numbers 23780050 and 25292199.	Tomoyasu Y, 2004, DEV GENES EVOL, V214, P575, DOI 10.1007/s00427-004-0434-0; CAMPBELL S, 1992, GENE DEV, V6, P367, DOI 10.1101/gad.6.3.367; Riddiford LM, 2012, GEN COMP ENDOCR, V179, P477, DOI 10.1016/j.ygcen.2012.06.001; Black BL, 1998, ANNU REV CELL DEV BI, V14, P167, DOI 10.1146/annurev.cellbio.14.1.167; Minakuchi C, 2008, FEBS J, V275, P2919, DOI 10.1111/j.1742-4658.2008.06428.x; WILLIAMS JA, 1993, DEVELOPMENT, V117, P571; Goulev Y, 2008, CURR BIOL, V18, P435, DOI 10.1016/j.cub.2008.02.034; Huang JB, 2005, CELL, V122, P421, DOI 10.1016/j.cell.2005.06.007; Arakane Y, 2008, INSECT BIOCHEM MOLEC, V38, P959, DOI 10.1016/j.ibmb.2008.07.006; Minakuchi C, 2009, DEV BIOL, V325, P341, DOI 10.1016/j.ydbio.2008.10.016; Wu S, 2008, DEV CELL, V14, P388, DOI 10.1016/j.devcel.2008.01.007; Zhang L, 2008, DEV CELL, V14, P377, DOI 10.1016/j.devcel.2008.01.006; Koontz LM, 2013, DEV CELL, V25, P388, DOI 10.1016/j.devcel.2013.04.021; Deng H, 2009, MOL BIOL CELL, V20, P256, DOI 10.1091/mbc.E08-03-0288; Hentze JL, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0055131; Ohde T, 2009, INSECT MOL BIOL, V18, P571, DOI 10.1111/j.1365-2583.2009.00898.x; Simmonds AJ, 1998, GENE DEV, V12, P3815, DOI 10.1101/gad.12.24.3815; Richards S, 2008, NATURE, V452, P949, DOI 10.1038/nature06784; WILLIAMS JA, 1991, GENE DEV, V5, P2481, DOI 10.1101/gad.5.12b.2481; Yokoi Kakeru, 2012, Results Immunol, V2, P72, DOI 10.1016/j.rinim.2012.03.002	20	0	0	SPRINGER JAPAN KK	TOKYO	CHIYODA FIRST BLDG EAST, 3-8-1 NISHI-KANDA, CHIYODA-KU, TOKYO, 101-0065, JAPAN	0003-6862	1347-605X		APPL ENTOMOL ZOOL	Appl. Entomol. Zoolog.	FEB	2015	50	1					17	26		10.1007/s13355-014-0297-4		10	Entomology	Entomology	CB0HE	WOS:000349305700004		
J	Mita, T; Nishimoto, H; Shimizu, N; Mizutani, N				Mita, Toshiharu; Nishimoto, Hiroyuki; Shimizu, Nobutaka; Mizutani, Nobuo			Occurrence of Trissolcus basalis (Hymenoptera, Platygastridae), an egg parasitoid of Nezara viridula (Hemiptera, Pentatomidae), in Japan	APPLIED ENTOMOLOGY AND ZOOLOGY			English	Article						Distribution; DNA barcoding; Identification; Mitochondrial COI gene	SCELIONIDAE; MORPHOLOGY; BUG	Trissolcus basalis (Wollaston), a cosmopolitan egg parasitoid of Nezara viridula (Linnaeus), was newly discovered in Central Honshu and Kyushu, Japan. The morphological characteristics useful to identify Tr. basalis from other species of Trissolcus occurring in Japan were indicated. Partial mitochondrial COI gene sequences of samples obtained from Aichi to Fukuoka Prefectures almost completely correspond to those obtained from overseas retrieved from the DDBJ/Genbank database. The sequence of Tr. basalis was different by 13-17 % from Trissolcus species compared and Telenomus turesis (Dalman). Further field research is needed to clarify the impact of Tr. basalis on local parasitoid guilds.	[Mita, Toshiharu; Mizutani, Nobuo] NARO Kyushu Okinawa Agr Res Ctr, Koshi, Kumamoto 8611192, Japan; [Nishimoto, Hiroyuki] Aichi Agr Res Ctr, Nagakute, Aichi 4801193, Japan; [Shimizu, Nobutaka] Fukuoka Agr & Forestry Res Ctr, Chikushino, Fukuoka 8188549, Japan	Mita, T (reprint author), NARO Kyushu Okinawa Agr Res Ctr, Koshi, Kumamoto 8611192, Japan.	tkp_ex@hotmail.com			Tokyo University of Agriculture; KAKENHI from the Japan Society of the Promotion of Science [26850032]	Field collecting was kindly aided by Ikumi Moriya, Aoi Mizuochi, Tomomi Nakamura, Hiroaki Odaira, Yu Hikosaka, Yusuke Kawano, Kazunori Matsuo, Mizuki Satake, Reo Ito, Akira Matsuura and Kunihiko Matsuhira. The loan of materials was arranged by Kenzo Yamagishi. K. Yamagishi and Norman F. Johnson are thanked for providing comments on an earlier draft of the manuscript. We also thank Yoshimi Hirose for critically reviewing the manuscript. This study was financially supported by the Support Project for Young Researchers from Tokyo University of Agriculture and KAKENHI (26850032) from the Japan Society of the Promotion of Science.	Aichi Agricultural Research Center, 2008, HEIS 20 PEST FOR SPE; Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404; Folmer O., 1994, Molecular Marine Biology and Biotechnology, V3, P294; Mao M, 2012, GENOME, V55, P194, DOI [10.1139/g2012-005, 10.1139/G2012-005]; CLARKE AR, 1990, AUST J AGR RES, V41, P1127, DOI 10.1071/AR9901127; Jinbo U, 2011, ENTOMOL SCI, V14, P107, DOI 10.1111/j.1479-8298.2011.00449.x; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; JOHNSON NF, 1985, CAN ENTOMOL, V117, P431; Hidaka T., 1958, Acta Hymenopterologica Tokyo, V1, P75; JONES WA, 1988, ANN ENTOMOL SOC AM, V81, P262; Matsuo K, 2014, APPL ENTOMOL ZOOL, V49, P385, DOI 10.1007/s13355-014-0260-4; Mineo Giovanni, 2010, Irish Naturalists' Journal, V31, P113; Nakagawa H, 1900, I SPEC REP AGR EXP S, V6, P1; RYU J, 1984, J FAC AGR KYUSHU U, V29, P35; Sawada H, 2014, ENTOMOL SCI, V17, P324, DOI 10.1111/ens.12061; Su T. H., 1984, Journal of Agriculture and Forestry, V33, P49; Taekul C, 2013, SYST ENTOMOL, V39, P24; Takai M, 2012, FIELD GUIDE JAPANESE, V3, P466; Tomokuni M, 1993, FIELD GUIDE JAPANESE, V1; Watanabe C., 1951, Transactions of the Shikoku Entomological Society, V2, P17; Waterhouse DF, 1998, BIOL CONTROL INSECT; Yukawa J, 2007, APPL ENTOMOL ZOOL, V42, P205, DOI 10.1303/aez.2007.205	22	0	0	SPRINGER JAPAN KK	TOKYO	CHIYODA FIRST BLDG EAST, 3-8-1 NISHI-KANDA, CHIYODA-KU, TOKYO, 101-0065, JAPAN	0003-6862	1347-605X		APPL ENTOMOL ZOOL	Appl. Entomol. Zoolog.	FEB	2015	50	1					27	31		10.1007/s13355-014-0298-3		5	Entomology	Entomology	CB0HE	WOS:000349305700005		
J	Maehara, N; Aikawa, T; Kanzaki, N				Maehara, Noritoshi; Aikawa, Takuya; Kanzaki, Natsumi			Relationship between pine wilt disease development in asymptomatic carrier trees of Bursaphelenchus xylophilus (Nematoda: Apelenchoididae) and their use by Monochamus alternatus (Coleoptera: Cerambycidae)	APPLIED ENTOMOLOGY AND ZOOLOGY			English	Article						Asymptomatic carrier trees; Japanese pine sawyer; Pine wilt disease; Pinewood nematode	HOPE COLEOPTERA; SAWYER; VECTOR	To clarify the effect of asymptomatic carrier trees on the epidemic spread of pine wilt disease, we inoculated Bursaphelenchus xylophilus (Steiner and Buhrer) Nickle into similar to 10-year-old Pinus thunbergii Parl. trees to make asymptomatic carrier trees of the nematodes, and then we examined the relationship between pine wilt disease development in these trees and their use by Monochamus alternatus Hope. Mature adults of M. alternatus were attracted by and oviposited on trees that died in summer and fall, regardless of whether they died in the year of nematode infection or were asymptomatic during the infection year and died the next year. These results suggest that trees that die in summer and fall should be disposed of to help control M. alternatus and limit epidemic spread of the disease. In addition, we suggest the possibility that M. alternatus larvae may not grow and develop in trees that die after the infection year or that M. alternatus adults that emerge from such trees do not carry many B. xylophilus.	[Maehara, Noritoshi; Aikawa, Takuya] Forestry & Forest Prod Res Inst, Tohoku Res Ctr, Morioka, Iwate 0200123, Japan; [Kanzaki, Natsumi] Forestry & Forest Prod Res Inst, Forest Pathol Lab, Tsukuba, Ibaraki 3058687, Japan	Maehara, N (reprint author), Forestry & Forest Prod Res Inst, Tohoku Res Ctr, 92-25 Nabeyashiki, Morioka, Iwate 0200123, Japan.	maehara@ffpri.affrc.go.jp			Japan Society for the Promotion of Science [23380092, 24658143]	We are grateful to the staff of the Experimental Forest, FFPRI, for their assistance in preparing P. thunbergii trees. This work was supported in part by Grants-in-Aid for Scientific Research (B) (No. 23380092) and for Exploratory Research (No. 24658143) from the Japan Society for the Promotion of Science.	Kikuchi T, 2009, PHYTOPATHOLOGY, V99, P1365, DOI 10.1094/PHYTO-99-12-1365; MAMIYA Y, 1972, NEMATOLOGICA, V18, P159; Mota MM, 1999, NEMATOLOGY, V1, P727, DOI 10.1163/156854199508757; Robertson L, 2011, NEMATOLOGY, V13, P755, DOI 10.1163/138855411X578888; MAMIYA Y, 1983, ANNU REV PHYTOPATHOL, V21, P201, DOI 10.1146/annurev.py.21.090183.001221; Arihara T, 1984, T 95 ANN M JPN FOR S, V95, P463; Bergdahl D. R., 1999, Sustainability of pine forests in relation to pine wilt and decline. Proceedings of International Symposium, Tokyo, Japan, 27-28 October, 1998, P73; Furuno T, 1983, B KYOTO U FOR, V55, P1; Futai K, 2003, J FOR RES, V8, P253, DOI [10.1007/s10310-003-0034-2, DOI 10.1007/S10310-003-0034-2]; Hooper D. J., 1986, Laboratory methods for work with plant and soil nematodes., P51; Ichihara Y., 2006, Tohoku Journal of Forest Science, V11, P7; IKEDA T, 1980, Journal of the Japanese Forestry Society, V62, P432; IKEDA T, 1980, APPL ENTOMOL ZOOL, V15, P358; Kishi Y., 1995, PINE WOOD NEMATODE J; Kiyohara T, 1986, T KYUSYU BR JPN FOR, V39, P157; Kiyohara T., 1971, Journal of the Japanese Forestry Society, V53, P210; KOBAYASHI F, 1984, ANNU REV ENTOMOL, V29, P115; LINIT MJ, 1988, J NEMATOL, V20, P227; Morimoto K., 1972, Journal of the Japanese Forestry Society, V54, P177; SHIBATA E, 1986, APPL ENTOMOL ZOOL, V21, P184; Takeuchi Y, 2007, NEMATOLOGY, V9, P243, DOI 10.1163/156854107780739027; Takeuchi Y, 2006, NEMATOLOGY, V8, P869, DOI 10.1163/156854106779799295; Zhao BG, 2008, PINE WILT DIS; Zhou ZJ, 2006, J FOREST RES-JPN, V11, P35, DOI 10.1007/s10310-005-0184-5	24	0	0	SPRINGER JAPAN KK	TOKYO	CHIYODA FIRST BLDG EAST, 3-8-1 NISHI-KANDA, CHIYODA-KU, TOKYO, 101-0065, JAPAN	0003-6862	1347-605X		APPL ENTOMOL ZOOL	Appl. Entomol. Zoolog.	FEB	2015	50	1					33	39		10.1007/s13355-014-0299-2		7	Entomology	Entomology	CB0HE	WOS:000349305700006		
J	Konagaya, T; Watanabe, M				Konagaya, Tatsuro; Watanabe, Mamoru			Adaptive significance of the mating of autumn-morph females with non-overwintering summer-morph males in the Japanese Common Grass Yellow, Eurema mandarina (Lepidoptera: Pieridae)	APPLIED ENTOMOLOGY AND ZOOLOGY			English	Article						Apyrene sperm; Eupyrene sperm; Seasonal polyphenism; Spermatheca; Spermatophore	BUTTERFLIES; HECABE; INSECT; SPERM; REPRODUCTION; PLASTICITY; BEHAVIOR	Autumn-morph adults of the Japanese Common Grass Yellow, Eurema mandarina (de l'Orza), overwinter with reproductive diapause, while the summer-morph adults do not. A low temperature and short photoperiod induce autumn-morph adults. Because of different critical photoperiods between the sexes, the summer-morph males coexist with the autumn-morph adults in late autumn. While autumn-morph males show little mating activity, mating between summer-morph males and autumn-morph females frequently occurs. Thereafter, mated autumn-morph females re-mate with autumn-morph males the following spring. Two hypotheses, a nuptial gift hypothesis and a risk-hedge hypothesis, explaining the adaptive significance of pre-overwinter copulation by autumn-morph females were examined. Wild autumn-morph females were collected in November, late March, April and early May. The decrease in the number of eggs contained in autumn-morph females indicated that they started oviposition in mid-April. The shape of the spermatophore suggested that autumn-morph females could re-mate with autumn-morph males before mid-April. Although the eupyrene sperm of the summer-morph males remained in the spermatheca just after overwintering, the nuptial gift hypothesis is more plausible than the risk-hedge hypothesis because most females re-mated in the spring before the onset of oviposition. A counter-adaptation of summer-morph males acting as a strategy for mating with autumn-morph females was also discussed.	[Konagaya, Tatsuro; Watanabe, Mamoru] Univ Tsukuba, Grad Sch Life & Environm Sci, Lab Conservat Ecol, Tsukuba, Ibaraki 3058572, Japan	Watanabe, M (reprint author), Univ Tsukuba, Grad Sch Life & Environm Sci, Lab Conservat Ecol, Tsukuba, Ibaraki 3058572, Japan.	watanabe@kankyo.envr.tsukuba.ac.jp			JSPS KAKENHI grant [24570019]	We thank Dr. T. Yokoi, Assistant Professor, University of Tsukuba, for valuable comments on this research. This work was supported in part by JSPS KAKENHI grant no. 24570019 (MW).	LEOPOLD RA, 1976, ANNU REV ENTOMOL, V21, P199, DOI 10.1146/annurev.en.21.010176.001215; Watanabe M, 2000, J ETHOL, V18, P91, DOI 10.1007/s101640070006; BOGGS CL, 1979, SCIENCE, V206, P83, DOI 10.1126/science.206.4414.83; Tatar M, 2001, EXP GERONTOL, V36, P723, DOI 10.1016/S0531-5565(00)00238-2; Cook PA, 1999, NATURE, V397, P486, DOI 10.1038/17257; WIKLUND C, 1993, BEHAV ECOL SOCIOBIOL, V33, P25, DOI 10.1007/BF00164343; BOGGS CL, 1981, OECOLOGIA, V50, P320, DOI 10.1007/BF00344970; Danks HV, 1987, INSECT DORMANCY ECOL; Fukuda H, 1982, LIFE HIST BUTTERFLIE, VI; KATO Y, 1986, J ETHOL, V4, P81, DOI 10.1007/BF02348109; KATO Y, 1987, PHYSIOL ENTOMOL, V12, P417, DOI 10.1111/j.1365-3032.1987.tb00768.x; KATO Y, 1989, J INSECT BEHAV, V2, P419, DOI 10.1007/BF01068066; Leong KHL, 2012, J LEPID SOC, V66, P205; NYLIN S, 1992, BIOL J LINN SOC, V47, P301, DOI 10.1111/j.1095-8312.1992.tb00672.x; Prudic KL, 2011, SCIENCE, V331, P73, DOI 10.1126/science.1197114; R Development Core Team, 2013, LANG ENV STAT COMP; Rasband WS, 2014, IMAGEJ; Roth S, 2003, P ROY SOC B-BIOL SCI, V270, pS54, DOI 10.1098/rsbl.2003.0008; RUTOWSKI RL, 1987, BEHAV ECOL SOCIOBIOL, V20, P319, DOI 10.1007/BF00300677; Simmons LW, 2001, SPERM COMPETITION IT; STEVENS L, 1989, ECOL ENTOMOL, V14, P219, DOI 10.1111/j.1365-2311.1989.tb00772.x; SUGAWARA T, 1979, J COMP PHYSIOL, V130, P191; Tomioka K, 1970, INSECTS NATURE, V5, P16; Watanabe Mamoru, 1993, Japanese Journal of Entomology, V61, P691; Yata O., 1974, Tyo to Ga, V25, P47	25	1	1	SPRINGER JAPAN KK	TOKYO	CHIYODA FIRST BLDG EAST, 3-8-1 NISHI-KANDA, CHIYODA-KU, TOKYO, 101-0065, JAPAN	0003-6862	1347-605X		APPL ENTOMOL ZOOL	Appl. Entomol. Zoolog.	FEB	2015	50	1					41	47		10.1007/s13355-014-0300-0		7	Entomology	Entomology	CB0HE	WOS:000349305700007		
J	Yumino, M; Togashi, K				Yumino, Mizuho; Togashi, Katsumi			Large variation in length of egg period in Psacothea hilaris (Coleoptera: Cerambycidae)	APPLIED ENTOMOLOGY AND ZOOLOGY			English	Article						Egg period; Conflict between parent and offspring; Postembryonic development; Yellow-spotted longicorn beetle	SPOTTED LONGICORN BEETLE; PASCOE COLEOPTERA; GEOGRAPHIC-VARIATION; LARVAL DIAPAUSE; LIFE-CYCLE; ECOTYPES; JAPAN	To determine the difference in egg-period length and its effects on postembryonic development in Psacothea hilaris (Pascoe), 14 adult females, which were captured in Yayoi, Tokyo, and their offspring were reared at 25 A degrees C under a photoperiodic regime of 16-h photophase and 8-h scotophase. When 1,486 eggs were placed on wet tissue paper within a day of oviposition, they took from 7 to > 40 days to hatch, although 85.9 % of larvae hatched between 7 and 13 days following oviposition; 71 % of females produced larvae with long egg periods of 21 or more days. When 78 newly hatched larvae with different egg-period lengths were reared singly in sections of mulberry shoots, 39 emerged as adults between 57 and 117 days posthatching. Dissection showed two feeding larvae and a diapause pupa in shoot sections 141-168 days after larval hatching. A tradeoff was observed between the egg-period length and the time taken for postembryonic development in females, but not in males. Egg-period length did not affect adult body size. An increased amount of available food (volume of shoot sections) increased adult body size but did not affect the time for postembryonic development.	[Yumino, Mizuho] Univ Tokyo, Fac Agr, Bunkyo Ku, Tokyo 1138657, Japan; [Togashi, Katsumi] Univ Tokyo, Grad Sch Agr & Life Sci, Lab Forest Zool, Bunkyo Ku, Tokyo 1138657, Japan	Togashi, K (reprint author), Univ Tokyo, Grad Sch Agr & Life Sci, Lab Forest Zool, Bunkyo Ku, Tokyo 1138657, Japan.	togashi@fr.a.u-tokyo.ac.jp					Danks HV, 2006, APPL ENTOMOL ZOOL, V41, P1, DOI 10.1303/aez.2006.1; Hopper KR, 1999, ANNU REV ENTOMOL, V44, P535, DOI 10.1146/annurev.ento.44.1.535; Arnaud L, 2005, J INSECT SCI, V5; Iba Masaki, 1993, Bulletin of the National Institute of Sericultural and Entomological Science, V8, P1; Iba M, 1976, J SERIC SCI JPN, V45, P156; Iba M, 1980, J SERIC SCI JPN, V49, P429; IBA M., 1976, J SERIC SCI JPN, V45, P443; Munyiri FN, 2003, APPL ENTOMOL ZOOL, V38, P509, DOI 10.1303/aez.2003.509; ROFF DA, 1986, BIOSCIENCE, V36, P316, DOI 10.2307/1310236; Sakakibara M, 1992, PLANT PROTECTION, V46, P513; SAKAKIBARA M, 1995, JPN J APPL ENTOMOL Z, V39, P59; SAKAKIBARA M, 1995, JPN J APPL ENTOMOL Z, V39, P213; SAKAKIBARA M, 1992, APPL ENTOMOL ZOOL, V27, P47; Shimane T, 1991, B NATL I SERICULTURA, V2, P65; Shintani Y, 1996, APPL ENTOMOL ZOOL, V31, P495; Shintani Y, 1999, PHYSIOL ENTOMOL, V24, P158, DOI 10.1046/j.1365-3032.1999.00126.x; Shintani Y, 1996, APPL ENTOMOL ZOOL, V31, P489; Shintani Y, 1999, ENVIRON ENTOMOL, V28, P690; TAKAHASHI F, 1977, Researches on Population Ecology (Tokyo), V18, P235, DOI 10.1007/BF02510850; Watari Y, 2002, APPL ENTOMOL ZOOL, V37, P559, DOI 10.1303/aez.2002.559	20	0	0	SPRINGER JAPAN KK	TOKYO	CHIYODA FIRST BLDG EAST, 3-8-1 NISHI-KANDA, CHIYODA-KU, TOKYO, 101-0065, JAPAN	0003-6862	1347-605X		APPL ENTOMOL ZOOL	Appl. Entomol. Zoolog.	FEB	2015	50	1					49	55		10.1007/s13355-014-0301-z		7	Entomology	Entomology	CB0HE	WOS:000349305700008		
J	Katsuma, S; Bando, H; Shimada, T				Katsuma, Susumu; Bando, Hisanori; Shimada, Toru			Deletion analysis of a superoxide dismutase gene of Bombyx mori (Lepidoptera: Bombycidae) nucleopolyhedrovirus	APPLIED ENTOMOLOGY AND ZOOLOGY			English	Article						Baculovirus; SOD; BmNPV; Bombyx mori; Bacmid	GENOME SEQUENCE; CELL-LINES; BACULOVIRUS; INFECTION; IDENTIFICATION; SILKWORM	Superoxide dismutase (SOD) is an enzyme that catalyzes the dismutation of the superoxide anion. Homologs of a Cu/Zn-SOD gene were found in the genomes of most lepidopteran baculoviruses; however, its function is poorly understood. In this study, we characterized the sod gene of Bombyx mori (Lepidoptera: Bombycidae) nucleopolyhedrovirus (BmNPV). Western blot analysis revealed that His-tagged BmNPV SOD was expressed as an approximately 17-kDa protein. Reverse transcription-quantitative polymerase chain reaction demonstrated that BmNPV sod mRNA was detected at 8 h postinfection (hpi), peaked at 36 hpi, and declined gradually. In contrast, B. mori sod declined rapidly and was almost completely diminished from 36 hpi. To comprehend the role of BmNPV sod during virus infection, we used an sod-disrupted BmNPV bacmid. We found that deletion of sod from the BmNPV genome had little effect on virus propagation in cultured cells, whereas production of budded viruses and occlusion bodies were significantly delayed in B. mori larvae. These results indicate that BmNPV SOD plays a role in efficient virus propagation in B. mori larvae.	[Katsuma, Susumu; Shimada, Toru] Univ Tokyo, Grad Sch Agr & Life Sci, Dept Agr & Environm Biol, Bunkyo Ku, Tokyo 1138657, Japan; [Bando, Hisanori] Hokkaido Univ, Grad Sch Agr, Div Appl Biosci, Lab Appl Mol Entomol, Sapporo, Hokkaido 0608589, Japan	Katsuma, S (reprint author), Univ Tokyo, Grad Sch Agr & Life Sci, Dept Agr & Environm Biol, Bunkyo Ku, Yayoi 1-1-1, Tokyo 1138657, Japan.	katsuma@ss.ab.a.u-tokyo.ac.jp	Shimada, Toru/A-2033-2011	Shimada, Toru/0000-0002-5791-0000	JSPS KAKENHI Grant [19688004, 25292196]	We thank Dr. K. Iiyama (Kyushu University) for technical advice. We also thank Munetaka Kawamoto for clerical assistance. This work was supported by JSPS KAKENHI Grant Numbers 19688004 and 25292196 to S.K.	MAEDA S, 1985, NATURE, V315, P592, DOI 10.1038/315592a0; Katsuma S, 2006, VIROLOGY, V355, P62, DOI 10.1016/j.virol.2006.07.008; Ono C, 2012, VIRUS RES, V165, P197, DOI 10.1016/j.virusres.2012.02.016; Katsuma S, 2006, J VIROL, V80, P5474, DOI 10.1128/JVI.00248-06; Hou DH, 2013, J VIROL, V87, P829, DOI 10.1128/JVI.02329-12; Herniou EA, 2001, J VIROL, V75, P8117, DOI 10.1128/JVI.75.17.8117-8126.2001; Katsuma S, 2012, J VIROL, V86, P2545, DOI 10.1128/JVI.06308-11; Bergin D, 2005, INFECT IMMUN, V73, P4161, DOI 10.1128/IAI.73.7.4161-4170.2005; Nobiron I, 2003, J GEN VIROL, V84, P3029, DOI 10.1099/vir.0.19270-0; Wang Y, 2001, FREE RADICAL BIO MED, V31, P1448, DOI 10.1016/S0891-5849(01)00728-6; OOI BG, 1988, VIROLOGY, V166, P515, DOI 10.1016/0042-6822(88)90522-3; Iwanaga M, 2004, BIOCHEM BIOPH RES CO, V323, P599, DOI 10.1016/j.bbrc.2004.08.114; Kamita SG, 2005, P NATL ACAD SCI USA, V100, P14121; Katsuma S, 2011, J GEN VIROL, V92, P200, DOI 10.1099/vir.0.025908-0; Katsuma S, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002644; Katsuma S, 2008, INSECT BIOCHEM MOLEC, V38, P1080, DOI 10.1016/j.ibmb.2008.05.008; Ono Chikako, 2007, Journal of Insect Biotechnology and Sericology, V76, P161; TOMALSKI MD, 1991, VIROLOGY, V184, P149, DOI 10.1016/0042-6822(91)90831-U; Wang YS, 2012, J VIROL, V86, P11948, DOI 10.1128/JVI.02119-12; Yamamoto K, 2005, BIOSCI BIOTECH BIOCH, V69, P507, DOI 10.1271/bbb.69.507	20	0	0	SPRINGER JAPAN KK	TOKYO	CHIYODA FIRST BLDG EAST, 3-8-1 NISHI-KANDA, CHIYODA-KU, TOKYO, 101-0065, JAPAN	0003-6862	1347-605X		APPL ENTOMOL ZOOL	Appl. Entomol. Zoolog.	FEB	2015	50	1					57	62		10.1007/s13355-014-0304-9		6	Entomology	Entomology	CB0HE	WOS:000349305700009		
J	Sogo, K; Miura, K; Aizawa, M; Watanabe, T; Stouthamer, R				Sogo, Kazushi; Miura, Kazuki; Aizawa, Misato; Watanabe, Takeo; Stouthamer, Richard			Genetic structure in relation to reproduction mode in Thrips tabaci (Insecta: Thysanoptera)	APPLIED ENTOMOLOGY AND ZOOLOGY			English	Article						Mitochondrial DNA; Phylogeny; Reproductive mode; Thrips tabaci	LIRIOMYZA-HUIDOBRENSIS DIPTERA; LINDEMAN THYSANOPTERA; VECTOR COMPETENCE; RIBOSOMAL DNA; MITOCHONDRIAL; POPULATIONS; AGROMYZIDAE; FORMS; DIFFERENTIATION; DISCRIMINATION	In agriculture, although it is important to identify species of pest insects, their morphological identification is often difficult. DNA genotyping is useful for identifying morphologically indiscriminable species. Thrips tabaci Lindeman has two reproductive modes (arrhenotoky and thelytoky), which differ in their pesticide resistance, but morphological discrimination is not possible. Studies have established a simple method of discriminating the strains by using their mitochondrial DNA sequences. Previous studies have placed so-called arrhenotokous individuals into a "polyphagous thelytokous clade." We made the discovery of new arrhenotokous strains that place them in the thelytokous monophyletic group. We show that this polyphagous thelytokous clade is not a monophyletic group. Therefore, the methods currently used to distinguish thelytokous and arrhenotokous individuals need to be updated, and we need to detect another region of DNA that will enable us to discriminate between the two types.	[Sogo, Kazushi; Aizawa, Misato; Watanabe, Takeo] Kagawa Prefectural Agr Expt Stn, Ayakawa 7612306, Japan; [Miura, Kazuki] NARO Western Reg Agr Res Ctr, Fukuyama, Hiroshima 7218514, Japan; [Stouthamer, Richard] Univ Calif Riverside, Dept Entomol, Riverside, CA 92521 USA	Miura, K (reprint author), NARO Western Reg Agr Res Ctr, Fukuyama, Hiroshima 7218514, Japan.	miurak@affrc.go.jp					Chatzivassiliou EK, 2002, PHYTOPATHOLOGY, V92, P603, DOI 10.1094/PHYTO.2002.92.6.603; Murai T, 2001, ENTOMOL EXP APPL, V101, P281, DOI 10.1023/A:1019252708938; Sota T, 2001, SYST BIOL, V50, P39, DOI 10.1080/106351501750107459; Toda S, 2007, APPL ENTOMOL ZOOL, V42, P309, DOI 10.1303/aez.2007.309; WEISBURG WG, 1991, J BACTERIOL, V173, P697; Mallet J, 2007, NATURE, V446, P279, DOI 10.1038/nature05706; Brunner PC, 2004, HEREDITY, V93, P364, DOI 10.1038/sj.hdy.6800512; Chatzivassiliou EK, 1999, PLANT PATHOL, V48, P700, DOI 10.1046/j.1365-3059.1999.00414.x; Kobayashi K, 2012, J ECON ENTOMOL, V105, P555, DOI 10.1603/EC11320; Westmore GC, 2013, HEREDITY, V111, P210, DOI 10.1038/hdy.2013.39; Nault BA, 2006, ENVIRON ENTOMOL, V35, P1264, DOI 10.1603/0046-225X(2006)35[1264:RMIOTT]2.0.CO;2; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; STOUTHAMER R, 1990, P NATL ACAD SCI USA, V87, P2424, DOI 10.1073/pnas.87.7.2424; Inoue T, 2007, APPL ENTOMOL ZOOL, V42, P71, DOI 10.1303/aez.2007.71; Jacobson AL, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054484; KENDALL DM, 1990, SOUTHWEST ENTOMOL, V15, P80; Kobayashi K, 2013, SCI REP-UK, V3, DOI 10.1038/srep03286; Torres-Vila L.M., 1994, Boletin de Sanidad Vegetal Plagas, V20, P661; Lewis T., 1973, THRIPS THEIR BIOL EC; Lewis Trevor, 1997, P175; Miura K, 2004, J ECON ENTOMOL, V97, P964, DOI 10.1603/0022-0493(2004)097[0964:AOMTTD]2.0.CO;2; Palumbi Stephen R., 1996, P205; Parrella M. P., 1984, Bulletin of the Entomological Society of America, V30, P22; Rossman AY, 1996, ANN MO BOT GARD, V83, P17, DOI 10.2307/2399964; Scheffer SJ, 2000, J ECON ENTOMOL, V93, P1146; Scheffer SJ, 2001, ANN ENTOMOL SOC AM, V94, P648, DOI 10.1603/0013-8746(2001)094[0648:TNGCME]2.0.CO;2; Suomalainen Esko, 1993, P100; Takeuchi R, 2011, JPN J APPL ENTOMOL Z, V55, P254, DOI 10.1303/jjaez.2011.254; Toda S, 2009, J ECON ENTOMOL, V102, P2296; WIJKAMP I, 1995, PHYTOPATHOLOGY, V85, P1069, DOI 10.1094/Phyto-85-1069; Zhang DX, 1996, INSECT MOL BIOL, V6, P143, DOI DOI 10.1111/J.1365-2583.1997.TB00082.X	32	0	0	SPRINGER JAPAN KK	TOKYO	CHIYODA FIRST BLDG EAST, 3-8-1 NISHI-KANDA, CHIYODA-KU, TOKYO, 101-0065, JAPAN	0003-6862	1347-605X		APPL ENTOMOL ZOOL	Appl. Entomol. Zoolog.	FEB	2015	50	1					73	77		10.1007/s13355-014-0306-7		5	Entomology	Entomology	CB0HE	WOS:000349305700011		
J	Suenaga, H; Hamamura, T				Suenaga, Hiroshi; Hamamura, Tetsuzo			Effects of manipulated density of the wolf spider, Pardosa astrigera (Araneae: Lycosidae), on pest populations and cabbage yield: a field enclosure experiment	APPLIED ENTOMOLOGY AND ZOOLOGY			English	Article						Wolf spiders; Plutella xylostella; Straw mulch; Conservation biological control; Generalist predators	CARABID BEETLES COLEOPTERA; GENERALIST PREDATORS; DIAMONDBACK MOTH; TROPHIC CASCADES; BIOCONTROL AGENTS; WINTER-WHEAT; INTERFERENCE; CANNIBALISM; LEPIDOPTERA; COMPLEX	We manipulated the density of the wolf spider, Pardosa astrigera L. Koch in enclosed cabbage plots (2 x 2 m) to assess the impact on the herbivore density and crop yield. P. astrigera was introduced to half of the enclosures at densities of 25 and 50 individuals/m(2) in the spring and autumn experiments, respectively; spiders were removed from other enclosures. The results indicated that P. astrigera significantly suppressed the densities of the diamondback moth, Plutella xylostella (L.), in the spring, and the green peach aphid, Myzus persicae (Sulzer), in the autumn experiments. The cabbage yield did not increase, despite the suppression of these herbivores. P. astrigera had no impact on three other lepidopteran species: Pieris rapae crucivora Boisduval, Autographa nigrisigna (Walker), and Mamestra brassicae (L.). The number of spiders increased by 23 % but decreased by 62 % at the end of the spring and autumn experiments, respectively, compared with the initial numbers introduced. Our results show that wolf spiders (Lycosidae) would be effective biocontrol agents of certain herbivore species if spiders abundantly occur early in the crop season and remain stable throughout the season. However, further investigations are required to determine the effect of spiders on the crop yield.	[Suenaga, Hiroshi; Hamamura, Tetsuzo] Natl Res Inst Vegetables Ornamental Plants & Tea, Ano, Mie 5142392, Japan; [Hamamura, Tetsuzo] Kubota, Tsu, Mie 5140125, Japan	Suenaga, H (reprint author), Kagoshima Prefectural Inst Agr Dev, 2200 Ohno, Minami Satsuma, Kagoshima 8993401, Japan.	suenaga-hiroshi@pref.kagoshima.lg.jp					Halaj J, 2000, ENVIRON ENTOMOL, V29, P383, DOI 10.1603/0046-225X(2000)029[0383:MHREGP]2.0.CO;2; Schmidt MH, 2004, ENTOMOL EXP APPL, V113, P87, DOI 10.1111/j.0013-8703.2004.00205.x; Halaj J, 2002, ECOLOGY, V83, P3141, DOI 10.2307/3071849; Snyder WE, 2001, ECOLOGY, V82, P1571, DOI 10.1890/0012-9658(2001)082[1571:CTCGBA]2.0.CO;2; Yamamura K, 1999, RES POPUL ECOL, V41, P229; de Roince CB, 2013, B ENTOMOL RES, V103, P148, DOI 10.1017/S0007485312000636; Finke DL, 2004, NATURE, V429, P407, DOI 10.1038/nature02554; Furlong MJ, 2013, ANNU REV ENTOMOL, V58, P517, DOI 10.1146/annurev-ento-120811-153605; CARTER PE, 1995, OIKOS, V72, P433, DOI 10.2307/3546129; Snyder WE, 1999, BIOL CONTROL, V15, P283, DOI 10.1006/bcon.1999.0723; Birkhofer K, 2008, B ENTOMOL RES, V98, P249, DOI 10.1017/S0007485308006019; RIECHERT SE, 1990, ECOLOGY, V71, P1441, DOI 10.2307/1938281; Sunderland K, 2000, ENTOMOL EXP APPL, V95, P1, DOI 10.1023/A:1003986225443; Symondson WOC, 2002, ANNU REV ENTOMOL, V47, P561, DOI 10.1146/annurev.ento.47.091201.145240; Ayalew G, 2006, CROP PROT, V25, P915, DOI 10.1016/j.cropro.2005.12.001; CHIKUNI Y., 1989, PICTORIAL ENCY SPIDE; Ditner N, 2013, BIODIVERS CONSERV, V22, P1049, DOI 10.1007/s10531-013-0469-5; Furlong MJ, 2004, J ECON ENTOMOL, V97, P1814; Keppel G., 1991, DESIGN ANAL RES HDB; KIRITANI K, 1972, Researches on Population Ecology (Tokyo), V13, P187, DOI 10.1007/BF02521977; KIRITANI K, 1975, Researches on Population Ecology (Tokyo), V17, P29, DOI 10.1007/BF02510875; Lang A, 2003, OECOLOGIA, V134, P144, DOI 10.1007/s00442-002-1091-5; Langellotto GA, 2006, ECOL ENTOMOL, V31, P575, DOI 10.1111/j.1365-2311.2006.00816.x; Liu YQ, 2014, BIOL CONTROL, V68, P37, DOI 10.1016/j.biocontrol.2013.06.008; Luff M.L., 1987, Agricultural Zoology Reviews, V2, P237; Miranda F, 2011, ENVIRON ENTOMOL, V40, P333, DOI 10.1603/EN10277; Miyashita K., 1968, Bull natn Inst agr Sci Japan (Ser C), VNo. 22, P329; MIYASHITA K, 1969, Applied Entomology and Zoology, V4, P1; Morishita M, 1998, P KANSCI PL PROT, V40, P77; NAKASUJI F, 1973, Kontyu, V41, P220; Nemoto H., 1986, Diamondback Moth Management. Proceedings of the First International Workshop, Tainan, Taiwan, 11-15 March, 1985., P387; Nentwig W., 1987, P249; Okada T, 2003, AGR INSECT PESTS JAP, P195; Ozaki Y, 1977, P ASS PL PROT SHIKOK, V12, P75; Rickers S, 2005, BASIC APPL ECOL, V6, P471, DOI 10.1016/j.baae.2005.02.007; Riechert Susan E., 1998, P211; SASABA T, 1974, Applied Entomology and Zoology, V9, P273; Senior LJ, 2011, P 6 INT WORKSH MAN D, P114; StatSoft Inc, 1999, US MAN; Suenaga H, 1998, ENVIRON ENTOMOL, V27, P767; Suenaga H, 2001, APPL ENTOMOL ZOOL, V36, P151, DOI 10.1303/aez.2001.151; Suzuki Y., 1975, Acta Arachnologica, V26, P58, DOI 10.2476/asjaa.26.58; Toft S, 2005, EUR J ENTOMOL, V102, P371; Vichitbandha P, 2002, AGR FOREST ENTOMOL, V4, P31, DOI 10.1046/j.1461-9563.2002.00118.x; Von Ende C. N., 2001, DESIGN ANAL ECOLOGIC, P134; Welch K.D., 2012, P41; Wise D. H., 1993, SPIDERS ECOLOGICAL W; YAMADA H, 1985, JPN J APPL ENTOMOL Z, V29, P170; Yasudomi N, 1993, P ASS PL PROT SHINKO, V28, P89	49	1	1	SPRINGER JAPAN KK	TOKYO	CHIYODA FIRST BLDG EAST, 3-8-1 NISHI-KANDA, CHIYODA-KU, TOKYO, 101-0065, JAPAN	0003-6862	1347-605X		APPL ENTOMOL ZOOL	Appl. Entomol. Zoolog.	FEB	2015	50	1					89	97		10.1007/s13355-014-0310-y		9	Entomology	Entomology	CB0HE	WOS:000349305700013		
J	Trisnawati, DW; Tsukamoto, T; Yasuda, H				Trisnawati, Dina Wahyu; Tsukamoto, Takayuki; Yasuda, Hironori			Indirect effects of nutrients in organic and conventional paddy field soils on the rice grasshopper, Oxya japonica (Orthoptera: Acrididae), mediated by rice plant nutrients	APPLIED ENTOMOLOGY AND ZOOLOGY			English	Article						Chemical fertilizer; Rice grasshopper; Insect response; Plant quality; Soil fertility	FERTILITY MANAGEMENT; INSECT HERBIVORES; NITROGEN; RESPONSES; QUALITY; FERTILIZATION; METAANALYSIS; PERFORMANCE; GENERALIST; OUTBREAKS	Current agricultural technology depends on synthetic fertilizers and enhances the growth of herbivorous insect populations. Some organic farming uses bio-based nutrients instead and is considered the most promising way to mitigate the negative effects of conventional farming. The rice grasshopper Oxya japonica (Thunberg) (Orthoptera: Acrididae) is the most abundant herbivore in both conventional and organic fields in northern Japan. This study investigated the effects of soil nutrients associated with conventional versus organic farming on rice plant quality,and the growth and performance of O. japonica in paddy fields at Sakata, Yamagata Prefecture. A laboratory experiment was also conducted to understand the effects, as mediated by host plant quality, of organic and conventional soil nutrients on the growth and feeding (as measured by the leaf area consumed) of O. japonica. Nymphs of O. japonica that fed on nitrogen-rich, carbon-poor plants cultivated in conventional soil grew and developed faster than those feeding on organic plants. The rice plants in conventional fields had greater biomasses, suggesting that they were more likely to tolerate grasshopper damage. These results support the importance of soil nutrient management as a factor that influences plant-herbivore interactions.	[Trisnawati, Dina Wahyu] Iwate Univ, United Grad Sch Agr Sci, Morioka, Iwate 0208550, Japan; [Tsukamoto, Takayuki; Yasuda, Hironori] Yamagata Univ, Fac Agr, Tsuruoka, Yamagata 9978555, Japan	Trisnawati, DW (reprint author), Iwate Univ, United Grad Sch Agr Sci, Morioka, Iwate 0208550, Japan.	dee.wtrisnawati@tds1.tr.yamagata-u.ac.jp			Yamagata University Center of Excellence Program (YU-COE); Japan Society for the Promotion of Science [23405045]	We thank Dr. Koichi Tanaka and Dr. Koji Ueda for making helpful suggestions regarding the manuscript, and Prof. E.W. Evans for providing valuable comments and English correction. We also greatly appreciate the two anonymous reviewers who gave us valuable and fruitful comments. This study was supported by funding from the Yamagata University Center of Excellence Program (YU-COE) and a grant-in-aid from the Japan Society for the Promotion of Science (No. 23405045).	ANDO Y, 1993, APPL ENTOMOL ZOOL, V28, P217; Joern A, 1997, OECOLOGIA, V112, P201, DOI 10.1007/s004420050301; Bengtsson J, 2005, J APPL ECOL, V42, P261, DOI 10.1111/j.1365-2664.2005.01005.x; Altieri MA, 2003, SOIL TILL RES, V72, P203, DOI 10.1016/S0167-1987(03)00089-8; Awmack CS, 2002, ANNU REV ENTOMOL, V47, P817, DOI 10.1146/annurev.ento.47.091201.145300; Sarfraz M, 2009, BIOL CONTROL, V51, P34, DOI 10.1016/j.biocontrol.2009.07.004; Hsu YT, 2009, J ECON ENTOMOL, V102, P160; Ponce C, 2011, AGR ECOSYST ENVIRON, V141, P193, DOI 10.1016/j.agee.2011.02.030; Bulluck LR, 2002, APPL SOIL ECOL, V19, P147, DOI 10.1016/S0929-1393(01)00187-1; Staley JT, 2010, P R SOC B, V277, P779, DOI 10.1098/rspb.2009.1631; Phelan PL, 1995, AGR ECOSYST ENVIRON, V56, P1, DOI 10.1016/0167-8809(95)00640-0; Hansen B, 2000, EUR J AGRON, V13, P65, DOI 10.1016/S1161-0301(00)00060-5; Stafford DB, 2012, AGR FOREST ENTOMOL, V14, P270, DOI 10.1111/j.1461-9563.2011.00565.x; MATTSON WJ, 1987, BIOSCIENCE, V37, P110, DOI 10.2307/1310365; Loaiza V, 2011, INSECT SCI, V18, P533, DOI 10.1111/j.1744-7917.2010.01376.x; Mattson WJ, 2005, OIKOS, V111, P337, DOI 10.1111/j.0030-1299.2005.13634.x; Forkner RE, 2000, ECOLOGY, V81, P1588, DOI 10.1890/0012-9658(2000)081[1588:WGUMCD]2.0.CO;2; Batjes NH, 1996, EUR J SOIL SCI, V47, P151, DOI 10.1111/j.1365-2389.1996.tb01386.x; Butler J, 2012, ANN APPL BIOL, V161, P223, DOI 10.1111/j.1744-7348.2012.00567.x; Condron LM, 2010, NZ J AGR RES, V43, P443; Dixon AFG, 2000, INSECT PREDATOR PREY; Ebeling A, 2013, BASIC APPL ECOL, V14, P246, DOI 10.1016/j.baae.2013.01.006; Facknath S, 2005, ENTOMOL EXP APPL, V115, P67, DOI 10.1111/j.1570-7458.2005.00288.x; Fukuhara N, 1982, PLANT PROTECT, V36, P524; Fukuhara N, 1982, PLANT PROT, V36, P571; Garratt MPD, 2010, ENTOMOL EXP APPL, V134, P211, DOI 10.1111/j.1570-7458.2009.00957.x; Japan Meteorological Agency Web site, 2013, 1008122 JAP MET AG; Joern A., 1990, P415; Jones C. G., 1991, RESPONSE PLANTS MULT, P249; KAJIMURA T, 1993, JPN J APPL ENTOMOL Z, V37, P137; Kidokoro T, 1998, ANN REPT PLANT PROT, V49, P109; Konno Y, 1999, ANN REPT PLANT PROT, V50, P145; Lu ZhongXian, 2007, Rice Science, V14, P56, DOI 10.1016/S1672-6308(07)60009-2; Lue A, 2007, MAN CARB CYCL KAT WO; MATTSON WJ, 1980, ANNU REV ECOL SYST, V11, P119, DOI 10.1146/annurev.es.11.110180.001003; McNeil S, 1978, BIOCH ASPECTS PLANT, P77; Pidwirny M, 2011, KOPPEN CLIMATE CLASS; Pope TW, 2012, J APPL ENTOMOL, V136, P445, DOI 10.1111/j.1439-0418.2011.01667.x; Ritchie ME, 1998, ECOLOGY, V79, P165, DOI 10.2307/176872; Scriber J.M., 1984, P159; Staley JT, 2011, J APPL ENTOMOL, V135, P658, DOI 10.1111/j.1439-0418.2010.01604.x; van Huis A, 2008, ENTOMOL EXP APPL, V127, P144, DOI 10.1111/j.1570-7458.2008.00682.x; WHITE TCR, 1976, OECOLOGIA, V22, P119, DOI 10.1007/BF00344712; Zuur A., 2009, MIXED EFFECTS MODELS	44	0	0	SPRINGER JAPAN KK	TOKYO	CHIYODA FIRST BLDG EAST, 3-8-1 NISHI-KANDA, CHIYODA-KU, TOKYO, 101-0065, JAPAN	0003-6862	1347-605X		APPL ENTOMOL ZOOL	Appl. Entomol. Zoolog.	FEB	2015	50	1					99	107		10.1007/s13355-014-0309-4		9	Entomology	Entomology	CB0HE	WOS:000349305700014		
J	Funayama, K				Funayama, Ken			Nutritional status of overwintering adults of the brown marmorated stink bug, Halyomorpha halys (Hemiptera: Pentatomidae), is affected by cone counts of Japanese cedar, Cryptomeria japonica, in northern Japan	APPLIED ENTOMOLOGY AND ZOOLOGY			English	Article						Halyomorpha halys; Japanese cedar cone; Overwintering adult; Nutritional status	CROSSOTA STALI SCOTT; POPULATION-DENSITY; HETEROPTERA; FLUCTUATIONS; DIAPAUSE; FOOD	Although researchers have proposed that the abundance of Japanese cedar cones is the main factor affecting outbreaks of the brown marmorated stink bug, Halyomorpha halys (StAyenl), in Japan, it remains to be clarified whether the reproduction of field populations is indeed influenced by variation in the number of cones. This study investigated the relationship of the nutritional status of field populations of overwintering adults with the airborne pollen count of Japanese cedar, which served as a proxy for cone-bearing by Japanese cedars, based on data gathered from 2000 to 2010 in Akita Prefecture, northern Japan. The nutritional level and airborne pollen counts varied significantly over the 11 years considered. There was a significant correlation between pollen count and the nutritional level of adults of each sex. These results suggest that Japanese cedar cones serve as an important nutritional source for the overwintering adults of H. halys as they prepare for overwintering.	Akita Fruit Tree Expt Stn, Yokote, Akita 0130102, Japan	Funayama, K (reprint author), Akita Fruit Tree Expt Stn, Yokote, Akita 0130102, Japan.	funayamak@pref.akita.lg.jp					MASAKI S, 1980, ANNU REV ENTOMOL, V25, P1, DOI 10.1146/annurev.en.25.010180.000245; Kiritani K, 2006, POPUL ECOL, V48, P5, DOI 10.1007/s10144-005-0225-0; Funayama K, 2013, J ECON ENTOMOL, V106, P2141, DOI 10.1603/EC13240; Funayama K, 2004, APPL ENTOMOL ZOOL, V39, P617, DOI 10.1303/aez.2004.617; Asakawa S, 1983, WHOLE JAPANESE CEDAR, P45; BROWN E. S., 1962, BULL ENTOMOL RES, V53, P445; DURHAM OC, 1946, J ALLERGY, V17, P79, DOI 10.1016/0021-8707(46)90025-1; Fujiie A, 1985, B CHIBA AGR EXP STN, V26, P87; Fujiwara R, 1997, DISTRIBUTION VASCULA, P1167; Funayama K, 2006, APPL ENTOMOL ZOOL, V41, P415, DOI 10.1303/aez.2006.415; Funayama K, 2005, JPN J APPL ENTOMOL Z, V49, P265, DOI 10.1303/jjaez.2005.265; Funayama K, 2008, JPN J APPL ENTOMOL Z, V52, P69, DOI 10.1303/jjaez.2008.69; Funayama K, 2012, JPN J APPL ENTOMOL Z, V56, P12, DOI 10.1303/jjaez.2012.12; HODEK I, 1967, ANNU REV ENTOMOL, V12, P79, DOI 10.1146/annurev.en.12.010167.000455; HODEK I, 1971, ENTOMOL EXP APPL, V14, P212; ITO K, 1984, APPL ENTOMOL ZOOL, V19, P461; KONDOH M, 1968, Japanese Journal of Ecology, V18, P171; Leskey T. C., 2012, Outlooks on Pest Management, V23, P218, DOI 10.1564/23oct07; Morishita M, 2001, JPN J APPL ENTOMOL Z, V45, P143, DOI 10.1303/jjaez.2001.143; Moriya S, 1995, B OKINAWA AGR EXP ST, V5, P1; Oda M, 1981, B NARA AGR EXP STN, V12, P120; Oda M, 1982, B NARA AGR EXP STN, V13, P66; Ohira Y, 2003, PLANT PROT, V57, P164; SAS Institute, 2008, JMP VERS 802; Shiga M, 1989, B FRUIT TREE RES S A, V16, P133; SOLBRECK C, 1972, Entomologica Scandinavica, V3, P267; Takahashi K., 2004, Tohoku Journal of Forest Science, V9, P6; Tobioka K, 1973, B MIE U FORESTS, V8, P1; Yamada K, 1980, B FUKUOKA HORT EXP S, V18, P54; Yanagi T, 1980, PLANT PROT, V34, P315; Yanase T, 1997, PLANT PROT, V51, P160; Zhu GP, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031246	32	0	0	SPRINGER JAPAN KK	TOKYO	CHIYODA FIRST BLDG EAST, 3-8-1 NISHI-KANDA, CHIYODA-KU, TOKYO, 101-0065, JAPAN	0003-6862	1347-605X		APPL ENTOMOL ZOOL	Appl. Entomol. Zoolog.	FEB	2015	50	1					117	121		10.1007/s13355-014-0312-9		5	Entomology	Entomology	CB0HE	WOS:000349305700016		
J	Fitriana, Y; Shinohara, S; Satoh, K; Narumi, I; Saito, T				Fitriana, Yuyun; Shinohara, Shinobu; Satoh, Katsuya; Narumi, Issay; Saito, Tsutomu			Benomyl-resistant Beauveria bassiana (Hypocreales: Clavicipitaceae) mutants induced by ion beams	APPLIED ENTOMOLOGY AND ZOOLOGY			English	Article						Fungicide compatibility; 50 % Effective concentration; Integrated pest management; beta-Tubulin; Cross tolerance	BETA-TUBULIN GENE; BENZIMIDAZOLE RESISTANCE; ENTOMOPATHOGENIC FUNGUS; ISARIA-FUMOSOROSEA; MUTATIONS; FUNGICIDES; DIETHOFENCARB; SENSITIVITY; PESTICIDES; PATHOGEN	Fungicides targeted at phytopathogens can be harmful to entomopathogenic fungi. The purpose of this study was to use ion-beam irradiation technology to produce benomyl-resistant mutants of the entomopathogenic fungus Beauveria bassiana (Bals.-Criv.) Vuill. After irradiation of conidia at 150 Gy, two mutant isolates, BB22 and BB24, were selected on media containing the fungicide. In an assay of vegetative growth, BB22 and BB24 were over 500 and 800 times more tolerant to benomyl, respectively, compared with the wild isolate. However, in an assay of conidial germination, neither mutant had increased tolerance compared with the wild isolate. Both mutant isolates also had increased tolerance to thiophanate-methyl during vegetative growth, but reduced tolerance to diethofencarb. A mutation was found at position 198 of the beta-tubulin gene in the mutant isolates, with a substitution of glutamate for alanine (E198A). Ion beams have great potential as a tool to improve the traits of entomopathogenic fungi such as increasing tolerance to fungicides. Fungicide-resistant mutants produced in this way could be useful agents for biological control within IPM programmes where fungicides are also used.	[Fitriana, Yuyun; Shinohara, Shinobu; Saito, Tsutomu] Shizuoka Univ, Fac Agr, Shizuoka 4228529, Japan; [Satoh, Katsuya; Narumi, Issay] Japan Atom Energy Agcy, Quantum Beam Sci Directorate, Gunma 3701292, Japan	Saito, T (reprint author), Shizuoka Univ, Fac Agr, Shizuoka 4228529, Japan.	atsaito@ipc.shizuoka.ac.jp			JSPS KAKENHI grant [24510121]; Directorate General of Higher Education of Indonesia	We thank Prof. I. Uwafuji for helpful advice on statistical analyses. We thank J. K. Pell Consulting for editing of the manuscript. This work was supported financially by JSPS KAKENHI grant no. 24510121 and by the program of the Directorate General of Higher Education of Indonesia.	DAVIDSE LC, 1986, ANNU REV PHYTOPATHOL, V24, P43; Das SK, 2008, LETT APPL MICROBIOL, V47, P534, DOI 10.1111/j.1472-765X.2008.02456.x; Keinath AP, 1998, PLANT DIS, V82, P479, DOI 10.1094/PDIS.1998.82.5.479; Zou G, 2006, ENVIRON MICROBIOL, V8, P2096, DOI 10.1111/j.1462-2920.2006.01086.x; Tanaka A, 2010, J RADIAT RES, V51, P223, DOI 10.1269/jrr.09143; KOENRAADT H, 1992, PHYTOPATHOLOGY, V82, P1348, DOI 10.1094/Phyto-82-1348; Hollomon DW, 1998, ANTIMICROB AGENTS CH, V42, P2171; Qiu JB, 2011, PEST MANAG SCI, V67, P191, DOI 10.1002/ps.2050; Ma ZH, 2003, APPL ENVIRON MICROB, V69, P7145, DOI 10.1128/AEM.69.12.7145-7152.2003; Albertini C, 1999, PESTIC BIOCHEM PHYS, V64, P17, DOI 10.1006/pest.1999.2406; Abbott WS, 1925, J ECON ENTOMOL, V18, P265; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; Boucias D.G., 1998, PRINCIPLES INSECT PA; Butters JA, 2003, MYCOL RES, V107, P260, DOI 10.1017/S0953756203007196; CLARK RA, 1982, ENVIRON ENTOMOL, V11, P67; Copping LG, 2009, MANUAL BIOL AGENTS; D'Alessandro CP, 2011, BIOCONTROL SCI TECHN, V21, P189, DOI 10.1080/09583157.2010.536200; Davidson RM, 2006, J PHYTOPATHOL, V154, P321, DOI 10.1111/j.1439-0434.2006.01080.x; FUJIMURA M, 1992, CURR GENET, V21, P399, DOI 10.1007/BF00351701; Goettel Mark S., 1997, P213, DOI 10.1016/B978-012432555-5/50013-0; Inglis G. D., 2001, Fungi as biocontrol agents: progress, problems and potential, P23, DOI 10.1079/9780851993560.0023; James RR, 1998, ENVIRON ENTOMOL, V27, P1506; Kim SoonKee, 2005, International Journal of Industrial Entomology, V10, P119; Koo BS, 2009, APPL MICROBIOL BIOT, V82, P513, DOI 10.1007/s00253-008-1821-7; Matuo Y, 2006, MUTAT RES-FUND MOL M, V602, P7, DOI 10.1016/j.mrfmmm.2006.07.001; SAITO T, 1984, JPN J APPL ENTOMOL Z, V28, P87; Shinohara S, 2013, FEMS MICROBIOL LETT, V349, P54, DOI 10.1111/1574-6968.12295; SPSS I, 2009, PASW STAT 18; Toyoshima Y, 2012, MUTAT RES-FUND MOL M, V740, P43, DOI 10.1016/j.mrfmmm.2012.12.005; Valadares-Inglis MC, 1997, FEMS MICROBIOL LETT, V155, P199, DOI 10.1016/S0378-1097(97)00387-X; ZIOGAS BN, 1993, PESTIC SCI, V39, P199, DOI 10.1002/ps.2780390306	31	0	0	SPRINGER JAPAN KK	TOKYO	CHIYODA FIRST BLDG EAST, 3-8-1 NISHI-KANDA, CHIYODA-KU, TOKYO, 101-0065, JAPAN	0003-6862	1347-605X		APPL ENTOMOL ZOOL	Appl. Entomol. Zoolog.	FEB	2015	50	1					123	129		10.1007/s13355-014-0314-7		7	Entomology	Entomology	CB0HE	WOS:000349305700017		
J	Ohashi, H; Sakai, T				Ohashi, Hirono; Sakai, Takaomi			Novel behavioral assay of wasabi avoidance in Drosophila melanogaster (Diptera: Drosophilidae) using a video tracking system	APPLIED ENTOMOLOGY AND ZOOLOGY			English	Article						Drosophila; Wasabi; Allyl isothiocyanate; Locomotion; Video tracking system; painless	PAINLESS; NOCICEPTION; CHANNEL; TRPA1; GENE	The fruit fly Drosophila melanogaster Meigen is a very useful model organism for studying the molecular and neural bases of nociceptive behavior. Drosophila shows robust wasabi avoidance behavior, as do mammals. Feeding-based behavioral assays have been exclusively used in previous studies of such behavior. Here, we present a novel locomotor-based behavioral assay of wasabi avoidance in Drosophila using a video tracking system. Our results showed that, in wild-type flies, the approach to a wasabi source is inhibited in a dose-dependent manner, whereas their general locomotion is unaffected. In addition, the wasabi avoidance behavior was suppressed by mutations in the painless gene, which is involved in the regulation of wasabi response. Conventional behavioral assays have not shown wasabi avoidance without ingestion, whereas our behavioral assay revealed that flies avoid highly concentrated wasabi sources even without ingestion. Thus, this behavioral assay can be used to elucidate the molecular and neural mechanisms underlying non-feeding-based wasabi avoidance in Drosophila.	[Ohashi, Hirono; Sakai, Takaomi] Tokyo Metropolitan Univ, Dept Biol Sci, Tokyo 1920397, Japan	Sakai, T (reprint author), Tokyo Metropolitan Univ, Dept Biol Sci, Tokyo 1920397, Japan.	sakai-takaomi@tmu.ac.jp			MEXT KAKENHI grant [23115714]; JSPS KAKENHI grant [25650116]	We thank Eri Sakurai for technical assistance and Junjiro Horiuchi for helpful comments. This study was supported by MEXT KAKENHI grant number 23115714 (to T.S.) and JSPS KAKENHI grant number 25650116 (to T.S.).	Aldrich BT, 2010, J NEUROGENET, V24, P33, DOI 10.3109/01677060903419751; Anholt RRH, 1996, GENETICS, V143, P293; Kang K, 2010, NATURE, V464, P597, DOI 10.1038/nature08848; Al-Anzi B, 2006, CURR BIOL, V16, P1034, DOI 10.1016/j.cub.2006.04.002; Iyengar A, 2012, J NEUROGENET, V26, P306, DOI 10.3109/01677063.2012.729626; Bautista DM, 2005, P NATL ACAD SCI USA, V102, P12248, DOI 10.1073/pnas.0505356102; Tracey WD, 2003, CELL, V113, P261, DOI 10.1016/S0092-8674(03)00272-1; Fujii S, 2007, CURR BIOL, V17, P244, DOI 10.1016/j.cub.2006.11-049; Martin JR, 2004, BEHAV PROCESS, V67, P207, DOI 10.1016/j.beproc.2004.04.003; Sokabe T, 2008, J NEUROSCI, V28, P9929, DOI 10.1523/JNEUROSCI.2757-08.2008; Root CM, 2011, CELL, V145, P133, DOI 10.1016/j.cell.2011.02.008; Jordt SE, 2004, NATURE, V427, P260, DOI 10.1038/nature02282; Xu SY, 2006, GENES BRAIN BEHAV, V5, P602, DOI 10.1111/j.1601-183X.2006.00213.x; Brown EB, 2013, GENES BRAIN BEHAV, V12, P503, DOI 10.1111/gbb.12048; Khuong TM, 2013, FEBS J, V280, P5298, DOI 10.1111/febs.12464; Milinkeviciute G, 2012, CLIN GENET, V82, P359, DOI 10.1111/j.1399-0004.2012.01941.x; Sakai T, 2009, GENES BRAIN BEHAV, V8, P546, DOI 10.1111/j.1601-183X.2009.00503.x; Sharma P, 2009, J NEUROSCI METH, V182, P43, DOI 10.1016/j.jneumeth.2009.05.024; Tsai HY, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034784; Wang KY, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025890	20	1	1	SPRINGER JAPAN KK	TOKYO	CHIYODA FIRST BLDG EAST, 3-8-1 NISHI-KANDA, CHIYODA-KU, TOKYO, 101-0065, JAPAN	0003-6862	1347-605X		APPL ENTOMOL ZOOL	Appl. Entomol. Zoolog.	FEB	2015	50	1					137	142		10.1007/s13355-014-0302-y		6	Entomology	Entomology	CB0HE	WOS:000349305700019		
J	Saito, Y; Kunimi, Y; Nakai, M				Saito, Yasumasa; Kunimi, Yasuhisa; Nakai, Madoka			Construction of Adoxophyes honmai nucleopolyhedrovirus bacmid DNA by using a gene-repair BAC cassette	APPLIED ENTOMOLOGY AND ZOOLOGY			English	Article						Baculovirus; Bacmid; Unique restriction site; Site-specific recombination	ESCHERICHIA-COLI; IN-VITRO; BACULOVIRUS; TRANSPOSON; EXPRESSION; VIRULENCE; INSERTION	Recombinant baculoviruses have traditionally been generated by homologous recombination, in insect cells, of the virus DNA and a transfer vector. This method is, however, restricted to the small number of baculoviruses for which permissive cell lines are available. An alternative method, which avoids this limitation, is the bacmid system, in which a bacterial DNA cassette (BAC cassette) comprising a bacterial replication origin, an antibiotic resistance marker gene, and a transposon element, is inserted into a unique restriction endonuclease site of the virus genome and the recombinant DNA is produced in Escherichia coli K-12 strain. However, if the unique cleavage site is located within an open reading frame (ORF), the ORF will be disrupted by BAC cassette insertion. In this study, we propose a gene-repair BAC method which simultaneously restores the disrupted ORF and inserts a BAC cassette into the full genome of Adoxophyes honmai nucleopolyhedrovirus.	[Saito, Yasumasa; Kunimi, Yasuhisa] Tokyo Univ Agr & Technol, United Grad Sch Agr Sci, Dept Biol Prod Sci, Fuchu, Tokyo 1838509, Japan; [Nakai, Madoka] Tokyo Univ Agr & Technol, Inst Agr, Dept Appl Biol Sci, Tokyo, Japan; [Saito, Yasumasa; Kunimi, Yasuhisa; Nakai, Madoka] Tokyo Univ Agr & Technol, United Grad Sch Agr Sci, Dept Biol Prod Sci, Fuchu, Tokyo 1838509, Japan	Nakai, M (reprint author), Tokyo Univ Agr & Technol, Inst Agr, Dept Appl Biol Sci, Tokyo, Japan.	madoka@cc.tuat.ac.jp	NAKAI, Madoka/G-1088-2013; Kunimi, Yasuhisa/C-8350-2013	NAKAI, Madoka/0000-0003-1929-9543; 	JSPS KAKENHI [18380038, 21580064]; Career-Advance team of the Women's Future Development Organization of Tokyo University of Agriculture and Technology; Ministry of Education, Culture, Sports, Science and Technology, Japan	This work was supported by JSPS KAKENHI (grant numbers 18380038 and 21580064) and by the Career-Advance team of the Women's Future Development Organization of Tokyo University of Agriculture and Technology, from Special Coordination Funds for Promoting Science and Technology "Supporting positive activities for female researchers" provided by the Ministry of Education, Culture, Sports, Science and Technology, Japan. Authors would like to thank Dr Ian Smith for critical review of this manuscript and Dr Sally Hilton for technical advice.	Hilton S, 2008, J VIROL METHODS, V152, P56, DOI 10.1016/j.jviromet.2008.05.015; Kost TA, 2005, NAT BIOTECHNOL, V23, P567, DOI 10.1038/nbt1095; LUCKOW VA, 1993, J VIROL, V67, P4566; Ishii T, 2003, J INVERTEBR PATHOL, V83, P206, DOI 10.1016/S0022-2011(03)00087-9; Wang YJ, 2010, J VIROL METHODS, V167, P95, DOI 10.1016/j.jviromet.2009.11.026; Katsuma S, 2012, J VIROL, V86, P2545, DOI 10.1128/JVI.06308-11; Cleaver SH, 2000, GENE, V254, P37, DOI 10.1016/S0378-1119(00)00283-3; Kang WK, 2005, J GEN VIROL, V86, P3031, DOI 10.1099/vir.0.81270-0; Martignoni ME, 1986, MICROBIAL CONTROL PE, P897; Nakai M, 2003, VIROLOGY, V316, P171, DOI 10.1016/S0042-6822(03)00599-3; O'Reilly DR, 1992, BACULOVIRUS EXPRESSI; Simon O, 2008, VIRUS RES, V136, P202, DOI 10.1016/j.virusres.2008.04.023; Takahashi M, 2008, BIOL CONTROL, V46, P542, DOI 10.1016/j.biocontrol.2008.06.003; Theilmann D.A., 2005, VIRUS TAXONOMY, P177; van Oers MM, 2011, J INVERTEBR PATHOL, V107, pS3, DOI 10.1016/j.jip.2011.05.001	15	0	0	SPRINGER JAPAN KK	TOKYO	CHIYODA FIRST BLDG EAST, 3-8-1 NISHI-KANDA, CHIYODA-KU, TOKYO, 101-0065, JAPAN	0003-6862	1347-605X		APPL ENTOMOL ZOOL	Appl. Entomol. Zoolog.	FEB	2015	50	1					143	146		10.1007/s13355-014-0313-8		4	Entomology	Entomology	CB0HE	WOS:000349305700020		
J	Ohara, R; Kurita, M; Yoneyama, T; Okuyama, F; Sakamoto, Y				Ohara, Ryuichi; Kurita, Masanobu; Yoneyama, Takuo; Okuyama, Fumio; Sakamoto, Yuji			Response of accommodation and vergence to electro-holographic images	APPLIED OPTICS			English	Article							DISPLAY	Studies on measuring accommodation and vergence responses of human vision are important to evaluate three-dimensional (3D) display technologies. Electro-holography is expected to be an ideal 3D display. However, there has been little research on measuring responses to it. In this study, the static responses to electro-holographic images with a large visual field and correct stimuli were measured. In addition, responses to real objects were measured for comparison with those to displayed images. There were more subjects than in conventional studies for statistical analysis. The experimental results statistically confirmed the equivalence of the responses to electro-holographic images and those to real objects. Therefore, it was experimentally suggested that electro-holography enables human vision to perform correct accommodation and vergence responses in accordance with the depths. (C) 2015 Optical Society of America	[Ohara, Ryuichi; Yoneyama, Takuo; Sakamoto, Yuji] Hokkaido Univ, Grad Sch Informat Sci & Technol, Sapporo, Hokkaido 0600814, Japan; [Kurita, Masanobu] Hokkaido Univ, Sch Engn, Sapporo, Hokkaido 0600814, Japan; [Okuyama, Fumio] Suzuka Univ Med Sci, Suzuka, Mie 5100293, Japan	Ohara, R (reprint author), Hokkaido Univ, Grad Sch Informat Sci & Technol, Sapporo, Hokkaido 0600814, Japan.	ohara@ist.hokudai.ac.jp			 [23300032]	We would like to thank the Yoshida Gakuen Medical & Dental College Department of Orthoptics for cooperating in our experiments. This work was supported by the Grant-in-Aid for Scientific Research (B) KAKENHI(23300032).	Takaki Y, 2012, OPT EXPRESS, V20, P3918, DOI 10.1364/OE.20.003918; WATERS JP, 1966, APPL PHYS LETT, V9, P405, DOI 10.1063/1.1754630; Gekeler F, 1997, OPTOMETRY VISION SCI, V74, P472, DOI 10.1097/00006324-199707000-00013; Ito T, 2004, OPT EXPRESS, V12, P4320, DOI 10.1364/OPEX.12.004320; Piaggio G, 2006, JAMA-J AM MED ASSOC, V295, P1152, DOI 10.1001/jama.295.10.1152; Ukai K, 2008, DISPLAYS, V29, P106, DOI 10.1016/j.displa.2007.09.004; Geng JS, 2013, ADV OPT PHOTONICS, V5, P456, DOI 10.1364/AOP.5.000456; Dixon W. J., 1957, INTRO STAT ANAL; Fukushima T, 2009, J VISION, V9, DOI 10.1167/9.13.21; Fukutomi T., 2004, Journal of the Institute of Image Information and Television Engineers, V58; Hiura H., 2013, P 3D SYSTEMS APPL; Hoffman D. M., 2008, J VISION, V8, P1, DOI DOI 10.1167/8.3.33; Marr D., 1982, VISION COMPUTATIONAL; MIZUSHINA H, 2012, ITE TECHNICAL REPORT, V36, P9; Ohara R., 2014, J I IMAGE INFORM TEL, V68, pJ144; Shiomi T., 2012, SID S, V43, p1178 ; Takeda T, 1999, VISION RES, V39, P2087, DOI 10.1016/S0042-6989(98)00258-2; Yang CY, 2013, J PHYS CONF SER, V415, DOI 10.1088/1742-6596/415/1/012043	18	0	0	OPTICAL SOC AMER	WASHINGTON	2010 MASSACHUSETTS AVE NW, WASHINGTON, DC 20036 USA	1559-128X	2155-3165		APPL OPTICS	Appl. Optics	FEB 1	2015	54	4					615	621		10.1364/AO.54.000615		7	Optics	Optics	CA8II	WOS:000349161300037		
J	Wu, Q; Okabe, Y				Wu, Qi; Okabe, Yoji			Waveform reconstruction for an ultrasonic fiber Bragg grating sensor demodulated by an erbium fiber laser	APPLIED OPTICS			English	Article							RING LASER; SYSTEM	Fiber Bragg grating (FBG) demodulated by an erbium fiber laser (EFL) has been used for ultrasonic detection recently. However, due to the inherent relaxation oscillation (RO) of the EFL, the detected ultrasonic signals have large deformations, especially in the low-frequency range. We proposed a novel data processing method to reconstruct an actual ultrasonic waveform. The noise spectrum was smoothed first; the actual ultrasonic spectrum was then obtained by deconvolution in order to mitigate the influence of the RO of the EFL. We proved by experiment that this waveform reconstruction method has high precision, and demonstrated that the FBG sensor demodulated by the EFL will have large practical applications in nondestructive testing. (C) 2015 Optical Society of America	[Wu, Qi; Okabe, Yoji] Univ Tokyo, Inst Ind Sci, Meguro Ku, Tokyo 1538505, Japan	Wu, Q (reprint author), Univ Tokyo, Inst Ind Sci, Meguro Ku, 4-6-1 Komaba, Tokyo 1538505, Japan.	wuqi@iis.u-tokyo.ac.jp					Minardo A, 2005, IEEE T ULTRASON FERR, V52, P304, DOI 10.1109/TUFFC.2005.1406556; Stewart G, 2007, J LIGHTWAVE TECHNOL, V25, P1786, DOI [10.1109/JLT.2007.899192, 10.1109/JLT.2007.988192]; Kessler SS, 2002, SMART MATER STRUCT, V11, P269, DOI 10.1088/0964-1726/11/2/310; Tsuda H, 2010, OPT LETT, V35, P2349, DOI 10.1364/OL.35.002349; Lissak B, 1998, OPT LETT, V23, P1930, DOI 10.1364/OL.23.001930; Ding M, 1996, IEEE PHOTONIC TECH L, V8, P1151, DOI 10.1109/68.531819; Han M, 2013, OPT EXPRESS, V21, P29269, DOI 10.1364/OE.21.029269; Liu TQ, 2014, OPT LETT, V39, P4462, DOI 10.1364/OL.39.004462; Wu Q, 2014, OPT EXPRESS, V22, P8405, DOI 10.1364/OE.22.008405	9	0	0	OPTICAL SOC AMER	WASHINGTON	2010 MASSACHUSETTS AVE NW, WASHINGTON, DC 20036 USA	1559-128X	2155-3165		APPL OPTICS	Appl. Optics	FEB 1	2015	54	4					694	698		10.1364/AO.54.000694		5	Optics	Optics	CA8II	WOS:000349161300046		
J	Beppu, S; Hotta, H; Shafiee, H; Tagaya, A; Koike, Y				Beppu, Shotaro; Hotta, Hikaru; Shafiee, Houran; Tagaya, Akihiro; Koike, Yasuhiro			Investigation of optical and thermal properties of N-(alkyl-substituted) maleimides for use in zero-zero-birefringence polymer	APPLIED OPTICS			English	Article							RADICAL POLYMERIZATION; METHACRYLATE; COPOLYMERS; POLY(N-TERT-ALKYLMALEIMIDE)S; ORIENTATION; DESIGN	N-(alkyl-substituted) maleimides (RMIs) were proposed as materials useful for the development of a zero-zero-birefringence polymer that exhibits no birefringence. We analyzed the optical and thermal properties of poly(RMI)s, such as the refractive index, birefringence, and glass transition temperature. The characteristics of the obtained polymers varied significantly because the shift of the density and polarizability derived from the change of the substituent structure influenced the optical properties, and the bulkiness of the substituents influenced the thermal properties. We also designed a zero-zero-birefringence polymer using N-ethyl maleimide (EMI) as a comonomer, and the obtained copolymer had no birefringence, relatively high heat resistance, and high transparency. (C) 2015 Optical Society of America	[Beppu, Shotaro; Hotta, Hikaru; Shafiee, Houran; Tagaya, Akihiro; Koike, Yasuhiro] Keio Univ, Grad Sch Sci & Technol, Kohoku Ku, Yokohama, Kanagawa 2238522, Japan; [Beppu, Shotaro; Hotta, Hikaru; Shafiee, Houran; Tagaya, Akihiro; Koike, Yasuhiro] Keio Univ, Keio Photon Res Inst, Saiwai Ku, Kawasaki, Kanagawa 2120032, Japan	Tagaya, A (reprint author), Keio Univ, Grad Sch Sci & Technol, Kohoku Ku, 3-14-1 Hiyoshi, Yokohama, Kanagawa 2238522, Japan.	a-tagaya@kpri.keio.ac.jp	Koike, Yasuhiro /G-2104-2014		Japan Society for the Promotion of Science (JSPS) through its Funding Program for World-Leading Innovative R&D on Science and Technology (FIRST Program)	This research was partly supported by the Japan Society for the Promotion of Science (JSPS) through its Funding Program for World-Leading Innovative R&D on Science and Technology (FIRST Program).	GORDON M, 1952, J APPL CHEM, V2, P493; Beppu S, 2014, J APPL POLYM SCI, V131, DOI 10.1002/app.40423; Hisano M, 2013, MACROMOLECULES, V46, P7733, DOI 10.1021/ma401499v; Iwasaki S, 2012, POLYMER, V53, P3287, DOI 10.1016/j.polymer.2012.05.025; Iwasaki S, 2013, J APPL POLYM SCI, V130, P138, DOI 10.1002/app.39136; Iwata S, 1997, APPL OPTICS, V36, P4549, DOI 10.1364/AO.36.004549; JASSE B, 1979, J MACROMOL SCI R M C, VC17, P61; Lorentz H. A., 1880, ANN PHYS, V9, P641; LORENZ L, 1880, ANN PHYS, V11, P70; Lou LP, 2012, J POLYM SCI POL CHEM, V50, P3530, DOI 10.1002/pola.26137; Mao M, 2011, POLYMER, V52, P4498, DOI 10.1016/j.polymer.2011.08.009; MATSUMOTO A, 1990, POLYM BULL, V24, P459, DOI 10.1007/BF00395565; Matsumoto A., 1990, POLYM B, V23, P43; MATSUMOTO A, 1990, MACROMOLECULES, V23, P4508, DOI 10.1021/ma00223a002; Muraki K., 2006, MACROMOL S, V242, P235, DOI 10.1002/masy.200651032; Nakao R, 2012, J LIGHTWAVE TECHNOL, V30, P247, DOI 10.1109/JLT.2011.2180700; OTSU T, 1990, POLYM BULL, V24, P467, DOI 10.1007/BF00395566; Paesschen G. V., 1964, MAKROMOL CHEM, V78, P112; SAITO H, 1987, J POLYM SCI POL PHYS, V25, P1629, DOI 10.1002/polb.1987.090250806; Shafiee H, 2010, J POLYM SCI POL PHYS, V48, P2029, DOI 10.1002/polb.22082; Tagaya A., 2009, SEIKEI KAKOU, V21, P426; Tagaya A, 2006, MACROMOLECULES, V39, P3019, DOI 10.1021/ma0527000; Umeda N., 1991, Electronics and Communications in Japan, Part 2 (Electronics), V74, DOI 10.1002/ecjb.4420740503; ZHAO Y, 1986, MAKROMOL CHEM-M SYMP, V5, P87, DOI 10.1002/masy.19860050110	24	0	0	OPTICAL SOC AMER	WASHINGTON	2010 MASSACHUSETTS AVE NW, WASHINGTON, DC 20036 USA	1559-128X	2155-3165		APPL OPTICS	Appl. Optics	FEB 1	2015	54	4					779	788		10.1364/AO.54.000779		10	Optics	Optics	CA8II	WOS:000349161300058		
J	Banh, TQ; Suzuki, K; Kimura, M; Shioda, T				Tuan Quoc Banh; Suzuki, Kohei; Kimura, Munehiro; Shioda, Tatsutoshi			Two-dimensional high-speed and long-range tomography and profilometry using liquid-crystal Fabry-Perot resonator	APPLIED OPTICS			English	Article							OPTICAL COHERENCE TOMOGRAPHY; SPATIAL PHASE MODULATOR; SINGLE-SHOT TOMOGRAPHY; INTERFEROMETER	A two-dimensional high-speed, long-range tomography and profilometry based on a low-coherence optical interferometry has been developed. A liquid-crystal Fabry-Perot resonator is fabricated to be a low-coherence optical frequency comb generator for expanding the measurement depth of the tomography and profilometry. The line-shape interference fringes with the individual fringe orders are obtained by a CCD camera in real time. The relative optical length, corresponding to the sample depth information, can be derived from the positions of the interference fringes on the CCD camera and their corresponding fringe orders. The fringe orders can be rapidly calculated using the effectiveness of the changeable extraordinary refractive index of the liquid-crystal material of the resonator. The finesse of the liquid-crystal resonator is approximate 9, giving an expansion of the measurement range of up to 9-fold (similar to 8 mm depth) with a resolution of profilometry and tomography of 3.7 mu m and 11 mu m, respectively. (C) 2015 Optical Society of America	[Tuan Quoc Banh; Shioda, Tatsutoshi] Saitama Univ, Grad Sch Sci & Engn, Sakura Ku, Saitama 3388570, Japan; [Suzuki, Kohei; Kimura, Munehiro] Nagaoka Univ Technol, Dept Elect Engn, Nagaoka, Niigata 9402188, Japan	Banh, TQ (reprint author), Saitama Univ, Grad Sch Sci & Engn, Sakura Ku, 255 Shimo Okubo, Saitama 3388570, Japan.	bqtuan79@mail.saitama-u.ac.jp			Ministry of Public Management, Home Affairs, Posts and Tele-communications; Tateishi Science and Technology Foundation; Konica Minolta Science and Technology Foundation;  [23686014]	This work was partially supported by R&D fund from Ministry of Public Management, Home Affairs, Posts and Tele-communications. Also, this work was partially supported by the others such as the Grants-in-Aid for Scientific Research (A) (23686014), Tateishi Science and Technology Foundation, and Konica Minolta Science and Technology Foundation.	Lee SJ, 2001, JPN J APPL PHYS 2, V40, pL878, DOI 10.1143/JJAP.40.L878; Humbert G, 2006, OPT EXPRESS, V14, P1596, DOI 10.1364/OE.14.001596; JEROME B, 1991, REP PROG PHYS, V54, P391, DOI 10.1088/0034-4885/54/3/002; HUANG D, 1991, SCIENCE, V254, P1178, DOI 10.1126/science.1957169; Leitgeb R, 2000, OPT LETT, V25, P820, DOI 10.1364/OL.25.000820; Choi S, 2006, OPT LETT, V31, P1976, DOI 10.1364/OL.31.001976; Banh TQ, 2013, OPT COMMUN, V296, P1, DOI 10.1016/j.optcom.2013.01.027; Choi S, 2007, JPN J APPL PHYS 1, V46, P6842, DOI 10.1143/JJAP.46.6842; Choi S, 2009, JPN J APPL PHYS, V48, DOI 10.1143/JJAP.48.09LF01; Lias Jais Bin, 2011, Journal of Information Display, V12, P101; Shioda T, 2011, OPT COMMUN, V284, P144, DOI 10.1016/j.optcom.2010.09.028; Shioda T, 2012, APPL OPTICS, V51, P5224, DOI 10.1364/AO.51.005224	12	1	1	OPTICAL SOC AMER	WASHINGTON	2010 MASSACHUSETTS AVE NW, WASHINGTON, DC 20036 USA	1559-128X	2155-3165		APPL OPTICS	Appl. Optics	FEB 1	2015	54	4					912	918		10.1364/AO.54.000912		7	Optics	Optics	CA8II	WOS:000349161300075		
J	Hioki, S; Iwabuchi, H				Hioki, Souichiro; Iwabuchi, Hironobu			Photographic observation and optical simulation of a pollen corona display in Japan	APPLIED OPTICS			English	Article							LUNAR CORONA; MIE THEORY; CLOUDS; IRIDESCENCE	Brightness and chromaticity profiles were extracted from a vivid solar corona image taken with a digital camera in Sendai, Japan, to compare with a radiative transfer simulation applying Lorenz-Mie theory and single-scattering approximation. The comparison revealed suspended particles having a narrow particle size distribution peaking at radius 14.5 mu m. Presumably, pollen of an indigenous coniferous tree, the cryptomeria (Cryptomeria japonica), is responsible for the corona display. The extracted brightness and chromaticity profiles are reproduced well by assuming the presence of a water soluble aerosol and dust in addition to the pollen. We find that photographic analysis of corona displays, similar to that used to measure cloud particle size, is applicable to estimating pollen particle size distribution and column number density. (C) 2014 Optical Society of America	[Hioki, Souichiro; Iwabuchi, Hironobu] Tohoku Univ, Grad Sch Sci, Ctr Atmospher & Ocean Studies, Sendai, Miyagi 9808578, Japan	Iwabuchi, H (reprint author), Tohoku Univ, Grad Sch Sci, Ctr Atmospher & Ocean Studies, 6-3 Aramaki Aza Aoba, Sendai, Miyagi 9808578, Japan.	hiroiwa@m.tohoku.ac.jp		Hioki, Souichiro/0000-0001-6307-1832			Hess M, 1998, B AM METEOROL SOC, V79, P831, DOI 10.1175/1520-0477(1998)079<0831:OPOAAC>2.0.CO;2; Laven P, 2003, APPL OPTICS, V42, P436, DOI 10.1364/AO.42.000436; Bohren C. F., 1983, ABSORPTION SCATTERIN; Gedzelman SD, 2003, APPL OPTICS, V42, P497, DOI 10.1364/AO.42.000497; Gedzelman SD, 2008, APPL OPTICS, V47, pH157, DOI 10.1364/AO.47.00H157; Hayashi R, 2012, JPN J PALYNOL, V58, P5; Inamura N, 1988, Nihon Jibiinkoka Gakkai Kaiho, V91, P907; LOCK JA, 1991, APPL OPTICS, V30, P3408, DOI 10.1364/AO.30.003408; Mims FM, 1998, APPL OPTICS, V37, P1486, DOI 10.1364/AO.37.001486; Molesini G, 2006, J OPT A-PURE APPL OP, V8, P423, DOI 10.1088/1464-4258/8/5/009; PARVIAINEN P, 1994, APPL OPTICS, V33, P4548, DOI 10.1364/AO.33.004548; Sassen K, 1998, APPL OPTICS, V37, P1477, DOI 10.1364/AO.37.001477; SASSEN K, 1991, APPL OPTICS, V30, P3421, DOI 10.1364/AO.30.003421; Sassen K, 2008, GEOPHYS RES LETT, V35, DOI 10.1029/2008GL035085; Schneider WB, 2005, APPL OPTICS, V44, P5746, DOI 10.1364/AO.44.005746; Shaw JA, 2011, APPL OPTICS, V50, pF6, DOI 10.1364/AO.50.0000F6; Shaw JA, 2003, APPL OPTICS, V42, P476, DOI 10.1364/AO.42.000476; Takahashi Y., 1999, JPN J PALYNOL, V45, P153; TRANKLE E, 1994, APPL OPTICS, V33, P4552, DOI 10.1364/AO.33.004552; Ueno J., 1987, KAFUN GAKU KENKYU; van de Hulst H. C., 1957, LIGHT SCATTERING SMA	21	1	1	OPTICAL SOC AMER	WASHINGTON	2010 MASSACHUSETTS AVE NW, WASHINGTON, DC 20036 USA	1559-128X	2155-3165		APPL OPTICS	Appl. Optics	FEB 1	2015	54	4					B12	B21		10.1364/AO.54.000B12		10	Optics	Optics	CA8II	WOS:000349161300003		
J	Wu, PR; Chien, WC; Okuda, M; Takeshita, M; Yeh, SD; Wang, YC; Chen, TC				Wu, Pei-Ru; Chien, Wan-Chu; Okuda, Mitsuru; Takeshita, Minoru; Yeh, Shyi-Dong; Wang, Yun-Chi; Chen, Tsung-Chi			Genetic and serological characterization of chrysanthemum stem necrosis virus, a member of the genus Tospovirus	ARCHIVES OF VIROLOGY			English	Article							SPOTTED-WILT-VIRUS; RNA SILENCING SUPPRESSOR; 1ST REPORT; IDENTIFICATION; PROTEIN; ZUCCHINI; DIVERSITY; MOVEMENT	Chrysanthemum stem necrosis virus (CSNV) is a member of a tentative tospovirus species. In this study, the complete genomic sequence of the Japanese CSNV isolate TcCh07A was determined. The L RNA is 8960 nt long and encodes the 331.0-kDa RNA-dependent RNA polymerase. The M RNA is 4828 nt long and encodes the 34.1-kDa movement protein (NSm) and the 127.7-kDa glycoprotein precursor (Gn/Gc). The S RNA is 2949 nt long and encodes the 52.4-kDa silencing suppressor protein (NSs) and the 29.3-kDa nucleocapsid (N) protein. The N protein of CSNV-TcCh07A was purified from virus-infected plant tissues and used for production of a rabbit polyclonal antiserum (RAs) and a monoclonal antibody (MAb). Results of serological tests by indirect ELISA and western blotting using the prepared RAs and MAb and a previously produced RAs against the N protein of tomato spotted wilt virus (TSWV) indicated that CSNV-TcCh07A, TSWV, tomato chlorotic spot virus, groundnut ringspot virus, alstroemeria necrotic streak virus and impatiens necrotic spot virus are serologically related.	[Wu, Pei-Ru; Chien, Wan-Chu; Wang, Yun-Chi; Chen, Tsung-Chi] Asia Univ, Dept Biotechnol, Taichung 41354, Taiwan; [Okuda, Mitsuru] Natl Agr & Food Res Org, Agr Res Ctr, Tsukuba, Ibaraki 3058666, Japan; [Takeshita, Minoru] Kyushu Univ, Plant Pathol Lab, Fac Agr, Higashi Ku, Fukuoka 8128581, Japan; [Yeh, Shyi-Dong] Natl Chung Hsing Univ, Dept Plant Pathol, Taichung 40227, Taiwan; [Yeh, Shyi-Dong] Natl Chung Hsing Univ, Agr Biotechnol Ctr, Taichung 40227, Taiwan; [Chen, Tsung-Chi] China Med Univ, China Med Univ Hosp, Dept Med Res, Taichung 40402, Taiwan	Chen, TC (reprint author), Asia Univ, Dept Biotechnol, Taichung 41354, Taiwan.	kikichenwolf@hotmail.com			National Science Council [NSC92-2317-B-005-024, NSC-101-2911-I-005-301, NSC-102-2911-I-005-301]; Ministry of Education, Taiwan, R.O.C.	We thank the virus providers: Dr. Dennis Gonsalves for GRSV; Dr. James W. Moyer for INSV; Dr. Richard Kormelink for ANSV, IYSV and TYRV; Dr. Prem A. Rajagopalan for GBNV and WBNV; Dr. Ioannis E. Tzanetakis for SVNaV; the DSMZ Plant Virus Collection, Germany, for TCSV; and the Bureau of Animal and Plant Health Inspection and Quarantine, Council of Agriculture, Executive Yuan, for permission to import the virus. We also thank Dr. Lei Wan for providing myeloma cells. Funding was provided by the National Science Council (NSC92-2317-B-005-024, NSC-101-2911-I-005-301 and NSC-102-2911-I-005-301) and the Ministry of Education, Taiwan, R.O.C. under the ATU plan for study.	Pappu HR, 2009, VIRUS RES, V141, P219, DOI 10.1016/j.virusres.2009.01.009; Whitfield AE, 2008, PHYTOPATHOLOGY, V98, P45, DOI 10.1094/PHYTO-98-1-0045; Cheng YH, 2014, ANN APPL BIOL, V164, P107, DOI 10.1111/aab.12084; Bucher E, 2003, J VIROL, V77, P1329, DOI 10.1128/JVI.77.2.1329-1336.2003; De Ronde D, 2013, MOL PLANT PATHOL, V14, P405, DOI 10.1111/mpp.12016; Kikkert M, 1999, J VIROL, V73, P2288; Takeda A, 2002, FEBS LETT, V532, P75, DOI 10.1016/S0014-5793(02)03632-3; Okuda S, 2013, EUR J PLANT PATHOL, V136, P355, DOI 10.1007/s10658-013-0169-8; Ciuffo M, 2009, PLANT DIS, V93, P467, DOI 10.1094/PDIS-93-5-0467; DEHAAN P, 1990, J GEN VIROL, V71, P1001, DOI 10.1099/0022-1317-71-5-1001; Bezerra IC, 1999, PHYTOPATHOLOGY, V89, P823, DOI 10.1094/PHYTO.1999.89.9.823; Lewandowski DJ, 2005, VIROLOGY, V342, P26, DOI 10.1016/j.virol.2005.06.050; Chen S. M., 2014, Plant Protection Bulletin (Taipei), V56, P55; Chen TC, 2010, ARCH VIROL, V155, P1085, DOI 10.1007/s00705-010-0688-y; Chen TC, 2005, J VIROL METHODS, V129, P113, DOI 10.1016/j.jviromet.2005.05.014; Jonghe K. de, 2013, New Disease Reports, V28, P14, DOI 10.5197/j.2044-0588.2013.028.014; Gooderham K, 1984, Methods Mol Biol, V1, P165, DOI 10.1385/0-89603-062-8:165; King AMQ, 2012, VIRUS TAXONOMY, P725; Li JT, 2011, ARCH VIROL, V156, P359, DOI 10.1007/s00705-010-0881-z; Matsuura S, 2007, PLANT DIS, V91, P468, DOI 10.1094/PDIS-91-4-0468C; Momonoi K, 2011, J GEN PLANT PATHOL, V77, P142, DOI 10.1007/s10327-011-0299-9; Mumford RA, 2003, PLANT PATHOL, V52, P779, DOI 10.1111/j.1365-3059.2003.00888.x; Nagata T, 2007, VIRUS GENES, V35, P785, DOI 10.1007/s11262-007-0107-y; Ravnikar M, 2003, 8 INT C PLANT PATH I; Shimomoto Y, 2014, J GEN PLANT PATHOL, V80, P169, DOI 10.1007/s10327-014-0503-9; Silva MS, 2001, ARCH VIROL, V146, P1267, DOI 10.1007/s007050170090; Takeshita M, 2011, EUR J PLANT PATHOL, V131, P9, DOI 10.1007/s10658-011-9797-z; van Knippenberg I, 2002, VIROLOGY, V303, P278, DOI 10.1006/viro.2002.1632; Verhoeven J.T., 1996, ACTA HORTIC, V432, P44; Yeh SD, 1996, ACTA HORTIC, V431, P122	30	0	0	SPRINGER WIEN	WIEN	SACHSENPLATZ 4-6, PO BOX 89, A-1201 WIEN, AUSTRIA	0304-8608	1432-8798		ARCH VIROL	Arch. Virol.	FEB	2015	160	2					529	536		10.1007/s00705-014-2287-9		8	Virology	Virology	CB2CE	WOS:000349433500022		
J	Kuhn, JH; Durrwald, R; Bao, YM; Briese, T; Carbone, K; Clawson, AN; deRisi, JL; Garten, W; Jahrling, PB; Kolodziejek, J; Rubbenstroth, D; Schwemmle, M; Stenglein, M; Tomonaga, K; Weissenbock, H; Nowotny, N				Kuhn, Jens H.; Duerrwald, Ralf; Bao, Yiming; Briese, Thomas; Carbone, Kathryn; Clawson, Anna N.; deRisi, Joseph L.; Garten, Wolfgang; Jahrling, Peter B.; Kolodziejek, Jolanta; Rubbenstroth, Dennis; Schwemmle, Martin; Stenglein, Mark; Tomonaga, Keizo; Weissenboeck, Herbert; Nowotny, Norbert			Taxonomic reorganization of the family Bornaviridae	ARCHIVES OF VIROLOGY			English	Article							BORNA-DISEASE-VIRUS; PROVENTRICULAR DILATATION DISEASE; STRAND RNA VIRUS; AVIAN BORNAVIRUS; STANDARDIZED NOMENCLATURE; PSITTACINE BIRDS; SPECIES LEVEL; IDENTIFICATION; VARIANTS; GENOTYPE	Knowledge of bornaviruses has expanded considerably during the last decade. A possible reservoir of mammalian Borna disease virus has been identified, divergent bornaviruses have been detected in birds and reptiles, and endogenous bornavirus-like elements have been discovered in the genomes of vertebrates of several species. Previous sequence comparisons and alignments have indicated that the members of the current family Bornaviridae are phylogenetically diverse and are not adequately classified in the existing bornavirus taxonomy supported by the International Committee on Taxonomy of Viruses (ICTV). We provide an update of these analyses and describe their implications for taxonomy. We propose retaining the family name Bornaviridae and the genus Bornavirus but reorganizing species classification. PAirwise Sequence Comparison (PASC) of bornavirus genomes and Basic Local Alignment Search Tool (BLAST) comparison of genomic and protein sequences, in combination with other already published phylogenetic analyses and known biological characteristics of bornaviruses, indicate that this genus should include at least five species: Mammalian 1 bornavirus (classical Borna disease virus and divergent Borna disease virus isolate No/98), Psittaciform 1 bornavirus (avian/psittacine bornaviruses 1, 2, 3, 4, 7), Passeriform 1 bornavirus (avian/canary bornaviruses C1, C2, C3, LS), Passeriform 2 bornavirus (estrildid finch bornavirus EF), and Waterbird 1 bornavirus (avian bornavirus 062(CG)). This classification is also in line with biological characteristics of these viruses and their vertebrate hosts. A snake bornavirus, proposed to be named Loveridge's garter snake virus 1, should be classified as a member of an additional species (Elapid 1 bornavirus), unassigned to a genus, in the family Bornaviridae. Avian bornaviruses 5, 6, MALL, and another "reptile bornavirus" ("Gaboon viper virus") should stay unclassified until further information becomes available. Finally, we propose new virus names and abbreviations when necessary to achieve clear differentiation and unique identification.	[Kuhn, Jens H.; Clawson, Anna N.; Jahrling, Peter B.] NIAID, Integrated Res Facil Ft Detrick IRF Frederick, DCR, NIH, Ft Detrick, MD 20884 USA; [Duerrwald, Ralf] IDT Biol GmbH, Dessau Rosslau, Germany; [Bao, Yiming] NIH, Informat Engn Branch, Natl Ctr Biotechnol Informat, Natl Lib Med, Bethesda, MD 20892 USA; [Briese, Thomas] Columbia Univ, Mailman Sch Publ Hlth, Ctr Infect & Immun, New York, NY USA; [Carbone, Kathryn] NIH, Bethesda, MD 20892 USA; [deRisi, Joseph L.] Univ Calif San Francisco, Dept Med, San Francisco, CA USA; [deRisi, Joseph L.] Univ Calif San Francisco, Dept Biochem & Biophys, San Francisco, CA 94143 USA; [deRisi, Joseph L.] Univ Calif San Francisco, Dept Microbiol, San Francisco, CA 94143 USA; [Garten, Wolfgang] Univ Marburg, Inst Virol, D-35032 Marburg, Germany; [Kolodziejek, Jolanta; Nowotny, Norbert] Univ Vet Med Vienna, Dept Pathobiol, Viral Zoonoses Emerging & Vector Borne Infect Grp, Inst Virol, A-1210 Vienna, Austria; [Rubbenstroth, Dennis; Schwemmle, Martin] Univ Med Ctr Freiburg, Inst Virol, Freiburg, Germany; [Stenglein, Mark] Colorado State Univ, Dept Microbiol Immunol & Pathol, Ft Collins, CO 80523 USA; [Tomonaga, Keizo] Kyoto Univ, Inst Virus Res, Kyoto 606, Japan; [Weissenboeck, Herbert] Univ Vet Med Vienna, Dept Pathobiol, Inst Pathol & Forens Vet Med, A-1210 Vienna, Austria; [Nowotny, Norbert] Sultan Qaboos Univ, Dept Microbiol & Immunol, Coll Med & Hlth Sci, Muscat, Oman	Kuhn, JH (reprint author), NIAID, Integrated Res Facil Ft Detrick IRF Frederick, DCR, NIH, B-8200 Res Plaza, Ft Detrick, MD 20884 USA.	kuhnjens@mail.nih.gov; Norbert.Nowotny@vetmeduni.ac.at	Kuhn, Jens H./B-7615-2011	Kuhn, Jens H./0000-0002-7800-6045	National Institutes of Health/National Institute of Allergy and Infectious Diseases [HHSN272200700016I]; National Institutes of Health, National Library of Medicine	We would like to thank Laura Bollinger and Jiro Wada of the IRF-Frederick for critically editing the manuscript and creating/editing figures. JHK performed this work as an employee of Tunnell Government Services, Inc., and ANC, as the owner of Logos Consulting, Inc., both subcontractors to Battelle Memorial Institute under its prime contract with the National Institutes of Health/National Institute of Allergy and Infectious Diseases, under Contract No. HHSN272200700016I. This research was also supported in part by the Intramural Research Program of the National Institutes of Health, National Library of Medicine (YB).	Adams MJ, 2013, ARCH VIROL, V158, P2633, DOI 10.1007/s00705-013-1749-9; BRIESE T, 1992, P NATL ACAD SCI USA, V89, P11486, DOI 10.1073/pnas.89.23.11486; Jackson AO, 2005, ANNU REV PHYTOPATHOL, V43, P623, DOI 10.1146/annurev.phyto.43.011205.141136; Pringle CR, 1996, ARCH VIROL, V141, P2251, DOI 10.1007/BF01718231; Delnatte P, 2011, VET REC, V169, P108, DOI 10.1136/vr.d4620; CUBITT B, 1994, VIRUS RES, V34, P69, DOI 10.1016/0168-1702(94)90120-1; Rubbenstroth D, 2013, VET MICROBIOL, V165, P287, DOI 10.1016/j.vetmic.2013.03.024; Horie M, 2013, PHILOS T R SOC B, V368, DOI 10.1098/rstb.2012.0499; Staeheli P, 2000, J GEN VIROL, V81, P2123; Horie M, 2010, NATURE, V463, P84, DOI 10.1038/nature08695; Kistler AL, 2008, VIROL J, V5, DOI 10.1186/1743-422X-5-88; Weissenbock H, 2009, EMERG INFECT DIS, V15, P1453, DOI 10.3201/eid1509.090353; LIPKIN WI, 1990, P NATL ACAD SCI USA, V87, P4184, DOI 10.1073/pnas.87.11.4184; Payne S, 2011, AVIAN PATHOL, V40, P15, DOI 10.1080/03079457.2010.536978; Weissenbock H, 2009, J VIROL, V83, P11367, DOI 10.1128/JVI.01343-09; Rinder M, 2009, J VIROL, V83, P5401, DOI 10.1128/JVI.00133-09; DELATORRE JC, 1994, J VIROL, V68, P7669; Rubbenstroth D, 2014, VET MICROBIOL, V168, P318, DOI 10.1016/j.vetmic.2013.11.032; Honkavuori KS, 2008, EMERG INFECT DIS, V14, P1883, DOI 10.3201/eid1412.080984; Kuhn JH, 2014, ARCH VIROL, V159, P1229, DOI 10.1007/s00705-013-1877-2; Kuhn JH, 2013, ARCH VIROL, V158, P1425, DOI 10.1007/s00705-012-1594-2; BRIESE T, 1994, P NATL ACAD SCI USA, V91, P4362, DOI 10.1073/pnas.91.10.4362; Rubbenstroth D, 2012, VET MICROBIOL, V161, P36, DOI 10.1016/j.vetmic.2012.07.004; SCHNEIDER PA, 1994, J VIROL, V68, P5007; Kuhn JH, 2013, ARCH VIROL, V158, P301, DOI 10.1007/s00705-012-1454-0; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; Authenrieth CF, 1823, UEBER HITZIGE KOPF K; Bao Y, 2008, ENCY VIROLOGY, P342; Bao YM, 2014, ARCH VIROL, V159, P3293, DOI 10.1007/s00705-014-2197-x; Belyi VA, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1001030; de la Torre JC, 2000, VIRUS TAXONOMY, P531; Durrwald R, 1997, J VET MED B, V44, P147; Durrwald R, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0093659; Durrwald R, 2006, MICROBES INFECT, V8, P917, DOI 10.1016/j.micinf.2005.08.013; FENNER F, 1976, Intervirology, V7, P1, DOI 10.1159/000149938; Francki RIB, 1991, ARCH VIROLOGY S, V2; Fujino K, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0051161; Gilbert C, 2014, P BIOL SCI, V281, DOI [10.1098/rspb.2014.1122, DOI 10.1098/RSPB.2014.1122]; He M, 2014, MOL PHYLOGENET EVOL, V79, P385, DOI 10.1016/j.ympev.2014.07.006; Joest E, 1909, Z INF KRANKHEIT HAUS, V6, P348; Katzourakis A, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1001191; King AMQ, 2011, VIRUS TAXONOMY, P1273; Kolodziejek J, 2005, J GEN VIROL, V86, P385, DOI 10.1099/vir.0.80587-0; Ladner JT, 2014, MBIO, V5; Ludwig T H, 1973, Med Microbiol Immunol, V158, P275; Masayuki Horie, 2010, UIRUSU, V60, P143; Matthews REF, 1979, VIROLOGY, V12, P129; MATTHEWS R E F, 1982, Intervirology, V17, P1, DOI 10.1159/000149278; NEEDLEMA.SB, 1970, J MOL BIOL, V48, P443, DOI 10.1016/0022-2836(70)90057-4; NITZSCHKE E., 1957, Berl. Munch. Tierarztl. Wschr., V70, P101; Nowotny N, 2000, J VIROL, V74, P5655, DOI 10.1128/JVI.74.12.5655-5658.2000; ROTT R., 1958, ZU. Vet Med., V5, P629; SCHNEEMANN A, 1994, J VIROL, V68, P6514; SCHNEIDER PA, 1994, J VIROL, V68, P63; Schwemmle M, 2011, VIRUS TAXONOMY, P658; Schwemmle M, 2005, VIRUS TAXONOMY, P615; Staeheli P, 2010, J VIROL, V84, P6269, DOI 10.1128/JVI.02567-09; Stenglein MD, 2014, GENOME ANNOUNC, V2, DOI [10.1128/genomeA.00779-14, DOI 10.1128/GENOMEA.00779-1425301640, 10.1128/genomeA.00779-1425301640]; Van Regenmortel MHV, 2010, ARCH VIROL, V155, P1909, DOI 10.1007/s00705-010-0831-9; Vetten HJ, 2006, ARCH VIROL, V151, P1249, DOI 10.1007/s00705-006-0743-x; Wildy P., 1971, CLASSIFICATION NOMEN; Worz JJ, 1858, HALB ACUTE GEHIRN EN; Zimmermann V, 2014, J VET DIAGN INVEST, V26, P769, DOI 10.1177/1040638714547258; Zwick W, 1929, ARCH WISS PRAKT TIER, V59, P511; ZWICK W., 1924, Berl. tierarztl. Wschr., V40, P465	65	8	9	SPRINGER WIEN	WIEN	SACHSENPLATZ 4-6, PO BOX 89, A-1201 WIEN, AUSTRIA	0304-8608	1432-8798		ARCH VIROL	Arch. Virol.	FEB	2015	160	2					621	632		10.1007/s00705-014-2276-z		12	Virology	Virology	CB2CE	WOS:000349433500042		
J	Abo, T				Abo, Tetsuo			Researching international transfer of the Japanese-style management and production system: Hybrid factories in six continents	ASIAN BUSINESS & MANAGEMENT			English	Article						international production-technology transfer; Japanese-style management and production; application-adaptation (hybrid) model; hybrid factory; management geography; BoP markets		This article reviews the research on international transfer of the Japanese management and production system carried out by the Japanese Multinational Enterprises Study Group for over 25 years across 6 continents. It also provides a historical and theoretical review of the Japanese system compared with other management styles during the 'Post-Fordism' period. The group's findings, encompassing around 500 factories across 30 countries, are based on an 'application-adaptation (hybrid) model' and represent a significant contribution to theories of Japanese technology transfer. The relationship between technology transfer and the creation of competitive advantage in newly developing regions, especially BoP markets, is also discussed.	Univ Tokyo, Bunkyo Ku, Tokyo 1130033, Japan	Abo, T (reprint author), Univ Tokyo, Bunkyo Ku, Tokyo 1130033, Japan.	t-abo@abox8.so-net.ne.jp					Abegglen J.C., 1957, THE JAPANESE FACTORY; Abo T., 2013, AKAMON MANAGEMENT RE, V12, P795; Abo T., 1989, JAPANESE AND EUROPEA, P3; Abo T., 2004, TRANSFORMATIVE ORGAN, P231; Abo T., 1992, MANAGERIAL EFFICIENC, P105; Abo T., 1981, ANNALS OF THE INSTIT, V22, P183; Abo T., 2007, JAPANESE HYBRID FACT; Abo T., 1998, JAPANESE BUSINESS MA, P80; Abo T., 2010, COMPETING CHINESE AN; Abo T., 1994, HYBRID FACTORY THE J; Abo T., 1998, BETWEEN IMITATION AN, P216; Abo T., 2012, SPACES OF INTERNATIO, P176; Abo T, 2000, THE OXFORD HANDBOOK, P625; Abo T., 1988, NIHON KIGYO NO AMERI; Adler P. S., 1993, RES ORGAN BEHAV, P111; Mudambi R, 2004, J INT BUS STUD, V35, P385, DOI 10.1057/palgrave.jibs.8400093; Cantwell J, 2005, STRATEGIC MANAGE J, V26, P1109, DOI 10.1002/smj.497; [Anonymous], 1997, DIMINISHING JAPAN TH, P1; Aoki M., 2001, INFORMATION CORPORAT; Aoshima Y., 2001, BIJINESU AAKITEKUCHU; Asakawa K, 2001, R&D MANAGE, V31, P1, DOI 10.1111/1467-9310.00192; Bayari C., 2011, JAPANESE HYBRID FACT; Bayari C., 2012, 15TH ANNUAL CONVENTI; Bayari C., 2010, EURO ASIA JOURNAL OF, V20, P111; Birkinshaw J., 1998, ACAD MANAGE REV, V23, P773; Boyer R, 1997, FTER FORDISM; Boyer R., 1998, BETWEEN IMITATION AN, P23; Boyer R., 1998, BETWEEN IMITATION AN; Cho D, 2009, 16TH ANNUAL MEETING, P1; Dore R. P., 1973, BRITISH FACTORY JAPA; Doyukai Keizai, 1997, MAN MARK OR EC ACT P; Elger T, 1994, GLOBAL JAPANIZATION; Fujimoto T., 2007, EVOLUTIONARY I EC RE, V4, P55; Fujimoto T., 1991, PRODUCT DEVELOPMENT; Hall E. T., 1976, BEYOND CULTURE; Hymer S., 1976, THE INTERNATIONAL OP; Itagaki H., 1997, THE JAPANESE PRODUCT; Juhn W., 2014, AKAMON MANAGEMENT RE, V13, P209; Juhn W., 2011, CHU KYO KEIEI KENKYU, V20, P109; Kamiyama K., 2005, KYODAIKA SURU CHUGOK; Kawamura T., 2011, HYBRID FACTORIES IN; Kenney M., 1994, BEYOND MASS PRODUCTI; Koike K., 1988, UNDERSTANDING INDUST; Kojima K., 1978, JAPANESE DIRECT FORE; Kumon H., 2004, THE HYBRID FACTORY I; Mazrui A.A., 1986, THE AFRICANS A TRIPL; METI, 2014, INFORMATION ON THE G; MIT Commission on Industrial Productivity, 1989, WORKING PAPERS OF TH, V2; MIT Commission on Industrial Productivity, 1989, WORKING PAPERS OF TH, V1; Nakagawa K., 2011, JOURNAL OF INTERNATI, V3, P49; Noronha C., 2002, THE THEORY OF CULTUR; Okamoto Y., 2000, HOKUBEI NIKKEI KIGYO; Oliver N., 1988, THE JAPANIZATION OF; Ozawa T., 1979, MULTINATIONALISM JAP; Piore M., 1984, THE SECOND INDUSTRIA; Porter M., 2000, CAN JAPAN COMPETE; Porter Michael, 1990, THE COMPETITIVE ADVA; Schlunze R. D., 2012, SPACES OF INTERNATIO, P24; Trevor M., 1983, JAPANS RELUCTANT MUL; Wada M., 2005, CHU TOHOLZ NO NIHON; Wilkins M., 1964, AMERICAN BUSINESS AB; Womack J. P., 1990, THE MACHINE THAT CHA; Yamazaki K, 2013, HYBRID FACTORIES IN LATIN AMERICA: JAPANESE MANAGEMENT TRANSFERRED, P1, DOI 10.1057/9781137287007; Yasumuro K., 1981, KOKUSAI KEIEI KODO R; Yoshihara H., 1989, SOSHIKI KAGAKU, V23, P10; Yoshino M. Y., 1969, JAPANS MANAGERIAL SY; Yuan Z. J., 2006, CHU TOH NO NIKKEI HA	67	2	2	PALGRAVE MACMILLAN LTD	BASINGSTOKE	BRUNEL RD BLDG, HOUNDMILLS, BASINGSTOKE RG21 6XS, HANTS, ENGLAND	1472-4782	1476-9328		ASIAN BUS MANAG	Asian. Bus. Manag.	FEB	2015	14	1					5	35		10.1057/abm.2014.13		31	Business; Management	Business & Economics	CB3EW	WOS:000349512000002		
J	Hishimura, Y				Hishimura, Yutaka			Interactions with conspecific attenuate conditioned taste aversions in mice	BEHAVIOURAL PROCESSES			English	Article						Mice; Conditioned taste aversion; Social buffering; Stress-induced analgesia	STRESS; ANALGESIA; BEHAVIOR	Social animals both increase and decrease their stress levels by interacting with conspecifics. The present study examines the effect of interaction with a conspecific on conditioned taste aversion in 32 male mice. Subjects were injected with lithium chloride immediately after drinking saccharin solution for 30 min. They were then exposed to a male conspecific for 3 h following the poisoning. In the subsequent three consecutive days of two-bottle tests involving a choice between saccharin solution and water, they showed attenuated conditioned taste aversion compared with controls exposed to no conspecific after poisoning. These results confirm social interaction with a conspecific reduces conditioned taste aversion in mice. The implications of these findings are discussed with regard to social buffering effect and stress-induced analgesia. (C) 2014 Elsevier B.V. All rights reserved.	Hiroshima Int Univ, Fac Psychol Sci, Dept Clin Psychol, Hiroshima 7392695, Japan	Hishimura, Y (reprint author), Hiroshima Int Univ, Fac Psychol Sci, Dept Clin Psychol, Kurose Cho, Hiroshima 7392695, Japan.	y-hishi@he.hirokoku-u.ac.jp			JSPS KAKENHI [14710058]	This research was supported by JSPS KAKENHI Grant Number 14710058.	DESS NK, 1988, PHYSIOL BEHAV, V44, P483, DOI 10.1016/0031-9384(88)90309-5; Kikusui T, 2006, PHILOS T R SOC B, V361, P2215, DOI 10.1098/rstb.2006.1941; Langford DJ, 2006, SCIENCE, V312, P1967, DOI 10.1126/science.1128322; Langford DJ, 2010, SOC NEUROSCI-UK, V5, P163, DOI 10.1080/17470910903216609; Kiyokawa Y, 2005, CHEM SENSES, V30, P513, DOI 10.1093/chemse/bji044; Blanchard RJ, 2001, PHYSIOL BEHAV, V73, P261, DOI 10.1016/S0031-9384(01)00449-8; BOURNE MJ, 1992, PHYSIOL BEHAV, V51, P1227, DOI 10.1016/0031-9384(92)90313-Q; Carter C.S., 2005, ATTACHMENT BONDING N; D'Amato FR, 1998, BEHAV PHARMACOL, V9, P369; GALEF BG, 1985, ANIM LEARN BEHAV, V13, P415, DOI 10.3758/BF03208018; Gilbert MH, 2011, J MED PRIMATOL, V40, P71, DOI 10.1111/j.1600-0684.2010.00447.x; HOLDER MD, 1989, BEHAV NEUROSCI, V103, P605, DOI 10.1037//0735-7044.103.3.605; Masaki T, 2004, LEARN MOTIV, V35, P406, DOI 10.1016/j.lmot.2004.04.003; REVUSKY S, 1989, PHARMACOL BIOCHEM BE, V33, P219, DOI 10.1016/0091-3057(89)90453-X; RODGERS RJ, 1983, PHYSIOL BEHAV, V30, P775, DOI 10.1016/0031-9384(83)90177-4; RODGERS RJ, 1986, PHYSIOL BEHAV, V36, P947, DOI 10.1016/0031-9384(86)90458-0	16	1	1	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	0376-6357	1872-8308		BEHAV PROCESS	Behav. Processes	FEB	2015	111						34	36		10.1016/j.beproc.2014.11.006		3	Psychology, Biological; Behavioral Sciences; Zoology	Psychology; Behavioral Sciences; Zoology	CB2AU	WOS:000349429900005		
J	Arai, Y; Kanda, J; Nakasone, H; Kondo, T; Uchida, N; Fukuda, T; Ohashi, K; Ogawa, H; Nagamura-Inoue, T; Morishima, Y; Hirokawa, M; Atsuta, Y; Murata, M				Arai, Yasuyuki; Kanda, Junya; Nakasone, Hideki; Kondo, Tadakazu; Uchida, Naoyuki; Fukuda, Takahiro; Ohashi, Kazuteru; Ogawa, Hiroyasu; Nagamura-Inoue, Tokiko; Morishima, Yasuo; Hirokawa, Makoto; Atsuta, Yoshiko; Murata, Makoto			Analysis of Risk Factors for Hepatic Acute Graft-Versus-Host Disease By Using Transplant Registry Data in Japan	BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION			English	Meeting Abstract	BMT Tandem Meetings	FEB 11-15, 2015	San Diego, CA						[Arai, Yasuyuki; Kondo, Tadakazu] Kyoto Univ, Grad Sch Med, Dept Hematol & Oncol, Kyoto, Japan; [Kanda, Junya; Nakasone, Hideki] Jichi Med Univ, Saitama Med Ctr, Div Hematol, Saitama, Japan; [Nakasone, Hideki] Stanford Univ, Sch Med, Div Blood & Marrow Transplantat, Stanford, CA 94305 USA; [Uchida, Naoyuki] Toranomon Gen Hosp, Dept Hematol, Tokyo, Japan; [Fukuda, Takahiro] Natl Canc Ctr, Stem Cell Transplantat Div, Tokyo, Japan; [Ohashi, Kazuteru] Komagome Hosp, Tokyo Metropolitan Canc & Infect Dis Ctr, Div Hematol, Tokyo, Japan; [Ogawa, Hiroyasu] Hyogo Coll Med, Dept Internal Med, Div Hematol, Nishinomiya, Hyogo 6638501, Japan; [Nagamura-Inoue, Tokiko] Univ Tokyo, Inst Med Sci, Dept Cell Proc & Transfus, Tokyo, Japan; [Morishima, Yasuo] Aichi Canc Ctr, Res Inst, Div Epidemiol & Prevent, Nagoya, Aichi 464, Japan; [Hirokawa, Makoto] Akita Univ, Grad Sch Med, Dept Gen Internal Med & Clin Lab Med, Akita 010, Japan; [Atsuta, Yoshiko] Japanese Data Ctr Hematopoiet Cell Transplantat, Nagoya, Aichi, Japan; [Atsuta, Yoshiko] Nagoya Univ, Grad Sch Med, Dept Healthcare Adm, Nagoya, Aichi 4648601, Japan; [Murata, Makoto] Nagoya Univ, Grad Sch Med, Dept Hematol & Oncol, Nagoya, Aichi 4648601, Japan								0	0	0	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	1083-8791	1523-6536		BIOL BLOOD MARROW TR	Biol. Blood Marrow Transplant.	FEB	2015	21	2		1		470	S325	S326				2	Hematology; Immunology; Transplantation	Hematology; Immunology; Transplantation	CA0UZ	WOS:000348633000472		
J	Arora, M; Cutler, CS; Jagasia, MH; Pidala, J; Chai, XY; Martin, PJ; Flowers, MED; Inamoto, Y; Chen, GL; Wood, B; Khera, N; Palmer, J; Duong, HK; Arai, S; Lee, SJ				Arora, Mukta; Cutler, Corey S.; Jagasia, Madan H.; Pidala, Joseph; Chai, Xiaoyu; Martin, Paul J.; Flowers, Mary E. D.; Inamoto, Yoshihiro; Chen, George L.; Wood, Bill; Khera, Nandita; Palmer, Jeanne; Duong, Hien K.; Arai, Sally; Lee, Stephanie J.			Incidence, Risk Factors, and Prognosis of Late Immune-Mediated Disorders after Allogeneic Hematopoietic Cell Transplantation (HCT)	BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION			English	Meeting Abstract	BMT Tandem Meetings	FEB 11-15, 2015	San Diego, CA						[Arora, Mukta] Univ Minnesota, Med Ctr, Minneapolis, MN 55455 USA; [Cutler, Corey S.] Harvard Univ, Sch Med, Dana Farber Canc Inst, Boston, MA 02115 USA; [Jagasia, Madan H.] Vanderbilt Univ, Med Ctr, Dept Med, Div Hematol Oncol, Nashville, TN USA; [Pidala, Joseph] H Lee Moffitt Canc Ctr & Res Inst, Tampa, FL USA; [Chai, Xiaoyu; Martin, Paul J.; Flowers, Mary E. D.; Lee, Stephanie J.] Fred Hutchinson Canc Res Ctr, Div Clin Res, Seattle, WA 98104 USA; [Inamoto, Yoshihiro] Natl Canc Ctr, Stem Cell Transplantat Div, Tokyo, Japan; [Chen, George L.] Roswell Pk Canc Inst, Dept Med, Buffalo, NY 14263 USA; [Wood, Bill] Univ N Carolina, Chapel Hill, NC USA; [Khera, Nandita] Mayo Clin, Phoenix, AZ USA; [Palmer, Jeanne] Mayo Clin Arizona, Phoenix, AZ USA; [Duong, Hien K.] Cleveland Clin, Blood & Marrow Transplant Program, Cleveland, OH 44106 USA; [Arai, Sally] Stanford Univ, Med Ctr, Div Blood & Marrow Transplantat, Stanford, CA 94305 USA								0	0	0	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	1083-8791	1523-6536		BIOL BLOOD MARROW TR	Biol. Blood Marrow Transplant.	FEB	2015	21	2		1		36	S54	S54				1	Hematology; Immunology; Transplantation	Hematology; Immunology; Transplantation	CA0UZ	WOS:000348633000041		
J	Doki, N; Igarashi, A; Najima, Y; Kobayashi, T; Kakihana, K; Sakamaki, H; Ohashi, K				Doki, Noriko; Igarashi, Aiko; Najima, Yuho; Kobayashi, Takeshi; Kakihana, Kazuhiko; Sakamaki, Hisashi; Ohashi, Kazuteru			The Clinical Outcome of Allogeneic Hematopoietic Stem Cell Transplantation (allo-HSCT) for Elderly Philadelphia Chromosome-Positive (Ph plus ) Acute Lymphoblastic Leukemia (ALL) in the Era of Tyrosine Kinase Inhibitor (TKI) : A Single Institute Experience	BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION			English	Meeting Abstract	BMT Tandem Meetings	FEB 11-15, 2015	San Diego, CA						[Doki, Noriko; Igarashi, Aiko; Najima, Yuho; Kobayashi, Takeshi; Kakihana, Kazuhiko; Sakamaki, Hisashi; Ohashi, Kazuteru] Komagome Hosp, Tokyo Metropolitan Canc & Infect Dis Ctr, Div Hematol, Tokyo, Japan								0	0	0	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	1083-8791	1523-6536		BIOL BLOOD MARROW TR	Biol. Blood Marrow Transplant.	FEB	2015	21	2		1		396	S279	S279				1	Hematology; Immunology; Transplantation	Hematology; Immunology; Transplantation	CA0UZ	WOS:000348633000398		
J	Hashida, R; Mori, T; Kato, J; Kohashi, S; Okamoto, S				Hashida, Risa; Mori, Takehiko; Kato, Jun; Kohashi, Sumiko; Okamoto, Shinichiro			Effect of Linezolid Administration on Myeloid Engraftment after Allogeneic Hematopoietic Stem Cell Transplantation	BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION			English	Meeting Abstract	BMT Tandem Meetings	FEB 11-15, 2015	San Diego, CA						[Hashida, Risa; Mori, Takehiko; Kato, Jun; Kohashi, Sumiko; Okamoto, Shinichiro] Keio Univ, Sch Med, Div Hematol, Tokyo, Japan								0	0	0	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	1083-8791	1523-6536		BIOL BLOOD MARROW TR	Biol. Blood Marrow Transplant.	FEB	2015	21	2		1		348	S251	S251				1	Hematology; Immunology; Transplantation	Hematology; Immunology; Transplantation	CA0UZ	WOS:000348633000350		
J	Ikeda, M; Tsukada, N; Shingaki, S; Miyazaki, K; Meshitsuka, S; Yoshiki, Y; Abe, Y; Suzuki, K				Ikeda, Masahiro; Tsukada, Nobuhiro; Shingaki, Sumito; Miyazaki, Kanji; Meshitsuka, Sosuke; Yoshiki, Yumiko; Abe, Yu; Suzuki, Kenshi			Allogeneic Stem Cell Transplantation for Relapsed and Refractory Multiple Myeloma-a Single Institute Analysis of 10 Cases	BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION			English	Meeting Abstract	BMT Tandem Meetings	FEB 11-15, 2015	San Diego, CA						[Ikeda, Masahiro; Tsukada, Nobuhiro; Shingaki, Sumito; Miyazaki, Kanji; Meshitsuka, Sosuke; Yoshiki, Yumiko; Abe, Yu; Suzuki, Kenshi] Japanese Red Cross Med Ctr, Div Hematol, Tokyo, Japan								0	0	0	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	1083-8791	1523-6536		BIOL BLOOD MARROW TR	Biol. Blood Marrow Transplant.	FEB	2015	21	2		1		258	S197	S198				2	Hematology; Immunology; Transplantation	Hematology; Immunology; Transplantation	CA0UZ	WOS:000348633000262		
J	Ikegame, K; Kaida, K; Ishii, S; Yoshihara, S; Taniguchi, K; Inoue, T; Tamaki, H; Okada, M; Soma, T; Ogawa, H				Ikegame, Kazuhiro; Kaida, Katsuji; Ishii, Shinichi; Yoshihara, Satoshi; Taniguchi, Kyoko; Inoue, Takayuki; Tamaki, Hiroya; Okada, Masaya; Soma, Toshihiro; Ogawa, Hiroyasu			Spousal Hematopoietic Stem Cell Transplantation for Post-Transplant Relapse/Rejection	BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION			English	Meeting Abstract	BMT Tandem Meetings	FEB 11-15, 2015	San Diego, CA						[Ikegame, Kazuhiro; Kaida, Katsuji; Inoue, Takayuki; Tamaki, Hiroya; Okada, Masaya; Soma, Toshihiro; Ogawa, Hiroyasu] Hyogo Coll Med, Dept Internal Med, Div Hematol, Nishinomiya, Hyogo 6638501, Japan; [Ishii, Shinichi; Yoshihara, Satoshi; Taniguchi, Kyoko] Hyogo Coll Med, Dept Hematol, Nishinomiya, Hyogo 6638501, Japan								0	0	0	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	1083-8791	1523-6536		BIOL BLOOD MARROW TR	Biol. Blood Marrow Transplant.	FEB	2015	21	2		1		191	S158	S159				2	Hematology; Immunology; Transplantation	Hematology; Immunology; Transplantation	CA0UZ	WOS:000348633000196		
J	Inoue, Y; Fuji, S; Tanosaki, R; Ito, R; Tanaka, T; Inamoto, Y; Okinaka, K; Kurosawa, S; Kim, SW; Yamashita, T; Fukuda, T				Inoue, Yoshitaka; Fuji, Shigeo; Tanosaki, Ryuji; Ito, Reiko; Tanaka, Takashi; Inamoto, Yoshihiro; Okinaka, Keiji; Kurosawa, Saiko; Kim, Sung-Won; Yamashita, Takuya; Fukuda, Takahiro			Administration of Mogamulizumab before Allogeneic Hematopoietic Cell Transplantation Against ATLL Might Increase Risks of Acute Gvhd and Non-Relapse Mortality	BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION			English	Meeting Abstract	BMT Tandem Meetings	FEB 11-15, 2015	San Diego, CA						[Inoue, Yoshitaka; Fuji, Shigeo; Ito, Reiko; Tanaka, Takashi; Inamoto, Yoshihiro; Okinaka, Keiji; Kurosawa, Saiko; Kim, Sung-Won; Yamashita, Takuya; Fukuda, Takahiro] Natl Canc Ctr, Stem Cell Transplantat Div, Tokyo, Japan; [Tanosaki, Ryuji] Natl Canc Ctr, Dept Blood Transfus & Cellular Therapy, Tokyo, Japan								0	0	0	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	1083-8791	1523-6536		BIOL BLOOD MARROW TR	Biol. Blood Marrow Transplant.	FEB	2015	21	2		1		259	S198	S198				1	Hematology; Immunology; Transplantation	Hematology; Immunology; Transplantation	CA0UZ	WOS:000348633000263		
J	Itamura, H; Shindo, T; Tawara, I; Kariya, R; Okada, S; Komanduri, KV; Kimura, S				Itamura, Hidekazu; Shindo, Takero; Tawara, Isao; Kariya, Ryusho; Okada, Seiji; Komanduri, Krishna V.; Kimura, Shinya			The MEK Inhibitor Trametinib Selectively Suppresses GVHD, While Sparing GVT Effects	BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION			English	Meeting Abstract	BMT Tandem Meetings	FEB 11-15, 2015	San Diego, CA						[Itamura, Hidekazu; Shindo, Takero; Kimura, Shinya] Saga Univ, Sch Med, Dept Hematol Oncol, Saga 840, Japan; [Tawara, Isao] Mie Univ Hosp, Tsu, Mie, Japan; [Kariya, Ryusho; Okada, Seiji] Kumamoto Univ, Ctr AIDS Res, Kumamoto, Japan; [Komanduri, Krishna V.] Univ Miami, Sylvester Comprehens Canc Ctr, Adult Stem Cell Transplant Program, Miami, FL USA								0	0	0	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	1083-8791	1523-6536		BIOL BLOOD MARROW TR	Biol. Blood Marrow Transplant.	FEB	2015	21	2		1		485	S333	S334				2	Hematology; Immunology; Transplantation	Hematology; Immunology; Transplantation	CA0UZ	WOS:000348633000487		
J	Kamishohara, M; Komatsubara, H; Kakinuma, H; Tanaka, R; Nakamura, Y; Kobayashi, H				Kamishohara, Masaru; Komatsubara, Hirofumi; Kakinuma, Hayato; Tanaka, Ryo; Nakamura, Yuki; Kobayashi, Hiroyuki			Is Lymphoid Leukemia Less Susceptible to Busulfan Than Myeloid Leukemia? Comparison of Cytotoxicities of Busulfan, Melphalan, Fludarabine, Clofarabine, Cytosine Arabinoside, and Etoposide in Human Myeloid and Lymphoid Leukemia Cell Lines	BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION			English	Meeting Abstract	BMT Tandem Meetings	FEB 11-15, 2015	San Diego, CA						[Kamishohara, Masaru] Otsuka Pharmaceut Co Ltd, Med Affairs Oncol, Tokyo, Japan; [Komatsubara, Hirofumi; Kakinuma, Hayato; Tanaka, Ryo] Hamri Co Ltd, Tsukuba Res Ctr, Koga, Japan; [Nakamura, Yuki; Kobayashi, Hiroyuki] Otsuka Pharmaceut Co Ltd, Med Affairs, Tokyo, Japan								0	0	0	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	1083-8791	1523-6536		BIOL BLOOD MARROW TR	Biol. Blood Marrow Transplant.	FEB	2015	21	2		1		244	S188	S189				2	Hematology; Immunology; Transplantation	Hematology; Immunology; Transplantation	CA0UZ	WOS:000348633000248		
J	Kanaya, M; Shibuya, K; Abe, F; Teshima, T; Shibuya, A				Kanaya, Minoru; Shibuya, Kazuko; Abe, Fumie; Teshima, Takanori; Shibuya, Akira			CD155 Regulates Regulatory T Cell Population and Attenuates Acute Graft-Versus-Host Disease	BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION			English	Meeting Abstract	BMT Tandem Meetings	FEB 11-15, 2015	San Diego, CA						[Kanaya, Minoru; Teshima, Takanori] Hokkaido Univ, Grad Sch Med, Dept Hematol, Sapporo, Hokkaido, Japan; [Kanaya, Minoru; Shibuya, Kazuko; Abe, Fumie; Shibuya, Akira] Univ Tsukuba, Fac Med, Dept Immunol, Tsukuba, Ibaraki, Japan; [Shibuya, Akira] Univ Tsukuba, TARA, Life Sci Ctr, Tsukuba, Ibaraki, Japan								0	0	0	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	1083-8791	1523-6536		BIOL BLOOD MARROW TR	Biol. Blood Marrow Transplant.	FEB	2015	21	2		1		487	S335	S335				1	Hematology; Immunology; Transplantation	Hematology; Immunology; Transplantation	CA0UZ	WOS:000348633000489		
J	Kanda, J; Kuwatsuka, Y; Brazauskas, R; Hu, ZH; Nagafuji, K; Fukuda, T; Sakamaki, H; Bonfim, C; Dalal, J; Hahn, T; Pasquini, MC; Atsuta, Y; Saber, W				Kanda, Junya; Kuwatsuka, Yachiyo; Brazauskas, Ruta; Hu, Zhen-Huan; Nagafuji, Koji; Fukuda, Takahiro; Sakamaki, Hisashi; Bonfim, Carmem; Dalal, Jignesh; Hahn, Theresa; Pasquini, Marcelo C.; Atsuta, Yoshiko; Saber, Wael			Impact of Race on Graft-Versus-Host Disease Rates after HLA-Matched Sibling Bone Marrow or Peripheral Blood Hematopoietic Cell Transplantation: Comparison of North American Caucasian Versus Japanese Populations	BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION			English	Meeting Abstract	BMT Tandem Meetings	FEB 11-15, 2015	San Diego, CA						[Kanda, Junya] Jichi Med Univ, Saitama Med Ctr, Div Hematol, Saitama, Japan; [Kuwatsuka, Yachiyo] Nagoya Univ Hosp, Ctr Adv Med & Clin Res, Nagoya, Aichi, Japan; [Brazauskas, Ruta; Hu, Zhen-Huan; Saber, Wael] Med Coll Wisconsin, CIBMTR, Milwaukee, WI 53226 USA; [Nagafuji, Koji] Kurume Univ, Sch Med, Dept Med, Div Hematol & Oncol, Kurume, Fukuoka 830, Japan; [Fukuda, Takahiro] Natl Canc Ctr, Stem Cell Transplantat Div, Tokyo, Japan; [Sakamaki, Hisashi] Komagome Hosp, Tokyo Metropolitan Canc & Infect Dis Ctr, Div Hematol, Tokyo, Japan; [Bonfim, Carmem] Univ Fed Parana, Bone Marrow Transplantat Unit, BR-80060000 Curitiba, Parana, Brazil; [Dalal, Jignesh] Childrens Mercy Hosp, Sect Stem Cell Transplant, Kansas City, MO 64108 USA; [Hahn, Theresa] Roswell Pk Canc Inst, Buffalo, NY 14263 USA; [Pasquini, Marcelo C.] Med Coll Wisconsin, CIBMTR, Milwaukee, WI 53226 USA; [Atsuta, Yoshiko] Japanese Data Ctr Hematopoiet Cell Transplantat, Nagoya, Aichi, Japan; [Atsuta, Yoshiko] Nagoya Univ, Grad Sch Med, Dept Healthcare Adm, Nagoya, Aichi 4648601, Japan								0	0	0	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	1083-8791	1523-6536		BIOL BLOOD MARROW TR	Biol. Blood Marrow Transplant.	FEB	2015	21	2		1		13	S34	S35				2	Hematology; Immunology; Transplantation	Hematology; Immunology; Transplantation	CA0UZ	WOS:000348633000018		
J	Kanda, J; Morishima, Y; Wake, A; Terakura, S; Uchida, N; Takahashi, S; Ono, Y; Onishi, Y; Kanamori, H; Aotsuka, N; Kato, K; Atsuta, Y; Murata, M				Kanda, Junya; Morishima, Yasuo; Wake, Atsushi; Terakura, Seitaro; Uchida, Naoyuki; Takahashi, Satoshi; Ono, Yuju; Onishi, Yasushi; Kanamori, Heiwa; Aotsuka, Nobuyuki; Kato, Koji; Atsuta, Yoshiko; Murata, Makoto			Impact of Acute and Chronic Graft-Versus-Host Disease on Outcomes after Single Cord Blood Transplantation: A Retrospective Analysis By the JSHCT Gvhd Working Group	BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION			English	Meeting Abstract	BMT Tandem Meetings	FEB 11-15, 2015	San Diego, CA						[Kanda, Junya] Jichi Med Univ, Saitama Med Ctr, Div Hematol, Saitama, Japan; [Morishima, Yasuo] Aichi Canc Ctr, Res Inst, Div Epidemiol & Prevent, Nagoya, Aichi 464, Japan; [Wake, Atsushi; Uchida, Naoyuki] Toranomon Gen Hosp, Dept Hematol, Tokyo, Japan; [Terakura, Seitaro; Murata, Makoto] Nagoya Univ, Grad Sch Med, Dept Hematol & Oncol, Nagoya, Aichi 4648601, Japan; [Takahashi, Satoshi] Univ Tokyo, Inst Med Sci, Dept Mol Therapy, Tokyo, Japan; [Ono, Yuju] Kitakyushu Municipal Med Ctr, Dept Internal Med, Kitakyushu, Fukuoka, Japan; [Onishi, Yasushi] Tohoku Univ Hosp, Dept Hematol & Rheumatol, Sendai, Miyagi, Japan; [Kanamori, Heiwa] Kanagawa Canc Ctr, Dept Hematol, Yokohama, Kanagawa, Japan; [Aotsuka, Nobuyuki] Narita Hosp, Japanese Red Cross Soc, Div Hematol Oncol, Narita, Japan; [Kato, Koji] Japanese Red Cross Nagoya First Hosp, Childrens Med Ctr, Dept Hematol & Oncol, Nagoya, Aichi, Japan; [Atsuta, Yoshiko] Nagoya Univ, Grad Sch Med, Dept Healthcare Adm, Nagoya, Aichi 4648601, Japan								0	0	0	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	1083-8791	1523-6536		BIOL BLOOD MARROW TR	Biol. Blood Marrow Transplant.	FEB	2015	21	2		1		488	S335	S336				2	Hematology; Immunology; Transplantation	Hematology; Immunology; Transplantation	CA0UZ	WOS:000348633000490		
J	Kanda, J; Ikegame, K; Fuji, S; Fukuda, T; Kurokawa, M; Ogawa, H; Ohashi, K; Kanamori, H; Ishikawa, J; Inoue, M; Ichinohe, T; Atsuta, Y; Kanda, Y				Kanda, Junya; Ikegame, Kazuhiro; Fuji, Shigeo; Fukuda, Takahiro; Kurokawa, Mineo; Ogawa, Hiroyasu; Ohashi, Kazuteru; Kanamori, Heiwa; Ishikawa, Jun; Inoue, Masami; Ichinohe, Tatsuo; Atsuta, Yoshiko; Kanda, Yoshinobu			The Impact of HLA Mismatch Only in the Host-Versus-Graft Direction on the Outcome of Related Hematopoietic Stem Cell Transplantation for Patients with HLA-Homozygous Haplotypes: A Retrospective Analysis of the JSHCT HLA Working Group Study	BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION			English	Meeting Abstract	BMT Tandem Meetings	FEB 11-15, 2015	San Diego, CA						[Kanda, Junya; Kanda, Yoshinobu] Jichi Med Univ, Saitama Med Ctr, Div Hematol, Saitama, Japan; [Ikegame, Kazuhiro; Ogawa, Hiroyasu] Hyogo Coll Med, Dept Internal Med, Div Hematol, Nishinomiya, Hyogo 6638501, Japan; [Fuji, Shigeo; Fukuda, Takahiro] Natl Canc Ctr, Stem Cell Transplantat Div, Tokyo, Japan; [Kurokawa, Mineo] Tokyo Univ Hosp, Dept Cell Therapy & Transplantat Med, Tokyo 113, Japan; [Ohashi, Kazuteru] Komagome Hosp, Tokyo Metropolitan Canc & Infect Dis Ctr, Div Hematol, Tokyo, Japan; [Kanamori, Heiwa] Kanagawa Canc Ctr, Dept Hematol, Yokohama, Kanagawa, Japan; [Ishikawa, Jun] Osaka Med Ctr Canc & Cardiovasc Dis, Dept Hematol & Oncol, Osaka, Japan; [Inoue, Masami] Osaka Med Ctr, Dept Hematol Oncol, Osaka, Japan; [Inoue, Masami] Res Inst Maternal & Child Hlth, Osaka, Japan; [Ichinohe, Tatsuo] Hiroshima Univ Hosp, Dept Hematol & Oncol, Hiroshima, Japan; [Atsuta, Yoshiko] Nagoya Univ, Dept Healthcare Adm, Grad Sch Med, Nagoya, Aichi 4648601, Japan								0	0	0	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	1083-8791	1523-6536		BIOL BLOOD MARROW TR	Biol. Blood Marrow Transplant.	FEB	2015	21	2		1		193	S159	S160				2	Hematology; Immunology; Transplantation	Hematology; Immunology; Transplantation	CA0UZ	WOS:000348633000198		
J	Kawashima, N; Sato, T; Kato, M; Nakashima, M; Kagaya, Y; Watakabe, K; Seto, A; Fukushima, N; Kurahashi, S; Ozawa, Y; Miyamura, K				Kawashima, Naomi; Sato, Takahiko; Kato, Miho; Nakashima, Marie; Kagaya, Yusuke; Watakabe, Kyoko; Seto, Aika; Fukushima, Nobuaki; Kurahashi, Shingo; Ozawa, Yukiyasu; Miyamura, Koichi			Long-Term Outcomes of Allogeneic Hematopoietic Stem Cell Transplantation with Intensified Myeloablative Conditioning for Refractory Hematologic Malignancies	BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION			English	Meeting Abstract	BMT Tandem Meetings	FEB 11-15, 2015	San Diego, CA						[Kawashima, Naomi; Sato, Takahiko; Kato, Miho; Nakashima, Marie; Kagaya, Yusuke; Watakabe, Kyoko; Seto, Aika; Fukushima, Nobuaki; Kurahashi, Shingo; Ozawa, Yukiyasu; Miyamura, Koichi] Japanese Red Cross Nagoya First Hosp, Dept Hematol, Nagoya, Aichi, Japan								0	0	0	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	1083-8791	1523-6536		BIOL BLOOD MARROW TR	Biol. Blood Marrow Transplant.	FEB	2015	21	2		1		418	S293	S294				2	Hematology; Immunology; Transplantation	Hematology; Immunology; Transplantation	CA0UZ	WOS:000348633000420		
J	Khera, N; Chai, XY; Duong, HK; Inamoto, Y; Chen, GL; Mayer, S; Arora, M; Palmer, J; Flowers, MED; Cutler, CS; Lukezw, A; Arai, S; Lazaryan, A; Jagasia, MH; Pusic, I; Wood, W; Lee, SJ; Pidala, J				Khera, Nandita; Chai, Xiaoyu; Duong, Hien K.; Inamoto, Yoshihiro; Chen, George L.; Mayer, Sebastian; Arora, Mukta; Palmer, Jeanne; Flowers, Mary E. D.; Cutler, Corey S.; Lukezw, Alexander; Arai, Sally; Lazaryan, Aleksandr; Jagasia, Madan H.; Pusic, Iskra; Wood, William; Lee, Stephanie J.; Pidala, Joseph			Prospective Longitudinal Study of Late Acute Graft Versus Host Disease after Hematopoietic Cell Transplantation: A Report from Chronic GVHD Consortium	BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION			English	Meeting Abstract	BMT Tandem Meetings	FEB 11-15, 2015	San Diego, CA						[Khera, Nandita] Mayo Clin, Phoenix, AZ USA; [Chai, Xiaoyu; Flowers, Mary E. D.; Lee, Stephanie J.] Fred Hutchinson Canc Res Ctr, Div Clin Res, Seattle, WA 98104 USA; [Duong, Hien K.] Cleveland Clin, Blood & Marrow Transplant Program, Cleveland, OH 44106 USA; [Inamoto, Yoshihiro] Natl Canc Ctr, Stem Cell Transplantat Div, Tokyo, Japan; [Chen, George L.] Roswell Pk Canc Inst, Dept Med, Buffalo, NY 14263 USA; [Mayer, Sebastian] Weill Cornell Med Ctr, Dept Med, New York, NY USA; [Arora, Mukta; Lazaryan, Aleksandr] Univ Minnesota, Med Ctr, Minneapolis, MN 55455 USA; [Palmer, Jeanne] Mayo Clin Arizona, Phoenix, AZ USA; [Cutler, Corey S.] Harvard Univ, Sch Med, Dana Farber Canc Inst, Boston, MA 02115 USA; [Lukezw, Alexander] Dana Farber Canc Inst, Boston, MA 02115 USA; [Arai, Sally] Stanford Univ, Med Ctr, Div Blood & Marrow Transplantat, Stanford, CA 94305 USA; [Jagasia, Madan H.] Vanderbilt Univ, Med Ctr, Div Hematol Oncol, Nashville, TN USA; [Pusic, Iskra] Washington Univ, Med Ctr, St Louis, MO USA; [Wood, William] Univ North Carolina Healthcare, Chapel Hill, NC USA; [Pidala, Joseph] Univ S Florida, Coll Med, H Lee Moffitt Canc Ctr & Res Inst, Tampa, FL 33612 USA								0	0	0	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	1083-8791	1523-6536		BIOL BLOOD MARROW TR	Biol. Blood Marrow Transplant.	FEB	2015	21	2		1		489	S336	S337				2	Hematology; Immunology; Transplantation	Hematology; Immunology; Transplantation	CA0UZ	WOS:000348633000491		
J	Kurihara, T; Ueki, T; Kaiume, H; Takeda, W; Kirihara, T; Sato, K; Hiroshima, Y; Sumi, M; Ueno, M; Ichikawa, N; Kobayashi, H				Kurihara, Taro; Ueki, Toshimitsu; Kaiume, HIroko; Takeda, Wataru; Kirihara, Takehiko; Sato, Keijiro; Hiroshima, Yuki; Sumi, Masahiko; Ueno, Mayumi; Ichikawa, Naoaki; Kobayashi, Hikaru			The Blood Concentration of Tacrolimus Is Affected By PIR Following Cord Blood Transplantation	BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION			English	Meeting Abstract	BMT Tandem Meetings	FEB 11-15, 2015	San Diego, CA						[Kurihara, Taro; Ueki, Toshimitsu; Kaiume, HIroko; Takeda, Wataru; Kirihara, Takehiko; Sato, Keijiro; Hiroshima, Yuki; Sumi, Masahiko; Ueno, Mayumi; Ichikawa, Naoaki; Kobayashi, Hikaru] Nagano Red Cross Hosp, Nagano, Japan								0	0	0	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	1083-8791	1523-6536		BIOL BLOOD MARROW TR	Biol. Blood Marrow Transplant.	FEB	2015	21	2		1		422	S295	S296				2	Hematology; Immunology; Transplantation	Hematology; Immunology; Transplantation	CA0UZ	WOS:000348633000424		
J	Mizumaki, H; Takagi, S; Uchida, N; Kageyama, K; Kaji, D; Wada, S; Nishida, A; Ishiwata, K; Tsuji, M; Yamamoto, H; Yamamoto, G; Asano-Mori, Y; Makino, S; Yoneyama, A; Wake, A; Izutsu, K; Taniguchi, S				Mizumaki, Hiroki; Takagi, Shinsuke; Uchida, Naoyuki; Kageyama, Kosei; Kaji, Daisuke; Wada, Sachie; Nishida, Aya; Ishiwata, Kazuya; Tsuji, Masanori; Yamamoto, Hisashi; Yamamoto, Go; Asano-Mori, Yuki; Makino, Shigeyoshi; Yoneyama, Akiko; Wake, Atsushi; Izutsu, Koji; Taniguchi, Shuichi			Allogeneic Hematopoietic Cell Transplantation Is a Curative Treatment Option for Advanced-Stage Chronic Myeloid Leukemia in the TKI Era, a Single Institution Retrospective Study of 29 Post AP/BC Cases	BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION			English	Meeting Abstract	BMT Tandem Meetings	FEB 11-15, 2015	San Diego, CA						[Mizumaki, Hiroki; Takagi, Shinsuke; Uchida, Naoyuki; Kageyama, Kosei; Kaji, Daisuke; Wada, Sachie; Nishida, Aya; Ishiwata, Kazuya; Tsuji, Masanori; Yamamoto, Hisashi; Yamamoto, Go; Asano-Mori, Yuki; Wake, Atsushi; Izutsu, Koji; Taniguchi, Shuichi] Toranomon Gen Hosp, Dept Hematol, Tokyo, Japan; [Makino, Shigeyoshi] Toranomon Gen Hosp, Dept Transfus Med, Tokyo, Japan; [Yoneyama, Akiko] Toranomon Gen Hosp, Dept Infect Dis, Tokyo, Japan								0	0	0	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	1083-8791	1523-6536		BIOL BLOOD MARROW TR	Biol. Blood Marrow Transplant.	FEB	2015	21	2		1		429	S299	S300				2	Hematology; Immunology; Transplantation	Hematology; Immunology; Transplantation	CA0UZ	WOS:000348633000431		
J	Mori, T; Kato, J; Kohashi, S; Okamoto, S				Mori, Takehiko; Kato, Jun; Kohashi, Sumiko; Okamoto, Shinichiro			Transplant-Acquired Food Allergy Following Cord Blood Transplantation in Adult Patients	BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION			English	Meeting Abstract	BMT Tandem Meetings	FEB 11-15, 2015	San Diego, CA						[Mori, Takehiko; Kato, Jun; Kohashi, Sumiko; Okamoto, Shinichiro] Keio Univ, Sch Med, Div Hematol, Tokyo, Japan								0	0	0	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	1083-8791	1523-6536		BIOL BLOOD MARROW TR	Biol. Blood Marrow Transplant.	FEB	2015	21	2		1		356	S255	S255				1	Hematology; Immunology; Transplantation	Hematology; Immunology; Transplantation	CA0UZ	WOS:000348633000358		
J	Nakano, N; Itoyama, T; Kubota, A; Tokunaga, M; Tokunaga, M; Makino, T; Takeuchi, S; Takatsuka, Y; Utsunomiya, A				Nakano, Nobuaki; Itoyama, Takahiro; Kubota, Ayumu; Tokunaga, Mashahito; Tokunaga, Mayumi; Makino, Torahiko; Takeuchi, Shogo; Takatsuka, Yoshifusa; Utsunomiya, Atae			Impact of Chromosomal Abnormalities in the Recipients of Allogeneic Hematopoietic Stem Cell Transplantation with Adult T-Cell Leukemia/Lymphoma	BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION			English	Meeting Abstract	BMT Tandem Meetings	FEB 11-15, 2015	San Diego, CA						[Nakano, Nobuaki; Itoyama, Takahiro; Kubota, Ayumu; Tokunaga, Mashahito; Tokunaga, Mayumi; Makino, Torahiko; Takeuchi, Shogo; Takatsuka, Yoshifusa; Utsunomiya, Atae] Imamura Bun In Hosp, Dept Hematol, Kagoshima, Japan								0	0	0	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	1083-8791	1523-6536		BIOL BLOOD MARROW TR	Biol. Blood Marrow Transplant.	FEB	2015	21	2		1		83	S87	S87				1	Hematology; Immunology; Transplantation	Hematology; Immunology; Transplantation	CA0UZ	WOS:000348633000088		
J	Palmer, J; Chai, XY; Martin, PJ; Pidala, J; Lazaryan, A; Arora, M; Cutler, CS; Pavletic, SZ; Pusic, I; Jagasia, MH; Inamoto, Y; Flowers, MED; Vogelsang, G; Lee, SJ				Palmer, Jeanne; Chai, Xiaoyu; Martin, Paul J.; Pidala, Joseph; Lazaryan, Aleksandr; Arora, Mukta; Cutler, Corey S.; Pavletic, Steven Z.; Pusic, Iskra; Jagasia, Madan H.; Inamoto, Yoshihiro; Flowers, Mary E. D.; Vogelsang, Georgia; Lee, Stephanie J.			Physician-Reported CR+PR at 6 Months Predicts Subsequent Survival in Patients with Chronic GVHD	BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION			English	Meeting Abstract	BMT Tandem Meetings	FEB 11-15, 2015	San Diego, CA						[Palmer, Jeanne] Mayo Clin, Div Hematol Oncol, Phoenix, AZ USA; [Chai, Xiaoyu; Martin, Paul J.; Flowers, Mary E. D.; Lee, Stephanie J.] Fred Hutchinson Canc Res Ctr, Div Clin Res, Seattle, WA 98104 USA; [Pidala, Joseph] Univ S Florida, Coll Med, H Lee Moffitt Canc Ctr & Res Inst, Tampa, FL 33612 USA; [Lazaryan, Aleksandr; Arora, Mukta] Univ Minnesota, Med Ctr, Minneapolis, MN 55455 USA; [Cutler, Corey S.] Harvard Univ, Sch Med, Dana Farber Canc Inst, Boston, MA 02115 USA; [Pavletic, Steven Z.] NCI, Expt Transplantat & Immunol Branch, NIH, Bethesda, MD 20892 USA; [Pusic, Iskra] Washington Univ, Med Ctr, St Louis, MO USA; [Jagasia, Madan H.] Vanderbilt Univ, Med Ctr, Dept Med, Div Hematol Oncol, Nashville, TN USA; [Inamoto, Yoshihiro] Natl Canc Ctr, Stem Cell Transplantat Div, Tokyo, Japan; [Vogelsang, Georgia] Johns Hopkins Med Ctr, Lutherville Timonium, MD USA								0	0	0	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	1083-8791	1523-6536		BIOL BLOOD MARROW TR	Biol. Blood Marrow Transplant.	FEB	2015	21	2		1		43	S59	S60				2	Hematology; Immunology; Transplantation	Hematology; Immunology; Transplantation	CA0UZ	WOS:000348633000048		
J	Shimoji, S; Hashimoto, D; Kato, K; Tujigiwa, H; Akashi, K; Teshima, T				Shimoji, Sonoko; Hashimoto, Daigo; Kato, Koji; Tujigiwa, Hidetsugu; Akashi, Koichi; Teshima, Takanori			Graft-Versus-Host Disease Targets Granulosa Cell of Ovarian Follicle and Causes Infertility after Allogeneic Hematopoietic Stem Cell Transplantation	BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION			English	Meeting Abstract	BMT Tandem Meetings	FEB 11-15, 2015	San Diego, CA						[Shimoji, Sonoko; Kato, Koji; Akashi, Koichi] Kyushu Univ, Grad Sch Med Sci, Dept Med & Biosyst Sci, Fukuoka 812, Japan; [Hashimoto, Daigo; Teshima, Takanori] Hokkaido Univ, Grad Sch Med, Dept Hematol, Sapporo, Hokkaido, Japan; [Tujigiwa, Hidetsugu] Okayama Univ Sci, Dept Life Sci, Okayama, Japan								0	0	0	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	1083-8791	1523-6536		BIOL BLOOD MARROW TR	Biol. Blood Marrow Transplant.	FEB	2015	21	2		1		2	S26	S27				2	Hematology; Immunology; Transplantation	Hematology; Immunology; Transplantation	CA0UZ	WOS:000348633000007		
J	Shono, Y; Docampo, MD; Smith, OM; Gupta, J; Liberman, SR; Taur, Y; Honda, K; van den Brink, MRM; Jenq, R				Shono, Yusuke; Docampo, Melissa D.; Smith, Odette M.; Gupta, Jyotsna; Liberman, Sophia R.; Taur, Ying; Honda, Kenya; van den Brink, Marcel R. M.; Jenq, Robert			Treatment with Antibiotics Containing Activity Against Obligate Anaerobes Worsens GVHD Survival in Mice and Humans after Allogeneic BMT	BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION			English	Meeting Abstract	BMT Tandem Meetings	FEB 11-15, 2015	San Diego, CA						[Shono, Yusuke; Docampo, Melissa D.; Smith, Odette M.; Gupta, Jyotsna; Liberman, Sophia R.] Mem Sloan Kettering Canc Ctr, Dept Immunol, New York, NY 10021 USA; [Taur, Ying; van den Brink, Marcel R. M.; Jenq, Robert] Mem Sloan Kettering Canc Ctr, Dept Med, New York, NY 10021 USA; [Honda, Kenya] Keio Univ, Tokyo, Japan								0	0	0	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	1083-8791	1523-6536		BIOL BLOOD MARROW TR	Biol. Blood Marrow Transplant.	FEB	2015	21	2		1		3	S27	S28				2	Hematology; Immunology; Transplantation	Hematology; Immunology; Transplantation	CA0UZ	WOS:000348633000008		
J	Sugita, J; Kawashima, N; Fujisaki, T; Kakihana, K; Uchida, N; Maeda, Y; Ota, S; Matsuo, K; Miyamoto, T; Nagafuji, K; Eto, T; Akashi, K; Taniguchi, S; Harada, M; Teshima, T				Sugita, Junichi; Kawashima, Naomi; Fujisaki, Tomoaki; Kakihana, Kazuhiko; Uchida, Naoyuki; Maeda, Yoshinobu; Ota, Shuichi; Matsuo, Keitaro; Miyamoto, Toshihiro; Nagafuji, Koji; Eto, Tetsuya; Akashi, Koichi; Taniguchi, Shuichi; Harada, Mine; Teshima, Takanori			Prospective Multicenter Phase II Study of HLA-Haploidentical Peripheral Blood Stem Cell Transplantation after Reduced-Intensity Conditioning with Post-Transplant Cyclophosphamide: First Analysis of the JSCT Haplo13 Study	BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION			English	Meeting Abstract	BMT Tandem Meetings	FEB 11-15, 2015	San Diego, CA						[Sugita, Junichi; Teshima, Takanori] Hokkaido Univ, Grad Sch Med, Dept Hematol, Sapporo, Hokkaido, Japan; [Kawashima, Naomi] Japanese Red Cross Nagoya First Hosp, Dept Hematol, Nagoya, Aichi, Japan; [Fujisaki, Tomoaki] Matsuyama Red Cross Hosp, Dept Hematol, Matsuyama, Ehime, Japan; [Kakihana, Kazuhiko] Tokyo Metropolitan Canc & Infect Dis Ctr, Komagome Hosp, Div Hematol, Tokyo, Japan; [Uchida, Naoyuki; Taniguchi, Shuichi] Toranomon Gen Hosp, Dept Hematol, Tokyo, Japan; [Maeda, Yoshinobu] Okayama Univ, Grad Sch Med, Dept Hematol & Oncol, Okayama 7008530, Japan; [Ota, Shuichi] Sapporo Hokuyu Hosp, Dept Hematol, Sapporo, Hokkaido, Japan; [Matsuo, Keitaro] Kyushu Univ, Fac Med Sci, Dept Prevent Med, Fukuoka 812, Japan; [Miyamoto, Toshihiro; Akashi, Koichi] Kyushu Univ, Grad Sch Med Sci, Dept Med & Biosyst Sci, Fukuoka 812, Japan; [Nagafuji, Koji] Kurume Univ, Sch Med, Dept Med, Div Hematol & Oncol, Kurume, Fukuoka 830, Japan; [Eto, Tetsuya] Hamanomachi Hosp, Dept Hematol, Fukuoka, Japan; [Harada, Mine] Karatsu Higashimatsuura Med Assoc, Med Ctr, Saga, Japan								0	0	0	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	1083-8791	1523-6536		BIOL BLOOD MARROW TR	Biol. Blood Marrow Transplant.	FEB	2015	21	2		1		453	S313	S314				2	Hematology; Immunology; Transplantation	Hematology; Immunology; Transplantation	CA0UZ	WOS:000348633000455		
J	Tamaki, H; Ikegame, K; Yoshihara, S; Kaida, K; Inoue, T; Okada, M; Soma, T; Ogawa, H				Tamaki, Hiroya; Ikegame, Kazuhiro; Yoshihara, Satoshi; Kaida, Katsuji; Inoue, Takayuki; Okada, Masaya; Soma, Toshihiro; Ogawa, Hiroyasu			Low Incidence of Human Herpesvirus 6 Reactivation in Unmanipulated HLA-Haploidentical Related Stem Cell Transplantation with Corticosteroid As Graft-Versus-Host Disease Prophylaxis	BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION			English	Meeting Abstract	BMT Tandem Meetings	FEB 11-15, 2015	San Diego, CA						[Tamaki, Hiroya; Ikegame, Kazuhiro; Yoshihara, Satoshi; Kaida, Katsuji; Inoue, Takayuki; Okada, Masaya; Soma, Toshihiro; Ogawa, Hiroyasu] Hyogo Coll Med, Dept Internal Med, Div Hematol, Nishinomiya, Hyogo 6638501, Japan								0	0	0	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	1083-8791	1523-6536		BIOL BLOOD MARROW TR	Biol. Blood Marrow Transplant.	FEB	2015	21	2		1		196	S160	S161				2	Hematology; Immunology; Transplantation	Hematology; Immunology; Transplantation	CA0UZ	WOS:000348633000201		
J	Tsukada, N; Ikeda, M; Shingaki, S; Miyazaki, K; Meshitsuka, S; Abe, Y; Yoshiki, Y; Suzuki, K				Tsukada, Nobuhiro; Ikeda, Masahiro; Shingaki, Sumito; Miyazaki, Kanji; Meshitsuka, Sosuke; Abe, Yu; Yoshiki, Yumiko; Suzuki, Kenshi			Induction Therapy with Bortezomib-Cyclophosphamide-Dexamethasone (BCD) for Newly Diagnosed Transplant Eligible Patients with Multiple Myeloma	BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION			English	Meeting Abstract	BMT Tandem Meetings	FEB 11-15, 2015	San Diego, CA						[Tsukada, Nobuhiro; Ikeda, Masahiro; Shingaki, Sumito; Miyazaki, Kanji; Meshitsuka, Sosuke; Abe, Yu; Yoshiki, Yumiko; Suzuki, Kenshi] Japanese Red Cross Med Ctr, Div Hematol, Tokyo, Japan								0	0	0	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	1083-8791	1523-6536		BIOL BLOOD MARROW TR	Biol. Blood Marrow Transplant.	FEB	2015	21	2		1		270	S205	S205				1	Hematology; Immunology; Transplantation	Hematology; Immunology; Transplantation	CA0UZ	WOS:000348633000273		
J	Ueki, S; Tsujitani, M; Teranishi, Y; Miyamoto, J; Mori, R; Ogawa, H; Ikegame, K				Ueki, Satoko; Tsujitani, Masaaki; Teranishi, Yumiko; Miyamoto, Junko; Mori, Reiko; Ogawa, Hiroyasu; Ikegame, Kazuhiro			Prediction of Skin Trouble in Patients Undergoing Allogeneic Hematopoietic Stem Cell Transplantation Using Generalized Additive Model	BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION			English	Meeting Abstract	BMT Tandem Meetings	FEB 11-15, 2015	San Diego, CA						[Ueki, Satoko; Teranishi, Yumiko; Miyamoto, Junko] Hyogo Coll Med, Div Nursing, Nishinomiya, Hyogo 6638501, Japan; [Tsujitani, Masaaki] Osaka Electrocommun Univ, Div Informat & Comp Sci, Grad Sch Engn, Osaka, Japan; [Mori, Reiko] Hyogo Coll Med, Dept Clin Psychol, Nishinomiya, Hyogo 6638501, Japan; [Ogawa, Hiroyasu; Ikegame, Kazuhiro] Hyogo Coll Med, Dept Internal Med, Div Hematol, Nishinomiya, Hyogo 6638501, Japan								0	0	0	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	1083-8791	1523-6536		BIOL BLOOD MARROW TR	Biol. Blood Marrow Transplant.	FEB	2015	21	2		1		593	S389	S390				2	Hematology; Immunology; Transplantation	Hematology; Immunology; Transplantation	CA0UZ	WOS:000348633000589		
J	Ueki, T; Kaiume, H; Kirihara, T; Takeda, W; Kurihara, T; Sato, K; Shimizu, I; Hiroshima, Y; Sumi, M; Ueno, M; Ichikawa, N; Kobayashi, H				Ueki, Toshimitsu; Kaiume, Hiroko; Kirihara, Takehiko; Takeda, Wataru; Kurihara, Taro, Jr.; Sato, Keijiro; Shimizu, Ikuo; Hiroshima, Yuki; Sumi, Masahiko; Ueno, Mayumi; Ichikawa, Naoaki; Kobayashi, Hikaru			Delayed and Sudden Lymphocyte Recovery Is the Predictive Sign of Primary Graft Failure Following CBT, Single Institute Analysis of 105 CBT	BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION			English	Meeting Abstract	BMT Tandem Meetings	FEB 11-15, 2015	San Diego, CA						[Ueki, Toshimitsu; Kaiume, Hiroko; Kirihara, Takehiko; Takeda, Wataru; Kurihara, Taro, Jr.; Sato, Keijiro; Shimizu, Ikuo; Hiroshima, Yuki; Sumi, Masahiko; Ueno, Mayumi; Ichikawa, Naoaki; Kobayashi, Hikaru] Nagano Red Cross Hosp, Nagano, Japan								0	0	0	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	1083-8791	1523-6536		BIOL BLOOD MARROW TR	Biol. Blood Marrow Transplant.	FEB	2015	21	2		1		457	S316	S316				1	Hematology; Immunology; Transplantation	Hematology; Immunology; Transplantation	CA0UZ	WOS:000348633000459		
J	Williams, KM; Cheng, GS; Pusic, I; Jagasia, MH; Burns, LJ; Ho, VT; Pidala, J; Palmer, J; Johnston, L; Mayer, S; Jacobsohn, DA; Martin, PJ; Storer, BE; Inamoto, Y; Chai, XY; Flowers, MED; Lee, SJ				Williams, Kirsten M.; Cheng, Guang-Shing; Pusic, Iskra; Jagasia, Madan H.; Burns, Linda J.; Ho, Vincent T.; Pidala, Joseph; Palmer, Jeanne; Johnston, Laura; Mayer, Sebastian; Jacobsohn, David A.; Martin, Paul J.; Storer, Barry E.; Inamoto, Yoshihiro; Chai, Xiaoyu; Flowers, Mary E. D.; Lee, Stephanie J.			Encouraging Results of a Phase II Trial of Inhaled Fluticasone Propionate, Azithromycin, and Montelukast (FAM) May Maintain Lung Function in Bronchiolitis Obliterans Syndrome (BOS) after Hematopoietic Cell Transplantation	BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION			English	Meeting Abstract	BMT Tandem Meetings	FEB 11-15, 2015	San Diego, CA						[Williams, Kirsten M.] NCI, CNMC, NIH, Bethesda, MD 20892 USA; [Cheng, Guang-Shing] Univ Washington, Sch Med, Div Pulm & Crit Care Med, Seattle, WA USA; [Pusic, Iskra] Washington Univ, Med Ctr, St Louis, MO USA; [Jagasia, Madan H.] Vanderbilt Univ, Med Ctr, Dept Med, Div Hematol Oncol, Nashville, TN USA; [Burns, Linda J.] Univ Minnesota, Med Ctr, Minneapolis, MN 55455 USA; [Ho, Vincent T.] Dana Farber Canc Inst, Boston, MA 02115 USA; [Pidala, Joseph] Univ S Florida, Coll Med, H Lee Moffitt Canc Ctr & Res Inst, Tampa, FL 33612 USA; [Palmer, Jeanne] Mayo Clin Arizona, Phoenix, AZ USA; [Johnston, Laura] Stanford Univ, Med Ctr, Stanford, CA 94305 USA; [Mayer, Sebastian] Weill Cornell Med Ctr, Dept Med, New York, NY USA; [Jacobsohn, David A.] Childrens Natl Med Ctr, Div Blood & Marrow Transplantat, Washington, DC 20010 USA; [Martin, Paul J.; Storer, Barry E.; Chai, Xiaoyu; Flowers, Mary E. D.; Lee, Stephanie J.] Fred Hutchinson Canc Res Ctr, Div Clin Res, Seattle, WA 98104 USA; [Inamoto, Yoshihiro] Natl Canc Ctr, Stem Cell Transplantat Div, Tokyo, Japan								0	0	0	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	1083-8791	1523-6536		BIOL BLOOD MARROW TR	Biol. Blood Marrow Transplant.	FEB	2015	21	2		1		46	S61	S62				2	Hematology; Immunology; Transplantation	Hematology; Immunology; Transplantation	CA0UZ	WOS:000348633000051		
J	Yoshimitsu, M; Tanosaki, R; Kato, K; Ishida, T; Choi, I; Fukuda, T; Takatsuka, Y; Eto, T; Uchida, N; Moriuchi, Y; Nagamura-Inoue, T; Mori, SI; Sakamaki, H; Atsuta, Y; Utsunomiya, A				Yoshimitsu, Makoto; Tanosaki, Ryuji; Kato, Koji; Ishida, Takashi; Choi, Ilseung; Fukuda, Takahiro; Takatsuka, Yoshifusa; Eto, Tetsuya; Uchida, Naoyuki; Moriuchi, Yukiyoshi; Nagamura-Inoue, Tokiko; Mori, Shin-Ichiro; Sakamaki, Hisashi; Atsuta, Yoshiko; Utsunomiya, Atae			Risk Stratification of Outcomes Among Patients with Adult T-Cell Leukemia/Lymphoma Receiving Allogeneic Hematopoietic Cell Transplantation: A Retrospective Analysis of the JSHCT An Working Group	BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION			English	Meeting Abstract	BMT Tandem Meetings	FEB 11-15, 2015	San Diego, CA						[Yoshimitsu, Makoto] Kagoshima Univ, Grad Sch Med & Dent Sci, Div Hematol & Immunol, Kagoshima 890, Japan; [Tanosaki, Ryuji] Natl Canc Ctr, Dept Blood Transfus & Cellular Therapy, Tokyo, Japan; [Kato, Koji] Kyushu Univ, Grad Sch Med Sci, Dept Med & Biosyst Sci, Fukuoka 812, Japan; [Ishida, Takashi] Nagoya City Univ, Grad Sch Med Sci, Dept Hematol & Oncol, Nagoya, Aichi, Japan; [Choi, Ilseung] Kyushu Natl Canc Ctr, Dept Hematol, Fukuoka, Japan; [Fukuda, Takahiro] Natl Canc Ctr, Stem Cell Transplantat Div, Tokyo, Japan; [Takatsuka, Yoshifusa; Utsunomiya, Atae] Imamura Bun In Hosp, Dept Hematol, Kagoshima, Japan; [Eto, Tetsuya] Hamanomachi Hosp, Dept Hematol, Fukuoka, Japan; [Uchida, Naoyuki] Toranomon Gen Hosp, Dept Hematol, Tokyo, Japan; [Moriuchi, Yukiyoshi] Sasebo City Gen Hosp, Dept Hematol, Sasebo, Japan; [Nagamura-Inoue, Tokiko] Univ Tokyo, Inst Med Sci, Tokyo, Japan; [Mori, Shin-Ichiro] St Lukes Int Hosp, Hematol Oncol Dept, Tokyo, Japan; [Sakamaki, Hisashi] Komagome Hosp, Tokyo Metropolitan Canc & Infect Dis Ctr, Div Hematol, Tokyo, Japan; [Atsuta, Yoshiko] Nagoya Univ, Grad Sch Med, Dept Healthcare Adm, Nagoya, Aichi 4648601, Japan; [Atsuta, Yoshiko] Japanese Data Ctr Hematopoiet Cell Transplantat, Nagoya, Aichi, Japan								0	0	0	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	1083-8791	1523-6536		BIOL BLOOD MARROW TR	Biol. Blood Marrow Transplant.	FEB	2015	21	2		1		86	S89	S90				2	Hematology; Immunology; Transplantation	Hematology; Immunology; Transplantation	CA0UZ	WOS:000348633000091		
J	Zhang, JL; Ulrich, B; Ramadan, A; Helmut, H; Andrew, M; Tawara, I; Paczesny, S				Zhang, Jilu; Ulrich, Benjamin; Ramadan, Abdulraouf; Helmut, Hanenberg; Andrew, McKenzie; Tawara, Isao; Paczesny, Sophie			Targeting ST2 Alleviates Graft-Versus-Host Disease Mortality and Maintains Graft-Versus-Leukemia	BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION			English	Meeting Abstract	BMT Tandem Meetings	FEB 11-15, 2015	San Diego, CA						[Zhang, Jilu; Ulrich, Benjamin; Ramadan, Abdulraouf; Helmut, Hanenberg] Indiana Univ Sch Med, Indianapolis, IN 46202 USA; [Andrew, McKenzie] MRC, Mol Biol Lab, Cambridge CB2 2QH, England; [Tawara, Isao] Mie Univ Hosp, Tsu, Mie, Japan; [Paczesny, Sophie] Indiana Univ, Sch Med, Indianapolis, IN USA								0	0	0	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	1083-8791	1523-6536		BIOL BLOOD MARROW TR	Biol. Blood Marrow Transplant.	FEB	2015	21	2		1		48	S63	S64				2	Hematology; Immunology; Transplantation	Hematology; Immunology; Transplantation	CA0UZ	WOS:000348633000053		
J	Nagase, K; Hatakeyama, Y; Shimizu, T; Matsuura, K; Yamato, M; Takeda, N; Okano, T				Nagase, Kenichi; Hatakeyama, Yuri; Shimizu, Tatsuya; Matsuura, Katsuhisa; Yamato, Masayuki; Takeda, Naoya; Okano, Teruo			Thermoresponsive Cationic Copolymer Brushes for Mesenchymal Stem Cell Separation	BIOMACROMOLECULES			English	Article							POLYMER BRUSHES; POLY(N-ISOPROPYLACRYLAMIDE) BRUSHES; BIOMEDICAL APPLICATIONS; SURFACE; SHEETS; SILICA; CHROMATOGRAPHY; PROLIFERATION; ADHESION; PROTEIN	Thermoresponsive, cationic, copolymer brushes poly(N-isopropylacrylamide(IPAAm)-co-N,N-dimethylaminopropylacrylamide-co-N-tert-butylacrylamide(tBAAm)) and poly(IPAAm-co-3-acrylamidopropyl trimethylammonium chloride-co-tBAAm) were prepared on glass substrates through surface-initiated atom transfer radical polymerization. Prepared copolymer brushes were investigated as thermally modulated cell separation materials. Densely packed cationic copolymer brushes were formed on the glass substrates, and the positive charge density was modulated by controlling the composition of cationic moieties and species. During observation of cell adhesion and detachment properties on copolymer brushes, human bone marrow mesenchymal stem cells (hbmMSC) exhibited thermally modulated cell adhesion and detachment, while other bone-marrow-derived cells did not adhere. Using these properties, hbmMSC could be purified from mixtures of human bone-marrow-derived cells simply by changing the external temperature. Therefore, the prepared cationic copolymer brush is useful for separation of hbmMSC.	[Nagase, Kenichi; Hatakeyama, Yuri; Shimizu, Tatsuya; Matsuura, Katsuhisa; Yamato, Masayuki; Okano, Teruo] Tokyo Womens Med Univ TWIns, Inst Adv Biomed Engn & Sci, Shinjuku Ku, Tokyo 1628666, Japan; [Hatakeyama, Yuri; Takeda, Naoya] Waseda Univ TWIns, Sch Adv Sci & Engn, Dept Life Sci & Med Biosci, Shinjuku Ku, Tokyo 1628480, Japan	Nagase, K (reprint author), Tokyo Womens Med Univ TWIns, Inst Adv Biomed Engn & Sci, Shinjuku Ku, 8-1 Kawadacho, Tokyo 1628666, Japan.	nagase.kenichi@twmu.ac.jp; tokano@twmu.ac.jp			Funding Program for World-Leading Innovative R&D on Science and Technology (FIRST Program); Council for Science and Technology Policy from the Japan Society for the Promotion of Science (JSPS), Japan; Japan Society for the Promotion of Science (JSPS), Japan [26420714]	Part of the present research was financially supported by "Funding Program for World-Leading Innovative R&D on Science and Technology (FIRST Program)", initiated by the Council for Science and Technology Policy from the Japan Society for the Promotion of Science (JSPS), Japan. Grants-in-Aid for Scientific Research (C) No. 26420714 from the Japan Society for the Promotion of Science (JSPS), Japan. We thank Ms. Ayaka Kimura for valuable suggestions and discussion.	Mizutani A, 2010, J CHROMATOGR A, V1217, P522, DOI 10.1016/j.chroma.2009.11.073; Kushida A, 1999, J BIOMED MATER RES, V45, P355, DOI 10.1002/(SICI)1097-4636(19990615)45:4<355::AID-JBM10>3.0.CO;2-7; Xiao DQ, 2002, MACROMOLECULES, V35, P2919, DOI 10.1021/ma011313x; Nagase K, 2012, J MATER CHEM, V22, P19514, DOI 10.1039/c2jm31797d; Tu H, 2004, LANGMUIR, V20, P8313, DOI 10.1021/la049663a; Kikuchi A, 2002, PROG POLYM SCI, V27, P1165, DOI 10.1016/S0079-6700(02)00013-8; Nishida K, 2004, NEW ENGL J MED, V351, P1187, DOI 10.1056/NEJMoa040455; Lu HX, 2009, J BIOMAT SCI-POLYM E, V20, P577, DOI 10.1163/156856209X426402; Menasche P, 2001, LANCET, V357, P279, DOI 10.1016/S0140-6736(00)03617-5; LANGER R, 1993, SCIENCE, V260, P920, DOI 10.1126/science.8493529; Sawa Y, 2012, SURG TODAY, V42, P181, DOI 10.1007/s00595-011-0106-4; Salem HK, 2010, STEM CELLS, V28, P585, DOI 10.1002/stem.269; Yakushiji T, 1999, ANAL CHEM, V71, P1125, DOI 10.1021/ac980677t; Kikuchi A, 2005, J CONTROL RELEASE, V101, P69, DOI 10.1016/j.jconrel.2004.08.026; Semenov OV, 2009, TISSUE ENG PT A, V15, P2977, DOI 10.1089/ten.TEA.2008.0602; Wei X, 2013, ACTA PHARMACOL SIN, V34, P747, DOI 10.1038/aps.2013.50; Matsuura K, 2011, BIOMATERIALS, V32, P7355, DOI 10.1016/j.biomaterials.2011.05.042; Nagase K, 2012, MACROMOL BIOSCI, V12, P333, DOI 10.1002/mabi.201100283; Sekiya S, 2006, BIOCHEM BIOPH RES CO, V341, P573, DOI 10.1016/j.bbrc.2005.12.217; Kim YJ, 2012, ANGEW CHEM INT EDIT, V51, P10537, DOI 10.1002/anie.201204139; Hoffman AS, 2007, PROG POLYM SCI, V32, P922, DOI 10.1016/j.progpolymsci.2007.05.005; Balamurugan S, 2003, LANGMUIR, V19, P2545, DOI 10.1021/la026787j; Iwata R, 2004, BIOMACROMOLECULES, V5, P2308, DOI 10.1021/bm049613k; Nagase K, 2011, LANGMUIR, V27, P10830, DOI 10.1021/la201360p; Nagase K, 2011, BIOMATERIALS, V32, P619, DOI 10.1016/j.biomaterials.2010.09.012; Hoffman AS, 2002, ADV DRUG DELIVER REV, V54, P3, DOI 10.1016/S0169-409X(01)00239-3; Mano JF, 2008, ADV ENG MATER, V10, P515, DOI 10.1002/adem.200700355; Edmondson S, 2004, CHEM SOC REV, V33, P14, DOI 10.1039/b210143m; Ulbricht M, 2006, POLYMER, V47, P2217, DOI 10.1016/j.polymer.2006.01.084; Gil ES, 2004, PROG POLYM SCI, V29, P1173, DOI 10.1016/j.progpolymsci.2004.08.003; Nagase K, 2007, LANGMUIR, V23, P9409, DOI 10.1021/la700956b; Yoshikawa C, 2006, MACROMOLECULES, V39, P2284, DOI 10.1021/ma0520242; Sekine H, 2008, CIRCULATION, V118, pS145, DOI 10.1161/CIRCULATIONAHA.107.757286; Kanazawa H, 1996, ANAL CHEM, V68, P100, DOI 10.1021/ac950359j; Shinoka Toshiharu, 2008, Yale Journal of Biology and Medicine, V81, P161; Chianea T, 2000, TALANTA, V51, P835, DOI 10.1016/S0039-9140(99)00335-5; CIAMPOLI.M, 1966, INORG CHEM, V5, P41, DOI 10.1021/ic50035a010; [Anonymous], 1991, ACS SYM SER; Heskins M.a.G.J.E., 1968, J MACROMOL SCI CHEM, V2, P1441, DOI DOI 10.1080/10601326808051910; KATAOKA K, 1988, BIOMATERIALS, V9, P218, DOI 10.1016/0142-9612(88)90087-7; Kataoka K., 1991, CELL SEPARATION SCI, V464, P159, DOI 10.1021/bk-1991-0464.ch011; [Anonymous], 1991, ACS SYM SER; Makino K, 1996, COLLOID SURFACE B, V7, P235, DOI 10.1016/0927-7765(96)01303-3; Makino K, 1995, COLLOID SURFACE B, V5, P221, DOI 10.1016/0927-7765(95)01220-3; Matyjaszewski K., 2001, J CHEM REV, V101, P2921; Moldavan A, 1934, Science, V80, P188, DOI 10.1126/science.80.2069.188; Mori T, 2004, LANGMUIR, V20, P313, DOI 10.1021/la0356194; Nagase K, 2014, BIOMACROMOLECULES, V15, P1031, DOI 10.1021/bm401918a; Nagase K, 2013, BIOMACROMOLECULES, V14, P3423, DOI 10.1021/bm4006722; Ohki T., 2012, GASTROENTEROLOGY, V143, P582; Tamura A, 2012, BIOMACROMOLECULES, V13, P1765, DOI 10.1021/bm300256e	51	1	1	AMER CHEMICAL SOC	WASHINGTON	1155 16TH ST, NW, WASHINGTON, DC 20036 USA	1525-7797	1526-4602		BIOMACROMOLECULES	Biomacromolecules	FEB	2015	16	2					532	540		10.1021/bm501591s		9	Biochemistry & Molecular Biology; Chemistry, Organic; Polymer Science	Biochemistry & Molecular Biology; Chemistry; Polymer Science	CA9VN	WOS:000349273000012		
J	Hiraoki, R; Ono, Y; Saito, T; Isogai, A				Hiraoki, Ryoya; Ono, Yuko; Saito, Tsuguyuki; Isogai, Akira			Molecular Mass and Molecular-Mass Distribution of TEMPO-Oxidized Celluloses and TEMPO-Oxidized Cellulose Nanofibrils	BIOMACROMOLECULES			English	Article							SIZE-EXCLUSION CHROMATOGRAPHY; MEDIATED OXIDATION; NATIVE CELLULOSE; MICROFIBRILLATED CELLULOSE; NEUTRAL CONDITIONS; LIGHT-SCATTERING; KRAFT PULPS; STRENGTH; FIBRILS; WATER	Native wood cellulose was oxidized by 2,2,6,6-tetramethylpiperidine-1-oxyl (TEMPO)-mediated oxidation, and the fibrous TEMPO-oxidized celluloses (TOCs) thus obtained were disintegrated in water to prepare TOC nanofibrils (TOCNs). The carboxyl groups of TOCs and TOCNs were methyl-esterified, and the methylated samples were dissolved in 8% LiCl/N,N-dimethylacetamide for size-exclusion chromatography/multiangle laser-light scattering (SEC-MALLS) analysis to obtain their molecular-mass (MM) values and MM distributions (MMDs). The results showed that remarkable depolymerization occurred in TOCs and TOCNs and depended on the oxidation and sonication conditions. Because single peaks without bimodal patterns were observed in the MMDs for all of the TOC and TOCN samples, depolymerization may have randomly occurred on whole cellulose molecules and oxidized cellulose molecules in the microfibrils during these treatments. Compared with the MM values obtained by SEC-MALLS, the intrinsic viscosities of TOCs dissolved in 0.5 M copper ethylenediamine solution provided lower MM values owing to depolymerization during the dissolution and postreduction processes.	[Hiraoki, Ryoya; Ono, Yuko; Saito, Tsuguyuki; Isogai, Akira] Univ Tokyo, Grad Sch Agr & Life Sci, Dept Biomat Sci, Tokyo 1138657, Japan	Isogai, A (reprint author), Univ Tokyo, Grad Sch Agr & Life Sci, Dept Biomat Sci, Tokyo 1138657, Japan.	aisogai@mail.ecc.u-tokyo.ac.jp			Core Research for Evolutional Science and Technology (CREST) of the Japan Science and Technology Agency (JST)	This research was supported by the Core Research for Evolutional Science and Technology (CREST) of the Japan Science and Technology Agency (JST).	Saito T, 2007, BIOMACROMOLECULES, V8, P2485, DOI 10.1021/bm0703970; Saito T, 2013, BIOMACROMOLECULES, V14, P248, DOI 10.1021/bm301674e; Schult T, 2002, CELLULOSE, V9, P149, DOI 10.1023/A:1020139409903; DENOOY AEJ, 1995, CARBOHYD RES, V269, P89, DOI 10.1016/0008-6215(94)00343-E; Huang YY, 2009, ADV MATER, V21, P3945, DOI 10.1002/adma.200900498; Stefanovic B, 2013, CARBOHYD POLYM, V92, P921, DOI 10.1016/j.carbpol.2012.09.039; Wagberg L, 2008, LANGMUIR, V24, P784, DOI 10.1021/la702481v; Wang SQ, 2009, J APPL POLYM SCI, V113, P1270, DOI 10.1002/app.30072; Mohod AV, 2011, ULTRASON SONOCHEM, V18, P727, DOI 10.1016/j.ultsonch.2010.11.002; Chen WS, 2011, CARBOHYD POLYM, V83, P1804, DOI 10.1016/j.carbpol.2010.10.040; Strlic M, 1998, J CHROMATOGR A, V805, P93, DOI 10.1016/S0021-9673(98)00008-9; Tanaka R, 2014, CELLULOSE, V21, P1581, DOI 10.1007/s10570-014-0196-4; Xu HX, 2013, CHEM SOC REV, V42, P2555, DOI 10.1039/c2cs35282f; Okita Y, 2010, BIOMACROMOLECULES, V11, P1696, DOI 10.1021/bm100214b; Hirota M, 2009, CARBOHYD POLYM, V78, P330, DOI 10.1016/j.carbpol.2009.04.012; Lavoine N, 2012, CARBOHYD POLYM, V90, P735, DOI 10.1016/j.carbpol.2012.05.026; Isogai A, 2013, J WOOD SCI, V59, P449, DOI 10.1007/s10086-013-1365-z; Tot I, 2009, HOLZFORSCHUNG, V63, P657, DOI 10.1515/HF.2009.103; Tejado A, 2012, CELLULOSE, V19, P831, DOI 10.1007/s10570-012-9694-4; Iwamoto S, 2009, BIOMACROMOLECULES, V10, P2571, DOI 10.1021/bm900520n; Chen RH, 1997, CARBOHYD RES, V299, P287; Isogai A, 2011, NANOSCALE, V3, P71, DOI 10.1039/c0nr00583e; Klemm D, 2011, ANGEW CHEM INT EDIT, V50, P5438, DOI 10.1002/anie.201001273; Potthast A, 2009, HOLZFORSCHUNG, V63, P12, DOI 10.1515/HF.2009.108; Shinoda R, 2012, BIOMACROMOLECULES, V13, P842, DOI 10.1021/bm2017542; Takaichi S, 2014, CELLULOSE, V21, P4093, DOI 10.1007/s10570-014-0444-7; Siro I, 2010, CELLULOSE, V17, P459, DOI 10.1007/s10570-010-9405-y; Kuramae R, 2014, REACT FUNCT POLYM, V85, P126, DOI 10.1016/j.reactfunctpolym.2014.06.011; Paakko M, 2007, BIOMACROMOLECULES, V8, P1934, DOI 10.1021/bm061215p; Saito T, 2004, BIOMACROMOLECULES, V5, P1983, DOI 10.1021/bm0497769; Nishiyama Y, 2003, BIOMACROMOLECULES, V4, P1013, DOI 10.1021/bm025772x; Saito T, 2009, BIOMACROMOLECULES, V10, P1992, DOI 10.1021/bm900414t; Tischer PCSF, 2010, BIOMACROMOLECULES, V11, P1217, DOI 10.1021/bm901383a; Somerville C, 2004, SCIENCE, V306, P2206, DOI 10.1126/science.1102765; Hirota M, 2010, ANGEW CHEM INT EDIT, V49, P7670, DOI 10.1002/anie.201003848; HASHIMOTO N, 1981, CHEM PHARM BULL, V29, P1475; Brown RM, 2000, PLANT PHYSIOL BIOCH, V38, P57, DOI 10.1016/S0981-9428(00)00168-6; deNooy AEJ, 1996, MACROMOLECULES, V29, P6541, DOI 10.1021/ma960492t; Fujisawa S, 2010, CELLULOSE, V17, P607, DOI 10.1007/s10570-010-9407-9; Hiraoki R., 2014, CELLULOSE, V21, P164; Hori R, 2005, CELLULOSE, V12, P479, DOI 10.1007/s10570-005-5967-5; Kes M, 2013, J CHROMATOGR A, V1281, P32, DOI 10.1016/j.chroma.2013.01.038; Mishra SP, 2012, J WOOD CHEM TECHNOL, V32, P137, DOI 10.1080/02773813.2011.624666; SUGIYAMA J, 1991, MACROMOLECULES, V24, P4168, DOI 10.1021/ma00014a033; Tamura N., 2009, CARBOHYD POLYM, V77, P200; WESTERMARK U, 1994, HOLZFORSCHUNG, V48, P146, DOI 10.1515/hfsg.1994.48.s1.146; Yamamoto M, 2011, BIOMACROMOLECULES, V12, P3982, DOI 10.1021/bm201211z; Yanagisawa M, 2005, BIOMACROMOLECULES, V6, P1258, DOI 10.1021/bm0493686m; Yanagisawa M, 2007, HOLZFORSCHUNG, V61, P236, DOI 10.1515/HF.2007.046	49	5	5	AMER CHEMICAL SOC	WASHINGTON	1155 16TH ST, NW, WASHINGTON, DC 20036 USA	1525-7797	1526-4602		BIOMACROMOLECULES	Biomacromolecules	FEB	2015	16	2					675	681		10.1021/bm501857c		7	Biochemistry & Molecular Biology; Chemistry, Organic; Polymer Science	Biochemistry & Molecular Biology; Chemistry; Polymer Science	CA9VN	WOS:000349273000027		
J	Gladys, FM; Matsuda, M; Lim, YH; Jackin, BJ; Imai, T; Otani, Y; Yatagai, T; Cense, B				Gladys, Fanny Moses; Matsuda, Masaru; Lim, Yiheng; Jackin, Boaz Jessie; Imai, Takuto; Otani, Yukitoshi; Yatagai, Toyohiko; Cense, Barry			Developmental and morphological studies in Japanese medaka with ultra-high resolution optical coherence tomography	BIOMEDICAL OPTICS EXPRESS			English	Article							ZEBRAFISH DANIO-RERIO; ORYZIAS-LATIPES TELEOSTEI; HIGH-SPEED; IN-VIVO; RETINAL DEGENERATION; PROLIFERATION ZONES; ADULT ZEBRAFISH; HEART-RATE; BRAIN; MORPHOGENESIS	We propose ultra-high resolution optical coherence tomography to study the morphological development of internal organs in medaka fish in the post-embryonic stages at micrometer resolution. Different stages of Japanese medaka were imaged after hatching in vivo with an axial resolution of 2.8 mu m in tissue. Various morphological structures and organs identified in the OCT images were then compared with the histology. Due to the medaka's close resemblance to vertebrates, including humans, these morphological features play an important role in morphogenesis and can be used to study diseases that also occur in humans. (C)2015 Optical Society of America	[Gladys, Fanny Moses; Lim, Yiheng; Jackin, Boaz Jessie; Otani, Yukitoshi; Yatagai, Toyohiko; Cense, Barry] Utsunomiya Univ, CORE, Utsunomiya, Tochigi, Japan; [Matsuda, Masaru; Imai, Takuto] Utsunomiya Univ, Ctr Biosci Res & Educ, Utsunomiya, Tochigi, Japan; [Imai, Takuto] Tokyo Univ Agr & Technol, United Grad Sch Agr Sci, Fuchu, Tokyo 183, Japan	Gladys, FM (reprint author), Utsunomiya Univ, CORE, Utsunomiya, Tochigi, Japan.	fannymgladys@opt.utsunomiya-u.ac.jp			MEXT KAKENHI Grant [23360026]; Ministry of Education, Culture, Sports, Science and Technology (MEXT)	The authors would like to thank Mr. Kawashima, Mr. Kamiyama, Mr. Takahashi and Mr. Nakayama from the mechanical engineering department for machining of parts for this project. This research is part of the Project for Bio-imaging and sensing at Utsunomiya University which is funded by the Ministry of Education, Culture, Sports, Science and Technology (MEXT). This work was also partly supported by MEXT KAKENHI Grant Number 23360026.	Srinivasan VJ, 2006, INVEST OPHTH VIS SCI, V47, P5522, DOI 10.1167/iovs.06-0195; Nagata A, 2009, INVEST OPHTH VIS SCI, V50, P2809, DOI 10.1167/iovs.08-2764; Schneider CA, 2012, NAT METHODS, V9, P671, DOI 10.1038/nmeth.2089; Cubbage CC, 1996, J MORPHOL, V229, P121, DOI 10.1002/(SICI)1097-4687(199608)229:2<121::AID-JMOR1>3.0.CO;2-4; Saito D, 2007, DEV BIOL, V310, P280, DOI 10.1016/j.ydbio.2007.07.039; Matsuda M, 2002, NATURE, V417, P559, DOI 10.1038/nature751; Rao KD, 2012, BIRTH DEFECTS RES B, V95, P7, DOI 10.1002/bdrb.20332; Davis AM, 2008, BIOL MED PHYS BIOMED, P919, DOI 10.1007/978-3-540-77550-8_30; Jenkins MW, 2007, OPT EXPRESS, V15, P6251, DOI 10.1364/OE.15.006251; Neues F, 2007, J STRUCT BIOL, V160, P236, DOI 10.1016/j.jsb.2007.08.010; Finn J, 2012, AQUAT TOXICOL, V122, P214, DOI 10.1016/j.aquatox.2012.06.013; Cense B, 2004, OPT EXPRESS, V12, P2435, DOI 10.1364/OPEX.12.002435; Yasuno Y, 2005, OPT EXPRESS, V13, P10652, DOI 10.1364/OPEX.13.010652; Wittbrodt J, 2002, NAT REV GENET, V3, P53, DOI 10.1038/nrg704; Ekstrom P, 2001, J COMP NEUROL, V436, P92; Wojtkowski M, 2004, OPT EXPRESS, V12, P2404, DOI 10.1364/OPEX.12.002404; Rao KD, 2009, J BIOPHOTONICS, V2, P288, DOI 10.1002/jbio.200910032; Islinger M, 2003, AQUAT TOXICOL, V62, P85, DOI 10.1016/S0166-445X(02)00049-8; Iwamatsu T, 2004, MECH DEVELOP, V121, P605, DOI 10.1016/j.mod.2004.03.012; Iftimia NV, 2008, OPT EXPRESS, V16, P13624, DOI 10.1364/OE.16.013624; Huber G, 2009, INVEST OPHTH VIS SCI, V50, P5888, DOI 10.1167/iovs.09-3724; Kim KH, 2008, J VISION, V8, DOI 10.1167/8.1.17; Nguyen V, 1999, J COMP NEUROL, V413, P385, DOI 10.1002/(SICI)1096-9861(19991025)413:3<385::AID-CNE3>3.0.CO;2-P; Barrionuevo WR, 1999, AM J PHYSIOL-REG I, V276, pR505; Davis CR, 2002, AQUAT TOXICOL, V60, P185, DOI 10.1016/S0166-445X(02)00004-8; Debiais-Thibaud M, 2007, J EXP ZOOL PART B, V308B, P693, DOI 10.1002/jez.b.21183; Ekanayake B. K., 1990, CAN J ZOOL, V11, P1171; Hano Takeshi, 2012, Bulletin of Fisheries Research Agency, P1; Ishikawa Y, 1999, BRAIN BEHAV EVOLUT, V53, P2, DOI 10.1159/000006577; Ishikawa Y, 2010, BRAIN BEHAV EVOLUT, V75, P88, DOI 10.1159/000300566; Iwamatsu T., 2012, B AICHI U ED, V61, P55; Kabli S, 2006, ZEBRAFISH, V3, P431, DOI 10.1089/zeb.2006.3.431; Kinoshita M., 2009, MEDAKA BIOL MANAGEME; Kuroyanagi Y, 2010, BRAIN RES, V1323, P33, DOI 10.1016/j.brainres.2010.01.045; LANGILLE RM, 1988, ANAT EMBRYOL, V177, P297, DOI 10.1007/BF00315836; LANGILLE RM, 1987, J MORPHOL, V193, P135, DOI 10.1002/jmor.1051930203; Renn J, 2006, PROTOPLASMA, V229, P209, DOI 10.1007/s00709-006-0215-x; Sato M, 2012, APPL OPTICS, V51, P1436, DOI 10.1364/AO.51.001436; Srivastava V, 2013, APPL PHYS LETT, V102, DOI 10.1063/1.4802084; Weber A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0080483; Zha JM, 2005, AGR ECOSYST ENVIRON, V107, P187, DOI 10.1016/j.agee.2004.11.009	41	1	1	OPTICAL SOC AMER	WASHINGTON	2010 MASSACHUSETTS AVE NW, WASHINGTON, DC 20036 USA	2156-7085			BIOMED OPT EXPRESS	Biomed. Opt. Express	FEB 1	2015	6	2					297	308		10.1364/BOE.6.000297		12	Biochemical Research Methods; Optics; Radiology, Nuclear Medicine & Medical Imaging	Biochemistry & Molecular Biology; Optics; Radiology, Nuclear Medicine & Medical Imaging	CB2KI	WOS:000349455700002		
J	Yamanari, M; Tsuda, S; Kokubun, T; Shiga, Y; Omodaka, K; Yokoyama, Y; Himori, N; Ryu, M; Kunimatsu-Sanuki, S; Takahashi, H; Maruyama, K; Kunikata, H; Nakazawa, T				Yamanari, Masahiro; Tsuda, Satoru; Kokubun, Taiki; Shiga, Yukihiro; Omodaka, Kazuko; Yokoyama, Yu; Himori, Noriko; Ryu, Morin; Kunimatsu-Sanuki, Shiho; Takahashi, Hidetoshi; Maruyama, Kazuichi; Kunikata, Hiroshi; Nakazawa, Toru			Fiber-based polarization-sensitive OCT for birefringence imaging of the anterior eye segment	BIOMEDICAL OPTICS EXPRESS			English	Article							OPTICAL COHERENCE TOMOGRAPHY; SWEPT-SOURCE; IN-VIVO; MODE DISPERSION; HUMAN RETINA; REAL-TIME; NOISE; PERFORMANCE; MODULATION; PARAMETERS	We demonstrate a prototype system of polarization-sensitive optical coherence tomography (PS-OCT) designed for clinical studies of the anterior eye segment imaging. The system can measure Jones matrices of the sample with depth-multiplexing of two orthogonal incident polarizations and polarization-sensitive detection. An optical clock is generated using a quadrature modulator and a logical circuit to double the clock frequency. Systematic artifacts in measured Jones matrices are theoretically analyzed and numerically compensated using signals at the surface of the sample. Local retardation images of filtering blebs after trabeculectomy show improved visualization of subconjunctival tissue, sclera, and scar tissue of the bleb wall in the anterior eye segment. (C) 2015 Optical Society of America	[Yamanari, Masahiro] Tomey Corp, Dept Engn, Nishi Ku, Nagoya, Aichi 4510051, Japan; [Tsuda, Satoru; Kokubun, Taiki; Shiga, Yukihiro; Omodaka, Kazuko; Yokoyama, Yu; Himori, Noriko; Ryu, Morin; Kunimatsu-Sanuki, Shiho; Takahashi, Hidetoshi; Maruyama, Kazuichi; Kunikata, Hiroshi; Nakazawa, Toru] Tohoku Univ, Grad Sch Med, Dept Ophthalmol, Aoba Ku, Sendai, Miyagi 9808574, Japan; [Kokubun, Taiki] Iwaki Kyoritsu Hosp, Dept Ophthalmol, Iwaki, Fukushima 9738555, Japan	Yamanari, M (reprint author), Tomey Corp, Dept Engn, Nishi Ku, 2-11-33 Noritakeshinmachi, Nagoya, Aichi 4510051, Japan.	ntoru@oph.med.tohoku.ac.jp					Lim Y, 2011, BIOMED OPT EXPRESS, V2, P2392, DOI 10.1364/BOE.2.002892; Braaf B, 2014, BIOMED OPT EXPRESS, V5, P2736, DOI 10.1364/BOE.5.002736; de Boer JF, 2003, OPT LETT, V28, P2067, DOI 10.1364/OL.28.002067; Schmitt JM, 1999, J BIOMED OPT, V4, P95, DOI 10.1117/1.429925; Wojtkowski M, 2002, OPT LETT, V27, P1415, DOI 10.1364/OL.27.001415; HUANG D, 1991, SCIENCE, V254, P1178, DOI 10.1126/science.1957169; Villiger M, 2013, OPT EXPRESS, V21, P16353, DOI 10.1364/OE.21.016353; Makita S, 2010, OPT EXPRESS, V18, P854, DOI 10.1364/OE.18.000854; Pircher M, 2011, PROG RETIN EYE RES, V30, P431, DOI 10.1016/j.preteyeres.2011.06.003; Ju MJ, 2013, OPT EXPRESS, V21, P19412, DOI 10.1364/OE.21.019412; Yamanari M, 2008, OPT EXPRESS, V16, P5892, DOI 10.1364/OE.16.005892; Pircher M, 2004, PHYS MED BIOL, V49, P1257, DOI 10.1088/0031-9155/49/7/013; Baumann B, 2012, BIOMED OPT EXPRESS, V3, P1670, DOI 10.1364/BOE.3.001670; Lim Y, 2012, OPT LETT, V37, P1958, DOI 10.1364/OL.37.001958; Yasuno Y, 2010, J BIOMED OPT, V15, DOI 10.1117/1.3499421; Fukuda S, 2013, INVEST OPHTH VIS SCI, V54, P1384, DOI 10.1167/iovs.12-10979; Choma MA, 2003, OPT EXPRESS, V11, P2183, DOI 10.1364/OE.11.002183; Yasuno Y, 2005, OPT EXPRESS, V13, P10652, DOI 10.1364/OPEX.13.010652; Meyer-Spradow J, 2009, IEEE COMPUT GRAPH, V29, P6, DOI 10.1109/MCG.2009.130; Choi W, 2013, OPT LETT, V38, P338, DOI 10.1364/OL.38.000338; Dhalla AH, 2012, BIOMED OPT EXPRESS, V3, P633, DOI 10.1364/BOE.3.000633; Nassif N, 2004, OPT LETT, V29, P480, DOI 10.1364/OL.29.000480; Leitgeb R, 2003, OPT EXPRESS, V11, P889, DOI 10.1364/OE.11.000889; Park BH, 2004, OPT LETT, V29, P2512, DOI 10.1364/OL.29.002512; Oh WY, 2008, OPT EXPRESS, V16, P1096, DOI 10.1364/OE.16.001096; Saxer CE, 2000, OPT LETT, V25, P1355, DOI 10.1364/OL.25.001355; Yun SH, 2003, OPT EXPRESS, V11, P2953, DOI 10.1364/OE.11.002953; Moon S, 2010, OPT EXPRESS, V18, P24395, DOI 10.1364/OE.18.024395; Baumann B, 2012, OPT EXPRESS, V20, DOI 10.1364/OE.20.010229; Fukuda S, 2014, INVEST OPHTH VIS SCI, V55, P5200, DOI 10.1167/iovs.14-14474; Geissbuehler M, 2013, OPT EXPRESS, V21, P9862, DOI 10.1364/OE.21.009862; Gotzinger E, 2007, INVEST OPHTH VIS SCI, V48, P3551, DOI 10.1167/iovs.06-0727; IZATT JA, 1994, ARCH OPHTHALMOL-CHIC, V112, P1584; Jiao SL, 2003, OPT LETT, V28, P1206, DOI 10.1364/OL.28.001206; Kerbage C, 2007, OPT EXPRESS, V15, P7117, DOI 10.1364/OE.15.007117; Li JN, 2014, OPT EXPRESS, V22, P21382, DOI 10.1364/OE.22.021382; Miyazawa A, 2009, OPT EXPRESS, V17, P17426, DOI 10.1364/OE.17.017426; Nagase S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0058716; Oh WY, 2008, OPT LETT, V33, P1330, DOI 10.1364/OL.33.001330; Park BH, 2008, BIOL MED PHYS BIOMED, P653, DOI 10.1007/978-3-540-77550-8_22; Sarunic MV, 2008, ARCH OPHTHALMOL-CHIC, V126, P537, DOI 10.1001/archopht.126.4.537; Villiger M, 2013, OPT LETT, V38, P923, DOI 10.1364/OL.38.000923; Wang Z, 2014, BIOMED OPT EXPRESS, V5, P2931, DOI 10.1364/BOE.5.002931; Xi JF, 2010, OPT EXPRESS, V18, P9511, DOI 10.1364/OE.18.009511; Yamanari M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044026; Yamanari M, 2014, BIOMED OPT EXPRESS, V5, P1391, DOI 10.1364/BOE.5.001391; Yasuno Y, 2007, P SOC PHOTO-OPT INS, V6426, pU4260, DOI 10.1117/12.698968; Zhang EZ, 2013, OPT EXPRESS, V21, P1163, DOI 10.1364/OE.21.001163; Zhang EZ, 2011, OPT EXPRESS, V19, P16830, DOI 10.1364/OE.19.016830	49	3	3	OPTICAL SOC AMER	WASHINGTON	2010 MASSACHUSETTS AVE NW, WASHINGTON, DC 20036 USA	2156-7085			BIOMED OPT EXPRESS	Biomed. Opt. Express	FEB 1	2015	6	2					369	389		10.1364/BOE.6.000369		21	Biochemical Research Methods; Optics; Radiology, Nuclear Medicine & Medical Imaging	Biochemistry & Molecular Biology; Optics; Radiology, Nuclear Medicine & Medical Imaging	CB2KI	WOS:000349455700007		
J	Kiyomatsu, H; Oshima, Y; Saitou, T; Miyazaki, T; Hikita, A; Miura, H; Iimura, T; Imamura, T				Kiyomatsu, Hiroshi; Oshima, Yusuke; Saitou, Takashi; Miyazaki, Tsuyoshi; Hikita, Atsuhiko; Miura, Hiromasa; Iimura, Tadahiro; Imamura, Takeshi			Quantitative SHG imaging in osteoarthritis model mice, implying a diagnostic application	BIOMEDICAL OPTICS EXPRESS			English	Article							2-PHOTON EXCITATION MICROSCOPY; ARTICULAR-CARTILAGE; KNEE OSTEOARTHRITIS; SUPERFICIAL ZONE; COLLAGEN; MOUSE; GUIDELINES; MANAGEMENT; SYSTEM; DAMAGE	Osteoarthritis (OA) restricts the daily activities of patients and significantly decreases their quality of life. The development of noninvasive quantitative methods for properly diagnosing and evaluating the process of degeneration of articular cartilage due to OA is essential. Second harmonic generation (SHG) imaging enables the observation of collagen fibrils in live tissues or organs without staining. In the present study, we employed SHG imaging of the articular cartilage in OA model mice ex vivo. Consequently, three-dimensional SHG imaging with successive image processing and statistical analyses allowed us to successfully characterize histopathological changes in the articular cartilage consistently confirmed on histological analyses. The quantitative SHG imaging technique presented in this study constitutes a diagnostic application of this technology in the setting of OA. (C) 2015 Optical Society of America	[Kiyomatsu, Hiroshi; Miura, Hiromasa] Ehime Univ, Grad Sch Med, Dept Orthoped Surg, Shitukawa Toon City, Ehime 7910295, Japan; [Kiyomatsu, Hiroshi; Oshima, Yusuke; Saitou, Takashi; Hikita, Atsuhiko; Imamura, Takeshi] Ehime Univ, Grad Sch Med, Shitukawa Toon City, Ehime 7910295, Japan; [Kiyomatsu, Hiroshi; Saitou, Takashi; Miura, Hiromasa; Iimura, Tadahiro; Imamura, Takeshi] Ehime Univ Hosp, Artificial Joint Integrated Ctr, Shitukawa Toon City, Ehime 7910295, Japan; [Oshima, Yusuke; Miura, Hiromasa; Iimura, Tadahiro; Imamura, Takeshi] Ehime Univ Hosp, Translat Res Ctr, Shitukawa Toon City, Ehime 7910295, Japan; [Oshima, Yusuke; Hikita, Atsuhiko; Iimura, Tadahiro; Imamura, Takeshi] Core Res Evolut Sci & Technol, Shitukawa Toon City, Ehime 7910295, Japan; [Oshima, Yusuke; Hikita, Atsuhiko; Iimura, Tadahiro; Imamura, Takeshi] Ehime Univ, Proteosci Ctr, Div Bioimaging, Shitukawa Toon City, Ehime 7910295, Japan; [Miyazaki, Tsuyoshi] Tokyo Metropolitan Geriatr Hosp, Dept Orthopaed Surg, Tokyo 1730015, Japan; [Miyazaki, Tsuyoshi] Inst Gerontol, Itabashi Ku, Tokyo 1730015, Japan	Kiyomatsu, H (reprint author), Ehime Univ, Grad Sch Med, Dept Orthoped Surg, Shitukawa Toon City, Ehime 7910295, Japan.	oshima-ehm@umin.ac.jp; iimura@ehime-u.ac.jp			CREST JST (Japan Science and Technology); MEXT KAKENHI [22113004]; JSPS KAKENHI [23390368, 26670667, 24680060, 26293392]; JSPS Core-to-Core Program "Cooperative International Framework in TGF-beta Family Signaling"; Naito Foundation	The authors are grateful to Dr. Toshihiko Fujimori (NIBB, Japan) for providing the H2B-GFP line mice, Dr. Yoshitaka Shiraishi (Ehime University, Japan) for providing technical support and Dr. Tsutomu Hirata, Hiroko Ninomiya and Hiromi Yamamoto (Ehime University, Japan) for conducting the sample preparation for the histological study and providing assistance with mouse husbandry. The authors thank members of Nikon Corporation (Japan) for providing technical support of multi-photon microscopy. Funding for this work was supported by CREST JST (Japan Science and Technology), and MEXT KAKENHI Grant Number 22113004; JSPS KAKENHI Grant Numbers 23390368, 26670667, 24680060, and 26293392; and the JSPS Core-to-Core Program "Cooperative International Framework in TGF-beta Family Signaling". T. Im. and A. H. were supported by the Naito Foundation.	Akune T, 2014, J ORTHOP SCI, V19, P489, DOI 10.1007/s00776-014-0537-z; VANDERKRAAN PM, 1990, J EXP PATHOL, V71, P19; Brown CP, 2012, J MECH BEHAV BIOMED, V5, P62, DOI 10.1016/j.jmbbm.2011.08.004; Legare F, 2007, BIOPHYS J, V93, P1312, DOI 10.1529/biophysj.106.100586; McAlindon TE, 2014, OSTEOARTHR CARTILAGE, V22, P363, DOI 10.1016/j.joca.2014.01.003; Panula HE, 1998, ANN RHEUM DIS, V57, P237, DOI 10.1136/ard.57.4.237; Gonzalez S, 2007, MICROSC RES TECHNIQ, V70, P1072, DOI 10.1002/jemt.20516; Mansfield J, 2009, J ANAT, V215, P682, DOI 10.1111/j.1469-7580.2009.01149.x; Kamekura S, 2005, OSTEOARTHR CARTILAGE, V13, P632, DOI 10.1016/j.joca.2005.03.004; Glasson SS, 2007, OSTEOARTHR CARTILAGE, V15, P1061, DOI 10.1016/j.joca.2007.03.006; Zhang W, 2008, OSTEOARTHR CARTILAGE, V16, P137, DOI [10.1016/j.joca.2007.12.013, 10.1016/j.joca.2010.01.013]; Eltawil NM, 2009, OSTEOARTHR CARTILAGE, V17, P695, DOI 10.1016/j.joca.2008.11.003; Pritzker KPH, 2006, OSTEOARTHR CARTILAGE, V14, P13, DOI 10.1016/j.joca.2005.07.014; Sherwood JC, 2014, DRUG DISCOV TODAY, V19, P1172, DOI 10.1016/j.drudis.2014.05.014; Nissi MJ, 2004, J ORTHOP RES, V22, P557, DOI 10.1016/j.orthres.2003.09.008; Mansfield JC, 2012, J ANAT, V220, P405, DOI 10.1111/j.1469-7580.2012.01479.x; Tew SR, 2000, ARTHRITIS RHEUM-US, V43, P215, DOI 10.1002/1529-0131(200001)43:1<215::AID-ANR26>3.0.CO;2-X; Filova E, 2010, J BIOMED OPT, V15, DOI 10.1117/1.3509112; Koga S, 2014, CANCER SCI, V105, P1299, DOI 10.1111/cas.12500; Kurotaki Y, 2007, SCIENCE, V316, P719, DOI 10.1126/science.1138591; Longo Umile Giuseppe, 2012, Open Orthop J, V6, P558, DOI 10.2174/1874325001206010558; Lutz V, 2012, INT J COSMETIC SCI, V34, P209, DOI 10.1111/j.1468-2494.2012.00705.x; Oshima Y, 2014, LASER SURG MED, V46, P563, DOI 10.1002/lsm.22266; Werkmeister E, 2010, PHOTOCHEM PHOTOBIOL, V86, P302, DOI 10.1111/j.1751-1097.2009.00648.x	24	1	1	OPTICAL SOC AMER	WASHINGTON	2010 MASSACHUSETTS AVE NW, WASHINGTON, DC 20036 USA	2156-7085			BIOMED OPT EXPRESS	Biomed. Opt. Express	FEB 1	2015	6	2					405	420		10.1364/BOE.6.000405		16	Biochemical Research Methods; Optics; Radiology, Nuclear Medicine & Medical Imaging	Biochemistry & Molecular Biology; Optics; Radiology, Nuclear Medicine & Medical Imaging	CB2KI	WOS:000349455700009		
J	Li, JW; Aizawa, Y; Hiramoto, K; Kasahara, E; Tsuruta, D; Suzuki, T; Ikeda, A; Azuma, H; Nagasaki, T				Li, Jiawei; Aizawa, Yui; Hiramoto, Keiichi; Kasahara, Emiko; Tsuruta, Daisuke; Suzuki, Toshio; Ikeda, Atsushi; Azuma, Hideki; Nagasaki, Takeshi			Anti-inflammatory effect of water-soluble complex of 1 '-acetoxychavicol acetate with highly branched beta-1,3-glucan on contact dermatitis	BIOMEDICINE & PHARMACOTHERAPY			English	Article						beta-1,3-glucan; Anti-inflammatory effect; Dectin-1; Drug delivery; Contact dermatitis	WALLED CARBON NANOTUBES; NITRIC-OXIDE; SCHIZOPHYLLUM-COMMUNE; ALPINIA-GALANGA; CELLS; POLYSACCHARIDE; RECOGNITION; SOLUBILIZATION; DEGRANULATION; INFLAMMATION	The anti-inflammatory effect on contact dermatitis of the water solubilized 1'-Acetoxychavicol Acetate (ACA) by complexation with beta-1,3-glucan isolated form Aureobasidium pullulans black yeast is reported. It is well-known that ACA possesses a function to inhibit the activation of NF-kappa B by which genes encoding proinflammatory cytokines, chemokines, and growth factors are regulated. However, because ACA is quite insoluble in water, its usefulness has been extremely limited. On the other hand, a triple-helical polysaccharide beta-1,3-glucan can include hydrophobic compounds into intrastrand hydrophobic cavity and solubilize poorly water-soluble compounds. In this study, solubilization of ACA by complexation with highly branched beta-1,3-glucan was achieved. The effect of anti-inflammatory response of water-soluble ACA complex with beta-1,3-glucan was confirmed in vitro and in vivo. (C) 2014 Elsevier Masson SAS. All rights reserved.	[Li, Jiawei; Aizawa, Yui; Suzuki, Toshio; Azuma, Hideki; Nagasaki, Takeshi] Osaka City Univ, Grad Sch Engn, Dept Appl Chem & Bioengn, Sumiyoshi Ku, Osaka 5588585, Japan; [Hiramoto, Keiichi; Kasahara, Emiko] Osaka City Univ, Grad Sch Med, Dept Biochem & Mol Pathol, Abeno Ku, Osaka 5458585, Japan; [Tsuruta, Daisuke] Osaka City Univ, Grad Sch Med, Dept Dermatol, Abeno Ku, Osaka 5458585, Japan; [Ikeda, Atsushi] Hiroshima Univ, Grad Sch Engn, Dept Appl Chem, Higashihiroshima 7398527, Japan	Nagasaki, T (reprint author), Osaka City Univ, Grad Sch Engn, Dept Appl Chem & Bioengn, Sumiyoshi Ku, 3-3-138 Sugimoto, Osaka 5588585, Japan.	nagasaki@bioa.eng.osaka-cu.ac.jp	Ikeda, Atsushi/J-1880-2015	Ikeda, Atsushi/0000-0003-3492-3455	Ministry of Education, Culture, Sports, Science and Technology of Japan [26350528]	This work was supported by a Grant-in-Aid for Scientific Research (C) (No. 26350528) from Ministry of Education, Culture, Sports, Science and Technology of Japan.	KIKUMOTO S, 1971, J AGR CHEM SOC JPN, V45, P162; KNOWLES RG, 1994, BIOCHEM J, V298, P249; Granger DL, 1996, METHOD ENZYMOL, V268, P142; Sletmoen M, 2008, BIOPOLYMERS, V89, P310, DOI 10.1002/bip.20920; Ichikawa H, 2005, J IMMUNOL, V174, P7383; Leonardi CL, 2003, NEW ENGL J MED, V349, P2014, DOI 10.1056/NEJMoa030409; BEUTLER B, 1989, ANNU REV IMMUNOL, V7, P625, DOI 10.1146/annurev.iy.07.040189.003205; Matsuda H, 2003, BIOORG MED CHEM LETT, V13, P3197, DOI 10.1016/S0960-894X(03)00710-8; Hayden MS, 2008, CELL, V132, P344, DOI 10.1016/j.cell.2008.01.020; YANAKI T, 1980, MACROMOLECULES, V13, P1462, DOI 10.1021/ma60078a019; Taylor PR, 2007, NAT IMMUNOL, V8, P31, DOI 10.1038/ni1408; Chaudhari U, 2001, LANCET, V357, P1842, DOI 10.1016/S0140-6736(00)04954-0; Brown GD, 2001, NATURE, V413, P36, DOI 10.1038/35092620; Sakurai K, 2000, J AM CHEM SOC, V122, P4520, DOI 10.1021/ja0000145; NUSSLER AK, 1993, J LEUKOCYTE BIOL, V54, P171; Numata M, 2005, J AM CHEM SOC, V127, P5875, DOI 10.1021/ja044168m; Sato H, 2012, BIOSCI BIOTECH BIOCH, V76, P84, DOI 10.1271/bbb.110536; Ghosh S, 2002, CELL, V109, pS81, DOI 10.1016/S0092-8674(02)00703-1; Azuma H, 2011, BIOORGAN MED CHEM, V19, P3855, DOI 10.1016/j.bmc.2011.04.038; Azuma H, 2006, BIOORGAN MED CHEM, V14, P1811, DOI 10.1016/j.bmc.2005.10.029; Bae AH, 2005, ANGEW CHEM INT EDIT, V44, P2030, DOI 10.1002/anie.200462810; Benjamin CL, 2011, AGR FOOD CHEM, V59, P6813; Sigala JLD, 2004, SCIENCE, V304, P1963, DOI 10.1126/science.1098387; GORBUNOV N, 1993, INT J IMMUNOPATH PH, V6, P67; Ikeda A, 2004, CHEM COMMUN, P1334, DOI 10.1039/b402042a; Ito K, 2005, CANCER RES, V65, P4417, DOI 10.1158/0008-5472.CAN-05-0072; Ito K, 2004, CLIN CANCER RES, V10, P2120, DOI 10.1158/1078-0432.CCR-1142-03; Jacquat C, 1990, PLANTS MARKETS THAIL; JANSSEN AM, 1985, PLANTA MED, V51, P507, DOI 10.1055/s-2007-969577; Kikumoto S., 1970, J AGR CHEM SOC JPN, V44, P337; Komatsu K, 1999, J CHEM SOC PERK T 1, P2963, DOI 10.1039/a904736k; Li C, 2005, CHEM LETT, V34, P1532, DOI 10.1246/cl.2005.1532; Min HJ, 2009, INT IMMUNOPHARMACOL, V9, P448, DOI 10.1016/j.intimp.2009.01.008; Murakami A, 2000, J AGR FOOD CHEM, V48, P1518, DOI 10.1021/jf990528r; Numata M, 2007, CHEM LETT, V36, P668, DOI 10.1246/cl.2007.668; Seo JW, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0056447; Suzuki T, 2005, FOOD FUNCT, V1, P1; Xu SH, 2008, CHEM-BIOL INTERACT, V172, P216, DOI 10.1016/j.cbi.2008.01.002; Yang XG, 1999, J AGR FOOD CHEM, V47, P1657, DOI 10.1021/jf9808224	39	0	0	ELSEVIER FRANCE-EDITIONS SCIENTIFIQUES MEDICALES ELSEVIER	PARIS	23 RUE LINOIS, 75724 PARIS, FRANCE	0753-3322	1950-6007		BIOMED PHARMACOTHER	Biomed. Pharmacother.	FEB	2015	69						201	207		10.1016/j.biopha.2014.11.026		7	Medicine, Research & Experimental; Pharmacology & Pharmacy	Research & Experimental Medicine; Pharmacology & Pharmacy	CB3SM	WOS:000349548800029		
J	Miyazaki, K				Miyazaki, Kentaro			Molecular engineering of a PheS counterselection marker for improved operating efficiency in Escherichia coli	BIOTECHNIQUES			English	Article						counterselection; Escherichia coli; PheS; phenylalanyl-tRNA synthetase; 4-chloro-phenylalanine	TRANSFER-RNA-SYNTHETASE; SUBSTRATE-SPECIFICITY; IN-VIVO; GENE; MUTAGENESIS; PROTEINS	Escherichia coli phenylalanyl-tRNA synthetase, alpha-subunit (ePheS) can be useful as a counterselection marker since its A294G variant misincorporates 4-chloro-phenylalanine (4CP) into cellular proteins during translation, thereby causing cell death. The drawback of this method is that selection must be performed in minimal or semisynthetic medium to avoid interference from phenylalanine in the medium. Here, I reengineered ePheS for improved 4CP incorporation efficiency, obtaining variants (T251A/A294G and T251S/A294G) that exhibited high lethality in Luria-Bertani medium (LB) containing 4CP. These new variants were superior to the A294G variant when used as a counterselection marker in vector curing experiments.	[Miyazaki, Kentaro] Natl Inst Adv Ind Sci & Technol, Bioprod Res Inst, Sapporo, Hokkaido, Japan; [Miyazaki, Kentaro] Univ Tokyo, Grad Sch Frontier Sci, Dept Med Genome Sci, Sapporo, Hokkaido, Japan	Miyazaki, K (reprint author), Natl Inst Adv Ind Sci & Technol, Bioprod Res Inst, Sapporo, Hokkaido, Japan.	miyazaki-kentaro@aist.go.jp			Japan Society for the Promotion of Science (JSPS) [26292048, 26670219]	This work was partly supported by the Japan Society for the Promotion of Science (JSPS) Grant-in-Aid for Scientific Research (B) 26292048 and Grant-in-Aid for Scientific Research on Innovative Areas 26670219. K.M. thanks Miyuki Tsukuda for E. coli JM109 mutant library.	Mizoguchi H, 2007, BIOSCI BIOTECH BIOCH, V71, P2905, DOI 10.1271/bbb.70274; WEINER MP, 1994, GENE, V151, P119, DOI 10.1016/0378-1119(94)90641-6; Nakashima N, 2014, INT J MOL SCI, V15, P2773, DOI 10.3390/ijms15022773; KAST P, 1991, J MOL BIOL, V222, P99, DOI 10.1016/0022-2836(91)90740-W; Mermershtain I, 2011, PROTEIN SCI, V20, P160, DOI 10.1002/pro.549; Kitahara K, 2012, P NATL ACAD SCI USA, V109, P19220, DOI 10.1073/pnas.1213609109; Tsukuda M, 2013, J BIOSCI BIOENG, V116, P540, DOI 10.1016/j.jbiosc.2013.05.013; STEINMETZ M, 1983, MOL GEN GENET, V191, P138, DOI 10.1007/BF00330901; IBBA M, 1995, FEBS LETT, V364, P272, DOI 10.1016/0014-5793(95)00408-2; IBBA M, 1994, BIOCHEMISTRY-US, V33, P7107, DOI 10.1021/bi00189a013; KAST P, 1994, GENE, V138, P109, DOI 10.1016/0378-1119(94)90790-0; Miyazaki K, 1999, J MOL EVOL, V49, P716, DOI 10.1007/PL00006593; RICHMOND MH, 1962, BACTERIOL REV, V26, P398; Sharma N, 2000, FEBS LETT, V467, P37, DOI 10.1016/S0014-5793(00)01120-0	14	1	1	BIOTECHNIQUES OFFICE	NEW YORK	52 VANDERBILT AVE, NEW YORK, NY 10017 USA	0736-6205	1940-9818		BIOTECHNIQUES	Biotechniques	FEB	2015	58	2					86	88		10.2144/000114257		3	Biochemical Research Methods; Biochemistry & Molecular Biology	Biochemistry & Molecular Biology	CB1YH	WOS:000349423400007		
J	Suzuki, H; Ishii, J; Kondo, A; Yoshida, K				Suzuki, Hirokazu; Ishii, Jun; Kondo, Akihiko; Yoshida, Ken-ichi			Polyamino acid display on cell surfaces enhances salt and alcohol tolerance of Escherichia coli	BIOTECHNOLOGY LETTERS			English	Article						Alcohol tolerance; Cell surface display; Polyamino acids; Polyarginine; Polyaspartate; Polytryptophan; Salt tolerance	SACCHAROMYCES-CEREVISIAE; YEAST; ETHANOL; PROTEIN	Microbes employ cell membranes for reducing exogenous stresses. Polyamino acid display on microbial cell surfaces and their effects on microbial chemical stress tolerance were examined. Growth analysis revealed that displays of polyarginine, polyaspartate and polytryptophan substantially enhanced tolerance of Escherichia coli to NaCl. A titration assay indicated that polyarginine and polyaspartate altered cell surface charges, implying tolerance enhancement via ion atmosphere and/or ionic bond network formations for electrostatic ion repulsion. The enhancement by polytryptophan may have arisen from surface hydrophobicity increase for hydrophobic ion exclusion, because of a strong correlation between hydrophobic characters of amino acids and their effects on tolerance enhancement. The display also enhanced tolerance to other salts and/or alcohols in E. coli and to NaCl in Saccharomyces cerevisiae. Thus polyamino acid display has the potential as an approach for conferring chemical stress tolerance on various microbes.	[Suzuki, Hirokazu; Ishii, Jun] Kobe Univ, Org Adv Sci & Technol, Kobe, Hyogo 6578501, Japan; [Suzuki, Hirokazu] Tottori Univ, Grad Sch Engn, Dept Chem & Biotechnol, Tottori 6808552, Japan; [Kondo, Akihiko] Kobe Univ, Grad Sch Engn, Dept Chem Sci & Engn, Kobe, Hyogo 6578501, Japan; [Yoshida, Ken-ichi] Kobe Univ, Grad Sch Agr Sci, Dept Agrobiosci, Kobe, Hyogo 6578501, Japan	Suzuki, H (reprint author), Kobe Univ, Org Adv Sci & Technol, Kobe, Hyogo 6578501, Japan.	hirokap@xpost.plala.or.jp; junjun@port.kobe-u.ac.jp; akondo@kobe-u.ac.jp; kenyoshi@kobe-u.ac.jp			Special Coordination Funds for Promoting Science and Technology under the project of Creation of Innovation Centers for Advanced Interdisciplinary Research Areas (Innovative Bioproduction Kobe), MEXT, Japan	This work was supported by Special Coordination Funds for Promoting Science and Technology under the project of Creation of Innovation Centers for Advanced Interdisciplinary Research Areas (Innovative Bioproduction Kobe), MEXT, Japan.	Ishii J, 2009, J BIOCHEM, V145, P701, DOI 10.1093/jb/mvp028; Tanaka T, 2010, J BIOTECHNOL, V145, P79, DOI 10.1016/j.jbiotec.2009.10.011; Narita J, 2006, APPL MICROBIOL BIOT, V70, P564, DOI 10.1007/s00253-005-0111-x; Fozo EA, 2004, APPL ENVIRON MICROB, V70, P929, DOI 10.1128/AEM.70.2.929-936.2004; Chang YY, 1999, MOL MICROBIOL, V33, P249, DOI 10.1046/j.1365-2958.1999.01456.x; You KM, 2003, APPL ENVIRON MICROB, V69, P1499, DOI 10.1128/AEM.69.3.1499-1503.2003; Turner BF, 2006, COMPUT GEOSCI-UK, V32, P1344, DOI 10.1016/j.cageo.2005.12.005; Zou W, 2002, APPL MICROBIOL BIOT, V58, P806, DOI 10.1007/s00253-002-0961-4; Kondo A, 2004, APPL MICROBIOL BIOT, V64, P28, DOI 10.1007/s00253-003-1492-3; Matsui K, 2009, APPL MICROBIOL BIOT, V82, P105, DOI 10.1007/s00253-008-1761-2; CAREY VC, 1983, J BACTERIOL, V154, P1291; FUJITA A, 1954, Pharm Bull, V2, P163; Henriques ST, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0080474; Kuroda K, 2011, BIOTECHNOL LETT, V33, P1, DOI 10.1007/s10529-010-0403-9; Sokolov I, 2001, ENVIRON SCI TECHNOL, V35, P341, DOI 10.1021/es001258s; Tsujii K, 2002, COLLOID SURFACE B, V24, P247, DOI 10.1016/S0927-7765(01)00244-2; UCHIDA K, 1974, BIOCHIM BIOPHYS ACTA, V348, P86; Zhai L, 2014, BIOTECHNOL LETT, V36, P601, DOI 10.1007/s10529-013-1398-9	18	0	0	SPRINGER	DORDRECHT	VAN GODEWIJCKSTRAAT 30, 3311 GZ DORDRECHT, NETHERLANDS	0141-5492	1573-6776		BIOTECHNOL LETT	Biotechnol. Lett.	FEB	2015	37	2					429	435		10.1007/s10529-014-1689-9		7	Biotechnology & Applied Microbiology	Biotechnology & Applied Microbiology	CA9GT	WOS:000349230800022		
J	Budhathoki, S; Iwasaki, M; Sawada, N; Yamaji, T; Shimazu, T; Sasazuki, S; Inoue, M; Tsugane, S				Budhathoki, S.; Iwasaki, M.; Sawada, N.; Yamaji, T.; Shimazu, T.; Sasazuki, S.; Inoue, M.; Tsugane, S.		JPHC Study Grp	Soy food and isoflavone intake and endometrial cancer risk: the Japan Public Health Center-based prospective study	BJOG-AN INTERNATIONAL JOURNAL OF OBSTETRICS AND GYNAECOLOGY			English	Article						Endometrial cancer risk; epidemiology; isoflavone; prospective study; soy food	SPINAL-EPIDURAL ANALGESIA; CESAREAN DELIVERY; NULLIPAROUS WOMEN; SPONTANEOUS LABOR; NEURAXIAL ANALGESIA; UTERINE ACTIVITY; PLASMA CORTISOL; ANESTHESIA; TRIAL; CATECHOLAMINES	Objective Compared with western populations, the consumption of soy foods among Japanese is very high and the incidence of endometrial cancer very low. We evaluated the association of soy food and isoflavone intake with endometrial cancer risk in Japanese women. Design Prospective cohort study. Setting Ten public health centre areas in Japan. Population Forty nine thousand one hundred and twenty-one women of age 45-74 years who responded to a 5-year follow-up survey questionnaire. Methods Intakes of soy foods as well as other covariates were assessed in 1995-1998 by a self-administered food frequency questionnaire. Cox proportional hazards regression models were used to estimate hazard ratios (HR) and 95% confidence intervals (CI). Main outcome measure Incidence of endometrial cancer. Results During an average of 12.1 years of follow up, 112 newly diagnosed endometrial cancer cases were identified. Energy-adjusted intakes of soy food and isoflavone were not associated with the risk of endometrial cancer. The multivariate-adjusted HR per 25 g/day increase in the intake of soy food was 1.02 (95% CI 0.94-1.10), and the corresponding value for isoflavone intake per 15 mg/day was 1.01 (95% CI 0.841.22). Conclusion In this population-based prospective cohort study of Japanese women, we observed no evidence of a protective association between soy food or isoflavone intake and endometrial cancer risk.	[Budhathoki, S.; Iwasaki, M.; Sawada, N.; Yamaji, T.; Shimazu, T.; Sasazuki, S.; Inoue, M.; Tsugane, S.; JPHC Study Grp] Natl Canc Ctr, Epidemiol & Prevent Grp, Res Ctr Canc Prevent & Screening, Tokyo 1040045, Japan	Iwasaki, M (reprint author), Natl Canc Ctr, Div Epidemiol, Epidemiol & Prevent Grp, Res Ctr Canc Prevent & Screening,Chuo Ku, 5-1-1 Tsukiji, Tokyo 1040045, Japan.	moiwasak@ncc.go.jp	budhathoki, sanjeev/C-7358-2015	budhathoki, sanjeev/0000-0003-1662-3109	National Cancer Center Research and Development Fund from Ministry of Health, Labour and Welfare of Japan [23-A31[toku]]; Ministry of Health, Labour and Welfare of Japan	National Cancer Center Research and Development Fund (23-A31[toku]) (since 2011) and Grants-in-Aid for Cancer Research (from 1989 to 2010) and the Third-Term Comprehensive Ten-Year Strategy for Cancer Control from the Ministry of Health, Labour and Welfare of Japan.	American College of Obstetricians and Gynecologists, 2004, OBSTET GYNECOL, V104, P213; American College of Obstetricians and Gynecologists, 2003, ACOG PRACTICE B, V102, P1445; Anim-Somuah M, 2011, COCHRANE DB SYST REV, V12, DOI DOI 10.1002/14651858.CD000331.PUB3; RIGLER ML, 1991, ANESTH ANALG, V72, P275; Wong CA, 2005, NEW ENGL J MED, V352, P655, DOI 10.1056/NEJMoa042573; FRIEDMAN EA, 1955, OBSTET GYNECOL, V6, P567; Arkoosh VA, 2008, ANESTHESIOLOGY, V108, P286, DOI 10.1097/01.anes.0000299429.52105.e5; Ohel G, 2006, AM J OBSTET GYNECOL, V194, P600, DOI 10.1016/j.ajog.2005.10.821; Zhang J, 2010, OBSTET GYNECOL, V115, P705, DOI 10.1097/AOG.0b013e3181d55925; Alexander JM, 2001, ANESTH ANALG, V92, P1524; BREEN TW, 1993, ANESTH ANALG, V77, P919; Zhang J, 2010, OBSTET GYNECOL, V116, P1281, DOI 10.1097/AOG.0b013e3181fdef6e; Gambling DR, 1998, ANESTHESIOLOGY, V89, P1336, DOI 10.1097/00000542-199812000-00010; FRIEDMAN EA, 1954, AM J OBSTET GYNECOL, V68, P1568; Wang FZ, 2009, ANESTHESIOLOGY, V111, P871, DOI 10.1097/ALN.0b013e3181b55e65; BATES RG, 1985, BRIT J OBSTET GYNAEC, V92, P1246, DOI 10.1111/j.1471-0528.1985.tb04870.x; THORP JA, 1993, AM J OBSTET GYNECOL, V169, P851; SHNIDER SM, 1983, AM J OBSTET GYNECOL, V147, P13; Panni MK, 2003, ANESTHESIOLOGY, V98, P957, DOI 10.1097/00000542-200304000-00024; Bloom SL, 1998, NEW ENGL J MED, V339, P76, DOI 10.1056/NEJM199807093390203; CHESTNUT DH, 1994, ANESTHESIOLOGY, V80, P1201, DOI 10.1097/00000542-199406000-00006; CHESTNUT DH, 1994, ANESTHESIOLOGY, V80, P1193, DOI 10.1097/00000542-199406000-00005; Collis RE, 1999, ANAESTHESIA, V54, P535, DOI 10.1046/j.1365-2044.1999.00802.x; Cortes C, 2007, REV BRAS ANESTESIOL, V57, P45; Cunningham FG, 2010, WILLIAMS OBSTET, P464; FAIRLIE FM, 1988, BRIT J OBSTET GYNAEC, V95, P57, DOI 10.1111/j.1471-0528.1988.tb06480.x; Friedman E, 1983, MANAGEMENT LABOR, P11; Frigo MG, 2011, J OBSTET GYNAECOL RE, V37, P1532, DOI 10.1111/j.1447-0756.2011.01568.x; Hamilton Brady E, 2013, Natl Vital Stat Rep, V62, P1; Hinebaugh M, 1944, ANN SURG, V120, P129; Hunter S, 2007, COCHRANE DB SYST REV; JOUPPILA R, 1976, ACTA ANAESTH SCAND, V20, P259; LEDERMAN RP, 1978, AM J OBSTET GYNECOL, V132, P495; LONGO LD, 1974, AM J PHYSIOL, V226, P703; Luxman D, 1998, INT J OBSTET ANESTH, V7, P161, DOI 10.1016/S0959-289X(98)80004-6; MAY DPL, 1976, BRIT MED J, V2, P944; Nageotte MP, 1997, NEW ENGL J MED, V337, P1715, DOI 10.1056/NEJM199712113372402; NOBLE AD, 1970, BRIT MED J, V2, P296; Norris MC, 2001, ANESTHESIOLOGY, V95, P913, DOI 10.1097/00000542-200110000-00020; ODRISCOL.K, 1969, BRIT MED J, V2, P477; Osterman Michelle J K, 2011, Natl Vital Stat Rep, V59, P1; REYNOLDS S R M, 1948, Obstet Gynecol Surv, V3, P629, DOI 10.1097/00006254-194810000-00003; Sharma SK, 2003, CLIN OBSTET GYNECOL, V46, P633, DOI 10.1097/00003081-200309000-00016; Simmons S, 2007, COCHRANE DB SYST REV, V18; Skupski DW, 2009, INT J GYNECOL OBSTET, V106, P242, DOI 10.1016/j.ijgo.2009.04.019; THORNTON CA, 1976, BRIT J OBSTET GYNAEC, V83, P631, DOI 10.1111/j.1471-0528.1976.tb00901.x; Tsen L, 1999, ANESTHESIOLOGY, V91, P907; Vahratian A, 2004, AM J OBSTET GYNECOL, V191, P259, DOI 10.1016/j.ajog.2003.11.021; Vallejo M, 2011, ANESTHESIOLOGY, V95, P857; Wassen M, 2014, BJOG, DOI [10.1111/1471-0528.12854, DOI 10.1111/1471-0528.12854]; Wassen MMLH, 2011, BJOG-INT J OBSTET GY, V118, P655, DOI 10.1111/j.1471-0528.2011.02906.x	51	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1470-0328	1471-0528		BJOG-INT J OBSTET GY	BJOG	FEB	2015	122	3					304	310		10.1111/1471-0528.12853		7	Obstetrics & Gynecology	Obstetrics & Gynecology	CA4HZ	WOS:000348866600006		
J	Miyake, Y; Tanaka, K; Okubo, H; Sasaki, S; Arakawa, M				Miyake, Y.; Tanaka, K.; Okubo, H.; Sasaki, S.; Arakawa, M.			Intake of dairy products and calcium and prevalence of depressive symptoms during pregnancy in Japan: a cross-sectional study	BJOG-AN INTERNATIONAL JOURNAL OF OBSTETRICS AND GYNAECOLOGY			English	Article						Calcium; dairy products; depression; intake; Japanese; pregnancy	VULVAR VESTIBULITIS SYNDROME; PROVOKED VESTIBULODYNIA; SEXUAL DYSFUNCTIONS; WOMEN; VAGINISMUS; PAIN; DYSPAREUNIA; VULVODYNIA; DELIVERY; RISK	Objective To examine the relationship between the intake of dairy products and calcium and the prevalence of depressive symptoms during pregnancy. Design Cross-sectional study. Setting Kyushu Okinawa Maternal and Child Health Study (KOMCHS). Sample A cohort of 1745 pregnant Japanese women. Methods Dietary intake during the preceding month was assessed using a self-administered diet history questionnaire. Scores of 16 or higher on the Center for Epidemiologic Studies Depression Scale denoted depressive symptoms. Adjustment was made for age, gestation, region of residence, number of children, family structure, history of depression, family history of depression, smoking, secondhand smoke exposure at home and at work, job type, household income, education, and body mass index. In our analyses regarding dairy products in general, adjustment was also made for fish intake; in our analysis regarding calcium, adjustment was also made for the intake of saturated fatty acids, eicosapentaenoic acid plus docosahexaenoic acid, and vitamin D. Main outcome measures Depressive symptoms during pregnancy. Results Higher intake levels of yogurt and calcium were independently related to a lower prevalence of depressive symptoms during pregnancy: the adjusted odds ratios between extreme quartiles were 0.69 (95% CI 0.48-0.99, P for trend = 0.03) and 0.59 (95% CI 0.40-0.88, P for trend = 0.006), respectively. No relationships were observed between the intake of all dairy products, milk, or cheese and depressive symptoms during pregnancy. Conclusions The current results suggest that a higher intake of yogurt and calcium may be associated with a lower prevalence of depressive symptoms during pregnancy.	[Miyake, Y.; Tanaka, K.] Fukuoka Univ, Fac Med, Dept Prevent Med & Publ Hlth, Fukuoka 8140180, Japan; [Okubo, H.; Sasaki, S.] Univ Tokyo, Grad Sch Med, Dept Social & Prevent Epidemiol, Tokyo, Japan; [Arakawa, M.] Univ Ryukyus, Grad Sch Tourism Sci, Hlth Tourism Res Ctr, Nishihara, Okinawa 90301, Japan	Miyake, Y (reprint author), Fukuoka Univ, Fac Med, Dept Prevent Med & Publ Hlth, Fukuoka 8140180, Japan.	miyake-y@fukuoka-u.ac.jp			JSPS KAKENHI [19590606, 20791654, 21590673, 22592355, 22119507, 24390158, 25463275, 25670305]; Health and Labour Sciences Research Grants for Research on Allergic Disease and Immunology and Health Research on Children, Youth and Families from the Ministry of Health, Labour and Welfare, Japan; Meiji Co. Ltd.; Food Science Institute Foundation	This study was supported by JSPS KAKENHI grant numbers 19590606, 20791654, 21590673, 22592355, 22119507, 24390158, 25463275, and 25670305, by Health and Labour Sciences Research Grants for Research on Allergic Disease and Immunology and Health Research on Children, Youth and Families from the Ministry of Health, Labour and Welfare, Japan, by Meiji Co. Ltd., and by the Food Science Institute Foundation. YM and KT received a total of (sic)17,500,000 from Meiji Co. Ltd., between 2007 and 2013.	American Psychiatric Association, 2013, DIAGN STAT MAN MENT; Rosenbaum TY, 2012, J SEX MED, V9, P1726, DOI 10.1111/j.1743-6109.2012.02811.x; Goldsmith T, 2009, J MATERN-FETAL NEO M, V22, P863, DOI 10.1080/14767050902994598; Christensen BS, 2011, ARCH SEX BEHAV, V40, P121, DOI 10.1007/s10508-010-9599-y; Engman M, 2004, J PSYCHOSOM OBST GYN, V25, P281, DOI 10.1080/01674820400017921; Nieminen K, 2009, ACTA OBSTET GYN SCAN, V88, P807, DOI 10.1080/00016340902998436; Reed BD, 2013, BJOG-INT J OBSTET GY, V120, P1678, DOI 10.1111/1471-0528.12407; Backman H, 2008, J SEX RES, V45, P378, DOI 10.1080/00224490802398365; Desrochers G, 2008, J SEX MARITAL THER, V34, P198, DOI 10.1080/00926230701866083; Jindal UN, 2010, FERTIL STERIL, V94, P2393, DOI 10.1016/j.fertnstert.2010.03.071; Danielsson I, 2003, SCAND J PUBLIC HEALT, V31, P113, DOI 10.1080/14034940210134040; Ehrstrom S, 2009, J PSYCHOSOM OBST GYN, V30, P73, DOI 10.1080/01674820802604359; Babula O, 2004, AM J OBSTET GYNECOL, V191, P762, DOI 10.1016/j.ajog.2004.03.073; Bouchard C, 2002, AM J EPIDEMIOL, V156, P254, DOI 10.1093/aje/kwf037; Centre for Epidemiology National Board of Health and Welfare, 2013, KODN PAT ETT NYTT VE; Fugl-Meyer KS, 2013, J SEX MED, V10, P83, DOI 10.1111/j.1743-6109.2012.02867.x; Gerber S, 2003, EUR J OBSTET GYN R B, V107, P74, DOI 10.1016/S0301-2115(02)00276-2; Heddini U, 2012, MOL PAIN, V8, DOI 10.1186/1744-8069-8-68; Lev-Sagie A., 2009, AM J OBSTET GYNECOL, V200, DOI DOI 10.1016/J.AJ0G.2008.10.039; Munday P, 2005, BJOG-INT J OBSTET GY, V112, P500, DOI 10.1111/j.1471-0528.2004.00446.x; National Board of Health and Welfare Centre for Epidemiology, 2012, CAUS DEATH 2011; National Board of Health and Welfare Centre for Epidemiology, 2010, SWED VERS 10 REV WHO; National Board on Health and Welfare, 2003, SWED MED BIRTH REG S; Nguyen RHN, 2013, J PAIN RES, V6, P303, DOI 10.2147/JPR.S42940; Nguyen Ruby H N, 2012, Pain Ther, V1, P2, DOI 10.1007/s40122-012-0002-7; Oberg K, 2004, INT J IMPOT RES, V16, P261, DOI 10.1038/sj.ijir.3901151; Smith Elaine M, 2002, Infect Dis Obstet Gynecol, V10, P193, DOI 10.1155/S1064744902000224; Statistics Sweden, 2005, ED ATT POP 2004; Statistics Sweden, 2002, NEW TOT POP REG SYST; Statistics Sweden, 2011, MULT REG 2010 DESCR; TersKuile MM, 2005, J PSYCHOSOM OBST GYN, V26, P245; tersKuile MM, 2007, BEHAV RES THER, V45, P359; Tommola P, 2012, ACTA OBSTET GYN SCAN, V91, P1086, DOI 10.1111/j.1600-0412.2012.01466.x	33	1	1	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1470-0328	1471-0528		BJOG-INT J OBSTET GY	BJOG	FEB	2015	122	3					336	343		10.1111/1471-0528.12972		8	Obstetrics & Gynecology	Obstetrics & Gynecology	CA4HZ	WOS:000348866600013		
J	Matsubara, S; Baba, Y				Matsubara, S.; Baba, Y.			Transverse uterine fundal incision for placenta praevia with accreta: concern regarding its 'overuse'	BJOG-AN INTERNATIONAL JOURNAL OF OBSTETRICS AND GYNAECOLOGY			English	Letter									[Matsubara, S.; Baba, Y.] Jichi Med Univ, Dept Obstet & Gynecol, Shimotsuke, Tochigi, Japan	Matsubara, S (reprint author), Jichi Med Univ, Dept Obstet & Gynecol, Shimotsuke, Tochigi, Japan.						Moran C, 2014, BJOG-INT J OBSTET GY, V121, P761, DOI [10.1111/1471-0528.12578, 10.1111/1471-0528.12621]	1	1	1	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1470-0328	1471-0528		BJOG-INT J OBSTET GY	BJOG	FEB	2015	122	3					448	448		10.1111/1471-0528.13256		1	Obstetrics & Gynecology	Obstetrics & Gynecology	CA4HZ	WOS:000348866600043		
J	Nishijima, K; Takahashi, J; Orisaka, M; Kurokawa, T; Tamamura, C; Yoshida, A; Masuzaki, H; Sekiya, T; Yoshida, Y; Kotsuji, F				Nishijima, K.; Takahashi, J.; Orisaka, M.; Kurokawa, T.; Tamamura, C.; Yoshida, A.; Masuzaki, H.; Sekiya, T.; Yoshida, Y.; Kotsuji, F.			Transverse uterine fundal incision for placenta praevia with accreta: concern regarding its 'overuse' Reply	BJOG-AN INTERNATIONAL JOURNAL OF OBSTETRICS AND GYNAECOLOGY			English	Letter									[Nishijima, K.; Takahashi, J.; Orisaka, M.; Kurokawa, T.; Tamamura, C.; Yoshida, Y.; Kotsuji, F.] Univ Fukui, Fac Med Sci, Dept Obstet & Gynecol, Fukui 910, Japan; [Yoshida, A.; Masuzaki, H.] Nagasaki Univ, Sch Med, Dept Obstet & Gynecol, Nagasaki 852, Japan; [Sekiya, T.] Fujita Hlth Univ, Sch Med, Dept Obstet & Gynecol, Toyoake, Aichi, Japan	Nishijima, K (reprint author), Univ Fukui, Fac Med Sci, Dept Obstet & Gynecol, Fukui 910, Japan.						OBRIEN PC, 1979, BIOMETRICS, V35, P549, DOI 10.2307/2530245; Martinez de Tejada B, 2014, BJOG, V122, P80; Norwitz ER, 2015, BJOG-INT J OBSTET GY, V122, P447, DOI 10.1111/1471-0528.13258	3	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1470-0328	1471-0528		BJOG-INT J OBSTET GY	BJOG	FEB	2015	122	3					448	449		10.1111/1471-0528.13259		2	Obstetrics & Gynecology	Obstetrics & Gynecology	CA4HZ	WOS:000348866600044		
J	Yasui, N; Kawamoto, H; Fujiwara, M; Aihara, Y; Ogawa, C; Hosono, A; Suzuki, S				Yasui, N.; Kawamoto, H.; Fujiwara, M.; Aihara, Y.; Ogawa, C.; Hosono, A.; Suzuki, S.			High-dose chemotherapy for high-risk retinoblastoma: clinical course and outcome of 14 cases in the National Cancer Center, Japan	BONE MARROW TRANSPLANTATION			English	Article							STEM-CELL RESCUE; METASTATIC RETINOBLASTOMA; CONSOLIDATION; NEUROBLASTOMA; EXPERIENCE	The prognosis of high-risk retinoblastoma (RB) with extraocular disease, relapse, or invasion of the cut end of the optic nerve is extremely poor. Following the discontinuation of thiotepa production in Japan, BU- and melphalan (Mel)-based regimens have been used, followed by the standard treatment for neuroblastoma. This study retrospectively analyzed 14 high-risk RB patients who underwent high-dose chemotherapy (HDC) and hematopoietic SCT; 8 received a BU/Mel conditioning regimen and 6 received other regimens. The disease status at HDC was relapse in 8 patients and extraocular involvement in 5. All patients received peripheral blood stem cell infusion >1.5 x 10(6)/kg. Engraftment occurred within a median of 11 days (BU/Mel: 10-13, others: 9-13). Primary toxicities included mucositis (>= grade 3) in 9 patients (4 with BU/Mel, 5 with others). Veno-occlusive disease (VOD) occurred in two 1-year-old patients in the BU/Mel group. There were no treatment-related deaths. Of 4 (2 with BU/Mel, 2 with others) patients with central nervous system (CNS) relapse after HDC, 3 died. In conclusion, the BU/Mel regimen may be feasible for high-risk RB under careful monitoring for VOD, particularly in younger patients. CNS relapse associated with a lethal prognosis occurred after all regimens; therefore, further evaluation of HDC efficacy for high-risk RB is required.	[Yasui, N.; Kawamoto, H.; Ogawa, C.] Natl Canc Ctr, Div Pediat Oncol, Tokyo 1040045, Japan; [Fujiwara, M.; Aihara, Y.; Suzuki, S.] Natl Canc Ctr, Dept Ophthalm Oncol, Tokyo, Japan; [Hosono, A.] Natl Canc Ctr Hosp East, Div Pediat Oncol, Tokya, Japan	Yasui, N (reprint author), Natl Canc Ctr, Div Pediat Oncol, Chuo Ku, 5-1-1 Tsukiji, Tokyo 1040045, Japan.	naoko_murakami_yasui@yahoo.co.jp					Friedman DN, 2013, PEDIATR BLOOD CANCER, V60, P694, DOI 10.1002/pbc.24280; Berthold F, 2005, LANCET ONCOL, V6, P649, DOI 10.1016/S1470-2045(05)70291-6; Antoneli CBG, 2003, CANCER, V98, P1292, DOI 10.1002/cncr.11647; Jaradat Imad, 2012, Hematol Oncol Stem Cell Ther, V5, P107; Kremens B, 2003, BONE MARROW TRANSPL, V31, P281, DOI 10.1038/sj.bmt.1703832; Ladenstein RL, 2011, J CLIN ONCOL S, V29; Matsubara H, 2005, BONE MARROW TRANSPL, V35, P763, DOI 10.1038/sj.bmt.1704882; Matsubara H, 2003, PEDIATR HEMAT ONCOL, V20, P201, DOI 10.1080/08880010390158829; Namouni F, 1997, EUR J CANCER, V33, P2368, DOI 10.1016/S0959-8049(97)10019-3; Palma J, 2012, BONE MARROW TRANSPL, V47, P522, DOI 10.1038/bmt.2011.108; Valteau-Couanet D, 2000, BONE MARROW TRANSPL, V25, P937, DOI 10.1038/sj.bmt.1702376	11	0	0	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0268-3369	1476-5365		BONE MARROW TRANSPL	Bone Marrow Transplant.	FEB	2015	50	2					221	224		10.1038/bmt.2014.256		4	Biophysics; Oncology; Hematology; Immunology; Transplantation	Biophysics; Oncology; Hematology; Immunology; Transplantation	CB1QM	WOS:000349402900011		
J	Ariizumi, H; Saito, B; Uto, Y; Hattori, N; Nakashima, H; Yanagisawa, K; Harada, H; Mori, H; Nakamaki, T				Ariizumi, H.; Saito, B.; Uto, Y.; Hattori, N.; Nakashima, H.; Yanagisawa, K.; Harada, H.; Mori, H.; Nakamaki, T.			Predictive role of levels of soluble interleukin-2 receptor and C-reactive protein in selecting autologous PBSC transplantation for lymphoma	BONE MARROW TRANSPLANTATION			English	Letter							STEM-CELL TRANSPLANTATION; MALIGNANT-LYMPHOMA; CHEMOTHERAPY; THERAPY		[Ariizumi, H.; Saito, B.; Uto, Y.; Hattori, N.; Nakashima, H.; Yanagisawa, K.; Harada, H.; Mori, H.; Nakamaki, T.] Showa Univ, Sch Med, Dept Med, Div Hematol, Tokyo 142, Japan	Ariizumi, H (reprint author), Showa Univ, Sch Med, Dept Med, Div Hematol, Tokyo 142, Japan.	arizu@marble.ocn.ne.jp					Burger R, 2013, TRANSFUS MED HEMOTH, V40, P336, DOI 10.1159/000354194; Goto N, 2012, ANN HEMATOL, V91, P705, DOI 10.1007/s00277-011-1363-4; Kameoka Y, 2012, INT J HEMATOL, V96, P624, DOI 10.1007/s12185-012-1186-7; SEYMOUR JF, 1995, J CLIN ONCOL, V13, P575; Cheson BD, 1999, J CLIN ONCOL, V17, P1244; Numata A, 2010, BONE MARROW TRANSPL, V45, P311, DOI 10.1038/bmt.2009.165; Tomita N, 2012, CANCER SCI, V103, P1518, DOI 10.1111/j.1349-7006.2012.02331.x; Cao Y, 2012, TUMOR BIOL, V33, P1039, DOI 10.1007/s13277-012-0337-z; Okada M, 2010, RADIOGRAPHICS, V30, P939, DOI 10.1148/rg.304095150; Karin M, 2005, NAT REV IMMUNOL, V5, P749, DOI 10.1038/nri1703; Oliansky DM, 2011, BIOL BLOOD MARROW TR, V17, P20, DOI 10.1016/j.bbmt.2010.07.008; Li YJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0064158; Nagafuji K, 1995, Rinsho Ketsueki, V36, P530; Salem K, 2013, EXP HEMATOL, V41, P209, DOI 10.1016/j.exphem.2012.10.002; Tabata M, 2001, INTERNAL MED, V40, P471, DOI 10.2169/internalmedicine.40.471	15	0	0	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0268-3369	1476-5365		BONE MARROW TRANSPL	Bone Marrow Transplant.	FEB	2015	50	2					301	303		10.1038/bmt.2014.236		3	Biophysics; Oncology; Hematology; Immunology; Transplantation	Biophysics; Oncology; Hematology; Immunology; Transplantation	CB1QM	WOS:000349402900025		
J	Arai, Y; Kondo, T; Kitano, T; Hishizawa, M; Yamashita, K; Kadowaki, N; Yamamoto, T; Yano, I; Matsubara, K; Takaori-Kondo, A				Arai, Y.; Kondo, T.; Kitano, T.; Hishizawa, M.; Yamashita, K.; Kadowaki, N.; Yamamoto, T.; Yano, I.; Matsubara, K.; Takaori-Kondo, A.			Monitoring mycophenolate mofetil is necessary for the effective prophylaxis of acute GVHD after cord blood transplantation	BONE MARROW TRANSPLANTATION			English	Letter							HEMATOPOIETIC-CELL TRANSPLANTATION; VERSUS-HOST-DISEASE; PHARMACOKINETICS		[Arai, Y.; Kondo, T.; Kitano, T.; Hishizawa, M.; Yamashita, K.; Kadowaki, N.; Takaori-Kondo, A.] Kyoto Univ, Grad Sch Med, Dept Hematol & Oncol, Kyoto, Japan; [Yamamoto, T.; Yano, I.; Matsubara, K.] Kyoto Univ Hosp, Dept Clin Pharmacol & Therapeut, Kyoto 606, Japan	Arai, Y (reprint author), Kyoto Univ, Grad Sch Med, Dept Hematol & Oncol, Kyoto, Japan.	tadakazu@kuhp.kyoto-u.ac.jp					Arai Y, 2013, BIOL BLOOD MARROW TR, V19, P1683, DOI 10.1016/j.bbmt.2013.09.005; Arai Y, 2014, BONE MARROW TRANSPL, V49, P859, DOI 10.1038/bmt.2014.28; Frymoyer A, 2013, BRIT J CLIN PHARMACO, V75, P463, DOI 10.1111/j.1365-2125.2012.04372.x; Jacobson P, 2009, BONE MARROW TRANSPL, V44, P113, DOI 10.1038/bmt.2008.428; Kodawara T, 2007, JPN J PHARM HLTH CAR, V33, P804; Minagawa K, 2012, INT J HEMATOL, V96, P10, DOI 10.1007/s12185-012-1086-x; Okamura A, 2008, INT J HEMATOL, V88, P104, DOI 10.1007/s12185-008-0093-4; Patel KJ, 2010, BIOL BLOOD MARROW TR, V16, P435, DOI 10.1016/j.bbmt.2009.10.022; Raggi MC, 2010, TRANSPLANTATION, V90, P1536, DOI 10.1097/TP.0b013e3182000027; Uchida N, 2011, TRANSPLANTATION, V92, P366, DOI 10.1097/TP.0b013e318223d7ac; van Hest RM, 2007, THER DRUG MONIT, V29, P353, DOI 10.1097/FTD.0b013e31805d8816; Wakahashi K, 2011, INT J HEMATOL, V94, P193, DOI 10.1007/s12185-011-0888-6	12	1	1	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0268-3369	1476-5365		BONE MARROW TRANSPL	Bone Marrow Transplant.	FEB	2015	50	2					312	314		10.1038/bmt.2014.258		3	Biophysics; Oncology; Hematology; Immunology; Transplantation	Biophysics; Oncology; Hematology; Immunology; Transplantation	CB1QM	WOS:000349402900029		
J	Azuma, J; Nabatame, S; Nakano, S; Iwatani, Y; Kitai, Y; Tominaga, K; Kagitani-Shimono, K; Okinaga, T; Yamamoto, T; Nagai, T; Ozono, K				Azuma, Junji; Nabatame, Shin; Nakano, Sayaka; Iwatani, Yoshiko; Kitai, Yukihiro; Tominaga, Koji; Kagitani-Shimono, Kuriko; Okinaga, Takeshi; Yamamoto, Takehisa; Nagai, Toshisaburo; Ozono, Keiichi			Prognostic factors for acute encephalopathy with bright tree appearance	BRAIN & DEVELOPMENT			English	Article						Acute encephalopathy; Acute encephalopathy with biphasic seizures and late reduced diffusion; Bright tree appearance; Prognostic factors; Creatinine; Magnetic resonance spectroscopy; Lactate peak	MAGNETIC-RESONANCE-SPECTROSCOPY; HYPOTHERMIA; BRAIN; ISCHEMIA; CREATINE; CHILDREN; HYPOXIA; KIDNEY; SERUM	Objective: To determine the prognostic factors for encephalopathy with bright tree appearance (BTA) in the acute phase through retrospective case evaluation. Methods: We recruited 10 children with encephalopathy who presented with BTA and classified them into 2 groups. Six patients with evident regression and severe psychomotor developmental delay after encephalopathy were included in the severe group, while the remaining 4 patients with mild mental retardation were included in the mild group. We retrospectively analyzed their clinical symptoms, laboratory data, and magnetic resonance imaging (MRI) and magnetic resonance spectroscopy (MRS) findings. Results: Patients in the severe group developed subsequent complications such as epilepsy and severe motor impairment. Univariate analysis revealed that higher maximum lactate dehydrogenase (LDH) levels (p = 0.055) were a weak predictor of poor outcome. Maximum creatinine levels were significantly higher (p < 0.05) and minimal platelet counts were significantly lower (p < 0.05) in the severe group than in the mild group. Acute renal failure was not observed in any patient throughout the study. MRS of the BTA lesion during the BTA period showed elevated lactate levels in 5 children in the severe group and 1 child in the mild group. MRI performed during the chronic phase revealed severe brain atrophy in all patients in the severe group. Conclusions: Higher creatinine and LDH levels and lower platelet counts in the acute phase correlated with poor prognosis. Increased lactate levels in the BTA lesion during the BTA period on MRS may predict severe physical and mental disability. (C) 2014 The Japanese Society of Child Neurology. Published by Elsevier B.V. All rights reserved.	[Azuma, Junji; Nabatame, Shin; Nakano, Sayaka; Iwatani, Yoshiko; Tominaga, Koji; Kagitani-Shimono, Kuriko; Okinaga, Takeshi; Ozono, Keiichi] Osaka Univ, Dept Pediat, Grad Sch Med, Suita, Osaka 5650871, Japan; [Azuma, Junji; Nabatame, Shin; Nakano, Sayaka; Iwatani, Yoshiko; Tominaga, Koji; Kagitani-Shimono, Kuriko; Okinaga, Takeshi; Ozono, Keiichi] Osaka Univ Hosp, Epilepsy Ctr, Suita, Osaka, Japan; [Tominaga, Koji; Kagitani-Shimono, Kuriko] Osaka Univ, Dept Pediat, United Grad Sch Child Dev, Suita, Osaka 5650871, Japan; [Yamamoto, Takehisa] Minoh City Hosp, Dept Pediat, Mino, Osaka, Japan; [Nagai, Toshisaburo] Osaka Univ, Div Hlth Sci, Grad Sch Med, Suita, Osaka 5650871, Japan; [Kitai, Yukihiro] Morinomiya Hosp, Dept Pediat, Osaka, Japan	Azuma, J (reprint author), Osaka Univ, Dept Pediat, Grad Sch Med, 2-2 Yamadaoka, Suita, Osaka 5650871, Japan.	jazuma@ped.med.osaka-u.ac.jp					Aaen GS, 2010, PEDIATRICS, V125, P295, DOI 10.1542/peds.2008-3312; ALGER JR, 1990, RADIOLOGY, V177, P633; BUSTO R, 1989, STROKE, V20, P904; Tachikawa M, 2008, J NEUROCHEM, V107, P432, DOI 10.1111/j.1471-4159.2008.05641.x; Iwata O, 2007, BRAIN RES, V1154, P173, DOI 10.1016/j.brainres.2007.03.083; Waikar SS, 2009, J AM SOC NEPHROL, V20, P672, DOI 10.1681/ASN.2008070669; Uemura O, 2011, CLIN EXP NEPHROL, V15, P694, DOI 10.1007/s10157-011-0452-y; Ishikawa Junichi, 2010, No To Hattatsu, V42, P283; Holzer M, 2002, NEW ENGL J MED, V346, P549; Takanashi J, 2009, AM J NEURORADIOL, V30, P132, DOI 10.3174/ajnr.A1247; Jacobs SE, 2011, ARCH PEDIAT ADOL MED, V165, P692, DOI 10.1001/archpediatrics.2011.43; Andres RH, 2008, BRAIN RES BULL, V76, P329, DOI 10.1016/j.brainresbull.2008.02.035; GIDEON P, 1992, STROKE, V23, P1566; Hayakawa F, 2013, SHOUNI NAIKA TOKYO, V45, P195; Hayashi N, 2012, BRAIN DEV-JPN, V34, P632, DOI 10.1016/j.braindev.2011.11.007; Ichiyama Takashi, 2008, Brain Dev, V30, P47, DOI 10.1016/j.braindev.2007.05.008; Ishii C, 2007, SHONIKA RINSHO TOKYO, V60, P1702; Jequier Gygax M, 2011, EUR J PAEDIATR NEURO, V15, P158; Krohn KA, 2008, J NUCL MED, V49, p129S, DOI 10.2967/jnumed.107.045914; Kubota M, 2012, BRAIN DEV-JPN, V34, P20, DOI 10.1016/j.braindev.2010.12.012; MARESCAU B, 1992, METABOLISM, V41, P526, DOI 10.1016/0026-0495(92)90213-T; Mathews P M, 1993, Neurology, V43, P2484; Morita H, 2005, BRAIN DEV-JPN, V27, P477, DOI 10.1016/j.braindev.2004.11.007; Muñoz Maniega Susana, 2008, Stroke, V39, P2467, DOI 10.1161/STROKEAHA.107.507020; Nagao T, 2008, PEDIATR INFECT DIS J, V27, P384, DOI 10.1097/INF.0b013e318162a13b; Nakagawa Taku, 2011, No To Hattatsu, V43, P459; REHNCRONA S, 1981, J CEREBR BLOOD F MET, V1, P297; Shiomi M, 2005, NO TO HATTATSU S, V37, P166; Yadav Saroj S, 2013, J Pediatr Neurosci, V8, P64, DOI 10.4103/1817-1745.111429	29	1	1	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	0387-7604	1872-7131		BRAIN DEV-JPN	Brain Dev.	FEB	2015	37	2					191	199		10.1016/j.braindev.2014.04.001		9	Clinical Neurology	Neurosciences & Neurology	CB2AS	WOS:000349429700002		
J	Sakamoto, A; Moriuchi, H; Matsuzaki, J; Motoyama, K; Moriuchi, M				Sakamoto, Ayako; Moriuchi, Hiroyuki; Matsuzaki, Junko; Motoyama, Kazunori; Moriuchi, Masako			Retrospective diagnosis of congenital cytomegalovirus infection in children with autism spectrum disorder but no other major neurologic deficit	BRAIN & DEVELOPMENT			English	Article						Autism spectrum disorder; Congenital cytomegalovirus infection; Dried blood spots; Dried umbilical cords	PERVASIVE DEVELOPMENTAL DISORDERS; UMBILICAL-CORD; RUBELLA; DISEASE	Aim: Congenital cytomegalovirus (CMV) infection can cause a variety of neurological deficits of delayed onset in infants who are asymptomatic at birth. The aim of this study was to investigate the prevalence of congenital CMV infection among children with autism spectrum disorder (ASD) in Nagasaki, Japan. Methods: Twenty-nine children with ASD who were born in Nagasaki and had no other major neurological deficits were recruited. Two of the patients were excluded due to significant perinatal events. The remaining 27 children were investigated retrospectively for congenital CMV infection by analyzing dried blood spot samples or dried umbilical cords for CMV DNA using real-time PCR. Results: CMV DNA was detected in two (7.4%) of the 27 children. Neither of the patients had perinatal histories suggestive of congenital CMV disease or other neurological deficits, including hearing impairment and epilepsy. The severity of their autistic disorders varied considerably. Conclusions: The rate of congenital CMV infection in this study (two of 27 children with ASD), which was significantly (p = 0.004) higher than the incidence of congenital CMV infection in Nagasaki (0.31%, 10/3230 live births), suggests the involvement of congenital CMV infection in a portion of children with ASD, although definite diagnosis was not obtained due to limited clinical data of the study subjects. (C) 2014 The Japanese Society of Child Neurology. Published by Elsevier B.V. All rights reserved.	[Sakamoto, Ayako; Moriuchi, Hiroyuki; Moriuchi, Masako] Nagasaki Univ, Grad Sch Biomed Sci, Dept Mol Microbiol & Immunol, Nagasaki 852, Japan; [Sakamoto, Ayako; Moriuchi, Hiroyuki] Nagasaki Univ Hosp, Dept Pediat, Nagasaki 8528501, Japan; [Matsuzaki, Junko] Nagasaki Municipal Welf Ctr Handicapped, Nagasaki, Japan; [Motoyama, Kazunori] Nagasaki Prefectural Child Hlth & Welf Ctr, Isahaya, Japan	Moriuchi, M (reprint author), Nagasaki Univ Hosp, Dept Pediat, 1-7-1 Sakamoto, Nagasaki 8528501, Japan.	hiromori@nagasaki-u.ac.jp			JSPS [22591185]	This work was supported by JSPS Grants-in-Aid for Scientific Research Grant Number 22591185 (for M. Moriuchi).	Cheeran MCJ, 2009, CLIN MICROBIOL REV, V22, P99, DOI 10.1128/CMR.00023-08; Hagberg H, 2012, ANN NEUROL, V71, P444, DOI 10.1002/ana.22620; Sweeten TL, 2004, J AUTISM DEV DISORD, V34, P583, DOI 10.1007/s10803-004-2552-y; CHESS S, 1977, J AUTISM CHILD SCHIZ, V7, P69, DOI 10.1007/BF01531116; Koyama T, 2009, PSYCHIAT CLIN NEUROS, V63, P241, DOI 10.1111/j.1440-1819.2009.01931.x; Yamashita Y, 2003, J AUTISM DEV DISORD, V33, P455, DOI 10.1023/A:1025023131029; Barbi M, 1996, CLIN DIAGN VIROL, V6, P27, DOI 10.1016/0928-0197(96)00228-0; Berger BE, 2011, BMC PUBLIC HEALTH, V11, DOI 10.1186/1471-2458-11-340; Blaxill MF, 2004, PUBLIC HEALTH REP, V119, P536, DOI 10.1016/j.phr.2004.09.003; Bransfield RC, 2009, PEDIAT HLTH, V3, P125, DOI 10.2217/phe.09.5; Buonsenso D, 2012, EUR REV MED PHARMACO, V16, P919; CHESS S, 1978, J PEDIATR-US, V93, P699, DOI 10.1016/S0022-3476(78)80921-4; Enjoji M., 1961, PAEDIAT JPN, V4, P2, DOI 10.1111/j.1442-200X.1961.tb01032.x; Inoue N, 2008, PEDIATR INFECT DIS J, V27, P182, DOI 10.1097/INF.0b013e318161a2d5; IVARSSON SA, 1990, NEUROPEDIATRICS, V21, P102, DOI 10.1055/s-2008-1071471; Kawatani M, 2010, PEDIATR INT, V52, P304, DOI 10.1111/j.1442-200X.2010.03027.x; Koyano S, 2011, BMJ OPEN, V1, DOI 10.1136/bmjopen-2011-000118; Lopez-Pison J, 2005, REV NEUROLOGIA, V40, P733; MARKOWITZ PI, 1983, J AUTISM DEV DISORD, V13, P249, DOI 10.1007/BF01531564; Numazaki K, 2004, BMC INFECT DIS, V4, DOI 10.1186/1471-2334-4-22; STUBBS EG, 1984, J AUTISM DEV DISORD, V14, P183, DOI 10.1007/BF02409660; Tagawa M, 2009, J PEDIATR-US, V155, P749, DOI 10.1016/j.jpeds.2009.04.033; Tateno M, 2011, PSYCHIAT INVEST, V8, P67, DOI 10.4306/pi.2011.8.1.67	23	2	2	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	0387-7604	1872-7131		BRAIN DEV-JPN	Brain Dev.	FEB	2015	37	2					200	205		10.1016/j.braindev.2014.03.016		6	Clinical Neurology	Neurosciences & Neurology	CB2AS	WOS:000349429700003		
J	Goto, M; Saito, Y; Honda, R; Saito, T; Sugai, K; Matsuda, Y; Miyatake, C; Takeshita, E; Ishiyama, A; Komaki, H; Nakagawa, E; Sasaki, M; Uto, C; Kikuchi, K; Motoki, T; Saitoh, S				Goto, Masahide; Saito, Yoshiaki; Honda, Ryoko; Saito, Takashi; Sugai, Kenji; Matsuda, Yuko; Miyatake, Chiharu; Takeshita, Eri; Ishiyama, Akihiko; Komaki, Hirofumi; Nakagawa, Eiji; Sasaki, Masayuki; Uto, Chieko; Kikuchi, Kenjiro; Motoki, Takahiro; Saitoh, Shinji			Episodic tremors representing cortical myoclonus are characteristic in Angelman syndrome due to UBE3A mutations	BRAIN & DEVELOPMENT			English	Article						Jerk-locked averaging; Levetiracetam; Myoclonic absence; Tremor; UBE3A mutations	EPILEPSY; DELETION; SEIZURES; ABSENCES	Objective: Neurological manifestations including psychomotor developmental delay and epilepsy in patients with Angelman syndrome caused by ubiquitin protein ligase E3A (UBE3A) mutations has been considered similar but is relatively milder than that in patients with deletion-type Angelman syndrome. This makes the diagnosis of the former subgroup often difficult. We here characterized epilepsy, specifically the types of tremulous movement, in 4 patients (age, 3-38 years) with Angelman syndrome caused by UBE3A mutations. Methods: Ictal electroencephalography was used to record episodic tremors in all study patients. Jerk-locked averaging was performed using digital electroencephalography and surface electromyogram data from patients who were monitored for 24 h. Results: All patients had tremors in the limbs, head, and trunk, which resulted in 2 patients falling backward. These tremors lasted several seconds, and could emerge in clusters for hours in older patients. In addition, the tremors coincided with 7-8 Hz rhythmic activity with a frontocentral predominance, diffuse spike-wave bursts, or no apparent change on electroencephalography. In 2 patients, these tremors were confirmed as cortical myoclonus using jerk-locked averaging. The other seizure types were isolated generalized myoclonus and tonic seizures. None of the patients experienced atypical absence seizures. Levetiracetam therapy was effective in controlling the myoclonic events in 2 of the 3 patients. Conclusion: Semirhythmic myoclonus is common in patients with Angelman syndrome caused by UBE3A mutations, and such myoclonic events are often life disabling. The preserved expression of gamma-aminobutyric acid type A receptor subunit genes located proximal to UBE3A might explain the low prevalence of absence seizures in this population. (C) 2014 The Japanese Society of Child Neurology. Published by Elsevier B.V. All rights reserved.	[Goto, Masahide; Saito, Yoshiaki; Honda, Ryoko; Saito, Takashi; Sugai, Kenji; Matsuda, Yuko; Miyatake, Chiharu; Takeshita, Eri; Ishiyama, Akihiko; Komaki, Hirofumi; Nakagawa, Eiji; Sasaki, Masayuki] Natl Ctr Neurol & Psychiat, Dept Child Neurol, Kodaira, Tokyo 1878551, Japan; [Uto, Chieko] Isawa Kyoritu Hosp, Dept Pediat, Yamanashi, Japan; [Kikuchi, Kenjiro] Saitama Childrens Med Ctr, Div Neurol, Saitama, Japan; [Motoki, Takahiro] Uwajima City Hosp, Dept Pediat, Uwajima, Ehime, Japan; [Saitoh, Shinji] Nagoya City Univ, Grad Sch Med Sci, Dept Pediat & Neonatol, Nagoya, Aichi, Japan	Goto, M (reprint author), Natl Ctr Neurol & Psychiat, Dept Child Neurol, 4-1-1 Ogawahigashi Cho, Kodaira, Tokyo 1878551, Japan.	masapon.go@gmail.com			Japanese Ministry of Health, Labour and Welfare (Research Grant for Nervous and Mental Disorders) [24-7]	Drs. Yoshiaki Saito and Masayuki Sasaki received financial support from the Japanese Ministry of Health, Labour and Welfare (Research Grant for Nervous and Mental Disorders 24-7).	Dan B, 2004, BRAIN DEV-JPN, V26, P389, DOI 10.1016/j.braindev.2003.12.002; Lossie AC, 2001, J MED GENET, V38, P834, DOI 10.1136/jmg.38.12.834; Pelc K, 2008, SEIZURE-EUR J EPILEP, V17, P211, DOI 10.1016/j.seizure.2007.08.004; Valente KD, 2006, ARCH NEUROL-CHICAGO, V63, P122, DOI 10.1001/archneur.63.1.122; MATSUMOTO A, 1992, EPILEPSIA, V33, P1083, DOI 10.1111/j.1528-1157.1992.tb01763.x; Bureau M, 2005, BRAIN DEV-JPN, V27, P178, DOI 10.1016/j.braindev.2004.01.008; Dan B, 2003, NEUROPEDIATRICS, V34, P169; Elia M, 2009, EPILEPSIA, V50, P41, DOI 10.1111/j.1528-1167.2009.02119.x; Elia M, 1998, EPILEPSIA, V39, P660, DOI 10.1111/j.1528-1157.1998.tb01435.x; Espay AJ, 2005, EPILEPTIC DISORD, V7, P227; Fiumara A, 2010, ITAL J PEDIATR, V36, DOI 10.1186/1824-7288-36-31; Guerrini Renzo, 2003, Paediatr Drugs, V5, P647, DOI 10.2165/00148581-200305100-00001; Guerrini R, 1996, ANN NEUROL, V40, P39, DOI 10.1002/ana.410400109; Moncla A, 1999, EUR J HUM GENET, V7, P131, DOI 10.1038/sj.ejhg.5200258; Moncla A, 1999, J MED GENET, V36, P554; Ogawa K, 1996, EPILEPSIA, V37, P83, DOI 10.1111/j.1528-1157.1996.tb01852.x; Uemura N, 2005, BRAIN DEV-JPN, V27, P383, DOI 10.1016/j.braindev.2004.01.009; Weber P, 2010, J CHILD NEUROL, V25, P393, DOI 10.1177/0883073809338626	18	0	2	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	0387-7604	1872-7131		BRAIN DEV-JPN	Brain Dev.	FEB	2015	37	2					216	222		10.1016/j.braindev.2014.04.005		7	Clinical Neurology	Neurosciences & Neurology	CB2AS	WOS:000349429700005		
J	Toda, Y; Kobayashi, K; Hayashi, Y; Inoue, T; Oka, M; Endo, F; Yoshinaga, H; Ohtsuka, Y				Toda, Yoshihiro; Kobayashi, Katsuhiro; Hayashi, Yumiko; Inoue, Takushi; Oka, Makio; Endo, Fumika; Yoshinaga, Harumi; Ohtsuka, Yoko			High-frequency EEG activity in epileptic encephalopathy with suppression-burst	BRAIN & DEVELOPMENT			English	Article						High-frequency oscillations; Ohtahara syndrome; Early myoclonic encephalopathy; Trace alternant; Time-frequency analysis	OSCILLATIONS; SPASMS; SCALP; ANESTHESIA; CHILDHOOD	Objective: We explored high-frequency activity in the suppression-burst (SB) pattern of interictal electroencephalogram (EEG) in early infantile epileptic encephalopathy including Ohtahara syndrome (OS) and early myoclonic encephalopathy (EME) to investigate the pathophysiological characteristics of SB. Methods: Subjects included six patients with the SB EEG pattern related to OS or EME (Group SB). The results were evaluated in comparison to trace alternant (TA) observed during the neonatal period in nine patients to rule out possible nonspecific relationships between high-frequency activity and periodic EEG patterns (Group TA). EEG was digitally recorded with a sampling rate of 500 Hz and the analysis was performed in each of the particular bipolar channel-pairs. We visually selected 20 typical consecutive burst sections and 160 inter-burst sections for comparison from the sleep record of each patient and performed the time frequency analysis. We investigated the maximum frequencies of power enhancement in each derivation in both groups. Results: In Group SB, a significant increase in power at a frequency of 80-150 Hz was observed in association with the bursts, particularly in the bilateral parieto-occipital. derivations, in all patients. In Group TA, on the contrary, no significant increase in high-frequency power was found. The maximum frequencies of power enhancement were significantly higher in Group SB than in Group TA (p < 0.001 by repeated-measures ANOVA). Conclusion: Interictal high frequencies of up to 150 Hz were detected in the suppression-burst EEG patterns in epileptic encephalopathy in early infancy. Further studies will be necessary to identify the role of the interictal high-frequency activity in the pathophysiology of such early epileptic encephalopathy. (C) 2014 The Japanese Society of Child Neurology. Published by Elsevier B.V. All rights reserved.	[Toda, Yoshihiro; Kobayashi, Katsuhiro; Hayashi, Yumiko; Inoue, Takushi; Oka, Makio; Endo, Fumika; Yoshinaga, Harumi; Ohtsuka, Yoko] Okayama Univ, Grad Sch Med Dent & Pharmaceut Sci, Dept Child Neurol, Okayama 7008558, Japan; [Toda, Yoshihiro; Kobayashi, Katsuhiro; Hayashi, Yumiko; Inoue, Takushi; Oka, Makio; Endo, Fumika; Yoshinaga, Harumi; Ohtsuka, Yoko] Okayama Univ Hosp, Okayama 7008558, Japan; [Toda, Yoshihiro] Univ Tokushima, Sch Med, Dept Pediat, Tokushima 770, Japan; [Ohtsuka, Yoko] Asahigawaso Rehabil & Med Ctr, Okayama, Japan	Kobayashi, K (reprint author), Okayama Univ, Grad Sch Med Dent & Pharmaceut Sci, Dept Child Neurol, Kita Ku, 5-1 Shikatacho 2 Chome, Okayama 7008558, Japan.	k_koba@md.okayama-u.ac.jp			Health and Labour Sciences Research Grant: Research on catastrophic epilepsy in infancy and early childhood epidemiology, diagnosis and treatment guid; Research Grant for Nervous and Mental Disorders from the Ministry of Health, Labour and Welfare [21B-5]	Dr. Kobayashi is a recipient of the Health and Labour Sciences Research Grant: Research on catastrophic epilepsy in infancy and early childhood epidemiology, diagnosis and treatment guide, and is also supported in part by a Research Grant (21B-5) for Nervous and Mental Disorders from the Ministry of Health, Labour and Welfare.	Nariai H, 2011, EPILEPSIA, V52, P63, DOI 10.1111/j.1528-1167.2010.02786.x; Ohtahara S, 2006, EPILEPSY RES, V70, pS58, DOI 10.1016/j.eplepsyres.2005.11.021; Zijlmans M, 2009, NEUROLOGY, V72, P979, DOI 10.1212/01.wnl.0000344402.20334.81; Kroeger D, 2007, J NEUROSCI, V27, P10597, DOI 10.1523/JNEUROSCI.3440-07.2007; Ferron JF, 2009, J NEUROSCI, V29, P9850, DOI 10.1523/JNEUROSCI.5176-08.2009; Kobayashi K, 2009, CLIN NEUROPHYSIOL, V120, P1070, DOI 10.1016/j.clinph.2009.03.020; Iwatani Y, 2012, EPILEPSY RES, V102, P60, DOI 10.1016/j.eplepsyres.2012.04.020; Akiyama T, 2005, CLIN NEUROPHYSIOL, V116, P2819, DOI 10.1016/j.clinph.2005.08.029; Kobayashi K, 2004, EPILEPSIA, V45, P488, DOI 10.1111/j.0013-9580.2004.45703.x; Kobayashi K, 2011, EPILEPSIA, V52, P1812, DOI 10.1111/j.1528-1167.2011.03169.x; Jacobs J, 2010, ANN NEUROL, V67, P209, DOI 10.1002/ana.21847; Amzica F, 2011, EPILEPSIA, V52, P25, DOI 10.1111/j.1528-1167.2011.03229.x; Bragin A, 2000, EPILEPSIA, V41, pS144, DOI 10.1111/j.1528-1157.2000.tb01573.x; Lachaux JP, 2012, PROG NEUROBIOL, V98, P279, DOI 10.1016/j.pneurobio.2012.06.008; Brown EC, 2008, NEUROIMAGE, V41, P1120, DOI 10.1016/j.neuroimage.2008.03.011; Commission on Classification and Terminology of the International League Against Epilepsy, 1989, EPILEPSIA, V30, P389; Inoue T, 2008, BRAIN DEV-JPN, V30, P321, DOI 10.1016/j.braindev.2007.10.003; Jacobs J, 2011, CLIN NEUROPHYSIOL, V122, P32, DOI 10.1016/j.clinph.2010.05.033; Kobayashi K, 2007, NEUROPEDIATRICS, V38, P244, DOI 10.1055/s-2008-1062716; Kobayashi K, 2010, EPILEPSIA, V51, P2190, DOI 10.1111/j.1528-1167.2010.02565.x; Mizrahi EM, 2012, EPILEPTIC SYNDROMES, P89; PFURTSCHELLER G, 1975, ELECTROEN CLIN NEURO, V38, P93, DOI 10.1016/0013-4694(75)90215-1; RamachandranNair R, 2008, EPILEPSY RES, V78, P216, DOI 10.1016/j.eplepsyres.2007.12.007; Toda Y, 2013, BRAIN DEV-JPN, V35, P540, DOI 10.1016/j.braindev.2012.09.002	24	0	0	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	0387-7604	1872-7131		BRAIN DEV-JPN	Brain Dev.	FEB	2015	37	2					230	236		10.1016/j.braindev.2014.04.004		7	Clinical Neurology	Neurosciences & Neurology	CB2AS	WOS:000349429700007		
J	Ito, T; Otsubo, H; Shiraishi, H; Yagyu, K; Takahashi, Y; Ueda, Y; Takeuchi, F; Takahashi, K; Nakane, S; Kohsaka, S; Saitoh, S				Ito, Tomoshiro; Otsubo, Hiroshi; Shiraishi, Hideaki; Yagyu, Kazuyori; Takahashi, Yumi; Ueda, Yuki; Takeuchi, Fumiya; Takahashi, Kayoko; Nakane, Shingo; Kohsaka, Shinobu; Saitoh, Shinji			Advantageous information provided by magnetoencephalography for patients with neocortical epilepsy	BRAIN & DEVELOPMENT			English	Article						Diagnosis and treatment; Equivalent current dipole; Symptomatic localization-related epilepsy; Idiopathic localization-related epilepsy; Tertiary care	BENIGN PARTIAL EPILEPSY; PRESURGICAL EVALUATION; MEG; SURGERY; EEG; ZONE	Purpose: We evaluated whether magnetoencephalography (MEG), in addition to surgery, was valuable for the diagnosis and management of epileptic syndromes in patients with neocortical epilepsy (NE). Methods: We studied MEG in 73 patients (29 females; aged 1-26 years; mean 10.3 years) for the clinical diagnosis of epilepsy and for preoperative evaluation. MEG data were recorded by 204-channel whole head gradiometers with a 600 Hz sampling rate. MEG spike sources were localized on magnetic resonance images (MRI) using a single dipole model to project equivalent current dipoles. Results: MEG localized an epileptic focus with single clustered dipoles in 24 (33%) of 73 NE patients: 16 (25%) of 64 symptomatic localization-related epilepsy (SLRE) patients and eight (89%) of nine idiopathic localization-related epilepsy (ILRE) patients. MEG provided advantageous information in 12 (50%) of 24 patients with clustered dipoles and confirmed the diagnosis in the remaining 12 (50%). Furthermore, the use of MEG resulted in changes to surgical treatments in nine (38%) patients and in medical management in eight (33%). MEG confirmed the diagnosis in eight (16%) of 49 patients with scattered dipoles. MRI identified a single lesion (28 patients, 38%), multiple lesions (5, 7%), and no lesion (40, 55%). MRI provided confirming information in 19 of 28 patients with a single lesion and 18 of them required surgical resections. MRI did not provide any supportive information in 54 (74%) patients with a single (9), multiple (5) and no lesion (40). Conclusion: Our study shows that MEG provides fundamental information to aid the choice of diagnostic and therapeutic procedures including changes in medication in addition to surgical treatments for NE. (C) 2014 The Japanese Society of Child Neurology. Published by Elsevier B.V. All rights reserved.	[Ito, Tomoshiro; Shiraishi, Hideaki; Yagyu, Kazuyori; Takahashi, Yumi; Ueda, Yuki; Kohsaka, Shinobu; Saitoh, Shinji] Hokkaido Univ, Grad Sch Med, Dept Pediat, Sapporo, Hokkaido, Japan; [Otsubo, Hiroshi] Hosp Sick Children, Dept Pediat, Div Neurol, Toronto, ON M5G 1X8, Canada; [Otsubo, Hiroshi] Univ Toronto, Toronto, ON, Canada; [Takeuchi, Fumiya] Hokkaido Univ, Grad Sch Med, Fac Hlth Sci, Sapporo, Hokkaido, Japan; [Takahashi, Kayoko; Nakane, Shingo] Hokkaido Univ Hosp, Div Magnetoencephalog, Sapporo, Hokkaido 060, Japan; [Saitoh, Shinji] Nagoya City Univ, Grad Sch Med Sci, Dept Pediat & Neonatol, Nagoya, Aichi, Japan	Otsubo, H (reprint author), 555 Univ Ave, Toronto, ON M5G 1X8, Canada.	hiroshi.otsubo@sickkids.ca					Oguni H, 2011, BRAIN DEV-JPN, V33, P207, DOI 10.1016/j.braindev.2010.10.024; AICARDI J, 1982, DEV MED CHILD NEUROL, V24, P281; Kim YH, 2011, EPILEPSIA, V52, P722, DOI 10.1111/j.1528-1167.2010.02950.x; Barkley GL, 2003, J CLIN NEUROPHYSIOL, V20, P163, DOI 10.1097/00004691-200305000-00002; Knake S, 2006, EPILEPSY RES, V69, P80, DOI 10.1016/j.eplepsyres.2006.01.001; Carney Patrick, 2005, Aust Fam Physician, V34, P1009; Commission on Classification Terminology of the International League Against Epilepsy, 1989, EPILEPSIA, V30, P389; Engel J, 1993, SURG TREATMENT EPILE, P609; Fujii A, 2010, PEDIATR NEUROL, V43, P411, DOI 10.1016/j.pediatrneurol.2010.06.018; Kakisaka Y, 2009, EPILEPSY RES, V84, P153, DOI 10.1016/j.eplepsyres.2009.01.012; Kubota M, 2005, SEIZURE-EUR J EPILEP, V14, P28, DOI 10.1016/j.seizure.2004.02.007; Moore KR, 2002, RADIOLOGY, V225, P880, DOI 10.1148/radiol.2253011597; NAKASATO N, 1994, ELECTROEN CLIN NEURO, V91, P171, DOI 10.1016/0013-4694(94)90067-1; Oishi M, 2006, EPILEPSIA, V47, P355, DOI 10.1111/j.1528-1167.2006.00428.x; Otsubo H, 2001, EPILEPSIA, V42, P1523, DOI 10.1046/j.1528-1157.2001.16701.x; RamachandranNair R, 2007, EPILEPSIA, V48, P149, DOI 10.1111/j.1528-1167.2006.00901.x; Shibasaki H, 2007, CLIN NEUROPHYSIOL, V118, P1438, DOI 10.1016/j.clinph.2007.03.002; Shiraishi H, 2014, BRAIN DEV-JPN, V36, P21, DOI 10.1016/j.braindev.2012.12.011; Shiraishi H, 2011, BRAIN DEV-JPN, V33, P276, DOI 10.1016/j.braindev.2010.10.019; Shiraishi H, 2007, INT C SERIES, V1300, P689, DOI 10.1016/j.ics.2007.03.012; Zang W, 2003, NEUROL RES, V25, P53	21	0	0	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	0387-7604	1872-7131		BRAIN DEV-JPN	Brain Dev.	FEB	2015	37	2					237	242		10.1016/j.braindev.2014.04.006		6	Clinical Neurology	Neurosciences & Neurology	CB2AS	WOS:000349429700008		
J	Kouga, T; Shimbo, H; Iai, M; Yamashita, S; Ishii, A; Ihara, Y; Hirose, S; Yamakawa, K; Osaka, H				Kouga, Takeshi; Shimbo, Hiroko; Iai, Mizue; Yamashita, Sumimasa; Ishii, Atsushi; Ihara, Yukiko; Hirose, Shinichi; Yamakawa, Kazuhiro; Osaka, Hitoshi			Effect of CYP2C19 polymorphisnis on stiripentol administration in Japanese cases of Dravet syndrome	BRAIN & DEVELOPMENT			English	Article						Dravet syndrome; CYP2C19 polyrnorphisms; Stiripentol; Clobazarn; Norclobazam	SEVERE MYOCLONIC EPILEPSY; CLOBAZAM METABOLISM; IN-VITRO; MUTATIONS; EFFICACY; INFANCY; CODON; SCN1A	Objective: The objective of this study was to investigate stiripentol (STP) administration in cases of Dravet syndrome (DS) by comparing CYP2C19 allelic polymorphisms with the clinical effects of STP, including plasma concentrations of concomitant drugs and adverse effects of STP. Materials and methods: Eleven cases of DS cases were included. Demographic and clinical characteristics of the cases (age at the study period, body weight, mean dose and plasma concentration of valproate acid (VPA)/clobazam (CLB) off and on STP, mean plasma concentration of norclobazam (N-CLB) off and on STP, degree of seizure reduction, and adverse effects of STP) were examined with each CYP2C19 polymorphism. Results: There were 3 cases of DS with wild type, 6 with intermediate type, and 2 with poor type of CYP2C19 polymorphisms. The N-CLB coneentration/CLB dose ratio and N-CLB/CLB concentration ratio off STP were significantly higher in poor metabolizers. Three (37%) of 8 cases showed no effectiveness of STP regardless of the N-CLB concentration increase, and 1 (33%) of 3 cases showed effectiveness of STP regardless of N-CLB concentration decrease. In total, 6 (54%) of 11 cases with DS had >50% reduction in seizure frequency without significant differences in CYP2C19 polymorphisms. Conclusion: This study demonstrated an effect of CYP2C19 polymorphisms on STP administration in Japanese cases of DS. There were cases of seizure reduction regardless of N-CLB concentration decrease on STP, which suggests a significant anti-convulsant action of STP. N-CLB concentration decrease on STP was observed in 1 case with ketogenic diet and 2 cases with *3 allelic polymorphisms of CYP2C19. (C) 2014 The Japanese Society of Child Neurology. Published by Elsevier B.V. All rights reserved.	[Kouga, Takeshi; Shimbo, Hiroko; Iai, Mizue; Yamashita, Sumimasa; Osaka, Hitoshi] Kanagawa Childrens Med Ctr, Div Neurol, Yokohama, Kanagawa 2328555, Japan; [Ishii, Atsushi; Ihara, Yukiko; Hirose, Shinichi] Fukuoka Univ, Sch Med, Dept Pediat, Fukuoka 81401, Japan; [Ishii, Atsushi; Hirose, Shinichi] Fukuoka Univ, Cent Res Inst Pathomech Epilepsy, Fukuoka 81401, Japan; [Yamakawa, Kazuhiro] RIKEN, Brain Sci Inst, Neurogenet Lab, Saitama, Japan; [Osaka, Hitoshi] Jichi Med Univ, Dept Pediat, Shimotsuke, Japan	Osaka, H (reprint author), Kanagawa Childrens Med Ctr, Div Neurol, Minami Ku, 2-138-4 Mutsukawa, Yokohama, Kanagawa 2328555, Japan.	hosaka@jichi.ac.jp	Yamakawa, Kazuhiro/N-5050-2015		Bilateral Joint Research Projects from Japan Society for the Promotion of Science (JSPS) [23791201, 24249060, 25670481]; Ministry of Education, Culture, Sports, Science, and Technology (MEXT) [221S0002, 25129708]; MEXT; Ministry of Health, Labor and Welfare [H23-Nanji-Ippan-78]; Intramural Research Grant for Neurological and Psychiatric Disorders of NCNP [24-7]; Joint Usage/Research Program of Medical Research Institute, Tokyo Medical and Dental University; Mitsubishi Foundation; Takeda Scientific Foundation; Research grants for Central Research Institute for the Molecular Pathomechanisms of Epilepsy of Fukuoka University; Recommended Projects of Fukuoka University [117016]	This work was supported by a Grant-in-Aid for Young Scientists (B) (23791201 to A.I.), Grant-in-Aid for Scientific Research (A) (24249060 to S.H.), Grant-in-Aid for Challenging Exploratory Research (25670481 to S.H.), Bilateral Joint Research Projects (S.H.) from Japan Society for the Promotion of Science (JSPS), Grants for Scientific Research on Innovative Areas (221S0002 and 25129708 to A.I. and S.H.) from the Ministry of Education, Culture, Sports, Science, and Technology (MEXT), MEXT-supported Program for the Strategic Research Foundation at Private Universities 2013-2017 (S.H.), a Grant-in-aid for the Research on Measures for Intractable Diseases (No. H23-Nanji-Ippan-78 to S.H.) from the Ministry of Health, Labor and Welfare, Intramural Research Grant (24-7) for Neurological and Psychiatric Disorders of NCNP (S.H.), the Joint Usage/Research Program of Medical Research Institute, Tokyo Medical and Dental University (S.H.), Grants from The Mitsubishi Foundation (S.H.) and Takeda Scientific Foundation (S.H.), 2013-2017 "Research grants for Central Research Institute for the Molecular Pathomechanisms of Epilepsy of Fukuoka University" (S.H.), Recommended Projects of Fukuoka University (117016 to S.H.).	Giraud C, 2006, DRUG METAB DISPOS, V34, P608, DOI 10.1124/dmd.105.007237; Hattori J, 2008, EPILEPSIA, V49, P626, DOI 10.1111/j.1528-1167.2007.01475.x; Fisher JL, 2011, EPILEPSIA, V52, P76, DOI 10.1111/j.1528-1167.2011.03008.x; Perez J, 1999, EPILEPSIA, V40, P1618, DOI 10.1111/j.1528-1157.1999.tb02048.x; Fukuma G, 2004, EPILEPSIA, V45, P140, DOI 10.1111/j.0013-9580.2004.15103.x; Chiron C, 2000, LANCET, V356, P1638, DOI 10.1016/S0140-6736(00)03157-3; Nabbout R, 2011, EPILEPSIA, V52, pE54, DOI 10.1111/j.1528-1167.2011.03107.x; Fisher JL, 2009, NEUROPHARMACOLOGY, V56, P190, DOI 10.1016/j.neuropharm.2008.06.004; Fujiwara T, 2003, BRAIN, V126, P531, DOI 10.1093/brain/awg053; Quilichini PP, 2006, EPILEPSIA, V47, P704, DOI 10.1111/j.1528-1167.2006.00497.x; Chiron C, 2011, DEV MED CHILD NEUROL, V53, P16, DOI 10.1111/j.1469-8749.2011.03967.x; Ferguson RJ, 1998, J PHARMACOL EXP THER, V284, P356; Fuchshuber-Moraes M, 2011, PHARMACOGENET GENOM, V21, P694, DOI 10.1097/FPC.0b013e328349daba; Giraud C, 2004, DRUG METAB DISPOS, V32, P1279; Inoue Y, 2009, EPILEPSIA, V50, P2362, DOI 10.1111/j.1528-1167.2009.02179.x; Kinoshita M, 2007, J NEUROL SCI, V263, P44, DOI 10.1016/j.jns.2007.05.025; Kosaki K, 2004, BRAIN DEV-JPN, V26, P530, DOI 10.1016/j.braindev.2004.02.010; Nabbout Rima, 2012, Eur J Paediatr Neurol, V16 Suppl 1, pS13, DOI 10.1016/j.ejpn.2012.04.009	18	0	0	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	0387-7604	1872-7131		BRAIN DEV-JPN	Brain Dev.	FEB	2015	37	2					243	249		10.1016/j.braindev.2014.04.003		7	Clinical Neurology	Neurosciences & Neurology	CB2AS	WOS:000349429700009		
J	Kawase, K; Nishino, I; Sugimoto, M; Kouwaki, M; Koyama, N; Yokochi, K				Kawase, Koya; Nishino, Ichizo; Sugimoto, Mari; Kouwaki, Masanori; Koyama, Norihisa; Yokochi, Kenji			Hypoxic ischemic encephalopathy in a case of intranuclear rod myopathy without any prenatal sentinel event	BRAIN & DEVELOPMENT			English	Article						Nemaline myopathy; Intranuclear rod myopathy; Hypoxic ischemic encephalopathy; Congenital myopathy; Magnetic resonance imaging	CONGENITAL MYOTONIC-DYSTROPHY; NEMALINE MYOPATHY; MUTATIONS; COUNT; ACTA1; GENE	Intranuclear rod myopathy (IRM), a variant of nemaline myopathy, is characterized by the presence of nemaline bodies in myonuclei. We report a case of IRM presenting with hypoxic ischemic encephalopathy (HIE). There were no prenatal complications caused by fetal brain injury. Although no nemaline bodies were observed in the cytoplasm, intranuclear rods were observed in some fibers under light and electron microscopy. Molecular analysis identified a heterozygous variant, c.449C>T (p.Thr150I1e), in ACTA1. On magnetic resonance imaging at 9 days of age, injuries to the basal ganglia, thalamus, and brainstem consistent with perinatal HIE were seen. Respiratory insufficiency at birth was strongly suspected to be the cause of HIE. Our case highlights that a patient with a congenital neuromuscular disorder who presents with severe respiratory dysfunction requiring substantial resuscitative efforts at birth can be complicated by HIE without any prenatal sentinel event. Prenatal detection of neuromuscular disorders, careful management of delivery, and neonatal resuscitation and adequate respiratory management are important in preventing irreversible brain injury in these patients. (C) 2014 The Japanese Society of Child Neurology. Published by Elsevier B.V. All rights reserved..	[Kawase, Koya; Sugimoto, Mari; Kouwaki, Masanori; Koyama, Norihisa; Yokochi, Kenji] Toyohashi Municipal Hosp, Dept Pediat, Toyohashi, Aichi 4418570, Japan; [Nishino, Ichizo] Natl Ctr Neurol & Psychiat, Dept Neuromuscular Res, Natl Inst Neurosci, Tokyo, Japan; [Yokochi, Kenji] Seirei Mikatahara Gen Hosp, Dept Pediat Neurol, Hamamatsu, Shizuoka, Japan	Kawase, K (reprint author), Toyohashi Municipal Hosp, Dept Pediat, 50 Aza Hachiken Nishi,Aotake Cho, Toyohashi, Aichi 4418570, Japan.	pisces-koya@yacht.ocn.ne.jp					Laing NG, 2009, HUM MUTAT, V30, P1267, DOI 10.1002/humu.21059; Hoff JM, 2011, EUR J OBSTET GYN R B, V159, P347, DOI 10.1016/j.ejogrb.2011.09.027; Bharucha-Goebel DX, 2013, NEUROLOGY, V80, P1584, DOI 10.1212/WNL.0b013e3182900380; Ravenscroft G, 2013, AM J HUM GENET, V93, P6, DOI 10.1016/j.ajhg.2013.05.004; Hutchinson DO, 2006, NEUROMUSCULAR DISORD, V16, P113, DOI 10.1016/j.nmd.2005.11.004; BARKOVICH AJ, 1992, AM J NEURORADIOL, V13, P959; HAGEMAN ATM, 1993, J NEUROL SCI, V115, P95, DOI 10.1016/0022-510X(93)90072-7; Kaimaktchiev V, 2006, MUSCLE NERVE, V34, P369, DOI 10.1002/mus.20521; Kuwata T, 2008, J OBSTET GYNAECOL RE, V34, P318, DOI 10.1111/j.1447-0756.2008.00791.x; Kuwata T, 2011, J OBSTET GYNAECOL RE, V37, P921, DOI 10.1111/j.1447-0756.2010.01438.x; Myers R E, 1975, Adv Neurol, V10, P223; Rudnik-Schoneborn S, 2009, CLIN GENET, V76, P168, DOI 10.1111/j.1399-0004.2009.01200.x; TANABE Y, 1992, ACTA PAEDIATR, V81, P613, DOI 10.1111/j.1651-2227.1992.tb12312.x	13	0	0	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	0387-7604	1872-7131		BRAIN DEV-JPN	Brain Dev.	FEB	2015	37	2					265	269		10.1016/j.braindev.2014.04.002		5	Clinical Neurology	Neurosciences & Neurology	CB2AS	WOS:000349429700011		
J	Kawashima, M; Hashimoto, H; Saenz, ABA; Ono, M; Yamada, M				Kawashima, M.; Hashimoto, H.; Saenz, A. B. Alio; Ono, M.; Yamada, M.			Clindamycin phosphate 1.2%-benzoyl peroxide 3.0% fixed-dose combination gel has an effective and acceptable safety and tolerability profile for the treatment of acne vulgaris in Japanese patients: a phase III, multicentre, randomised, single-blinded, active-controlled, parallel-group study	BRITISH JOURNAL OF DERMATOLOGY			English	Article							BENZOYL PEROXIDE; IMPROVE OUTCOMES; GLOBAL ALLIANCE; ADAPALENE; EFFICACY; 2.5-PERCENT; 0.1-PERCENT; FORMULATION; MANAGEMENT; 5-PERCENT	Background A topical fixed-dose clindamycin phosphate 1.2% and benzoyl peroxide 3.0% combination gel (CLNP/BPO 3%) is known to be effective and safe in white people with acne. Objectives To evaluate the efficacy and safety of CLNP/BPO 3.0% topically applied once or twice daily vs. CLNP twice daily in Japanese patients with acne. Methods Eight hundred patients were randomized to receive CLNP/BPO 3.0% once daily, CLNP/BPO 3.0% twice daily or CLNP twice daily for 12 weeks. Primary end-points were absolute change in number of total lesions (TLs) from baseline to week 12 to demonstrate the superiority of CLNP/BPO 3.0% twice daily and noninferiority of CLNP/BPO 3.0% once daily vs. CLNP twice daily. Secondary end-points were absolute and percentage changes in TLs, inflammatory lesions (ILs), noninflammatory lesions (non-ILs) and Investigator's Static Global Assessment (ISGA) score. Safety assessments included adverse events (AEs), laboratory tests, vital signs and local skin tolerability. Results Change in TL counts from baseline to week 12 for CLNP/BPO 3.0% twice daily was superior to CLNP twice daily (difference -11.0; P < 0.01); CLNP/BPO 3.0% once daily was not inferior to CLNP twice daily (difference -10.3; P < 0.01). Absolute and percentage reductions in TL, IL and non-IL counts and ISGA score were greater for CLNP/BPO 3.0% once or twice daily than for CLNP twice daily with significant differences seen from early on. Most AEs were mild or moderate. The incidence of adverse drug reactions was higher for CLNP/BPO 3.0% once (24.0%) or twice (35.1%) daily than for CLNP twice daily (9.0%). Conclusions Compared with CLNP twice daily, CLNP/BPO 3.0% once daily was more effective and CLNP/BPO 3.0% twice daily at least as effective, with an early onset of action and an acceptable safety and tolerability profile in Japanese patients.	[Kawashima, M.] Tokyo Womens Med Univ, Dept Dermatol, Tokyo, Japan; [Hashimoto, H.] GlaxoSmithKline KK, Japan Dev & Med Affairs, Biomed Data Sci, Tokyo, Japan; [Yamada, M.] GlaxoSmithKline KK, Japan Dev & Med Affairs, Med Dev, Tokyo, Japan; [Saenz, A. B. Alio] Stiefel, Med Dev R&D, Res Triangle Pk, NC USA; [Ono, M.] GlaxoSmithKline KK, Business Innovat, Tokyo, Japan	Yamada, M (reprint author), GlaxoSmithKline KK, Japan Dev & Med Affairs, Med Dev, Tokyo, Japan.	masahiro.5.yamada@gsk.com			GlaxoSmithKline K.K. (GSK Japan); Stiefel, a GSK company	This study was sponsored by GlaxoSmithKline K.K. (GSK Japan). Editorial support was provided by apothecom scopemedical, funded with support from Stiefel, a GSK company.	Harper JC, 2010, J DRUGS DERMATOL, V9, P482; MILLS OH, 1986, INT J DERMATOL, V25, P664, DOI 10.1111/j.1365-4362.1986.tb04534.x; Gollnick H, 2003, J AM ACAD DERMATOL, V49, pS1, DOI 10.1067/mjd.2003.618; Nakase K, 2012, J DERMATOL, V39, P794, DOI 10.1111/j.1346-8138.2011.01423.x; Draelos ZD, 2008, CUTIS, V82, P281; Eichenfield LF, 2011, J DRUGS DERMATOL, V10, P1382; Sagransky M, 2009, EXPERT OPIN PHARMACO, V10, P2555, DOI 10.1517/14656560903277228; Kawashima M, 2008, J DERMATOL SCI, V49, P241, DOI 10.1016/j.jdermsci.2007.09.012; PACE WE, 1965, CAN MED ASSOC J, V93, P252; Ko HC, 2009, J EUR ACAD DERMATOL, V23, P245, DOI 10.1111/j.1468-3083.2008.02920.x; LONG CC, 1991, CLIN EXP DERMATOL, V16, P444, DOI 10.1111/j.1365-2230.1991.tb01232.x; Webster G, 2009, J DRUGS DERMATOL, V8, P736; Dutil Maha, 2010, Skin Therapy Lett, V15, P5; Eady AE, 2003, AM J CLIN DERMATOL, V4, P813, DOI 10.2165/00128071-200304120-00002; Gold Michael H, 2009, J Clin Aesthet Dermatol, V2, P44; Hayashi N., 2008, JPN J DERMATOL, V118, P1893; Iinuma Katsuhiro, 2011, Clin Cosmet Investig Dermatol, V4, P161, DOI 10.2147/CCID.S23840; International Conference on Harmonisation, GUID E9 STAT PRINC C; Ishida N, 2008, MICROBIOL IMMUNOL, V52, P621, DOI 10.1111/j.1348-0421.2008.00081.x; Jones TM, 2013, CLIN PHARM DRUG DEV, V2, P33, DOI 10.1002/cpdd.7; Kawashima M, 2008, CLIN DERMATOL, V62, P673; Langner A, 2008, BRIT J DERMATOL, V158, P122, DOI 10.1111/j.1365-2133.2007.08308.x; Muizzuddin N, 2010, J DERMATOL SCI, V59, P123, DOI 10.1016/j.jdermsci.2010.06.003; Nast A, 2012, J EUR ACAD DERMAT S1, V26, pS1; Purdy S, 2008, CLIN EVID, V2008; Stiefel: a GSK company, SUMM PROD CHAR DUAC; Thiboutot D, 2009, J AM ACAD DERMATOL, V60, pS1, DOI 10.1016/j.jaad.2009.01.019; Waller JM, 2006, SKIN PHARMACOL PHYS, V19, P283, DOI 10.1159/000093984	28	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0007-0963	1365-2133		BRIT J DERMATOL	Br. J. Dermatol.	FEB	2015	172	2					494	503		10.1111/bjd.13265		10	Dermatology	Dermatology	CB4RS	WOS:000349616200035		
J	Takeichi, T; Nanda, A; Liu, L; Aristodemou, S; McMillan, JR; Sugiura, K; Akiyama, M; Al-Ajmi, H; Simpson, MA; McGrath, JA				Takeichi, T.; Nanda, A.; Liu, L.; Aristodemou, S.; McMillan, J. R.; Sugiura, K.; Akiyama, M.; Al-Ajmi, H.; Simpson, M. A.; McGrath, J. A.			Founder mutation in dystonin-e underlying autosomal recessive epidermolysis bullosa simplex in Kuwait	BRITISH JOURNAL OF DERMATOLOGY			English	Article							MIGRATION; BPAG1	Only two homozygous nonsense mutations in the epidermal isoform of the dystonin gene, DST-e, have been reported previously in autosomal recessive epidermolysis bullosa simplex (EBS); the affected pedigrees were Kuwaiti and Iranian. This subtype of EBS is therefore considered to be a rare clinicopathological entity. In this study, we identified four seemingly unrelated Kuwaiti families in which a total of seven individuals had predominantly acral trauma-induced blistering since infancy. All affected individuals were homozygous for the mutation p.Gln1124* in DST-e, the same mutation that was identified in the originally reported family from Kuwait. Haplotype analysis in the five pedigrees (including the previous case) revealed a shared block of similar to 60 kb of genomic DNA across the site of the mutation, consistent with a founder effect. Most heterozygotes had no clinical abnormalities although one subject had mild transient skin fragility during childhood, an observation noted in the previously reported Iranian pedigree, suggesting that the condition may also be semidominant in some pedigrees rather than purely autosomal recessive. Our study reveals propagation of a mutant ancestral allele in DST-e throughout Kuwait, indicating that this subtype of EBS may be more common in Kuwait, and perhaps other Middle Eastern countries, than is currently appreciated.	[Takeichi, T.; McGrath, J. A.] Guys Hosp, Kings Coll London, St Johns Inst Dermatol, London SE1 9RT, England; [Simpson, M. A.] Guys Hosp, Kings Coll London, Dept Genet & Mol Med, London SE1 9RT, England; [Takeichi, T.; Sugiura, K.; Akiyama, M.] Nagoya Univ, Grad Sch Med, Dept Dermatol, Nagoya, Aichi 4648601, Japan; [Nanda, A.; Al-Ajmi, H.] Al Sabah Hosp, Asad Al Hamad Dermatol Ctr, Kuwait, Kuwait; [Liu, L.; Aristodemou, S.; McMillan, J. R.] St Thomas Hosp, Natl Diagnost EB Lab, London, England	McGrath, JA (reprint author), Guys Hosp, Kings Coll London, St Johns Inst Dermatol, London SE1 9RT, England.	john.mcgrath@kcl.ac.uk	Sugiura, Kazumitsu /M-8913-2014; McGrath, John/D-6824-2012	Sugiura, Kazumitsu /0000-0002-5207-4592; McGrath, John/0000-0002-3708-9964	DebRA U.K.; Department of Health via the U.K. National Institute for Health Research Comprehensive Biomedical Research Centre; King's College London; King's College Hospital NHS Foundation Trust; Great Britain Sasakawa Foundation [4314]; Japan Society for the Promotion of Science [S2404]	The authors acknowledge financial support from DebRA U.K. and the Department of Health via the U.K. National Institute for Health Research Comprehensive Biomedical Research Centre award to Guy's & St Thomas' NHS Foundation Trust in partnership with King's College London and King's College Hospital NHS Foundation Trust. This study was also supported in part by the Great Britain Sasakawa Foundation (no. 4314) and Strategic Young Researcher Overseas Visits Program for Accelerating Brain Circulation (S2404) from the Japan Society for the Promotion of Science.	AlFadhli S, 2012, MOL VIS, V18, P2931; Barrett JC, 2005, BIOINFORMATICS, V21, P263, DOI 10.1093/bioinformatics/bth457; Takeichi T, 2013, EXP DERMATOL, V22, P825, DOI 10.1111/exd.12276; Fine JD, 2014, J AM ACAD DERMATOL, V70, P1103, DOI 10.1016/j.jaad.2014.01.903; Groves RW, 2010, J INVEST DERMATOL, V130, P1551, DOI 10.1038/jid.2010.19; GUO LF, 1995, CELL, V81, P233, DOI 10.1016/0092-8674(95)90333-X; Liu L, 2012, J INVEST DERMATOL, V132, P742, DOI 10.1038/jid.2011.379; Michael M, 2014, J INVEST DERMATOL, V134, P773, DOI 10.1038/jid.2013.382; Gibbs RA, 2003, NATURE, V426, P789, DOI 10.1038/nature02168; Xing JC, 2008, GENOMICS, V92, P41, DOI 10.1016/j.ygeno.2008.03.011	10	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0007-0963	1365-2133		BRIT J DERMATOL	Br. J. Dermatol.	FEB	2015	172	2					527	531		10.1111/bjd.13294		5	Dermatology	Dermatology	CB4RS	WOS:000349616200039		
J	Fukunaga, A; Hatakeyama, M; Tsujimoto, M; Oda, Y; Washio, K; Nishigori, C				Fukunaga, A.; Hatakeyama, M.; Tsujimoto, M.; Oda, Y.; Washio, K.; Nishigori, C.			Steroid treatment can improve the impaired quality of life of patients with acquired idiopathic generalized anhidrosis	BRITISH JOURNAL OF DERMATOLOGY			English	Letter							CHOLINERGIC URTICARIA; AUTOLOGOUS SWEAT; SKINDEX-16		[Fukunaga, A.; Hatakeyama, M.; Tsujimoto, M.; Oda, Y.; Washio, K.; Nishigori, C.] Kobe Univ, Grad Sch Med, Dept Internal Related, Div Dermatol,Chuo Ku, Kobe, Hyogo 6500017, Japan	Fukunaga, A (reprint author), Kobe Univ, Grad Sch Med, Dept Internal Related, Div Dermatol,Chuo Ku, 7-5-1 Kusunoki Cho, Kobe, Hyogo 6500017, Japan.	atsushi@med.kobe-u.ac.jp					Chren MM, 2007, J INVEST DERMATOL, V127, P1351, DOI 10.1038/sj.jid.5700740; Fukunaga A, 2005, J ALLERGY CLIN IMMUN, V116, P397, DOI 10.1016/j.jaci.2005.05.024; Fukunaga A, 2009, BRIT J DERMATOL, V160, P1337, DOI 10.1111/j.1365-2133.2009.09113.x; Higaki Y, 2002, J DERMATOL, V29, P693; Kawashima M, 2007, J DERMATOL, V34, P9, DOI 10.1111/j.1346-8138.2007.00209.x; Kozaru Takeshi, 2011, Allergology International, V60, P277, DOI 10.2332/allergolint.10-OA-0269; Nakamizo S, 2012, J EUR ACAD DERMATOL, V26, P114, DOI 10.1111/j.1468-3083.2011.04017.x; Ohshima Y, 2013, BRIT J DERMATOL, V168, P430, DOI 10.1111/j.1365-2133.2012.11112.x; Okubo Y, 2011, J DERMATOL, V38, P465, DOI 10.1111/j.1346-8138.2010.01041.x; Sawada Y, 2014, J INVEST DERMATOL, V134, P276, DOI 10.1038/jid.2013.244	10	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0007-0963	1365-2133		BRIT J DERMATOL	Br. J. Dermatol.	FEB	2015	172	2					537	538		10.1111/bjd.13285		2	Dermatology	Dermatology	CB4RS	WOS:000349616200042		
J	Solano-Lopez, G; Concha-Garzon, MJ; Sanchez-Perez, J; Hirako, Y; Li, X; Ishii, N; Hashimoto, T; Dauden, E				Solano-Lopez, G.; Concha-Garzon, M. J.; Sanchez-Perez, J.; Hirako, Y.; Li, X.; Ishii, N.; Hashimoto, T.; Dauden, E.			Pure ocular mucous membrane pemphigoid reactive with both beta 4 integrin and the BP180 C-terminal domain	BRITISH JOURNAL OF DERMATOLOGY			English	Letter									[Solano-Lopez, G.; Concha-Garzon, M. J.; Sanchez-Perez, J.; Dauden, E.] Hosp Univ Princesa, Dept Dermatol, Madrid 28006, Spain; [Hirako, Y.] Nagoya Univ, Sch Informat & Sci, Dept Nat Sci Informat, Nagoya, Aichi 4648601, Japan; [Li, X.; Ishii, N.; Hashimoto, T.] Kurume Univ, Sch Med, Dept Dermatol, Kurume, Fukuoka 830, Japan; [Li, X.; Ishii, N.; Hashimoto, T.] Kurume Univ, Inst Cutaneous Cell Biol, Kurume, Fukuoka 830, Japan	Solano-Lopez, G (reprint author), Hosp Univ Princesa, Dept Dermatol, Madrid 28006, Spain.	guitje1@hotmail.com					Foster CS, 2010, OPHTHALMOLOGY, V117, P861, DOI 10.1016/j.ophtha.2009.09.049; Chan LS, 2002, ARCH DERMATOL, V138, P370, DOI 10.1001/archderm.138.3.370; Bhol KC, 2000, J IMMUNOL, V165, P2824; Foster C S, 1986, Trans Am Ophthalmol Soc, V84, P527; Hirako Y, 2014, EXP CELL RES, V324, P172, DOI 10.1016/j.yexcr.2014.04.002; Hisamatsu Y, 2003, J DERMATOL SCI, V33, P113, DOI 10.1016/S0923-1811(03)00158-0; Nie ZX, 1999, J INVEST DERMATOL, V112, P254; Tyagi S, 1996, P NATL ACAD SCI USA, V93, P14714, DOI 10.1073/pnas.93.25.14714	8	1	1	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0007-0963	1365-2133		BRIT J DERMATOL	Br. J. Dermatol.	FEB	2015	172	2					542	544		10.1111/bjd.13290		3	Dermatology	Dermatology	CB4RS	WOS:000349616200045		
J	Harada-Shirado, K; Ikeda, K; Ogawa, K; Ohkawara, H; Kimura, H; Kai, T; Noji, H; Morishita, S; Komatsu, N; Takeishi, Y				Harada-Shirado, Kayo; Ikeda, Kazuhiko; Ogawa, Kazuei; Ohkawara, Hiroshi; Kimura, Hideo; Kai, Tatsuyuki; Noji, Hideyoshi; Morishita, Soji; Komatsu, Norio; Takeishi, Yasuchika			Dysregulation of the MIRLET7/HMGA2 axis with methylation of the CDKN2A promoter in myeloproliferative neoplasms	BRITISH JOURNAL OF HAEMATOLOGY			English	Article						primary myelofibrosis; polycythaemia vera; essential thrombocythaemia; HMGA2; micro RNA	PAROXYSMAL-NOCTURNAL HEMOGLOBINURIA; TYROSINE KINASE JAK2; ACUTE-LEUKEMIA CELLS; POLYCYTHEMIA-VERA; ESSENTIAL THROMBOCYTHEMIA; HEMATOPOIETIC STEM; DEACETYLASE INHIBITOR; PRIMARY MYELOFIBROSIS; MYELOID MALIGNANCIES; ABERRANT EXPRESSION	Overexpression of high mobility group AT-hook 2 (Hmga2), which is negatively regulated by MIRLET7 micro RNAs through 3-untranslated region (3UTR), causes proliferative haematopoiesis mimicking myeloproliferative neoplasms (MPNs) and contributes to progression of myelofibrosis in mice. Thus, we investigated HMGA2 mRNA expression in 66 patients with MPNs including 23 polycythaemia vera (PV), 33 essential thrombocythaemia (ET) and 10 primary myelofibrosis (PMF). HMGA2 mRNA expression, especially variant 1 with 3UTR that contains MIRLET7-specific sites, rather than variant 2 lacking 3UTR, is frequently deregulated due to decreased MIRLET7 expression in granulocytes from over 20% of PV and ET, and in either granulocytes or CD34(+) cells from 100% of PMF. Patients with deregulated HMGA2 mRNA expression were significantly more likely to show splenomegaly, high serum lactate dehydrogenase values, and methylation of the CDKN2A promoter compared with other patients without deregulation of HMGA2. A histone deacetylase inhibitor, panobinostat, significantly increased MIRLET7 expression and reduced variant 1 of HMGA2 mRNA expression, but not variant 2, in both U937 cells and PMF-derived CD34(+) cells. Moreover, both panobinostat and small interfering RNA of HMGA2 demethylated the CDKN2A promoter in U937 cells. In conclusion, the frequently dysregulated MIRLET7/HMGA2 axis could be a therapeutic target in MPNs.	[Harada-Shirado, Kayo; Ikeda, Kazuhiko; Ogawa, Kazuei; Ohkawara, Hiroshi; Noji, Hideyoshi; Takeishi, Yasuchika] Fukushima Med Univ, Dept Cardiol & Haematol, Fukushima 9601295, Japan; [Kimura, Hideo; Kai, Tatsuyuki] Kita Fukushima Med Ctr, Dept Hematol, Date, Date, Japan; [Morishita, Soji] Juntendo Univ, Dept Transfus Med & Stem Cell Regulat, Tokyo, Japan; [Komatsu, Norio] Juntendo Univ, Dept Hematol, Tokyo, Japan	Ikeda, K (reprint author), Fukushima Med Univ, Dept Cardiol & Haematol, 1 Hikariga Oka, Fukushima 9601295, Japan.	kazu-ike@fmu.ac.jp			Ministry of Education, Science, Technology, Sports and Culture of Japan [24591405]; Japan Leukaemia Research Fund; SENSHIN Medical Research Foundation; NOVARATIS Foundation (Japan) for the Promotion of Science [11-120]; Fukushima Medical University Research Project [KKI23034]	We thank A. Nakamura-Shichishima (Fukushima Medical University), R. Abe (Saiseikai Fukushima Hospital), Y. Shiga (Kita-Fukushima Medical Centre), M. Mita (Shirakawa-kosei Hospital), K. Nakamura (Shirakawa-kosei Hospital) for providing the samples from patients with MPNs. We are grateful to E. Kaneda and A. Haneda for their skillful assays. This work was in part supported by the Grant-in-Aid for Scientific Research from the Ministry of Education, Science, Technology, Sports and Culture of Japan (No. 24591405); Japan Leukaemia Research Fund; SENSHIN Medical Research Foundation; the NOVARATIS Foundation (Japan) for the Promotion of Science (No. 11-120); and Fukushima Medical University Research Project (No. KKI23034) to K.I.	Andrieux J, 2004, GENE CHROMOSOME CANC, V39, P82, DOI 10.1002/gcc.10297; Akada H, 2012, BLOOD, V119, P3779, DOI 10.1182/blood-2011-02-336743; Chen ZX, 2011, J BIOL CHEM, V286, P18347, DOI 10.1074/jbc.R110.205286; Beer PA, 2008, BLOOD, V112, P141, DOI 10.1182/blood-2008-01-131664; Nangalia J, 2013, NEW ENGL J MED, V369, P2391, DOI 10.1056/NEJMoa1312542; Fiskus W, 2009, CANCER BIOL THER, V8, P939, DOI 10.4161/cbt.8.10.8213; Vardiman JW, 2009, BLOOD, V114, P937, DOI 10.1182/blood-2009-03-209262; Ferguson M, 2003, NUCLEIC ACIDS RES, V31, P3123, DOI 10.1093/nar/gkg403; James C, 2005, NATURE, V434, P1144, DOI 10.1038/nature03546; Harrison C, 2012, NEW ENGL J MED, V366, P787, DOI 10.1056/NEJMoa1110556; Bruchova H, 2008, HAEMATOL-HEMATOL J, V93, P1009, DOI 10.3324/haematol.12706; Lee S, 2011, CELL MOL LIFE SCI, V68, P325, DOI 10.1007/s00018-010-0457-9; Young ARJ, 2007, GENE DEV, V21, P1005, DOI 10.1101/gad.1554707; Baxter EJ, 2005, LANCET, V365, P1054, DOI 10.1016/S0140-6736(05)71142-9; Kralovics R, 2005, NEW ENGL J MED, V352, P1779, DOI 10.1056/NEJMoa051113; Sgarra R, 2004, FEBS LETT, V574, P1, DOI 10.1016/j.febslet.2004.08.013; Muto T, 2013, J EXP MED, V210, P2627, DOI 10.1084/jem.20131144; Levine RL, 2008, BLOOD, V112, P2190, DOI 10.1182/blood-2008-03-077966; Klampfl T, 2013, NEW ENGL J MED, V369, P2379, DOI 10.1056/NEJMoa1311347; Abdel-Wahab O, 2010, CANCER RES, V70, P447, DOI 10.1158/0008-5472.CAN-09-3783; Fusco A, 2007, NAT REV CANCER, V7, P899, DOI 10.1038/nrc2271; Mascarenhas J, 2013, BRIT J HAEMATOL, V161, P68, DOI 10.1111/bjh.12220; Copley MR, 2013, NAT CELL BIOL, V15, P916, DOI 10.1038/ncb2783; Lee YS, 2007, GENE DEV, V21, P1025, DOI 10.1101/gad.1540407; Rambaldi A, 2010, BRIT J HAEMATOL, V150, P446, DOI 10.1111/j.1365-2141.2010.08266.x; Mayr C, 2007, SCIENCE, V315, P1576, DOI 10.1126/science.1137999; Li JA, 2010, BLOOD, V116, P1528, DOI 10.1182/blood-2009-12-259747; Zhan HC, 2013, BRIT J HAEMATOL, V161, P471, DOI 10.1111/bjh.12276; Mullally A, 2010, CANCER CELL, V17, P584, DOI 10.1016/j.ccr.2010.05.015; DeAngelo DJ, 2013, BRIT J HAEMATOL, V162, P326, DOI 10.1111/bjh.12384; Tefferi A, 2012, BLOOD, V119, P2721, DOI 10.1182/blood-2011-11-395228; Shih AH, 2012, NAT REV CANCER, V12, P599, DOI 10.1038/nrc3343; Fiskus W, 2006, MOL CANCER THER, V5, P3096, DOI 10.1158/1535-7163.MCT-06-0418; Jost E, 2007, LEUKEMIA, V21, P505, DOI 10.1038/sj.leu.2404513; Wang YC, 2009, BLOOD, V114, P5024, DOI 10.1182/blood-2009-05-222133; Christiansen DH, 2003, LEUKEMIA, V17, P1813, DOI 10.1038/sj.leu.2403054; Guglielmelli P, 2007, STEM CELLS, V25, P165, DOI 10.1634/stemcells.2006-0351; Nishino J, 2008, CELL, V135, P227, DOI 10.1016/j.cell.2008.09.017; DeAngelo DJ, 2013, LEUKEMIA, V27, P1628, DOI 10.1038/leu.2013.38; Levine RL, 2005, CANCER CELL, V7, P387, DOI 10.1016/j.ccr.2005.03.023; Edahiro Y, 2014, INT J HEMATOL, V99, P625, DOI 10.1007/s12185-014-1567-1; Fazio P. Di., 2012, EXP CELL RES, V318, P1832; Huang ZXL, 2001, EXP BIOL MED, V226, P222; Ikeda K, 2007, EXP HEMATOL, V35, P618, DOI 10.1016/j.exphem.2007.01.045; Ikeda K, 2011, BLOOD, V117, P5860, DOI 10.1182/blood-2011-02-334425; Murakami Y, 2012, BRIT J HAEMATOL, V156, P383, DOI 10.1111/j.1365-2141.2011.08914.x; Nishino J, 2013, ELIFE, V2, DOI 10.7554/eLife.00924; Odero MD, 2005, LEUKEMIA, V19, P245, DOI 10.1038/sj.leu.2403605; Oguro H, 2012, J EXP MED, V209, P445, DOI 10.1084/jem.20111709; SUN M, 2013, P NATL ACAD SCI US, V0110; Zong Y, 2012, P NATL ACAD SCI USA, V109, pE3395, DOI 10.1073/pnas.1217982109	51	1	1	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0007-1048	1365-2141		BRIT J HAEMATOL	Br. J. Haematol.	FEB	2015	168	3					338	349		10.1111/bjh.13129		12	Hematology	Hematology	CA4AB	WOS:000348845500005		
J	Kawashima, N; Narita, A; Wang, XN; Xu, YY; Sakaguchi, H; Doisaki, S; Muramatsu, H; Hama, A; Nakanishi, K; Takahashi, Y; Kojima, S				Kawashima, Nozomu; Narita, Atsushi; Wang, Xinan; Xu, Yinyan; Sakaguchi, Hirotoshi; Doisaki, Sayoko; Muramatsu, Hideki; Hama, Asahito; Nakanishi, Koji; Takahashi, Yoshiyuki; Kojima, Seiji			Aldehyde dehydrogenase-2 polymorphism contributes to the progression of bone marrow failure in children with idiopathic aplastic anaemia	BRITISH JOURNAL OF HAEMATOLOGY			English	Letter						ALDH2; haematopoietic stem cells; children; idiopathic aplastic anaemia; bone marrow failure	JAPANESE CHILDREN; IMMUNOSUPPRESSION; TRANSPLANTATION; ALDH2		[Kawashima, Nozomu; Narita, Atsushi; Wang, Xinan; Xu, Yinyan; Sakaguchi, Hirotoshi; Doisaki, Sayoko; Muramatsu, Hideki; Hama, Asahito; Nakanishi, Koji; Takahashi, Yoshiyuki; Kojima, Seiji] Nagoya Univ, Grad Sch Med, Dept Paediat, Nagoya, Aichi 4648601, Japan	Kawashima, N (reprint author), Nagoya Univ, Grad Sch Med, Dept Paediat, Nagoya, Aichi 4648601, Japan.	kojimas@med.nagoya-u.ac.jp	Muramatsu, Hideki/I-3763-2012				Hira A, 2013, BLOOD, V122, P3206, DOI 10.1182/blood-2013-06-507962; CAMITTA BM, 1975, BLOOD, V45, P355; Liang J, 2006, HAEMATOL-HEMATOL J, V91, P656; Kulagin A, 2014, BRIT J HAEMATOL, V164, P546, DOI 10.1111/bjh.12661; Chen CH, 2014, PHYSIOL REV, V94, P1, DOI 10.1152/physrev.00017.2013; BACIGALUPO A, 1988, BRIT J HAEMATOL, V70, P177, DOI 10.1111/j.1365-2141.1988.tb02460.x; Garaycoechea JI, 2012, NATURE, V489, P571, DOI 10.1038/nature11368; Matsuo K, 2006, CANCER EPIDEM BIOMAR, V15, P1009, DOI 10.1158/1055-9965.EPI-05-0911; Tamakoshi A, 2003, ALCOHOL ALCOHOLISM, V38, P407, DOI 10.1093/alcalc/agg096; Wang Y, 2007, HAEMATOL-HEMATOL J, V92, P1573, DOI 10.3324/haematol.11568	10	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0007-1048	1365-2141		BRIT J HAEMATOL	Br. J. Haematol.	FEB	2015	168	3					460	463		10.1111/bjh.13122		4	Hematology	Hematology	CA4AB	WOS:000348845500019		
J	Aoki, K; Ishikawa, T; Ishiyama, K; Aoki, J; Itonaga, H; Fukuda, T; Kakihana, K; Uchida, N; Ueda, Y; Eto, T; Mori, T; Kondo, T; Iwato, K; Morishima, Y; Tanaka, J; Atsuta, Y; Miyazaki, Y				Aoki, Kazunari; Ishikawa, Takayuki; Ishiyama, Ken; Aoki, Jun; Itonaga, Hidehiro; Fukuda, Takahiro; Kakihana, Kazuhiko; Uchida, Naoyuki; Ueda, Yasunori; Eto, Tetsuya; Mori, Takehiko; Kondo, Tadakazu; Iwato, Koji; Morishima, Yasuo; Tanaka, Junji; Atsuta, Yoshiko; Miyazaki, Yasushi		Japan Soc Hematopoietic Cell	Allogeneic haematopoietic cell transplantation with reduced-intensity conditioning for elderly patients with advanced myelodysplastic syndromes: a nationwide study	BRITISH JOURNAL OF HAEMATOLOGY			English	Letter						myelodysplastic syndromes; allogeneic transplantation; reduced-intensity conditioning; elderly	BONE-MARROW-TRANSPLANTATION; SYSTEM		[Aoki, Kazunari; Kondo, Tadakazu] Kyoto Univ, Grad Sch Med, Dept Hematol & Oncol, Kyoto, Japan; [Aoki, Kazunari; Ishikawa, Takayuki] Kobe City Med Ctr, Dept Hematol, Gen Hosp, Kobe, Hyogo, Japan; [Ishiyama, Ken; Aoki, Jun; Kakihana, Kazuhiko] Komagome Hosp, Tokyo Metropolitan Canc & Infect Dis Ctr, Div Hematol, Tokyo, Japan; [Ishiyama, Ken] Tokyo Metropolitan Otsuka Hosp, Div Hematol, Tokyo, Japan; [Itonaga, Hidehiro] Sasebo City Gen Hosp, Dept Hematol, Sasebo, Japan; [Fukuda, Takahiro] Natl Canc Ctr, Div Hematopoiet Stem Cell Transplantat, Tokyo, Japan; [Uchida, Naoyuki] Toranomon Gen Hosp, Dept Hematol, Tokyo, Japan; [Ueda, Yasunori] Kurashiki Cent Hosp, Dept Hematol Oncol, Kurashiki, Okayama, Japan; [Eto, Tetsuya] Hamanomachi Hosp, Dept Hematol, Fukuoka, Japan; [Mori, Takehiko] Keio Univ, Sch Med, Div Hematol, Tokyo, Japan; [Iwato, Koji] Hiroshima Red Cross Hosp, Dept Hematol, Hiroshima, Japan; [Iwato, Koji] Atom Bomb Survivors Hosp, Hiroshima, Japan; [Morishima, Yasuo] Aichi Canc Ctr, Res Inst, Div Epidemiol & Prevent, Nagoya, Aichi 464, Japan; [Tanaka, Junji] Tokyo Womens Med Univ, Dept Hematol, Tokyo, Japan; [Atsuta, Yoshiko] Nagoya Univ, Sch Med, Dept Hematopoiet Stem Cell Transplantat Data Mana, Nagoya, Aichi 466, Japan; [Miyazaki, Yasushi] Nagasaki Univ, Atom Bomb Dis Inst, Atom Bomb Dis & Hibakusha Med Unit, Dept Hematol, Nagasaki 852, Japan	Aoki, K (reprint author), Kyoto Univ, Grad Sch Med, Dept Hematol & Oncol, Kyoto, Japan.	kaoki@kuhp.kyoto-u.ac.jp					Atsuta Y, 2007, INT J HEMATOL, V86, P269, DOI 10.1532/IJH97.06239; Shimoni A, 2006, LEUKEMIA, V20, P322, DOI 10.1038/sj.leu.2404037; Sorror ML, 2005, BLOOD, V106, P2912, DOI 10.1182/blood-2005-05-2004; Arnold R, 1998, BONE MARROW TRANSPL, V21, P1213, DOI 10.1038/sj.bmt.1701269; Giralt S, 2009, BIOL BLOOD MARROW TR, V15, P367, DOI 10.1016/j.bbmt.2008.12.497; Greenberg P, 1997, BLOOD, V89, P2079; Sierra J, 2002, BLOOD, V100, P1997; Weisdorf D, 2008, BIOL BLOOD MARROW TR, V14, P748, DOI 10.1016/j.bbmt.2008.04.003; desLima M, 2004, BLOOD, V104, P865; desWitte T., 2000, BRIT J HAEMATOL, V110, P620	10	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0007-1048	1365-2141		BRIT J HAEMATOL	Br. J. Haematol.	FEB	2015	168	3					463	466		10.1111/bjh.13124		4	Hematology	Hematology	CA4AB	WOS:000348845500020		
J	Yamamoto, E; Tomita, N; Ishigatsubo, Y				Yamamoto, Eri; Tomita, Naoto; Ishigatsubo, Yoshiaki			Primary diffuse large B-cell lymphoma of the testis relapsing in the right atrium	BRITISH JOURNAL OF HAEMATOLOGY			English	Article									[Yamamoto, Eri; Tomita, Naoto; Ishigatsubo, Yoshiaki] Yokohama City Univ, Grad Sch Med, Dept Internal Med & Clin Immunol, Yokohama, Kanagawa 232, Japan	Yamamoto, E (reprint author), Yokohama City Univ, Grad Sch Med, Dept Internal Med & Clin Immunol, Yokohama, Kanagawa 232, Japan.	eri-oharu@umin.ac.jp						0	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0007-1048	1365-2141		BRIT J HAEMATOL	Br. J. Haematol.	FEB	2015	168	4					469	469		10.1111/bjh.13212		1	Hematology	Hematology	CA8GZ	WOS:000349157200001		
J	Maeda, T; Babazono, A; Nishi, T; Matsuda, S; Fushimi, K; Fujimori, K				Maeda, Toshiki; Babazono, Akira; Nishi, Takumi; Matsuda, Shinya; Fushimi, Kiyohide; Fujimori, Kenji			Quantification of the effect of chemotherapy and steroids on risk of Pneumocystis jiroveci among hospitalized patients with adult T-cell leukaemia	BRITISH JOURNAL OF HAEMATOLOGY			English	Article						Pneumocystis pneumonia; adult T cell leukaemia; prophylaxis; chemotherapy; steroid	RECOMMENDATIONS; PNEUMONIA; SOCIETY	This study aimed to quantify the risks of Pneumocystis pneumonia (PCP) among adult T-cell leukaemia (ATL) patients without prophylaxis. We used hospital administrative data collected nationwide in Japan over 4years. The research design was a retrospective cohort study. Subjects were 4369 patients diagnosed with ATL aged 18years or older. The subjects were categorized into four treatment groups: no agent, chemotherapy, chemotherapy+steroids and steroids. We described the risks of PCP among ATL patients without prophylaxis. Risks of PCP were 32% for the no agent group, 97% for the chemotherapy group, 100% for the chemotherapy+steroids group and 166% for the steroids group. Logistic regression analyses showed that the chemotherapy, chemotherapy+steroids and steroids groups had significantly higher risk of PCP than did the no agent group [adjusted odds ratio (AOR) 330 (155-702), P=0002 for the chemotherapy group; AOR 335 (218-517), P<0001 for the chemotherapy+steroids group; AOR 612 (399-938), P<0001 for the steroids group]. In conclusion, the chemotherapy, chemotherapy+steroids and steroids groups had significantly higher risks of PCP. Prophylaxis for PCP among ATL patients being treated with chemotherapy, chemotherapy+steroids and steroids is highly recommended.	[Maeda, Toshiki; Babazono, Akira; Nishi, Takumi] Kyushu Univ, Grad Sch Healthcare Sci, Dept Healthcare Adm & Management, Fukuoka 8128582, Japan; [Matsuda, Shinya] Univ Occupat & Environm Hlth, Dept Prevent Med & Community Hlth, Fukukoka, Japan; [Fushimi, Kiyohide] Tokyo Med & Dent Univ, Dept Hlth Policy & Informat, Grad Sch Med, Tokyo, Japan; [Fujimori, Kenji] Tohoku Univ, Dept Hlth Adm & Policy, Sendai, Miyagi 980, Japan	Maeda, T (reprint author), Kyushu Univ, Grad Sch Healthcare Sci, Dept Healthcare Adm & Management, Higashi Ku, 3-1-1 Maidashi, Fukuoka 8128582, Japan.	toshikimaeda1216@gmail.com					Thomas CF, 2004, NEW ENGL J MED, V350, P2487, DOI 10.1056/NEJMra032588; Stringer JR, 2002, EMERG INFECT DIS, V8, P891; Tsukasaki K, 2009, J CLIN ONCOL, V27, P453, DOI 10.1200/JCO.2008.18.2428; EDMAN JC, 1988, NATURE, V334, P519, DOI 10.1038/334519a0; Green H, 2007, MAYO CLIN PROC, V82, P1052; MACKALL CL, 1994, BLOOD, V84, P2221; Thompson MA, 2012, JAMA-J AM MED ASSOC, V308, P387, DOI 10.1001/jama.2012.7961; Matsuoka M, 2007, NAT REV CANCER, V7, P270, DOI 10.1038/nrc2111; Kaplan Jonathan E., 2009, Morbidity and Mortality Weekly Report, V58, P1; Sundararajan V, 2004, J CLIN EPIDEMIOL, V57, P1288, DOI 10.1016/j.jclinepi.2004.03.012; Ishitsuka K, 2008, EUR J HAEMATOL, V80, P185, DOI 10.1111/j.1600-0609.2007.01016.x; Limper A. H., 2011, AM J RESP CRIT CARE, V183, P6; Matsuda S., 2007, JPN J SOC SEC POLICY, V6, P43; Matsuda S., 2008, Eurohealth, V14, P25; Rothman KJ, 2002, EPIDEMIOLOGY INTRO; Shimoyama M., 1993, BYORI TO RINSHO, V11, P132; The National Comprehensive Cancer Network (NCCN), 2013, PREV TREATM CANC REL; vonsElm E, 2007, LANCET, V370, P1453	18	1	1	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0007-1048	1365-2141		BRIT J HAEMATOL	Br. J. Haematol.	FEB	2015	168	4					501	506		10.1111/bjh.13154		6	Hematology	Hematology	CA8GZ	WOS:000349157200006		
J	Fukano, R; Mori, T; Kobayashi, R; Mitsui, T; Fujita, N; Iwasaki, F; Suzumiya, J; Chin, M; Goto, H; Takahashi, Y; Hara, J; Park, YD; Inoue, M; Koga, Y; Inagaki, J; Sakamaki, H; Adachi, S; Kawa, K; Kato, K; Suzuki, R				Fukano, Reiji; Mori, Tetsuya; Kobayashi, Ryoji; Mitsui, Tetsuo; Fujita, Naoto; Iwasaki, Fuminori; Suzumiya, Junji; Chin, Motoaki; Goto, Hiroaki; Takahashi, Yoshiyuki; Hara, Junichi; Park, Yong-Dong; Inoue, Masami; Koga, Yuhki; Inagaki, Jiro; Sakamaki, Hisashi; Adachi, Souichi; Kawa, Keisei; Kato, Koji; Suzuki, Ritsuro			Haematopoietic stem cell transplantation for relapsed or refractory anaplastic large cell lymphoma: a study of children and adolescents in Japan	BRITISH JOURNAL OF HAEMATOLOGY			English	Article						anaplastic large cell lymphoma; children; adolescents; haematopoietic stem cell transplantation; reduced-intensity conditioning	NON-HODGKIN-LYMPHOMA; NONMALIGNANT DISEASES; PEDIATRIC ONCOLOGY; FRENCH SOCIETY; BLOOD; CHEMOTHERAPY; CHILDHOOD; REGIMENS	To evaluate haematopoietic stem cell transplantation (HSCT) in children and adolescents, we reviewed the records of 47 patients who were 18years, had relapsed or refractory anaplastic large cell lymphoma, and received HSCT between 1990 and 2010. At HSCT, complete remission (CR) was less common in allogeneic HSCT recipients (n=24) than in autologous HSCT recipients (n=23) (P=001). The autologous and allogeneic HSCT groups differed in terms of 5-year event-free survival (EFS) (38% vs. 50%, P=063), cumulative incidence of progress or relapse (49% vs. 28%, P=025), and treatment-related mortality (12% vs. 25%, P=040). However, these differences were not significant. Patients with non-CR at autologous HSCT had a significantly lower EFS rate (14% vs. 48%, P=003). Conversely, although those with non-CR at allogeneic HSCT had a lower EFS rate, this was not significant (44% vs. 63%, P=026). Reduced-intensity conditioning regimens were used for three of the 16 allogeneic HSCTs received by patients with non-CR. These three patients achieved CR, surviving 32-65months after HSCT. These results demonstrated that allogeneic HSCT might be a treatment option for patients who do not achieve CR through conventional chemotherapy.	[Fukano, Reiji; Inagaki, Jiro] Kyushu Natl Canc Ctr, Dept Paediat, Fukuoka 8111395, Japan; [Mori, Tetsuya] Natl Ctr Child Hlth & Dev, Div Paediat Oncol, Tokyo, Japan; [Kobayashi, Ryoji] Sapporo Hokuyu Hosp, Dept Paediat, Sapporo, Hokkaido, Japan; [Mitsui, Tetsuo] Yamagata Univ Hosp, Dept Paediat, Yamagata, Japan; [Fujita, Naoto] Hiroshima Red Cross Hosp, Dept Paediat, Hiroshima, Japan; [Fujita, Naoto] Atom Bomb Survivors Hosp, Hiroshima, Japan; [Iwasaki, Fuminori; Goto, Hiroaki] Kanagawa Childrens Med Ctr, Div Haematooncol Regenerat Med, Yokohama, Kanagawa, Japan; [Suzumiya, Junji] Shimane Univ Hosp, Ctr Canc, Dept Oncol Haematol, Izumo, Shimane, Japan; [Chin, Motoaki] Nihon Univ, Itabashi Hosp, Dept Paediat & Child Hlth, Tokyo, Japan; [Takahashi, Yoshiyuki] Nagoya Univ, Dept Paediat, Grad Sch Med, Nagoya, Aichi 4648601, Japan; [Hara, Junichi] Osaka City Gen Hosp, Dept Paediat Haematol Oncol, Osaka, Japan; [Park, Yong-Dong] Osaka Red Cross Hosp, Dept Paediat, Osaka, Japan; [Inoue, Masami] Osaka Med Ctr, Dept Haematol Oncol, Osaka, Japan; [Inoue, Masami] Res Inst Maternal & Child Hlth, Osaka, Japan; [Koga, Yuhki] Kyushu Univ Hosp, Dept Paediat, Fukuoka 812, Japan; [Sakamaki, Hisashi] Komagome Hosp, Div Haematol, Tokyo Metropolitan Canc & Infect Dis Ctr, Tokyo, Japan; [Adachi, Souichi] Kyoto Univ, Kyoto, Japan; [Kawa, Keisei] Japanese Red Cross Kinki Block Blood Ctr, Osaka, Japan; [Kato, Koji] Japanese Red Cross Nagoya First Hosp, Childrens Med Ctr, Dept Haematol & Oncol, Nagoya, Aichi, Japan; [Suzuki, Ritsuro] Nagoya Univ, Dept HSCT Data Management & Biostat, Grad Sch Med, Nagoya, Aichi 4648601, Japan	Fukano, R (reprint author), Kyushu Natl Canc Ctr, Dept Paediat, Minami Ku, 3-1-1 Notame, Fukuoka 8111395, Japan.	fukano.r@nk-cc.go.jp					Brugieres L, 1998, BLOOD, V92, P3591; Carella AM, 2000, J CLIN ONCOL, V18, P3918; Brugieres L, 2000, ANN ONCOL, V11, P53, DOI 10.1023/A:1008352726155; Giralt S, 2009, BIOL BLOOD MARROW TR, V15, P367, DOI 10.1016/j.bbmt.2008.12.497; Luger SM, 2012, BONE MARROW TRANSPL, V47, P203, DOI 10.1038/bmt.2011.69; Brugieres L, 2009, J CLIN ONCOL, V27, P5056, DOI 10.1200/JCO.2008.20.1764; Mosse YP, 2013, LANCET ONCOL, V14, P472, DOI 10.1016/S1470-2045(13)70095-0; Seidemann K, 2001, BLOOD, V97, P3699, DOI 10.1182/blood.V97.12.3699; Pro B, 2012, J CLIN ONCOL, V30, P2190, DOI 10.1200/JCO.2011.38.0402; Brugieres L, 2009, J CLIN ONCOL, V27, P897, DOI 10.1200/JCO.2008.18.1487; Gross TG, 2010, BIOL BLOOD MARROW TR, V16, P223, DOI 10.1016/j.bbmt.2009.09.021; Woessmann W, 2011, J CLIN ONCOL, V29, P3065, DOI 10.1200/JCO.2011.34.8417; Dreger P, 2003, LEUKEMIA, V17, P841, DOI 10.1038/sj.leu.2402905; Williams DM, 2002, BRIT J HAEMATOL, V117, P812, DOI 10.1046/j.1365-2141.2002.03482.x; Jacobsohn DA, 2004, LANCET, V364, P156, DOI 10.1016/S0140-6736(04)16628-2; Bradley MB, 2007, BONE MARROW TRANSPL, V40, P621, DOI 10.1038/sj.bmt.1705785; Fanin R, 1999, BONE MARROW TRANSPL, V23, P437, DOI 10.1038/sj.bmt.1701596; Giulino-Roth L, 2013, PEDIATR BLOOD CANCER, V60, P2018, DOI 10.1002/pbc.24722; LesDeley M. C., 2010, J CLIN ONCOL, V28, P3987; Mori T, 2006, BRIT J HAEMATOL, V132, P594, DOI 10.1111/j.1365-2141.2005.05910.x; Murphy S B, 1994, Ann Oncol, V5 Suppl 1, P31; Ohta H, 2010, INT J HEMATOL, V92, P190, DOI 10.1007/s12185-010-0620-y; Stockklausner C, 2008, PEDIATR BLOOD CANCER, V50, P126, DOI 10.1002/pbc.20838; Woessmann W, 2006, BRIT J HAEMATOL, V133, P176, DOI 10.1111/j.1365-2141.2006.06004.x; Yaniv I, 2008, BONE MARROW TRANSPL, V41, pS18, DOI 10.1038/bmt.2008.48	25	1	1	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0007-1048	1365-2141		BRIT J HAEMATOL	Br. J. Haematol.	FEB	2015	168	4					557	563		10.1111/bjh.13167		7	Hematology	Hematology	CA8GZ	WOS:000349157200014		
J	Kato, M; Hasegawa, D; Koh, K; Kato, K; Takita, J; Inagaki, J; Yabe, H; Goto, H; Adachi, S; Hayakawa, A; Takeshita, Y; Sawada, A; Atsuta, Y; Kato, K				Kato, Motohiro; Hasegawa, Daiichiro; Koh, Katsuyoshi; Kato, Keisuke; Takita, Junko; Inagaki, Jiro; Yabe, Hiromasa; Goto, Hiroaki; Adachi, Souichi; Hayakawa, Akira; Takeshita, Yasufumi; Sawada, Akihisa; Atsuta, Yoshiko; Kato, Koji			Allogeneic haematopoietic stem cell transplantation for infant acute lymphoblastic leukaemia with KMT2A (MLL) rearrangements: a retrospective study from the paediatric acute lymphoblastic leukaemia working group of the Japan Society for Haematopoietic Cell Transplantation	BRITISH JOURNAL OF HAEMATOLOGY			English	Article						infant; acute lymphoblastic leukaemia; stem cell transplantation; busulfan; total body irradiation	BONE-MARROW-TRANSPLANTATION; CHILDRENS ONCOLOGY GROUP; UMBILICAL-CORD BLOOD; GENE REARRANGEMENTS; RANDOMIZED-TRIAL; CHILDHOOD; CHEMOTHERAPY; INTERFANT-99; CONSORTIUM; REGIMENS	Allogeneic haematopoietic stem cell transplantation (HSCT) is still considered to play an important role as a consolidation therapy for high-risk infants with acute lymphoblastic leukaemia (ALL). Here, we retrospectively analysed outcomes of HSCT in infants with ALL based on nationwide registry data of the Japan Society for Haematopoietic Cell Transplantation. A total of 132 allogeneic HSCT for infant ALL with KMT2A (MLL) gene rearrangements, which were performed in first complete remission (CR1), were analysed. The 5-year overall survival rate after transplantation was 674 +/- 45%). Although recent HSCT (after 2004) had a trend toward better survival, no statistical correlation was observed between outcomes and each factor, including age at diagnosis, initial leucocyte count, cytogenetics, donor types or conditioning of HSCT. Myeloablative conditioning with total body irradiation did not provide a better survival (607 +/- 92%) over that with busulfan (BU; 678 +/- 57%). Two of the 28 patients treated with irradiation, but none of the 90 BU-treated patients, developed a secondary malignant neoplasm. In conclusion, allogeneic HSCT using BU was a valuable option for infant ALL with KMT2A rearrangements in CR1.	[Kato, Motohiro; Takita, Junko] Univ Tokyo, Dept Paediat, Tokyo, Japan; [Kato, Motohiro] Univ Tokyo, Dept Cell Therapy & Transplantat Med, Tokyo, Japan; [Hasegawa, Daiichiro] Hyogo Childrens Hosp, Dept Haematol Oncol, Kobe, Hyogo, Japan; [Koh, Katsuyoshi] Saitama Childrens Med Ctr, Dept Haematol Oncol, Saitama, Japan; [Kato, Keisuke] Ibaraki Childrens Hosp, Dept Haematol Oncol, Mito, Ibaraki, Japan; [Inagaki, Jiro] Kyushu Natl Canc Ctr, Dept Paediat, Fukuoka, Japan; [Yabe, Hiromasa] Tokai Univ, Dept Cell Transplantat & Regenerat Med, Isehara, Kanagawa, Japan; [Goto, Hiroaki] Kanagawa Childrens Med Ctr, Div Haematooncol Regenerat Med, Yokohama, Kanagawa, Japan; [Adachi, Souichi] Kyoto Univ, Dept Human Hlth Sci, Kyoto, Japan; [Hayakawa, Akira] Kobe Univ, Dept Paediat, Kobe, Hyogo 657, Japan; [Takeshita, Yasufumi] Nara Med Univ, Dept Paediat, Kashihara, Nara 634, Japan; [Sawada, Akihisa] Osaka Med Ctr, Dept Haematol Oncol, Izumi, Japan; [Sawada, Akihisa] Res Inst Maternal & Child Hlth, Izumi, Japan; [Atsuta, Yoshiko] Nagoya Univ, Grad Sch Med, Japanese Data Ctr Haematopoiet Cell Transplantat, Nagoya, Aichi 4648601, Japan; [Atsuta, Yoshiko] Nagoya Univ, Grad Sch Med, Dept Healthcare Adm, Nagoya, Aichi 4648601, Japan; [Kato, Koji] Japanese Red Cross Nagoya First Hosp, Childrens Med Ctr, Dept Haematol & Oncol, Nagoya, Aichi, Japan	Kato, M (reprint author), 7-3-1 Hongo,Bunkyo Ku, Tokyo 1138655, Japan.	katom-tky@umin.ac.jp			Japanese Ministry of Health, Labor, and Welfare	We would like to thank all the staff at the hospitals and centres that provided precise data via the registry of the Japan Society for Haematopoietic Cell Transplantation (JSHCT). A script kindly provided by Dr. Yoshinobu Kanda, Saitama Medical Centre, Jichi Medical University, was used for data manipulation. This work was supported in part by a Research Grant for Allergic Disease and Immunology from the Japanese Ministry of Health, Labor, and Welfare. All authors had no conflict of interest to disclose.	Eapen M, 2007, LANCET, V369, P1947, DOI 10.1016/S0140-6736(07)60915-5; Hilden JM, 2006, BLOOD, V108, P441, DOI 10.1182/blood-2005-07-3011; Cohen A, 2007, J CLIN ONCOL, V25, P2449, DOI 10.1200/JCO.2006.08.9276; Curtis RE, 1997, NEW ENGL J MED, V336, P897, DOI 10.1056/NEJM199703273361301; Atsuta Y, 2007, INT J HEMATOL, V86, P269, DOI 10.1532/IJH97.06239; Gooley TA, 2010, NEW ENGL J MED, V363, P2091, DOI 10.1056/NEJMoa1004383; Mann G, 2010, BLOOD, V116, P2644, DOI 10.1182/blood-2010-03-273532; Bunin N, 2003, BONE MARROW TRANSPL, V32, P543, DOI 10.1038/sj.bmt.1704198; Sanders JE, 2005, BLOOD, V105, P3749, DOI 10.1182/blood-2004-08-3312; Tomizawa D, 2009, PEDIATR BLOOD CANCER, V52, P808, DOI 10.1002/pbc.21975; Dreyer ZE, 2011, J CLIN ONCOL, V29, P214, DOI 10.1200/JCO.2009.26.8938; Nagayama J, 2006, BLOOD, V107, P4663, DOI 10.1182/blood-2005-11-4728; Leung W, 2004, J IMMUNOL, V172, P644; Tomizawa D, 2007, LEUKEMIA, V21, P2258, DOI 10.1038/sj.leu.2404903; Bacigalupo A, 2009, BIOL BLOOD MARROW TR, V15, P1628, DOI 10.1016/j.bbmt.2009.07.004; Dvorak CC, 2011, BIOL BLOOD MARROW TR, V17, P1725, DOI 10.1016/j.bbmt.2011.10.006; Davies SM, 2000, J CLIN ONCOL, V18, P340; Willemze R, 2009, LEUKEMIA, V23, P492, DOI 10.1038/leu.2008.365; Inaba H, 2013, LANCET, V381, P1943, DOI 10.1016/S0140-6736(12)62187-4; Kosaka Y, 2004, BLOOD, V104, P3527, DOI 10.1182/blood-2004-04-1390; Pieters R, 2007, LANCET, V370, P240, DOI 10.1016/S0140-6736(07)61126-X; Pui CH, 2002, LANCET, V359, P1909, DOI 10.1016/S0140-6736(02)08782-2; Jacobsohn DA, 2005, BIOL BLOOD MARROW TR, V11, P999, DOI 10.1016/j.bbmt.2005.08.031; Rubnitz JE, 1999, J CLIN ONCOL, V17, P191; Sarafoglou K, 1997, J PEDIATR-US, V130, P210, DOI 10.1016/S0022-3476(97)70345-7; Schmiegelow K, 2013, J CLIN ONCOL, V31, P2469, DOI 10.1200/JCO.2012.47.0500; Silverman LB, 1997, CANCER, V80, P2285; Somali M, 2005, GYNECOL ENDOCRINOL, V21, P18, DOI 10.1080/09513590500099255	28	1	1	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0007-1048	1365-2141		BRIT J HAEMATOL	Br. J. Haematol.	FEB	2015	168	4					564	570		10.1111/bjh.13174		7	Hematology	Hematology	CA8GZ	WOS:000349157200015		
J	Kumazoe, M; Tsukamoto, S; Lesnick, C; Kay, NE; Yamada, K; Shanafelt, TD; Tachibana, H				Kumazoe, Motofumi; Tsukamoto, Shuntaro; Lesnick, Connie; Kay, Neil E.; Yamada, Koji; Shanafelt, Tait D.; Tachibana, Hirofumi			Vardenafil, a clinically available phosphodiesterase inhibitor, potentiates the killing effect of EGCG on CLL cells	BRITISH JOURNAL OF HAEMATOLOGY			English	Letter						chronic lymphocytic leukaemia; 67-kDa laminin receptor; phosphodiesterase 5; protein kinase C delta; apoptosis	CHRONIC LYMPHOCYTIC-LEUKEMIA; RECEPTOR		[Kumazoe, Motofumi; Tsukamoto, Shuntaro; Yamada, Koji; Tachibana, Hirofumi] Kyushu Univ, Fac Agr, Div Appl Biol Chem, Dept Biosci & Biotechnol, Fukuoka 812, Japan; [Lesnick, Connie; Kay, Neil E.; Shanafelt, Tait D.] Mayo Clin, Dept Med, Rochester, MN USA; [Tachibana, Hirofumi] Kyushu Univ, Food Funct Design Res Ctr, Fukuoka 812, Japan	Kumazoe, M (reprint author), Kyushu Univ, Fac Agr, Div Appl Biol Chem, Dept Biosci & Biotechnol, Fukuoka 812, Japan.	tatibana@agr.kyushu-u.ac.jp		Kumazoe, Motofumi/0000-0002-3002-2994			Oscier D, 2012, BRIT J HAEMATOL, V159, P541, DOI 10.1111/bjh.12067; Jaumann M, 2012, NAT MED, V18, P252, DOI 10.1038/nm.2634; Cheng S, 2014, LEUKEMIA, V28, P649, DOI 10.1038/leu.2013.358; Furman RR, 2014, NEW ENGL J MED, V370, P997, DOI 10.1056/NEJMoa1315226; Zhang LZ, 2008, P NATL ACAD SCI USA, V105, P19532, DOI 10.1073/pnas.0806152105; Britschgi A, 2010, BRIT J HAEMATOL, V149, P55, DOI 10.1111/j.1365-2141.2009.08040.x; Kumazoe M, 2013, J CLIN INVEST, V123, P787, DOI 10.1172/JCI64768; Shanafelt TD, 2013, CANCER-AM CANCER SOC, V119, P363, DOI 10.1002/cncr.27719; Tachibana H, 2004, NAT STRUCT MOL BIOL, V11, P380, DOI 10.1038/nsmb743; Hallek M, 2013, BLOOD, V122, P3723, DOI 10.1182/blood-2013-05-498287	10	3	3	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0007-1048	1365-2141		BRIT J HAEMATOL	Br. J. Haematol.	FEB	2015	168	4					610	613		10.1111/bjh.13135		4	Hematology	Hematology	CA8GZ	WOS:000349157200023		
J	Ishimaru, K; Ohba, S; Yoshimura, H; Matsuda, S; Ishimaru, J; Sano, K				Ishimaru, Kyoko; Ohba, Seigo; Yoshimura, Hitoshi; Matsuda, Shinpei; Ishimaru, Jun-Ichi; Sano, Kazuo			Antioxidant capacity of synovial fluid in the temporomandibular joint correlated with radiological morphology of temporomandibular disorders	BRITISH JOURNAL OF ORAL & MAXILLOFACIAL SURGERY			English	Article						Temporomandibular disorders; Antioxidant capacity; Radiological morphology; Hydroxyl radical; Synovial fluid; Oxidative stress	SUPEROXIDE-DISMUTASE ACTIVITY; LUMINOL CHEMILUMINESCENCE; INTERNAL DERANGEMENT; VARIABLES; SYMPTOMS; DISEASE	We investigated the correlation between the antioxidant capacity of synovial fluid and radiological findings of intra-articular structures inpatients with disorders of the temporomandibular joint (TMJ). We recruited 21 patients (9 men and 12 women, aged 18-84 years of age) with such disorders, excluding myofascial pain and dysfunction syndrome, or other muscular disorders. The clinical variables recorded included age, sex, interincisal distance, and visual analogue pain scores (VAS). Radiological findings were obtained from diagnostic arthrogram and cone-beam computed tomography (CT). The antioxidant capacity of the synovial fluid was measured by chemiluminescence. Eleven patients were radiologically diagnosed with closed lock, and the remaining 10 with no closed lock. An anchored intra-articular disc was most often seen on cone-beam CT (n = 19) followed by perforated disc (n = 7), osteoarthrosis (n = 7), and anterior disc displacement without reduction( n = 5). Although there were no significant differences between antioxidant capacity and age, sex, VAS, or any findings on cone-beam CT, antioxidant capacity was significantly decreased in the patients with closed lock compared with those who did not have closed lock (p = 0.02). The results suggest an association between the oxidative stress of the synovial fluid and closed-lock in disorders of the TMJ. (C) 2014 The British Association of Oral and Maxillofacial Surgeons. Published by Elsevier Ltd. All rights reserved.	[Ishimaru, Kyoko; Ohba, Seigo; Yoshimura, Hitoshi; Matsuda, Shinpei; Sano, Kazuo] Univ Fukui, Fac Med Sci, Dept Sensory & Locomotor Med, Div Dent & Oral Surg, Fukui 910, Japan; [Ishimaru, Jun-Ichi] Gifu Prefectural Gen Med Ctr, Dept Oral & Maxillofacial Surg, Gifu, Japan	Sano, K (reprint author), Univ Fukui, Fac Med Sci, Dept Sensory & Locomotor Med, Div Dent & Oral Surg, Fukui 910, Japan.	sano@u-fukui.ac.jp					Akiyama K, 2012, J ORAL MAXILLOFACIAL, V24, P23; Luan Y, 2008, OSTEOARTHR CARTILAGE, V16, P1413, DOI 10.1016/j.joca.2008.03.017; Parejo I, 2000, J PHARMACOL TOXICOL, V43, P183, DOI 10.1016/S1056-8719(00)00085-X; Yildiz G, 1998, J PHARMACOL TOXICOL, V39, P179, DOI 10.1016/S1056-8719(98)00025-2; Kawamoto A, 2012, J PERIODONTAL RES, V47, P593, DOI 10.1111/j.1600-0765.2012.01471.x; Magnusson T, 2005, ACTA ODONTOL SCAND, V63, P99, DOI 10.1080/00016350510019739; Cai HX, 2006, J OROFAC PAIN, V20, P53; Lee MC, 2004, REDOX REP, V9, P331, DOI 10.1179/135100004225006830; Herr MM, 2011, J ORAL MAXIL SURG, V69, P41, DOI 10.1016/j.joms.2010.05.013; Tomida M, 2003, JPN J PHYSIOL, V53, P351, DOI 10.2170/jjphysiol.53.351; Dworkin Samuel F., 1992, Journal of Craniomandibular Disorders, V6, P301; Etoz OA, 2012, CLIN ORAL INVEST, V16, P1557, DOI 10.1007/s00784-011-0666-0; Gutteridge J.M.C., 2007, FREE RADICALS BIOL M; Guven O, 2007, J ORAL MAXIL SURG, V65, P1940, DOI 10.1016/j.joms.2006.10070; Madland G, 2000, PAIN, V84, P225, DOI 10.1016/S0304-3959(99)00210-9; Milam SB, 1998, J ORAL MAXIL SURG, V56, P214, DOI 10.1016/S0278-2391(98)90872-2; Mizui T, 2001, BRIT J ORAL MAX SURG, V39, P310, DOI 10.1054/bjom.2001.0634; Nitzan DW, 2001, J ORAL MAXILLOFAC SU, V59, P26; Okubo H, 2014, NUTR METAB CARDIOVAS, V24, P301, DOI 10.1016/j.numecd.2013.08.001; ROBERTS CA, 1987, ORAL SURG ORAL MED O, V63, P645, DOI 10.1016/0030-4220(87)90361-6; SADRZADEH SMH, 1984, J BIOL CHEM, V259, P4354; Sato J, 2007, ORAL SURG ORAL MED O, V103, P467, DOI 10.1016/j.tripleo.2006.06.058; Suantawee Tanyawan, 2013, J Clin Diagn Res, V7, P1855, DOI 10.7860/JCDR/2013/5802.3333; Tomida M., 2004, British Journal of Oral & Maxillofacial Surgery, V42, P405, DOI 10.1016/j.bjoms.2004.06.003; Zhang SY, 2009, BMC MUSCULOSKEL DIS, V10, DOI 10.1186/1471-2474-10-70	25	0	0	CHURCHILL LIVINGSTONE	EDINBURGH	JOURNAL PRODUCTION DEPT, ROBERT STEVENSON HOUSE, 1-3 BAXTERS PLACE, LEITH WALK, EDINBURGH EH1 3AF, MIDLOTHIAN, SCOTLAND	0266-4356	1532-1940		BRIT J ORAL MAX SURG	Br. J. Oral Maxillofac. Surg.	FEB	2015	53	2					114	120		10.1016/j.bjoms.2014.10.006		7	Dentistry, Oral Surgery & Medicine; Surgery	Dentistry, Oral Surgery & Medicine; Surgery	CB2RX	WOS:000349476800003		
J	Adachi, M; Motohashi, M; Muramatsu, Y				Adachi, M.; Motohashi, M.; Muramatsu, Y.			Technique of sliding tongue flap after partial glossectomy	BRITISH JOURNAL OF ORAL & MAXILLOFACIAL SURGERY			English	Article						Tongue cancer; Slinding tongue flap technic; Partial glossectomy			[Adachi, M.; Motohashi, M.; Muramatsu, Y.] Asahi Univ, Murakami Mem Hosp, Dept Oral & Maxillofacial Surg, Gifu 5008523, Japan	Adachi, M (reprint author), Asahi Univ, Murakami Mem Hosp, Dept Oral & Maxillofacial Surg, 3-23 Hashiotocho, Gifu 5008523, Japan.	madachi_dds_phd@yahoo.co.jp	Adachi, Makoto/B-1979-2012	Adachi, Makoto/0000-0002-9382-7052			Carew JF, 2003, ORAL CANC; CHICARILLI ZN, 1987, PLAST RECONSTR SURG, V79, P697, DOI 10.1097/00006534-198705000-00002; Lam DK, 2012, J ORAL MAXIL SURG, V70, P2440, DOI 10.1016/j.joms.2011.11.005; Lore JM, 2005, ATLAS HEAD NECK SURG	4	0	0	CHURCHILL LIVINGSTONE	EDINBURGH	JOURNAL PRODUCTION DEPT, ROBERT STEVENSON HOUSE, 1-3 BAXTERS PLACE, LEITH WALK, EDINBURGH EH1 3AF, MIDLOTHIAN, SCOTLAND	0266-4356	1532-1940		BRIT J ORAL MAX SURG	Br. J. Oral Maxillofac. Surg.	FEB	2015	53	2					206	207		10.1016/j.bjoms.2014.11.006		2	Dentistry, Oral Surgery & Medicine; Surgery	Dentistry, Oral Surgery & Medicine; Surgery	CB2RX	WOS:000349476800021		
J	Matsushita, K				Matsushita, K.			Wide-bladed mandibular channel retractor efficiently secures surgical manoeuvres during ramus osteotomy	BRITISH JOURNAL OF ORAL & MAXILLOFACIAL SURGERY			English	Article						Sagittal split ramus osteotomy; Retractor; Facial artery; Facial vein; Complication			Hokkaido Univ, Grad Sch Dent Med, Div Oral Pathobiol Sci, Dept Oral & Maxillofacial Surg,Kita Ku, Sapporo, Hokkaido 0608586, Japan	Matsushita, K (reprint author), Hokkaido Univ, Grad Sch Dent Med, Div Oral Pathobiol Sci, Dept Oral & Maxillofacial Surg,Kita Ku, N13 W7, Sapporo, Hokkaido 0608586, Japan.	matsushi@den.hokudai.ac.jp					EPKER BN, 1977, J ORAL SURG, V35, P157; Bell WH, 1980, SURG CORRECTION DENT; Jo H-W, 2013, Oral Maxillofac Surg, V17, P151, DOI 10.1007/s10006-012-0339-4; LANIGAN DT, 1991, J ORAL MAXIL SURG, V49, P713	4	0	0	CHURCHILL LIVINGSTONE	EDINBURGH	JOURNAL PRODUCTION DEPT, ROBERT STEVENSON HOUSE, 1-3 BAXTERS PLACE, LEITH WALK, EDINBURGH EH1 3AF, MIDLOTHIAN, SCOTLAND	0266-4356	1532-1940		BRIT J ORAL MAX SURG	Br. J. Oral Maxillofac. Surg.	FEB	2015	53	2					210	211		10.1016/j.bjoms.2014.11.015		2	Dentistry, Oral Surgery & Medicine; Surgery	Dentistry, Oral Surgery & Medicine; Surgery	CB2RX	WOS:000349476800023		
J	Bruffaerts, R; Posada-Villa, J; Al-Hamzawi, AB; Gureje, O; Huang, YQ; Hu, CY; Bromet, EJ; Viana, MC; Hinkov, HR; Karam, EG; Borges, G; Florescu, SE; Williams, DR; Demyttenaere, K; Kovess-Masfety, V; Matschinger, H; Levinson, D; de Girolamo, G; Ono, Y; de Graaf, R; Browne, MO; Bunting, B; Xavier, M; Haro, JM; Kessler, RC				Bruffaerts, Ronny; Posada-Villa, Jose; Al-Hamzawi, Ali Bald; Gureje, Oye; Huang, Yueqin; Hu, Chiyi; Bromet, Evelyn J.; Viana, Maria Carmen; Hinkov, Hristo Ruskov; Karam, Elie G.; Borges, Guilherme; Florescu, Silvia E.; Williams, David R.; Demyttenaere, Koen; Kovess-Masfety, Viviane; Matschinger, Herbert; Levinson, Daphna; de Girolamo, Giovanni; Ono, Yutaka; de Graaf, Ron; Browne, Mark Oakley; Bunting, Brendan; Xavier, Miguel; Maria Haro, Josep; Kessler, Ronald C.			Proportion of patients without mental disorders being treated in mental health services worldwide	BRITISH JOURNAL OF PSYCHIATRY			English	Article							SUBSTANCE USE DISORDERS; UNITED-STATES; UNMET NEED; CARE; ORGANIZATION; POPULATION; PREVALENCE; COUNTRIES; SEVERITY; ONTARIO	Background Previous research suggests that many people receiving mental health treatment do not meet criteria for a mental disorder but are rather the worried well'. Aims To examine the association of past-year mental health treatment with DSM-IV disorders. Method The World Health Organization's World Mental Health (WMH) Surveys interviewed community samples of adults in 23 countries (n = 62 305) about DSM-IV disorders and treatment in the past 12 months for problems with emotions, alcohol or drugs. Results Roughly half (52%) of people who received treatment met criteria for a past-year DSM-IV disorder, an additional 18% for a lifetime disorder and an additional 13% for other indicators of need (multiple subthreshold disorders, recent stressors or suicidal behaviours). Dose-response associations were found between number of indicators of need and treatment. Conclusions The vast majority of treatment in the WMH countries goes to patients with mental disorders or other problems expected to benefit from treatment.	[Bruffaerts, Ronny; Demyttenaere, Koen] Katholieke Univ Leuven, Univ Psychiat Ctr, B-3000 Louvain, Belgium; [Posada-Villa, Jose] Colegio Mayor Cundinamarca Univ, Bogota, Colombia; [Al-Hamzawi, Ali Bald] FICMSAI Qadisia Univ, Coll Med, Diwania, Iraq; [Gureje, Oye] Univ Coll Hosp, WHO Collaborating Ctr Res & Training Mental Hlth, Dept Psychiat, Ibadan, Nigeria; [Huang, Yueqin] Peking Univ, Inst Mental Hlth, Key Lab Minist Hlth, Beijing 100871, Peoples R China; [Hu, Chiyi] Shenzhen Inst Mental Hlth, Shenzhen, Guangdong, Peoples R China; [Hu, Chiyi] Shenzhen Kangning Hosp, Shenzhen, Guangdong, Peoples R China; [Bromet, Evelyn J.] SUNY Stony Brook, Dept Psychiat, Stony Brook, NY 11794 USA; [Viana, Maria Carmen] Univ Fed Espirito Santo, Dept Social Med, Vitoria, Espirito Santo, Brazil; [Hinkov, Hristo Ruskov] Natl Ctr Publ Hlth & Analyses, Sofia, Bulgaria; [Karam, Elie G.] Balamand Univ, St George Hosp Univ, Fac Med, Med Ctr,IDRAA,MIND, Beirut, Lebanon; [Borges, Guilherme] Natl Inst Psychiat Mexico, Div Epidemiol & Psychosocial Res, Mexico City, DF, Mexico; [Borges, Guilherme] Metropolitan Autonomous Univ, Mexico City, DF, Mexico; [Florescu, Silvia E.] Natl Sch Publ Hlth Management & Profess Dev, Bucharest, Romania; [Williams, David R.] Harvard Univ, Sch Publ Hlth, Dept Social & Behav Sci, Boston, MA 02115 USA; [Kovess-Masfety, Viviane] Univ Paris 05, EA 4069, Paris, France; [Kovess-Masfety, Viviane] EHESP Sch Publ Hlth, Dept Epidemiol, Paris, France; [Matschinger, Herbert] Univ Leipzig, Inst Social Med Occupat Hlth & Publ Hlth, D-04109 Leipzig, Germany; [Levinson, Daphna] Minist Hlth, Mental Hlth Serv, Jerusalem, Israel; [de Girolamo, Giovanni] IRCCS Ctr S Giovanni Dio Fatebenefratelli, Brescia, Italy; [Ono, Yutaka] Natl Ctr Neurol & Psychiat, Tokyo, Japan; [de Graaf, Ron] Netherlands Inst Mental Hlth & Addict, Trimbos Inst, Utrecht, Netherlands; [Browne, Mark Oakley] Dept Hlth, Melbourne, Vic, Australia; [Bunting, Brendan] Univ Ulster, Res Inst, Coleraine BT52 1SA, Londonderry, North Ireland; [Xavier, Miguel] Univ Nova Lisboa, Fac Ciencias Med, Chron Dis Res Ctr CEDOC, P-1200 Lisbon, Portugal; [Xavier, Miguel] Univ Nova Lisboa, Fac Ciencias Med, Dept Mental Hlth, P-1200 Lisbon, Portugal; [Maria Haro, Josep] Univ Barcelona, CIBERSAM, Barcelona, Spain; [Kessler, Ronald C.] Harvard Univ, Sch Med, Dept Hlth Care Policy, Boston, MA USA	Bruffaerts, R (reprint author), Katholieke Univ Leuven, Univ Psychiat Ctr, Campus Leuven,Herestr 49, B-3000 Louvain, Belgium.	ronny.bruffaerts@imed.kuleuven.be			United States National Institute of Mental Health [R01MH070884]; Mental Health Burden Study [HHSN271203700030C]; John D. and Catherine T. MacArthur Foundation; Pfizer Foundation; US Public Health Service [R13-MH066849, R01-MH069864, R01 DA016558]; Fogarty International Center [FIRCA R03-TW006481]; Pan American Health Organization; Eli Lilly & Company Foundation; Ortho-McNeil Pharmaceutical, Inc.; GlaxoSmithKline; Bristol-Myers Squibb; Shire; State of Sao Paulo Research Foundation (FAPESP) [03/00204-3]; Ministry of Health; National Center for Public Health Protection; Shenzhen Bureau of Health; Shenzhen Bureau of Science, Technology, and Information; Ministry of Social Protection; European Commission [QLG5-1999-01042, SANCO 2004123]; Piedmont Region (Italy); Fondo de Investigacion Sanitaria, Instituto de Salud Carlos III, Spain [FIS 00/0028]; Ministerio de Ciencia y Tecnologia, Spain [SAF 2000-158-CE]; Departament de Salut, Generalitat de Catalunya, Spain, Instituto de Salud Carlos III [CIBER CB06/02/0046, RETICS RD06/0011 REM-TAP]; Government of India; WHO; United Nations Development Group Iraq Trust Fund (UNDG ITF); Israel National Institute for Health Policy and Health Services Research; National Insurance Institute of Israel; Japan Ministry of Health, Labour and Welfare [H13-SHOGAI-023, H14-TOKUBETSU-026, H16-KOKORO-013]; Lebanese Ministry of Public Health; WHO (Lebanon); Fogarty International; Janssen Cilag; Eli Lilly; Roche; Novartis; National Institute of Psychiatry Ramon de la Fuente [INPRFMDIES 4280]; National Council on Science and Technology [CONACyT-G30544- H]; Pan American Health Organization (PAHO); New Zealand Ministry of Health; Alcohol Advisory Council; Health Research Council; WHO (Geneva); WHO (Nigeria); Federal Ministry of Health, Abuja, Nigeria; Health & Social Care Research & Development Division of the Public Health Agency; Ministry of Public Health; Eli Lilly Romania SRL; US National Institute of Mental Health [R01-MH059575, RO1-MH61905]; National Institute of Drug Abuse; South African Department of Health; University of Michigan; National Institute of Mental Health (NIMH) [U01-MH60220]; National Institute of Drug Abuse (NIDA); Substance Abuse and Mental Health Services Administration (SAMHSA); Robert Wood Johnson Foundation (RWJF) [044708]; John W. Alden Trust	This report is carried out in conjunction with the World Health Organization World Mental Health (WMH) Survey Initiative. These activities were supported by the United States National Institute of Mental Health (R01MH070884), the Mental Health Burden Study. Contract number HHSN271203700030C, the John D. and Catherine T. MacArthur Foundation, the Pfizer Foundation the US Public Health Service (R13-MH066849, R01-MH069864, and R01 DA016558), the Fogarty International Center (FIRCA R03-TW006481), the Pan American Health Organization, the Eli Lilly & Company Foundation, Ortho-McNeil Pharmaceutical, Inc., GlaxoSmithKline, Bristol-Myers Squibb and Shire. A complete list of WMH publications can be found at http://www.hcp.med.harvard.edu/wmh/. The Sao Paulo Megacity Mental Health Survey is supported by the State of Sao Paulo Research Foundation (FAPESP) Thematic Project Grant 03/00204-3. The Bulgarian Epidemiological Study of common mental disorders EPIBUL is supported by the Ministry of Health and the National Center for Public Health Protection. The Chinese World Mental Health Survey Initiative is supported by the Pfizer Foundation. The Shenzhen Mental Health Survey is supported by the Shenzhen Bureau of Health and the Shenzhen Bureau of Science, Technology, and Information. The Colombian National Study of Mental Health (NSMH) is supported by the Ministry of Social Protection. The ESEMeD project is funded by the European Commission (Contracts QLG5-1999-01042; SANCO 2004123), the Piedmont Region (Italy), Fondo de Investigacion Sanitaria, Instituto de Salud Carlos III, Spain (FIS 00/0028), Ministerio de Ciencia y Tecnologia, Spain (SAF 2000-158-CE), Departament de Salut, Generalitat de Catalunya, Spain, Instituto de Salud Carlos III (CIBER CB06/02/0046, RETICS RD06/0011 REM-TAP), and other local agencies and by an unrestricted educational grant from GlaxoSmithKline. The Epidemiological Study on Mental Disorders in India was funded jointly by Government of India and WHO. Implementation of the Iraq Mental Health Survey (IMHS) and data entry were carried out by the staff of the Iraqi MOH and MOP with direct support from the Iraqi IMHS team with funding from both the Japanese and European Funds through United Nations Development Group Iraq Trust Fund (UNDG ITF). The Israel National Health Survey is funded by the Ministry of Health with support from the Israel National Institute for Health Policy and Health Services Research and the National Insurance Institute of Israel. The World Mental Health Japan (WMHJ) Survey is supported by the Grant for Research on Psychiatric and Neurological Diseases and Mental Health (H13-SHOGAI-023, H14-TOKUBETSU-026, H16-KOKORO-013) from the Japan Ministry of Health, Labour and Welfare. The Lebanese National Mental Health Survey (LEBANON) is supported by the Lebanese Ministry of Public Health, the WHO (Lebanon), Fogarty International, anonymous private donations to IDRAAC, Lebanon, and unrestricted grants from Janssen Cilag, Eli Lilly, GlaxoSmithKline, Roche and Novartis. The Mexican National Comorbidity Survey (MNCS) is supported by The National Institute of Psychiatry Ramon de la Fuente (INPRFMDIES 4280) and by the National Council on Science and Technology (CONACyT-G30544- H), with supplemental support from the Pan American Health Organization (PAHO). Te Rau Hinengaro: The New Zealand Mental Health Survey (NZMHS) is supported by the New Zealand Ministry of Health, Alcohol Advisory Council and the Health Research Council.; The Nigerian Survey of Mental Health and Wellbeing (NSMHW) is supported by the WHO (Geneva), the WHO (Nigeria) and the Federal Ministry of Health, Abuja, Nigeria. The Northern Ireland Study of Mental Health was funded by the Health & Social Care Research & Development Division of the Public Health Agency. The Romania WMH study projects 'Policies in Mental Health Area' and 'National Study regarding Mental Health and Services Use' were carried out by National School of Public Health & Health Services Management (former National Institute for Research & Development in Health), with technical support of Metro Media Transilvania, the National Institute of Statistics-National Centre for Training in Statistics, SC. Cheyenne Services SRL, Statistics Netherlands and were funded by Ministry of Public Health (former Ministry of Health) with supplemental support of Eli Lilly Romania SRL. The South Africa Stress and Health Study (SASH) is supported by the US National Institute of Mental Health (R01-MH059575) and National Institute of Drug Abuse with supplemental funding from the South African Department of Health and the University of Michigan. The Ukraine Comorbid Mental Disorders during Periods of Social Disruption (CMDPSD) study is funded by the US National Institute of Mental Health (RO1-MH61905). The US National Comorbidity Survey Replication (NCS-R) is supported by the National Institute of Mental Health (NIMH; U01-MH60220) with supplemental support from the National Institute of Drug Abuse (NIDA), the Substance Abuse and Mental Health Services Administration (SAMHSA), the Robert Wood Johnson Foundation (RWJF; Grant 044708) and the John W. Alden Trust.	American Psychiatric Association, 1994, DIAGN STAT MAN MENT; Andrews G, 2000, UNMET NEED PSYCHIAT; SIMON GE, 1995, EPIDEMIOL REV, V17, P221; Druss BG, 2007, ARCH GEN PSYCHIAT, V64, P1196, DOI 10.1001/archpsyc.64.10.1196; SHAPIRO S, 1985, MED CARE, V23, P1033, DOI 10.1097/00005650-198509000-00002; Haro JM, 2006, INT J METH PSYCH RES, V15, P167, DOI 10.1002/mpr.196; Wittchen HU, 2005, EUR NEUROPSYCHOPHARM, V15, P357, DOI 10.1016/j.euroneuro.2005.04.012; Wang PS, 2007, WORLD PSYCHIATRY, V6, P177; Sareen J, 2005, CAN J PSYCHIAT, V50, P87; REGIER DA, 1993, ARCH GEN PSYCHIAT, V50, P85; Mojtabai R, 2009, PSYCHIAT SERV, V60, P297, DOI 10.1176/appi.ps.60.3.297; de Graaf R, 2013, J AFFECT DISORDERS, V149, P100, DOI 10.1016/j.jad.2013.01.009; Kessler RC, 2004, INT J METH PSYCH RES, V13, P93, DOI 10.1002/mpr.168; KESSLER RC, 1993, AM J COMMUN PSYCHOL, V21, P607, DOI 10.1007/BF00942174; Ross HE, 1999, CAN J PSYCHIAT, V44, P570; Wang PS, 2007, LANCET, V370, P841, DOI 10.1016/S0140-6736(07)61414-7; Bijl RV, 2003, HEALTH AFFAIR, V22, P122, DOI 10.1377/hlthaff.22.3.122; Angold A, 1999, J AM ACAD CHILD PSY, V38, P129, DOI 10.1097/00004583-199902000-00011; Aoun, 2004, MENT HLTH SERV RES, V6, P33; Druss BG, 2006, HEALTH AFFAIR, V25, P614, DOI 10.1377/hlthaff.25.3.614; Evans-Lacko S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0069792; Harkness J., 2008, The WHO world mental health surveys: global perspectives on the epidemiology of mental disorders, P91; Heeringa S. G., 2008, The WHO world mental health surveys: global perspectives on the epidemiology of mental disorders, P14; Henderson S, 2001, PSYCHOL MED, V31, P769; Hu Teh-wei, 2003, J Ment Health Policy Econ, V6, P145; Kessler RC, 1997, NEW ENGL J MED, V336, P551, DOI 10.1056/NEJM199702203360806; KLERMAN GL, 1992, HEALTH AFFAIR, V11, P23, DOI 10.1377/hlthaff.11.3.23; Lin E, 1997, SOC PSYCH PSYCH EPID, V32, P355, DOI 10.1007/BF00805441; Maercker A, 2001, GERMAN J PSYCHIAT, V4, P17; Pennell B. E., 2008, The WHO world mental health surveys: global perspectives on the epidemiology of mental disorders, P33; Petrou S, 2002, INT J TECHNOL ASSESS, V18, P705; ten Have M, 2013, PSYCHOL MED, V43, P2203, DOI 10.1017/S0033291713000135; Waza K, 1999, FAM PRACT, V16, P528, DOI 10.1093/fampra/16.5.528; Demyttenaere K, 2004, JAMA-J AM MED ASSOC, V291, P2581; Wolter KM, 1985, INTRO VARIANCE ESTIM; World Bank, 2008, WORLD BANK COUNTRY, P1, DOI 10.1596/978-0-8213-7462-7	36	1	1	ROYAL COLLEGE OF PSYCHIATRISTS	LONDON	BRITISH JOURNAL OF PSYCHIATRY 17 BELGRAVE SQUARE, LONDON SW1X 8PG, ENGLAND	0007-1250	1472-1465		BRIT J PSYCHIAT	Br. J. Psychiatry	FEB	2015	206	2					101	109		10.1192/bjp.bp.113.141424		9	Psychiatry	Psychiatry	CA9XC	WOS:000349277100004		
J	Sonoshita, M; Itatani, Y; Kakizaki, F; Sakimura, K; Terashima, T; Katsuyama, Y; Sakai, Y; Taketo, MM				Sonoshita, Masahiro; Itatani, Yoshiro; Kakizaki, Fumihiko; Sakimura, Kenji; Terashima, Toshio; Katsuyama, Yu; Sakai, Yoshiharu; Taketo, M. Mark			Promotion of Colorectal Cancer Invasion and Metastasis through Activation of NOTCH-DAB1-ABL-RHOGEF Protein TRIO	CANCER DISCOVERY			English	Article							EPITHELIAL-MESENCHYMAL TRANSITION; TYROSINE KINASE INHIBITOR; EXCHANGE FACTOR DOMAINS; CELL-MIGRATION; STEM-CELLS; CARCINOMA-CELLS; IN-VIVO; C-ABL; GENE; EXPRESSION	We have recently identified a metastasis suppressor gene for colorectal cancer: AES/Aes, which encodes an endogenous inhibitor of NOTCH signaling. When Aes is knocked out in the adenomatous epithelium of intestinal polyposis mice, their tumors become malignant, showing marked submucosal invasion and intravasation. Here, we show that one of the genes induced by NOTCH signaling in colorectal cancer is DAB1/Dab1. Genetic depletion of DAB1 suppresses cancer invasion and metastasis in the NOTCH signaling-activated mice. DAB1 is phosphorylated by ABL tyrosine kinase, which activates ABL reciprocally. Consistently, inhibition of ABL suppresses cancer invasion in mice. Furthermore, we show that one of the targets of ABL is the RAC/RHOGEF protein TRIO, and that phosphorylation at its Tyr residue 2681 (pY2681) causes RHO activation in colorectal cancer cells. Its unphosphorylatable mutation TRIO Y2681F reduces RHOGEF activity and inhibits invasion of colorectal cancer cells. Importantly, TRIO pY2681 correlates with significantly poorer prognosis of patients with colorectal cancer after surgery. SIGNIFICANCE: These results indicate that TRIO pY2681 is one of the downstream effectors of NOTCH signaling activation in colorectal cancer, and can be a prognostic marker, helping to determine the therapeutic modality of patients with colorectal cancer. (C) 2014 AACR.	[Sonoshita, Masahiro; Itatani, Yoshiro; Kakizaki, Fumihiko; Taketo, M. Mark] Kyoto Univ, Grad Sch Med, Dept Pharmacol, Kyoto 6068501, Japan; [Itatani, Yoshiro; Sakai, Yoshiharu; Taketo, M. Mark] Kyoto Univ, Grad Sch Med, Dept Surg, Kyoto 6068501, Japan; [Sakimura, Kenji] Niigata Univ, Brain Res Inst, Dept Cellular Neurobiol, Niigata, Japan; [Terashima, Toshio] Kobe Univ, Grad Sch Med, Div Anat & Neurobiol, Dept Physiol & Cell Biol, Kobe, Hyogo 657, Japan; [Katsuyama, Yu] Tohoku Univ, Grad Sch Med, Div Dev Neurosci, Sendai, Miyagi 980, Japan	Taketo, MM (reprint author), Kyoto Univ, Grad Sch Med, Sakyo Ku, Yoshida Konoe Cho, Kyoto 6068501, Japan.	taketo@mfour.med.kyoto-u.ac.jp			Ministry of Education, Culture, Sports, Science and Technology (MEXT) of Japan; Kanae Foundation for the Promotion of Medical Science; Sagawa Foundation for Promotion of Cancer Research	This work was supported in part by grants-in-aid from the Ministry of Education, Culture, Sports, Science and Technology (MEXT) of Japan (to M. Sonoshita and M.M. Taketo) and grants from The Kanae Foundation for the Promotion of Medical Science and The Sagawa Foundation for Promotion of Cancer Research (to M. Sonoshita).	SEKINE A, 1989, J BIOL CHEM, V264, P8602; Gorre ME, 2001, SCIENCE, V293, P876, DOI 10.1126/science.1062538; Hashimoto-Torii K, 2008, NEURON, V60, P273, DOI 10.1016/j.neuron.2008.09.026; Blom N, 1999, J MOL BIOL, V294, P1351, DOI 10.1006/jmbi.1999.3310; Sanada K, 2004, NEURON, V42, P197, DOI 10.1016/S0896-6273(04)00222-3; Wolf K, 2003, J CELL BIOL, V160, P267, DOI 10.1083/jcb.200209006; Friedl P, 2004, CURR OPIN CELL BIOL, V16, P14, DOI 10.1016/j.ceb.2003.11.001; Hantschel O, 2004, NAT REV MOL CELL BIO, V5, P33, DOI 10.1038/nrm1280; Strickler JH, 2014, INVEST NEW DRUG, V32, P330, DOI 10.1007/s10637-013-0042-9; Spano D, 2012, SEMIN CANCER BIOL, V22, P234, DOI 10.1016/j.semcancer.2012.03.006; Barker N, 2007, NATURE, V449, P1003, DOI 10.1038/nature06196; OSHIMA M, 1995, P NATL ACAD SCI USA, V92, P4482, DOI 10.1073/pnas.92.10.4482; VanDussen KL, 2012, DEVELOPMENT, V139, P488, DOI 10.1242/dev.070763; Ramalingam S, 2012, AM J PHYSIOL-GASTR L, V302, pG10, DOI 10.1152/ajpgi.00277.2011; Narumiya S, 2000, METHOD ENZYMOL, V325, P273; Gaggioli C, 2007, NAT CELL BIOL, V9, P1392, DOI 10.1038/ncb1658; Debant A, 1996, P NATL ACAD SCI USA, V93, P5466, DOI 10.1073/pnas.93.11.5466; Milano J, 2004, TOXICOL SCI, V82, P341, DOI 10.1093/toxsci/kfh254; Bellanger JM, 1998, ONCOGENE, V16, P147, DOI 10.1038/sj.onc.1201532; Bellone G, 2004, CANCER BIOL THER, V3, P385; Li YC, 2012, STEM CELLS, V30, P741, DOI 10.1002/stem.1030; Mani SA, 2008, CELL, V133, P704, DOI 10.1016/j.cell.2008.03.027; Hall A, 2009, CANCER METAST REV, V28, P5, DOI 10.1007/s10555-008-9166-3; Gao Y, 2004, P NATL ACAD SCI USA, V101, P7618, DOI 10.1073/pnas.0307512101; Croft DR, 2008, CANCER CELL, V14, P349, DOI 10.1016/j.ccr.2008.10.009; Han H, 2002, INT IMMUNOL, V14, P637, DOI 10.1093/intimm/dxf030; Okabe M, 1997, FEBS LETT, V407, P313, DOI 10.1016/S0014-5793(97)00313-X; Dowell RD, 2010, TRENDS GENET, V26, P468, DOI 10.1016/j.tig.2010.08.005; Reffay M, 2014, NAT CELL BIOL, V16, P217, DOI 10.1038/ncb2917; Friedl P, 2012, NAT CELL BIOL, V14, P777, DOI 10.1038/ncb2548; El Marjou F, 2004, GENESIS, V39, P186, DOI 10.1002/gene.20042; Arnaud L, 2003, CURR BIOL, V13, P9, DOI 10.1016/S0960-9822(02)01397-0; Buchdunger E, 2001, BBA-REV CANCER, V1551, pM11, DOI 10.1016/S0304-419X(01)00022-1; Ridley AJ, 2001, J CELL SCI, V114, P2713; Nosaka T, 1999, EMBO J, V18, P4754, DOI 10.1093/emboj/18.17.4754; Markowitz SD, 2009, NEW ENGL J MED, V361, P2449, DOI 10.1056/NEJMra0804588; MIZUSHIMA S, 1990, NUCLEIC ACIDS RES, V18, P5322, DOI 10.1093/nar/18.17.5322; Sonoshita M, 2011, CANCER CELL, V19, P125, DOI 10.1016/j.ccr.2010.11.008; Sanz-Moreno V, 2008, CELL, V135, P510, DOI 10.1016/j.cell.2008.09.043; Shah NP, 2004, SCIENCE, V305, P399, DOI 10.1126/science.1099480; Sahai E, 2003, NAT CELL BIOL, V5, P711, DOI 10.1038/ncb1019; Kitadai Y, 2006, AM J PATHOL, V169, P2054, DOI 10.2353/ajpath.2006.060653; Fre S, 2005, NATURE, V435, P964, DOI 10.1038/nature03589; Hanke JH, 1996, J BIOL CHEM, V271, P695; Barila D, 2000, EMBO J, V19, P273, DOI 10.1093/emboj/19.2.273; Chen XD, 2008, J MOL HISTOL, V39, P283, DOI 10.1007/s10735-008-9164-3; Colicelli J, 2010, SCI SIGNAL, V3, DOI 10.1126/scisignal.3139re6; Fidler IJ, 2003, NAT REV CANCER, V3, P453, DOI 10.1038/nrc1098; Forsthoefel DJ, 2005, DEVELOPMENT, V132, P1983, DOI 10.1242/dev.01736; Howell BW, 1997, EMBO J, V16, P121, DOI 10.1093/emboj/16.1.121; Kakizaki F, 2010, GASTROENTEROLOGY, V138, P627, DOI 10.1053/j.gastro.2009.10.047; Krejci A., 2009, SCI SIGNAL, V2, pra1; Nellesen DT, 1999, DEV BIOL, V213, P33, DOI 10.1006/dbio.1999.9324; Weinberg R. A., 2014, BIOL CANC, P587	54	3	3	AMER ASSOC CANCER RESEARCH	PHILADELPHIA	615 CHESTNUT ST, 17TH FLOOR, PHILADELPHIA, PA 19106-4404 USA	2159-8274	2159-8290		CANCER DISCOV	Cancer Discov.	FEB	2015	5	2					198	211		10.1158/2159-8290.CD-14-0595		14	Oncology	Oncology	CB1NC	WOS:000349393600027		
J	Sato, N; Maeda, M; Sugiyama, M; Ito, S; Hyodo, T; Masuda, A; Tsunoda, N; Kokuryo, T; Hamaguchi, M; Nagino, M; Senga, T				Sato, Naoki; Maeda, Masao; Sugiyama, Mai; Ito, Satoko; Hyodo, Toshinori; Masuda, Akio; Tsunoda, Nobuyuki; Kokuryo, Toshio; Hamaguchi, Michinari; Nagino, Masato; Senga, Takeshi			Inhibition of SNW1 association with spliceosomal proteins promotes apoptosis in breast cancer cells	CANCER MEDICINE			English	Article						Apoptosis; EFTUD2; PRPF8; RNA splicing; SNRNP200; SNW1	PRE-MESSENGER-RNA; INTERACTING PROTEIN; SKIP INTERACTS; HIV-1 TAT; PRP8; TRANSCRIPTION; HELICASE; RECEPTOR; SNU114P; DOMAIN	RNA splicing is a fundamental process for protein synthesis. Recent studies have reported that drugs that inhibit splicing have cytotoxic effects on various tumor cell lines. In this report, we demonstrate that depletion of SNW1, a component of the spliceosome, induces apoptosis in breast cancer cells. Proteomics and biochemical analyses revealed that SNW1 directly associates with other spliceosome components, including EFTUD2 (Snu114) and SNRNP200 (Brr2). The SKIP region of SNW1 interacted with the N-terminus of EFTUD2 as well as two independent regions in the C-terminus of SNRNP200. Similar to SNW1 depletion, knockdown of EFTUD2 increased the numbers of apoptotic cells. Furthermore, we demonstrate that exogenous expression of either the SKIP region of SNW1 or the N-terminus region of EFTUD2 significantly promoted cellular apoptosis. Our results suggest that the inhibition of SNW1 or its associating proteins may be a novel therapeutic strategy for cancer treatment.	[Sato, Naoki; Tsunoda, Nobuyuki; Kokuryo, Toshio; Nagino, Masato] Nagoya Univ, Grad Sch Med, Dept Surg Oncol, Showa Ku, Nagoya, Aichi 4668550, Japan; [Maeda, Masao; Sugiyama, Mai; Ito, Satoko; Hyodo, Toshinori; Hamaguchi, Michinari; Senga, Takeshi] Nagoya Univ, Grad Sch Med, Div Canc Biol, Showa Ku, Nagoya, Aichi 4668550, Japan; [Masuda, Akio] Nagoya Univ, Grad Sch Med, Div Neurogenet, Showa Ku, Nagoya, Aichi 4668550, Japan	Senga, T (reprint author), 65 Tsurumai, Nagoya, Aichi 4668550, Japan.	tsenga@med.nagoya-u.ac.jp			Ministry of Education, Culture, Sports, Science and Technology of Japan [23107010]	This research was funded by a grant from the Ministry of Education, Culture, Sports, Science and Technology of Japan (Nanomedicine molecular science, 23107010.	Abankwa D, 2013, BMC BIOCHEM, V14, DOI 10.1186/1471-2091-14-10; Kotake Y, 2007, NAT CHEM BIOL, V3, P570, DOI 10.1038/nchembio.2007.16; Grainger RJ, 2005, RNA, V11, P533, DOI 10.1261/rna.2220705; Bonnal S, 2012, NAT REV DRUG DISCOV, V11, P847, DOI 10.1038/nrd3823; Zhang C, 2003, J BIOL CHEM, V278, P35325, DOI 10.1074/jbc.M305191200; Corrionero A, 2011, GENE DEV, V25, P445, DOI 10.1101/gad.2014311; Achsel T, 1998, MOL CELL BIOL, V18, P6756; Kittler R, 2004, NATURE, V432, P1036, DOI 10.1038/nature03159; Lehalle D, 2014, HUM MUTAT, V35, P478, DOI 10.1002/humu.22517; Frazer LN, 2008, BIOCHEM SOC T, V36, P551, DOI 10.1042/BST0360551; Kaida D, 2007, NAT CHEM BIOL, V3, P576, DOI 10.1038/nchembio.2007.18; Hegele A, 2012, MOL CELL, V45, P567, DOI 10.1016/j.molcel.2011.12.034; Bartels C, 2002, EMBO REP, V3, P875, DOI 10.1093/embo-reports/kvf172; Neumann B, 2010, NATURE, V464, P721, DOI 10.1038/nature08869; Wahl MC, 2009, CELL, V136, P701, DOI 10.1016/j.cell.2009.02.009; Mozaffari-Jovin S, 2012, GENE DEV, V26, P2422, DOI 10.1101/gad.200949.112; Small EC, 2006, MOL CELL, V23, P389, DOI 10.1016/j.molcel.2006.05.043; Albers M, 2003, RNA, V9, P138, DOI 10.1261/rna.2119903; Chen YP, 2011, GENE DEV, V25, P701, DOI 10.1101/gad.2002611; Hutchins JRA, 2010, SCIENCE, V328, P593, DOI 10.1126/science.1181348; Makarov EM, 2002, SCIENCE, V298, P2205, DOI 10.1126/science.1077783; Mozaffari-Jovin S, 2013, SCIENCE, V341, P80, DOI 10.1126/science.1237515; Maeder C, 2009, NAT STRUCT MOL BIOL, V16, P42, DOI 10.1038/nsmb.1535; Chanarat S, 2013, BBA-MOL CELL RES, V1833, P2126, DOI 10.1016/j.bbamcr.2013.05.023; Hasegawa M, 2011, ACS CHEM BIOL, V6, P229, DOI 10.1021/cb100248e; Pena V, 2007, MOL CELL, V25, P615, DOI 10.1016/j.molcel.2007.01.023; Zhou SF, 2000, MOL CELL BIOL, V20, P2400, DOI 10.1128/MCB.20.7.2400-2410.2000; Barry JB, 2003, J BIOL CHEM, V278, P8224, DOI 10.1074/jbc.C200712200; Bres V, 2005, GENE DEV, V19, P1211, DOI 10.1101/gad.1291705; Bres V, 2009, MOL CELL, V36, P75, DOI 10.1016/j.molcel.2009.08.015; Hahn D, 2010, BIOCHEM SOC T, V38, P1105, DOI 10.1042/BST0381105; Kang MR, 2010, NUCLEIC ACIDS RES, V38, P822, DOI 10.1093/nar/gkp1056; Will CL, 2011, CSH PERSPECT BIOL, V3, DOI 10.1101/cshperspect.a003707	33	0	1	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	2045-7634			CANCER MED-US	Cancer Med.	FEB	2015	4	2					268	277		10.1002/cam4.366		10	Oncology	Oncology	CB0IS	WOS:000349309800010		
J	Nakajima, K; Inomata, M; Iha, H; Hiratsuka, T; Etoh, T; Shiraishi, N; Kashima, K; Kitano, S				Nakajima, Kentaro; Inomata, Masafumi; Iha, Hidekatsu; Hiratsuka, Takahiro; Etoh, Tsuyoshi; Shiraishi, Norio; Kashima, Kenji; Kitano, Seigo			Establishment of new predictive markers for distant recurrence of colorectal cancer using lectin microarray analysis	CANCER MEDICINE			English	Article						Colorectal cancer; glycoprotein; lectin; prediction; recurrence	II COLON-CANCER; ADJUVANT CHEMOTHERAPY; LIVER METASTASES; MONOCLONAL-ANTIBODY; SIALOSYL-TN; FOLLOW-UP; MUCIN 1; GLYCOSYLATION; ANTIGEN; OLIGOSACCHARIDES	We evaluated the clinical benefits of novel predictive markers for distant recurrence with colorectal cancer using lectin microarray analysis of cell surface glycan modifications. Glycoproteins were extracted from formalin-fixed, paraffin-embedded tumor specimens and normal epithelium from 53 consecutive curatively resected stage I-III colorectal cancer cases and then subjected to lectin microarray to obtain lectin-glycan interaction (LGI) values. In addition, clinicopathological factors associated with distant recurrence were identified. LGI values that were associated with distant recurrence were validated with an additional 55 curatively resected stage II colorectal cancer cases. LGI values for Agaricus bisporus (ABA) lectin, prominent in cancer tissues, were statistically associated with distant recurrence. ABA lectin staining exhibited strikingly intense signals in the cytoplasm and apical surfaces of cancer cells, while weak staining was observed in the supranuclear regions of normal epithelium. This ABA tumor/normal LGI ratio may be a new predictive biomarker for distant recurrence of curatively resected colorectal cancer.	[Nakajima, Kentaro; Inomata, Masafumi; Hiratsuka, Takahiro; Etoh, Tsuyoshi; Shiraishi, Norio; Kitano, Seigo] Oita Univ, Fac Med, Dept Gastrointestinal & Pediat Surg, Oita 8795593, Japan; [Iha, Hidekatsu] Oita Univ, Fac Med, Dept Microbiol, Oita 8795593, Japan; [Kashima, Kenji] Oita Univ, Fac Med, Dept Diagnost Pathol, Oita 8795593, Japan	Inomata, M (reprint author), Oita Univ, Fac Med, Dept Gastrointestinal & Pediat Surg, Hasama Machi, Oita 8795593, Japan.	inomata@oita-u.ac.jp			Health and Labor Sciences Research Grant for Clinical Cancer Research from the Ministry of Health, Labor and Welfare of Japan [19-Gan-21]	This study was supported by a Health and Labor Sciences Research Grant for Clinical Cancer Research (19-Gan-21) from the Ministry of Health, Labor and Welfare of Japan.	Andre T, 2006, ANN SURG ONCOL, V13, P887, DOI 10.1245/ASO.2006.07.003; CAO Y, 1995, CANCER, V76, P1700, DOI 10.1002/1097-0142(19951115)76:10<1700::AID-CNCR2820761005>3.0.CO;2-Z; ITZKOWITZ SH, 1989, CANCER RES, V49, P197; Ogino S, 2009, CLIN CANCER RES, V15, P7322, DOI 10.1158/1078-0432.CCR-09-1570; Schippinger W, 2007, BRIT J CANCER, V97, P1021, DOI 10.1038/sj.bjc.6604011; Park IJ, 2009, ANN SURG ONCOL, V16, P3087, DOI 10.1245/s10434-009-0625-z; ZENG ZS, 1993, DIS COLON RECTUM, V36, P1063, DOI 10.1007/BF02047301; DENNIS JW, 1987, SCIENCE, V236, P582, DOI 10.1126/science.2953071; Munro AJ, 2005, BRIT J CANCER, V92, P434, DOI 10.1038/sj.bjc.6602358; Watanabe T, 2001, NEW ENGL J MED, V344, P1196, DOI 10.1056/NEJM200104193441603; Bhattacharjya S, 2006, BRIT J CANCER, V95, P21, DOI 10.1038/sj.bjc.6603219; Nishijima Y, 2012, GENES CELLS, V17, P826, DOI 10.1111/gtc.12003; Benson AB, 2004, J CLIN ONCOL, V22, P3408, DOI 10.1200/JCO.2004.05.063; Park JH, 2010, CANCER RES, V70, P2759, DOI 10.1158/0008-5472.CAN-09-3911; Labianca R, 2010, ANN ONCOL, V21, pv70, DOI 10.1093/annonc/mdq168; Vanderschaeghe D, 2010, BIOL CHEM, V391, P149, DOI 10.1515/BC.2010.031; Matsuda A, 2010, HEPATOLOGY, V52, P174, DOI 10.1002/hep.23654; Chen GQ, 2012, J PROTEOMICS, V75, P2824, DOI 10.1016/j.jprot.2012.02.001; Deschoolmeester V, 2010, ONCOLOGIST, V15, P699, DOI 10.1634/theoncologist.2010-0025; Ohtsubo K, 2011, NAT MED, V17, P1067, DOI 10.1038/nm.2414; Lange T, 2012, CLIN CANCER RES, V18, P1364, DOI 10.1158/1078-0432.CCR-11-2900; VARKI A, 1993, GLYCOBIOLOGY, V3, P97, DOI 10.1093/glycob/3.2.97; Popat S, 2005, J CLIN ONCOL, V23, P609, DOI 10.1200/JCO.2005.01.186; Tol J, 2009, NEW ENGL J MED, V361, P98, DOI 10.1056/NEJMc0904160; Carrizo ME, 2005, J BIOL CHEM, V280, P10614, DOI 10.1074/jbc.M411989200; Fry SA, 2011, GLYCOBIOLOGY, V21, P1060, DOI 10.1093/glycob/cwr045; Hanisch FG, 1997, HISTOL HISTOPATHOL, V12, P263; Iha H., 2013, T CELL LEUKEMIA CHAR, P89, DOI [10. 5772/45997, DOI 10.5772/45997]; Inomata M, 1998, JPN J CLIN ONCOL, V28, P123, DOI 10.1093/jjco/28.2.123; KIM YS, 1977, CANCER, V40, P2473, DOI 10.1002/1097-0142(197711)40:5+<2473::AID-CNCR2820400913>3.0.CO;2-C; LANGKILDE NC, 1992, CANCER, V69, P219, DOI 10.1002/1097-0142(19920101)69:1<219::AID-CNCR2820690136>3.0.CO;2-A; Matsuda A, 2008, BIOCHEM BIOPH RES CO, V370, P259, DOI 10.1016/j.bbrc.2008.03.090; MCMAHON RFT, 1994, HISTOCHEM J, V26, P504, DOI 10.1007/BF00157896; Gray R, 2007, LANCET, V370, P2020; Saldova R, 2011, EPIGENETICS-US, V6, P1362, DOI 10.4161/epi.6.11.17977; Shigeoka H, 1999, TUMOR BIOL, V20, P139, DOI 10.1159/000030056; STEIN R, 1989, CANCER RES, V49, P32	37	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	2045-7634			CANCER MED-US	Cancer Med.	FEB	2015	4	2					293	302		10.1002/cam4.342		10	Oncology	Oncology	CB0IS	WOS:000349309800012		
J	Hayabuchi, Y; Sakata, M; Kagami, S				Hayabuchi, Yasunobu; Sakata, Miho; Kagami, Shoji			Fibromyxoid excrescence of the aortic valve that manifested after catheterisation and required resection	CARDIOLOGY IN THE YOUNG			English	Article						Fibromyxoid excrescence; aortic valve; catheterisation		A 2-year-old boy developed fibromyxoid excrescence of the aortic valve 2 years after balloon dilatation for simple coarctation. Transthoracic echocardiography showed a mobile mass on the non-coronary cusp of the aortic valve. Definitive diagnosis was achieved after operative resection. This pathology was attributed to injury during catheter manipulation. Catheterised patients should be followed up carefully to avoid missing morphological changes.	[Hayabuchi, Yasunobu; Sakata, Miho; Kagami, Shoji] Univ Tokushima, Dept Pediat, Tokushima 7708305, Japan	Hayabuchi, Y (reprint author), Univ Tokushima, Dept Pediat, Kuramoto Cho 3, Tokushima 7708305, Japan.	hayabuchi@clin.med.tokushima-u.ac.jp					Becker AE, 2000, PEDIATR CARDIOL, V21, P317, DOI 10.1007/s002460010071; Boroumand MA, 2008, CARDIOVASC PATHOL, V17, P124, DOI 10.1016/j.carpath.2007.03.003; Censi Stefano, 2008, Interact Cardiovasc Thorac Surg, V7, P1201, DOI 10.1510/icvts.2008.184499; Ovaert C, 1998, PEDIATR CARDIOL, V19, P27, DOI 10.1007/s002469900243; Parker RI, 2010, CRIT CARE MED, V38, pS71, DOI 10.1097/CCM.0b013e3181c9cce9; Shim CY, 2012, J AM COLL CARDIOL, V60, pE3, DOI 10.1016/j.jacc.2011.11.076	6	0	0	CAMBRIDGE UNIV PRESS	CAMBRIDGE	EDINBURGH BLDG, SHAFTESBURY RD, CB2 8RU CAMBRIDGE, ENGLAND	1047-9511	1467-1107		CARDIOL YOUNG	Cardiol. Young	FEB	2015	25	2					362	364		10.1017/S1047951114000092		3	Cardiac & Cardiovascular Systems; Pediatrics	Cardiovascular System & Cardiology; Pediatrics	CB1KU	WOS:000349387000028		
J	Hoashi, T; Shiraishi, I; Ichikawa, H				Hoashi, Takaya; Shiraishi, Isao; Ichikawa, Hajime			Surgical experience for prolapse of both atrioventricular valves in a patient with filamin A mutation	CARDIOLOGY IN THE YOUNG			English	Article						Filamin A mutation; Ehlers-Danlos syndrome; mitral valve prolapse; paediatric		A 21-year-old man underwent mitral valve replacement and tricuspid annuloplasty for severe mitral regurgitation and moderate tricuspid regurgitation. Until the operation, he had been treated for hypermobility type Ehlers-Danlos syndrome. Gene examination revealed a mutation in filamin A gene, which is the gene responsible for X-linked myxomatous valvular dystrophy.	[Hoashi, Takaya; Ichikawa, Hajime] Natl Cerebral & Cardiovasc Ctr, Dept Pediat Cardiovasc Surg, Suita, Osaka, Japan; [Shiraishi, Isao] Natl Cerebral & Cardiovasc Ctr, Dept Pediat Cardiol, Suita, Osaka, Japan	Hoashi, T (reprint author), 5-7-1 Fujishiro Dai, Suita, Osaka 5658565, Japan.	thoashi@surg1.med.osaka-u.ac.jp					Bernstein JA, 2011, AM J MED GENET A, V155A, P2236, DOI 10.1002/ajmg.a.34132; Kyndt F, 2007, CIRCULATION, V115, P40, DOI 10.1161/CIRCULATIONAHA.106.622621; Lardeux A, 2011, J CARDIOVASC TRANSL, V4, P748, DOI 10.1007/s12265-011-9308-9; Sheen VL, 2005, NEUROLOGY, V64, P254; NEWBURYECOB RA, 1993, J MED GENET, V30, P873, DOI 10.1136/jmg.30.10.873	5	0	0	CAMBRIDGE UNIV PRESS	CAMBRIDGE	EDINBURGH BLDG, SHAFTESBURY RD, CB2 8RU CAMBRIDGE, ENGLAND	1047-9511	1467-1107		CARDIOL YOUNG	Cardiol. Young	FEB	2015	25	2					365	367		10.1017/S1047951114000122		3	Cardiac & Cardiovascular Systems; Pediatrics	Cardiovascular System & Cardiology; Pediatrics	CB1KU	WOS:000349387000029		
J	Nakanishi, K; Morita, T; Amano, A				Nakanishi, Keisuke; Morita, Terumasa; Amano, Atsushi			Novel visualised three-dimensional images are useful for treating coronary artery fistulas in infants	CARDIOLOGY IN THE YOUNG			English	Article						Coronary artery fistula; congenital heart; three-dimensional computed tomography	SURGICAL-TREATMENT	Here we report an infant with coronary artery fistulas. To clearly visualise the fistulas and surrounding materials, we utilised three-dimensional computed tomography, and the images were transferred as novel visualised three-dimensional images using a reconstruction technique. With the images, we could repair the fistulas accurately. We believe that these images are useful for repairing coronary artery fistulas in infants.	[Nakanishi, Keisuke; Morita, Terumasa; Amano, Atsushi] Juntendo Univ, Dept Cardiovasc Surg, Sch Med, Tokyo 1138421, Japan	Morita, T (reprint author), Juntendo Univ, Dept Cardiovasc Surg, Bunkyo Ku, 2-1-1 Hongo, Tokyo 1138421, Japan.	temorita@juntendo.ac.jp					Han BK, 2012, J CARDIOVASC COMPUT, V6, P252, DOI 10.1016/j.jcct.2012.01.004; Gowda RM, 2006, INT J CARDIOL, V107, P7, DOI 10.1016/j.ijcard.2005.01.067; LEVIN DC, 1978, CIRCULATION, V58, P25; Balanescu S, 2001, Ital Heart J, V2, P669; Darwazah AK, 2011, J CARDIAC SURG, V26, P608, DOI 10.1111/j.1540-8191.2011.01283.x; Dodge-Khatami A, 2000, ANN THORAC SURG, V69, P270, DOI 10.1016/S0003-4975(99)01248-5; Kamiya H, 2002, J CARDIAC SURG, V17, P173, DOI 10.1111/j.1540-8191.2002.tb01195.x; Malekahmadi M, 2005, PEDIATR CARDIOL, V26, P328, DOI 10.1007/s00246-004-0656-y	8	0	0	CAMBRIDGE UNIV PRESS	CAMBRIDGE	EDINBURGH BLDG, SHAFTESBURY RD, CB2 8RU CAMBRIDGE, ENGLAND	1047-9511	1467-1107		CARDIOL YOUNG	Cardiol. Young	FEB	2015	25	2					388	390		10.1017/S1047951114000286		3	Cardiac & Cardiovascular Systems; Pediatrics	Cardiovascular System & Cardiology; Pediatrics	CB1KU	WOS:000349387000035		
J	Luft, V; Reinhard, J; Shibuya, M; Fischer, KD; Faissner, A				Luft, Veronika; Reinhard, Jacqueline; Shibuya, Masabumi; Fischer, Klaus D.; Faissner, Andreas			The guanine nucleotide exchange factor Vav3 regulates differentiation of progenitor cells in the developing mouse retina	CELL AND TISSUE RESEARCH			English	Article						Guanine nucleotide exchange factor; Vav3; Retinal progenitor cell; Retinogenesis; Mouse	CHONDROITIN SULFATE PROTEOGLYCAN; MOLECULE TENASCIN-C; NEURITE OUTGROWTH; GANGLION-CELLS; DEVELOPMENTAL EXPRESSION; VERTEBRATE RETINA; FAMILY PROTEINS; PHOTORECEPTOR CELLS; FATE DETERMINATION; GROWTH-FACTORS	The seven main cell types in the mammalian retina arise from multipotent retinal progenitor cells, a process that is tightly regulated by intrinsic and extrinsic signals. However, the molecular mechanisms that control proliferation, differentiation and cell-fate decisions of retinal progenitor cells are not fully understood yet. Here, we report that the guanine nucleotide exchange factor Vav3, a regulator of Rho-GTPases, is involved in retinal development. We demonstrate that Vav3 is expressed in the mouse retina during the embryonic period. In order to study the role of Vav3 in the developing retina, we generate Vav3-deficient mice. The loss of Vav3 results in an accelerated differentiation of retinal ganglion cells and cone photoreceptors during early and late embryonic development. We provide evidence that more retinal progenitor cells express the late progenitor marker Sox9 in Vav3-deficient mice than in wild-types. This premature differentiation is compensated during the postnatal period and late-born cell types such as bipolar cells and Muller glia display normal numbers. Taken together, our data imply that Vav3 is a regulator of retinal progenitor cell differentiation, thus highlighting a novel role for guanine nucleotide exchange factors in retinogenesis.	[Luft, Veronika; Reinhard, Jacqueline; Faissner, Andreas] Ruhr Univ Bochum, Dept Cell Morphol & Mol Neurobiol, D-44780 Bochum, Germany; [Luft, Veronika] IGSN, D-44780 Bochum, Germany; [Shibuya, Masabumi] Univ Tokyo, Inst Med Sci, Div Genet, Minato Ku, Tokyo 1088639, Japan; [Fischer, Klaus D.] Univ Magdeburg, Inst Biochem & Cell Biol, D-39120 Magdeburg, Germany	Faissner, A (reprint author), Ruhr Univ Bochum, Dept Cell Morphol & Mol Neurobiol, NDEF 05-594 Univ Str 150, D-44780 Bochum, Germany.	Andreas.Faissner@ruhr-uni-bochum.de	Faissner, Andreas/A-5314-2008	Faissner, Andreas/0000-0002-2211-8259	Germany's Excellence Initiative for further funding [DFG GSC 98/1]; German Research Foundation (DFG) [SFB 509, Fa 159/16-1]; Ministry of Innovation, Research and Technology of the Land NRW (Stem Cell Network NRW); Ruhr-University (President's special programme call)	V.L. was a graduate student of the International Graduate School of Neuroscience (IGSN) of the Ruhr-University Bochum during part of this work. V. L. and J. R. thank the Ruhr-University Research School funded by Germany's Excellence Initiative for further funding (DFG GSC 98/1) and the German Research Foundation (DFG, SFB 509 and Fa 159/16-1 to A. F.), the Ministry of Innovation, Research and Technology of the Land NRW (Stem Cell Network NRW) and the Ruhr-University (President's special programme call 2008 to A. F.) for grant support.	Agathocleous M, 2007, CELL CYCLE, V6, P156, DOI 10.4161/cc.6.2.3745; Fujikawa K, 2003, J EXP MED, V198, P1595, DOI 10.1084/jem.20030874; Cherfils J, 1999, TRENDS BIOCHEM SCI, V24, P306, DOI 10.1016/S0968-0004(99)01429-2; Namekata K, 2013, CELL DEATH DIFFER, V20, P1250, DOI 10.1038/cdd.2013.91; Hunter SG, 2006, MOL CELL BIOL, V26, P4830, DOI 10.1128/MCB.02215-05; Besser M, 2012, DEV BIOL, V369, P163, DOI 10.1016/j.ydbio.2012.05.020; Dyer MA, 2003, NAT GENET, V34, P53, DOI 10.1038/ng1144; Rowan S, 2004, DEV BIOL, V271, P388, DOI 10.1016/j.ydbio.2004.03.039; Martinez-Morales JR, 2005, DEV CELL, V8, P565, DOI 10.1016/j.devcel.2005.01.022; Bard JBL, 1998, MECH DEVELOP, V74, P111, DOI 10.1016/S0925-4773(98)00069-0; Aoki K, 2005, MOL BIOL CELL, V16, P2207, DOI 10.1091/mbc.E04-10-0904; Solovei I, 2009, CELL, V137, P356, DOI 10.1016/j.cell.2009.01.052; Baas D, 2000, MOL BRAIN RES, V78, P26, DOI 10.1016/S0169-328X(00)00060-7; Karus M, 2011, DEVELOPMENT, V138, P5321, DOI 10.1242/dev.067413; Garcion E, 2004, DEVELOPMENT, V131, P3423, DOI 10.1242/dev.01202; YOUNG RW, 1985, ANAT REC, V212, P199, DOI 10.1002/ar.1092120215; Gan L, 1996, P NATL ACAD SCI USA, V93, P3920, DOI 10.1073/pnas.93.9.3920; Klausmeyer A, 2007, J COMP NEUROL, V504, P659, DOI 10.1002/cne.21479; Locker M, 2006, GENE DEV, V20, P3036, DOI 10.1101/gad.391106; Wang J, 2014, PROG RETIN EYE RES, V38, P1, DOI 10.1016/j.preteyeres.2013.08.004; FRIEDLANDER DR, 1994, J CELL BIOL, V125, P669, DOI 10.1083/jcb.125.3.669; Ohsawa R, 2008, BRAIN RES, V1192, P90, DOI 10.1016/j.brainres.2007.04.014; Poche RA, 2008, J COMP NEUROL, V510, P237, DOI 10.1002/cne.21746; Movilla N, 1999, MOL CELL BIOL, V19, P7870; Herder C, 2013, DEVELOPMENT, V140, P2787, DOI 10.1242/dev.096487; LILIENBAUM A, 1995, MOL CELL NEUROSCI, V6, P139, DOI 10.1006/mcne.1995.1013; Hatakeyama J, 2004, SEMIN CELL DEV BIOL, V15, P83, DOI 10.1016/j.semcdb.2003.09.005; Inatani M, 2001, INVEST OPHTH VIS SCI, V42, P1930; Quina LA, 2005, J NEUROSCI, V25, P11595, DOI 10.1523/JNEUROSCI.2837-05.2005; Wang YP, 2005, DEVELOPMENT, V132, P5103, DOI 10.1242/dev.02096; Sauzeau V, 2006, NAT MED, V12, P841, DOI 10.1038/nm1426; Kazanis I, 2007, J NEUROSCI, V27, P13991, DOI 10.1523/JNEUROSCI.3279-07.2007; Sharma RK, 2007, BRAIN RES, V1176, P11, DOI 10.1016/j.brainres.2007.07.090; Hatakeyama J, 2001, DEVELOPMENT, V128, P1313; Cowan CW, 2005, NEURON, V46, P205, DOI 10.1016/j.neuron.2005.03.019; Pollard SM, 2008, MOL CELL NEUROSCI, V38, P393, DOI 10.1016/j.mcn.2008.03.012; Agathocleous M, 2009, ANNU REV CELL DEV BI, V25, P45, DOI 10.1146/annurev.cellbio.042308.113259; RIDLEY AJ, 1992, CELL, V70, P389, DOI 10.1016/0092-8674(92)90163-7; Marquardt T, 2002, TRENDS NEUROSCI, V25, P32, DOI 10.1016/S0166-2236(00)02028-2; Leu ST, 2004, DEV BIOL, V276, P416, DOI 10.1016/j.ydbio.2004.09.003; Morrow EM, 1999, DEVELOPMENT, V126, P23; CARTERDAWSON LD, 1979, J COMP NEUROL, V188, P263, DOI 10.1002/cne.901880205; Faccio R, 2005, NAT MED, V11, P284, DOI 10.1038/nm1194; Ray A, 2005, EUR J NEUROSCI, V21, P3277, DOI 10.1111/j.1460-9568.2005.04139.x; Brown NL, 2001, DEVELOPMENT, V128, P2497; Dyer MA, 2001, NAT REV NEUROSCI, V2, P333, DOI 10.1038/35072555; FAISSNER A, 1994, J CELL BIOL, V126, P783, DOI 10.1083/jcb.126.3.783; Nishida A, 2003, NAT NEUROSCI, V6, P1255, DOI 10.1038/nn1155; Burmeister M, 1996, NAT GENET, V12, P376, DOI 10.1038/ng0496-376; Gakidis MAM, 2004, J CELL BIOL, V166, P273, DOI 10.1083/jcb.200404166; Brzezinski JA, 2010, DEVELOPMENT, V137, P619, DOI 10.1242/dev.043968; Taranova OV, 2006, GENE DEV, V20, P1187, DOI 10.1101/gad.1407906; Katzav S, 2009, INT J BIOCHEM CELL B, V41, P1245, DOI 10.1016/j.biocel.2008.11.006; Inatani M, 2002, PROG RETIN EYE RES, V21, P429, DOI 10.1016/S1350-9462(02)00009-5; Bai N, 2013, MOL BRAIN, V6, DOI 10.1186/1756-6606-6-22; Bustelo XR, 2001, ONCOGENE, V20, P6372, DOI 10.1038/sj.onc.1204780; Cann GM, 1996, DEV BIOL, V180, P82, DOI 10.1006/dbio.1996.0286; Cepko CL, 1996, P NATL ACAD SCI USA, V93, P589, DOI 10.1073/pnas.93.2.589; Eguchi K, 2013, EXP CELL RES, V319, P2179, DOI 10.1016/j.yexcr.2013.05.024; Fujikawa K, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009050; Fujikawa K, 2002, P NATL ACAD SCI USA, V99, P4313, DOI 10.1073/pnas.052715699; Henning S, 1999, IMMUNOL RES, V20, P29, DOI 10.1007/BF02786505; Horvat-Broecker A, 2008, NEUROSCIENCE, V152, P618, DOI 10.1016/j.neuroscience.2008.01.016; Kusuhara S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0045858; LILLIEN L, 1992, DEVELOPMENT, V115, P253; Lillien L, 1998, MOL CELL NEUROSCI, V10, P296, DOI 10.1006/mcne.1997.0659; LIU ISC, 1994, NEURON, V13, P377, DOI 10.1016/0896-6273(94)90354-9; Mao CA, 2008, DEVELOPMENT, V135, P271, DOI 10.1242/dev.009688; Miletic AV, 2007, BLOOD, V109, P3360, DOI 10.1182/blood-2006-07-033662; Mitchell DC, 2007, MOL VIS, V13, P1144; Moores SL, 2000, MOL CELL BIOL, V20, P6364, DOI 10.1128/MCB.20.17.6364-6373.2000; Moritz S, 2008, STEM CELLS, V26, P2321, DOI 10.1634/stemcells.2007-1095; OOHIRA A, 1991, J NEUROSCI, V11, P822; Pearce AC, 2007, BIOCHEM J, V401, P753, DOI 10.1042/BJ20061508; Pfaffl MW, 2002, NUCLEIC ACIDS RES, V30, DOI 10.1093/nar/30.9.e36; Quevedo C, 2010, MOL BIOL CELL, V21, P1125, DOI 10.1091/mbc.E09-04-0292; Sakagami H, 2013, J COMP NEUROL, V521, P860, DOI 10.1002/cne.23206; Sherry DM, 2013, BMC NEUROSCI, V14, DOI 10.1186/1471-2202-14-70; Tham M, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015341; Toumaniantz G, 2010, CARDIOVASC RES, V86, P131, DOI 10.1093/cvr/cvp387; Tsapara A, 2010, MOL BIOL CELL, V21, P860, DOI 10.1091/mbc.E09-07-0567; von Holst A, 2007, J BIOL CHEM, V282, P9172, DOI 10.1074/jbc.M608067200; Xiong B, 2012, PLOS BIOL, V10, DOI 10.1371/journal.pbio.1001438; Young R W, 1985, Brain Res, V353, P229; Zou W, 2010, ANN NY ACAD SCI, V1192, P27, DOI 10.1111/j.1749-6632.2009.05245.x	85	1	1	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0302-766X	1432-0878		CELL TISSUE RES	Cell Tissue Res.	FEB	2015	359	2					423	440		10.1007/s00441-014-2050-2		18	Cell Biology	Cell Biology	CA9JY	WOS:000349240600004		
J	Takaki, F; Nakamuta, N; Kusakabe, T; Yamamoto, Y				Takaki, Fumiya; Nakamuta, Nobuaki; Kusakabe, Tatsumi; Yamamoto, Yoshio			Sympathetic and sensory innervation of small intensely fluorescent (SIF) cells in rat superior cervical ganglion	CELL AND TISSUE RESEARCH			English	Article						Sympathetic ganglion; Superior cervical ganglion; Small intensely fluorescent cells; Interneuron; Sensory nerve ending; P2X3 purinoreceptor; Paraganglionic cells; Rat (Wistar)	CAT CAROTID-BODY; TASTE-BUDS; CHOLINERGIC NEURONS; AFFERENT NEURONS; NERVOUS-SYSTEM; MESSENGER-RNA; ATP RELEASE; EXPRESSION; DOPAMINE; HYPOXIA	The sympathetic ganglion contains small intensely fluorescent (SIF) cells derived from the neural crest. We morphologically characterize SIF cells and focus on their relationship with ganglionic cells, preganglionic nerve fibers and sensory nerve endings. SIF cells stained intensely for tyrosine hydroxylase (TH), with a few cells also being immunoreactive for dopamine beta-hydroxylase (DBH). Vesicular acetylcholine transporter (VAChT)-immunoreactive puncta were distributed around some clusters of SIF cells, whereas some SIF cells closely abutted DBH-immunoreactive ganglionic cells. SIF cells contained bassoon-immunoreactive products beneath the cell membrane at the attachments and on opposite sites to the ganglionic cells. Ganglion neurons and SIF cells were immunoreactive to dopamine D2 receptors. Immunohistochemistry for P2X3 revealed ramified nerve endings with P2X3 immunoreactivity around SIF cells. Triple-labeling for P2X3, TH and VAChT allowed the classification of SIF cells into three types based on their innervation: (1) with only VAChT-immunoreactive puncta, (2) with only P2X3-immunoreactive nerve endings, (3) with both P2X3-immunoreactive nerve endings and VAChT-immunoreactive puncta. The results of retrograde tracing with fast blue dye indicated that most of these nerve endings originated from the petrosal ganglion. Thus, SIF cells in the superior cervical ganglion are innervated by preganglionic fibers and glossopharyngeal sensory nerve endings and can be classified into three types. SIF cells might modulate sympathetic activity in the superior cervical ganglion.	[Takaki, Fumiya; Nakamuta, Nobuaki; Yamamoto, Yoshio] Iwate Univ, Fac Agr, Lab Vet Anat & Cell Biol, Morioka, Iwate 0208550, Japan; [Kusakabe, Tatsumi] Kokushikan Univ, Dept Sport & Med Sci, Lab Anat & Physiol, Tama Ku, Tokyo 2068515, Japan	Yamamoto, Y (reprint author), Iwate Univ, Fac Agr, Lab Vet Anat & Cell Biol, 3-18-8 Ueda, Morioka, Iwate 0208550, Japan.	yyoshio@iwate-u.ac.jp			Japan Society for the Promotion of Science [25350823, 22580330]	This study was partly supported by Grants-in-Aid from the Japan Society for the Promotion of Science to T.K. (25350823) and Y.Y. (22580330).	Masson JF, 2008, ANAL CHEM, V80, P3991, DOI 10.1021/ac7018969; Beaulieu JM, 2011, PHARMACOL REV, V63, P182, DOI 10.1124/pr.110.002642; CZYZYKKRZESKA MF, 1992, J AUTONOM NERV SYST, V41, P31, DOI 10.1016/0165-1838(92)90124-Y; Huber K, 2006, DEV BIOL, V298, P335, DOI 10.1016/j.ydbio.2006.07.010; Uchigashima M, 2007, J NEUROSCI, V27, P3663, DOI 10.1523/JNEUROSCI.0448-07.2007; Bairam A, 2003, BIOL NEONATE, V84, P222, DOI 10.1159/000072306; Nurse CA, 2013, SEMIN CELL DEV BIOL, V24, P22, DOI 10.1016/j.semcdb.2012.09.006; MATTHEWS MR, 1989, J ELECTRON MICR TECH, V12, P408, DOI 10.1002/jemt.1060120413; Fuxe K, 2010, PROG NEUROBIOL, V90, P82, DOI 10.1016/j.pneurobio.2009.10.012; Narushima M, 2006, EUR J NEUROSCI, V24, P2246, DOI 10.1111/j.1460-9568.2006.05119.x; Roper SD, 2013, SEMIN CELL DEV BIOL, V24, P71, DOI 10.1016/j.semcdb.2012.12.002; Buttigieg J, 2004, BIOCHEM BIOPH RES CO, V322, P82, DOI 10.1016/j.bbrc.2004.07.081; Prasad M, 2001, J PHYSIOL-LONDON, V537, P667; Schafer MKH, 1998, NEUROSCIENCE, V84, P361, DOI 10.1016/S0306-4522(97)80196-0; Huang YJ, 2007, P NATL ACAD SCI USA, V104, P6436, DOI 10.1073/pnas.0611280104; Schoch S, 2006, CELL TISSUE RES, V326, P379, DOI 10.1007/s00441-006-0244-y; Moreira TS, 2006, J PHYSIOL-LONDON, V577, P369, DOI 10.1113/jphysiol.2006.115600; BORGHINI N, 1994, MICROSC RES TECHNIQ, V29, P112, DOI 10.1002/jemt.1070290208; BROKAW JJ, 1987, J AUTONOM NERV SYST, V18, P185, DOI 10.1016/0165-1838(87)90117-2; Brouns I, 2009, HISTOCHEM CELL BIOL, V131, P55, DOI 10.1007/s00418-008-0495-7; Case CP, 1985, NEUROSCIENCE, V15, P257; DALMAZ Y, 1988, J AUTONOM NERV SYST, V24, P57, DOI 10.1016/0165-1838(88)90135-X; DALMAZ Y, 1993, ADV EXP MED BIOL, V337, P393; ERANKO O, 1978, ANNU REV PHARMACOL, V18, P417, DOI 10.1146/annurev.pa.18.040178.002221; Fan L, 2014, MOL PAIN, V10, DOI 10.1186/1744-8069-10-8; FIDONE SJ, 1977, BRAIN RES, V124, P9, DOI 10.1016/0006-8993(77)90860-5; HESS A, 1972, FED PROC, V31, P1365; HEYM C, 1993, ANN ANAT, V175, P309; HEYM C, 1994, MICROSC RES TECHNIQ, V29, P143, DOI 10.1002/jemt.1070290211; Hirakawa H, 1997, AM J PHYSIOL-REG I, V273, pR747; Huang B, 2011, NEUROSCIENCE, V193, P421, DOI 10.1016/j.neuroscience.2011.07.031; HUANG W, 1988, J AUTONOM NERV SYST, V25, P95, DOI 10.1016/0165-1838(88)90014-8; Itturiaga R, 2004, BRAIN RES REV, V47, P46; KALIA M, 1978, BRAIN RES, V149, P477, DOI 10.1016/0006-8993(78)90489-4; Kameda Y, 2014, CELL TISSUE RES, V357, P527, DOI 10.1007/s00441-014-1847-3; Kataoka S, 2006, ARCH HISTOL CYTOL, V69, P281, DOI 10.1679/aohc.69.281; KONDO H, 1977, BIOL CELLULAIRE, V30, P253; KUMMER W, 1989, J ELECTRON MICR TECH, V12, P343, DOI 10.1002/jemt.1060120407; Lahiri S, 2001, INT J BIOCHEM CELL B, V33, P755, DOI 10.1016/S1357-2725(01)00042-5; LIBET B, 1974, J PHYSIOL-LONDON, V237, P635; LIBET B, 1969, J NEUROPHYSIOL, V32, P43; MATTHEWS MR, 1969, J ANAT, V105, P255; MCDONALD DM, 1983, J NEUROCYTOL, V12, P345, DOI 10.1007/BF01159380; Piskuric NA, 2011, J COMP NEUROL, V519, P856, DOI 10.1002/cne.22553; Prud'homme MJ, 1999, BRAIN RES, V821, P141, DOI 10.1016/S0006-8993(99)01094-X; Shtukmaster S, 2013, NEURAL DEV, V8, DOI 10.1186/1749-8104-8-12; Unsicker K., 1997, ANATOMIC ENDOCRINE I, P315; Yang RB, 2012, BMC NEUROSCI, V13, DOI 10.1186/1471-2202-13-51; Zeidi ZF, 2013, AUTON NEUROSCI-BASIC, V173, P28	49	0	0	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0302-766X	1432-0878		CELL TISSUE RES	Cell Tissue Res.	FEB	2015	359	2					441	451		10.1007/s00441-014-2051-1		11	Cell Biology	Cell Biology	CA9JY	WOS:000349240600005		
J	Haraguchi, R; Kitazawa, R; Kitazawa, S				Haraguchi, Ryuma; Kitazawa, Riko; Kitazawa, Sohei			Epigenetic regulation of Tbx18 gene expression during endochondral bone formation	CELL AND TISSUE RESEARCH			English	Article						TBX18; Endochondral bone formation; Gene expression analysis; DNA methylation; Epigenetic; Mouse	CHONDROCYTE-SPECIFIC ENHANCER; DNA METHYLATION; MAMMALIAN DEVELOPMENT; SKELETAL DEVELOPMENT; COLLAGEN GENE; GROWTH-PLATE; II COLLAGEN; SOX9; BOX; DIFFERENTIATION	Endochondral bone formation is tightly regulated by the spatial and sequential expression of a series of transcription factors. To disclose the roles of TBX18, a member of the T-box transcription factor family, during endochondral bone formation, its spatial and temporal expression patterns were characterized in the limb skeletal region of the developing mouse together with those of established osteochondrogenic markers Sox9, Col2a1, and Runx2. TBX18 expression first appeared in condensed mesenchymal cells (chondro-progenitors) in embryonic-day-10.5 (E10.5) limb bud and was co-localized with Sox9 expression, whereas at E11.5 and E12.5, it became undetectable in mesenchymal cells committed to the chondrocyte lineage. From E13.5 to E18.5, TBX18 expression reappeared in chondrocytes, correlating strongly with Col2a1 expression; furthermore, low level TBX18 expression was found in the Runx2-positive perichondral osteoblastic cell lineage. At the postnatal stage, TBX18 expression was observed in epiphyseal chondrocytes and osteocytes within the lacunae of mature trabecular bone. On the assumption that such characteristic Tbx18 gene expression is epigenetically regulated during mouse limb development, we examined the methylation status of the CpG-island in the mouse Tbx18 gene by methylation-specific polymerase chain reaction. Hypermethylation of the Tbx18 gene promoter became evident at an early embryonic stage in TBX18-negative cells and then disappeared at a late embryonic stage in TBX18-positive cells. Therefore, the temporal suppression of Tbx18 gene expression by the hypermethylation of its promoter seems to trigger the differentiation of mesenchymal cells into hypertrophic chondrocytes in the early stages of endochondral ossification.	[Haraguchi, Ryuma; Kitazawa, Riko; Kitazawa, Sohei] Ehime Univ, Grad Sch Med, Dept Mol Pathol, Toon City, Ehime 7910295, Japan	Kitazawa, S (reprint author), Ehime Univ, Grad Sch Med, Dept Mol Pathol, Toon City, Ehime 7910295, Japan.	kitazawa@m.ehime-u.ac.jp			Ehime University;  [23790228];  [25860143]	This work was supported by a Grant-in-Aid for Young Scientists B (23790228 and 25860143) and by the Tenure-Track System at Ehime University.	Airik R, 2010, HUM MOL GENET, V19, P4918, DOI 10.1093/hmg/ddq426; Akiyama H, 2005, P NATL ACAD SCI USA, V102, P14665, DOI 10.1073/pnas.0504750102; Bridgewater LC, 1998, J BIOL CHEM, V273, P14998, DOI 10.1074/jbc.273.24.14998; Naiche LA, 2005, ANNU REV GENET, V39, P219, DOI 10.1146/annurev.genet.39.073003.105925; Kitazawa R, 2007, MOL ENDOCRINOL, V21, P148, DOI 10.1210/me.2006-0205; Kraus F, 2001, MECH DEVELOP, V100, P83, DOI 10.1016/S0925-4773(00)00494-9; Song MR, 2006, DEVELOPMENT, V133, P4945, DOI 10.1242/dev.02694; Zhao Q, 1997, DEV DYNAM, V209, P377, DOI 10.1002/(SICI)1097-0177(199708)209:4<377::AID-AJA5>3.0.CO;2-F; Zhou G, 2006, P NATL ACAD SCI USA, V103, P19004, DOI 10.1073/pnas.0605170103; Christoffels VM, 2009, NATURE, V458, pE8, DOI 10.1038/nature07916; Kapoor N, 2011, J BIOL CHEM, V286, P14073, DOI 10.1074/jbc.M110.185298; Brummelkamp TR, 2002, J BIOL CHEM, V277, P6567, DOI 10.1074/jbc.M110492200; Nilsson O, 2005, J ENDOCRINOL, V186, P241, DOI 10.1677/joe.1.06016; Kronenberg HM, 2003, NATURE, V423, P332, DOI 10.1038/nature01657; Olsen BR, 2000, ANNU REV CELL DEV BI, V16, P191, DOI 10.1146/annurev.cellbio.16.1.191; Takizawa T, 2001, DEV CELL, V1, P749, DOI 10.1016/S1534-5807(01)00101-0; ERLEBACHER A, 1995, CELL, V80, P371, DOI 10.1016/0092-8674(95)90487-5; Lefebvre V, 1997, MOL CELL BIOL, V17, P2336; Darwanto A, 2008, ACTA HISTOCHEM CYTOC, V41, P135, DOI 10.1267/ahc.08025; Akiyama H, 2002, GENE DEV, V16, P2813, DOI 10.1101/gad.1017802; Farin HF, 2008, J BIOL CHEM, V283, P25372, DOI 10.1074/jbc.M802723200; LI E, 1992, CELL, V69, P915, DOI 10.1016/0092-8674(92)90611-F; Karsenty G, 2002, DEV CELL, V2, P389, DOI 10.1016/S1534-5807(02)00157-0; Bussen M, 2004, GENE DEV, V18, P1209, DOI 10.1101/gad.300104; Walsh CP, 1999, GENE DEV, V13, P26, DOI 10.1101/gad.13.1.26; Hojo H, 2012, J BIOL CHEM, V287, P17860, DOI 10.1074/jbc.M112.347716; Okano M, 1999, CELL, V99, P247, DOI 10.1016/S0092-8674(00)81656-6; Wang YQ, 2009, GENESIS, V47, P409, DOI 10.1002/dvg.20515; Clavel C, 2012, DEV CELL, V23, P981, DOI 10.1016/j.devcel.2012.10.013; Sugimoto Y, 2013, DEVELOPMENT, V140, P2280, DOI 10.1242/dev.096354; Soeda T, 2010, GENESIS, V48, P635, DOI 10.1002/dvg.20667; Bell DM, 1997, NAT GENET, V16, P174, DOI 10.1038/ng0697-174; Vlahovic M, 1999, INT J DEV BIOL, V43, P843; Nishino K, 2004, J BIOL CHEM, V279, P22306, DOI 10.1074/jbc.M309513200; Ng LJ, 1997, DEV BIOL, V183, P108, DOI 10.1006/dbio.1996.8487; Johnson RL, 1997, CELL, V90, P979, DOI 10.1016/S0092-8674(00)80364-5; Cai CL, 2008, NATURE, V454, P104, DOI 10.1038/nature06969; Trowe MO, 2010, DEV BIOL, V342, P51, DOI 10.1016/j.ydbio.2010.03.014; Cheung JOP, 2001, J BONE MINER RES, V16, P309, DOI 10.1359/jbmr.2001.16.2.309; Dias RR, 2007, INT J CARDIOL, V114, P98, DOI 10.1016/j.ijcard.2005.09.056; Farin HF, 2007, J BIOL CHEM, V282, P25748, DOI 10.1074/jbc.M703724200; Ghoshal K, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010338; Haraguchi R, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042245; Nakagawa M, 2013, ACTA HISTOCHEM CYTOC, V46, P19, DOI 10.1267/ahc.12022; SCHMAHL W, 1984, ARCH TOXICOL, V55, P143, DOI 10.1007/BF00346054; Takeichi M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057829; Xiao ZS, 2006, J BIOL CHEM, V281, P30884, DOI 10.1074/jbc.M604772200; Yokonishi T, 2013, BIOL REPROD IN PRESS; Zeng B, 2011, J BIOMED SCI, V18, DOI 10.1186/1423-0127-18-67	49	0	0	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0302-766X	1432-0878		CELL TISSUE RES	Cell Tissue Res.	FEB	2015	359	2					503	512		10.1007/s00441-014-2028-0		10	Cell Biology	Cell Biology	CA9JY	WOS:000349240600010		
J	Mukoyama, S; Sasho, T; Akatsu, Y; Yamaguchi, S; Muramatsu, Y; Katsuragi, J; Fukawa, T; Endo, J; Hoshi, H; Yamamoto, Y; Takahashi, K				Mukoyama, Shunsuke; Sasho, Takahisa; Akatsu, Yorikazu; Yamaguchi, Satoshi; Muramatsu, Yuta; Katsuragi, Joe; Fukawa, Taisuke; Endo, Jun; Hoshi, Hiroko; Yamamoto, Yohei; Takahashi, Kazuhisa			Spontaneous repair of partial thickness linear cartilage injuries in immature rats	CELL AND TISSUE RESEARCH			English	Article						Partial thickness cartilage injury; Spontaneous immediate repair; CD166; CD105; Rat (immature)	RABBIT KNEE-JOINT; MESENCHYMAL PROGENITOR CELLS; ARTICULAR-CARTILAGE; OSTEOCHONDRAL ALLOGRAFTS; SYNOVIAL-MEMBRANE; DEFECTS; PRESERVATION; MODEL; ADHESION; SURFACE	Partial thickness articular cartilage injuries (PTCIs) were not previously thought to heal spontaneously. Immature rats have the capacity for spontaneous repair of PTCIs, although it is a long-term process. Our aim has been to examine the spontaneous repair response mechanism in immature rats. Single linear PTCIs were created in 3-week-old and 12-week-old rats in the direction of joint motion. On day 1 and at 1, 2, and 4 weeks after PTCI, evaluations of histological changes and immunohistology at the injury site and in the surrounding cartilage were performed. Anti-CD105 and anti-CD166 anti-bodies (as stem cell markers to identify mesenchymal stem cells in reparative cartilage tissue) were used for immunohistological evaluations. To determine whether endogenous repair ability existed in articular cartilage, an ex vivo experiment was also carried out. Femoral condyles with PTCIs were incubated in Dulbecco's modified Eagle's medium containing 10% fetal bovine serum for 1 day and for 1 and 2 weeks. Histological changes were subsequently examined. Immature cartilage showed a higher repair response than did mature cartilage, and the response occurred immediately after PTCI. In immature rats, CD105- and CD166-positive cells were found in the superficial and transitional zones of the articular cartilage. Few CD166-positive cells were identified in mature articular cartilage. No significant in vivo differences in the spontaneous repair responses to PTCIs were observed between mature and immature groups. Thus, the repair response to PTCIs seems to be associated not only with CD105- and CD166-positive cells, but also with other perichondral factors.	[Mukoyama, Shunsuke; Sasho, Takahisa; Akatsu, Yorikazu; Yamaguchi, Satoshi; Muramatsu, Yuta; Katsuragi, Joe; Fukawa, Taisuke; Endo, Jun; Hoshi, Hiroko; Yamamoto, Yohei; Takahashi, Kazuhisa] Chiba Univ, Grad Sch Med, Chiba, Japan	Mukoyama, S (reprint author), Chiba Univ, Grad Sch Med, Chiba, Japan.	muko.524729@gmail.com			Japan Sports Medicine Foundation	This study was supported by a grant from the Japan Sports Medicine Foundation.	BAB I, 1988, BONE MINER, V4, P373; WAKITANI S, 1994, J BONE JOINT SURG AM, V76A, P579; Wei XC, 1999, J BIOMED MATER RES, V46, P539, DOI 10.1002/(SICI)1097-4636(19990915)46:4<539::AID-JBM12>3.0.CO;2-S; Curl WW, 1997, ARTHROSCOPY, V13, P456, DOI 10.1016/S0749-8063(97)90124-9; Garrity JT, 2012, AM J SPORT MED, V40, P2542, DOI 10.1177/0363546512458575; Hunziker EB, 1996, J BONE JOINT SURG AM, V78A, P721; Alford JW, 2005, AM J SPORT MED, V33, P295, DOI 10.1177/0363546504273510; Dowthwaite GP, 2004, J CELL SCI, V117, P889, DOI 10.1242/jcs.00912; Namba RS, 1998, J BONE JOINT SURG AM, V80A, P4; Lee JC, 2013, J ORTHOP RES, V31, P1293, DOI 10.1002/jor.22353; Swart GWM, 2002, EUR J CELL BIOL, V81, P313, DOI 10.1078/0171-9335-00256; Zhang W, 2013, BIOMATERIALS, V34, P713, DOI 10.1016/j.biomaterials.2012.10.027; PINEDA S, 1992, ACTA ANAT, V143, P335; Onuma K, 2012, CLIN ORTHOP RELAT R, V470, P2905, DOI 10.1007/s11999-011-2182-6; Alsalameh S, 2004, ARTHRITIS RHEUM, V50, P1522, DOI 10.1002/art.20269; KIM HKW, 1991, J BONE JOINT SURG AM, V73A, P1301; Williams SK, 2003, J BONE JOINT SURG AM, V85A, P2111; Wei XC, 1997, J BIOMED MATER RES, V34, P63, DOI 10.1002/(SICI)1097-4636(199701)34:1<63::AID-JBM9>3.0.CO;2-L; BOUMEDIENE K, 1995, CELL PROLIFERAT, V28, P221, DOI 10.1111/j.1365-2184.1995.tb00065.x; Chang Hong-Xing, 2011, Orthopedics, V34, pe382, DOI 10.3928/01477447-20110627-06; Hunziker EB, 1998, J BONE JOINT SURG BR, V80B, P144, DOI 10.1302/0301-620X.80B1.7531; Jansen EJ, 2008, CLIN ORTHOP RELAT R, V466, P487, DOI 10.1007/s11999-007-0050-1; Kumahashi N, 2004, CELL TISSUE RES, V317, P117, DOI 10.1007/s00441-004-0893-7; Lu Y, 2006, J ORTHOP RES, V24, P1974, DOI 10.1002/jor.20249; Pennock Andrew T, 2006, J Knee Surg, V19, P265; Pretzel D, 2011, ARTHRITIS RES THER, V13, DOI 10.1186/ar3320; Stoker A, 2012, J KNEE SURG, V25, P117, DOI 10.1055/s-0032-1319809; Tsuruoka H, 2011, CELL TISSUE RES, V346, P263, DOI 10.1007/s00441-011-1259-6; Wei XC, 1998, OSTEOARTHR CARTILAGE, V6, P10, DOI 10.1053/joca.1997.0087; Yoshioka M, 1998, OSTEOARTHR CARTILAGE, V6, P66, DOI 10.1053/joca.1997.0093	30	0	0	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0302-766X	1432-0878		CELL TISSUE RES	Cell Tissue Res.	FEB	2015	359	2					513	520		10.1007/s00441-014-2041-3		8	Cell Biology	Cell Biology	CA9JY	WOS:000349240600011		
J	Fujita, A; Inanobe, A; Hibino, H; Nielsen, S; Ottersen, OP; Kurachi, Y				Fujita, Akikazu; Inanobe, Atsushi; Hibino, Hiroshi; Nielsen, Soren; Ottersen, Ole Petter; Kurachi, Yoshihisa			Clustering of Kir4.1 at specialized compartments of the lateral membrane in ependymal cells of rat brain	CELL AND TISSUE RESEARCH			English	Article						K+ channel; Aquaporin; K+-buffering; Immunohistochemistry; Immuno-electron microscopy; Adherens junction; Rat (Wistar, male)	RECTIFYING K+ CHANNEL; CENTRAL-NERVOUS-SYSTEM; WATER-CHANNEL; GAP-JUNCTIONS; GLIAL-CELLS; CEREBROSPINAL-FLUID; TISSUE DISTRIBUTION; POTASSIUM CHANNEL; MULLER CELLS; OPTIC-NERVE	Brain ependymal cells, which form an epithelial layer covering the cerebral ventricles, have been shown to play a role in the regulation of cerebrospinal and interstitial fluids. The machinery underlying this, however, remains largely unknown. Here, we report the specific localization of an inwardly rectifying K+ channel, Kir4.1, on the ependymal cell membrane suggesting involvement of the channel in this function. Immunohistochemical study with confocal microscopy identified Kir4.1 labeling on the lateral but not apical membrane of ependymal cells. Ultrastructural analysis revealed that Kir4.1-immunogold particles were specifically localized and clustered on adjacent membranes at puncta adherens type junctions, whereas an aquaporin water channel, AQP4, that was also detected on the lateral membrane only occurred at components other than adherens junctions. Therefore, in ependymal cells, Kir4.1 and AQP4 are partitioned into distinct membrane compartments that might respectively transport either K+ or water. Kir4.1 was also expressed in a specialized form of ependymal cell, namely the tanycyte, being abundant in tanycyte processes wrapping neuropils and blood vessels. These specific localizations suggest that Kir4.1 mediates intercellular K+ exchange between ependymal cells and also K+-buffering transport via tanycytes that can interconnect neurons and vessels/ventricles. We propose that ependymal cells and tanycytes differentially operate Kir4.1 and AQP4 actively to control the property of fluids at local areas in the brain.	[Fujita, Akikazu; Inanobe, Atsushi; Hibino, Hiroshi; Kurachi, Yoshihisa] Osaka Univ, Grad Sch Med, Dept Pharmacol, Div Mol & Cellular Pharmacol, Suita, Osaka 5650871, Japan; [Ottersen, Ole Petter] Univ Oslo, Ctr Mol Biol & Neurosci, Oslo, Norway; [Ottersen, Ole Petter] Univ Oslo, Inst Basic Med Sci, Dept Anat, Oslo, Norway; [Nielsen, Soren] Aarhus Univ, Dept Biomed, Water & Salt Res Ctr, Aarhus, Denmark	Fujita, A (reprint author), Kagoshima Univ, Joint Fac Vet Med, Dept Vet Med, Field Vet Pathobiol, Korimoto 1-21-24, Kagoshima 8900065, Japan.	afujita@agri.kagoshima-u.ac.jp; ykurachi@pharma2.med.osaka-u.ac.jp					Barth AI, 1997, CURR OPIN CELL BIOL, V9, P683, DOI 10.1016/S0955-0674(97)80122-6; BIANCHI L, 1995, BIOCHEM BIOPH RES CO, V210, P823, DOI 10.1006/bbrc.1995.1732; Siu MKY, 2003, ENDOCRINOLOGY, V144, P2141, DOI 10.1210/en.2002-221035; Brone B, 2005, AM J PHYSIOL-CELL PH, V288, pC20, DOI 10.1152/ajpcell.00368.2004; Sheng M, 2001, ANNU REV NEUROSCI, V24, P1, DOI 10.1146/annurev.neuro.24.1.1; Gumbiner BM, 2000, J CELL BIOL, V148, P399, DOI 10.1083/jcb.148.3.399; Simons K, 1997, NATURE, V387, P569, DOI 10.1038/42408; Nagelhus EA, 1999, GLIA, V26, P47, DOI 10.1002/(SICI)1098-1136(199903)26:1<47::AID-GLIA5>3.0.CO;2-5; Hibino H, 2004, J BIOL CHEM, V279, P44065, DOI 10.1074/jbc.M405985200; BONDY C, 1993, P NATL ACAD SCI USA, V90, P4500, DOI 10.1073/pnas.90.10.4500; Nielsen S, 1997, J NEUROSCI, V17, P171; WALZ W, 1983, PROG NEUROBIOL, V20, P133, DOI 10.1016/0301-0082(83)90013-8; Fujita A, 2002, J PHYSIOL-LONDON, V540, P85, DOI 10.1113/jphysiol.2001.013439; DERMIETZEL R, 1989, P NATL ACAD SCI USA, V86, P10148, DOI 10.1073/pnas.86.24.10148; Johansson CB, 1999, CELL, V96, P25, DOI 10.1016/S0092-8674(00)80956-3; Amiry-Moghaddam M, 2003, P NATL ACAD SCI USA, V100, P2106, DOI 10.1073/pnas.0437946100; YAMAMOTO T, 1990, BRAIN RES, V508, P313, DOI 10.1016/0006-8993(90)90415-8; Nagelhus EA, 1998, J NEUROSCI, V18, P2506; FRIGERI A, 1995, J CELL SCI, V108, P2993; Steinhauser C, 2012, GLIA, V60, P1192, DOI 10.1002/glia.22313; HASEGAWA H, 1994, AM J PHYSIOL, V266, pC893; JUNG JS, 1994, P NATL ACAD SCI USA, V91, P13052, DOI 10.1073/pnas.91.26.13052; NILSSON C, 1992, BRAIN RES REV, V17, P109, DOI 10.1016/0165-0173(92)90011-A; Neusch C, 2006, J NEUROPHYSIOL, V95, P1843, DOI 10.1152/jn.00996.2005; Terris J, 1995, AM J PHYSIOL-RENAL, V269, pF775; DIETZEL I, 1980, EXP BRAIN RES, V40, P432; NIELSEN S, 1993, P NATL ACAD SCI USA, V90, P7275, DOI 10.1073/pnas.90.15.7275; Avizienyte E, 2002, NAT CELL BIOL, V4, P632, DOI 10.1038/ncb829; BROWN DA, 1992, CELL, V68, P533, DOI 10.1016/0092-8674(92)90189-J; MARRS JA, 1993, J CELL BIOL, V123, P149, DOI 10.1083/jcb.123.1.149; JARVIS CR, 1988, J NEUROSCI, V8, P3691; Matsubara A, 1996, J NEUROSCI, V16, P4457; Ikonen E, 2001, CURR OPIN CELL BIOL, V13, P470, DOI 10.1016/S0955-0674(00)00238-6; Bruni JE, 1998, MICROSC RES TECHNIQ, V41, P2, DOI 10.1002/(SICI)1097-0029(19980401)41:1<2::AID-JEMT2>3.3.CO;2-T; Beardslee MA, 2000, CIRC RES, V87, P656; Ishii M, 1997, J NEUROSCI, V17, P7725; Hibino H, 2010, PHYSIOL REV, V90, P291, DOI 10.1152/physrev.00021.2009; Manley GT, 2000, NAT MED, V6, P159, DOI 10.1038/72256; Djukic B, 2007, J NEUROSCI, V27, P11354, DOI 10.1523/JNEUROSCI.0723-07.2007; Takai Y, 2003, J CELL SCI, V116, P17, DOI 10.1242/jcs.00167; ROSENBERG GA, 1986, AM J PHYSIOL, V251, pF485; Niermann H, 2001, J NEUROSCI, V21, P3045; BRIGHTMAN MW, 1963, J CELL BIOL, V19, P415, DOI 10.1083/jcb.19.2.415; De Maio A, 2002, J CELL PHYSIOL, V191, P269, DOI 10.1002/jcp.10108; Eid T, 2005, P NATL ACAD SCI USA, V102, P1193, DOI 10.1073/pnas.0409308102; Fujita A, 2000, BIOCHEM BIOPH RES CO, V269, P1, DOI 10.1006/bbrc.1999.1893; GOULD SJ, 1990, DEV BRAIN RES, V55, P255, DOI 10.1016/0165-3806(90)90207-F; Hertz L, 2000, J NEUROSCI RES, V62, P480, DOI 10.1002/1097-4547(20001115)62:4<480::AID-JNR2>3.0.CO;2-K; Hibino H, 2007, EUR J NEUROSCI, V26, P2539, DOI 10.1111/j.1460-9568.2007.05876.x; Higashi K, 2001, AM J PHYSIOL-CELL PH, V281, pC922; Ito M, 1996, FEBS LETT, V388, P11, DOI 10.1016/0014-5793(96)00502-9; Madrid R, 2001, EMBO J, V20, P7008, DOI 10.1093/emboj/20.24.7008; Martinez AD, 2000, BRAIN RES REV, V32, P250, DOI 10.1016/S0165-0173(99)00086-7; Mugnaini E, 1986, DEV MORPHOLOGY REGIO, V1, P329; POLLAY M, 1967, AM J PHYSIOL, V213, P1031; SARNAT HB, 1992, J NEUROPATH EXP NEUR, V51, P58, DOI 10.1097/00005072-199201000-00008; Simons K, 2000, SCIENCE, V290, P1721, DOI 10.1126/science.290.5497.1721; TAKUMI T, 1995, J BIOL CHEM, V270, P16339; Tanemoto M, 2005, J AM SOC NEPHROL, V16, P2608, DOI 10.1681/ASN.2005030266; Yakushigawa H, 1998, ANAT REC, V250, P465, DOI 10.1002/(SICI)1097-0185(199804)250:4<465::AID-AR10>3.0.CO;2-M; YAMAMOTO T, 1991, BRAIN RES, V554, P336, DOI 10.1016/0006-8993(91)90213-F; Zahs KR, 1998, GLIA, V24, P85, DOI 10.1002/(SICI)1098-1136(199809)24:1<85::AID-GLIA9>3.0.CO;2-#	62	1	1	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0302-766X	1432-0878		CELL TISSUE RES	Cell Tissue Res.	FEB	2015	359	2					627	634		10.1007/s00441-014-2030-6		8	Cell Biology	Cell Biology	CA9JY	WOS:000349240600021		
J	Uejyo, T; Kuki, C; Oyama, S; Kumura, H; Kobayashi, K				Uejyo, Takaaki; Kuki, Chinatsu; Oyama, Shoko; Kumura, Haruto; Kobayashi, Ken			Early down-regulation of milk production after weaning by pup removal and prior to involution in mouse mammary glands	CELL AND TISSUE RESEARCH			English	Article						Mammary gland; Alveolar epithelial cell; Involution; Lactation; Weaning	EPITHELIAL-CELLS; SECRETORY EPITHELIUM; LIPID-SYNTHESIS; LACTATING MICE; MESSENGER-RNA; KEY STAGES; EXPRESSION; APOPTOSIS; PROTEIN; PREGNANCY	The mammary gland is a highly specialized organ that is able to repeat development and regression (involution) of alveolar structures for milk production. Mammary involution consists in two phases. The first phase is reversible and lasts until approximately 48 h after weaning in mice. Interestingly, an extended milking interval can change the milk-secretory activity of alveolar epithelial cells (AECs) before the first phase of involution begins. In this study, we investigate the changes in the ability of AECs to secrete milk during the involution progression. Careful observation of the number and locations of cleaved caspase-3 positive AECs revealed that the first phase of involution occurred approximately 24 h after weaning and the second phase began between 48 and 72 h after weaning. However, initial changes in the milk production ability of AECs began just 1 h after weaning and milk production gradually ceased within 24 h. In addition, activation of STAT3 and inactivation of STAT5 had occurred in some AECs by 6 h after weaning and more broadly by 24 h. In addition, milk production processes such as nutrient uptake, synthesis, and secretion ceased by 24 h post-weaning. Interestingly, enlarged cytoplasmic lipid droplets were observed in AECs 12 h after weaning even though the expression levels of genes relevant to triglyceride production (Srebp1 and AQP3) were down-regulated. These results indicate that several changes in the milk production ability of AECs occur during expanded suckling intervals and prior to involution.	[Uejyo, Takaaki; Kuki, Chinatsu; Oyama, Shoko; Kumura, Haruto; Kobayashi, Ken] Hokkaido Univ, Res Fac Agr, Lab Dairy Food Sci, Sapporo, Hokkaido 0608589, Japan	Kobayashi, K (reprint author), Hokkaido Univ, Res Fac Agr, Lab Dairy Food Sci, North 9,West 9, Sapporo, Hokkaido 0608589, Japan.	kkobaya@anim.agr.hokudai.ac.jp			Japan Society for the Promotion of Science [24780281]	This work was supported by a Grant-in-Aid for Young Scientists (24780281) from the Japan Society for the Promotion of Science.	Anderson SM, 2007, BREAST CANCER RES, V9, DOI 10.1186/bcr1653; Rudolph MC, 2010, AM J PHYSIOL-ENDOC M, V299, pE918, DOI 10.1152/ajpendo.00376.2010; Rudolph MC, 2007, J MAMMARY GLAND BIOL, V12, P269, DOI 10.1007/s10911-007-9061-5; Connelly L, 2010, J CELL PHYSIOL, V222, P73, DOI 10.1002/jcp.21922; Hughes K, 2012, J PATHOL, V227, P106, DOI 10.1002/path.3961; Monks J, 2008, BIOL REPROD, V78, P586, DOI 10.1095/biolreprod.107.065045; Kreuzaler PA, 2011, NAT CELL BIOL, V13, P303, DOI 10.1038/ncb2171; Watson CJ, 2006, BREAST CANCER RES, V8, DOI 10.1186/bcr1401; Liu XW, 1997, GENE DEV, V11, P179, DOI 10.1101/gad.11.2.179; Brisken C, 2002, J MAMMARY GLAND BIOL, V7, P39, DOI 10.1023/A:1015718406329; Li ML, 1997, P NATL ACAD SCI USA, V94, P3425, DOI 10.1073/pnas.94.7.3425; Lund LR, 1996, DEVELOPMENT, V122, P181; Tolkunov YA, 1997, J DAIRY RES, V64, P39, DOI 10.1017/S0022029996001859; Stelwagen K, 1997, AM J PHYSIOL-REG I, V273, pR379; Han LQ, 2010, GENET MOL RES, V9, P1250, DOI 10.4238/vol9-2gmr814; Neville MC, 2001, PEDIATR CLIN N AM, V48, P35, DOI 10.1016/S0031-3955(05)70284-4; Teglund S, 1998, CELL, V93, P841, DOI 10.1016/S0092-8674(00)81444-0; Scribner KC, 2011, MOL ENDOCRINOL, V25, P635, DOI 10.1210/me.2010-0423; Clarkson RWE, 2006, MOL ENDOCRINOL, V20, P675, DOI 10.1210/me.2005-0392; Clarkson RWE, 2000, J BIOL CHEM, V275, P12737, DOI 10.1074/jbc.275.17.12737; Watson CJ, 2011, INT J DEV BIOL, V55, P757, DOI 10.1387/ijdb.113414cw; Ben Chedly H, 2013, ANIMAL, V7, P124, DOI 10.1017/S1751731112001176; Matsuzaki T, 2005, HISTOCHEM CELL BIOL, V123, P501, DOI 10.1007/s00418-005-0753-x; Rudolph MC, 2003, J MAMMARY GLAND BIOL, V8, P287, DOI 10.1023/B:JOMG.0000010030.73983.57; Schwertfeger KL, 2003, J LIPID RES, V44, P1100, DOI 10.1194/jlr.M300045-JLR200; Ayadi M, 2009, J DAIRY SCI, V92, P1452, DOI 10.3168/jds.2008-1447; Blanchard AAA, 2006, DNA CELL BIOL, V25, P79, DOI 10.1089/dna.2006.25.79; BREW K, 1968, P NATL ACAD SCI USA, V59, P491, DOI 10.1073/pnas.59.2.491; Brisken C, 2002, P NATL ACAD SCI USA, V99, P14241, DOI 10.1073/pnas.222549599; CAMPS M, 1994, ENDOCRINOLOGY, V134, P924, DOI 10.1210/en.134.2.924; Chat S, 2011, EUR J CELL BIOL, V90, P401, DOI 10.1016/j.ejcb.2011.01.002; Iavnilovitch E, 2002, MOL CANCER RES, V1, P32; Kobayashi K, 2013, VET RES, V44, DOI 10.1186/1297-9716-44-119; Kobayashi K, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0062187; Kobayashi K, 2013, CELL TISSUE RES, V354, P495, DOI 10.1007/s00441-013-1688-5; Laspiur JP, 2004, J DAIRY SCI, V87, P3235; MARKOV AG, 1992, EXP CLIN ENDOCRINOL, V100, P112; Nakatani H, 2013, J BIOCHEM, V153, P31, DOI 10.1093/jb/mvs116; Nakatani H, 2006, BIOCHEM J, V395, P21, DOI 10.1042/BJ20051459; Nudda A, 2002, J DAIRY SCI, V85, P2879, DOI 10.3168/jds.S0022-0302(02)74375-0; PITELKA DR, 1973, J CELL BIOL, V56, P797, DOI 10.1083/jcb.56.3.797; Quaglino A, 2009, BMC CELL BIOL, V10, DOI 10.1186/1471-2121-10-55; STRANGE R, 1992, DEVELOPMENT, V115, P49	43	2	2	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0302-766X	1432-0878		CELL TISSUE RES	Cell Tissue Res.	FEB	2015	359	2					643	653		10.1007/s00441-014-2013-7		11	Cell Biology	Cell Biology	CA9JY	WOS:000349240600022		
J	Uesaka, N; Uchigashima, M; Mikuni, T; Hirai, H; Watanabe, M; Kano, M				Uesaka, Naofumi; Uchigashima, Motokazu; Mikuni, Takayasu; Hirai, Hirokazu; Watanabe, Masahiko; Kano, Masanobu			Retrograde Signaling for Climbing Fiber Synapse Elimination	CEREBELLUM			English	Review						Climbing fiber; Purkinje cell; Synapse elimination; Postnatal development; Retrograde signal; Semaphorin	CEREBELLAR PURKINJE-CELLS; MGLUR1; BRAIN	Neurons form exuberant synapses with target cells early in development. Then, necessary synapses are selectively strengthened whereas unnecessary connections are weakened and eventually eliminated during postnatal development. This process is known as synapse elimination and is a crucial step for shaping immature neural circuits into functionally mature versions. Accumulating evidence suggests that retrograde signaling from postsynaptic cells regulates synapse elimination, but the underlying mechanisms remain unknown. Here, we show that semaphorin3A (Sema3A) and semaphorin7A (Sema7A) mediate retrograde signals for elimination of redundant climbing fiber (CF) to Purkinje cell (PC) synapses in the developing cerebellum, a representative model of synapse elimination in the central nervous system. We picked up candidate retrograde signaling molecules that are expressed in PCs during the period of CF synapse elimination and the receptors of these candidate molecules that are present in CFs. We then assessed the effects of lentivirus-mediated RNAi-knockdown of these molecules on CF synapse elimination. By this systematic screening, we found that knockdown of Sema3A in PCs or its co-receptor, plexinA4 (PlxnA4), in CFs accelerated CF synapse elimination and decreased CF-mediated synaptic inputs. Conversely, knockdown of Sema7A in PCs or either of the two receptors for Sema7A, plexinC1 (PlxnC1) and integrinB1 (ItgB1), in CFs impaired CF synapse elimination. Importantly, the effect of Sema7A involves signaling by type 1 metabotropic glutamate receptor (mGluR1), a canonical pathway in PCs for the final stage of CF synapse elimination. These results demonstrate that specific semaphorins act as retrograde signaling molecules and regulate distinct processes of CF synapse elimination during postnatal cerebellar development.	[Uesaka, Naofumi; Mikuni, Takayasu; Kano, Masanobu] Univ Tokyo, Grad Sch Med, Dept Neurophysiol, Bunkyo Ku, Tokyo 1130033, Japan; [Uchigashima, Motokazu; Watanabe, Masahiko] Hokkaido Univ, Grad Sch Med, Dept Anat, Sapporo, Hokkaido 0608638, Japan; [Hirai, Hirokazu] Gunma Univ, Grad Sch Med, Dept Neurophysiol, Maebashi, Gunma 3718511, Japan	Kano, M (reprint author), Univ Tokyo, Grad Sch Med, Dept Neurophysiol, Bunkyo Ku, 7-3-1 Hongo, Tokyo 1130033, Japan.	mkano-tky@m.u-tokyo.ac.jp	WATANABE, Masahiko/A-4055-2012		Funding Program for Next Generation World-Leading Researchers [LS021]; Strategic Research Program for Brain Sciences; Global COE Program from MEXT, Japan;  [19100005];  [21220006];  [25000015];  [23650160]	The authors thank A. Nienhuis, St. Jude Children's Research Hospital and George Washington University for the gifts of the lentiviral backbone vector and the packaging plasmid; K. Kitamura and K. Hashimoto for helpful discussions; and K. Matsuyama, M. Sekiguchi, S. Tanaka, and A. Koseki for technical assistance. This work was supported by Grants-in-Aid for Scientific Research (19100005 to M.W. 21220006 and 25000015 to M.K. and 23650160 to N.U.), the Funding Program for Next Generation World-Leading Researchers (LS021) to H.H., the Strategic Research Program for Brain Sciences (Development of biomarker candidates for social behavior), and the Global COE Program (Integrative Life Science Based on the Study of Biosignaling Mechanisms) from MEXT, Japan.	Kano M, 1997, NEURON, V18, P71, DOI 10.1016/S0896-6273(01)80047-7; Pasterkamp RJ, 2009, CURR OPIN NEUROBIOL, V19, P263, DOI 10.1016/j.conb.2009.06.001; Hashimoto K, 2013, CELL MOL LIFE SCI, V70, P4667, DOI 10.1007/s00018-013-1405-2; Uesaka N, 2014, SCIENCE, V344, P1020, DOI 10.1126/science.1252514; Lichtman JW, 2000, NEURON, V25, P269, DOI 10.1016/S0896-6273(00)80893-4; Kano M, 2009, CURR OPIN NEUROBIOL, V19, P154, DOI 10.1016/j.conb.2009.05.002; Watanabe M, 2011, EUR J NEUROSCI, V34, P1697, DOI 10.1111/j.1460-9568.2011.07894.x; Mikuni T, 2013, NEURON, V78, P1024, DOI 10.1016/j.neuron.2013.04.036; Nakayama H, 2012, NEURON, V74, P384, DOI 10.1016/j.neuron.2012.02.032; CREPEL F, 1982, TRENDS NEUROSCI, V5, P266, DOI 10.1016/0166-2236(82)90168-0; Hashimoto K, 2001, J NEUROSCI, V21, P9701; Hashimoto K, 2011, P NATL ACAD SCI USA, V108, P9987, DOI 10.1073/pnas.1101488108; Kawamura Y, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3732; Lorenzetto E, 2009, P NATL ACAD SCI USA, V106, P16475, DOI 10.1073/pnas.0907298106; Uesaka N, 2012, J NEUROSCI, V32, P11657, DOI 10.1523/JNEUROSCI.1097-12.2012	15	0	0	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	1473-4222	1473-4230		CEREBELLUM	Cerebellum	FEB	2015	14	1					4	7		10.1007/s12311-014-0615-y		4	Neurosciences	Neurosciences & Neurology	CB1SN	WOS:000349408400002		
J	Zhao, Y; Mercier, NB; Byon, HR				Zhao, Yu; Mercier, Nadege Bonnet; Byon, Hye Ryung			An Aqueous Lithium-Iodine Battery with Solid Polymer Electrolyte-Coated Metallic Lithium Anode	CHEMPLUSCHEM			English	Article						batteries; cathodes; iodine; lithium; solid polymer electrolytes	AIR SECONDARY BATTERIES; ION BATTERIES; RECHARGEABLE BATTERIES; LI METAL; PERFORMANCE; CATHODE; LIQUIDS; STABILITY; COMPOSITE	An aqueous lithium-iodine (Li-I-2) cell with solid polymer electrolyte (SPE)-passivated metallic Li is demonstrated. The metallic Li anode is isolated from the aqueous I-3(-)/I- cathode by the SPE and a Li-ion-conductive solid electrolyte layer. The proposed aqueous Li-I-2 cells exhibit a discharge potential of approximately 3.4 V versus Li+/Li, stable capacity retention for 50 cycles, and adequate rate capability.	[Zhao, Yu; Mercier, Nadege Bonnet; Byon, Hye Ryung] RIKEN, Byon Initiat Res Unit IRU, Wako, Saitama 3510198, Japan	Byon, HR (reprint author), RIKEN, Byon Initiat Res Unit IRU, Hirosawa 2-1, Wako, Saitama 3510198, Japan.	hrbyon@riken.jp	Zhao, Yu/F-5602-2013	Zhao, Yu/0000-0002-6184-2530	RIKEN	This study was financially supported by RIKEN.	Weber AZ, 2011, J APPL ELECTROCHEM, V41, P1137, DOI 10.1007/s10800-011-0348-2; Kotobuki M, 2010, J ELECTROCHEM SOC, V157, pA1076, DOI 10.1149/1.3474232; Zhao Y, 2013, ADV ENERGY MATER, V3, P1630, DOI 10.1002/aenm.201300627; Imanishi N, 2008, J POWER SOURCES, V185, P1392, DOI 10.1016/j.jpowsour.2008.07.080; He P, 2010, ELECTROCHEM COMMUN, V12, P1686, DOI 10.1016/j.elecom.2010.09.025; Appetecchi GB, 2003, J POWER SOURCES, V114, P105, DOI 10.1016/S0378-7753(02)00543-8; Zhang T, 2008, J ELECTROCHEM SOC, V155, pA965, DOI 10.1149/1.2990717; Hasegawa S, 2009, J POWER SOURCES, V189, P371, DOI 10.1016/j.jpowsour.2008.08.009; Luo JY, 2010, NAT CHEM, V2, P760, DOI 10.1038/nchem.763; Chen L, 2013, CHEM COMMUN, V49, P2204, DOI 10.1039/c3cc00064h; Svensson PH, 2003, CHEM REV, V103, P1649, DOI 10.1021/cr0204101; Liu FC, 2011, ENERG ENVIRON SCI, V4, P1261, DOI 10.1039/c0ee00528b; Lu YH, 2011, J AM CHEM SOC, V133, P5756, DOI 10.1021/ja201118f; Bruce PG, 2012, NAT MATER, V11, P19, DOI [10.1038/nmat3191, 10.1038/NMAT3191]; Shin JH, 2005, J ELECTROCHEM SOC, V152, pA978, DOI 10.1149/1.1890701; Wang GJ, 2007, ANGEW CHEM INT EDIT, V46, P295, DOI 10.1002/anie.200603699; Zhao Y, 2014, ENERG ENVIRON SCI, V7, P1990, DOI 10.1039/c4ee00407h; Lu YH, 2011, J MATER CHEM, V21, P10113, DOI 10.1039/c0jm04222f; Shin JH, 2003, ELECTROCHEM COMMUN, V5, P1016, DOI 10.1016/j.elecom.2003.09.017; Xu K, 2004, CHEM REV, V104, P4303, DOI 10.1021/cr030203g; Zhang T, 2011, CHEM LETT, V40, P668, DOI 10.1246/cl.2011.668; Meyer WH, 1998, ADV MATER, V10, P439, DOI 10.1002/(SICI)1521-4095(199804)10:6<439::AID-ADMA439>3.0.CO;2-I; Croce F, 1998, NATURE, V394, P456; Liu S, 2010, J ELECTROCHEM SOC, V157, pA1092, DOI 10.1149/1.3473790; Whittingham MS, 2004, CHEM REV, V104, P4271, DOI 10.1021/cr020731c; Dunn B, 2011, SCIENCE, V334, P928, DOI 10.1126/science.1212741; Zhao Y, 2014, NANO LETT, V14, P1085, DOI 10.1021/nl404784d; Tarascon JM, 2001, NATURE, V414, P359, DOI 10.1038/35104644; Dean J. A., 1992, LANGES CHEM HDB; Owens B. B., 1986, BATTERIES IMPLANTABL; Wang G., 2007, ANGEW CHEM, V119, P299, DOI 10.1002/ange.200603699; Wang XJ, 2013, SCI REP-UK, V3, DOI 10.1038/srep01401; Wang YL, 2011, ENERG ENVIRON SCI, V4, P3947, DOI 10.1039/c1ee01875b; Zhao Y, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms2907; Zhu CB, 2008, J ELECTROCHEM SOC, V155, pA569, DOI 10.1149/1.2931523	35	5	5	WILEY-V C H VERLAG GMBH	WEINHEIM	BOSCHSTRASSE 12, D-69469 WEINHEIM, GERMANY	2192-6506			CHEMPLUSCHEM	ChemPlusChem	FEB	2015	80	2			SI		344	348		10.1002/cplu.201402038		5	Chemistry, Multidisciplinary	Chemistry	CB2PH	WOS:000349469400007		
J	Inoishi, A; Matsuka, M; Sakai, T; Ju, YW; Ida, S; Ishihara, T				Inoishi, Atsushi; Matsuka, Maki; Sakai, Takaaki; Ju, Young-Wan; Ida, Shintaro; Ishihara, Tatsumi			Lithium-Air Oxygen Shuttle Battery with a ZrO2-Based Ion-Conducting Oxide Electrolyte	CHEMPLUSCHEM			English	Article						electrochemistry; electrolytes; fuel cells; lithium; oxidation	ENERGY-STORAGE; REDOX BATTERY; FE; DURABILITY; ANODE	A lithium-air battery based on the concept of an "oxygen shuttle" with a calcium-stabilized ZrO2 electrolyte is described. The observed open-circuit voltage and discharge capacity are 1.81 V and 2179 mAh per gram of lithium, respectively, at 1073 K. When considering the transport number of an oxide ion at P-O2 in an anode chamber, the observed open-circuit voltage is reasonable. The internal resistance of the lithium-air battery has been analyzed with complex impedance, and the main internal resistance is anodic overpotential because of the platinum electrode used. After discharge, a much larger diffusion resistance, which may suggest surface oxidation of lithium, is observed. However, the observed anodic overpotential is similar to that in a magnesium-air cell reported previously, and much smaller than that of the H-2-air fuel cell.	[Inoishi, Atsushi; Matsuka, Maki; Ju, Young-Wan; Ida, Shintaro; Ishihara, Tatsumi] Kyushu Univ, Fac Engn, Dept Appl Chem, Nishu Ku, Fukuoka 8190395, Japan; [Sakai, Takaaki] Kyushu Univ, Ctr Mol Syst, Fukuoka 8190395, Japan; [Ida, Shintaro; Ishihara, Tatsumi] Kyushu Univ, Int Inst Carbon Neutral, Energy Res WPI I2CNER, Fukuoka 8190395, Japan	Inoishi, A (reprint author), Kyushu Univ, Fac Engn, Dept Appl Chem, Nishu Ku, 744 Motooka, Fukuoka 8190395, Japan.	Ishihara@cstf.kyushu-u.ac.jp			Advanced Low Carbon Technology Research and Development Program (ALCA) from the Japan Science Technology and New Energy Development Organization (NEDO) Japan; WPI program of the Ministry of Education, Sports, Culture, Science, and Technology (MEXT), Japan	This study was financially supported by the Advanced Low Carbon Technology Research and Development Program (ALCA) from the Japan Science Technology and New Energy Development Organization (NEDO) Japan. I2CNER are supported by the WPI program of the Ministry of Education, Sports, Culture, Science, and Technology (MEXT), Japan	Inoishi A, 2013, RSC ADV, V3, P3024, DOI 10.1039/c2ra23370c; Zhao X, 2013, CHEM COMMUN, V49, P5357, DOI 10.1039/c3cc42075b; Inoishi A, 2012, PHYS CHEM CHEM PHYS, V14, P12818, DOI 10.1039/c2cp42166f; Ju YW, 2011, J POWER SOURCES, V196, P6062, DOI 10.1016/j.jpowsour.2011.03.086; Cheng FY, 2012, CHEM SOC REV, V41, P2172, DOI 10.1039/c1cs15228a; Bruce PG, 2012, NAT MATER, V11, P19, DOI [10.1038/nmat3191, 10.1038/NMAT3191]; Zhao X, 2012, RSC ADV, V2, P10163, DOI 10.1039/c2ra21992a; Xu NS, 2011, ENERG ENVIRON SCI, V4, P4942, DOI 10.1039/c1ee02489b; Chen HS, 2009, PROG NAT SCI, V19, P291, DOI 10.1016/j.pnsc.2008.07.014; Dunn B, 2011, SCIENCE, V334, P928, DOI 10.1126/science.1212741; Eberle U, 2010, ENERG ENVIRON SCI, V3, P689, DOI 10.1039/c001674h; Inoishi A, 2014, J POWER SOURCES, V262, P310, DOI 10.1016/j.jpowsour.2014.03.125; Ettler M, 2010, J POWER SOURCES, V195, P5452, DOI 10.1016/j.jpowsour.2010.03.049; Hatae T, 2009, SOLID STATE IONICS, V180, P1305, DOI 10.1016/j.ssi.2009.08.003; Inoishi A, 2013, RSC ADV, V3, P8820, DOI 10.1039/c3ra23337e; Inoishi A, 2013, J POWER SOURCES, V229, P12, DOI 10.1016/j.jpowsour.2012.11.121; Inoishi A, 2013, J MATER CHEM A, V1, P15212, DOI 10.1039/c3ta14023g; Inoishi A, 2013, CHEM COMMUN, V49, P4691, DOI 10.1039/c3cc40880a; PATTERSO.JW, 1967, J ELECTROCHEM SOC, V114, P752, DOI 10.1149/1.2426723; Zhao X, 2013, J MATER CHEM A, V1, P14858, DOI 10.1039/c3ta12726e; Zhao X, 2014, CHEM COMMUN, V50, P623, DOI 10.1039/c3cc47673a	21	0	0	WILEY-V C H VERLAG GMBH	WEINHEIM	BOSCHSTRASSE 12, D-69469 WEINHEIM, GERMANY	2192-6506			CHEMPLUSCHEM	ChemPlusChem	FEB	2015	80	2			SI		359	362		10.1002/cplu.201402041		4	Chemistry, Multidisciplinary	Chemistry	CB2PH	WOS:000349469400010		
J	Carr, LL; Chung, JH; Achcar, RD; Lesic, Z; Rho, JY; Yagihashi, K; Tate, RM; Swigris, RJ; Kern, JRA				Carr, Laurie L.; Chung, Jonathan H.; Achcar, Rosane Duarte; Lesic, Zoran; Rho, Ji Y.; Yagihashi, Kunihiro; Tate, Robert M.; Swigris, Rey J.; Kern, Jeff Rey A.			The Clinical Course of Diffuse Idiopathic Pulmonary Neuroendocrine Cell Hyperplasia	CHEST			English	Article							CARCINOID-TUMOR; SPECTRUM; DISEASE; VALUES	BACKGROUND: Current understanding of the clinical course of diffuse idiopathic pulmonary neuroendocrine cell hyperplasia (DIPNECH) is poor and based predominantly on small case series. In our clinical experience, we have found that the diagnosis of DIPNECH is frequently delayed because respiratory symptoms are ascribed to other lung conditions. The objectives of this study were to collect and analyze longitudinal clinical data on pulmonary physiology, chest high-resolution CT (HRCT) imaging, and therapies to better delineate the course of disease. METHODS: We established a cohort of patients (N=30) with DIPNECH seen at our institution. We used descriptive statistics to summarize cohort characteristics and longitudinal analytic techniques to model FEV1% predicted (FEV1%) over time. RESULTS: All subjects were women who presented with long-standing cough and dyspnea. The majority had an FEV1%<50% at the time of diagnosis. Forty percent were given a diagnosis of asthma as the cause for physiologic obstruction. The mean FEV1% for the entire cohort showed no statistically significant decline over time, but 26% of the subjects experienced a 10% decline in FEV1 within 2 years. Among the pathology samples available for review, 28% (five of 18) had typical carcinoids and 44% had associated constrictive bronchiolitis. We propose clinical diagnostic criteria for DIPNECH that incorporate demographic, pulmonary physiology, HRCT imaging, and transbronchial and surgical lung biopsy data. CONCLUSIONS: DIPNECH is a female-predominant lung disease manifested by dyspnea and cough, physiologic obstruction, and nodules on HRCT imaging. Additional research is needed to understand the natural history of this disease and validate the proposed diagnostic criteria.	[Carr, Laurie L.; Kern, Jeff Rey A.] Natl Jewish Hlth, Dept Med, Div Oncol, Denver, CO 80206 USA; [Chung, Jonathan H.; Yagihashi, Kunihiro] Natl Jewish Hlth, Dept Med, Div Radiol, Denver, CO 80206 USA; [Achcar, Rosane Duarte] Natl Jewish Hlth, Dept Med, Div Pathol, Denver, CO 80206 USA; [Tate, Robert M.; Swigris, Rey J.] Natl Jewish Hlth, Dept Med, Div Pulm Crit Care & Sleep Med, Denver, CO 80206 USA; [Lesic, Zoran] St Anthony Hosp, Dept Med, Lakewood, CO USA; [Rho, Ji Y.] CHA Univ, CHA Bundang Med Ctr, Div Radiol, Seoul, South Korea; [Yagihashi, Kunihiro] St Marianna Univ, Sch Med, Dept Radiol, Kawasaki, Kanagawa, Japan	Carr, LL (reprint author), Natl Jewish Hlth, Dept Med, Div Oncol, 1400 Jackson St, Denver, CO 80206 USA.	carrl@njhealth.org					Lamberts SWJ, 1996, NEW ENGL J MED, V334, P246; MILLER RR, 1995, AM J SURG PATHOL, V19, P653, DOI 10.1097/00000478-199506000-00005; Adams H, 2006, RESPIRATION, V73, P690, DOI 10.1159/000088007; Gosney JR, 2011, HISTOPATHOLOGY, V59, P751, DOI 10.1111/j.1365-2559.2011.03992.x; Hankinson JL, 1999, AM J RESP CRIT CARE, V159, P179; Gorshtein A, 2012, CANCER-AM CANCER SOC, V118, P612, DOI 10.1002/cncr.26200; Lee JS, 2002, J COMPUT ASSIST TOMO, V26, P180, DOI 10.1097/00004728-200203000-00003; Irshad S, 2010, J THORAC ONCOL, V5, P921, DOI 10.1097/JTO.0b013e3181db6ddd; Davies SJ, 2007, THORAX, V62, P248, DOI 10.1136/thx.2006.063065; AGUAYO SM, 1992, NEW ENGL J MED, V327, P1285, DOI 10.1056/NEJM199210293271806; Johney EC, 2006, J THORAC CARDIOV SUR, V131, P1207, DOI 10.1016/j.jtcvs.2005.12.064; CRAPO RO, 1981, AM REV RESPIR DIS, V123, P185; Koo CW, 2010, AM J ROENTGENOL, V195, P661, DOI 10.2214/AJR.09.3811; Travis WD, 2004, WHO CLASSIFICATION T; Zhou ST, 2013, AM J PATHOL, V182, P1248, DOI 10.1016/j.ajpath.2012.12.024	15	2	2	AMER COLL CHEST PHYSICIANS	GLENVIEW	2595 PATRIOT BLVD, GLENVIEW, IL 60026 USA	0012-3692			CHEST	Chest	FEB	2015	147	2					415	422		10.1378/chest.14-0711		8	Critical Care Medicine; Respiratory System	General & Internal Medicine; Respiratory System	CB1YF	WOS:000349423200022		
J	Kojima, T; Green, J; Barron, JP				Kojima, Takako; Green, Joseph; Barron, J. Patrick			How Japanese Medical Journals Manage Conflicts of Interest	CHEST			English	Letter									[Kojima, Takako] Tokyo Med Univ, Dept Internal Med Commun, Tokyo 1600023, Japan; [Green, Joseph] Univ Tokyo, Grad Sch Med, Tokyo 1138654, Japan; [Barron, J. Patrick] Tokyo Med Univ, Tokyo 1608402, Japan	Kojima, T (reprint author), Tokyo Med Univ, Dept Internal Med Commun, Shinjuku Ku, 6-7-1 Nishishinjuku, Tokyo 1600023, Japan.	tkojima@tokyo-med.ac.jp					Wager E, 2010, CHEST, V137, P221, DOI 10.1378/chest.09-1565; Barron JP, 2014, COI MANAGEMENT VIEWE; Irwin Richard S, 2009, Chest, V136, P253, DOI 10.1378/chest.09-0890	3	1	1	AMER COLL CHEST PHYSICIANS	GLENVIEW	2595 PATRIOT BLVD, GLENVIEW, IL 60026 USA	0012-3692			CHEST	Chest	FEB	2015	147	2					E60	E60		10.1378/chest.14-2396		1	Critical Care Medicine; Respiratory System	General & Internal Medicine; Respiratory System	CB1YF	WOS:000349423200050		
J	Yamagishi, T; Ochi, N; Yamane, H; Kuribayashi, F; Takigawa, N				Yamagishi, Tomoko; Ochi, Nobuaki; Yamane, Hiromichi; Kuribayashi, Futoshi; Takigawa, Nagio			A 60-Year-Old Asymptomatic Woman With Pulmonary Lesions and Cervical Lymphadenopathy	CHEST			English	Editorial Material							CHRONIC GRANULOMATOUS-DISEASE; INFECTION	A 60-year-old asymptomatic woman was referred to our hospital because of an abnormal chest roentgenogram during a routine medical checkup. The patient had no history of memorable infectious diseases, except a liver abscess caused by Serratia marcescens at age 46 years. Her son was diagnosed with chronic granulomatous disease at the age of 1 year. She had never smoked cigarettes and drank only occasionally.	[Yamagishi, Tomoko; Ochi, Nobuaki; Yamane, Hiromichi; Takigawa, Nagio] Kawasaki Med Univ, Dept Gen Internal Med 4, Okayama 7008505, Japan; [Kuribayashi, Futoshi] Kawasaki Med Univ, Dept Biochem, Okayama 7008505, Japan	Takigawa, N (reprint author), Kawasaki Med Univ, Dept Gen Internal Med 4, Kita Ku, 2-1-80 Nakasange, Okayama 7008505, Japan.	ntakigaw@gmail.com					Roos D, 2014, CLIN EXP IMMUNOL, V175, P139, DOI 10.1111/cei.12202; Marciano BE, 2004, PEDIATRICS, V114, P462, DOI 10.1542/peds.114.2.462; Seger RA, 2008, BRIT J HAEMATOL, V140, P255, DOI 10.1111/j.1365-2141.2007.06880.x; Matute JD, 2009, BLOOD, V114, P3309, DOI 10.1182/blood-2009-07-231498; Segal BH, 2011, BIOL BLOOD MARROW TR, V17, pS123, DOI 10.1016/j.bbmt.2010.09.008; De Pauw B, 2008, CLIN INFECT DIS, V46, P1813, DOI 10.1086/588660; Mahdaviani SA, 2013, EXPERT REV CLIN IMMU, V9, P153, DOI [10.1586/eci.12.98, 10.1586/ECI.12.98]; Rosen-Wolff A, 2001, ANN HEMATOL, V80, P113, DOI 10.1007/s002770000230; Segal BH, 1998, MEDICINE, V77, P345, DOI 10.1097/00005792-199809000-00004; Towbin AJ, 2010, PEDIATR RADIOL, V40, P657, DOI 10.1007/s00247-009-1503-3	10	0	0	AMER COLL CHEST PHYSICIANS	GLENVIEW	2595 PATRIOT BLVD, GLENVIEW, IL 60026 USA	0012-3692			CHEST	Chest	FEB	2015	147	2					E48	E51		10.1378/chest.14-1215		4	Critical Care Medicine; Respiratory System	General & Internal Medicine; Respiratory System	CB1YF	WOS:000349423200045		
J	Xu, GJ; Tang, J; Huang, QH; Uyeshima, M				Xu Guang-Jing; Tang Ji; Huang Qing-Hua; Uyeshima, Makoto			Study on the conductivity structure of the upper mantle and transition zone beneath North China	CHINESE JOURNAL OF GEOPHYSICS-CHINESE EDITION			Chinese	Article						Geomagnetic deep sounding; North China; Mantle transition zone; Electrical conductivity structure	ELECTRICAL-CONDUCTIVITY; MID-MANTLE; CRATON; INVERSION; HYDROGEN; REGION; WATER	In order to reveal the deep geodynamics of the North China, 14 geomagnetic stations with long-period observation data in North China were used to obtain the electrical structure under the lithosphere, especially between the mantle transition zone. Remote reference method and robust estimation were conducted to obtain the high quality data (the data coherencies are higher than 0. 8). The Geomagnetic Deep Sounding (GDS) response of the periods 105 10 seconds was obtained and transformed into an equivalent scalar magnetotelluric (MT) transfer function. rho(+) theory was conducted to check the consistency of the apparent resistivity and phase. The smooth conductivity models of Occam inversion were obtained and compared with the past models. The real and imaginary parts of tipper were also analyzed. The rho(+) inversion indicates that conductivity discontinuity surfaces exist at depth about 417 km and 850 km. Occam inversion shows that electrical conductivities in the eastern part are much higher than those of the western part in North China. The real and imaginary parts. of tipper reveal that a high conductivity object along nearly north to south direction exists in the eastern part of North China. The conductivity of the mantle transition zone in the east and west of the North China are different. The conductivities of the mantle transition zone near the Ordos in the west of North China are similar as that of Tucson in the North America, while the conductivities of the east part are approximately 2 similar to 5 times higher. This feature may correspond to the subduction of the Pacific plate.	[Xu Guang-Jing; Huang Qing-Hua] Peking Univ, Sch Earth & Space Sci, Dept Geophys, Beijing 100871, Peoples R China; [Tang Ji] China Earthquake Adm, Inst Geol, Beijing 100029, Peoples R China; [Uyeshima, Makoto] Univ Tokyo, Earthquake Res Inst, Tokyo 1130032, Japan	Huang, QH (reprint author), Peking Univ, Sch Earth & Space Sci, Dept Geophys, Beijing 100871, Peoples R China.	xgj@pku.edu.cn; huangq@pku.edu.cn	Huang, Qinghua/A-1007-2011				SCHULTZ A, 1987, GEOPHYS J INT, V88, P733, DOI 10.1111/j.1365-246X.1987.tb01654.x; He LJ, 2014, CHINESE J GEOPHYS-CH, V57, P53, DOI 10.6038/cjg20140106; Utada H, 2003, GEOPHYS RES LETT, V30, DOI 10.1029/2002GL016092; Zhao DP, 2009, GONDWANA RES, V16, P401, DOI 10.1016/j.gr.2009.01.005; SCHULTZ A, 1993, GEOPHYS RES LETT, V20, P2941, DOI 10.1029/93GL02833; Tang J, 2006, ACTA PETROL SIN, V22, P1503; KARATO S, 1990, NATURE, V347, P272, DOI 10.1038/347272a0; THOMPSON AB, 1992, NATURE, V358, P295, DOI 10.1038/358295a0; CONSTABLE SC, 1987, GEOPHYSICS, V52, P289, DOI 10.1190/1.1442303; Maruyama S, 2009, GONDWANA RES, V16, P414, DOI 10.1016/j.gr.2009.07.002; Wu FY, 2008, ACTA PETROL SIN, V24, P1145; BANKS RJ, 1969, GEOPHYS J ROY ASTR S, V17, P457, DOI 10.1111/j.1365-246X.1969.tb00252.x; GAMBLE TD, 1979, GEOPHYSICS, V44, P53, DOI 10.1190/1.1440923; PARKER RL, 1980, J GEOPHYS RES, V85, P4421, DOI 10.1029/JB085iB08p04421; BAI Q, 1992, NATURE, V357, P672; CHAVE AD, 1987, J GEOPHYS RES-SOLID, V92, P633, DOI 10.1029/JB092iB01p00633; [陈凌 Chen Ling], 2010, [地学前缘, Earth Science Frontiers], V17, P212; Chen X B, 2004, EARTH SCI FRONTIERS, V11, P626; Deng J F, 1994, GEOSCIENCE, V8, P349; FUKAO Y, 1992, J GEOPHYS RES-SOL EA, V97, P4809, DOI 10.1029/91JB02749; Huang JL, 2006, J GEOPHYS RES-SOL EA, V111, DOI 10.1029/2005JB004066; Ichiki M, 2001, GEOPHYS RES LETT, V28, P3773, DOI 10.1029/2001GL012983; Lachenbruch A. H., 1978, GEOL SOC AM MEM, V152, P209; Li C, 2010, J GEOPHYS RES-SOL EA, V115, DOI 10.1029/2009JB006882; Lin W, 2013, ACTA PETROL SIN, V29, P1791; Liu QS, 2000, CHINESE J GEOPHYS-CH, V43, P64; Maruyama S, 1994, J GEOL SOC JPN, V100, P4; Neal SL, 2000, J GEOPHYS RES-SOL EA, V105, P8229, DOI 10.1029/1999JB900447; Parker RL, 1996, PHYS EARTH PLANET IN, V98, P269, DOI 10.1016/S0031-9201(96)03191-3; Schmucker U, 1970, ANOMALIES GEOMAGNETI; Stott G M, 1997, GREENSTONE BELTS OXF, V35, P480; Teng J W, 2003, GEOTECTONICA METALLO, V27, P3; [魏文博 Wei Wenbo], 2003, [地学前缘, Earth science frontiers], V10, P15; Wei W B, 2008, EARTH SCI FRONTIERS, V15; Weidelt P, 1972, J GEOPHYS, V38, P257; XU G J, 2009, THESIS I GEOLOGY BEI; 许卫卫, 2011, [中国科学. 地球科学, Scientia Sinica Terrae], V41, P678; 翟明国, 2011, [中国科学. 地球科学, Scientia Sinica Terrae], V41, P1037; Zhao G Z, 2001, SEISMOLOGY GEOLOGY, V23, P143; 朱日祥, 2011, [中国科学. 地球科学, Scientia Sinica Terrae], V41, P583; 朱日祥, 2012, [中国科学. 地球科学, Scientia Sinica Terrae], V42, P1135; [朱日祥 ZHU Rixiang], 2007, [地球物理学进展, Progress in Geophysiscs], V22, P1090; Zhu RiXiang, 2008, Chinese Science Bulletin, V54, DOI 10.1007/s11434-009-0451-5	43	0	0	SCIENCE PRESS	BEIJING	16 DONGHUANGCHENGGEN NORTH ST, BEIJING 100717, PEOPLES R CHINA	0001-5733			CHINESE J GEOPHYS-CH	Chinese J. Geophys.-Chinese Ed.	FEB	2015	58	2					566	575		10.6038/cjg20150219		10	Geochemistry & Geophysics	Geochemistry & Geophysics	CB2BL	WOS:000349431600019		
J	Xu, M; Wang, LM; Peng, R; Ge, QQ; Chen, F; Ye, ZR; Zhang, Y; Chen, SD; Xia, M; Liu, RH; Arita, M; Shimada, K; Namatame, H; Taniguchi, M; Matsunami, M; Kimura, S; Shi, M; Chen, XH; Yin, WG; Ku, W; Xie, BP; Feng, DL				Xu Min; Wang Li-Min; Peng Rui; Ge Qing-Qin; Chen Fei; Ye Zi-Rong; Zhang Yan; Chen Su-Di; Xia Miao; Liu Rong-Hua; Arita, M.; Shimada, K.; Namatame, H.; Taniguchi, M.; Matsunami, M.; Kimura, S.; Shi Ming; Chen Xian-Hui; Yin Wei-Guo; Ku Wei; Xie Bin-Ping; Feng Dong-Lai			Electronic Structure Reconstruction across the Antiferromagnetic Transition in TaFe1.23Te3 Spin Ladder	CHINESE PHYSICS LETTERS			English	Article								Employing the angle-resolved photoemission spectroscopy, we study the electronic structure of TaFe1.23Te3, a two-leg spin ladder compound with a novel antiferromagnetic ground state. Quasi-two-dimensional (2D) Fermi surface is observed, with sizable inter-ladder hopping. Moreover, instead of observing an energy gap at the Fermi surface in the antiferromagnetic state, we observe the shifts of various bands. Combining these observations with density-functional-theory calculations, we propose that the large scale reconstruction of the electronic structure, caused by the interactions between the coexisting itinerant electrons and local moments, is most likely the driving force of the magnetic transition. Thus TaFe1.23Te3 serves as a simpler platform that contains similar ingredients to the parent compounds of iron-based superconductors.	[Xu Min; Peng Rui; Ge Qing-Qin; Chen Fei; Ye Zi-Rong; Zhang Yan; Chen Su-Di; Xia Miao; Xie Bin-Ping; Feng Dong-Lai] Fudan Univ, Dept Phys, State Key Lab Surface Phys, Shanghai 200433, Peoples R China; [Xu Min; Peng Rui; Ge Qing-Qin; Chen Fei; Ye Zi-Rong; Zhang Yan; Chen Su-Di; Xia Miao; Xie Bin-Ping; Feng Dong-Lai] Fudan Univ, Adv Mat Lab, Shanghai 200433, Peoples R China; [Wang Li-Min; Yin Wei-Guo; Ku Wei] Brookhaven Natl Lab, Condensed Matter Phys & Mat Sci Dept, Upton, NY 11973 USA; [Liu Rong-Hua; Chen Xian-Hui] Univ Sci & Technol China, Hefei Natl Lab Phys Sci Microscale, Hefei 230026, Peoples R China; [Liu Rong-Hua; Chen Xian-Hui] Univ Sci & Technol China, Dept Phys, Hefei 230026, Peoples R China; [Arita, M.; Shimada, K.; Namatame, H.; Taniguchi, M.] Hiroshima Univ, Hiroshima Synchrotron Radiat Ctr, Hiroshima 7398526, Japan; [Matsunami, M.; Kimura, S.] Natl Inst Nat Sci, Inst Mol Sci, UVSOR Facil, Okazaki, Aichi 4448585, Japan; [Shi Ming] Paul Scherrer Inst, Swiss Light Source, CH-5232 Villigen, Switzerland; [Peng Rui; Xie Bin-Ping; Feng Dong-Lai] Collaborat Innovat Ctr Adv Microstruct, Nanjing 210093, Jiangsu, Peoples R China	Ku, W (reprint author), Brookhaven Natl Lab, Condensed Matter Phys & Mat Sci Dept, Upton, NY 11973 USA.	weiku@bnl.gov; dlfeng@fudan.edu.cn	Matsunami, Masaharu/H-8817-2012; Liu, Ronghua/A-9790-2013	Liu, Ronghua/0000-0002-4053-3923	National Basic Research Program of China [2012CB921400, 2011CB921802, 2011CBA00112]	Supported by the National Basic Research Program of China under Grant Nos 2012CB921400, 2011CB921802 and 2011CBA00112.	Yang LX, 2009, PHYS REV LETT, V102, DOI 10.1103/PhysRevLett.102.107002; Zhang Y, 2010, PHYS REV B, V82, DOI 10.1103/PhysRevB.82.165113; Wang XF, 2009, PHYS REV LETT, V102, DOI 10.1103/PhysRevLett.102.117005; Haule K, 2009, NEW J PHYS, V11, DOI 10.1088/1367-2630/11/2/025021; Yin WG, 2010, PHYS REV LETT, V105, DOI 10.1103/PhysRevLett.105.107004; Yi M, 2011, P NATL ACAD SCI USA, V108, P6878, DOI 10.1073/pnas.1015572108; Li SL, 2009, PHYS REV B, V79, DOI 10.1103/PhysRevB.79.054503; Liu ZK, 2013, PHYS REV LETT, V110, DOI 10.1103/PhysRevLett.110.037003; Tan SY, 2013, NAT MATER, V12, P634, DOI [10.1038/nmat3654, 10.1038/NMAT3654]; Schwarz K, 2002, COMPUT PHYS COMMUN, V147, P71, DOI 10.1016/S0010-4655(02)00206-0; He C, 2010, PHYS REV LETT, V105, DOI 10.1103/PhysRevLett.105.117002; Ku W, 2010, PHYS REV LETT, V104, DOI 10.1103/PhysRevLett.104.216401; Caron JM, 2011, PHYS REV B, V84, DOI 10.1103/PhysRevB.84.180409; Ge QQ, 2013, PHYS REV X, V3, DOI 10.1103/PhysRevX.3.011020; Jiang J, 2013, PHYS REV B, V88, DOI 10.1103/PhysRevB.88.115130; Ke X, 2012, PHYS REV B, V85, DOI 10.1103/PhysRevB.85.214404; Lei HC, 2011, PHYS REV B, V84, DOI 10.1103/PhysRevB.84.214511; Li W, 2012, ARXIV12104619CONDMAT; Liu RH, 2011, PHYS REV B, V84, DOI 10.1103/PhysRevB.84.184432; LIU SX, 1993, ACTA CRYSTALLOGR C, V49, P4, DOI 10.1107/S010827019200355X; McCabe EE, 2011, CHEM COMMUN, V47, P1261, DOI 10.1039/c0cc03477k; Tzen Ong T, 2012, PHYS REV LETT, V108; Yin WG, 2012, PHYS REV B, V86, DOI 10.1103/PhysRevB.86.081106; Zhang Y, 2012, PHYS REV B, V85, DOI 10.1103/PhysRevB.85.085121	24	0	0	IOP PUBLISHING LTD	BRISTOL	TEMPLE CIRCUS, TEMPLE WAY, BRISTOL BS1 6BE, ENGLAND	0256-307X	1741-3540		CHINESE PHYS LETT	Chin. Phys. Lett.	FEB	2015	32	2							027401	10.1088/0256-307X/32/2/027401		4	Physics, Multidisciplinary	Physics	CB1WP	WOS:000349419000032		
J	Yamazaki, K; Watanabe, M				Yamazaki, Kuniko; Watanabe, Masahiro			Effects of extratropical warming on ENSO amplitudes in an ensemble of a coupled GCM	CLIMATE DYNAMICS			English	Article						El Nino-southern oscillation; ITCZ; Atmospheric energy transport	SOUTHERN-OSCILLATION; EL-NINO; SURFACE-TEMPERATURE; OCEAN; PRECIPITATION; CIRCULATION; IMPACT; ICE; SST	The El Nio-Southern Oscillation (ENSO) amplitudes in an ensemble of twentieth-century coupled general circulation model experiments performed for the Coupled Model Intercomparison Project phase 5 were found to have a systematic relationship with the time-averaged Southern Ocean sea surface temperature (SST). That is, the ENSO amplitudes were greater in the ensemble members with warmer Southern Ocean SST. Here we propose a mechanism that explains how the anomalous extratropical warming remotely affects the ENSO strength. First, the reduction in the meridional temperature gradient over the Southern Hemisphere gives rise to an anomalous northward heat transport by transient eddies across the extratropics into the tropics. This induces an anomalous Hadley cell that leads to a northward heat transport within the tropics in its upper branch and a southward moisture transport in the lower branch. The latter reduces maximum precipitation in the intertropical convergence zone in the equatorial Pacific Ocean and increases precipitation in the adjacent region to the south. Since the amount of precipitation over the eastern equatorial Pacific dictates the strength of ENSO through the shift in the zonal wind stress response to El Nio/La Nia, we conclude that there is an energy transport pathway through which the ENSO strength can be remotely modulated by the anomalous heating in the extratropics.	[Yamazaki, Kuniko; Watanabe, Masahiro] Univ Tokyo, Atmosphere & Ocean Res Inst, Kashiwa, Chiba 2778564, Japan	Yamazaki, K (reprint author), Univ Tokyo, Atmosphere & Ocean Res Inst, 5-1-5 Kashiwanoha, Kashiwa, Chiba 2778564, Japan.	kuniko@aori.u-tokyo.ac.jp					Li ZX, 2000, GEOPHYS RES LETT, V27, P3505, DOI 10.1029/1999GL011182; Broccoli AJ, 2006, GEOPHYS RES LETT, V33, DOI 10.1029/2005GL024546; Kang SM, 2008, J CLIMATE, V21, P3521, DOI 10.1175/2007JCLI2146.1; TRENBERTH KE, 1994, CLIM DYNAM, V10, P107, DOI 10.1007/BF00210625; Watanabe M, 2010, J CLIMATE, V23, P6312, DOI 10.1175/2010JCLI3679.1; Ropelewski CF, 1989, J CLIMATE, V2, P268, DOI 10.1175/1520-0442(1989)002<0268:PPAWTH>2.0.CO;2; Kang SM, 2011, SCIENCE, V332, P951, DOI 10.1126/science.1202131; Rayner NA, 2003, J GEOPHYS RES-ATMOS, V108, DOI 10.1029/2002JD002670; Gregory JM, 1997, GEOPHYS RES LETT, V24, P1943, DOI 10.1029/97GL01930; Collins M, 2010, NAT GEOSCI, V3, P391, DOI 10.1038/NGEO868; HALPERT MS, 1992, J CLIMATE, V5, P577, DOI 10.1175/1520-0442(1992)005<0577:STPAWT>2.0.CO;2; Mitas CM, 2006, GEOPHYS RES LETT, V33, DOI 10.1029/2005GL024406; Gastineau G, 2008, TELLUS A, V60, P863, DOI 10.1111/j.1600-0870.2008.00344.x; Watanabe M, 2012, GEOPHYS RES LETT, V39, DOI 10.1029/2012GL052013; Yoshimori M, 2009, GEOPHYS RES LETT, V36, DOI [10.1029/2009GL040483, 10.1029/2009GL040488]; Meehl GA, 2007, B AM METEOROL SOC, V88, P1383, DOI 10.1175/BAMS-88-9-1383; Kang SM, 2009, J ATMOS SCI, V66, P2812, DOI 10.1175/2009JAS2924.1; ROPELEWSKI CF, 1987, MON WEATHER REV, V115, P1606, DOI 10.1175/1520-0493(1987)115<1606:GARSPP>2.0.CO;2; Watanabe M, 2012, GEOPHYS RES LETT, V39, DOI 10.1029/2012GL053305; Chiang JCH, 2005, CLIM DYNAM, V25, P477, DOI 10.1007/s00382-005-0040-5; Menviel L, 2010, PALEOCEANOGRAPHY, V25, DOI 10.1029/2009PA001892; Frierson DMW, 2012, J CLIMATE, V25, P720, DOI 10.1175/JCLI-D-11-00116.1; Taylor KE, 2012, B AM METEOROL SOC, V93, P485, DOI 10.1175/BAMS-D-11-00094.1; Bellenger H, 2014, CLIM DYNAM, V42, P1999, DOI 10.1007/s00382-013-1783-z; Guilyardi E, 2012, CLIVAR EXCH, V58, P29; Gupta Alexander Sen, 2013, Journal of Climate, V26, DOI 10.1175/JCLI-D-12-00521.1; Hasumi H., 2006, CCSR OCEAN COMPONENT; Klingaman NP, 2009, 2 UJCC NCAS CLIM MOD; Lu J, 2007, GEOPHYS RES LETT, V34, DOI 10.1029/2006GL028443; Peixoto J. P., 1991, PHYS CLIMATE; Su JZ, 2008, J CLIMATE, V21, P2019, DOI 10.1175/2007JCLI1692.1; Wittenberg AT, 2009, GEOPHYS RES LETT, V36, DOI 10.1029/2009GL038710	32	0	0	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0930-7575	1432-0894		CLIM DYNAM	Clim. Dyn.	FEB	2015	44	3-4					679	693		10.1007/s00382-014-2145-1		15	Meteorology & Atmospheric Sciences	Meteorology & Atmospheric Sciences	CB1RQ	WOS:000349406100005		
J	Matsumoto, K; Hayakawa, N; Nakamura, S; Oya, M				Matsumoto, Kazuhiro; Hayakawa, Nozomi; Nakamura, So; Oya, Mototsugu			Bladder metastasis from renal cell carcinoma: retrospective analysis of 65 reported cases	CLINICAL & EXPERIMENTAL METASTASIS			English	Article						Bladder metastasis; Renal cell carcinoma; RCC; Kidney cancer; Metastatic tumor	SURGICAL-TREATMENT; CANCER; ADENOCARCINOMA; SURVEILLANCE	This study was carried out to clarify the presentation, treatment options, and prognosis of renal cell carcinoma (RCC) metastasis to the bladder in which we do not yet have a comprehensive understanding. A systematic Medline, Web of Science, Embase, Google, and Ichushi Web search was performed to identify articles describing RCC metastasis to the bladder. The final cohort included 65 patients. The majority (75 %) experienced gross hematuria at the point of diagnosis of RCC. RCC metastasis to the bladder occurred both synchronously (23 %) and metachronously (77 %), and the median time for metachronous bladder metastasis following the diagnosis of RCC was 33 months. Of the 58 patients whose metastatic data were available, 36 (62 %) had metastasis to the bladder only, while 22 (38 %) had additional sites of metastasis. On pathology, clear cell carcinoma was the most common histology (92 %) and all bladder tumors were consistent with RCC metastasis; the median tumor size was 2.1 cm, and two-thirds of cases were superficial (non-muscle invasive) disease. The 2-year cancer-specific survival rate in patients with solitary bladder metastasis was 71.1 %, which was significantly higher than in patients with additional distant metastasis (25.8 %, p = 0.007). Regarding the interval after the diagnosis of primary RCC, the 2-year cancer-specific survival rate in patients who experienced bladder metastasis after more than a 1 year follow-up was 58.4 %, compared to 34.6 % in their counterparts (p = 0.063). A curative resection may provide a good possibility of long-term survival, particularly in those with a solitary bladder metastasis and/or a long interval after nephrectomy.	[Matsumoto, Kazuhiro; Hayakawa, Nozomi; Oya, Mototsugu] Keio Univ, Sch Med, Dept Urol, Shinjuku Ku, Tokyo 1608582, Japan; [Matsumoto, Kazuhiro; Hayakawa, Nozomi; Nakamura, So] Tokyo Saiseikai Cent Hosp, Dept Urol, Minato Ku, Tokyo 1080073, Japan	Matsumoto, K (reprint author), Keio Univ, Sch Med, Dept Urol, Shinjuku Ku, 35 Shinanomachi, Tokyo 1608582, Japan.	kazz_matsumoto@yahoo.co.jp			Project for Development of Innovative Research on Cancer Therapeutics (P-Direct), Ministry of Education, Culture, Sports, Science and Technology of Japan	This study was performed as a research program of the Project for Development of Innovative Research on Cancer Therapeutics (P-Direct), Ministry of Education, Culture, Sports, Science and Technology of Japan.	ABESHOUSE B S, 1956, J Int Coll Surg, V25, P117; Kavolius JP, 1998, J CLIN ONCOL, V16, P2261; Chung PH, 2012, UROL ONCOL-SEMIN ORI, V30, P476, DOI 10.1016/j.urolonc.2010.04.010; Kuczyk MA, 2005, BJU INT, V96, P721, DOI 10.1111/j.1464-410X.2005.05771.x; Hock LM, 2002, J UROLOGY, V167, P57, DOI 10.1016/S0022-5347(05)65382-7; Shiraishi K, 2003, INT J UROL, V10, P453, DOI 10.1046/j.1442-2042.2003.00652.x; Mazumdar M, 2000, STAT MED, V19, P113, DOI 10.1002/(SICI)1097-0258(20000115)19:1<113::AID-SIM245>3.3.CO;2-F; SAITOH H, 1981, CANCER, V48, P1487, DOI 10.1002/1097-0142(19810915)48:6<1487::AID-CNCR2820480635>3.0.CO;2-9; Joshi DP, 2002, J NATL MED ASSOC, V94, P912; Antonelli A, 2006, BJU INT, V97, P505, DOI 10.1111/j.1464-410X.2006.05934.x; Antonelli A, 2012, BJU INT, V110, pE559, DOI 10.1111/j.1464-410X.2012.11271.x; BOLKIER M, 1993, UROL INT, V50, P101; BUTLER MJ, 1974, BRIT J UROL, V46, P584, DOI 10.1111/j.1464-410X.1974.tb03861.x; Doo Seung Whan, 2013, Korean J Urol, V54, P69, DOI 10.4111/kju.2013.54.1.69; Faure Jean-Pierre, 2001, Journal of Urology, V165, P20, DOI 10.1097/00005392-200101000-00005; Frank I, 2003, J UROLOGY, V170, P2225, DOI 10.1097/01.ju.0000095541.10333.a7; HAJDU SI, 1971, ACTA CYTOL, V15, P31; Harding IJ, 1998, INT J CLIN PRACT, V52, P522; Kruck Stephan, 2013, Rare Tumors, V5, P72, DOI 10.4081/rt.2013.e19; Kume Haruki, 2007, Nihon Hinyokika Gakkai Zasshi, V98, P718; Matsuo Manabu, 2002, Urology, V60, P911, DOI 10.1016/S0090-4295(02)01900-3; Nair HT, 1991, J POSTGRAD MED, V37, P232; Pagano S, 1996, SCAND J UROL NEPHROL, V30, P165; Raviv Stacy, 2002, Urology, V60, P697, DOI 10.1016/S0090-4295(02)01846-0; SHAW RICHARD E., 1961, BRIT JOUR SURG, V48, P420, DOI 10.1002/bjs.18004821011; Sim SJ, 1999, MODERN PATHOL, V12, P351; Swanson D A, 2004, Scand J Surg, V93, P150; Tanikawa K, 1990, Hinyokika Kiyo, V36, P927; Tashiro K, 1984, Hinyokika Kiyo, V30, P249; Tsui KH, 2000, J UROLOGY, V163, P426, DOI 10.1016/S0022-5347(05)67892-5; Vecchioli Scaldazza C, 1998, MINERVA UROL NEFROL, V50, P191	31	0	0	SPRINGER	DORDRECHT	VAN GODEWIJCKSTRAAT 30, 3311 GZ DORDRECHT, NETHERLANDS	0262-0898	1573-7276		CLIN EXP METASTAS	Clin. Exp. Metastasis	FEB	2015	32	2					135	141		10.1007/s10585-015-9698-1		7	Oncology	Oncology	CB3SJ	WOS:000349548500004		
J	Alachkar, H; Mutonga, M; Malnassy, G; Park, J; Woods, A; Raca, G; Odenike, OM; Matsuo, Y; Stock, W; Nakamura, Y				Alachkar, H.; Mutonga, M.; Malnassy, G.; Park, J.; Woods, A.; Raca, G.; Odenike, O. M.; Matsuo, Y.; Stock, W.; Nakamura, Y.			PRECLINICAL EFFICACY OF T-LAK CELL-ORIGINATED PROTEIN KINASE INHIBITOR IN FLT3-ITD MUTANT ACUTE MYELOID LEUKEMIA.	CLINICAL PHARMACOLOGY & THERAPEUTICS			English	Meeting Abstract	Annual Meeting of the American-Society-for-Clinical-Pharmacology-and-Therapeutics (ASCPT)	MAR 03-07, 2015	New Orleans, LA	Amer Soc Clin Pharmacol & Therapeut					[Alachkar, H.; Mutonga, M.; Malnassy, G.; Park, J.; Woods, A.; Raca, G.; Odenike, O. M.; Stock, W.; Nakamura, Y.] Univ Chicago, Chicago, IL 60637 USA; [Matsuo, Y.] OncoTherapy Sci Inc, Kawasaki, Kanagawa, Japan								0	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0009-9236	1532-6535		CLIN PHARMACOL THER	Clin. Pharmacol. Ther.	FEB	2015	97			1		PII-007	S61	S62				2	Pharmacology & Pharmacy	Pharmacology & Pharmacy	CA2HW	WOS:000348730500185		
J	Bai, JP; Babiskin, A; Zhang, X; Lionberger, RA; Burckart, G; Mulberg, AE; Sinha, V; Uno, T				Bai, J. P.; Babiskin, A.; Zhang, X.; Lionberger, R. A.; Burckart, G.; Mulberg, A. E.; Sinha, V.; Uno, T.			PHYSIOLOGICALLY-BASED ABSORPTION MODELING AND SIMULATION FOR ASSESSING BIOAVAILABILITY IN ELDERLY, CHILDREN AND GASTROINTESTINAL DISEASES.	CLINICAL PHARMACOLOGY & THERAPEUTICS			English	Meeting Abstract	Annual Meeting of the American-Society-for-Clinical-Pharmacology-and-Therapeutics (ASCPT)	MAR 03-07, 2015	New Orleans, LA	Amer Soc Clin Pharmacol & Therapeut					[Bai, J. P.; Babiskin, A.; Zhang, X.; Lionberger, R. A.; Burckart, G.; Mulberg, A. E.; Sinha, V.] US FDA, Silver Spring, MD USA; [Uno, T.] Zikeikai Aoimori Hosp, Aomori, Japan								0	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0009-9236	1532-6535		CLIN PHARMACOL THER	Clin. Pharmacol. Ther.	FEB	2015	97			1		QP-23	S9	S9				1	Pharmacology & Pharmacy	Pharmacology & Pharmacy	CA2HW	WOS:000348730500024		
J	Bai, JP; Babiskin, A; Zhang, X; Lionberger, RA; Burckart, G; Mulberg, AE; Sinha, V; Uno, T				Bai, J. P.; Babiskin, A.; Zhang, X.; Lionberger, R. A.; Burckart, G.; Mulberg, A. E.; Sinha, V.; Uno, T.			PHYSIOLOGICALLY-BASED ABSORPTION MODELING AND SIMULATION FOR ASSESSING BIOAVAILABILITY IN ELDERLY, CHILDREN AND GASTROINTESTINAL DISEASES.	CLINICAL PHARMACOLOGY & THERAPEUTICS			English	Meeting Abstract	Annual Meeting of the American-Society-for-Clinical-Pharmacology-and-Therapeutics (ASCPT)	MAR 03-07, 2015	New Orleans, LA	Amer Soc Clin Pharmacol & Therapeut					[Bai, J. P.; Babiskin, A.; Zhang, X.; Lionberger, R. A.; Burckart, G.; Mulberg, A. E.; Sinha, V.] US FDA, Silver Spring, MD USA; [Uno, T.] Zikeikai Aoimori Hosp, Aomori, Japan								0	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0009-9236	1532-6535		CLIN PHARMACOL THER	Clin. Pharmacol. Ther.	FEB	2015	97			1		PI-084	S45	S45				1	Pharmacology & Pharmacy	Pharmacology & Pharmacy	CA2HW	WOS:000348730500137		
J	Choi, Y; Yoon, S; Ismatova, E; Kumagai, Y; Lee, H; Yu, K; Chung, J; Jang, I				Choi, Y.; Yoon, S.; Ismatova, E.; Kumagai, Y.; Lee, H.; Yu, K.; Chung, J.; Jang, I.			CLINICAL PHARMACOLOGY STUDY OF TELAPREVIR IN HEALTHY KOREAN VOLUNTEERS AFTER SINGLE AND MULTIPLE ORAL ADMINISTRATIONS.	CLINICAL PHARMACOLOGY & THERAPEUTICS			English	Meeting Abstract	Annual Meeting of the American-Society-for-Clinical-Pharmacology-and-Therapeutics (ASCPT)	MAR 03-07, 2015	New Orleans, LA	Amer Soc Clin Pharmacol & Therapeut					[Choi, Y.; Yoon, S.; Ismatova, E.; Lee, H.; Yu, K.; Jang, I.] Seoul Natl Univ, Coll Med & Hosp, Seoul, South Korea; [Kumagai, Y.] Kitasato Univ Hosp, Clin Trial Ctr, Kitamoto, Japan; [Chung, J.] Seoul Natl Univ, Bundang Hosp, Songnam, South Korea								0	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0009-9236	1532-6535		CLIN PHARMACOL THER	Clin. Pharmacol. Ther.	FEB	2015	97			1		PII-069	S79	S80				2	Pharmacology & Pharmacy	Pharmacology & Pharmacy	CA2HW	WOS:000348730500247		
J	Fujita, K; Masuo, Y; Okumura, H; Sasaki, Y; Kato, Y				Fujita, K.; Masuo, Y.; Okumura, H.; Sasaki, Y.; Kato, Y.			OPTIMIZATION OF THE DOSE OF IRINOTECAN IN CANCER PATIENTS WITH SEVERE RENAL FAILURE (SRF) BASED ON PHYSIOLOGICALLY-BASED PHARMACOKINETIC (PBPK) MODEL.	CLINICAL PHARMACOLOGY & THERAPEUTICS			English	Meeting Abstract	Annual Meeting of the American-Society-for-Clinical-Pharmacology-and-Therapeutics (ASCPT)	MAR 03-07, 2015	New Orleans, LA	Amer Soc Clin Pharmacol & Therapeut					[Fujita, K.; Sasaki, Y.] Showa Univ, Tokyo, Japan; [Masuo, Y.; Okumura, H.; Kato, Y.] Kanazawa Univ, Kanazawa, Ishikawa, Japan								0	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0009-9236	1532-6535		CLIN PHARMACOL THER	Clin. Pharmacol. Ther.	FEB	2015	97			1		PI-035	S30	S31				2	Pharmacology & Pharmacy	Pharmacology & Pharmacy	CA2HW	WOS:000348730500088		
J	Furuta, T; Sugimoto, M; Yamade, M; Uotani, T; Sahara, S; Ichikawa, H; Kagami, T; Watanabe, H; Umemura, K				Furuta, T.; Sugimoto, M.; Yamade, M.; Uotani, T.; Sahara, S.; Ichikawa, H.; Kagami, T.; Watanabe, H.; Umemura, K.			PERSONALIZED THERAPY FOR H. PYLORI INFECTION.	CLINICAL PHARMACOLOGY & THERAPEUTICS			English	Meeting Abstract	Annual Meeting of the American-Society-for-Clinical-Pharmacology-and-Therapeutics (ASCPT)	MAR 03-07, 2015	New Orleans, LA	Amer Soc Clin Pharmacol & Therapeut					[Furuta, T.; Sugimoto, M.; Yamade, M.; Uotani, T.; Sahara, S.; Ichikawa, H.; Kagami, T.; Watanabe, H.; Umemura, K.] Hamamatsu Univ Sch Med, Hamamatsu, Shizuoka 4313192, Japan								0	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0009-9236	1532-6535		CLIN PHARMACOL THER	Clin. Pharmacol. Ther.	FEB	2015	97			1		OIII-2	S103	S103				1	Pharmacology & Pharmacy	Pharmacology & Pharmacy	CA2HW	WOS:000348730500313		
J	Goswami, S; Yee, S; Mosley, J; Hedderson, M; Kabu, M; Maeda, S; Roden, DM; Simpson, MD; Giacomini, KM; Savic, RM				Goswami, S.; Yee, S.; Mosley, J.; Hedderson, M.; Kabu, M.; Maeda, S.; Roden, D. M.; Simpson, M. D.; Giacomini, K. M.; Savic, R. M.			A PHARMACOMETRICS APPROACH COMBINED WITH VARIOUS GENETIC ANALYSES UNCOVERS GENES LINKED TO THE DYNAMICS OF HBA1C.	CLINICAL PHARMACOLOGY & THERAPEUTICS			English	Meeting Abstract	Annual Meeting of the American-Society-for-Clinical-Pharmacology-and-Therapeutics (ASCPT)	MAR 03-07, 2015	New Orleans, LA	Amer Soc Clin Pharmacol & Therapeut					[Goswami, S.; Yee, S.; Giacomini, K. M.; Savic, R. M.] Univ Calif San Francisco, San Francisco, CA 94143 USA; [Mosley, J.; Roden, D. M.] Vanderbilt Univ, Nashville, TN 37235 USA; [Hedderson, M.] Kaiser Permanente Div Res, Oakland, CA USA; [Kabu, M.; Maeda, S.] RIKEN Yokohama Inst, Yokohama, Kanagawa, Japan; [Simpson, M. D.] Marshfield Clin Res Fdn, Marshfield, WI USA								0	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0009-9236	1532-6535		CLIN PHARMACOL THER	Clin. Pharmacol. Ther.	FEB	2015	97			1		QP-08	S3	S3		10.1002/cpt.55		1	Pharmacology & Pharmacy	Pharmacology & Pharmacy	CA2HW	WOS:000348730500009		
J	Goswami, S; Yee, S; Mosley, J; Hedderson, M; Kabu, M; Maeda, S; Roden, DM; Simpson, MD; Giacomini, KM; Savic, RM				Goswami, S.; Yee, S.; Mosley, J.; Hedderson, M.; Kabu, M.; Maeda, S.; Roden, D. M.; Simpson, M. D.; Giacomini, K. M.; Savic, R. M.			A PHARMACOMETRICS APPROACH COMBINED WITH VARIOUS GENETIC ANALYSES UNCOVERS GENES LINKED TO THE DYNAMICS OF HBA1C	CLINICAL PHARMACOLOGY & THERAPEUTICS			English	Meeting Abstract	Annual Meeting of the American-Society-for-Clinical-Pharmacology-and-Therapeutics (ASCPT)	MAR 03-07, 2015	New Orleans, LA	Amer Soc Clin Pharmacol & Therapeut					[Goswami, S.; Yee, S.; Giacomini, K. M.; Savic, R. M.] Univ Calif San Francisco, San Francisco, CA 94143 USA; [Mosley, J.; Roden, D. M.] Vanderbilt Univ, Nashville, TN 37235 USA; [Hedderson, M.] Kaiser Permanente Div Res, Oakland, CA USA; [Kabu, M.] RIKEN, Yokohama Inst, Yokohama, Kanagawa, Japan; [Maeda, S.] RIKEN, Yokohama Inst, Yokohama City, CA USA; [Simpson, M. D.] Marshfield Clin Res Fdn, Marshfield, WI USA								0	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0009-9236	1532-6535		CLIN PHARMACOL THER	Clin. Pharmacol. Ther.	FEB	2015	97			1		PI-030	S29	S29				1	Pharmacology & Pharmacy	Pharmacology & Pharmacy	CA2HW	WOS:000348730500083		
J	Hamada, A; Yonemori, K; Shimoi, T; Shimma, S; Osawa, S; Tanabe, Y; Hashimoto, J; Kodaira, M; Yamamoto, H; Yunokawa, M; Shimizu, C; Fujiwara, Y; Tamura, K				Hamada, A.; Yonemori, K.; Shimoi, T.; Shimma, S.; Osawa, S.; Tanabe, Y.; Hashimoto, J.; Kodaira, M.; Yamamoto, H.; Yunokawa, M.; Shimizu, C.; Fujiwara, Y.; Tamura, K.			IN VITRO MOLECULAR IMAGING OF UNLABELED DRUGS IN HUMAN TUMOR SPECIMENS USING IMAGING MASS SPECTROMETRY.	CLINICAL PHARMACOLOGY & THERAPEUTICS			English	Meeting Abstract	Annual Meeting of the American-Society-for-Clinical-Pharmacology-and-Therapeutics (ASCPT)	MAR 03-07, 2015	New Orleans, LA	Amer Soc Clin Pharmacol & Therapeut					[Hamada, A.; Yonemori, K.; Shimoi, T.; Shimma, S.; Osawa, S.; Tanabe, Y.; Hashimoto, J.; Kodaira, M.; Yamamoto, H.; Yunokawa, M.; Shimizu, C.; Fujiwara, Y.; Tamura, K.] Natl Canc Ctr, Tokyo 104, Japan								0	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0009-9236	1532-6535		CLIN PHARMACOL THER	Clin. Pharmacol. Ther.	FEB	2015	97			1		PI-038	S31	S31				1	Pharmacology & Pharmacy	Pharmacology & Pharmacy	CA2HW	WOS:000348730500091		
J	Ho, M; Wang, L; Ingle, J; Goss, P; Mushiroda, T; Kubo, M; Nakamura, Y; Shepherd, L; Weinshilboum, R; Bongartz, T				Ho, M.; Wang, L.; Ingle, J.; Goss, P.; Mushiroda, T.; Kubo, M.; Nakamura, Y.; Shepherd, L.; Weinshilboum, R.; Bongartz, T.			AROMATASE INHIBITOR-INDUCED ARTHRALGIA ASSOCIATED WITH TCL1A SNP AND ESTROGEN-DEPENDENT VARIATION IN CYTOKINE EXPRESSION: POSSIBLE LINKS BETWEEN ESTROGEN AND ARTHRITIS.	CLINICAL PHARMACOLOGY & THERAPEUTICS			English	Meeting Abstract	Annual Meeting of the American-Society-for-Clinical-Pharmacology-and-Therapeutics (ASCPT)	MAR 03-07, 2015	New Orleans, LA	Amer Soc Clin Pharmacol & Therapeut					[Ho, M.; Wang, L.; Ingle, J.; Weinshilboum, R.; Bongartz, T.] Mayo Clin, Rochester, MN USA; [Goss, P.] Massachusetts Gen Hosp, Boston, MA 02114 USA; [Mushiroda, T.; Kubo, M.] Riken Ctr, Yokohama, Kanagawa, Japan; [Nakamura, Y.] Univ Chicago, Knapp Ctr Biomed Discovery, Chicago, IL 60637 USA; [Shepherd, L.] NCIC Clin Trials Grp, Kingston, ON, Canada			Mushiroda, Taisei/E-3022-2010					0	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0009-9236	1532-6535		CLIN PHARMACOL THER	Clin. Pharmacol. Ther.	FEB	2015	97			1		PT-08	S13	S13				1	Pharmacology & Pharmacy	Pharmacology & Pharmacy	CA2HW	WOS:000348730500035		
J	Mu, S; Tajima, T; Corrado, C; Sunami, K; Suzuki, K; Hino, M; Kuroda, Y; Shibayama, H; Lin, R; Waldron, E; Binlich, F				Mu, S.; Tajima, T.; Corrado, C.; Sunami, K.; Suzuki, K.; Hino, M.; Kuroda, Y.; Shibayama, H.; Lin, R.; Waldron, E.; Binlich, F.			PANOBINOSTATPK/PD IN COMBINATION WITH BORTEZOMIB AND DEXAMETHASONE IN PATIENTS WITHRELAPSED AND RELAPSED/REFRACTORY MULTIPLE MYELOMA (RRMM).	CLINICAL PHARMACOLOGY & THERAPEUTICS			English	Meeting Abstract	Annual Meeting of the American-Society-for-Clinical-Pharmacology-and-Therapeutics (ASCPT)	MAR 03-07, 2015	New Orleans, LA	Amer Soc Clin Pharmacol & Therapeut					[Mu, S.; Lin, R.; Waldron, E.] Novartis Pharmaceut, E Hanover, NJ USA; [Tajima, T.] Novartis Pharmaceut, Tokyo, Japan; [Corrado, C.] Novartis Pharmaceut, Basel, Switzerland; [Sunami, K.] Natl Hosp Org, Okayama, Japan; [Suzuki, K.] Japenese Red Cross Med Ctr, Tokyo, Japan; [Hino, M.] Osaka City Univ Hosp, Okayama, Japan; [Kuroda, Y.] Hiroshima Univ Hosp, Hiroshima, Japan; [Shibayama, H.] Osaka Univ, Osaka, Japan; [Binlich, F.] Novartis Pharma SAS, Rueil Malmaison, France								0	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0009-9236	1532-6535		CLIN PHARMACOL THER	Clin. Pharmacol. Ther.	FEB	2015	97			1		PI-097	S49	S49				1	Pharmacology & Pharmacy	Pharmacology & Pharmacy	CA2HW	WOS:000348730500150		
J	Nakamura, M; Koh, S; Hisaka, A; Suzuki, H				Nakamura, M.; Koh, S.; Hisaka, A.; Suzuki, H.			SYSTEMATIC ASSESSMENT OF INTESTINAL METABOLISM AND DEGREE OF INHIBITION IN DRUG-DRUG INTERACTIONS CAUSED BY INHIBITION OF CYP3A	CLINICAL PHARMACOLOGY & THERAPEUTICS			English	Meeting Abstract	Annual Meeting of the American-Society-for-Clinical-Pharmacology-and-Therapeutics (ASCPT)	MAR 03-07, 2015	New Orleans, LA	Amer Soc Clin Pharmacol & Therapeut					[Nakamura, M.] Chugai Pharmaceut Co Ltd, Tokyo, Japan; [Koh, S.] Asahi Kasei Pharma Corp, Izunokuni, Japan; [Hisaka, A.] Chiba Univ, Chiba, Japan; [Suzuki, H.] Univ Tokyo, Tokyo, Japan								0	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0009-9236	1532-6535		CLIN PHARMACOL THER	Clin. Pharmacol. Ther.	FEB	2015	97			1		PI-049	S35	S35				1	Pharmacology & Pharmacy	Pharmacology & Pharmacy	CA2HW	WOS:000348730500102		
J	Nakamura, M; Diack, C; Ohishi, N; Xu, C; Phipps, A; Rossin, C; Muehlig, A; Kawanishi, T; Ohtomo, T; Lee, R; Chen, Y				Nakamura, M.; Diack, C.; Ohishi, N.; Xu, C.; Phipps, A.; Rossin, C.; Muehlig, A.; Kawanishi, T.; Ohtomo, T.; Lee, R.; Chen, Y.			TIME TO EVENT MODELING OF CODRITUZUMAB(GC33) ON OVERALL SURVIVAL IN PATIENTS WITH HEPATOCELLULAR CARCINOMA.	CLINICAL PHARMACOLOGY & THERAPEUTICS			English	Meeting Abstract	Annual Meeting of the American-Society-for-Clinical-Pharmacology-and-Therapeutics (ASCPT)	MAR 03-07, 2015	New Orleans, LA	Amer Soc Clin Pharmacol & Therapeut					[Nakamura, M.; Ohishi, N.; Kawanishi, T.; Ohtomo, T.] Chugai, Tokyo, Japan; [Diack, C.] F Hoffmann La Roche, Basel, Switzerland; [Xu, C.; Rossin, C.; Muehlig, A.; Lee, R.; Chen, Y.] Roche TCRC, New York, NY USA; [Phipps, A.] F Hoffmann La Roche, Welwyn Garden City, Herts, England								0	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0009-9236	1532-6535		CLIN PHARMACOL THER	Clin. Pharmacol. Ther.	FEB	2015	97			1		PI-116	S54	S54				1	Pharmacology & Pharmacy	Pharmacology & Pharmacy	CA2HW	WOS:000348730500169		
J	Neavin, D; Taddei, A; Ray, B; Biernacka, J; Zhu, H; Jenkins, G; Kalari, K; Mushiroda, T; Nakamura, Y; Kubo, M; Matson, W; Wang, L; Kaddurah-Daouk, R; Weinshilboum, R				Neavin, D.; Taddei, A.; Ray, B.; Biernacka, J.; Zhu, H.; Jenkins, G.; Kalari, K.; Mushiroda, T.; Nakamura, Y.; Kubo, M.; Matson, W.; Wang, L.; Kaddurah-Daouk, R.; Weinshilboum, R.			TRYPTOPHAN METABOLITE RATIO PHARMACOGENOMICS AND PHARMACOMETABOLOMICS: SOD2 AS A MARKER FOR SSRI RESPONSE IN PATIENTS WITH MAJOR DEPRESSIVE DISORDER (MDD).	CLINICAL PHARMACOLOGY & THERAPEUTICS			English	Meeting Abstract	Annual Meeting of the American-Society-for-Clinical-Pharmacology-and-Therapeutics (ASCPT)	MAR 03-07, 2015	New Orleans, LA	Amer Soc Clin Pharmacol & Therapeut					[Neavin, D.; Taddei, A.; Ray, B.; Biernacka, J.; Jenkins, G.; Kalari, K.; Wang, L.; Weinshilboum, R.] Mayo Clin, Rochester, MN USA; [Zhu, H.; Kaddurah-Daouk, R.] Duke Univ, Sch Med, Pharmacometabol Res Network, Durham, NC USA; [Mushiroda, T.; Kubo, M.] RIKEN Ctr Integrat Med Sci, Yokohama, Kanagawa, Japan; [Nakamura, Y.] Univ Chicago, Chicago, IL 60637 USA; [Matson, W.] Bedford VA Med Ctr, Bedford, MA USA			Mushiroda, Taisei/E-3022-2010					0	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0009-9236	1532-6535		CLIN PHARMACOL THER	Clin. Pharmacol. Ther.	FEB	2015	97			1		PT-12	S15	S15				1	Pharmacology & Pharmacy	Pharmacology & Pharmacy	CA2HW	WOS:000348730500039		
J	Ono, C; Hsyu, P; Abbas, R; Loi, C; Yamazaki, S				Ono, C.; Hsyu, P.; Abbas, R.; Loi, C.; Yamazaki, S.			APPLICATION OF PHYSIOLOGICALLY-BASED PHARMACOKINETIC MODELING TO BOSUTINIB PHARMACOKINETICS: PREDICTION OF DRUG-DRUG INTERACTIONS AS CYP3A SUBSTRATE.	CLINICAL PHARMACOLOGY & THERAPEUTICS			English	Meeting Abstract	Annual Meeting of the American-Society-for-Clinical-Pharmacology-and-Therapeutics (ASCPT)	MAR 03-07, 2015	New Orleans, LA	Amer Soc Clin Pharmacol & Therapeut					[Ono, C.] Pfizer Japan Inc, Tokyo, Japan; [Hsyu, P.; Loi, C.; Yamazaki, S.] Pfizer Inc, San Diego, CA USA; [Abbas, R.] Pfizer Inc, Collegeville, PA USA								0	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0009-9236	1532-6535		CLIN PHARMACOL THER	Clin. Pharmacol. Ther.	FEB	2015	97			1		PII-051	S74	S74				1	Pharmacology & Pharmacy	Pharmacology & Pharmacy	CA2HW	WOS:000348730500229		
J	Ono, C; Hsyu, P; Abbas, R; Loi, C; Yamazaki, S				Ono, C.; Hsyu, P.; Abbas, R.; Loi, C.; Yamazaki, S.			APPLICATION OF PHYSIOLOGICALLY-BASED PHARMACOKINETIC MODELING TO BOSUTINIB PHARMACOKINETICS: PREDICTION OF DRUG-DISEASE INTERACTION IN ORGAN DYSFUNCTION PATIENTS.	CLINICAL PHARMACOLOGY & THERAPEUTICS			English	Meeting Abstract	Annual Meeting of the American-Society-for-Clinical-Pharmacology-and-Therapeutics (ASCPT)	MAR 03-07, 2015	New Orleans, LA	Amer Soc Clin Pharmacol & Therapeut					[Ono, C.] Pfizer Japan Inc, Tokyo, Japan; [Hsyu, P.; Loi, C.; Yamazaki, S.] Pfizer Inc, San Diego, CA USA; [Abbas, R.] Pfizer Inc, Collegeville, PA USA								0	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0009-9236	1532-6535		CLIN PHARMACOL THER	Clin. Pharmacol. Ther.	FEB	2015	97			1		PII-052	S74	S74				1	Pharmacology & Pharmacy	Pharmacology & Pharmacy	CA2HW	WOS:000348730500230		
J	Orito, Y; Iwasa, T; Uemura, N; Fujimoto, G; Yama, S; Gao, W; Caro, L; Fandozzi, C; Prucksaritanont, T; Anderson, M; Butterton, J; Hasegawa, S				Orito, Y.; Iwasa, T.; Uemura, N.; Fujimoto, G.; Yama, S.; Gao, W.; Caro, L.; Fandozzi, C.; Prucksaritanont, T.; Anderson, M.; Butterton, J.; Hasegawa, S.			PHARMACOKINETIC INTERACTION OF HCV NS3/4A PROTEASE INHIBITOR VANIPREVIR AND ROSUVASTATIN.	CLINICAL PHARMACOLOGY & THERAPEUTICS			English	Meeting Abstract	Annual Meeting of the American-Society-for-Clinical-Pharmacology-and-Therapeutics (ASCPT)	MAR 03-07, 2015	New Orleans, LA	Amer Soc Clin Pharmacol & Therapeut					[Orito, Y.; Iwasa, T.; Fujimoto, G.; Yama, S.] MSD KK, Tokyo, Japan; [Uemura, N.] Oita Univ, Oita 87011, Japan; [Gao, W.; Caro, L.; Fandozzi, C.; Prucksaritanont, T.; Anderson, M.; Butterton, J.] Merck Sharp & Dolune Corp, Whitehouse Stn, NJ USA; [Hasegawa, S.] Pharmaspur Inc, Tokyo, Japan								0	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0009-9236	1532-6535		CLIN PHARMACOL THER	Clin. Pharmacol. Ther.	FEB	2015	97			1		PI-013	S24	S25				2	Pharmacology & Pharmacy	Pharmacology & Pharmacy	CA2HW	WOS:000348730500066		
J	Ray, B; Boakye-Agyeman, F; Zhu, H; Biernacka, J; Liu, D; Taddei, A; Jenkins, G; Kalari, K; Mushiroda, T; Kubo, M; Nakamura, Y; Matson, W; Wang, L; Kaddurah-Daouk, R; Weinshilboum, RM				Ray, B.; Boakye-Agyeman, F.; Zhu, H.; Biernacka, J.; Liu, D.; Taddei, A.; Jenkins, G.; Kalari, K.; Mushiroda, T.; Kubo, M.; Nakamura, Y.; Matson, W.; Wang, L.; Kaddurah-Daouk, R.; Weinshilboum, R. M.			ARYL HYDROCARBON RECEPTOR (AHR) GENETIC VARIATION ASSOCIATED WITH KYNURENINE LEVELS IN MAJOR DEPRESSIVE DISORDER: PHARMACOMETABOLOMICS-INFORMED PHARMACOGENOMICS.	CLINICAL PHARMACOLOGY & THERAPEUTICS			English	Meeting Abstract	Annual Meeting of the American-Society-for-Clinical-Pharmacology-and-Therapeutics (ASCPT)	MAR 03-07, 2015	New Orleans, LA	Amer Soc Clin Pharmacol & Therapeut					[Ray, B.; Boakye-Agyeman, F.; Biernacka, J.; Liu, D.; Taddei, A.; Jenkins, G.; Kalari, K.; Wang, L.; Weinshilboum, R. M.] Mayo Clin, Rochester, MN USA; [Zhu, H.; Kaddurah-Daouk, R.] Duke Univ, Sch Med, Pharmacometabol Res Network, Durham, NC USA; [Mushiroda, T.; Kubo, M.] RIKEN Ctr Integrat Med Sci, Yokohama, Kanagawa, Japan; [Nakamura, Y.] Univ Chicago, Chicago, IL 60637 USA; [Matson, W.] Bedford VA Res Corp Inc, Bedford, MA USA			Mushiroda, Taisei/E-3022-2010					0	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0009-9236	1532-6535		CLIN PHARMACOL THER	Clin. Pharmacol. Ther.	FEB	2015	97			1		PT-21	S17	S18				2	Pharmacology & Pharmacy	Pharmacology & Pharmacy	CA2HW	WOS:000348730500048		
J	Saito, K; Mochizuki, T; Shimatsu, A; Kasahara, Y				Saito, K.; Mochizuki, T.; Shimatsu, A.; Kasahara, Y.			POPULATION PHARMACODYNAMIC MODELING OF LANREOTIDE AUTOGEL IN JAPANESE ACROMEGALIC PATIENTS.	CLINICAL PHARMACOLOGY & THERAPEUTICS			English	Meeting Abstract	Annual Meeting of the American-Society-for-Clinical-Pharmacology-and-Therapeutics (ASCPT)	MAR 03-07, 2015	New Orleans, LA	Amer Soc Clin Pharmacol & Therapeut					[Saito, K.; Mochizuki, T.; Kasahara, Y.] Teijin Pharma Ltd, Tokyo, Japan; [Shimatsu, A.] Natl Hosp Org Kyoto Med Ctr, Clin Res Inst, Kyoto, Japan								0	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0009-9236	1532-6535		CLIN PHARMACOL THER	Clin. Pharmacol. Ther.	FEB	2015	97			1		PII-048	S73	S73				1	Pharmacology & Pharmacy	Pharmacology & Pharmacy	CA2HW	WOS:000348730500226		
J	Yamaguchi, K; Watanabe, M; Motoki, T; Tanaka, H; Asakura, M; Tai, T; Takahashi, K; Nozaki, T; Kosaka, S; Houchi, H				Yamaguchi, K.; Watanabe, M.; Motoki, T.; Tanaka, H.; Asakura, M.; Tai, T.; Takahashi, K.; Nozaki, T.; Kosaka, S.; Houchi, H.			CLINICAL PHARMACOKINETICS STUDIES AIMED AT EFFECTIVELY AND EFFICIENTLY MONITORING THERAPEUTIC DRUG MONITORING METHOD OF MYCOPHENOLIC ACID IN RENAL TRANSPLANT RECIPIENTS.	CLINICAL PHARMACOLOGY & THERAPEUTICS			English	Meeting Abstract	Annual Meeting of the American-Society-for-Clinical-Pharmacology-and-Therapeutics (ASCPT)	MAR 03-07, 2015	New Orleans, LA	Amer Soc Clin Pharmacol & Therapeut					[Yamaguchi, K.; Watanabe, M.; Motoki, T.; Tanaka, H.; Asakura, M.; Tai, T.; Takahashi, K.; Nozaki, T.; Kosaka, S.; Houchi, H.] Kagawa Univ Hosp, Dept Pharm, Miki, Kagawa, Japan								0	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0009-9236	1532-6535		CLIN PHARMACOL THER	Clin. Pharmacol. Ther.	FEB	2015	97			1		PII-064	S78	S78				1	Pharmacology & Pharmacy	Pharmacology & Pharmacy	CA2HW	WOS:000348730500242		
J	Yoshida, K; Yeung, CK; Kusama, M; Zhang, H; Ragueneau-Majlessi, I; Argon, S; Zhao, P; Zhang, L; Zineh, I; Sugiyama, Y; Huang, S				Yoshida, K.; Yeung, C. K.; Kusama, M.; Zhang, H.; Ragueneau-Majlessi, I.; Argon, S.; Zhao, P.; Zhang, L.; Zineh, I.; Sugiyama, Y.; Huang, S.			ANALYSIS OF THE EFFECT OF VARIOUS DEGREES OF RENAL IMPAIRMENT ON THE PHARMACOKINETICS OF NONRENALLY ELIMINATED DRUGS.	CLINICAL PHARMACOLOGY & THERAPEUTICS			English	Meeting Abstract	Annual Meeting of the American-Society-for-Clinical-Pharmacology-and-Therapeutics (ASCPT)	MAR 03-07, 2015	New Orleans, LA	Amer Soc Clin Pharmacol & Therapeut					[Yoshida, K.; Zhang, H.; Zhao, P.; Zhang, L.; Zineh, I.; Huang, S.] US FDA, Silver Spring, MD USA; [Yeung, C. K.; Ragueneau-Majlessi, I.; Argon, S.] Univ Washington, Seattle, WA 98195 USA; [Kusama, M.] Univ Tokyo, Tokyo, Japan; [Sugiyama, Y.] Inst Phys & Chem Res RIKEN, Yokohama, Kanagawa, Japan			YOSHIDA, KENTA/B-3037-2012	YOSHIDA, KENTA/0000-0003-4967-3831				0	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0009-9236	1532-6535		CLIN PHARMACOL THER	Clin. Pharmacol. Ther.	FEB	2015	97			1		PII-107	S92	S92				1	Pharmacology & Pharmacy	Pharmacology & Pharmacy	CA2HW	WOS:000348730500285		
J	Lennikov, A; Alekberova, Z; Goloeva, R; Kitaichi, N; Denisov, L; Namba, K; Takeno, M; Ishigatsubo, Y; Mizuki, N; Nasonov, E; Ishida, S; Ohno, S				Lennikov, Anton; Alekberova, Zemfira; Goloeva, Regina; Kitaichi, Nobuyoshi; Denisov, Lev; Namba, Kenichi; Takeno, Mitsuhiro; Ishigatsubo, Yoshiaki; Mizuki, Nobuhisa; Nasonov, Eugeny; Ishida, Susumu; Ohno, Shigeaki			Single center study on ethnic and clinical features of Behcet's disease in Moscow, Russia	CLINICAL RHEUMATOLOGY			English	Article						Behcet's disease; Caucasus; Central Asia; Clinical symptoms; Russia; Silk Road disease	GENOME-WIDE ASSOCIATION; KOREAN POPULATION; IL23R-IL12RB2; IL10; MHC	For the purpose of investigating Behcet's disease (BD) in Russia, 250 consecutive patients (177 men and 73 women) diagnosed with BD between 1990 and 2010 at the Research Institute of Rheumatology, Russian Academy of Medical Sciences in Moscow were enrolled in this study. The ethnic backgrounds of the patients were reported as follows: 23.2 % (58 cases) from Russia, 12.8 % (32 cases) from Azerbaijan, 14.4 % (36 cases) from Armenia, 8.8 % (22 cases) from Chechnya, and 21.6 % (55 cases) from Dagestan. The remaining 19.2 % (48 cases) were from other regions or of unknown origin. More than half (57.6 %) of the Behcet's disease patients originated from Central Asia, specifically Azerbaijan, Armenia, Chechnya, and Dagestan. The mean age at disease onset was 31.5 +/- 9.38 (13-60) years old, and the most typical initial manifestations were oral aphthous ulcers. Patients aged 20-39 years old were more commonly affected and displayed a wide clinical spectrum of the disease, with varieties of severe internal organ involvement. The manifestations observed throughout the course of the disease included oral aphthous ulcers (100 %), various cutaneous lesions (88.8 %), genital ulcers (81.2 %), and ocular lesions (54.0 %). Besides these, many organs/systems were implicated in patient cases, namely joint (53.2 %), vascular (25.2 %), neurological (8.0 %), gastrointestinal (25.2 %), and cardiac (5.6 %) systems. Involvements of ocular (p < 0.01) and skin (p < 0.01) lesions were more frequent in men than in women. HLA-B51 and HLA-A26 typing was performed in 127 patients and 508 healthy controls. HLA-B51 was found in 63.0 % of BD patients compared to 20.7 % of the healthy control subjects (p < 0.001), and HLA-A26 was present in 11.3 % of BD patients and 18.9 % of the control group. This study shows the presence of BD in Russia, and it is suggested that its prevalence in Central Asian people is much higher than that in White Russian.	[Lennikov, Anton; Namba, Kenichi; Ishida, Susumu; Ohno, Shigeaki] Hokkaido Univ, Grad Sch Med, Dept Ophthalmol, Sapporo, Hokkaido 0608638, Japan; [Alekberova, Zemfira; Goloeva, Regina; Denisov, Lev; Nasonov, Eugeny] Russian Acad Med Sci, Res Inst Rheumatol, Moscow, Russia; [Kitaichi, Nobuyoshi] Hlth Sci Univ Hokkaido, Dept Ophthalmol, Sapporo, Hokkaido, Japan; [Kitaichi, Nobuyoshi; Ishida, Susumu] Hokkaido Univ, Grad Sch Med, Dept Ocular Inflammat & Immunol, Kita Ku, Sapporo, Hokkaido 0608638, Japan; [Takeno, Mitsuhiro; Ishigatsubo, Yoshiaki] Yokohama City Univ, Grad Sch Med, Dept Internal Med & Clin Immunol, Yokohama, Kanagawa 232, Japan; [Mizuki, Nobuhisa] Yokohama City Univ, Grad Sch Med, Dept Ophthalmol & Visual Sci, Yokohama, Kanagawa 232, Japan	Kitaichi, N (reprint author), Hokkaido Univ, Grad Sch Med, Dept Ocular Inflammat & Immunol, Kita Ku, Kita 15,Nishi 7, Sapporo, Hokkaido 0608638, Japan.	nobukita@med.hokudai.ac.jp			Japan Society for the Promotion of Science (JSPS) KAKENHI [25462731, 23592602, 22133010]; Russian Academy of Medical Science (RAMS)	This work was supported by grants from the Japan Society for the Promotion of Science (JSPS) KAKENHI (grant numbers: 25462731, 23592602, and 22133010) and Russian Academy of Medical Science (RAMS) as part of study on Behcet's disease in Russia.	Sakane T, 1999, NEW ENGL J MED, V341, P1284, DOI 10.1056/NEJM199910213411707; OHNO S, 1973, LANCET, V2, P1383; Remmers EF, 2010, NAT GENET, V42, P698, DOI 10.1038/ng.625; El Menyawi MM, 2009, RHEUMATOL INT, V29, P641, DOI 10.1007/s00296-008-0741-2; Verity DH, 1999, TISSUE ANTIGENS, V54, P213, DOI 10.1034/j.1399-0039.1999.540301.x; Horie Y, 2009, RHEUMATOLOGY, V48, P638, DOI 10.1093/rheumatology/kep077; Kitaichi N, 2007, BRIT J OPHTHALMOL, V91, P1579, DOI 10.1136/bjo.2007.123554; Meguro A, 2010, ANN RHEUM DIS, V69, P747, DOI 10.1136/ard.2009.108571; Horie Y, 2012, RHEUMATOLOGY, V51, P983, DOI 10.1093/rheumatology/ker444; Azizlerli G, 2003, INT J DERMATOL, V42, P803, DOI 10.1046/j.1365-4362.2003.01893.x; Davatchi F, 2010, INT J RHEUM DIS, V13, P367, DOI 10.1111/j.1756-185X.2010.01549.x; Ideguchi H, 2011, MEDICINE, V90, P125, DOI 10.1097/MD.0b013e318211bf28; Krause I, 1999, JCR-J CLIN RHEUMATOL, V5, P137, DOI 10.1097/00124743-199906000-00005; Bang Dongsik, 1997, Yonsei Medical Journal, V38, P428; Barkhudaryan S, 1969, PATMA BANASIRAKAN HA, V3, P125; SILMAN AJ, 1990, LANCET, V335, P1078; Kaneko F, 2003, ADV EXP MED BIOL, V528, P25; Kaya TI, 2002, CLIN EXP DERMATOL, V27, P498, DOI 10.1046/j.1365-2230.2002.01060.x; Kaya TI, 2012, PATHOLOGY RES INT, V2012, DOI DOI 10.1155/2012/912589; Kitaichi N, 2009, BRIT J OPHTHALMOL, V93, P1428, DOI 10.1136/bjo.2008.154476; Mizuki N, 2010, NAT GENET, V42, P703, DOI 10.1038/ng.624; Neves FS, 2009, CLIN RHEUMATOL, V28, P543, DOI 10.1007/s10067-008-1081-z; OHNO S, 1982, ARCH OPHTHALMOL-CHIC, V100, P1455; Sachetto Z, 2011, RHEUMATOL INT, V32, P2063; Zhang Z, 2012, RHEUMATOL INT, V33, P645	25	0	0	SPRINGER LONDON LTD	LONDON	236 GRAYS INN RD, 6TH FLOOR, LONDON WC1X 8HL, ENGLAND	0770-3198	1434-9949		CLIN RHEUMATOL	Clin. Rheumatol.	FEB	2015	34	2					321	327		10.1007/s10067-013-2442-9		7	Rheumatology	Rheumatology	CA3JT	WOS:000348803000019		
J	Bindzus, N; Cargnoni, F; Gatti, C; Richter, B; Jensen, TR; Takata, M; Iversen, BB				Bindzus, Niels; Cargnoni, Fausto; Gatti, Carlo; Richter, Bo; Jensen, Torben R.; Takata, Masaki; Iversen, Bo B.			Mapping the complete bonding network in KBH4 using the combined power of powder diffraction and maximum entropy method	COMPUTATIONAL AND THEORETICAL CHEMISTRY			English	Article						Synchrotron powder diffraction; Electron density; Maximum entropy method; Hydrogen storage	CHARGE-DENSITY ANALYSIS; X-RAY-DIFFRACTION; BOROHYDRIDES MBH4 M; ELECTRON-DENSITY; HYDROGEN STORAGE; ALKALI BOROHYDRIDES; REORIENTATIONAL MOTION; RIETVELD REFINEMENT; CRYSTAL-STRUCTURE; METHOD MEM	The combined power of the maximum entropy method (MEM) and synchrotron powder X-ray diffraction (SPXRD) is exerted to accurately reconstruct the electron density distribution (EDD) of the hydrogen storage material, KBH4. Its crystal structure features thermally activated disorder among the BH4- moieties, and weak secondary bonding effects occupy a key role in determining the energetic barrier for this dynamical effect. The MEM reconstruction is meticulously optimised and inspected for errors, in what may be envisaged as a general manual for this kind of studies. The successful outcome constitutes an experimental EDD of cutting-edge quality, from which atomic charges and the complete bonding network are mapped by topological descriptors. Remarkably, the chemical insights even extend to the delicate interplay of closed-shell bonding in excellent correspondence with ab initio and two-channel MEM calculations. For the current class of functional materials, access to such subtle electronic features is essential for the fundamental understanding of hydrogen desorption pathways. (C) 2014 Elsevier B.V. All rights reserved.	[Bindzus, Niels; Richter, Bo; Jensen, Torben R.; Iversen, Bo B.] Aarhus Univ, Dept Chem, Ctr Mat Crystallog, DK-8000 Aarhus C, Denmark; [Bindzus, Niels; Richter, Bo; Jensen, Torben R.; Iversen, Bo B.] Aarhus Univ, iNANO, DK-8000 Aarhus C, Denmark; [Cargnoni, Fausto; Gatti, Carlo] ISTM, CNR, I-20133 Milan, Italy; [Takata, Masaki] Japan Synchrotron Radiat Res Inst, Sayo, Hyogo 6795198, Japan	Bindzus, N (reprint author), Aarhus Univ, Dept Chem, Ctr Mat Crystallog, Langelandsgade 140, DK-8000 Aarhus C, Denmark.	nielsb@chem.au.dk; bo@chem.au.dk	Gatti, Carlo/B-7410-2009	Gatti, Carlo/0000-0002-0047-1596	Danish National Research Foundation (Center for Materials Crystallography) [DNRF93]; Danish Research Council for Nature and Universe (Danscatt)	We thank the Danish National Research Foundation (Center for Materials Crystallography, DNRF93) and the Danish Research Council for Nature and Universe (Danscatt) for funding this work. The RIKEN-Harima Institute is gratefully acknowledged for beam time at BL02B2 at the SPring-8 synchrotron facility.	Iversen BB, 1997, ACTA CRYSTALLOGR A, V53, P376, DOI 10.1107/S0108767397000792; Grochala W, 2004, CHEM REV, V104, P1283, DOI 10.1021/cr030691s; Momma K, 2011, J APPL CRYSTALLOGR, V44, P1272, DOI 10.1107/S0021889811038970; Wolstenholme DJ, 2014, CHEM COMMUN, V50, P3820, DOI 10.1039/c4cc00987h; Weigend F, 2005, PHYS CHEM CHEM PHYS, V7, P3297, DOI 10.1039/b508541a; Blanco MA, 2005, J CHEM THEORY COMPUT, V1, P1096, DOI 10.1021/ct0501093; Nishimura S, 2008, NAT MATER, V7, P707, DOI 10.1038/nmat2251; Nishibori E, 2007, ACTA CRYSTALLOGR A, V63, P43, DOI 10.1107/S0108767306047210; Snyder GJ, 2004, NAT MATER, V3, P458, DOI 10.1038/nmat1154; Bindzus N, 2014, ACTA CRYSTALLOGR A, V70, P39, DOI 10.1107/S2053273313026600; Palatinus L, 2012, J APPL CRYSTALLOGR, V45, P575, DOI 10.1107/S0021889812016068; Mondal S, 2012, ACTA CRYSTALLOGR A, V68, P568, DOI 10.1107/S0108767312029005; Wolstenholme DJ, 2012, CHEM COMMUN, V48, P2597, DOI 10.1039/c2cc16111g; Kastbjerg S, 2013, ADV FUNCT MATER, V23, P5477, DOI 10.1002/adfm.201300722; GATTI C, 1994, J CHEM PHYS, V101, P10686, DOI 10.1063/1.467882; Rude LH, 2011, PHYS STATUS SOLIDI A, V208, P1754, DOI 10.1002/pssa.201001214; COLLINS DM, 1982, NATURE, V298, P49, DOI 10.1038/298049a0; THOMPSON P, 1987, J APPL CRYSTALLOGR, V20, P79, DOI 10.1107/S0021889887087090; Maki S, 2013, J AM CHEM SOC, V135, P918, DOI 10.1021/ja311070v; SAKATA M, 1990, ACTA CRYSTALLOGR A, V46, P263, DOI 10.1107/S0108767389012377; Zuttel A, 2003, J ALLOY COMPD, V356, P515, DOI 10.1016/S0925-8388(02)01253-7; Nishibori E, 2001, NUCL INSTRUM METH A, V467, P1045, DOI 10.1016/S0168-9002(01)00639-8; Wolstenholme DJ, 2011, J AM CHEM SOC, V133, P16598, DOI 10.1021/ja206357a; Sirsch P, 2012, CHEM-EUR J, V18, P9476, DOI 10.1002/chem.201200803; Babanova OA, 2010, J PHYS CHEM C, V114, P3712, DOI 10.1021/jp9119606; Chen XW, 2012, J PHYS CHEM C, V116, P21162, DOI 10.1021/jp302866w; Renaudin G, 2004, J ALLOY COMPD, V375, P98, DOI 10.1016/j.jallcom.2003.11.018; Babanova OA, 2011, J PHYS CHEM C, V115, P10305, DOI 10.1021/jp201735q; Bindzus N, 2012, ACTA CRYSTALLOGR A, V68, P750, DOI 10.1107/S0108767312037269; Bindzus N, 2013, J PHYS CHEM C, V117, P2308, DOI 10.1021/jp308777n; Buchter F., 2011, PHYS REV B, V83; Coppens P, 2005, COORDIN CHEM REV, V249, P179, DOI 10.1016/j.ccr.2004.02.019; DEVRIES RY, 1994, ACTA CRYSTALLOGR A, V50, P383, DOI 10.1107/S0108767393012802; deVries RY, 1996, PHYS REV LETT, V77, P1719, DOI 10.1103/PhysRevLett.77.1719; Dovesi R., 2006, CRYSTAL06 USERS MANU; Filinchuk Y, 2008, EUR J INORG CHEM, P3127, DOI 10.1002/ejic.200800053; Gatti C., 1999, TOPOND 98 ELECT DENS; Hofmann A, 2007, ACTA CRYSTALLOGR B, V63, P285, DOI 10.1107/S0108768106052153; IVERSEN BB, 1995, ACTA CRYSTALLOGR B, V51, P580, DOI 10.1107/S0108768194010360; JAUCH W, 1994, ACTA CRYSTALLOGR A, V50, P650, DOI 10.1107/S0108767394004472; JAUCH W, 1993, ACTA CRYSTALLOGR A, V49, P590, DOI 10.1107/S0108767392010948; Jimura K, 2012, J PHYS CHEM C, V116, P4883, DOI 10.1021/jp300092q; Jorgensen MRV, 2012, ACTA CRYSTALLOGR A, V68, P301, DOI [10.1107/S0108767312003066, 10.1107/S0108767312003066301]; Koritsanszky TS, 2001, CHEM REV, V101, P1583, DOI 10.1021/cr990112c; LUCK RL, 1999, ACTA CRYSTALLOGRAP C, V0055; Nielsen TK, 2010, ACS NANO, V4, P3903, DOI 10.1021/nn1006946; Noritake T, 2005, J ALLOY COMPD, V393, P264, DOI 10.1016/j.jallcom.2004.09.063; Noritake T, 2003, J ALLOY COMPD, V356, P84, DOI 10.1016/S0925-8388(03)00104-X; Noritake T, 2010, J ALLOY COMPD, V491, P57, DOI 10.1016/j.jallcom.2009.11.032; Palatinus L, 2002, ACTA CRYSTALLOGR A, V58, P559, DOI 10.1107/S0108767302015556; PAPOULAR RJ, 1990, EUROPHYS LETT, V13, P429, DOI 10.1209/0295-5075/13/5/009; Papoular RJ, 1996, ACTA CRYSTALLOGR A, V52, P397, DOI 10.1107/S0108767395017132; Papoular RJ, 2002, AIP CONF PROC, V617, P204; Prathapa SJ, 2013, ACTA CRYSTALLOGR B, V69, P203, DOI [10.1107/S2052519213004879, 10.1107/S0108768113004874]; Remhof A, 2010, PHYS REV B, V81, DOI 10.1103/PhysRevB.81.214304; RODRIGUEZCARVAJAL J, 1993, PHYSICA B, V192, P55, DOI 10.1016/0921-4526(93)90108-I; SAKATA M, 1990, J APPL CRYSTALLOGR, V23, P526, DOI 10.1107/S0021889890008214; Samy A, 2010, ACTA CRYSTALLOGR B, V66, P184, DOI 10.1107/S0108768109052616; STEPHENSON CC, 1955, J CHEM PHYS, V23, P1960, DOI 10.1063/1.1740617; Svendsen H, 2010, ACTA CRYSTALLOGR A, V66, P458, DOI 10.1107/S0108767310014236; TAKATA M, 1995, NATURE, V377, P46, DOI 10.1038/377046a0; Vajo JJ, 2007, SCRIPTA MATER, V56, P829, DOI 10.1016/j.scriptamat.2007.01.002; van Smaalen S., 2009, PHYS SCR, V79, P1; van Smaalen S, 2003, ACTA CRYSTALLOGR A, V59, P459, DOI 10.1107/S010876730301434X; Verdal N, 2010, J PHYS CHEM C, V114, P10027, DOI 10.1021/jp1006473; Volkov A., 2006, XD2006 COMPUTER PROG	66	1	1	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	2210-271X	1872-7999		COMPUT THEOR CHEM	Comput. Theor. Chem.	FEB 1	2015	1053				SI		245	253		10.1016/j.comptc.2014.09.014		9	Chemistry, Physical	Chemistry	CB4IO	WOS:000349591600028		
J	Li, B; Lu, YJ; Li, CY; Godil, A; Schreck, T; Aono, M; Burtscher, M; Chen, Q; Chowdhury, NK; Fang, B; Fu, HB; Furuya, T; Li, HS; Liu, JZ; Johan, H; Kosaka, R; Koyanagi, H; Ohbuchi, R; Tatsuma, A; Wan, YJ; Zhang, CL; Zou, CQ				Li, Bo; Lu, Yijuan; Li, Chunyuan; Godil, Afzal; Schreck, Tobias; Aono, Masaki; Burtscher, Martin; Chen, Qiang; Chowdhury, Nihad Karim; Fang, Bin; Fu, Hongbo; Furuya, Takahiko; Li, Haisheng; Liu, Jianzhuang; Johan, Henry; Kosaka, Ryuichi; Koyanagi, Hitoshi; Ohbuchi, Ryutarou; Tatsuma, Atsushi; Wan, Yajuan; Zhang, Chaoli; Zou, Changqing			A comparison of 3D shape retrieval methods based on a large-scale benchmark supporting multimodal queries	COMPUTER VISION AND IMAGE UNDERSTANDING			English	Article						3D shape retrieval; Large-scale benchmark; Multimodal queries; Unified; Performance evaluation; Query-by-Model; Query-by-Sketch; SHREC	MODEL RETRIEVAL; OBJECT RETRIEVAL; SIMILARITY SEARCH; IMAGE; RECOGNITION; DIFFUSION; CLASSIFICATION; DESCRIPTORS; FEATURES; CORRESPONDENCES	Large-scale 3D shape retrieval has become an important research direction in content-based 3D shape retrieval. To promote this research area, two Shape Retrieval Contest (SHREC) tracks on large scale comprehensive and sketch-based 3D model retrieval have been organized by us in 2014. Both tracks were based on a unified large-scale benchmark that supports multimodal queries (3D models and sketches). This benchmark contains 13680 sketches and 8987 3D models, divided into 171 distinct classes. It was compiled to be a superset of existing benchmarks and presents a new challenge to retrieval methods as it comprises generic models as well as domain-specific model types. Twelve and six distinct 3D shape retrieval methods have competed with each other in these two contests, respectively. To measure and compare the performance of the participating and other promising Query-by-Model or Query-by-Sketch 3D shape retrieval methods and to solicit state-of-the-art approaches, we perform a more comprehensive comparison of twenty-six (eighteen originally participating algorithms and eight additional state-of-the-art or new) retrieval methods by evaluating them on the common benchmark. The benchmark, results, and evaluation tools are publicly available at our websites (C) 2014 Elsevier Inc. All rights reserved.	[Li, Bo; Lu, Yijuan; Burtscher, Martin] Texas State Univ, Dept Comp Sci, San Marcos, TX 78666 USA; [Li, Chunyuan; Godil, Afzal] NIST, Informat Technol Lab, Gaithersburg, MD 20899 USA; [Schreck, Tobias] Univ Konstanz, Constance, Germany; [Aono, Masaki; Chowdhury, Nihad Karim; Kosaka, Ryuichi; Tatsuma, Atsushi] Toyohashi Univ Technol, Dept Comp Sci & Engn, Toyohashi, Aichi, Japan; [Burtscher, Martin; Chen, Qiang; Fang, Bin] Chongqing Univ, Coll Comp Sci, Chongqing, Peoples R China; [Fu, Hongbo] City Univ Hong Kong, Sch Creat Media, Hong Kong, Hong Kong, Peoples R China; [Furuya, Takahiko; Ohbuchi, Ryutarou] Univ Yamanashi, Dept Comp Sci & Engn, Yamanashi, Japan; [Li, Haisheng; Wan, Yajuan; Zhang, Chaoli] Beijing Technol & Business Univ, Sch Comp & Informat Engn, Beijing, Peoples R China; [Liu, Jianzhuang] Huawei Technol Co Ltd, Media Lab, Shenzhen, Peoples R China; [Johan, Henry] Fraunhofer IDM NTU, Singapore, Singapore; [Zou, Changqing] Chinese Acad Sci, Shenzhen Inst Adv Technol, Shenzhen, Peoples R China	Li, B (reprint author), Texas State Univ, Dept Comp Sci, 601 Univ Dr, San Marcos, TX 78666 USA.	b_l58@txstate.edu		Ohbuchi, Ryutarou/0000-0002-7605-9135; FU, Hongbo/0000-0002-0284-726X	Texas State University Research Enhancement Program (REP), Army Research Office [W911NF-12-1-0057]; NSF CRI [1305302]; Fraunhofer IDM@NTU; National Research Foundation (NRF)	The work of Bo Li and Yijuan Lu is supported by the Texas State University Research Enhancement Program (REP), Army Research Office grant W911NF-12-1-0057, and NSF CRI 1305302 to Dr. Yijuan Lu.; Henry Johan is supported by Fraunhofer IDM@NTU, which is funded by the National Research Foundation (NRF) and managed through the multi-agency Interactive & Digital Media Programme Office (IDMPO) hosted by the Media Development Authority of Singapore (MDA).	Alcantarilla P.F., 2012, EUR C COMP VIS, V7577, P214; Belongie S, 2002, IEEE T PATTERN ANAL, V24, P509, DOI 10.1109/34.993558; Heikkila M, 2006, LECT NOTES COMPUT SC, V4338, P58; Perronnin F, 2010, PROC CVPR IEEE, P3384, DOI 10.1109/CVPR.2010.5540009; Ohbuchi R, 2008, IEEE INTERNATIONAL CONFERENCE ON SHAPE MODELING AND APPLICATIONS 2008, PROCEEDINGS, P93, DOI 10.1109/SMI.2008.4547955; Reuter M, 2006, COMPUT AIDED DESIGN, V38, P342, DOI 10.1016/j.cad.2005.10.011; Zhou X, 2010, LECT NOTES COMPUT SC, V6315, P141; Bengio Y, 2013, IEEE T PATTERN ANAL, V35, P1798, DOI 10.1109/TPAMI.2013.50; Sun JA, 2009, COMPUT GRAPH FORUM, V28, P1383; Bustos B, 2005, ACM COMPUT SURV, V37, P345, DOI 10.1145/1118890.1118893; Chen DY, 2003, COMPUT GRAPH FORUM, V22, P223, DOI 10.1111/1467-8659.00669; Gong BQ, 2013, IEEE T MULTIMEDIA, V15, P369, DOI 10.1109/TMM.2012.2231059; Laga H, 2008, LECT NOTES ARTIF INT, V4938, P210, DOI 10.1007/978-3-540-78159-2_20; Yang XW, 2009, PROC CVPR IEEE, P357; Daras P, 2010, INT J COMPUT VISION, V89, P229, DOI 10.1007/s11263-009-0277-2; Sanchez J, 2012, PATTERN RECOGN LETT, V33, P2216, DOI 10.1016/j.patrec.2012.07.019; Li B, 2013, MULTIMED TOOLS APPL, V62, P821, DOI 10.1007/s11042-011-0873-3; Iyer N, 2005, COMPUT AIDED DESIGN, V37, P509, DOI 10.1016/j.cad.2004.07.002; Jayanti S, 2006, COMPUT AIDED DESIGN, V38, P939, DOI 10.1016/j.cad.2006.06.007; DeCarlo D, 2003, ACM T GRAPHIC, V22, P848, DOI 10.1145/882262.882354; Berg AC, 2005, PROC CVPR IEEE, P26; Tangelder JH, 2008, MULTIMED TOOLS APPL, V39, P441, DOI 10.1007/s11042-007-0181-0; Coifman RR, 2006, APPL COMPUT HARMON A, V21, P5, DOI 10.1016/j.acha.2006.04.006; Bay H, 2008, COMPUT VIS IMAGE UND, V110, P346, DOI 10.1016/j.cviu.2007.09.014; Carlsson G, 2009, B AM MATH SOC, V46, P255; Papadakis P, 2010, INT J COMPUT VISION, V89, P177, DOI 10.1007/s11263-009-0281-6; Osada R, 2002, ACM T GRAPHIC, V21, P807, DOI 10.1145/571647.571648; Li CY, 2014, MULTIMEDIA SYST, V20, P253, DOI 10.1007/s00530-013-0318-0; Hilaga M, 2001, COMP GRAPH, P203; Barra V, 2013, PATTERN RECOGN, V46, P2985, DOI 10.1016/j.patcog.2013.03.019; Sundar H, 2003, SMI 2003: SHAPE MODELING INTERNATIONAL 2003, PROCEEDINGS, P130; Ankerst M, 1999, LECT NOTES COMPUT SC, V1651, P207; Geurts P, 2006, MACH LEARN, V63, P3, DOI 10.1007/s10994-006-6226-1; Edelsbrunner H, 2002, DISCRETE COMPUT GEOM, V28, P511, DOI 10.1007/s00454-002-2885-2; Gebal K, 2009, COMPUT GRAPH FORUM, V28, P1405; HORN BKP, 1984, P IEEE, V72, P1671, DOI 10.1109/PROC.1984.13073; Jegou H, 2010, PROC CVPR IEEE, P3304, DOI 10.1109/CVPR.2010.5540039; Li PJ, 2013, MULTIMED TOOLS APPL, V65, P335, DOI 10.1007/s11042-012-1000-9; Mikolajczyk K, 2005, IEEE T PATTERN ANAL, V27, P1615, DOI 10.1109/TPAMI.2005.188; Siddiqi K, 2008, MACH VISION APPL, V19, P261, DOI 10.1007/s00138-007-0097-8; Lowe DG, 2004, INT J COMPUT VISION, V60, P91, DOI 10.1023/B:VISI.0000029664.99615.94; Aono M., 2013, PHYS STATUS SOLIDI C, P1; Aubry M., 2011, P COMP METH INN DES, P1626; Axenopoulos A., 2011, P 1 ACM INT C MULT R, P1; Ben-Chen M., 2008, EUR WORKSH 3D OBJ RE, P1; Bezdek J. C., 1981, PATTERN RECOGNITION; Biasotti S, 2007, LECT NOTES COMPUT SC, V4816, P140; Biasotti S, 2013, COMPUT GRAPH FORUM, V32, P13, DOI 10.1111/cgf.12168; Bonaventura X., 2013, COMPUT ANIMAT VIRTUA; Bosch A., 2007, P 6 ACM INT C IM VID, V5, P401; Boyer E., 2011, EUR WORKSH SHAP RETR, V2, P79; Bronstein AM, 2008, MONOGR COMPUT SCI, P1, DOI 10.1007/978-0-387-73301-2_1; Bronstein AM, 2011, ACM T GRAPHIC, V30, DOI 10.1145/1899404.1899405; Bustos B., 2004, IEEE INT C MULT EXP, P1303; Bustos B., 2004, Proceedings. IEEE Sixth International Symposium on Multimedia Software; Chaouch M., 2007, IEEE INT C IM PROC I, V6, P373, DOI DOI 10.1109/ICIP.2007.4379599; Chen C. H., 1998, HDB PATTERN RECOGNIT; Chen J., 2012, J SYST SIMUL, P1777; Chen L., 2011, SPIE C SERIES, V8205; Chen Q., 2014, MULTIMEDIA TOOLS APP; Deng J, 2009, CVPR09; Ding K, 2014, IEEE T MULTIMEDIA, V16, P1369, DOI 10.1109/TMM.2014.2314073; Douze M., 2009, P 8 ACM INT C IM VID; Eitz Mathias, 2012, ACM T GRAPHIC, V31, P31; Eitz Mathias, 2012, ACM T GRAPHIC, V31, P31; Fang R, 2008, LECT NOTES COMPUT SC, V5358, P381; Frome A., 2004, P EUR C COMP VIS ECC; Frosini P., 1992, INTELLIGENT ROBOTS C, P122; Furuya T., 2009, P ACM INT C IM VID R; Furuya T., 2013, CYBERWORLDS 2013, P274; Gao BY, 2009, 2009 INTERNATIONAL CONFERENCE ON ARTIFICIAL INTELLIGENCE AND COMPUTATIONAL INTELLIGENCE, VOL II, PROCEEDINGS, P54, DOI 10.1109/AICI.2009.482; Gao Y., 2010, ACM MULTIMEDIA, P955; Goldfeder Corey, 2008, Joint Conference on Digital Libraries (JCDL 2008), DOI 10.1145/1378889.1378950; Hou S., 2005, COMPUT AIDED DESIGN, V2, P155; Huang K.S., 2005, P CVPR 05 SAN DIEG C, P80; Jia Y., 2013, CAFFE OPEN SOURCE CO; Kassimi M.A., 2011, ABS11116387 CORR; Kazhdan M.M., 2003, S GEOM PROC EUR ASS, V43, P156; KHOTANZAD A, 1990, IEEE T PATTERN ANAL, V12, P489, DOI 10.1109/34.55109; Kortgen M., 2003, P 7 CENTR EUR SEM CO; Laga H, 2013, ACM T GRAPHIC, V32, DOI 10.1145/2516971.2516975; Laga H., 2010, 3DOR, P15; Laga H, 2007, GRAPHITE 2007: 5TH INTERNATIONAL CONFERENCE ON COMPUTER GRAPHICS AND INTERACTIVE TECHNIQUES IN AUSTRALASIA AND SOUTHERN ASIA, PROCEEDINGS, P227; Laga H., 2008, J SOC ART SCI, V7, P124; Leifman G, 2005, VISUAL COMPUT, V21, P865, DOI 10.1007/s00371-005-0341-z; Levy B., 2006, SMI; Li B, 2012, EUR WORKSH 3D OBJ RE, P109; Li B, 2014, COMPUT VIS IMAGE UND, V119, P57, DOI 10.1016/j.cviu.2013.11.008; Li B, 2013, MULTIMED TOOLS APPL, P1; Li B., 2013, EUR C MACH LEARN, P49; Li B., 2014, EUR WORKSH 3D OBJ RE, P121; Li B., 2011, WACV IEEE COMP SOC, P45; Li B., 2013, ICME, P1; Li B., 2013, EUR WORKSH 3D OBJ RE, P89; Li B., 2012, 3DOR, P119; Li C., 2013, INT J MULTIMEDIA INF, V2, P261; Li C., 2013, MOL BASED MATH BIOL, P1; Li CY, 2013, VISUAL COMPUT, V29, P513, DOI 10.1007/s00371-013-0815-3; Li C., 2014, COMPUTER VISION PATT; Li L., 2013, COMP AID DES COMP GR, P172; Lian Zhouhui, 2010, SHAPE MODELING INT, P25; Liu Q., 2012, ABS12083670 CORR; Liu Z., 2014, LECT NOTES COMPUTER, V8326, P116; Liu ZB, 2013, J COMPUT SCI TECH-CH, V28, P836, DOI 10.1007/s11390-013-1382-9; Loop C., 1987, THESIS U UTAH; Lv T., 2013, LECT NOTES COMPUTER, V7923, P757; Maire M., 2008, CVPR IEEE COMP SOC; Ohbuchi R., 2008, MIR 08, P411, DOI DOI 10.1145/1460096.1460163; Ohbuchi R., 2010, P ACM WORKSH 3D OBJ, P63, DOI 10.1145/1877808.1877822; Ohbuchi R., 2010, SQUEEZING BAG OF FEA, P1; Ohbuchi R., 2007, MULTIMEDIA INFORM RE, P31; Osada R., 2001, Proceedings International Conference on Shape Modeling and Applications, DOI 10.1109/SMA.2001.923386; Pan XA, 2011, PATTERN RECOGN LETT, V32, P787, DOI 10.1016/j.patrec.2011.01.003; Papadakis P., 2008, EUR WORKSH 3D OBJ RE, P9; Sfikas K, 2013, VISUAL COMPUT, V29, P1351, DOI 10.1007/s00371-013-0876-3; Shilane P., 2004, SHAPE MODELING INT, P167, DOI DOI 10.1109/SMI.2004.1314504; Sipiran I, 2013, COMPUT GRAPH-UK, V37, P460, DOI 10.1016/j.cag.2013.04.002; Ta AP, 2009, INT WORK CONTENT MUL, P189; Tabia H., 2014, CVPR, P4185; Tatsuma A., 2008, VISUAL COMPUT, V25, P785; Tatsuma A., 2012, P 2012 AS PAC SIGN I; Veltkamp R.C., 2007, UUCS2007015 DEP INF; Vranic D., 2004, THESIS U LEIPZIG; Vranic D.V., 2005, ICME, P962, DOI DOI 10.1109/ICME.2005.1521584; Wang J. J.-Y., 2014, MULTIMED TOOLS APPL, P1, DOI [DOI 10.3109/19401736.2014.961137, 10.3109/19401736.2014.961137]; Wessel R., 2009, 3DOR, P53; Wessel R., 2010, 3DOR, P39; Xu D., 2007, 4 INT C IM GRAPH 200, P774; Yamamoto A, 2008, IEEE INTERNATIONAL CONFERENCE ON SHAPE MODELING AND APPLICATIONS 2008, PROCEEDINGS, P241, DOI 10.1109/SMI.2008.4547987; yang Lv T., 2009, FSKD, P452; Zhang D, 2001, P INT C INT MULT DIS, P1; Zhang H., 2013, ACM MULTIMEDIA, P33; Zhou D., 2004, ADV NEURAL INFORM PR, V16; Zhou D., 2003, LEARNING LOCAL GLOBA; Zou KS, 2014, MULTIMED TOOLS APPL, V69, P799, DOI 10.1007/s11042-012-1130-0	135	5	5	ACADEMIC PRESS INC ELSEVIER SCIENCE	SAN DIEGO	525 B ST, STE 1900, SAN DIEGO, CA 92101-4495 USA	1077-3142	1090-235X		COMPUT VIS IMAGE UND	Comput. Vis. Image Underst.	FEB	2015	131						1	27		10.1016/j.cviu.2014.10.006		27	Computer Science, Artificial Intelligence; Engineering, Electrical & Electronic	Computer Science; Engineering	CB4HN	WOS:000349588900002		
J	Ng, W; Onishi, Y; Inomata, N; Teshima, K; Chan, H; Baba, S; Changtragoon, S; Siregar, I; Szmidt, A				Ng, Wei Lun; Onishi, Yoshitaka; Inomata, Nobuyuki; Teshima, Kosuke M.; Chan, Hung Tuck; Baba, Shigeyuki; Changtragoon, Suchitra; Siregar, Iskandar Z.; Szmidt, Alfred E.			Closely related and sympatric but not all the same: genetic variation of Indo-West Pacific Rhizophora mangroves across the Malay Peninsula	CONSERVATION GENETICS			English	Article						Population structure; Sunda Shelf; Sympatric species; Hybridization; Land barrier; Propagule dispersal	FORSK. VIERH. AVICENNIACEAE; MULTILOCUS GENOTYPE DATA; POPULATION-STRUCTURE; DEMOGRAPHIC HISTORY; SOUTHEAST-ASIA; BRUGUIERA-GYMNORRHIZA; EXCOECARIA-AGALLOCHA; NONMODEL ORGANISMS; DNA POLYMORPHISM; MUTATION-RATES	Members of the mangrove genus Rhizophora represent the most commonly occurring and highly valued species in the Indo-West Pacific region. However, to date, few studies have been directed towards the understanding of their genetic variation. The levels and patterns of genetic variation at chloroplast and nuclear gene regions were studied in R. apiculata, R. mucronata, and R. stylosa sampled from Southeast Asia and Japan. All three species were characterized by low intraspecific genetic variation and a deficiency of heterozygotes in populations within the region, consistent with findings in studies on other mangrove species. Rhizophora mucronata and R. stylosa were also found to be more closely related than any of them with R. apiculata. During the Last Glacial Maximum, sea levels dropped to 120 m below the current levels, exposing part of the Sunda Shelf that became a barrier that limited gene flow between marine species living in the Pacific and Indian Oceans. Today, the Malay Peninsula is thought to still serve as a barrier to gene flow between populations occurring on its coasts. The pattern of genetic differentiation of R. apiculata supports the hypothesis of the land barrier effect of the Malay Peninsula, but such patterns were not found in R. mucronata and R. stylosa. Our findings suggest that R. apiculata, R. mucronata, and R. stylosa have different demographic histories despite being closely related and having sympatric distributions today. Furthermore, all three species appear to have high levels of inbreeding due to limited pollen and propagule dispersal, and that both these factors contributed to population differentiation.	[Ng, Wei Lun; Onishi, Yoshitaka; Inomata, Nobuyuki; Teshima, Kosuke M.; Szmidt, Alfred E.] Kyushu Univ, Grad Sch Syst Life Sci, Fukuoka 812, Japan; [Chan, Hung Tuck; Baba, Shigeyuki] ISME, Okinawa, Japan; [Changtragoon, Suchitra] Forest & Plant Conservat Res Off, Dept Natl Pk Wildlife & Plant Conservat, Forest Genet & Biotechnol Div, Bangkok, Thailand; [Siregar, Iskandar Z.] Bogor Agr Univ IPB, Dept Silviculture, Fac Forestry, Bogor, Indonesia	Szmidt, A (reprint author), Kyushu Univ, Grad Sch Syst Life Sci, Fukuoka 812, Japan.	aszmiscb@kyushu-u.org			Global Environment Research Fund from Ministry of Environment, Japan [D-0901]; Global COE Program, Ministry of Education, Culture, Sports, Science & Technology (MEXT), Japan	We thank Prof. Cecep Kusmana of the Bogor Agricultural University (Indonesia) for assisting with the access to the Rhizophora samples in Indonesia. Dr. Marko Jusup, Dr. Firouzeh Javadi, and anonymous reviewers provided helpful comments and suggestions to an earlier draft of the manuscript. This study was supported in part by the Global Environment Research Fund (D-0901) from the Ministry of Environment, Japan, and the Global COE Program, Ministry of Education, Culture, Sports, Science & Technology (MEXT), Japan.	Maguire TL, 2002, THEOR APPL GENET, V104, P388, DOI 10.1007/s001220100724; Rosenberg NA, 2004, MOL ECOL NOTES, V4, P137, DOI 10.1046/j.1471-8286.2003.00566.x; Duke NC, 2002, TREES-STRUCT FUNCT, V16, P65, DOI 10.1007/s00468-001-0141-7; Guo MM, 2011, AQUAT BOT, V95, P59, DOI 10.1016/j.aquabot.2011.03.001; Fitzpatrick JM, 2011, MOL ECOL, V20, P219, DOI 10.1111/j.1365-294X.2010.04942.x; Giri C, 2008, J BIOGEOGR, V35, P519, DOI 10.1111/j.1365-2699.2007.01806.x; Giri C, 2011, GLOBAL ECOL BIOGEOGR, V20, P154, DOI 10.1111/j.1466-8238.2010.00584.x; Ng WL, 2013, TREE GENET GENOMES, V9, P1151, DOI 10.1007/s11295-013-0619-7; Minobe S, 2010, CONSERV GENET, V11, P301, DOI 10.1007/s10592-009-9806-3; Excoffier L, 2010, MOL ECOL RESOUR, V10, P564, DOI 10.1111/j.1755-0998.2010.02847.x; Pritchard JK, 2000, GENETICS, V155, P945; Duke NC, 1998, GLOBAL ECOL BIOGEOGR, V7, P27, DOI 10.2307/2997695; Wee AKS, 2014, J BIOGEOGR, V41, P954, DOI 10.1111/jbi.12263; Tan FX, 2005, AQUAT BOT, V81, P175, DOI 10.1016/j.aquabot.2004.11.004; Jakobsson M, 2007, BIOINFORMATICS, V23, P1801, DOI 10.1093/bioinformatics/btm233; Lo EYY, 2010, J EVOLUTION BIOL, V23, P2249, DOI 10.1111/j.1420-9101.2010.02087.x; Jian SG, 2010, AQUAT BOT, V92, P23, DOI 10.1016/j.aquabot.2009.09.003; [Anonymous], 2012, CONSERV GENET RESOUR, DOI DOI 10.1007/S12686-011-9548-7; Evanno G, 2005, MOL ECOL, V14, P2611, DOI 10.1111/j.1365-294X.2005.02553.x; Maguire TL, 2000, MOL ECOL, V9, P1853, DOI 10.1046/j.1365-294x.2000.01089.x; Zhang ZH, 2008, AQUAT BOT, V89, P57, DOI 10.1016/j.aquabot.2008.03.002; Ceron-Souza I, 2010, AM J BOT, V97, P945, DOI 10.3732/ajb.0900172; Takayama K, 2013, AM J BOT, V100, P1191, DOI 10.3732/ajb.1200567; TAJIMA F, 1989, GENETICS, V123, P585; Alongi DM, 2008, ESTUAR COAST SHELF S, V76, P1, DOI 10.1016/j.ecss.2007.08.024; Bandelt HJ, 1999, MOL BIOL EVOL, V16, P37; Zhou RC, 2005, MOL PHYLOGENET EVOL, V35, P595, DOI 10.1016/j.ympev.2005.03.012; Valiela I, 2001, BIOSCIENCE, V51, P807, DOI 10.1641/0006-3568(2001)051[0807:MFOOTW]2.0.CO;2; Huang YL, 2008, GENETICA, V133, P47, DOI 10.1007/s10709-007-9182-1; Wang BS, 2014, ECOL EVOL, V4, P2228, DOI 10.1002/ece3.1091; Duke NC, 2007, SCIENCE, V317, P41; Zhou RC, 2011, MOL BIOL EVOL, V28, P2833, DOI 10.1093/molbev/msr102; Arnaud-Haond S, 2006, MOL ECOL, V15, P3515, DOI 10.1111/j.1365-294X.2006.02997.x; Librado P, 2009, BIOINFORMATICS, V25, P1451, DOI 10.1093/bioinformatics/btp187; Inomata N, 2009, GENES GENET SYST, V84, P277; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; Voris HK, 2000, J BIOGEOGR, V27, P1153, DOI 10.1046/j.1365-2699.2000.00489.x; Spielman D, 2004, P NATL ACAD SCI USA, V101, P15261, DOI 10.1073/pnas.0403809101; Falush D, 2003, GENETICS, V164, P1567; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; Crandall ED, 2008, MOL ECOL, V17, P611, DOI 10.1111/j.1365-294X.2007.03600.x; Drexler Judy Z., 2001, Pacific Science, V55, P17, DOI 10.1353/psc.2001.0004; Duke NC, 2006, SPECIES PROFILES PAC; Food and Agricultural Organization (FAO), 2007, WORLDS MANGR 1980 20; Ge Xue-Jun, 2001, Wetlands Ecology and Management, V9, P203; Hamrick J. L., 1992, New Forests, V6, P95, DOI 10.1007/BF00120641; Ishiyama H, 2003, TROPICS, V13, P89, DOI 10.3759/tropics.13.89; Ishiyama H, 2008, CAN J FOREST RES, V38, P996, DOI 10.1139/X07-218; Iwanaga H, 2012, ECOL EVOL, V2, P1663, DOI 10.1002/ece3.284; JUKES T H, 1969, P21; Kathiresan K., 2012, INT J MAR SCI, V2, P70; Klekowski EJ, 1998, GENETICA, V102-3, P325, DOI 10.1023/A:1017026907407; KONDO K, 1987, BIOTROPICA, V19, P377, DOI 10.2307/2388639; Lakshmi M, 2000, GENOME, V43, P110, DOI 10.1139/gen-43-1-110; Lee S. Y., 2002, Wetlands Ecology and Management, V10, P215, DOI 10.1023/A:1020175729972; Liao PC, 2007, CONSERV GENET, V8, P89, DOI 10.1007/s10592-006-9151-8; LOWENFELD R, 1992, INT J PLANT SCI, V153, P394, DOI 10.1086/297043; Nasir HM, 2007, J TROP FOR SCI, V19, P57; Nei M., 1987, MOL EVOLUTIONARY GEN; Ng WL, 2014, AQUAT BOT IN PRESS; Ng WL, 2012, ISME GLOMIS ELECT J, V10, P4; Osti R, 2009, DISASTERS, V33, P203, DOI 10.1111/j.1467-7717.2008.01070.x; Polidoro BA, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010095; RIESEBERG LH, 1991, EVOL TREND PLANT, V5, P65; Salas-Leiva DE, 2009, AQUAT BOT, V91, P187, DOI 10.1016/j.aquabot.2009.06.001; Spalding M., 2010, WORLD ATLAS MANGROVE; Tomlinson P. B., 1986, BOT MANGROVES; Urashi C, 2013, ECOL EVOL, V3, P2251, DOI 10.1002/ece3.624; Wolanski E, 1997, MANGROVES SALT MARSH, V1, P187, DOI 10.1023/A:1009938628639; Yahya AF, 2014, J PLANT RES, V127, P287, DOI 10.1007/s10265-013-0613-z; Zhou RC, 2010, BIOCHEM SYST ECOL, V38, P697, DOI 10.1016/j.bse.2010.04.012; Zhou RC, 2007, MOL BIOL EVOL, V24, P2746, DOI 10.1093/molbev/msm209	72	4	4	SPRINGER	DORDRECHT	VAN GODEWIJCKSTRAAT 30, 3311 GZ DORDRECHT, NETHERLANDS	1566-0621	1572-9737		CONSERV GENET	Conserv. Genet.	FEB	2015	16	1					137	150		10.1007/s10592-014-0647-3		14	Biodiversity Conservation; Genetics & Heredity	Biodiversity & Conservation; Genetics & Heredity	AZ6XF	WOS:000348360700011		
J	Horkan, CM; Purtle, SW; Mendu, ML; Moromizato, T; Gibbons, FK; Christopher, KB				Horkan, Clare M.; Purtle, Steven W.; Mendu, Mallika L.; Moromizato, Takuhiro; Gibbons, Fiona K.; Christopher, Kenneth B.			The Association of Acute Kidney Injury in the Critically III and Postdischarge Outcomes: A Cohort Study	CRITICAL CARE MEDICINE			English	Article						acute kidney injury; critical care; hospital readmission; outcomes; risk; injury; failure; loss of kidney function; and end-stage kidney disease	ACUTE-RENAL-FAILURE; QUALITY-OF-LIFE; INTENSIVE-CARE-UNIT; RANDOMIZED CONTROLLED-TRIAL; ILL PATIENTS; HOSPITAL READMISSION; RIFLE CRITERIA; REPLACEMENT THERAPY; 30-DAY READMISSION; MEDICAL PATIENTS	Objective: Hospital readmissions contribute significantly to the cost of inpatient care and are targeted as a marker for quality of care. Little is known about risk factors associated with hospital readmission in survivors of critical illness. We hypothesized that acute kidney injury in patients who survived critical care would be associated with increased risk of 30-day postdischarge hospital readmission, postdischarge mortality, and progression to end-stage renal disease. Design: Two center observational cohort study. Setting: Medical and surgical ICUs at the Brigham and Women's Hospital and the Massachusetts General Hospital in Boston, Massachusetts. Patients: We studied 62,096 patients, 18 years old and older, who received critical care between 1997 and 2012 and survived hospitalization. Interventions: None Measurements and Main Results: All data was obtained from the Research Patient Data Registry at Partners HealthCare. The exposure of interest was acute kidney injury defined as meeting Risk, Injury, Failure, Loss of kidney function, and End-stage kidney disease Risk, Injury or Failure Criteria occurring 3 days prior to 7 days after critical care initiation. The primary outcome was hospital readmission in the 30 days following hospital discharge. The secondary outcome was mortality in the 30 days following hospital discharge. Adjusted odds ratios were estimated by multivariable logistic regression models with inclusion of covariate terms thought to plausibly interact with both acute kidney injury and readmission status. Adjustment included age, race (white vs nonwhite), gender, Deyo-Charlson Index, patient type (medical vs surgical) and sepsis. Additionally, long-term progression to End Stage Renal Disease in patients with acute kidney injury was analyzed with a risk-adjusted Cox proportional hazards regression model. The absolute risk of 30-day readmission was 12.3%, 19.0%, 21.2%, and 21.1% in patients with No Acute Kidney Injury, Risk, Injury, Failure, Loss of kidney function, and End-stage kidney disease class Risk, Risk, Injury, Failure, Loss of kidney function, and End-stage kidney disease class Injury, and Risk, Injury, Failure, Loss of kidney function, and End-stage kidney disease class Failure, respectively. In patients who received critical care and survived hospitalization, acute kidney injury was a robust predictor of hospital readmission and post-discharge mortality and remained so following multivariable adjustment. The odds of 30-day post-discharge hospital readmission in patients with Risk, Injury, Failure, Loss of kidney function, and End-stage kidney disease class Risk, Injury, or Failure fully adjusted were 1.44 (95% CI, 1.25-1.66), 1.98 (95% CI, 1.66-2.36), and 1.55 (95% CI, 1.26-1.91) respectively, relative to patients without acute kidney injury. Further, the odds of 30-day post-discharge mortality in patients with Risk, Injury, Failure, Loss of kidney function, and End-stage kidney disease class Risk, Injury, or Failure fully adjusted per our primary analysis were 1.39 (95% Cl, 1.28-1.51), 1.46 (95% CI, 1.30-1.64), and 1..42 (95% CI, 1.26-1.61) respectively, relative to patients without acute kidney injury. The addition of the propensity score to the multivariable model did not change the point estimates significantly. Finally, taking into account age, gender, race, Deyo-Charlson Index, and patient type, we observed a relationship between acute kidney injury and development of end-stage renal disease. Patients with Risk, Injury, Failure, Loss of kidney function, and End-stage kidney disease class Risk, Injury, Failure experienced a significantly higher risk of end-stage renal disease during follow-up than patients without acute kidney injury (hazard ratio, 2.03; 95% CI, 1.56-2.65; hazard ratio, 3.99; 95% CI, 3.04-5.23; hazard ratio, 10.40; 950/o CI, 8.54-12.69, respectively). Conclusions: Patients who suffer acute kidney injury are among a high-risk group of ICU survivors for adverse outcomes. In patients treated with critical care who survive hospitalization, acute kidney injury is a robust Predictor of subsequent unplanned hospital readmission. In critical illness survivors, acute kidney injury is also associated with the odds of 30-day postdischarge mortality and the risk of subsequent end-stage renal disease.	[Horkan, Clare M.] Brigham & Womens Hosp, Dept Med, Boston, MA 02115 USA; [Purtle, Steven W.] Univ Colorado, Div Pulm Sci & Crit Care Med, Boulder, CO 80309 USA; [Mendu, Mallika L.] Brigham & Womens Hosp, Div Renal, Boston, MA 02115 USA; [Moromizato, Takuhiro] Hokubu Prefectural Hosp, Dept Med, Okinawa, Okinawa, Japan; [Gibbons, Fiona K.] Massachusetts Gen Hosp, Div Pulm, Boston, MA 02114 USA; [Christopher, Kenneth B.] Brigham & Womens Hosp, Div Renal, Nathan E Hellman Mem Lab, Boston, MA 02115 USA	Christopher, KB (reprint author), Brigham & Womens Hosp, Div Renal, Nathan E Hellman Mem Lab, Boston, MA 02115 USA.	kbchristopher@partners.org					Ahlstrom A, 2005, INTENS CARE MED, V31, P1222, DOI 10.1007/s00134-005-2681-6; KNAUS WA, 1985, CRIT CARE MED, V13, P818, DOI 10.1097/00003246-198510000-00009; Zager S, 2011, CHEST, V139, P1368, DOI 10.1378/chest.10-2594; Bradley EH, 2012, J AM COLL CARDIOL, V60, P607, DOI 10.1016/j.jacc.2012.03.067; Thakar CV, 2012, AM J CARDIOL, V109, P1482, DOI 10.1016/j.amjcard.2012.01.362; Barrantes F, 2008, CRIT CARE MED, V36, P1397, DOI 10.1097/CCM.0b013e318168fbe0; Donze J, 2013, JAMA INTERN MED, V173, P632, DOI 10.1001/jamainternmed.2013.3023; Lo LJ, 2009, KIDNEY INT, V76, P893, DOI 10.1038/ki.2009.289; Coleman EA, 2006, ARCH INTERN MED, V166, P1822, DOI 10.1001/archinte.166.17.1822; Wald R, 2009, JAMA-J AM MED ASSOC, V302, P1179, DOI 10.1001/jama.2009.1322; Amdur RL, 2009, KIDNEY INT, V76, P1089, DOI 10.1038/ki.2009.332; Naylor MD, 2004, J AM GERIATR SOC, V52, P675, DOI 10.1111/j.1532-5415.2004.52202.x; Rosenberg AL, 2000, CHEST, V118, P492, DOI 10.1378/chest.118.2.492; Jencks SF, 2009, NEW ENGL J MED, V360, P1418, DOI 10.1056/NEJMsa0803563; Abosaif NY, 2005, AM J KIDNEY DIS, V46, P1038, DOI 10.1053/j.ajkd.2005.08.033; Coleman EA, 2004, HEALTH SERV RES, V39, P1449, DOI 10.1111/j.1475-6773.2004.00298.x; Jiang HJ, 2005, AM J PUBLIC HEALTH, V95, P1561, DOI 10.2105/AJPH.2004.044222; Kellum JA, 2008, CRIT CARE MED, V36, pS141, DOI 10.1097/CCM.0b013e318168c4a4; Korkeila M, 2000, INTENS CARE MED, V26, P1824, DOI 10.1007/s001340000726; Lone NI, 2013, CRIT CARE MED, V41, P1832, DOI 10.1097/CCM.0b013e31828a409c; Catlin A, 2008, HEALTH AFFAIR, V27, P14, DOI 10.1377/hlthaff.27.1.14; Uchino S, 2006, CRIT CARE MED, V34, P1913, DOI 10.1097/01.CCM.0000224227.70642.4F; Ricci Z, 2008, KIDNEY INT, V73, P538, DOI 10.1038/sj.ki.5002743; Dennen P, 2010, CRIT CARE MED, V38, P261, DOI 10.1097/CCM.0b013e3181bfb0b5; Bagshaw SM, 2009, INTENS CARE MED, V35, P871, DOI 10.1007/s00134-008-1367-2; Oddone EZ, 1996, J GEN INTERN MED, V11, P597, DOI 10.1007/BF02599027; Bagshaw SM, 2008, NEPHROL DIAL TRANSPL, V23, P1203, DOI 10.1093/ndt/gfm744; Bagshaw SM, 2009, NEPHROL DIAL TRANSPL, V24, P2739, DOI 10.1093/ndt/gfp159; Beck DH, 2002, INTENS CARE MED, V28, P1287, DOI 10.1007/s00134-002-1412-5; Wunsch H, 2010, JAMA-J AM MED ASSOC, V303, P849, DOI 10.1001/jama.2010.216; Meduri GU, 2007, CHEST, V131, P954, DOI 10.1373/chest.06-2100; Uchino S, 2004, CRIT CARE MED, V32, P1669, DOI 10.1097/01.CCM.0000132892.51063.2F; Quan HD, 2005, MED CARE, V43, P1130, DOI 10.1097/01.mlr.0000182534.19832.83; Chrusch CA, 2009, CRIT CARE MED, V37, P2753, DOI 10.1097/CCM.0b013e3181a57b0c; Ahlstrom A, 2006, AM J KIDNEY DIS, V48, P262, DOI 10.1053/j.ajkd.2006.04.086; Frost SA, 2009, RESUSCITATION, V80, P505, DOI 10.1016/j.resuscitation.2009.02.015; Braun A, 2011, CRIT CARE MED, V39, P671, DOI 10.1097/CCM.0b013e318206ccdf; Braun AB, 2012, CRIT CARE MED, V40, P3170, DOI 10.1097/CCM.0b013e318260c928; Desai SV, 2011, CRIT CARE MED, V39, P371, DOI 10.1097/CCM.0b013e3181fd66e5; Brown JR, 2014, ANN THORAC SURG, V97, P111, DOI 10.1016/j.athoracsur.2013.07.090; Stefan MS, 2013, J GEN INTERN MED, V28, P377, DOI 10.1007/s11606-012-2229-8; RAPOPORT J, 1992, ARCH INTERN MED, V152, P2207, DOI 10.1001/archinte.152.11.2207; Levey AS, 1999, ANN INTERN MED, V130, P461; FRANKL SE, 1991, AM J MED, V90, P667; Halfon P, 2002, J CLIN EPIDEMIOL, V55, P573, DOI 10.1016/S0895-4356(01)00521-2; D'Agostino RB, 1998, STAT MED, V17, P2265, DOI 10.1002/(SICI)1097-0258(19981015)17:19<2265::AID-SIM918>3.0.CO;2-B; Beier K, 2011, CRIT CARE MED, V39, P305, DOI 10.1097/CCM.0b013e3181ffe22a; Jack BW, 2009, ANN INTERN MED, V150, P178; Koehler BE, 2009, J HOSP MED, V4, P211, DOI 10.1002/jhm.427; Morris DS, 2011, J SURG RES, V170, P297, DOI 10.1016/j.jss.2011.04.049; Linde-Zwirble WT, 2004, CRIT CARE, V8, P222, DOI 10.1186/cc2917; Chawla LS, 2011, KIDNEY INT, V79, P1361, DOI 10.1038/ki.2011.42; Ishani A, 2009, J AM SOC NEPHROL, V20, P223, DOI 10.1681/ASN.2007080837; Morgera S, 2002, AM J KIDNEY DIS, V40, P275, DOI 10.1053/ajkd.2002.34505; Bellomo R, 2004, CRIT CARE, V8, pR204, DOI 10.1186/cc2872; CHARLSON ME, 1987, J CHRON DIS, V40, P373, DOI 10.1016/0021-9681(87)90171-8; Dartmouth Atlas Project PerryUndem Research & Communications, 2013, REV DOOR REP US HOSP; Gammelager H, 2012, CRIT CARE, V16, DOI 10.1186/cc11420; Garzotto F, 2011, BLOOD PURIFICAT, V31, P159, DOI 10.1159/000322161; Gopal I, 1997, INTENS CARE MED, V23, P766, DOI 10.1007/s001340050407; Hamel MB, 1997, ANN INTERN MED, V127, P195; Heggestad T, 2003, INT J QUAL HEALTH C, V15, P147, DOI 10.1093/intqhc/mzg019; Hoste EAJ, 2006, CRIT CARE, V10, DOI 10.1186/cc4915; Landrum Laurie, 2006, Qual Manag Health Care, V15, P83; Leuven E, 2003, PSMATCH2 STATA MODUL; Lone NI, 2012, AM J RESP CRIT CARE, V186, P640, DOI 10.1164/rccm.201201-0059OC; Marcantonio ER, 1999, AM J MED, V107, P13, DOI 10.1016/S0002-9343(99)00159-X; Martin GS, 2003, NEW ENGL J MED, V348, P1546, DOI 10.1056/NEJMoa022139; Maynard SE, 2003, INTENS CARE MED, V29, P1589, DOI 10.1007/s00134-003-1837-5; Medicare Payment Advisory Commission, 2006, HEALTHC SPEND MED PR; Medicare Payment Advisory Commission (MedPAC), 2007, REP C PROM GREAT EFF; Murphy SN, 2002, P AMIA S, V2002, P552; Noble JSC, 2006, RENAL FAILURE, V28, P323, DOI 10.1080/08860220600591487; Quach S, 2009, BMC HEALTH SERV RES, V9, DOI 10.1186/1472-6963-9-129; Rumball-Smith Juliet, 2009, N Z Med J, V122, P63; Silverstein Marc D, 2008, Proc (Bayl Univ Med Cent), V21, P363	76	6	6	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0090-3493	1530-0293		CRIT CARE MED	Crit. Care Med.	FEB	2015	43	2					354	364		10.1097/CCM.0000000000000706		11	Critical Care Medicine	General & Internal Medicine	AZ2YX	WOS:000348096200012		
J	Aifaa, M; Kodama, T; Ohmura, R				Aifaa, Muhammad; Kodama, Takehide; Ohmura, Ryo			Crystal Growth of Clathrate Hydrate in a Flowing Liquid Water System with Methane Gas	CRYSTAL GROWTH & DESIGN			English	Article							MORPHOLOGY; DROPLETS; ETHANE; DECOMPOSITION; SUBSTANCE; CONTACT	This paper reports the visual observation of the growth and formation of clathrate hydrate crystals in a stream of flowing liquid water presaturated with methane gas. The experimental apparatus used in this study was devised by inserting a porous pipe inside the reactor, thereby allowing methane hydrate crystals to form and grow in the liquid water stream. The morphology of methane hydrate crystals grown in a liquid water stream varied depending on the system subcooling temperature, Delta T-sub > Delta T-sub is defined as the difference between the equilibrium temperature of the hydrate, Teq, and the system temperature, T-ex. The crystal growth in the bulk of liquid water was observed when Delta T-sub > 4.5 K. When 4.5 K < Delta T-sub < 9.0 K, polygonal flat plate crystals were observed growing from the porous pipe surface. At 9.0-10.0 K, the crystal morphology enters the transition phase, where the polygonal flat plate crystals started to change into dendritic crystals. When the subcooling temperature, Delta T-sub, is greater than 10.0 K, only dendritic crystals were seen to grow into the liquid water. On the basis of these observations, a continuous supply of the guest substance will enhance the growth of methane hydrate as the particle size of the crystals formed in this study was larger than that of the crystals observed in the previous study.	[Aifaa, Muhammad; Kodama, Takehide; Ohmura, Ryo] Keio Univ, Dept Mech Engn, Yokohama, Kanagawa 2238522, Japan	Ohmura, R (reprint author), Keio Univ, Dept Mech Engn, Kohoku Ku, 3-14-1 Hiyoshi, Yokohama, Kanagawa 2238522, Japan.	rohmura@mech.keio.ac.jp			JKA Foundation; JPS KAKENHI [25289045]	This study was supported by Keirin-Racing-based research promotion funds from the JKA Foundation and by JPS KAKENHI Grant 25289045. We express our gratitude to Mr. K. Matsushita (HBM Co., Hokkaido, Japan) for his help in the experimental work.	Lee JD, 2005, CHEM ENG SCI, V60, P4203, DOI 10.1016/j.ces.2005.03.003; Tanaka R, 2009, CRYST GROWTH DES, V9, P2529, DOI 10.1021/cg9001048; Kvenvolden KA, 1999, P NATL ACAD SCI USA, V96, P3420, DOI 10.1073/pnas.96.7.3420; Katsuki D, 2006, PHILOS MAG, V86, P1753, DOI 10.1080/14786430500509062; Peng BZ, 2007, J PHYS CHEM B, V111, P12485, DOI 10.1021/jp074606m; Ohmura R, 1999, J CRYST GROWTH, V196, P164, DOI 10.1016/S0022-0248(98)00759-3; Servio P, 2002, J CHEM ENG DATA, V47, P87, DOI 10.1021/je0102255; Servio P, 2003, AICHE J, V49, P269, DOI 10.1002/aic.690490125; Ohmura R, 2005, CRYST GROWTH DES, V5, P953, DOI 10.1021/cg049675u; Mao WL, 2004, P NATL ACAD SCI USA, V101, P708, DOI 10.1073/pnas.0307449100; Hammerschmidt EG, 1934, IND ENG CHEM, V26, P851, DOI 10.1021/ie50296a010; Ogawa T, 2006, APPL THERM ENG, V26, P2157, DOI 10.1016/j.applthermaleng.2006.04.003; Ohmura R, 2004, PHILOS MAG, V84, P1, DOI 10.1080/14786430310001623542; Yang SO, 2001, FLUID PHASE EQUILIBR, V185, P53, DOI 10.1016/S0378-3812(01)00456-3; Bruusgaard H, 2009, CRYST GROWTH DES, V9, P3014, DOI 10.1021/cg070568k; Horiguchi K., 2011, P 7 INT C GAS HYDR; Kodama T, 2014, J CHEM TECHNOL BIOT, V89, P1982, DOI 10.1002/jctb.4292; Miller B., 1946, AM GAS ASS MON, V28, P63; Saito K, 2011, CRYST GROWTH DES, V11, P295, DOI 10.1021/cg101310z; Sakemoto R, 2010, CRYST GROWTH DES, V10, P1296, DOI 10.1021/cg901334z; Sloan E.D., 2007, CLATHRATE HYDRATES N; Smelik EA, 1997, AM MINERAL, V82, P88; Takahashi M., 2008, P 6 INT C GAS HYDR; Watanabe S., 2008, P 6 INT C GAS HYDR V; Zatsepina OY, 1998, J GEOPHYS RES-SOL EA, V103, P24127, DOI 10.1029/98JB02137	25	3	3	AMER CHEMICAL SOC	WASHINGTON	1155 16TH ST, NW, WASHINGTON, DC 20036 USA	1528-7483	1528-7505		CRYST GROWTH DES	Cryst. Growth Des.	FEB	2015	15	2					559	563		10.1021/cg500992c		5	Chemistry, Multidisciplinary; Crystallography; Materials Science, Multidisciplinary	Chemistry; Crystallography; Materials Science	CA7ZY	WOS:000349137500007		
J	Tanaka, K; Nasu, T; Miyamoto, Y; Ozaki, N; Tanaka, S; Nagata, T; Hakoe, F; Yoshikiyo, M; Nakagawa, K; Umeta, Y; Imoto, K; Tokoro, H; Namai, A; Ohkoshi, S				Tanaka, Kenji; Nasu, Tomomichi; Miyamoto, Yasuto; Ozaki, Noriaki; Tanaka, Shu; Nagata, Toshiaki; Hakoe, Fumiyoshi; Yoshikiyo, Marie; Nakagawa, Kosuke; Umeta, Yoshikazu; Imoto, Kenta; Tokoro, Hiroko; Namai, Asuka; Ohkoshi, Shin-ichi			Structural Phase Transition between gamma-Ti3O5 and delta-Ti3O5 by Breaking of a One-Dimensionally Conducting Pathway	CRYSTAL GROWTH & DESIGN			English	Article							SEMICONDUCTOR-METAL TRANSITION; CRYSTAL STRUCTURE; SOLAR-CELLS; TI3O5; TEMPERATURE; TI4O7; TI2O3; OXIDE; PHOTOCATALYSIS; DYNAMICS	The phase transition between gamma-trititanium-pentoxide (gamma-Ti3O5) and delta-trititanium-pentoxide (delta-Ti3O5) was clarified from both experimental and theoretical viewpoints. With decreasing temperature, the monoclinic I2/c crystal structure of gamma-Ti3O5 was found to switch to a monoclinic P2/a crystal structure of delta-Ti3O5 due to lowering of symmetry. Electrical conductivity (s) measurement shows that gamma-Ti3O5 behaves like a metallic conductor with a s value of 4.7 S cm(-1) at 320 K, while delta-Ti3O5 shows a semiconductive property with a s value of 2.5 x 10-5 S cm(-1) at 70 K. Optical measurement also supports that gamma-Ti3O5 is a metallic conductor, while delta-Ti3O5 is a semiconductor with a band gap of 0.07 eV. First-principles calculations show that gamma-Ti3O5 is a metallic conductor, and the energy state on the Fermi energy is composed of the 3d orbital of Ti and 2p orbital of O with one-dimensional linkage along the crystallographic c-axis. On the contrary, delta-Ti3O5 has a band gap, and the energy state around the Fermi energy is split into the valence band and the conduction band, which are assigned to the lower and upper Hubbard bands, respectively. Thus, the phase transition between gamma-Ti3O5 and delta-Ti3O5 is caused by breaking of a one-dimensionally conducting pathway due to a Mott-Hubbard metal-insulator phase transition.	[Tanaka, Kenji; Nasu, Tomomichi; Miyamoto, Yasuto; Ozaki, Noriaki; Tanaka, Shu; Nagata, Toshiaki; Hakoe, Fumiyoshi; Yoshikiyo, Marie; Nakagawa, Kosuke; Umeta, Yoshikazu; Imoto, Kenta; Tokoro, Hiroko; Namai, Asuka; Ohkoshi, Shin-ichi] Univ Tokyo, Sch Sci, Dept Chem, Bunkyo Ku, Tokyo 1130033, Japan; [Tokoro, Hiroko] Univ Tsukuba, Fac Pure & Appl Sci, Div Mat Sci, Tsukuba, Ibaraki 3058577, Japan; [Ohkoshi, Shin-ichi] Japan Sci & Technol Agcy JST, CREST, Chiyoda Ku, Tokyo 1020076, Japan	Ohkoshi, S (reprint author), Univ Tokyo, Sch Sci, Dept Chem, Bunkyo Ku, 7-3-1 Hongo, Tokyo 1130033, Japan.	ohkoshi@chem.s.u-tokyo.ac.jp		Nagata, Toshiaki/0000-0002-7127-1487	CREST project of JST; APSA from MEXT; MEXT; JSPS	We are grateful to Mr. K. Chiba of Ryoka Systems Inc. for the valuable advice and discussions. This work was supported by the CREST project of JST, and APSA from MEXT. We also recognize the Cryogenic Research Center, The University of Tokyo, and the Center for Nano Lithography & Analysis, The University of Tokyo, which are supported by MEXT. M.Y. is grateful to the ALPS program. T.N, Y.M., and Y.U. are grateful to the MERIT program. H.T, A.N., and K.N. are thankful to the Grant-in-Aid for Young Scientists (A), (B), and the Research Activity Start-up, respectively, and N.O., S.T, and M.Y. are grateful for a Research Fellowship for Young Scientists of JSPS.	ANDERSSON S, 1956, NATURWISSENSCHAFTEN, V43, P495; Chen JS, 2010, J AM CHEM SOC, V132, P6124, DOI 10.1021/ja100102y; MAREZIO M, 1971, J SOLID STATE CHEM, V3, P340, DOI 10.1016/0022-4596(71)90069-7; Kresse G, 1996, PHYS REV B, V54, P11169, DOI 10.1103/PhysRevB.54.11169; ASBRINK S, 1959, ACTA CRYSTALLOGR, V12, P575, DOI 10.1107/S0365110X59001694; BRAUN JH, 1992, PROG ORG COAT, V20, P105, DOI 10.1016/0033-0655(92)80001-D; LAKKIS S, 1976, PHYS REV B, V14, P1429, DOI 10.1103/PhysRevB.14.1429; Hashimoto K, 2005, JPN J APPL PHYS 1, V44, P8269, DOI 10.1143/JJAP.44.8269; RAO CNR, 1971, J SOLID STATE CHEM, V3, P83, DOI 10.1016/0022-4596(71)90011-9; HOFFMANN MR, 1995, CHEM REV, V95, P69, DOI 10.1021/cr00033a004; Nazeeruddin MK, 2001, J AM CHEM SOC, V123, P1613, DOI 10.1021/ja003299u; Yoon SD, 2006, J PHYS-CONDENS MAT, V18, pL355, DOI 10.1088/0953-8984/18/27/L01; Li HX, 2007, J AM CHEM SOC, V129, P8406, DOI 10.1021/ja072191c; VANZANDT LL, 1968, J APPL PHYS, V39, P594, DOI 10.1063/1.2163536; Poteryaev AI, 2004, PHYS REV LETT, V93, DOI 10.1103/PhysRevLett.93.086401; Izumi F, 2007, SOL ST PHEN, V130, P15; Listorti A, 2011, CHEM MATER, V23, P3381, DOI 10.1021/cm200651e; MORIN FJ, 1959, PHYS REV LETT, V3, P34, DOI 10.1103/PhysRevLett.3.34; RICE CE, 1977, ACTA CRYSTALLOGR B, V33, P1342, DOI 10.1107/S0567740877006062; Yuan ZY, 2004, COLLOID SURFACE A, V241, P173, DOI 10.1016/j.colsurfa.2004.04.030; Ohkoshi S, 2010, NAT CHEM, V2, P539, DOI [10.1038/nchem.670, 10.1038/NCHEM.670]; Asahara A, 2014, PHYS REV B, V90, DOI 10.1103/PhysRevB.90.014303; ASBRINK G, 1971, ACTA CHEM SCAND, V25, P3889, DOI 10.3891/acta.chem.scand.25-3889; ASBRINK S, 1991, PHYS STATUS SOLIDI A, V128, pK77, DOI 10.1002/pssa.2211280235; BARTHOLO.RF, 1969, PHYS REV, V187, P828, DOI 10.1103/PhysRev.187.828; Brunette D.M., 2001, TITANIUM MED; Buxbaum G, 2005, IND INORGANIC PIGMEN; Eyert V, 2004, CHEM PHYS LETT, V390, P151, DOI 10.1016/j.cplett.2004.04.015; HONG SH, 1982, ACTA CHEM SCAND A, V36, P207, DOI 10.3891/acta.chem.scand.36a-0207; KEYS LK, 1967, PHYS REV, V154, P453, DOI 10.1103/PhysRev.154.453; KRESSE G, 1993, PHYS REV B, V48, P13115, DOI 10.1103/PhysRevB.48.13115; Liu R, 2012, MODEL SIMUL MATER SC, V20, DOI 10.1088/0965-0393/20/3/035020; Makiura R, 2011, CHEM-ASIAN J, V6, P1886, DOI 10.1002/asia.201100125; Ogale SB, 2013, FUNCTIONAL METAL OXIDES: NEW SCIENCE AND NOVEL APPLICATIONS, pXV; Onoda M, 1998, J SOLID STATE CHEM, V136, P67, DOI 10.1006/jssc.1997.7657; Wang W., 2011, TITANIUM OXIDE NONVO; Youngblood WJ, 2009, ACCOUNTS CHEM RES, V42, P1966, DOI 10.1021/ar9002398	37	0	0	AMER CHEMICAL SOC	WASHINGTON	1155 16TH ST, NW, WASHINGTON, DC 20036 USA	1528-7483	1528-7505		CRYST GROWTH DES	Cryst. Growth Des.	FEB	2015	15	2					653	657		10.1021/cg5013439		5	Chemistry, Multidisciplinary; Crystallography; Materials Science, Multidisciplinary	Chemistry; Crystallography; Materials Science	CA7ZY	WOS:000349137500019		
J	Sasaki, T; Ida, Y; Yuge, T; Yamamoto, A; Hisaki, I; Tohnai, N; Miyata, M				Sasaki, Toshiyuki; Ida, Yoko; Yuge, Tetsuharu; Yamamoto, Atsushi; Hisaki, Ichiro; Tohnai, Norimitsu; Miyata, Mikiji			Chirality Generation in Supramolecular Clusters: Analogues of Octacoordinated Polyhedrons	CRYSTAL GROWTH & DESIGN			English	Article							HYDROGEN-BOND NETWORKS; CRYSTAL-STRUCTURE; SALTS; CUBE; COORDINATION; COMPLEXES; ACID	Metal-free supramolecular clusters, comprising organic salts of triphenylacetic acid and primary amines, were characterized for the first time as the analogues of octacoordinated polyhedrons with a novel supramolecular chirality in the crystalline state. A ternary system yields triangular dodecahedrons with chiral belts composed of four triphenylmethyl (trityl) groups involving right- or left-handed twist combinations (Delta:Lambda = 4:0 or 0:4). The 12 benzene rings are divided into three layers along a 2-fold axis of symmetry, affording a structure that is similar to a censer (a traditional vessel for fragrance) comprising three parts: a head, body, and foot. A binary system with t-butylammonium or t-amylammonium provides different chiral triangular dodecahedrons, while the system with isobutylammonium provides a trans-bicapped octahedron with a 3-fold rotational axis of symmetry to yield a chiral belt of four trityl groups (Delta:Lambda = 3:1 or 1:3).	[Sasaki, Toshiyuki; Ida, Yoko; Yuge, Tetsuharu; Yamamoto, Atsushi; Hisaki, Ichiro; Tohnai, Norimitsu; Miyata, Mikiji] Osaka Univ, Grad Sch Engn, Dept Mat & Life Sci, Suita, Osaka 5650871, Japan	Sasaki, T (reprint author), Osaka Univ, Grad Sch Engn, Dept Mat & Life Sci, 2-1 Yamadaoka, Suita, Osaka 5650871, Japan.	t.devi.sasaki@gmail.com; miyata@mls.eng.osaka-u.ac.jp			MEXT [24350072, 25288036, 24108723]; JSPS, Japan; GCOE Program of Osaka University; Grants for Excellent Graduate Schools, MEXT, Japan;  [25763]	This work was financially supported by Grant-in-Aid for Scientific Research B (24350072, 25288036) and Grant-in-Aid for Scientific Research on Innovative Areas (24108723) from MEXT and JSPS, Japan. T.S. acknowledges Grant-in-Aid for JSPS Fellows (25763), the GCOE Program of Osaka University and Grants for Excellent Graduate Schools, MEXT, Japan.	Sada K, 2004, CHEM LETT, V33, P160, DOI 10.1246/cl.2004.160; MORSE PM, 1989, J AM CHEM SOC, V111, P4114, DOI 10.1021/ja00193a061; Yamamoto A, 2013, ANGEW CHEM INT EDIT, V52, P1709, DOI 10.1002/anie.201208153; Nakano T, 2001, CHEM REV, V101, P4013, DOI 10.1021/cr0000978; Tsujimoto Y, 2007, NATURE, V450, P1062, DOI 10.1038/nature06382; McDonald S, 1998, J PHYS CHEM A, V102, P2824, DOI 10.1021/jp9803539; Constable EC, 2013, CHEM SOC REV, V42, P1429, DOI 10.1039/c2cs35428d; Liu YZ, 2011, SCIENCE, V333, P436, DOI 10.1126/science.1204369; MacGillivray LR, 1997, NATURE, V389, P469; Sasaki T, 2014, CHEM-EUR J, V20, P2478, DOI 10.1002/chem.201303770; Tohnai N, 2007, ANGEW CHEM INT EDIT, V46, P2220, DOI 10.1002/anie.200603841; Belair S. D., 2003, PHYS REV A, V67; Bond AD, 2003, CHEM COMMUN, P2324, DOI 10.1039/b307400e; Bond AD, 2004, CHEM-EUR J, V10, P1885, DOI 10.1002/chem.200305700; Connelly N.G., 2005, NOMENCLATURE INORGAN; Dang DB, 2008, J CHEM CRYSTALLOGR, V38, P557, DOI 10.1007/s10870-008-9335-9; Glaser R., 1992, ACYCLIC ORGANONITROG, P123; Kobayashi Y, 2004, ORG LETT, V6, P4227, DOI 10.1021/ol0483145; MUETTERT.EL, 1974, J AM CHEM SOC, V96, P1748, DOI 10.1021/ja00813a017; OKAMOTO Y, 1983, CHEM LETT, P1221, DOI 10.1246/cl.1983.1221; Sun ZM, 1998, POLYHEDRON, V17, P1511, DOI 10.1016/S0277-5387(97)00416-6; Ugalde JM, 2000, ANGEW CHEM INT EDIT, V39, P717, DOI 10.1002/(SICI)1521-3773(20000218)39:4<717::AID-ANIE717>3.0.CO;2-E; von Zelewsld A., 1996, STEREOCHEMISTRY COOR; Yuge T, 2007, CHEM-EUR J, V13, P4163, DOI 10.1002/chem.200700099; Yuge T, 2008, CRYSTENGCOMM, V10, P263, DOI 10.1039/b715926a; Yuge T, 2007, CHEM LETT, V36, P1390, DOI 10.1246/cl.2007.1390	26	0	0	AMER CHEMICAL SOC	WASHINGTON	1155 16TH ST, NW, WASHINGTON, DC 20036 USA	1528-7483	1528-7505		CRYST GROWTH DES	Cryst. Growth Des.	FEB	2015	15	2					658	665		10.1021/cg5013445		8	Chemistry, Multidisciplinary; Crystallography; Materials Science, Multidisciplinary	Chemistry; Crystallography; Materials Science	CA7ZY	WOS:000349137500020		
J	Kusumi, R; Kimura, F; Kimura, T				Kusumi, Ryosuke; Kimura, Fumiko; Kimura, Tsunehisa			Determination of P-31 Chemical Shift Tensor from Microcrystalline Powder by Using a Magnetically Oriented Microcrystal Array	CRYSTAL GROWTH & DESIGN			English	Article							PSEUDO-SINGLE-CRYSTAL; ANGLE-SPINNING NMR; SOLID-STATE NMR; CORRELATION SPECTROSCOPY; SHIELDING TENSORS; ANISOTROPY; ACID; DIFFRACTION; FIELD	The P-31 chemical shift tensor for phenylphosphonic acid (PPA) was determined by using a magnetically oriented microcrystal array (MOMA)-a single-crystal-like composite in which microcrystals are aligned three-dimensionally in a polymer matrix-prepared from a microcrystalline powder of PPA. High-resolution P-31 NMR spectra were obtained for a PPA-MOMA without magic angle spinning (MAS), from which the chemical shift anisotropy (CSA) was determined. The single-crystal rotation method was applied to the MOMA to determine the principal axes of the P-31 chemical shift tensor with respect to the crystallographic axes. The present results demonstrate that the MOMA method can provide a powerful means of determining all of the information on P-31 CSA from a microcrystalline powder without MAS.	[Kusumi, Ryosuke; Kimura, Fumiko; Kimura, Tsunehisa] Kyoto Univ, Div Forest & Biomat Sci, Kyoto 6068502, Japan	Kimura, T (reprint author), Kyoto Univ, Div Forest & Biomat Sci, Kyoto 6068502, Japan.	tkimura@kais.kyoto-u.ac.jp					Liu SF, 2002, J MAGN RESON, V155, P15, DOI 10.1006/jmre.2002.2503; Taulelle F, 2013, CRYSTENGCOMM, V15, P8613, DOI 10.1039/c3ce41178h; TYCKO R, 1989, J MAGN RESON, V85, P265, DOI 10.1016/0022-2364(89)90142-X; Brouwer DH, 2005, J AM CHEM SOC, V127, P542, DOI 10.1021/ja043228l; JAMESON CJ, 1990, CHEM PHYS LETT, V167, P575, DOI 10.1016/0009-2614(90)85472-O; Chan JCC, 2003, J CHEM PHYS, V118, P8378, DOI 10.1063/1.1565109; Kimura T, 2006, LANGMUIR, V22, P3464, DOI 10.1021/la053479n; Kimura T, 2005, LANGMUIR, V21, P4805, DOI 10.1021/la050182g; Kimura T, 2009, J APPL CRYSTALLOGR, V42, P535, DOI 10.1107/S0021889809013430; Antzutkin O. N., 1998, J MAGN RESON, V135, P144; CARTER CM, 1987, J MAGN RESON, V73, P114, DOI 10.1016/0022-2364(87)90229-0; Fyfe C. A., 1983, SOLID STATE NMR CHEM, P187; Goldstein H., 2002, CLASSICAL MECH, P4; Grant D. M., 1996, ENCY NUCL MAGNETIC R, P1322; Harper J. K., 2012, ENCY NMR, P472; Harris R. K., 2009, NMR CRYSTALLOGRAPHY, P3; Kimura F, 2010, J APPL CRYSTALLOGR, V43, P151, DOI 10.1107/S0021889809048006; Kimura F, 2011, CRYST GROWTH DES, V11, P12, DOI 10.1021/cg100790r; Kimura F, 2010, CRYST GROWTH DES, V10, P48, DOI 10.1021/cg901321h; Kimura T, 2013, CRYST GROWTH DES, V13, P1815, DOI 10.1021/cg4002225; Kimura T, 2012, JPN J APPL PHYS, V51, DOI 10.1143/JJAP.51.040202; Kusumi R, 2012, J MAGN RESON, V223, P68, DOI 10.1016/j.jmr.2012.08.006; Mahmoudkhani AH, 2002, J MOL STRUCT, V609, P97, DOI 10.1016/S0022-2860(01)00954-1; Ohms G, 1996, PHOSPHORUS SULFUR, V114, P75, DOI 10.1080/10426509608046412; ROHONCZY J, 1991, CHEM PHYS LETT, V180, P23, DOI 10.1016/0009-2614(91)87110-W; Sehnert J, 2007, J MOL STRUC-THEOCHEM, V824, P58, DOI 10.1016/j.theochem.2007.08.029; SHERWOOD MH, 1989, J MAGN RESON, V84, P466, DOI 10.1016/0022-2364(89)90114-5; Song GJ, 2012, JPN J APPL PHYS, V51, DOI 10.1143/JJAP.51.060203; Vasa SK, 2010, PHYS CHEM CHEM PHYS, V12, P4813, DOI 10.1039/b927449a; Weber J, 2012, INORG CHEM, V51, P11466, DOI 10.1021/ic301192y; WELLER T, 1982, Z CHEM, V22, P62	31	1	1	AMER CHEMICAL SOC	WASHINGTON	1155 16TH ST, NW, WASHINGTON, DC 20036 USA	1528-7483	1528-7505		CRYST GROWTH DES	Cryst. Growth Des.	FEB	2015	15	2					718	722		10.1021/cg501483s		5	Chemistry, Multidisciplinary; Crystallography; Materials Science, Multidisciplinary	Chemistry; Crystallography; Materials Science	CA7ZY	WOS:000349137500026		
J	Hayashi, F; Shirasaki, A; Wagata, H; Kamikawa, H; Aoki, Y; Oishi, S; Teshima, K				Hayashi, Fumitaka; Shirasaki, Akemi; Wagata, Hajime; Kamikawa, Hideya; Aoki, Yoshie; Oishi, Shuji; Teshima, Katsuya			Flux-Assisted Fabrication of Vertically Aligned Layered Double Hydroxide Plates on in Situ Formed Alumina Particles	CRYSTAL GROWTH & DESIGN			English	Article							HYDROTALCITE-LIKE COMPOUNDS; ANION-EXCHANGE PROPERTIES; CRYSTALS; GROWTH	Layered double hydroxide (LDH) is an environmentally benign anion exchanger that can adsorb various toxic anions. In this work, we demonstrate the fabrication of plate-like Mg-Al-type LDH crystals on in situ formed alumina particles using a flux method at a relatively low temperature (similar to 350 degrees C). At or below 300 degrees C, the melted Al source crystallized to form AlOOH or gamma-alumina particles in KNO3-NaNO3 flux. However, LDH crystals did not form due to the inferior crystallization properties of the Mg precursor. Increasing the holding temperature up to 350 degrees C and above facilitated crystallization of the dissolved Mg and Al species in flux to yield plate-like LDH crystals on the preformed alumina particles. Top-surface and cross-sectional FE-SEM and EPMA analyses revealed the vertical alignment of the crystalline LDH plates on the surface of the alumina particles. On the other hand, solid-state reactions did not yield these well-grown, plate-like LDH crystals. The TG-DTA profile of the LDH precursors with flux depicted the decomposition and crystallization events that the Al and Mg precursors undergo. On the basis of the results from these characterization studies, we propose a mechanism in which LDH crystals sequentially form on the surface of the alumina particles.	[Hayashi, Fumitaka; Teshima, Katsuya] Shinshu Univ, Ctr Energy & Environm Sci, Nagano 3808553, Japan; [Shirasaki, Akemi; Wagata, Hajime; Oishi, Shuji; Teshima, Katsuya] Shinshu Univ, Dept Environm Sci & Technol, Fac Engn, Nagano 3808553, Japan; [Kamikawa, Hideya] TOCLAS Corp, Technol Dev Ctr, Nishi Ku, Hamamatsu, Shizuoka 4328001, Japan; [Aoki, Yoshie] Nagoya Univ, Grad Sch Engn, Dept Mat Engn, Chikusa Ku, Nagoya, Aichi 4648603, Japan	Teshima, K (reprint author), Shinshu Univ, Ctr Energy & Environm Sci, 4-17-1 Wakasato, Nagano 3808553, Japan.	teshima@shinshu-u.ac.jp	HAYASHI, Fumitaka/I-5366-2014	HAYASHI, Fumitaka/0000-0002-4494-739X	Center of Innovation Program, "Global Aqua Innovation Center for Increasing Water-Sustainability and Improving Living Standards in the World" from Japan Science and Technology Agency, JST	This work was supported by the Center of Innovation Program, "Global Aqua Innovation Center for Increasing Water-Sustainability and Improving Living Standards in the World" from Japan Science and Technology Agency, JST. We are grateful to Mr. Makoto Urano (ESCO, Co., Ltd.) for the TPD experiments.	Teshima K, 2010, CRYST GROWTH DES, V10, P4471, DOI 10.1021/cg100705d; Ogawa M, 2002, LANGMUIR, V18, P4240, DOI 10.1021/la0117045; DREZDZON MA, 1988, INORG CHEM, V27, P4628, DOI 10.1021/ic00298a024; Olfs HW, 2009, APPL CLAY SCI, V43, P459, DOI 10.1016/j.clay.2008.10.009; Oishi S, 2004, J AM CHEM SOC, V126, P4768, DOI 10.1021/ja049678v; Teshima K, 2011, CRYST GROWTH DES, V11, P4401, DOI 10.1021/cg200578r; Morandi S, 2006, SENSOR ACTUAT B-CHEM, V118, P215, DOI 10.1016/j.snb.2006.04.025; Debecker DP, 2009, CHEM-EUR J, V15, P3920, DOI 10.1002/chem.200900060; Newman SP, 1999, J SOLID STATE CHEM, V148, P26, DOI 10.1006/jssc.1999.8330; Abello S, 2005, CHEM COMMUN, P1453, DOI 10.1039/b417322h; Wang Q, 2012, CHEM REV, V112, P4124, DOI 10.1021/cr200434v; Balboul BAA, 2004, THERMOCHIM ACTA, V419, P173, DOI 10.1016/j.tca.2003.12.029; Constantino U, 1998, EUR J INORG CHEM, V1998, P1439; GIANNELIS EP, 1987, INORG CHEM, V26, P203, DOI 10.1021/ic00248a039; Iyi N, 2008, J COLLOID INTERF SCI, V322, P237, DOI 10.1016/j.jcis.2008.02.047; Janz G.J., 1967, MOLTEN SALT HDB; MIYATA S, 1980, CLAY CLAY MINER, V28, P50, DOI 10.1346/CCMN.1980.0280107; MIYATA S, 1983, CLAY CLAY MINER, V31, P305, DOI 10.1346/CCMN.1983.0310409; Shin HS, 1996, WATER SCI TECHNOL, V34, P161, DOI 10.1016/0273-1223(96)00506-9; Tagawa H., 1987, YOKOHAMA KOKURITSU D, V14, P41; Teshima K, 2012, CRYST GROWTH DES, V12, P4890, DOI 10.1021/cg3007469; Teshima K, 2006, CHEM MATER, V18, P3693, DOI 10.1021/cm060672+	22	1	1	AMER CHEMICAL SOC	WASHINGTON	1155 16TH ST, NW, WASHINGTON, DC 20036 USA	1528-7483	1528-7505		CRYST GROWTH DES	Cryst. Growth Des.	FEB	2015	15	2					732	736		10.1021/cg501534f		5	Chemistry, Multidisciplinary; Crystallography; Materials Science, Multidisciplinary	Chemistry; Crystallography; Materials Science	CA7ZY	WOS:000349137500028		
J	Mitarai, M; Kishimoto, M; Suh, D; Ohmura, R				Mitarai, Makoto; Kishimoto, Masatoshi; Suh, Donguk; Ohmura, Ryo			Surfactant Effects on the Crystal Growth of Clathrate Hydrate at the Interface of Water and Hydrophobic-Guest Liquid	CRYSTAL GROWTH & DESIGN			English	Article							UNSTIRRED GAS/LIQUID SYSTEM; MASS-TRANSFER RESISTANCE; SODIUM DODECYL-SULFATE; FILM GROWTH; NATURAL-GAS; METHANE; MORPHOLOGY; OIL	Visual observations of the effect of surfactants on clathrate hydrate crystal growth at the interface of water and cyclopentane has been studied. Surfactants used in the present study are sorbitan monooleate (Span 80), naphthenic acid, and polypropylene glycol. The surfactants were each used at a mass fraction of 0.001% and 0.01%. All the surfactants were soluble in cyclopentane. The crystalline morphology and crystal growth behavior of the hydrate at the interface were found to be substantially affected by the addition of all surfactants. The size of the individual hydrate crystals in the surfactant system was larger than those in the pure cyclopentane system. The observations showed a distinct variation in the behavior of cyclopentane hydrate crystal growth depending on the chemical species of the surfactants, their concentration, and Delta T-sub, which is defined as the difference between the equilibrium temperature and the experimental temperature. For the system with surfactants, the growing hydrate crystals did not engulf the interface, because the crystal grains that have grown detached from the interface and fallen into the water. From the observations, it is clear that hydrate crystal production increased in comparison to systems without surfactants due to the interface area being preserved. These observations explain the physical mechanism of two surfactant effects, where one is the prevention of hydrate agglomeration (interface area preservation) and the other is the promotion of hydrate production.	[Mitarai, Makoto; Kishimoto, Masatoshi; Suh, Donguk; Ohmura, Ryo] Keio Univ, Dept Mech Engn, Kohoku Ku, Yokohama, Kanagawa 2238522, Japan	Ohmura, R (reprint author), Keio Univ, Dept Mech Engn, Kohoku Ku, 3-14-1 Hiyoshi, Yokohama, Kanagawa 2238522, Japan.	rohmura@mech.keio.ac.jp			JKA foundation [26-102]; JSPS KAKENHI [25289045]	This study was supported by Keirin-racing-based research promotion fund from the JKA foundation Grant Number 26-102 and by JSPS KAKENHI Grant Number 25289045.	Aman M. Z., 2013, LANGMUIR, V29, P2676; Aman ZM, 2010, ENERG FUEL, V24, P5441, DOI 10.1021/ef100762r; Lo C, 2010, J PHYS CHEM C, V114, P13385, DOI 10.1021/jp102846d; Karanjkar PU, 2012, CHEM ENG SCI, V68, P481, DOI 10.1016/j.ces.2011.10.014; Tanaka R, 2009, CRYST GROWTH DES, V9, P2529, DOI 10.1021/cg9001048; Karanjkar PU, 2012, CRYST GROWTH DES, V12, P3817, DOI 10.1021/cg300255g; Watanabe K, 2005, CHEM ENG SCI, V60, P4846, DOI 10.1016/j.ces.2005.03.043; Dieker LE, 2009, ENERG FUEL, V23, P5966, DOI 10.1021/ef9006615; Sloan ED, 2003, NATURE, V426, P353, DOI 10.1038/nature02135; Kishimoto M, 2012, ENERGIES, V5, P92, DOI 10.3390/en5010092; Servio P, 2003, AICHE J, V49, P269, DOI 10.1002/aic.690490125; Lim YA, 2013, CRYST GROWTH DES, V13, P2047, DOI 10.1021/cg400118p; Mao WL, 2004, P NATL ACAD SCI USA, V101, P708, DOI 10.1073/pnas.0307449100; Okutani K, 2008, CHEM ENG SCI, V63, P183, DOI 10.1016/j.ces.2007.09.012; Nakajima M, 2008, IND ENG CHEM RES, V47, P8933, DOI 10.1021/ie800949k; Watanabe S, 2011, CRYST GROWTH DES, V11, P3235, DOI 10.1021/cg2005024; Seo YT, 2005, ENVIRON SCI TECHNOL, V39, P2315, DOI 10.1021/es049269z; Ogawa T, 2006, APPL THERM ENG, V26, P2157, DOI 10.1016/j.applthermaleng.2006.04.003; Freer EM, 2001, FLUID PHASE EQUILIBR, V185, P65, DOI 10.1016/S0378-3812(01)00457-5; Taylor CJ, 2007, CHEM ENG SCI, V62, P6524, DOI 10.1016/j.ces.2007.07.038; Sakamoto H, 2011, RSC ADV, V1, P315, DOI 10.1039/c1ra00108f; Saito K, 2010, IND ENG CHEM RES, V49, P7102, DOI 10.1021/ie1000696; Gayet P., 2005, CHEM ENG SCI, V21, P5441; Kelland A. M., 2009, J PETROL SCI ENG, V64, P1; Li X., 2010, ENERG FUEL, V24, P4397; Mori Y. H., 2003, IND ENG CHEM RES, V54, P1; Ogoshi H., 2004, JFE TECH REP, V3, P1; Pietoro D. P., 2007, J FUEL CELL SCI TECH, V4/49; Saito K, 2011, CRYST GROWTH DES, V11, P295, DOI 10.1021/cg101310z; Sakemoto R, 2010, CRYST GROWTH DES, V10, P1296, DOI 10.1021/cg901334z; Sloan ED, 2008, CHEM IND-SER, V119, pXIX; Takahashi M., 2008, P 6 INT C GAS HYDR; Watanabe S, 2008, P 6 INT C GAS HYDR	33	1	1	AMER CHEMICAL SOC	WASHINGTON	1155 16TH ST, NW, WASHINGTON, DC 20036 USA	1528-7483	1528-7505		CRYST GROWTH DES	Cryst. Growth Des.	FEB	2015	15	2					812	821		10.1021/cg501613a		10	Chemistry, Multidisciplinary; Crystallography; Materials Science, Multidisciplinary	Chemistry; Crystallography; Materials Science	CA7ZY	WOS:000349137500037		
J	Bashiruddin, NK; Suga, H				Bashiruddin, Nasir K.; Suga, Hiroaki			Construction and screening of vast libraries of natural product-like macrocyclic peptides using in vitro display technologies	CURRENT OPINION IN CHEMICAL BIOLOGY			English	Review							MESSENGER-RNA DISPLAY; RIBOSOMAL SYNTHESIS; CYCLIC-PEPTIDES; STRUCTURAL BASIS; AMINO ACIDS; TRANSLATION INITIATION; BICYCLIC PEPTIDES; DRUG DISCOVERY; SELECTION; INHIBITORS	Macrocyclic structure and backbone N-methylation represent characteristic features of peptidic natural products, which play critical roles in their biological activity. Although natural products have been the traditional source of such peptides, recent developments in synthesizing natural product-like macrocyclic peptides using reconstituted translation systems have enabled us to construct vast trillion-member libraries of non-standard macrocyclic peptides. In addition, a method for displaying such libraries on their corresponding mRNA templates allows us to rapidly screen them for potent ligands against various drug targets. This review describes methodologies for the ribosomal synthesis of novel natural product-like macrocyclic peptides and their recent applications in the discovery of bioactive molecules using in vitro display technologies.	[Bashiruddin, Nasir K.; Suga, Hiroaki] Univ Tokyo, Dept Chem, Grad Sch Sci, Tokyo 1130033, Japan	Suga, H (reprint author), Univ Tokyo, Dept Chem, Grad Sch Sci, Tokyo 1130033, Japan.	hsuga@chem.s.u-tokyo.ac.jp			Platform for Drug Discovery, Informatics, and Structural Life Science from MEXT, Japan	We thank Dr. Christopher J Hipolito, Prof. Osamu Nureki's group at the University of Tokyo, and Prof. Hiroaki Kato's group at Kyoto University for the collaborations related to this work. This work was supported by the Platform for Drug Discovery, Informatics, and Structural Life Science from MEXT, Japan to HS.	Goto Y, 2009, J AM CHEM SOC, V131, P5040, DOI 10.1021/ja900597d; Passioura T, 2013, CHEM-EUR J, V19, P6530, DOI 10.1002/chem.201300247; Kawakami T, 2013, ACS CHEM BIOL, V8, P1205, DOI 10.1021/cb300697h; Yamagishi Y, 2009, CHEMBIOCHEM, V10, P1469, DOI 10.1002/cbic.200900021; Chatterjee J, 2008, ACCOUNTS CHEM RES, V41, P1331, DOI 10.1021/ar8000603; Rezai T, 2006, J AM CHEM SOC, V128, P2510, DOI 10.1021/ja0563455; Kawakami T, 2009, NAT CHEM BIOL, V5, P888, DOI 10.1038/nchembio.259; Murakami H, 2006, NAT METHODS, V3, P357, DOI 10.1038/NMETH877; Derda R, 2011, MOLECULES, V16, P1776, DOI 10.3390/molecules16021776; Kawakami T, 2008, J AM CHEM SOC, V130, P16861, DOI 10.1021/ja806998v; Schlippe YVG, 2012, J AM CHEM SOC, V134, P10469, DOI 10.1021/ja301017y; Iwasaki K, 2012, ORG BIOMOL CHEM, V10, P5783, DOI 10.1039/c2ob25306b; Yamagishi Y, 2011, CHEM BIOL, V18, P1562, DOI 10.1016/j.chembiol.2011.09.013; Sako Y, 2008, J AM CHEM SOC, V130, P7232, DOI 10.1021/ja800953c; Fischbach MA, 2006, CHEM REV, V106, P3468, DOI 10.1021/cr0503097; Weissman KJ, 2008, CHEMBIOCHEM, V9, P826, DOI 10.1002/cbic.200700751; Millward SW, 2007, ACS CHEM BIOL, V2, P625, DOI 10.1021/cb7001126; Driggers EM, 2008, NAT REV DRUG DISCOV, V7, P608, DOI 10.1038/nrd2590; Kodan A, 2014, P NATL ACAD SCI USA, V111, P4049, DOI 10.1073/pnas.1321562111; Ishizawa T, 2013, J AM CHEM SOC, V135, P5433, DOI 10.1021/ja312579u; Walsh CT, 2008, ACCOUNTS CHEM RES, V41, P4, DOI 10.1021/ar7000414; Goto Y, 2011, NAT PROTOC, V6, P779, DOI 10.1038/nprot.2011.331; Yamagata K, 2014, STRUCTURE, V22, P345, DOI 10.1016/j.str.2013.12.001; Fujino T, 2013, J AM CHEM SOC, V135, P1830, DOI 10.1021/ja309570x; Heinis C, 2009, NAT CHEM BIOL, V5, P502, DOI 10.1038/nchembio.184; Hipolito CJ, 2012, CURR OPIN CHEM BIOL, V16, P196, DOI 10.1016/j.cbpa.2012.02.014; Shimizu Y, 2001, NAT BIOTECHNOL, V19, P751, DOI 10.1038/90802; Craik DJ, 2013, CHEM BIOL DRUG DES, V81, P136, DOI 10.1111/cbdd.12055; Goto Y, 2008, ACS CHEM BIOL, V3, P120, DOI [10.1021/cb700233t, 10.1021/c6700233t]; Kawakami T, 2008, CHEM BIOL, V15, P32, DOI 10.1016/j.chembiol.2007.12.008; Hofmann FT, 2012, J AM CHEM SOC, V134, P8038, DOI 10.1021/ja302082d; Roberts RW, 1997, P NATL ACAD SCI USA, V94, P12297, DOI 10.1073/pnas.94.23.12297; Tanaka Y, 2013, NATURE, V496, P247, DOI 10.1038/nature12014; Morimoto J, 2012, ANGEW CHEM INT EDIT, V51, P3423, DOI 10.1002/anie.201108118; Hayashi Y, 2012, ACS CHEM BIOL, V7, P607, DOI 10.1021/cb200388k; Dinsmore CJ, 2001, J AM CHEM SOC, V123, P2107, DOI 10.1021/ja003673q; Frankel A, 2003, CHEM BIOL, V10, P1043, DOI 10.1016/j.chembiol.2003.11.004; Goto Y, 2008, RNA, V14, P1390, DOI 10.1261/rna.1020708; Goto Y, 2009, CHEM COMMUN, P3419, DOI 10.1039/b904314d; Hipolito CJ, 2013, BIOPOLYMERS, V100, P238; Hipolito CJ, 2013, MOLECULES, V18, P10514, DOI 10.3390/molecules180910514; Ito K, 2013, MOLECULES, V18, P3502, DOI 10.3390/molecules18033502; Kang TJ, 2011, ANGEW CHEM INT EDIT, V50, P2159, DOI 10.1002/anie.201006963; Khan AR, 1998, BIOCHEMISTRY-US, V37, P16839, DOI 10.1021/bi9821364; Millward SW, 2005, J AM CHEM SOC, V127, P14142, DOI 10.1021/ja054373h; Nakajima E, 2009, CHEMBIOCHEM, V10, P1186, DOI 10.1002/cbic.200900058; Ohshiro Y, 2011, CHEMBIOCHEM, V12, P1183, DOI 10.1002/cbic.201100104; Passioura T, 2014, TOP CURR CHEM, V344, P331, DOI 10.1007/128_2013_421; Raffler NA, 2003, CHEM BIOL, V10, P69, DOI 10.1016/S1074-5521(02)00309-5; Sako Y, 2008, ACS CHEM BIOL, V3, P241, DOI 10.1021/cb800010p; Seebeck FP, 2011, CHEM COMMUN, V47, P6141, DOI 10.1039/c0cc05663d; Tian Feng, 2004, J Am Chem Soc, V126, P15962, DOI 10.1021/ja045673m	52	3	3	ELSEVIER SCI LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND	1367-5931	1879-0402		CURR OPIN CHEM BIOL	Curr. Opin. Chem. Biol.	FEB	2015	24						131	138		10.1016/j.cbpa.2014.11.011		8	Biochemistry & Molecular Biology; Biophysics	Biochemistry & Molecular Biology; Biophysics	CB4CB	WOS:000349574700016		
J	Lonborg, C; Yokokawa, T; Herndl, GJ; Alvarez-Salgado, XA				Lonborg, Christian; Yokokawa, Taichi; Herndl, Gerhard J.; Anton Alvarez-Salgado, Xose			Production and degradation of fluorescent dissolved organic matter in surface waters of the eastern north Atlantic ocean	DEEP-SEA RESEARCH PART I-OCEANOGRAPHIC RESEARCH PAPERS			English	Article						Coloured dissolved organic matter; Bioavailability; Absorption and fluorescence spectroscopy; Eastern North Atlantic Ocean	PARALLEL FACTOR-ANALYSIS; COASTAL ENVIRONMENTS; AZORES FRONT; MARINE; CARBON; PHYTOPLANKTON; DOM; SPECTROSCOPY; MASSES; REMINERALIZATION	The distribution and fate of coloured dissolved organic matter (CDOM) in the epipelagic Eastern North Atlantic was investigated during a cruise in the summer 2009 by combining field observations and culture experiments. Dissolved organic carbon (DOC) and nitrogen (DON), the absorption spectra of CDOM and the fluorescence intensity of proteins (Ex/Em 280/320 nm; F(280/320)) and marine humic-like substances (F(320/410)) were measured in the upper 200 m. DOC and DON showed higher concentrations in the top 20 m than below, and DOC increased southwards, while DON decreased. F(280/320) and F(320/410) showed maxima near the deep chlorophyll maximum (at about 50 m), suggesting that these fluorophores were linked to phytoplankton production and the metabolism of the associated microbial community. The coloured and fluorescent fractions of DOM showed low levels south of the Azores Front, at about 35 degrees N, likely due to the accumulated photobleaching of the waters transported eastwards by the Azores current into the study area (at 20 degrees W). Twelve culture experiments were also conducted with surface water (5 m) to assess the impact of microbial degradation processes on the bulk, coloured and fluorescent fractions of DOM. After 72 h of incubation in the darkness, 14 +/- 9% (average +/- SD) of the initial DON was consumed at an average rate of 0.24 +/- 0.14 mu mol l(-1) d(-1) and the protein-like fluorescence decayed by 29 +/- 9% at a net rate of 0.06 +/- 0.03 QSU d(-1). These rates were significantly lower south of the Azores front, suggesting that DOM in this region was of a more recalcitrant nature. Conversely, the marine humic-like fluorescence increased at a net rate of 0.013 +/- 0.003 QSU d(-1). The close linear relationship of DON uptake with F(280/320) consumption (R-2= 0.91, p < 0.0001, n=12) and F(320/410) production (R-2= 0.52, p < 0.008, n=12) that we found during these incubation experiments suggest that the protein-like fluorescence can be used as a proxy for the dynamics of the labile DON pool and that marine humic-like materials can be produced as a by-product of microbial DOM degradation. (C) 2014 Elsevier Ltd. All rights reserved.	[Lonborg, Christian; Anton Alvarez-Salgado, Xose] CSIC, IIM, Vigo 36208, Spain; [Lonborg, Christian] Australian Inst Marine Sci, Townsville, Qld 4810, Australia; [Yokokawa, Taichi] Ehime Univ, Ctr Marine Environm Studies, Matsuyama, Ehime 7908577, Japan; [Herndl, Gerhard J.] Univ Vienna, Dept Limnol & Oceanog, A-1090 Vienna, Austria; [Herndl, Gerhard J.] Royal Netherlands Inst Sea Res NIOZ, Dept Biol Oceanog, NL-1790 AB Den Burg, Netherlands	Lonborg, C (reprint author), Australian Inst Marine Sci, PMB 3, Townsville, Qld 4810, Australia.	clonborg@gmail.com	Alvarez-Salgado, Xose Anton/A-8365-2012		Spanish Ministry of Science and Innovation [CTM2007-66408-C02-01/MAR]; Carlsberg Foundation; Austrian Science Fund project [P23234-B11]	We like to thank the captain and crew of R/V Sarmiento de Gamboa and the technicians of the CSIC Unidad de Tecnologia Marina (UTM) for their help during the CAIBOX cruise. The collaboration of the chief scientist, M. Gilcoto, and the scientific party on board is also acknowledged. V. Vieitez analysed the inorganic nutrient and Mj. Pazo the DOC/TDN samples. This study was funded by the Spanish Ministry of Science and Innovation, grant CTM2007-66408-C02-01/MAR. C.L. was funded by a Postdoctoral fellowship from the Carlsberg Foundation. GM was supported by an Austrian Science Fund project (P23234-B11). We thank 2 anonymous reviewers for their valuable comments on the manuscript.	Jiao N, 2010, NAT REV MICROBIOL, V8, P593, DOI 10.1038/nrmicro2386; Hansell DA, 2009, OCEANOGRAPHY, V22, P202; Alvarez-Salgado XA, 2013, LIMNOL OCEANOGR, V58, P681, DOI 10.4319/lo.2013.58.2.0681; Coble PG, 2007, CHEM REV, V107, P402, DOI 10.1021/cr050350+; Friedline CJ, 2012, BIOGEOSCIENCES, V9, P2177, DOI 10.5194/bg-9-2177-2012; Peliz A, 2005, DEEP-SEA RES PT I, V52, P621, DOI [10.1016/j.dsr.2004.11.005, 10.1016/j.dsar.2004.11.005]; Mendoza WG, 2014, PROG OCEANOGR, V120, P189, DOI 10.1016/j.pocean.2013.08.010; Hansell DA, 2013, ANNU REV MAR SCI, V5, P421, DOI 10.1146/annurev-marine-120710-100757; KIRCHMAN DL, 1991, NATURE, V352, P612, DOI 10.1038/352612a0; Flerus R, 2012, BIOGEOSCIENCES, V9, P1935, DOI 10.5194/bg-9-1935-2012; Tedetti M, 2006, PHOTOCHEM PHOTOBIOL, V82, P389, DOI 10.1562/2005-11-09-IR-733; Romera-Castillo C, 2010, LIMNOL OCEANOGR, V55, P446, DOI 10.4319/lo.2010.55.1.0446; Nieto-Cid M, 2006, LIMNOL OCEANOGR, V51, P1391; Andrew AA, 2013, MAR CHEM, V148, P33, DOI 10.1016/j.marchem.2012.11.001; YENTSCH CS, 1963, DEEP-SEA RES, V10, P221, DOI 10.1016/0011-7471(63)90358-9; Carlson CA, 2010, DEEP-SEA RES PT II, V57, P1433, DOI 10.1016/j.dsr2.2010.02.013; Fichot CG, 2011, GEOPHYS RES LETT, V38, DOI 10.1029/2010GL046152; Letscher RT, 2013, GLOBAL BIOGEOCHEM CY, V27, P141, DOI 10.1029/2012GB004449; Lonborg C, 2013, BIOGEOCHEMISTRY, V116, P231, DOI 10.1007/s10533-013-9853-1; Yamashita Y, 2008, LIMNOL OCEANOGR, V53, P1900, DOI 10.4319/lo.2008.53.5.1900; Yamashita Y, 2003, MAR CHEM, V82, P255, DOI 10.1016/S0304-4203(03)00073-2; Rochelle-Newall EJ, 2002, MAR CHEM, V77, P7, DOI 10.1016/S0304-4203(01)00072-X; Lonborg C, 2014, DEEP-SEA RES PT I, V85, P35, DOI 10.1016/j.dsr.2013.11.002; Helms JR, 2013, MAR CHEM, V155, P81, DOI 10.1016/j.marchem.2013.05.015; Nelson NB, 2013, ANNU REV MAR SCI, V5, P447, DOI 10.1146/annurev-marine-120710-100751; Kowalczuk P, 2013, MAR CHEM, V157, P170, DOI 10.1016/j.marchem.2013.10.004; Yamashita Y, 2004, GEOPHYS RES LETT, V31, DOI 10.1029/2004GL019734; Jorgensen L, 2011, MAR CHEM, V126, P139, DOI 10.1016/j.marchem.2011.05.002; Yamashita Y, 2008, NAT GEOSCI, V1, P579, DOI 10.1038/ngeo279; Coble PG, 1996, MAR CHEM, V51, P325, DOI 10.1016/0304-4203(95)00062-3; Benavides M, 2013, DEEP-SEA RES PT I, V81, P36, DOI 10.1016/j.dsr.2013.07.004; Moran MA, 2000, LIMNOL OCEANOGR, V45, P1254; RIOS AF, 1992, DEEP-SEA RES, V39, P645, DOI 10.1016/0198-0149(92)90093-9; Lonborg C, 2010, MAR CHEM, V119, P121, DOI 10.1016/j.marchem.2010.02.001; Blough N. V., 2002, BIOGEOCHEMISTRY MARI, P509, DOI DOI 10.1016/B978-012323841-2/50012-9; Bronk D. A., 2002, BIOGEOCHEMISTRY MARI, P153, DOI DOI 10.1016/B978-012323841-2/50007-5; Castro CG, 2006, DEEP-SEA RES PT I, V53, P1925, DOI 10.1016/j.dsr.2006.09.002; Coble P.G., 1990, NATURE, V348, P432; Doval MD, 2001, J MARINE SYST, V30, P33, DOI 10.1016/S0924-7963(01)00036-7; Guillemette F., 2012, ENV MICRO, V14, P1432; Hansen HP, 1999, METHODS SEAWATER ANA, P159, DOI DOI 10.1002/9783527613984.CH10; Lakowic J. R., 2006, PRINCIPLES FLUORESCE; Lonborg C., 2012, GLOBAL BIOGEOCHEM CY, P26; Lonborg C, 2009, ESTUAR COAST SHELF S, V82, P682, DOI 10.1016/j.ecss.2009.02.026; MILLARD RC, 1990, DEEP-SEA RES, V37, P167, DOI 10.1016/0198-0149(90)90035-T; Nagata T., 2000, MICROBIAL ECOLOGY OC, V1, P121; Perez FF, 2003, J GEOPHYS RES-OCEANS, V108, DOI 10.1029/2000JC000360; Schlitzer R., 2010, OCEAN DATA VIEW; Sokal F. F., 1995, BIOMETRY; Stedmon C. A., 2011, MICROBIAL CARBON PUM, P62; Yokokawa T, 2012, AQUAT MICROB ECOL, V66, P247, DOI 10.3354/ame01575	51	1	1	PERGAMON-ELSEVIER SCIENCE LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND	0967-0637	1879-0119		DEEP-SEA RES PT I	Deep-Sea Res. Part I-Oceanogr. Res. Pap.	FEB	2015	96						28	37		10.1016/j.dsr.2014.11.001		10	Oceanography	Oceanography	CB3DC	WOS:000349507400003		
J	Sawada, R; Kamei, H; Hakuno, F; Takahashi, SI; Shimizu, T				Sawada, Rie; Kamei, Hiroyasu; Hakuno, Fumihiko; Takahashi, Shin-Ichiro; Shimizu, Toshiaki			In Vivo Loss of Function Study Reveals the short stature homeobox- containing (shox) Gene Plays Indispensable Roles in Early Embryonic Growth and Bone Formation in Zebrafish	DEVELOPMENTAL DYNAMICS			English	Article						Shox; morpholino-based knockdown; Danio rerio; body growth; cartilaginous ossification	IDIOPATHIC SHORT STATURE; LERI-WEILL-SYNDROME; TURNER-SYNDROME; LIMB DEVELOPMENT; PROXIMAL LIMB; EXPRESSION; HAPLOINSUFFICIENCY; ABNORMALITIES; INTERACTS; ENHANCER	Background: Congenital loss of the SHOX gene is considered to be a genetic cause of short stature phenotype in Turner syndrome and Leri-Weill dyschondrosteosis patients. Though SHOX expression initiates during early fetal development, little is known about the embryonic roles of SHOX. The evolutionary conservation of the zebrafish shox gene and the convenience of the early developmental stages for analyses make zebrafish a preferred model. Here, we characterized structure, expression, and developmental roles of zebrafish shox through a loss-of-function approach. Results: We found a previously undiscovered Shox protein that has both a homeodomain and an OAR-domain in zebrafish. The shox transcript emerged during the segmentation period and it increased in later stages. The predominant domains of shox expression were mandibular arch, pectoral fin, anterior notochord, rhombencephalon, and mesencephalon, suggesting that Shox is involved in bone and neural development. Translational blockade of Shox mRNA by an antisense morpholino oligo delayed embryonic growth, which was restored by the co-overexpression of morpholino-resistant Shox mRNA. At later stages, impaired Shox expression markedly delayed the calcification process in the anterior vertebral column and craniofacial bones. Conclusions Our data demonstrate evolutionarily conserved Shox plays roles in early embryonic growth and in later bone formation. Developmental Dynamics 244:146-156, 2015. (c) 2014 Wiley Periodicals, Inc. Key findings	[Sawada, Rie; Shimizu, Toshiaki] Juntendo Univ, Grad Sch Med, Tokyo, Japan; [Sawada, Rie; Kamei, Hiroyasu; Hakuno, Fumihiko; Takahashi, Shin-Ichiro] Univ Tokyo, Grad Sch Agr & Life Sci, Dept Anim Sci, Tokyo 1138657, Japan; [Sawada, Rie; Kamei, Hiroyasu; Hakuno, Fumihiko; Takahashi, Shin-Ichiro] Univ Tokyo, Grad Sch Agr & Life Sci, Dept Appl Biol Chem, Tokyo 1138657, Japan	Kamei, H (reprint author), Univ Tokyo, Dept Anim Sci, Lab Cell Regulat, Bunkyo Ku, 1-1-1 Yayoi, Tokyo 1138657, Japan.	ahkamei@mail.ecc.u-tokyo.ac.jp; atkshin@mail.u-tokyo.ac.jp			Japan Society for the Promotion of Science (JSPS); National Institute of Genetics; Science and Technology Research Promotion Program for Agriculture, Forestry, Fisheries and Food Industry	Grant sponsor: Japan Society for the Promotion of Science (JSPS); Grant sponsor: National Institute of Genetics; Grant sponsor: Science and Technology Research Promotion Program for Agriculture, Forestry, Fisheries and Food Industry.	Aza-Carmona M, 2011, HUM MOL GENET, V20, P1547, DOI 10.1093/hmg/ddr032; Uccelli A, 2008, NAT REV IMMUNOL, V8, P726, DOI 10.1038/nri2395; Clement-Jones M, 2000, HUM MOL GENET, V9, P695, DOI 10.1093/hmg/9.5.695; Cubbage CC, 1996, J MORPHOL, V229, P121, DOI 10.1002/(SICI)1097-4687(199608)229:2<121::AID-JMOR1>3.0.CO;2-4; Kawakami K, 2004, DEV CELL, V7, P133, DOI 10.1016/j.devcel.2004.06.005; Asakawa K, 2008, P NATL ACAD SCI USA, V105, P1255, DOI 10.1073/pnas.0704963105; Rao E, 1997, NAT GENET, V16, P54, DOI 10.1038/ng0597-54; Tiecke E, 2006, DEV BIOL, V298, P585, DOI 10.1016/j.ydbio.2006.07.008; Marchini A, 2004, J BIOL CHEM, V279, P37103, DOI 10.1074/jbc.M307006200; KIMURA M, 1989, GENOME, V31, P24; Walker MB, 2007, BIOTECH HISTOCHEM, V82, P23, DOI 10.1080/10520290701333558; Rao E, 2001, HUM MOL GENET, V10, P3083, DOI 10.1093/hmg/10.26.3083; Puskaric S, 2010, HUM MOL GENET, V19, P4625, DOI 10.1093/hmg/ddq393; Nusslein-Volhard C, 2012, DEVELOPMENT, V139, P4099, DOI 10.1242/dev.085217; Sabherwal N, 2007, HUM MOL GENET, V16, P210, DOI 10.1093/hmg/ddl470; Kamei H, 2011, DEVELOPMENT, V138, P777, DOI 10.1242/dev.056853; Ranke MB, 2001, LANCET, V358, P309, DOI 10.1016/S0140-6736(01)05487-3; Decker E, 2011, HUM MOL GENET, V20, P1524, DOI 10.1093/hmg/ddr030; MULLINS MC, 1994, CURR BIOL, V4, P189, DOI 10.1016/S0960-9822(00)00048-8; Marchini A, 2007, HUM MOL GENET, V16, P3081, DOI 10.1093/hmg/ddm266; Durand C, 2013, NAT REV ENDOCRINOL, V9, P171, DOI 10.1038/nrendo.2012.251; Shears DJ, 1998, NAT GENET, V19, P70, DOI 10.1038/ng0198-70; Beiser KU, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0098543; Bernasconi S, 2001, J ENDOCRINOL INVEST, V24, P737; Blaschke RJ, 1998, P NATL ACAD SCI USA, V95, P2406, DOI 10.1073/pnas.95.5.2406; Bobick BE, 2012, J CELL SCI, V125, P6071, DOI 10.1242/jcs.111997; Durand C, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018115; Fukami M, 2003, EUR J ENDOCRINOL, V149, P337, DOI 10.1530/eje.0.1490337; Glaser A, 2014, DEV DYNAM, V243, P629, DOI 10.1002/dvdy.24104; Gu SP, 2008, MECH DEVELOP, V125, P729, DOI 10.1016/j.mod.2008.04.003; HOOK EB, 1978, NEW ENGL J MED, V299, P1036, DOI 10.1056/NEJM197811092991903; Kamei H, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003091; Kenyon EJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021498; KIMMEL CB, 1995, DEV DYNAM, V203, P253; Kosho T, 1999, J CLIN ENDOCR METAB, V84, P4613, DOI 10.1210/jc.84.12.4613; Marchini Antonio, 2007, Archives of Physiology and Biochemistry, V113, P116, DOI 10.1080/13813450701531201; Munns CJF, 2004, J CLIN ENDOCR METAB, V89, P4130, DOI 10.1210/jc.2003-032230; Ogata T, 2002, J PEDIATR ENDOCR MET, V15, P1439; Rappold G, 2002, J CLIN ENDOCR METAB, V87, P1911; Sabherwal N, 2004, J CELL SCI, V117, P3041, DOI 10.1242/jcs.01152; Stuppia L, 2003, J Med Genet, V40, pE11, DOI 10.1136/jmg.40.2.e11; Thomas NS, 2004, AM J MED GENET A, V128A, P179, DOI 10.1002/ajmg.a.30095; Vickerman L, 2011, DEV BIOL, V350, P323, DOI 10.1016/j.ydbio.2010.11.031; Yu L, 2007, DEV BIOL, V306, P549, DOI 10.1016/j.ydbio.2007.03.518; Yu L, 2005, DEVELOPMENT, V132, P4397, DOI 10.1242/dev.02013	45	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1058-8388	1097-0177		DEV DYNAM	Dev. Dyn.	FEB	2015	244	2					146	156		10.1002/dvdy.24239		11	Anatomy & Morphology; Developmental Biology	Anatomy & Morphology; Developmental Biology	CA4XQ	WOS:000348911100005		
J	Freeman, SD; Keino-Masu, K; Masu, M; Ladher, RK				Freeman, Stephen D.; Keino-Masu, Kazuko; Masu, Masayuki; Ladher, Raj K.			Expression of the Heparan Sulfate 6-O-endosulfatases, Sulf1 and Sulf2, in the Avian and Mammalian Inner Ear Suggests a Role for Sulfation during Inner Ear Development	DEVELOPMENTAL DYNAMICS			English	Article						FGF; hair cell; cochlea	HAIR CELL-DEVELOPMENT; OTIC PLACODE; PROSENSORY PATCHES; SONIC HEDGEHOG; ANIONIC SITES; NOTCH; CHICK; WNT; FATE; COCHLEA	Background: Inner ear morphogenesis is tightly regulated by the temporally and spatially coordinated action of signaling ligands and their receptors. Ligand-receptor interactions are influenced by heparan sulfate proteoglycans (HSPGs), cell surface molecules that consist of glycosaminoglycan chains bound to a protein core. Diversity in the sulfation pattern within glycosaminoglycan chains creates binding sites for numerous cell signaling factors, whose activities and distribution are modified by their association with HSPGs. Results: Here we describe the expression patterns of two extracellular 6-O-endosulfatases, Sulf1 and Sulf2, whose activity modifies the 6-O-sulfation pattern of HSPGs. We use in situ hybridization to determine the temporal and spatial distribution of transcripts during the development of the chick and mouse inner ear. We also use immunocytochemistry to determine the cellular localization of Sulf1 and Sulf2 within the sensory epithelia. Furthermore, we analyze the organ of Corti in Sulf1/Sulf2 double knockout mice and describe an increase in the number of mechanosensory hair cells Conclusions: Our results suggest that the tuning of intracellular signaling, mediated by Sulf activity, plays an important role in the development of the inner ear. Developmental Dynamics 244:168-180, 2015. (c) 2014 Wiley Periodicals, Inc. Key Findings	[Freeman, Stephen D.; Ladher, Raj K.] RIKEN Ctr Dev Biol, Lab Sensory Dev, Chuo Ku, Kobe, Hyogo 6500047, Japan; [Keino-Masu, Kazuko; Masu, Masayuki] Univ Tsukuba, Tsukuba, Ibaraki, Japan	Freeman, SD (reprint author), RIKEN Ctr Dev Biol, Lab Sensory Dev, Chuo Ku, Kobe, Hyogo 6500047, Japan.	stephen@riken.cdb.jp			JSPS	We thank Dr. Cathy Soula for providing the template for synthesis of the cSulf1 riboprobe. A JSPS Post-Doctoral Fellowship for Overseas Researchers funded this work.	Jayasena CS, 2008, DEVELOPMENT, V135, P2251, DOI 10.1242/dev.017905; Freter S, 2008, DEVELOPMENT, V135, P3415, DOI 10.1242/dev.026674; Daudet N, 2007, DEVELOPMENT, V134, P2369, DOI 10.1242/dev.001842; Ohto T, 2002, GENES CELLS, V7, P173, DOI 10.1046/j.1356-9597.2001.00502.x; Ladher RK, 2000, SCIENCE, V290, P1965, DOI 10.1126/science.290.5498.1965; Ai XB, 2003, J CELL BIOL, V162, P341, DOI 10.1083/jcb.200212083; Bernfield M, 1999, ANNU REV BIOCHEM, V68, P729, DOI 10.1146/annurev.biochem.68.1.729; Ai XB, 2006, J BIOL CHEM, V281, P4969, DOI 10.1074/jbc.M511902200; Wang SW, 2004, P NATL ACAD SCI USA, V101, P4833, DOI 10.1073/pnas.0401028101; Morimoto-Tomita M, 2002, J BIOL CHEM, V277, P49175, DOI 10.1074/jbc.M205131200; Ohyama T, 2006, DEVELOPMENT, V133, P865, DOI 10.1242/dev.02271; Ohyama T, 2007, INT J DEV BIOL, V51, P463, DOI 10.1387/ijdb.072320to; Ai XB, 2007, DEVELOPMENT, V134, P3327, DOI 10.1242/dev.007674; Danesin C, 2006, J NEUROSCI, V26, P5037, DOI 10.1523/JNEUROSCI.0715-06.2006; Hayashi T, 2008, J NEUROSCI, V28, P5991, DOI 10.1523/JNEUROSCI.1690-08.2008; Chapman E, 2004, ANGEW CHEM INT EDIT, V43, P3526, DOI 10.1002/anie.200300631; Lin XH, 2004, DEVELOPMENT, V131, P6009, DOI 10.1242/dev.01522; Lanford PJ, 1999, NAT GENET, V21, P289; Chen P, 2002, DEVELOPMENT, V129, P2495; Lai JP, 2004, ONCOGENE, V23, P1439, DOI 10.1038/sj.onc.1207258; Hayashi T, 2007, DEV DYNAM, V236, P525, DOI 10.1002/dvdy.21026; Lindahl U, 1998, J BIOL CHEM, V273, P24979, DOI 10.1074/jbc.273.39.24979; Ornitz DM, 2000, BIOESSAYS, V22, P108, DOI 10.1002/(SICI)1521-1878(200002)22:2<108::AID-BIES2>3.0.CO;2-M; Ratzka A, 2008, DEV DYNAM, V237, P339, DOI 10.1002/dvdy.21423; Groves AK, 2012, DEVELOPMENT, V139, P245, DOI 10.1242/dev.067074; Kusche-Gullberg M, 2003, CURR OPIN STRUC BIOL, V13, P605, DOI 10.1016/j.sbi.2003.08.002; Dhoot GK, 2001, SCIENCE, V293, P1663, DOI 10.1126/science.293.5535.1663; Bermingham NA, 1999, SCIENCE, V284, P1837, DOI 10.1126/science.284.5421.1837; Ledin J, 2004, J BIOL CHEM, V279, P42732, DOI 10.1074/jbc.M405382200; Daudet N, 2005, DEVELOPMENT, V132, P541, DOI 10.1242/dev.01589; Riccomagno MM, 2005, GENE DEV, V19, P1612, DOI 10.1101/gad.1303905; Adam J, 1998, DEVELOPMENT, V125, P4645; GOODYEAR R, 1995, J COMP NEUROL, V351, P81, DOI 10.1002/cne.903510108; Turnbull J, 2001, TRENDS CELL BIOL, V11, P75, DOI 10.1016/S0962-8924(00)01897-3; Pisconti A, 2010, J CELL BIOL, V190, P427, DOI 10.1083/jcb.201003081; Nagamine S, 2012, J BIOL CHEM, V287, P9579, DOI 10.1074/jbc.M111.290262; Freeman SD, 2008, DEV BIOL, V320, P436, DOI 10.1016/j.ydbio.2008.05.554; Bissonnette JP, 1996, J COMP NEUROL, V368, P620, DOI 10.1002/(SICI)1096-9861(19960513)368:4<620::AID-CNE12>3.0.CO;2-L; Braquart-Varnier C, 2004, MOL CELL NEUROSCI, V25, P612, DOI 10.1016/j.mcn.2003.11.013; Chambers D, 2000, MECH DEVELOP, V91, P361, DOI 10.1016/S0925-4773(99)00288-9; Chang WI, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000050; Garcia-Lopez R, 2009, DEV DYNAM, V238, P2418, DOI 10.1002/dvdy.22039; Gorsi B, 2010, DEV DYNAM, V239, P3312, DOI 10.1002/dvdy.22456; Gorsi B, 2014, ANGIOGENESIS, V17, P77, DOI 10.1007/s10456-013-9379-0; Guiral EC, 2010, DEV BIOL, V341, P375, DOI 10.1016/j.ydbio.2010.02.034; Heller S, 1998, P NATL ACAD SCI USA, V95, P11400, DOI 10.1073/pnas.95.19.11400; Kamimura K, 2004, J CELL BIOL, V166, P1069, DOI 10.1083/jcb.200403077; Ladher RK, 2005, GENE DEV, V19, P603, DOI 10.1101/gad.1273605; Meyers JR, 2013, DEV BIOL, V378, P107, DOI 10.1016/j.ydbio.2013.04.002; Nagamine S, 2005, DEV BRAIN RES, V159, P135, DOI 10.1016/j.devbrainres.2005.07.006; Ohta S, 2010, DEV BIOL, V347, P369, DOI 10.1016/j.ydbio.2010.09.002; Ohyama T, 2010, J NEUROSCI, V30, P15044, DOI 10.1523/JNEUROSCI.3547-10.2010; Ono K, 2014, PLOS GENET, V10, DOI 10.1371/journal.pgen.1004118; Pirvola U, 2002, NEURON, V35, P671, DOI 10.1016/S0896-6273(02)00824-3; Ratzka A, 2010, DEV DYNAM, V239, P1779, DOI 10.1002/dvdy.22294; Riccomagno MM, 2002, GENE DEV, V16, P2365, DOI 10.1101/gad.1013302; TORIHARA K, 1994, HEARING RES, V77, P69, DOI 10.1016/0378-5955(94)90253-4; TORIHARA K, 1995, J HISTOCHEM CYTOCHEM, V43, P299; Tsuprun V, 2001, HEARING RES, V157, P65, DOI 10.1016/S0378-5955(01)00278-7; Winterbottom EF, 2009, GENE EXPR PATTERNS, V9, P166, DOI 10.1016/j.gep.2008.11.003	60	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1058-8388	1097-0177		DEV DYNAM	Dev. Dyn.	FEB	2015	244	2					168	180		10.1002/dvdy.24223		13	Anatomy & Morphology; Developmental Biology	Anatomy & Morphology; Developmental Biology	CA4XQ	WOS:000348911100007		
J	Ropert-Coudert, Y; Kato, A; Meyer, X; Pelle, M; MacIntosh, AJJ; Angelier, F; Chastel, O; Widmann, M; Arthur, B; Raymond, B; Raclot, T				Ropert-Coudert, Yan; Kato, Akiko; Meyer, Xavier; Pelle, Marie; MacIntosh, Andrew J. J.; Angelier, Frederic; Chastel, Olivier; Widmann, Michel; Arthur, Ben; Raymond, Ben; Raclot, Thierry			A complete breeding failure in an Adelie penguin colony correlates with unusual and extreme environmental events	ECOGRAPHY			English	Article							ANTARCTICA; POLYNYAS	Among the outcomes of the drastic changes affecting the Earth's ecosystems, nothing is more telling than a complete failure in the reproductive success of a sentinel species: a 'zero' year. Here, we found that unusual environmental conditions in the Terre Adelie sector of Antarctica disrupted the breeding activity of Adelie penguins Pygoscelis adeliae on land - but also their foraging activity at sea - to such a degree that no chicks survived in the 2013/2014 breeding season. Uncommonly heavy precipitation for this normally dry desert killed chicks en masse, while weak katabatic winds maintained a persistent sea ice around the colony, thereby impacting chick provisioning by adults. Extreme events such as this have direct repercussions for the species in question, and may also affect the wider sea-ice dependent food web. Understanding the nature, frequency, and consequences of such events are central to the management and conservation of this remote yet crucial ecosystem.	[Ropert-Coudert, Yan; Kato, Akiko; Meyer, Xavier; Pelle, Marie; Widmann, Michel; Raclot, Thierry] CNRS, FR-67087 Strasbourg, France; [Ropert-Coudert, Yan; Kato, Akiko; Meyer, Xavier; Pelle, Marie; Widmann, Michel; Raclot, Thierry] Univ Strasbourg, UMR7178, IPHC, FR-67087 Strasbourg, France; [MacIntosh, Andrew J. J.] Kyoto Univ, Primate Res Inst, Ctr Int Collaborat & Adv Studies Primatol, Inuyama, Aichi 4848506, Japan; [Angelier, Frederic; Chastel, Olivier] Ctr Etud Biol Chize, FR-79360 Villiers En Bois, France; [Arthur, Ben; Raymond, Ben] Univ Tasmania, Inst Marine & Antarctic Studies, Hobart, Tas 7001, Australia; [Raymond, Ben] Australian Govt, Dept Environm, Australian Antarctic Div, Kingston, Tas 7050, Australia	Ropert-Coudert, Y (reprint author), CNRS, FR-67087 Strasbourg, France.	docyaounde@gmail.com	MacIntosh, Andrew/B-2242-2013	MacIntosh, Andrew/0000-0002-9136-7099	French Polar Inst. (IPEV) [1091, 109]; WWF; zone atelier Antarctique at CNRS	This project was supported by the French Polar Inst. (IPEV, prog. 1091, YR-C, and partly prog. 109, H. Weimerskirch), the WWF and the zone atelier Antarctique at CNRS. The meteorological team of TA64 at Dumont d'Urville, especially D. Lacoste, gave us access to a wealth of data. M. Bruecker, N. Chatelain and F. Crenner at the IPHC customized the GPS devices used in this study. The study was authorized by IPEV and the Terres Australes et Antarctiques Francaises through the Arrete no. 2013-79 from the 29 October 2013.	ADOLPHS U, 1995, ANTARCT SCI, V7, P307; Ainley DG, 2002, ADELIE PENGUIN BELLW; Smith RC, 1999, BIOSCIENCE, V49, P393, DOI 10.2307/1313632; Xavier JC, 2003, IBIS, V145, P593, DOI 10.1046/j.1474-919X.2003.00196.x; Cottin M, 2012, MAR BIOL, V159, P1843, DOI 10.1007/s00227-012-1974-x; Kennicutt MC, 2014, NATURE, V512, P23, DOI 10.1038/512023a; Wilson PR, 2001, MAR ECOL PROG SER, V213, P301, DOI 10.3354/meps213301; Jenouvrier S, 2006, POLAR BIOL, V29, P413, DOI 10.1007/s00300-005-0073-6; Massom RA, 1998, ANN GLACIOL, V27, P420; Dee Boersma P., 2014, PLOS ONE, V9; Duchamp C, 2002, COMP BIOCHEM PHYS A, V131, P765, DOI 10.1016/S1095-6433(02)00014-4; IPCC, 2007, CONTRIBUTION WORKING; Irvine LG, 2000, CCAMLR SCI, V7, P151; Lescroel A, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0085291; Lynch HJ, 2014, AUK, V131, P457, DOI 10.1642/AUK-14-31.1	15	1	1	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0906-7590	1600-0587		ECOGRAPHY	Ecography	FEB	2015	38	2					111	113		10.1111/ecog.01182		3	Biodiversity Conservation; Ecology	Biodiversity & Conservation; Environmental Sciences & Ecology	CB2NC	WOS:000349463400001		
J	Pinkantayong, P; Suzuki, S; Kubo, M; Muramoto, K; Kamata, N				Pinkantayong, Panisara; Suzuki, Satoshi; Kubo, Mamoru; Muramoto, Ken-ichiro; Kamata, Naoto			A hierarchical Bayesian model to estimate the unobservable predation rate on sawfly cocoons by small mammals	ECOLOGY AND EVOLUTION			English	Article						Apodemus argenteus; Apodemus speciosus; cocoon dynamic models; Myodes rufocanus bedfordiae; predation rate estimation	POPULATIONS; HYMENOPTERA; DYNAMICS; FOREST; JAPAN	Predation by small mammals has been reported as an important mortality factor for the cocoons of sawfly species. However, it is difficult to provide an accurate estimate of newly spun cocoons and subsequent predation rates by small mammals for several reasons. First, all larvae do not spin cocoons at the same time. Second, cocoons are exposed to small mammal predation immediately after being spun. Third, the cocoons of the current generation are indistinguishable from those of the previous generation. We developed a hierarchical Bayesian model to estimate these values from annual one-time soil sampling datasets. To apply this model to an actual data set, field surveys were conducted in eight stands of larch plantations in central Hokkaido (Japan) from 2009 to 2012. Ten 0.04-m(2) soil samples were annually collected from each site in mid-October. The abundance of unopened cocoons (I), cocoons emptied by small-mammal predation (M), and empty cocoons caused by something other than small-mammal predation (H) were determined. The abundance of newly spun cocoons, the predation rate by small mammals before and after cocoon sampling, and the annual rate of empty cocoons that remained were estimated. A posterior predictive check yielded Bayesian P-values of 0.54, 0.48, and 0.07 for I, M, and H, respectively. Estimated predation rates showed a significant positive correlation with the number of trap captures of small mammals. Estimates of the number of newly spun cocoons had a significant positive correlation with defoliation intensity. These results indicate that our model showed an acceptable fit, with reasonable estimates. Our model is expected to be widely applicable to all hymenopteran and lepidopteran insects that spin cocoons in soil.	[Pinkantayong, Panisara] Univ Tokyo, Grad Sch Agr & Life Sci, Univ Tokyo Forests, Tokyo, Japan; [Suzuki, Satoshi; Kamata, Naoto] Univ Tokyo, Grad Sch Agr & Life Sci, Univ Tokyo Chichibu Forest, Chichibu, Saitama, Japan; [Kubo, Mamoru] Kanazawa Univ, Grad Sch Nat Sci & Technol, Dept Elect & Comp Engn, Kanazawa, Ishikawa 9201192, Japan; [Muramoto, Ken-ichiro] Ishikawa Natl Coll Technol, Tsubata, Ishikawa, Japan	Pinkantayong, P (reprint author), Univ Tokyo, Grad Sch Agr & Life Sci, Univ Tokyo Forests, Tokyo, Japan.	magibao225@hotmail.com	Kubo, Mamoru/C-3786-2015		Japan Society for the Promotion of Science [20254001, 12934444, 25292084]	Japan Society for the Promotion of Science. Grant Number: 20254001, 12934444, 25292084.	Munch D, 2008, FUNCT ECOL, V22, P407, DOI 10.1111/j.1365-2435.2008.01419.x; HASTINGS WK, 1970, BIOMETRIKA, V57, P97, DOI 10.2307/2334940; Sikes RS, 2011, J MAMMAL, V92, P235, DOI 10.1644/10-MAMM-F-355.1; HANSKI I, 1985, OIKOS, V45, P125, DOI 10.2307/3565230; BUCKNER C. H., 1959, CANADIAN ENT, V91, P275; Buckner C. H., 1956, P 10 INT C ENT GOV C, P353; Conn PB, 2006, ECOL APPL, V16, P829, DOI 10.1890/1051-0761(2006)016[0829:ETAOMP]2.0.CO;2; CRANSHAW W., 2004, GARDEN INSECTS N AM; DAHLSTEN DL, 1967, ECOLOGY, V48, P275, DOI 10.2307/1933111; Gelman A., 2004, BAYESIAN DATA ANAL; Graham SA, 1928, J ECON ENTOMOL, V21, P301; HARDY JOHN ELIOT, 1939, BULL ENT RES, V30, P237; Higashiura Y., 1981, HOPPO RINGYO NO FORE, V33, P180; HOLLING C. S., 1959, CANADIAN ENT, V91, P293; IVES W. G. H., 1959, CANADIAN ENT, V91, P650; IVES WGH, 1976, CAN ENTOMOL, V108, P701; Kamata N, 2002, B ENTOMOL RES, V92, P109, DOI 10.1070/BER2002159; Katovich S. A., 1995, NC179 USDA FOR SERV; Krause SC, 1996, ECOL ENTOMOL, V21, P259, DOI 10.1046/j.1365-2311.1996.00004.x; LEJEUNE R. R., 1955, CANADIAN ENT, V87, P111; LE JEUNE R. R., 1947, CANADIAN ENT, V79, P130; Lynch Ann M., 2012, P126; METROPOLIS N, 1953, J CHEM PHYS, V21, P1087, DOI 10.1063/1.1699114; MORRIS R. F., 1949, CANADIAN ENT, V81, P114; NAIRN L. D., 1962, CANADIAN ENTOMOL, V94, P242; Owari Toshiaki, 2011, Journal of Forestry Research (Harbin), V22, P13, DOI 10.1007/s11676-011-0118-3; Pinkantayong P., 2015, J FOR RES, V20, DOI [10.1007/s10310-10014-10442-10315, DOI 10.1007/S10310-10014-10442-10315]; Plummer M., 2012, CODA OUTPUT ANAL DIA; R Development Core Team, 2013, R LANG ENV STAT COMP; REEKS W. A., 1954, CANADIAN ENT, V86, P471; The University of Tokyo Forest, 2012, MISC INFORM TOKYO U, V51, P67; TURNOCK W. J., 1960, CANADIAN ENT, V92, P500; Wagner MR, 1993, SAWFLY LIFE HIST ADA; Zeileis A., 2013, BETA REGRESSION R PA	34	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	2045-7758			ECOL EVOL	Ecol. Evol.	FEB	2015	5	3					733	742		10.1002/ece3.1394		10	Ecology	Environmental Sciences & Ecology	CB1KK	WOS:000349386000017		
J	Sasaki, N; Maekawa, C; Sato, K				Sasaki, Naoki; Maekawa, Chisaki; Sato, Kae			Alternating current cloud point extraction on a microchip: The effect of electrode geometry	ELECTROPHORESIS			English	Article						AC electrokinetics; Dielectrophoresis; Membrane proteins; Phase separation	AC ELECTROOSMOTIC MICROMIXER; CAPILLARY-ELECTROPHORESIS; ELECTROKINETICS; SYSTEMS; MICROCHANNELS; FLOW	We report on the effect of electrode geometry on alternating current cloud point extraction (ACPE). ACPE is a technique utilized to extract membrane-associated biomolecules in an electrode-integrated microfluidic channel. In this study, we investigated the effect of gap size (4 approximate to 22 m) between microband electrodes on ACPE. A decrease in gap size resulted in efficient and rapid concentration of fluorescent-labeled phospholipids, a model of membrane-associated biomolecules. We also investigated the effect of applied voltage amplitude on ACPE using devices with decreased electrode gap size. When the gap was small, ACPE was achieved with low applied voltages. ACPE of membrane proteins extracted from HeLa cells was also studied to demonstrate the applicability of the ACPE to real samples. The results provide a guideline to improve the performance of ACPE and facilitate application of the ACPE technique as part of an overall analytical process.	[Sasaki, Naoki; Maekawa, Chisaki; Sato, Kae] Japan Womens Univ, Fac Sci, Dept Chem & Biol Sci, Bunkyo Ku, Tokyo 112, Japan	Sasaki, N (reprint author), Toyo Univ, Fac Sci & Engn, Dept Appl Chem, 2100 Kujirai, Kawagoe, Saitama, Japan.	nsasaki@toyo.jp	Sato, Kae/J-4592-2015	Sato, Kae/0000-0002-1618-2086			Mark JJP, 2012, J CHROMATOGR A, V1267, P45, DOI 10.1016/j.chroma.2012.07.009; Lu Y, 2013, ANAL CHEM, V85, P3971, DOI 10.1021/ac4004248; Yuan Q, 2013, BIOMED MICRODEVICES, V15, P125, DOI 10.1007/s10544-012-9694-z; Studer V, 2004, ANALYST, V129, P944, DOI 10.1039/b408382m; Cheng IF, 2013, ANALYST, V138, P4656, DOI 10.1039/c3an00190c; Sasaki N, 2012, ANAL SCI, V28, P3; Ouyang MX, 2013, ANALYST, V138, P3660, DOI 10.1039/c3an00259d; Sasaki N, 2006, LAB CHIP, V6, P550, DOI 10.1039/b515852d; Sasaki N, 2012, ELECTROPHORESIS, V33, P2668, DOI 10.1002/elps.201200099; Kovarik ML, 2013, ANAL CHEM, V85, P451, DOI 10.1021/ac3031543; Silva MF, 2006, MICROCHIM ACTA, V155, P349, DOI 10.1007/s00604-006-0511-3; Carabias-Martinez R, 2000, J CHROMATOGR A, V902, P251, DOI 10.1016/S0021-9673(00)00837-2; Chen JK, 2009, LAB CHIP, V9, P1267, DOI 10.1039/b819547a; Cui HC, 2013, ANALYST, V138, P7188, DOI 10.1039/c3an01112g; Han J, 2004, J CHROMATOGR A, V1049, P205, DOI 10.1016/j.chroma.2004.08.018; Huang SH, 2007, SENSOR ACTUAT B-CHEM, V125, P326, DOI 10.1016/j.snb.2007.01.046; Huang SH, 2010, MICROFLUID NANOFLUID, V8, P187, DOI 10.1007/s10404-009-0453-2; Jie W., 2007, APPL PHYS LETT, V90; Morgan H, 2003, AC ELECTROKINETICS C; Sasaki N, 2012, ELECTROPHORESIS, V33, P3159, DOI 10.1002/elps.201200229; Sasaki N, 2009, LAB CHIP, V9, P1168, DOI 10.1039/b901007f; Sasaki N, 2010, ANAL SCI, V26, P815; Schagger H, 2006, NAT PROTOC, V1, P16, DOI 10.1038/nprot.2006.4; Tani H, 1998, ANAL SCI, V14, P875, DOI 10.2116/analsci.14.875; Vandaveer WR, 2004, ELECTROPHORESIS, V25, P3528, DOI 10.1002/elps.200406115	25	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0173-0835	1522-2683		ELECTROPHORESIS	Electrophoresis	FEB	2015	36	3					424	427		10.1002/elps.201400410		4	Biochemical Research Methods; Chemistry, Analytical	Biochemistry & Molecular Biology; Chemistry	CA9DL	WOS:000349220500009		
J	Yamauchi, M; Yamaguchi, T; Nawata, K; Tanaka, K; Takaoka, S; Sugimoto, T				Yamauchi, Mika; Yamaguchi, Toru; Nawata, Kiyoko; Tanaka, Ken-ichiro; Takaoka, Shin; Sugimoto, Toshitsugu			Increased low-density lipoprotein cholesterol level is associated with non-vertebral fractures in postmenopausal women	ENDOCRINE			English	Article						Low-density lipoprotein cholesterol; Non-vertebral fracture; Osteoporosis; Postmenopausal women; Bone mineral density; Dislipidemia; Hypercholesterolemia; Vitamin D	BONE-MINERAL DENSITY; VITAMIN-D STATUS; SERUM 25-HYDROXYVITAMIN D; ALL-CAUSE MORTALITY; CARDIOVASCULAR-DISEASE; RISK-FACTORS; ARTERIAL CALCIFICATION; PARATHYROID-HORMONE; METABOLIC SYNDROME; OXIDIZED LIPIDS	Although a high serum low-density lipoprotein cholesterol (LDL-C) level is an established risk factor for atherosclerosis, it is unclear whether it is associated with osteoporosis. In this study, the associations between the serum LDL-C level and bone mineral density (BMD), bone metabolic markers, and the presence of prevalent vertebral or non-vertebral fractures were examined. A total of 211 healthy postmenopausal women (age range, 46-80 years) who visited a community health center were recruited consecutively. Their radiographic and biochemical characteristics were collected. Prevalent vertebral and non-vertebral fractures were found in 49 (23.2 %) and 36 (17.1 %) subjects, respectively. Simple regression analyses showed that the serum LDL-C level was not significantly correlated with lumbar or femoral BMD or serum levels of total amino-terminal propeptide of type I collagen (PINP) or carboxy-terminal telopeptide of type I collagen (CTX). Logistic regression analyses adjusted for age and BMI showed that the increased serum LDL-C level was selected as an index affecting the presence of prevalent non-vertebral fractures, but not vertebral fractures. This result was still significant after additional adjustments for years since menopause, physical activity, previous cardiovascular events, bone markers, BMD, serum Ca, P, Cr, 25(OH)D, grip strength, tandem gait test, and use of drugs for hyperlipidemia [odds ratio 1.76 (1.13-2.73), p = 0.012]. These findings suggest that a high serum LDL-C level may be a risk factor for prevalent non-vertebral fragility fractures independent of bone turnover, bone mass, vitamin D insufficiency, or frail status in postmenopausal women, and that it may be detrimental to bone, as well as blood vessels.	[Yamauchi, Mika; Yamaguchi, Toru; Nawata, Kiyoko; Tanaka, Ken-ichiro; Takaoka, Shin; Sugimoto, Toshitsugu] Shimane Univ, Fac Med, Izumo, Shimane 6938501, Japan; [Nawata, Kiyoko] Shimane Univ, Izumo, Shimane 6938501, Japan	Yamauchi, M (reprint author), Shimane Univ, Fac Med, 89-1 Enya Cho, Izumo, Shimane 6938501, Japan.	yamauchi@med.shimane-u.ac.jp			Ministry of Education, Culture, Sports, Science, and Technology of Japan [23590882]	This work was supported in part by Grants-in-Aid Scientific Research (C) No. 23590882 (to M. Yamauchi) from the Ministry of Education, Culture, Sports, Science, and Technology of Japan.	Trimpou P, 2011, OSTEOPOROSIS INT, V22, P1615, DOI 10.1007/s00198-010-1367-2; Parhami F, 2001, J BONE MINER RES, V16, P182, DOI 10.1359/jbmr.2001.16.1.182; Vestergaard P, 2007, OSTEOPOROSIS INT, V18, P427, DOI 10.1007/s00198-006-0253-4; Ensrud KE, 2007, ARCH INTERN MED, V167, P133, DOI 10.1001/archinte.167.2.133; Mani A, 2007, SCIENCE, V315, P1278, DOI 10.1126/science.1136370; Cauley JA, 2008, ANN INTERN MED, V149, P242; Skaaby T, 2013, ENDOCRINE, V43, P618, DOI 10.1007/s12020-012-9805-x; Lewiecki EM, 2006, J CLIN ENDOCR METAB, V91, P4215, DOI 10.1210/jc.2006-1178; Fuerst T, 2009, OSTEOPOROSIS INT, V20, P1199, DOI 10.1007/s00198-008-0806-9; Tanko LB, 2005, J BONE MINER RES, V20, P1912, DOI 10.1359/JBMR.050711; Kuroo M, 1997, NATURE, V390, P45, DOI 10.1038/36285; Tamai K, 2000, NATURE, V407, P530; Bauer DC, 2004, ARCH INTERN MED, V164, P146, DOI 10.1001/archinte.164.2.146; Saliba W, 2012, J CLIN ENDOCR METAB, V97, P2792, DOI 10.1210/jc.2012-1747; Farhat GN, 2006, J BONE MINER RES, V21, P1839, DOI 10.1359/JBMR.060903; Pennisi P, 2004, OSTEOPOROSIS INT, V15, P389, DOI 10.1007/s00198-003-1550-9; Janghorbani M, 2007, AM J EPIDEMIOL, V166, P495, DOI 10.1093/aje/kwm106; Garnero P, 2007, BONE, V40, P716, DOI 10.1016/j.bone.2006.09.026; Li LH, 2013, ENDOCRINE, V44, P465, DOI 10.1007/s12020-013-9885-2; Hsu YH, 2006, AM J CLIN NUTR, V83, P146; Gagnon C, 2012, J CLIN ENDOCR METAB, V97, P1953, DOI 10.1210/jc.2011-3187; Tintut Y, 2002, J BIOL CHEM, V277, P14221, DOI 10.1074/jbc.M11551200; GENANT HK, 1993, J BONE MINER RES, V8, P1137; Schulz E, 2004, J CLIN ENDOCR METAB, V89, P4246, DOI 10.1210/jc.2003-030964; Silva HC, 2013, BONE, V52, P562, DOI 10.1016/j.bone.2012.11.004; Bucay N, 1998, GENE DEV, V12, P1260, DOI 10.1101/gad.12.9.1260; Baron R, 2006, CURR TOP DEV BIOL, V76, P103, DOI 10.1016/S0070-2153(06)76004-5; Tanko LB, 2003, CALCIFIED TISSUE INT, V73, P15, DOI 10.1007/s00223-002-2070-x; Leu M, 2011, BEST PRACT RES CL EN, V25, P633, DOI 10.1016/j.beem.2011.04.001; Esposito K, 2013, ENDOCRINE, V44, P326, DOI 10.1007/s12020-013-9924-z; Bagger YZ, 2006, J INTERN MED, V259, P598, DOI 10.1111/j.1365-2796.2006.01640.x; Parhami F, 1999, J BONE MINER RES, V14, P2067, DOI 10.1359/jbmr.1999.14.12.2067; Schmidt-Gayk H, 2004, CLIN CHEM LAB MED, V42, P90, DOI 10.1515/CCLM.2004.017; Mattila C, 2007, DIABETES CARE, V30, P2569, DOI 10.2337/dc07-0292; Leino A, 2008, CLIN CHEM, V54, P2059, DOI 10.1373/clinchem.2008.111732; Ponda MP, 2012, CIRCULATION, V126, P270, DOI 10.1161/CIRCULATIONAHA.111.077875; Bagger YZ, 2007, OSTEOPOROSIS INT, V18, P505, DOI 10.1007/s00198-006-0255-2; Chung JY, 2013, NUTR RES PRACT, V7, P495, DOI 10.4162/nrp.2013.7.6.495; Cui LH, 2005, OSTEOPOROSIS INT, V16, P1975, DOI 10.1007/s00198-005-1977-2; Delmas PD, 2003, BONE, V33, P522, DOI 10.1016/S8756-3282(03)00241-2; Parhami F, 1997, CURR OPIN LIPIDOL, V8, P312, DOI 10.1097/00041433-199710000-00010; Dukas L, 2005, OSTEOPOROSIS INT, V16, P1683, DOI 10.1007/s00198-005-1903-7; FRIEDEWA.WT, 1972, CLIN CHEM, V18, P499; Garnero P, 2008, CLIN CHEM, V54, P188, DOI 10.1373/clinchem.2007.094953; Huang MS, 2008, J BONE MINER RES, V23, P1672, DOI [10.1359/jbmr.080513, 10.1359/JBMR.080513]; Jeong IK, 2010, CALCIFIED TISSUE INT, V87, P507, DOI 10.1007/s00223-010-9427-3; Majima T, 2008, ENDOCR J, V55, P143, DOI 10.1507/endocrj.K07E-004; Nakaoka D, 2000, J CLIN ENDOCR METAB, V85, P1901, DOI 10.1210/jc.85.5.1901; Pinheiro MM, 2006, J GERONTOL A-BIOL, V61, P196; Sage AP, 2011, J BONE MINER RES, V26, P1197, DOI 10.1002/jbmr.312; Sarkis KS, 2012, LIPIDS HEALTH DIS, V11, DOI 10.1186/1476-511X-11-37; Sivas F, 2009, RHEUMATOL INT, V29, P885, DOI 10.1007/s00296-008-0784-4; Solomon Daniel H, 2005, Am J Med, V118, P1414; Yamaguchi T, 2002, ENDOCR J, V49, P211, DOI 10.1507/endocrj.49.211; Yamauchi M, 2011, CALCIFIED TISSUE INT, V88, P362, DOI 10.1007/s00223-011-9464-6	55	1	1	HUMANA PRESS INC	TOTOWA	999 RIVERVIEW DRIVE SUITE 208, TOTOWA, NJ 07512 USA	1355-008X	1559-0100		ENDOCRINE	Endocrine	FEB	2015	48	1					279	286		10.1007/s12020-014-0292-0		8	Endocrinology & Metabolism	Endocrinology & Metabolism	CB0RQ	WOS:000349334800039		
J	Tamura, T; Kurishima, K; Watanabe, H; Nakazawa, K; Ishikawa, H; Satoh, H; Hizawa, N				Tamura, T.; Kurishima, K.; Watanabe, H.; Nakazawa, K.; Ishikawa, H.; Satoh, H.; Hizawa, N.			Stage IV non-small cell lung cancer patients aged 75 years and older	EUROPEAN GERIATRIC MEDICINE			English	Article						Non-small-cell lung cancer; Elderly; Treatment; Survival	ELDERLY-PATIENTS; PHASE-III; RANDOMIZED-TRIAL; CHEMOTHERAPY; CARBOPLATIN; COMORBIDITY; COMBINATION; MONOTHERAPY; MANAGEMENT; CISPLATIN	Objectives: The purpose of this study is to examine clinical and pathological features and chemotherapy in the elderly with metastatic non-small cell lung cancer (NSCLC), especially in patients aged 75 years and older. Methods: From the databases at two teaching hospitals during the period from January 1999 to December 2013, medical records of lung cancer patients were retrospectively reviewed. The patient population was divided into two age groups: 75 years or older (the >= 75 age group) and less than 75 years (the < 75 age group). Time trends were also studied in three time periods: 1999-2003, 2004-2008, and 2009-2013. The years 2004 and 2009 were chosen as cutoff points because of the introduction of gefitinib and bevacizumab, respectively around these years to treat NSCLC patients. Results: Patients aged 75 years and older comprised 27.3% of 772 consecutive stage IV NSCLC patients; there was an increase in the proportion of >= 75 age patients treated with chemotherapy; a trend of improvement in survival of these patients was found. No statistical difference was found in survival between the two age groups of patients treated with chemotherapy (P = 0.883). Age >= 75 was not an unfavorable prognostic factor in multivariate analysis. Conclusion: In order to improve survival, detection of appropriate candidates for effective chemotherapy is indeed essential even for the >= 75 age group of stage IV NSCLC patients. (C) 2014 Elsevier Masson SAS and European Union Geriatric Medicine Society. All rights reserved.	[Tamura, T.; Watanabe, H.; Nakazawa, K.; Hizawa, N.] Univ Tsukuba, Fac Med, Div Resp Med, Mito, Ibaraki 3100015, Japan; [Kurishima, K.; Ishikawa, H.] Tsukuba Med Ctr, Div Resp Med, Tsukuba, Ibaraki, Japan; [Satoh, H.] Univ Tsukuba, Mito Med Ctr, Div Resp Med, Mito, Ibaraki 3100015, Japan	Satoh, H (reprint author), Univ Tsukuba, Mito Med Ctr, Div Resp Med, Miya Machi 3-2-7, Mito, Ibaraki 3100015, Japan.	hirosato@md.tsukuba.ac.jp					Lilenbaum RC, 2005, J CLIN ONCOL, V23, P190, DOI 10.1200/JCO.2005.07.172; Finlayson E, 2007, J AM COLL SURGEONS, V205, P729, DOI 10.1016/j.jamcollsurg.2007.06.307; Asmis TR, 2008, J CLIN ONCOL, V26, P54, DOI 10.1200/JCO.2007.12.8322; PETO R, 1972, J R STAT SOC SER A-G, V135, P185, DOI 10.2307/2344317; Gridelli C, 2003, J NATL CANCER I, V95, P362; Blanchard EM, 2011, J THORAC ONCOL, V6, P115, DOI 10.1097/JTO.0b013e3181fbebfd; Belani CP, 2005, CANCER, V104, P2766, DOI 10.1002/cncr.21495; Ebi N, 2008, J THORAC ONCOL, V3, P1166, DOI 10.1097/JTO.0b013e318186a88d; Detterbeck FC, 2013, CHEST, V143, pE191, DOI 10.1378/chest.12-2354; Langer CJ, 2002, J NATL CANCER I, V94, P173; Chrischilles EA, 2010, J CLIN ONCOL, V28, P620, DOI 10.1200/JCO.2009.23.8485; Owonikoko TK, 2007, J CLIN ONCOL, V25, P5570, DOI 10.1200/JCO.2007.12.5435; Quoix E, 2011, LANCET, V378, P1079, DOI 10.1016/S0140-6736(11)60780-0; Ansari RH, 2011, CRIT REV ONCOL HEMAT, V78, P162, DOI 10.1016/j.critrevonc.2010.03.003; Breen D, 2007, CLIN LUNG CANCER, V8, P331, DOI 10.3816/CLC.2007.n.013; Dy SM, 2006, CRIT REV ONCOL HEMAT, V59, P218, DOI 10.1016/j.critrevonc.2006.04.001; Ganti AK, 2012, J NATL COMPR CANC NE, V10, P230; Hurria A, 2003, CA-CANCER J CLIN, V53, P325; Kagohashi Katsunori, 2009, Tuberk Toraks, V57, P192; KAPLAN EL, 1958, J AM STAT ASSOC, V53, P457, DOI 10.2307/2281868; Kuo CW, 2000, CHEST, V117, P354, DOI 10.1378/chest.117.2.354; Kurishima K, 2001, ONCOL REP, V8, P63; Kurishima K, 2001, ONCOL REP, V8, P1251; Satoh H, 2009, LUNG CANCER, V65, P112, DOI 10.1016/j.lungcan.2008.10.020; The Elderly Lung Cancer Vinorelbine Italian Study Group, 1999, JNCI-J NATL CANCER I, V91, P66; van der Drift MA, 2012, J THORAC ONCOL, V7, P291, DOI 10.1097/JTO.0b013e31823a01fb; White HK, 2006, MED CLIN N AM, V90, P967, DOI 10.1016/j.mcna.2006.05.017; World Health Organizations, 1999, INT HISTOLOGICAL CLA	28	0	0	ELSEVIER MASSON	MILANO	VIA PALEOCAPA 7, 20121 MILANO, ITALY	1878-7649	1878-7657		EUR GERIATR MED	Eur. Geriatr. Med.	FEB	2015	6	1					31	35		10.1016/j.eurger.2014.10.008		5	Geriatrics & Gerontology	Geriatrics & Gerontology	CA9BE	WOS:000349214500007		
J	Yoshino, H; Kawakami, K; Watanabe, T; Yoshino, G; Kohriyama, K				Yoshino, H.; Kawakami, K.; Watanabe, T.; Yoshino, G.; Kohriyama, K.			A case of insulin autoimmune syndrome in an elder patient	EUROPEAN GERIATRIC MEDICINE			English	Letter							HYPOGLYCEMIA		[Yoshino, H.; Kawakami, K.; Watanabe, T.; Yoshino, G.] Shin Suma Gen Hosp, Ctr Diabet, Kobe, Hyogo, Japan; [Kohriyama, K.] Shin Suma Gen Hosp, Dept Internal Med, Kobe, Hyogo, Japan	Yoshino, H (reprint author), Shin Suma Gen Hosp, Ctr Diabet, Kobe, Hyogo, Japan.	hgmdktree2236@yahoo.co.jp					TAYLOR SI, 1989, ENDOCRIN METAB CLIN, V18, P123; Redmon JB, 1999, ENDOCRIN METAB CLIN, V28, P603, DOI 10.1016/S0889-8529(05)70090-6; HIRATA Y, 1972, TOHOKU J EXP MED, V107, P277; FOLLING I, 1972, DIABETES, V21, P814; Hirata Y, 1970, J JAP DIABETIC SOC, V13, P312; Kondou S, 2013, J JAPAN DIAB SOC, V56, P227; Nasu T, 2011, INTERNAL MED, V50, P339, DOI 10.2169/internalmedicine.50.4145; Uchigata Y, 1999, ANN MED INTERNE, V150, P245	8	0	0	ELSEVIER MASSON	MILANO	VIA PALEOCAPA 7, 20121 MILANO, ITALY	1878-7649	1878-7657		EUR GERIATR MED	Eur. Geriatr. Med.	FEB	2015	6	1					85	86		10.1016/j.eurger.2014.04.009		2	Geriatrics & Gerontology	Geriatrics & Gerontology	CA9BE	WOS:000349214500021		
